PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, L; Xu, XH; Cao, YQ; Li, ZW; Cheng, H; Zhu, GY; Duan, FY; Na, J; Han, JDJ; Chen, YG				Wang, Lu; Xu, Xuanhao; Cao, Yaqiang; Li, Zhongwei; Cheng, Hao; Zhu, Gaoyang; Duan, Fuyu; Na, Jie; Han, Jing-Dong J.; Chen, Ye-Guang			Activin/Smad2-induced Histone H3 Lys-27 Trimethylation (H3K27me3) Reduction Is Crucial to Initiate Mesendoderm Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ENDODERM DIFFERENTIATION; DEMETHYLASE JMJD3; MOUSE DEVELOPMENT; DNA METHYLATION; SELF-RENEWAL; TARGET GENES; IN-VITRO; HUMAN ES; TRANSCRIPTION	Differentiation of human embryonic stem cells into mesendoderm (ME) is directed by extrinsic signals and intrinsic epigenetic modifications. However, the dynamics of these epigenetic modifications and the mechanisms by which extrinsic signals regulate the epigenetic modifications during the initiation of ME differentiation remain elusive. In this study, we report that levels of histone H3 Lys-27 trimethylation (H3K27me3) decrease during ME initiation, which is essential for subsequent differentiation induced by the combined effects of activin and Wnt signaling. Furthermore, we demonstrate that activin mediates the H3K27me3 decrease via the Smad2-mediated reduction of EZH2 protein level. Our results suggest a two-step process of ME initiation: first, epigenetic priming via removal of H3K27me3 marks and, second, transcription activation. Our findings demonstrate a critical role of H3K27me3 priming and a direct interaction between extrinsic signals and epigenetic modifications during ME initiation.	[Wang, Lu; Xu, Xuanhao; Li, Zhongwei; Zhu, Gaoyang; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Cao, Yaqiang; Cheng, Hao; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Partner Inst Computat, Key Lab Computat Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Duan, Fuyu; Na, Jie] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Zhongwei] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Tsinghua University; Salk Institute	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Na, Jie/U-4518-2019; Chen, Ye-Guang/L-6998-2019; Cao, Yaqiang/ABC-3753-2021; Na, Jie/N-3522-2018	Na, Jie/0000-0003-1820-0548; Cao, Yaqiang/0000-0002-4665-1517; Na, Jie/0000-0003-1820-0548; Duan, Fuyu/0000-0001-5628-5226	National Natural Science Foundation of China [91519310, 31330049]; 973 Program Grant [2013CB933700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program Grant(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 91519310 and 31330049 and 973 Program Grant 2013CB933700 (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Auerbach RK, 2013, BIOINFORMATICS, V29, P1922, DOI 10.1093/bioinformatics/btt316; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Estaras C, 2015, MOL CELL, V58, P780, DOI 10.1016/j.molcel.2015.04.001; FAUST C, 1995, DEVELOPMENT, V121, P273; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Howard TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026791; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Kartikasari AER, 2013, EMBO J, V32, P1393, DOI 10.1038/emboj.2013.78; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pethe P, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-18; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang L, 2016, J MOL BIOL, V428, P1409, DOI 10.1016/j.jmb.2015.06.013; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yoon SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7546; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	54	21	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1339	1350		10.1074/jbc.M116.766949	http://dx.doi.org/10.1074/jbc.M116.766949			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27965357	hybrid, Green Published			2022-12-26	WOS:000393339800016
J	Dunoyer-Geindre, S; Rivier-Cordey, AS; Caetano, C; Fish, RJ; Kruithof, EKO				Dunoyer-Geindre, Sylvie; Rivier-Cordey, Anne-Sophie; Caetano, Carlos; Fish, Richard J.; Kruithof, Egbert K. O.			Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CPG METHYLATION; IN-VIVO; T-PA; PROMOTER; IDENTIFICATION; BINDING; PROTEIN; STIMULATION; GENERATION	Expression of the tissue-type plasminogen activator gene (t-PA; gene name PLAT) is regulated, in part, by epigenetic mechanisms. We investigated the relationship between PLAT methylation and PLAT expression in five primary human cell types and six transformed cell lines. CpG methylation was analyzed in the proximal PLAT gene promoter and near the multihormone responsive enhancer (MHRE) -7.3 kilobase pairs upstream of the PLAT transcriptional start site (TSS,-7.3 kb). In Bowes melanoma cells, the PLAT promoter and the MHRE were fully unmethylated and t-PA secretion was extremely high. In other cell types the region from-647 to-366 was fully methylated, whereas an unmethylated stretch of DNA from -121 to + 94 was required but not sufficient for detectable t-PA mRNA and t-PA secretion. DNA methylation near the MHRE was not correlated with t-PA secretion. Specific methylation of the PLAT promoter region -151 to +151, inserted into a firefly luciferase reporter gene, abolished reporter gene activity. The region -121 to +94 contains two well-described regulatory elements, a PMA-responsive element (CRE) near-106 and a GC-rich region containing an Sp1 binding site near +59. Methylation of double-stranded DNA oligonucleotides containing the CRE or the GC-rich region had little or no effect on transcription factor binding. Methylated CpGs may attract co-repressor complexes that contain histone deacetylases (HDAC). However, reporter gene activity of methylated plasmids was not restored by the HDAC inhibitor trichostatin. In conclusion, efficient PLAT gene expression requires a short stretch of unmethylated CpG sites in the proximal promoter.	[Dunoyer-Geindre, Sylvie; Rivier-Cordey, Anne-Sophie; Caetano, Carlos; Kruithof, Egbert K. O.] Univ Geneva, Univ Med Ctr, Div Angiol & Hemostasis, Geneva, Switzerland; [Fish, Richard J.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, Geneva, Switzerland	University of Geneva; University of Geneva	Dunoyer-Geindre, S (corresponding author), Univ Geneva, Univ Med Ctr, Div Angiol & Hemostasis, Geneva, Switzerland.	Sylvie.Geindre@unige.ch	Kruithof, Egbert/AGR-4755-2022		Swiss National Science Foundation [320000-118125, 310030-133099, 31003A - 149269]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.SNF.ch) grants nos. 320000-118125, 310030-133099 and 31003A - 149269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMANT M, 1995, J IMMUNOL, V155, P4868; Arts J, 1997, NUCLEIC ACIDS RES, V25, P311, DOI 10.1093/nar/25.2.311; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; BULENS F, 1995, J BIOL CHEM, V270, P7167, DOI 10.1074/jbc.270.13.7167; Bulens F, 1997, J BIOL CHEM, V272, P663; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Collen D, 2009, ARTERIOSCL THROM VAS, V29, P1151, DOI 10.1161/ATVBAHA.108.179655; Costa M, 2000, FEBS LETT, V482, P75, DOI 10.1016/S0014-5793(00)02030-5; Costa M, 1998, EUR J BIOCHEM, V258, P123, DOI 10.1046/j.1432-1327.1998.2580123.x; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; dos Santos JM, 2015, METABOLISM, V64, P1619, DOI 10.1016/j.metabol.2015.09.013; Dunoyer-Geindre S, 2001, THROMB HAEMOSTASIS, V85, P903; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; FISHER R, 1985, J BIOL CHEM, V260, P1223; Gao S, 2005, THROMB HAEMOSTASIS, V94, P651, DOI 10.1160/TH05-02-0114; GILES AR, 1990, THROMB HAEMOSTASIS, V63, P476; HENDERSON BR, 1992, FEBS LETT, V309, P130, DOI 10.1016/0014-5793(92)81080-6; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; Kruithof EKO, 2014, THROMB HAEMOSTASIS, V112, P243, DOI 10.1160/TH13-06-0517; Kruithof EKO, 1997, THROMB HAEMOSTASIS, V77, P905; Kwak SH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.7; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; LAUG WE, 1992, INT J CANCER, V52, P298, DOI 10.1002/ijc.2910520224; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; Magnusson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141805; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Olsson M, 2016, GENE REGUL SYST BIO, V10, P9, DOI 10.4137/GRSB.S30241; Ortolano S, 2013, RECENT PATENTS ENDOC, V7, P65, DOI 10.2174/187221413804660962; Pan W, 2008, J THROMB HAEMOST, V6, P976, DOI 10.1111/j.1538-7836.2008.02977.x; Pawlak R, 2002, J CLIN INVEST, V109, P1529, DOI 10.1172/JCI200215961; Pham NL, 2004, ARTERIOSCL THROM VAS, V24, P982, DOI 10.1161/01.ATV.0000126679.70877.d0; Riviere G, 2011, EPIGENETICS-US, V6, P479, DOI 10.4161/epi.6.4.14961; Ronn T, 2015, EPIGENOMICS-UK, V7, P451, DOI 10.2217/epi.15.7; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Svennerholm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097260; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Wolffe AP, 2000, BIOCHEM SOC T, V28, P379, DOI 10.1042/0300-5127:0280379; Xu SB, 2009, J CANCER RES CLIN, V135, P1791, DOI 10.1007/s00432-009-0627-z; Xu XG, 2015, ONCOTARGET, V6, P13925, DOI 10.18632/oncotarget.4215; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006	56	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167588	10.1371/journal.pone.0167588	http://dx.doi.org/10.1371/journal.pone.0167588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973546	gold, Green Submitted, Green Published			2022-12-26	WOS:000392754300034
J	Puig, MS; Pallares, JM; Zapata, LP; Puigcerver, L; Canete, J; Super, H				Sole Puig, Maria; Marco Pallares, Josep; Perez Zapata, Laura; Puigcerver, Laura; Canete, Josep; Super, Hans			Attentional Selection Accompanied by Eye Vergence as Revealed by Event-Related Brain Potentials	PLOS ONE			English	Article							SUPERIOR COLLICULUS; NEURAL MECHANISMS; MOVEMENTS; DYNAMICS; CONVERGENCE; NEURONS; CORTEX; STIMULATION; INHIBITION; DISORDERS	Neural mechanisms of attention allow selective sensory information processing. Top-down deployment of visual-spatial attention is conveyed by cortical feedback connections from frontal regions to lower sensory areas modulating late stimulus responses. A recent study reported the occurrence of small eye vergence during orienting top-down attention. Here we assessed a possible link between vergence and attention by comparing visual event related potentials (vERPs) to a cue stimulus that induced attention to shift towards the target location to the vERPs to a no-cue stimulus that did not trigger orienting attention. The results replicate the findings of eye vergence responses during orienting attention and show that the strength and time of eye vergence coincide with the onset and strength of the vERPs when subjects oriented attention. Our findings therefore support the idea that eye vergence relates to and possibly has a role in attentional selection.	[Sole Puig, Maria; Marco Pallares, Josep; Perez Zapata, Laura; Super, Hans] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Marco Pallares, Josep; Super, Hans] Univ Barcelona, Neurosci Inst, Barcelona, Spain; [Marco Pallares, Josep; Puigcerver, Laura; Super, Hans] Hosp St Joan de Deu, Pediat Res Inst, Barcelona, Spain; [Canete, Josep] Consorci Sanitari Maresme, Dept Mental Hlth, Mataro, Spain; [Super, Hans] Pg Lluis Co, ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain.; Super, H (corresponding author), Univ Barcelona, Neurosci Inst, Barcelona, Spain.; Super, H (corresponding author), Hosp St Joan de Deu, Pediat Res Inst, Barcelona, Spain.; Super, H (corresponding author), Pg Lluis Co, ICREA, Barcelona, Spain.	hans.super@icrea.cat	CAÑETE, JOSE/H-6715-2014	CAÑETE, JOSE/0000-0002-1368-6801; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432	Ministry of Economy, Spain; ICREA Funding Source: Custom	Ministry of Economy, Spain; ICREA(ICREA)	The sole funder of the study is Ministry of Economy, Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez TL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00050; Betta E, 2007, VISION RES, V47, P428, DOI 10.1016/j.visres.2006.09.010; Bichot NP, 2006, PROG BRAIN RES, V155, P147, DOI 10.1016/S0079-6123(06)55009-5; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Chaturvedi V, 2000, EXP BRAIN RES, V132, P72, DOI 10.1007/s002219900221; Chella F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036016; Coubard OA, 2013, EUR J NEUROSCI, V38, P3384, DOI 10.1111/ejn.12356; EIMER M, 1994, PERCEPT PSYCHOPHYS, V55, P667, DOI 10.3758/BF03211681; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Galfano G, 2004, EXP BRAIN RES, V159, P400, DOI 10.1007/s00221-004-2111-y; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Grau C, 2007, NEUROIMAGE, V36, P522, DOI 10.1016/j.neuroimage.2007.03.027; Heinrich H, 2014, NEUROSCI LETT, V582, P49, DOI 10.1016/j.neulet.2014.08.050; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Johnston BA, 2014, HUM BRAIN MAPP, V35, P5179, DOI 10.1002/hbm.22542; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Esposito FL, 2016, EUR PSYCHIAT, V33, pS135, DOI 10.1016/j.eurpsy.2016.01.211; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Muller NG, 2003, J NEUROSCI, V23, P3561; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Nobre AC, 2000, NEUROPSYCHOLOGIA, V38, P964, DOI 10.1016/S0028-3932(00)00015-4; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; RUGG MD, 1987, NEUROPSYCHOLOGIA, V25, P85, DOI 10.1016/0028-3932(87)90045-5; Puig MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145281; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072041; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; Van Velzen J, 2003, PSYCHOPHYSIOLOGY, V40, P827, DOI 10.1111/1469-8986.00083; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Woodman GF, 2009, BRAIN RES, V1297, P101, DOI 10.1016/j.brainres.2009.08.011; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167646	10.1371/journal.pone.0167646	http://dx.doi.org/10.1371/journal.pone.0167646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973591	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300036
J	Xie, ZJ; Shah, F; Tu, SX; Xu, CX; Cao, WD				Xie, Zhijian; Shah, Farooq; Tu, Shuxin; Xu, Changxu; Cao, Weidong			Chinese Milk Vetch as Green Manure Mitigates Nitrous Oxide Emission from Monocropped Rice System in South China	PLOS ONE			English	Article							RESIDUE INCORPORATION; CROPPING SYSTEMS; USE EFFICIENCY; CH4 EMISSIONS; GAS INTENSITY; N2O EMISSIONS; COVER CROPS; SOIL; FERTILIZER; TERM	Monocropped rice system is an important intensive cropping system for food security in China. Green manure (GM) as an alternative to fertilizer N (FN) is useful for improving soil quality. However, few studies have examined the effect of Chinese milk vetch (CMV) as GM on nitrous oxide (N2O) emission from monocropped rice field in south China. Therefore, a pot-culture experiment with four treatments (control, no FN and CMV; CMV as GM alone, M; fertilizer N alone, FN; integrating fertilizer N with CMV, NM) was performed to investigate the effect of incorporating CMV as GM on N2O emission using a closed chamber-gas chromatography (GC) technique during the rice growing periods. Under the same N rate, incorporating CMV as GM (the treatments of M and NM) mitigated N2O emission during the growing periods of rice plant, reduced the NO3- content and activities of nitrate and nitrite reductase as well as the population of nitrifying bacteria in top soil at maturity stage of rice plant versus FN pots. The global warming potential (GWP) and greenhouse gas intensity (GHGI) of N2O from monocropped rice field was ranked as M<NM<FN. However, the treatment of NM increased rice grain yield and soil NH4+ content, which were dramatically decreased in the M pots, over the treatment of FN. Hence, it can be concluded that integrating FN with CMV as GM is a feasible tactic for food security and N2O mitigation in the monocropped rice based system.	[Xie, Zhijian; Shah, Farooq; Xu, Changxu] Jiangxi Acad Agr Sci, Inst Soil & Fertilizer & Resources Environm, Natl Engn & Technol Res Ctr Red Soil Improvement, Nanchang, Jiangxi, Peoples R China; [Xie, Zhijian; Tu, Shuxin] Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Hubei, Peoples R China; [Shah, Farooq] Abdul Wali Khan Univ Mardan, Dept Agr, Khyber Pakhtunkhwa, Pakistan; [Xie, Zhijian; Tu, Shuxin] Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China; [Cao, Weidong] CAAS, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Xu, CX (corresponding author), Jiangxi Acad Agr Sci, Inst Soil & Fertilizer & Resources Environm, Natl Engn & Technol Res Ctr Red Soil Improvement, Nanchang, Jiangxi, Peoples R China.; Tu, SX (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Hubei, Peoples R China.; Tu, SX (corresponding author), Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	stu@mail.hzau.edu.cn; changxux@sina.com	Zhang, Kevin/F-5215-2010; Shah, Farooq/GVT-6352-2022	Tu, Shuxin/0000-0001-7180-1794	Special Fund for Agro-Scientific Research in the Public Interest [201103005, 201303106, 201503123]; National Science Foundation [41471407]	Special Fund for Agro-Scientific Research in the Public Interest; National Science Foundation(National Science Foundation (NSF))	This study was funded by the Special Fund for Agro-Scientific Research in the Public Interest (Project no., 201103005, 201303106, 201503123) and the National Science Foundation (41471407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAGID HM, 1987, SOIL BIOL BIOCHEM, V19, P421, DOI 10.1016/0038-0717(87)90033-2; Alexander M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P815; BARNES H, 1951, ANALYST, V76, P599, DOI 10.1039/an9517600599; Bedada W, 2014, AGR ECOSYST ENVIRON, V195, P193, DOI 10.1016/j.agee.2014.06.017; Bouwman L, 2010, NITROUS OXIDE CLIMAT; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; BREMNER J. M., 1965, Monographs of the American Society of Agronomists, V9, P1179; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; COCHRAN WG, 1950, BIOMETRICS, V6, P105, DOI 10.2307/3001491; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Ding WX, 2013, SCI TOTAL ENVIRON, V465, P115, DOI 10.1016/j.scitotenv.2012.11.020; Fageria NK, 2005, COMMUN SOIL SCI PLAN, V36, P2733, DOI 10.1080/00103620500303939; FAO, 2004, FAO STAT YB; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Frolking S, 2004, GLOBAL CHANGE BIOL, V10, P1180, DOI 10.1111/j.1529-8817.2003.00798.x; Gabriel JL, 2011, EUR J AGRON, V34, P133, DOI 10.1016/j.eja.2010.11.006; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gao B, 2015, AGR ECOSYST ENVIRON, V203, P46, DOI 10.1016/j.agee.2015.01.020; Groenigen JWV, 2011, EUR J SOIL SCI, V61, P903; Gunapala N, 1998, SOIL BIOL BIOCHEM, V30, P805, DOI 10.1016/S0038-0717(97)00162-4; HARGROVE WL, 1986, AGRON J, V78, P70, DOI 10.2134/agronj1986.00021962007800010016x; Herzog T., 2006, TARGET INTENSITY AN; IFA/FAO, 2001, GLOB EST GAS EM NH3; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Ishii S, 2011, ISME J, V5, P1936, DOI 10.1038/ismej.2011.69; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Lin H., 2014, ADV MAT RES, V955-959, P3552, DOI [DOI 10.4028/www.scientific.net/AMR.955-959.3552, 10.4028/www.scientific.net/AMR.955-959.3552]; Liu YL, 2015, ATMOS ENVIRON, V116, P92, DOI 10.1016/j.atmosenv.2015.06.018; Lu R.K, 2000, ANAL METHOD SOIL AGR; Meng HQ, 2013, J INTEGR AGR, V12, P2092, DOI 10.1016/S2095-3119(13)60398-6; Miao YX, 2010, REV AGRON SUSTAIN DE, V31, P397, DOI [10.1051/agro/2010034, DOI 10.1051/AGR0/2010034]; Migliorati MD, 2015, AGR ECOSYST ENVIRON, V204, P27, DOI 10.1016/j.agee.2015.02.007; Minamikawa K, 2010, GLOBAL CHANGE BIOL, V16, P796, DOI 10.1111/j.1365-2486.2009.01931.x; Morgan MF, 1930, SCIENCE, V71, P343, DOI 10.1126/science.71.1839.343; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nishimura S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002207; NORMAN RJ, 1985, SOIL SCI SOC AM J, V49, P1182, DOI 10.2136/sssaj1985.03615995004900050022x; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Poeplau C., 2015, GERODERMA REG, V4, P126, DOI DOI 10.1016/J.GEODRS.2015.01.004; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Rodriguez-Lado L, 2015, PROCEDIA ENVIRON SCI, V27, P45, DOI 10.1016/j.proenv.2015.07.112; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Sanz-Cobena A, 2014, SCI TOTAL ENVIRON, V466, P164, DOI 10.1016/j.scitotenv.2013.07.023; Schmidt EL, 1982, METHOD SOIL ANAL 2, P1011; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Tabatabai MA, 1982, METHODS SOIL ANAL 2, P775; Tang HM, 2015, ENVIRON SCI POLLUT R, V22, P12689, DOI 10.1007/s11356-015-4557-9; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang JY, 2011, AGR ECOSYST ENVIRON, V141, P437, DOI 10.1016/j.agee.2011.04.009; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Wrage N, 2004, RAPID COMMUN MASS SP, V18, P1201, DOI 10.1002/rcm.1461; Xie ZJ, 2016, FIELD CROP RES, V188, P142, DOI 10.1016/j.fcr.2016.01.006; Xu ZJ, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2004GB002233, 10.1029/2003GB002167]; Yao ZS, 2012, AGR ECOSYST ENVIRON, V152, P1, DOI 10.1016/j.agee.2012.02.004; Yao ZS, 2009, SOIL BIOL BIOCHEM, V41, P2131, DOI 10.1016/j.soilbio.2009.07.025; Zhang Hongwei, 2012, AISS, V4, P155; Zhang JE, 2008, ARCH ENVIRON CON TOX, V54, P167, DOI 10.1007/s00244-007-9014-4; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao YC, 2014, ENVIRON SCI POLLUT R, V21, P7586, DOI 10.1007/s11356-014-2671-8; ZHENG X., 2000, CHEMOSPH GLOB CHANG, V2, P207, DOI DOI 10.1016/S1465-9972(99)00056-2; Zhu B, 2012, J INTEGR AGR, V11, P1537, DOI 10.1016/S2095-3119(12)60154-3	71	5	10	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168134	10.1371/journal.pone.0168134	http://dx.doi.org/10.1371/journal.pone.0168134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959949	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900039
J	Pollak, A; Lechowicz, U; Kedra, A; Stawinski, P; Rydzanicz, M; Furmanek, M; Brzozowska, M; Mrowka, M; Skarzynski, H; Skarzynski, PH; Oldak, M; Ploski, R				Pollak, Agnieszka; Lechowicz, Urszula; Kedra, Anna; Stawinski, Piotr; Rydzanicz, Malgorzata; Furmanek, Mariusz; Brzozowska, Malgorzata; Mrowka, Maciej; Skarzynski, Henryk; Skarzynski, Piotr H.; Oldak, Monika; Ploski, Rafal			Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss	PLOS ONE			English	Article							X-LINKED DEAFNESS; COCHLEAR IMPLANTATION; IMPAIRMENT; GENE; PROTEIN; DFN3; PRESERVATION; CHILDREN; SPECTRUM; BRAIN-4	POU3F4 mutations (DFNX2) are the most prevalent among non-syndromic X-linked hearing loss (HL) identified to date. Clinical manifestations of DFNX2 usually comprise congenital HL either sensorineural or mixed, a tendency towards perilymphatic gusher during otologic surgery and temporal bone malformations. The aim of the present study was to screen for POU3F4 mutations in a group of 30 subjects with a suggestive clinical phenotype as well as a group (N = 1671-2018) of unselected hearing loss patients. We also planned to analyze audiological and radiological features in patients with HL caused by POU3F4 defects. The molecular techniques used to detect POU3F4 mutations included whole exome sequencing (WES), Sanger sequencing and real-time polymerase chain reaction. Hearing status was assessed with pure-tone audiometry and auditory brainstem response. Computer tomography scans were evaluated to define the pattern of structural changes in the temporal bones. Six novel (p.Gln27*, p.Glu187*, p.Leu217*, p.Gln275*, p.Gln306*, p.Val324Asp) and two known (p.Ala116fs141*, p.Leu208*) POU3F4 mutations were detected in the studied cohort. All probands with POU3F4 defects suffered from bilateral, prelingual, severe to profound HL. Morphological changes of the temporal bone in these patients presented a similar pattern, including malformations of the internal auditory canal, vestibular aqueduct, modiolus and vestibule. Despite different localization in the POU3F4 gene all mutations severely impair the protein structure affecting at least one functional POU3F4 domain, and results in similar and severe clinical manifestations. Sequencing of the entire POU3F4 gene is recommended in patients with characteristic temporal bone malformations. Results of POU3F4 mutation testing are important not only for a proper genetic counseling, but also for adequate preparation and conduction of a surgical procedure.	[Pollak, Agnieszka; Lechowicz, Urszula; Stawinski, Piotr; Oldak, Monika] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland; [Kedra, Anna; Rydzanicz, Malgorzata; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Kedra, Anna] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Furmanek, Mariusz] Inst Physiol & Pathol Hearing, World Hearing Ctr, Bioimaging Res Ctr, Warsaw, Poland; [Furmanek, Mariusz] Med Ctr Postgrad Educ, Dept Radiol & Diagnost Imaging, Warsaw, Poland; [Brzozowska, Malgorzata] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Mrowka, Maciej; Skarzynski, Henryk; Skarzynski, Piotr H.] Inst Physiol & Pathol Hearing, Oto Rhino Laryngol Surg Clin, Warsaw, Poland; [Skarzynski, Piotr H.] Med Univ Warsaw, Dept Heart Failure & Cardiac Rehabil, Warsaw, Poland; [Skarzynski, Piotr H.] Inst Sensory Organs, Kajetany, Poland	Institute of Physiology & Hearing Pathology; Medical University of Warsaw; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Medical University of Warsaw	Oldak, M (corresponding author), Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	m.oldak@ifps.org.pl; rploski@wp.pl	Skarzynski, Piotr H./A-9642-2012; Lechowicz, Urszula/ABB-9967-2020; Mrowka, Maciej/S-7930-2016	Skarzynski, Piotr H./0000-0002-4978-1915; Ploski, Rafal/0000-0001-6286-5526; Lechowicz, Urszula/0000-0002-2645-8779; Mrowka, Maciej/0000-0003-4346-9290; Pollak, Agnieszka/0000-0002-2847-1782; Rydzanicz, Malgorzata/0000-0002-6969-0535; Skarzynski, Henryk/0000-0001-7141-9851; Oldak, Monika/0000-0002-4216-9141	Narodowe Centrum Nauki [NCN 2011/03/D/NZ5/05592, 2012/05/N/NZ5/02629, 2013/09/D/NZ5/00251]; NCBiR project INNOSENSE, STRATEGMED Program	Narodowe Centrum Nauki(National Science Centre, Poland); NCBiR project INNOSENSE, STRATEGMED Program	Funding was received from Narodowe Centrum Nauki (grants NCN 2011/03/D/NZ5/05592, 2012/05/N/NZ5/02629 and 2013/09/D/NZ5/00251) and from NCBiR project "Integrated system of tools designed for diagnostics and telerehabilitation of the sense organs disorders (hearing, vision, speech, balance, taste, smell)" INNOSENSE, STRATEGMED Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITNERGLINDZICZ M, 1995, HUM MOL GENET, V4, P1467, DOI 10.1093/hmg/4.8.1467; Cremers F, 2008, OXFORD MONOGRAPHS ME, V54, P1042; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Friedman RA, 1997, ANN OTO RHINOL LARYN, V106, P320; Gong WX, 2014, INT J PEDIATR OTORHI, V78, P1756, DOI 10.1016/j.ijporl.2014.08.013; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoefsloot LH, 2013, EUR J HUM GENET, V21, P1325, DOI 10.1038/ejhg.2013.83; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar G, 2003, AM J NEURORADIOL, V24, P1130; Lee HK, 2009, PHYSIOL GENOMICS, V39, P195, DOI 10.1152/physiolgenomics.00100.2009; Liu XZ, 2013, INT J AUDIOL, V52, P23, DOI 10.3109/14992027.2012.736032; Marlin S, 2009, CLIN GENET, V76, P558, DOI 10.1111/j.1399-0004.2009.01215.x; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moteki H, 2015, ANN OTO RHINOL LARYN, V124, p169S, DOI 10.1177/0003489415575042; Parzefall T, 2013, HUM MUTAT, V34, P1102, DOI 10.1002/humu.22339; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Pourova R, 2010, ANN HUM GENET, V74, P299, DOI 10.1111/j.1469-1809.2010.00581.x; Rost S, 2014, EUR J HUM GENET, V22, P208, DOI 10.1038/ejhg.2013.108; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Sennaroglu L, 2006, OTOL NEUROTOL, V27, P615, DOI 10.1097/01.mao.0000224090.94882.b4; Skarzynski H, 2016, J LARYNGOL OTOL, V130, P332, DOI 10.1017/S0022215115003436; Skarzynski H, 2012, J HEAR SCI, V2, P11; Skarzynski H, 2010, MED SCI MONITOR, V16, pCR555; Song MH, 2010, CLIN GENET, V78, P524, DOI 10.1111/j.1399-0004.2010.01426.x; Stankovic KM, 2010, ANN OTO RHINOL LARYN, V119, P815, DOI 10.1177/000348941011901205; Tan XF, 2010, CELL BIOL INT, V34, P877, DOI 10.1042/CBI20100214; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VanCamp G, 1997, AM J HUM GENET, V60, P758	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0166618	10.1371/journal.pone.0166618	http://dx.doi.org/10.1371/journal.pone.0166618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941975	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600004
J	Adnan, H; Zhang, ZB; Park, HJ; Tailor, C; Che, C; Kamani, M; Spitalny, G; Binnington, B; Lingwood, C				Adnan, Humaira; Zhang, Zhenbo; Park, Hyun-Joo; Tailor, Chetankumar; Che, Clare; Kamani, Mustafa; Spitalny, George; Binnington, Beth; Lingwood, Clifford			Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases	PLOS ONE			English	Article							ER-ASSOCIATED DEGRADATION; ESCHERICHIA-COLI O157-H7; CHOLERA-TOXIN; RETROGRADE TRANSPORT; SHIGA TOXIN; PLASMA-MEMBRANE; UNFOLDED PROTEIN; B-SUBUNIT; IN-VITRO; CFTR	Many germ line diseases stem from a relatively minor disturbance in mutant protein endoplasmic reticulum (ER) 3D assembly. Chaperones are recruited which, on failure to correct folding, sort the mutant for retrotranslocation and cytosolic proteasomal degradation (ER-associated degradation-ERAD), to initiate/exacerbate deficiency-disease symptoms. Several bacterial (and plant) subunit toxins, retrograde transport to the ER after initial cell surface receptor binding/internalization. The A subunit has evolved to mimic a misfolded protein and hijack the ERAD membrane translocon (dislocon), to effect cytosolic access and cytopathology. We show such toxins compete for ERAD to rescue endogenous misfolded proteins. Cholera toxin or verotoxin (Shiga toxin) containing genetically inactivated (+/- an N-terminal polyleucine tail) A subunit can, within 2 -4 hrs, temporarily increase F508delCFTR protein, the major cystic fibrosis (CF) mutant (5-10x), F508delCFTR Golgi maturation (< 10x), cell surface expression (20x) and chloride transport (2x) in F508del CFTR transfected cells and patient-derived F508delCFTR bronchiolar epithelia, without apparent cytopathology. These toxoids also increase glucocerobrosidase (GCC) in N370SGCC Gaucher Disease fibroblasts (3x), another ERAD -exacerbated misfiling disease. We identify a new, potentially benign approach to the treatment of certain genetic protein misfolding diseases.	[Adnan, Humaira; Zhang, Zhenbo; Park, Hyun-Joo; Che, Clare; Kamani, Mustafa; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Div Mol Struct & Funct, Toronto, ON, Canada; [Tailor, Chetankumar] Hosp Sick Children, Res Inst, Div Cell Biol, Toronto, ON, Canada; [Spitalny, George] ERAD Therapeut, Caledon, ON, Canada; [Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Div Mol Struct & Funct, Toronto, ON, Canada.; Lingwood, C (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada.; Lingwood, C (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada.	cling@sickkids.on.ca		Zhang, Zhenbo/0000-0002-2353-7869	MITACS industrial pdf fellowship awards; BREATHE program - Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics	MITACS industrial pdf fellowship awards; BREATHE program - Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics(Canadian Institutes of Health Research (CIHR))	The commercial affiliation provided support in the form of partial industrial support for the MITACS industrial pdf fellowship awards to H. A. and Z.Z. The company facilitated the third party cloning and purification of codon optimized CTO, and the third party using chamber chloride transport studies. The specific roles of these authors are articulated in the 'author contributions' section.; Valued discussion with Drs. C. Bear and L-J Huan at this Institute is gratefully acknowledged. We thank Dr D. Rotin for the kind supply of F508del CFTR and WT CFTR transfected HEK293 cells. This work was in part supported by a BREATHE program grant funded by the Canadian Cystic Fibrosis Foundation and a Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics. We acknowledge ERAD Therapeutics and the Ontario Centre for Excellence support for codon optimized CT0, FLIPR assay and the work performed at Charles River Discovery.	Amessou M, 2008, BIOCONJUGATE CHEM, V19, P532, DOI 10.1021/bc7003999; Arab S, 1999, ONCOL RES, V11, P33; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Bendikov-Bar I, 2013, BLOOD CELL MOL DIS, V50, P141, DOI 10.1016/j.bcmd.2012.10.007; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bhargava A, 2012, J BIOL CHEM; Brem GJ, 2013, GYNECOL ONCOL, V128, P383, DOI 10.1016/j.ygyno.2012.10.021; Castilla J, 2015, EUR J MED CHEM, V90, P258, DOI 10.1016/j.ejmech.2014.11.002; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Chiang W.C., 2014, MOL NEUROBIOL; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Devenica D, 2011, MED ONCOL, V28, pS675, DOI 10.1007/s12032-010-9732-8; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Douce G, 1997, INFECT IMMUN, V65, P2821, DOI 10.1128/IAI.65.7.2821-2828.1997; Einsele H, 2010, RECENT RESULTS CANC, V184, P173, DOI 10.1007/978-3-642-01222-8_12; Elfrink HL, 2013, MOL CELLS, V35, P291, DOI 10.1007/s10059-013-2286-9; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Eshraghi A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004295; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Garcia-Castillo MD, 2015, J CELL SCI; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Horimoto S, 2013, J BIOL CHEM, V288, P31517, DOI 10.1074/jbc.M113.476010; Ishitoya S, 2004, J UROLOGY, V171, P1309, DOI 10.1097/01.ju.0000100110.11129.85; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kaiser ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117260; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Kruse KB, 2006, AUTOPHAGY, V2, P135, DOI 10.4161/auto.2.2.2388; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; Lord JM, 2003, BIOCHEM SOC T, V31, P1260; Maegawa GHB, 2009, J BIOL CHEM, V284, P23502, DOI 10.1074/jbc.M109.012393; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Maitra R, 2013, J BIOMOL SCREEN, V18, P1132, DOI 10.1177/1087057113488420; Majoul I, 2002, J CELL SCI, V115, P817; Mayor T, 2012, NAT CELL BIOL, V14, P46, DOI 10.1038/ncb2412; McHugh ML, 2011, BIOCHEM MEDICA, V21, P203; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Murphy LA, 2011, CELL STRESS CHAPERON, V16, P607, DOI 10.1007/s12192-011-0270-x; Noakes KL, 1999, FEBS LETT, V453, P95, DOI 10.1016/S0014-5793(99)00609-2; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Sandvig K, 2010, TOXICON, V56, P1181, DOI 10.1016/j.toxicon.2009.11.021; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Shun Zhenming, 2003, J Biopharm Stat, V13, P17, DOI 10.1081/BIP-120017723; Smith DC, 2002, TRAFFIC, V3, P697, DOI 10.1034/j.1600-0854.2002.31001.x; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Thompson H W, 1998, Nutr Neurosci, V1, P165, DOI 10.1080/1028415X.1998.11747226; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang BJ, 2009, LANDSLIDES, V6, P61, DOI 10.1007/s10346-008-0139-y; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang L, 2008, HEPATOLOGY, V48, P1558, DOI 10.1002/hep.22499; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wilke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052070; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Wu KL, 2005, HAEMATOLOGICA, V90, P996; Yagishita N, 2008, NAT CLIN PRACT RHEUM, V4, P91, DOI 10.1038/ncprheum0699; Yasuda Y, 1998, FEMS IMMUNOL MED MIC, V20, P311, DOI 10.1016/S0928-8244(98)00027-3; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	104	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166948	10.1371/journal.pone.0166948	http://dx.doi.org/10.1371/journal.pone.0166948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935997	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100051
J	Grattepanche, JD; McManus, GB; Katz, LA				Grattepanche, Jean-David; McManus, George B.; Katz, Laura A.			Patchiness of Ciliate Communities Sampled at Varying Spatial Scales along the New England Shelf	PLOS ONE			English	Article							PHYTOPLANKTON BLOOM; COASTAL ECOSYSTEM; PROTIST DIVERSITY; MICROZOOPLANKTON; TEMPERATE; SEA; PERFORMANCE; OLIGOTRICH; MESOSCALE; PATTERNS	Although protists (microbial eukaryotes) provide an important link between bacteria and Metazoa in food webs, we do not yet have a clear understanding of the spatial scales on which protist diversity varies. Here, we use a combination of DNA fingerprinting (denaturant gradient gel electrophoresis or DGGE) and high-throughput sequencing (HTS) to assess the ciliate community in the class Spirotrichea at varying scales of 1-3 km sampled in three locations separated by at least 25 km-offshore, midshelf and inshore-along the New England shelf. Analyses of both abundant community (DGGE) and the total community (HTS) members reveal that: 1) ciliate communities are patchily distributed inshore (i.e. the middle station of a transect is distinct from its two neighboring stations), whereas communities are more homogeneous among samples within the midshelf and offshore stations; 2) a ciliate closely related to Pelagostrobilidium paraepacrum 'blooms' inshore and; 3) environmental factors may differentially impact the distributions of individual ciliates (i.e. OTUs) rather than the community as a whole as OTUs tend to show distinct biogeographies (e.g. some OTUs are restricted to the offshore locations, some to the surface, etc.). Together, these data show the complexity underlying the spatial distributions of marine protists, and suggest that biogeography may be a property of ciliate species rather than communities.	[Grattepanche, Jean-David; Katz, Laura A.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA; [McManus, George B.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Katz, Laura A.] Univ Massachusetts, Program Organism & Evolutionary Biol, Amherst, MA 01003 USA	Smith College; University of Connecticut; University of Massachusetts System; University of Massachusetts Amherst	Grattepanche, JD (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	jgrattepanche@smith.edu	Grattepanche, Jean-David/C-7101-2013; McManus, George/AAW-9055-2020; Katz, Laura A/AAF-4802-2019	Grattepanche, Jean-David/0000-0002-1854-3762; Katz, Laura/0000-0002-9138-4702; McManus, George/0000-0002-2768-1286	National Science Foundation [OCE-1436003, OCE-1129734, OCE-1130033, OCE-1435515]; University of Connecticut; Smith College; National Science Foundation (MRI) [DBI-0215393]; National Science Foundation (EPSCoR) [0554548, EPS-1004057]; US Department of Agriculture [2002-34438-12688, 2003-34438-13111]; University of Rhode Island; Directorate For Geosciences [1436003] Funding Source: National Science Foundation; Division Of Ocean Sciences [1435515] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut; Smith College; National Science Foundation (MRI)(National Science Foundation (NSF)); National Science Foundation (EPSCoR)(National Science Foundation (NSF)); US Department of Agriculture(United States Department of Agriculture (USDA)); University of Rhode Island; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation awards OCE-1436003 and OCE-1129734 to LAK and awards OCE-1130033 and OCE-1435515 to GBM, the University of Connecticut and Smith College. This research is based in part upon work conducted using the Rhode Island Genomics and Sequencing Center which is supported in part by the National Science Foundation (MRI Grant No. DBI-0215393 and EPSCoR Grant Nos. 0554548 & EPS-1004057), the US Department of Agriculture (Grant Nos. 2002-34438-12688 and 2003-34438-13111), and the University of Rhode Island.	Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; [Anonymous], 2021, LANG ENV STAT COMP; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Bulit C, 2003, AQUAT MICROB ECOL, V30, P185, DOI 10.3354/ame030185; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Christaki U, 2011, BIOGEOSCIENCES, V8, P1839, DOI 10.5194/bg-8-1839-2011; Christaki U, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv068; Colwell RK, 2013, COMPUTER PROGRAM EST; Costas BA, 2007, LIMNOL OCEANOGR-METH, V5, P163, DOI 10.4319/lom.2007.5.163; Countway PD, 2010, LIMNOL OCEANOGR, V55, P2381, DOI 10.4319/lo.2010.55.6.2381; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dierssen H, 2015, P NATL ACAD SCI USA, V112, P14783, DOI 10.1073/pnas.1512538112; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2002, DEEP-SEA RES PT I, V49, P1217, DOI 10.1016/S0967-0637(02)00021-3; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5; George JA, 2015, LIMNOL OCEANOGR, V60, P110, DOI 10.1002/lno.10020; Grattepanche JD, 2016, MOL ECOL, V25, P3987, DOI 10.1111/mec.13745; Grattepanche JD, 2015, MAR ECOL PROG SER, V526, P1, DOI 10.3354/meps11256; Grattepanche JD, 2014, TRENDS MICROBIOL, V22, P432, DOI 10.1016/j.tim.2014.04.006; Grattepanche JD, 2014, AQUAT MICROB ECOL, V71, P211, DOI 10.3354/ame01675; Grattepanche JD, 2011, J PLANKTON RES, V33, P37, DOI 10.1093/plankt/fbq097; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HOUGHTON RW, 1986, J PHYS OCEANOGR, V16, P60, DOI 10.1175/1520-0485(1986)016<0060:OOAAEN>2.0.CO;2; Hu SK, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw050; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Li L, 2016, AM NATURALIST, V188, pE000; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; MacKinnon JA, 2003, J PHYS OCEANOGR, V33, P1476, DOI 10.1175/1520-0485(2003)033<1476:MOTLNE>2.0.CO;2; Mann K.H., 1982, ECOLOGY COASTAL WATE; Massana R, 2015, ENVIRON MICROBIOL, V17, P4035, DOI 10.1111/1462-2920.12955; Menden-Deuer S, 2010, MAR ECOL PROG SER, V420, P57, DOI 10.3354/meps08855; Monchy S, 2012, PLOS ONE, V7; Montagnes DJS, 1999, MAR BIOL, V134, P167, DOI 10.1007/s002270050535; Olson MB, 2013, DEEP-SEA RES PT I, V75, P28, DOI 10.1016/j.dsr.2013.01.001; PORTER KG, 1985, J PROTOZOOL, V32, P409, DOI 10.1111/j.1550-7408.1985.tb04036.x; Santoferrara LF, 2014, ENV MICROBIOLOGY; Santoferrara LF, 2016, ISME J; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; SOURNIA A, 1987, ESTUAR COAST SHELF S, V25, P355, DOI 10.1016/0272-7714(87)90078-3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Tamura M, 2011, AQUAT MICROB ECOL, V64, P51, DOI 10.3354/ame01509; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207; Zhang WFG, 2011, J PHYS OCEANOGR, V41, P1874, DOI 10.1175/2011JPO4604.1	59	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167659	10.1371/journal.pone.0167659	http://dx.doi.org/10.1371/journal.pone.0167659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936137	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100142
J	Kostadinovic, M; Ignjatovic-Micic, D; Vancetovic, J; Ristic, D; Bozinovic, S; Stankovic, G; Drinic, SM				Kostadinovic, Marija; Ignjatovic-Micic, Dragana; Vancetovic, Jelena; Ristic, Danijela; Bozinovic, Sofija; Stankovic, Goran; Drinic, Snezana Mladenovic			Development of High Tryptophan Maize Near Isogenic Lines Adapted to Temperate Regions through Marker Assisted Selection Impediments and Benefits	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; MUTANT-GENE; INTROGRESSION; PERFORMANCE; GERMPLASM; LYSINE; QPM; GRAIN	Breeding program aimed at converting standard maize inbred lines to their quality protein maize (QPM) counterparts for growing in temperate climate is being conducted at Maize Research Institute (MRI). The objective of the research presented herein was to develop QPM versions of two commercial ZP inbreds through marker assisted selection (MAS) with opaque2 specific molecular markers, while maintaining their good agronomic performances and combining abilities. Donor line was a tropical QPM line CML 144. After two backcross and three selfing generations, six near isogenic lines (NILs) with 93% recovery of the recurrent parent genome were created from one cross. Average increments of 30% in tryptophan content and 36% in quality index were obtained, as well as kernels with less than 25% opaque endosperm. Grain yield was increased by 11-31% and combining abilities of the improved lines were on a par with the original line. Correlations between biochemical and agronomic parameters revealed that selection for plant height, ear length and kernel row number together with tryptophan content could be recommended for development of QPM with this material. However, several impediments emerged during selection. Major drawbacks in NIL development were small number of opaque2 recessive homozygotes (4.5% and 7.6% in BC2F2 of two crosses) and poor seed set throughout selection, which led to the loss of one cross. Moreover, in the other cross many plants in different generations had to be omitted from further selection due to the insufficient number of kernels. This phenomenon could be explained by incompatibility between pollen and style, possibly due to the exotic donor germplasm. Overall, it could be expected that the use of NILs, which are adapted to temperate climate and have high percentage of domestic germplasm, would outbalance the noted impediments and increase MAS efficiency in different breeding programs.	[Kostadinovic, Marija; Ignjatovic-Micic, Dragana; Ristic, Danijela; Drinic, Snezana Mladenovic] Maize Res Inst, Lab Mol Genet & Physiol, Belgrade, Serbia; [Vancetovic, Jelena; Bozinovic, Sofija] Maize Res Inst, Grp Breeding Early Matur Maize Hybrids Desirable, Belgrade, Serbia; [Stankovic, Goran] Maize Res Inst, Late Maize Hybrid Breeding Grp, Belgrade, Serbia		Kostadinovic, M (corresponding author), Maize Res Inst, Lab Mol Genet & Physiol, Belgrade, Serbia.	kmarija@mrizp.rs			Ministry of Education, Science and Technological Development of Republic of Serbia [TR31068, TR31028]	Ministry of Education, Science and Technological Development of Republic of Serbia	This research was supported by the Ministry of Education, Science and Technological Development of Republic of Serbia through the projects TR31068 "Improvement of maize and soybean characteristics by molecular and conventional breeding" and TR31028 "Exploitation of maize diversity to improve grain quality and drought tolerance". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P. K., 2010, ANIMAL NUTR FEED T S, V10s, P79; Akuamoa-Boateng A., 2002, EXPT DESIGN; Ali Q, 2010, J AM OIL CHEM SOC, V87, P1179, DOI 10.1007/s11746-010-1599-5; Babu BK, 2015, PLANT CELL REP, V34, P37, DOI 10.1007/s00299-014-1685-5; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; BRESSANI R, 1991, CEREAL FOOD WORLD, V36, P806; CROSSA J, 1989, MAYDICA, V34, P53; Crow JF, 2002, GENETICS, V160, P819; Danson JW, 2006, AFR J BIOTECHNOL, V5, P2417; Denic M, 2012, GENETIKA-BELGRADE, V44, P13, DOI 10.2298/GENSR1201013D; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doyle J. J., 1987, PHYTOCHEM B, P11; DUDLEY JW, 1982, CROP SCI, V22, P631, DOI 10.2135/cropsci1982.0011183X002200030049x; Gernah D. I., 2011, American Journal of Food Technology, V6, P404, DOI 10.3923/ajft.2011.404.412; Gimenes MA, 2000, GENET MOL BIOL, V23, P375, DOI 10.1590/S1415-47572000000200023; GOODMAN MM, 1985, IOWA STATE J RES, V59, P497; GORLA MS, 1980, THEOR APPL GENET, V57, P37, DOI 10.1007/BF00276008; Gupta HS, 2013, PLANT BREEDING, V132, P77, DOI 10.1111/pbr.12009; Hernandez H.H., 1969, CIMMYT RES B, V13; Idukut L, 2009, J ANIM VET ADV, V8, P1945; Ignjatovi-Micic D, 2009, GENETIKA-BELGRADE, V41, P81, DOI 10.2298/GENSR0901081I; Ignjatovic-Micic D, 2015, J AGR FOOD CHEM, V63, P1251, DOI 10.1021/jf504301u; Ignjatovic-Micic D, 2013, MAYDICA, V58, P311; Ignjatovic-Micic D, 2010, GENETIKA-BELGRADE, V42, P267, DOI 10.2298/GENSR1002267M; Jompuk C., 2011, Kasetsart Journal, Natural Sciences, V45, P666; Kostadinovic M, 2014, GENETIKA-BELGRADE, V46, P579, DOI 10.2298/GENSR1402579K; Krivanek AF, 2007, AFR J BIOTECHNOL, V6, P312; MA Y, 1975, CEREAL CHEM, V52, P412; Mbuya K., 2011, International Journal of Plant Breeding and Genetics, V5, P317; MCWHIRTER KS, 1971, MAIZE GENET NEWSLETT, V45, P184; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; MSTAT Development Team, 1989, MSTAT C MICR PROGR D; NELSON OE, 1965, SCIENCE, V150, P1469, DOI 10.1126/science.150.3702.1469; Nurit E, 2009, J AGR FOOD CHEM, V57, P7233, DOI 10.1021/jf901315x; PAEZ AV, 1969, CROP SCI, V9, P251, DOI 10.2135/cropsci1969.0011183X000900020045x; Panda AK, 2010, ASIAN AUSTRAL J ANIM, V23, P1626, DOI 10.5713/ajas.2010.10036; Prakash O, 2006, NEW BOT, V33, P91; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Reddy YR, 2013, FIELD CROP RES, V153, P63, DOI 10.1016/j.fcr.2013.06.013; Ribaut JM, 2002, CROP SCI, V42, P557, DOI 10.2135/cropsci2002.0557; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Scott MP, 2009, MAYDICA, V54, P449; Selvaraj C. I., 2011, International Journal of Plant Breeding and Genetics, V5, P209, DOI 10.3923/ijpbg.2011.209.223; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; VILLEGAS E, 1992, QUALITY PROTEIN MAIZE, P27; Villegas E, 1984, CHEM METHODS USED CI; Vivek B., 2008, BREEDING QUALITY PRO; Wani, 2009, J PLANT BREED CROP S, V1, P244, DOI DOI 10.5897/JPBCS.9000113; Worku M, 2008, MAYDICA, V53, P279; Worral HM, 2015, J PLANT REGIST, V9, P371, DOI 10.3198/jpr2014.11.0080crg; Zaidi PH, 2008, MAYDICA, V53, P249	51	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167635	10.1371/journal.pone.0167635	http://dx.doi.org/10.1371/journal.pone.0167635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936171	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100137
J	Muller, F; Xu, JM; Kristensen, L; Wolters-Arts, M; de Groot, PFM; Jansma, SY; Mariani, C; Park, S; Rieu, I				Mueller, Florian; Xu, Jiemeng; Kristensen, Lieke; Wolters-Arts, Mieke; de Groot, Peter F. M.; Jansma, Stuart Y.; Mariani, Celestina; Park, Sunghun; Rieu, Ivo			High-Temperature-Induced Defects in Tomato (Solanum lycopersicum) Anther and Pollen Development Are Associated with Reduced Expression of B-Class Floral Patterning Genes	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MADS-BOX GENES; HEAT-STRESS; MALE-STERILITY; CARBOHYDRATE CONCENTRATION; FLOWER DEVELOPMENT; STAMEN DEVELOPMENT; DROUGHT STRESS; L.; EVOLUTION	Sexual reproduction is a critical process in the life-cycle of plants and very sensitive to environmental perturbations. To better understand the effect of high temperature on plant reproduction, we cultivated tomato (Solanum lycopersicum) plants in continuous mild heat. Under this condition we observed a simultaneous reduction in pollen viability and appearance of anthers with pistil-like structures, while in a more thermotolerant genotype, both traits were improved. Ectopic expression of two pistil-specific genes, TRANSMITTING TISSUE SPECIFIC and TOMATO AGAMOUS LIKE11, in the anthers confirmed that the anthers had gained partial pistil identity. Concomitantly, expression of the B-class genes TOMATO APETALA3, TOMATO MADS BOX GENE6 (TM6) and LePISTILLATA was reduced in anthers under continuous mild heat. Plants in which TM6 was partially silenced reacted hypersensitively to temperature elevation with regard to the frequency of pistilloid anthers, pollen viability and pollen quantity. Taken together, these results suggest that high-temperature induced down-regulation of tomato B-class genes contributes to anther deformations and reduced male fertility. Improving our understanding of how temperature perturbs the molecular mechanisms of anther and pollen development will be important in the view of maintaining agricultural output under current climate changes.	[Mueller, Florian; Xu, Jiemeng; Kristensen, Lieke; Wolters-Arts, Mieke; de Groot, Peter F. M.; Jansma, Stuart Y.; Mariani, Celestina; Rieu, Ivo] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands; [Park, Sunghun] Kansas State Univ, Dept Hort & Human Hlth, Manhattan, KS 66506 USA	Radboud University Nijmegen; Kansas State University	Rieu, I (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Mol Plant Physiol, Nijmegen, Netherlands.	i.rieu@science.ru.nl	Rieu, Ivo/B-3055-2008; Xu, Jiemeng/AAO-9278-2021; Rieu, Ivo/AAW-8656-2021; Xu, Jiemeng/Z-2085-2019; Mariani, Celestina/C-6920-2013	Rieu, Ivo/0000-0001-8575-0959; Xu, Jiemeng/0000-0001-9629-8400; Rieu, Ivo/0000-0001-8575-0959; 	European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN) [289220]; China Scholarship Council [201207565002]	European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN); China Scholarship Council(China Scholarship Council)	This research was supported by a grant from the European Commission (Marie Curie Initial Training Network: Solanaceae pollen thermotolerance/SPOT-ITN, grant number 289220) to IR and a grant from the China Scholarship Council (grant number 201207565002) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko M, 2005, SEX PLANT REPROD, V18, P91, DOI 10.1007/s00497-005-0004-2; AHMED FE, 1992, AM J BOT, V79, P784, DOI 10.2307/2444945; Alghabari F, 2014, J AGRON CROP SCI, V200, P36, DOI 10.1111/jac.12038; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; CHAPMAN GP, 1987, INT REV CYTOL, V107, P111, DOI 10.1016/S0074-7696(08)61074-8; CHEUNG AY, 1993, PLANT J, V3, P151, DOI 10.1111/j.1365-313X.1993.tb00018.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Firon N, 2006, SCI HORTIC-AMSTERDAM, V109, P212, DOI 10.1016/j.scienta.2006.03.007; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gomez P, 1999, PLANTA, V209, P172, DOI 10.1007/s004250050619; Gourdji SM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024041; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; Hedhly A, 2009, TRENDS PLANT SCI, V14, P30, DOI 10.1016/j.tplants.2008.11.001; Horn R, 2014, MITOCHONDRION, V19, P198, DOI 10.1016/j.mito.2014.04.004; Iwahori S., 1965, J JAPANESE SOC HORTI, V34, P33, DOI [DOI 10.2503/JJSHS.34.33, 10.2503/jjshs.34.33]; Kramer EM, 1998, GENETICS, V149, P765; Ku SJ, 2003, PLANTA, V217, P559, DOI 10.1007/s00425-003-1030-7; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lozano R, 1998, PLANT PHYSIOL, V117, P91, DOI 10.1104/pp.117.1.91; Mazzucato A, 2008, PHYSIOL PLANTARUM, V132, P526, DOI 10.1111/j.1399-3054.2007.01035.x; Min L, 2013, PLANT J, V75, P823, DOI 10.1111/tpj.12245; NASH AF, 1985, HORTSCIENCE, V20, P440; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Parish RW, 2012, FUNCT PLANT BIOL, V39, P553, DOI 10.1071/FP12090; Peet MM, 1998, PLANT CELL ENVIRON, V21, P225, DOI 10.1046/j.1365-3040.1998.00281.x; Pino-Nunes LE, 2009, ACTA HORTIC, V821, P63; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quinet M, 2014, J EXP BOT, V65, P2243, DOI 10.1093/jxb/eru089; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; SAINI HS, 1984, AUST J PLANT PHYSIOL, V11, P243, DOI 10.1071/PP9840243; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; SAWHNEY VK, 1973, AM J BOT, V60, P514, DOI 10.2307/2441374; Singh I, 2005, PLANT GROWTH REGUL, V47, P111, DOI 10.1007/s10725-005-3252-0; Song JJ, 2002, PLANT CELL PHYSIOL, V43, P619, DOI 10.1093/pcp/pcf078; Su Z, 2013, PLANT CELL, V25, P3785, DOI 10.1105/tpc.113.115428; Suzuki K, 2001, SEX PLANT REPROD, V13, P293, DOI 10.1007/s004970100071; Tang RS, 2008, PLANT GROWTH REGUL, V54, P37, DOI 10.1007/s10725-007-9225-8; Teixeira RT, 2005, PLANT J, V42, P731, DOI 10.1111/j.1365-313X.2005.02407.x; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wu QY, 2012, PLANT BIOTECHNOL J, V10, P945, DOI 10.1111/j.1467-7652.2012.00723.x; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; ZHANG HQ, 1983, PLANT CELL ENVIRON, V6, P471; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	56	25	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167614	10.1371/journal.pone.0167614	http://dx.doi.org/10.1371/journal.pone.0167614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936079	Green Published, gold			2022-12-26	WOS:000389587100130
J	Rajabi, M; Roxhed, N; Shafagh, RZ; Haraldson, T; Fischer, AC; van der Wijngaart, W; Stemme, G; Niklaus, F				Rajabi, Mina; Roxhed, Niclas; Shafagh, Reza Zandi; Haraldson, Tommy; Fischer, Andreas Christin; van der Wijngaart, Wouter; Stemme, Goran; Niklaus, Frank			Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing	PLOS ONE			English	Article							POLYMER MICRONEEDLES; DRUG; SKIN; ELECTRONICS; PREDICTION; SENSORS; FORCE; PAIN	This paper demonstrates flexible and stretchable microneedle patches that combine soft and flexible base substrates with hard and sharp stainless steel microneedles. An elastomeric polymer base enables conformal contact between the microneedle patch and the complex topography and texture of the underlying skin, while robust and sharp stainless steel microneedles reliably pierce the outer layers of the skin. The flexible microneedle patches have been realized by magnetically assembling short stainless steel microneedles into a flexible polymer supporting base. In our experimental investigation, the microneedle patches were applied to human skin and an excellent adaptation of the patch to the wrinkles and deformations of the skin was verified, while at the same time the microneedles reliably penetrate the surface of the skin. The unobtrusive flexible and stretchable microneedle patches have great potential for transdermal biointerfacing in a variety of emerging applications such as transdermal drug delivery, bioelectric treatments and wearable bio-electronics for health and fitness monitoring.	[Rajabi, Mina; Roxhed, Niclas; Shafagh, Reza Zandi; Haraldson, Tommy; Fischer, Andreas Christin; van der Wijngaart, Wouter; Stemme, Goran; Niklaus, Frank] KTH Royal Inst Technol, Sch Elect Engn, Dept Micro & Nanosyst, Stockholm, Sweden; [Fischer, Andreas Christin] Karlsruhe Inst Technol, Inst Nanotechnol, Karlsruhe, Germany	Royal Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Rajabi, M (corresponding author), KTH Royal Inst Technol, Sch Elect Engn, Dept Micro & Nanosyst, Stockholm, Sweden.	minar@kth.s	Shafagh, Reza Zandi/AAH-4641-2020; van der Wijngaart, Wouter/O-2378-2019	Shafagh, Reza Zandi/0000-0003-4322-6192; van der Wijngaart, Wouter/0000-0001-8248-6670; Roxhed, Niclas/0000-0002-7147-6730	European Research Council (ERC) [277879 MM's, 267528 xMEMS]	European Research Council (ERC)(European Research Council (ERC))	The authors are grateful to European Research Council (ERC) for the grant agreements No. 277879 M&M's and No. 267528 xMEMS. Novo Nordisk A/S is gratefully acknowledged for kindly providing stainless steel needles.	Bandodkar AJ, 2014, BIOSENS BIOELECTRON, V54, P603, DOI 10.1016/j.bios.2013.11.039; Bleiker SJ, 2016, PROC IEEE MICR ELECT, P577, DOI 10.1109/MEMSYS.2016.7421691; Carlborg CF, 2014, J POLYM SCI POL CHEM, V52, P2604, DOI 10.1002/pola.27276; Choi S, 2016, ADV MATER, V28, P4203, DOI 10.1002/adma.201504150; Dagdeviren C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5496; Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010; DONNELLY RF, 2010, J DRUG DELIV, V17, P187, DOI DOI 10.3109/10717541003667798; Feng X, 2011, ACS NANO, V5, P3326, DOI 10.1021/nn200477q; Fischer AC, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/10/105001; Gill HS, 2008, CLIN J PAIN, V24, P585, DOI 10.1097/AJP.0b013e31816778f9; Hattori Y, 2014, ADV HEALTHC MATER, V3, P1597, DOI 10.1002/adhm.201400073; Huang X, 2014, ADV FUNCT MATER, V24, P3846, DOI 10.1002/adfm.201303886; Huang X, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0052-8; Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849; Ito Y, 2012, INT J PHARMACEUT, V436, P387, DOI 10.1016/j.ijpharm.2012.06.047; Jicheng Y, 2015, PNAS, V112, P8260, DOI [10.1073/pnas.1505405112, DOI 10.1073/PNAS.1505405112]; Kaushik S, 2001, ANESTH ANALG, V92, P502, DOI 10.1213/00000539-200102000-00041; Kim DH, 2012, ANNU REV BIOMED ENG, V14, P113, DOI [10.1146/annurev-bioeng-071811-150018, 10.1146/annurev.bioeng-071811-150018]; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Lee H, 2016, NAT NANOTECHNOL, V11, P566, DOI [10.1038/NNANO.2016.38, 10.1038/nnano.2016.38]; Lu NS, 2014, SOFT ROBOT, V1, P53, DOI 10.1089/soro.2013.0005; Miller PR, 2014, HEALTHC MATER, V3, P948, DOI DOI 10.1002/adhm.201470032; Olatunji O, 2013, J PHARM SCI-US, V102, P1209, DOI 10.1002/jps.23439; Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Roxhed N, 2007, J MICROELECTROMECH S, V16, P1429, DOI 10.1109/JMEMS.2007.907461; Son D, 2014, NAT NANOTECHNOL, V9, P397, DOI [10.1038/nnano.2014.38, 10.1038/NNANO.2014.38]; Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005; Vecchione R, 2014, ADV FUNCT MATER, V24, P3515, DOI 10.1002/adfm.201303679; Xiang ZL, 2016, MICROSYST NANOENG, V2, DOI 10.1038/micronano.2016.12; Xiang ZL, 2016, ADV MATER, V28, P4472, DOI 10.1002/adma.201503423; Yang SX, 2015, ADV MATER, V27, P6423, DOI 10.1002/adma.201502386; Yung KL, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/015016	34	38	42	9	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166330	10.1371/journal.pone.0166330	http://dx.doi.org/10.1371/journal.pone.0166330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935976	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100025
J	Suzuki, K; Takano, H; Kubota, Y; Inui, K; Nakamura, S; Tokita, Y; Kato, K; Asai, K; Shimizu, W				Suzuki, Keishi; Takano, Hitoshi; Kubota, Yoshiaki; Inui, Keisuke; Nakamura, Shunichi; Tokita, Yukichi; Kato, Koji; Asai, Kuniya; Shimizu, Wataru			Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CARDIOVASCULAR-DISEASE; FIBROUS CAP; RISK-FACTOR; PATHOPHYSIOLOGY; ATHEROSCLEROSIS; HYPERGLYCEMIA; POPULATION; THROMBOSIS; MORPHOLOGY	Background Impaired glucose tolerance (IGT) patients are known to have a high risk of cardiovascular events and their prognosis has been reported to be poor. The present study aimed to compare coronary plaque characteristics among coronary artery disease (CAD) patients with normal glucose tolerance (NGT), those with IGT, and those with diabetes mellitus (DM) by using optical coherence tomography (OCT). Methods The present study included 101 coronary artery disease patients (mean age, 67.9 +/- 10.4 years; 82.4% male). OCT was performed for target and non-target vessels during percutaneous coronary intervention. The patients were divided into the following 3 groups: the NGT, IGT, and DM groups. Results A total of 136 non-target residual plaques were found in 101 patients (27, 30, and 44 in the NGT, IGT, and DM groups, respectively). The size of the lipid core expressed as the mean angle of the lipid arc was significantly greater in the IGT and DM groups than in the NGT group (163.0 +/- 58.7 E, 170.1 +/- 59.3 E, and 130.9 +/- 37.7 E, respectively, P < 0.05). The fibrous cap covering the lipid core was significantly thinner in the IGT group than in the NGT group (77.0 +/- 23.4 mu m vs. 105.6 +/- 47.0 mu m, P = 0.040). Conclusion The coronary plaques in CAD patients are more vulnerable when having IGT compared to those with NGT, and similar to those with DM. This finding may explain the high risk of cardiovascular events in CAD patients with IGT.	[Suzuki, Keishi; Takano, Hitoshi; Kubota, Yoshiaki; Inui, Keisuke; Nakamura, Shunichi; Tokita, Yukichi; Kato, Koji; Asai, Kuniya; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan	Nippon Medical School	Takano, H (corresponding author), Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan.	htakano@nms.ac.jp						Ahmadi A, 2016, CIRC RES, V119, P317, DOI 10.1161/CIRCRESAHA.116.308952; Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Capaldo B, 2013, DIABETES CARE, V36, P992, DOI 10.2337/dc12-1501; Chiasson JL, 1998, DIABETES CARE, V21, P1720, DOI 10.2337/diacare.21.10.1720; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Inami S, 2012, INT HEART J, V53, P261, DOI 10.1536/ihj.53.261; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Kato K, 2012, JACC-CARDIOVASC INTE, V5, P1150, DOI 10.1016/j.jcin.2012.06.019; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Kuhl J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0283-3; Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Kurihara O, 2013, DIABETES CARE, V36, P729, DOI 10.2337/dc12-1635; Kuroda M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0236-x; Lenzen M., 2006, J APPL INPUT OUTPUT, V11 12, P1, DOI DOI 10.1093/EURHEARTJ/EHL363; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Noor R, 2007, ATHEROSCLEROSIS, V192, P92, DOI 10.1016/j.atherosclerosis.2006.06.023; Ozaki Y, 2013, CIRC J, V77, P2982, DOI 10.1253/circj.CJ-13-0512; Rodriguez BL, 1996, DIABETES CARE, V19, P587, DOI 10.2337/diacare.19.6.587; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Takano M, 2009, J AM COLL CARDIOL, V55, P26, DOI 10.1016/j.jacc.2009.08.032; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920	35	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167645	10.1371/journal.pone.0167645	http://dx.doi.org/10.1371/journal.pone.0167645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936195	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100140
J	Yamamoto, T; Furuhashi, M; Sugaya, T; Oikawa, T; Matsumoto, M; Funahashi, Y; Matsukawa, Y; Gotoh, M; Miura, T				Yamamoto, Tokunori; Furuhashi, Masato; Sugaya, Takeshi; Oikawa, Tsuyoshi; Matsumoto, Megumi; Funahashi, Yasuhito; Matsukawa, Yoshihisa; Gotoh, Momokazu; Miura, Tetsuji			Transcriptome and Metabolome Analyses in Exogenous FABP4-and FABP5-Treated Adipose-Derived Stem Cells	PLOS ONE			English	Article							ACID-BINDING PROTEIN; STRESS URINARY-INCONTINENCE; PERIURETHRAL INJECTION; PLASMA FATTY-ACID-BINDING-PROTEIN-4; REGENERATIVE CELLS; APOLIPOPROTEIN-E; OBESITY; BIOMARKER; AP2; ATHEROSCLEROSIS	Adipose-derived stem cells (ADSC), which exist near adipocytes in adipose tissue, have been used as a potential tool of regenerative medicine. Lipid chaperones, fatty acid-binding protein 4 (FABP4) and 5 (FABP5), are abundantly expressed in adipocytes. FABP4 has recently been shown to be secreted from adipocytes during lipolysis in a non-classical pathway and may act as an adipokine. Here, we investigated the role of exogenous FABP4 and FABP5 in transcriptional and metabolic regulation in ADSC. FABP4 and FABP5 were little expressed in ADSC. However, both FABP4 and FABP5 were significantly induced after adipocyte differentiation of ADSC and were secreted from the differentiated adipocytes. Analysis of microarray data, including gene ontology enrichment analysis and cascade analysis of the protein-protein interaction network using a transcription factor binding site search, demonstrated that treatment of ADSC with FABP4 or FABP5 affected several kinds of genes related to inflammatory and metabolic responses and the process of cell differentiation. Notably, myogenic factors, including myocyte enhancer factors, myogenic differentiation 1 and myogenin, were modulated by treatment of ADSC with FABP4, indicating that exogenous FABP4 treatment is partially associated with myogenesis in ADSC. Metabolome analysis showed that treatment of ADSC with FABP4 and with FABP5 similarly, but differently in extent, promoted hydrolysis and/or uptake of lipids, consequentially together with enhancement of beta oxidation, inhibition of downstream of the glycolysis pathway, accumulation of amino acids, reduction of nucleic acid components and increase in the ratio of reduced and oxidized nicotinamide adenine dinucleotide phosphates (NADPH/NADP(+)), an indicator of reducing power, and the ratio of adenosine triphosphate and adenosine monophosphate (ATP/AMP), an indicator of the energy state, in ADSC. In conclusion, secreted FABP4 and FABP5 from adipocytes as adipokines differentially affect transcriptional and metabolic regulation in ADSC near adipocytes. The adiposity condition in the host of regenerative medicine may affect characteristics of ADSC by exposure of the balance of FABP4 and FABP5.	[Yamamoto, Tokunori; Funahashi, Yasuhito; Matsukawa, Yoshihisa; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi, Japan; [Furuhashi, Masato; Matsumoto, Megumi; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido, Japan; [Sugaya, Takeshi] St Marianna Univ, Sch Med, Dept Hypertens & Nephrol, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Sugaya, Takeshi; Oikawa, Tsuyoshi] CIMIC Co Ltd, Bunkyo Ku, Mass Bldg Yushima, Tokyo, Japan	Nagoya University; Sapporo Medical University; Saint Marianna University	Furuhashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Furuhashi, Masato/AAT-5518-2021; Gotoh, Momokazu/I-7239-2014	Furuhashi, Masato/0000-0002-0145-3541; Oikawa, Tsuyoshi/0000-0002-1546-6714	Nagoya University Hospital; Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan; JSPS KAKENHI; MEXT Translational Research Network Program; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation; Naito Foundation Natural Science Scholarship; Suhara Memorial Foundation; Kondou Kinen Medical Foundation; CIMIC Co., Ltd.	Nagoya University Hospital; Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Translational Research Network Program; Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation; Naito Foundation Natural Science Scholarship; Suhara Memorial Foundation; Kondou Kinen Medical Foundation; CIMIC Co., Ltd.	MG and TY have been supported by a grant from Nagoya University Hospital and a Health Labor Science Research Grant for Research on incurable disease and cancer from the Ministry of Health, Labor and Welfare of Japan. M.F. has been supported by grants from JSPS KAKENHI, MEXT Translational Research Network Program, Uehara Memorial Foundation, SENSHIN Medical Research Foundation, Japan Diabetes Foundation, Takeda Medical Research Foundation, Ono Medical Research Foundation, Takeda Science Foundation, Akiyama Life Science Foundation, Yamaguchi Endocrine Research Foundation, Naito Foundation Natural Science Scholarship, Suhara Memorial Foundation and Kondou Kinen Medical Foundation. CIMIC Co., Ltd. provided support in the form of salaries for TS and TO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Babaev VR, 2011, ARTERIOSCL THROM VAS, V31, P1283, DOI 10.1161/ATVBAHA.111.225839; Bagheri R, 2010, AM J CARDIOL, V106, P1118, DOI 10.1016/j.amjcard.2010.06.028; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Burak MF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6336; Cabre A, 2007, Atherosclerosis, V195, pe150; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Cabre A, 2008, CLIN CHEM, V54, P181, DOI 10.1373/clinchem.2007.094672; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; Ertunc ME, 2015, J LIPID RES, V56, P423, DOI 10.1194/jlr.M055798; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Furuhashi M, 2016, AM J CARDIOL, V118, P198, DOI 10.1016/j.amjcard.2016.04.037; Furuhashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154482; Furuhashi M, 2016, ARTERIOSCL THROM VAS, V36, P825, DOI 10.1161/ATVBAHA.116.307225; Furuhashi M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0177-8; Furuhashi M, 2015, J LIPID RES, V56, P2372, DOI 10.1194/jlr.M059469; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Girona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081914; Gotoh M, 2014, INT J UROL, V21, P294, DOI 10.1111/iju.12266; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.01835.x; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P358, DOI 10.1128/AEM.69.1.358-366.2003; Kralisch S, 2013, INT J OBES; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Masoodi M, 2014, BIOCH BIOPHYS ACTA; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Saito N, 2010, CURR OPIN MICROBIOL, V13, P358, DOI 10.1016/j.mib.2010.04.006; Schlottmann I, 2013, INT J OBES; Simpson MA, 1999, MOL CELL BIOCHEM, V192, P33, DOI 10.1023/A:1006819715146; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Watanabe T, 2011, INT J UROL, V18, P659, DOI 10.1111/j.1442-2042.2011.02795.x; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu LE, 2014, MOL METAB, V3, P465, DOI 10.1016/j.molmet.2014.02.005; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamamoto T, 2012, INT J UROL, V19, P652, DOI 10.1111/j.1442-2042.2012.02999.x; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295	55	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167825	10.1371/journal.pone.0167825	http://dx.doi.org/10.1371/journal.pone.0167825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936164	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100208
J	Wu, H; Zhang, XY; Hu, Z; Hou, Q; Zhang, H; Li, Y; Li, S; Yue, J; Jiang, Z; Weissman, SM; Pan, X; Ju, BG; Wu, S				Wu, H.; Zhang, X-Y; Hu, Z.; Hou, Q.; Zhang, H.; Li, Y.; Li, S.; Yue, J.; Jiang, Z.; Weissman, S. M.; Pan, X.; Ju, B-G; Wu, S.			Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing	ONCOGENE			English	Article							COLON-CANCER; INTRATUMOR HETEROGENEITY; SOMATIC MUTATIONS; EPITHELIAL-CELLS; PROSTATE-CANCER; BREAST-CANCER; IN-VIVO; TUMOR; IDENTIFICATION; INSTABILITY	Recently single-cell whole-exome sequencing (scWES) has deeply expanded and sharpened our knowledge of cancer evolution and subclonality. Herein, with scWES and matched bulk whole-exome sequencing (bulk WES) on two colorectal cancer (CRC) patients with normal or adenomatous polyps, we found that both the adenoma and cancer were of monoclonal origin, and both shared partial mutations in the same signaling pathways, but each showed a specific spectrum of heterogeneous somatic mutations. In addition, the adenoma and cancer further developed intratumor heterogeneity with the accumulation of nonrandom somatic mutations specifically in GPCR, PI3K-Akt and FGFR signaling pathways. We identified novel driver mutations that developed during adenoma and cancer evolution, particularly in OR1B1 (GPCR signaling pathway) for adenoma evolution, and LAMA1 (PI3K-Akt signaling pathway) and ADCY3 (FGFR signaling pathway) for CRC evolution. In summary, we demonstrated that both colorectal adenoma and CRC are monoclonal in origin, and the CRCs further diversified into different subclones with heterogeneous mutation profiles accumulating in GPCR, PI3K-Akt and FGFR signaling pathways. ScWES provides evidence for the importance of mutations in certain pathways that would not be as apparent from bulk sequencing of tumors, and can potentially establish whether specific mutations are mutually exclusive or occur sequentially in the same subclone of cells.	[Wu, H.; Zhang, X-Y; Hu, Z.; Hou, Q.; Zhang, H.; Li, Y.; Li, S.; Yue, J.; Jiang, Z.; Wu, S.] Hangzhou Canc Hosp, Canc Res Inst, 34 Yanguan St, Hangzhou 310002, Zhejiang, Peoples R China; [Wu, H.; Ju, B-G] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Weissman, S. M.; Pan, X.] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA	Sogang University; Yale University	Wu, S (corresponding author), Hangzhou Canc Hosp, Canc Res Inst, 34 Yanguan St, Hangzhou 310002, Zhejiang, Peoples R China.; Ju, BG (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.; Pan, X (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.	xinghua.pan@yale.edu; bgju@sogang.ac.kr; wushixiu@medmail.com.cn	Wu, Hongjin/AAF-6122-2019	Wu, Hongjin/0000-0002-2053-7441; Pan, Xinghua (Victor)/0000-0002-7421-8155	Natural Science Foundation of Zhejiang Province [LZ15H220001, LY14H160005]; Zhejiang Medical and Health Ministry Training Program [2015PYA009]; The Science and Technology of Hangzhou Medical and Health Project [2012ZD001]; National Natural Science Foundation of China (CN) [81402529]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Medical and Health Ministry Training Program; The Science and Technology of Hangzhou Medical and Health Project; National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC))	We thank Dr Sherman Weissman for his critical comments on the manuscript. We are indebted to all the individuals who consented to participate in this study. ScWES and bulk WES was performed at the Genseeq Company. The sequenced data was analyzed by Yunkang Biotechnology Co. Ltd. This work was supported by Natural Science Foundation of Zhejiang Province (LZ15H220001 and LY14H160005), Zhejiang Medical and Health Ministry Training Program (2015PYA009), The Science and Technology of Hangzhou Medical and Health Project (2012ZD001), National Natural Science Foundation of China (CN; 81402529).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ashktorab H, 2013, EPIGENETICS-US, V8, P807, DOI 10.4161/epi.25497; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Cebrat M, 2004, CANCER LETT, V206, P107, DOI 10.1016/j.canlet.2003.10.024; Charbonneau B, 2012, AM J HEMATOL, V87, P880, DOI 10.1002/ajh.23273; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gemoll T., 2015, CANCER RES, V200, P81; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Gylfe AE, 2010, INT J CANCER, V127, P2974, DOI 10.1002/ijc.25529; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Huang L, 2015, ANNU REV GENOM HUM G, V16, P79, DOI 10.1146/annurev-genom-090413-025352; Kanojia D, 2015, ONCOTARGET, V6, P42429, DOI 10.18632/oncotarget.6464; Katayama K, 2013, CANCER SCI, V104, P694, DOI 10.1111/cas.12145; Kirley SD, 2005, CANCER BIOL THER, V4, P861, DOI 10.4161/cbt.4.8.1894; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Latini FRM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-11; Lederer A, 2015, HEPATOLOGY, V62, P841, DOI 10.1002/hep.27885; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lind GE, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-85; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Lum AM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-40; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Palamaro L, 2014, INT REV IMMUNOL, V33, P83, DOI 10.3109/08830185.2013.870171; Patel Swati G, 2012, Curr Gastroenterol Rep, V14, P428, DOI 10.1007/s11894-012-0280-6; Pericas JM, 2016, NEW ENGL J MED, V375, P387, DOI [10.1056/NEJMra1513581, 10.1056/NEJMc1604867]; Peters U, 2015, GUT, V64, P1623, DOI 10.1136/gutjnl-2013-306705; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Ross JB, 2015, NAT CELL BIOL, V17, P651, DOI 10.1038/ncb3148; Rowe J, 2001, J CELL SCI, V114, P3323; Seneviratne D, 2015, GASTROENTEROLOGY, V148, P181, DOI 10.1053/j.gastro.2014.09.019; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Tsukahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081139; Vasen HFA, 2000, J CLIN ONCOL, V18, p81S; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wang ZY, 2012, GYNECOL ONCOL, V127, P403, DOI 10.1016/j.ygyno.2012.08.007; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yu C, 2014, CELL RES, V24, P701, DOI 10.1038/cr.2014.43; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang R, 2014, TUMOR BIOL, V35, P4419, DOI 10.1007/s13277-013-1581-6; Zhang XY, 2016, CANCER RES, V76, P1305, DOI 10.1158/0008-5472.CAN-15-1907	52	39	39	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2857	2867		10.1038/onc.2016.438	http://dx.doi.org/10.1038/onc.2016.438			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27941887				2022-12-26	WOS:000401697800008
J	Papadopoulos, T; Rhee, HJ; Subramanian, D; Paraskevopoulou, F; Mueller, R; Schultz, C; Brose, N; Rhee, JS; Betz, H				Papadopoulos, Theofilos; Rhee, Hong Jun; Subramanian, Devaraj; Paraskevopoulou, Foteini; Mueller, Rainer; Schultz, Carsten; Brose, Nils; Rhee, Jeong-Seop; Betz, Heinrich			Endosomal Phosphatidylinositol 3-Phosphate Promotes Gephyrin Clustering and GABAergic Neurotransmission at Inhibitory Postsynapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PHOSPHOINOSITIDE 3-KINASE; RECEPTOR-ASSOCIATED PROTEIN; GLYCINE RECEPTOR; PLASMA-MEMBRANE; DEFICIENT MICE; ALPHA-ISOFORM; COLLYBISTIN; ACTIVATION; TRAFFICKING; SYNAPSES	The formation of neuronal synapses and the dynamic regulation of their efficacy depend on the proper assembly of the postsynaptic neurotransmitter receptor apparatus. Receptor recruitment to inhibitory GABAergic postsynapses requires the scaffold protein gephyrin and the guanine nucleotide exchange factor collybistin (Cb). In vitro, the pleckstrin homology domain of Cb binds phosphoinositides, specifically phosphatidylinositol 3-phosphate (PI3P). However, whether PI3P is required for inhibitory postsynapse formation is currently unknown. Here, we investigated the role of PI3P at developing GABAergic postsynapses by using a membrane-permeant PI3P derivative, time-lapse confocal imaging, electrophysiology, as well as knockdown and overexpression of PI3P-metabolizing enzymes. Our results provide the first in cellula evidence that PI3P located at early/sorting endosomes regulates the postsynaptic clustering of gephyrin and GABAA receptors and the strength of inhibitory, but not excitatory, postsynapses in cultured hippocampal neurons. In human embryonic kidney 293 cells, stimulation of gephyrin cluster formation by PI3P depends on Cb. We therefore conclude that the endosomal pool of PI3P, generated by the class III phosphatidylinositol 3-kinase, is important for the Cb-mediated recruitment of gephyrin and GABAA receptors to developing inhibitory postsynapses and thus the formation of postsynaptic membrane specializations.	[Papadopoulos, Theofilos; Paraskevopoulou, Foteini] Univ Med Gottingen, Dept Mol Biol, Ctr Biochem & Mol Cell Biol, Humboldtallee 23, D-37073 Gottingen, Germany; [Rhee, Hong Jun; Brose, Nils; Rhee, Jeong-Seop] Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Subramanian, Devaraj; Mueller, Rainer; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Schultz, Carsten] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany; [Betz, Heinrich] Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany; [Paraskevopoulou, Foteini] Charite, NeuroCure Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany	University of Gottingen; Max Planck Society; European Molecular Biology Laboratory (EMBL); Oregon Health & Science University; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Papadopoulos, T (corresponding author), Univ Med Gottingen, Dept Mol Biol, Ctr Biochem & Mol Cell Biol, Humboldtallee 23, D-37073 Gottingen, Germany.	theofilos.papadopoulos@med.uni-goettingen.de		Papadopoulos, Theofilos/0000-0002-0684-2407; Mueller, Rainer/0000-0003-3464-494X	German Research Foundation [PA2087/1-3, SFB1190/P10, TRR83]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grants PA2087/1-3 (to T. P.), SFB1190/P10 (to N. B.), and TRR83 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Brown RA, 2001, BIOCHEM SOC T, V29, P535, DOI 10.1042/BST0290535; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgalossi A, 2012, NAT PROTOC, V7, P1351, DOI 10.1038/nprot.2012.074; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Ktori C, 2003, BIOCHEM BIOPH RES CO, V306, P139, DOI 10.1016/S0006-291X(03)00933-1; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Long P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00083; Ludolphs M, 2016, J BIOL CHEM, V291, P244, DOI 10.1074/jbc.M115.673400; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Mentel M, 2011, ANGEW CHEM INT EDIT, V50, P3811, DOI 10.1002/anie.201007796; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos T, 2015, J BIOL CHEM, V290, P8256, DOI 10.1074/jbc.M114.633024; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SEITANIDOU T, 1992, J NEUROSCI, V12, P116; Soykan T, 2014, EMBO J, V33, P2113, DOI 10.15252/embj.201488143; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stopkova P, 2004, BIOL PSYCHIAT, V55, P981, DOI 10.1016/j.biopsych.2004.01.014; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Traer Colin J, 2006, Bull Cancer, V93, pE53; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012	59	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1160	1177		10.1074/jbc.M116.771592	http://dx.doi.org/10.1074/jbc.M116.771592			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941024	Green Published, hybrid			2022-12-26	WOS:000393339800002
J	Aizpurua, O; Alberdi, A; Aihartza, J; Garin, I				Aizpurua, Ostaizka; Alberdi, Antton; Aihartza, Joxerra; Garin, Inazio			Fishing Technique of Long-Fingered Bats Was Developed from a Primary Reaction to Disappearing Target Stimuli	PLOS ONE			English	Article							MYOTIS-CAPACCINII BONAPARTE; INNATE; PREY; BEHAVIOR; ECHOLOCATION; PLASTICITY; PISCIVORY	Behavioral plasticity is a key feature allowing animals to broaden their dietary niche when novel food resources become available, and long-fingered bats provide an appropriate model system to study the underpinnings of behavioral plasticity, since although generally being an insectivorous species, some individuals have been reported to catch fish. Aiming to get insight into the origin of fishing behavior in long-fingered bats, we studied in the field the differences in sensorial and mechanical reactions to insect-like (stationary) and fish-like (temporary) prey stimuli between well-known piscivorous and strictly insectivorous individuals. Both piscivorous and insectivorous individuals exhibited a qualitatively similar reaction to temporary target stimuli (longer and deeper dips and terminal echolocation phase skewed towards buzz I compared to stationary stimuli). Nevertheless, the quantitative differences observed in the sensorial and mechanical features (the intensity of the shift was significantly greater in piscivorous than in insectivorous individuals) show that piscivorous individuals have honed their capture technique likely enhancing the fishing success. Thus, our results suggest that the fishing technique was developed from a primary reaction shared by all long-fingered bats. All individuals seem to be mechanically and sensorially adapted to detect and capture fish, although under appropriate environmental conditions, they would further improve their technique by experience and/or social learning.	[Aizpurua, Ostaizka; Alberdi, Antton] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Aizpurua, Ostaizka; Alberdi, Antton; Aihartza, Joxerra; Garin, Inazio] Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, UPV EHU, Leioa, The Basque Coun, Spain	University of Copenhagen; University of Basque Country	Aizpurua, O (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark.; Aizpurua, O (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, UPV EHU, Leioa, The Basque Coun, Spain.	ostaizka.aizpurua@snm.ku.dk	Aihartza, Joxerra/GSO-2446-2022; Aizpurua, Ostaizka/V-9490-2019; Aihartza, Joxerra/Z-3061-2019; Garin, Inazio/B-8115-2009; Alberdi, Antton/M-2423-2017	Aizpurua, Ostaizka/0000-0001-8053-3672; Aihartza, Joxerra/0000-0003-0882-8964; Alberdi, Antton/0000-0002-2875-6446	Ministerio de Ciencia e Innovacion (MICINN) project [CGL2009-12393]; University of The Basque Country (UPV/EHU) [INF09/15]; Basque Government [IT385-07, IT301-10, BFI-2009-252, BFI-2010-190]	Ministerio de Ciencia e Innovacion (MICINN) project; University of The Basque Country (UPV/EHU); Basque Government(Basque Government)	This study was part of the Ministerio de Ciencia e Innovacion (MICINN) project CGL2009-12393. The University of The Basque Country (UPV/EHU) (INF09/15) and the Basque Government (IT385-07 and IT301-10) funded this study and provided grant support to O.A. and A.A. (BFI-2009-252, BFI-2010-190, Doktore berriak eta Ikertraile doktoreak espezializatreko kontratatzeko laguntzak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihartza J, 2008, ACTA CHIROPTEROL, V10, P287, DOI 10.3161/150811008X414863; Aihartza JR, 2003, ACTA CHIROPTEROL, V5, P193, DOI 10.3161/001.005.0204; Aizpurua O, 2015, SCI REP-UK, V5, DOI 10.1038/srep12392; Aizpurua O, 2014, J EXP BIOL, V217, P3318, DOI 10.1242/jeb.104992; Aizpurua O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080163; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Almenar David, 2009, Endangered Species Research, V8, P69, DOI 10.3354/esr00183; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Bateson P, 2007, DEV PSYCHOBIOL, V49, P818, DOI 10.1002/dev.20277; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; Geberl C, 2015, P NATL ACAD SCI USA, V112, P4122, DOI 10.1073/pnas.1424457112; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Heyes CM., 1996, SOCIAL LEARNING ANIM; Jablonski PG, 2006, BEHAV ECOL, V17, P925, DOI 10.1093/beheco/arl039; Jakobsen L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00089; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; Nelson DA, 2000, P NATL ACAD SCI USA, V97, P13348, DOI 10.1073/pnas.240457797; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Wright GS, 2011, ANIM BEHAV, V82, P1075, DOI 10.1016/j.anbehav.2011.07.044	24	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167164	10.1371/journal.pone.0167164	http://dx.doi.org/10.1371/journal.pone.0167164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973529	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300018
J	Beck, ON; Taboga, P; Grabowski, AM				Beck, Owen N.; Taboga, Paolo; Grabowski, Alena M.			Characterizing the Mechanical Properties of Running-Specific Prostheses	PLOS ONE			English	Article							LEG STIFFNESS; STRIDE FREQUENCY; SPEED; GRAVITY; FORCE; POWER; KNEE	The mechanical stiffness of running-specific prostheses likely affects the functional abilities of athletes with leg amputations. However, each prosthetic manufacturer recommends prostheses based on subjective stiffness categories rather than performance based metrics. The actual mechanical stiffness values of running-specific prostheses (i.e. kN/m) are unknown. Consequently, we sought to characterize and disseminate the stiffness values of running-specific prostheses so that researchers, clinicians, and athletes can objectively evaluate prosthetic function. We characterized the stiffness values of 55 running-specific prostheses across various models, stiffness categories, and heights using forces and angles representative of those measured from athletes with transtibial amputations during running. Characterizing prosthetic force-displacement profiles with a 2nd degree polynomial explained 4.4% more of the variance than a linear function (p< 0.001). The prosthetic stiffness values of manufacturer recommended stiffness categories varied between prosthetic models (p< 0.001). Also, prosthetic stiffness was 10% to 39% less at angles typical of running 3 m/s and 6 m/s (10 degrees-25 degrees) compared to neutral (0 degrees) (p< 0.001). Furthermore, prosthetic stiffness was inversely related to height in J-shaped (p< 0.001), but not C-shaped, prostheses. Running-specific prostheses should be tested under the demands of the respective activity in order to derive relevant characterizations of stiffness and function. In all, our results indicate that when athletes with leg amputations alter prosthetic model, height, and/ or sagittal plane alignment, their prosthetic stiffness profiles also change; therefore variations in comfort, performance, etc. may be indirectly due to altered stiffness.	[Beck, Owen N.; Taboga, Paolo; Grabowski, Alena M.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Grabowski, Alena M.] Eastern Colorado Healthcare Syst, Dept Vet Affairs, Denver, CO USA	University of Colorado System; University of Colorado Boulder	Beck, ON (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	Owen.Beck@colorado.edu		GRABOWSKI, ALENA/0000-0002-4432-618X; TABOGA, PAOLO/0000-0001-6529-8299	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement [W81XWH-11-2-0222]	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement	This project was supported by the BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement (W81XWH-11-2-0222), http://www.defense.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Orthopedic Specialty Hospital in Murray, Utah. We also thank Freedom Innovations, Ossur, and Ottobock for donating the running -specific prostheses used in this study. This project was supported by the BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement (W81XWH-11-2-0222). The authors have no conflicts of interest to disclose.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; [Anonymous], 2006, PROSTHETICS STRUCTUR; [Anonymous], 2014, INSTR US FLEX RUN, P1; [Anonymous], FITT GUID TT SPORTS, P9; [Anonymous], 2014, CAT CAT INF, P2; Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Arellano CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115637; Arellano CJ, 2011, J BIOMECH, V44, P1291, DOI 10.1016/j.jbiomech.2011.01.002; Baum BS, 2013, ARCH PHYS MED REHAB, V94, P1776, DOI 10.1016/j.apmr.2013.03.010; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; Chang YH, 2001, J BIOMECH, V34, P679, DOI 10.1016/S0021-9290(00)00196-2; CZERNIECKI JM, 1991, J BIOMECH, V24, P63, DOI 10.1016/0021-9290(91)90327-J; Dyer BTJ, 2014, ASSIST TECHNOL, V26, P157, DOI 10.1080/10400435.2014.888599; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; FARLEY CT, 1993, J EXP BIOL, V185, P71; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Grabowski AM, 2008, J APPL BIOMECH, V24, P288, DOI 10.1123/jab.24.3.288; Grabowski AM, 2009, BIOL LETT; HE JP, 1991, J APPL PHYSIOL, V71, P863, DOI 10.1152/jappl.1991.71.3.863; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Nolan Lee, 2008, Foot Ankle Surg, V14, P125, DOI 10.1016/j.fas.2008.05.007; Pilkey W.D, 2002, ANAL DESIGN ELASTIC; Snyder KL, 2011, J EXP BIOL, V214, P2089, DOI 10.1242/jeb.053157; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009	31	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168298	10.1371/journal.pone.0168298	http://dx.doi.org/10.1371/journal.pone.0168298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973573	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300074
J	Kjaer, MA; Ruyter, B; Berge, GM; Sun, YJ; Ostbye, TKK				Kjaer, Marte Avranden; Ruyter, Bente; Berge, Gerd Marit; Sun, Yajing; Ostbye, Tone-Kari Knutsdatter			Regulation of the Omega-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALPHA-LINOLENIC ACID; DIETARY VEGETABLE-OIL; RAPESEED OIL; ACYL DESATURASE; FISH-OIL; BETA-OXIDATION; DELTA-6 DESATURASES; LIVER-CELLS; MURRAY COD	Limited availability of the n-3 fatty acids EPA and DHA have led to an interest in better understanding of the n-3 biosynthetic pathway and its regulation. The biosynthesis of alphalinolenic acid to EPA and DHA involves several complex reaction steps including desaturation-, elongation-and peroxisomal beta-oxidation enzymes. The aims of the present experiments were to gain more knowledge on how this biosynthesis is regulated over time by different doses and fatty acid combinations. Hepatocytes isolated from salmon were incubated with various levels and combinations of oleic acid, EPA and DHA. Oleic acid led to a higher expression of the Delta 6 fatty acid desaturase (fad) genes Delta 6fad_a, Delta 6fad_b, Delta 6fad_c and the elongase genes elovl2 compared with cells cultured in medium enriched with DHA. Further, the study showed rhythmic variations in expression over time. Levels were reached where a further increase in specific fatty acids given to the cells not stimulated the conversion further. The gene expression of Delta 6fad_a_ and Delta 6fad_b responded similar to fatty acid treatment, suggesting a co-regulation of these genes, whereas Delta 5fad and Delta 6fad_c showed a different regulation pattern. EPA and DHA induced different gene expression patterns, especially of Delta 6fad_a. Addition of radiolabelled alpha-linolenic acid to the hepatocytes confirmed a higher degree of elongation and desaturation in cells treated with oleic acid compared to cells treated with DHA. This study suggests a complex regulation of the conversion process of n-3 fatty acids. Several factors, such as that the various gene copies are differently regulated, the gene expression show rhythmic variations and gene expression only affected to a certain level, determines when you get the maximum conversion of the beneficial n-3 fatty acids.	[Kjaer, Marte Avranden; Ruyter, Bente; Sun, Yajing; Ostbye, Tone-Kari Knutsdatter] Nofima, As, Norway; [Berge, Gerd Marit] Nofima, Sunndalsora, Norway	Nofima; Nofima	Ostbye, TKK (corresponding author), Nofima, As, Norway.	tone-kari.ostbye@nofima.no		Ostbye, Tone-Kari Knutsdatter/0000-0001-5173-7115	Norwegian Research Council [NFR-207621/E40]; Nofima	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nofima(Nofima)	This work was funded by The Norwegian Research Council (grant no. NFR-207621/E40, www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nofima provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACTISDATO SM, 1973, LIPIDS, V8, P1, DOI 10.1007/BF02533231; Alhazzaa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073719; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell JG, 2003, AQUACULTURE, V218, P515, DOI 10.1016/S0044-8486(02)00462-3; Betancor MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106739; BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; CHRISTIANSEN R, 1976, FEBS LETT, V62, P313, DOI 10.1016/0014-5793(76)80083-X; DANNEVIG BH, 1985, COMP BIOCHEM PHYS B, V82, P683, DOI 10.1016/0305-0491(85)90508-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Francis DS, 2009, AQUAC RES, V40, P1123, DOI 10.1111/j.1365-2109.2009.02208.x; Gibson RA, PROSTAGLANDINS LEUKO; Goyens PLL, 2005, J LIPID RES, V46, P1474, DOI 10.1194/jlr.M400514-JLR200; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; HOSHI M, 1973, J LIPID RES, V14, P599; Izquierdo MS, 2008, FISH PHYSIOL BIOCHEM, V34, P117, DOI 10.1007/s10695-007-9152-7; Kjaer MA, 2008, LIPIDS, V43, P813, DOI 10.1007/s11745-008-3208-z; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARRA CA, 1992, MOL CELL BIOCHEM, V117, P107, DOI 10.1007/BF00230749; MASON ME, 1964, ANAL CHEM, V36, P583, DOI 10.1021/ac60209a008; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Moya-Falcon C, 2004, COMP BIOCHEM PHYS B, V139, P657, DOI 10.1016/j.cbpc.2004.08.009; Moya-Falon C, 2005, LIPIDS, V40, P709, DOI 10.1007/s11745-005-1434-9; NARCE M, 1988, J CHROMATOGR, V448, P249, DOI 10.1016/S0021-9673(01)84587-8; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruyter B, 2003, LIPIDS, V38, P833, DOI 10.1007/s11745-003-1133-6; Ruyter B, 2000, AQUACULT NUTR, V6, P109; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; Ruyter B, 1999, LIPIDS, V34, P1167, DOI 10.1007/s11745-999-0468-3; Sargent John R., 2002, P181; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Sprecher H, 1995, J LIPID RES, V36, P2471; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Thomassen MS, 2012, AQUACULTURE, V360, P78, DOI 10.1016/j.aquaculture.2012.07.001; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2002, FISH PHYSIOL BIOCHEM, V26, P157, DOI 10.1023/A:1025416731014; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Torstensen BE, 2004, LIPIDS, V39, P153, DOI 10.1007/s11745-004-1213-7; Tu WC, 2010, PROSTAG LEUKOTR ESS, V83, P61, DOI 10.1016/j.plefa.2010.04.001; Turchini GM, 2011, FOOD CHEM, V124, P609, DOI 10.1016/j.foodchem.2010.06.083; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	60	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168230	10.1371/journal.pone.0168230	http://dx.doi.org/10.1371/journal.pone.0168230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973547	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000392754300067
J	Zhao, F; Wang, N; Yi, YL; Lin, PF; Tang, KQ; Wang, AH; Jin, YP				Zhao, Fan; Wang, Nan; Yi, Yanglei; Lin, Pengfei; Tang, Keqiong; Wang, Aihua; Jin, Yaping			Knockdown of CREB3/Luman by shRNA in Mouse Granulosa Cells Results in Decreased Estradiol and Progesterone Synthesis and Promotes Cell Proliferation	PLOS ONE			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR LUMAN; UNFOLDED PROTEIN RESPONSE; SIMPLEX-VIRUS VP16; GENE-EXPRESSION; FOLLICULAR DEVELOPMENT; CYCLE ARREST; IN-VITRO; APOPTOSIS	Luman (also known as LZIP or CREB3) is a transcription factor and a member of the cAMP responsive element-binding (CREB) family proteins. Although Luman has been detected in apoptotic granulosa cells and disorganized atretic bodies, the physiological function of Luman in follicular development has not been reported. Our objective is to determine the role of Luman in folliculogenesis by knocking down Luman expression in mouse GCs (granulosa cells) using shRNA. Luman expression was successfully knocked down in mouse GCs at the mRNA and protein level, as confirmed by real-time quantitative PCR, western blot and immunofluorescence staining, respectively. Knockdown of Luman significantly decreased the concentrations of estradiol (E2) and progesterone (P4) in cell culture medium. Furthermore, Luman knockdown promoted cell proliferation but had no effect on cell apoptosis. To elucidate the regulatory mechanism underlying the effects of Luman knockdown on steroid synthesis and cell cycle, we measured the mRNA and protein expression levels of several related genes. The expression of Star, Cyp19a1, and Cyp1b1, which encode steroidogenic enzymes, was down-regulated, while that of Cyp11a1 and Runx2, which also encode steroidogenic enzymes, was up-regulated. The expression of the cell cycle factors Cyclin A1, Cyclin B1, Cyclin D2, and Cyclin E was significantly up-regulated. Among apoptosis-related genes, only Bcl-2 was down-regulated, while Caspase 3, Bax and p53 were not significantly affected, suggesting that Luman knockdown may regulate cell cycle activity and hormone secretion at the transcriptional and translational level in mouse GCs. The expression of two important genes associated with folliculogenesis in mouse GCs, Has2 and Ptgs2, were also significantly altered by Luman knockdown. In conclusion, the findings of this study indicate that Luman regulates mouse GCs modulation of steroid synthesis, cell cycle activity and other regulators of folliculogenesis.	[Zhao, Fan; Wang, Nan; Lin, Pengfei; Tang, Keqiong; Jin, Yaping] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Zhao, Fan; Wang, Nan; Lin, Pengfei; Tang, Keqiong; Wang, Aihua; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yi, Yanglei] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Jin, YP (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com	yi, yi/HHY-7381-2022	zhao, fan/0000-0001-9547-7116; Jin, Yaping/0000-0001-5708-3159	Specialized Natural Science Basic Research Plan in Shaanxi Province, China [2014JQ3096]	Specialized Natural Science Basic Research Plan in Shaanxi Province, China	This work was funded by the Specialized Natural Science Basic Research Plan in Shaanxi Province, China (2014JQ3096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Baufeld A, 2013, CELL TISSUE RES, V354, P869, DOI 10.1007/s00441-013-1712-9; Boone DL, 1998, BIOL REPROD, V58, P1533, DOI 10.1095/biolreprod58.6.1533; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Chen FL, 2014, PLASMID, V76, P24, DOI 10.1016/j.plasmid.2014.08.004; Cox N, 1996, J REPROD FERTILITY S, V52, P31; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Eleveld-Trancikova D, 2010, MOL IMMUNOL, V47, P1963, DOI 10.1016/j.molimm.2010.04.019; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Fuchimoto D, 2001, BIOL REPROD, V65, P986, DOI 10.1095/biolreprod65.4.986; Gillio-Meina C, 2005, BIOL REPROD, V72, P1194, DOI 10.1095/biolreprod.104.035246; GUTHRIE HD, 1995, BIOL REPROD, V52, P920, DOI 10.1095/biolreprod52.4.920; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jang SW, 2007, J BIOL CHEM, V282, P11092, DOI 10.1074/jbc.M607962200; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kolb G, 2008, J VIROL, V82, P9555, DOI 10.1128/JVI.01174-08; Kugu K, 1998, CELL DEATH DIFFERENT, V5; Lan XL, 2013, THERIOGENOLOGY, V80, P138, DOI 10.1016/j.theriogenology.2013.02.024; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; MCNATTY KP, 1984, J REPROD FERTIL, V72, P39, DOI 10.1530/jrf.0.0720039; Molden S, 1756, GLOB LIB WOMENS MED; Pan ZX, 2012, MOL BIOL REP, V39, P10823, DOI 10.1007/s11033-012-1976-2; Papamentzelopoulou M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-99; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Pradeep PK, 2002, ENDOCRINOLOGY, V143, P2930, DOI 10.1210/en.143.8.2930; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Riaz H, 2014, J STEROID BIOCHEM, V141, P150, DOI 10.1016/j.jsbmb.2014.02.001; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rose RE, 1997, GENETICS, V146, P595; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Sanecka A, 2012, MOL IMMUNOL, V50, P66, DOI 10.1016/j.molimm.2011.12.003; Sifer C, 2002, EUR J OBSTET GYN R B, V103, P150, DOI 10.1016/S0301-2115(02)00043-X; Sung HJ, 2008, EXP MOL MED, V40, P332, DOI 10.3858/emm.2008.40.3.332; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Yang YZ, 2013, THERIOGENOLOGY, V79, P633, DOI 10.1016/j.theriogenology.2012.11.017; Ye J, 2013, BBA-BIOMEMBRANES, V1828, P2926, DOI 10.1016/j.bbamem.2013.05.005; Zhen YH, 2014, J STEROID BIOCHEM, V143, P90, DOI 10.1016/j.jsbmb.2014.02.013	48	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168246	10.1371/journal.pone.0168246	http://dx.doi.org/10.1371/journal.pone.0168246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973579	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300069
J	Rizvi, W; Fayazuddin, M; Singh, O; Naeem, SS; Moin, S; Akhtar, K; Kumar, A				Rizvi, Waseeem; Fayazuddin, Mohd; Singh, Ompal; Naeem, Syed Shariq; Moin, Shagufta; Akhtar, Kafil; Kumar, Anil			Cytokine Attenuation and Free Radical Scavenging Activity of a New Flavanone7,4 '-Dihydroxy-3 '',3 ''-Dimethyl-(5,6-Pyrano-2 ''-One)-8-(3 ''',3 '''-Dimethyl Allyl)-Isolated from Mallotus philippensis: Possible Mechanism for Its Anti-Inflammatory Activity	PLoS One			English	Article							INDUCED PAW EDEMA; LIPID PEROXIDES; CARRAGEENAN; BIOLOGY; LEUKOTRIENES; INFLAMMATION; JAPONICUS; DISEASE; ASSAY; RATS	Mallotus philippensis L.(MP) commonly known as Kamala tree in Hindi, is a small to medium-sized monoecious tree. The objective of the study was to evaluate the anti-inflammatory activity of MPand a new flavanoneisolated from it by using in vivo models of inflammation. Albino wistar rats of either sex weighing 150-200g were used. Seven groups were made (n = 6), namely normal control group (normal saline, 1 ml/kg), standard control group (acetylsalicylic acid, 100 mg/kg), methanol crude extract (300 and 500 mg/kg), ethylacetate fraction (300 and 500 mg/kg) and active compound 4 (new flavanone, 50 mg/kg). The anti-inflammatory activity was studied using carrageenan induced paw edema method and cotton pellet granuloma method. Levels of cytokines (TNF-alpha, IL-1and IL-6) and activity of antioxidant enzymeslike catalase and glutathione peroxidase were estimated. It was found that the methanol extract, ethylacetate fraction and Flavanonedemonstrated significant reduction in paw edema in carrageenan induced paw edema method as compared to control. They also diminished the serum TNF-alpha, IL-6 and IL-1 levels. Significantly attenuated the malondialdehyde levels and increased the activities of catalase and glutathione peroxidase in paw tissue. Similarly there was asignificant decrease in granuloma formation in cotton pellet induced granuloma method. In conclusion, MP extracts and the newflavanone-possess anti-inflammatory activity and this might be due to the inhibition of various cytokines and increased free radical scavenging activity.	[Rizvi, Waseeem; Fayazuddin, Mohd; Naeem, Syed Shariq; Kumar, Anil] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pharmacol, Aligarh, Uttar Pradesh, India; [Singh, Ompal] Aligarh Muslim Univ, Chem Res Unit, Dept Res Unani Med, Aligarh, Uttar Pradesh, India; [Moin, Shagufta] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Biochem, Aligarh, Uttar Pradesh, India; [Akhtar, Kafil] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pathol, Aligarh, Uttar Pradesh, India; [Fayazuddin, Mohd] Raichur Inst Med Sci, Dept Pharmacol, Raichur, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Rizvi, W (corresponding author), Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pharmacol, Aligarh, Uttar Pradesh, India.	waseemnakhat@gmail.com	Akhtar, Kafil/AAA-9467-2021	Akhtar, Kafil/0000-0002-3482-1195	University Grant Commission, New Delhi, India	University Grant Commission, New Delhi, India(University Grants Commission, India)	Funded by University Grant Commission, New Delhi, India (http//www.ugcnetonline.in/).	Arfan M, 2007, J FOOD LIPIDS, V14, P280, DOI 10.1111/j.1745-4522.2007.00086.x; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bignotto L, 2009, BRIT J NUTR, V102, P126, DOI 10.1017/S0007114508137886; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chang CT, 2011, FOOD CHEM, V127, P1131, DOI 10.1016/j.foodchem.2011.01.114; Chattopadhyay D, 2002, J ETHNOPHARMACOL, V82, P229, DOI 10.1016/S0378-8741(02)00165-4; Chaturvedi P, 2008, EVID-BASED COMPL ALT, V5, P55, DOI 10.1093/ecam/nel077; DAWSON J, 1991, INT J TISSUE REACT, V13, P171; Dmitrieva OS, 2016, BIOCHEMISTRY-MOSCOW+, V81, P80, DOI 10.1134/S0006297916020024; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gangwar M., 2012, INT J PHARM PHARM SC, V4, P643; Hewageegana H, 2014, J NATL SCI FOUND SRI, V42, P291; Huang GJ, 2012, J NAT PROD, V75, P54, DOI 10.1021/np200512a; Ishii R, 2003, BBA-GEN SUBJECTS, V1620, P108, DOI 10.1016/S0304-4165(02)00514-7; Jayweera D.M.A., 2006, MED PLANTS INDIGENOU, P225; Kim HS, 2000, J ETHNOPHARMACOL, V69, P79, DOI 10.1016/S0378-8741(99)00137-3; Kirtikar K.R., 1975, INDIAN MED PLANTS, VIII, P2266; Lee YM, 2009, J MOL MED, V87, P1251, DOI 10.1007/s00109-009-0532-6; Liao CH, 2011, FOOD CHEM, V125, P930, DOI 10.1016/j.foodchem.2010.09.082; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manandhar NP, 2000, PLANT PEOPLE NEPAL; Narayana K. Raj, 2001, Indian Journal of Pharmacology, V33, P2; OHISHI N, 1985, BIOCHEM INT, V10, P205; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pankajoudhia, 2001, MED HERBS CHHATTISGA; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SWINGLE KF, 1972, J PHARMACOL EXP THER, V183, P226; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; WINTER CA, 1957, J AM PHARM ASSOC, V46, P515, DOI 10.1002/jps.3030460902; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167294	10.1371/journal.pone.0167294	http://dx.doi.org/10.1371/journal.pone.0167294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941980	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600012
J	Mukherjee, N; Bartelli, D; Patra, C; Chauhan, BV; Dowd, SE; Banerjee, P				Mukherjee, Nabanita; Bartelli, Debra; Patra, Cyril; Chauhan, Bhavin V.; Dowd, Scot E.; Banerjee, Pratik			Microbial Diversity of Source and Point-of-Use Water in Rural Haiti - A Pyrosequencing-Based Metagenomic Survey	PLOS ONE			English	Article							TOXIGENIC VIBRIO-CHOLERAE; BIOFILM FORMATION; DRINKING-WATER; KLEBSIELLA-PNEUMONIAE; BACTERIAL COMMUNITIES; RISK-ASSESSMENT; SURFACE WATERS; TAP WATER; AEROMONAS; IDENTIFICATION	Haiti endures the poorest water and sanitation infrastructure in the Western Hemisphere, where waterborne diseases cause significant morbidity and mortality. Most of these diseases are reported to be caused by waterborne pathogens. In this study, we examined the overall bacterial diversity of selected source and point-of-use water from rural areas in Central Plateau, Haiti using pyrosequencing of 16s rRNA genes. Taxonomic composition of water samples revealed an abundance of Firmicutes phyla, followed by Proteobacteria and Bacteroidetes. A total of 38 bacterial families and 60 genera were identified. The presence of several Klebsiella spp. (tentatively, K. pneumoniae, K. variicola and other Klebsiella spp.) was detected in most water samples. Several other human pathogens such as Aeromonas, Bacillus, Clostridium, and Yersinia constituted significantly higher proportion of bacterial communities in the point-of-use water samples compared to source water. Bacterial genera traditionally associated with biofilm formation, such as Chryseobacterium, Fusobacterium, Prevotella, Pseudomonas were found in the point-of-use waters obtained from water filters or domestic water storage containers. Although the pyrosequencing method utilized in this study did not reveal the viability status of these pathogens, the abundance of genetic footprints of the pathogens in water samples indicate the probable risk of bacterial transmission to humans. Therefore, the importance of appropriate handling, purification, and treatment of the source water needed to be clearly communicated to the communities in rural Haiti to ensure the water is safe for their daily use and intake.	[Mukherjee, Nabanita; Bartelli, Debra; Patra, Cyril; Chauhan, Bhavin V.; Banerjee, Pratik] Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Desoto Ave, Memphis, TN 38152 USA; [Dowd, Scot E.] Mol Res LP MR DNA, Shallowater, TX USA	University of Memphis	Banerjee, P (corresponding author), Univ Memphis, Sch Publ Hlth, Div Epidemiol Biostat & Environm Hlth, Desoto Ave, Memphis, TN 38152 USA.	pbnerjee@memphis.edu	Banerjee, Pratik/H-9521-2012; Dowd, Scot E/M-5386-2017	Banerjee, Pratik/0000-0001-5553-5350; Dowd, Scot E/0000-0002-6296-1427	University of Memphis; Memphis Research Consortium; U.S. Food & Drug Administration [1U54FD004330-01]; MR DNA Molecular Research; FOOD AND DRUG ADMINISTRATION [U54FD004330] Funding Source: NIH RePORTER	University of Memphis; Memphis Research Consortium; U.S. Food & Drug Administration; MR DNA Molecular Research; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This research was partly supported by start-up funds from University of Memphis (PB, DB), Memphis Research Consortium (PB, DB), and a grant from the U.S. Food & Drug Administration (1U54FD004330-01) to PB. MR DNA Molecular Research provided support in the form of salaries for author [SD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; Bai YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061011; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Balleste E, 2010, APPL ENVIRON MICROB, V76, P7608, DOI 10.1128/AEM.00883-10; Bao K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0258-7; Be NA, 2015, MICROB ECOL, V69, P346, DOI 10.1007/s00248-014-0517-z; Berger T, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.32.20877; Bhotmange DU, 2015, J APPL MICROBIOL, V119, P1046, DOI 10.1111/jam.12914; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dunn G, 2014, SCI TOTAL ENVIRON, V468, P544, DOI 10.1016/j.scitotenv.2013.08.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Fang MX, 2012, INT J SYST EVOL MICR, V62, P3018, DOI 10.1099/ijs.0.034660-0; Fernandez N, 2009, WATER SCI TECHNOL, V59, P1227, DOI 10.2166/wst.2009.092; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; Hill VR, 2011, EMERG INFECT DIS, V17, P2147, DOI 10.3201/eid1711.110748; Hwang G, 2014, BIOFOULING, V30, P1079, DOI 10.1080/08927014.2014.969249; Hwang HG, 2014, INT J ENV RES PUB HE, V11, P2033, DOI 10.3390/ijerph110202033; Isozaki A, 2010, J INFECT CHEMOTHER, V16, P436, DOI 10.1007/s10156-010-0067-3; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kahler AM, 2015, AM J TROP MED HYG, V92, P118, DOI 10.4269/ajtmh.13-0601; Kivanc M, 2011, BRAZ J MICROBIOL, V42, P126, DOI 10.1590/S1517-83822011000100016; KLIPSTEIN FA, 1976, GASTROENTEROLOGY, V70, P1035; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kupferschmidt K, 2012, SCIENCE, V336, P1493, DOI 10.1126/science.336.6088.1493; Limbago BM, 2011, J CLIN MICROBIOL, V49, P4239, DOI 10.1128/JCM.05297-11; Lin WH, 2014, EUR J CLIN MICROBIOL, V33, P1533, DOI 10.1007/s10096-014-2100-4; Lo HH, 2014, DIAGN MICR INFEC DIS, V79, P298, DOI 10.1016/j.diagmicrobio.2014.01.027; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Mehrshad M, 2016, APPL ENVIRON MICROB, V82, P1599, DOI 10.1128/AEM.03381-15; Mukherjee N, 2014, INT J ENV RES PUB HE, V11, P12544, DOI 10.3390/ijerph111212544; Nathisuwan S, 2001, PHARMACOTHERAPY, V21, P920, DOI 10.1592/phco.21.11.920.34529; Nelson WC, 2016, APPL ENVIRON MICROB, V82, P255, DOI 10.1128/AEM.02274-15; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; PALUMBO SA, 1989, J CLIN MICROBIOL, V27, P854, DOI 10.1128/JCM.27.5.854-859.1989; Passariello C, 2013, EUR J PAEDIATR DENT, V14, P199; Patrick M, 2013, AM J TROP MED HYG, V89, P647, DOI 10.4269/ajtmh.13-0308; Podschun R, 2001, APPL ENVIRON MICROB, V67, P3325, DOI 10.1128/AEM.67.7.3325-3327.2001; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Revell PA, 2001, FEMS MICROBIOL LETT, V205, P159, DOI [10.1111/j.1574-6968.2001.tb10941.x, 10.1016/S0378-1097(01)00476-1]; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rudi K, 2010, LETT APPL MICROBIOL, V50, P1, DOI 10.1111/j.1472-765X.2009.02743.x; Shaheed A, 2014, B WORLD HEALTH ORGAN, V92, P283, DOI 10.2471/BLT.13.119594; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; TDR, 2020, JOINT MON PROGR WAT; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Thomson AA, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4677-1; Torre D, 2005, SCAND J INFECT DIS, V37, P375, DOI 10.1080/00365540410021180-1; Turska-Szewczuk A, 2010, CARBOHYD RES, V345, P680, DOI 10.1016/j.carres.2009.12.030; USAID, WAT SAN HYG SECT TRE; Wampler PJ, 2011, ENVIRON EARTH SCI, V62, P1619, DOI 10.1007/s12665-010-0645-9; Wang J, 1998, MAIZE SCI, V6, P26; WHO-UNICEF, 2015, WHO UNICEF JOINT MON; Widmer JM, 2014, AM J TROP MED HYG, V91, P790, DOI 10.4269/ajtmh.14-0165; World Health Organization, 2015, PROGR SAN DRINK WAT; World-Bank-Group, 2016, WORLD DEV IND HAIT; Wu HT, 2015, APPL MICROBIOL BIOT, V99, P1947, DOI 10.1007/s00253-014-6095-7; Zhang DY, 2011, BIOMED ENVIRON SCI, V24, P122, DOI 10.3967/0895-3988.2011.02.006; Zhou JZ, 2015, MBIO, V6, DOI 10.1128/mBio.02288-14; Zilm PS, 2007, ANAEROBE, V13, P146, DOI 10.1016/j.anaerobe.2007.04.005	65	18	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167353	10.1371/journal.pone.0167353	http://dx.doi.org/10.1371/journal.pone.0167353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936055	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100088
J	Olsson, LE; Hockings, PD				Olsson, Lars E.; Hockings, Paul D.			In Vivo Measurements of T2 Relaxation Time of Mouse Lungs during Inspiration and Expiration	PLOS ONE			English	Article							T-2 RELAXATION; TRANSVERSE RELAXATION; SKELETAL-MUSCLE; MRI; TISSUE; SIGNAL; T-2-ASTERISK; INFLATION; SMOKERS; BLOOD	Purpose The interest in measurements of magnetic resonance imaging relaxation times, T1, T2, T2*, with intention to characterize healthy and diseased lungs has increased recently. Animal studies play an important role in this context providing models for understanding and linking the measured relaxation time changes to the underlying physiology or disease. The aim of this work was to study how the measured transversal relaxation time (T2) in healthy lungs is affected by normal respiration in mouse. Method T2 of lung was measured in anaesthetized freely breathing mice. Image acquisition was performed on a 4.7 T, Bruker BioSpec with a multi spin-echo sequence (Car-Purcell-MeiboomGill) in both end-expiration and end-inspiration. The echo trains consisted of ten echoes of inter echo time 3.5 ms or 4.0 ms. The proton density, T2 and noise floor were fitted to the measured signals of the lung parenchyma with a Levenberg-Marquardt least-squares three-parameter fit. Results T2 in the lungs was longer (p< 0.01) at end-expiration (9.7 +/- 0.7 ms) than at end-inspiration (9.0 +/- 0.8 ms) measured with inter-echo time 3.5 ms. The corresponding relative proton density (lung/muscle tissue) was higher (p< 0.001) during end-expiration, (0.61 +/- 0.06) than during end-inspiration (0.48 +/- 0.05). The ratio of relative proton density at end-inspiration to that at end-expiration was 0.78 +/- 0.09. Similar results were found for inter-echo time 4.0 ms and there was no significant difference between the T2 values or proton densities acquired with different interecho times. The T2 value increased linearly (p< 0.001) with proton density. Conclusion The measured T2 in-vivo is affected by diffusion across internal magnetic susceptibility gradients. In the lungs these gradients are modulated by respiration, as verified by calculations. In conclusion the measured T2 was found to be dependent on the size of the alveoli.	[Olsson, Lars E.] Lund Univ, Dept Med Radiat Phys, Translat Med, Malmo, Sweden; [Hockings, Paul D.] BioVenture Hub, Antaros Med, Molndal, Sweden; [Hockings, Paul D.] Chalmers Univ Technol, Medtech West, Gothenburg, Sweden	Lund University; Chalmers University of Technology	Olsson, LE (corresponding author), Lund Univ, Dept Med Radiat Phys, Translat Med, Malmo, Sweden.	lars_e.olsson@med.lu.se	Hockings, Paul D/AAM-7950-2020	Hockings, Paul D/0000-0002-7154-9047; Olsson, Lars E./0000-0001-6090-6697	AstraZeneca; Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer; AstraZenenca, Molndal	AstraZeneca(AstraZeneca); Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer; AstraZenenca, Molndal	This work was supported by AstraZeneca and Allmanna sjukhusets i Malmo stiftelse for bekampande av cancer. The funders provided support in form of salaries for LEO and PDH, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors wish to express their gratitude to AstraZenenca, Molndal for supporting the study and to Ms M. Palmer for her excellent technical assistance.	Alamidi DF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149760; Araujo ECA, 2014, BIOPHYS J, V106, P2267, DOI 10.1016/j.bpj.2014.04.010; Beckmann N, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P47, DOI 10.1007/978-3-642-12945-2_4; Buzan MTA, 2015, EUR RADIOL, V25, P3167, DOI 10.1007/s00330-015-3751-y; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Carinci F, 2015, SOC MAGN RES IM, P3975; Cutillo AG, 1998, MAGNET RESON MED, V39, P190, DOI 10.1002/mrm.1910390205; Cutillo AG., 1996, APPL MAGNETIC RESONA; Estilaei M, 1999, JMRI-J MAGN RESON IM, V9, P699, DOI 10.1002/(SICI)1522-2586(199905)9:5<699::AID-JMRI12>3.0.CO;2-H; Ganesan K, 1988, SOC MAGN RES IM, P577; Ganesan KAD, 1996, APPL MAGNETIC RESONA, P115; Haacke EM, 1999, MAGNETIC RESONANCE I, P624; Hajari AJ, 2012, J APPL PHYSIOL, V112, P937, DOI 10.1152/japplphysiol.00768.2011; HUBER DJ, 1985, INVEST RADIOL, V20, P460, DOI 10.1097/00004424-198508000-00004; Kindvall SSI, 2016, J MAGN RESON IMAGING, V43, P1250, DOI 10.1002/jmri.25085; Kolem H, 1989, P ANN M SOC MAGN RES, P783; Kurz FT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141894; Mulkern R, 2014, CONCEPT MAGN RESON A, V43, P29, DOI 10.1002/cmr.a.21297; Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5; Ohno Y, 2014, J MAGN RESON IMAGING, V39, P988, DOI 10.1002/jmri.24232; Olsson LE, 2007, J MAGN RESON IMAGING, V25, P488, DOI 10.1002/jmri.20840; Pracht ED, 2005, MAGNET RESON MED, V53, P1193, DOI 10.1002/mrm.20448; PURVES MJ, 1966, RESP PHYSIOL, V1, P281, DOI 10.1016/0034-5687(66)90047-8; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Shioya S, 1997, RADIAT RES, V148, P359, DOI 10.2307/3579521; Shioya S, 1990, SOC MAGN RES MED, P581; Shioya S, 2000, J MAGNETIC RESONANCE; Shioya S, 1996, APPL MAGNETIC RESONA, P227; Shioya S, 1990, SOC MAGN RES IM, P591; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Stadler A, 2005, J MAGN RESON IMAGING, V21, P759, DOI 10.1002/jmri.20319; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x; Yung KT, 2003, MAGN RESON IMAGING, V21, P451, DOI 10.1016/S0730-725X(02)00640-9	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166879	10.1371/journal.pone.0166879	http://dx.doi.org/10.1371/journal.pone.0166879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936061	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100046
J	Weng, QN; Liu, ZQ; Li, BJ; Liu, KQ; Wu, WJ; Liu, HL				Weng, Qiannan; Liu, Zequn; Li, Bojiang; Liu, Kaiqing; Wu, Wangjun; Liu, Honglin			Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK/FoxO1 Pathway	PLOS ONE			English	Article							IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; JNK ACTIVATION; SURVIVAL; INVOLVEMENT; CANCER; INHIBITION; EXPRESSION	The c-Jun N-terminal protein kinase (JNK) plays an important role in the regulation of cell apoptosis. Forkhead box O (FoxO) transcription factors are involved in diverse biological processes, including cellular metabolism, cell apoptosis, and cell cycle. However, the JNK/FoxO1 pathway involved in the process of apoptosis induced by oxidative stress remains to be elucidated. Here, we demonstrated that the JNK activity significantly increased in response to oxidative stress in mouse follicular granulosa cells (MGCs). SP600125, a selective JNK inhibitor, attenuated the oxidative stress-induced MGCs apoptosis. Oxidative stress enhanced the FoxO1 nuclear translocation by activating the JNK activity. Moreover, JNK mediated the dissociation of FoxO1 from 14-3-3 proteins in MGCs after the treatment with H2O2. Finally, oxidative stress up-regulated the expression of FoxO1 via JNK mediation of FoxO1 self-regulation in MGCs. Taken together, our findings suggest that JNK/FoxO1 is involved in the regulation of oxidative stress-induced cell apoptosis in MGCs.	[Weng, Qiannan; Liu, Zequn; Li, Bojiang; Liu, Kaiqing; Wu, Wangjun; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Liu, Zequn] Liaoning Prov Anim Product Safety Supervis, Shenyang, Peoples R China	Nanjing Agricultural University	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022; Wu, Wangjun/AAA-9684-2019	liu, honglin/0000-0002-1254-3163; 	973 Program [2014CB138502]; National Natural Science Foundation of China [31472073, 31630072, 31501920]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was supported by the 973 Program (2014CB138502), the National Natural Science Foundation of China (31472073), the State Key Program of National Natural Science Foundation of China (31630072), the National Natural Science Foundation of China (31501920), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao JL, 2015, AQUAT TOXICOL, V167, P180, DOI 10.1016/j.aquatox.2015.08.004; Chae HD, 2011, STEM CELLS DEV, V20, P1277, DOI 10.1089/scd.2010.0465; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cui W, 2012, PLOS ONE, V7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diebold I, 2011, MOL BIOL CELL, V22, P4424, DOI 10.1091/mbc.E10-12-0971; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fontani F, 2015, CALCIFIED TISSUE INT, V96, P335, DOI 10.1007/s00223-015-9961-0; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Huang F., 2016, INT J MOL SCI, V17; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jiao GZ, 2016, CELL REPROGRAM, V18, P17, DOI 10.1089/cell.2015.0055; Jiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058018; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1016/J.FUPR0C.2015.01.025; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ou XH, 2010, CELL CYCLE, V9, P4130, DOI 10.4161/cc.9.20.13389; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127558; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shen M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.400; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; Shukla S, 2016, TOXICOL APPL PHARM, V291, P70, DOI 10.1016/j.taap.2015.12.006; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Sun W, 2016, FREE RADICAL BIO MED, V92, P61, DOI 10.1016/j.freeradbiomed.2016.01.014; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tang HB, 2011, FASEB J, V25, P2921, DOI 10.1096/fj.11-183798; Wang HL, 2011, CELL REPROGRAM, V13, P225, DOI 10.1089/cell.2010.0101; Wang TY, 2014, MOL HUM REPROD, V20, P318, DOI 10.1093/molehr/gat088; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yoon JD, 2015, THERIOGENOLOGY, V83, P294, DOI 10.1016/j.theriogenology.2014.09.025; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830; Zhou P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095281	48	44	49	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167869	10.1371/journal.pone.0167869	http://dx.doi.org/10.1371/journal.pone.0167869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936150	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100222
J	Xie, X; Kaoud, TS; Edupuganti, R; Zhang, T; Kogawa, T; Zhao, Y; Chauhan, GB; Giannoukos, DN; Qi, Y; Tripathy, D; Wang, J; Gray, NS; Dalby, KN; Bartholomeusz, C; Ueno, NT				Xie, X.; Kaoud, T. S.; Edupuganti, R.; Zhang, T.; Kogawa, T.; Zhao, Y.; Chauhan, G. B.; Giannoukos, D. N.; Qi, Y.; Tripathy, D.; Wang, J.; Gray, N. S.; Dalby, K. N.; Bartholomeusz, C.; Ueno, N. T.			c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun	ONCOGENE			English	Article							NH2-TERMINAL KINASE; JNK; EXPRESSION; APOPTOSIS; SURVIVAL; PROLIFERATION; MODELS; MOUSE	c-Jun N-terminal kinase (JNK) plays a vital role in malignant transformation of different cancers, and JNK is highly activated in basallike triple-negative breast cancer (TNBC). However, the roles of JNK in regulating cancer stem-like cell (CSC) phenotype and tumorigenesis in TNBC are not well defined. JNK is known to mediate many cellular events via activating c-Jun. Here, we found that JNK regulated c-Jun activation in TNBC cells and that JNK activation correlated with c-Jun activation in TNBC tumors. Furthermore, the expression level of c-Jun was significantly higher in TNBC tumors than in non-TNBC tumors, and high c-Jun mRNA level was associated with shorter disease-free survival of patients with TNBC. Thus, we hypothesized that the JNK/c-Jun signaling pathway contributes to TNBC tumorigenesis. We found that knockdown of JNK1 or JNK2 or treatment with JNK-IN-8, an adenosine triphosphate-competitive irreversible pan-JNK inhibitor, significantly reduced cell proliferation, the ALDH1(+) and CD44(+)/CD24 -CSC subpopulations, and mammosphere formation, indicating that JNK promotes CSC self-renewal and maintenance in TNBC. We further demonstrated that both JNK1 and JNK2 regulated Notch1 transcription via activation of c-Jun and that the JNK/c-Jun signaling pathway promoted CSC phenotype through Notch1 signaling in TNBC. In a TNBC xenograft mouse model, JNK-IN-8 significantly suppressed tumor growth in a dose-dependent manner by inhibiting acquisition of the CSC phenotype. Taken together, our data demonstrate that JNK regulates TNBC tumorigenesis by promoting CSC phenotype through Notch1 signaling via activation of c-Jun and indicate that JNK/c-Jun/Notch1 signaling is a potential therapeutic target for TNBC.	[Xie, X.; Kogawa, T.; Chauhan, G. B.; Giannoukos, D. N.; Tripathy, D.; Bartholomeusz, C.; Ueno, N. T.] Univ Texas MD Anderson Canc Ctr, Sect Translat Breast Canc Res, Houston, TX 77030 USA; [Xie, X.; Kogawa, T.; Chauhan, G. B.; Giannoukos, D. N.; Tripathy, D.; Bartholomeusz, C.; Ueno, N. T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Kaoud, T. S.; Edupuganti, R.; Dalby, K. N.] Univ Texas Austin, Coll Pharm, Div Med Chem, 107 West Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA; [Zhang, T.; Gray, N. S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Kogawa, T.] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Kashiwa, Chiba, Japan; [Zhao, Y.; Qi, Y.; Wang, J.] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; National Cancer Center - Japan; University of Texas System; UTMD Anderson Cancer Center	Dalby, KN (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, 107 West Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA.; Bartholomeusz, C; Ueno, NT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Sect Translat Breast Canc Res, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dalby@austin.utexas.edu; chbartho@mdanderson.org; nueno@mdanderson.org	Kaoud, Tamer S/C-3618-2019; Dalby, Kevin N/A-1905-2013	Kaoud, Tamer S/0000-0003-1298-8725; Dalby, Kevin N/0000-0001-9272-5129	MD Anderson Cancer Center Inflammatory Breast Cancer funds [105655]; Nylene Eckles funds [101478]; MD Anderson Cancer Center [111411]; Cancer Prevention and Research Institute of Texas [RP140648, RP140649]; Susan G Komen for the Cure Postdoctoral Fellowship [KG111170]; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center Inflammatory Breast Cancer funds; Nylene Eckles funds; MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Susan G Komen for the Cure Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MIGR1 vectors were generous gifts from Dr Khaled A. Hassan (University of Michigan, Ann Arbor, MI). We thank Naoko Matsuda of the Department of Breast Medical Oncology at MD Anderson for assistance with the RPPA data analysis. We acknowledge Stephanie P Deming of the Department of Scientific Publications at MD Anderson for editorial assistance and Wendy Schober, Nalini Patel and Duncan Mak of the Flow Cytometry and Cellular Imaging Facility at MD Anderson for assistance with cell cycle distribution and stem cell subpopulation analyses. This work was supported by MD Anderson Cancer Center Inflammatory Breast Cancer funds (105655) and Nylene Eckles funds (101478) to Naoto T Ueno; startup funds from MD Anderson Cancer Center (111411) to Chandra Bartholomeusz; Cancer Prevention and Research Institute of Texas (RP140648 and RP140649) to Kevin N Dalby; a Susan G Komen for the Cure Postdoctoral Fellowship to Xuemei Xie (KG111170); and National Institutes of Health Cancer Center Support Grant to MD Anderson Cancer Center (CA016672).	Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cantrell MA, 2015, ONCOTARGET, V6, P11863, DOI 10.18632/oncotarget.3787; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chang QS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-64; Chaterjee M, 2011, BONE MARROW RES, DOI 10.1155/2011/362938; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Cheng L, 2010, TOXICOL PATHOL, V38, P62, DOI 10.1177/0192623309354109; Cubero Francisco Javier, 2011, Hepatology, V54, P1470, DOI 10.1002/hep.24532; D'Amato NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045684; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Economopoulou P, 2012, ONCOLOGIST, V17, P1394, DOI 10.1634/theoncologist.2012-0163; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Gee JMW, 2000, INT J CANCER, V89, P177, DOI 10.1002/(SICI)1097-0215(20000320)89:2<177::AID-IJC13>3.0.CO;2-0; Gozdecka M, 2014, CELL REP, V9, P1361, DOI 10.1016/j.celrep.2014.10.043; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kappelmann M, 2014, EUR J CELL BIOL, V93, P76, DOI 10.1016/j.ejcb.2013.10.003; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Malhotra Gautam K, 2011, J Carcinog, V10, P38, DOI 10.4103/1477-3163.91413; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; She QB, 2002, CANCER RES, V62, P1343; Song WQ, 2014, CANCER RES, V74, P2444, DOI 10.1158/0008-5472.CAN-13-2136; Trosko JE, 2009, VET PATHOL, V46, P176, DOI 10.1354/vp.46-2-176; Tsuiki H, 2003, CANCER RES, V63, P250; Wang JL, 2012, ADV EXP MED BIOL, V727, P174, DOI 10.1007/978-1-4614-0899-4_13; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wang X, 2010, HUM PATHOL, V41, P401, DOI 10.1016/j.humpath.2009.08.018; Wang Yue J, 2013, Methods Mol Biol, V980, P281, DOI 10.1007/978-1-62703-287-2_15; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wojtaszek PA, 1998, J BIOL CHEM, V273, P800, DOI 10.1074/jbc.273.2.800; Xia Y, 2013, J BIOL CHEM, V288, P19321, DOI 10.1074/jbc.M113.475442; Yeh YT, 2006, INT J CANCER, V118, P2678, DOI 10.1002/ijc.21707; Yoon CH, 2012, ONCOGENE, V31, P4655, DOI 10.1038/onc.2011.634; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	46	54	56	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2599	2608		10.1038/onc.2016.417	http://dx.doi.org/10.1038/onc.2016.417			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27941886	Green Accepted			2022-12-26	WOS:000400597300010
J	Bose, C; Shah, SV; Karaduta, OK; Kaushal, GP				Bose, Chhanda; Shah, Sudhir V.; Karaduta, Oleg K.; Kaushal, Gur P.			Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury	PLOS ONE			English	Article							PROTEIN CARBAMYLATION; AMINO-ACIDS; DEATH; PROLIFERATION; MORTALITY; ADHESION; DISEASE; STRESS; UREMIA; TYPE-2	Patients with chronic kidney disease (CKD) have high risk of cardiovascular complications. Plasma levels of carbamylated proteins produced by urea-derived isocyanate or thiocyanate are elevated in CKD patients and that they are significant predictors of cardiovascular events and all-cause mortality. Carbamylated LDL (cLDL) has pro-atherogenic properties and is known to affect major biological processes relevant to atherosclerosis including endothelial cell injury. The underlying mechanisms of cLDL-induced endothelial cell injury are not well understood. Although autophagy has been implicated in atherosclerosis, cLDL-mediated induction of autophagy and its role in endothelial cell injury is unknown. Our studies demonstrate that human coronary artery endothelial cells (HCAECs) respond to cLDL by specific induction of key autophagy proteins including LC3-I, beclin-1, Atg5, formation of lipid-conjugated LC3-II protein, and formation of punctate dots of autophagosome-associated LC3-II. We demonstrated that autophagy induction is an immediate response to cLDL and occurred in a dose and time-dependent manner. Inhibition of cLDL-induced autophagy by a specific siRNA to LC3 as well as by an autophagy inhibitor provided protection from cLDL-induced cell death and DNA fragmentation. Our studies demonstrate that autophagy plays an important role in cLDL-mediated endothelial cell injury and may provide one of the underlying mechanisms for the pathogenesis of cLDL-induced atherosclerosis in CKD patients.	[Bose, Chhanda; Shah, Sudhir V.; Kaushal, Gur P.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Bose, Chhanda; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Karaduta, Oleg K.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kaushal, GP (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.; Kaushal, GP (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA.; Kaushal, GP (corresponding author), Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA.	kaushalgurp@uams.edu			Department of Veterans Affairs [BX000444, BX001519]; National Institutes of Health-NIDDK grant [DK081690]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001519, I01BX000444] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health-NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	VA Merit Award (BX000444) to GPK from Department of Veterans Affairs, VA Merit Award (BX001519) to SVS from Depertment of Veterans Affairs, and National Institutes of Health-NIDDK grant (DK081690) to GPK.	Apostolov EO, 2007, AM J PHYSIOL-HEART C, V292, pH1836, DOI 10.1152/ajpheart.01079.2006; Apostolov EO, 2007, ARTERIOSCL THROM VAS, V27, P826, DOI 10.1161/01.ATV.0000258795.75121.8a; Apostolov EO, 2011, AM J PHYSIOL-HEART C, V300, pH1997, DOI 10.1152/ajpheart.01311.2010; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Asci G, 2008, NEPHROLOGY, V13, P480, DOI 10.1111/j.1440-1797.2008.00948.x; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Carracedo J, 2011, FASEB J, V25, P1314, DOI 10.1096/fj.10-173377; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Drechsler C, 2015, KIDNEY INT, V87, P1201, DOI 10.1038/ki.2014.429; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Gajjala PR, 2015, NEPHROL DIAL TRANSPL, V30, P1814, DOI 10.1093/ndt/gfv048; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Gillery P, 2014, CLIN CHEM LAB MED, V52, P33, DOI 10.1515/cclm-2012-0880; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Kobayashi S, 2015, BBA-MOL BASIS DIS, V1852, P252, DOI 10.1016/j.bbadis.2014.05.020; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nilsson L, 1996, CLIN CHEM, V42, P482; NOBLE RP, 1968, J LIPID RES, V9, P693; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; Shiu SWM, 2014, CLIN SCI, V126, P175, DOI 10.1042/CS20130369; Son JN, 2011, INT J CARDIOL, V146, P428, DOI 10.1016/j.ijcard.2010.10.098; Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111; STARK GR, 1960, J BIOL CHEM, V235, P3177; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Trepanier DJ, 1996, CLIN BIOCHEM, V29, P347, DOI 10.1016/0009-9120(96)00038-0; Varga ZV, 2015, BBA-MOL BASIS DIS, V1852, P232, DOI 10.1016/j.bbadis.2014.06.030; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165576	10.1371/journal.pone.0165576	http://dx.doi.org/10.1371/journal.pone.0165576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973558	gold, Green Submitted, Green Published			2022-12-26	WOS:000392754300004
J	Kollmann, M; Schmidt, R; Heuer, CM; Schachtner, J				Kollmann, Martin; Schmidt, Rovenna; Heuer, Carsten M.; Schachtner, Joachim			Variations on a Theme: Antennal Lobe Architecture across Coleoptera	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SCHISTOCERCA-GREGARIA ORTHOPTERA; COCKROACH PERIPLANETA-AMERICANA; TACHYKININ-RELATED PEPTIDES; OLFACTORY RECEPTOR NEURONS; LIBELLULA-DEPRESSA ODONATA; INSECT MUSHROOM BODIES; DROSOPHILA-MELANOGASTER; SEXUAL-DIMORPHISM; LADYBIRD BEETLE	Beetles comprise about 400,000 described species, nearly one third of all known animal species. The enormous success of the order Coleoptera is reflected by a rich diversity of lifestyles, behaviors, morphological, and physiological adaptions. All these evolutionary adaptions that have been driven by a variety of parameters over the last about 300 million years, make the Coleoptera an ideal field to study the evolution of the brain on the interface between the basic bauplan of the insect brain and the adaptions that occurred. In the current study we concentrated on the paired antennal lobes (AL), the part of the brain that is typically responsible for the first processing of olfactory information collected from olfactory sensilla on antenna and mouthparts. We analyzed 63 beetle species from 22 different families and thus provide an extensive comparison of principal neuroarchitecture of the AL. On the examined anatomical level, we found a broad diversity including AL containing a wide range of glomeruli numbers reaching from 50 to 150 glomeruli and several species with numerous small glomeruli, resembling the microglomerular design described in acridid grasshoppers and diving beetles, and substructures within the glomeruli that have to date only been described for the small hive beetle, Aethina tumida. A first comparison of the various anatomical features of the AL with available descriptions of lifestyle and behaviors did so far not reveal useful correlations. In summary, the current study provides a solid basis for further studies to unravel mechanisms that are basic to evolutionary adaptions of the insect olfactory system.	[Kollmann, Martin; Schmidt, Rovenna; Heuer, Carsten M.; Schachtner, Joachim] Philipps Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany; [Schmidt, Rovenna] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Heuer, Carsten M.] Fraunhofer Inst Nat Wissensch Tech Trendanalysen, Euskirchen, Germany	Philipps University Marburg; Justus Liebig University Giessen; Fraunhofer Gesellschaft	Schachtner, J (corresponding author), Philipps Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany.	Joachim.schachtner@biologie.uni-marburg.de	Schachtner, Joachim/AAG-1101-2020	Schachtner, Joachim/0000-0001-7268-0699				Abjornsson K, 1997, OECOLOGIA, V111, P166, DOI 10.1007/s004420050221; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; AHRENS D, 2014, P ROY SOC B-BIOL SCI, V281, DOI DOI 10.1098/RSPB.2014.1470; Al Abassi S, 1998, CELL MOL LIFE SCI, V54, P876, DOI 10.1007/s000180050215; Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; [Anonymous], 2001, LEARN MEMORY, V8, P53, DOI [10.1101/lm.38801, DOI 10.1101/LM.38801]; Anton S., 1999, INSECT OLFACTION; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Bense U, 1994, LONGHORN BEETLES ILL; Binzer M, 2014, J COMP NEUROL, V522, P337, DOI 10.1002/cne.23399; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; BROCKMANN A, 1995, INT J INSECT MORPHOL, V24, P405, DOI 10.1016/0020-7322(95)00010-2; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Browne J, 1999, SYST ENTOMOL, V24, P51, DOI 10.1046/j.1365-3113.1999.00067.x; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chapman A. D., 2009, NUMBER LIVING SPECIE; CHASE R, 1986, CELL TISSUE RES, V246, P567, DOI 10.1007/BF00215198; Couto A, 2016, J COMP NEUROL, V524, P2335, DOI 10.1002/cne.23975; Crespo JG, 2012, ARTHROPOD STRUCT DEV, V41, P227, DOI 10.1016/j.asd.2012.02.008; Crowson RA, 1981, BIOL COLEOPTERA; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2011, CHEM SENSES, V36, P209, DOI 10.1093/chemse/bjq121; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; de Bruyne M, 2010, J COMP PHYSIOL A, V196, P97, DOI 10.1007/s00359-009-0496-6; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Dreyer D, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.003.2010; ERNST KD, 1983, CELL TISSUE RES, V229, P1, DOI 10.1007/BF00217877; Erwin TL, 1985, TAXONOMY PHYLOGENY Z, P437; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Farris SM, 2008, ARTHROPOD STRUCT DEV, V37, P492, DOI 10.1016/j.asd.2008.05.005; Farris SM, 2005, P NATL ACAD SCI USA, V102, P17394, DOI 10.1073/pnas.0508430102; FISCHER DC, 1986, ENTOMOL EXP APPL, V40, P3, DOI 10.1007/BF00187017; FONTA C, 1993, CHEM SENSES, V18, P101, DOI 10.1093/chemse/18.2.101; Foottit R.G., 2009, INSECT BIODIVERSITY, DOI 10.1002/9781118945582; Fusca D, 2015, J COMP NEUROL, V523, P1569, DOI 10.1002/cne.23757; Galizia CG, 2014, EUR J NEUROSCI, V39, P1784, DOI 10.1111/ejn.12558; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; Gencer NS, 2009, PHYTOPARASITICA, V37, P217, DOI 10.1007/s12600-009-0032-9; Gerstmeier R., 2003, EXTRA VORRATSSCHADLI; GOLL WOLFGANG, 1967, Z MORPHOL OKOL TIERE, V59, P143, DOI 10.1007/BF00407612; Gomez-Zurita J, 2008, CLADISTICS, V24, P34, DOI 10.1111/j.1096-0031.2007.00167.x; Grimaldi David, 2005, pi; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hansson BS, 1996, J COMP PHYSIOL A, V179, P157, DOI 10.1007/BF00222783; Hanstrom B, 1940, INKRETORISCHE ORGANE, V18, P1; HATFIELD L D, 1976, International Journal of Insect Morphology and Embryology, V5, P279, DOI 10.1016/0020-7322(76)90028-3; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Herbst C, 2011, CHEMOECOLOGY, V21, P19, DOI 10.1007/s00049-010-0061-3; Heuer CM, 2012, ARTHROPOD STRUCT DEV, V41, P199, DOI 10.1016/j.asd.2012.02.005; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HODGSON ES, 1953, THE BIOLOGICAL BULLE, V105, P115, DOI DOI 10.2307/1538560; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Horn H, 2000, UNSERE HAUFIGSTEN SC; Hu JH, 2011, ARTHROPOD STRUCT DEV, V40, P420, DOI 10.1016/j.asd.2011.03.003; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; Ignell R, 2001, CELL TISSUE RES, V306, P143, DOI 10.1007/s004410100434; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Iperti G., 1965, 90EME C SOC SAV NIC, V2, P544; Iwasaki M, 1995, ZOOL SCI, V12, P725, DOI 10.2108/zsj.12.725; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; Jung JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081361; Kelber C, 2009, BRAIN BEHAV EVOLUT, V73, P273, DOI 10.1159/000230672; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; Kim MY, 1998, CELL TISSUE RES, V294, P351, DOI 10.1007/s004410051185; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Kollmann M, 2016, CELL TISSUE RES, V363, P679, DOI 10.1007/s00441-015-2282-9; Kollmann M, 2011, ARTHROPOD STRUCT DEV, V40, P304, DOI 10.1016/j.asd.2011.02.003; Kollmann M, 2011, CELL TISSUE RES, V343, P343, DOI 10.1007/s00441-010-1099-9; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; KOONTZ MA, 1987, CELL TISSUE RES, V249, P39, DOI 10.1007/BF00215416; Kreissl S, 2010, J COMP NEUROL, V518, P1391, DOI 10.1002/cne.22343; Kristoffersen L, 2008, CHEM SENSES, V33, P771, DOI 10.1093/chemse/bjn044; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Kuhnle K. F., 1913, Jenaische Zeitschrift fuer Naturwissenschaft, V50; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x; Lau T. F. S., 2007, Journal of Asia-Pacific Entomology, V10, P27; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lin C, 2012, J COMP NEUROL, V520, P2562, DOI [10.1002/cne.23092, 10.1002/cne.23158]; Maddison DR, 1999, SYST ENTOMOL, V24, P103, DOI 10.1046/j.1365-3113.1999.00088.x; Magro A, 2010, MOL PHYLOGENET EVOL, V54, P833, DOI 10.1016/j.ympev.2009.10.022; Marshall DC, 1002, ANN ENTOMOLOGICAL SO, V94, P386; Missbach C, 2011, ARTHROPOD STRUCT DEV, V40, P317, DOI 10.1016/j.asd.2011.03.004; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Mysore K, 2009, ARTHROPOD STRUCT DEV, V38, P485, DOI 10.1016/j.asd.2009.06.001; Nagel KI, 2015, NAT NEUROSCI, V18, P56, DOI 10.1038/nn.3895; Nakanishi A, 2010, J COMP NEUROL, V518, P2186, DOI 10.1002/cne.22326; Nassel DR, 2000, NATURWISSENSCHAFTEN, V87, P439, DOI 10.1007/s001140050756; NISHIKAWA M, 1995, J COMP NEUROL, V361, P165, DOI 10.1002/cne.903610113; Ochieng' SA, 1999, PHYSIOL ENTOMOL, V24, P28, DOI 10.1046/j.1365-3032.1999.00107.x; Ochieng SA, 1998, CELL TISSUE RES, V291, P525, DOI 10.1007/s004410051022; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Panov A. A., 2013, ENTOMOLOGICAL REV, V94, P654; PARETO A, 1972, Z ZELLFORSCH MIK ANA, V131, P109, DOI 10.1007/BF00307204; Piersanti S, 2014, J INSECT PHYSIOL, V62, P26, DOI 10.1016/j.jinsphys.2014.01.006; RAKSHPAL R, 1959, PARASITOLOGY, V49, P232, DOI 10.1017/S0031182000026846; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rebora M, 2008, ARTHROPOD STRUCT DEV, V37, P504, DOI 10.1016/j.asd.2008.03.003; Rebora M, 2013, ZOOLOGY, V116, P205, DOI 10.1016/j.zool.2013.04.001; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sarkar N, 2013, ARTHROPOD-PLANT INTE, V7, P339, DOI 10.1007/s11829-013-9249-0; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schaller M, 2000, EUR J ENTOMOL, V97, P155, DOI 10.14411/eje.2000.029; Schwalb H. H., 1961, Zoologische Jahrbuecher Jena Systematik, V88, P399; SHANBHAG SR, 1995, CELL TISSUE RES, V282, P237, DOI 10.1007/BF00319115; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Siju KP, 2014, J COMP NEUROL, V522, P592, DOI 10.1002/cne.23434; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Sinakevitch IT, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00070; SMITH CM, 1976, INT J INSECT MORPHOL, V5, P349, DOI 10.1016/0020-7322(76)90010-6; Smith DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0060; Smith VS, 2001, ZOOL J LINN SOC-LOND, V132, P81, DOI [10.1006/zjls.2000.0264, 10.1111/j.1096-3642.2001.tb02272.x]; Stacconi MVR, 2014, CHEM SENSES, V39, P282, DOI 10.1093/chemse/bjt114; Steinbrecht RA, 1996, CIBA F SYMP, V200, P158; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Utz S, 2008, DEV NEUROBIOL, V68, P123, DOI 10.1002/dneu.20579; VEENSTRA JA, 1995, HISTOCHEM CELL BIOL, V104, P337, DOI 10.1007/BF01458127; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wertz Adrian, 2006, Frontiers in Zoology, V3, P1; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2010, FLY, V4, P167, DOI 10.4161/fly.4.2.11467; Yoritsune A, 2012, INVERTEBR NEUROSCI, V12, P103, DOI 10.1007/s10158-012-0137-6; Zahradnik J., 2010, ILLUSTRIERTES LEXIKO; Zahradnik J., 1985, BESTIMMUNGSBUCH BIOL	145	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166253	10.1371/journal.pone.0166253	http://dx.doi.org/10.1371/journal.pone.0166253			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973569	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300008
J	Chan, DK; Rouse, SL				Chan, Dylan K.; Rouse, Stephanie L.			Sound-Induced Intracellular Ca2+ Dynamics in the Adult Hearing Cochlea	PLOS ONE			English	Article							HAIR CELL-DEATH; MAMMALIAN COCHLEA; INNER-EAR; SUPPORTING CELLS; GJB2 DEFICIENCY; IN-VITRO; ATP; NOISE; ORGAN; CALCIUM	Ca2+ signaling has been implicated in the initial pathophysiologic mechanisms underlying the cochlea's response to acoustic overstimulation. Intracellular Ca2+ signaling (ICS) waves, which occur in glia and retinal cells in response to injury to activate cell regulatory pathways, have been proposed as an early event in cochlear injury. Disruption of ICS activity is thought to underlie Connexin 26-associated hearing loss, the most common genetic form of deafness, and downstream sequelae of ICS wave activity, such as MAP kinase pathway activation, have been implicated in noise-induced hearing loss. However, ICS waves have only been observed in neonatal cochlear cultures and are thought to be quiescent after the onset of hearing. In this study, we employ an acute explant model of an adult, hearing cochlea that retains many in vivo physiologic features to investigate Ca2+ changes in response to sound. We find that both slow monotonic changes in intracellular Ca2+ concentration as well as discrete ICS waves occur with acoustic overstimulation. The ICS waves share many intrinsic features with their better-described neonatal counterparts, including ATP and gap-junction dependence, and propagation velocity and distance. This identification of ICS wave activity in the adult, hearing cochlea thus confirms and characterizes an important early detection mechanism for cochlear trauma and provides a target for interventions for noise-induced and Connexin 26-associated hearing loss.	[Chan, Dylan K.; Rouse, Stephanie L.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chan, DK (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	dylan.chan@ucsf.edu		Rouse, Stephanie/0000-0002-2967-3351	National Institute on Deafness and Other Communication Disorders (NIDCD) [R03DC015082]; American Hearing Research Foundation (AHRF); American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC015082] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Hearing Research Foundation (AHRF); American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by: 1) National Institute on Deafness and Other Communication Disorders (NIDCD; https://www.nidcd.nih.gov): R03DC015082; 2) American Hearing Research Foundation (AHRF; http://american-hearing.org): 2015 Research Award; 3) American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS; http://www.entnet.org): 2014 Herb Silverstein Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Battaglia A, 2003, NEUROSCIENCE, V122, P1025, DOI 10.1016/j.neuroscience.2003.08.041; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Ceriani F, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-20; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Chen J, 2014, BIOCHEM BIOPH RES CO, V448, P28, DOI 10.1016/j.bbrc.2014.04.016; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; Esterberg R, 2013, J NEUROSCI, V33, P7513, DOI 10.1523/JNEUROSCI.4559-12.2013; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Horvath T, 2016, NEUROCHEM RES, V41, P364, DOI 10.1007/s11064-015-1818-4; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; Lahne M, 2008, J NEUROSCI, V28, P4918, DOI 10.1523/JNEUROSCI.4914-07.2008; Lee HY, 2016, J NEUROSCI, V36, P8160, DOI 10.1523/JNEUROSCI.1157-16.2016; Maeda Y, 2012, PLOS ONE, V8; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Wang J, 2003, J NEUROSCI, V23, P8596; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Zhou XX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030301; Zhu Y, 2015, NEUROSCIENCE, V284, P719, DOI 10.1016/j.neuroscience.2014.10.061	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167850	10.1371/journal.pone.0167850	http://dx.doi.org/10.1371/journal.pone.0167850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959894	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900018
J	Notaro, M; Schummer, M; Zhong, YF; Vavrus, S; Van Den Elsen, L; Coluccy, J; Hoving, C				Notaro, Michael; Schummer, Michael; Zhong, Yafang; Vavrus, Stephen; Van Den Elsen, Lena; Coluccy, John; Hoving, Christopher			Projected Influences of Changes in Weather Severity on Autumn-Winter Distributions of Dabbling Ducks in the Mississippi and Atlantic Flyways during the Twenty-First Century	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; CLIMATE-CHANGE; ANAS-PLATYRHYNCHOS; ICE COVER; EFFECT SNOWSTORMS; EFFECT SNOWFALL; BLACK DUCK; EL-NINO; SURVIVAL; TEMPERATURE	Projected changes in the relative abundance and timing of autumn-winter migration are assessed for seven dabbling duck species across the Mississippi and Atlantic Flyways for the mid-and late 21(st) century. Species-specific observed relationships are established between cumulative weather severity in autumn-winter and duck population rate of change. Dynamically downscaled projections of weather severity are developed using a highresolution regional climate model, interactively coupled to a one-dimensional lake model to represent the Great Lakes and associated lake-effect snowfall. Based on the observed relationships and downscaled climate projections of rising air temperatures and reduced snow cover, delayed autumn-winter migration is expected for all species, with the least delays for the Northern Pintail and the greatest delays for the Mallard. Indeed, the Mallard, the most common and widespread duck in North America, may overwinter in the Great Lakes region by the late 21 st century. This highlights the importance of protecting and restoring wetlands across the mid-latitudes of North America, including the Great Lakes Basin, because dabbling ducks are likely to spend more time there, which would impact existing wetlands through increased foraging pressure. Furthermore, inconsistency in the timing and intensity of the traditional autumn-winter migration of dabbling ducks in the Mississippi and Atlantic Flyways could have social and economic consequences to communities to the south, where hunting and birdwatching would be affected.	[Notaro, Michael; Vavrus, Stephen] Univ Wisconsin Madison, Nelson Inst Ctr Climat Res, Madison, WI 53706 USA; [Schummer, Michael] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY 13126 USA; [Zhong, Yafang] Univ Wisconsin Madison, Space Sci & Engn Ctr, Madison, WI USA; [Van Den Elsen, Lena] Long Point Waterfowl Bird Studies Canada, Port Rowan, ON, Canada; [Coluccy, John] Ducks Unltd, Ann Arbor, MI USA; [Hoving, Christopher] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA	University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; University of Wisconsin System; University of Wisconsin Madison	Notaro, M (corresponding author), Univ Wisconsin Madison, Nelson Inst Ctr Climat Res, Madison, WI 53706 USA.	mnotaro@wisc.edu	Schummer, Michael/FDB-4240-2022		Northeast Climate Science Center; National Oceanic and Atmospheric Administration; National Science Foundation; Great Lakes Restoration Initiative through the Environmental Protection Agency; Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative; Long Point Waterfowl; Ontario Federation of Anglers and Hunters; University of Western Ontario through the Western Graduate Research Scholarship	Northeast Climate Science Center; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Great Lakes Restoration Initiative through the Environmental Protection Agency; Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative; Long Point Waterfowl; Ontario Federation of Anglers and Hunters; University of Western Ontario through the Western Graduate Research Scholarship	The research was funded by the Northeast Climate Science Center, National Oceanic and Atmospheric Administration, National Science Foundation, Great Lakes Restoration Initiative through the Environmental Protection Agency, Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative, Long Point Waterfowl, Ontario Federation of Anglers and Hunters, and the University of Western Ontario through the Western Graduate Research Scholarship.; The research was funded by the Northeast Climate Science Center, National Oceanic and Atmospheric Administration, National Science Foundation, Great Lakes Restoration Initiative through the Environmental Protection Agency, Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative, Long Point Waterfowl, Ontario Federation of Anglers and Hunters, and the University of Western Ontario through the Western Graduate Research Scholarship. Modeling contributions from Dr. Val Bennington are acknowledged. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. Computational resources were provided through the National Center for Atmospheric Research and the Teragrid from the University of Texas at Austin and the University of Illinois at Urbana-Champaign. Comments from Dr. Matthew Guillemain and an anonymous reviewer are greatly appreciated. Publication of the Nelson Institute Center for Climatic Research.	Albright J.J., 1983, Transactions of the Northeast Fish and Wildlife Conference, V40, P118; Alerstam T., 1990, P331; ANDERSON HARRY G., 1959, ILLINOIS NAT HIST SURV BULL, V27, P289; Ankney C.D., 1996, 7 INT WAT S I WETL W, P50; Anthes N, 2004, BIRD STUDY, V51, P203, DOI 10.1080/00063650409461355; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baldassarre G.A., 2006, WATERFOWL ECOLOGY MA; Baldassarre G. A., 2014, DUCKS GEESE SWANS N, V1; Barshep Y, 2012, ORNIS FENNICA, V89, P120; Bellrose F, 1980, DUCKS GEESE SWANS N; Bellrose F. C, 1970, Bull. Ill. nat. Hist. Surv., V30, P167; Bengtsson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100764; Bennington V, 2014, J CLIMATE, V27, P2886, DOI 10.1175/JCLI-D-13-00110.1; Blums P, 2002, J ANIM ECOL, V71, P438, DOI 10.1046/j.1365-2656.2002.00613.x; Bossenmaier EF, 1958, WILDLIFE MONOGRAPHS, V1; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brook RW, 2009, J WILDLIFE MANAGE, V73, P98, DOI 10.2193/2007-424; Browne DM, 2007, CONSERVING WATERFOWL; Burnett AW, 2003, J CLIMATE, V16, P3535, DOI [10.1175/1520-0442(2003)016<3535:IGLSDT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3535:IGLSDT&gt;2.0.CO;2]; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CALDER WA, 1974, AVIAN ENERGETICS, P86; Cox RR, 1998, J WILDLIFE MANAGE, V62, P124, DOI 10.2307/3802270; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dahl T.E., 1990, WETLAND LOSSES US 17; Dahl TE, 2006, FISH; Dalby L, 2013, IBIS, V155, P80, DOI 10.1111/j.1474-919X.2012.01257.x; Fuller K, 1995, GREAT LAKES ENV ATLA; Giorgi F, 2012, CLIM RES, V52, P7, DOI 10.3354/cr01018; Grado SC, 2001, WILDLIFE SOC B, V29, P846; Green AW, 2008, J WILDLIFE MANAGE, V72, P1328, DOI 10.2193/2007-028; Guillemain Matthieu, 2015, Wildfowl, V65, P51; Guillemain M, 2015, J ORNITHOL, V156, P647, DOI 10.1007/s10336-015-1171-z; Guillemain M, 2013, WILDLIFE BIOL, V19, P404, DOI 10.2981/12-118; Gunnarsson G, 2004, CAN J ZOOL, V82, P1698, DOI 10.1139/Z04-153; Gunnarsson G, 2012, IBIS, V154, P307, DOI 10.1111/j.1474-919X.2011.01206.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hatzofe O, 2002, ISRAEL J ZOOL, V48, P351, DOI 10.1560/F9CC-X3UM-XJBJ-FPW6; HAVERA SP, 1999, SPECIAL PUBLICATION, V21; Henderson E, 2005, 20019 US FISH WILDL; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Hostetler S.W., 1991, CLIM DYNAM, V6, P43, DOI DOI 10.1007/BF00210581; HOSTETLER SW, 1990, WATER RESOUR RES, V26, P2603, DOI 10.1029/90WR01240; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B., 2007, CLIMATIC ATLAS EUROP; Inkley D. B., 2004, WILDLIFE SOC TECHNIC; Johnson Douglas H., 1992, P446; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; JORDE DG, 1983, J WILDLIFE MANAGE, V47, P1044, DOI 10.2307/3808163; Keller V, 2005, ENTWICKLUNG WASSERVO; Kershaw M, 2002, MIGRATION ATLAS MOVE, P204; KOSKIMIES JUKKA, 1964, AUK, V81, P281; Kunkel KE, 2009, J GREAT LAKES RES, V35, P23, DOI 10.1016/j.jglr.2008.11.003; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lehikoinen A, 2013, GLOBAL CHANGE BIOL, V19, P2071, DOI 10.1111/gcb.12200; Lensink CJ, 1964, 89 US FISH WILDL SER, V89; Longcore JR, 2000, BIRDS N AM; LOVVORN JR, 1994, J ANIM ECOL, V63, P11, DOI 10.2307/5578; Mallory ML, 2003, J BIOGEOGR, V30, P441, DOI 10.1046/j.1365-2699.2003.00819.x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Moller A.P., 2011, EFFECTS CLIMATE CHAN; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1998, POPULATION LIMITATIO; NICHOLS JD, 1983, AUK, V100, P932, DOI 10.1093/auk/100.4.932; Nilsson Leif, 1984, Wildfowl, V35, P71; Nilsson Leif, 2008, Ornis Svecica, V18, P135; Notaro M, 2015, J CLIMATE, V28, P9721, DOI 10.1175/JCLI-D-14-00847.1; Notaro M, 2015, J CLIMATE, V28, P1661, DOI 10.1175/JCLI-D-14-00467.1; Notaro M, 2014, J CLIMATE, V27, P6526, DOI 10.1175/JCLI-D-13-00520.1; Notaro M, 2013, MON WEATHER REV, V141, P1990, DOI 10.1175/MWR-D-11-00369.1; Notaro M, 2013, J CLIMATE, V26, P789, DOI 10.1175/JCLI-D-12-00140.1; Palmer, 1976, HDB N AM BIRDS 1, V2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PATTERSON JC, 1988, LIMNOL OCEANOGR, V33, P323, DOI 10.4319/lo.1988.33.3.0323; Pearse AT, 2007, THESIS; Price J. T., 2000, PREPARING CHANGING C, P65; Price JT, 2002, BIRD CONSERVATION, V17, P12; Raty O, 2014, CLIM DYNAM, V42, P2287, DOI 10.1007/s00382-014-2130-8; Rebetez M, 1996, THEOR APPL CLIMATOL, V54, P99, DOI 10.1007/BF00865152; Reinecke K.J., 1989, P203; Ridgill S.C., 1990, INT WATERFOWL WETLAN, V13; RUSCH DH, 1989, WILDLIFE SOC B, V17, P379; Sauter A, 2010, IBIS, V152, P600, DOI 10.1111/j.1474-919X.2010.01028.x; Schummer Michael L., 2014, Wildfowl, P451; Schummer ML, 2010, J WILDLIFE MANAGE, V74, P94, DOI 10.2193/2008-524; Scott D.A., 1996, ATLAS ANATIDAE POPUL; Sedinger JS, 2006, ECOLOGY, V87, P151, DOI 10.1890/04-1013; Sparks T. H., 2001, ESSEX BIRD REPORT, V1999, P154; Suter W., 1991, Ornithologische Beobachter, V88, P111; Svazas S, 2001, OISEAUX MIGRATEURS P; Svazas Saulius, 2001, Acta Zoologica Lituanica, V11, P235; TALENT LG, 1983, CONDOR, V85, P74, DOI 10.2307/1367893; Temple S.A., 1987, Passenger Pigeon, V49, P70; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thornton PE, 1999, AGR FOREST METEOROL, V93, P211, DOI 10.1016/S0168-1923(98)00126-9; Thornton PE, DAYMET ANN CLIMATE S; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8; U. S. Fish & Wildlife Service, 2013, 20111 US FISH WILDL; Van Cleave K, 2014, LIMNOL OCEANOGR, V59, P1889, DOI 10.4319/lo.2014.59.6.1889; Van Den Elsen L, 2013, ESTIMATED EFFECTS CL; Van Den Elsen LM, 2016, THESIS; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vavrus S, 2013, MON WEATHER REV, V141, P148, DOI 10.1175/MWR-D-12-00107.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang J, 2012, J CLIMATE, V25, P1318, DOI 10.1175/2011JCLI4066.1	108	26	26	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167506	10.1371/journal.pone.0167506	http://dx.doi.org/10.1371/journal.pone.0167506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959911	Green Submitted, Green Published, gold			2022-12-26	WOS:000392753900009
J	Enanoria, WTA; Liu, FC; Zipprich, J; Harriman, K; Ackley, S; Blumberg, S; Worden, L; Porco, TC				Enanoria, Wayne T. A.; Liu, Fengchen; Zipprich, Jennifer; Harriman, Kathleen; Ackley, Sarah; Blumberg, Seth; Worden, Lee; Porco, Travis C.			The Effect of Contact Investigations and Public Health Interventions in the Control and Prevention of Measles Transmission: A Simulation Study	PLOS ONE			English	Article							HUMAN PLASMA FRACTIONATION; IMMUNE SERUM GLOBULIN; INFECTIOUS-DISEASES; EPIDEMIC; OUTBREAK; PROPHYLAXIS; ELIMINATION; VACCINATION; QUARANTINE; PRODUCTS	Background Measles cases continue to occur despite its elimination status in the United States. To control transmission, public health officials confirm the measles diagnosis, identify close contacts of infectious cases, deliver public health interventions (i.e., post-exposure prophylaxis) among those who are eligible, and follow-up with the close contacts to determine overall health outcomes. A stochastic network simulation of measles contact tracing was conducted using existing agent-based modeling software and a synthetic population with high levels of immunity in order to estimate the impact of different interventions in controlling measles transmission. Methods and Findings The synthetic population was created to simulate California's population in terms of population demographics, household, workplace, school, and neighborhood characteristics using California Department of Finance 2010 census data. Parameters for the model were obtained from a review of the literature, California measles case surveillance data, and expert opinion. Eight different scenarios defined by the use of three different public health interventions were evaluated: (a) post-exposure measles, mumps, and rubella (MMR) vaccine, (b) post-exposure immune globulin (IG), and (c) voluntary isolation and home quarantine in the presence or absence of public health response delays. Voluntary isolation and home quarantine coupled with one or two other interventions had the greatest reduction in the number of secondary cases infected by the index case and the probability of escape situations (i.e., the outbreak continues after 90 days). Conclusions Interrupting contact patterns via voluntary isolation and home quarantine are particularly important in reducing the number of secondary cases infected by the index case and the probability of uncontrolled outbreaks.	[Enanoria, Wayne T. A.; Ackley, Sarah; Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Liu, Fengchen; Ackley, Sarah; Blumberg, Seth; Worden, Lee; Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Zipprich, Jennifer; Harriman, Kathleen] Calif Dept Publ Hlth, Div Communicable Dis Control, Immunizat Branch, Richmond, CA USA; [Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Department of Public Health; University of California System; University of California San Francisco	Porco, TC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Porco, TC (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.; Porco, TC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu			Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health [U01GM087728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, U01GM087728] Funding Source: NIH RePORTER	Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health to the University of California, San Francisco (Award Number U01GM087728). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blumberg S, 2015, PLOS CURR; Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068; Brewer DD, 2005, SEX TRANSM DIS, V32, P78, DOI 10.1097/01.olq.0000153574.38764.0e; Britton T, 2009, MATH BIOSCI, V222, P109, DOI 10.1016/j.mbs.2009.10.001; California Department of Public Health, 2006, VACC PREV DIS IMMM C; Centers for Disease Control and Prevention, 2012, EPIDEMIOLOGY PREVENT; Cowling BJ, 2008, EPIDEMIOL INFECT, V136, P562, DOI 10.1017/S0950268807008722; Dayan GH, 2005, PEDIATRICS, V116, pE1, DOI 10.1542/peds.2004-2512; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Eames KTD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-141; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; Flint J, 2003, Can Commun Dis Rep, V29, P105; Grefenstette JJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-940; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; James L, 2006, PUBLIC HEALTH, V120, P20, DOI 10.1016/j.puhe.2005.10.005; Jezek Z, 1988, HUMAN MONKEYPOX; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Liu FC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1766-6; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; McLean Huang, 2011, Morbidity and Mortality Weekly Report, V60, P666; McQuillan GM, 2007, J INFECT DIS, V196, P1459, DOI 10.1086/522866; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Ordman CW, 1944, J CLIN INVEST, V23, P541, DOI 10.1172/JCI101519; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Papania M, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e59; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Sippl-Swezey N, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/952381; Stokes J, 1944, J CLIN INVEST, V23, P531, DOI 10.1172/JCI101518; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Uzicanin A, 2011, J INFECT DIS, V204, pS133, DOI 10.1093/infdis/jir102; Vogel C, 2008, J TRAVEL MED, V15, P65, DOI 10.1111/j.1708-8305.2008.00182.x; Watson JC, 1998, MMWR RECOMM REP, V47, P1; WILLCOX RR, 1966, BRIT J VENER DIS, V42, P167; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; WYKOFF RF, 1988, JAMA-J AM MED ASSOC, V259, P3563, DOI 10.1001/jama.259.24.3563; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Young MK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010056.pub2; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	51	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167160	10.1371/journal.pone.0167160	http://dx.doi.org/10.1371/journal.pone.0167160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941976	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600010
J	Bonafiglia, JT; Rotundo, MP; Whittall, JP; Scribbans, TD; Graham, RB; Gurd, BJ				Bonafiglia, Jacob T.; Rotundo, Mario P.; Whittall, Jonathan P.; Scribbans, Trisha D.; Graham, Ryan B.; Gurd, Brendon J.			Inter-Individual Variability in the Adaptive Responses to Endurance and Sprint Interval Training: A Randomized Crossover Study	PLOS ONE			English	Article							EXERCISE PERFORMANCE; LACTATE THRESHOLD; SKELETAL-MUSCLE; INDIVIDUAL PATTERNS; AEROBIC CAPACITY; HERITAGE FAMILY; ADAPTATIONS; VO2MAX; FITNESS; NONRESPONSE	The current study examined the adaptive response to both endurance (END) and sprint interval training (SIT) in a group of twenty-one recreationally active adults. All participants completed three weeks (four days/week) of both END (30 minutes at similar to 65% VO(2)peak work rate (WR) and SIT (eight, 20-second intervals at similar to 170% VO(2)peak WR separated by 10 seconds of active rest) following a randomized crossover study design with a three-month washout period between training interventions. While a main effect of training was observed for VO(2)peak, lactate threshold, and submaximal heart rate (HR), considerable variability was observed in the individual responses to both END and SIT. No significant positive relationships were observed between END and SIT for individual changes in any variable. Nonresponses were determined using two times the typical error (TE) of measurement for VO(2)peak (0.107 L/min), lactate threshold (15.7 W), and submaximal HR (10.7bpm). Nonresponders in VO(2)peak, lactate threshold, and submaximal HR were observed following both END and SIT, however, the individual patterns of response differed following END and SIT. Interestingly, all individuals responded in at least one variable when exposed to both END and SIT. These results suggest that the individual response to exercise training is highly variable following different training protocols and that the incidence of non-response to exercise training may be reduced by changing the training stimulus for non-responders to three weeks of END or SIT.	[Bonafiglia, Jacob T.; Rotundo, Mario P.; Whittall, Jonathan P.; Scribbans, Trisha D.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Graham, Ryan B.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Queens University - Canada; University of Ottawa	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca	Bonafiglia, Jacob T./AAA-1768-2019		Natural Sciences and Engineering Council of Canada [402635]; Canadian Foundation for Innovation [25476]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding was provided by the Natural Sciences and Engineering Council of Canada (grant number: 402635; http://www.nserc-crsng.gc.ca/index_eng.asp) and the Canadian Foundation for Innovation (grant number: 25476;https://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Astorino TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097638; Atkinson G, 2015, EXP PHYSIOL, V6, P1; Bacon AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073182; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Buford TW, 2013, SPORTS MED, V43, P157, DOI 10.1007/s40279-013-0018-0; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Esfarjani F, 2007, J SCI MED SPORT, V10, P27, DOI 10.1016/j.jsams.2006.05.014; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gist NH, 2014, SPORTS MED, V44, P269, DOI 10.1007/s40279-013-0115-0; Granata C, 2015, FASEB J; Gurd BJ, 2016, APPL PHYSIOL NUTR ME, V41, P229, DOI 10.1139/apnm-2015-0449; Hautala AJ, 2006, EUR J APPL PHYSIOL, V96, P535, DOI 10.1007/s00421-005-0116-2; He Z, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.042945; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; Hecksteden A, 2015, J APPL PHYSIOL, V118, P1450, DOI 10.1152/japplphysiol.00714.2014; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2015, J APPL PHYSIOL, V118, P1444, DOI 10.1152/japplphysiol.00098.2015; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Matsuo T, 2014, MED SCI SPORT EXER, V46, P42, DOI 10.1249/MSS.0b013e3182a38da8; McPhee JS, 2011, EXP PHYSIOL, V96, P699, DOI 10.1113/expphysiol.2011.057729; Montero D, 2015, J PHYSIOL-LONDON, V593, P4677, DOI 10.1113/JP270250; Ross R, 2015, MAYO CLIN PROC, V90, P1506, DOI 10.1016/j.mayocp.2015.07.024; Scharhag-Rosenberger F, 2012, SCAND J MED SCI SPOR, V22, P113, DOI 10.1111/j.1600-0838.2010.01139.x; Scribbans TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098119; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Svedahl K, 2003, CAN J APPL PHYSIOL, V28, P299, DOI 10.1139/h03-023; Timmons JA, 2012, J APPL PHYSL; Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Wolpern AE, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0011-z; Zelt JGE, 2014, EUR J APPL PHYSL	46	101	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167790	10.1371/journal.pone.0167790	http://dx.doi.org/10.1371/journal.pone.0167790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936084	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100191
J	Li, P; Quan, W; Lu, D; Wang, Y; Zhang, HH; Liu, SA; Jiang, RC; Zhou, YY				Li, Pan; Quan, Wei; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Jiang, Rong-Cai; Zhou, Yu-Ying			Association between Metabolic Syndrome and Cognitive Impairment after Acute Ischemic Stroke: A Cross-Sectional Study in a Chinese Population	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; ELDERLY-PEOPLE; OLDER-ADULTS; RISK; VERSION; AGE; INFLAMMATION; RELIABILITY; PERFORMANCE	Background and Objectives Metabolic syndrome (MetS), a risk factor for many vascular conditions, is associated with vascular cognitive disorders. The objective of the present study was to explore the associations of MetS and its individual components with the risks of cognitive impairment and neurological dysfunction in patients after acute stroke. Methods This cross-sectional study enrolled 840 patients ranging in age from 53 to 89 years from the Tianjin area of North China. Cognitive function was evaluated using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination. Neuropsychiatric behavior was assessed using the Neuropsychiatric Inventory Questionnaire. Emotional state was examined according to the Hamilton Depression Rating Scale, and neuromotor function was evaluated using the National Institutes of Health Stroke Scale, Barthel index, and the Activity of Daily Living test. After overnight fasting, blood samples were obtained to measure biochemistry indicators. Results MetS and its individual components were closely correlated with MoCA score. MetS patients had high levels of inflammation and a 3.542-fold increased odds ratio (OR) for cognitive impairment [95% confidence interval (CI): 1.972-6.361]. Of the individual MetS components, central obesity (OR 3.039; 95% CI: 1.839-5.023), high fasting plasma glucose (OR 1.915; 95% CI: 1.016-3.607), and type 2 diabetes (OR 2.241; 95% CI: 1.630-3.081) were associated with an increased incidence of cognitive impairment. Consistent and significant worsening in different neurological domains was observed with greater numbers of MetS components. Conclusions MetS was associated with worse cognitive function, neuromotor dysfunction, and neuropsychological symptoms among Chinese acute stroke patients.	[Li, Pan; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Zhou, Yu-Ying] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Li, Pan; Lu, Da; Wang, Yan; Zhang, Hui-Hong; Liu, Shuai; Zhou, Yu-Ying] Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab of Cerebral Vasc & Neurodegenerat, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Gen Hosp, Minist Educ, Tianjin Neurol Inst, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Quan, Wei; Jiang, Rong-Cai] Gen Hosp, Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China	Tianjin Medical University	Li, P; Zhou, YY (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.; Li, P; Zhou, YY (corresponding author), Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab of Cerebral Vasc & Neurodegenerat, Tianjin, Peoples R China.	doc_panpan@163.com; professor_yyzhou@163.com			Science and Technology Project of the Tianjin Municipal Health Bureau [2013KG121]; Tianjin Science and Technology Plan Foundation [13ZCZDSY01600]; National Clinical and Medical Research [L2014071]; National Nature Science Foundation of China [81301629]	Science and Technology Project of the Tianjin Municipal Health Bureau; Tianjin Science and Technology Plan Foundation; National Clinical and Medical Research; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Science and Technology Project of the Tianjin Municipal Health Bureau (http://www.tjwsj.gov.cn/html/WSJn/portal/index/index.htm) (2013KG121), the Tianjin Science and Technology Plan Foundation (http://www.tstc.gov.cn/) (grant no. 13ZCZDSY01600), the Special Fund of National Clinical and Medical Research (http://www.nsfc.gov.cn/) (grant no. L2014071), the Youth fund of National Nature Science Foundation of China (http://www.nsfc.gov.cn/) (grant no. 81301629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Azizi Gholamreza, 2015, Sultan Qaboos Univ Med J, V15, pe305, DOI 10.18295/squmj.2015.15.03.002; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crichton GE, 2012, J ALZHEIMERS DIS, V30, pS77, DOI 10.3233/JAD-2011-111022; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hachinski V, 2012, ARCH NEUROL-CHICAGO, V69, P169, DOI 10.1001/archneurol.2011.1698; Ho RCM, 2008, AM J GERIAT PSYCHIAT, V16, P519, DOI 10.1097/JGP.0b013e31816b7841; Hu JB, 2013, ARCH GERONTOL GERIAT, V56, P38, DOI 10.1016/j.archger.2012.05.008; Jung WB, 2014, PSYCHIAT CLIN NEUROS, V68, P821, DOI 10.1111/pcn.12196; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kester MI, 2014, JAMA NEUROL, V71, P855, DOI 10.1001/jamaneurol.2014.754; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Kwon HM, 2006, STROKE, V37, P466, DOI 10.1161/01.STR.0000199081.17935.81; Liu CY, 2009, EUR J NEUROL, V16, P1022, DOI 10.1111/j.1468-1331.2009.02640.x; Liu M, 2015, CLIN ENDOCRINOL, V82, P844, DOI 10.1111/cen.12734; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Misiak B, 2012, BRAIN RES BULL, V89, P144, DOI 10.1016/j.brainresbull.2012.08.003; Muller M, 2007, DEMENT GERIATR COGN, V24, P185, DOI 10.1159/000105927; Pan YS, 2014, J STROKE CEREBROVASC, V23, P2335, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.031; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Rao M., 2007, CHINA GUIDELINE CERE; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c; Roriz-Cruz M, 2007, NEUROBIOL AGING, V28, P1723, DOI 10.1016/j.neurobiolaging.2006.07.013; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Skoog I, 2000, J NEURAL TRANSM-SUPP, P37; Solfrizzi V, 2010, J NEUROL NEUROSUR PS, V81, P433, DOI 10.1136/jnnp.2009.181743; Spielman L. J., 2014, IMMUNOENDOCRINOLOGY, V1, P1, DOI [10.14800/Immunoendocrinology.391, DOI 10.1016/J.JNEUR0IM.2014.06.004]; Vanhanen M, 2006, NEUROLOGY, V67, P843, DOI 10.1212/01.wnl.0000234037.91185.99; Wang Dewen, 2009, Environmental Health and Preventive Medicine, V14, P128, DOI 10.1007/s12199-008-0072-7; Wang J, 2008, STROKE, V39, P1078, DOI 10.1161/STROKEAHA.107.499830; Wang T, 2012, INT J GERIATR PSYCH, V27, P539, DOI 10.1002/gps.2757; Wotton CJ, 2014, POSTGRAD MED J, V90, P547, DOI 10.1136/postgradmedj-2014-132571; Zhang JL, 2015, SPINAL CORD, V53, P679, DOI 10.1038/sc.2014.206; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660	39	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167327	10.1371/journal.pone.0167327	http://dx.doi.org/10.1371/journal.pone.0167327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936074	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100086
J	Olguin-Alor, R; de la Fuente-Granada, M; Bonifaz, LC; Antonio-Herrera, L; Garcia-Zepeda, EA; Soldevila, G				Olguin-Alor, Roxana; de la Fuente-Granada, Marisol; Bonifaz, Laura C.; Antonio-Herrera, Laura; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria			A Key Role for Inhibins in Dendritic Cell Maturation and Function	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; REGULATORY T-CELLS; ACTIVIN-A; BONE-MARROW; THYMOCYTE DEVELOPMENT; SEMI-MATURE; IN-VITRO; MICE; SKIN; CYTOKINE	Inhibins are members of the TGF beta superfamily, which regulate many cellular processes including differentiation, proliferation, survival and apoptosis. Although initially described as hormones regulating the hypothalamus-pituitary-gonadal axis, based on their ability to antagonize Activins, our group has recently reported that they play a role in thymocyte differentiation and survival, as well as in thymic stromal cell maturation and nTreg generation. Here, we used Inhibin knock out mice (Inh alpha(-/-)) to investigate the role of Inhibins in peripheral dendritic cell maturation and function. We first demonstrated that LPS treated Inh alpha(+/+) bone marrow derived dendritic cells (BMDC) were capable to produce significant levels of Inhibin A. Interestingly, Inh alpha(-/-) BMDC showed reduced MHCII and CD86 upregulation and increased PD-L1 expression in response to LPS compared to Inh alpha(+/+), which correlated with reduced ability to induce proliferation of allogeneic T cells. The "semi-mature" phenotype displayed by Inh alpha(-/-) mBMDC correlated with increased levels of IL-10 and slightly decreased IL-6 production after LPS stimulation. In addition, Inh alpha(-/-) mBMDC showed impaired migration towards CCL19 and CCL21, assessed by in vitro chemotaxis and in vivo competitive homing experiments, despite their normal CCR7 expression. Furthermore, in vivo LPS-induced DC maturation was also diminished in Inh alpha(-/-) mice, specially within the LC (CD207+ CD11b+ CD103-) subpopulation. Finally, analysis of delayed type hypersensitivity responses in Inh alpha(-/-) mice, showed reduced ear swelling as a result of reduced cellular infiltration in the skin, correlating with impaired homing of CD207+ DCs to the draining lymph nodes. In summary, our data demonstrate for the first time that Inhibins play a key role in peripheral DC maturation and function, regulating the balance between immunity and tolerance.	[Olguin-Alor, Roxana; de la Fuente-Granada, Marisol; Garcia-Zepeda, Eduardo A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico; [Bonifaz, Laura C.; Antonio-Herrera, Laura] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Unidad Invest Med Inmunoquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	soldevi@servidor.unam.mx	De La Fuente-Granada, Marisol/F-3745-2019	De La Fuente-Granada, Marisol/0000-0002-6878-4265; Soldevila, Gloria/0000-0003-1539-2548; Olguin-Alor, Roxana/0000-0003-2976-3370	Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico [IN209615]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [339203, 344606]	Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was funded by Direccion General de Asuntos del Personal Academico (DGAPA) UNAM, Mexico;http://dgapa.unam.mx; Grant # IN209615.ROA was a student in the Ph.D program "Programa de Doctorado en Ciencias Bioquimicas, Universidad Nacional Autonoma de Mexico". ROA and MFG were recipients of pre-doctoral fellowships from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico; http;///www.conacyt.gob.mx, ROA # 339203; MFG # 344606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Muench G R, 2011, IMMUNOLOGY CELL BIOL; Ambriz-Pena X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088014; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Carbajal-Franco E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/837859; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Dudek AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00438; Garcia-Zepeda EA, 2007, IMMUNOLOGY, V122, P247, DOI 10.1111/j.1365-2567.2007.02634.x; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Licona P, 2006, DEV DYNAM, V235, P1124, DOI 10.1002/dvdy.20707; Licona-Limon P, 2007, IMMUNOL LETT, V109, P1, DOI 10.1016/j.imlet.2006.12.010; Licona-Limon P, 2009, BIOCHEM BIOPH RES CO, V381, P229, DOI 10.1016/j.bbrc.2009.02.029; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Musso T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003271; Nusing RM, 1999, BRIT J PHARMACOL, V127, P919, DOI 10.1038/sj.bjp.0702626; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Ramos RN, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/806025; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rivas-Caicedo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007066; Robson NC, 2008, BLOOD, V111, P2733, DOI 10.1182/blood-2007-03-080994; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146; Seeger P, 2015, CYTOKINE GROWTH FACT; Segerer SE, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-17; Stenvers KL, 2010, TRENDS ENDOCRIN MET, V21, P174, DOI 10.1016/j.tem.2009.11.009; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhang XJ, 2005, CELL MOL IMMUNOL, V2, P63; Zhou J, 2009, CELL IMMUNOL, V255, P69, DOI 10.1016/j.cellimm.2008.11.001	43	9	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167813	10.1371/journal.pone.0167813	http://dx.doi.org/10.1371/journal.pone.0167813			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936218	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100203
J	Santiago, MD; Fonseca, BDFE; Marques, CDD; da Silva, ED; Bertho, AL; Nogueira, ACMD				Santiago, Marta de Almeida; Fonseca e Fonseca, Bruna de Paula; da Silva Marques, Christiane de Fatima; da Silva, Edimilson Domingos; Bertho, Alvaro Luiz; Martins de Almeida Nogueira, Ana Cristina			Flow Cytometry as a Tool for Quality Control of Fluorescent Conjugates Used in Immunoassays	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PERFORMANCE EVALUATION; PHYCOERYTHRIN; CALIBRATION; PLATFORMS; INTENSITY; STANDARDIZATION; ERYTHROPOIETIN; QUANTITATION; EXPRESSION	The use of antibodies in immunodiagnostic kits generally implies the conjugation of these proteins with other molecules such as chromophores or fluorochromes. The development of more sensitive quality control procedures than spectrophotometry is essential to assure the use of better fluorescent conjugates since the fluorescent conjugates are critical reagents for a variety of immunodiagnostic kits. In this article, we demonstrate a new flow cytometric protocol to evaluate conjugates by molecules of equivalent soluble fluorochromes (MESF) and by traditional flow cytometric analysis. We have coupled microspheres with anti-IgG-PE and anti-HBSAg-PE conjugates from distinct manufactures and/or different lots and evaluated by flow cytometry. Their fluorescence intensities were followed for a period of 18 months. Our results showed that there was a great difference in the fluorescence intensities between the conjugates studied. The differences were observed between manufactures and lots from both anti-IgG-PE and anti-HBSAg-PE conjugates. Coefficients of variation (CVs) showed that this parameter can be used to determine better coupling conditions, such as homogenous coupling. The MESF analysis, as well as geometric mean evaluation by traditional flow cytometry, showed a decrease in the values for all conjugates during the study and were indispensable tools to validate the results of stability tests. Our data demonstrated the feasibility of the flow cytometric method as a standard quality control of immunoassay kits.	[Santiago, Marta de Almeida; Fonseca e Fonseca, Bruna de Paula; da Silva Marques, Christiane de Fatima; da Silva, Edimilson Domingos] Fiocruz MS, Immunobiol Technol Inst, Lab Diagnost Technol, Rio De Janeiro, RJ, Brazil; [Bertho, Alvaro Luiz] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Bertho, Alvaro Luiz] Fiocruz MS, Inst Oswaldo Cruz, Flow Cytometry Core Facil, Rio De Janeiro, RJ, Brazil; [Martins de Almeida Nogueira, Ana Cristina] Fiocruz MS, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bertho, AL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.; Bertho, AL (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Flow Cytometry Core Facil, Rio De Janeiro, RJ, Brazil.; Nogueira, ACMD (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, RJ, Brazil.	alvaro.bertho@hotmail.com; ana.martins@ioc.fiocruz.br	Nogueira, Ana Cristina M A/C-2200-2013					Barth T, 2008, J AOAC INT, V91, P285; Bertho AL, 2013, CITOMETRIA FLUXO APL, P3; Carey JL, 2007, CLIN LAB MED, V27, P687, DOI 10.1016/j.cll.2007.05.010; Chan Huai En Huang, 2007, Methods Mol Biol, V378, P65, DOI 10.1007/978-1-59745-323-3_5; Comas-Riu J, 2009, J IND MICROBIOL BIOT, V36, P999, DOI 10.1007/s10295-009-0608-x; de Oliveira ERA, 2012, J IMMUNOL METHODS, V375, P271, DOI 10.1016/j.jim.2011.11.005; dos Santos R.V., 2006, REV BRAS ALERG IMUNO, V29, P77; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Fonseca BPF, 2011, CLIN VACCINE IMMUNOL, V18, P802, DOI 10.1128/CVI.00265-10; Gratama JW, 1998, CYTOMETRY, V33, P166, DOI 10.1002/(SICI)1097-0320(19981001)33:2<166::AID-CYTO11>3.0.CO;2-S; Guryev O, 2011, ANAL CHEM, V83, P7109, DOI 10.1021/ac2014146; Hayashi-Takanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106271; Henderson LO, 1998, CYTOMETRY, V33, P97, DOI 10.1002/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H; Hsu HY, 2009, ELECTROPHORESIS, V30, P4008, DOI 10.1002/elps.200900211; Ishida H, 2011, TRANSPL INT, V24, P150, DOI 10.1111/j.1432-2277.2010.01166.x; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Jung KM, 2010, TOXICOL LETT, V192, P229, DOI 10.1016/j.toxlet.2009.10.024; Kay S, 2006, CYTOM PART B-CLIN CY, V70B, P218, DOI 10.1002/cyto.b.20078; Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0; Li F, 2010, MABS-AUSTIN, V2, P466, DOI 10.4161/mabs.2.5.12720; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Lysak D, 2010, INT J LAB HEMATOL, V32, pE229, DOI 10.1111/j.1751-553X.2010.01244.x; Mahmoudian J, 2011, CELL J, V13, P169; Mittag A, 2009, J BIOPHOTONICS, V2, P470, DOI 10.1002/jbio.200910033; Mobarrez F, 2010, THROMB RES, V125, pE110, DOI 10.1016/j.thromres.2009.10.006; Munier M, 2014, FOOD CHEM, V150, P400, DOI 10.1016/j.foodchem.2013.10.113; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Patsenker L, 2008, ANN NY ACAD SCI, V1130, P179, DOI 10.1196/annals.1430.035; Randlev B, 2010, BIOLOGICALS, V38, P249, DOI 10.1016/j.biologicals.2009.12.001; Reilly JT, 1996, CLIN LAB HAEMATOL, V18, P1; Rigato PO, 2013, CITOMETRIA FLUXO APL, P35; Rossmann ED, 2007, CYTOM PART B-CLIN CY, V72B, P450, DOI 10.1002/cyto.b.20359; SCHMIDT C, 1989, J BIOTECHNOL, V11, P235, DOI 10.1016/0168-1656(89)90120-X; Schwartz A, 2002, J RES NATL INST STAN, V107, P83, DOI 10.6028/jres.107.009; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Sousa S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002371; Tighe P, 2013, METHODS, V61, P23, DOI 10.1016/j.ymeth.2013.01.003; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vogt RF, 2000, METHODS, V21, P289, DOI 10.1006/meth.2000.1009; Voskuil JLA., 2014, F1000 RES; Wang L, 2008, CYTOM PART A, V73A, P279, DOI 10.1002/cyto.a.20507; Wang LL, 2006, CYTOM PART B-CLIN CY, V70B, P410, DOI 10.1002/cyto.b.20140; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiczling P, 2009, CYTOM PART A, V75A, P584, DOI 10.1002/cyto.a.20736	46	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167669	10.1371/journal.pone.0167669	http://dx.doi.org/10.1371/journal.pone.0167669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936034	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100145
J	Skrivanova, E; Van Immerseel, F; Hovorkova, P; Kokoska, L				Skrivanova, Eva; Van Immerseel, Filip; Hovorkova, Petra; Kokoska, Ladislav			In Vitro Selective Growth-Inhibitory Effect of 8-Hydroxyquinoline on Clostridium perfringens versus Bifidobacteria in a Medium Containing Chicken Ileal Digesta	PLOS ONE			English	Article							NECROTIC ENTERITIS; BROILER-CHICKENS; ANTIMICROBIAL ACTIVITY; ESSENTIAL OILS; MICROBIOTA; ACID; 8-QUINOLINOL; PATHOGENESIS; ANTIBIOTICS; CLIOQUINOL	Clostridium perfringens-induced necrotic enteritis is generally controlled by antibiotics. However, because of increasing antibiotic resistance, other antibacterial agents are required, preferably ones that do not affect the beneficial intestinal microbiota of the host. This study evaluated the in vitro selective growth-inhibitory effect of 8-hydroxyquinoline (8HQ) on C. perfringens vs. bifidobacteria in a medium containing chicken ileal digesta. Prior to the experiments, the minimum inhibitory concentrations of 8HQ and penicillin G were determined by broth microdilution assay. The minimum inhibitory concentration values of 8HQ for C. perfringens were 16-32 times lower than the values for bifidobacteria. Treatment of autoclaved and non-autoclaved chicken ileal digesta with 8HQ showed a selective anticlostridial effect. After incubation of C. perfringens with autoclaved ileal digesta for 3 h, all 8HQ concentrations tested (32-2048 mu g/mL) significantly reduced C. perfringens bacterial count. In contrast, the same treatment had no or only a slight effect on bifidobacteria counts. Unlike 8HQ, penicillin G did not exhibit any selectivity. Similar results were obtained after incubation for 24 h. In non-autoclaved ileal digesta, all 8HQ concentrations tested significantly reduced C. perfringens bacterial counts after incubation for 30 min and 3 h, while no effect was observed on bifidobacteria. These results suggest that 8HQ may serve as a prospective veterinary compound for use against necrotic enteritis in poultry.	[Skrivanova, Eva; Hovorkova, Petra] Inst Anim Sci, Dept Physiol Nutr & Qual Anim Prod, Prague, Czech Republic; [Skrivanova, Eva; Hovorkova, Petra] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic; [Van Immerseel, Filip] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Kokoska, Ladislav] Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic	Czech Research Institute of Animal Science; Czech University of Life Sciences Prague; Ghent University; Czech University of Life Sciences Prague	Kokoska, L (corresponding author), Czech Univ Life Sci, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic.	kokoska@ftz.czu.cz	Van Immerseel, Filip/K-3701-2014; Kokoska, Ladislav/AAH-9857-2019; Skrivanova, Eva/V-6389-2019	Van Immerseel, Filip/0000-0003-0455-3350; Skrivanova, Eva/0000-0001-9336-5436; Kokoska, Ladislav/0000-0002-5677-692X	Ministry of Agriculture of the Czech Republic [MZERO0716]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The study was supported by the Ministry of Agriculture of the Czech Republic (project No. MZERO0716).; This study was supported by the Ministry of Agriculture of the Czech Republic (project No. MZERO0716).	Agunos A, 2012, CAN VET J, V53, P1289; Baumans V, 2004, GENE THER, V11, pS64, DOI 10.1038/sj.gt.3302371; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Chen C, 2014, BIOORG MED CHEM LETT, V24, P595, DOI 10.1016/j.bmcl.2013.12.015; Cheng GY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00217; Chobot V, 2011, NAT PROD COMMUN, V6, P597; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Duarte MC, 2016, VET PARASITOL, V217, P81, DOI 10.1016/j.vetpar.2016.01.002; FOX LK, 1994, J DAIRY SCI, V77, P2281, DOI 10.3168/jds.S0022-0302(94)77171-X; FRASER RSS, 1975, BIOCHEM J, V147, P401, DOI 10.1042/bj1470401; Fuller R., 2001, POULTRY SCI, V38, P189, DOI [10.2141/jpsa. 38. 189, DOI 10.2141/JPSA.38.189]; Gadbois P, 2008, AVIAN DIS, V52, P407, DOI 10.1637/8114-091807-Reg; Gosselin RE, 1984, CLIN TOXICOLOGY COMM, pII; Hecht DW., 1999, MANUAL CLIN MICROBIO, V7th ed, P1555; Jeon JH, 2009, J KOREAN SOC APPL BI, V52, P202, DOI 10.3839/jksabc.2009.037; Jung WJ, 2008, J MICROBIOL BIOTECHN, V18, P1836, DOI 10.4014/jmb.0800.120; Kanakaraj R, 1998, VET MICROBIOL, V63, P29, DOI 10.1016/S0378-1135(98)00229-6; Kim YM, 2006, FOOD SCI BIOTECHNOL, V15, P817; Lee KW, 2011, POULTRY SCI, V90, P1381, DOI 10.3382/ps.2010-01319; Magyar K, 1989, U.S. Patent, Patent No. [4,871,722, 4871722]; Namkung H, 2011, POULTRY SCI, V90, P2217, DOI 10.3382/ps.2011-01498; Novakova J, 2016, LETT APPL MICROBIOL, V62, P330, DOI 10.1111/lam.12552; Novakova J, 2014, J MED MICROBIOL, V63, P1663, DOI 10.1099/jmm.0.080796-0; Novakova J, 2013, ANAEROBE, V22, P134, DOI 10.1016/j.anaerobe.2013.05.008; Pang Y, 2009, POULTRY SCI, V88, P586, DOI 10.3382/ps.2008-00243; Park SS, 2008, AVIAN DIS, V52, P14, DOI 10.1637/7997-041707-Reg; Prachayasittikul V, 2013, DRUG DES DEV THER, V7, P1157, DOI 10.2147/DDDT.S49763; Rada V, 2000, J MICROBIOL METH, V43, P127, DOI 10.1016/S0167-7012(00)00205-0; SAS Institute, 2001, SAS SYST WIND REL 8; SAWADA Y, CHEM PHARM B, V26, P1357; Shojadoost B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-74; Si W, 2009, J APPL MICROBIOL, V106, P213, DOI 10.1111/j.1365-2672.2008.03994.x; Si W, 2007, APPL ENVIRON MICROB, V73, P7110, DOI 10.1128/AEM.01108-07; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Timbermont L, 2010, AVIAN PATHOL, V39, P117, DOI 10.1080/03079451003610586; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Vasudevan P, 2005, J APPL POULTRY RES, V14, P122, DOI 10.1093/japr/14.1.122; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Yoshinari K, 2011, TOXICOL LETT, V206, P229, DOI 10.1016/j.toxlet.2011.07.023	42	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167638	10.1371/journal.pone.0167638	http://dx.doi.org/10.1371/journal.pone.0167638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936245	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100138
J	Yang, WW; Wang, AN; Zhao, CL; Li, QH; Pan, ZF; Han, XF; Zhang, CJ; Wang, GH; Ji, C; Wang, GL; Jia, GT; Ju, JY; Gao, W; Yu, WJ; Liu, XY; Chen, X; Feng, WG; Gao, ZQ; Li, J; Ren, CN				Yang, Weiwei; Wang, Anning; Zhao, Chunling; Li, Qinghua; Pan, Zhifang; Han, Xuefu; Zhang, Cuijuan; Wang, Guohui; Ji, Chao; Wang, Guili; Jia, Guangtao; Ju, Jiyu; Gao, Wei; Yu, Wenjing; Liu, Xiaoying; Chen, Xi; Feng, Weiguo; Gao, Zhiqin; Li, Jie; Ren, Chune			miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1	PLOS ONE			English	Article							MICRORNA FUNCTIONS; INVASION; INTERLEUKIN-8; PATHOGENESIS; PLASMA; GROWTH; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS; MIGRATION	Preeclampsia (PE) is one of the leading causes of maternal and perinatal mortality and morbidity. One of the main hallmarks observed in PE is impaired inflammation state. In the current study, we found that miR-125b was deregulated in placental tissues and plasma derived from PE patients, which suggest a potential association between this miRNA and the pathogenesis of PE. Overexpression of miR-125b significantly reduced SGPL1 expression, and luciferase assays confirmed that SGPL1 is a direct target of miR-125b. We also found that miR-125b enhanced IL-8 production by directly targeting sphingosine-1-phosphate lyase 1 (SGPL1), and this effect could be reversed by SGPL1 overexpression. In placentas derived from PE patients, a negative correlation of miR-125b and SGPL1 was observed, and IL-8 was validated to be increased in the circulation of PE patients. Our data demonstrated a critical role of miR-125b in IL-8 production and the development of PE.	[Yang, Weiwei; Zhao, Chunling; Pan, Zhifang; Wang, Guohui; Ji, Chao; Jia, Guangtao; Ju, Jiyu; Gao, Wei; Yu, Wenjing; Liu, Xiaoying; Feng, Weiguo; Gao, Zhiqin] Weifang Med Univ, Sch Biol Sci, Weifang, Peoples R China; [Wang, Anning] Weifang Peoples Hosp, Dept Cardiol, Weifang, Peoples R China; [Li, Qinghua] Weifang Med Univ, Coll Publ Hlth, Weifang, Peoples R China; [Han, Xuefu] Weifang Peoples Hosp, Dept Cardiol, Weifang, Peoples R China; [Zhang, Cuijuan; Li, Jie] Weifang Med Univ, Dept Obstet, Affiliated Hosp, Weifang, Peoples R China; [Wang, Guili; Ren, Chune] Weifang Med Univ, Ctr Reprod Med, Affiliated Hosp, Weifang, Peoples R China; [Chen, Xi] Weifang Matern & Child Care Hosp, Dept Dent, Weifang, Peoples R China; [Yang, Weiwei; Zhao, Chunling; Gao, Zhiqin] Weifang Med Univ, Biopharmaceut Lab Hlth & Family Planning Commiss, Weifang, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University; Weifang Medical University	Gao, ZQ (corresponding author), Weifang Med Univ, Sch Biol Sci, Weifang, Peoples R China.; Gao, ZQ (corresponding author), Weifang Med Univ, Biopharmaceut Lab Hlth & Family Planning Commiss, Weifang, Peoples R China.	zhiqingao2013@163.com			Natural Science Foundation of China [81601318, 31671208, 81572578, 81274093]; Natural Science Foundation of Shandong Province [ZR2015HL021, ZR2014AQ025, ZR2013CM032]; Shandong Province Higher Educational Science and Technology Program [J16LM06]; Shandong Outstanding Youth Scientists [BS2013YY063]; Weifang Medical University [K1302021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Province Higher Educational Science and Technology Program; Shandong Outstanding Youth Scientists; Weifang Medical University	This work was supported by grants from the Natural Science Foundation of China (81601318, 31671208, 81572578, 81274093), Natural Science Foundation of Shandong Province (ZR2015HL021, ZR2014AQ025, ZR2013CM032), Shandong Province Higher Educational Science and Technology Program (J16LM06), Shandong Outstanding Youth Scientists (BS2013YY063), Weifang Medical University (No. K1302021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chen DB, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107805; Chen SW, 2015, FEBS LETT, V589, P710, DOI 10.1016/j.febslet.2015.01.038; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Dai Y, 2012, PLACENTA, V33, P824, DOI 10.1016/j.placenta.2012.07.012; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Hod T, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023473; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kauma S, 2002, OBSTET GYNECOL, V100, P706, DOI 10.1016/S0029-7844(02)02169-5; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lalevee S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.368; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Li DS, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/827130; Li JYZ, 2014, HYPERTENS PREGNANCY, V33, P102, DOI 10.3109/10641955.2013.832772; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017; Nadeem U, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119065; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; So AY-L, 2014, BLOOD; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yang Q, 2014, ONCOTARGET; Zhang C, 2015, PLACENTA, V36, P250, DOI 10.1016/j.placenta.2014.11.020; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114; Zhao X, 2015, ANIM BIOL, V65, P1, DOI 10.1163/15707563-00002455; Zhou S, 2014, BURNS J INT SOC BURN; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, P661, DOI [DOI 10.1016/J.AJ0G.2008.12.045, DOI 10.1016/J.AJOG.2008.12.045]	51	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166940	10.1371/journal.pone.0166940	http://dx.doi.org/10.1371/journal.pone.0166940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935985	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100049
J	Yu, MZ; Yang, CW				Yu, Manzhu; Yang, Chaowei			Improving the Non-Hydrostatic Numerical Dust Model by Integrating Soil Moisture and Greenness Vegetation Fraction Data with Different Spatiotemporal Resolutions	PLOS ONE			English	Article							AEROSOL OPTICAL-THICKNESS; PREDICTION; AERONET; SUN	Dust storms are devastating natural disasters that cost billions of dollars and many human lives every year. Using the Non-Hydrostatic Mesoscale Dust Model (NMM-dust), this research studies how different spatiotemporal resolutions of two input parameters (soil moisture and greenness vegetation fraction) impact the sensitivity and accuracy of a dust model. Experiments are conducted by simulating dust concentration during July 1-7, 2014, for the target area covering part of Arizona and California (31, 37, -118, -112), with a resolution of similar to 3 km. Using ground-based and satellite observations, this research validates the temporal evolution and spatial distribution of dust storm output from the NMM-dust, and quantifies model error using measurements of four evaluation metrics (mean bias error, root mean square error, correlation coefficient and fractional gross error). Results showed that the default configuration of NMM-dust (with a low spatiotemporal resolution of both input parameters) generates an overestimation of Aerosol Optical Depth (AOD). Although it is able to qualitatively reproduce the temporal trend of the dust event, the default configuration of NMM-dust cannot fully capture its actual spatial distribution. Adjusting the spatiotemporal resolution of soil moisture and vegetation cover datasets showed that the model is sensitive to both parameters. Increasing the spatiotemporal resolution of soil moisture effectively reduces model's overestimation of AOD, while increasing the spatiotemporal resolution of vegetation cover changes the spatial distribution of reproduced dust storm. The adjustment of both parameters enables NMM-dust to capture the spatial distribution of dust storms, as well as reproducing more accurate dust concentration.	[Yang, Chaowei] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA; George Mason Univ, Dept Geog & Geoinformat Sci, Fairfax, VA 22030 USA	George Mason University; George Mason University	Yang, CW (corresponding author), George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA.	cyang3@gmu.edu	Yang, Chaowei/A-9881-2017; Yu, Manzhu/J-6953-2019	Yang, Chaowei/0000-0001-7768-4066; Yu, Manzhu/0000-0001-6769-7517	NSF [PLR-1349259, IIP-1338925, CNS-1117300]; NASA [NNX15AM85G, NNG16PU001, NNG14HH38I]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NSF (PLR-1349259, IIP-1338925, CNS-1117300) and NASA (NNX15AM85G, NNG16PU001, NNG14HH38I).	Ament F, 2006, BOUND-LAY METEOROL, V121, P153, DOI 10.1007/s10546-006-9066-4; Arizona Department of Environmental Quality, 2014, STAT AR EXC EV DOC J, P49; Bagnold R.A., 1941, PHYS BLOWN SAND DESE, V265; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1996, DOI 10.1175/JAMC-D-13-0356.1; Case JL, 2011, P 15 INT OBS ASS SYS; Cesnulyte V, 2014, ATMOS CHEM PHYS, V14, P593, DOI 10.5194/acp-14-593-2014; Cheng T, 2008, ATMOS CHEM PHYS, V8, P1105, DOI 10.5194/acp-8-1105-2008; Chin M, 2002, J ATMOS SCI, V59, P461, DOI 10.1175/1520-0469(2002)059<0461:TAOTFT>2.0.CO;2; Dubovik O, 2000, J GEOPHYS RES-ATMOS, V105, P20673, DOI 10.1029/2000JD900282; Fecan F, 1998, ANN GEOPHYS; Gesch D.B., 1999, EOS T AM GEOPHYS UN, V80, P69, DOI [10.1029/99EO00050, DOI 10.1029/99EO00050]; Gong SL, 2008, ATMOS CHEM PHYS, V8, P2333, DOI 10.5194/acp-8-2333-2008; Govaerts A, 2010, QUANT GEO G, V16, P219, DOI 10.1007/978-90-481-2322-3_20; Gui Z, 2016, PLOS ONE IN PRESS; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Hain CR, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015633; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Hong SB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011249; Hsu NC, 2004, IEEE T GEOSCI REMOTE, V42, P557, DOI 10.1109/TGRS.2004.824067; Huang QY, 2013, INT J GEOGR INF SCI, V27, P765, DOI 10.1080/13658816.2012.715650; Janjic Z, 2005, UNIFIED MODEL APPROA; Janjic Z, 2011, MON WEATHER REV, V139, P1556, DOI 10.1175/2010MWR3448.1; Jiang L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013204; Kinne S, 2006, ATMOS CHEM PHYS, V6, P1815, DOI 10.5194/acp-6-1815-2006; Kumar SV, 2012, WATER RESOURCES RES, V48; Laurent B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033654; Lee YH, 2010, ATMOS CHEM PHYS, V10, P2129, DOI 10.5194/acp-10-2129-2010; Lingli Wang, 2009, Frontiers of Earth Science in China, V3, P237, DOI 10.1007/s11707-009-0023-7; Menut L, 2009, J GEOPHYS RES ATMOSP; Menut L, 2013, J GEOPHYS RES-ATMOS, V118, P6505, DOI 10.1002/jgrd.50313; Nickovic S, 2001, J GEOPHYS RES-ATMOS, V106, P18113, DOI 10.1029/2000JD900794; Perez C, 2011, ATMOS CHEM PHYS, V11, P13001, DOI 10.5194/acp-11-13001-2011; Shao YP, 1997, J GEOPHYS RES-ATMOS, V102, P30091, DOI 10.1029/97JD02298; Takemura T, 2000, J GEOPHYS RES-ATMOS, V105, P17853, DOI 10.1029/2000JD900265; Tegen I, 1996, J GEOPHYS RES-ATMOS, V101, P19237, DOI 10.1029/95JD03610; Tegen I, 2002, ATMOSPHERES, V107, P2156; Terradellas E, 2016, MODEL INTER COMPARIS; Todd MC, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010476; Valari M, 2008, J ATMOS OCEAN TECH, V25, P1955, DOI 10.1175/2008JTECHA1123.1; WHITE BR, 1979, J GEOPHYS RES, V84, P4643, DOI 10.1029/JB084iB09p04643; Xia Y., 2012, J GEOPHYS RES ATMOSP, V117; Xie JB, 2010, COMPUT ENVIRON URBAN, V34, P278, DOI 10.1016/j.compenvurbsys.2009.08.002; Yang C., 2016, INT J DIGITAL EARTH; Yang C, 2016, COMPUTERS ENV URBAN; Yang CW, 2011, P NATL ACAD SCI USA, V108, P5498, DOI 10.1073/pnas.0909315108; Yu M, 2016, LECT NOTES COMPUT SC, V9864, P3, DOI 10.1007/978-3-319-45940-0_1; Zender C.S., 2003, J GEOPHYS RES ATMOSP, V108	49	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165616	10.1371/journal.pone.0165616	http://dx.doi.org/10.1371/journal.pone.0165616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936136	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100012
J	Yang, N; Zou, DS; Yang, MY; Lin, ZG				Yang, Ning; Zou, Dongsheng; Yang, Manyuan; Lin, Zhonggui			Variations in Soil Microbial Biomass Carbon and Soil Dissolved Organic Carbon in the Re-Vegetation of Hilly Slopes with Purple Soil	PLOS ONE			English	Article							RESPIRATION; DYNAMICS	Crust restoration is increasingly being done but we lack quantitative information on soil improvements. The study aimed to elucidate the dynamics involving soil microbial biomass carbon and soil dissolved organic carbon in the re-vegetation chronosequences of a hillslope land with purple soil in Hengyang, Hunan Province. The soil can cause serious disasters with both soil erosion and seasonal drought, and also becomes a typical representative of ecological disaster area in South China. Using the space-for-time method, we selected six typical sampling plots, designated as follows: grassplot community, meadow thicket community, frutex community, frutex and arbor community, arbor community, and top-level vegetation community. These plots were established to analyze the changes in soil microbial biomass carbon, soil microbial quotien, dissolved organic carbon, dissolved organic carbon/soil organic carbon, and soil basal respiration in 0-10, 10-20, and 20-40 cm soil layers. The relationships of these parameters with soils physic-chemical properties were also determined. The ecological environment of the 6 plant communities is similar and typical; they denoted six different successive stages of restoration on hillslopes with purple soils in Hengyang, Hunan Province. The soil microbial biomass carbon and soil basal respiration contents decreased with increasing soil depth but increased with re-vegetation. By contrast, soil microbial quotient increased with increasing soil depth and re-vegetation. From 0-10 cm soil layer to 20-40 cm soil layer, the dissolved organic carbon content decreased in different re-vegetation stages. In the process of re-vegetation, the dissolved organic carbon content increased in the 0-10 and 10-20 cm soil layers, whereas the dissolved organic carbon content decreased after an initial increase in the 20-40 cm soil layers. Meanwhile, dissolved organic carbon/soil organic carbon increased with increasing soil depth but decreased with re-vegetation. Significant correlations existed among soil microbial biomass carbon, soil microbial quotient, dissolved organic carbon, soil basal respiration and soil physic-chemical properties associated with soil fertility. The results showed that re-vegetation was conducive to the soil quality improvement and the accumulation of soil organic carbon pool of the hillslope land with purple soil in Hengyang, Hunan Province.	[Yang, Ning; Yang, Manyuan; Lin, Zhonggui] Hunan Environm Biol Polytech Coll, Coll Landscape Architecture, Hengyang, Peoples R China; [Yang, Ning; Zou, Dongsheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Zou, DS (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	cndongshengzou@126.com			Project of the Hunan Provincial Science and Technology Department [S2006N332]; Scientific Research Project of the Education Department of Hunan Province [16C0559]; Forestry Science and Technology Project of Hunan Province [XLK201341]; Agricultural Science and Technology Support Project of Hengyang City, Hunan Province [2014KN27]; Support Project for Young Teachers in Colleges and Universities of Hunan Province; Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology	Project of the Hunan Provincial Science and Technology Department; Scientific Research Project of the Education Department of Hunan Province; Forestry Science and Technology Project of Hunan Province; Agricultural Science and Technology Support Project of Hengyang City, Hunan Province; Support Project for Young Teachers in Colleges and Universities of Hunan Province; Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology	This work was financially supported by the Project of the Hunan Provincial Science and Technology Department (S2006N332), Scientific Research Project of the Education Department of Hunan Province (16C0559), Forestry Science and Technology Project of Hunan Province (XLK201341), Agricultural Science and Technology Support Project of Hengyang City, Hunan Province (2014KN27), Support Project for Young Teachers in Colleges and Universities of Hunan Province, and Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology.; This work was financially supported by the Project of the Hunan Provincial Science and Technology Department (S2006N332), Scientific Research Project of the Education Department of Hunan Province (16C0559), Forestry Science and Technology Project of Hunan Province (XLK201341), Agricultural Science and Technology Support Project of Hengyang City, Hunan Province (2014KN27), Support Project for Young Teachers in Colleges and Universities of Hunan Province, and Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology.	Bao S.D., 2000, AGROCHEMICAL ANAL SO, P22; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gong C, 2011, J ECOL, V30, P1935; Harris JA, 2003, EUR J SOIL SCI, V54, P801, DOI 10.1046/j.1351-0754.2003.0559.x; Huang Zong-sheng, 2012, Yingyong Shengtai Xuebao, V23, P2715; Institute of Soil Science Chinese Academy of Sciences, 1985, RS METH SOIL MICR; Jiang P, 2005, FORESTRY SCI, V41, P10; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Li L.-Q., 2007, CHINESE J ORG CHEM, V27, P519; Liu HS, 2006, APPL SOIL ECOL, V32, P284, DOI 10.1016/j.apsoil.2005.08.001; [刘爽 Liu Shuang], 2010, [生态学报, Acta Ecologica Sinica], V30, P3135; [刘占锋 Liu Zhanfeng], 2007, [生态学报, Acta Ecologica Sinica], V27, P1011; Lu R.Q., 2000, ANAL METHODS SOIL AG, P12; Montserrat G, 2006, APPL SOIL ECOL, V34, P52, DOI 10.1016/j.apsoil.2005.12.005; Rai A, 2016, ECOL ENG, V93, P76, DOI 10.1016/j.ecoleng.2016.05.014; Shao Y, 2002, NATURAL SCI EDITION, V33, P541; Singh AK, 2016, GEODERMA, V277, P41, DOI 10.1016/j.geoderma.2016.05.004; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; Thurman E. M., 1985, ORGANIC GEOCHEMISTRY; Traore S, 2007, APPL SOIL ECOL, V35, P660, DOI 10.1016/j.apsoil.2006.09.004; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang QK, 2005, J FORESTRY RES, V16, P23, DOI DOI 10.1007/BF02856848; Wei Yuan, 2009, Research of Agricultural Modernization, V30, P487; [杨满元 Yang Manyuan], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P229; [杨宁 Yang Ning], 2013, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V19, P1516; [杨宁 Yang Ning], 2012, [农业现代化研究, Research of Agricultural Modernization], V33, P757; [易志刚 YI Zhigang], 2006, [生态环境, Ecology and Environment], V15, P611; Zhang Jiang-shan, 2005, Journal of Forestry Research (Harbin), V16, P205, DOI 10.1007/BF02856815; Zhao B, 2006, J ECOLOGICAL ENV, V22, P239; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2	31	14	14	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166536	10.1371/journal.pone.0166536	http://dx.doi.org/10.1371/journal.pone.0166536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977678	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400003
J	Choi, HY; Huh, KH; Lee, JG; Song, MK; Kim, MS; Kim, YS; Kim, BS				Choi, Hoon Young; Huh, Kyu Ha; Lee, Jae Geun; Song, Mi Kyung; Kim, Myoung Soo; Kim, Yu Seun; Kim, Beom Seok			Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study	PLOS ONE			English	Article							GRAFT-SURVIVAL; DISEASE; PROGRESSION; FAILURE; POSTTRANSPLANT; REJECTION; DEATH; EPIDEMIOLOGY; NEPHROPATHY; PREDICTOR	Renal function in the first year after kidney transplantation (KT) can predict long-term renal graft survival. This study investigated whether estimated glomerular filtration rate (eGFR) variability during the first year after KT is a risk factor for poor renal allograft outcomes. This retrospective cohort study included 3077 patients who underwent repeated eGFR measurements for 1 year after KT at Severance Hospital Transplantation Center between 1979 and 2012. The eGFR variability during the first year after KT was the predictor. The patients were divided into four quartile groups of eGFR variability according to the coefficient of variation for eGFR (eGFR-CV). We selected a cutoff of eGFR-CV for graft failure and performed the sensitivity analyses. The graft outcome was worse in the highest quartile group of eGFR variability than in the other groups among all patients (Q4: HR 1.631, 95% CI 1.278-2.081; p < 0.0001) and among patients without AR (Q4: HR 1.425, 95% CI 1.024-1.982; p = 0.0358) after adjusting for eGFR at 1 year after KT and other covariates. Additionally, all-cause mortality was higher in this highest quartile group than in the other groups among all patients but not among patients without AR. Higher eGFR-CVs than the cutoff were significantly associated with a high risk of graft failure among all patients (HR 1.670, 95% CI 1.395-2.000; p < 0.0001) and among patients without AR (HR 1.899, 95% CI 1.457-2.477; p < 0.0001) after fully adjusting for covariates. For all-cause mortality, a higher eGFR-CV was an independent risk factor among all patients but not among patients without AR after adjusting for covariates. eGFR variability in the first year after KT is an independent risk factor for poor renal allograft outcomes.	[Choi, Hoon Young; Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Huh, Kyu Ha; Lee, Jae Geun; Kim, Myoung Soo; Kim, Yu Seun] Yonsei Univ Hlth Syst, Severance Hosp, Dept Transplantat Surg, Seoul, South Korea; [Huh, Kyu Ha; Lee, Jae Geun; Kim, Myoung Soo; Kim, Yu Seun; Kim, Beom Seok] Yonsei Univ, Coll Med, Res Inst Transplantat, Seoul, South Korea; [Song, Mi Kyung] Yonsei Univ, Coll Med, Dept Biostat, Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	docbsk@yuhs.ac		CHOI, HOON YOUNG/0000-0002-4245-0339; Huh, Kyu Ha/0000-0003-1364-6989; Lee, Jae Geun/0000-0002-6722-0257; Kim, Yu Seun/0000-0002-5105-1567; Kim, Beom Seok/0000-0002-5732-2583; Kim, Myoun Soo/0000-0002-8975-8381				Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; Bestard O, 2010, CURR OPIN ORGAN TRAN, V15, P467, DOI 10.1097/MOT.0b013e32833b9ccb; Choi HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002682; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; First MR, 2003, NEPHROL DIAL TRANSPL, V18, P3, DOI 10.1093/ndt/gfg1027; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hartmann LC, 2007, INT J CANCER, V121, P938, DOI 10.1002/ijc.22811; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; Kasiske BL, 2011, AM J KIDNEY DIS, V57, P466, DOI 10.1053/j.ajkd.2010.10.054; Kasiske BL, 2005, AM J TRANSPLANT, V5, P1405, DOI 10.1111/j.1600-6143.2005.00853.x; Kasiske BL, 2001, AM J KIDNEY DIS, V38, P1065, DOI 10.1053/ajkd.2001.28605; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1996, AM J KIDNEY DIS, V27, P652, DOI 10.1016/S0272-6386(96)90099-2; Li C, 2009, NAT REV NEPHROL, V5, P513, DOI 10.1038/nrneph.2009.113; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Loupy A, 2015, J AM SOC NEPHROL, V26, P1721, DOI 10.1681/ASN.2014040399; Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x; Naesens M, 2016, J AM SOC NEPHROL, V27, P281, DOI 10.1681/ASN.2015010062; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Perkins RM, 2012, KIDNEY INT, V82, P1332, DOI 10.1038/ki.2012.281; Salvadori M, 2003, TRANSPL P, V35, P2863, DOI 10.1016/j.transproceed.2003.10.070; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Traitanon O, 2014, CURR OPIN NEPHROL HY, V23, P625, DOI 10.1097/MNH.0000000000000064; Tseng CL, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0025-5; Waden J, 2009, DIABETES, V58, P2649, DOI 10.2337/db09-0693; Wilflingseder J, 2015, NEPHROL DIAL TRANSPL, V30, P910, DOI 10.1093/ndt/gfu280; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	32	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168337	10.1371/journal.pone.0168337	http://dx.doi.org/10.1371/journal.pone.0168337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973553	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300078
J	Dijkstra, AR; Alkema, W; Starrenburg, MJC; Hugenholtz, J; van Hijum, SAFT; Bron, PA				Dijkstra, Annereinou R.; Alkema, Wynand; Starrenburg, Marjo J. C.; Hugenholtz, Jeroen; van Hijum, Sacha A. F. T.; Bron, Peter A.			Strain-Dependent Transcriptome Signatures for Robustness in Lactococcus lactis	PLOS ONE			English	Article							ACID BACTERIA; GENE-EXPRESSION; RESPIRATION METABOLISM; STREPTOCOCCUS-LACTIS; OXIDATIVE STRESS; STARTER CULTURES; GROWTH-RATE; HEAT-SHOCK; SURVIVAL; FERMENTATION	Recently, we demonstrated that fermentation conditions have a strong impact on subsequent survival of Lactococcus lactis strain MG1363 during heat and oxidative stress, two important parameters during spray drying. Moreover, employment of a transcriptome- phenotype matching approach revealed groups of genes associated with robustness towards heat and/or oxidative stress. To investigate if other strains have similar or distinct transcriptome signatures for robustness, we applied an identical transcriptome-robustness phenotype matching approach on the L. lactis strains IL1403, KF147 and SK11, which have previously been demonstrated to display highly diverse robustness phenotypes. These strains were subjected to an identical fermentation regime as was performed earlier for strain MG1363 and consisted of twelve conditions, varying in the level of salt and/or oxygen, as well as fermentation temperature and pH. In the exponential phase of growth, cells were harvested for transcriptome analysis and assessment of heat and oxidative stress survival phenotypes. The variation in fermentation conditions resulted in differences in heat and oxidative stress survival of up to five 10-log units. Effects of the fermentation conditions on stress survival of the L. lactis strains were typically strain-dependent, although the fermentation conditions had mainly similar effects on the growth characteristics of the different strains. By association of the transcriptomes and robustness phenotypes highly strain-specific transcriptome signatures for robustness towards heat and oxidative stress were identified, indicating that multiple mechanisms exist to increase robustness and, as a consequence, robustness of each strain requires individual optimization. However, a relatively small overlap in the transcriptome responses of the strains was also identified and this generic transcriptome signature included genes previously associated with stress (ctsR and lplL) and novel genes, including nanE and genes encoding transport proteins. The transcript levels of these genes can function as indicators of robustness and could aid in selection of fermentation parameters, potentially resulting in more optimal robustness during spray drying.	[Dijkstra, Annereinou R.; Alkema, Wynand; van Hijum, Sacha A. F. T.; Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Dijkstra, Annereinou R.; Alkema, Wynand; Starrenburg, Marjo J. C.; van Hijum, Sacha A. F. T.; Bron, Peter A.] NIZO Food Res, Ede, Netherlands; [Dijkstra, Annereinou R.; Hugenholtz, Jeroen] Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, Xh Amsterdam, Netherlands; [Alkema, Wynand; van Hijum, Sacha A. F. T.] Radboudumc, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.; Bron, Peter A.] TI Food & Nutr, Nieuwe Kanaal 9A, Pa Wageningen, Netherlands	NIZO Food Research; University of Amsterdam; Radboud University Nijmegen; Top Institute Food & Nutrition	Hugenholtz, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, Xh Amsterdam, Netherlands.	jeroen.hugenholtz@wur.nl	Alkema, Wynand/G-5826-2018; van Hijum, Sacha/F-6445-2014	Alkema, Wynand/0000-0002-5523-9217; van Hijum, Sacha/0000-0003-0741-2991	Kluyver centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)	Kluyver centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)	AD was funded by the Kluyver centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSIT N, 1993, APPL ENVIRON MICROB, V59, P1893, DOI 10.1128/AEM.59.6.1893-1897.1993; Boyaval P, 1989, DAIRY SCI TECHNOL, V69, P87; Bron Peter A, 2011, Bioeng Bugs, V2, P80, DOI 10.4161/bbug.2.2.13910; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Cretenet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1054; Dijkstra AR, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0148-6; Dijkstra AR, 2014, APPL ENVIRON MICROB, V80, P603, DOI 10.1128/AEM.03434-13; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Fernandez M, 2002, J BACTERIOL, V184, P82, DOI 10.1128/JB.184.1.82-90.2002; Frees D, 2003, INT J FOOD MICROBIOL, V87, P293, DOI 10.1016/S0168-1605(03)00104-1; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Ghandi A, 2012, J FOOD ENG, V113, P194, DOI 10.1016/j.jfoodeng.2012.06.005; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Kim WS, 1999, FEMS MICROBIOL LETT, V171, P57, DOI [10.1111/j.1574-6968.1999.tb13412.x, 10.1016/S0378-1097(98)00578-3]; Koch B, 1998, J BACTERIOL, V180, P3873, DOI 10.1128/JB.180.15.3873-3881.1998; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Nielsen AK, 2010, J MOL MICROB BIOTECH, V18, P162, DOI 10.1159/000315457; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Peighambardoust SH, 2011, TRENDS FOOD SCI TECH, V22, P215, DOI 10.1016/j.tifs.2011.01.009; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Santivarangkna C, 2008, J APPL MICROBIOL, V105, P1, DOI 10.1111/j.1365-2672.2008.03744.x; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Teuber M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P205, DOI 10.1007/0-387-30744-3_7; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Varmanen P, 2000, MICROBIOL-UK, V146, P1447, DOI 10.1099/00221287-146-6-1447; Xie Y, 2004, APPL ENVIRON MICROB, V70, P6738, DOI 10.1128/AEM.70.11.6738-6747.2004; Zakrzewska A, 2011, MOL BIOL CELL, V22, P4435, DOI 10.1091/mbc.E10-08-0721	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167944	10.1371/journal.pone.0167944	http://dx.doi.org/10.1371/journal.pone.0167944			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973578	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300049
J	Neilands, PD; Jelbert, SA; Breen, AJ; Schiestl, M; Taylor, AH				Neilands, P. D.; Jelbert, S. A.; Breen, A. J.; Schiestl, M.; Taylor, A. H.			How Insightful Is 'Insight'? New Caledonian Crows Do Not Attend to Object Weight during Spontaneous Stone Dropping	PLOS ONE			English	Article							ANIMAL COGNITION; ET-AL.; TOOL; END; RAVENS; DEVIL; BIRDS	It is highly difficult to pinpoint what is going through an animal's mind when it appears to solve a problem by 'insight'. Here, we searched for an information processing error during the emergence of seemingly insightful stone dropping in New Caledonian crows. We presented these birds with the platform apparatus, where a heavy object needs to be dropped down a tube and onto a platform in order to trigger the release of food. Our results show New Caledonian crows exhibit a weight inattention error: they do not attend to the weight of an object when innovating stone dropping. This suggests that these crows do not use an understanding of force when solving the platform task in a seemingly insightful manner. Our findings showcase the power of the signature-testing approach, where experiments search for information processing biases, errors and limits, in order to make strong inferences about the functioning of animal minds.	[Neilands, P. D.; Taylor, A. H.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Jelbert, S. A.] Univ Cambridge, Dept Psychol, Cambridge, England; [Breen, A. J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Schiestl, M.] Max Planck Inst Sci Human Hist, Jena, Germany	University of Auckland; University of Cambridge; University of St Andrews	Neilands, PD (corresponding author), Univ Auckland, Sch Psychol, Auckland, New Zealand.	pnei460@aucklanduni.ac.nz	Taylor, Alex H/D-6428-2012	Breen, Alexis/0000-0002-2331-0920; Jelbert, Sarah/0000-0002-7503-0648	Rutherford Discovery Fellowship from the Royal Society of New Zealand; ERC	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand); ERC(European Research Council (ERC)European Commission)	Work was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (AHT). SAJ would like to thank the ERC for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, LEARNING INSTINCT AN; Ash IK, 2006, PSYCHON B REV, V13, P66, DOI 10.3758/BF03193814; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bogale BA, 2012, ANIM COGN, V15, P285, DOI 10.1007/s10071-011-0439-9; Boogert NJ, 2013, P NATL ACAD SCI USA, V110, pE273, DOI 10.1073/pnas.1219664110; Cuthill Innes C., 2006, P3; Dymond S, 2013, P NATL ACAD SCI USA, V110, pE336, DOI 10.1073/pnas.1218931110; Fleck JI, 2013, J COGN PSYCHOL, V25, P436, DOI 10.1080/20445911.2013.779248; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Haslam M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0421; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B., 2000, EVOLUTION COGNITION; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Kacelnik A, 2009, P NATL ACAD SCI USA, V106, P10071, DOI 10.1073/pnas.0904735106; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Kohler W., 1927, MENTALITY APES, V2nd ed.; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Range F, 2008, ACTA ETHOL, V11, P34, DOI 10.1007/s10211-008-0039-0; Schuck-Paim C, 2009, ANIM COGN, V12, P287, DOI 10.1007/s10071-008-0190-z; Seed A, 2012, PHILOS T R SOC B, V367, P2743, DOI 10.1098/rstb.2012.0222; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Shettleworth SJ, 2012, CAN J EXP PSYCHOL, V66, P217, DOI 10.1037/a0030674; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shettleworth SJ, 2009, CURR BIOL, V19, pR1039, DOI 10.1016/j.cub.2009.10.022; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0796; Taylor AH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0837; Taylor AH, 2014, WIRES COGN SCI, V5, P361, DOI 10.1002/wcs.1286; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE337, DOI 10.1073/pnas.1219586110; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE274, DOI 10.1073/pnas.1220564110; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Taylor AH, 2009, CURR BIOL, V19, pR731, DOI 10.1016/j.cub.2009.07.055; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weisberg RW, 2015, THINK REASONING, V21, P5, DOI 10.1080/13546783.2014.886625; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167419	10.1371/journal.pone.0167419	http://dx.doi.org/10.1371/journal.pone.0167419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973610	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300029
J	Spooner, L; Fernandes, K; Martins, D; Juurlink, D; Mamdani, M; Paterson, JM; Singh, S; Gomes, T				Spooner, Luke; Fernandes, Kimberly; Martins, Diana; Juurlink, David; Mamdani, Muhammad; Paterson, J. Michael; Singh, Samantha; Gomes, Tara			High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; GUIDELINE; MORTALITY; THERAPY; FLORIDA; DEATHS	Aims To examine the impact of national clinical practice guidelines and provincial drug policy interventions on prevalence of high-dose opioid prescribing and rates of hospitalization for opioid toxicity. Design Interventional time-series analysis. Setting Ontario, Canada, from 2003 to 2014. Participants Ontario Drug Benefit (ODB) beneficiaries aged 15 to 64 years from 2003 to 2014. Interventions Publication of Canadian clinical practice guidelines for use of opioids in chronic non-cancer pain (May 2010) and implementation of Ontario's Narcotics Safety and Awareness Act (NSAA; November 2011). Measurements Three outcomes were explored: the rate of opioid use among ODB beneficiaries, the prevalence of opioid prescriptions exceeding 200 mg and 400 mg morphine equivalents per day, and rates of opioid-related emergency department visits and hospital admissions. Findings Over the 12 year study period, the rate of opioid use declined 15.2%, from 2764 to 2342 users per 10,000 ODB eligible persons. The rate of opioid use was significantly impacted by the Canadian clinical practice guidelines (p-value =.03) which led to a decline in use, but no impact was observed by the enactment of the NSAA (p-value =.43). Among opioid users, the prevalence of high-dose prescribing doubled (from 4.2% to 8.7%) over the study period. By 2014, 40.9% of recipients of long-acting opioids exceeded daily doses of 200 mg morphine or equivalent, including 55.8% of long-acting oxycodone users and 76.3% of transdermal fentanyl users. Moreover, in the last period, 18.7% of long-acting opioid users exceeded daily doses of 400 mg morphine or equivalent. Rates of opioid-related emergency department visits and hospital admissions increased 55.0% over the study period from 9.0 to 14.0 per 10,000 ODB beneficiaries from 2003 to 2013. This rate was not significantly impacted by the Canadian clinical practice guidelines (p-value = .68) or enactment of the NSAA (p-value = .59). Conclusions Although the Canadian clinical practice guidelines for use of opioids in chronic non-cancer pain led to a decline in opioid prescribing rates among ODB beneficiaries these guidelines and subsequent Ontario legislation did not result in a significant change in rates of opioid-related hospitalizations. Given the prevalence of high dose opioid prescribing in this population, this suggests that improved strategies and programs for the safe prescribing of longacting opioids are needed.	[Spooner, Luke] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Fernandes, Kimberly; Martins, Diana; Juurlink, David; Mamdani, Muhammad; Paterson, J. Michael; Singh, Samantha; Gomes, Tara] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Mamdani, Muhammad; Paterson, J. Michael; Gomes, Tara] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Singh, Samantha] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	University of British Columbia; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University	Gomes, T (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Gomes, T (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Gomes, T (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.; Gomes, T (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	GomesT@smh.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - MOHLTC; Ontario MOHLTC	Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - MOHLTC; Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund. It also was supported by the Institute for Clinical Evaluative Sciences (ICES), an independent, non-profit research institute funded by an annual grant from the MOHLTC. The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed herein are those of the authors and not necessarily those of CIHI. The Ontario MOHLTC provided support in the form of a research grant for MM, DJ, TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Ms. Fernandes had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Barbera L, 2012, J CLIN ONCOL, V30, P1095, DOI 10.1200/JCO.2011.37.3068; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Clarke EA, 1991, IARC SCI PUBL, P246; Delcher C, 2015, DRUG ALCOHOL DEPEN, V150, P63, DOI 10.1016/j.drugalcdep.2015.02.010; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Fulton-Kehoe D, 2013, AM J IND MED, V56, P1452, DOI 10.1002/ajim.22266; Gilmour Stuart, 2006, BMC Med Res Methodol, V6, P16, DOI 10.1186/1471-2288-6-16; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes Tara, 2011, Open Med, V5, pe13; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Kahan M, 2011, CAN FAM PHYSICIAN, V57, P1257; Kenan Kristen, 2012, Open Med, V6, pe41; National Opioid Use Guideline Group (NOUGG), 2010, CAN GUID SAT EFF US; Paone D, 2015, MMWR-MORBID MORTAL W, V64, P491; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553	21	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167479	10.1371/journal.pone.0167479	http://dx.doi.org/10.1371/journal.pone.0167479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973601	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300031
J	Nie, ZJ; Gu, RB; Du, FK; Shao, NL; Xu, P; Xu, GC				Nie, Zhi-Juan; Gu, Ruo-Bo; Du, Fu-Kuan; Shao, Nai-Lin; Xu, Pao; Xu, Gang-Chun			Monogonont Rotifer, Brachionus calyciflorus, Possesses Exceptionally Large, Fragmented Mitogenome	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; GENOME; RNA; GENES; PHYLOGENY	In contrast to the highly conserved mitogenomic structure and organisation in most animals (including rotifers), the two previously sequenced monogonont rotifer mitogenomes were fragmented into two chromosomes similar in size, each of which possessed one major noncoding region (mNCR) of about 4-5 Kbp. To further explore this phenomenon, we have sequenced and analysed the mitogenome of one of the most studied monogonont rotifers, Brachionus calyciflorus. It is also composed of two circular chromosomes, but the chromosome-I is extremely large (27 535 bp; 3 mNCRs), whereas the chromosome-II is relatively small (9 833 bp; 1 mNCR). With the total size of 37 368 bp, it is one of the largest metazoan mitogenomes ever reported. In comparison to other monogononts, gene distribution between the two chromosomes and gene order are different and the number of mNCRs is doubled. Atp8 was not found (common in rotifers), and Cytb was present in two copies (the first report in rotifers). A high number (99) of SNPs indicates fast evolution of the Cytb-1 copy. The four mNCRs (5.3-5.5 Kb) were relatively similar. Publication of this sequence shall contribute to the understanding of the evolutionary history of the unique mitogenomic organisation in this group of rotifers.	[Nie, Zhi-Juan; Gu, Ruo-Bo; Du, Fu-Kuan; Shao, Nai-Lin; Xu, Pao; Xu, Gang-Chun] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Xu, GC (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China.	xugc@ffrc.cn			Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF] [CX(13)2039]; Three New Projects of Agricultural Aquaculture Program of Jiangsu Province [D2015-14]	Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF]; Three New Projects of Agricultural Aquaculture Program of Jiangsu Province	This study was supported by the Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF; grant no. CX(13)2039] and Three New Projects of Agricultural Aquaculture Program of Jiangsu Province (grant no. D2015-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2000, GENETICS, V154, P181; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Declerck SAJ, 2016, HYDROBIOLOGIA; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hwang DS, 2014, MITOCHONDR DNA, V25, P29, DOI 10.3109/19401736.2013.775274; Judson OP, 1996, TRENDS ECOL EVOL, V11, pA41; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lasek-Nesselquist E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043554; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liu YG, 2013, COMP BIOCHEM PHYS D, V8, P72, DOI 10.1016/j.cbd.2012.12.003; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pont-Kingdon G, 2000, J MOL EVOL, V51, P404, DOI 10.1007/s002390010103; Rand DM, 2009, GENOME RES, V19, P700, DOI 10.1101/gr.091132.109; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Segers H., 2002, FRESHWATER INVERTEBR, P106; Serra M, 1997, HYDROBIOLOGIA, V358, P63, DOI 10.1023/A:1003155617297; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sielaff M, 2016, MOL PHYLOGENET EVOL, V96, P79, DOI 10.1016/j.ympev.2015.11.017; Smith DR, 2007, J MOL EVOL, V65, P380, DOI 10.1007/s00239-007-9016-x; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Stelzer CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012854; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Vasileiadou K, 2009, MAR BIOTECHNOL, V11, P53, DOI 10.1007/s10126-008-9119-4; Wallace RL, 2010, AQUAT ECOL-SAN DIEGO, P173, DOI 10.1016/B978-0-12-374855-3.00008-X; Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Xiang XL, 2011, MOL PHYLOGENET EVOL, V59, P386, DOI 10.1016/j.ympev.2011.02.011	37	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168263	10.1371/journal.pone.0168263	http://dx.doi.org/10.1371/journal.pone.0168263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959933	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900052
J	Bhagirath, D; Zhao, XS; Mirza, S; West, WW; Band, H; Band, V				Bhagirath, Divya; Zhao, Xiangshan; Mirza, Sameer; West, William W.; Band, Hamid; Band, Vimla			Mutant PIK3CA Induces EMT in a Cell Type Specific Manner	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; IDENTIFICATION; TRANSFORMATION; PHENOTYPES; DRIVERS; GROWTH; GENES	Breast cancer is characterized into different molecular subtypes, and each subtype is characterized by differential gene expression that are associated with distinct survival outcomes in patients. PIK3CA mutations are commonly associated with most breast cancer subtypes. More recently PIK3CA mutations have been shown to induce tumor heterogeneity and are associated with activation of EGFR-signaling and reduced relapse free survival in basal subtype of breast cancer. Thus, understanding what determines PIK3CA induced heterogeneity and oncogenesis, is an important area of investigation. In this study, we assessed the effect of mutant PIK3CA together with mutant Ras plus mutant p53 on oncogenic behavior of two distinct stem/progenitor breast cell lines, designated as K5+/K19- and K5+/K19+. Constructs were ectopically overexpressed in K5+/K19- and K5+/K19+ stem/progenitor cells, followed by various in-vitro and in-vivo analyses. Oncogene combination m-Ras/m-p53/m-PIK3CA efficiently transformed both K5+/K19- and K5+/K19+ cell lines in-vitro, as assessed by anchorage-independent soft agar colony formation assay. Significantly, while this oncogene combination induced a complete epithelial-to-mesenchymal transition (EMT) in K5+/K19- cell line, mostly epithelial phenotype with minor EMT component was seen in K5+/K19+ cell line. However, both K5+/K19- and K5+/K19+ transformed cells exhibited increased invasion and migration abilities. Analyses of CD44 and CD24 expression showed both cell lines had tumor-initiating CD44(+)/CD24(low) cell population, however transformed K5+/K19- cells had more proportion of these cells. Significantly, both cell types exhibited in-vivo tumorigenesis, and maintained their EMT and epithelial nature in-vivo in mice tumors. Notably, while both cell types exhibited increase in tumor-initiating cell population, differential EMT phenotype was observed in these cell lines. These results suggest that EMT is a cell type dependent phenomenon and does not dictate oncogenesis.	[Bhagirath, Divya; Zhao, Xiangshan; Mirza, Sameer; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [West, William W.; Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Pathol & Microbiol, Omaha, NE USA; [Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE USA; [West, William W.; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Band, V (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Band, V (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Band, Hamid/AAF-4701-2020; Bhagirath, Divya/X-1416-2019		NIH [CA116552, CA87986, CA105489, CA96844, CA144027]; Department of Defense [W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171]; NCI Cancer Center Support Grant [P30CA036727]; Susan Komen Foundation for breast cancer research; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA105489, R01CA116552, R01CA144027, R01CA087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Foundation for breast cancer research(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants CA116552, CA87986 and CA105489 to HB, and CA96844 and CA144027 to VB; Department of Defense grants W81WH-11-1-0167 to HB, and W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB. We acknowledge support to the UNMC Core Facility from the NCI Cancer Center Support Grant (P30CA036727) to Fred & Pamela Buffett Cancer Center and the Nebraska Research Initiative. SM received a postdoctoral fellowship from Susan Komen Foundation for breast cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bhagirath D, 2015, ONCOTARGET, V6, P9018, DOI 10.18632/oncotarget.3379; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Johnson JPS, 2014, CANCER GENOM PROTEOM, V11, P115; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Melchor L, 2014, J PATHOL, V233, P124, DOI 10.1002/path.4345; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soundararajan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11766; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Wang GM, 2013, CANCER RES, V73, P3248, DOI 10.1158/0008-5472.CAN-12-1578; Young CD, 2015, MOL CELL PROTEOMICS, V14, P1959, DOI 10.1074/mcp.M115.049783; Zhao X, PLOS ONE, V7, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE.]; Zhao XS, 2012, BREAST CANCER RES TR, V134, P171, DOI 10.1007/s10549-011-1946-8; Zhao Xiangshan, 2011, J Carcinog, V10, P39, DOI 10.4103/1477-3163.91415; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	30	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167064	10.1371/journal.pone.0167064	http://dx.doi.org/10.1371/journal.pone.0167064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941987	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600008
J	Gaucher, JF; Reille-Seroussi, M; Gagey-Eilstein, N; Broussy, S; Coric, P; Seijo, B; Lascombe, MB; Gautier, B; Liu, WQ; Huguenot, F; Inguimbert, N; Bouaziz, S; Vidal, M; Broutin, I				Gaucher, Jean-Francois; Reille-Seroussi, Marie; Gagey-Eilstein, Nathalie; Broussy, Sylvain; Coric, Pascale; Seijo, Bili; Lascombe, Marie-Bernard; Gautier, Benoit; Liu, Wang-Quing; Huguenot, Florent; Inguimbert, Nicolas; Bouaziz, Serge; Vidal, Michel; Broutin, Isabelle			Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A	PLOS ONE			English	Article							GROWTH-FACTOR BINDING; PEPTIDE ANTAGONIST; CRYSTAL-STRUCTURE; TRACE-ELEMENTS; COPPER; ANGIOGENESIS; PROTEINS; MODEL; COORDINATION; SCATTERING	Angiogenesis is tightly regulated through the binding of vascular endothelial growth factors (VEGFs) to their receptors (VEGFRs). In this context, we showed that human VEGFR1 domain 2 crystallizes in the presence of Zn2+, Co2+ or Cu2+ as a dimer that forms via metalion interactions and interlocked hydrophobic surfaces. SAXS, NMR and size exclusion chromatography analyses confirm the formation of this dimer in solution in the presence of Co2+, Cd2+ or Cu2+. Since the metal-induced dimerization masks the VEGFs binding surface, we investigated the ability of metal ions to displace the VEGF-A binding to hVEGFR1: using a competition assay, we evidenced that the metals displaced the VEGF-A binding to hVEGFR1 extracellular domain binding at micromolar level.	[Gaucher, Jean-Francois; Coric, Pascale; Seijo, Bili; Lascombe, Marie-Bernard; Bouaziz, Serge; Broutin, Isabelle] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8015, Paris, France; [Reille-Seroussi, Marie; Gagey-Eilstein, Nathalie; Broussy, Sylvain; Gautier, Benoit; Liu, Wang-Quing; Huguenot, Florent; Vidal, Michel] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8638, Paris, France; [Inguimbert, Nicolas] Univ Perpignan, CNRS, USR 3278, Ctr Rech Insulaire & Observ Environm,CRIOBE, Via Domitia, Perpignan, France; [Vidal, Michel] Hop Cochin, AP HP, UF Pharmacocinet & Pharmacochim, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaucher, JF (corresponding author), Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8015, Paris, France.	jean-francois.gaucher@parisdescartes.fr	Inguimbert, Nicolas/N-3703-2015; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Broussy, Sylvain/AAX-1833-2020; Broutin, Isabelle/A-2003-2017; Vidal, Michel/ABA-3396-2020; LIU, Wang-Qing/V-5422-2017	Inguimbert, Nicolas/0000-0002-0309-9048; Bouaziz, Serge/0000-0001-7792-8307; Broussy, Sylvain/0000-0003-3098-5317; CORIC, Pascale/0000-0001-8484-1381; Broutin, isabelle/0000-0001-9862-1232; Reille-Seroussi, Marie/0000-0002-4136-1297; Vidal, Michel/0000-0002-4858-1591; LIU, Wang-Qing/0000-0003-0511-3058; Gautier, Benoit/0000-0002-8249-2525; huguenot, florent/0000-0001-8400-0857	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by: 1- Centre National de la Recherche Scientifique (CNRS), http://www.cnrs.fr: JFG MRS NGE SBr PC BS MBL BG WQL FH NI SBo MV IB. The CNRS had no role in study design, data collection and analysis,	Ahmadova Z, 2014, ANTICANCER RES, V34, P2123; Ascone I, 2006, P 13 INT C XRAY ABS, DOI [10.1093/nar/gkq535PMID:20542909, DOI 10.1093/NAR/GKQ535]; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Boyaud F, 2013, ORG LETT, V15, P3898, DOI 10.1021/ol401645m; Brozzo MS, 2012, BLOOD, V119, P1781, DOI 10.1182/blood-2011-11-390922; Buckley WT, 2008, BIOMETALS, V21, P601, DOI 10.1007/s10534-008-9146-7; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; Czisch M, 1998, J MAGN RESON, V134, P158, DOI 10.1006/jmre.1998.1483; D'Andrea LD, 2010, DALTON T, V39, P7625, DOI 10.1039/c002439b; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; DISALVO J, 1995, J BIOL CHEM, V270, P7717, DOI 10.1074/jbc.270.13.7717; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e; Fedorova A, 2011, CHEM BIOL, V18, P839, DOI 10.1016/j.chembiol.2011.05.011; Feillet-Coudray C, 2005, AM J CLIN NUTR, V82, P103, DOI 10.1093/ajcn/82.1.103; Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Goncalves V, 2008, J PEPT SCI, V14, P767, DOI 10.1002/psc.965; Goncalves V, 2007, ANAL BIOCHEM, V366, P108, DOI 10.1016/j.ab.2007.03.027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hemmingsen L, 2004, J BIOL INORG CHEM, V9, P591, DOI 10.1007/s00775-004-0553-0; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; Iyer S, 2010, J BIOL CHEM, V285, P23779, DOI 10.1074/jbc.M110.130658; Janek T, 2016, COLLOID SURFACE B, V146, P498, DOI 10.1016/j.colsurfb.2016.06.055; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kenrick SA, 2010, PROTEIN ENG DES SEL, V23, P9, DOI 10.1093/protein/gzp065; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Li QF, 2014, J NUTR BIOCHEM, V25, P44, DOI 10.1016/j.jnutbio.2013.08.013; Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Malgieri G, 2011, BIOPOLYMERS, V95, P801, DOI 10.1002/bip.21680; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris LA, 2002, J CHEM SOC PERK T 2, P1072, DOI 10.1039/b201823n; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Pan B, 2002, J MOL BIOL, V316, P769, DOI 10.1006/jmbi.2001.5370; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qin ZY, 2011, METALLOMICS, V3, P28, DOI 10.1039/c0mt00048e; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reille-Seroussi M, 2015, BIOCHEMISTRY-US, V54, P5147, DOI 10.1021/acs.biochem.5b00722; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Saghiri MA, 2015, CRIT REV ONCOL HEMAT, V96, P143, DOI 10.1016/j.critrevonc.2015.05.011; Shoshan MS, 2013, INORG CHEM, V52, P2993, DOI 10.1021/ic302404w; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tsai YCI, 2016, FEBS J, V283, P1921, DOI 10.1111/febs.13711; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zheng LL, 2015, PHARMACOL THERAPEUT, V148, P66, DOI 10.1016/j.pharmthera.2014.11.014; Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	74	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167755	10.1371/journal.pone.0167755	http://dx.doi.org/10.1371/journal.pone.0167755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942001	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600030
J	Huang, JJ; Gardenier, JC; Hespe, GE; Nores, GDG; Kataru, RP; Ly, CL; Martinez-Corral, I; Ortega, S; Mehrara, BJ				Huang, Jung-Ju; Gardenier, Jason C.; Hespe, Geoffrey E.; Nores, Gabriela D. Garcia; Kataru, Raghu P.; Ly, Catherine L.; Martinez-Corral, Ines; Ortega, Sagrario; Mehrara, Babak J.			Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema	PLOS ONE			English	Article							POSTMASTECTOMY LYMPHEDEMA; REGENERATION; DIFFERENTIATION; ADIPOGENESIS; RESTORATION; EXPRESSION; IMPROVES; FLAP	Introduction Secondary lymphedema is a common complication of cancer treatment and recent studies have demonstrated that lymph node transplantation (LNT) can decrease swelling, as well as the incidence of infections. However, although these results are exciting, the mechanisms by which LNT improves these pathologic findings of lymphedema remain unknown. Using a transgenic mouse model of lymphedema, this study sought to analyze the effect of LNT on lymphatic regeneration and T cell-mediated immune responses. Methods We used a mouse model in which the expression of the human diphtheria toxin receptor is driven by the FLT4 promoter to enable the local ablation of the lymphatic system through subdermal hindlimb diphtheria toxin injections. Popliteal lymph node dissection was subsequently performed after a two-week recovery period, followed by either orthotopic LNT or sham surgery after an additional two weeks. Hindlimb swelling, lymphatic vessel regeneration, immune cell trafficking, and T cell-mediated immune responses were analyzed 10 weeks later. Results LNT resulted in a marked decrease in hindlimb swelling, fibroadipose tissue deposition, and decreased accumulation of perilymphatic inflammatory cells, as compared to controls. In addition, LNT induced a marked lymphangiogenic response in both capillary and collecting lymphatic vessels. Interestingly, the resultant regenerated lymphatics were abnormal in appearance on lymphangiography, but LNT also led to a notable increase in dendritic cell trafficking from the periphery to the inguinal lymph nodes and improved adaptive immune responses. Conclusions LNT decreases pathological changes of lymphedema and was shown to potently induce lymphangiogenesis. Lymphatic vessels induced by LNT were abnormal in appearance, but were functional and able to transport antigen-presenting cells. Animals treated with LNT have an increased ability to mount T cell-mediated immune responses when sensitized to antigens in the affected hindlimb.	[Huang, Jung-Ju; Gardenier, Jason C.; Hespe, Geoffrey E.; Nores, Gabriela D. Garcia; Kataru, Raghu P.; Ly, Catherine L.; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA; [Huang, Jung-Ju] Chang Gung Univ, Chang Gung Mem Hosp, Div Reconstruct Microsurg, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Martinez-Corral, Ines] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ortega, Sagrario] Spanish Natl Canc Res Ctr, Transgen Mice Unit, Biotechol Programme, Madrid, Spain	Memorial Sloan Kettering Cancer Center; Chang Gung Memorial Hospital; Chang Gung University; Uppsala University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org	Martinez-Corral, Ines/F-1799-2016; Kataru, Raghu P/AAB-9990-2022	Martinez-Corral, Ines/0000-0001-9194-2412; Kataru, Raghu/0000-0003-1315-7982; Huang, Jung-ju/0000-0001-9568-7834	National Institutes of Health [R01 HL111130-01, R21-CA194882, T32 CA9501-27, T32 CA9501-29]; Plastic Surgery Foundation [312436]; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery [350627]; Ministry of Science and Innovation of Spain [BIO2009-09488]; National Institutes of Health/National Cancer Institute Cancer Center [P30 CA008748]; Molecular Cytology Core at Memorial Sloan Kettering Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009501, R21CA194882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery; Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health/National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Cytology Core at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health R01 HL111130-01 and R21-CA194882 (http://grants.nih.gov/grants/oer.htm) awarded to B.J.M.; Plastic Surgery Foundation Pilot Grant 312436 and Research Fellowship Grant 312436 (http://www.thepsf.org/research/psf-grant-funding.htm) to J.C.G.; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery Combined Research Grant 350627 (http://www.thepsf.org/research/psf-grant-funding.htm) and National Institutes of Health T32 CA9501-27 grant (https://grants.nih.gov/grants/oer.htm) to G.D.G.N.; National Institutes of Health T32 CA9501-29 grant (https://grants.nih.gov/grants/oer.htm) to C.L.L.; Ministry of Science and Innovation of Spain Grant BIO2009-09488 to S.O.; and National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.; The authors are grateful to Mesruh Turkekul, Sho Fujisawa, and Yevgeniy Romin of the Molecular Cytology Core at Memorial Sloan Kettering Cancer Center for assistance with both histology and tissue imaging (Core Grant P30 CA008748).	Ahmed RL, 2008, J CLIN ONCOL, V26, P5689, DOI 10.1200/JCO.2008.16.4731; [Anonymous], 1997, COMPOSITE GRAFTS; Aschen S, 2012, PLAST RECONSTR SURG, V129, P838, DOI 10.1097/PRS.0b013e3182450b47; Aschen SZ, 2014, PLAST RECONSTR SURG, V133, P301, DOI 10.1097/01.prs.0000436840.69752.7e; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Baker A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2638; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Becker C, 2015, J RECONSTRUCTIVE MIC; Becker C, 2012, CLIN PLAST SURG, V39, P385, DOI 10.1016/j.cps.2012.08.002; Blum KS, 2010, BREAST CANCER RES TR, V120, P59, DOI 10.1007/s10549-009-0367-4; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Carlson JA, 2014, CLIN DERMATOL, V32, P599, DOI 10.1016/j.clindermatol.2014.04.007; Chang DW, 2016, PLAST RECONSTR SURG, V138, p209S, DOI 10.1097/PRS.0000000000002683; CHEN HC, 1990, BRIT J PLAST SURG, V43, P578, DOI 10.1016/0007-1226(90)90123-H; Cheng MH, 2013, PLAST RECONSTR SURG, V131, P1286, DOI 10.1097/PRS.0b013e31828bd3b3; Cheng MH, 2012, GYNECOL ONCOL, V126, P93, DOI 10.1016/j.ygyno.2012.04.017; Cornelissen AJ, 2016, J SURG ONCOL; Davies-Venn CA, 2012, MOL IMAGING BIOL, V14, P301, DOI 10.1007/s11307-011-0499-x; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Gardenier JC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84095; Gharb BB, 2011, ANN PLAS SURG, V67, P589, DOI 10.1097/SAP.0b013e3181f88e8a; Hadamitzky C, 2009, J VASC RES, V46, P389, DOI 10.1159/000194269; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Joseph WJ, 2014, PLAST RECONSTR SURG, V134, P60, DOI 10.1097/PRS.0000000000000286; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kurt H, 2016, MODERN PATHOL, V29, P75, DOI 10.1038/modpathol.2015.135; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Lin CH, 2009, PLAST RECONSTR SURG, V123, P1265, DOI 10.1097/PRS.0b013e31819e6529; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234; Nettles MK, 2016, INT J RADIAT ONCOL, V96, pE507, DOI 10.1016/j.ijrobp.2016.06.1899; Nores GDG, 2016, INT J OBESITY, V40, P1582, DOI 10.1038/ijo.2016.96; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; Robinson HA, 2013, JOVE-J VIS EXP, DOI 10.3791/4326; Saaristo AM, 2012, ANN SURG, V255, P468, DOI 10.1097/SLA.0b013e3182426757; Savetsky IL, 2015, J INVEST DERMATOL, V135, P2742, DOI 10.1038/jid.2015.283; Sharkey AR, 2016, MICROSURGERY; SHESOL BF, 1979, PLAST RECONSTR SURG, V63, P817, DOI 10.1097/00006534-197963060-00007; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Tobbia D, 2009, PLAST RECONSTR SURG, V124, P777, DOI 10.1097/PRS.0b013e3181b03787; Torrisi JS, 2015, LYMPHAT RES BIOL, V13, P46, DOI 10.1089/lrb.2014.0022; Vignes S, 2013, EUR J VASC ENDOVASC, V45, P516, DOI 10.1016/j.ejvs.2012.11.026; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011	47	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168259	10.1371/journal.pone.0168259	http://dx.doi.org/10.1371/journal.pone.0168259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942023	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600059
J	Cadogan, A; McNair, PJ; Laslett, M; Hing, WA				Cadogan, Angela; McNair, Peter J.; Laslett, Mark; Hing, Wayne A.			Diagnostic Accuracy of Clinical Examination and Imaging Findings for Identifying Subacromial Pain	PLOS ONE			English	Article							PHYSICAL-EXAMINATION TESTS; ROTATOR CUFF DISEASE; ACROMIOCLAVICULAR JOINT; CALCIFYING TENDINITIS; IMPINGEMENT SYNDROME; SHOULDER DISORDERS; PREVALENCE; MANAGEMENT; TEARS; METAANALYSIS	Background The diagnosis of subacromial pathology is limited by the poor accuracy of clinical tests for specific pathologies. The aim of this study was to estimate the diagnostic accuracy of clinical examination and imaging features for identifying subacromial pain (SAP) defined by a positive response to diagnostic injection, and to evaluate the influence of imaging findings on the clinical diagnosis of SAP. Methods and Findings In a prospective, diagnostic accuracy design, 208 consecutive patients presenting to their primary healthcare practitioner for the first time with a new episode of shoulder pain were recruited. All participants underwent a standardized clinical examination, shoulder x-ray series and diagnostic ultrasound scan. Results were compared with the response to a diagnostic block of xylocaine (TM) injected into the SAB under ultrasound guidance using >= 80% post-injection reduction in pain intensity as the positive anaesthetic response (PAR) criterion. Diagnostic accuracy statistics were calculated for combinations of clinical and imaging variables demonstrating the highest likelihood of a PAR. A PAR was reported by 34% of participants. In participants with no loss of passive external rotation, combinations of three clinical variables (anterior shoulder pain, strain injury, absence of symptoms at end-range external rotation (in abduction)) demonstrated 100% specificity for a PAR when all three were positive (LR+ infinity; 95% CI 2.9, infinity). A full-thickness supraspinatus tear on ultrasound increased the likelihood of a PAR irrespective of age (specificity 98% (95% CI 94, 100); LR+ 6.2; 95% CI 1.5, 25.7)). Imaging did not improve the ability to rule-out a PAR. Conclusion Combinations of clinical examination findings and a full-thickness supraspinatus tear on ultrasound scan can help confirm, but not exclude, the presence of subacromial pain. Other imaging findings were of limited value for diagnosing SAP.	[Cadogan, Angela; McNair, Peter J.; Laslett, Mark] AUT Univ, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Hing, Wayne A.] Bond Univ, Fac Hlth Sci & Med, Robina, Qld, Australia	Auckland University of Technology; Bond University	Cadogan, A (corresponding author), AUT Univ, Hlth & Rehabil Res Inst, Auckland, New Zealand.	acadogan@vodafone.co.nz		Hing, Wayne/0000-0002-5507-9778; Cadogan, Angela/0000-0002-7972-5463	Health Research Council of New Zealand; New Zealand Manipulative Physiotherapists Association; Physiotherapy New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Manipulative Physiotherapists Association; Physiotherapy New Zealand	This work was supported by the Health Research Council of New Zealand, Clinical Research Training Fellowship to AC, New Zealand Manipulative Physiotherapists Association to AC, and Physiotherapy New Zealand to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M, 2009, THE EVIDENCE BASE OF; Anderson J, 1998, ATLAS IMAGING SPORTS, V1, P96; Awerbuch MS, 2008, MED J AUSTRALIA, V188, P50, DOI 10.5694/j.1326-5377.2008.tb01507.x; Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Baring T, 2007, BEST PRACT RES CL RH, V21, P279, DOI 10.1016/j.berh.2006.12.001; berg B, 2012, BMJ, V344; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOGDUK N, 2004, PRACTICE GUIDELINES; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bryant TN, 2000, STATISTICS WITH CONF; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Cadogan A, 2012, J REHABIL MED, V44, P877, DOI 10.2340/16501977-1049; Cadogan A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-119; Cadogan A, 2011, MANUAL THER, V16, P97, DOI 10.1016/j.math.2010.05.005; Calis M, 2000, ANN RHEUM DIS, V59, P44, DOI 10.1136/ard.59.1.44; Chronopoulos E, 2004, AM J SPORT MED, V32, P655, DOI 10.1177/0363546503261723; Codman EA, 1934, RUPTURE SUPRASPINATU, P123; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; Dong W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000510; Dreyfuss P, 1996, SPINE, V21, P2594, DOI 10.1097/00007632-199611150-00009; Eubank BH, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0165-8; Feleus A, 2008, MANUAL THER, V13, P426, DOI 10.1016/j.math.2007.05.010; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; GARTNER J, 1995, ORTHOPADE, V24, P284; Greving K, 2012, SCAND J RHEUMATOL, V41, P150, DOI 10.3109/03009742.2011.605390; Haik MN, 2016, BRIT J SPORT MED, V50, P1124, DOI 10.1136/bjsports-2015-095771; Hanchard NCA, 2008, COCHRANE DB SYST REV; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hegedus EJ, 2008, BRIT J SPORT MED, V42, P80, DOI 10.1136/bjsm.2007.038406; Hegedus EJ, 2012, BRIT J SPORT MED, V46, P964, DOI 10.1136/bjsports-2012-091066; Hertel R, 1996, J Shoulder Elbow Surg, V5, P307, DOI 10.1016/S1058-2746(96)80058-9; IBM Corp, 2013, SPSS WINDOWS; International Spine Intervention Society [ISIS], 2004, PRACTICE GUIDELINES, P61; Itoi E, 1999, AM J SPORT MED, V27, P65, DOI 10.1177/03635465990270011901; Jobe F W, 1989, Orthop Rev, V18, P963; JOBE FW, 1982, AM J SPORT MED, V10, P336, DOI 10.1177/036354658201000602; Johol P, 2008, AUST FAM PHYSICIAN, V37, P263; Kim SH, 2005, AM J SPORT MED, V33, P1188, DOI 10.1177/0363546504272687; Lam F, 2006, CURR ORTHOPAED, V20, P446, DOI 10.1016/j.cuor.2006.09.005; Laslett Mark, 2006, Spine J, V6, P370, DOI 10.1016/j.spinee.2006.01.004; LEROUX JL, 1995, REV RHUM, V62, P423; Louwerens JKG, 2014, J SHOULDER ELB SURG, V23, P1240, DOI 10.1016/j.jse.2014.02.002; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; MacDonald PB, 2000, J SHOULDER ELB SURG, V9, P299, DOI 10.1067/mse.2000.106918; Magarey ME, 2016, BRIT J SPORT MED, V50, P1151, DOI 10.1136/bjsports-2014-094339; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Moosmayer S, 2009, J BONE JOINT SURG BR, V91B, P196, DOI 10.1302/0301-620X.91B2.21069; Morgan CD, 1998, ARTHROSCOPY, V14, P553, DOI 10.1016/S0749-8063(98)70049-0; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; O'Brien SJ, 1998, AM J SPORT MED, V26, P610, DOI 10.1177/03635465980260050201; Ombregt L, 2003, SYSTEM OF ORTHOPAEDI, P291; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; Parentis MA, 2006, AM J SPORT MED, V34, P265, DOI 10.1177/0363546505279911; Park HB, 2005, J BONE JOINT SURG AM, V87A, P1446, DOI 10.2106/JBJS.D.02335; Ruotolo C, 2002, ARTHROSCOPY, V18, P527, DOI 10.1053/jars.2002.31707; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Stein BES, 2006, J SHOULDER ELB SURG, V15, P56, DOI 10.1016/j.jse.2005.05.013; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Stoller DW, 2007, MAGNETIC RESONANCE I, V2, P1131; Strobel K, 2003, AM J ROENTGENOL, V181, P755, DOI 10.2214/ajr.181.3.1810755; Tallia AF, 2003, AM FAM PHYSICIAN, V67, P1271; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Walch G, 1998, J BONE JOINT SURG BR, V80B, P624, DOI 10.1302/0301-620X.80B4.8651; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Wittich CM, 2009, MAYO CLIN PROC, V84, P831, DOI 10.1016/S0025-6196(11)60493-X; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9; [No title captured]	70	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167738	10.1371/journal.pone.0167738	http://dx.doi.org/10.1371/journal.pone.0167738			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936246	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100170
J	Fung, FKC; Law, BYK; Lo, ACY				Fung, Frederic K. C.; Law, Betty Y. K.; Lo, Amy C. Y.			Lutein Attenuates Both Apoptosis and Autophagy upon Cobalt (II) Chloride-Induced Hypoxia in Rat Muller Cells	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RETINAL GANGLION-CELLS; MACULAR DEGENERATION; OXIDATIVE STRESS; PROTECTS; ZEAXANTHIN; PATHWAY; PIGMENT; ISCHEMIA/REPERFUSION; RETINOPATHY	Retinal ischemia/reperfusion injury is a common feature of various retinal diseases such as glaucoma and diabetic retinopathy. Lutein, a potent anti-oxidant, is used to improve visual function in patients with age-related macular degeneration (AMD). Lutein attenuates apoptosis, oxidative stress and inflammation in animal models of acute retinal ischemia/hypoxia. Here, we further show that lutein improved Muller cell viability and enhanced cell survival upon hypoxia-induced cell death through regulation of intrinsic apoptotic pathway. Moreover, autophagy was activated upon treatment of cobalt (II) chloride, indicating that hypoxic injury not only triggered apoptosis but also autophagy in our in vitro model. Most importantly, we report for the first time that lutein treatment suppressed autophagosome formation after hypoxic insult and lutein administration could inhibit autophagic event after activation of autophagy by a pharmacological approach (rapamycin). Taken together, lutein may have a beneficial role in enhancing glial cell survival after hypoxic injury through regulating both apoptosis and autophagy.	[Fung, Frederic K. C.; Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Law, Betty Y. K.] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Macau University of Science & Technology; University of Hong Kong	Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.; Lo, ACY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk	Lo, Amy C. Y./C-1195-2009	Lo, Amy C. Y./0000-0003-4239-6851	Hong Kong Research Grants Council (GRF) [HKU773210M]; FDCT grant from the Science and Technology Development Fund of Macao [090/2013/A3]	Hong Kong Research Grants Council (GRF)(Hong Kong Research Grants Council); FDCT grant from the Science and Technology Development Fund of Macao	Support was provided by Hong Kong Research Grants Council (GRF#HKU773210M) and an FDCT grant from the Science and Technology Development Fund of Macao (Project code: 090/2013/A3). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867; Bian QN, 2012, ADV EXP MED BIOL, V723, P43, DOI 10.1007/978-1-4614-0631-0_7; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chang CL, 2013, J DENT SCI, V8, P8, DOI 10.1016/j.jds.2012.09.006; Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037; Gallo S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.155; Gao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046092; Garcia M, 2003, ROLE MULLER GLIA NEU; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Jin XH, 2006, INVEST OPHTH VIS SCI, V47, P2562, DOI 10.1167/iovs.05-1429; Jung JY, 2008, BRAIN RES BULL, V76, P579, DOI 10.1016/j.brainresbull.2008.04.006; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawasaki A, 2000, INVEST OPHTH VIS SCI, V41, P3444; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koh PO, 2008, NEUROSCI LETT, V444, P74, DOI 10.1016/j.neulet.2008.08.024; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li HF, 2015, NEUROSCI LETT, V588, P178, DOI 10.1016/j.neulet.2015.01.007; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Li SJ, 2012, APPL MATH COMPUT, V218, P6874, DOI 10.1016/j.amc.2011.12.064; Li SY, 2012, INVEST OPHTH VIS SCI, V53, P5976, DOI 10.1167/iovs.12-10007; Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nataraj J, 2015, NUTR NEUROSCIENCE; OJIMA F, 1993, FREE RADICAL BIO MED, V15, P377, DOI 10.1016/0891-5849(93)90037-U; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Peng PH, 2008, EXP EYE RES, V86, P637, DOI 10.1016/j.exer.2008.01.008; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Produit-Zengaffinen N, 2014, AUTOPHAGY INDUCTION, P677; Qin L, 2014, INVESTIGATIVE OPHTHA; Ribaya-Mereado JD, 2004, J AM COLL NUTR, V23, p567S, DOI 10.1080/07315724.2004.10719427; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Shinjo SK, 2007, CLIN RHEUMATOL, V26, P1248, DOI 10.1007/s10067-006-0478-9; Sommerburg O, 1998, BRIT J OPHTHALMOL, V82, P907, DOI 10.1136/bjo.82.8.907; Song H, 2015, LIFE SCI, V126, P69, DOI 10.1016/j.lfs.2015.02.004; Song ZC, 2012, CELL PROLIFERAT, V45, P239, DOI 10.1111/j.1365-2184.2012.00810.x; Tian H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116453; Wang AL, 2009, AUTOPHAGY, V5, P563, DOI 10.4161/auto.5.4.8163; Wang M., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1155/2015/892549; Wang X, 2014, OPHTHALMIC RES, V52, P198, DOI 10.1159/000363327; Wei T, 2015, EXP THER MED, V9, P476, DOI 10.3892/etm.2014.2084; Willcox JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090864; Woo TTY, 2013, GRAEF ARCH CLIN EXP, V251, P41, DOI 10.1007/s00417-012-2128-z; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063232; Yang L, 2012, CELL MOL NEUROBIOL, V32, P1275, DOI 10.1007/s10571-012-9852-0; Yao J, 2014, CELL PHYSIOL BIOCHEM, V33, P107, DOI 10.1159/000356654; Zheng YQ, 2014, J PHARMACOL SCI, V124, P354, DOI 10.1254/jphs.13220FP	60	33	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167828	10.1371/journal.pone.0167828	http://dx.doi.org/10.1371/journal.pone.0167828			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936094	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100209
J	Jaakkola, J; Mustonen, P; Kiviniemi, T; Hartikainen, JEK; Palomaki, A; Hartikainen, P; Nuotio, I; Ylitalo, A; Airaksinen, KEJ				Jaakkola, Jussi; Mustonen, Pirjo; Kiviniemi, Tuomas; Hartikainen, Juha E. K.; Palomaki, Antti; Hartikainen, Palvi; Nuotio, Ilpo; Ylitalo, Antti; Airaksinen, K. E. Juhani			Stroke as the First Manifestation of Atrial Fibrillation	PLOS ONE			English	Article							THROMBOEMBOLIC COMPLICATIONS; CARDIOVERSION; THERAPY; ARRHYTHMIAS; POPULATION; MANAGEMENT; MECHANISMS; FIBSTROKE; QUALITY; TIME	Atrial fibrillation may remain undiagnosed until an ischemic stroke occurs. In this retrospective cohort study we assessed the prevalence of ischemic stroke or transient ischemic attack as the first manifestation of atrial fibrillation in 3,623 patients treated for their first ever stroke or transient ischemic attack during 2003-2012. Two groups were formed: patients with a history of atrial fibrillation and patients with new atrial fibrillation diagnosed during hospitalization for stroke or transient ischemic attack. A control group of 781 patients with intracranial hemorrhage was compiled similarly to explore causality between new atrial fibrillation and stroke. The median age of the patients was 78.3 [13.0] years and 2,009 (55.5%) were women. New atrial fibrillation was diagnosed in 753 (20.8%) patients with stroke or transient ischemic attack, compared to 15 (1.9%) with intracranial hemorrhage. Younger age and no history of coronary artery disease or other vascular diseases, heart failure, or hypertension were the independent predictors of new atrial fibrillation detected concomitantly with an ischemic event. Thus, ischemic stroke was the first clinical manifestation of atrial fibrillation in 37% of younger (<75 years) patients with no history of cardiovascular diseases. In conclusion, atrial fibrillation is too often diagnosed only after an ischemic stroke has occurred, especially in middle-aged healthy individuals. New atrial fibrillation seems to be predominantly the cause of the ischemic stroke and not triggered by the acute cerebrovascular event.	[Jaakkola, Jussi; Kiviniemi, Tuomas; Palomaki, Antti; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku, Finland; [Jaakkola, Jussi; Kiviniemi, Tuomas; Palomaki, Antti; Airaksinen, K. E. Juhani] Univ Turku, Turku, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Med, Jyvaskyla, Finland; [Hartikainen, Juha E. K.] Kuopio Univ Hosp, Ctr Heart, Kuopio, Finland; [Hartikainen, Palvi] Kuopio Univ Hosp, Neuroctr, Neurol, Kuopio, Finland; [Nuotio, Ilpo] Turku Univ Hosp, Div Med, Dept Acute Internal Med, Turku, Finland; [Ylitalo, Antti] Satakunta Cent Hosp, Ctr Heart, Pori, Finland	University of Turku; University of Turku; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Turku; Satakunta Central Hospital	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, Turku, Finland.; Airaksinen, KEJ (corresponding author), Univ Turku, Turku, Finland.	juhani.airaksinen@tyks.fi	Kiviniemi, Tuomas/A-1107-2016; Airaksinen, Juhani/AAC-7857-2021	Kiviniemi, Tuomas/0000-0002-0908-3741; Airaksinen, Juhani/0000-0002-0193-568X; Palomaki, Antti/0000-0002-8835-8116	Finnish Foundation for Cardiovascular Research (Helsinki, Finland); Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland)	Finnish Foundation for Cardiovascular Research (Helsinki, Finland); Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland)	This study was funded by the Finnish Foundation for Cardiovascular Research (Helsinki, Finland [http://www.sydantutkimussaatio.fi/en/foundation], and the Clinical Research Fund (EVO) of Turku University Hospital (Turku, Finland [http://www.vsshp.fl/en/tutkijoille/rahoitus/Pages/default.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Boriani G, 2015, AM J MED, V128, P509, DOI 10.1016/j.amjmed.2014.11.026; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Kamel H, 2016, STROKE, V47, P895, DOI 10.1161/STROKEAHA.115.012004; Kiviniemi T, 2015, INT J CARDIOL, V183, P105, DOI 10.1016/j.ijcard.2015.01.056; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LIN HJ, 1995, STROKE, V26, P1527, DOI 10.1161/01.STR.26.9.1527; Nuotio I, 2014, JAMA-J AM MED ASSOC, V312, P647, DOI 10.1001/jama.2014.3824; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Palomaki A, 2016, EUR J NEUROL, V23, P133, DOI 10.1111/ene.12820; Palomaki A, 2016, INT J CARDIOL, V203, P269, DOI 10.1016/j.ijcard.2015.10.168; Roche FDR, 2002, PACE, V25, P1587, DOI 10.1046/j.1460-9592.2002.01587.x; Savelieva I, 2000, J INTERV CARD ELECTR, V4, P369, DOI 10.1023/A:1009823001707; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Toledo ME Gonzalez, 2013, STROKE CEREBROVASC D, V22, pe486; VINGERHOETS F, 1993, STROKE, V24, P26, DOI 10.1161/01.STR.24.1.26; Virtanen R, 2014, EUR J PREV CARDIOL, V21, P1437, DOI 10.1177/2047487313494041; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	24	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168010	10.1371/journal.pone.0168010	http://dx.doi.org/10.1371/journal.pone.0168010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936187	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100251
J	Rodolfo, C; Rocco, M; Cattaneo, L; Tartaglia, M; Sassi, M; Aducci, P; Scaloni, A; Camoni, L; Marra, M				Rodolfo, Carlo; Rocco, Mariapina; Cattaneo, Lucia; Tartaglia, Maria; Sassi, Mauro; Aducci, Patrizia; Scaloni, Andrea; Camoni, Lorenzo; Marra, Mauro			Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GLYCOLYTIC-ENZYMES; MCF-7 CELLS; CANCER; IDENTIFICATION; DEATH; EXPRESSION; CARCINOMA; STATHMIN; INACTIVATION	Ophiobolin A, a fungal toxin from Bipolaris species known to affect different cellular processes in plants, has recently been shown to have anti-cancer activity in mammalian cells. In the present study, we investigated the anti-proliferative effect of Ophiobolin A on human melanoma A375 and CHL-1 cell lines. This cellular model was chosen because of the incidence of melanoma malignant tumor on human population and its resistance to chemical treatments. Ophyobolin A strongly reduced cell viability of melanoma cells by affecting mitochondrial functionality. The toxin induced depolarization of mitochondrial membrane potential, reactive oxygen species production and mitochondrial network fragmentation, leading to autophagy induction and ultimately resulting in cell death by activation of the mitochondrial pathway of apoptosis. Finally, a comparative proteomic investigation on A375 cells allowed to identify several Ophiobolin A down-regulated proteins, which are involved in fundamental processes for cell homeostasis and viability.	[Rodolfo, Carlo; Cattaneo, Lucia; Aducci, Patrizia; Camoni, Lorenzo; Marra, Mauro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Rocco, Mariapina; Tartaglia, Maria] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Sassi, Mauro; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy	University of Rome Tor Vergata; University of Sannio; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Camoni, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	camoni@uniroma2.it	Tartaglia, Maria/AAS-9004-2021; Rodolfo, Carlo/H-8953-2019	Tartaglia, Maria/0000-0002-3797-9377; Rodolfo, Carlo/0000-0001-7087-545X; CAMONI, LORENZO/0000-0001-9020-0812; ROCCO, Mariapina/0000-0002-5869-029X; Scaloni, Andrea/0000-0001-9362-8515	Italian Ministry of Economy and Finance [191/2009]; Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R.)	Italian Ministry of Economy and Finance; Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R.)	This work was supported by funds from the Italian Ministry of Economy and Finance to the National Research Council for the project "Innovazione e sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare" - Legge n.191/2009, and from Regione Campania for the Project BenTeN - Nuovi Processi e Prodotti per la Nutraceutica, la Cosmeceutica e la Nutrizione umana" (P.O.R. 2007/2013, objectives 2.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiya AA, 1997, INT J CANCER, V73, P678, DOI 10.1002/(SICI)1097-0215(19971127)73:5<678::AID-IJC11>3.0.CO;2-2; Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Ashkenazi A, 2014, ANNU REV CELL DEV BI, V30, P337, DOI 10.1146/annurev-cellbio-100913-013226; Atallah Ehab, 2005, Curr Treat Options Oncol, V6, P185; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Au TK, 2000, INT J BIOCHEM CELL B, V32, P1173, DOI 10.1016/S1357-2725(00)00058-3; Benbrook D. M., 2012, Experimental Oncology, V34, P286; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Bury M, 2013, INT J ONCOL, V43, P575, DOI 10.3892/ijo.2013.1979; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Chan THM, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/369384; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Fujiwara Hironori, 2000, Pharmacy and Pharmacology Communications, V6, P427; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Kajita E, 2001, MECH DEVELOP, V102, P283, DOI 10.1016/S0925-4773(01)00324-0; Ko JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086569; Kuang XY, 2015, ONCOTARGET, V6, P22227, DOI 10.18632/oncotarget.4276; Lee WH, 2010, TOXICOLOGY, V278, P224, DOI 10.1016/j.tox.2010.02.005; Li D, 2015, CHIN J NAT MEDICINES, V13, P41, DOI 10.1016/S1875-5364(15)60005-X; Li ZY, 2013, CANCER CHEMOTH PHARM, V72, P1001, DOI 10.1007/s00280-013-2285-8; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu HS, 2005, INT J FOOD ENG, V1, DOI 10.2202/1556-3758.1004; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lv CT, 2015, MAR DRUGS, V13, P431, DOI 10.3390/md13010431; Machado-Neto JA, 2014, BMB REP, V47, P660, DOI 10.5483/BMBRep.2014.47.12.020; Marugame T, 2010, JPN J CLIN ONCOL, V40, P710, DOI 10.1093/jjco/hyq107; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; Ostrov DA, 2007, TISSUE ANTIGENS, V69, P181, DOI 10.1111/j.1399-0039.2006.00730.x; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; PFLEIDERER G, 1975, BEITR PATHOL, V156, P266; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; Scippa GS, 2010, ELECTROPHORESIS, V31, P497, DOI 10.1002/elps.200900459; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; SUGAWARA F, 1987, P NATL ACAD SCI USA, V84, P3081, DOI 10.1073/pnas.84.10.3081; Sun W, 2001, Curr Treat Options Oncol, V2, P193, DOI 10.1007/s11864-001-0033-5; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; Tanaka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096785; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tawbi Hussein A, 2010, Clin Adv Hematol Oncol, V8, P259; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Unwin RD, 2003, PROTEOMICS, V3, P1620, DOI 10.1002/pmic.200300464; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yang TT, 2012, BIOORG MED CHEM LETT, V22, P579, DOI 10.1016/j.bmcl.2011.10.079; Ying LS, 2013, ONCOL LETT, V5, P1315, DOI 10.3892/ol.2013.1144	58	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167672	10.1371/journal.pone.0167672	http://dx.doi.org/10.1371/journal.pone.0167672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936075	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100146
J	Wu, DC; He, DM; Gu, HL; Wu, PP; Yi, X; Wang, WJ; Shi, HF; Wu, DX; Sun, GL				Wu, De-Chuan; He, Deng-Min; Gu, Hai-Lan; Wu, Pan-Pan; Yi, Xu; Wang, Wei-Jie; Shi, Han-Feng; Wu, De-Xiang; Sun, Genlou			Origin and Evolution of Allopolyploid Wheatgrass Elymus fibrosus (Schrenk) Tzvelev (Poaceae: Triticeae) Reveals the Effect of Its Origination on Genetic Diversity	PLOS ONE			English	Article							NORTH-AMERICAN ELYMUS; GENOME CONSTITUTION; BRASSICA-NAPUS; H-GENOME; MOLECULAR PHYLOGENY; RPB2 GENE; POPULATIONS; DIFFERENTIATION; CANINUS; RECOMBINATION	Origin and evolution of tetraploid Elymus fibrosus (Schrenk) Tzvelev were characterized using low-copy nuclear gene Rpb2 (the second largest subunit of RNA polymerase II), and chloroplast region trnL-trnF (spacer between the tRNA Leu (UAA) gene and the tRNA-Phe (GAA) gene). Ten accessions of E. fibrosus along with 19 Elymus species with StH genomic constitution and diploid species in the tribe Triticeae were analyzed. Chloroplast trnL-trnF sequence data suggested that Pseudoroegneria (St genome) was the maternal donor of E. fibrosus. Rpb2 data confirmed the presence of StH genomes in E. fibrosus, and suggested that St and H genomes in E. fibrosus each is more likely originated from single gene pool. Single origin of E. fibrosus might be one of the reasons causing genetic diversity in E. fibrosus lower than those in E. caninus and E. trachycaulus, which have similar ecological preferences and breeding systems with E. fibrosus, and each was originated from multiple sources. Convergent evolution of St and H copy Rpb2 sequences in some accessions of E. fibrosus might have occurred during the evolutionary history of this allotetraploid.	[Wu, De-Chuan; He, Deng-Min; Gu, Hai-Lan; Wu, Pan-Pan; Yi, Xu; Wang, Wei-Jie; Shi, Han-Feng; Wu, De-Xiang; Sun, Genlou] Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS, Canada	Anhui Agricultural University; Saint Marys University - Canada	Wu, DX; Sun, GL (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Anhui, Peoples R China.; Sun, GL (corresponding author), St Marys Univ, Dept Biol, Halifax, NS, Canada.	dexiangwu198@163.com; genlou.sun@smu.ca			Research Foundation for Talented Scholars from Anhui Agricultural University; introduced leading talent research team for Universities in Anhui Province; Natural Sciences and Engineering Research Council of Canada [DDG-2015-00039]	Research Foundation for Talented Scholars from Anhui Agricultural University; introduced leading talent research team for Universities in Anhui Province; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported in part by a Research Foundation for Talented Scholars from Anhui Agricultural University and the introduced leading talent research team for Universities in Anhui Province, a discovery development grants DDG-2015-00039 from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; Diaz O, 2000, GENET RESOUR CROP EV, V47, P11, DOI 10.1023/A:1008719119756; Diaz O, 1999, THEOR APPL GENET, V99, P210, DOI 10.1007/s001220051227; Diaz O, 1999, HEREDITAS, V131, P63, DOI 10.1111/j.1601-5223.1999.00063.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frankel O.H., 1995, CONSERVATION PLANT B; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gaudett M, 2005, PLANT SYST EVOL, V250, P81, DOI 10.1007/s00606-004-0199-y; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; JENSEN KB, 1995, INT J PLANT SCI, V156, P731, DOI 10.1086/297295; JUNGHANS H, 1990, BIOTECHNIQUES, V8, P176; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Love A., 1984, Feddes Repertorium, V95, P425; Mahelka V, 2007, ANN BOT-LONDON, V100, P249, DOI 10.1093/aob/mcm093; Mahelka V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-127; Mason-Gamer RJ, 2002, GENOME, V45, P991, DOI [10.1139/g02-065, 10.1139/G02-065]; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mason-Gamer RJ, 1995, METHODS OF GENOME AN; Mason-Gamer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010989; Mason-Gamer Roberta J., 2007, Aliso, V23, P372; McMillan E, 2004, THEOR APPL GENET, V108, P535, DOI 10.1007/s00122-003-1453-3; Ni Y, 2011, BIOL PLANTARUM, V55, P68, DOI 10.1007/s10535-011-0009-7; Redinbaugh MG, 2000, GENOME, V43, P846, DOI 10.1139/gen-43-5-846; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Sun G, 2005, PLANT SYST EVOL, V256, P179, DOI 10.1007/s00606-005-0368-7; Sun G, 2003, GENOME, V46, P729, DOI [10.1139/g03-052, 10.1139/G03-052]; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun GL, 2014, J SYST EVOL, V52, P706, DOI 10.1111/jse.12080; Sun GL, 2011, GENOME, V54, P655, DOI [10.1139/G11-036, 10.1139/g11-036]; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Sun GL, 2002, PLANT SYST EVOL, V234, P101, DOI 10.1007/s00606-002-0211-3; Sun GL, 1999, GENOME, V42, P420, DOI 10.1139/gen-42-3-420; Sun GL, 1998, HEREDITAS, V129, P275, DOI 10.1111/j.1601-5223.1998.00275.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; Wang R.R.-C., 1994, P 2 INT TRIT S LOG U, P20; Xu DH, 2004, THEOR APPL GENET, V108, P1443, DOI 10.1007/s00122-004-1588-x; Yan C, 2012, MOL PHYLOGENET EVOL, V64, P441, DOI 10.1016/j.ympev.2012.04.017; Zhang C, 2009, BIOL PLANTARUM, V53, P759, DOI 10.1007/s10535-009-0139-3; Zhang XQ, 2002, GENET RESOUR CROP EV, V49, P397; Zou HW, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]	51	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167795	10.1371/journal.pone.0167795	http://dx.doi.org/10.1371/journal.pone.0167795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936163	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100194
J	Yamaguchi, S; Hirata, K; Toyonaga, T; Kobayashi, K; Ishi, Y; Motegi, H; Kobayashi, H; Shiga, T; Tamaki, N; Terasaka, S; Houkin, K				Yamaguchi, Shigeru; Hirata, Kenji; Toyonaga, Takuya; Kobayashi, Kentaro; Ishi, Yukitomo; Motegi, Hiroaki; Kobayashi, Hiroyuki; Shiga, Tohru; Tamaki, Nagara; Terasaka, Shunsuke; Houkin, Kiyohiro			Change in F-18-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEWLY-DIAGNOSED GLIOBLASTOMA; ANTIANGIOGENIC TREATMENT; F-18 FLUOROMISONIDAZOLE; MALIGNANT GLIOMA; RESPONSE ASSESSMENT; BLOOD PERFUSION; PHASE-II; HYPOXIA; SURVIVAL	Background Bevacizumab (BEV), a humanized monoclonal antibody, become a currently important chemotherapeutic option for the patients with recurrent glioma. The aim of this retrospective study is to investigate whether 18 F-Fluoromisonidazole (FMISO) PET have the potential to detect BEV-resistant gliomas in the early-stage. Methods We reviewed the FMISO PET and MRI appearances before and 3 to 4 courses after BEV treatment on 18 recurrent glioma patients. FMISO accumulation was assessed by visual inspection and semi-quantitative values which were tumor-to-normal (T/N) ratio and hypoxic volume. MRI responses were evaluated based on RANO (Response Assessment in Neuro-Oncology) criteria. The prognostic analysis was performed in relation to the response assessment by FMISO PET and MRI using overall survival (OS) after BEV application. Results After BEV application, MRI revealed partial response in 14 of 18 patients (78%), of which 9 patients also demonstrated decreased FMISO accumulation. These 9 patients (50%) were classified as "MRI-FMISO double responder". As for the other 5 patients (28%), FMISO accumulation volumes increased or remained stable after BEV treatment although partial responses were achieved on MRI. Therefore, these cases were classified as "MRI-only responder". The remaining 4 patients (22%) did not show treatment response on FMISO PET or MRI ("non-responder"). MRI-FMISO double responders showed significantly longer OS than that in other groups (median 12.4 vs 5.7 months; P < 0.001), whereas there were no overall survival difference between MRI-only responders and non-responders (median OS, 5.7 and 4.8 months; P = 0.58). Among the pre-treatment clinical factors, high FMISO T/N ratio was a significant prognostic factor of overall survival in these patients under the assessment of Cox proportional hazard model. Conclusions Recurrent gliomas with decreasing FMISO accumulation after short-term BEV application could derive a survival benefit from BEV treatment. Change in FMISO PET appearance can identify BEV-resistant gliomas in early-stage regardless of MRI findings in a comprehensible way.	[Yamaguchi, Shigeru; Ishi, Yukitomo; Motegi, Hiroaki; Kobayashi, Hiroyuki; Terasaka, Shunsuke; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Yamaguchi, Shigeru; Hirata, Kenji; Toyonaga, Takuya; Kobayashi, Kentaro; Shiga, Tohru; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Terasaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	terasas@med.hokudai.ac.jp	Toyonaga, Takuya/ABE-1742-2021; Yamaguchi, Shigeru/G-5419-2012	Toyonaga, Takuya/0000-0002-0369-8294; Yamaguchi, Shigeru/0000-0003-3710-5888; Ishi, Yukitomo/0000-0003-4834-2619; mao mu, yang huang/0000-0001-6153-5461	Japan Society for the Promotion of Science [24700999]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was partly supported by a Grant-in-Aid for General Scientific Research from the Japan Society for the Promotion of Science (#24700999). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barajas Ramon F Jr, 2015, Case Rep Radiol, V2015, P731361, DOI 10.1155/2015/731361; Batchelor TT, 2013, P NATL ACAD SCI USA, V110, P19059, DOI 10.1073/pnas.1318022110; Bell C, 2015, SEMIN NUCL MED, V45, P136, DOI 10.1053/j.semnuclmed.2014.10.001; Boxerman JL, 2013, NEURO-ONCOLOGY, V15, P945, DOI 10.1093/neuonc/not049; Bruehlmeier M, 2004, J NUCL MED, V45, P1851; Cher LM, 2006, J NUCL MED, V47, P410; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P401, DOI 10.1093/neuonc/noq206; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fueger BJ, 2010, J NUCL MED, V51, P1532, DOI 10.2967/jnumed.110.078592; Galldiks N, 2013, EUR J NUCL MED MOL I, V40, P22, DOI 10.1007/s00259-012-2251-4; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hirata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105682; Hirata K, 2012, EUR J NUCL MED MOL I, V39, P760, DOI 10.1007/s00259-011-2037-0; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Huang RY, 2013, CANCER-AM CANCER SOC, V119, P3479, DOI 10.1002/cncr.28210; Hutterer M, 2015, NEURO-ONCOLOGY, V17, P784, DOI 10.1093/neuonc/nou322; Hutterer M, 2011, J NUCL MED, V52, P856, DOI 10.2967/jnumed.110.086645; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Kawai N, 2011, EUR J NUCL MED MOL I, V38, P441, DOI 10.1007/s00259-010-1645-4; Koch CJ, 2003, ADV EXP MED BIOL, V510, P285; KOH WJ, 1992, INT J RADIAT ONCOL, V22, P199, DOI 10.1016/0360-3016(92)91001-4; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Liang BC, 1996, J NEURO-ONCOL, V29, P149; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Narita T, 2012, JPN J CLIN ONCOL, V42, P120, DOI 10.1093/jjco/hyr181; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Piert M, 1999, EUR J NUCL MED, V26, P95, DOI 10.1007/s002590050365; RASEY JS, 1990, RADIAT RES, V122, P301, DOI 10.2307/3577760; Schaub C, 2013, ONCOLOGY-BASEL, V85, P191, DOI 10.1159/000354692; Schwarzenberg J, 2014, CLIN CANCER RES, V20, P3550, DOI 10.1158/1078-0432.CCR-13-1440; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Spence AM, 2008, CLIN CANCER RES, V14, P2623, DOI 10.1158/1078-0432.CCR-07-4995; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Swanson KR, 2009, J NUCL MED, V50, P36, DOI 10.2967/jnumed.108.055467; Thomas AA, 2014, CURR TREAT OPTION ON, V15, P551, DOI 10.1007/s11864-014-0308-2; Valable S, 2011, NUCL MED BIOL, V38, P781, DOI 10.1016/j.nucmedbio.2011.01.010; Weathers SP, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0443-y; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336	42	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167917	10.1371/journal.pone.0167917	http://dx.doi.org/10.1371/journal.pone.0167917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936194	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100230
J	Zeng, ZP; Wang, K; Li, YY; Xia, N; Nie, SF; Lv, BJ; Zhang, M; Tu, X; Li, QQ; Tang, TT; Cheng, X				Zeng, Zhipeng; Wang, Ke; Li, Yuanyuan; Xia, Ni; Nie, Shaofang; Lv, Bingjie; Zhang, Min; Tu, Xin; Li, Qianqian; Tang, Tingting; Cheng, Xiang			Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4(+) T cells by targeting Myc in patients with dilated cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; inflammation; microRNA (miRNA); Myc (c-Myc); T helper cells	CARDIAC-HYPERTROPHY; TUMOR-SUPPRESSOR; HEART-FAILURE; C-MYC; EXPRESSION; RECEPTOR; AUTOANTIBODIES; CLASSIFICATION; INTERLEUKIN-2; CARDIOLOGY	CD4(+) T cells are abnormally activated in patients with dilated cardiomyopathy (DCM) and might be associated with the immunopathogenesis of the disease. However, the underlying mechanisms of CD4(+) T cell activation remain largely undefined. Our aim was to investigate whether the dysregulation of microRNAs (miRNAs) was associated with CD4(+) T cell activation in DCM. CD4(+) T cells from DCM patients showed increased expression levels of CD25 and CD69 and enhanced proliferation in response to anti-CD3/28, indicating an activated state. miRNA profiling analysis of magnetically sorted CD4(+) T cells revealed a distinct pattern of miRNA expression in CD4(+) T cells from DCM patients compared with controls. The level of miRNA-451a (miR-451a) was significantly decreased in the CD4(+) T cells of DCM patients compared with that of the controls. The transfection of T cells with an miR-451a mimic inhibited their activation and proliferation, whereas an miR-451a inhibitor produced the opposite effects. Myc was directly inhibited by miR-451a via interaction with its 3-UTR, thus identifying it as an miR-451a target in T cells. The knockdown of Myc suppressed the activation and proliferation of T cells, and the expression of Myc was significantly up-regulated at the mRNA level in CD4(+) T cells from patients with DCM. A strong inverse correlation was observed between the Myc mRNA expression and miR-451a transcription level. Our data suggest that the down-regulation of miR-451a contributes to the activation and proliferation of CD4(+) T cells by targeting the transcription factor Myc in DCM patients and may contribute to the immunopathogenesis of DCM.	[Zeng, Zhipeng; Wang, Ke; Li, Yuanyuan; Xia, Ni; Nie, Shaofang; Lv, Bingjie; Zhang, Min; Tang, Tingting; Cheng, Xiang] Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy,Minist Educ, Inst Cardiol,Union Hosp,Tongji Med Coll, Wuhan 430022, Peoples R China; [Tu, Xin; Li, Qianqian] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Tu, Xin; Li, Qianqian] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tang, TT; Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy,Minist Educ, Inst Cardiol,Union Hosp,Tongji Med Coll, Wuhan 430022, Peoples R China.	tangtingting@hust.edu.cn; nathancx@hust.edu.cn	li, yuanyuan/GZA-4435-2022; 饭, 蔡/AAI-5850-2020	Li, Qianqian/0000-0002-8974-9768	National Basic Research Program of China 973 Program [2013CB531103, 2012CB517805]; National Natural Science Foundation of China [91339118, 81561130161, 81525003, 81200177, 81670361, 81400364, 81500186, 81600187]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2013CB531103 and 2012CB517805 (to X. C.) and National Natural Science Foundation of China Grants 91339118, 81561130161, and 81525003 (to X. C.), 81200177 and 81670361 (to T. T. T.), 81400364 (to N. X.), 81500186 (to S. F. N.), and 81600187 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bocharov G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00264; Charlot-Rabiega P, 2011, J BIOL CHEM, V286, P27350, DOI 10.1074/jbc.M111.221010; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen DQ, 2014, EUR J CANCER, V50, P3050, DOI 10.1016/j.ejca.2014.09.008; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Gupta MK, 2013, J MOL CELL CARDIOL, V62, P131, DOI 10.1016/j.yjmcc.2013.05.011; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 2008, AUTOIMMUNITY, V41, P454, DOI 10.1080/08916930802031603; Kim IM, 2014, CIRC RES, V114, P833, DOI 10.1161/CIRCRESAHA.114.302766; Kroesen BJ, 2015, IMMUNOLOGY, V144, P1, DOI 10.1111/imm.12367; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Lauer B, 2000, J AM COLL CARDIOL, V35, P11, DOI 10.1016/S0735-1097(99)00485-4; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Morandi F, 2013, INT IMMUNOL, V25, P279, DOI 10.1093/intimm/dxs108; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Posternak V., 2016, F1000RESEARCH, V5, DOI [DOI 10.12688/F1000RESEARCH.7879.1, 10.12688/f1000research.7879.1]; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Satoh M, 2011, J CARD FAIL, V17, P923, DOI 10.1016/j.cardfail.2011.07.012; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Takahashi Y, 2010, CLIN SCI, V119, P395, DOI 10.1042/CS20100003; Teteloshvili Nato, 2015, Microrna, V4, P117; Ueno A, 2007, HEART VESSELS, V22, P316, DOI 10.1007/s00380-007-0977-x; Wang HM, 2015, J CANCER RES THER, V11, pC216, DOI 10.4103/0973-1482.168189; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196; Zhao YY, 2015, BBA-MOL BASIS DIS, V1852, P2024, DOI 10.1016/j.bbadis.2015.07.016; Zhu XM, 2013, J CELL MOL MED, V17, P1173, DOI 10.1111/jcmm.12096; Zhu ZF, 2015, J LEUKOCYTE BIOL, V97, P797, DOI 10.1189/jlb.5A1014-469RR	42	24	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					6004	6013		10.1074/jbc.M116.765107	http://dx.doi.org/10.1074/jbc.M116.765107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	27974462	hybrid, Green Published			2022-12-26	WOS:000398813200033
J	Le Bras, Y; Jouma'a, J; Picard, B; Guinet, C				Le Bras, Yves; Jouma'a, Joffrey; Picard, Baptiste; Guinet, Christophe			How Elephant Seals (Mirounga leonina) Adjust Their Fine Scale Horizontal Movement and Diving Behaviour in Relation to Prey Encounter Rate	PLOS ONE			English	Article							BREATH-HOLD DIVERS; FORAGING SUCCESS; MARINE PREDATOR; WEDDELL SEALS; STROKING PATTERNS; FEEDING-BEHAVIOR; ANIMAL BEHAVIOR; TEMPERATURE; PENGUINS; FISH	Understanding the diving behaviour of diving predators in relation to concomitant prey distribution could have major practical applications in conservation biology by allowing the assessment of how changes in fine scale prey distribution impact foraging efficiency and ultimately population dynamics. The southern elephant seal (Mirounga leonina, hereafter SES), the largest phocid, is a major predator of the southern ocean feeding on myctophids and cephalopods. Because of its large size it can carry bio-loggers with minimal disturbance. Moreover, it has great diving abilities and a wide foraging habitat. Thus, the SES is a well suited model species to study predator diving behaviour and the distribution of ecologically important prey species in the Southern Ocean. In this study, we examined how SESs adjust their diving behaviour and horizontal movements in response to fine scale prey encounter densities using high resolution accelerometers, magnetometers, pressure sensors and GPS loggers. When high prey encounter rates were encountered, animals responded by (1) diving and returning to the surface with steeper angles, reducing the duration of transit dive phases (thus improving dive efficiency), and (2) exhibiting more horizontally and vertically sinuous bottom phases. In these cases, the distance travelled horizontally at the surface was reduced. This behaviour is likely to counteract horizontal displacement from water currents, as they try to remain within favourable prey patches. The prey encounter rate at the bottom of dives decreased with increasing diving depth, suggesting a combined effect of decreased accessibility and prey density with increasing depth. Prey encounter rate also decreased when the bottom phases of dives were spread across larger vertical extents of the water column. This result suggests that the vertical aggregation of prey can regulate prey density, and as a consequence impact the foraging success of SESs. To our knowledge, this is one of only a handful of studies showing how the vertical distributions and structure of prey fields influence the prey encounter rates of a diving predator.	[Le Bras, Yves; Jouma'a, Joffrey; Picard, Baptiste; Guinet, Christophe] UMR, Ctr Etude Biol Chize, CNRS ULR, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Le Bras, Y (corresponding author), UMR, Ctr Etude Biol Chize, CNRS ULR, Villiers En Bois, France.	yves.lebras@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020	Baptiste, Picard/0000-0001-9565-9446	 [ANR-11-BSV7-0022];  [ANR-07-VULN-0005]	; 	This work was supported by: http://www.poitou-charentes.fr/accueil.html; http://www.deux-sevres.com/deux-sevres/default.aspx; http://www.agence-nationale-recherche.fr/?Project=ANR-11-BSV7-0022; http://www.agence-nationale-recherche.fr/?Projet=ANR-07-VULN-0005; http://www.fondation.total.com/; https://cnes.fr/fr.	Ainley DG, 2009, ANTARCT SCI, V21, P317, DOI 10.1017/S0954102009001953; [Anonymous], 2014, R LANG ENV STAT COMP; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Barton K., 2016, MUMIN MULTIMODEL INF; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Collins MA, 2006, ADV MAR BIOL, V50, P191, DOI 10.1016/S0065-2881(05)50003-8; Cornick LA, 2003, CAN J ZOOL, V81, P1799, DOI 10.1139/Z03-179; Cribari-Neto F, 2010, BETA REGRESSION IN R; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Della Penna A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18063; Doniol-Valcroze T, 2011, BEHAV ECOL; Dragon A-C, 2011, THESIS; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Sala JE, 2011, POLAR BIOL, V34, P1197, DOI 10.1007/s00300-011-0981-6; Farrell E, 2013, ANIMAL TRACK RECONST; Foo D, 2016, ANIM BEHAV, V112, P127, DOI 10.1016/j.anbehav.2015.11.028; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Gallon S, 2013, DEEP-SEA RES PT II, V88-89, P14, DOI 10.1016/j.dsr2.2012.09.002; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Genin A, 2015, MAR MAMMAL SCI, V31, P1452, DOI 10.1111/mms.12235; Goldbogen JA, 2015, FUNCT ECOL, V29, P951, DOI 10.1111/1365-2435.12395; Guinet C, 1996, ANTARCT SCI, V8, P23, DOI 10.1017/S0954102096000053; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halsey LG, 2007, POLAR BIOL, V30, P991, DOI 10.1007/s00300-007-0257-3; Hanuise N, 2013, J ZOOL, V290, P181, DOI 10.1111/jzo.12026; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hassrick JL, 2007, DEEP-SEA RES PT II, V54, P369, DOI 10.1016/j.dsr2.2006.12.001; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Iwata T, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0227; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Jouma'a J, 2015, FUNCT ECOL; Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kirkman SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152370; KOCK KH, 1987, ENVIRON INT, V13, P37, DOI 10.1016/0160-4120(87)90042-0; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lascelles BG, 2016, DIVERS DISTRIB, V22, P422, DOI 10.1111/ddi.12411; Lawson GL., 2015, ANIM BIOTELEM, V3, P22, DOI [10.1186/s40317-015-0054-7, DOI 10.1186/S40317-015-0054-7]; Le Bras Y., 2016, RBL BIOL TOOLS DIVIN; Lund U., 2012, TOPICS CIRCULAR STAT; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McIntyre T, 2014, AFR J MAR SCI, V36, P409, DOI 10.2989/1814232X.2014.976655; McIntyre T, 2013, POLAR BIOL, V36, P1693, DOI 10.1007/s00300-013-1384-7; McIntyre T, 2011, MAR BIOL, V158, P2125, DOI 10.1007/s00227-011-1719-2; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MCNAMARA J, 1982, THEOR POPUL BIOL, V21, P269, DOI 10.1016/0040-5809(82)90018-1; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Naimi B, 2021, RTS RATER TIME SERIE; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pakhomov E., 2010, REPORT ADVISORY PANE; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Pinheiro J, 2015, NLME LINEAR NONLINEA; Richard G, 2014, J EXP BIOL, V217, P2609, DOI 10.1242/jeb.088542; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; RODHOUSE PG, 1995, BIOL BULL, V189, P77, DOI 10.2307/1542457; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2004, J EXP BIOL, V207, P4057, DOI 10.1242/jeb.01265; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; signal developers, 2013, SIGNAL DEV SIGNAL SI; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Stephens D.W., 1986, pi; Strass VH, 2002, DEEP-SEA RES PT II, V49, P3735, DOI 10.1016/S0967-0645(02)00109-1; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Venables WN., 2007, MODERN APPL STAT S; Viviant M, 2016, FUNCT ECOL; Viviant M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088503; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2006, J EXP BIOL, V209, P3269, DOI 10.1242/jeb.02402; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Williams A, 1997, MAR BIOL, V130, P259, DOI 10.1007/s002270050246; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659	96	19	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167226	10.1371/journal.pone.0167226	http://dx.doi.org/10.1371/journal.pone.0167226			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973587	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300021
J	Zahedi, A; Monis, P; Aucote, S; King, B; Paparini, A; Jian, FC; Yang, RC; Oskam, C; Ball, A; Robertson, I; Ryan, U				Zahedi, Alireza; Monis, Paul; Aucote, Sarah; King, Brendon; Paparini, Andrea; Jian, Fuchun; Yang, Rongchang; Oskam, Charlotte; Ball, Andrew; Robertson, Ian; Ryan, Una			Zoonotic Cryptosporidium Species in Animals Inhabiting Sydney Water Catchments	PLOS ONE			English	Article							SPORADIC HUMAN CRYPTOSPORIDIOSIS; GENETIC-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; QUANTITATIVE PCR; RABBIT GENOTYPE; IDENTIFICATION; GIARDIA; PARVUM; HOMINIS; TRANSMISSION	Cryptosporidium is one of the most common zoonotic waterborne parasitic diseases worldwide and represents a major public health concern of water utilities in developed nations. As animals in catchments can shed human-infectious Cryptosporidium oocysts, determining the potential role of animals in dissemination of zoonotic Cryptosporidium to drinking water sources is crucial. In the present study, a total of 952 animal faecal samples from four dominant species (kangaroos, rabbits, cattle and sheep) inhabiting Sydney's drinking water catchments were screened for the presence of Cryptosporidium using a quantitative PCR (qPCR) and positives sequenced at multiple loci. Cryptosporidium species were detected in 3.6% (21/576) of kangaroos, 7.0% (10/142) of cattle, 2.3% (3/128) of sheep and 13.2% (14/106) of rabbit samples screened. Sequence analysis of a region of the 18S rRNA locus identified C. macropodum and C. hominis in 4 and 17 isolates from kangaroos respectively, C. hominis and C. parvum in 6 and 4 isolates respectively each from cattle, C. ubiquitum in 3 isolates from sheep and C. cuniculus in 14 isolates from rabbits. All the Cryptosporidium species identified were zoonotic species with the exception of C. macropodum. Subtyping using the 5' half of gp60 identified C. hominis IbA10G2 (n = 12) and IdA15G1 (n = 2) in kangaroo faecal samples; C. hominis IbA10G2 (n = 4) and C. parvum IIaA18G3R1 (n = 4) in cattle faecal samples, C. ubiquitum subtype XIIa (n = 1) in sheep and C. cuniculus VbA23 (n = 9) in rabbits. Additional analysis of a subset of samples using primers targeting conserved regions of the MIC1 gene and the 3' end of gp60 suggests that the C. hominis detected in these animals represent substantial variants that failed to amplify as expected. The significance of this finding requires further investigation but might be reflective of the ability of this C. hominis variant to infect animals. The finding of zoonotic Cryptosporidium species in these animals may have important implications for the management of drinking water catchments to minimize risk to public health.	[Zahedi, Alireza; Paparini, Andrea; Yang, Rongchang; Oskam, Charlotte; Robertson, Ian; Ryan, Una] Murdoch Univ, Sch Vet & Life Sci, Vector & Waterborne Pathogen Res Grp, Perth, WA, Australia; [Monis, Paul; King, Brendon] South Australian Water Corp, Australian Water Qual Ctr, Adelaide, SA, Australia; [Monis, Paul; Aucote, Sarah; King, Brendon] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia; [Jian, Fuchun] Henan Agr Univ, Zhengzhou, Henan, Peoples R China; [Ball, Andrew] WaterNSW, Sydney, NSW, Australia	Murdoch University; Flinders University South Australia; Henan Agricultural University	Zahedi, A (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Vector & Waterborne Pathogen Res Grp, Perth, WA, Australia.	a.zahediabdi@murdoch.edu.au	Yang, Rongchang/AAJ-4557-2020; Paparini, Andrea/T-8057-2019; Ball, Andrew S/I-3389-2013; Monis, Paul T/B-8539-2011; Oskam, Charlotte/N-4097-2018	Monis, Paul T/0000-0002-9052-4742; Oskam, Charlotte/0000-0001-8886-2120; Zahedi, Alireza/0000-0002-0165-3797; Robertson, Ian/0000-0002-4255-4752; Paparini, Andrea/0000-0002-1105-5184; Yang, Rongchang/0000-0003-2563-2015; Ryan, Una/0000-0003-2710-9324	Australian Research Council Linkage Grant [LP130100035]; WaterNSW	Australian Research Council Linkage Grant(Australian Research Council); WaterNSW	This study was financially supported by an Australian Research Council Linkage Grant number LP130100035. WaterNSW are an Industry Partner on this ARC Linkage grant and the funder contributed financial support in the form of salaries for authors [AP] and laboratory work. WaterNSW played a significant role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of WaterNSW authors [AB] are articulated in the 'author contributions' section.	Abeywardena H, 2015, ADV PARASIT, V88, P243, DOI 10.1016/bs.apar.2015.02.001; Abeywardena H, 2013, INFECT GENET EVOL, V20, P96, DOI 10.1016/j.meegid.2013.07.019; Abeywardena H, 2013, ELECTROPHORESIS, V34, P2259, DOI 10.1002/elps.201300146; Abeywardena H, 2012, INFECT GENET EVOL, V12, P1984, DOI 10.1016/j.meegid.2012.08.004; Alagappan A, 2008, J MICROBIOL METH, V75, P535, DOI 10.1016/j.mimet.2008.08.007; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; ANOFEL Cryptosporidium National Network, 2010, Euro Surveill, V15, P19642; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Bhalchandra S, 2013, INFECT IMMUN, V81, P3356, DOI 10.1128/IAI.00436-13; Caccio S, 2001, INT J PARASITOL, V31, P1082, DOI 10.1016/S0020-7519(01)00233-8; Chalmers RM, 2011, EMERG INFECT DIS, V17, P536, DOI 10.3201/eid1703.100410; Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; Cinque K, 2008, WATER SCI TECHNOL, V58, P127, DOI 10.2166/wst.2008.632; Cox P, 2005, APPL ENVIRON MICROB, V71, P5929, DOI 10.1128/AEM.71.10.5929-5934.2005; Davies CM, 2003, APPL ENVIRON MICROB, V69, P2842, DOI 10.1128/AEM.69.5.2842-2847.2003; Dowle M, 2013, VET PARASITOL, V198, P197, DOI 10.1016/j.vetpar.2013.08.017; Elwin K, 2012, EPIDEMIOL INFECT, V140, P673, DOI 10.1017/S0950268811000860; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2014, J CLIN MICROBIOL, V52, P524, DOI 10.1128/JCM.02973-13; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Hill NJ, 2008, APPL ENVIRON MICROB, V74, P5549, DOI 10.1128/AEM.00809-08; Holubova N, 2016, PARASITOL RES, V115, P2243, DOI 10.1007/s00436-016-4967-8; Jex AR, 2008, J CLIN MICROBIOL, V46, P2252, DOI 10.1128/JCM.00116-08; Jex AR, 2007, ELECTROPHORESIS, V28, P3875, DOI 10.1002/elps.200700279; Jex AR, 2012, MOL CELL PROBE, V26, P11, DOI 10.1016/j.mcp.2011.10.004; Josephine SYN, 2012, EXP PARASITOL, V130, P437, DOI 10.1016/j.exppara.2012.01.014; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; King BJ, 2005, APPL ENVIRON MICROB, V71, P3848, DOI 10.1128/AEM.71.7.3848-3857.2005; Koehler AV, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0492-8; Koehler AV, 2014, ELECTROPHORESIS, V35, P2600, DOI 10.1002/elps.201400225; Koehler AV, 2013, ELECTROPHORESIS, V34, P1720, DOI 10.1002/elps.201300100; Kvac M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147090; Li N, 2014, EMERG INFECT DIS, V20, P217, DOI 10.3201/eid2002.121797; Li XD, 2015, INT J PARASITOL-PAR, V4, P343, DOI 10.1016/j.ijppaw.2015.08.005; McCarthy S, 2008, EXP PARASITOL, V118, P596, DOI 10.1016/j.exppara.2007.10.014; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Morgan UM, 1997, J PARASITOL, V83, P825, DOI 10.2307/3284275; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Ng J, 2011, EXP PARASITOL, V128, P138, DOI 10.1016/j.exppara.2011.02.013; Ng J, 2011, VET PARASITOL, V176, P145, DOI 10.1016/j.vetpar.2010.10.056; Ng JSY, 2010, EXP PARASITOL, V125, P325, DOI 10.1016/j.exppara.2010.02.012; Ng-Hublin JSY, 2015, EPIDEMIOL INFECT, V143, P1037, DOI 10.1017/S095026881400106X; Ng-Hublin JSY, 2013, J CLIN MICROBIOL, V51, P2463, DOI 10.1128/JCM.00424-13; Nolan MJ, 2013, WATER RES, V47, P1726, DOI 10.1016/j.watres.2012.12.027; Nolan MJ, 2010, INFECT GENET EVOL, V10, P1179, DOI 10.1016/j.meegid.2010.07.020; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Operario DJ, 2015, AM J TROP MED HYG, V92, P45, DOI 10.4269/ajtmh.14-0488; Park Jae-Hwan, 2006, Korean Journal of Parasitology, V44, P27, DOI 10.3347/kjp.2006.44.1.27; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Power ML, 2004, INFECT GENET EVOL, V4, P59, DOI 10.1016/j.meegid.2004.01.002; Power ML, 2011, FEMS MICROBIOL LETT, V314, P34, DOI 10.1111/j.1574-6968.2010.02134.x; Power ML, 2005, APPL ENVIRON MICROB, V71, P6159, DOI 10.1128/AEM.71.10.6159-6164.2005; Puleston RL, 2014, J WATER HEALTH, V12, P41, DOI 10.2166/wh.2013.097; Putignani L, 2008, MOL BIOCHEM PARASIT, V157, P98, DOI 10.1016/j.molbiopara.2007.09.004; Robertson B, 2002, EPIDEMIOL INFECT, V128, P419, DOI 10.1017/S0950268802006933; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Ryan U, 2015, INT J PARASITOL, V45, P367, DOI 10.1016/j.ijpara.2015.01.009; Ryan U, 2012, PARASITOLOGY, V139, P1673, DOI 10.1017/S0031182012001151; Segura R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121753; Sharma P, 2013, INT J INFECT DIS, V 17, pE601, DOI 10.1016/j.ijid.2012.12.003; Silva SOS, 2013, EXP PARASITOL, V135, P551, DOI 10.1016/j.exppara.2013.09.003; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Swaffer BA, 2014, WATER RES, V67, P310, DOI 10.1016/j.watres.2014.08.055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Triggs B., 2004, TRACKS SCATS OTHER T; U. S. Environment Protection Agency, 2012, 1623 US EPA OFF WAT; Vermeulen ET, 2015, INT J PARASITOL-PAR, V4, P190, DOI 10.1016/j.ijppaw.2015.02.005; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7766, DOI 10.1128/AEM.00616-11; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Webber MA, 2014, ZOONOSES PUBLIC HLTH, V61, P324, DOI 10.1111/zph.12074; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5492, DOI 10.1128/AEM.66.12.5492-5498.2000; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2014, INT J PARASITOL, V44, P1105, DOI 10.1016/j.ijpara.2014.08.004; Yang RC, 2014, VET PARASITOL, V200, P50, DOI 10.1016/j.vetpar.2013.11.014; Yang RC, 2013, EXP PARASITOL, V135, P142, DOI 10.1016/j.exppara.2013.06.014; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020; Zahedi A, 2016, INT J PARASITOL-PAR, V5, P88, DOI 10.1016/j.ijppaw.2015.12.001; Zhou L, 2003, J CLIN MICROBIOL, V41, P5254, DOI 10.1128/JCM.41.11.5254-5257.2003	87	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168169	10.1371/journal.pone.0168169	http://dx.doi.org/10.1371/journal.pone.0168169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973572	gold, Green Published, Green Accepted			2022-12-26	WOS:000392754300061
J	Diaz, EH; Yachnin, J; Gronberg, H; Lindberg, J				Diaz, Emanuela Henao; Yachnin, Jeffrey; Gronberg, Henrik; Lindberg, Johan			The In Vitro Stability of Circulating Tumour DNA	PLOS ONE			English	Article							CELL-FREE DNA; PLASMA	Objective DNA from apoptotic cancer cells, present in the circulation, has the potential to facilitate genomic profiling and disease monitoring. However, only low fractions of total cell-free DNA originates from cancer cells, limiting the applicability of circulating tumour DNA (ctDNA). Optimal sample processing is consequently of uttermost importance. Therefore, we evaluated the in vitro stability of ctDNA. Experimental design Blood was collected in 10 ml EDTA or Streck tubes. Three conditions (EDTA and Streck tubes in room temperature, EDTA tubes at five degrees) and four time points (plasma harvested from blood aliquots of each 10 ml tube in a time series up to 24 h) were investigated. Each condition was evaluated in five metastatic prostate cancer patients. Subsequently, three additional patients were collected enabling investigation of the in vitro stability in EDTA tubes up to 48 h. Methods The in vitro stability of ctDNA was interrogated by low-pass whole genome sequencing which allows for the identification of somatic copy-number alterations (CNAs). In silico simulations demonstrated that non-parametric testing could detect a 1% contamination by white blood cell DNA. Mutational profiling was performed by targeted, in-solution based hybridization capture and subsequent sequencing. The allelic fraction of individual mutations was used as an estimate of the in vitro stability. Results Somatic CNAs were detected in all patients. Surprisingly, the ctDNA levels at zero hours were not significantly different to 24 or 48 hour in vitro incubation in any investigated condition. Subsequently, mutational profiling corroborated the conclusions from the CNA analysis. Conclusions The stability of ctDNA simplifies logistics without the requirement of immediate processing or applying fixatives to prevent white blood cell lysis.	[Diaz, Emanuela Henao; Lindberg, Johan] Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden; [Yachnin, Jeffrey] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Yachnin, Jeffrey] Univ Hosp, Stockholm, Sweden; [Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Lindberg, J (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden.	johan.lindberg@ki.se		Lindberg, Johan/0000-0003-3610-6774	AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science [2360/12]; Swedish Research Council [K2010-70X-20430-04-3]; Swedish Cancer Foundation [09-0677]	AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This study was supported by AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science (grant number 2360/12); the Swedish Research Council (grant number K2010-70X-20430-04-3) and the Swedish Cancer Foundation (grant number 09-0677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025202; Buysse K, 2013, CLIN BIOCHEM, V46, P1783, DOI 10.1016/j.clinbiochem.2013.07.020; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Fernando MR, 2010, PRENAT DIAGN, V30; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hodgkinson CL, 2014, NAT MED, P1; Jahr S, 2001, CANCER RES, V61, P1659; Kang Q, 2016, CLIN BIOCHEM, P1; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Le DT, 2015, NEW ENGL J MED; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Newman AM, 2014, NAT MED, P1; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rothwell DG, 2015, MOL ONCOLOGY, P1; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Team R.C, R LANG ENV STAT COMP	27	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168153	10.1371/journal.pone.0168153	http://dx.doi.org/10.1371/journal.pone.0168153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959945	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900040
J	Dietrich, N; Kolibabka, M; Busch, S; Bugert, P; Kaiser, U; Lin, J; Fleming, T; Morcos, M; Klein, T; Schlotterer, A; Hammes, HP				Dietrich, Nadine; Kolibabka, Matthias; Busch, Stephanie; Bugert, Petra; Kaiser, Ulrike; Lin, Jihong; Fleming, Thomas; Morcos, Michael; Klein, Thomas; Schlotterer, Andrea; Hammes, Hans-Peter			The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy	PLOS ONE			English	Article							RECEPTOR AGONISTS; OXIDATIVE STRESS; METHYLGLYOXAL; PATHWAYS; INTERLEUKIN-1-BETA; DEGENERATION; LIRAGLUTIDE; ACTIVATION; BIOLOGY; CELLS	Background/aims Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in type 2 diabetes, however, their influence on the retinal neurovascular unit remains unclear. Methods Vasculo-and neuroprotective effects were assessed in experimental diabetic retinopathy and high glucose-cultivated C. elegans, respectively. In STZ-diabetic Wistar rats (diabetes duration of 24 weeks), DPP4 activity (fluorometric assay), GLP-1 (ELISA), methylglyoxal (LC-MS/MS), acellular capillaries and pericytes (quantitative retinal morphometry), SDF-1a and heme oxygenase-1 (ELISA), HMGB-1, Iba1 and Thy1.1 (immunohistochemistry), nuclei in the ganglion cell layer, GFAP (western blot), and IL-1beta, Icam1, Cxcr4, catalase and beta-actin (quantitative RT-PCR) were determined. In C. elegans, neuronal function was determined using worm tracking software. Results Linagliptin decreased DPP4 activity by 77% and resulted in an 11.5-fold increase in active GLP-1. Blood glucose and HbA(1c) were reduced by 13% and 14% and retinal methylglyoxal by 66%. The increase in acellular capillaries was diminished by 70% and linagliptin prevented the loss of pericytes and retinal ganglion cells. The rise in Iba-1 positive microglia was reduced by 73% with linagliptin. In addition, the increase in retinal Il1b expression was decreased by 65%. As a functional correlate, impairment of motility (body bending frequency) was significantly prevented in C. elegans. Conclusion Our data suggest that linagliptin has a protective effect on the microvasculature of the diabetic retina, most likely due to a combination of neuroprotective and antioxidative effects of linagliptin on the neurovascular unit.	[Dietrich, Nadine; Kolibabka, Matthias; Busch, Stephanie; Bugert, Petra; Kaiser, Ulrike; Lin, Jihong; Morcos, Michael; Schlotterer, Andrea; Hammes, Hans-Peter] Heidelberg Univ, Univ Med Mannheim, Med Dept 5, Mannheim, Germany; [Fleming, Thomas] Heidelberg Univ, Dept Med 1, Heidelberg, Germany; [Klein, Thomas] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Boehringer Ingelheim	Hammes, HP (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Dept 5, Mannheim, Germany.	hp.hammes@umm.de	Schlotterer, Andrea/GWC-7442-2022; Hammes, Hans-Peter/S-3719-2019; Kolibabka, Matthias/T-5812-2017	Kolibabka, Matthias/0000-0001-6741-5436	German Research Foundation (International Research Training group) [880, 1874]; German Research Foundation (Collaborative Research Center 1118) [GRK 1874-1]; Boehringer Ingelheim	German Research Foundation (International Research Training group); German Research Foundation (Collaborative Research Center 1118); Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by fellowships from the German Research Foundation (International Research Training group 880 and 1874), a grant from the German Research Foundation (Collaborative Research Center 1118, Project C03), "Reactive metabolites as cause of diabetic complications" and GRK 1874-1 "DIAMICOM", and a grant from Boehringer Ingelheim; https://www.klinikum.uni-heidelberg.de/Willkommen.132204.0.html, http://www.umm.uni-heidelberg.de/ag/grk880/, http://www.umm.uni-heidelberg.de/ag/grk1874/. The funder provided support in the form of salaries for authors ND and PB. The specific roles of these authors are articulated in the 'author contribution' section.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Castilho AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042428; Chrysant SG, 2012, AM J CARDIOL, V109, P1681, DOI 10.1016/j.amjcard.2012.01.398; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Giacco F, 2015, DIABETES, V64, P3273, DOI 10.2337/db15-0084; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giordano CR, 2015, INVEST OPHTH VIS SCI, V56, P3095, DOI 10.1167/iovs.14-16194; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Haluzik M, 2013, INT J ENDOCRINOL, V2013, DOI [10.1155/2013/, DOI 10.1155/2013/985102]; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hernandez C, 2016, DIABETES, V65, P172, DOI 10.2337/db15-0443; Ishibashi Y, 2010, BIOCHEM BIOPH RES CO, V391, P1405, DOI 10.1016/j.bbrc.2009.12.075; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Kroller-Schon S, CARDIOVASC RES; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Lu M, 1999, INVEST OPHTH VIS SCI, V40, P1808; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Mendler M, 2012, EXP CLIN ENDOCR DIAB, V120, P182, DOI 10.1055/s-0032-1304570; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mustata GT, 2005, DIABETES, V54, P517, DOI 10.2337/diabetes.54.2.517; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schwartz EA, 2010, ATHEROSCLEROSIS, V212, P217, DOI 10.1016/j.atherosclerosis.2010.05.028; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Takai S, 2014, J PHARM SCI; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wang J, 2014, ACTA DIABETOL, V51, P813, DOI 10.1007/s00592-014-0616-9; Wang Q, 2011, CELL PHYSIOL BIOCHEM, V27, P769, DOI 10.1159/000330085; Wongchai K, 2016, HORM METAB RES, V48, P70, DOI 10.1055/s-0035-1549876; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7	49	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167853	10.1371/journal.pone.0167853	http://dx.doi.org/10.1371/journal.pone.0167853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942008	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600035
J	Herring, G; Eagles-Smith, CA; Wagner, MT				Herring, Garth; Eagles-Smith, Collin A.; Wagner, Mason T.			Ground Squirrel Shooting and Potential Lead Exposure in Breeding Avian Scavengers	PLOS ONE			English	Article							COEUR-DALENE RIVER; BULLET FRAGMENTS; RIFLE BULLETS; PB EXPOSURE; BLOOD-LEAD; GROWTH; WILDLIFE; EAGLES; SHOT; APPLICABILITY	Recreational ground squirrel shooting is a popular activity throughout the western United States and serves as a tool for managing ground squirrel populations in agricultural regions. Belding's ground squirrels (Spermophilus beldingi) are routinely shot in California, Nevada, and Oregon across habitats that overlap with breeding avian scavengers. Ground squirrels shot with lead (Pb)-based bullets may pose a risk to avian scavengers if they consume carcasses containing Pb fragments. To assess the potential risk to breeding avian scavengers we developed a model to estimate the number, mass, and distribution of Pb fragments in shot ground squirrels using radiographic images. Eighty percent of shot carcasses contained detectible Pb fragments with an average of 38.6 mg of Pb fragments. Seven percent of all carcasses contained Pb fragment masses exceeding a lethal dose for a model raptor nestling (e.g. American kestrel Falco sparverius). Bullet type did not influence the number of fragments in shot ground squirrels, but did influence the mass of fragments retained. Belding's ground squirrels shot with .17 Super Mag and unknown ammunition types contained over 28 and 17 times more mass of Pb fragments than those shot with .22 solid and .22 hollow point bullets, respectively. Ground squirrel body mass was positively correlated with both the number and mass of Pb fragments in carcasses, increasing on average by 76% and 56% respectively across the range of carcass masses. Although the mass of Pb retained in ground squirrel carcasses was small relative to the original bullet mass, avian scavenger nestlings that frequently consume shot ground squirrels may be at risk for Pb-induced effects (e.g., physiology, growth, or survival). Using modeling efforts we found that if nestling golden eagles (Aquila chrysaetos), red-tailed hawks (Buteo jamaicensis), and Swainson's hawks (B. swainsoni) consumed shot ground squirrels proportionately to the nestling's mass, energy needs, and diet, 100% of the nestling period would exceed a 50% reduction in delta-aminolevulinic acid dehydratase production threshold, the last 13-27% of the nestling stage would exceed a reduced growth rate threshold, but no nestlings would be expected to exceed a level of Pb ingestion that would be lethal.	[Herring, Garth; Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA; [Wagner, Mason T.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	United States Department of the Interior; United States Geological Survey; Oregon State University	Herring, G (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA.	gherring@usgs.gov	Herring, Garth/AAF-6604-2019; Eagles-Smith, Collin/AAH-3811-2019; Eagles-Smith, Collin/T-8580-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Herring, Garth/0000-0003-1106-4731	Western Golden Eagle Conservation Strategy; U.S. Fish and Wildlife Service [4500063135]; U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program)	Western Golden Eagle Conservation Strategy; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program)	This research was funded by the Western Golden Eagle Conservation Strategy, U.S. Fish and Wildlife Service (Grant number: 4500063135, Grantee: CAE), and U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CONSERVATION BLACK T; BARLTROP D, 1979, ARCH ENVIRON HEALTH, V34, P280, DOI 10.1080/00039896.1979.10667414; Bechard MJ, 2010, SWAINSONS HAWK BUTEO; Behmke S, 2015, ENVIRON INT, V79, P51, DOI 10.1016/j.envint.2015.03.010; Berglund AMM, 2010, ENVIRON POLLUT, V158, P1368, DOI 10.1016/j.envpol.2010.01.005; Bingham RJ, 2015, WILDLIFE SOC B, V39, P94, DOI 10.1002/wsb.527; BURGER J, 1994, FUND APPL TOXICOL, V23, P553, DOI 10.1006/faat.1994.1140; Caudell JN, 2013, WILDLIFE SOC B, V37, P824, DOI 10.1002/wsb.311; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Chase L, 2016, PLOS ONE, V10; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Cochrane JF, 2015, ECOL APPL, V25, P1518, DOI 10.1890/14-0996.1; COLLOPY MW, 1984, AUK, V101, P753, DOI 10.2307/4086902; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Cruz-Martinez L, 2015, HUM-WILDL INTERACT, V9, P211; Douglas-Stroebel E, 2004, ENVIRON POLLUT, V131, P215, DOI 10.1016/j.envpol.2004.02.002; DUKE GE, 1976, COMP BIOCHEM PHYS A, V53, P1, DOI 10.1016/S0300-9629(76)80001-1; Fair JM, 2002, ARCH ENVIRON CON TOX, V42, P77; Finkelstein ME, 2003, ENVIRON SCI TECHNOL, V37, P3256, DOI 10.1021/es026272e; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Franson JC, 2014, ECOTOXICOLOGY, V23, P1722, DOI 10.1007/s10646-014-1337-0; Franson JC, 2003, WATERBIRDS, V26, P345, DOI 10.1675/1524-4695(2003)026[0345:LFWAOF]2.0.CO;2; FRANSON JC, 1982, VET HUM TOXICOL, V24, P421; GRUE CE, 1986, ENVIRON POLLUT A, V42, P157, DOI 10.1016/0143-1471(86)90005-X; Haig SM, 2014, CONDOR, V116, P408, DOI 10.1650/CONDOR-14-36.1; Hansen James A., 2011, Integrated Environmental Assessment and Management, V7, P587, DOI 10.1002/ieam.201; Harmata A. R., 1995, INTERMT J SCI, V1, P1; HENNY CJ, 1994, ENVIRON MONIT ASSESS, V29, P267, DOI 10.1007/BF00547991; Hoffman DJ, ARCH ENV CONTAM TOXI, V14, P89; Hoogland JL, 2003, J MAMMAL, V84, P1254, DOI 10.1644/BME-008; HOOGLAND JL, 2003, WILD MAMMALS N AM BI, P232; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; KALINOWSKI S A, 1981, Wildlife Society Bulletin, V9, P268; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Kochert M. N., 2002, GOLDEN EAGLE AQUILA; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; LAWLER EM, 1991, ARCH ENVIRON CON TOX, V21, P78, DOI 10.1007/BF01055560; Legagneux P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111546; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Mateo R, 2014, ENVIRON INT, V63, P163, DOI 10.1016/j.envint.2013.11.006; McBride TJ, 2004, J RAPTOR RES, V38, P118; Mills L. S., 2012, CONSERVATION WILDLIF; Nadjafzadeh M, 2015, EUR J WILDLIFE RES, V61, P763, DOI 10.1007/s10344-015-0953-1; OLENDORFF RR, 1974, CONDOR, V76, P466, DOI 10.2307/1365822; PARKER JW, 1976, CONDOR, V78, P557, DOI 10.2307/1367108; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; PLATT J B, 1976, American Birds, V30, P783; Pokras Mark A., 2009, P283; Preston CR, 2009, RED TAILED HAWK BUTE; R Development Core Team, 2012, R LANG ENV STAT COMP; REDIG PT, 1991, ARCH ENVIRON CON TOX, V21, P72, DOI 10.1007/BF01055559; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; SCHMUTZ J K, 1989, Journal of Raptor Research, V23, P147; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; Schulz JH, 2006, J WILDLIFE MANAGE, V70, P413, DOI 10.2193/0022-541X(2006)70[413:ALTIMD]2.0.CO;2; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; SPRINGER MA, 1983, OHIO J SCI, V83, P13; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Stephens Robert M., 2007, Intermountain Journal of Sciences, V13, P116; Stewart WF, 1999, NEUROLOGY, V52, P1610, DOI 10.1212/WNL.52.8.1610; USDA United Stated Department of Agriculture, 2015, CROP PRODUCTION; Vallverdu-Coll N, 2015, ENVIRON SCI TECHNOL, V49, P3839, DOI 10.1021/es505148d; Vermeulen A, 2015, SCI TOTAL ENVIRON, V508, P297, DOI 10.1016/j.scitotenv.2014.11.095; Vosburgh TC, 1998, J WILDLIFE MANAGE, V62, P363, DOI 10.2307/3802300; Whisson DA, 1999, WILDLIFE SOC B, V27, P178; Whisson DA, 2000, P USDA NAT WILDL RES, P104; White C, 2006, J WILDLIFE MANAGE, V70, P539, DOI 10.2193/0022-541X(2006)70[539:IEOEHO]2.0.CO;2; Whitfield DP, 2004, BIOL CONSERV, V118, P249, DOI 10.1016/j.biocon.2003.09.003	71	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167926	10.1371/journal.pone.0167926	http://dx.doi.org/10.1371/journal.pone.0167926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942006	gold, Green Submitted, Green Published			2022-12-26	WOS:000392745600039
J	Arffa, ML; Zapf, MA; Kothari, AN; Chang, V; Gupta, GN; Ding, X; Al-Gayyar, MM; Syn, W; Elsherbiny, NM; Kuo, PC; Mi, Z				Arffa, M. L.; Zapf, M. A.; Kothari, A. N.; Chang, V.; Gupta, G. N.; Ding, X.; Al-Gayyar, M. M.; Syn, W.; Elsherbiny, N. M.; Kuo, P. C.; Mi, Z.			Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis	PLOS ONE			English	Article							GREEN TEA CATECHINS; FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; OXIDATIVE STRESS; EXPRESSION; GALLATE; RNA; CELLS; MODEL	Osteopontin (OPN) promotes hepatic fibrosis, and developing therapies targeting OPN expression in settings of hepatic injury holds promise. The polyphenol epigallocatechin-3-gallate (EGCG), found in high concentrations in green tea, downregulates OPN expression through OPN mRNA degradation, but the mechanism is unknown. Previous work has shown that microRNAs can decrease OPN mRNA levels, and other studies have shown that EGCG modulates the expression of multiple microRNAs. In our study, we first demonstrated that OPN induces hepatic stellate cells to transform into an activated state. We then identified three microRNAs which target OPN mRNA: miR-181a, miR-10b, and miR-221. In vitro results show that EGCG upregulates all three microRNAs, and all three microRNAs are capable of down regulating OPN mRNA when administered alone. Interestingly, only miR-221 is necessary for EGCG-mediated OPN mRNA degradation and miR-221 inhibition reduces the effects of EGCG on cell function. In vivo experiments show that thioacetamide (TAA)-induced cell cytotoxicity upregulates OPN expression; treatment with EGCG blocks the effects of TAA. Furthermore, chronic treatment of EGCG in vivo upregulates all three microRNAs equally, suggesting that in more chronic treatment all three microRNAs are involved in modulating OPN expression. We conclude that in in vitro and in vivo models of TAA-induced hepatic fibrosis, EGCG inhibits OPN-dependent injury and fibrosis. EGCG works primarily by upregulating miR-221 to accelerate OPN degradation. EGCG may therefore have utility as a protective agent in settings of liver injury.	[Arffa, M. L.; Zapf, M. A.; Kothari, A. N.; Chang, V.; Gupta, G. N.; Ding, X.; Kuo, P. C.; Mi, Z.] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA; [Al-Gayyar, M. M.; Elsherbiny, N. M.] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura, Egypt; [Syn, W.] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA; [Syn, W.] Ralph H Johnson Vet Affairs Med Ctr, Gastroenterol Sect, Charleston, SC USA; [Al-Gayyar, M. M.] Univ Tabuk, Dept Pharmaceut Chem, Tabuk, Saudi Arabia	Loyola University Chicago; Egyptian Knowledge Bank (EKB); Mansoura University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Tabuk	Kuo, PC (corresponding author), Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA.	pkuo@lumc.edu	elsherbiny, nehal N/M-5006-2018; Syn, Wing-Kin/AAB-8406-2020; Zapf, Matthew/GRS-0086-2022; Elsherbiny, Nehal/AAF-9206-2019; Al-Gayyar, Mohammed M H/E-8250-2014	elsherbiny, nehal N/0000-0001-5167-3377; Elsherbiny, Nehal/0000-0001-5167-3377; Al-Gayyar, Mohammed M H/0000-0003-4777-3919; Zapf, Matthew/0000-0001-5544-8900; Arffa, Matthew/0000-0002-9539-9100				Ahn JI, 2010, MOL CELL TOXICOL, V6, P169, DOI 10.1007/s13273-010-0024-3; Arola-Arnal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025982; Arriazu E., 2016, GUT; Baselga-Escudero L, 2014, NUCLEIC ACIDS RES, V42, P882, DOI 10.1093/nar/gkt1011; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549; Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484; Coombes JD, 2015, BIOCH BIOPHYS ACTA; Darweish MM, 2014, J PHARM PHARMACOL, V66, P1032, DOI 10.1111/jphp.12229; Ding Y, 2015, EUR J PHARMACOL, V761, P405, DOI 10.1016/j.ejphar.2015.05.005; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Hung GD, 2012, J FORMOS MED ASSOC, V111, P550, DOI 10.1016/j.jfma.2011.06.026; John K, 2014, HEPATOLOGY, V60, P1346, DOI 10.1002/hep.27250; Kim HK, 2009, WORLD J GASTROENTERO, V15, P5200, DOI 10.3748/wjg.15.5200; Koelz M, 2011, INT J ONCOL, V38, P503, DOI 10.3892/ijo.2010.857; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuzuhara T, 2007, MOL CARCINOGEN, V46, P640, DOI 10.1002/mc.20332; Kuzuhara T, 2006, J BIOL CHEM, V281, P17446, DOI 10.1074/jbc.M601196200; Leung TM, 2013, LAB INVEST, V93, P1082, DOI 10.1038/labinvest.2013.104; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Matsue Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118744; Mi ZY, 2009, MOL THER, V17, P153, DOI 10.1038/mt.2008.235; Milenkovic D, 2012, PLOS ONE, V7, P156, DOI 10.1371/journal.pone.0029837; Oh K, 2015, IMMUNE NETW, V15, P142, DOI 10.4110/in.2015.15.3.142; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Safer AM, 2015, EXP THER MED, V9, P787, DOI 10.3892/etm.2014.2158; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Santamarina AB, 2015, J NUTR BIOCHEM, V26, P1348, DOI 10.1016/j.jnutbio.2015.07.002; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Shen CJ, 2014, BIOMED RES INT, V2014; Simao A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0307-1; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sriram N, 2015, CLIN EXP PHARMACOL P, V42, P849, DOI 10.1111/1440-1681.12428; Strazzabosco M, 2014, GUT, V63, P1693, DOI 10.1136/gutjnl-2014-307712; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Torres AG, 2011, RNA, V17, P933, DOI 10.1261/rna.2533811; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; Ui A, 2009, CANCER CAUSE CONTROL, V20, P1939, DOI 10.1007/s10552-009-9388-x; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Wang XD, 2014, GUT, V63, P1805, DOI 10.1136/gutjnl-2013-306373; Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8; Yamada S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19225; Yang JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114533; Yin XR, 2015, INT J CLIN EXP MED, V8, P8339; Yuan JM, 2013, AM J CLIN NUTR, V98, p1676S, DOI 10.3945/ajcn.113.058271; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zapf MAC, 2015, SURGERY, V158, P1039, DOI 10.1016/j.surg.2015.06.011; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003	57	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167435	10.1371/journal.pone.0167435	http://dx.doi.org/10.1371/journal.pone.0167435			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935974	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100097
J	Colard, T; Falgayrac, G; Bertrand, B; Naji, S; Devos, O; Balsack, C; Delannoy, Y; Penel, G				Colard, Thomas; Falgayrac, Guillaume; Bertrand, Benoit; Naji, Stephan; Devos, Olivier; Balsack, Clara; Delannoy, Yann; Penel, Guillaume			New Insights on the Composition and the Structure of the Acellular Extrinsic Fiber Cementum by Raman Analysis	PLOS ONE			English	Article							COLLAGEN FIBRILS; MECHANICAL-PROPERTIES; CHEMICAL-COMPOSITION; DENTAL CEMENTUM; AGE ESTIMATION; BONE; ORIENTATION; ANNULATION; ULTRASTRUCTURE; ARCHITECTURE	Acellular extrinsic fiber cementum is a mineralized tissue that covers the cervical half of the tooth root surface. It contains mainly extrinsic or Sharpey's fibers that run perpendicular to the root surface to anchor the tooth via the periodontal ligament. Acellular cementum is continuously and slowly produced throughout life and exhibits an alternating bright and dark pattern under light microscopy. However, although a better understanding of the structural background of acellular cementum is relevant to many fields, such as cementochronology, periodontology and tissue engineering, acellular cementum remains rarely studied and poorly understood. In this work, we studied the acellular cementum at the incremental line scale of five human mandibular canines using polarized Raman spectroscopy. We provided Raman imaging analysis and polarized acquisitions as a function of the angular orientation of the sample. The results showed that mineral crystals were always parallel to collagen fibrils, and at a larger scale, we proposed an organizational model in which we found radial collagen fibers, "orthogonal" to the cementum surface, and "non-orthogonal" fibers, which consist of branching and bending radial fibers. Concerning the alternating pattern, we observed that the dark lines corresponded to smaller, more mineralized and probably more organized bands, which is consistent with the zoological assumption that incremental lines are produced during a winter rest period of acellular cementum growth.	[Colard, Thomas; Bertrand, Benoit; Balsack, Clara; Delannoy, Yann] Univ Lille, CHU Lille, UTML, EA 7367, Lille, France; [Falgayrac, Guillaume; Penel, Guillaume] Univ Lille, PMOI, EA 4490, Lille, France; [Naji, Stephan] NYU, CIRHUS, New York, NY USA; [Devos, Olivier] Univ Lille, CNRS, LASIR Lab Spectrochim & Raman, UMR 8516, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille	Colard, T (corresponding author), Univ Lille, CHU Lille, UTML, EA 7367, Lille, France.	thomas.colard@univ-lille2.fr	, Falgayrac/O-2917-2013; Devos, Olivier/B-3974-2009; naji, Stephan/AAF-6478-2019	, Falgayrac/0000-0003-1806-1509; Devos, Olivier/0000-0002-3354-0420; naji, Stephan/0000-0003-1396-3204; Bertrand, Benoit/0000-0001-7640-6929; Colard, Thomas/0000-0002-2235-6759				Aboulfadl H, 2015, J STRUCT BIOL, V192, P67, DOI 10.1016/j.jsb.2015.08.011; Bertrand B, 2015, INT J PALEO IN PRESS; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; Cape AT, 1930, J AM DENT ASSOC, V17, P193, DOI [10.14219/JADA.ARCHIVE.1930.0047, DOI 10.14219/JADA.ARCHIVE.1930.0047]; Catros S, 2008, J PERIODONTOL, V79, P1095, DOI [10.1902/jop.2008.070482, 10.1902/jop.2008.070482 ]; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Colard T, 2018, INT J LEGAL MED, V132, P1117, DOI 10.1007/s00414-015-1172-8; Cool SM, 2002, BONE, V30, P386, DOI 10.1016/S8756-3282(01)00686-X; Falgayrac G, 2012, ANAL CHEM, V84, P9116, DOI 10.1021/ac301758y; Falgayrac G, 2010, APPL SPECTROSC, V64, P775, DOI 10.1366/000370210791666255; Foster BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038393; FURSETH R, 1968, ARCH ORAL BIOL, V13, P1197, DOI 10.1016/0003-9969(68)90075-7; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Gamsjaeger S, 2010, BONE, V47, P392, DOI 10.1016/j.bone.2010.04.608; Gauthier J, 2013, HOMO, V64, P42, DOI 10.1016/j.jchb.2012.11.001; Gebhardt FS., 1905, ROUX ARCH, V20, P187; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; HALS E, 1977, CARIES RES, V11, P62, DOI 10.1159/000260250; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; Ho SP, 2009, ACTA BIOMATER, V5, P707, DOI 10.1016/j.actbio.2008.08.013; Jones SJ, 1981, DENT ANATOMY EMBRYOL; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; LAWS RM, 1952, NATURE, V169, P972, DOI 10.1038/169972b0; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; Maat GJR, 2006, FORENSIC SCI INT, V159, pS95, DOI 10.1016/j.forsciint.2006.02.038; Mandair GS, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.115; MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402; Masic A, 2011, BIOMACROMOLECULES, V12, P3989, DOI 10.1021/bm201008b; Naji S, 2015, INT J PALEO IN PRESS; Raspanti M, 2000, ARCH ORAL BIOL, V45, P185, DOI 10.1016/S0003-9969(99)00145-4; Renz H, 1997, Adv Dent Res, V11, P472; Reznikov N, 2014, ACTA BIOMATER, V10, P3815, DOI 10.1016/j.actbio.2014.05.024; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Ritz C, 2008, USE R, P1; Saygin NE, 2000, PERIODONTOL 2000, V24, P73, DOI 10.1034/j.1600-0757.2000.2240105.x; Schroeder H.E., 1986, HDB MICROSCOPIC ANAT, VV/5, P246; Schrof S, 2014, J STRUCT BIOL, V187, P266, DOI 10.1016/j.jsb.2014.07.001; Schug GR, 2012, HOMO, V63, P94, DOI 10.1016/j.jchb.2012.01.002; SELVIG KA, 1977, J PERIODONTAL RES, V12, P419, DOI 10.1111/j.1600-0765.1977.tb00137.x; SMITH KG, 1994, J MAMMAL, V75, P406, DOI 10.2307/1382560; SONI NN, 1962, J PERIODONTOL, V33, P372, DOI 10.1902/jop.1962.33.4.372; STOTT GG, 1982, J DENT RES, V61, P814, DOI 10.1177/00220345820610063401; Team RC, 2014, R LANG ENV STAT COMP; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Wittwer-Backofen U, 2004, AM J PHYS ANTHROPOL, V123, P119, DOI 10.1002/ajpa.10303; Yamamoto H, 2009, J HARD TISSUE BIOL, V18, P41; Yamamoto T, 1997, ANAT EMBRYOL, V196, P115, DOI 10.1007/s004290050084; Yamamoto T, 2012, J ELECTRON MICROSC, V61, P113, DOI 10.1093/jmicro/dfs033; Yamamoto T, 2010, ODONTOLOGY, V98, P102, DOI 10.1007/s10266-010-0134-3	50	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167316	10.1371/journal.pone.0167316	http://dx.doi.org/10.1371/journal.pone.0167316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936010	gold, Green Published			2022-12-26	WOS:000389587100083
J	Dipnall, JF; Pasco, JA; Berk, M; Williams, LJ; Dodd, S; Jacka, FN; Meyer, D				Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.; Meyer, Denny			Into the Bowels of Depression: Unravelling Medical Symptoms Associated with Depression by Applying Machine-Learning Techniques to a Community Based Population Sample	PLOS ONE			English	Article							LOGISTIC-REGRESSION; DIETARY PATTERNS; GUT; MICROBIOME; MECHANISMS; DISORDERS; HEALTH; IMPACT	Background Depression is commonly comorbid with many other somatic diseases and symptoms. Identification of individuals in clusters with comorbid symptoms may reveal new pathophysiological mechanisms and treatment targets. The aim of this research was to combine machine-learning (ML) algorithms with traditional regression techniques by utilising self-reported medical symptoms to identify and describe clusters of individuals with increased rates of depression from a large cross-sectional community based population epidemiological study. Methods A multi-staged methodology utilising ML and traditional statistical techniques was performed using the community based population National Health and Nutrition Examination Study (2009 - 2010) (N = 3,922). A Self-organised Mapping (SOM) ML algorithm, combined with hierarchical clustering, was performed to create participant clusters based on 68 medical symptoms. Binary logistic regression, controlling for sociodemographic confounders, was used to then identify the key clusters of participants with higher levels of depression (PHQ-9 >= 10, n = 377). Finally, a Multiple Additive Regression Tree boosted ML algorithm was run to identify the important medical symptoms for each key cluster within 17 broad categories: heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain, blood pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels and urinary. Results Five clusters of participants, based on medical symptoms, were identified to have significantly increased rates of depression compared to the cluster with the lowest rate: odds ratios ranged from 2.24 ( 95% CI 1.56, 3.24) to 6.33 ( 95% CI 1.67, 24.02). The ML boosted regression algorithm identified three key medical condition categories as being significantly more common in these clusters: bowel, pain and urinary symptoms. Bowel- related symptoms was found to dominate the relative importance of symptoms within the five key clusters. Conclusion This methodology shows promise for the identification of conditions in general populations and supports the current focus on the potential importance of bowel symptoms and the gut in mental health research.	[Dipnall, Joanna F.; Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal; Jacka, Felice N.] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic, Australia; [Dipnall, Joanna F.; Meyer, Denny] Swinburne Univ Technol, Dept Stat, Data Sci & Epidemiol, Melbourne, Vic, Australia; [Pasco, Julie A.] Univ Melbourne, Melbourne Clin School, Western Campus, St Albans, Vic, Australia; [Pasco, Julie A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Pasco, Julie A.; Berk, Michael; Williams, Lana J.; Dodd, Seetal] Univ Hosp Geelong, Geelong, Vic, Australia; [Berk, Michael; Dodd, Seetal; Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Berk, Michael; Dodd, Seetal] Natl Ctr Excellence Youth Mental Hlth, Orygen, Parkville, Vic, Australia; [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia	Deakin University; Swinburne University of Technology; University of Melbourne; Monash University; Geelong Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; Murdoch Children's Research Institute; Black Dog Institute	Dipnall, JF (corresponding author), Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic, Australia.; Dipnall, JF (corresponding author), Swinburne Univ Technol, Dept Stat, Data Sci & Epidemiol, Melbourne, Vic, Australia.	jdipnall@deakin.edu.au	Jacka, Felice N/ABE-6322-2020; Berk, Michael/M-7891-2013; Jacka, Felice N/D-9424-2012; Berk, Michael/M-3585-2019	Jacka, Felice N/0000-0002-9825-0328; Berk, Michael/0000-0002-5554-6946; Jacka, Felice N/0000-0002-9825-0328; Berk, Michael/0000-0002-5554-6946; Dipnall, Joanna/0000-0001-7543-0687; Williams, Lana/0000-0002-1377-1272	NHMRC [1059660, 1064272, 1108125, GNT1064272]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	MB is supported by a NHMRC Senior Principal Research Fellowship 1059660. LJW is supported by a NHMRC Career Development Fellowship 1064272. FNJ is supported by an NHMRC Career Development Fellowship 1108125. The author(s) received no specific funding for this work.; LJW is supported by a NHMRC Career Development Fellowship (GNT1064272).	Abu Abbas O, 2008, INT ARAB J INF TECHN, V5, P320; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; [Anonymous], 2009, NAT HLTH NUTR EX SUR; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Arnrich B, 2010, MACHINE LEARNING ASS, V45; Berry M.J.A., 2011, DATA MINING TECHNIQU; Black MM, 2004, PEDIATRICS, V114, P169, DOI 10.1542/peds.114.1.169; Bureau U.S.C., 2008, CURRENT POPULATION S; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Chaovalitwongse W, 2010, SPRINGER SER OPTIM A, V38, P1, DOI 10.1007/978-0-387-88630-5; Chekroud AM, 2016, LANCET PSYCHIAT; Crofts DJ, 1999, ACTA PAEDIATR, V88, P969, DOI 10.1080/08035259950168478; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dash S, 2015, CURR OPIN PSYCHIATR, V28, P1, DOI 10.1097/YCO.0000000000000117; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dipnall J, 2017, EUR PSYCHIAT, V39, P40; Dipnall JF, 2014, DATA INTEGRATION PRO; Dipnall JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148195; Dipnall JF, 2015, J AFFECT DISORDERS, V174, P215, DOI 10.1016/j.jad.2014.11.030; Eshghi A., 2011, J DATA SCI, V9, P271, DOI [10.6339/JDS.201104_09(2).0009, DOI 10.6339/JDS.201104_09(2).0009]; Fernandes BS, 2016, DRUG AGING, V33, P21, DOI 10.1007/s40266-015-0323-4; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Freund Y., 1999, JAPANESE SOC ART INT, V14, P1612; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman J, 2001, SPRINGER SERIES STAT, V10; Gabor AJ, 1996, ELECTROEN CLIN NEURO, V99, P257, DOI 10.1016/0013-4694(96)96001-0; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; HARRIS B, 1992, BMJ-BRIT MED J, V305, P152, DOI 10.1136/bmj.305.6846.152; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Jacka FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087657; Joanna F, 2016, EUR PSYCHIAT; Kapfhammer Hans-Peter, 2006, Dialogues Clin Neurosci, V8, P227; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kohenen T., 1997, LECT NOTES INFORM SC, V30; Kohn H.F., 2014, WILEY STATSREF STAT, P1, DOI [10.1002/9781118445112.stat02449, DOI 10.1002/9781118445112.STAT02449]; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS, P501; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kronish IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052771; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maes M, 2012, J AFFECT DISORDERS, V141, P55, DOI 10.1016/j.jad.2012.02.023; Magdolen J, 1997, PSYCHIAT RES-NEUROIM, V68, P171; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Mitchell TM, 1997, MACH LEARN, P45; Monteith S, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-016-0051-7; Mykletun A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-88; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Olver JS, 2013, MED J AUSTRALIA, V199, P9, DOI 10.5694/mjao12.10597; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Sanna L, 2014, J AFFECT DISORDERS, V155, P261, DOI 10.1016/j.jad.2013.11.009; Sanna L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-194; Sanna L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-110; Schonlau M, 2005, STATA J, V5, P330, DOI 10.1177/1536867X0500500304; Seref O, 2007, DATA MINING SYSTEMS; Shim L, 2013, SCAND J GASTROENTERO, V48, P295, DOI 10.3109/00365521.2012.758767; Shim RS, 2011, J AM BOARD FAM MED, V24, P33, DOI 10.3122/jabfm.2011.01.100121; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Tran T, 2015, KNOWL INF SYST, V43, P555, DOI 10.1007/s10115-014-0740-4; Van Hulle MM, 2012, SELF ORGANIZING MAPS, P585; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Wehrens R, 2007, J STAT SOFTW, V21, P1; Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	70	11	13	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167055	10.1371/journal.pone.0167055	http://dx.doi.org/10.1371/journal.pone.0167055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935995	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100056
J	Hamad, HA; Thurston, J; Teague, T; Ackad, E; Yousef, MS				Hamad, Hamzah A.; Thurston, Jeremy; Teague, Thomas; Ackad, Edward; Yousef, Mohammad S.			The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MOLECULAR-DYNAMICS SIMULATIONS; SWISS-MODEL; PEGYLATED INTERFERON; COMPLEX-FORMATION; IN-VITRO; INHIBITORS; PROTEINASE; RESISTANCE; ACTIVATION	We are developing a 4D computational methodology, based on 3D structure modeling and molecular dynamics simulation, to analyze the active site of HCV NS3 proteases, in relation to their catalytic activity. In our previous work, the 4D analyses of the interactions between the catalytic triad residues (His57, Asp81, and Ser139) yielded divergent, gradual and genotype -dependent, 4D conformational instability measures, which strongly correlate with the known disparate catalytic activities among genotypes. Here, the correlation of our 4D geometrical measure is extended to intra-genotypic alterations in NS3 protease activity, due to sequence variations in the NS4A activating cofactor. The correlation between the 4D measure and the enzymatic activity is qualitatively evident, which further validates our methodology, leading to the development of an accurate quantitative metric to predict protease activity in silico. The results suggest plausible "communication" pathways for conformational propagation from the activation subunit (the NS4A cofactor binding site) to the catalytic subunit (the catalytic triad). The results also strongly suggest that the well-sampled (via convergence quantification) structural dynamics are more connected to the divergent catalytic activity observed in HCV NS3 proteases than to rigid structures. The method could also be applicable to predict patients' responses to interferon therapy and better understand the innate interferon activation pathway.	[Hamad, Hamzah A.; Thurston, Jeremy; Teague, Thomas; Ackad, Edward; Yousef, Mohammad S.] Southern Illinois Univ Edwardsville, Coll Arts & Sci, Dept Phys, Edwardsville, IL 62026 USA; [Yousef, Mohammad S.] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt	Southern Illinois University System; Southern Illinois University Edwardsville; Egyptian Knowledge Bank (EKB); Cairo University	Yousef, MS (corresponding author), Southern Illinois Univ Edwardsville, Coll Arts & Sci, Dept Phys, Edwardsville, IL 62026 USA.; Yousef, MS (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.	myousef@siue.edu	Ackad, Edward/AAD-1947-2021	Yousef, Mohammad/0000-0003-0492-7658	SIUE's URCA program; AFOSR [FA9550-14-1-0247]	SIUE's URCA program; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	T. Teague, H. Hamad and J. Thurston were supported by SIUE's URCA program. E. Ackad is supported by AFOSR award No FA9550-14-1-0247.	Anjum S, 2013, J INFECT DIS, V208, P1888, DOI 10.1093/infdis/jit376; Anwar MI, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-351; Aparicio E, 2011, J VIROL, V85, P5961, DOI 10.1128/JVI.00308-11; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbato G, 2000, EMBO J, V19, P1195, DOI 10.1093/emboj/19.6.1195; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Butkiewicz NJ, 1996, VIROLOGY, V225, P328, DOI 10.1006/viro.1996.0607; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Cerny A, 1999, HEPATOLOGY, V30, P595, DOI 10.1002/hep.510300312; Chatel-Chaix L, 2010, VIRUSES-BASEL, V2, P1752, DOI 10.3390/v2081752; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Du GX, 2002, WORLD J GASTROENTERO, V8, P1088, DOI 10.3748/wjg.v8.i6.1088; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Foster DV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.010101; Franco S, 2008, VIRUS RES, V131, P260, DOI 10.1016/j.virusres.2007.10.003; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Guan Y, 2015, MOL BIOSYST, V11, P2568, DOI 10.1039/c5mb00394f; Guan Y, 2014, ANTIVIR RES, V103, P60, DOI 10.1016/j.antiviral.2014.01.010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heintges T, 2001, J MED VIROL, V65, P671, DOI 10.1002/jmv.2089; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hospital A, 2012, BIOINFORMATICS, V28, P1278, DOI 10.1093/bioinformatics/bts139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imhof I, 2011, HEPATOLOGY, V53, P1090, DOI 10.1002/hep.24172; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Koch JO, 1996, VIROLOGY, V221, P54, DOI 10.1006/viro.1996.0352; Koukos PI, 2014, J CHEM INF MODEL, V54, P209, DOI 10.1021/ci4005817; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kramer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104425; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Large MK, 1999, J IMMUNOL, V162, P931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauletta G, 2012, CLIN DEV IMMUNOL, V2012, P11; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lin C., 2006, HEPATITIS C VIRUSES; Lin C, 1995, J VIROL, P69; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; McCoy MA, 2001, J MOL BIOL, V305, P1099, DOI 10.1006/jmbi.2000.4365; Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Nagpal N, 2015, GENE, V570, P115, DOI 10.1016/j.gene.2015.06.008; Nevot M, 2014, J VIRAL HEPATITIS, V21, pE19, DOI 10.1111/jvh.12254; Nguyen Mindie H, 2005, Clin Liver Dis, V9, P411, DOI 10.1016/j.cld.2005.05.010; Nishiya AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086413; Ozen A, 2013, J CHEM THEORY COMPUT, V9, P5693, DOI 10.1021/ct400603p; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polavarapu P. L., 1998, VIBRATIONAL SPECTRA; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rennebaum S, 2012, PROTEINS, V80, P1998, DOI 10.1002/prot.24088; Rimmert B, 2014, J BIOMOL STRUCT DYN, V32, P950, DOI 10.1080/07391102.2013.800001; Rong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052467; Saleha Shamim, 2014, Hepat Res Treat, V2014, P165826, DOI 10.1155/2014/165826; SATOH S, 1995, J VIROL, V69, P4255, DOI 10.1128/JVI.69.7.4255-4260.1995; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Soumana DI, 2016, ACS CHEM BIOL, V11, P900, DOI 10.1021/acschembio.5b00647; Steinkuhler C, 1996, J VIROL, V70, P6694; Tamori A, 2016, MEDIAT INFLAMM, V2016, P11; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Tomei L, 1996, J GEN VIROL, V77, P1065, DOI 10.1099/0022-1317-77-5-1065; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong MT, 2016, CELL MOL IMMUNOL, V13, P11, DOI 10.1038/cmi.2014.127; Yan YW, 1998, PROTEIN SCI, V7, P837	78	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168002	10.1371/journal.pone.0168002	http://dx.doi.org/10.1371/journal.pone.0168002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936126	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100247
J	Navas, J; Fernandez-Martinez, M; Salas, C; Cano, ME; Martinez-Martinez, L				Navas, Jesus; Fernandez-Martinez, Marta; Salas, Carlos; Cano, Maria Eliecer; Martinez-Martinez, Luis			Susceptibility to Aminoglycosides and Distribution of aph and aac(3)-XI Genes among Corynebacterium striatum Clinical Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NOSOCOMIAL PATHOGEN; LIFE-STYLE; BACTERIA; STRAINS; PATIENT; SAMPLES	Corynebacterium striatum is an opportunistic pathogen, often multidrug-resistant, which has been associated with serious infections in humans. Aminoglycosides are second-line or complementary antibiotics used for the treatment of Corynebacterium infections. We investigated the susceptibility to six aminoglycosides and the molecular mechanisms involved in aminoglycoside resistance in a collection of 64 Corynebacterium striatum isolated in our laboratory during the period 2005-2009. Antimicrobial susceptibility was determined using E-test. The mechanisms of aminoglycoside resistance were investigated by PCR and sequencing. The 64 C. striatum were assessed for the possibility of clonal spreading by Pulsed-field Gel Electrophoresis (PFGE). Netilmicin and amikacin were active against the 64 C. striatum isolates (MICs90 = 0.38 and 0.5 mg/L, respectively). Twenty-seven of the 64 C. striatum strains showed a MIC90 for kanamycin > 256 mg/L, and 26 out the 27 were positive for the aph(3')-Ic gene. Thirty-six out of our 64 C. striatum were streptomycin resistant, and 23 out of the 36 carried both the aph(3 '')-Ib and aph(6)-Id genes. The gene aac(3)-XI encoding a new aminoglycoside 3-N acetyl transferase from C. striatum was present in 44 out of the 64 isolates, all of them showing MICs of gentamicin and tobramycin > 1 mg/L. CS4933, a C. striatum showing very low susceptibility to kanamycin and streptomycin, contains an aminoglycoside resistance region that includes the aph(3')-Ic gene, and the tandem of genes aph(3 '')-Ib and aph(6)-Id. Forty-six major PFGE types were identified among the 64 C. striatum isolates, indicating that they were mainly not clonal. Our results showed that the 64 clinical C. striatum were highly resistant to aminoglycosides and mostly unrelated.	[Navas, Jesus; Martinez-Martinez, Luis] Univ Cantabria, Dept Mol Biol, Fac Med, Herrera Oria S-N, Santander, Spain; [Fernandez-Martinez, Marta; Salas, Carlos; Cano, Maria Eliecer; Martinez-Martinez, Luis] Hosp Univ Marques Valdecilla IDIVAL, Microbiol Serv, Avda Valdecilla S-N, Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV)	Navas, J (corresponding author), Univ Cantabria, Dept Mol Biol, Fac Med, Herrera Oria S-N, Santander, Spain.	navasj@unican.es	Martínez, Luis Martínez/U-1801-2017	Martínez, Luis Martínez/0000-0002-6091-4045; FERNANDEZ-MARTINEZ, MARTA/0000-0002-1748-4481	Ministerio de Economia y Competitividad, Institute de Salud Carlos III; European Development Regional Fund "A way to achieve Europe"; Spanish Network for the Research in Infectious Diseases [REIPI RD12/0015]; BBSRC [BBS/E/D/20310000] Funding Source: UKRI	Ministerio de Economia y Competitividad, Institute de Salud Carlos III; European Development Regional Fund "A way to achieve Europe"; Spanish Network for the Research in Infectious Diseases; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Support was provided by the Ministerio de Economia y Competitividad, Institute de Salud Carlos III (co-financed by European Development Regional Fund "A way to achieve Europe") and the Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015).	Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Brandenburg AH, 1996, J CLIN MICROBIOL, V34, P2089, DOI 10.1128/JCM.34.9.2089-2094.1996; Campanile F, 2009, EMERG INFECT DIS, V15, P75, DOI 10.3201/eid1501.080804; Clinical and Laboratoy Standars Institute, 2015, M45ED3 CLIN LAB STAN; European Committee on Antimicrobial Susceptibility Testing, 2016, BREAKP TABL INT MICS; Guerrero MLF, 2013, J HEART VALVE DIS, V22, P428; Galimand M, 2015, ANTIMICROB AGENTS CH, V59, P5647, DOI 10.1128/AAC.01203-15; Gomez-Garces JL, 2007, INT J ANTIMICROB AG, V29, P688, DOI 10.1016/j.ijantimicag.2006.11.032; Lee PP, 2005, J INFECTION, V50, P338, DOI 10.1016/j.jinf.2004.05.005; LEONARD RB, 1994, J CLIN MICROBIOL, V32, P164, DOI 10.1128/JCM.32.1.164-169.1994; Martinez-Martinez L., 1997, Clin Microbiol Infect, V3, P634, DOI 10.1111/j.1469-0691.1997.tb00470.x; MARTINEZMARTINEZ L, 1995, J CLIN MICROBIOL, V33, P2458; Marull J, 2008, CASES J, V1, P388; Otsuka Y, 2006, DIAGN MICR INFEC DIS, V54, P109, DOI 10.1016/j.diagmicrobio.2005.08.005; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; RUFAEL DW, 1994, CLIN INFECT DIS, V19, P1054, DOI 10.1093/clinids/19.6.1054; Schroder J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-141; Tauch A, 2000, MOL GEN GENET, V263, P1, DOI 10.1007/PL00008668; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009	19	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167856	10.1371/journal.pone.0167856	http://dx.doi.org/10.1371/journal.pone.0167856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936101	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100217
J	Pimenta, AFR; Serro, AP; Paradiso, P; Saramago, B; Colaco, R				Pimenta, Andreia F. R.; Serro, Ana Paula; Paradiso, Patrizia; Saramago, Benilde; Colaco, Rogerio			Diffusion-Based Design of Multi-Layered Ophthalmic Lenses for Controlled Drug Release	PLOS ONE			English	Article							HYDROGEL CONTACT-LENSES; IN-VITRO; HEMA HYDROGEL; DELIVERY; CIPROFLOXACIN; FORMULATIONS; PERFORMANCE	The study of ocular drug delivery systems has been one of the most covered topics in drug delivery research. One potential drug carrier solution is the use of materials that are already commercially available in ophthalmic lenses for the correction of refractive errors. In this study, we present a diffusion-based mathematical model in which the parameters can be adjusted based on experimental results obtained under controlled conditions. The model allows for the design of multi-layered therapeutic ophthalmic lenses for controlled drug delivery. We show that the proper combination of materials with adequate drug diffusion coefficients, thicknesses and interfacial transport characteristics allows for the control of the delivery of drugs from multi-layered ophthalmic lenses, such that drug bursts can be minimized, and the release time can be maximized. As far as we know, this combination of a mathematical modelling approach with experimental validation of non-constant activity source lamellar structures, made of layers of different materials, accounting for the interface resistance to the drug diffusion, is a novel approach to the design of drug loaded multi-layered contact lenses.	[Pimenta, Andreia F. R.; Paradiso, Patrizia; Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, Dept Mech Engn, Lisbon, Portugal; [Pimenta, Andreia F. R.; Paradiso, Patrizia; Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal; [Pimenta, Andreia F. R.; Serro, Ana Paula; Paradiso, Patrizia; Saramago, Benilde] Univ Lisbon, Inst Super Tecn, Ctr Qum Estrutural, Lisbon, Portugal; [Serro, Ana Paula] Inst Super Ciencias Saude Egas Moniz, CIIEM, Caparica, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz	Colaco, R (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Mech Engn, Lisbon, Portugal.; Colaco, R (corresponding author), Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal.	rogerio.colaco@tecnico.ulisboa.pt	Paradiso, Patrizia/L-7231-2019; Saramago, Benilde/A-4882-2012; Colaco, Rogerio/B-5432-2013; Serro, Ana/H-7797-2012	Paradiso, Patrizia/0000-0003-2531-8499; Saramago, Benilde/0000-0002-8968-4781; Colaco, Rogerio/0000-0001-7374-6741; Pimenta, Andreia/0000-0002-9990-4581; Colaco, Rogerio/0000-0002-5529-1621; Serro, Ana/0000-0002-6179-9296	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/52334/2013, SFRH/BD/71990/2010, PEstOE/QUI/UI0100/2013, M-ERA.NET/0005/2012]; Fundação para a Ciência e a Tecnologia [M-ERA.NET/0005/2012, PEst-OE/QUI/UI0100/2013] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by Fundacao para a Ciencia e a Tecnologia for A. Pimenta and P. Paradiso PhD grants (SFRH/BD/52334/2013 and SFRH/BD/71990/2010) and for funding through the projects PEstOE/QUI/UI0100/2013 and M-ERA.NET/0005/2012.	Ali M, 2008, EXPERT REV CLIN PHAR, V1, P145, DOI 10.1586/17512433.1.1.145; Ali M, 2007, J CONTROL RELEASE, V124, P154, DOI 10.1016/j.jconrel.2007.09.006; Anderson EM, 2009, BIOMATERIALS, V30, P5675, DOI 10.1016/j.biomaterials.2009.06.047; Ciolino JB, 2014, BIOMATERIALS, V35, P432, DOI 10.1016/j.biomaterials.2013.09.032; Ciolino JB, 2009, INVEST OPHTH VIS SCI, V50, P3346, DOI 10.1167/iovs.08-2826; Galante R, 2015, J BIOMAT SCI-POLYM E, V26, P235, DOI 10.1080/09205063.2014.994948; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Gulsen D, 2005, INT J PHARMACEUT, V292, P95, DOI 10.1016/j.ijpharm.2004.11.033; Hiratani H, 2004, BIOMATERIALS, V25, P1105, DOI 10.1016/S0142-9612(03)00622-7; Hui A, 2014, INVEST OPHTH VIS SCI, V55, P4896, DOI 10.1167/iovs.14-14855; Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8; Kleinmann G, 2006, J CATARACT REFR SURG, V32, P1717, DOI 10.1016/j.jcrs.2006.04.033; Kowalski RP, 2003, AM J OPHTHALMOL, V136, P500, DOI 10.1016/S0002-9394(03)00294-0; Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004; Packer M, 2011, J CATARACT REFR SURG, V37, P1699, DOI 10.1016/j.jcrs.2011.06.018; Paradiso P, 2014, J BIOMED MATER RES B, V102, P1170, DOI 10.1002/jbm.b.33099; Paradiso P, 2014, J BIOMED MATER RES B, V2010, P1; Peng CC, 2010, BIOMATERIALS, V31, P4032, DOI 10.1016/j.biomaterials.2010.01.113; PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y; Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Xinming Li, 2008, Cont Lens Anterior Eye, V31, P57, DOI 10.1016/j.clae.2007.09.002	22	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167728	10.1371/journal.pone.0167728	http://dx.doi.org/10.1371/journal.pone.0167728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936138	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100165
J	Rantala, AK; Mehtonen, IT; Jaakkola, MS; Nayha, S; Hugg, TT; Jaakkola, JJK				Rantala, Aino K.; Mehtonen, Ilkka T.; Jaakkola, Maritta S.; Nayha, Simo; Hugg, Timo T.; Jaakkola, Jouni J. K.			Early Respiratory Infections and Dental Caries in the First 27 Years of Life: A Population-Based Cohort Study	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; RISK-FACTORS; PREVALENCE; ENAMEL; ASTHMA; DETERMINANTS; ASSOCIATION; OPACITIES; VALIDITY; DEFECTS	Early-life respiratory tract infections (RTIs) and dental caries are among the most common infectious diseases worldwide. The relations between early RTIs and development of caries in permanent teeth have not been studied earlier. We assessed childhood RTIs as potential predictors of caries in young adulthood in a 20-year prospective population-based cohort study (The Espoo Cohort Study). Information on lower respiratory tract infections (LRTIs) that had required hospitalization was retrieved from the National Hospital Discharge Registry (n = 1623). Additional information on LRTIs and upper RTIs (URTIs) was assessed based on the questionnaire reports that covered the preceding 12 months. Caries was measured as the number of teeth with fillings (i.e. filled teeth, FT) reported in the 20-year follow-up questionnaire. The absolute and relative excess numbers of FT were estimated applying negative binomial regression. The mean number of FT in young adulthood was 1.4 greater among subjects who had experienced LRTIs requiring hospitalization before the age of 2 years (SD 4.8) compared to those without any such infections (SD 3.4), and the adjusted relative excess number of FT was 1.5 (95% CI 1.0-2.2). LRTIs up to 7 years were associated with an absolute increase of 0.9 in the mean FT number, the adjusted relative excess being 1.3 (1.0-1.8). Also the questionnaire- based LRTIs (adjusted relative excess 1.3; 95% CI 0.9-1.8) and URTIs (adjusted relative excess 1.4, 1.0-1.8) before the age of 2 years predicted higher occurrence of FT. Findings suggest that early RTIs have a role in the development of dental caries in permanent teeth.	[Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; Med Res Ctr Oulu, Oulu, Finland	University of Oulu	Jaakkola, JJK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	jouni.jaakkola@oulu.fi	Hugg, Timo/P-5531-2018; Jaakkola, Jouni J.K./G-4314-2012; Rantala, Aino/AAZ-7578-2020	Rantala, Aino/0000-0002-4845-076X; Jaakkola, Jouni/0000-0003-4168-4683; Hugg, Timo/0000-0003-2558-1780; Jaakkola, Maritta S./0000-0003-1373-7784	Academy of Finland [129419, 138691, 266314]; Finnish Lung Health Association	Academy of Finland(Academy of Finland); Finnish Lung Health Association	This study was funded by the Academy of Finland [grant number 129419 of Responding to Public Health Challenges (SALVE) research program and grant numbers 138691 and 266314], and the Finnish Lung Health Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaki SM, 2008, PEDIATR DENT, V30, P105; Alavaikko S, 2011, AM J EPIDEMIOL, V174, P631, DOI 10.1093/aje/kwr129; Alm A, 2012, COMMUNITY DENT ORAL, V40, P125, DOI 10.1111/j.1600-0528.2011.00647.x; American Dental Association, CAR RISK ASS MAN; Arnadottir IB, 2005, COMMUNITY DENT HLTH, V22, P279; Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Clark MB, 2014, PEDIATRICS, V134, P626, DOI 10.1542/peds.2014-1699; Ditmyer M, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-24; Dye Bruce A, 2015, NCHS Data Brief, P1; Jaakkola JJK, 2005, ENVIRON HEALTH PERSP, V113, P357, DOI 10.1289/ehp.7242; JAAKKOLA JJK, 1993, J EXPO ANAL ENV EPID, V3, P129; Jaakkola JJK, 2010, AM J EPIDEMIOL, V172, P451, DOI 10.1093/aje/kwq110; Jalevik B, 2000, Int J Paediatr Dent, V10, P278, DOI 10.1046/j.1365-263x.2000.00210.x; Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x; Koskinen S, 2012, 682012 NAT I HLTH WE; Kumar S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-41; Laisi S, 2009, J DENT RES, V88, P132, DOI 10.1177/0022034508328334; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nelson Suchitra, 2005, Oral Health Prev Dent, V3, P165; Ollila P, 1997, ACTA ODONTOL SCAND, V55, P9, DOI 10.3109/00016359709091933; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; PARVINEN T, 1981, J DENT RES, V60, P1929, DOI 10.1177/00220345810600120201; Phipps Kathy R, 2010, J Evid Based Dent Pract, V10, P112, DOI 10.1016/j.jebdp.2010.02.015; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Rantala AK, 2015, AM J EPIDEMIOL, V182, P615, DOI 10.1093/aje/kwv093; Rothman K., 2012, EPIDEMIOLOGY INTRO; Saraiva MCD, 2007, COMMUNITY DENT ORAL, V35, P364, DOI 10.1111/j.1600-0528.2006.00345.x; Schwendicke F, 2015, J DENT RES, V94, P10, DOI 10.1177/0022034514557546; Simonsen RJ, 2011, AUST DENT J, V56, P45, DOI 10.1111/j.1834-7819.2010.01295.x; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner T, 2013, ACTA ODONTOL SCAND, V71, P1436, DOI 10.3109/00016357.2013.767932; Tanzer J M, 2001, J Dent Educ, V65, P1028; Vargas-Ferreira F, 2015, J DENT, V43, P619, DOI 10.1016/j.jdent.2015.03.011; William V, 2006, PEDIATR DENT, V28, P224	39	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168141	10.1371/journal.pone.0168141	http://dx.doi.org/10.1371/journal.pone.0168141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936203	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100275
J	Shatrova, AN; Mityushova, EV; Vassilieva, IO; Aksenov, ND; Zenin, VV; Nikolsky, NN; Marakhova, II				Shatrova, Alla N.; Mityushova, Elena V.; Vassilieva, Irina O.; Aksenov, Nikolay D.; Zenin, Valery V.; Nikolsky, Nikolay N.; Marakhova, Irina I.			Time-Dependent Regulation of IL-2R alpha-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes	PLOS ONE			English	Article							CELL ANTIGEN RECEPTOR; JANUS KINASE 3; CYTOPLASMIC DOMAINS; BETA-CHAIN; INTERLEUKIN-2; PROGRESSION; INHIBITORS; INDUCTION; GAMMA(C); COMPLEX	The expression of the IL-2R alpha-chain (IL-2R alpha) is regulated at the transcriptional level via TCR- and IL-2R-signaling. The question is how to precede in time the activation signals to induce the IL-2R alpha expression in native primary T cells. By comparing the effects of selective drugs on the dynamics of CD25 expression during the mitogen stimulation of human peripheral blood lymphocytes, we identified distinct Src- and JAK-dependent stages of IL-2R alpha upregulation. PP2, a selective inhibitor of TCR-associated Src kinase, prevents CD25 expression at initial stages of T cell activation, prior to the cell growth. This early IL-2R alpha upregulation underlies the T cell competence and the IL-2 responsiveness. We found that the activated with "weak" mitogen, the population of blood lymphocytes has some pool of competent CD25+ cells bearing a high affinity IL-2R. A distinct pattern of IL-2R signaling in resting and competent T lymphocytes has been shown. Based on the inhibitory effect of WHI-P131, a selective drug of JAK3 kinase activity, we concluded that in quiescent primary T lymphocytes, the constitutive STAT3 and the IL-2-induced prolonged STAT5 activity (assayed by tyrosine phosphorylation) is mostly JAK3-independent. In competent T cells, in the presence of IL-2 JAK3/STAT5 pathway is switched to maintain the higher and sustained IL-2R alpha expression as well as cell growth and proliferation. We believe that understanding the temporal coordination of antigen-and cytokine-evoked signals in primary T cells may be useful for improving immunotherapeutic strategies.	[Shatrova, Alla N.; Mityushova, Elena V.; Vassilieva, Irina O.; Aksenov, Nikolay D.; Zenin, Valery V.; Nikolsky, Nikolay N.; Marakhova, Irina I.] Russian Acad Sci, Inst Cytol, Dept Intracellular Signaling & Transport, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Marakhova, II (corresponding author), Russian Acad Sci, Inst Cytol, Dept Intracellular Signaling & Transport, St Petersburg, Russia.	iim@incras.ru	Shatrova, Alla/R-8042-2016; Vassilieva, Irina/F-3011-2017; Zenin, Valery/AAE-9303-2021; Aksenov, Nikolay D/F-1679-2017; Nikolsky, Nikolay/AAB-5657-2021	Vassilieva, Irina/0000-0002-0423-8118; Nikolsky, Nikolay/0000-0001-9914-874X	Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Science Foundation; Federal Agency of Scientific Organizations (Russia) [14-50-00068]	Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organizations (Russia)	This work was supported by the Molecular and Cell Biology Program of the Russian Academy of Sciences, NNN; the Russian Science Foundation with the financial support from the Federal Agency of Scientific Organizations (Russia),(project n. 14-50-00068, NNN.	Bani L, 1997, INT IMMUNOL, V9, P573, DOI 10.1093/intimm/9.4.573; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chueh FY, 2012, BIOCHEM BIOPH RES CO, V426, P242, DOI 10.1016/j.bbrc.2012.08.074; Ellery JM, 2002, IMMUNOL CELL BIOL, V80, P351, DOI 10.1046/j.1440-1711.2002.01097.x; Ellery JM, 2002, CYTOKINE GROWTH F R, V13, P27, DOI 10.1016/S1359-6101(01)00023-5; Ellery JM, 2000, CELL SIGNAL, V12, P367, DOI 10.1016/S0898-6568(00)00085-1; Frank DA., 2012, JAK STAT, V1, P1; Gorentla Balachandra K, 2012, J Clin Cell Immunol, V2012, P5; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hilbrands R, 2013, IMMUNOTHERAPY-UK, V5, P717, DOI 10.2217/imt.13.69; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Imbert V, 2002, EUR CYTOKINE NETW, V13, P331; Imbert V, 1999, EUR CYTOKINE NETW, V10, P71; Karitskaya I, 2010, PFLUG ARCH EUR J PHY, V460, P777, DOI 10.1007/s00424-010-0843-z; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; KIM HPJ, 2006, CYTOKINE GROWTH F R, V17, P350; KUMAGAI N, 1988, J CELL PHYSIOL, V137, P329, DOI 10.1002/jcp.1041370217; Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Leonard WJ, 1996, ANNU REV MED, V47, P229; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Leonard WJ, 1999, COLD SPRING HARB SYM, V64, P417, DOI 10.1101/sqb.1999.64.417; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Marakhova I, 2005, FEBS LETT, V579, P2773, DOI 10.1016/j.febslet.2005.03.096; Marakhova II, 1998, BBA-BIOMEMBRANES, V1368, P61, DOI 10.1016/S0005-2736(97)00164-8; Mayack SR, 2006, J IMMUNOL, V176, P2059, DOI 10.4049/jimmunol.176.4.2059; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PROUST JJ, 1991, EUR J IMMUNOL, V21, P335, DOI 10.1002/eji.1830210214; Rapecki S, 2002, J PHARMACOL EXP THER, V303, P1325, DOI 10.1124/jpet.102.038380; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Shatrova A N, 2011, Tsitologiia, V53, P652; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; Suzuki K, 2000, INT IMMUNOL, V12, P123, DOI 10.1093/intimm/12.2.123; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; Zenin V V, 2011, Tsitologiia, V53, P645	48	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167215	10.1371/journal.pone.0167215	http://dx.doi.org/10.1371/journal.pone.0167215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936140	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100073
J	Yin, HD; Han, BM; Li, DW; Wu, JJ; Sun, HJ				Yin, Haodong; Han, Baoming; Li, Dewei; Wu, Jianjun; Sun, Huijun			Modeling and Simulating Passenger Behavior for a Station Closure in a Rail Transit Network	PLOS ONE			English	Article							DESIGN PROBLEM; DISRUPTIONS; MANAGEMENT; RECOVERY	A station closure is an abnormal operational situation in which the entrances or exits of a rail transit station have to be closed for some time due to an unexpected incident. A novel approach is developed to estimate the impacts of the alternative station closure scenarios on both passenger behavioral choices at the individual level and passenger demand at the disaggregate level in a rail transit network. Therefore, the contributions of this study are twofold: (1) A basic passenger behavior optimization model is mathematically constructed based on 0-1 integer programming to describe passengers' responses to alternative origin station closure scenarios and destination station closure scenarios; this model also considers the availability of multi-mode transportation and the uncertain duration of the station closure; (2) An integrated solution algorithm based on the passenger simulation is developed to solve the proposed model and to estimate the effects of a station closure on passenger demand in a rail transit network. Furthermore, 13 groups of numerical experiments based on the Beijing rail transit network are performed as case studies with 2,074,267 records of smart card data. The comparisons of the model outputs and the manual survey show that the accuracy of our proposed behavior optimization model is approximately 80%. The results also show that our model can be used to capture the passenger behavior and to quantitatively estimate the effects of alternative closure scenarios on passenger flow demand for the rail transit network. Moreover, the closure duration and its overestimation greatly influence the individual behavioral choices of the affected passengers and the passenger demand. Furthermore, if the rail transit operator can more accurately estimate the closure duration (namely, as g approaches 1), the impact of the closure can be somewhat mitigated.	[Yin, Haodong; Han, Baoming; Wu, Jianjun; Sun, Huijun] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Yin, Haodong; Han, Baoming; Li, Dewei] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University	Li, DW (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	dwli.bjtu@163.com		Yin, Haodong/0000-0001-6653-6789	National Natural Science Foundation of China [U1434207]; China National Funds for Distinguished Young Scientists [71525002]; Beijing Municipal Natural Science Foundation [8162033]; NSFC [71621001]; Research Foundation of State Key Laboratory of Rail Traffic Control and Safety [RCS2016ZT001]; Fundamental Research Funds for the Central Universities [2016JBM030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); NSFC(National Natural Science Foundation of China (NSFC)); Research Foundation of State Key Laboratory of Rail Traffic Control and Safety; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (U1434207, http://www.nsfc.gov.cn/), BH; China National Funds for Distinguished Young Scientists (71525002, http://www.nsfc.gov.cn/), JW; and Beijing Municipal Natural Science Foundation (8162033, http://www.bjnsf.org/), BH.; This work was supported by the "China National Funds for Distinguished Young Scientists" (71525002), NSFC (71621001), "Research Foundation of State Key Laboratory of Rail Traffic Control and Safety" (RCS2016ZT001), the "Beijing Municipal Natural Science Foundation" (8162033), and the "Fundamental Research Funds for the Central Universities" (2016JBM030).	Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Batty M, 2001, ENVIRON PLANN B, V28, P321, DOI 10.1068/b2803ed; Bin Othman N, 2015, J COMPUT SCI-NETH, V10, P338, DOI 10.1016/j.jocs.2015.03.006; Blanco J.I., 2014, SIMULATION TECHNOLOG, P547; Bouman P, 2012, ATT2012, P113; Bouman P, 2013, IEEE INT C INTELL TR, P1047, DOI 10.1109/ITSC.2013.6728370; Cadarso L, 2014, PROCD SOC BEHV, V111, P528, DOI 10.1016/j.sbspro.2014.01.086; Cadarso L, 2013, TRANSPORT RES E-LOG, V53, P15, DOI 10.1016/j.tre.2013.01.013; Cats O., 2011, THESIS; Cats O, 2012, TRANSPORT RES REC, P100, DOI 10.3141/2274-11; Cats O, 2010, TRANSPORT RES REC, P9, DOI 10.3141/2188-02; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huang L, 2016, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0040-2; Kusakabe T, 2014, TRANSPORT RES C-EMER, V46, P179, DOI 10.1016/j.trc.2014.05.012; Li WJ, 2016, IEEE T INTELL TRANSP, V17, P960, DOI 10.1109/TITS.2015.2494017; Lin Y., 2006, IEEE PERVAS COMPUT, V4, P65; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Mehmood A, 2015, AD HOC SENS WIREL NE, V28, P1; NIELSEN LE, 2011, THESIS; Nuzzolo A, 2012, TRANSPORT RES C-EMER, V20, P16, DOI 10.1016/j.trc.2011.02.007; Passenger Focus, 2011, INF RAIL PASS NEEDS; Pelletier MP, 2011, TRANSPORT RES C-EMER, V19, P557, DOI 10.1016/j.trc.2010.12.003; Shojafar Mohammad, 2013, Journal of Computing Science and Engineering, V7, P44, DOI 10.5626/JCSE.2013.7.1.44; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Silva R, 2015, P NATL ACAD SCI USA, V112, P5643, DOI 10.1073/pnas.1412908112; Song H, 2009, TRANSP RES BOARD 88; Song H, 2006, DEV CALIBRATION ANIS; Tsuchiya R, 2006, WIT TRANS BUILT ENV, V88, P189, DOI 10.2495/CR060191; van der Hurk E., 2015, PASSENGERS INFORM DI; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Yin HD, 2011, ADV INTEL SOFT COMPU, V124, P689; Zhao W., 2013, THESIS; Zhou WT, 2014, APPL MECH MATER, V505-506, P689, DOI 10.4028/www.scientific.net/AMM.505-506.689; Zong F, 2009, J TRANSP SYST ENG IN, P114	34	5	6	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167126	10.1371/journal.pone.0167126	http://dx.doi.org/10.1371/journal.pone.0167126			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935963	gold, Green Published			2022-12-26	WOS:000389587100065
J	Zhang, XG; Ding, FS; Li, HN; Zhao, WF; Jing, H; Yan, YG; Chen, YP				Zhang, Xuguang; Ding, Fengshu; Li, Huaining; Zhao, Wenfeng; Jing, Hong; Yan, Yageng; Chen, Yanping			Low Serum Levels of Vitamins A, D, and E Are Associated with Recurrent Respiratory Tract Infections in Children Living in Northern China: A Case Control Study	PLOS ONE			English	Article							RETINOIC ACID; EXPRESSION; IMMUNITY; MUCIN	Background This study aimed to investigate the association of serum concentrations of vitamin A, D, and E with recurrent respiratory tract infections (RRTIs). Methods A total of 1200 children aged at 0.5-14 years were selected via a face-to-face survey in Harbin, China. Among the participants, 600 children with RRTIs comprised the symptomatic group (RRTI group), whereas 600 healthy children were used as controls (control group). Blood samples were collected to measure serum levels of vitamins A and E by HPLC; the serum level of 25-hydroxycholecalciferol (25(OH) D), was measured by HPLC-MS/MS. Results Serum levels of vitamins A and E, as well as 25(OH) D, were significantly lower in the RRTI group than the control group. The conditional logistic regression model and the receiver-operating characteristic curve showed that the insufficiency or deficiency of vitamins A, D, and E was positively correlated with RRTI occurrence (p < 0.05). Conclusions Low serum concentrations of vitamins A, D, and E were associated with RRTIs in children from northern China.	[Zhang, Xuguang; Ding, Fengshu; Li, Huaining; Jing, Hong; Chen, Yanping] Harbin Childrens Hosp, Dept Clin Nutr, Harbin, Peoples R China; [Zhao, Wenfeng] Harbin Childrens Hosp, Dept Clin Lab, Harbin, Peoples R China; [Yan, Yageng] Harbin Med Univ, Dept Clin Nutr, Affiliated Clin Hosp 1, Harbin, Peoples R China	Harbin Medical University	Chen, YP (corresponding author), Harbin Childrens Hosp, Dept Clin Nutr, Harbin, Peoples R China.	heyypchen@163.com			Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China [W2015EAE007]	Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China	This work was supported in part by grants from The Development Center for Medical Science and Technology National Health and Family Planning Commission of the People's Republic of China (no. W2015EAE007) to FSD, http://www.dcmst.org.cn/.	Abrams SA, 2011, PEDIATRICS, V127, P566, DOI 10.1542/peds.2010-3576; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CLEMENS TL, 1982, LANCET, V1, P74; COQUETTE A, 1986, ARCH INT PHYSIOL BIO, V94, pS29; Diez-Domingo J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0544-x; Dong F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1062-8; Drewel BT, 2006, J NUTR BIOCHEM, V17, P132, DOI 10.1016/j.jnutbio.2005.06.003; Esposito S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-194; Fares S, 2011, PUBLIC HEALTH NUTR, V14, P255, DOI 10.1017/S1368980010001631; FRIEDMAN A, 1989, BRIT J NUTR, V62, P439, DOI 10.1079/BJN19890044; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hardelid P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1191; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Maciel BLL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107564; Liu H, 2015, INT J DISTRIB SENS N, V2015, P12, DOI DOI 10.1088/1741-2560/12/5/056008; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moreira A, 2014, J STRENGTH COND RES, V28, P467, DOI 10.1519/JSC.0b013e31829b5512; Mustacich DJ, 2007, VITAM HORM, V76, P1, DOI 10.1016/S0083-6729(07)76001-6; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Organization WH, 2009, EN NUTR PUBL MICR VI; Raniszewska A, 2015, CENT EUR J IMMUNOL, V40, P167, DOI 10.5114/ceji.2015.52830; Singh Meenu, 1999, Indian Journal of Pediatrics, V66, P887, DOI 10.1007/BF02723862; SOMMER A, 1983, LANCET, V2, P585; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wu DY, 2014, ENDOCR METAB IMMUNE, V14, P283, DOI 10.2174/1871530314666140922143950; Yang C, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0170-0; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	36	14	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167689	10.1371/journal.pone.0167689	http://dx.doi.org/10.1371/journal.pone.0167689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936124	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100152
J	Zou, L; Chen, YX; Penttinen, P; Lan, Q; Wang, K; Liu, M; Peng, D; Zhang, XP; Chen, Q; Zhao, K; Zeng, XZ; Xu, KW				Zou, Lan; Chen, Yuan Xue; Penttinen, Petri; Lan, Qin; Wang, Ke; Liu, Ming; Peng, Dan; Zhang, Xiaoping; Chen, Qiang; Zhao, Ke; Zeng, Xiangzhong; Xu, Kai Wei			Genetic Diversity and Symbiotic Efficiency of Nodulating Rhizobia Isolated from Root Nodules of Faba Bean in One Field	PLOS ONE			English	Article							VICIA-FABA; PHASEOLUS-VULGARIS; SP NOV.; LEGUMINOSARUM; PHYLOGENY; STRAINS; L.; RECOMBINATION; REGIONS; SICHUAN	Thirty-one nodulating rhizobium strains were collected from root nodules of spring and winter type faba bean cultivars grown in micro ecoarea, i.e. the same field in Chengdu plain, China. The symbiotic efficiency and phylogeny of these strains were studied. Effectively nitrogen fixing strains were isolated from both winter type and spring type cultivars. Based on phylogenetic analysis of 16S rRNA gene and concatenated sequence of atpD, glnII and recA genes, the isolates were assigned as Rhizobium anhuiense and a potential new Rhizobium species. The isolates were diverse on symbiosis related gene level, carrying five, four and three variants of nifH, nodC and nodD, respectively. Strains carrying similar gene combinations were trapped by both winter and spring cultivars, disagreeing with the specificity of symbiotic genotypes to reported earlier faba bean ecotypes.	[Zou, Lan; Chen, Yuan Xue; Lan, Qin; Wang, Ke; Liu, Ming; Peng, Dan; Zhang, Xiaoping; Chen, Qiang; Zhao, Ke; Xu, Kai Wei] Sichuan Agr Univ, Coll Resources, Dept Microbiol, Chengdu, Peoples R China; [Penttinen, Petri] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Zeng, Xiangzhong] Sichuan Acad Agr Sci, Soil & Fertilizer Inst, Chengdu, Peoples R China	Sichuan Agricultural University; University of Helsinki; Sichuan Academy of Agricultural Sciences (SAAS)	Chen, YX; Xu, KW (corresponding author), Sichuan Agr Univ, Coll Resources, Dept Microbiol, Chengdu, Peoples R China.	cyxue11889@163.com; xkwei@sicau.edu.cn	Penttinen, Petri/AAJ-2143-2020; chen, qiang/HGU-5418-2022; Penttinen, Petri/CAJ-0885-2022	Penttinen, Petri/0000-0002-9203-9484	National Key Research and Development Program of China [2016YFD0300300]; Special Fund for Agro-scientific Research in the Public Interest of China [201103005]	National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by National Key Research and Development Program of China (2016YFD0300300) YXC, the Special Fund for Agro-scientific Research in the Public Interest of China (No.201103005) XZZ.	Cao Y, 2014, SOIL BIOL BIOCHEM, V78, P128, DOI 10.1016/j.soilbio.2014.07.026; Cardoso JD, 2012, APPL MICROBIOL BIOT, V93, P2035, DOI 10.1007/s00253-011-3708-2; Chen YX, 2015, BIOL FERT SOILS, V51, P707, DOI 10.1007/s00374-015-1019-y; Duc G, 2010, FIELD CROP RES, V115, P270, DOI 10.1016/j.fcr.2008.10.003; Flores F, 2012, AGRON SUSTAIN DEV, V32, P727, DOI 10.1007/s13593-012-0082-0; Gurkanli CT, 2014, ANN MICROBIOL, V64, P99, DOI 10.1007/s13213-013-0638-5; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Laguerre G, 2003, APPL ENVIRON MICROB, V69, P2276, DOI 10.1128/AEM.69.4.2276-2283.2003; Laguerre G, 1996, APPL ENVIRON MICROB, V62, P2029, DOI 10.1128/AEM.62.6.2029-2036.1996; Lindstrom K, 2010, RES MICROBIOL, V161, P453, DOI 10.1016/j.resmic.2010.05.005; Little MC, 1991, [No title captured], Patent No. [5,075,430, 5075430]; Luyten E, 2000, EUR J SOIL BIOL, V36, P1, DOI 10.1016/S1164-5563(00)00134-5; Mousavi SA, 2015, SYST APPL MICROBIOL, V38, P84, DOI 10.1016/j.syapm.2014.12.003; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Ribeiro RA, 2013, RES MICROBIOL, V164, P740, DOI 10.1016/j.resmic.2013.05.002; ROHLF FJ, 1993, NTSYS PC NUMERICAL T; Saidi S, 2014, INT J SYST EVOL MICR, V64, P242, DOI 10.1099/ijs.0.052191-0; Santillana N, 2008, ARCH MICROBIOL, V189, P239, DOI 10.1007/s00203-007-0313-y; Sarita S, 2005, FEMS MICROBIOL ECOL, V54, P1, DOI 10.1016/j.femsec.2005.02.015; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian CF, 2007, ARCH MICROBIOL, V188, P273, DOI 10.1007/s00203-007-0245-6; Tian CF, 2010, FEMS MICROBIOL ECOL, V73, P563, DOI 10.1111/j.1574-6941.2010.00909.x; Tian CF, 2008, INT J SYST EVOL MICR, V58, P2871, DOI 10.1099/ijs.0.2008/000703-0; VANBERKUM P, 1995, APPL ENVIRON MICROB, V61, P2649, DOI 10.1128/AEM.61.7.2649-2653.1995; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P98, DOI 10.1093/oxfordjournals.molbev.a026041; Xu KW, 2015, SYST APPL MICROBIOL, V38, P515, DOI 10.1016/j.syapm.2015.06.009; Xu KW, 2013, APPL MICROBIOL BIOT, V97, P783, DOI 10.1007/s00253-012-4246-2; Xu KW, 2013, WORLD J MICROBIOL BI, V29; Ye Y, 2003, GSET; Youseif SH, 2014, SYST APPL MICROBIOL, V37, P560, DOI 10.1016/j.syapm.2014.10.001; Zhang YJ, 2015, INT J SYST EVOL MICR, V65, P2960, DOI 10.1099/ijs.0.000365	35	3	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167804	10.1371/journal.pone.0167804	http://dx.doi.org/10.1371/journal.pone.0167804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936180	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100199
J	Janakiraman, H; House, RP; Talwar, S; Courtney, SM; Hazard, ES; Hardiman, G; Mehrotra, S; Howe, PH; Gangaraju, V; Palanisamy, V				Janakiraman, H.; House, R. P.; Talwar, S.; Courtney, S. M.; Hazard, E. S.; Hardiman, G.; Mehrotra, S.; Howe, P. H.; Gangaraju, V.; Palanisamy, V.			Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma	ONCOGENE			English	Article							COX-2 EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; MEDIATED CLEAVAGE; PROSTATE-CANCER; CYCLO-OXYGENASE-2; OVEREXPRESSION; APOPTOSIS; LESIONS	A well-studied RNA-binding protein Hu Antigen-R (HuR), controls post-transcriptional gene regulation and undergoes stress-activated caspase-3 dependent cleavage in cancer cells. The cleavage products of HuR are known to promote cell death; however, the underlying molecular mechanisms facilitating caspase-3 activation and HuR cleavage remains unknown. Here, we show that HuR cleavage associated with active caspase-3 in oral cancer cells treated with ionizing radiation and chemotherapeutic drug, paclitaxel. We determined that oral cancer cells overexpressing cyclooxygenase-2 (COX-2) limited the cleavage of caspase-3 and HuR, which reduced the rate of cell death in paclitaxel resistant oral cancer cells. Specific inhibition of COX-2 by celecoxib, promoted apoptosis through activation of caspase-3 and cleavage of HuR in paclitaxel-resistant oral cancer cells, both in vitro and in vivo. In addition, oral cancer cells overexpressing cellular HuR increased the half-life of COX-2 mRNA, promoted COX-2 protein expression and exhibited enhanced tumor growth in vivo in comparison with cells expressing a cleavable form of HuR. Finally, our ribonucleoprotein immunoprecipitation and sequencing (RIP-seq) analyses of HuR in oral cancer cells treated with ionizing radiation (IR), determined that HuR cleavage product-1 (HuR-CP1) bound and promoted the expression of mRNAs encoding proteins involved in apoptosis. Our results indicated that, cellular non-cleavable HuR controls COX-2 mRNA expression and enzymatic activity. In addition, overexpressed COX-2 protein repressed the cleavage of caspase-3 and HuR to promote drug resistance and tumor growth. Altogether, our observations support the use of the COX-2 inhibitor celecoxib, in combination with paclitaxel, for the management of paclitaxel resistant oral cancer cells.	[Janakiraman, H.; House, R. P.; Talwar, S.; Palanisamy, V.] Med Univ South Carolina, Coll Dent Med, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Janakiraman, H.; House, R. P.; Talwar, S.; Palanisamy, V.] Med Univ South Carolina, Coll Dent Med, Ctr Oral Hlth Res, Charleston, SC 29425 USA; [Courtney, S. M.; Hazard, E. S.; Hardiman, G.] Med Univ South Carolina, Ctr Genom Med, Charleston, SC 29425 USA; [Courtney, S. M.] Med Univ South Carolina, Dept Pathol, Charleston, SC 29425 USA; [Hazard, E. S.] Med Univ South Carolina, Lib Sci & Informat, Charleston, SC 29425 USA; [Hardiman, G.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Hardiman, G.] Med Univ South Carolina, Dept Publ Hlth, Charleston, SC 29425 USA; [Mehrotra, S.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Howe, P. H.; Gangaraju, V.; Palanisamy, V.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, V (corresponding author), Med Univ South Carolina, Dept Oral Hlth Sci, BSB 230-F, Charleston, SC 29425 USA.	visu@musc.edu		Hardiman, Gary/0000-0003-4558-0400; Janakiraman, Harinarayanan/0000-0002-3043-2352	National Institutes of Health [R01DE022776, R01DE022776S1]; NIH grant [P30 GM103331]; NATIONAL CANCER INSTITUTE [R01CA154663, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the funding source from the National Institutes of Health R01DE022776 and R01DE022776S1 to VP. We acknowledge the Center for Oral Health Research (L-COHR) which is supported by the NIH grant P30 GM103331.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Barbisan F, 2009, EUR UROL, V56, P105, DOI 10.1016/j.eururo.2008.04.043; Beauchamp P, 2010, CELL DEATH DIFFER; Bombard Y, 2013, J NATL COMPR CANC NE, V11, P1343, DOI 10.6004/jnccn.2013.0158; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brody JR, 2011, WIRES RNA, V2, P435, DOI 10.1002/wrna.62; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Dandekar DS, 2005, INT J CANCER, V115, P484, DOI 10.1002/ijc.20878; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Do SI, 2008, TUMORI, V94, P347; Ferrandina G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-182; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hague A, 2004, J PATHOL, V204, P175, DOI 10.1002/path.1630; Hida T, 1998, CANCER RES, V58, P3761; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Idro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014001; Itoh S, 2003, ORAL ONCOL, V39, P829, DOI 10.1016/S1368-8375(03)00105-2; KARGMAN SL, 1995, CANCER RES, V55, P2556; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kozak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074712; KULMACZ RJ, 1983, PROSTAGLANDINS, V25, P531, DOI 10.1016/0090-6980(83)90025-4; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; Li M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07380; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mohammad Shadab, 2011, Natl J Maxillofac Surg, V2, P17, DOI 10.4103/0975-5950.85848; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Niesporek S, 2008, INT J ONCOL, V32, P341; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Paolini P, 2014, PHARMACOGENOMICS, V15, P759, DOI [10.2217/PGS.14.39, 10.2217/pgs.14.39]; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Renkonen J, 2002, VIRCHOWS ARCH, V440, P594, DOI 10.1007/s00428-002-0616-y; Ristimaki A, 1997, CANCER RES, V57, P1276; Sakurai K, 2007, HEAD NECK-J SCI SPEC, V29, P1002, DOI 10.1002/hed.20627; Shirahama T, 2000, CLIN CANCER RES, V6, P2424; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Sudbo J, 2003, ORAL ONCOL, V39, P497, DOI 10.1016/S1368-8375(03)00012-5; Talwar S, 2014, J BIOL CHEM, V289, P3487, DOI 10.1074/jbc.M113.504951; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Yoshimura R, 2000, CANCER-AM CANCER SOC, V89, P589, DOI 10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C; Young LE, 2010, CURR COLORECT CANC R, V6, P60, DOI 10.1007/s11888-010-0044-3; Zimmermann KC, 1999, CANCER RES, V59, P198	51	24	24	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3137	3148		10.1038/onc.2016.451	http://dx.doi.org/10.1038/onc.2016.451			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	27941877	Green Accepted			2022-12-26	WOS:000402617900006
J	Fu, L; Dong, Q; He, J; Wang, X; Xing, J; Wang, E; Qiu, X; Li, Q				Fu, L.; Dong, Q.; He, J.; Wang, X.; Xing, J.; Wang, E.; Qiu, X.; Li, Q.			SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway	ONCOGENE			English	Article							CELL-PROLIFERATION; INSULIN-SECRETION; FISSION; CANCER; DRP1; PHOSPHORYLATION; MIGRATION; SIRTUINS; DIVISION; FUSION	SIRT4 is well-known for its deacetylase activity in energy metabolism, but little is known about its roles in carcinogenesis. We demonstrated that SIRT4 was decreased in 70 out of 133 non-small cell lung cancer (NSCLC) cases by immunohistochemical staining and localized in the mitochondria using confocal microscopy. Low levels of SIRT4 expression was correlated with tumor node metastasis (TNM) stage, histological type of tumor (adenocarcinoma), lymph nodal status, Ki-67 (proliferation index) and poor overall survival. We also studied the biological role of SIRT4 in lung cancer cell lines transfected with SIRT4 plasmid or SIRT4-siRNA. SIRT4 inhibited lung cancer cell proliferation, blocked the cell cycle and repressed cell invasion and migration. Mitochondrial dynamics has been implicated in malignant properties of cells, particularly metastasis that is the major cause of death in patients diagnosed with cancer including lung cancer. This is the first study to identify an association between SIRT4 expression and decreased mitochondrial fission, which was driven by Drp1. SIRT4 inhibited Drp1 phosphorylation and weakened Drp1 recruitment to the mitochondrial membrane via an interaction with Fis-1. SIRT4 expression was lower in nodal metastatic tumor samples than their corresponding primary tumors, and cases with low expression of SIRT4 tended to have high p-Drp1 labeling. Also, MEK/ERK activity appeared to be hampered by SIRT4 expression, which may have implications for cells' invasive capacities. In conclusion, our findings suggest that SIRT4 functions as an important antitumor protein in NSCLC, and should be investigated further with respect to future anticancer strategies.	[Li, Q.] China Med Univ, Coll Basic Med Sci, Shenyang 11000, Liaoning, Peoples R China; China Med Univ Shenyang, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China		Li, Q (corresponding author), China Med Univ, Coll Basic Med Sci, Shenyang 11000, Liaoning, Peoples R China.; Li, Q (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang 11000, Peoples R China.	liqingchangcmu@126.com			National Natural Science Foundation of China [81672964, 81302022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 81672964 to Qingchang Li and No. 81302022 to Qianze Dong).	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Argmann C, 2006, CELL, V126, P837, DOI 10.1016/j.cell.2006.08.031; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Carafa V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00004; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Fu L, 2015, MOL CARCINOGEN, V54, pE35, DOI 10.1002/mc.22148; Grandemange S, 2009, SEMIN CANCER BIOL, V19, P50, DOI 10.1016/j.semcancer.2008.12.001; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Huang GY, 2015, BIOMED PHARMACOTHER, V72, P135, DOI 10.1016/j.biopha.2015.04.013; Jeong SM, 2014, J BIOL CHEM, V289, P4135, DOI 10.1074/jbc.M113.525949; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lennon FE, 2014, EXPERT OPIN INV DRUG, V23, P675, DOI 10.1517/13543784.2014.899350; Miyo M, 2015, BRIT J CANCER, V113, P492, DOI 10.1038/bjc.2015.226; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Pal AD, 2014, CARCINOGENESIS, V35, P1592, DOI 10.1093/carcin/bgu069; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Roberts ER, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303019; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Thomas KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045319; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Webb CP, 1998, P NATL ACAD SCI USA, V95, P8773, DOI 10.1073/pnas.95.15.8773; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	38	80	82	2	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2724	2736		10.1038/onc.2016.425	http://dx.doi.org/10.1038/onc.2016.425			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27941873				2022-12-26	WOS:000401120900010
J	Omarjee, S; Jacquemetton, J; Poulard, C; Rochel, N; Dejaegere, A; Chebaro, Y; Treilleux, I; Marangoni, E; Corbo, L; Le Romancer, M				Omarjee, S.; Jacquemetton, J.; Poulard, C.; Rochel, N.; Dejaegere, A.; Chebaro, Y.; Treilleux, I.; Marangoni, E.; Corbo, L.; Le Romancer, M.			The molecular mechanisms underlying the ER alpha-36-mediated signaling in breast cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; REGULATED KINASE; ER-ALPHA; VARIANT; PAXILLIN; PROTEIN; CELLS; RECEPTOR-ALPHA-36; PHOSPHORYLATION; PROLIFERATION	Alterations in estrogen-mediated cellular signaling have largely been implicated in the pathogenesis of breast cancer. Here, we investigated the signaling regulation of a splice variant of the estrogen receptor, namely estrogen receptor (ER alpha-36), associated with a poor prognosis in breast cancers. Coupling in vitro and in vivo approaches we determined the precise sequential molecular events of a new estrogen signaling network in an ERa-negative cell line and in an original patient-derived xenograft. After estrogen treatment, ERa-36 rapidly associates with Src at the level of the plasma membrane, initiating downstream cascades, including MEK1/ERK activation and paxillin phosphorylation on S126, which in turn triggers a higher expression of cyclin D1. Of note, the direct binding of ERa-36 to ERK2 prevents its dephosphorylation by MKP3 and enhances the downstream signaling. These findings improve our understanding of the regulation of non-genomic estrogen signaling and open new avenues for personalized therapeutic approaches targeting Src or MEK in ERa-36-positive patients.	[Omarjee, S.; Jacquemetton, J.; Poulard, C.; Treilleux, I.; Corbo, L.; Le Romancer, M.] Univ Lyon 1, Lyon, France; [Omarjee, S.; Jacquemetton, J.; Poulard, C.; Treilleux, I.; Corbo, L.; Le Romancer, M.] INSERM, Ctr Rech Cancerol Lyon, U1052, Lyon, France; [Omarjee, S.; Jacquemetton, J.; Poulard, C.; Treilleux, I.; Corbo, L.; Le Romancer, M.] CNRS, Ctr Rech Cancerol Lyon, UMR5286, Lyon, France; [Poulard, C.] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Rochel, N.; Dejaegere, A.; Chebaro, Y.] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Rochel, N.; Dejaegere, A.; Chebaro, Y.] CNRS, UMR7104, Illkirch Graffenstaden, France; [Rochel, N.; Dejaegere, A.; Chebaro, Y.] INSERM, U964, Illkirch Graffenstaden, France; [Rochel, N.; Dejaegere, A.; Chebaro, Y.] Univ Strasbourg, Illkirch Graffenstaden, France; [Treilleux, I.] Ctr Leon Berard, Dept Pathol, Lyon, France; [Marangoni, E.] Inst Curie, Translat Res Dept, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; University of Southern California; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Le Romancer, M (corresponding author), Ctr Leon Berard, CNRS 5286, INSERM 1052, CRCL, 28 Rue Laennec, F-69373 Lyon, France.	muriel.leromancer@lyon.unicancer.fr	Chebaro, Yassmine/M-2174-2019; Marangoni, Elisabetta/GSO-3945-2022; Rochel, Natacha/A-5718-2016	Chebaro, Yassmine/0000-0002-5970-2117; Marangoni, Elisabetta/0000-0002-3337-6448; Rochel, Natacha/0000-0002-3573-5889; Poulard, coralie/0000-0003-4821-908X; Omarjee, Soleilmane/0000-0001-8686-7286	Fondation Arc Cancer [ANR-10-LABX-0030-INRT]	Fondation Arc Cancer	We thank F Nasri, C. Languilaire, A. Colombe, L Odeyer and F Assayag for technical support, Y Mikaelian (CRCL, Lyon) for the Histone-GFP vector, G Castoria for the PI3K plasmid, Dr Wang for the pCDNA3-ER alpha-36 plasmid, P Chambon for the HEGO plasmid, F Lenfant for the ERa-46 plasmid, B. Manship for the proofreading of the manuscript. Ligue Nationale Contre le Cancer (comite de Saone-et-Loire), 'Fondation Arc Cancer', Canceropole CLARA, INCA and DGOS. 'region Rhone-Alpes' and 'Ligue Contre le Cancer' for SO, French Ministry of Research, 'Fondation Arc Cancer' and NIH for CP. 'Fondation Arc Cancer' for JJ, NR, YC and AD: grant ANR-10-LABX-0030-INRT.	Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gu Y, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-16; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kong EH, 2003, BIOCHEM SOC T, V31, P56, DOI 10.1042/BST0310056; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Levin ER, 2015, ANNU REV MED, V66, P271, DOI 10.1146/annurev-med-050913-021703; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Luo ML, 2015, CELL REP, V11, P111, DOI 10.1016/j.celrep.2015.03.002; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martin MC, 2008, J BIOL CHEM, V283, P3854, DOI 10.1074/jbc.M705647200; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; Rao J, 2011, J STEROID BIOCHEM, V127, P231, DOI 10.1016/j.jsbmb.2011.08.004; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Sen A, 2012, J CLIN INVEST, V122, P2469, DOI 10.1172/JCI62044; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Wang ZY, 2015, MOL CELL ENDOCRINOL, V418, P193, DOI 10.1016/j.mce.2015.04.017; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107369; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030174	42	27	28	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2503	2514		10.1038/onc.2016.415	http://dx.doi.org/10.1038/onc.2016.415			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27941878	Green Published, hybrid			2022-12-26	WOS:000400597300002
J	Ruan, CC; Ma, Y; Ge, Q; Li, Y; Zhu, LM; Zhang, Y; Kong, LR; Wu, QH; Li, FH; Cheng, LX; Zhao, AZ; Zhu, DL; Gao, PJ				Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Li, Yan; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Li, Fanghong; Cheng, Lixian; Zhao, Allan Z.; Zhu, Ding-Liang; Gao, Ping-Jin			Complement-mediated inhibition of adiponectin regulates perivascular inflammation and vascular injury in hypertension	FASEB JOURNAL			English	Article						perivascular adipose tissue; macrophage; adipocyte	ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; ANGIOTENSIN-II; INSULIN SENSITIVITY; RECEPTOR-BINDING; EXPRESSION; PHENOTYPE; MICE; C5A; DYSFUNCTION	Perivascular adipose tissue (PVAT)-derived adiponectin (APN) is a secreted adipokine that protects against hypertension-related cardiovascular injury. However, the regulation of APN expression in hypertension remains to be explored. In this study, we demonstrated that down-regulation of APN was associated with complement activation in the PVAT of desoxycorticosterone acetate (DOCA)-salt hypertensive mice. Complement 3-deficient hypertensive mice were protected from ANP decrease in the PVAT. APN deficiency blockaded the protective effects of complement inhibition against hypertensive vascular injury. Mechanistically, complement 5a (C5a)-induced TNF-alpha secretion from macrophages is required for inhibiting APN expression in adipocytes. Macrophage depletion reversed C5a agonist peptide-induced TNF-alpha up-regulation and APN down-regulation in the PVAT of DOCA mice. Moreover, we detected increased macrophage infiltration and C5a expression associated with decreased APN expression in adipose tissue from patients with aldosterone-producing adenoma. These results identify a novel interaction between macrophages and adipocytes in the PVAT, where complement-mediated inhibition of APN acts as a potential risk factor for hypertensive vascular inflammation.	[Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, State Key Lab Med Gen, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Gao, Ping-Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Li, Yan] Ruijin Hospital, Dept Cardiol, Luwan Branch, Shanghai, Peoples R China; [Li, Fanghong; Cheng, Lixian; Zhao, Allan Z.] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University	Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.; Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	gaopingjin@sibs.ac.cn		Ruan, Cheng-Chao/0000-0001-5229-9428	National Natural Science Foundation of China [81230071, 81570221, 91539202]; National High-Tech Research and Developement Program [2012AA02A516]; Shanghai Municipal Commission of Health and Family Planning [201540222]; Science and Technology Commission of Shanghai Municipality [15140901800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Developement Program; Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. N. van Rooijen (Vrije University, Amsterdam, The Netherlands) for providing clodronate liposomes and Professor Chen Yan (University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) for valuable suggestions and critical reading of the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 81230071, 81570221, and 91539202), the National High-Tech Research and Developement Program (Grant 2012AA02A516), the Shanghai Municipal Commission of Health and Family Planning (Grant 201540222), and the Science and Technology Commission of Shanghai Municipality (Grant 15140901800). The authors declare no conflicts of interest.	Aurelie NDC, 2011, HYPERTENSION, V58, P479, DOI 10.1161/HYPERTENSIONAHA.110.168872; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Brown NK, 2014, ARTERIOSCL THROM VAS, V34, P1621, DOI 10.1161/ATVBAHA.114.303029; Bykov I, 2007, J HEPATOL, V46, P907, DOI 10.1016/j.jhep.2006.11.020; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Finch AM, 1997, J MED CHEM, V40, P877, DOI 10.1021/jm960727r; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Iyer A, 2011, J CARDIOVASC PHARM, V58, P479, DOI 10.1097/FJC.0b013e31822a7a09; Jadhav A, 2012, FREE RADICAL BIO MED, V53, P2277, DOI 10.1016/j.freeradbiomed.2012.10.529; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Lin ZH, 2004, HYPERTENSION, V44, P42, DOI 10.1161/01.HYP.0000129540.83284.ca; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ndisang JF, 2010, J PHARMACOL EXP THER, V334, P87, DOI 10.1124/jpet.109.164871; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Omar A, 2014, ARTERIOSCL THROM VAS, V34, P1631, DOI 10.1161/ATVBAHA.114.303030; RAIJ L, 1989, KIDNEY INT, V36, P582, DOI 10.1038/ki.1989.234; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruan CC, 2015, ARTERIOSCL THROM VAS, V35, P598, DOI 10.1161/ATVBAHA.114.304927; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151; Tano JY, 2014, ARTERIOSCL THROM VAS, V34, P1827, DOI 10.1161/ATVBAHA.114.303032; Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089; Uemura Y, 2015, FASEB J, V29, P141, DOI 10.1096/fj.14-258129; van Stijn CMW, 2015, FASEB J, V29, P636, DOI 10.1096/fj.14-253831; Verlohren S, 2004, HYPERTENSION, V44, P271, DOI 10.1161/01.HYP.0000140058.28994.ec; Vogen SM, 1999, J PEPT RES, V53, P8, DOI 10.1111/j.1399-3011.1999.tb01612.x; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Withers SB, 2014, ARTERIOSCL THROM VAS, V34, P1637, DOI 10.1161/ATVBAHA.114.303031; Withers SB, 2011, ARTERIOSCL THROM VAS, V31, P908, DOI 10.1161/ATVBAHA.110.221705; Zappala G, 2009, BIOCHEM BIOPH RES CO, V382, P785, DOI 10.1016/j.bbrc.2009.03.112; Zhang CC, 2014, ARTERIOSCL THROM VAS, V34, P1240, DOI 10.1161/ATVBAHA.113.303120; Zhang CC, 2014, AM J HYPERTENS, V27, P857, DOI 10.1093/ajh/hpt274; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	11	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1120	+		10.1096/fj.201600780R	http://dx.doi.org/10.1096/fj.201600780R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27974594				2022-12-26	WOS:000395671200025
J	Bischler, T; Hsieh, PK; Resch, M; Liu, QS; Tan, HS; Foley, PL; Hartleib, A; Sharma, CM; Belasco, JG				Bischler, Thorsten; Hsieh, Ping-kun; Resch, Marcus; Liu, Quansheng; Tan, Hock Siew; Foley, Patricia L.; Hartleib, Anika; Sharma, Cynthia M.; Belasco, Joel G.			Identification of the RNA Pyrophosphohydrolase RppH of Helicobacter pylori and Global Analysis of Its RNA Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; Helicobacter pylori; RNA degradation; RNA modification; RNA turnover; RNA-protein interaction; Nudix; deep sequencing	MESSENGER-RNA; ESCHERICHIA-COLI; NUDIX HYDROLASE; CHEMOTAXIS RECEPTOR; DEGRADATION; ENZYME; PROTEIN; SPECIFICITY; SEQUENCE; SEQ	RNA degradation is crucial for regulating gene expression in all organisms. Like the decapping of eukaryotic mRNAs, the conversion of the 5'-terminal triphosphate of bacterial transcripts to a monophosphate can trigger RNA decay by exposing the transcript to attack by 5'-monophosphate-dependent ribonucleases. In both biological realms, this deprotection step is catalyzed by members of the Nudix hydrolase family. The genome of the gastric pathogen Helicobacter pylori, a Gram-negative epsilonproteobacterium, encodes two proteins resembling Nudix enzymes. Here we present evidence that one of them, HP1228 (renamed HpRppH), is an RNA pyrophosphohydrolase that triggers RNA degradation in H. pylori, whereas the other, HP0507, lacks such activity. In vitro, HpRppH converts RNA 5'-triphosphates and diphosphates to monophosphates. It requires at least two unpaired nucleotides at the 5' end of its substrates and prefers three or more but has only modest sequence preferences. The influence of HpRppH on RNA degradation in vivo was examined by using RNA-seq to search the H. pylori transcriptome for RNAs whose 5'-phosphorylation state and cellular concentration are governed by this enzyme. Analysis of cDNA libraries specific for transcripts bearing a 5'-triphosphate and/or monophosphate revealed at least 63 potential HpRppH targets. These included mRNAs and sRNAs, several of which were validated individually by half-life measurements and quantification of their 5'-terminal phosphorylation state in wild-type and mutant cells. These findings demonstrate an important role for RppH in post-transcriptional gene regulation in pathogenic Epsilonproteobacteria and suggest a possible basis for the phenotypes of H. pylori mutants lacking this enzyme.	[Bischler, Thorsten; Resch, Marcus; Hartleib, Anika; Sharma, Cynthia M.] Univ Wurzburg, Res Ctr Infect Dis, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Bischler, Thorsten; Resch, Marcus; Tan, Hock Siew; Hartleib, Anika; Sharma, Cynthia M.] Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Hsieh, Ping-kun; Liu, Quansheng; Foley, Patricia L.; Belasco, Joel G.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Hsieh, Ping-kun; Liu, Quansheng; Foley, Patricia L.; Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	University of Wurzburg; University of Wurzburg; New York University; New York University	Sharma, CM (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany.; Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	cynthia.sharma@uni-wuerzburg.de; joel.belasco@med.nyu.edu	Sharma, Cynthia/D-2869-2013; Siew, Tan Hock/AAM-6779-2020	Siew, Tan Hock/0000-0003-0794-6782; Sharma, Cynthia Mira/0000-0002-2321-9705; Bischler, Thorsten/0000-0001-9288-9481	Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; Bavarian Research Network for Molecular Biosystems (BioSysNet); German Research Association (DFG) [Sh580/1-1]; National Institutes of Health [5R01GM035769, 5R01GM112940]; National Institutes of Health Fellowship [T32AI007180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769, R01GM112940] Funding Source: NIH RePORTER	Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; Bavarian Research Network for Molecular Biosystems (BioSysNet); German Research Association (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Sharma laboratory was supported by the Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; the Bavarian Research Network for Molecular Biosystems (BioSysNet); and DFG project Sh580/1-1 of the German Research Association (DFG). Research in the Belasco laboratory was supported by National Institutes of Health Grants 5R01GM035769 and 5R01GM112940 (to J.G.B.) and National Institutes of Health Fellowship T32AI007180 (to P.L.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], PYMOL MOL GRAPH SYST; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bischler T, 2015, METHODS, V86, P89, DOI 10.1016/j.ymeth.2015.06.012; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Bonnin RA, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/395753; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2006, J BACTERIOL, V188, P2656, DOI 10.1128/JB.188.7.2656-2665.2006; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Fulton DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-270; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Guo BP, 2002, P NATL ACAD SCI USA, V99, P8354, DOI 10.1073/pnas.122244899; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Kaberdin VR, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-23; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Pernitzsch SR, 2014, P NATL ACAD SCI USA, V111, pE501, DOI 10.1073/pnas.1315152111; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Redko Y, 2016, RNA BIOL, V13, P243, DOI 10.1080/15476286.2015.1132141; Redko Y, 2013, NUCLEIC ACIDS RES, V41, P288, DOI 10.1093/nar/gks945; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Yagi T, 2003, BIOCHEM J, V370, P409, DOI 10.1042/BJ20021140	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1934	1950		10.1074/jbc.M116.761171	http://dx.doi.org/10.1074/jbc.M116.761171			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974459	hybrid, Green Published			2022-12-26	WOS:000395515600032
J	Miller, WP; Ravi, S; Martin, TD; Kimball, SR; Dennis, MD				Miller, William P.; Ravi, Suhana; Martin, Tony D.; Kimball, Scot R.; Dennis, Michael D.			Activation of the Stress Response Kinase JNK (c-Jun N-terminal Kinase) Attenuates Insulin Action in Retina through a p70S6K1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); insulin resistance; mammalian target of rapamycin (mTOR); retina; Type 2 diabetes; insulin action; retinopathy	HIGH-FAT-DIET; DIABETIC-RETINOPATHY; PROTEIN-KINASE; S6 KINASE; AUTOINHIBITORY DOMAIN; NH2-TERMINAL KINASE; MTOR COMPLEX; PHOSPHORYLATION; RESISTANCE; GROWTH	Despite recent advances in therapeutics, diabetic retinopathy remains a leading cause of vision impairment. Improvement in the treatment of diabetic retinopathy requires a better understanding of the molecular mechanisms that cause neurovascular complications, particularly in type 2 diabetes. Recent studies demonstrate that rodents fed a high fat diet exhibit retinal dysfunction concomitant with attenuated Akt phosphorylation. The purpose of the present study was to evaluate the impact of a high fat/high sucrose diet on retinal insulin signaling and evaluate the mechanism(s) responsible for the changes. Mice fed a high fat/sucrose diet exhibited attenuated Akt phosphorylation in the retina as compared with mice fed normal chow. Retinas of mice fed a high fat/sucrose diet also exhibited elevated levels of activated JNK as well as enhanced p70S6K1 autoinhibitory domain phosphorylation. In cells, JNK activation enhanced p70S6K1 phosphorylation and mTORC1-dependent activation of the kinase, as evidenced by enhanced phosphorylation of key substrates. Rictor phosphorylation by p70S6K1 was specifically enhanced by the addition of phosphomimetic mutations in the autoinhibitory domain and was more sensitive to inhibition of the kinase as compared with rpS6. Notably, rictor and IRS-1 phosphorylation by p70S6K1 attenuate insulin action through a negative feedback pathway. Indeed, p70S6K1 inhibition prevented the repressive effect of JNK activation on insulin action in retinas. Overall, the results identify the JNK/S6K1 axis as a key molecular mechanism whereby a high fat/sucrose diet impairs insulin action in retina.	[Miller, William P.; Ravi, Suhana; Martin, Tony D.; Kimball, Scot R.; Dennis, Michael D.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, H166,500 Univ Dr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Dennis, Michael/0000-0002-0645-6864; MILLER, WILLIAM PHILLIP/0000-0003-0157-6389	National Institutes of Health [EY023612, DK13499]; American Diabetes Association Pathway to Stop Diabetes [1-14-INI-04]; NATIONAL EYE INSTITUTE [K99EY023612, R00EY023612, R01EY029702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY023612 (to M. D. D.) and DK13499 (to S. R. K.). This work was also supported by The American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Chang RCA, 2015, INVEST OPHTH VIS SCI, V56, P2367, DOI 10.1167/iovs.14-16143; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong Z, 2016, MOL CELL BIOCHEM, V419, P1, DOI 10.1007/s11010-016-2722-1; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kwak D, 2012, J BIOL CHEM, V287, P18398, DOI 10.1074/jbc.M111.326538; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liu XB, 2008, DIABETES, V57, P1651, DOI 10.2337/db07-1761; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mancini JE, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-14; Marcal AC, 2013, CELL BIOCHEM FUNCT, V31, P65, DOI 10.1002/cbf.2861; Martin TD, 2014, AM J PHYSIOL-ENDOC M, V306, pE1397, DOI 10.1152/ajpendo.00064.2014; Miller WP, 2016, INVEST OPHTH VIS SCI, V57, P1327, DOI 10.1167/iovs.15-18719; Parillo M, 2004, BRIT J NUTR, V92, P7, DOI 10.1079/BJN20041117; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rajagopal R, 2016, DIABETES, V65, P1072, DOI 10.2337/db15-1255; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Su KH, 2016, NAT CELL BIOL, V18, P527, DOI 10.1038/ncb3335; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; U.S. Department of Health and Human Service, 2014, NAT DIAB STAT REP, P9; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Zhang J, 2013, BBA-MOL BASIS DIS, V1832, P1980, DOI 10.1016/j.bbadis.2013.06.013; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	48	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1591	1602		10.1074/jbc.M116.760868	http://dx.doi.org/10.1074/jbc.M116.760868			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965359	hybrid, Green Published			2022-12-26	WOS:000395515600005
J	Ishii, T; Ueyama, T; Shigyo, M; Kohta, M; Kondoh, T; Kuboyama, T; Uebi, T; Hamada, T; Gutmann, DH; Aiba, A; Kohmura, E; Tohda, C; Saito, N				Ishii, Taiji; Ueyama, Takehiko; Shigyo, Michiko; Kohta, Masaaki; Kondoh, Takeshi; Kuboyama, Tomoharu; Uebi, Tatsuya; Hamada, Takeshi; Gutmann, David H.; Aiba, Atsu; Kohmura, Eiji; Tohda, Chihiro; Saito, Naoaki			A Novel Rac1-GSPT1 Signaling Pathway Controls Astrogliosis Following Central Nervous System Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; CELL-CYCLE ARREST; NADPH OXIDASE; RAC1 ACTIVITY; CANCER-CELLS; BRAIN-INJURY; IN-VIVO; REACTIVE ASTROGLIOSIS; ISCHEMIA-REPERFUSION; COMPLEX-FORMATION	Astrogliosis (i.e. glial scar), which is comprised primarily of proliferated astrocytes at the lesion site and migrated astrocytes from neighboring regions, is one of the key reactions in determining outcomes after CNS injury. In an effort to identify potential molecules/pathways that regulate astrogliosis, we sought to determine whether Rac/Rac-mediated signaling in astrocytes represents a novel candidate for therapeutic intervention following CNS injury. For these studies, we generated mice with Rac1 deletion under the control of the GFAP (glial fibrillary acidic protein) promoter (GFAP-Cre; Rac1(flox/flox)). GFAP-Cre; Rac1(flox/flox) (Rac1-KO) mice exhibited better recovery after spinal cord injury and exhibited reduced astrogliosis at the lesion site relative to control. Reduced astrogliosis was also observed in Rac1-KO mice following microbeam irradiation-induced injury. Moreover, knockdown (KD) or KO of Rac1 in astrocytes (LN229 cells, primary astrocytes, or primary astrocytes from Rac1-KO mice) led to delayed cell cycle progression and reduced cell migration. Rac1-KD or Rac1-KO astrocytes additionally had decreased levels of GSPT1 (G1 to S phase transition 1) expression and reduced responses of IL-1 beta and GSPT1 to LPS treatment, indicating that IL-1 beta and GSPT1 are downstream molecules of Rac1 associated with inflammatory condition. Furthermore, GSPT1-KD astrocytes had cell cycle delay, with no effect on cell migration. The cell cycle delay induced by Rac1-KD was rescued by overexpression of GSPT1. Based on these results, we propose that Rac1-GSPT1 represents a novel signaling axis in astrocytes that accelerates proliferation in response to inflammation, which is one important factor in the development of astrogliosis/glial scar following CNS injury.	[Ishii, Taiji; Ueyama, Takehiko; Uebi, Tatsuya; Hamada, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Shigyo, Michiko; Kuboyama, Tomoharu; Tohda, Chihiro] Toyama Univ, Inst Nat Med, Dept Biosci, Div Neuromed Sci, Toyama 9300194, Japan; [Kohta, Masaaki; Kondoh, Takeshi; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo 6500017, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Aiba, Atsu] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Anim Resources, Tokyo 1130033, Japan	Kobe University; University of Toyama; Kobe University; Washington University (WUSTL); University of Tokyo	Ueyama, T; Saito, N (corresponding author), 1-1 Rokkodai Cho,Nada Ku, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp	SHIGYO, MICHIKO/W-8435-2019; Kuboyama, Tomoharu/S-2639-2016	SHIGYO, MICHIKO/0000-0002-8523-9867; Kuboyama, Tomoharu/0000-0003-3037-9974; Aiba, Atsu/0000-0002-8192-0778; Kohta, Masaaki/0000-0001-5936-7163; Gutmann, David/0000-0002-3127-5045	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26460340, 25861276, 26670044, 25293060]; Suzuken Memorial Foundation [09-048]; Institute of Natural Medicine, University of Toyama	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Institute of Natural Medicine, University of Toyama	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 26460340 (to T. Ueyama), 25861276 (to M. K.), 26670044 (to C. T.), and 25293060 (to N. S.), by the Suzuken Memorial Foundation (Grant 09-048 to T. Ueyama), and by a Grant-in Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama in 2015 and 2016 (to T. Ueyama). The authors declare that they have no conflicts of interest with the contents of this article.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Chauvin C, 2005, MOL CELL BIOL, V25, P5801, DOI 10.1128/MCB.25.14.5801-5811.2005; Chauvin C, 2007, MOL CELL BIOL, V27, P5619, DOI 10.1128/MCB.00035-07; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Davies T, 2012, J CELL BIOL, V198, P769, DOI 10.1083/jcb.201207197; Denes A, 2013, DIS MODEL MECH, V6, P1043, DOI 10.1242/dmm.011601; Fujita Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00338; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; KIKUCHI Y, 1988, EMBO J, V7, P1175, DOI 10.1002/j.1460-2075.1988.tb02928.x; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9690; Liu LN, 2014, ONCOL REP, V32, P1395, DOI 10.3892/or.2014.3388; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Nair S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-173; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nariyama N, 2009, APPL RADIAT ISOTOPES, V67, P155, DOI 10.1016/j.apradiso.2008.08.002; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ovcharenko D, 2005, RNA, V11, P985, DOI 10.1261/rna.7288405; Ozaki M, 2000, FASEB J, V14, P418, DOI 10.1096/fasebj.14.2.418; Pedersen E, 2012, J CELL SCI, V125, P5379, DOI 10.1242/jcs.107011; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shirafuji T, 2014, J NEUROSCI, V34, P9268, DOI 10.1523/JNEUROSCI.4278-13.2014; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Talukder MAH, 2013, AM J PHYSIOL-HEART C, V304, pH294, DOI 10.1152/ajpheart.00367.2012; Teshigawara K, 2013, BRIT J PHARMACOL, V168, P903, DOI 10.1111/j.1476-5381.2012.02211.x; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2001, J NEUROCHEM, V79, P903, DOI 10.1046/j.1471-4159.2001.00624.x; Ueyama T, 2016, EMBO MOL MED, V8, P1310, DOI 10.15252/emmm.201606609; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P671, DOI 10.1107/S090904951101185X; Wang SJ, 2012, J CELL BIOL, V199, P331, DOI 10.1083/jcb.201202041; Xiao RL, 2015, BIOMED PHARMACOTHER, V74, P138, DOI 10.1016/j.biopha.2015.08.006; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Yukinaga H, 2014, J CELL SCI, V127, P1805, DOI 10.1242/jcs.139733; Zhang L, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/5026984	58	20	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1240	1250		10.1074/jbc.M116.748871	http://dx.doi.org/10.1074/jbc.M116.748871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941025	hybrid, Green Published			2022-12-26	WOS:000393339800009
J	Chowdhury, S; Yung, E; Pintilie, M; Muaddi, H; Chaib, S; Yeung, M; Fusciello, M; Sykes, J; Pitcher, B; Hagenkort, A; Mckee, T; Vellanki, R; Chen, E; Bristow, RG; Wouters, BG; Koritzinsky, M				Chowdhury, Sanjana; Yung, Eric; Pintilie, Melania; Muaddi, Hala; Chaib, Selim; Yeung, ManTek; Fusciello, Manlio; Sykes, Jenna; Pitcher, Bethany; Hagenkort, Anna; Mckee, Trevor; Vellanki, Ravi; Chen, Eric; Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne			MATE2 Expression Is Associated with Cancer Cell Response to Metformin	PLOS ONE			English	Article							CATION TRANSPORTER 1; GENETIC-VARIATION; POPULATION PHARMACOKINETICS; THERAPEUTIC RESPONSE; DIABETES-MELLITUS; RENAL CLEARANCE; BREAST-CANCER; TUMOR HYPOXIA; VARIANTS; POLYMORPHISMS	Background There is great interest in repurposing the commonly prescribed anti-diabetic drug metformin for cancer therapy. Intracellular uptake and retention of metformin is affected by the expression of organic cation transporters (OCT) 1-3 and by multidrug and toxic compound extrusion (MATE) 1-2. Inside cells, metformin inhibits mitochondrial function, which leads to reduced oxygen consumption and inhibition of proliferation. Reduced oxygen consumption can lead to improved tumor oxygenation and radiation response. Purpose Here we sought to determine if there is an association between the effects of metformin on inhibiting oxygen consumption, proliferation and expression of OCTs and MATEs in a panel of 19 cancer cell lines. Results There was relatively large variability in the anti-proliferative response of different cell lines to metformin, with a subset of cell lines being very resistant. In contrast, all cell lines demonstrated sensitivity to the inhibition of oxygen consumption by metformin, with relatively small variation. The expression of OCT1 correlated with expression of both OCT2 and OCT3. OCT1 and OCT2 were relatively uniformly expressed, whereas expression of OCT3, MATE1 and MATE2 showed substantial variation across lines. There were statistically significant associations between resistance to inhibition of proliferation and MATE2 expression, as well as between sensitivity to inhibition of oxygen consumption and OCT3 expression. One cell line (LNCaP) with high OCT3 and low MATE2 expression in concert, had substantially higher intracellular metformin concentration than other cell lines, and was exquisitely sensitive to both anti-proliferative and anti-respiratory effects. In all other celllines, the concentration of metformin required to inhibit oxygen consumption acutely in vitro was substantially higher than that achieved in the plasma of diabetic patients. However, administering anti-diabetic doses of metformin to tumor-bearing mice resulted in intratumoral accumulation of metformin and reduced hypoxic tumor fractions. Conclusions All cancer cells are susceptible to inhibition of oxygen consumption by metformin, which results in reduced hypoxic tumor fractions beneficial for the response to radiotherapy. High MATE2 expression may result in resistance to the anti-proliferative effect of metformin and should be considered as a negative predictive biomarker in clinical trials.	[Chowdhury, Sanjana; Yung, Eric; Pintilie, Melania; Muaddi, Hala; Chaib, Selim; Yeung, ManTek; Fusciello, Manlio; Sykes, Jenna; Pitcher, Bethany; Hagenkort, Anna; Mckee, Trevor; Vellanki, Ravi; Chen, Eric; Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Chowdhury, Sanjana; Yung, Eric; Muaddi, Hala; Bristow, Robert G.; Koritzinsky, Marianne] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Chaib, Selim; Fusciello, Manlio; Hagenkort, Anna; Wouters, Bradly G.] Maastricht Univ, Maastricht, Netherlands; [Bristow, Robert G.; Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Maastricht University; University of Toronto; University of Toronto	Koritzinsky, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.	mkoritzi@uhnresearch.ca	Vellanki, Ravi/M-8738-2019; Muaddi, Hala/AAE-1264-2021; McKee, Trevor David/N-4308-2019; Wouters, Bradly/T-1525-2017	Vellanki, Ravi/0000-0002-5081-3187; Muaddi, Hala/0000-0001-9721-2808; McKee, Trevor David/0000-0002-2195-6146; Wouters, Bradly/0000-0002-8187-592X; Bristow, Robert/0000-0002-8553-9544; Chaib, Selim/0000-0003-0497-2002; Fusciello, Manlio/0000-0002-7166-3018; Koritzinsky, Marianne/0000-0003-0547-2480	Ontario Ministry of Health and Long Term Care; Princess Margaret Cancer Foundation; Prostate Cancer Canada [20R17798]; Terry Fox Research Institute (New Frontiers Research Program) [PPG14-1036]	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Cancer Foundation(University of Toronto); Prostate Cancer Canada; Terry Fox Research Institute (New Frontiers Research Program)	This work was financially supported by the Ontario Ministry of Health and Long Term Care, the Princess Margaret Cancer Foundation, Prostate Cancer Canada (PG# 20R17798 to RGB and MK) and the Terry Fox Research Institute (New Frontiers Research Program PPG14-1036; to M.K, R.G.B and B.G.W). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Dr. R. Grenman at Turku University Hospital for providing cell lines 16A/B, 19A/B and 74A/B and Stephen Chung for technical assistance. This work was financially supported by the Ontario Ministry of Health and Long Term Care, the Princess Margaret Cancer Foundation, Prostate Cancer Canada (PG# 20R17798 to RGB and MK) and the Terry Fox Research Institute (New Frontiers Research Program PPG14-1036; to M.K, R.G.B and B.G.W). The views hereby expressed do not necessarily reflect the views of these organizations.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Cai H, 2016, INT J CANCER, V138, P2281, DOI 10.1002/ijc.29965; Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010; Chen EC, 2015, MOL PHARMACOL, V88, P75, DOI 10.1124/mol.114.096776; Chen Y, 2009, PHARMACOGENET GENOM, V19, P497, DOI 10.1097/FPC.0b013e32832cc7e9; Choi JH, 2011, CLIN PHARMACOL THER, V90, P674, DOI 10.1038/clpt.2011.165; Christensen MMH, 2013, PHARMACOGENET GENOM, V23, P526, DOI 10.1097/FPC.0b013e328364a57d; Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; Dowling RJO, 2016, CELL METAB, V23, P567, DOI 10.1016/j.cmet.2016.03.006; Dujic T, 2016, DIABETIC MED, V33, P511, DOI 10.1111/dme.13040; Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388; Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Hockel M, 1996, CANCER RES, V56, P4509; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Jang IS, 2014, BIOCOMPUT-PAC SYM, P63; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Joshua AM, 2014, PROSTATE CANCER P D, V17, P252, DOI 10.1038/pcan.2014.20; Kelly CJ, 2014, RADIOTHER ONCOL, V111, P72, DOI 10.1016/j.radonc.2014.02.007; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koritzinsky M, 2015, INT J RADIAT ONCOL, V93, P454, DOI 10.1016/j.ijrobp.2015.06.003; Kreso Antonija, 2008, Curr Protoc Stem Cell Biol, VChapter 3, DOI 10.1002/9780470151808.sc0301s7; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Margel D, 2013, JOURNAL OF CLINICAL; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Motohashi H, 2013, AAPS J, V15, P581, DOI 10.1208/s12248-013-9465-7; Muaddi H, 2013, RADIOTHERAPY ONCOLOG; Niraula S, 2012, BREAST CANCER RES TR, V135, P821, DOI 10.1007/s10549-012-2223-1; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelis RM, 2014, CURR TOP MEMBR, V73, P233, DOI 10.1016/B978-0-12-800223-0.00006-2; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Rieken M, 2013, BJU INT, V112, P1105, DOI 10.1111/bju.12448; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Skinner HD, 2013, CANCER MED-US, V2, P99, DOI 10.1002/cam4.54; Skinner HD, 2013, ACTA ONCOL, V52, P1002, DOI 10.3109/0284186X.2012.718096; Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Tkac I, 2013, DIABETES OBES METAB, V15, P189, DOI 10.1111/j.1463-1326.2012.01691.x; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; van den Beucken T, 2013, J CELL BIOL; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wouters BG, 2002, EUR J CANCER, V38, P240, DOI 10.1016/S0959-8049(01)00361-6; Wu W, 2014, BRIT J CANCER, V111, P628, DOI 10.1038/bjc.2014.307; Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z; Zannella VE, 2013, CLIN CANC RES	64	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0165214	10.1371/journal.pone.0165214	http://dx.doi.org/10.1371/journal.pone.0165214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959931	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900001
J	Zhang, WJ; He, WL; Shi, YJ; Gu, HF; Li, M; Liu, ZM; Feng, YL; Zheng, NZ; Xie, CM; Zhang, YN				Zhang, Weijing; He, Weiling; Shi, Yongjie; Gu, Haifeng; Li, Min; Liu, Zhimin; Feng, Yanling; Zheng, Nianzhen; Xie, Chuanmiao; Zhang, Yanna			High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASES; FOLLOW-UP; CANCER; KINESIN; ANTIGEN; IDENTIFICATION; INHIBITION; ACTIVATION; PROTEIN; GROWTH	Background The kinesin family member 20a (KIF20A) protein has been implicated in the development and progression of many human cancers; however, its precise function and role in cervical cancer remain largely unclear. This study aimed to investigate the expression profile and prognostic value of KIF20A in patients with early-stage cervical squamous cell carcinoma. Methods We examined the mRNA and protein levels of KIF20A in eight cervical cancer cell lines and eight paired cervical cancer samples, compared with normal cervical epithelial cells and adjacent normal cervical tissues, respectively. Immunohistochemistry was performed to detect the expression of KIF20A in paraffin-embedded specimens from 169 early-stage cervical squamous cell carcinoma patients. Statistical analyses were applied to analyze the association between KIF20A expression and clinical variables, as well with patient survival. Results The mRNA and protein expression levels of KIF20A were significantly elevated in cervical cancer cell lines and lesions compared with normal cells and corresponding normal tissues (P < 0.05). Immunohistochemistry analysis in 169 cervical cancer cases revealed that increased KIF20A expression was strongly associated with human papillomavirus (HPV) infection (P = 0.008), clinical stage (P = 0.001), tumor recurrence (P = 0.016), vital status (P < 0.001), the property of the surgical margin (P = 0.032), the lymphovascular space involvement (P = 0.014), and pelvic lymph node metastasis (P = 0.001). The overall survival and disease-free survival of patients with high levels of KIF20A expression were significantly poorer than those with low KIF20A expression. KIF20A was an independent survival prognostic factor, as evidenced by univariate and multivariate analysis. Conclusions Our results illustrate that elevated KIF20A expression correlates with HPV infection, clinical stage, tumor recurrence, lymphovascular space involvement, pelvic lymph node metastasis, and poor outcome in early-stage cervical squamous cell carcinoma patients. KIF20A aberrant expression is a novel independent unfavorable prognostic factor and may present a potential therapeutic target for cervical cancer.	[Zhang, Weijing; Gu, Haifeng; Li, Min; Liu, Zhimin; Feng, Yanling; Xie, Chuanmiao; Zhang, Yanna] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [He, Weiling] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China; [Shi, Yongjie] Guangzhou Med Univ, Affiliated Hosp 2, Clin Examinat Dept, Guangzhou, Guangdong, Peoples R China; [Zheng, Nianzhen] Sun Yat Sen Univ, Zhongshan Med Sch, Eight Year Program, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Xie, CM; Zhang, YN (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	xiechm@sysucc.org.cn; zhangyn@sysucc.org.cn	Zhang, Weijing/GQA-9455-2022					[Anonymous], 2003, WHO CLASSIFICATION T; Bedkowska Grazyna Ewa, 2007, Postepy Hig Med Dosw (Online), V61, P122; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Biewenga P, 2011, CANCER-AM CANCER SOC, V117, P768, DOI 10.1002/cncr.25658; Cesur O, 2015, VIRUSES-BASEL, V7, P3443, DOI 10.3390/v7072780; Chang TC, 2004, CANCER, V101, P164, DOI 10.1002/cncr.20349; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; de Moraes GN, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.26; DiSaia PJ, 2002, CLIN GYNECOLOGIC ONC, P53; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Esajas MD, 2001, J CLIN ONCOL, V19, P3960, DOI 10.1200/JCO.2001.19.19.3960; Exertier P, 2013, ONCOTARGET, V4, P2302, DOI 10.18632/oncotarget.1490; Fang H, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968467; Gaarenstroom KN, 2000, GYNECOL ONCOL, V77, P164, DOI 10.1006/gyno.2000.5732; Gadducci A, 2008, CRIT REV ONCOL HEMAT, V66, P10, DOI 10.1016/j.critrevonc.2007.09.002; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Hacker NF, 2015, BEREK HACKERS GYNECO, P326; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; Ikeda S, 2012, J OBSTET GYNAECOL RE, V38, P1260, DOI 10.1111/j.1447-0756.2012.01862.x; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim HJ, 2015, RADIAT ONCOL J, V33, P126, DOI 10.3857/roj.2015.33.2.126; Kitagawa M, 2014, CELL REP, V7, P166, DOI 10.1016/j.celrep.2014.02.034; Lai F, 2000, GENE, V248, P117, DOI 10.1016/S0378-1119(00)00135-9; Landoni F, 2014, GYNECOL ONCOL, V132, P611, DOI 10.1016/j.ygyno.2013.12.010; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Lekskul Navamol, 2015, Asian Pac J Cancer Prev, V16, P4719; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122361; Lin YJ, 2016, ASIAN NURS RES, V10, P45, DOI 10.1016/j.anr.2016.01.001; Liu F. L., 2016, ONCOTARGET; Liu LX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0183-5; Lu Y, 2011, AM J TRANSL RES, V3, P8; Markowska Janina, 2007, Ginekol Pol, V78, P715; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Pishas KI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11465; Porika M, 2010, ASIAN PAC J CANCER P, V11, P1745; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Richardson LA, 2015, CANCER CYTOPATHOL; Shang C, 2016, ONCOL REP; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stangel D, 2015, J SURG RES, V197, P91, DOI 10.1016/j.jss.2015.03.070; Taniuchi K, 2005, CANCER RES, V65, P105; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Yeh SA, 1999, GYNECOL ONCOL, V72, P10, DOI 10.1006/gyno.1998.5217; Yoon SM, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-78; Yuan SH, 2008, CLIN CANCER RES, V14, P5571, DOI 10.1158/1078-0432.CCR-08-0346; Zhang LF, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-4; Zhang W, 2016, ONCOGENE; Zhang W., 2015, TUMOUR BIOL; Zhang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144360; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	57	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167449	10.1371/journal.pone.0167449	http://dx.doi.org/10.1371/journal.pone.0167449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941992	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600017
J	Castro-Izaguirre, N; Chi, XL; Baruffol, M; Tang, ZY; Ma, KP; Schmid, B; Niklaus, PA				Castro-Izaguirre, Nadia; Chi, Xiulian; Baruffol, Martin; Tang, Zhiyao; Ma, Keping; Schmid, Bernhard; Niklaus, Pascal A.			Tree Diversity Enhances Stand Carbon Storage but Not Leaf Area in a Subtropical Forest	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SPECIES RICHNESS; STRUCTURAL COMPLEXITY; PRODUCTIVITY; BIODIVERSITY; INCREASES; GROWTH; ROOT	Research about biodiversity-productivity relationships has focused on herbaceous ecosystems, with results from tree field studies only recently beginning to emerge. Also, the latter are concentrated largely in the temperate zone. Tree species diversity generally is much higher in subtropical and tropical than in temperate or boreal forests, with reasons not fully understood. Niche overlap and thus complementarity in the use of resources that support productivity may be lower in forests than in herbaceous ecosystems, suggesting weaker productivity responses to diversity change in forests. We studied stand basal area, vertical structure, leaf area, and their relationship with tree species richness in a subtropical forest in south-east China. Permanent forest plots of 30 x 30 m were selected to span largely independent gradients in tree species richness and secondary successional age. Plots with higher tree species richness had a higher stand basal area. Also, stand basal area increases over a 4-year census interval were larger at high than at low diversity. These effects translated into increased carbon stocks in aboveground phytomass (estimated using allometric equations). A higher variability in tree height in more diverse plots suggested that these effects were facilitated by denser canopy packing due to architectural complementarity between species. In contrast, leaf area was not or even negatively affected by tree diversity, indicating a decoupling of carbon accumulation from leaf area. Alternatively, the same community leaf area might have assimilated more C per time interval in more than in less diverse plots because of differences in leaf turnover and productivity or because of differences in the display of leaves in vertical and horizontal space. Overall, our study suggests that in species-rich forests niche-based processes support a positive diversity-productivity relationship and that this translates into increased carbon storage in long-lived woody structures. Given the high growth rates of these forests during secondary succession, our results further indicate that a forest management promoting tree diversity after disturbance may accelerate CO2 sequestration from the atmosphere and thus be relevant in a climate-change context.	[Castro-Izaguirre, Nadia; Baruffol, Martin; Schmid, Bernhard; Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing, Peoples R China; [Chi, Xiulian; Tang, Zhiyao] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing, Peoples R China; [Ma, Keping] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	University of Zurich; Peking University; Peking University; Chinese Academy of Sciences; Institute of Botany, CAS	Castro-Izaguirre, N; Niklaus, PA (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	nadia.castro@ieu.uzh.ch; pascal.niklaus@ieu.uzh.ch	Niklaus, Pascal A/G-5786-2010; Tang, Zhiyao/B-8795-2008; Schmid, Bernhard/C-8625-2009; Baruffol, Martin/A-2406-2014	Niklaus, Pascal A/0000-0002-2360-1357; Schmid, Bernhard/0000-0002-8430-3214; Baruffol, Martin/0000-0001-9358-5885	German Science Foundation [DFG FOR-891]; Swiss National Science Foundation [130720]; University of Zurich; National Natural Science Foundation of China [30710103907, 31470486, 31321061]	German Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by a German Science Foundation grant to PAN (DFG FOR-891 TP1), a Swiss National Science Foundation grant to BS (130720), the University of Zurich, and National Natural Science Foundation of China grants to KPM (30710103907) and ZT (31470486, 31321061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Gutianshan National Nature Reserve and the BEF-China team for their logistic support. This project was funded a German research foundation grant to PAN (DFG FOR 891 TP1) and the University of Zurich.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barrufol M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081246; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Chisholm RA, 2013, J ECOL, P101; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Ewel JJ, 2015, BIOTROPICA, V47, P162, DOI 10.1111/btp.12190; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Farrior CE, 2016, SCIENCE, V351, P155, DOI 10.1126/science.aad0592; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Hardiman BS, 2013, FOREST ECOL MANAG, V298, P111, DOI 10.1016/j.foreco.2013.02.031; Hardiman BS, 2011, ECOLOGY, V92, P1818, DOI 10.1890/10-2192.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huang Y, 2017, J PLANT ECOLOGY; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jacob M, 2010, ANN FOREST SCI, V67, DOI [10.1051/forest/2009094, DOI 10.1051/FOREST/2009094]; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Jucker T, 2015, FUNCT ECOL, V29, P1078, DOI 10.1111/1365-2435.12428; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lou LuHuan, 2000, Journal of Beijing Forestry University, V22, P33; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; Meinen C, 2009, ECOSYSTEMS, V12, P1103, DOI 10.1007/s10021-009-9271-3; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Palacio S, 2014, NEW PHYTOL, V201, P1096, DOI 10.1111/nph.12602; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Piotto D, 2008, FOREST ECOL MANAG, V255, P781, DOI 10.1016/j.foreco.2007.09.065; Poorter L, 2015, GLOBAL ECOL BIOGEOGR, V24, P1314, DOI 10.1111/geb.12364; Potvin C, 2008, ECOL LETT, V11, P217, DOI 10.1111/j.1461-0248.2007.01148.x; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Ruiz-Benito P, 2014, GLOBAL ECOL BIOGEOGR, V23, P311, DOI 10.1111/geb.12126; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schleppi P, 2007, AGR FOREST METEOROL, V144, P236, DOI 10.1016/j.agrformet.2007.02.004; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Seidel D, 2013, FOREST ECOL MANAG, V310, P366, DOI 10.1016/j.foreco.2013.08.058; Shi L, 2011, PLOS ONE, V6; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Wang LC, 2014, ADV INTEL SYS RES, V109, P9, DOI 10.1371/journal.pone.0085683; WANG Y, 2011, BIOGEOSCIENCES, V8, P2099, DOI DOI 10.5194/bg-8-2099-2011; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	53	20	20	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167771	10.1371/journal.pone.0167771	http://dx.doi.org/10.1371/journal.pone.0167771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936198	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000389587100182
J	Gibellini, L; De Biasi, S; Bianchini, E; Bartolomeo, R; Fabiano, A; Manfredini, M; Ferrari, F; Albertini, G; Trenti, T; Nasi, M; Pinti, M; Iannone, A; Salvarani, C; Cossarizza, A; Pellacani, G				Gibellini, Lara; De Biasi, Sara; Bianchini, Elena; Bartolomeo, Regina; Fabiano, Antonella; Manfredini, Marco; Ferrari, Federica; Albertini, Giuseppe; Trenti, Tommaso; Nasi, Milena; Pinti, Marcello; Iannone, Anna; Salvarani, Carlo; Cossarizza, Andrea; Pellacani, Giovanni			Anti-TNF-alpha Drugs Differently Affect the TNF alpha-sTNFR System and Monocyte Subsets in Patients with Psoriasis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; PHASE-III; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS; THERAPY; INFLIXIMAB; ETANERCEPT; DISEASE	TNF-alpha has a central role in the development and maintenance of psoriatic plaques, and its serum levels correlate with disease activity. Anti-TNF-alpha drugs are, however, ineffective in a relevant percentage of patients for reasons that are currently unknown. To understand whether the response to anti-TNF-alpha drugs is influenced by the production of anti-drug antibodies or by the modulation of the TNF alpha-TNF alpha receptor system, and to identify changes in monocyte phenotype and activity, we analysed 119 psoriatic patients who either responded or did not respond to different anti-TNF-alpha therapies (adalimumab, etanercept or infliximab), and measured plasma levels of TNF-alpha, TNF-alpha soluble receptors, drug and anti-drug antibodies. Moreover, we analyzed the production of TNF-alpha and TNF-alpha soluble receptors by peripheral blood mononuclear cells (PBMCs), and characterized different monocyte populations. We found that: i) the drug levels varied between responders and non-responders; ii) anti-infliximab antibodies were present in 15% of infliximab-treated patients, while anti-etanercept or anti-adalimumab antibodies were never detected; iii) plasma TNF-alpha levels were higher in patients treated with etanercept compared to patients treated with adalimumab or infliximab; iv) PBMCs from patients responding to adalimumab and etanercept produced more TNF-alpha and sTNFRII in vitro than patients responding to infliximab; v) PBMCs from patients not responding to infliximab produce higher levels of TNF-alpha and sTNFRII than patients responding to infliximab; vi) anti-TNF-alpha drugs significantly altered monocyte subsets. A complex remodelling of the TNF alpha-TNF alpha receptor system thus takes place in patients treated with anti-TNF-alpha drugs, that involves either the production of anti-drug antibodies or the modulation of monocyte phenotype or inflammatory activity.	[Gibellini, Lara; De Biasi, Sara; Bartolomeo, Regina; Fabiano, Antonella; Manfredini, Marco; Ferrari, Federica; Nasi, Milena; Salvarani, Carlo; Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy; [Bianchini, Elena; Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Albertini, Giuseppe] IRCCS Santa Maria Nuova Hosp, Dermatol Unit, Reggio Emilia, Italy; [Trenti, Tommaso] NOCSAE Baggiovara, Dept Clin Pathol, Modena, Italy; [Iannone, Anna] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Salvarani, Carlo] IRCCS Santa Maria Nuova Hosp, Reumatol Unit, Reggio Emilia, Italy; [Cossarizza, Andrea] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy.	andrea.cossarizza@unimore.it	Iannone, Anna/A-8872-2017; pellacani, giovanni/E-8573-2011; Salvarani, Carlo/K-2431-2018; De Biasi, Sara/AAB-7520-2019; Trenti, Tommaso/K-8457-2016; Pinti, Marcello/C-9351-2015	Iannone, Anna/0000-0002-6151-7818; pellacani, giovanni/0000-0002-7222-2951; De Biasi, Sara/0000-0002-3217-9821; Trenti, Tommaso/0000-0001-8093-4011; Pinti, Marcello/0000-0001-9118-1262; Manfredini, Marco/0000-0003-3601-655X; Cossarizza, Andrea/0000-0002-5381-1558	Pfizer [WI128634]; Fondazione Cassa di Risparmio di Vignola	Pfizer(Pfizer); Fondazione Cassa di Risparmio di Vignola	This work was supported by an unrestricted grant from Pfizer (number: WI128634) to GP, and by Fondazione Cassa di Risparmio di Vignola to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardigo M, 2015, J EUR ACAD DERMATOL, V29, P2363, DOI 10.1111/jdv.13235; Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021; Atzeni F, 2008, EXPERT REV CLIN IMMU, V4, P275, DOI 10.1586/1744666X.4.2.275; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9; Bonifati C, 1999, INT J DERMATOL, V38, P241, DOI 10.1046/j.1365-4362.1999.00622.x; Cassinotti A, 2009, INFLAMM BOWEL DIS, V15, P1264, DOI 10.1002/ibd.20899; Chara L, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3928; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Cossarizza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050728; De Biasi S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0515-0; De Simone C, 2015, J EUR ACAD DERMATOL, V29, P1786, DOI 10.1111/jdv.13024; Fantuzzi F, 2008, EXPERT OPIN THER TAR, V12, P1085, DOI 10.1517/14728222.12.9.1085 ; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Gallo E, 2013, BRIT J DERMATOL, V169, P819, DOI 10.1111/bjd.12425; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Haider AS, 2008, J INVEST DERMATOL, V128, P655, DOI 10.1038/sj.jid.5701064; Haider AS, 2007, J INVEST DERM SYMP P, V12, P9, DOI 10.1038/sj.jidsymp.5650032; Hanai H, 2008, AM J GASTROENTEROL, V103, P1210, DOI 10.1111/j.1572-0241.2007.01714.x; Hsu L, 2014, BRIT J DERMATOL, V170, P261, DOI 10.1111/bjd.12654; Hunter HJA, 2013, BRIT J DERMATOL, V169, P965, DOI 10.1111/bjd.12478; Jankovic S, 2009, ACTA DERM-VENEREOL, V89, P364, DOI 10.2340/00015555-0669; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Mizutani H, 1997, J DERMATOL SCI, V14, P145, DOI 10.1016/S0923-1811(96)00562-2; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Nazareth N, 2014, CLIN EXP IMMUNOL, V177, P703, DOI 10.1111/cei.12375; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Romani J, 2013, ARCH DERMATOL RES, V305, P105, DOI 10.1007/s00403-012-1306-5; Shen C, 2005, ALIMENT PHARM THER, V21, P251, DOI 10.1111/j.1365-2036.2005.02309.x; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Vasilopoulos Y, 2012, MOL DIAGN THER, V16, P29, DOI 10.2165/11594660-000000000-00000; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	40	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167757	10.1371/journal.pone.0167757	http://dx.doi.org/10.1371/journal.pone.0167757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936119	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100176
J	Guihard, PJ; Yao, JY; Blazquez-Medela, AM; Iruela-Arispe, L; Bostrom, KI; Yao, YC				Guihard, Pierre J.; Yao, Jiayi; Blazquez-Medela, Ana M.; Iruela-Arispe, Luisa; Bostrom, Kristina I.; Yao, Yucheng			Endothelial-Mesenchymal Transition in Vascular Calcification of Ins2(Akita/+) Mice	PLOS ONE			English	Article							MATRIX GLA PROTEIN; BONE MORPHOGENETIC PROTEIN-4; TISSUE KALLIKREIN; DIABETIC-NEPHROPATHY; ATHEROSCLEROSIS PROGRESSION; TRANSENDOTHELIAL MIGRATION; CELLS; MOUSE; ANGIOGENESIS; DEFICIENCY	Endothelial-mesenchymal transition (EndMT) drives endothelium to contribute to normal development and disease processes. Here, we report that EndMTs occur in the diabetic endothelium of Ins(2Akita/wt) mouse, and show that induction of sex determining region Y-box 2 (Sox2) is a mediator of excess BMP signaling that results in activation of EndMTs and increased vascular calcification. We also find an induction of a complex of serine proteases in the diabetic endothelium, required for the up-regulation of Sox2. Our results suggest that EndMTs contribute to vascular calcification in diabetic arteries.	[Guihard, Pierre J.; Yao, Jiayi; Blazquez-Medela, Ana M.; Bostrom, Kristina I.; Yao, Yucheng] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Iruela-Arispe, Luisa; Bostrom, Kristina I.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Iruela-Arispe, Luisa; Yao, Yucheng] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Bostrom, KI; Yao, YC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA.; Bostrom, KI (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Yao, YC (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.	yyao@mednet.ucla.edu; kbostrom@mednet.ucla.edu	Guihard, Pierre J/S-1157-2018; Blázquez-Medela, Ana/ABC-1517-2021; Guihard, Pierre/AAT-3571-2020; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Blazquez-Medela, Ana/K-3142-2014	Guihard, Pierre J/0000-0001-5824-0160; Guihard, Pierre/0000-0001-5824-0160; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Blazquez-Medela, Ana/0000-0003-3829-6997; Yao, Jiayi/0000-0001-9235-2406	National Institute Health grants [NS79353, HL30568, HL81397, HL112839]; American Heart Association (Western Affiliate); NIH [NS79353, HL30568, HL81397, HL112839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL081397, R01HL112839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079353] Funding Source: NIH RePORTER	National Institute Health grants; American Heart Association (Western Affiliate)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided in part by National Institute Health grants NS79353, HL30568, HL81397 and HL112839, and the American Heart Association (Western Affiliate). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was provided in part by NIH grants NS79353, HL30568, HL81397 and HL112839, and the American Heart Association (Western Affiliate).	Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Azizi M, 2005, J CLIN INVEST, V115, P780, DOI 10.1172/JCI200523669; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Bieth Joseph G., 2001, Journal de la Societe de Biologie, V195, P173; Bostrom KI, 2012, STEM CELLS, V30, P386, DOI 10.1002/stem.1027; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Campbell DJ, 2010, DIABETOLOGIA, V53, P779, DOI 10.1007/s00125-009-1645-8; Cepinskas G, 1999, J CELL SCI, V112, P1937; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Emami N, 2007, CLIN CHIM ACTA, V381, P78, DOI 10.1016/j.cca.2007.02.023; Emanueli C, 2001, CIRCULATION, V103, P125; Feng B, 2016, DIABETES, V65, P768, DOI 10.2337/db15-1033; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gu HF, 2009, GENDER MED, V6, P555, DOI 10.1016/j.genm.2009.11.001; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Khavandgar Z, 2013, J BONE MINER RES; Kovacic JC, 2012, CIRCULATION, V125, P1795, DOI 10.1161/CIRCULATIONAHA.111.040352; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lin T, 2012, INT J DEV NEUROSCI, V30, P113, DOI 10.1016/j.ijdevneu.2011.12.004; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Maurice P, 2013, TRENDS CARDIOVAS MED, V23, P211, DOI 10.1016/j.tcm.2012.12.004; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Nagai T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/696475; Patschan D, 2014, AM J PHYSIOL-RENAL, V307, pF686, DOI 10.1152/ajprenal.00650.2013; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Sinha A, 2013, DIABETES VASC DIS RE, V10, P410, DOI 10.1177/1479164113485101; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Towler DA, 2015, CIRC RES, V117, P744, DOI 10.1161/CIRCRESAHA.115.307407; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Welch-Reardon KM, 2015, ARTERIOSCL THROM VAS, V35, P303, DOI 10.1161/ATVBAHA.114.303220; Yao JY, 2015, CIRC RES, V117, P758, DOI 10.1161/CIRCRESAHA.115.306751; Yao YC, 2008, CIRC RES, V102, P1065, DOI 10.1161/CIRCRESAHA.107.166124; Yao Y, 2007, J BIOL CHEM, V282, P30131, DOI 10.1074/jbc.M704297200; Yao YC, 2006, J BIOL CHEM, V281, P33921, DOI 10.1074/jbc.M604239200; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Yayama K, 2003, BBA-MOL CELL RES, V1593, P231, DOI 10.1016/S0167-4889(02)00393-2	51	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167936	10.1371/journal.pone.0167936	http://dx.doi.org/10.1371/journal.pone.0167936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936229	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100233
J	Jia, CL; Kong, XY; Koltes, JE; Gou, X; Yang, SL; Yan, DW; Lu, SX; Wei, ZH				Jia, Cunling; Kong, Xiaoyan; Koltes, James E.; Gou, Xiao; Yang, Shuli; Yan, Dawei; Lu, Shaoxiong; Wei, Zehui			Gene Co-Expression Network Analysis Unraveling Transcriptional Regulation of High Altitude Adaptation of Tibetan Pig	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REVEALS ADAPTATION; HEMOGLOBIN CONCENTRATION; HYPOXIA; GENOME; EXPRESSION; SELECTION; PATTERNS; PROTEIN; DOMAIN	Tibetan pigs have survived at high altitude for millennia and they have a suite of adaptive features to tolerate the hypoxic environment. However, the molecular mechanisms underlying the regulation of hypoxia-adaptive phenotypes have not been completely elucidated. In this study, we analyzed differentially expressed genes (DEGs), biological pathways and constructed co-expression regulation networks using whole-transcriptome microarrays from lung tissues of Tibetan and Duroc pigs both at high and low altitude. A total of 3,066 DEGs were identified and this list was over-represented for the ontology terms including metabolic process, catalytic activity, and KEGG pathway including metabolic pathway and PI3K-Akt signaling pathway. The regulatory (RIF) and phenotypic (PIF) impact factor analysis identified several known and several potentially novel regulators of hypoxia adaption, including: IKBKG, KLF6 and RBPJ(RIF1), SF3B1, EFEMP1, HOXB6 and ATF6(RIF2). These findings provide new details of the regulatory architecture of hypoxia-adaptive genes and also insight into which genes may undergo epigenetic modification for further study in the high altitude adaptation.	[Jia, Cunling; Wei, Zehui] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Kong, Xiaoyan; Gou, Xiao; Yang, Shuli; Yan, Dawei; Lu, Shaoxiong] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China; [Koltes, James E.] Univ Arkansas, Dept Anim Sci, Fayetteville, AR 72701 USA	Northwest A&F University - China; Yunnan Agricultural University; University of Arkansas System; University of Arkansas Fayetteville	Wei, ZH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Lu, SX (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.	shxl@126.com; weizehui7848@163.com		Jia, Cunling/0000-0002-2753-2352	National High Technology Research and Development Program 863 [2013AA102503]; National Natural Science Foundation of China [U1036604, 31260542]	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program 863 (http://program.most.gov.cn/) Grant # 2013AA102503, to XG; National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grant # U1036604, to ZHW and National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grant # 31260542 to DWY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-834; Bastian FB, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav043; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2000, HUM BIOL, V72, P201; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Chen JJ, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/768756; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; Clerici C, 2009, AM J PHYSIOL-LUNG C, V296, pL267, DOI 10.1152/ajplung.90528.2008; Dolatshad H, 2015, LEUKEMIA, V29, P1798, DOI 10.1038/leu.2015.178; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Koesterke L., 2013, P C EXTR SCI ENG DIS; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Liu L, 2013, AM J PATHOL, V182, P1412, DOI 10.1016/j.ajpath.2012.12.020; Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067; MacInnis MJ, 2010, HIGH ALT MED BIOL, V11, P349, DOI 10.1089/ham.2010.1030; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mirtschink P, 2016, BBA-MOL CELL RES, V1863, P1822, DOI 10.1016/j.bbamcr.2016.02.011; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Perez-Perri JI, 2011, INT J MOL SCI, V12, P4705, DOI 10.3390/ijms12074705; Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013; Qiu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10283; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Roach RC, 2013, HYPOXIA GENES BEDSID; Sakai A, 2003, JPN J PHYSIOL, V53, P377, DOI 10.2170/jjphysiol.53.377; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shifera AS, 2010, J CELL MOL MED, V14, P2404, DOI 10.1111/j.1582-4934.2010.01054.x; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Singh RS, 2015, GENOME, V58, P55, DOI 10.1139/gen-2015-0012; Sit B, 2013, UNIVERSITY OF TORONT, V7; Song S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2449-0; Stepanek J, 1998, WILD ENVIRON MED, V9, P8, DOI 10.1580/1080-6032(1998)009[0008:TPAAAM]2.3.CO;2; STREETER RG, 1975, J APPL PHYSIOL, V38, P309, DOI 10.1152/jappl.1975.38.2.309; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Watson JA, 2010, EPIGENETICS-US, V5, P293, DOI 10.4161/epi.5.4.11684; Wei CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26770; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00584; Zhang FX, 2015, INT J CLIN EXP PATHO, V8, P5189; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhang W. T., 2014, CHINESE TEA, V10, P10, DOI DOI 10.1371/J0URNAL.PPAT.1004244; Zimmermann F, 1997, BLOOD, V89, P2723, DOI 10.1182/blood.V89.8.2723	68	18	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168161	10.1371/journal.pone.0168161	http://dx.doi.org/10.1371/journal.pone.0168161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936142	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100276
J	Ratajczak, J; Hilkens, P; Gervois, P; Wolfs, E; Jacobs, R; Lambrichts, I; Bronckaers, A				Ratajczak, Jessica; Hilkens, Petra; Gervois, Pascal; Wolfs, Esther; Jacobs, Reinhilde; Lambrichts, Ivo; Bronckaers, Annelies			Angiogenic Capacity of Periodontal Ligament Stem Cells Pretreated with Deferoxamine and/or Fibroblast Growth Factor-2	PLOS ONE			English	Article							HYDROXYLASE INHIBITORS INCREASE; REGENERATIVE MEDICINE; FACTOR EXPRESSION; STROMAL CELLS; DIFFERENTIATION; CULTURE; VEGF	Periodontal ligament stem cells (PDLSCs) represent a good source of multipotent cells for cell-based therapies in regenerative medicine. The success rate of these treatments is severely dependent on the establishment of adequate vasculature in order to provide oxygen and nutrients to the transplanted cells. Pharmacological preconditioning of stem cells has been proposed as a promising method to augment their therapeutic efficacy. In this study, the aim was to improve the intrinsic angiogenic properties of PDLSCs by in vitro pretreatment with deferoxamine (DFX; 100 mu M), fibroblast growth factor-2 (FGF-2; 10ng/mL) or both substances combined. An antibody array revealed the differential expression of several proteins, including vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). ELISA data confirmed a 1.5 to 1.8-fold increase in VEGF for all tested conditions. Moreover, 48 hours after the removal of DFX, VEGF levels remained elevated (1.8-fold) compared to control conditions. FGF-2 and combination treatment resulted in a 5.4 to 13.1-fold increase in PlGF secretion, whereas DFX treatment had no effect. Furthermore, both PDLSCs as pretreated PDLSCs induced endothelial migration. Despite the significant elevated VEGF levels of pretreated PDLSCs, the induced endothelial migration was not higher by pretreated PDLSCs. We find that the observed induced endothelial cell motility was not dependent on VEGF, since blocking the VEGFR1-3 with Axitinib (0.5nM) did not inhibit endothelial motility towards PDLSCs. Taken together, this study provides evidence that preconditioning with DFX and/or FGF-2 significantly improves the angiogenic secretome of PDLSCs, in particular VEGF and PlGF secretion. However, our data suggest that VEGF is not the only player when it comes to influencing endothelial behavior by the PDLSCs.	[Ratajczak, Jessica; Hilkens, Petra; Gervois, Pascal; Wolfs, Esther; Lambrichts, Ivo; Bronckaers, Annelies] Hasselt Univ, Biomed Res Inst, Morphol Res Grp, Diepenbeek, Belgium; [Jacobs, Reinhilde] Univ Leuven, Fac Med, Dept Imaging & Pathol, OMFS IMPATH Res Grp,Oral Imaging Ctr, Leuven, Belgium	Hasselt University; KU Leuven	Bronckaers, A (corresponding author), Hasselt Univ, Biomed Res Inst, Morphol Res Grp, Diepenbeek, Belgium.	annelies.bronckaers@uhasselt.be	Lambrichts, Ivo/CAJ-1727-2022; Wolfs, Esther/H-1862-2017; Gervois, Pascal/AAC-4624-2022; Hilkens, Petra/ABE-4972-2020	Wolfs, Esther/0000-0001-9277-6524; Bronckaers, Annelies/0000-0001-8969-873X; jacobs, reinhilde/0000-0002-3461-0363; Lambrichts, Ivo/0000-0001-7520-0021; Gervois, Pascal/0000-0002-8320-1320	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO') [G089213N]	Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO')(FWO)	This research was supported by grants to Ivo Lambrichts, Reinhilde Jacobs and Jessica Ratajczak from the Research Foundation-Flanders ('Fonds Wetenschappelijk onderzoek Vlaanderen-FWO', grant no G089213N). Annelies Bronckaers and Petra Hilkens are postdoctoral fellows of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agis H, 2012, J PERIODONTAL RES, V47, P165, DOI 10.1111/j.1600-0765.2011.01415.x; Bando Y, 2009, J PERIODONTAL RES, V44, P395, DOI 10.1111/j.1600-0765.2008.01118.x; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chimote G, 2014, DRUG DES DEV THER, V8, P1107, DOI 10.2147/DDDT.S55621; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gerwins P, 2000, CRIT REV ONCOL HEMAT, V34, P185, DOI 10.1016/S1040-8428(00)00062-7; Hilkens P, 2014, STEM CELL RES, V12, P778, DOI 10.1016/j.scr.2014.03.008; Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x; Kubo M, 2008, AM J PHYSIOL-HEART C, V294, pH590, DOI 10.1152/ajpheart.00856.2007; Lee MJ, 2010, BIOCHEM BIOPH RES CO, V396, P370, DOI 10.1016/j.bbrc.2010.04.099; Liu GS, 2016, J TISSUE ENG REGEN M, V10, pE167, DOI 10.1002/term.1796; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Muller HD, 2012, J ENDODONT, V38, P1498, DOI 10.1016/j.joen.2012.08.003; Muscari C, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-63; Nakamura S, 2008, BIO-MED MATER ENG, V18, P129, DOI 10.3233/BME-2008-0516; Nokhbehsaim M, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/796565; Osathanon T, 2015, ARCH ORAL BIOL, V60, P29, DOI 10.1016/j.archoralbio.2014.08.018; Oyama T, 2000, J PERIODONTOL, V71, P1546, DOI 10.1902/jop.2000.71.10.1546; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Yanagita M, 2014, J DENT RES, V93, P89, DOI 10.1177/0022034513511640; Yeasmin S, 2014, TISSUE ENG PT A, V20, P1188, DOI [10.1089/ten.TEA.2013.0512, 10.1089/ten.tea.2013.0512]	28	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167807	10.1371/journal.pone.0167807	http://dx.doi.org/10.1371/journal.pone.0167807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936076	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100200
J	Reese, AT; Ames, GM; Wright, JP				Reese, Aspen T.; Ames, Gregory M.; Wright, Justin P.			Variation in Plant Response to Herbivory Underscored by Functional Traits	PLOS ONE			English	Article							LATITUDINAL VARIATION; SIMULATED HERBIVORY; HABITAT SPECIALIZATION; RESOURCE AVAILABILITY; TOLERANCE; RESISTANCE; EVOLUTION; PATTERNS; ECOLOGY; GROWTH	The effects of herbivory can shape plant communities and evolution. However, the many forms of herbivory costs and the wide variation in herbivory pressure, including across latitudinal gradients, can make predicting the effects of herbivory on different plant species difficult. Functional trait approaches may aid in contextualizing and standardizing the assessment of herbivory impacts. Here we assessed the response of 26 old-field plant species to simulated defoliation in a greenhouse setting by measuring whole plant and leaf level traits in control and treated individuals. Simulated defoliation had no significant effects on any plant traits measured. However, the baseline leaf level traits of healthy plants consistently predicted the log response ratio for these species whole plant response to defoliation. The latitudinal mid-point of species' distributions was also significantly correlated with aboveground biomass and total leaf area responses, with plants with a more northern distribution being more negatively impacted by treatment. These results indicate that even in the absence of significant overall impacts, functional traits may aid in predicting variability in plant responses to defoliation and in identifying the underlying limitations driving those responses.	[Reese, Aspen T.; Ames, Gregory M.; Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Reese, AT (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	aspen.reese@duke.edu	Wright, Justin/AAG-6461-2019	Wright, Justin/0000-0002-9102-5347; Ames, Gregory/0000-0003-4893-5318	National Science Foundation [DGE 1106401, DEB-1119715]; Division Of Environmental Biology [1119715] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ATR was supported by National Science Foundation Graduate Research Fellowship Program under Grant No. DGE 1106401. JPW was supported by National Science Foundation grant DEB-1119715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2016, J ECOL, V104, P580, DOI 10.1111/1365-2745.12512; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Ames GM, 2016, FUNCT ECOL, V30, P789, DOI 10.1111/1365-2435.12536; Anstett DN, 2015, ECOL LETT, V18, P1376, DOI 10.1111/ele.12532; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; BALDWIN IT, 1988, OECOLOGIA, V77, P378, DOI 10.1007/BF00378046; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; Bossdorf O, 2004, AM J BOT, V91, P856, DOI 10.3732/ajb.91.6.856; BROWN VK, 1989, OIKOS, V54, P67, DOI 10.2307/3565898; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carson WP, 1999, OECOLOGIA, V121, P260, DOI 10.1007/s004420050928; CHOONG MF, 1992, NEW PHYTOL, V121, P597, DOI 10.1111/j.1469-8137.1992.tb01131.x; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crawley M. J., 1983, Herbivory. The dynamics of animal--plant interactions.; Diaz A, 2000, AGR ECOSYST ENVIRON, V78, P249, DOI 10.1016/S0167-8809(99)00131-0; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Escarre J, 1996, OECOLOGIA, V105, P501, DOI 10.1007/BF00330013; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hjalten J, 2004, ECOL STU AN, V173, P243; HJALTEN J, 1993, ECOLOGY, V74, P1136, DOI 10.2307/1940483; Hjalten J, 1999, ECOSCIENCE, V6, P62; Houle G, 1996, OECOLOGIA, V107, P373, DOI 10.1007/BF00328454; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; Lamarre GPA, 2012, ECOLOGY, V93, pS195, DOI 10.1890/11-0397.1; Lehtila K, 2004, ECOL STU AN, V173, P257; Lim JY, 2015, GLOBAL ECOL BIOGEOGR, V24, P1106, DOI 10.1111/geb.12336; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Moles AT, 2011, NEW PHYTOL, V191, P777, DOI 10.1111/j.1469-8137.2011.03732.x; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moreira X, 2014, ECOL LETT, V17, P537, DOI 10.1111/ele.12253; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; QUESADA M, 1995, ECOLOGY, V76, P437, DOI 10.2307/1941202; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; ROOT RB, 1992, ECOL MONOGR, V62, P393, DOI 10.2307/2937117; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Siefert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111189; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strickland MS, 2013, P NATL ACAD SCI USA, V110, P11035, DOI 10.1073/pnas.1305191110; Tiffin P, 2000, EVOLUTION, V54, P1024, DOI 10.1111/j.0014-3820.2000.tb00101.x; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; TURNER IM, 1994, FUNCT ECOL, V8, P669, DOI 10.2307/2390225; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wieski K, 2014, ECOGRAPHY, V37, P763, DOI 10.1111/ecog.00498; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright JP, 2010, J BIOGEOGR, V37, P1584, DOI 10.1111/j.1365-2699.2010.02298.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	71	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166714	10.1371/journal.pone.0166714	http://dx.doi.org/10.1371/journal.pone.0166714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936155	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100043
J	Sato, S; Chiba, T				Sato, Shin'ichi; Chiba, Tomoki			Structural Changes in Molluscan Community over a 15-Year Period before and after the 2011 Great East Japan Earthquake and Subsequent Tsunami around Matsushima Bay, Miyagi Prefecture, Northeastern Japan	PLOS ONE			English	Article							GASTROPODA NATICIDAE; SENDAI BAY; RECOVERY; IMPACTS; SEA; POPULATIONS; VEGETATION; RESPONSES; INVASION; PREDATOR	We examined structural changes in the molluscan community for ten years (2001-2010) before and five years (2011-2015) after the 2011 Great East Japan Earthquake and subsequent tsunami around Matsushima Bay, Miyagi Prefecture, northeastern Japan. Before the earthquake and tsunami, Ruditapes philippinarum, Macoma incongrua, Pillucina pisidium, and Batillaria cumingii were dominant, and an alien predator Laguncula pulchella appeared in 2002 and increased in number. After the tsunami, R. philippinarum and M. incongrua populations quickly recovered in 2012, but P. pisidium and B. cumingii populations did not recover until 2015. By contrast, Musculista senhousia, Mya arenaria, Retusa sp., and Solen strictus were found in low densities before the tsunami, but they rapidly increased in abundance/number over five years after the tsunami. These results suggest that the molluscan community on the Tona Coast was drastically changed by the earthquake and tsunami, and some species mainly inhabiting the intertidal-subtidal zone may have increased in number because of land subsidence. We also emphasize that the seawall delayed recovery of the intertidal community after the earthquake and tsunami.	[Sato, Shin'ichi] Shizuoka Univ, Inst Geosci, Shizuoka, Japan	Shizuoka University	Sato, S (corresponding author), Shizuoka Univ, Inst Geosci, Shizuoka, Japan.	sato.shinichi.c@shizuoka.ac.jp			Tohoku Ecosystem-Associated Marine Science (TEAMS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan	Tohoku Ecosystem-Associated Marine Science (TEAMS) from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by the research fund from Tohoku Ecosystem-Associated Marine Science (TEAMS), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthis WL, 2006, ENVIRON MONIT ASSESS, V119, P367, DOI 10.1007/s10661-005-9031-6; Beukema JJ, 1999, J SEA RES, V42, P235, DOI 10.1016/S1385-1101(99)00027-1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borja A, 2010, ESTUAR COAST, V33, P1249, DOI 10.1007/s12237-010-9347-5; Chiba T, 2014, LETHAIA, V47, P4, DOI 10.1111/let.12033; Chiba T, 2013, BIOL INVASIONS, V15, P587, DOI 10.1007/s10530-012-0310-1; Chiba T, 2012, J MOLLUS STUD, V78, P205, DOI 10.1093/mollus/eys002; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; El uber M., 2015, COMPENDIUM BIVALVES, V2; Furota Toshio, 2002, Venus (Tokyo), V61, P15; Geospatial Information Authority of Japan, LAND SUBS CAUS 2011; Geospatial Information Authority of Japan, 5 YEARS 2011 TOH EAR; Hayasaka D, 2012, ECOL ENG, V44, P227, DOI 10.1016/j.ecoleng.2012.03.014; Huber M., 2010, COMPENDIUM BIVALVES; Japanese Association of Benthology, 2012, THREATENED ANIMALS J; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G, 2008, ESTUAR COAST SHELF S, V78, P674, DOI 10.1016/j.ecss.2008.02.005; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Kroeker KJ, 2013, NAT CLIM CHANGE, V3, P156, DOI [10.1038/NCLIMATE1680, 10.1038/nclimate1680]; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; MATSUSHIMA Y, 1984, B KANAGAWA PREF MUS, V15, P37; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Okutani T., 2017, MARINE MOLLUSKS JAPA; PETERSON CH, 1985, PALEOBIOLOGY, V11, P139; R Core Team, 2020, R LANG ENV STAT COMP; RHOADS DC, 1970, J MAR RES, V28, P150; Sato Shin'Ichi, 2006, Plankton & Benthos Research, V1, P123; Sato S, 2016, ECOL RES MONOGR, P179, DOI 10.1007/978-4-431-56448-5_13; Sato S, 2012, FISHERIES SCI, V78, P589, DOI 10.1007/s12562-012-0491-7; Schlacher TA, 2011, ESTUAR COAST, V34, P937, DOI 10.1007/s12237-010-9354-6; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Suzuki T., 2011, J JAPAN SOC WATER EN, V34, P395; Takami H, 2013, FISH OCEANOGR, V22, P113, DOI 10.1111/fog.12008; The 2011 Tohoku Earthquake Tsunami Joint Survey (TTJS) Group, 2011 OFF PAC COAST T; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001	42	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168206	10.1371/journal.pone.0168206	http://dx.doi.org/10.1371/journal.pone.0168206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936182	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100277
J	Tamaki, FK; Souza, DP; Souza, VP; Ikegami, CM; Farah, CS; Marana, SR				Tamaki, Fabio K.; Souza, Diorge P.; Souza, Valquiria P.; Ikegami, Cecilia M.; Farah, Chuck S.; Marana, Sandro R.			Using the Amino Acid Network to Modulate the Hydrolytic Activity of beta-Glycosidases	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; STRUCTURE VALIDATION; TRICHODERMA-REESEI; MIDGUT CELLS; GLUCOSIDASE; RESIDUES; SITE; PURIFICATION; MUTAGENESIS; RESOLUTION	The active site residues in GH1 beta-glycosidases are compartmentalized into 3 functional regions, involved in catalysis or binding of glycone and aglycone motifs from substrate. However, it still remains unclear how residues outside the active site modulate the enzymatic activity. To tackle this question, we solved the crystal structure of the GH1 beta-glycosidase from Spodoptera frugiperda (Sf beta gly) to systematically map its residue contact network and correlate effects of mutations within and outside the active site. External mutations neighbouring the functional residues involved in catalysis and glycone-binding are deleterious, whereas mutations neighbouring the aglycone-binding site are less detrimental or even beneficial. The large dataset of new and previously characterized Sfpgly mutants supports that external perturbations are coherently transmitted to active site residues possibly through contacts and specifically disturb functional regions they interact to, reproducing the effects observed for direct mutations of functional residues. This allowed us to suggest that positions related to the aglycone-binding site are preferential targets for introduction of mutations aiming to further improve the hydrolytic activity of beta-glycosidases.	[Tamaki, Fabio K.; Souza, Diorge P.; Souza, Valquiria P.; Ikegami, Cecilia M.; Farah, Chuck S.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Tamaki, Fabio K.] Inst Med Sci, Foresterhill, Aberdeen, Scotland	Universidade de Sao Paulo	Tamaki, FK (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.; Tamaki, FK (corresponding author), Inst Med Sci, Foresterhill, Aberdeen, Scotland.	fktamaki@gmail.com	Marana, Sandro/D-3867-2012; Tamaki, Fabio K./L-6024-2013; Farah, Chuck Shaker/G-5565-2012; Souza, Valquiria/F-8726-2015	Marana, Sandro/0000-0002-5117-1921; Tamaki, Fabio K./0000-0003-2515-8202; Farah, Chuck Shaker/0000-0003-3110-6302; Souza, Valquiria/0000-0002-3052-2112; Souza, Diorge/0000-0003-1303-1765	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/55914-9, 14/19439-5]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Instituto Nacional de Ciencias e Tecnologia para o Bioetanol [08/57908-1, 574002/2008-1]; FAPESP; CAPES/PNPD post-doctoral fellowship; Capes	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencias e Tecnologia para o Bioetanol; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PNPD post-doctoral fellowship; Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Grants 08/55914-9 and 14/19439-5), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and "Instituto Nacional de Ciencias e Tecnologia para o Bioetanol" (Grants: 08/57908-1 and 574002/2008-1). S.R.M and C.S.F are research fellows of CNPq. F.K.T. and D.P.S were supported by post-doctoral scholarships from FAPESP. D.P.S. and F.K.T. acknowledge a CAPES/PNPD post-doctoral fellowship. F.K.T. is a CNPq "Science Without Borders" fellow. C.M.I is a graduate student supported by Capes and V.P.S is a graduate student supported by FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MW, 1996, J BIOL CHEM, V271, P23749, DOI 10.1074/jbc.271.39.23749; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuenchor W, 2008, J MOL BIOL, V377, P1200, DOI 10.1016/j.jmb.2008.01.076; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA C, 1983, BIOCHEM J, V213, P43, DOI 10.1042/bj2130043; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Husebye H, 2005, INSECT BIOCHEM MOLEC, V35, P1311, DOI 10.1016/j.ibmb.2005.07.004; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Khan S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-11; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HL, 2012, PROTEIN ENG DES SEL, V25, P733, DOI 10.1093/protein/gzs073; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Marana SR, 2004, EUR J BIOCHEM, V271, P4169, DOI 10.1111/j.1432-1033.2004.04354.x; Marana SR, 2003, EUR J BIOCHEM, V270, P4866, DOI 10.1046/j.1432-1033.2003.03887.x; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Marana SR, 2000, INSECT BIOCHEM MOLEC, V30, P1139, DOI 10.1016/S0965-1748(00)00090-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendonca LMF, 2008, FEBS J, V275, P2536, DOI 10.1111/j.1742-4658.2008.06402.x; Mendonca LMF, 2011, BBA-PROTEINS PROTEOM, V1814, P1616, DOI 10.1016/j.bbapap.2011.08.012; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Resa P, 2011, ANAL BIOCHEM, V415, P1, DOI 10.1016/j.ab.2011.03.003; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Tamaki Fabio K, 2016, Biochem Biophys Rep, V7, P52, DOI 10.1016/j.bbrep.2016.05.014; Tamaki FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096627; Tomassi MH, 2010, BRAZ J MED BIOL RES, V43, P8, DOI 10.1590/S0100-879X2009007500033	46	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167978	10.1371/journal.pone.0167978	http://dx.doi.org/10.1371/journal.pone.0167978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936116	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100244
J	Zhang, I; Alizadeh, D; Liang, JL; Zhang, LY; Gao, H; Song, YY; Ren, H; Ouyang, M; Wu, XW; D'Apuzzo, M; Badie, B				Zhang, Ian; Alizadeh, Darya; Liang, Junling; Zhang, Leying; Gao, Hang; Song, Yanyan; Ren, Hui; Ouyang, Mao; Wu, Xiwei; D'Apuzzo, Massimo; Badie, Behnam			Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; MYELOID CELLS; PROMOTES; THERAPY; GROWTH; PROGRESSION; INVASION	Microglia (MG) and macrophages (MPs) represent a significant component of the inflammatory response to gliomas. When activated, MG/MP release a variety of pro-inflammatory cytokines, however, they also secrete anti-inflammatory factors that limit their cytotoxic function. The balance between pro and anti-inflammatory functions dictates their antitumor activity. To evaluate potential variations in MG and MP function in gliomas, we isolated these cells (and other Gr1(+) cells) from intracranial GL261 murine gliomas by FACS and evaluated their gene expression profiles by microarray analysis. As expected, arginase 1 (Arg1, M2 marker) was highly expressed by tumor-associated Gr1(+), MG and MP. However, in contrast to MP and Gr1(+) cells that expressed Arg1 shortly after tumor trafficking, Arg1 expression in MG was delayed and occurred in larger tumors. Interestingly, depletion of MPs in tumors did not prevent MG polarization, suggesting direct influence of tumor-specific factors on MG Arg1 upregulation. Finally, Arg1 expression was confirmed in human GBM samples, but most Arg1(+) cells were neutrophils and not MPs. These findings confirm variations in tumor MG and MP polarization states and its dependency on tumor microenvironmental factors.	[Zhang, Ian; Alizadeh, Darya; Zhang, Leying; Badie, Behnam] City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA; [Liang, Junling] Zhejiang Univ, Coll Life Sci, Res Ctr Siyuan Nat Pharm & Biotoxicol, Hangzhou, Zhejiang, Peoples R China; [Gao, Hang] Jilin Univ, Hosp 1, Dept Bone & Joint Surg, Changchun, Jilin Province, Peoples R China; [Song, Yanyan] Jilin Univ, Hosp 2, Dept Nephrol, Changchun, Jilin Province, Peoples R China; [Ren, Hui] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Jilin Province, Peoples R China; [Ouyang, Mao] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Hunan, Peoples R China; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA USA; [D'Apuzzo, Massimo] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; Jilin University; Jilin University; Jilin University; Central South University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Badie, B (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosurg, Duarte, CA 91010 USA.	bbadie@coh.org			National Cancer Institute and National Institute of Neurological Disorders [R01CA1 55769, R21NS081594, R21CA1 89223]; National Cancer Institute of the National Institutes of Health [P30CA33572]	National Cancer Institute and National Institute of Neurological Disorders; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute and National Institute of Neurological Disorders (R01CA1 55769, R21NS081594, R21CA1 89223), and the Flow Cytometry Core supported by the National Cancer Institute of the National Institutes of Health under award number (P30CA33572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, CLIN CANCER RES, V16, P3399, DOI 10.1158/1078-0432.CCR-09-3087; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Galarneau H, 2007, CANCER RES, V67, P8874, DOI 10.1158/0008-5472.CAN-07-0177; Kohanbash G, 2013, CANCER RES, V73, P6413, DOI 10.1158/0008-5472.CAN-12-4124; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Kushchayev SV, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2012.11.059; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sippel TR, 2011, CLIN CANCER RES, V17, P6992, DOI 10.1158/1078-0432.CCR-11-1107; Terada K, 2006, GENE THER, V13, P705, DOI 10.1038/sj.gt.3302717; Tripathi P, 2007, INDIAN J BIOCHEM BIO, V44, P310; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Van Overmeire E, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27561; Wang HQ, 2013, CLIN CANCER RES, V19, P3764, DOI 10.1158/1078-0432.CCR-12-3725; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248	25	32	32	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165118	10.1371/journal.pone.0165118	http://dx.doi.org/10.1371/journal.pone.0165118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936099	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100009
J	Jia, L; Yan, F; Cao, WF; Chen, ZM; Zheng, H; Li, HX; Pan, Y; Narula, N; Ren, XB; Li, H; Zhou, PB				Jia, Lei; Yan, Fan; Cao, Wenfeng; Chen, Zhengming; Zheng, Hong; Li, Haixin; Pan, Yi; Narula, Navneet; Ren, Xiubao; Li, Hui; Zhou, Pengbo			Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE MICROARRAY; P53 EXPRESSION; PROGRESSION; MUTATIONS; CARCINOMA; ENCODES; SUBUNIT; SMOKING	The Cullin-RING ubiquitin ligase 4 (CRL4) is implicated in controlling cell cycle, DNA damage repair, and checkpoint response based on studies employing cell lines and mouse models. CRL4 proteins, including CUL4A and CUL4B, are often highly accumulated in human malignancies. Elevated CRL4 attenuatesDNAdamage repair and increases genome instability that is believed to facilitate tumorigenesis. However, this has yet to be evaluated in human patients with cancer. In our study, 352 lung cancer and 62 normal lung specimens of Asian origin were constructed into tissue microarrays of four distinct lung cancer subtypes. Expression of CUL4A, CUL4B, and their substrates was detected by immunohistochemistry and analyzed statistically for their prognostic value and association with DNA damage response and genomic instability. Our results show that both CUL4A and CUL4B are overexpressed in the majority of lung carcinomas (P-CUL4A < 0.001 and P-CUL4B < 0.001) and significantly associated with tumor size (P-CUL4A < 0.001 and P-CUL4B = 0.002), lymphatic invasion (P-CUL4A = 0.004 and P-CUL4B < 0.001), metastasis (P-CUL4A = 0.019 and P-CUL4B = 0.006), and advanced TNM stage (P-CUL4A < 0.001 and P-CUL4B < 0.001), which parallels gene amplification and abnormal activation of the canonical WNT signaling. Moreover, overexpression of CUL4A, but not CUL4B, is significantly associated with tobacco smoking (p = 0.01) and is inversely correlated withXPC and P21, both of which are substrates ofCUL4A(P-CUL4A = 0.019 and P-CUL4B = 0.006). Higher levels of CUL4A or CUL4B are significantly associated with the overall survival of patients(P-CUL4A <0.001 and P-CUL4B <0.001) and progression-free survival (P-CUL4A <0.001 and P-CUL4B = 0.001). Our findings revealed that CUL4A and CUL4B are differentially associated with etiologic factors for pulmonary malignancies and are independent prognostic markers for the survival of distinct lung cancer subtypes.	[Jia, Lei; Yan, Fan; Ren, Xiubao; Li, Hui; Zhou, Pengbo] Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Key Lab Canc Immunol & Biotherapy, Tianjin 300060, Peoples R China; [Cao, Wenfeng; Pan, Yi] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Key Lab Tianjin Canc Prevent & Treatment, Tianjin 300060, Peoples R China; [Zheng, Hong; Li, Haixin] Tianjin Med Univ, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Dept Epidemiol & Biostat,Tianjin Key Lab Canc Pre, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin 300060, Peoples R China; [Li, Hui] Tianjin Med Univ, Canc Inst & Hosp, Dept Gastrointestinal Canc Biol, Tianjin 300060, Peoples R China; [Yan, Fan; Narula, Navneet; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Cornell University; Cornell University	Ren, XB; Li, H; Zhou, PB (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Key Lab Canc Immunol & Biotherapy, Tianjin 300060, Peoples R China.; Li, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Gastrointestinal Canc Biol, Tianjin 300060, Peoples R China.; Zhou, PB (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.	rwziyi@yahoo.com; lihui@tjmuch.com; pez2001@med.cornell.edu			National Key Technology R&D Program of China [2015BAI12B12]; National Sciences Foundation of China [81272221, 81472471]; Tianjin Medical University Cancer Institute and Hospital Research [B1309]; National Institutes of Health [R01 CA159925, CA098210]; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R56CA098210, R01CA098210, R01CA159925] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Medical University Cancer Institute and Hospital Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Key Technology R&D Program of China Grant 2015BAI12B12, National Sciences Foundation of China Grants 81272221 and 81472471 (to X.R.), Tianjin Medical University Cancer Institute and Hospital Research Grant B1309 (to F.Y.), National Institutes of Health Grants R01 CA159925 and CA098210, and translational grant from the V Foundation for Cancer Research (to P.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Camerini A, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-38; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen LC, 1998, CANCER RES, V58, P3677; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Dai W, 2016, ONCOTARGETS THER, V9, P2297, DOI 10.2147/OTT.S98875; Dohna M, 2000, GENE CHROMOSOME CANC, V28, P145, DOI 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7; Fujikawa H, 2012, J GASTROENTEROL, V47, P775, DOI 10.1007/s00535-012-0532-0; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Hotakainen K, 2003, INT J CANCER, V104, P631, DOI 10.1002/ijc.11000; Hung MS, 2011, J CELL MOL MED, V15, P350, DOI 10.1111/j.1582-4934.2009.00971.x; Idikio HA, 2011, INT J CLIN EXP PATHO, V4, P505; Ishida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103993; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0534-7; Kerzendorfer C, 2011, MECH AGEING DEV, V132, P366, DOI 10.1016/j.mad.2011.02.003; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00021; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Meyers DG, 2008, AM J CARDIOL, V102, P1421, DOI 10.1016/j.amjcard.2008.06.065; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; MORABIA A, 1991, CANCER, V68, P2074, DOI 10.1002/1097-0142(19911101)68:9<2074::AID-CNCR2820680939>3.0.CO;2-X; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Pan WW, 2013, J BIOL CHEM, V288, P29680, DOI 10.1074/jbc.M113.495069; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Sakoda LC, 2012, INT J MOL EPIDEMIOL, V3, P1; Salvi S, 2016, ONCOTARGET, V7, P37839, DOI 10.18632/oncotarget.9341; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; van Cruijsen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-180; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yin Y, 2016, J BIOL CHEM, V291, P6923, DOI 10.1074/jbc.M115.699660; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	46	31	35	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2966	2978		10.1074/jbc.M116.765230	http://dx.doi.org/10.1074/jbc.M116.765230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27974468	hybrid, Green Published			2022-12-26	WOS:000395535100036
J	Nordgren, H; Aaltonen, K; Raunio-Saarnisto, M; Sukura, A; Vapalahti, O; Sironen, T				Nordgren, Heli; Aaltonen, Kirsi; Raunio-Saarnisto, Mirja; Sukura, Antti; Vapalahti, Olli; Sironen, Tarja			Experimental Infection of Mink Enforces the Role of Arcanobacterium phocae as Causative Agent of Fur Animal Epidemic Necrotic Pyoderma (FENP)	PLOS ONE			English	Article							ALEUTIAN DISEASE; PATHOGENESIS	Fur Animal Epidemic Necrotic Pyoderma (FENP) is a severe, often lethal infectious disease affecting all three fur animal species: mink (Neovision vision), foxes (Vulpes lagopus) and finnraccoons (Nyctereutes procyonoides). Previous studies showed an association between Arcanobacterium phocae and FENP. An experimental infection was conducted to confirm the ability of A. phocae to infect mink either alone or concurrently with a novel Streptococcus sp. found together with A. phocae in many cases of FENP. Different inoculation methods were tested to study possible routes of transmission. Typical signs, and gross- and histopathological findings for FENP were detected when naive mink were infected with the tissue extract of mink with FENP, using a subcutaneous/intradermal infection route. Edema, hemorrhage, necrosis and pus formation were detected in the infection site. A pure culture preparation of A. phocae alone or concurrently with the novel Streptococcus sp. caused severe acute signs of lethargy, apathy and anorexia and even mortality. The histopathological findings were similar to those found in naturally occurring cases of FENP. In contrast, the perorally infected mink presented no clinical signs nor any gross-or histopathological lesions. This study showed that A. phocae is able to cause FENP. The study also indicated that predisposing factors such as the environment, the general condition of the animals, temperature and skin trauma contribute to the development of the disease.	[Nordgren, Heli] FFBA Finnish Breeders Assoc, Vantaa, Finland; [Nordgren, Heli] Fin Furlab FFBA, Vaasa, Finland; [Nordgren, Heli; Aaltonen, Kirsi; Sukura, Antti; Vapalahti, Olli; Sironen, Tarja] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Aaltonen, Kirsi; Vapalahti, Olli; Sironen, Tarja] Univ Helsinki, Dept Virol, Fac Med, Helsinki, Finland; [Raunio-Saarnisto, Mirja] Finnish Food Safety Author, Evira, Seinajoki, Finland; [Vapalahti, Olli] Hosp Dist Helsinki & Uusimaa, HUSLAB, Dept Virol & Immunol, Helsinki, Finland	University of Helsinki; University of Helsinki; Finnish Food Authority; University of Helsinki; Helsinki University Central Hospital	Nordgren, H (corresponding author), FFBA Finnish Breeders Assoc, Vantaa, Finland.; Nordgren, H (corresponding author), Fin Furlab FFBA, Vaasa, Finland.; Nordgren, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland.	heli.nordgren@helsinki.fi		Aaltonen, Kirsi/0000-0001-8901-6866; Sironen, Tarja/0000-0002-2344-2755; Vapalahti, Olli/0000-0003-2270-6824; Sukura, Antti Kalle Kalervo/0000-0002-8992-1695	Finnish Fur Breeders association (STKL) OV; Reino Rinne Foundation OV	Finnish Fur Breeders association (STKL) OV; Reino Rinne Foundation OV	This work was funded by Finnish Fur Breeders association (STKL) OV and Reino Rinne Foundation OV. Heli Nordgren was affiliated to FFBA Finnish Fur Breeders Association during the course of the study. FFBA Finnish Fur Breeders Association provided support in the form of salary for author HN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Brojer C., 2002, THESIS; Chalmers G, 2015, CAN J VET RES, V79, P129; Johnson SP, 2003, J WILDLIFE DIS, V39, P136, DOI 10.7589/0090-3558-39.1.136; Jost BH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-239; Nordgren H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110210; PORTER DD, 1969, J EXP MED, V130, P575, DOI 10.1084/jem.130.3.575; PORTER DD, 1973, AM J PATHOL, V71, P331; Ramos CP, 1997, INT J SYST BACTERIOL, V32, P419	8	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168129	10.1371/journal.pone.0168129	http://dx.doi.org/10.1371/journal.pone.0168129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973532	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300058
J	Okemoto, K; Maekawa, K; Tajima, Y; Tohkin, M; Saito, Y				Okemoto, Kazuo; Maekawa, Keiko; Tajima, Yoko; Tohkin, Masahiro; Saito, Yoshiro			Cross-Classification of Human Urinary Lipidome by Sex, Age, and Body Mass Index	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ARACHIDONIC-ACID; FATTY-ACIDS; QUANTIFICATION; IDENTIFICATION; HYPERTENSION; METABOLITES; MEDIATORS	Technological advancements in past decades have led to the development of integrative analytical approaches to lipidomics, such as liquid chromatography-mass spectrometry (LC/MS), and information about biogenic lipids is rapidly accumulating. Although several cohort-based studies have been conducted on the composition of urinary lipidome, the data on urinary lipids cross-classified by sex, age, and body mass index (BMI) are insufficient to screen for various abnormalities. To promote the development of urinary lipid metabolomebased diagnostic assay, we analyzed 60 urine samples from healthy white adults (young (c.a., 30 years) and old (c.a., 60 years) men/women) using LC/MS. Women had a higher urinary concentration of omega-3 12-lipoxygenase (LOX)-generated oxylipins with anti-inflammatory activity compared to men. In addition, young women showed increased abundance of poly-unsaturated fatty acids (PUFAs) and cytochrome P450 (P450)-produced oxylipins with anti-hypertensive activity compared with young men, whereas elderly women exhibited higher concentration of 5-LOX-generated anti-inflammatory oxylipins than elderly men. There were no significant differences in urinary oxylipin levels between young and old subjects or between subjects with low and high BMI. Our findings suggest that sex, but neither ages nor BMI could be a confounding factor for measuring the composition of urinary lipid metabolites in the healthy population. The information showed contribute to the development of reliable biomarker findings from urine.	[Okemoto, Kazuo; Maekawa, Keiko; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Okemoto, Kazuo; Tajima, Yoko; Tohkin, Masahiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan	National Institute of Health Sciences - Japan; Nagoya City University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan.	maekawa@nihs.go.jp			Ministry of Health, Labour, and Welfare; Japan Agency for Medical Research and development, AMED	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported in part by "Accelerating regulatory science initiative" from the Ministry of Health, Labour, and Welfare and in part by Grants from Japan Agency for Medical Research and development, AMED(YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FULL LENGTH BLOOD DO; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bruins MJ, 2013, J LIPID RES, V54, P1598, DOI 10.1194/jlr.M034918; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Chiabrando C, 1999, J BIOL CHEM, V274, P1313, DOI 10.1074/jbc.274.3.1313; CLOUET P, 1991, PROSTAGLANDINS, V42, P39; CUNNINGHAM FM, 1985, PROSTAGLANDINS, V30, P497, DOI 10.1016/0090-6980(85)90122-4; de Pinho PG, 2015, BIOANALYSIS; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Fu J, 2016, ANAL BIOANALYTICAL C; Fuller M, 2005, CLIN CHEM, V51, P688, DOI 10.1373/clinchem.2004.041418; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Imig JD, 1999, BRIT J PHARMACOL, V127, P1399, DOI 10.1038/sj.bjp.0702662; Imig JD, 2015, HYPERTENSION, V65, P476, DOI 10.1161/HYPERTENSIONAHA.114.03585; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Klawitter J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-165; KUMLIN M, 1990, ARCH BIOCHEM BIOPHYS, V282, P254, DOI 10.1016/0003-9861(90)90114-E; Lee H, 2014, BIOCHEM BIOPH RES CO, V453, P268, DOI 10.1016/j.bbrc.2014.05.111; Levison BS, 2013, FREE RADICAL BIO MED, V59, P2, DOI 10.1016/j.freeradbiomed.2013.03.001; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Pasikanti KK, 2013, J PROTEOME RES, V12, P3865, DOI 10.1021/pr4000448; Saito K, 2013, METABOLOMICS, V10; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shao SY, 2013, DNA CELL BIOL, V32, P41, DOI 10.1089/dna.2012.1874; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stachowska E, 2007, J AGR FOOD CHEM, V55, P5335, DOI 10.1021/jf0701077; Suzuki N, 2003, J CHROMATOGR B, V783, P383, DOI 10.1016/S1570-0232(02)00666-9; Tessaro FHG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/568408; Tsalik EL, 2015, KIDNEY INT; Zhang HY, 2010, ANAL BIOCHEM, V399, P302, DOI 10.1016/j.ab.2009.12.024; Zhao YY, 2015, ADV CLIN CHEM, V68, P153, DOI 10.1016/bs.acc.2014.11.002; Zosmer A, 2002, J STEROID BIOCHEM, V81, P369, DOI 10.1016/S0960-0760(02)00116-4	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168188	10.1371/journal.pone.0168188	http://dx.doi.org/10.1371/journal.pone.0168188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973561	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300063
J	Jiang, X; Jiang, XY; Feng, Y; Xu, RH; Wang, QT; Deng, HT				Jiang, Xu; Jiang, Xiaoyong; Feng, Yun; Xu, Renhua; Wang, Qingtao; Deng, Haiteng			Proteomic Analysis of eIF5B Silencing-Modulated Proteostasis	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTOR; AGE-DEPENDENT DECREASE; LIFE-SPAN EXTENSION; PROTEIN-SYNTHESIS; REGULATES MTOR; FACTOR 5B; AUTOPHAGY; RNA; TRANSCRIPTION; EXPRESSION	Protein translational machinery is an important component of the proteostasis network that maintains cellular proteostasis and regulates aging and other cellular processes. Ample evidence indicates that inhibition of translation initiation factor activities enhances stress resistance in model organisms. Eukaryotic translation initiation factor 5B (eIF5B) acts by joining the pre-40S subunit with the 60S ribosomal unit to form an 80S-like complex during protein translational initiation. Reduced eIF5B expression may disrupt proteostasis and trigger cellular processes associated with stress responses. In this study, the physiological effects of altered eIF5B expression were examined in 293T and HepG2 cells. Cells with eIF5B-knock-down (eIF5B-KN) grew more slowly than control cells, and had a lower level of intracellular reactive oxygen species (ROS), increased resistance to oxidative stress and enhanced autophagy. Proteomic analysis showed that eIF5B knockdown resulted in upregulation of 88 proteins and downregulation of 130 proteins compared with control cells. The differentially expressed proteins were associated with diverse cellular processes including amino acid metabolism, RNA processing and protein metabolism, and DNA synthesis. Autonomous downregulation of the mitogen-activated protein kinase (MAPK) signaling pathway was identified as confirmed by western blotting and qPCR. We proposed that deactivation of MAPK pathway modulated proteostasis and induced prolonged S-phase of the cell-cycle, contributing to the slow growth of eIF5B-KN cells. eIF5B silencing also inactivated the mTOR pathway, downregulated glutamine transporters, enhanced autophagy, and decreased 28S rRNA and 5.8S rRNA expression levels which were reversed by restoration of eIF5B expression. Taken together, these results suggest that eIF5B silencing provides a negative feedback to deactivate MAPK signaling, leading to reduced cell growth. These findings provide a useful resource to further biological exploration of the functions of protein synthesis in regulation of proteostasis and stress responses.	[Jiang, Xu; Jiang, Xiaoyong; Feng, Yun; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Xu, Renhua] Binzhou Med Univ, Sch Nursing, Yantai, Peoples R China; [Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China	Tsinghua University; Binzhou Medical University; Capital Medical University	Deng, HT (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China.	dht@tsinghua.edu.cn	Jiang, Xu/GQH-7192-2022	Jiang, Xu/0000-0002-2283-6322; Deng, Haiteng/0000-0001-9496-1280	National Natural Science Foundation of China [31270871]; Ministry of Education of China [2012Z02293]; Chinese Ministry of Science and Technology [2014CBA02005, 2014AA020907]; Global Science Alliance Program of Thermo-Fisher Scientific	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Global Science Alliance Program of Thermo-Fisher Scientific	This work was supported by the National Natural Science Foundation of China 31270871 (HTD), the Ministry of Education of China 2012Z02293 (HTD) and the Chinese Ministry of Science and Technology (2014CBA02005 and 2014AA020907) and the Global Science Alliance Program of Thermo-Fisher Scientific. The funders had not played a role in study design, data collection and analysis.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Avissar NE, 2008, DIGEST DIS SCI, V53, P2113, DOI 10.1007/s10620-007-0120-y; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Chen YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127788; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Galmozzi E, 2012, MED HYPOTHESES, V79, P471, DOI 10.1016/j.mehy.2012.06.026; Guegan JP, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/328372; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hiraishi H, 2013, MOL CELL BIOL, V33, P3540, DOI 10.1128/MCB.00771-13; Hu YD, 2014, J PROTEOME RES, V13, P786, DOI 10.1021/pr4010597; KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263; Kitano S, 1998, AM J PHYSIOL-CELL PH, V275, pC146, DOI 10.1152/ajpcell.1998.275.1.C146; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Lee JH, 2002, P NATL ACAD SCI USA, V99, P16689, DOI 10.1073/pnas.262569399; Lee S, 2014, P NATL ACAD SCI USA, V111, pE4315, DOI 10.1073/pnas.1320477111; MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; MOLDAVE K, 1979, FED PROC, V38, P1979; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pisareva VP, 2014, NUCLEIC ACIDS RES, V42, P12052, DOI 10.1093/nar/gku877; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; Thakor N, 2012, NUCLEIC ACIDS RES, V40, P541, DOI 10.1093/nar/gkr701; VARGAS R, 1983, MECH AGEING DEV, V21, P183, DOI 10.1016/0047-6374(83)90073-8; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WEBSTER GC, 1983, MECH AGEING DEV, V22, P121, DOI 10.1016/0047-6374(83)90105-7; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168387	10.1371/journal.pone.0168387	http://dx.doi.org/10.1371/journal.pone.0168387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959964	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900062
J	Konig, SU; Schumann, F; Keyser, J; Goeke, C; Krause, C; Wache, S; Lytochkin, A; Ebert, M; Brunsch, V; Wahn, B; Kaspar, K; Nagel, SK; Meilinger, T; Bulthoff, H; Wolbers, T; Buchel, C; Konig, P				Koenig, Sabine U.; Schumann, Frank; Keyser, Johannes; Goeke, Caspar; Krause, Carina; Wache, Susan; Lytochkin, Aleksey; Ebert, Manuel; Brunsch, Vincent; Wahn, Basil; Kaspar, Kai; Nagel, Saskia K.; Meilinger, Tobias; Buelthoff, Heinrich; Wolbers, Thomas; Buechel, Christian; Koenig, Peter			Learning New Sensorimotor Contingencies: Effects of Long-Term Use of Sensory Augmentation on the Brain and Conscious Perception	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; CROSS-MODAL PLASTICITY; PATH-INTEGRATION; HUMAN NAVIGATION; PARIETAL CORTEX; VISUAL-CORTEX; POSTERIOR PARIETAL; CAUDATE-NUCLEUS; SLEEP STATES; BLIND	Theories of embodied cognition propose that perception is shaped by sensory stimuli and by the actions of the organism. Following sensorimotor contingency theory, the mastery of lawful relations between own behavior and resulting changes in sensory signals, called sensorimotor contingencies, is constitutive of conscious perception. Sensorimotor contingency theory predicts that, after training, knowledge relating to new sensorimotor contingencies develops, leading to changes in the activation of sensorimotor systems, and concomitant changes in perception. In the present study, we spell out this hypothesis in detail and investigate whether it is possible to learn new sensorimotor contingencies by sensory augmentation. Specifically, we designed an fMRI compatible sensory augmentation device, the feelSpace belt, which gives orientation information about the direction of magnetic north via vibrotactile stimulation on the waist of participants. In a longitudinal study, participants trained with this belt for seven weeks in natural environment. Our EEG results indicate that training with the belt leads to changes in sleep architecture early in the training phase, compatible with the consolidation of procedural learning as well as increased sensorimotor processing and motor programming. The fMRI results suggest that training entails activity in sensory as well as higher motor centers and brain areas known to be involved in navigation. These neural changes are accompanied with changes in how space and the belt signal are perceived, as well as with increased trust in navigational ability. Thus, our data on physiological processes and subjective experiences are compatible with the hypothesis that new sensorimotor contingencies can be acquired using sensory augmentation.	[Koenig, Sabine U.; Schumann, Frank; Keyser, Johannes; Goeke, Caspar; Krause, Carina; Wache, Susan; Lytochkin, Aleksey; Ebert, Manuel; Brunsch, Vincent; Wahn, Basil; Kaspar, Kai; Nagel, Saskia K.; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Schumann, Frank] Univ Paris 05, Lab Psychol Percept, Paris, France; [Kaspar, Kai] Univ Cologne, Dept Psychol, Cologne, Germany; [Meilinger, Tobias; Buelthoff, Heinrich] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Wolbers, Thomas] German Ctr Neurodegenerat Dis DZNE, Aging & Cognit Res Grp, Magdeburg, Germany; [Buechel, Christian] Hamburg Univ Hosp Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf	Konig, SU (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	sabkoeni@uos.de	Wahn, Basil/AAV-5770-2021; Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012; König, Peter/ABB-2380-2020; Meilinger, Tobias/C-3969-2014	Bülthoff, Heinrich H/0000-0003-2568-0607; König, Peter/0000-0003-3654-5267; Meilinger, Tobias/0000-0002-1326-1213; Keyser, Johannes/0000-0001-8343-4362; Wahn, Basil/0000-0002-0318-7160; Wolbers, Thomas/0000-0003-2943-8949; Schumann, Frank/0000-0001-9262-4539	Deutsche Forschungsgemeinschaft [KO 3359/4-1]; European Research Council [269716]; CAN [W911NF-10-2-0022]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); CAN	Funded by KO 3359/4-1 Deutsche Forschungsgemeinschaft (http.//www.dfg.de/) PK. #269716 European Research Council (https://erc.europa.eu/) PK. #W911NF-10-2-0022 CAN PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bermejo F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00679; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Burton H, 2005, ADAPTIVE CHANGES EAR, P3359; Campus C, 2012, J NEUROPHYSIOL, V107, P2713, DOI 10.1152/jn.00624.2011; Cheung A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000992; Cholewiak RW, 2004, PERCEPT PSYCHOPHYS, V66, P970, DOI 10.3758/BF03194989; Clark A, 1999, TRENDS COGN SCI, V3, P345, DOI 10.1016/S1364-6613(99)01361-3; Clark A., 2006, PSYCHE, V12, P1, DOI DOI 10.1016/J.CONCOG.2009.03.005; Clark D, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fhurn.2015.00297, 10.3389/fnhum.2015.00297]; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Creem-Regehr SH, 2009, NEUROBIOL LEARN MEM, V91, P166, DOI 10.1016/j.nlm.2008.10.004; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Darwin C, 1873, NATURE, V7, P360, DOI [10.1038/007360c0, DOI 10.1038/007360C0]; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Deroy Ophelia, 2012, Front Psychol, V3, P457, DOI 10.3389/fpsyg.2012.00457; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Doeller CF, 2014, CEREB CORTEX, P132; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Ehinger BV, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00071; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellmore TM, 2004, SPAT COGN COMPUT, V4, P255; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Foulke E., 1982, SPATIAL ABILITIES DE, P55; Foulke E., 1971, AM FDN BLIND RES B, V23, P1; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Frisch K.v., 1949, Experientia Basel, V5, P142, DOI 10.1007/BF02174424; FUJITA N, 1993, GEOGR ANAL, V25, P295; Gassert R, 2006, CONCEPT MAGN RESON B, V29B, P191, DOI 10.1002/cmr.b.20070; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hassenzahl M., 2003, MENSCH COMPUTER, P187, DOI DOI 10.1097/00001756-200303030-00034; HENNEVIN E, 1971, CR ACAD SCI D NAT, V273, P2595; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Iaria G, 2003, J NEUROSCI, V23, P5945; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Iber C, 2007, J CLIN SLEEP MED, V3, P107; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Karcher SM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00037; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kaspar K, 2014, CONSCIOUS COGN, V28, P47, DOI 10.1016/j.concog.2014.06.006; Kassubek J, 2001, COGNITIVE BRAIN RES, V10, P207, DOI 10.1016/S0926-6410(00)00037-9; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Keyser J., 2010, THESIS; Konig P, 2013, BEHAV BRAIN SCI, V36, P219, DOI 10.1017/S0140525X12002294; Kuhl J., 1994, VOLITION PERSONALITY, P47; LECONTE P, 1971, CR ACAD SCI D NAT, V273, P86; Lenay C, 1997, SECOND INTERNATIONAL CONFERENCE ON COGNITIVE TECHNOLOGY, PROCEEDINGS, P44, DOI 10.1109/CT.1997.617681; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; Levy-Tzedek S, 2012, RESTOR NEUROL NEUROS, V30, P313, DOI 10.3233/RNN-2012-110219; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1997, J NEUROSCI, V17, P7103; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mallot H., 2006, SPAT COGN COMPUT, V6, P295; Mangen A, 2010, ADVANCES IN HAPTICS, P385; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marr D., 1982, VISION COMPUTATIONAL; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merkle T, 2008, J EXP BIOL, V211, P3370, DOI 10.1242/jeb.022715; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Munzer S, 2011, DIAGNOSTICA, V57, P111, DOI 10.1026/0012-1924/a000040; Nagel SK, 2005, J NEURAL ENG, V2, pR13, DOI 10.1088/1741-2560/2/4/R02; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Noe E A, 2004, ACTION PERCEPTION; Norimoto H, 2015, CURR BIOL, V25, P1091, DOI 10.1016/j.cub.2015.02.063; O'Regan J.K., 2011, WHY RED DOESNT SOUND; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P1, DOI 10.1016/j.neubiorev.2014.03.004; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2012, NEURAL PLAST, V2012; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Schumann F., 2012, SENSORIMOTOR ACCOUNT; Schwenkreis P, 2007, EUR J NEUROSCI, V26, P3291, DOI 10.1111/j.1460-9568.2007.05894.x; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Tashakkori A, 2010, HDB MIXED METHODS SO, P913; Tse ZTH, 2009, P I MECH ENG H, V223, P497, DOI 10.1243/09544119JEIM529; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Tyler Mitchell, 2003, J Integr Neurosci, V2, P159, DOI 10.1142/S0219635203000263; Varela FJ, 2017, EMBODIED MIND COGNIT; Voss P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-113; Wahn B, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00013; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wahn B, 2015, MULTISENS RES, V28, P371, DOI 10.1163/22134808-00002482; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wander JD, 2013, P NATL ACAD SCI USA, V110, P10818, DOI 10.1073/pnas.1221127110; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Wehner R, 1997, EXS, V84, P145; Weiss S, 1996, NEUROSCI LETT, V209, P17, DOI 10.1016/0304-3940(96)12581-7; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; WHITE BW, 1970, PERCEPT PSYCHOPHYS, V7, P22; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zeitlhofer J., 1993, Brain Topography, V6, P123, DOI 10.1007/BF01191077; Ziemke T, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P1305	140	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166647	10.1371/journal.pone.0166647	http://dx.doi.org/10.1371/journal.pone.0166647			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959914	gold, Green Submitted, Green Published			2022-12-26	WOS:000392753900003
J	Nkhoma, ET; Rosenblatt, L; Myers, J; Villasis-Keever, A; Coumbis, J				Nkhoma, Ella T.; Rosenblatt, Lisa; Myers, Joel; Villasis-Keever, Angelina; Coumbis, John			Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ANTIRETROVIRAL THERAPY; INTESTINAL-ABSORPTION; PROTEASE INHIBITORS; INITIAL TREATMENT; KIDNEY-FUNCTION; DOUBLE-BLIND; ALAFENAMIDE; COBICISTAT; ADULTS	Objectives Tenofovir disoproxil fumarate (TDF)-containing antiretroviral regimens have been associated with an increased incidence of renal and bone adverse outcomes. Here, we estimated the real-world incidence of renal and bone adverse outcomes among patients with HIV infection receiving different TDF-containing single-tablet regimens (STRs). Methods This cohort study used US health insurance data spanning the years 2008-2014. We identified HIV-infected patients aged >= 18 years (all HIV patients) and those with >= 6 months of continuous enrollment prior to initiating efavirenz/emtricitabine/TDF (EFV/FTC/TDF), rilpivirine/FTC/TDF (RPV/FTC/TDF) or elvitegravir/cobicistat/FTC/TDF (EVG/COBI/FTC/TDF). Renal adverse outcomes were identified using renal International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. Bone adverse outcomes were identified using ICD-9-CM diagnosis codes for fracture. Incidence rates (IRs) and associated 95% confidence intervals (CIs) were estimated assuming a Poisson distribution, and outcomes between STRs were compared using IR ratios (IRRs) and IR differences (IRDs). Results We identified 9876 and 10,383 eligible patients for the renal and fracture analyses, respectively. Observed IRs for renal adverse outcomes were 9.7, 10.5, 13.6, and 18.0 per 1000 person-years among those receiving EFV/FTC/TDF, RPV/FTC/TDF, or EVG/COBI/FTC/TDF, or all HIV patients, respectively. Corresponding values for IRs of fracture were 3.4, 3.6, 7.2, and 4.4 per 1000 person-years, respectively. Renal adverse outcomes with EFV/FTC/TDF were significantly less frequent than with EVG/COBI/FTC/TDF (IRD -3.96; 95% CI: -7.31, -1.06). No IRR differences were identified for the renal analysis. Fractures with EFV/FTC/TDF were significantly less frequent than with EVG/COBI/FTC/TDF (IRR 0.47; 95% CI: 0.27, 0.81 and IRD -3.85; 95% CI: -5.02, -2.78). Conclusions In this large real-world database, observed IRs for renal adverse outcomes with TDF-containing STRs were lower or similar to those for all HIV patients, with the lowest IRs observed among patients receiving EFV/FTC/TDF. Compared with all HIV patients, the observed IR for fracture was higher with EVG/COBI/FTC/TDF, comparable with RPV/FTC/TDF, and lower with EFV/FTC/TDF.	[Nkhoma, Ella T.] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Pennington, NJ 08534 USA; [Rosenblatt, Lisa] Bristol Myers Squibb, US Hlth Econ & Outcomes Res, Plainsboro, NJ USA; [Myers, Joel; Villasis-Keever, Angelina] Bristol Myers Squibb, Res & Dev, Plainsboro, NJ USA; [Coumbis, John] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Nkhoma, ET (corresponding author), Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Pennington, NJ 08534 USA.	ella.nkhoma@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was supported by Bristol-Myers Squibb, the manufacturer of efavirenz. All authors are employees of Bristol-Myers Squibb. The specific roles of these authors are articulated in the 'author contributions' section. Medical writing assistance was provided by Julian Martins of inScience Communications, Springer Healthcare, which was funded by Bristol-Myers Squibb. No additional external funding received for this study.	Astuti N, 2014, INFECT DIS THER, V3, P1, DOI 10.1007/s40121-014-0024-z; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bristol-Myers Squibb Company, 2015, PRESCR INF SUSTIVA; Bristol-Myers Squibb Company, PRESCR INF REYATAZ A; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Custodio J, 2013, 14 INT WORKSH CLIN P; Dong HV, 2014, AIDS, V28, P2119, DOI 10.1097/QAD.0000000000000363; Droste JAH, 2006, JAIDS-J ACQ IMM DEF, V41, P37, DOI 10.1097/01.qai.0000191997.70034.80; Dursteler-Macfarland KM, 2011, DRUG ALCOHOL REV, V30, P577, DOI 10.1111/j.1465-3362.2010.00242.x; Fafin C, 2012, NEPHRON CLIN PRACT, V120, pC205, DOI 10.1159/000342377; Flandre P, 2011, CLIN J AM SOC NEPHRO, V6, P1700, DOI 10.2215/CJN.09191010; German P, 2012, JAIDS-J ACQ IMM DEF, V61, P32, DOI 10.1097/QAI.0b013e3182645648; German P, 2010, JAIDS-J ACQ IMM DEF, V55, P323, DOI 10.1097/QAI.0b013e3181eb376b; Gilead Sciences, 2013, PRESCR INF TRUVADA E; Gilead Sciences, 2015, PRESCR INF HARVONI L; Gilead Sciences, 2015, PRESCR INF COMPLERA; Gilead Sciences, 2015, PRESCR INF VIREAD TE; Gilead Sciences, 2015, PRESCR INF STRIBILD; Hansen L., 2016, TRUVEN HLTH MARKETSC; Hemkens LG, 2015, HIV CLIN TRIALS, V16, P178, DOI 10.1179/1945577115Y.0000000004; Johnson & Johnson, 2015, PRESCR INF OLYSIO SI; Kim EY, 2009, FORENSIC SCI INT, V188, P75, DOI 10.1016/j.forsciint.2009.03.016; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Lepist EI, 2012, ANTIMICROB AGENTS CH, V56, P5409, DOI 10.1128/AAC.01089-12; Maggi P, 2014, AIDS REV, V16, P144; Mills A, 2016, LANCET INFECT DIS, V16, P43, DOI 10.1016/S1473-3099(15)00348-5; Mills A, 2015, JAIDS-J ACQ IMM DEF, V69, P439, DOI 10.1097/QAI.0000000000000618; Pasoto SG, 2012, RHEUMATOL INT, V32, P3149, DOI 10.1007/s00296-011-2154-x; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rijnders B, 2015, 15 EUR AIDS C OCT 21; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Shamblaw D, 2015, SWITCHING ATRIPLA AT; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; The Henry J. Kaiser Family Foundation, 2014, HLTH INS COV TOT POP; Thompson M, 2015, SWITCHING TDF TAF BA; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; Tong L, 2007, ANTIMICROB AGENTS CH, V51, P3498, DOI 10.1128/AAC.00671-07; van Lunzen J, 2016, AIDS, V30, P251, DOI 10.1097/QAD.0000000000000911; Winston A, 2015, CURR OPIN INFECT DIS, V28, P17, DOI 10.1097/QCO.0000000000000117; Winston J, 2014, HIV CLIN TRIALS, V15, P231, DOI 10.1310/hct1506-231; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0166982	10.1371/journal.pone.0166982	http://dx.doi.org/10.1371/journal.pone.0166982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941989	Green Submitted, gold, Green Published			2022-12-26	WOS:000392745600006
J	Torres, PC; Morsello, C; Parry, L; Pardini, R				Torres, Patricia Carignano; Morsello, Carla; Parry, Luke; Pardini, Renata			Who Cares about Forests and Why? Individual Values Attributed to Forests in a Post-Frontier Region in Amazonia	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; WILDLIFE CONSUMPTION; RURAL HOUSEHOLDS; CONSERVATION; BUSHMEAT; ATTITUDE; BIODIVERSITY; PERCEPTIONS; MANAGEMENT; INSIGHTS	Understanding the multiple ways people value forests is important, as individual values regarding nature have been shown to partly determine willingness to participate in conservation initiatives. As individual values are influenced by past experiences, the way people value forests may be related to the ecosystem services they use and receive. We here aim to investigate if people value forests because of material and non-material benefits forest provide (material and non-material values), and if these values are defined by previous experiences associated with using forest resources and having frequent contact with forests. By interviewing 363 residents across 20 landscapes varying in forest cover in a post-frontier region in Amazonia, we evaluated: (1) if the use of forest resources-especially bushmeat, important for sustenance and cash income in virtually all tropical forests-is associated with attributing higher material value to forests; (2) whether the contact with forest (estimated by local forest cover and visits to forests) is associated with attributing higher non-material value to forests. As expected, respondents from households where hunting occurs and bushmeat consumption is more frequent attributed higher material value to forests, and those living in more deforested landscapes and that visited forests less often attributed lower non-material value to forests. The importance of bushmeat in shaping the way people value forests suggests that encouraging the sustainable use of this product will encourage forest conservation. Results also point to a potential dangerous reinforcing cycle: low forest cover and the loss of contact with forests may erode forest values and facilitate further deforestation. Engaging rural communities in forest conservation initiatives is challenging yet urgent in degraded landscapes, although harnessing appreciation for bushmeat could offer a starting point.	[Torres, Patricia Carignano] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Cidade Univ, Sao Paulo, SP, Brazil; [Morsello, Carla] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil; [Parry, Luke] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Parry, Luke] Fed Univ Para, NAEA, Belem, Para, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, Cidade Univ, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Lancaster University; Universidade Federal do Para; Universidade de Sao Paulo	Torres, PC (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Cidade Univ, Sao Paulo, SP, Brazil.	patriciactorres@gmail.com	Morsello, Carla/D-7393-2012; Carignano Torres, Patricia/F-2794-2016; Pardini, Renata/C-4095-2012; Parry, Luke/ABD-4194-2021	Morsello, Carla/0000-0001-7548-6541; Carignano Torres, Patricia/0000-0003-0426-8277; Pardini, Renata/0000-0002-3769-8401; Parry, Luke/0000-0003-0330-9516	INCT - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; Embrapa [SEG: 02.08.06.005.00]; UK government Darwin Initiative [17-023]; Nature Conservancy; Natural Environment Research Council (NERC) [NE/F01614X/1, NE/G000816/1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/19108-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/19606-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308205/2014-6]; NERC [NE/F01614X/1, NE/G000816/1] Funding Source: UKRI; Natural Environment Research Council [NE/G000816/1, NE/F01614X/1, ceh010010] Funding Source: researchfish	INCT - Biodiversidade e Uso da Terra na Amazonia; Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); UK government Darwin Initiative; Nature Conservancy; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by INCT - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0), Embrapa (SEG: 02.08.06.005.00), the UK government Darwin Initiative (17-023), the Nature Conservancy, the Natural Environment Research Council (NERC) (NE/F01614X/1 and NE/G000816/1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(2011/19108-0). PCT had doctoral scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/19606-0). RP had a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (308205/2014-6) during the development of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albrechtsen L, 2005, ENVIRON CONSERV, V32, P340, DOI 10.1017/S0376892906002694; Angelsen A, 2014, WORLD DEV, V64, pS12, DOI 10.1016/j.worlddev.2014.03.006; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2014, R LANG ENV STAT COMP; ARCURY TA, 1990, ENVIRON BEHAV, V22, P387, DOI 10.1177/0013916590223004; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bhagwat SA, 2009, ENVIRON VALUE, V18, P417, DOI 10.3197/096327109X12532653285731; Brancalion PHS, 2014, RESTOR ECOL, V22, P65, DOI 10.1111/rec.12025; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown G, 2000, FOREST SCI, V46, P240; Brown G, 2012, APPL SPAT ANAL POLIC, V5, P317, DOI 10.1007/s12061-011-9072-x; Burnhan KP, 2002, MODEL SELECTION MULT; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; Castro E, 2004, DINAMICA ATORES USO, V179; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Crawley M.J., 2007, R BOOK; D'Antona AO, 2006, POPUL ENVIRON, V27, P373, DOI 10.1007/s11111-006-0031-4; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; De Vaus, 2002, SURVEYS SOCIAL RES; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Foerster S, 2012, CONSERV BIOL, V26, P335, DOI 10.1111/j.1523-1739.2011.01802.x; Fonseca WD, SANTAREM MOMENTOS HI; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Futemma C, 2003, HUM ECOL, V31, P369, DOI 10.1023/A:1025067721480; George D, 2003, SPSS WINDOWS STEP ST; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Hicks CC, 2015, CONSERV BIOL, V29, P1471, DOI 10.1111/cobi.12550; IBGE, 2010, CENS DEM; Ives CD, 2014, J ENVIRON MANAGE, V144, P67, DOI 10.1016/j.jenvman.2014.05.013; Jax K, 2013, ECOL ECON, V93, P260, DOI 10.1016/j.ecolecon.2013.06.008; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Justus J, 2009, TRENDS ECOL EVOL, V24, P187, DOI 10.1016/j.tree.2008.11.011; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kareiva P, 2007, SCI AM, V297, P50, DOI 10.1038/scientificamerican1007-50; Kijazi MH, 2010, FOREST POLICY ECON, V12, P357, DOI 10.1016/j.forpol.2010.02.007; Likert R, 1932, ARCH PSYCHOL, V22, P3; Lockwood M, 1999, ENVIRON VALUE, V8, P381, DOI 10.3197/096327199129341888; Lockwood M., 2005, Australasian Journal of Environmental Management, V12, P8; Luckert M., 2002, UNCOVERING HIDDEN HA; Maio G.R., 2003, HDB SOCIAL PSYCHOL, P283, DOI DOI 10.1007/0-387-36921-X_12; Marvier M, 2014, CONSERV BIOL, V28, P1, DOI 10.1111/cobi.12206; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Nesheim I, 2006, HUM ECOL, V34, P99, DOI 10.1007/s10745-005-9004-y; Olson JM, 2005, HANDBOOK OF ATTITUDES, P223; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Paletto A, 2013, ENVIRON MANAGE, V51, P414, DOI 10.1007/s00267-012-9974-7; Parry L, 2014, CONSERV LETT, V7, P565, DOI 10.1111/conl.12151; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; RAMCILOVIC-SUOMINEN S., 2013, VOLUME, V12, P235, DOI DOI 10.1007/S11842-012-9209-Z; Revelle W., 2014, PSYCH PROCEDURES PER; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Rokeach M., 1973, NATURE HUMAN VALUES; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Seymour E, 2010, AUSTRALAS J ENV MAN, V17, P142, DOI 10.1080/14486563.2010.9725261; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; STERN PC, 1995, J APPL SOC PSYCHOL, V25, P1611, DOI 10.1111/j.1559-1816.1995.tb02636.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tarrant MA, 2002, ENVIRON MANAGE, V30, P692, DOI 10.1007/s00267-002-2722-7; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Tomicevic J, 2010, FOREST POLICY ECON, V12, P157, DOI 10.1016/j.forpol.2009.09.006; Torres PC, 2014, THESIS; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Xu JY, 2006, J ENVIRON MANAGE, V78, P362, DOI 10.1016/j.jenvman.2005.05.003; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011; Zuur Alain F., 2009, P1; [No title captured]	81	6	6	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167691	10.1371/journal.pone.0167691	http://dx.doi.org/10.1371/journal.pone.0167691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942038	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600025
J	Tuttolomondo, A; Di Raimondo, D; Bellia, C; Clemente, G; Pecoraro, R; Maida, C; Simonetta, I; Vassallo, V; Di Bona, D; Gulotta, E; Ciaccio, M; Pinto, A				Tuttolomondo, Antonino; Di Raimondo, Domenico; Bellia, Chiara; Clemente, Giuseppe; Pecoraro, Rosaria; Maida, Carlo; Simonetta, Irene; Vassallo, Valerio; Di Bona, Danilo; Gulotta, Eliana; Ciaccio, Marcello; Pinto, Antonio			Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CHRONIC LIVER-DISEASE; CHRONIC HEPATITIS-C; NONALCOHOLIC STEATOHEPATITIS; DECOMPENSATED CIRRHOSIS; VIRUS-INFECTION; LEPTIN LEVELS; CYTOKINES; FIBROSIS; RESISTANCE	Introduction Patients with chronic liver diseases are usually thin as a result of hypermetabolism and malnutrition expressed by reduced levels of leptin and impairment of other adyponectins such as visfatin. Aims We evaluated the metabolic and inflammatory effects of intravenous high-dose furosemide plus hypertonic saline solutions (HSS) compared with repeated paracentesis and a standard oral diuretic schedule, in patients with cirrhosis and refractory ascites. Methods 59 consecutive cirrhotic patients with refractory ascites unresponsive to outpatient treatment. Enrolled subjects were randomized to treatment with intravenous infusion of furosemide (125-250mg/bid) plus small volumes of HSS from the first day after admission until 3 days before discharge (Group A, n: 38), or repeated paracentesis from the first day after admission until 3 days before discharge (Group B, n: 21). Plasma levels of ANP, BNP, Leptin, visfatin, IL-1 beta, TNF-a, IL-6 were measured before and after the two type of treatment. Results Subjects in group A were observed to have a significant reduction of serum levels of TNF-alpha, IL-1 beta, IL-6, ANP, BNP, and visfatin, thus regarding primary efficacy endpoints, in Group A vs. Group B we observed higher Delta-TNF-alpha, Delta-IL-1 beta, Delta-IL-6, Delta-ANP, Delta-BNP, Delta-visfatin, Delta-Leptin at discharge. Discussion Our findings underline the possible inflammatory and metabolic effect of saline overload correction in treatment of cirrhosis complications such as refractory ascites, suggesting a possible role of inflammatory and metabolic-nutritional variables as severity markers in these patients.	[Tuttolomondo, Antonino; Di Raimondo, Domenico; Clemente, Giuseppe; Pecoraro, Rosaria; Maida, Carlo; Simonetta, Irene; Vassallo, Valerio; Pinto, Antonio] Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, UOC Med Interna & Stroke Care, I-90133 Palermo, Italy; [Bellia, Chiara; Ciaccio, Marcello] Univ Palermo, Azienda Osped Univ Policlin, Dipartimento Biopatol & Biotecnol Med & Forensi, Sez Biochim Clin,UOC CoreLab, Palermo, Italy; [Bellia, Chiara; Ciaccio, Marcello] Univ Palermo, Azienda Osped Univ Policlin, Dipartimento Biopatol & Biotecnol Med & Forensi, UOC CoreLab,Med Mol Clin, Palermo, Italy; [Di Bona, Danilo] Univ Bari, Dipartimento Emergenze & Trapianti Organo, Sch & Chair Allergol, I-70121 Bari, Italy; [Gulotta, Eliana] Univ Palermo, Policlin Univ Paolo Giaccone, Dipartimento Chirurg Gen & Urgenza, I-90133 Palermo, Italy	University of Palermo; University of Palermo; Policlinico Paolo Giaccone; University of Palermo; Policlinico Paolo Giaccone; Universita degli Studi di Bari Aldo Moro; University of Palermo; Policlinico Paolo Giaccone	Tuttolomondo, A (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, UOC Med Interna & Stroke Care, I-90133 Palermo, Italy.	bruno.tuttolomondo@unipa.it	Bellia, Chiara/AAO-3725-2020; Simonetta, Irene/HDM-7402-2022; Di Raimondo, Domenico/AAB-2379-2019; Di+Raimondo, Domenico/AFM-3500-2022	Bellia, Chiara/0000-0003-0611-9363; Simonetta, Irene/0000-0003-1574-104X; Di Raimondo, Domenico/0000-0002-4529-3703; Di+Raimondo, Domenico/0000-0002-4529-3703; maida, carlo/0000-0002-4868-9033; Pinto, Antonio/0000-0002-8083-3699				Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; BAC DJ, 1995, LIVER, V15, P265; beda UA, 2010, HEPATOLOGY, V52, P2086, DOI [10.1002/hep.23961, DOI 10.1002/HEP.23961]; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Coombes JD, 2016, BBA-MOL BASIS DIS, V1862, P135, DOI 10.1016/j.bbadis.2015.10.028; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Figueiredo A, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/539412; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Giannini E, 2004, DIGEST DIS SCI, V49, P275, DOI 10.1023/B:DDAS.0000017451.48031.b6; Guglielmi FW, 2005, DIGEST LIVER DIS, V37, P681, DOI 10.1016/j.dld.2005.03.010; Henriksen JH, 2003, GUT, V52, P1511, DOI 10.1136/gut.52.10.1511; Hsu CS, 2015, HEPATOL INT, V9, P231, DOI 10.1007/s12072-015-9616-2; Jovicic N, 2015, PLOS ONE, V28; Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P3020, DOI 10.3748/wjg.v21.i10.3020; Kitaoka S, 2003, HEPATO-GASTROENTEROL, V50, P1569; Li Z, HEPATOLOGY, V42, P880, DOI DOI 10.1002/HEP; Licata G, 2009, ALIMENT PHARM THER, V30, P227, DOI 10.1111/j.1365-2036.2009.04040.x; Missale G, 1997, HEPATOLOGY, V26, P792, DOI 10.1053/jhep.1997.v26.pm0009303515; Phillip V, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-18; Pimenta J, 2010, LIVER INT, V30, P1059, DOI 10.1111/j.1478-3231.2010.02266.x; Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012; Prieto-Frias C, 2016, EUR J GASTROEN HEPAT, V28, P139, DOI 10.1097/MEG.0000000000000516; PRUIMBOOM WM, 1995, INT J IMMUNOPHARMACO, V17, P375, DOI 10.1016/0192-0561(95)00015-T; RECTOR WG, 1990, GASTROENTEROLOGY, V99, P766, DOI 10.1016/0016-5085(90)90966-5; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Santetti D, 2015, WORLD J GASTROENTERO, V21, P8927, DOI 10.3748/wjg.v21.i29.8927; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Simsek H, 1996, J INT MED RES, V24, P239, DOI 10.1177/030006059602400302; Tuttolomondo A, 2011, NUTR METAB CARDIOVAS, V21, P372, DOI 10.1016/j.numecd.2009.10.014; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Wong F, 2001, CLIN SCI, V101, P621, DOI 10.1042/CS20010183; Zekri ARN, 2005, WORLD J GASTROENTERO, V11, P6624, DOI 10.3748/wjg.v11.i42.6624	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0165443	10.1371/journal.pone.0165443	http://dx.doi.org/10.1371/journal.pone.0165443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941973	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600003
J	Alibardi, L; Holthaus, KB; Sukseree, S; Hermann, M; Tschachler, E; Eckhart, L				Alibardi, Lorenzo; Holthaus, Karin Brigit; Sukseree, Supawadee; Hermann, Marcela; Tschachler, Erwin; Eckhart, Leopold			Immunolocalization of a Histidine-Rich Epidermal Differentiation Protein in the Chicken Supports the Hypothesis of an Evolutionary Developmental Link between the Embryonic Subperiderm and Feather Barbs and Barbules	PLOS ONE			English	Article							BETA BETA KERATINS; MOLECULAR EVOLUTION; CELL-DEATH; ORIGIN; SKIN; GENES; DIVERSIFICATION; CORNIFICATION; EXPRESSION; FILAGGRIN	The morphogenesis of feathers is a complex process that depends on a tight spatiotemporal regulation of gene expression and assembly of the protein components of mature feathers. Recent comparative genomics and gene transcription studies have indicated that genes within the epidermal differentiation complex (EDC) encode numerous structural proteins of cornifying skin cells in amniotes including birds. Here, we determined the localization of one of these proteins, termed EDMTFH (Epidermal Differentiation Protein starting with a MTF motif and rich in Histidine), which belongs to a group of EDC-encoded proteins rich in aromatic amino acid residues. We raised an antibody against an EDMTFH-specific epitope and performed immunohistochemical investigations by light microscopy and immunogold labeling by electron microscopy of chicken embryos at days 14-18 of development. EDMTFH was specifically present in the subperiderm, a transient layer of the embryonic epidermis, and in barbs and barbules of feathers. In the latter, it partially localized to bundles of socalled feather beta-keratins (corneous beta-proteins, CBPs). Cells of the embryonic periderm, the epidermis proper, and the feather sheath were immunonegative for EDMTFH. The results of this study indicate that EDMTFH may contribute to the unique mechanical properties of feathers and define EDMTFH as a common marker of the subperiderm and the feather barbules. This expression pattern of EDMTFH resembles that of epidermal differentiation cysteine-rich protein (EDCRP) and feather CBPs and is in accordance with the hypothesis that a major part of the cyclically regenerating feather follicle is topologically, developmentally and evolutionarily related to the embryonic subperiderm.	[Alibardi, Lorenzo; Holthaus, Karin Brigit] Univ Bologna, Comparat Histolab, Bologna, Italy; [Alibardi, Lorenzo; Holthaus, Karin Brigit] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy; [Holthaus, Karin Brigit; Sukseree, Supawadee; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria; [Hermann, Marcela] Med Univ Vienna, Dept Med Biochem, Vienna, Austria	University of Bologna; University of Bologna; Medical University of Vienna; Medical University of Vienna	Eckhart, L (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Sukseree, Supawadee/AAT-6545-2020	Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036	Austrian Science Fund (FWF) [P23801, P28004]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (FWF): P23801 (LE) and Austrian Science Fund (FWF): P28004 (LE) (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P175; Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P51; Alibardi L, 2006, CELLS TISSUES ORGANS, V182, P35, DOI 10.1159/000091717; Alibardi L, 2015, ANAT REC, V298, P479, DOI 10.1002/ar.23039; Alibardi L, 2013, ANN ANAT, V195, P189, DOI 10.1016/j.aanat.2012.08.005; Alibardi L, 2003, J EXP ZOOL PART B, V298B, P12, DOI 10.1002/jez.b.00024; Alibardi L, 2002, J MORPHOL, V251, P294, DOI 10.1002/jmor.1090; Alibardi L., 2016, REV CORNIFICATION MO; Alibardi L, 2007, EXP DERMATOL, V16, P961, DOI 10.1111/j.1600-0625.2007.00609.x; Alibardi L, 2016, J EXP ZOOL PART B, V326, P338, DOI 10.1002/jez.b.22689; BARNES GL, 1995, J EXP ZOOL, V271, P307, DOI 10.1002/jez.1402710408; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Calvaresi M, 2016, J STRUCT BIOL, V194, P282, DOI 10.1016/j.jsb.2016.03.004; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Fischer H, 2005, DIFFERENTIATION, V73, P406, DOI 10.1111/j.1432-0436.2005.00046.x; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Greenwold MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0249-1; Greenwold MJ, 2013, J EXP ZOOL PART B, V320, P393, DOI 10.1002/jez.b.22514; Greenwold MJ, 2011, J EXP ZOOL PART B, V316B, P609, DOI 10.1002/jez.b.21436; Greenwold MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-148; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Holthaus KB, 2016, MOL BIOL EVOL, V33, P726, DOI 10.1093/molbev/msv265; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Lopes RJ, 2016, CURR BIOL, V26, P1427, DOI 10.1016/j.cub.2016.03.076; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Mlitz V, 2014, J INVEST DERMATOL, V134, P2685, DOI 10.1038/jid.2014.204; Ng CS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1966-6; Pendaries V, 2014, J INVEST DERMATOL, V134, P2938, DOI 10.1038/jid.2014.259; POWELL BC, 1979, NUCLEIC ACIDS RES, V7, P2165, DOI 10.1093/nar/7.8.2165; PRESLAND RB, 1989, J MOL BIOL, V209, P549, DOI 10.1016/0022-2836(89)90593-7; RAMSDEN M, 1983, DIFFERENTIATION, V23, P243; Rice RH, 2013, J PROTEOME RES, V12, P771, DOI 10.1021/pr301036k; ROGERS GE, 1985, ANN NY ACAD SCI, V455, P403, DOI 10.1111/j.1749-6632.1985.tb50425.x; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Sawyer R.H., 1986, P194; Sawyer RH, 2005, DEV DYNAM, V232, P256, DOI 10.1002/dvdy.20291; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Sawyer RH, 2003, J EXP ZOOL PART B, V295B, P12, DOI 10.1002/jez.b.00005; Sawyer RH, 2000, AM ZOOL, V40, P530, DOI 10.1668/0003-1569(2000)040[0530:TEOBKI]2.0.CO;2; SAWYER RH, 1974, J EXP ZOOL, V190, P57, DOI 10.1002/jez.1401900105; SCALA C, 1992, J HISTOCHEM CYTOCHEM, V40, P1799, DOI 10.1177/40.11.1431065; Strasser B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0360-y; Strasser B, 2014, MOL BIOL EVOL, V31, P3194, DOI 10.1093/molbev/msu251; WALKER ID, 1976, EUR J BIOCHEM, V69, P329, DOI 10.1111/j.1432-1033.1976.tb10917.x; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Widelitz RB, 2003, J EXP ZOOL PART B, V298B, P109, DOI 10.1002/jez.b.00029; Wu P, 2015, P NATL ACAD SCI USA, V112, pE6770, DOI 10.1073/pnas.1520566112; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196	52	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167789	10.1371/journal.pone.0167789	http://dx.doi.org/10.1371/journal.pone.0167789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936131	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100190
J	Govey, PM; Zhang, Y; Donahue, HJ				Govey, Peter M.; Zhang, Yue; Donahue, Henry J.			Mechanical Loading Attenuates Radiation-Induced Bone Loss in Bone Marrow Transplanted Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LONG-TERM SURVIVORS; IN-VIVO; CORTICAL BONE; TRABECULAR BONE; PHYSICAL-EXERCISE; RANDOMIZED-TRIAL; FRACTURE REPAIR; MOUSE MODEL; FEMALE	Exposure of bone to ionizing radiation, as occurs during radiotherapy for some localized malignancies and blood or bone marrow cancers, as well as during space travel, incites dose-dependent bone morbidity and increased fracture risk. Rapid trabecular and endosteal bone loss reflects acutely increased osteoclastic resorption as well as decreased bone formation due to depletion of osteoprogenitors. Because of this dysregulation of bone turnover, bone's capacity to respond to a mechanical loading stimulus in the aftermath of irradiation is unknown. We employed a mouse model of total body irradiation and bone marrow transplantation simulating treatment of hematologic cancers, hypothesizing that compression loading would attenuate bone loss. Furthermore, we hypothesized that loading would upregulate donor cell presence in loaded tibias due to increased engraftment and proliferation. We lethally irradiated 16 female C57Bl/6J mice at age 16 wks with 10.75 Gy, then IVinjected 20 million GFP(+) total bone marrow cells. That same day, we initiated 3 wks compression loading (1200 cycles 5x/wk, 10 N) in the right tibia of 10 of these mice while 6 mice were irradiated, non-mechanically-loaded controls. As anticipated, before-and-after microCT scans demonstrated loss of trabecular bone (-48.2% Tb.BV/TV) and cortical thickness (-8.3%) at 3 wks following irradiation. However, loaded bones lost 31% less Tb.BV/TV and 8% less cortical thickness (both p<0.001). Loaded bones also had significant increases in trabecular thickness and tissue mineral densities from baseline. Mechanical loading did not affect donor cell engraftment. Importantly, these results demonstrate that both cortical and trabecular bone exposed to high-dose therapeutic radiation remain capable of an anabolic response to mechanical loading. These findings inform our management of bone health in cases of radiation exposure.	[Govey, Peter M.; Zhang, Yue; Donahue, Henry J.] Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA; [Govey, Peter M.; Donahue, Henry J.] Penn State Coll Engn, Dept Biomed Engn, University Pk, PA 16802 USA; [Donahue, Henry J.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Zhang, Yue; Donahue, Henry J.] Virginia Commonwealth Coll Engn, Dept Biomed Engn, Richmond, VA 23220 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Donahue, HJ (corresponding author), Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA.; Donahue, HJ (corresponding author), Penn State Coll Engn, Dept Biomed Engn, University Pk, PA 16802 USA.; Donahue, HJ (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.; Donahue, HJ (corresponding author), Virginia Commonwealth Coll Engn, Dept Biomed Engn, Richmond, VA 23220 USA.	hjdonahue@vcu.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [7 R01 AR068132 17]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant number 7 R01 AR068132 17). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An NF, 2013, JOVE-J VIS EXP, DOI 10.3791/50193; Vazquez MA, 2015, J BONE MINER RES, V30, P1790, DOI 10.1002/jbmr.2519; Arrington SA, 2010, CALCIFIED TISSUE INT, V87, P263, DOI 10.1007/s00223-010-9390-z; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Calvi LM, 2015, BLOOD, V126, P2443, DOI 10.1182/blood-2015-07-533588; Calvi LM, 2013, BEST PRACT RES CL HA, V26, P249, DOI 10.1016/j.beha.2013.10.004; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2014, BONE, V67, P33, DOI 10.1016/j.bone.2014.06.030; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Clines GA, 2010, CURR OPIN ORGAN TRAN, V15, P73, DOI 10.1097/MOT.0b013e328333d52c; De Lisio M, 2013, EXP HEMATOL, V41, P143, DOI 10.1016/j.exphem.2012.10.003; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dumas A, 2009, OSTEOPOROSIS INT, V20, P435, DOI 10.1007/s00198-008-0658-3; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Fiuza-Luces C, 2013, MED SCI SPORT EXER, V45, P1703, DOI 10.1249/MSS.0b013e31828fa004; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gong B, 2013, BONE, V57, P252, DOI 10.1016/j.bone.2013.08.014; Gonzalez-Nieto D, 2012, BLOOD; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Green DE, 2014, BONE, V63, P87, DOI 10.1016/j.bone.2014.02.018; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Hartman A, 2009, PEDIATR BLOOD CANCER, V53, P64, DOI 10.1002/pbc.21942; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Keenawinna L, 2013, RADIAT RES, V180, P89, DOI 10.1667/RR3200.1; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kitase Y, 2014, J DENT RES, V93, P1108, DOI 10.1177/0022034514553008; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Leucht P, 2013, J ORTHOP RES, V31, P1828, DOI 10.1002/jor.22440; Li F, 2010, BONE, V47, P546, DOI 10.1016/j.bone.2010.05.040; Li S, 2008, J CELL PHYSIOL, V215, P204, DOI 10.1002/jcp.21302; Lloyd SA, 2012, J BONE MINER RES, V27, P2359, DOI 10.1002/jbmr.1687; Main RP, 2014, J EXP BIOL, V217, P1775, DOI 10.1242/jeb.085522; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Melville KM, 2015, METHODS MOL BIOL, V1226, P99, DOI 10.1007/978-1-4939-1619-1_9; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mostoufi-Moab S, 2015, J BONE MINER RES, V30, P1657, DOI 10.1002/jbmr.2512; Mostoufi-Moab S, 2012, J BONE MINER RES, V27, P760, DOI 10.1002/jbmr.1499; Nicolay NH, 2013, INT J RADIAT ONCOL, V87, P1171, DOI 10.1016/j.ijrobp.2013.09.003; Oest ME, 2015, J ORTHOP RES, V33, P334, DOI 10.1002/jor.22761; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park D, 2014, JOVE-J VIS EXP, DOI 10.3791/51289; Persoon S, 2013, CANCER TREAT REV, V39, P682, DOI 10.1016/j.ctrv.2013.01.001; Plotkin LI, 2014, CURR OSTEOPOROS REP, V12, P121, DOI 10.1007/s11914-014-0194-3; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rapp AE, 2015, EUR CELLS MATER, V29, P22, DOI 10.22203/eCM.v029a02; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Shirazi-Fard Y, 2015, BONE, V81, P260, DOI 10.1016/j.bone.2015.07.019; Spiegelberg L, 2015, J CRANIO MAXILL SURG, V43, P214, DOI 10.1016/j.jcms.2014.11.008; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; Thorsen K, 1996, J CLIN INVEST, V98, P2446, DOI 10.1172/JCI119061; Wang XJ, 2006, STEM CELLS, V24, P1869, DOI 10.1634/stemcells.2005-0430; Wernle JD, 2010, J BIOMECH, V43, P2738, DOI 10.1016/j.jbiomech.2010.06.017; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Wiskemann J, 2008, BONE MARROW TRANSPL, V41, P321, DOI 10.1038/sj.bmt.1705917; Wiskemann J, 2015, INT J CANCER, V137, P2749, DOI 10.1002/ijc.29633; Wiskemann J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1631-0; Wright LE, 2015, J BONE MINER RES OFF; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yang GC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/162410; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	75	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167673	10.1371/journal.pone.0167673	http://dx.doi.org/10.1371/journal.pone.0167673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936104	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100147
J	Kuroda, K; Nobu, MK; Mei, R; Narihiro, T; Bocher, BTW; Yamaguchi, T; Liu, WT				Kuroda, Kyohei; Nobu, Masaru K.; Mei, Ran; Narihiro, Takashi; Bocher, Benjamin T. W.; Yamaguchi, Takashi; Liu, Wen-Tso			A Single-Granule-Level Approach Reveals Ecological Heterogeneity in an Upflow Anaerobic Sludge Blanket Reactor	PLOS ONE			English	Article							WASTE-WATER TREATMENT; SYNTROPHIC ASSOCIATION; SOFTWARE ENVIRONMENT; SP. NOV.; COMMUNITY; BACTERIA; LOCALIZATION; DIVERSITY; DIGESTION; CONSORTIA	Upflow anaerobic sludge blanket (UASB) reactor has served as an effective process to treat industrial wastewater such as purified terephthalic acid (PTA) wastewater. For optimal UASB performance, balanced ecological interactions between syntrophs, methanogens, and fermenters are critical. However, much of the interactions remain unclear because UASB have been studied at a "macro"-level perspective of the reactor ecosystem. In reality, such reactors are composed of a suite of granules, each forming individual micro-ecosystems treating wastewater. Thus, typical approaches may be oversimplifying the complexity of the microbial ecology and granular development. To identify critical microbial interactions at both macro-and micro-level ecosystem ecology, we perform community and network analyses on 300 PTA-degrading granules from a lab-scale UASB reactor and two full-scale reactors. Based on MiSeq-based 16S rRNA gene sequencing of individual granules, different granule-types co-exist in both full-scale reactors regardless of granule size and reactor sampling depth, suggesting that distinct microbial interactions occur in different granules throughout the reactor. In addition, we identify novel networks of syntrophic metabolic interactions in different granules, perhaps caused by distinct thermodynamic conditions. Moreover, unseen methanogenic relationships (e.g. "Candidatus Aminicenantes" and Methanosaeta) are observed in UASB reactors. In total, we discover unexpected microbial interactions in granular micro-ecosystems supporting UASB ecology and treatment through a unique single-granule level approach.	[Kuroda, Kyohei; Nobu, Masaru K.; Mei, Ran; Narihiro, Takashi; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, North Mathews Ave, Urbana, IL 61801 USA; [Kuroda, Kyohei; Yamaguchi, Takashi] Nagaoka Univ Technol, Dept Environm Syst Engn, Nagaoka, Niigata, Japan; [Narihiro, Takashi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Bocher, Benjamin T. W.] BP Amer, Petrochem Technol, Naperville, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST); BP	Liu, WT (corresponding author), Univ Illinois, Dept Civil & Environm Engn, North Mathews Ave, Urbana, IL 61801 USA.	wtliu@illinois.edu	Liu, Wen-Tso/C-8788-2011; Narihiro, Takashi/L-8617-2016; Kuroda, Kyohei/AAQ-4452-2020	Liu, Wen-Tso/0000-0002-8700-9803; Narihiro, Takashi/0000-0003-2936-7204; Kuroda, Kyohei/0000-0002-3681-1265; Mei, Ran/0000-0002-6464-6519	Energy Bioscience Institute at UIUC; Petrochemicals Technology, BP America; Energy Bioscience Institute at University of Illinois at Urbana-Champaign	Energy Bioscience Institute at UIUC; Petrochemicals Technology, BP America; Energy Bioscience Institute at University of Illinois at Urbana-Champaign	This work was supported by a grant from Energy Bioscience Institute at UIUC. Petrochemicals Technology, BP America provided support in the form of salaries for author BTWB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This study was supported by a grant from Energy Bioscience Institute at University of Illinois at Urbana-Champaign to WTL. MKN, TN, BTWB, and WTL designed the experiments, KK, MKN, TN, and BTWB performed the experiments, and all authors participated in results discussion and manuscript preparation. The authors declare no conflict of interest.	Abbasi T, 2012, RENEW SUST ENERG REV, V16, P1696, DOI 10.1016/j.rser.2011.11.017; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Del Nery V, 2008, BIORESOURCE TECHNOL, V99, P2018, DOI 10.1016/j.biortech.2007.03.019; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang HHP, 2006, WATER RES, V40, P427, DOI 10.1016/j.watres.2005.11.025; Farag IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092139; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Kim JY, 2012, WATER RES, V46, P2805, DOI 10.1016/j.watres.2012.02.042; Kleerebezem R, 2003, CHEM ENG-NEW YORK, V110, P56; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuroda K, 2015, BIORESOURCE TECHNOL, V196, P225, DOI 10.1016/j.biortech.2015.07.070; Kuroda K, 2015, MICROB ECOL, V69, P586, DOI 10.1007/s00248-014-0525-z; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lykidis A, 2011, ISME J, V5, P122, DOI 10.1038/ismej.2010.125; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Narihiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119131; Nobu MK, 2015, ISME J, V9, P1710, DOI 10.1038/ismej.2014.256; Nobu MK, 2015, ENVIRON MICROBIOL, V17, P4861, DOI 10.1111/1462-2920.12444; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Perkins SD, 2011, WATER SCI TECHNOL, V64, P1406, DOI 10.2166/wst.2011.552; Pol LWH, 2004, WATER RES, V38, P1376, DOI 10.1016/j.watres.2003.12.002; Qiu YL, 2008, APPL ENVIRON MICROB, V74, P2051, DOI 10.1128/AEM.02378-07; Qiu YL, 2006, ARCH MICROBIOL, V185, P172, DOI 10.1007/s00203-005-0081-5; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schmidt JE, 1996, BIOTECHNOL BIOENG, V49, P229, DOI [10.1002/(SICI)1097-0290(19960205)49:3<229::AID-BIT1>3.0.CO;2-M, 10.1002/(SICI)1097-0290(19960205)49:3&lt;229::AID-BIT1&gt;3.0.CO;2-M]; Sekiguchi Y, 1999, APPL ENVIRON MICROB, V65, P1280; Sekiguchi Y, 1998, MICROBIOL-UK, V144, P2655, DOI 10.1099/00221287-144-9-2655; SEKIGUCHI Y, 2006, MICROBES ENVIRON, V21, P1, DOI DOI 10.1264/JSME2.21.1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Wu JH, 2013, APPL ENVIRON MICROB, V79, P105, DOI 10.1128/AEM.02327-12; Wu JH, 2001, MICROBIOL-UK, V147, P373, DOI 10.1099/00221287-147-2-373; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yan YG, 1997, WATER RES, V31, P1573, DOI 10.1016/S0043-1354(96)00354-5	43	25	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167788	10.1371/journal.pone.0167788	http://dx.doi.org/10.1371/journal.pone.0167788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936088	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100189
J	Pivot, D; Debouverie, M; Grzebyk, M; Brassat, D; Clanet, M; Clavelou, P; Confavreux, C; Edan, G; Leray, E; Moreau, T; Vukusic, S; Hedelin, G; Guillemin, F				Pivot, Diane; Debouverie, Marc; Grzebyk, Michel; Brassat, David; Clanet, Michel; Clavelou, Pierre; Confavreux, Christian; Edan, Gilles; Leray, Emmanuelle; Moreau, Thibault; Vukusic, Sandra; Hedelin, Guy; Guillemin, Francis			Geographical Heterogeneity of Multiple Sclerosis Prevalence in France	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; EPIDEMIOLOGY; METAANALYSIS	Introduction Geographical variation in the prevalence of multiple sclerosis (MS) is controversial. Heterogeneity is important to acknowledge to adapt the provision of care within the healthcare system. We aimed to investigate differences in prevalence of MS in departments in the French territory. Methods We estimated MS prevalence on October 31, 2004 in 21 administrative departments in France (22% of the metropolitan departments) by using multiple data sources: the main French health insurance systems, neurologist networks devoted to MS and the Technical Information Agency of Hospitalization. We used a spatial Bayesian approach based on estimating the number of MS cases from 2005 and 2008 capture-recapture studies to analyze differences in prevalence. Results The age-and sex-standardized prevalence of MS per 100,000 inhabitants ranged from 68.1 (95% credible interval 54.6, 84.4) in Hautes-Pyrenees (southwest France) to 296.5 (258.8, 338.9) in Moselle (northeast France). The greatest prevalence was in the northeast departments, and the other departments showed great variability. Discussion By combining multiple data sources into a spatial Bayesian model, we found heterogeneity in MS prevalence among the 21 departments of France, some with higher prevalence than anticipated from previous publications. No clear explanation related to health insurance coverage and hospital facilities can be advanced. Population migration, socioeconomic status of the population studied and environmental effects are suspected.	[Pivot, Diane; Guillemin, Francis] Nancy Univ Hosp, Clin & Evaluat Dept, Vandoeuvre Les Nancy, France; [Debouverie, Marc] Paris Descartes Univ, Lorraine Univ, EA Apemac 4360, Nancy, France; [Debouverie, Marc] Nancy Univ Hosp, Dept Neurol, Nancy, France; [Grzebyk, Michel; Hedelin, Guy] Natl Inst Occupat Safety & Hlth, Vandoeuvre Les Nancy, France; [Brassat, David; Clanet, Michel] Toulouse Univ Hosp, Dept Neurol, Toulouse, France; [Clavelou, Pierre] Clermont Ferrand Univ Hosp, Dept Neurol, Clermont Ferrand, France; [Confavreux, Christian; Vukusic, Sandra] Pierre Wertheimer Univ Hosp, Lyon Hosp Civils, Dept Neurol, Lyon, France; [Edan, Gilles] Rennes Univ Hosp, Dept Neurol, Rennes, France; [Leray, Emmanuelle] Ecoles Hautes Etud Sante Publ, Rennes, France; [Moreau, Thibault] Dijon Univ Hosp, Dept Neurol, Dijon, France; [Guillemin, Francis] INSERM, CIC EC, Nancy, France	CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; CHU de Nancy; CHU de Toulouse; CHU Clermont Ferrand; CHU Lyon; CHU Rennes; Universite de Rennes; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guillemin, F (corresponding author), Nancy Univ Hosp, Clin & Evaluat Dept, Vandoeuvre Les Nancy, France.; Guillemin, F (corresponding author), INSERM, CIC EC, Nancy, France.	francis.guillemin@chu-nancy.fr	Leray, Emmanuelle/ABH-4374-2020; Grzebyk, Michel/A-1574-2008; Edan, Gilles/AAI-5944-2020	Leray, Emmanuelle/0000-0001-8424-4499; Grzebyk, Michel/0000-0001-6522-7554; Clavelou, Pierre/0000-0003-2363-9352; pivot, diane/0000-0002-8225-9248	French State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme [ANR-10-COHO-002]; Eugene Devic EDMUS Foundation	French State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme(French National Research Agency (ANR)); Eugene Devic EDMUS Foundation	This work has been realized with the help of the Observatoire Francais de la Sclerose en Plaques (OFSEP), which is supported by a grant provided by the , under the referenceFrench State and handled by the "Agence Nationale de la Recherche," within the framework of the "Investments for the Future" programme ANR-10-COHO-002, and the Eugene Devic EDMUS Foundation against multiple sclerosis.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; Cressie NA., 1996, FAC INFORM PAP ARCH, P159; De Pedro-Cuesta J, 2009, BMC NEUROL, V13, P58, DOI DOI 10.1186/1471-2377-13-58; Debouverie M, 2007, REV NEUROL-FRANCE, V163, P637, DOI 10.1016/S0035-3787(07)90472-5; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; El Adssi H, 2012, MULT SCLER J, V18, P1244, DOI 10.1177/1352458512437811; Fromont A, 2010, BRAIN, V133, P1889, DOI 10.1093/brain/awq134; Ha-Vinh Philippe, 2016, Mult Scler J Exp Transl Clin, V2, p2055217316631762, DOI 10.1177/2055217316631762; HAMMOND SR, 1988, BRAIN, V111, P1, DOI 10.1093/brain/111.1.1; Horakova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053996; Koch-Henriksen N, 2011, J NEUROL SCI, V311, P58, DOI 10.1016/j.jns.2011.09.003; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; KUROIWA Y, 1982, JPN J MED, V21, P135; Kurtzke JF, 1997, NEUROLOGY, V48, P204, DOI 10.1212/WNL.48.1.204; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sagnes-Raffy C, 2010, REV EPIDEMIOL SANTE, V58, P23, DOI 10.1016/j.respe.2009.08.012; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Vukusic S, 2007, J NEUROL NEUROSUR PS, V78, P707, DOI 10.1136/jnnp.2006.101196; Zivadinov R, 2003, NEUROEPIDEMIOLOGY, V22, P65, DOI 10.1159/000067107	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167556	10.1371/journal.pone.0167556	http://dx.doi.org/10.1371/journal.pone.0167556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936086	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100124
J	Tang, JS; Ning, RH; Zeng, B; Li, Y				Tang, Jingsi; Ning, Ruihong; Zeng, Bo; Li, Ying			Molecular Evolution of PTEN Pseudogenes in Mammals	PLOS ONE			English	Article							CANCER RESISTANCE; RNA; PATHWAY; CERNA	Phosphatase and tensin homolog (PTEN) is a tumor-suppressor gene. PTEN pseudogene (PTENp) acts as an endogenous RNA, which regulates its parental gene by competitively binding to the 3' UTR of PTEN gene in the human. Despite the importance of this pseudogene, little is known about the molecular evolution of PTENp in mammals. In this study, we identified 37 pseudogenes from 65 mammalian genomes. Among them, 32 were from rodents or primates. Phylogenetic analyse showed a complex evolutionary history of this gene family. Some PTENps were shared both in primates and rodents. However, some PTENps were shown to be species-specific, such as the tasmanian devil PTENp1, nine banded armadillo PTENp1 and gibbon PTENp1. Most interestingly, the naked mole rat (NMR), an anticancer model organism, possessed 17 copies of PTENps, which were classified into four clades based on the phylogenetic analyses. Furthermore, we found that all the 3' UTR of PTEN and PTENps shared common microRNA (MicroRNA) binding sites in NMR, based on our prediction of specific MicroRNA binding sites. Our findings suggested that multiple gene duplications have occurred in the formation of PTEN/PTENp gene family during the evolution of mammals. Some PTENps were relatively ancient and were shared by primates and rodents; others were newly originated through species-specific gene duplications. PTENps in NMR may function as competitive endogenous RNAs (ceRNAs) to regulate their counterpart genes by competing for common MicroRNAs, which may be one of the interpretations for the cancer resistance in NMR.	[Tang, Jingsi; Ning, Ruihong; Zeng, Bo; Li, Ying] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China	Sichuan Agricultural University	Li, Y (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	yingli@sicau.edu.cn		Zeng, Bo/0000-0001-7482-7340	"1000-Talent Program" in Sichuan; University of Sichuan Bureau of Education	"1000-Talent Program" in Sichuan; University of Sichuan Bureau of Education	This work was supported by the "1000-Talent Program" in Sichuan and the Innovative Research Team in University of Sichuan Bureau of Education to Ying Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Esposito F, 2014, ONCOTARGET, V5, P8341, DOI 10.18632/oncotarget.2202; Fang X, 2014, NAT COMMUN, V5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Jansson MD, 2015, ONCOGENE, V34, P1908, DOI 10.1038/onc.2014.130; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kimura M., 1980, SIMPLE METHOD ESTIMA, DOI [10.1038/ng2135, DOI 10.1038/NG2135]; Kozomara A, 2014, MIRBASE ANNOTATING H; Nei M., 2000, MOL EVOLUTION PHYLOG; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rutnam ZJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3914; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2	23	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167851	10.1371/journal.pone.0167851	http://dx.doi.org/10.1371/journal.pone.0167851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936183	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100216
J	Yang, QQ; Xue, WZ; Zou, RX; Xu, Y; Du, Y; Wang, S; Xu, L; Chen, YZ; Wang, HL; Chen, XT				Yang, Qian-Qian; Xue, Wei-Zhen; Zou, Rong-Xin; Xu, Yi; Du, Yang; Wang, Shuang; Xu, Lai; Chen, Yuan-Zhi; Wang, Hui-Li; Chen, Xiang-Tao			beta-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACORI-GRAMINEI-RHIZOMA; CHONG-MYUNG-TANG; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; DENDRITIC SPINES; DENTATE GYRUS; IN-VIVO; HIPPOCAMPAL NEUROGENESIS; NEURONAL APOPTOSIS	Chronic lead (Pb) exposure causes cognitive deficits. This study aimed to explore the neuroprotective effect and mechanism of beta-asarone, an active component from Chinese Herbs Acorus tatarinowii Schott, to alleviate impairments of spatial memory and synaptogenesis in Pb-exposed rats. Both Sprague-Dawley developmental rat pups and adult rats were used in the study. Developmental rat pups were exposed to Pb throughout the lactation period and beta-asarone (10, 40mg kg(-1), respectively) was given intraperitoneally from postnatal day 14 to 21. Also, the adult rats were exposed to Pb from embryo stage to 11 weeks old and beta-asarone (2.5, 10, 40mg kg(-1), respectively) was given from 9 to 11 weeks old. The level of beta-asarone in brain tissue was measured by High Performance Liquid Chromatography. The Morris water maze test and Golgi-Cox staining method were used to assess spatial memory ability and synaptogenesis. The protein expression of NR2B subunit of NMDA receptor, Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) and Wnt family member 7A (Wnt7a) in hippocampus, as well as mRNA expression of Arc/Arg3.1 and Wnt7a, was also explored. We found that beta-asarone could pass through the blood brain barrier quickly. And beta-asarone effectively attenuated Pb-induced reduction of spine density in hippocampal CA1 and dentate gyrus areas in a dose-dependent manner both in developmental and adult rats, meanwhile the Pb-induced impairments of learning and memory were partially rescued. In addition, beta-asarone effectively up-regulated the protein expression of NR2B, Arc and Wnt7a, as well as the mRNA levels of Arc/Arg3.1 and Wnt7a, which had been suppressed by Pb exposure. The results suggest the neuroprotective properties of beta-asarone against Pb-induced memory impairments, and the effect is possibly through the regulation of synaptogenesis, which is mediated via Arc/Arg3.1 and Wnt pathway.	[Yang, Qian-Qian; Xue, Wei-Zhen; Zou, Rong-Xin; Xu, Yi; Du, Yang; Wang, Shuang; Wang, Hui-Li] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [Xu, Lai; Chen, Yuan-Zhi; Chen, Xiang-Tao] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China	Hefei University of Technology; Anhui Medical University	Chen, XT (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	chenxt@ustc.edu.cn	wang, hui/GRS-4730-2022	Wang, Hui-Li/0000-0001-6852-8002	National Key Basic Research Program of China [2012CB525003]; National Science Foundation of China [31200851, 31401671, 81673624]; Program for New Century Excellent Talents in University [NCET-12-0835]; Key Laboratory of Xin'an Medicine [2015sbgj005]; Huangshan Young Scholar Fund of Hefei University of Technology [407-037030]; Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University [201510366121]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Laboratory of Xin'an Medicine; Huangshan Young Scholar Fund of Hefei University of Technology; Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University	This work was supported by the National Key Basic Research Program of China (No. 2012CB525003, www.973.gov.cn), the National Science Foundation of China (No.31200851, 31401671, 81673624, www.nsfc.gov.cn), the Program for New Century Excellent Talents in University (NCET-12-0835, www.dost.moe.edu.cn), The Open Project of Key Laboratory of Xin'an Medicine (No. 2015sbgj005), the Huangshan Young Scholar Fund of Hefei University of Technology (No. 407-037030) and the Training Program of Innovation and Entrepreneurship for Undergraduates of Anhui Medical University (No.201510366121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen BY, 2013, J NEUROSCI RES, V91, P30, DOI 10.1002/jnr.23138; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chen WH, 2007, NEUROSCIENCE, V147, P853, DOI 10.1016/j.neuroscience.2007.04.042; Cho J, 2002, LIFE SCI, V71, P591, DOI 10.1016/S0024-3205(02)01729-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; David MD, 2008, J CELL SCI, V121, P2718, DOI 10.1242/jcs.029660; Dong HY, 2014, MOLECULES, V19, P5634, DOI 10.3390/molecules19055634; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Falsafi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032082; Fang YQ, 2012, PHARMAZIE, V67, P120, DOI 10.1691/ph.2012.1100; Geng YT, 2010, BIOL PHARM BULL, V33, P836, DOI 10.1248/bpb.33.836; Gortazar AR, 2013, J BIOL CHEM, V288, P8168, DOI 10.1074/jbc.M112.437921; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Hu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101894; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jeon SH, 2007, J BIOL CHEM, V282, P14482, DOI 10.1074/jbc.M611129200; Kim JH, 2009, EVID-BASED COMPL ALT, V6, P457, DOI 10.1093/ecam/nem158; Lee BB, 2003, LIFE SCI, V74, P435, DOI 10.1016/j.lfs.2003.06.034; Lee MR, 2010, J ETHNOPHARMACOL, V132, P70, DOI 10.1016/j.jep.2010.07.041; Li ZQ, 2012, J ETHNOPHARMACOL, V144, P305, DOI 10.1016/j.jep.2012.09.013; Lidsky TI, 2006, ENVIRON RES, V100, P284, DOI 10.1016/j.envres.2005.03.002; Lim H. S., 2014, SCI REP, V4, P1, DOI DOI 10.1016/J.FCT; Liu L, 2014, BIOSCI BIOTECH BIOCH, V78, P1710, DOI 10.1080/09168451.2014.930319; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mao JX, 2015, AGING CELL, V14, P784, DOI 10.1111/acel.12356; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Neal AP, 2011, NEUROTOXICOLOGY, V32, P281, DOI 10.1016/j.neuro.2010.12.013; Nihei MK, 2001, NEUROTOXICOLOGY, V22, P635, DOI 10.1016/S0161-813X(01)00035-3; Pina-Crespo JC, 2002, J PHYSIOL-LONDON, V541, P41, DOI 10.1113/jphysiol.2001.014001; Rajput SB, 2014, PHYTOMEDICINE, V21, P268, DOI 10.1016/j.phymed.2013.09.020; Rana TS, 2013, PHYSIOL MOL BIOL PLA, V19, P231, DOI 10.1007/s12298-013-0164-8; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rochefort NL, 2012, EMBO REP, V13, P699, DOI 10.1038/embor.2012.102; Satyal P, 2013, NAT PROD COMMUN, V8, P1179; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Toscano CD, 2002, DEV BRAIN RES, V139, P217, DOI 10.1016/S0165-3806(02)00569-2; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Unger Pascal, 2012, Sci Pharm, V80, P663; Wang HL, 2006, EUR J NEUROSCI, V23, P1111, DOI 10.1111/j.1460-9568.2006.04645.x; Wei G, 2013, J ALZHEIMERS DIS, V33, P863, DOI 10.3233/JAD-2012-120865; Yan L, 2015, J ETHNOPHARMACOL, V162, P155, DOI 10.1016/j.jep.2014.12.049; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang H, 2007, J PHARM PHARMACOL, V59, P301, DOI 10.1211/jpp.59.2.0016; Zhu KY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/731385; Zhu XQ, 2016, CEREB CORTEX, V26, P334, DOI 10.1093/cercor/bhu258	56	16	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167401	10.1371/journal.pone.0167401	http://dx.doi.org/10.1371/journal.pone.0167401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936013	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100091
J	Jia, PL; Zhang, LH; Chen, JJ; Zhao, PJ; Zhang, MM				Jia, Pengli; Zhang, Longhao; Chen, Jingjing; Zhao, Pujing; Zhang, Mingming			The Effects of Clinical Decision Support Systems on Medication Safety: An Overview	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; ADVERSE DRUG EVENTS; PATIENT OUTCOMES; PRIMARY-CARE; INTERVENTIONS; MANAGEMENT; IMPACT; ERRORS; PERFORMANCE; REMINDERS	Background The clinical decision support system(CDSS) has potential to improving medication safety. However, the effects of the intervention were conflicting and uncertain. Meanwhile, the reporting and methodological quality of this field were unknown. Objective The aim of this overview is to evaluate the effects of CDSS on medication safety and to examine the methodological and reporting quality. Methods PubMed, Embase and Cochrane Library were searched to August 2015. Systematic reviews (SRs) investigating the effects of CDSS on medication safety were included. Outcomes were determined in advance and assessed separately for process of care and patient outcomes. The methodological quality was assessed by Assessment of Multiple Systematic Reviews (AMSTAR) and the reporting quality was examined by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results Twenty systematic reviews, consisting of 237 unique randomized controlled trials(RCTs) and 176 non-RCTs were included. Evidence that CDSS significantly impacted process of care was found in 108 out of 143 unique studies of the 16 SRs examining this effect (75%). Only 18 out of 90 unique studies of the 13 SRs reported significantly evidence that CDSS positively impacted patient outcomes (20%). Ratings for the overall scores of AMSTAR resulted in a mean score of 8.3 with a range of scores from 7.5 to 10.5. The reporting quality was varied. Some contents were particularly strong. However, some contents were poor. Conclusions CDSS reduces medication error by obviously improving process of care and inconsistently improving patient outcomes. Larger samples and longer-term studies are required to ensure more reliable evidence base on the effects of CDSS on patient outcomes. The methodological and reporting quality were varied and some realms need to be improved.	[Jia, Pengli; Zhang, Longhao; Zhao, Pujing; Zhang, Mingming] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China; [Chen, Jingjing] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Hangzhou, Zhejiang, Peoples R China	Sichuan University; Zhejiang Chinese Medical University	Zhang, MM (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China.	mingming-zhang@163.com			National Natural Science Foundation [70973083]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation NO. 70973083.	Alldred DP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009095.pub2; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bayoumi I, 2014, INT J MED INFORM, V83, P406, DOI 10.1016/j.ijmedinf.2014.03.003; Bennett JW, 2003, MED J AUSTRALIA, V178, P217, DOI 10.5694/j.1326-5377.2003.tb05166.x; Berner ES, 2009, CLIN DECISION SUPPOR; Brahma DK, 2013, J PHARMACOL PHARMACO, V4, P91, DOI 10.4103/0976-500X.110872; Chiang SJ, 2010, CLIN DECISION SUPPOR; FERYLEMONNIER E, 1995, INTENS CARE MED, V21, P356, DOI 10.1007/BF01705416; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Ge L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085908; Gillaizeau F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002894.pub3; Haynes RB, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-12; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Julie B, 2012, COCHRANE DB SYST REV; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Keers RN, 2014, DRUG SAFETY, V37, P317, DOI 10.1007/s40264-014-0152-0; Kuperman GJ, 2007, J AM MED INFORM ASSN, V14, P29, DOI 10.1197/jamia.M2170; Lainer M, 2013, INT J QUAL HEALTH C, V25, P590, DOI 10.1093/intqhc/mzt043; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lees KR, 2003, QJM-INT J MED, V96, P143, DOI 10.1093/qjmed/hcg019; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Loganathan M, 2011, AGE AGEING, V40, P150, DOI 10.1093/ageing/afq161; Manias E, 2012, BRIT J CLIN PHARMACO, V74, P411, DOI 10.1111/j.1365-2125.2012.04220.x; Montesi G, 2009, BRIT J CLIN PHARMACO, V67, P651, DOI 10.1111/j.1365-2125.2009.03422.x; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Papageorgiou SN, 2014, EUR J ORTHODONT, V36, P74, DOI 10.1093/ejo/cjt008; Pearson Sallie-Anne, 2009, BMC Health Serv Res, V9, P154, DOI 10.1186/1472-6963-9-154; Robertson Jane, 2010, Int J Pharm Pract, V18, P69; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Sandars J, 2003, FAM PRACT, V20, P231, DOI 10.1093/fampra/cmg301; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Seo HJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-129; Sequeira-Byron P, 2011, J APPL ORAL SCI, V19, P440, DOI 10.1590/S1678-77572011000500002; Shamliyan TA, 2008, HEALTH SERV RES, V43, P32, DOI 10.1111/j.1475-6773.2007.00751.x; Shea BJ, 2007, BMC MED RES METHODOL, V15, P7, DOI [10.1186/1471-2288-7-10, DOI 10.1186/1471-2288-7-10]; Shojania Kaveh G, 2009, Cochrane Database Syst Rev, pCD001096, DOI 10.1002/14651858.CD001096.pub2; Tawadrous D, 2011, AM J KIDNEY DIS, V58, P903, DOI 10.1053/j.ajkd.2011.07.022; Teich JM, 2005, J AM MED INFORM ASSN, V12, P365, DOI 10.1197/jamia.M1822; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Walton R, 1999, BRIT MED J, V318, P984, DOI 10.1136/bmj.318.7189.984; Wolfstadt JI, 2008, J GEN INTERN MED, V23, P451, DOI 10.1007/s11606-008-0504-5	46	38	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167683	10.1371/journal.pone.0167683	http://dx.doi.org/10.1371/journal.pone.0167683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977697	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400028
J	Hussain, MM; Rahman, MM; Asiri, AM				Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.			Efficient 2-Nitrophenol Chemical Sensor Development Based on Ce2O3 Nanoparticles Decorated CNT Nanocomposites for Environmental Safety	PLOS ONE			English	Article							COPPER-OXIDE NANOCRYSTALS; ELECTROCHEMICAL DETECTION; SILVER NANOPARTICLES; CATALYTIC-REDUCTION; 4-NITROPHENOL; ZNO; TEMPERATURE; OXIDATION; POLYMER; PRECIPITATION	Ce2O3 nanoparticle decorated CNT nanocomposites (Ce2O3. CNT NCs) were prepared by a wet-chemical method in basic medium. The Ce2O3. CNT NCs were examined using FTIR, UV/Vis, Field-Emission Scanning Electron Microscopy (FESEM), X-ray electron dispersive spectroscopy (XEDS), X-ray photoelectron spectroscopy (XPS), and powder X-ray diffraction (XRD). A selective 2-nitrophenol (2-NP) sensor was developed by fabricating a thinlayer of NCs onto a flat glassy carbon electrode (GCE, surface area = 0.0316 cm 2). Higher sensitivity including linear dynamic range (LDR), long-term stability, and enhanced electrochemical performances towards 2-NP were achieved by a reliable current-voltage (I-V) method. The calibration curve was found linear (R-2 = 0.9030) over a wide range of 2-NP concentration (100 pM similar to 100.0 mM). Limit of detection (LOD) and sensor sensitivity were calculated based on noise to signal ratio (similar to 3N/S) as 60 +/- 0.02 pM and 1.6x10(-3) mu A mu M-1 cm(-2) respectively. The Ce2O3. CNT NCs synthesized by a wet-chemical process is an excellent way of establishing nanomaterial decorated carbon materials for chemical sensor development in favor of detecting hazardous compounds in health-care and environmental fields at broad-scales. Finally, the efficiency of the proposed chemical sensors can be applied and utilized in effectively for the selective detection of toxic 2-NP component in environmental real samples with acceptable and reasonable results.	[Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.; Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Hussain, Mohammad Musarraf/P-9590-2016; Rahman, Mohammed M./H-5823-2012; Asiri, Abdullah M./C-3458-2009	Hussain, Mohammad Musarraf/0000-0001-9270-0474; Rahman, Mohammed M./0000-0003-2773-1244; Asiri, Abdullah M./0000-0001-7905-3209				Ahmad M, 2015, J RARE EARTH, V33, P255, DOI 10.1016/S1002-0721(14)60412-9; Ahmad T, 2015, J MOL STRUCT, V1084, P9, DOI 10.1016/j.molstruc.2014.12.015; Ammar S., 2007, J ENV ENG MANAGE, V17, P89; Aoul A. T, 2012, PHYS CHEM CHEM PHYS, V14, P4463, DOI [10.1039/c2cp24069f, DOI 10.1039/C2CP24069F]; Baneshi J, 2014, CERAM INT, V40, P14177, DOI 10.1016/j.ceramint.2014.06.005; Barton LE, 2015, ENVIRON POLLUT, V203, P122, DOI 10.1016/j.envpol.2015.03.035; Cretu V, 2016, J MATER CHEM A, V4, P6527, DOI 10.1039/c6ta01355d; Dahle JT, 2015, CHEMOSPHERE, V119, P1365, DOI 10.1016/j.chemosphere.2014.02.027; Dos Santos ML, 2008, MATER LETT, V62, P4509, DOI 10.1016/j.matlet.2008.08.011; Duan XY, 2014, J TAIWAN INST CHEM E, V45, P2975, DOI 10.1016/j.jtice.2014.08.031; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Fang JH, 2008, J RARE EARTH, V26, P153, DOI 10.1016/S1002-0721(08)60056-3; Fang J, 2011, DALTON T, V40, P3122, DOI 10.1039/c0dt01651a; Gao YX, 2015, CATAL SCI TECHNOL, V5, P1568, DOI 10.1039/c4cy01220h; Han WL, 2014, COLLOID SURFACE A, V460, P422, DOI 10.1016/j.colsurfa.2014.03.017; Holken I, 2016, ACS APPL MATER INTER, V8, P20491, DOI 10.1021/acsami.6b06387; Hu T, 2007, CHINESE J CATAL, V28, P844, DOI 10.1016/S1872-2067(07)60069-2; Huang DS, 2015, NEW J CHEM, V39, P4685, DOI 10.1039/c5nj00673b; Hussain M. M., 2016, J ENV SCI; Hussain MM, 2016, RSC ADV, V6, P80511, DOI 10.1039/c6ra12256f; Isichei T. O., 2014, Environment and Pollution, V3, P99; Keyvanloo K, 2012, APPL CATAL A-GEN, V417, P53, DOI 10.1016/j.apcata.2011.12.024; Khan SB, 2014, J TAIWAN INST CHEM E, V45, P2770, DOI 10.1016/j.jtice.2014.07.005; Khan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085290; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P10965; Lee BN, 2002, WATER ENVIRON RES, V74, P28, DOI 10.2175/106143002X139721; Li JH, 2012, J HAZARD MATER, V201, P250, DOI 10.1016/j.jhazmat.2011.11.076; Li L, 2011, INT J HYDROGEN ENERG, V36, P8839, DOI 10.1016/j.ijhydene.2011.04.137; Liu JX, 2010, ANAL CHEM, V82, P7380, DOI 10.1021/ac101510b; Liu XY, 2010, B KOREAN CHEM SOC, V31, P1182, DOI 10.5012/bkcs.2010.31.5.1182; Lu WY, 2015, MATER LETT, V154, P33, DOI 10.1016/j.matlet.2015.04.051; Lupan O., J MAT CHEM; Lupan O, 2016, SENSOR ACTUAT B-CHEM, V224, P434, DOI 10.1016/j.snb.2015.10.042; Nistor C, 2001, ANAL CHIM ACTA, V426, P185, DOI 10.1016/S0003-2670(00)00825-4; Ogi T, 2012, CHEM ENG J, V210, P461, DOI 10.1016/j.cej.2012.09.033; Pawar RC, 2010, SENSOR ACTUAT B-CHEM, V151, P212, DOI 10.1016/j.snb.2010.09.019; Pedrosa VD, 2003, J BRAZIL CHEM SOC, V14, P530, DOI 10.1590/S0103-50532003000400007; Periyat P, 2011, RSC ADV, V1, P1794, DOI 10.1039/c1ra00524c; Rahman MM, 2016, RSC ADV, V6, P65338, DOI 10.1039/c6ra11582a; Rahman MM, 2015, RSC ADV, V5, P63252, DOI 10.1039/c5ra08224b; Rahman MM, 2013, ELECTROCHIM ACTA, V112, P422, DOI 10.1016/j.electacta.2013.08.164; Rahman MM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-60; Rajendran R, 2014, J MATER CHEM A, V2, P18480, DOI 10.1039/c4ta03996c; Rajgure AV, 2014, CERAM INT, V40, P5837, DOI 10.1016/j.ceramint.2013.11.025; Ribeiro RS, 2013, APPL CATAL B-ENVIRON, V140, P356, DOI 10.1016/j.apcatb.2013.04.031; Sarycheva AS, 2014, MATER LETT, V121, P66, DOI 10.1016/j.matlet.2014.01.101; Scandurra G, 2014, SENSORS-BASEL, V14, P8926, DOI 10.3390/s140508926; Shaari N, 2012, J RARE EARTH, V30, P651, DOI 10.1016/S1002-0721(12)60107-0; Shin HJ, 2011, SYNTHETIC MET, V161, P1284, DOI 10.1016/j.synthmet.2011.04.024; Vilian ATE, 2015, ANAL METHODS-UK, V7, P5627, DOI [10.1039/C5AY01005E, 10.1039/c5ay01005e]; Wang CC, 2007, SENSOR ACTUAT B-CHEM, V122, P591, DOI 10.1016/j.snb.2006.07.003; Wang F, 2009, MICROCHIM ACTA, V165, P1, DOI 10.1007/s00604-009-0136-4; Wang YZ, 2014, APPL SURF SCI, V292, P608, DOI 10.1016/j.apsusc.2013.12.017; Wu H, 2015, CATAL SCI TECHNOL, V5, P1888, DOI 10.1039/c4cy01158a; Xu JQ, 2008, SENSOR ACTUAT B-CHEM, V132, P334, DOI 10.1016/j.snb.2008.01.062; Zhang DS, 2013, RSC ADV, V3, P8811, DOI 10.1039/c3ra41400k; Zhang Y, 2015, PHYS CHEM CHEM PHYS, V17, P14656, DOI 10.1039/c5cp00373c; Zhao XH, 2015, RSC ADV, V5, P49534, DOI 10.1039/c5ra07821k; Zhou W, 2015, RSC ADV, V5, P50505, DOI 10.1039/c5ra04647e; Zhu ZK, 2014, J HAZARD MATER, V279, P436, DOI 10.1016/j.jhazmat.2014.07.030	61	46	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166265	10.1371/journal.pone.0166265	http://dx.doi.org/10.1371/journal.pone.0166265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973600	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300009
J	Lafoux, A; Baudry, C; Bonhomme, C; Le Ruyet, P; Huchet, C				Lafoux, Aude; Baudry, Charlotte; Bonhomme, Cecile; Le Ruyet, Pascale; Huchet, Corinne			Soluble Milk Protein Supplementation with Moderate Physical Activity Improves Locomotion Function in Aging Rats	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; FRAIL ELDERLY-PEOPLE; SKELETAL-MUSCLE MASS; DOUBLE-BLIND; RESISTANCE EXERCISE; AMINO-ACIDS; FOOD-INTAKE; STRENGTH; SARCOPENIA; HEALTH	Aging is associated with a loss of muscle mass and functional capacity. Present study was designed to compare the impact of specific dairy proteins on muscular function with or without a low-intensity physical activity program on a treadmill in an aged rat model. We investigated the effects of nutritional supplementation, five days a week over a 2-month period with a slow digestible protein, casein or fast digestible proteins, whey or soluble milk protein, on strength and locomotor parameters in sedentary or active aged Wistar RjHan rats (17-19 months of age). An extensive gait analysis was performed before and after protein supplementation. After two months of protein administration and activity program, muscle force was evaluated using a grip test, spontaneous activity using an openfield and muscular mass by specific muscle sampling. When aged rats were supplemented with proteins without exercise, only minor effects of different diets on muscle mass and locomotion were observed: higher muscle mass in the casein group and improvement of stride frequencies with soluble milk protein. By contrast, supplementation with soluble milk protein just after physical activity was more effective at improving overall skeletal muscle function in old rats compared to casein. For active old rats supplemented with soluble milk protein, an increase in locomotor activity in the open field and an enhancement of static and dynamic gait parameters compared to active groups supplemented with casein or whey were observed without any differences in muscle mass and forelimb strength. These results suggest that consumption of soluble milk protein as a bolus immediately after a low intensity physical activity may be a suitable nutritional intervention to prevent decline in locomotion in aged rats and strengthen the interest to analyze the longitudinal aspect of locomotion in aged rodents.	[Lafoux, Aude; Huchet, Corinne] Univ Nantes, INSERM Inst Thorax U1087, Therassay, Nantes, France; [Baudry, Charlotte; Le Ruyet, Pascale] LACTALIS Rech & Dev, Retiers, France; [Bonhomme, Cecile] LACTALIS Nutr Sante, Torce, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Lafoux, A (corresponding author), Univ Nantes, INSERM Inst Thorax U1087, Therassay, Nantes, France.	aude.lafoux@univ-nantes.fr			Lactalis	Lactalis	This study was supported by Lactalis. The funder had a role in study design (discussion and agreement) and correction of the manuscript. Aude Lafoux and Corinne Huchet have nothing to declare. Charlotte Baudry, Cecile Bonhomme and Pascale Le Ruyet are employed by Lactalis company.	Abourachid A, 2003, CR BIOL, V326, P625, DOI 10.1016/S1631-0691(03)00170-7; Babault N, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-36; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Bauer JM, 2008, J AM MED DIR ASSOC, V9, P545, DOI 10.1016/j.jamda.2008.04.010; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Beasley JM, 2013, J AM GERIATR SOC, V61, P1863, DOI 10.1111/jgs.12503; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; CAMPBELL WW, 1995, AM J PHYSIOL-ENDOC M, V268, pE1143, DOI 10.1152/ajpendo.1995.268.6.E1143; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dangin M, 2001, AM J PHYSIOL-ENDOC M, V280, pE340, DOI 10.1152/ajpendo.2001.280.2.E340; De Luca A., 2008, USE GRIP STRENGTH ME; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dreyer HC, 2005, J AM COLL NUTR, V24, p140S, DOI 10.1080/07315724.2005.10719455; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FIATARONE MA, 1993, J GERONTOL, V48, P77, DOI 10.1093/geronj/48.Special_Issue.77; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gryson C, 2014, J AM MED DIR ASS; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Holm L, 2006, J ORTHOP RES, V24, P2114, DOI 10.1002/jor.20147; Holm L, 2008, J APPL PHYSIOL, V105, P274, DOI 10.1152/japplphysiol.00935.2007; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Janssen I, 2011, CLIN GERIATR MED, V27, P355, DOI 10.1016/j.cger.2011.03.004; Kalapotharakos VI, 2004, J AGING PHYS ACTIV, V12, P131, DOI 10.1123/japa.12.2.131; Kanneboyinna N, 2008, BEHAV LOCOMOTOR MEAS; Karelis AD, 2015, J NUTR HEALTH AGING, V19, P531, DOI 10.1007/s12603-015-0442-y; Kukuljan S, 2009, J APPL PHYSIOL, V107, P1864, DOI 10.1152/japplphysiol.00392.2009; Mikkelsen UR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0758-3; Miyazaki Y, 2014, MOL NUTR FOOD RES, V58, P2046, DOI 10.1002/mnfr.201400100; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Morley JE, 2010, J AM MED DIR ASSOC, V11, P391, DOI 10.1016/j.jamda.2010.04.014; Mosoni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109098; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; O'Connell K, 2008, EXP GERONTOL, V43, P958, DOI 10.1016/j.exger.2008.07.006; Raj IS, 2010, EXP GERONTOL, V45, P81, DOI 10.1016/j.exger.2009.10.013; Rieu I, 2007, NUTRITION, V23, P323, DOI 10.1016/j.nut.2006.12.013; Rolland YM, 2007, J GERONTOL A-BIOL, V62, P330, DOI 10.1093/gerona/62.3.330; Roth S M, 2000, J Nutr Health Aging, V4, P143; Roubenoff R, 2001, JAMA-J AM MED ASSOC, V286, P1230, DOI 10.1001/jama.286.10.1230; SCHLETTW.D, 1970, GERONTOLOGY, V16, P111, DOI 10.1159/000211762; Scott D, 2010, J AM GERIATR SOC, V58, P2129, DOI 10.1111/j.1532-5415.2010.03147.x; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Vidal K, 2014, EUR J NUTR, V53, P963, DOI 10.1007/s00394-013-0600-0; Volek JS, 2013, J AM COLL NUTR, V32, P122, DOI 10.1080/07315724.2013.793580; Walker DK, 2011, MED SCI SPORT EXER, V43, P2249, DOI 10.1249/MSS.0b013e318223b037; Welle S, 1998, AM J PHYSIOL-ENDOC M, V274, pE677, DOI 10.1152/ajpendo.1998.274.4.E677; Zhu K, 2015, J NUTR, V145, P2520, DOI 10.3945/jn.115.218297	56	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167707	10.1371/journal.pone.0167707	http://dx.doi.org/10.1371/journal.pone.0167707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973615	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300041
J	Clark, SD; Nabity, MB; Cianciolo, RE; Dufek, B; Cosgrove, D				Clark, Sabrina D.; Nabity, Mary B.; Cianciolo, Rachel E.; Dufek, Brianna; Cosgrove, Dominic			X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage	PLOS ONE			English	Article							BASEMENT-MEMBRANE NEPHROPATHY; CHRONIC KIDNEY-DISEASE; LARGE ANIMAL-MODELS; MOUSE MODEL; HEREDITARY NEPHRITIS; RENAL-DISEASE; IV COLLAGEN; KNOCKOUT; CANINE; MICE	Background X-linked Alport syndrome (XLAS), caused by mutations in the type IV collagen COL4A5 gene, accounts for approximately 80% of human Alport syndrome. Dogs with XLAS have a similar clinical progression. Prior studies in autosomal recessive Alport mice demonstrated early mesangial cell invasion as the source of laminin 211 in the glomerular basement membrane (GBM), leading to proinflammatory signaling. The objective of this study was to verify this process in XLAS dogs. Methods XLAS dogs and WT littermates were monitored with serial clinicopathologic data and kidney biopsies. Biopsies were obtained at set milestones defined by the onset of microalbuminuria (MA), overt proteinuria, onset of azotemia, moderate azotemia, and euthanasia. Kidney biopsies were analyzed by histopathology, immunohistochemistry, and electron microscopy. Results XLAS dogs showed progressive decrease in renal function and progressive increase in interstitial fibrosis and glomerulosclerosis (based on light microscopy and immunostaining for fibronectin). The only identifiable structural abnormality at the time of microalbuminuria was ultrastructural evidence of mild segmental GBM multilamination, which was more extensive when overt proteinuria developed. Co-localization studies showed that mesangial laminin 211 and integrin alpha 8 beta 1 accumulated in the GBM at the onset of overt proteinuria and coincided with ultrastructural evidence of mild cellular interpositioning, consistent with invasion of the capillary loops by mesangial cell processes. Conclusion In a large animal model, the induction of mesangial filopodial invasion of the glomerular capillary loop leading to the irregular deposition of laminin 211 is an early initiating event in Alport glomerular pathology.	[Clark, Sabrina D.; Nabity, Mary B.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Cianciolo, Rachel E.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Dufek, Brianna; Cosgrove, Dominic] Boys Town Natl Res Hosp, Ctr Basic Res, Omaha, NE 68131 USA	Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; Boys Town National Research Hospital	Clark, SD (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	svobornik@cvm.tamu.edu		Clark, Sabrina/0000-0002-6431-4776	IDEXX Laboratories, Inc.; Morris Animal Foundation [D14CA-904]	IDEXX Laboratories, Inc.; Morris Animal Foundation	Funding support for the clinicopathological data was provided by IDEXX Laboratories, Inc. Fellowship funding for Dr. Clark in part is provided by Morris Animal Foundation (Grant ID# D14CA-904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Casal M, 2006, EUR J HUM GENET, V14, P266, DOI 10.1038/sj.ejhg.5201535; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Cosgrove D, 2012, PEDIATR NEPHROL, V27, P885, DOI 10.1007/s00467-011-1868-z; Cox ML, 2003, MAMM GENOME, V14, P396, DOI 10.1007/s00335-002-2253-9; Dehoux JP, 2007, FRONT BIOSCI-LANDMRK, V12, P4864, DOI 10.2741/2434; Delimont D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099083; Dufek B, 2016, KIDNEY INT; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hartner A, 1999, KIDNEY INT, V56, P1468, DOI 10.1046/j.1523-1755.1999.00662.x; HOFFSTEN PE, 1975, J LAB CLIN MED, V86, P920; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; JANSEN B, 1984, AM J PATHOL, V116, P175; Kashtan CE, 1999, MEDICINE, V78, P338, DOI 10.1097/00005792-199909000-00005; Kashtan CE, 2002, NEPHROL DIAL TRANSPL, V17, P1359, DOI 10.1093/ndt/17.8.1359; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Kashtan CE., 2002, CURR DIAGN PATHOL, V8, P349; Kashtan CE, 2013, PEDIATR NEPHROL, V28, P5, DOI 10.1007/s00467-012-2138-4; Korstanje R, 2014, KIDNEY INT, V85, P1461, DOI 10.1038/ki.2013.493; Lees GE, 1999, AM J VET RES, V60, P373; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Nabity MB, 2015, J VET INTERN MED, V29, P1036, DOI 10.1111/jvim.12835; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Noone D, 2013, PEDIATR NEPHROL, V28, P1025, DOI 10.1007/s00467-012-2272-z; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Randles MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35068; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Rao VH, 2003, KIDNEY INT, V63, P1736, DOI 10.1046/j.1523-1755.2003.00939.x; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Sachs N, 2012, J CLIN INVEST, V122, P348, DOI 10.1172/JCI58878; SAKAI T, 1987, ANAT EMBRYOL, V176, P373; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109; Thorner PS, 2007, NEPHRON CLIN PRACT, V106, pC82, DOI 10.1159/000101802; Zallocchi M, 2013, AM J PATHOL, V183, P1269, DOI 10.1016/j.ajpath.2013.06.015; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	44	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168343	10.1371/journal.pone.0168343	http://dx.doi.org/10.1371/journal.pone.0168343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959966	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900059
J	Eichmeier, A; Kominkova, M; Kominek, P; Baranek, M				Eichmeier, Ales; Kominkova, Marcela; Kominek, Petr; Baranek, Miroslav			Comprehensive Virus Detection Using Next Generation Sequencing in Grapevine Vascular Tissues of Plants Obtained from the Wine Regions of Bohemia and Moravia (Czech Republic)	PLOS ONE			English	Article							PINOT-GRIS-VIRUS; PITTING-ASSOCIATED-VIRUS; 1ST REPORT; SMALL RNAS; REVEALS; VARIABILITY; EVOLUTION; INFECTION; DISCOVERY; VARIANTS	Comprehensive next generation sequencing virus detection was used to detect the whole spectrum of viruses and viroids in selected grapevines from the Czech Republic. The novel NGS approach was based on sequencing libraries of small RNA isolated from grapevine vascular tissues. Eight previously partially-characterized grapevines of diverse varieties were selected and subjected to analysis: Chardonnay, Laurot, Guzal Kara, and rootstock Kober 125AA from the Moravia wine-producing region; plus Muller-Thurgau and Pinot Noir from the Bohemia wine-producing region, both in the Czech Republic. Using next generation sequencing of small RNA, the presence of 8 viruses and 2 viroids were detected in a set of eight grapevines; therefore, confirming the high effectiveness of the technique in plant virology and producing results supporting previous data on multiple infected grapevines in Czech vineyards. Among the pathogens detected, the Grapevine rupestris vein feathering virus and Grapevine yellow speckle viroid 1 were recorded in the Czech Republic for the first time.	[Eichmeier, Ales; Baranek, Miroslav] Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic; [Kominkova, Marcela; Kominek, Petr] Crop Res Inst, Ruzyne, Czech Republic	Mendel University in Brno; Czech Crop Research Institute (CRI)	Eichmeier, A (corresponding author), Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic.	ales.eichmeier@mendelu.cz	Eichmeier, Aleš/F-1209-2016; Baránek, Miroslav/E-8371-2016; Kominek, Petr/AAD-1578-2019	Eichmeier, Aleš/0000-0001-7358-3903; Baránek, Miroslav/0000-0002-1583-3588; Kominkova, Marcela/0000-0002-5989-5852; Kominek, Petr/0000-0001-7651-5236	COST [FA1407]; Ministry of Education, Youth and Sports; Ministry of Agriculture	COST(European Cooperation in Science and Technology (COST)); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by COST FA1407, http://www.cost.eu/COST_Actions/fa/FA1407; Ministry of Education, Youth and Sports, http.//www.msmt.cz/index.php?lang=2; Ministry of Agriculture, http://eagri.cz/public/web/en/mze/ministry/.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; Andrews S., 2010, FASTQC QUALITY CONTR; Baranek M, 2009, GENET MOL BIOL, V32, P834, DOI 10.1590/S1415-47572009005000079; Beber R., 2013, J PLANT PATHOL, V95, P36; Broeckx BJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12810; Cepin U, 2010, J VIROL METHODS, V170, P47, DOI 10.1016/j.jviromet.2010.08.018; Cho I. S., 2013, New Disease Reports, V27, P10, DOI 10.5197/j.2044-0588.2013.027.010; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Eichmeier A, 2016, J PLANT PATHOL, V98, P155; Eichmeier A., 2014, International Journal of Virology, V10, P263, DOI 10.3923/ijv.2014.263.271; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Glasa M, 2015, VIRUS GENES, V51, P112, DOI 10.1007/s11262-015-1201-1; Glasa M, 2014, ARCH VIROL, V159, P2103, DOI 10.1007/s00705-014-2031-5; Glasa M, 2011, J PHYTOPATHOL, V159, P805, DOI 10.1111/j.1439-0434.2011.01845.x; Gola EM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00263; Goszczynski DE, 2003, EUR J PLANT PATHOL, V109, P397, DOI 10.1023/A:1023555018700; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Kominek P, 2008, J PLANT PATHOL, V90, P357; Kominek P, 2005, VIRUS GENES, V31, P247, DOI 10.1007/s11262-005-3236-1; Kominek P, 2009, ACTA VIROL, V53, P281, DOI 10.4149/av_2009_04_281; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Matousek J, 2003, PLANT SOIL ENVIRON, V49, P168, DOI 10.17221/4109-PSE; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MINAFRA A, 1994, J VIROL METHODS, V47, P175, DOI 10.1016/0166-0934(94)90076-0; Morelli M, 2014, J PLANT PATHOL, V96, P439; Ong SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049662; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Plesko IM, 2014, PLANT DIS, V98, P1014, DOI 10.1094/PDIS-11-13-1137-PDN; Sabanadzovic S, 2000, ARCH VIROL, V145, P553, DOI 10.1007/s007050050046; Sahana AB, 2013, PLANT DIS, V97, P1517, DOI 10.1094/PDIS-05-13-0494-PDN; Saldarelli P, 2015, PHYTOPATHOLOGY, V105, P555, DOI 10.1094/PHYTO-09-14-0241-R; Subramanya Sastry K, 2013, SEED BORNE PLANT VIR, P285, DOI DOI 10.1007/978-81-322-0813-6_9; Szychowski JA, 1998, VIROLOGY, V248, P432, DOI 10.1006/viro.1998.9292; Terlizzi F, 2011, ANN APPL BIOL, V159, P478, DOI 10.1111/j.1744-7348.2011.00512.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008; Ward LI, 2011, PLANT DIS, V95, P617, DOI 10.1094/PDIS-12-10-0927; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167966	10.1371/journal.pone.0167966	http://dx.doi.org/10.1371/journal.pone.0167966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959951	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900027
J	Limgala, RP; Ioanou, C; Plassmeyer, M; Ryherd, M; Kozhaya, L; Austin, L; Abidoglu, C; Unutmaz, D; Alpan, O; Goker-Alpan, O				Limgala, Renuka Pudi; Ioanou, Chidima; Plassmeyer, Matthew; Ryherd, Mark; Kozhaya, Lina; Austin, Lauren; Abidoglu, Cem; Unutmaz, Derya; Alpan, Oral; Goker-Alpan, Ozlem			Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease	PLoS One			English	Article							HUMAN TH17 CELLS; DENDRITIC CELLS; SCORING SYSTEM; MOUSE MODEL; HIV; INFECTION; DIAGNOSIS; MYELOMA; ADULTS; GOALS	Gaucher disease (GD) patients often present with abnormalities in immune response that may be the result of alterations in cellular and/or humoral immunity. However, how the treatment and clinical features of patients impact the perturbation of their immunological status remains unclear. To address this, we assessed the immune profile of 26 GD patients who were part of an enzyme replacement therapy (ERT) study. Patients were evaluated clinically for onset of GD symptoms, duration of therapy and validated outcome measures for ERT. According to DS3 disease severity scoring system criteria, they were assigned to have mild, moderate or severe GD. Flow cytometry based immunophenotyping was performed to analyze subsets of T, B, NK, NKT and dendritic cells. GD patients showed multiple types of immune abnormalities associated to T and B lymphocytes with respect to their subpopulations as well as memory and activation markers. Skewing of CD4 and CD8 T cell numbers resulting in lower CD4/CD8 ratio and an increase in overall T cell activation were observed. A decrease in the overall B cells and an increase in NK and NKT cells were noted in the GD patients compared to controls. These immune alterations do not correlate with GD clinical type or level of biomarkers. However, subjects with persistent immune alterations, especially in B cells and DCs correlate with longer delay in initiation of ERT (Delta TX). Thus, while ERT may reverse some of these immune abnormalities, the immune cell alterations become persistent if therapy is further delayed. These findings have important implications in understanding the immune disruptions before and after treatment of GD patients.	[Limgala, Renuka Pudi; Ioanou, Chidima; Goker-Alpan, Ozlem] Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA USA; [Limgala, Renuka Pudi; Plassmeyer, Matthew; Ryherd, Mark; Austin, Lauren; Alpan, Oral] O&O Alpan LLC, Amerimmune, Fairfax, VA 22030 USA; [Kozhaya, Lina; Abidoglu, Cem; Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA	Jackson Laboratory	Limgala, RP (corresponding author), Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA USA.; Limgala, RP (corresponding author), O&O Alpan LLC, Amerimmune, Fairfax, VA 22030 USA.	rlimgala@ldrtc.org		Limgala, Renuka/0000-0001-6957-6284	Amerimmune, O O Alpan, LLC	Amerimmune, O O Alpan, LLC	Amerimmune, O & O Alpan, LLC provided support in the form of salaries to authors [RPL, MP, MR, LA and OA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ayto Robert, 2013, Critical Reviews in Oncogenesis, V18, P247; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Charrow J, 2015, AM J HEMATOL, V90, pS19, DOI 10.1002/ajh.24056; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Goker-Alpan O, 2010, THER CLIN RISK MANAG, V6, P315; Hemann EA, 2014, IMMUNOL RES, V59, P66, DOI 10.1007/s12026-014-8530-3; Hivroz C, 2012, CRIT REV IMMUNOL, V32, P139, DOI 10.1615/CritRevImmunol.v32.i2.30; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mistry PK, 2009, BRIT J HAEMATOL, V147, P561, DOI 10.1111/j.1365-2141.2009.07872.x; Mistry PK, 2007, AM J HEMATOL, V82, P697, DOI 10.1002/ajh.20908; Mackern-Oberti JP, 2015, AUTOIMMUN REV, V14, P127, DOI 10.1016/j.autrev.2014.10.010; Pandey MK, 2014, MOL GENET METAB, V111, P163, DOI 10.1016/j.ymgme.2013.09.002; Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197; Pandey MK, 2012, MOL GENET METAB, V106, P310, DOI 10.1016/j.ymgme.2012.04.020; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pavlova EV, 2013, J PATHOL, V231, P88, DOI 10.1002/path.4227; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Rawlings SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126917; Rodic P, 2013, BLOOD CELL MOL DIS, V50, P222, DOI 10.1016/j.bcmd.2012.11.012; Serrano-Villar S, 2015, LANCET HIV, V2, pE76, DOI 10.1016/S2352-3018(15)00018-1; Sonder SU, 2016, BLOOD CELL MOL DIS, V59, P8, DOI 10.1016/j.bcmd.2016.02.003; Thomas AS, 2014, BRIT J HAEMATOL, V165, P427, DOI 10.1111/bjh.12804; Weinreb N, 2008, AM J HEMATOL, V83, P890, DOI 10.1002/ajh.21280; Weinreb NJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0280-3; Weinreb NJ, 2010, GENET MED, V12, P44, DOI 10.1097/GIM.0b013e3181c39194; Zimran A, 2014, PEDIATR ENDOCR REV P, V12, P82	28	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168135	10.1371/journal.pone.0168135	http://dx.doi.org/10.1371/journal.pone.0168135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942037	Green Submitted, gold, Green Published			2022-12-26	WOS:000392745600053
J	Ngoi, CN; Price, MA; Fields, B; Bonventure, J; Ochieng, C; Mwashigadi, G; Hassan, AS; Thiong'o, AN; Micheni, M; Mugo, P; Graham, S; Sanders, EJ				Ngoi, Carolyne N.; Price, Matt A.; Fields, Barry; Bonventure, Juma; Ochieng, Caroline; Mwashigadi, Grace; Hassan, Amin S.; Thiong'o, Alexander N.; Micheni, Murugi; Mugo, Peter; Graham, Susan; Sanders, Eduard J.			Dengue and Chikungunya Virus Infections among Young Febrile Adults Evaluated for Acute HIV-1 Infection in Coastal Kenya	PLOS ONE			English	Article							ARBOVIRAL INFECTIONS; SEEKING CARE; RT-PCR; FEVER; MALARIA; TIME; ILLNESS; RISK	Background Fever is common among patients seeking care in sub-Saharan Africa (sSA), but causes other than malaria are rarely diagnosed. We assessed dengue and chikungunya virus infections among young febrile adults evaluated for acute HIV infection (AHI) and malaria in coastal Kenya. Methods We tested plasma samples obtained in a cross-sectional study from febrile adult patients aged 18-35 years evaluated for AHI and malaria at urgent care seeking at seven health facilities in coastal Kenya in 2014-2015. Dengue virus (DENV) and chikungunya virus (CHIKV) were amplified using quantitative real-time reverse-transcription polymerase chain reaction. We conducted logistic regression analyses to determine independent predictors of dengue virus infection. Results 489 samples that were negative for both AHI and malaria were tested, of which 43 (8.8%, 95% confidence interval [CI]: 6.4-11.7) were positive for DENV infection. No participant was positive for CHIKV infection. DENV infections were associated with clinic visits in the rainy season (adjusted odds ratio (AOR) = 3.0, 95% CI: 1.3-6.5) and evaluation at a private health facility (AOR 5.2, 95% CI: 2.0-13.1) or research health facility (AOR = 25.6, 95% CI: 8.9-73.2) instead of a public health facility. Conclusion A high prevalence of DENV infections was found in febrile young adult patients evaluated for AHI. Our data suggests that DENV, along with AHI and malaria, should be considered in the differential diagnosis of the adult patient seeking care for fever in coastal Kenya.	[Ngoi, Carolyne N.; Mwashigadi, Grace; Hassan, Amin S.; Thiong'o, Alexander N.; Micheni, Murugi; Mugo, Peter; Graham, Susan; Sanders, Eduard J.] Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Price, Matt A.] Int AIDS Vaccine Initiat IAVI New York, New York, NY USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Fields, Barry; Bonventure, Juma] Ctr Dis Control & Prevent CDC, Div Global Hlth Protect, Ctr Global Hlth, Nairobi, Kenya; [Ochieng, Caroline] Kenya Med Res Inst KEMRI CDC, Nairobi, Kenya; [Graham, Susan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Med, Headington, England	Kenya Medical Research Institute; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Ngoi, CN (corresponding author), Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya.	ngoicarol@gmail.com	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Hassan, Amin S./0000-0001-5296-4264	University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health [R25 MH064712]; Wellcome Trust [077092]; American people through the United States Agency for International Development (USAID); NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health; Wellcome Trust(Wellcome TrustEuropean Commission); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to acknowledge the support from the University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health R25 MH064712. The KEMRI-Wellcome Trust Research Programme at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). This study was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. This manuscript was submitted for publication with permission from the Director of the Kenya Medical Research Institute (KEMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkus JE, 2016, J ACQUIR IMMUNE DEFI; Carme B, 2009, EMERG INFECT DIS, V15, P668, DOI 10.3201/eid1504.080891; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Crump JA, 2014, T ROY SOC TROP MED H, V108, P61, DOI 10.1093/trstmh/trt120; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733; Garrett NJ, 2016, J ACQUIR IMMUNE DEFI; Grobusch MP, 2006, CLIN MICROBIOL INFEC, V12, P395, DOI 10.1111/j.1469-0691.2006.01353.x; JOHNSON BK, 1982, E AFR MED J, V59, P781; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436; Lanciotti Robert S, 2003, Adv Virus Res, V61, P67, DOI 10.1016/S0065-3527(03)61002-X; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6; Ninphanomchai S, 2014, INT J ENV RES PUB HE, V11, P10694, DOI 10.3390/ijerph111010694; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Prins HAB, 2014, INT HEALTH, V6, P82, DOI 10.1093/inthealth/ihu024; Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203	25	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167508	10.1371/journal.pone.0167508	http://dx.doi.org/10.1371/journal.pone.0167508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942016	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600019
J	Tanka-Salamon, A; Komorowicz, E; Szabo, L; Tenekedjiev, K; Kolev, K				Tanka-Salamon, Anna; Komorowicz, Erzsebet; Szabo, Laszlo; Tenekedjiev, Kiril; Kolev, Krasimir			Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots	PLoS One			English	Article							CRYSTAL-STRUCTURE; COMPLEX; STABILITY; PLASMA; HISTONES; OMEGA-3-FATTY-ACIDS; ENVIRONMENT; INHIBITORS; ARTERIAL; POSITION	Upon platelet activation, free fatty acids are released at the stage of thrombus formation, but their effects on fibrin formation are largely unexplored. Our objective was to characterize the kinetic effects of fatty acids on thrombin activity, as well as the structural and mechanical properties of the resultant fibrin clots. Thrombin activity on fibrinogen was followed by turbidimetry and detailed kinetic characterization was performed using a fluorogenic short peptide substrate. The viscoelastic properties of fibrin were measured with rotatory oscillation rheometer, whereas its structure was analyzed with scanning electron microscopy (SEM). In turbidimetric assays of fibrin generation, oleate and stearate at physiologically relevant concentrations (60-600 mu M) produced a bell-shaped inhibitory dose response, increasing 10- to 30-fold the time to half-maximal clotting. Oleate inhibited thrombin activity on a short peptide substrate according to a mixed-type inhibitor pattern (a 9-fold increase of the Michaelis constant, Km and a 20% decrease of the catalytic constant), whereas stearate resulted in only a minor (15%) drop in the catalytic constant without any change in the Km. Morphometric analysis of SEM images showed a 73% increase in the median fiber diameter in the presence of stearate and a 20% decrease in the presence of oleate. Concerning the viscoelastic parameters of the clots, storage and loss moduli, maximal viscosity and critical shear stress decreased by 32-65% in the presence of oleate or stearate, but loss tangent did not change indicating decreased rigidity, higher deformability and decreased internal resistance to shear stress. Our study provides evidence that free fatty acids (at concentrations comparable to those reported in thrombi) reduce the mechanical stability of fibrin through modulation of thrombin activity and the pattern of fibrin assembly.	[Tanka-Salamon, Anna; Komorowicz, Erzsebet; Kolev, Krasimir] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary; [Szabo, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, IMEC, Budapest, Hungary; [Tenekedjiev, Kiril] Nikola Vaptsarov Naval Acad, Varna, Bulgaria; [Tenekedjiev, Kiril] Univ Tasmania, Australian Maritime Coll, Newnham, Australia	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; IMEC; Nikola Vaptsarov Naval Academy; University of Tasmania	Kolev, K (corresponding author), Semmelweis Univ, Dept Med Biochem, Budapest, Hungary.	Krasimir.Kolev@eok.sote.hu	Kolev, Krasimir/A-3517-2008; Tenekedjiev, Kiril/D-8141-2012; Kolev, Krasimir/J-7648-2019	Kolev, Krasimir/0000-0002-5612-004X; Tenekedjiev, Kiril/0000-0003-3549-0671; Kolev, Krasimir/0000-0002-5612-004X	Hungarian Scientific Research Fund [OTKA 112612]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/) Grant OTKA 112612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; CHANG JY, 1986, BIOCHEM J, V240, P797, DOI 10.1042/bj2400797; Dag O, 2012, SCI WORLD J, DOI 10.1100/2012/673483; Douglass EF, 2013, J AM CHEM SOC, V135, P6092, DOI 10.1021/ja311795d; Fraser DA, 1999, RHEUMATOLOGY, V38, P948, DOI 10.1093/rheumatology/38.10.948; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HIGAZI AA, 1994, BIOCHEM J, V300, P251, DOI 10.1042/bj3000251; HOGG PJ, 1990, J BIOL CHEM, V265, P248; Idicula T, 2012, ACUTE ISCHEMIC STROK, P145; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Larson MK, 2013, AM J PHYSIOL-CELL PH, V304, pC273, DOI 10.1152/ajpcell.00174.2012; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; LONGSTAFF C, 1993, THROMB HAEMOSTASIS, V69, P430; Longstaff C, 2016, THROMB HAEMOSTASIS, V115, P591, DOI 10.1160/TH15-03-0214; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Lundblad R L, 1976, Methods Enzymol, V45, P156; Lyaker Michael R, 2013, Int J Crit Illn Inj Sci, V3, P77, DOI 10.4103/2229-5151.109429; Maalej N, 1996, CIRCULATION, V93, P1201, DOI 10.1161/01.CIR.93.6.1201; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; MARCUS AJ, 1969, J LIPID RES, V10, P108; McBane RD, 2000, THROMB HAEMOSTASIS, V84, P83, DOI 10.1055/s-0037-1613972; Melzig MF, 2005, PLANTA MED, V71, P787, DOI 10.1055/s-2005-871253; Nikolova N.D., 2013, THEORY APPL MONTE CA, P1, DOI DOI 10.5772/53049; Pancak J, 2016, NEUROENDOCRINOL LETT, V37, P137; Phang M, 2014, J NUTR BIOCHEM, V25, P997, DOI 10.1016/j.jnutbio.2014.05.001; Rabai G, 2007, J THROMB HAEMOST, V5, P1265, DOI 10.1111/j.1538-7836.2007.02556.x; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Scarsi M, 1999, PROTEINS, V37, P565, DOI 10.1002/(SICI)1097-0134(19991201)37:4<565::AID-PROT7>3.0.CO;2-V; Scheraga HA, 2004, BIOPHYS CHEM, V112, P117, DOI 10.1016/j.bpc.2004.07.011; Schwartz RS, 2009, J AM COLL CARDIOL, V54, P2167, DOI 10.1016/j.jacc.2009.07.042; Sila Cathy, 2014, Handb Clin Neurol, V119, P41, DOI 10.1016/B978-0-7020-4086-3.00004-7; Slatter DA, 2016, CELL METAB, V23, P930, DOI 10.1016/j.cmet.2016.04.001; Stanek F, 2013, INT ANGIOL, V32, P52; Tanka-Salamon A, 2008, FEBS J, V275, P1274, DOI 10.1111/j.1742-4658.2008.06288.x; Tucker TJ, 1998, J MED CHEM, V41, P3210, DOI 10.1021/jm9801713; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Vanschoonbeek K, 2004, ARTERIOSCL THROM VAS, V24, P1734, DOI 10.1161/01.ATV.0000137119.28893.0b; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; Viskupicova J, 2012, J ENZYM INHIB MED CH, V27, P800, DOI 10.3109/14756366.2010.616860; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; Wolberg AS, 2010, HAEMOPHILIA, V16, P7, DOI 10.1111/j.1365-2516.2010.02253.x; Yamada Tsuyoshi, 2012, BMC Res Notes, V5, P372, DOI 10.1186/1756-0500-5-372; Yeromonahos C, 2012, ARTERIOSCL THROM VAS, V32, P1320, DOI 10.1161/ATVBAHA.112.245308; Zhou ZG, 2012, CHINESE MED J-PEKING, V125, P2775, DOI 10.3760/cma.j.issn.0366-6999.2012.15.024	50	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167806	10.1371/journal.pone.0167806	http://dx.doi.org/10.1371/journal.pone.0167806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942000	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600032
J	Wu, YQ; Zhao, D; Zhuang, JN; Zhang, FQ; Xu, C				Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun			Caspase-8 and Caspase-9 Functioned Differently at Different Stages of the Cyclic Stretch-Induced Apoptosis in Human Periodontal Ligament Cells	PLoS One			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; MECHANICAL-STRESS; EXTRACELLULAR-MATRIX; MEDIATED APOPTOSIS; GENE-EXPRESSION; TOOTH MOVEMENT; DEATH; ACTIVATION; CLEAVAGE; RECEPTOR	Background Human periodontal ligament (PDL) cells underwent apoptosis after mechanical stretch loading. However, the exact signalling pathway remains unknown. This study aimed to elucidate how the apoptotic caspases functioned in the cyclic stretch-induced apoptosis in human PDL cells. Materials and Methods In the present study, 20% cyclic stretch was selected to load the cells for 6 or 24 h. The following parameters were analyzed: apoptotic rates, the protein levels of caspase-3, -7, -8 and -9 and the activities of caspase-8 and -9. Subsequently, the influences of caspase-8 and caspase-9 inhibitors on the apoptotic rate and the protein level of the activated caspase-3 were assessed as well. Results The apoptotic rates increased in response to cyclic stretch, but the cells entered different apoptotic stages after 6 and 24 h stretches. Caspase-3, -7, -8 and -9 were all activated after stretch loading. The stretch-induced apoptosis and the protein level of the activated caspase-3 were inhibited after inhibiting both caspase-8 and caspase-9 in both 6 and 24 h stretched cells and after inhibiting caspase-9 in 24 h stretched cells. Conclusion Caspase-8 and -9 functioned differently at different apoptotic stages in human PDL cells after cyclic stretch.	[Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, Shanghai, Peoples R China; [Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Res Inst Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, Shanghai, Peoples R China.; Xu, C (corresponding author), Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Xu, C (corresponding author), Shanghai Res Inst Stomatol, Shanghai, Peoples R China.	imxuchun@163.com		Xu, Chun/0000-0003-2212-631X	National Natural Science Foundation of China [31470903, 31270991, 30900282]; Shanghai Pujiang Program [13PJD021]; Science and Technology Commission of Shanghai [10QA1404200, 08411961500, 07ZR14070]; Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project [S30206-sms02, T0202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China (grant numbers 31470903, 31270991, 30900282); Shanghai Pujiang Program (grant number 13PJD021); Science and Technology Commission of Shanghai (grant numbers 10QA1404200, 08411961500, 07ZR14070); Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project (grant numbers S30206-sms02, T0202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrazzak AB, 2011, RADIAT RES, V176, P346, DOI 10.1667/RR2509.1; Bantel H, 2005, FEBS LETT, V579, P5559, DOI 10.1016/j.febslet.2005.09.020; Bian ZM, 2011, INVEST OPHTH VIS SCI, V52, P8646, DOI 10.1167/iovs.11-7570; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gamonal J, 2001, J PERIODONTOL, V72, P517, DOI 10.1902/jop.2001.72.4.517; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Hatai T, 2001, ORAL DIS, V7, P287, DOI 10.1034/j.1601-0825.2001.00663.x; Kaku M, 2005, J PERIODONTAL RES, V40, P59, DOI 10.1111/j.1600-0765.2004.00773.x; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krippner-Heidenreich A, 2001, BIOCHEM J, V358, P705, DOI 10.1042/0264-6021:3580705; Lee SI, 2012, CLIN EXP IMMUNOL, V168, P113, DOI 10.1111/j.1365-2249.2011.04549.x; Lee SK, 2008, J ENDODONT, V34, P1364, DOI 10.1016/j.joen.2008.08.024; Leone A, 2012, FOLIA HISTOCHEM CYTO, V50, P497, DOI [10.5603/20320, 10.5603/FHC.2012.0070]; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li X, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1292-z; Lin YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093926; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lucas H, 2010, J DENT RES, V89, P29, DOI 10.1177/0022034509350708; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ma JY, 2015, ARCH ORAL BIOL, V60, P447, DOI 10.1016/j.archoralbio.2014.11.019; Mabuchi R, 2002, J PERIODONTAL RES, V37, P118, DOI 10.1034/j.1600-0765.2001.10602.x; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; Pileczki Valentina, 2016, Clujul Med, V89, P50, DOI 10.15386/cjmed-512; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Reno F, 2003, BIOMATERIALS, V24, P3941, DOI 10.1016/S0142-9612(03)00276-X; Saminathan A, 2012, J PERIODONTAL RES, V47, P212, DOI 10.1111/j.1600-0765.2011.01423.x; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Srivastava SK, 2015, BRIT J CANCER, V113, P660, DOI 10.1038/bjc.2015.252; Stel AJ, 2007, J IMMUNOL, V178, P2287, DOI 10.4049/jimmunol.178.4.2287; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tu HP, 2009, J PERIODONTAL RES, V44, P767, DOI 10.1111/j.1600-0765.2008.01189.x; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075973; Wu MH, 2014, FISH SHELLFISH IMMUN, V41, P625, DOI 10.1016/j.fsi.2014.10.017; Xu C, 2011, J PERIODONTAL RES, V46, P742, DOI 10.1111/j.1600-0765.2011.01397.x; Xu C, 2012, ARCH ORAL BIOL, V57, P1602, DOI 10.1016/j.archoralbio.2012.07.002; Yamaguchi M, 1996, J DENT RES, V75, P889, DOI 10.1177/00220345960750030501; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x; Zhu Q, 2012, BBA-MOL CELL BIOL L, V1821, P1453, DOI 10.1016/j.bbalip.2012.08.005	46	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168268	10.1371/journal.pone.0168268	http://dx.doi.org/10.1371/journal.pone.0168268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942018	gold, Green Submitted, Green Published			2022-12-26	WOS:000392745600061
J	Audiffren, J; Bargiotas, I; Vayatis, N; Vidal, PP; Ricard, D				Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas; Vidal, Pierre-Paul; Ricard, Damien			A Non Linear Scoring Approach for Evaluating Balance: Classification of Elderly as Fallers and Non-Fallers	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; POSTURAL SWAY; DENSITY; TOOLS; TASK	Almost one third of population 65 years-old and older faces at least one fall per year. An accurate evaluation of the risk of fall through simple and easy-to-use measurements is an important issue in current clinic. A common way to evaluate balance in posturography is through the recording of the centre-of-pressure (CoP) displacement (statokinesigram) with force platforms. A variety of indices have been proposed to differentiate fallers from non fallers. However, no agreement has been reached whether these analyses alone can explain sufficiently the complex synergies of postural control. In this work, we study the statokinesigrams of 84 elderly subjects (80.3+-6.4 years old), which had no impairment related to balance control. Each subject was recorded 25 seconds with eyes open and 25 seconds with eyes closed and information pertaining to the presence of problems of balance, such as fall, in the last six months, was collected. Five descriptors of the statokinesigrams were computed for each record, and a Ranking Forest algorithm was used to combine those features in order to evaluate each subject's balance with a score. A classical train-test split approach was used to evaluate the performance of the method through ROC analysis. ROC analysis showed that the performance of each descriptor separately was close to a random classifier (AUC between 0.49 and 0.54). On the other hand, the score obtained by our method reached an AUC of 0.75 on the test set, consistent over multiple train-test split. This non linear multi-dimensional approach seems appropriate in evaluating complex postural control.	[Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas] Univ Paris Saclay, CNRS, ENS Cachan, CMLA, Cachan, France; [Audiffren, Julien; Bargiotas, Ioannis; Vayatis, Nicolas; Vidal, Pierre-Paul; Ricard, Damien] Univ Paris 05, CNRS, SSA, COGNAG G,UMR 8257, Paris, France; [Ricard, Damien] Serv Sante Armees, HIA Percy, Serv Neurol, Clamart, France; [Ricard, Damien] Ecole Val de Grace, Serv Sante Armees, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Audiffren, J (corresponding author), Univ Paris Saclay, CNRS, ENS Cachan, CMLA, Cachan, France.; Audiffren, J (corresponding author), Univ Paris 05, CNRS, SSA, COGNAG G,UMR 8257, Paris, France.	julien.audiffren@cmla.ens-cachan.fr		Audiffren, Julien/0000-0003-4321-2575; BARGIOTAS, IOANNIS/0000-0002-1069-1293	specific grant for the SmartCheck project	specific grant for the SmartCheck project	This work was funded by specific grant for the SmartCheck project thanks to the Societe d'Acceleration de Transfert Technologique (http://www.idfinnov.com/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiffren J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081208; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bigelow KE, 2010, J GERONTOL A-BIOL; Black Alex, 2005, Clin Exp Optom, V88, P212; Blaszczyk JW, 2007, EXP BRAIN RES, V183, P107, DOI 10.1007/s00221-007-1024-y; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Breiman L., 2001, MACH LEARN, V45, P5; Castelli L, 2015, J NEUROL SCI, V359, P440, DOI 10.1016/j.jns.2015.10.016; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clemencon S, 2013, J MACH LEARN RES, V14, P39; Marrega LHG, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P111, DOI 10.1109/ICDMW.2014.127; Jacono M, 2004, MOTOR CONTROL, V8, P292, DOI 10.1123/mcj.8.3.292; KANTNER RM, 1991, AM J OTOLARYNG, V12, P196, DOI 10.1016/0196-0709(91)90120-5; Leach JM, 2014, SENSORS-BASEL, V14, P18244, DOI 10.3390/s141018244; Liu CL, 2010, EXPERT SYST APPL, V37, P7174, DOI 10.1016/j.eswa.2010.04.014; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Muir JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070566; Pagnacco Guido, 2011, Biomed Sci Instrum, V47, P12; Perell KL, 2001, J GERONTOL A-BIOL, V56, pM761, DOI 10.1093/gerona/56.12.M761; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schoneburg B, 2013, MOVEMENT DISORD, V28, P1474, DOI 10.1002/mds.25613; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Swanenburg J, 2010, GAIT POSTURE, V31, P317, DOI 10.1016/j.gaitpost.2009.11.013; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Yelnik A, 2008, NEUROPHYSIOL CLIN, V38, P439, DOI 10.1016/j.neucli.2008.09.008; Young W, 2011, GAIT POSTURE, V33, P303, DOI 10.1016/j.gaitpost.2010.10.089; Zecevic AA, 2006, GERONTOLOGIST, V46, P367, DOI 10.1093/geront/46.3.367	37	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167456	10.1371/journal.pone.0167456	http://dx.doi.org/10.1371/journal.pone.0167456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936060	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100101
J	Li, B; Zhao, LN; Chen, HJ; Sun, DW; Deng, BX; Li, JW; Liu, YF; Wang, F				Li, Bo; Zhao, Lina; Chen, Hongjian; Sun, Dewei; Deng, Boxin; Li, Jinwei; Liu, Yuanfa; Wang, Fei			Inactivation of Lipase and Lipoxygenase of Wheat Germ with Temperature-Controlled Short Wave Infrared Radiation and Its Effect on Storage Stability and Quality of Wheat Germ Oil	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RICE BRAN; MOISTURE; STABILIZATION; OXIDATION; NUTRACEUTICALS; PURIFICATION; RANCIDITY	Wheat germ (WG) is quite susceptible to deterioration due to the presence of lipase (LA) and lipoxygenase (LOX). Therefore it is indispensable to adopt a stabilization step to decrease the activity of LA and LOX while retaining a maximum level of nutrients. But over-drying can make foodstuffs more susceptible to autoxidation. So a stabilization protocol for inactivating LA and LOX of WG with a temperature-controlled short wave infrared (SIR) radiation system was adopted to retard its rancidity and retain a maximum level of fat-soluble nutrients. Meanwhile, the critical storage water activity (Aw) of WG for inhibiting both hydrolytic and oxidative rancidity was appraised. Results indicate that WG irradiated at 90 degrees C for 20 min acquired the optimal stabilization effect, and its residual LA and LOX activity were 18.02% and 19.21%, respectively. At this condition, the free fatty acids (FFA) content and peroxide value (PV) increment of WG oil at 40 degrees C remained below 5% and 2.24 meq O-2/kg for 60 days, respectively. The residual Aw of this WG sample was 0.13, and it is near the Aw corresponding to its monolayer. No significant decrease of fatty acids was observed during SIR processing, while about 96.42% of its original tocopherols still retained inWG treated at 90 degrees C for 20 min.	[Li, Bo; Chen, Hongjian; Sun, Dewei; Deng, Boxin; Li, Jinwei; Liu, Yuanfa] Jiangnan Univ, Sch Food Sci & Technol, Synerget Innovat Ctr Food Safety & Nutr, State Key Lab Food Sci & Technol, Lihu Ave, Wuxi, Jiangsu, Peoples R China; [Zhao, Lina] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Wang, Fei] Jiangsu Berkgen Biopharmaceut Co Ltd, Yangzhou, Jiangsu, Peoples R China	Jiangnan University; Jiangsu University	Liu, YF (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Synerget Innovat Ctr Food Safety & Nutr, State Key Lab Food Sci & Technol, Lihu Ave, Wuxi, Jiangsu, Peoples R China.; Wang, F (corresponding author), Jiangsu Berkgen Biopharmaceut Co Ltd, Yangzhou, Jiangsu, Peoples R China.	yfliu@jiangnan.edu.cn; wangfei@berkgen.com			National Natural Science Foundation of China [31571878, 31171703]; Public sector research special food [201313011-7-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public sector research special food	This study was funded by National Natural Science Foundation of China (31571878 and 31171703), the Public sector research special food (201313011-7-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, WATER ACTIVITY FOODS; Barden L, 2013, CRIT REV FOOD SCI NU; Barnes P., 1991, Lipid Technology, V3, P23; Baysal T, 2007, ENZYME MICROB TECH, V40, P491, DOI 10.1016/j.enzmictec.2006.11.025; Brandolini A, 2012, INT J FOOD SCI NUTR, V63, P71, DOI 10.3109/09637486.2011.633898; Cao RG, 2012, FOOD BIOPROCESS TECH, V5, P1853, DOI 10.1007/s11947-011-0551-5; de Vasconcelos MCBM, 2013, IND CROP PROD, V42, P292, DOI 10.1016/j.indcrop.2012.06.007; Duckworth RB, 1963, RECENT ADV FOOD SCI, P230; Dunford NT, 2003, FOOD RES INT, V36, P905, DOI 10.1016/S0963-9969(03)00099-1; El Amrani F, 2003, SCI ALIMENT, V23, P209, DOI 10.3166/sda.23.209-221; Furmaniak S, 2009, FOOD RES INT, V42, P1203, DOI 10.1016/j.foodres.2009.06.004; GALLIARD T, 1986, J CEREAL SCI, V4, P179, DOI 10.1016/S0733-5210(86)80020-0; Ge YQ, 2001, EUR FOOD RES TECHNOL, V212, P344, DOI 10.1007/s002170000253; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; Jacques N, 1982, J SCI FOOD AGR, V33, P365; Kapranchikov VS, 2004, APPL BIOCHEM MICRO+, V40, P84, DOI 10.1023/B:ABIM.0000010360.46824.56; Kathiravan K., 2007, COMPR REV FOOD SCI F, V7, P2; Kim JY, 2014, FOOD CHEM, V146, P134, DOI 10.1016/j.foodchem.2013.09.025; Kumar GS, 2015, J FOOD SCI TECH MYS, V52, P1145, DOI 10.1007/s13197-013-1119-3; Kumar GS, 2014, INT J FOOD SCI NUTR, V65, P327, DOI 10.3109/09637486.2013.866640; Labuza T. P., 1971, CRC Critic. Rev. Fd Technol., V2, P355, DOI 10.1080/10408397109527127; LABUZA TP, 1971, J AM OIL CHEM SOC, V48, P86, DOI 10.1007/BF02635692; Li B, 2016, RSC ADV, V6, P37265, DOI 10.1039/c5ra23335f; LOEB JR, 1949, J AM OIL CHEM SOC, V26, P738, DOI 10.1007/BF02903184; MALONEY JF, 1966, J FOOD SCI, V31, P878, DOI 10.1111/j.1365-2621.1966.tb03264.x; Moreira R, 2010, IND CROP PROD, V32, P252, DOI 10.1016/j.indcrop.2010.04.021; Ng Lean-Teik, 2013, J AGR FOOD CHEM, V61, P12604; Ozcan MM, 2015, QUAL ASSUR SAF CROP, V7, P517, DOI 10.3920/QAS2014.0457; Piras A, 2009, MOLECULES, V14, P2573, DOI 10.3390/molecules14072573; QUAST DG, 1972, J FOOD SCI, V37, P584, DOI 10.1111/j.1365-2621.1972.tb02698.x; RAO PH, 1980, LEBENSM WISS TECHNOL, V13, P302; Rizzello CG, 2010, FOOD CHEM, V119, P1079, DOI 10.1016/j.foodchem.2009.08.016; Romani S, 2016, FOOD CHEM, V195, P97, DOI 10.1016/j.foodchem.2015.06.114; Rose DJ, 2006, J AM OIL CHEM SOC, V83, P415, DOI 10.1007/s11746-006-1220-0; SALWIN H, 1959, FOOD TECHNOL-CHICAGO, V13, P594; SHIIBA K, 1991, CEREAL CHEM, V68, P115; Shin TS, 1996, J AGR FOOD CHEM, V44, P567, DOI 10.1021/jf950386a; Sjovall O, 2000, J AGR FOOD CHEM, V48, P3522, DOI 10.1021/jf981309t; Srivastava AK, 2007, EUR FOOD RES TECHNOL, V224, P365, DOI 10.1007/s00217-006-0317-x; WEST AUGUSTUS P., 1933, PHILIPPINE JOYX SCI, V52, P1; Xu B, 2012, QUAL ASSUR SAF CROP, V4, P26, DOI 10.1111/j.1757-837X.2011.00120.x; Xu B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/437950; Yalcin S, 2015, FOOD CHEM, V169, P203, DOI 10.1016/j.foodchem.2014.07.114; Yilmaz N, 2016, FOOD CHEM, V190, P179, DOI 10.1016/j.foodchem.2015.05.094; Yilmaz N, 2014, J SCI FOOD AGR, V94, P1568, DOI 10.1002/jsfa.6459; Yondem-Makascioglu F, 2005, J SCI FOOD AGR, V85, P1329, DOI 10.1002/jsfa.2102; Yoshida H, 1999, J AM OIL CHEM SOC, V76, P915, DOI 10.1007/s11746-999-0106-3	47	41	43	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167330	10.1371/journal.pone.0167330	http://dx.doi.org/10.1371/journal.pone.0167330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936025	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100087
J	Wu, ZJ; Liu, Y; Li, XL; Li, XH				Wu, Zijing; Liu, Ye; Li, Xuelian; Li, Xiaohan			Resilience and Associated Factors among Mainland Chinese Women Newly Diagnosed with Breast Cancer	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL CARE; HOPE; TRAJECTORIES; CHEMOTHERAPY; ADOLESCENTS; PREDICTORS; DEPRESSION; SURVIVORS; CHILDREN	Purpose Resilience is the individual's ability to bounce back from trauma. It has been studied for some time in the U.S., but few studies in China have addressed this important construct. In mainland China, relatively little is known about the resilience of patients in clinical settings, especially among patients with breast cancer. In this study, we aimed to evaluate the level of resilience and identify predictors of resilience among mainland Chinese women newly diagnosed with breast cancer. Methods A cross-sectional descriptive study was conducted with 213 mainland Chinese women newly diagnosed with breast cancer between November 2014 and June 2015. Participants were assessed with the Connor-Davidson Resilience Scale (CD-RISC), Social Support Rating Scale (SSRS), Medical Coping Modes Questionnaire (MCMQ, including 3 subscales: confrontation, avoidance, and acceptance-resignation), Herth Hope Index (HHI), and demographic and disease-related information. Descriptive statistics, bivariate analyses and multiple stepwise regression were conducted to explore predictors for resilience. Results The average score for CD-RISC was 60.97, ranging from 37 to 69. Resilience was positively associated with educational level, family income, time span after diagnosis, social support, confrontation, avoidance, and hope. However, resilience was negatively associated with age, body mass index (BMI), and acceptance-resignation. Multiple stepwise regression analysis indicated that hope (beta = 0.343, P<0.001), educational level of junior college or above (beta = 0.272, P<0.001), educational level of high school (beta = 0.235, P<0.001), avoidance (beta = 0.220, P<0.001), confrontation (beta = 0.187, P = 0.001), and age (beta =-0.108, P = 0.037) significantly affected resilience and explained 50.1% of the total variance in resilience. Conclusions Women with newly diagnosed breast cancer from mainland China demonstrated particularly low resilience level, which was predicted by hope educational level, avoidance, confrontation, and age.	[Wu, Zijing; Li, Xiaohan] China Med Univ, Sch Nursing, Shenyang, Liaoning, Peoples R China; [Liu, Ye] China Med Univ, Dept Surg Oncol & Breast Surg, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Li, Xuelian] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Li, XH (corresponding author), China Med Univ, Sch Nursing, Shenyang, Liaoning, Peoples R China.	xhli@cmu.edu.cn			China Medical Board (CMB) Young Nursing Faculty Research Grant [13-168-201413]	China Medical Board (CMB) Young Nursing Faculty Research Grant	This study was supported by China Medical Board (CMB) Young Nursing Faculty Research Grant (grant number: 13-168-201413). No individuals employed or contracted by the funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburn G, 2016, J ADV NURS, V72, P980, DOI 10.1111/jan.12888; Casellas-Grau A, 2014, PSYCHO-ONCOLOGY, V23, P9, DOI 10.1002/pon.3353; Clayton JM, 2005, CANCER-AM CANCER SOC, V103, P1965, DOI 10.1002/cncr.21011; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Solano JPC, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0139-y; Del Mastro L, 2002, EUR J CANCER, V38, P359, DOI 10.1016/S0959-8049(01)00380-X; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Deshields T, 2006, PSYCHO-ONCOLOGY, V15, P398, DOI 10.1002/pon.962; Edward KL, 2009, J ADV NURS, V65, P587, DOI 10.1111/j.1365-2648.2008.04912.x; Eicher M, 2015, ONCOL NURS FORUM, V42, pE3, DOI 10.1188/15.ONF.E3-E16; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; FEIFEL H, 1987, PSYCHOSOM MED, V49, P616, DOI 10.1097/00006842-198711000-00007; Fu MR, 2008, J ADV NURS, V63, P155, DOI 10.1111/j.1365-2648.2008.04647.x; Haase Joan E, 2004, J Pediatr Oncol Nurs, V21, P289, DOI 10.1177/1043454204267922; Haase JE, 2014, CANCER NURS, V37, pE1, DOI 10.1097/NCC.0b013e31828941bb; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Herth K, 2000, J ADV NURS, V32, P1431, DOI 10.1046/j.1365-2648.2000.01619.x; Ho SMY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-279; Hou WK, 2010, HEALTH PSYCHOL, V29, P484, DOI 10.1037/a0020809; Howard A Fuchsia, 2007, Cancer Nurs, V30, pE27, DOI 10.1097/01.NCC.0000281737.33232.3c; Jacobsen PB, 2012, J CLIN ONCOL, V30, P1154, DOI 10.1200/JCO.2011.39.5046; Kim DH, 2010, J PAEDIATR CHILD H, V46, P431, DOI 10.1111/j.1440-1754.2010.01749.x; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lee Sunmin, 2013, N Am J Med Sci (Boston), V6, P1; Llewellyn CD, 2013, PSYCHO-ONCOLOGY, V22, P97, DOI 10.1002/pon.2065; Lopez-Tarruella S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2226; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Manne SL, 2015, CANCER NURS, V38, P375, DOI 10.1097/NCC.0000000000000215; Markovitz SE, 2015, PSYCHO-ONCOLOGY, DOI [10.1188/14.CJON.93-101, DOI 10.1188/14.CJON.93-101]; Masera Giuseppe, 2013, Epidemiol Prev, V37, P278; Molina Y, 2014, CLIN J ONCOL NURS, V18, P93, DOI 10.1188/14.CJON.93-101; Pandey Manoj, 2006, World J Surg Oncol, V4, P68, DOI 10.1186/1477-7819-4-68; Philip EJ, 2013, PSYCHO-ONCOLOGY, V22, P987, DOI 10.1002/pon.3088; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rosenberg AR, 2015, CANCER; Rowland JH, 2005, CANCER-AM CANCER SOC, V104, P2543, DOI 10.1002/cncr.21487; Ryan L., 2009, ASIAN SOCIAL SCI, V5, P39, DOI [10.5539/ass.v5n11p39, DOI 10.5539/ASS.V5N11P39]; Schumacher A, 2014, SUPPORT CARE CANCER, V22, P487, DOI 10.1007/s00520-013-2001-6; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson P, 2005, PSYCHO-ONCOLOGY, V14, P671, DOI 10.1002/pon.893; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Wang P, 2014, PROCD SOC BEHV, V116, P3259, DOI 10.1016/j.sbspro.2014.01.744; Wang Y., 2010, CHINESE NURSING RES, V24, P20, DOI [DOI 10.3969/J.ISSN.1009-6493.2010.01.008, 10.3969/j.issn.1009-6493.2010.01.008]; Wu LM, 2013, J ADV NURS, V69, P158, DOI 10.1111/j.1365-2648.2012.06003.x; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Ye ZJ, 2015, CANCER NURS, V38, P466, DOI 10.1097/NCC.0000000000000220; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19	50	38	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167976	10.1371/journal.pone.0167976	http://dx.doi.org/10.1371/journal.pone.0167976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936196	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100243
J	Raghawan, AK; Sripada, A; Gopinath, G; Pushpanjali, P; Kumar, Y; Radha, V; Swarup, G				Raghawan, Akhouri Kishore; Sripada, Anand; Gopinath, Gayathri; Pushpanjali, Pendyala; Kumar, Yatender; Radha, Vegesna; Swarup, Ghanshyam			A Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMASOME ACTIVATION; CAUSES AUTOINFLAMMATION; IL-1-BETA PRODUCTION; BACTERIAL LIGANDS; APOPTOSIS; IPAF; UBIQUITINATION; MUTATION; PHOSPHORYLATION; RECOGNITION	Nod-like receptor family card containing 4 (NLRC4)/Ipaf is involved in recognition of pathogen-associated molecular patterns leading to caspase-1 activation and cytokine release, which mediate protective innate immune response. Point mutations in NLRC4 cause autoinflammatory syndromes. Although all the mutations result in constitutive caspase-1 activation, their phenotypic presentations are different, implying that these mutations cause different alterations in properties of NLRC4. NLRC4 interacts with SUG1 and induces caspase-8-mediated cell death. Here, we show that one of the autoinflammatory syndrome-causing mutants of NLRC4, H443P, but not T337A and V341A, constitutively activates caspase-8 and induces apoptotic cell death in human lung epithelial cells. Compared with wild type NLRC4, the H443P mutant shows stronger interaction with SUG1 and with ubiquitinated cellular proteins. Phosphorylation of NLRC4 at Ser(533) plays a crucial role in caspase-8 activation and cell death. However, H443P mutant does not require Ser533 phosphorylation for caspase-8 activation and cell death. Caspase-8 activation by NLRC4 and its H443P mutant are dependent on the adaptor protein FADD. A phosphomimicking mutant of NLRC4, S533D does not require SUG1 activity for inducing cell death. Ubiquitin-tagged NLRC4 could induce cell death and activate caspase-8 independent of Ser533 phosphorylation. Our work suggests that SUG1-mediated signaling results in enhanced ubiquitination and regulates FADD-dependent caspase-8 activation by NLRC4. We show that the autoinflammation-associated H443P mutant is altered in interaction with SUG1 and ubiquitinated proteins, triggering constitutive caspase-8-mediated cell death dependent on FADD but independent of Ser533 phosphorylation.	[Raghawan, Akhouri Kishore; Sripada, Anand; Gopinath, Gayathri; Pushpanjali, Pendyala; Kumar, Yatender; Radha, Vegesna; Swarup, Ghanshyam] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Kumar, Yatender] Netaji Subhas Inst Technol, Dwarka Sect 3, New Delhi 110078, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Netaji Subhas University of Technology	Radha, V; Swarup, G (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in; gshyam@ccmb.res.in	Kishore Raghawan, Akhouri/AFJ-4326-2022; Kumar, Yatender/AAG-1920-2020	Kishore Raghawan, Akhouri/0000-0002-1628-5974; Swarup, Ghanshyam/0000-0002-8098-0509	Department of Biotechnology, Government of India [BT/PR14917/BRB/10/888/2010]; J. C. Bose National fellowship; Council for Scientific and Industrial Research of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); J. C. Bose National fellowship; Council for Scientific and Industrial Research of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Government of India Grant BT/PR14917/BRB/10/888/2010 (to G. S. and V. R.), a J. C. Bose National fellowship (to G. S.), and a fellowship from the Council for Scientific and Industrial Research of India (to A. K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bekes M, 2009, CELL, V137, P604, DOI 10.1016/j.cell.2009.04.052; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chi W, 2014, P NATL ACAD SCI USA, V111, P11181, DOI 10.1073/pnas.1402819111; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Durairaj G, 2014, BIOMOLECULES, V4, P827, DOI 10.3390/biom4030827; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kong H, 2015, TUMOR BIOL, V36, P7501, DOI 10.1007/s13277-015-3473-4; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Makino Y, 1997, J BIOL CHEM, V272, P23201, DOI 10.1074/jbc.272.37.23201; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Radha V, 2002, APOPTOSIS, V7, P195, DOI 10.1023/A:1015370512425; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Thalappilly S, 2006, FEBS J, V273, P2766, DOI 10.1111/j.1742-4658.2006.05293.x; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	38	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1218	1230		10.1074/jbc.M116.763979	http://dx.doi.org/10.1074/jbc.M116.763979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974463	Green Published, hybrid			2022-12-26	WOS:000393339800007
J	Ulbricht, D; Oertwig, K; Arnsburg, K; Saalbach, A; Pippel, J; Strater, N; Heiker, JT				Ulbricht, David; Oertwig, Kathrin; Arnsburg, Kristin; Saalbach, Anja; Pippel, Jan; Straeter, Norbert; Heiker, John T.			Basic Residues of beta-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL ADIPOSE-TISSUE; PROTEIN-C INHIBITOR; ENDOTHELIAL-CELLS; KALLIKREIN 7; COFACTOR-II; ANTITHROMBIN; SITE; IDENTIFICATION; SPECIFICITY; OBESITY	Many members of the serine protease inhibitor (serpin) family are activated by glycosaminoglycans (GAGs). Visceral adipose tissue-derived serpin (vaspin), serpin A12 of the serpin family, and its target protease kallikrein 7 (KLK7) are heparinbinding proteins, and inhibition of KLK7 by vaspin is accelerated by heparin. However, the nature of GAG binding to vaspin is not known. Here, we measured vaspin binding of various glycosaminoglycans and low molecular weight heparins by microscale thermophoresis and analyzed acceleration of protease inhibition by these molecules. In addition, basic residues contributing to heparin binding and heparin activation were identified by a selective labeling approach. Together, these data show that vaspin binds heparin with high affinity (KD = 21 +/- 2 nM) and that binding takes place at a basic patch on top of beta-sheet A and is different from other heparin-binding serpins. Mutation of basic residues decreased heparin binding and activation of vaspin. Similarly, reactive center loop insertion into sheet A decreased heparin binding because it disturbs the basic cluster. Finally, using vaspin-overexpressing keratinocyte cells, we show that a significant part of secreted vaspin is bound in the extracellular matrix on the cell surface. Together, basic residues of central beta-sheet A contribute to heparin binding and activation of vaspin. Thus, binding toGAGsin the extracellular matrix can direct and regulate vaspin interaction with target proteases or other proteins and may play an important role in the various beneficial functions of vaspin in different tissues. Many members of the serine protease inhibitor (serpin) family are activated by glycosaminoglycans (GAGs). Visceral adipose tissue-derived serpin (vaspin), serpin A12 of the serpin family, and its target protease kallikrein 7 (KLK7) are heparinbinding proteins, and inhibition of KLK7 by vaspin is accelerated by heparin. However, the nature of GAG binding to vaspin is not known. Here, we measured vaspin binding of various glycosaminoglycans and low molecular weight heparins by microscale thermophoresis and analyzed acceleration of protease inhibition by these molecules. In addition, basic residues contributing to heparin binding and heparin activation were identified by a selective labeling approach. Together, these data show that vaspin binds heparin with high affinity (K-D = 21 +/- 2 nM) and that binding takes place at a basic patch on top of beta-sheet A and is different from other heparin-binding serpins. Mutation of basic residues decreased heparin binding and activation of vaspin. Similarly, reactive center loop insertion into sheet A decreased heparin binding because it disturbs the basic cluster. Finally, using vaspin-overexpressing keratinocyte cells, we show that a significant part of secreted vaspin is bound in the extracellular matrix on the cell surface. Together, basic residues of central beta-sheet A contribute to heparin binding and activation of vaspin. Thus, binding toGAGsin the extracellular matrix can direct and regulate vaspin interaction with target proteases or other proteins and may play an important role in the various beneficial functions of vaspin in different tissues.	[Ulbricht, David; Oertwig, Kathrin; Arnsburg, Kristin; Heiker, John T.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Saalbach, Anja] Univ Leipzig, Dept Dermatol Venerol & Allergol, D-04103 Leipzig, Germany; [Pippel, Jan; Straeter, Norbert] Univ Leipzig, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Heiker, JT (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	jheiker@uni-leipzig.de	Saalbach, Anja/ABD-4003-2021; Heiker, John/O-9728-2019; Strater, Norbert/P-4856-2018	Saalbach, Anja/0000-0002-1084-3875; Heiker, John/0000-0003-2822-3006; Pippel, Jan/0000-0003-3829-3809; Strater, Norbert/0000-0002-2001-0500	European Union; Free State of Saxony; Deutsche Forschungsgemeinschaft [SFB1052]	European Union(European Commission); Free State of Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Union and the Free State of Saxony (to J. T. H.) and by Deutsche Forschungsgemeinschaft SFB1052 "Obesity Mechanisms" Grants C4 (to N. S.), C7 (to J. T. H.), and B5 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; Chen VC, 2001, J BIOL CHEM, V276, P1276, DOI 10.1074/jbc.M005791200; Chen VC, 2000, J BIOL CHEM, V275, P40371, DOI 10.1074/jbc.M005691200; Cosmi B, 1997, CIRCULATION, V95, P118, DOI 10.1161/01.CIR.95.1.118; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Heiker JT, 2014, J PEPT SCI, V20, P299, DOI 10.1002/psc.2621; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hida K, 2000, J LIPID RES, V41, P1615; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jung CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-41; Kim M.-S., 2011, Patent, Patent No. [WO2011138977 A1, 2011138977]; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Luo X, 2016, INT J OBESITY, V40, P947, DOI 10.1038/ijo.2016.24; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; Oliveira JR, 2015, BBA-PROTEINS PROTEOM, V1854, P73, DOI 10.1016/j.bbapap.2014.10.018; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Pippel J, 2016, BIOL CHEM, V397, P111, DOI 10.1515/hsz-2015-0229; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Saalbach A, 2016, AM J PATHOL, V186, P639, DOI 10.1016/j.ajpath.2015.10.030; Schultz S, 2013, BIOCHEM J, V452, P271, DOI 10.1042/BJ20121880; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Ulbricht D, 2015, BIOCHEM J, V470, P357, DOI 10.1042/BJ20150643; WHINNA HC, 1991, J BIOL CHEM, V266, P8129; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c	37	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					994	1004		10.1074/jbc.M116.748020	http://dx.doi.org/10.1074/jbc.M116.748020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27941022	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000392318700020
J	Cullen, L; Stanton, JC; Lima, F; Uezu, A; Perilli, MLL; Akcakaya, HR				Cullen, Laury, Jr.; Stanton, Jessica C.; Lima, Fernando; Uezu, Alexandre; Perilli, Miriam L. L.; Akcakaya, H. Resit			Implications of Fine-Grained Habitat Fragmentation and Road Mortality for Jaguar Conservation in the Atlantic Forest, Brazil	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; PANTHERA-ONCA; CONSEQUENCES; LANDSCAPE; MODEL; METAPOPULATION; RESPONSES; SELECTION; DYNAMICS; SAVE	Jaguar (Panthera onca) populations in the Upper Parana A River, in the Brazilian Atlantic Forest region, live in a landscape that includes highly fragmented areas as well as relatively intact ones. We developed a model of jaguar habitat suitability in this region, and based on this habitat model, we developed a spatially structured metapopulation model of the jaguar populations in this area to analyze their viability, the potential impact of road mortality on the populations' persistence, and the interaction between road mortality and habitat fragmentation. In more highly fragmented populations, density of jaguars per unit area is lower and density of roads per jaguar is higher. The populations with the most fragmented habitat were predicted to have much lower persistence in the next 100 years when the model included no dispersal, indicating that the persistence of these populations are dependent to a large extent on dispersal from other populations. This, in turn, indicates that the interaction between road mortality and habitat fragmentation may lead to source-sink dynamics, whereby populations with highly fragmented habitat are maintained only by dispersal from populations with less fragmented habitat. This study demonstrates the utility of linking habitat and demographic models in assessing impacts on species living in fragmented landscapes.	[Cullen, Laury, Jr.; Lima, Fernando; Uezu, Alexandre] IPE, Nazare Paulista, SP, Brazil; [Stanton, Jessica C.; Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY USA; [Lima, Fernando] Univ Estadual Paulista, UNESP, Inst Biosci, Programa Postgrad Ecol Biodiversidade, Sao Paulo, Brazil; [Perilli, Miriam L. L.] Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil; [Perilli, Miriam L. L.] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade Estadual Paulista; Universidade Federal de Vicosa	Cullen, L (corresponding author), IPE, Nazare Paulista, SP, Brazil.	laurycullen@gmail.com	Lima, Fernando/E-8023-2016; Uezu, Alexandre/G-5435-2014; Perilli, Miriam/AGX-1402-2022; Akcakaya, H. Resit/A-7830-2008	Lima, Fernando/0000-0002-8644-9647; Perilli, Miriam/0000-0002-4986-8041; Akcakaya, H. Resit/0000-0002-8679-5929; Stanton, Jessica/0000-0002-6225-3703	Boticario Group Foundation in Brazil; Scott Neotropical Fund of the Lincoln Park Zoological Society; Wildlife Trust, IdeaWild Grant Program; World Wildlife Fund/U.S, DICE Small Grant Program; Liz Claiborne Art Ortenberg Foundation; Ashoka Foundation; Conservation, Food and Health Foundation; Fauna and Flora International; Woodland Park Zoo; Whitley Awards; Rolex Awards; Durrell Wildlife Conservation Trust; Rufford Small Grant Program; Ridgeway Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Center for Latin American Studies (University of Florida); Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA); National Aeronautics and Space Administration through the NASA Biodiversity Program [NNX09AK19G]; National Science Foundation [DEB-1146198]; Division Of Environmental Biology [1146198] Funding Source: National Science Foundation	Boticario Group Foundation in Brazil; Scott Neotropical Fund of the Lincoln Park Zoological Society; Wildlife Trust, IdeaWild Grant Program; World Wildlife Fund/U.S, DICE Small Grant Program; Liz Claiborne Art Ortenberg Foundation; Ashoka Foundation; Conservation, Food and Health Foundation; Fauna and Flora International; Woodland Park Zoo; Whitley Awards; Rolex Awards; Durrell Wildlife Conservation Trust; Rufford Small Grant Program; Ridgeway Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center for Latin American Studies (University of Florida); Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA); National Aeronautics and Space Administration through the NASA Biodiversity Program; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for field work was provided by the Boticario Group Foundation in Brazil (http://www.fundacaogrupoboticario.org.br/en/), The Scott Neotropical Fund of the Lincoln Park Zoological Society (http://www.clevelandmetroparks.com/Main/Home.aspx), The Species Survival Fund from Wildlife Trust, IdeaWild Grant Program (http://www.ideawild.org/), World Wildlife Fund/U.S, DICE Small Grant Program, The Liz Claiborne Art Ortenberg Foundation (http://www.lcaof.org/), The Ashoka Foundation (http://brasil.ashoka.org/), Conservation, Food and Health Foundation (http://cfhfoundation.grantsmanagement08.com/), 100% Fund from Fauna and Flora International, The Woodland Park Zoo (http://www.zoo.org/), The Whitley Awards (http://whitleyaward.org/), The Rolex Awards (http://www.rolexawards.com/), Durrell Wildlife Conservation Trust (https://www.durrell.org/wildlife/), The Rufford Small Grant Program (http://www.rufford.org/) and Ridgeway Trust. All the above mentioned funding was received by LC. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided support during LC PhD and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Center for Latin American Studies (University of Florida) during the post-doctoral studies of LC. LC, FL, AU and MLLP received financial support for data and metadata management, curation and analysis from Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA). Contributions of HRA and JCS were supported in part by the National Aeronautics and Space Administration under Grant No. NNX09AK19G awarded through the NASA Biodiversity Program, and the National Science Foundation under Grant No. DEB-1146198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. R., 2005, APPL BIOMATHEMATICS; Akcakaya HR, 1998, BIODIVERS CONSERV, V7, P875, DOI 10.1023/A:1008867602813; AKCAKAYA HR, 1995, BIOL CONSERV, V73, P169, DOI 10.1016/0006-3207(95)00054-8; Akcakaya HR, 1997, CONSERV BIOL, V11, P422, DOI 10.1046/j.1523-1739.1997.96164.x; AKCAKAYA HR, 1991, ECOL MODEL, V54, P133; Akcakaya HR, 2004, SPECIES CONSERVATION; Akcakaya HR, 2000, RES POPUL ECOL KYOTO, V42; Beisiegel B, 2012, CAT NEWS; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Brodie JF, 2015, MAMM BIOL, V80, P7, DOI 10.1016/j.mambio.2014.06.001; Cattarino L, 2013, LANDSCAPE ECOL, V28, P1321, DOI 10.1007/s10980-013-9881-1; Cavalcanti SMC, 2010, J MAMMAL, V91, P722, DOI 10.1644/09-MAMM-A-171.1; CIESIN, 2004, GLOB RUR URB MAPP PR; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Crawshaw P., 2004, HUM DIMENS WILDL, V9, P329; Cullen Jr L, 2005, BRAZAIL NAT E CONSER, V3, P124; Cullen Jr L, 2006, JAGUARS LANDSCAPE DE; Cullen L, 2013, ZOOLOGIA-CURITIBA, V30, P379, DOI 10.1590/S1984-46702013000400003; De Angelo C, 2011, ORYX, V45, P534, DOI 10.1017/S0030605310000840; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Eizirik E, 2002, JAGUAR NUEVO MILENIO; FAHRIG L, 2009, ECOL SOC, V14; Fordham DA, 2013, NAT CLIM CHANGE, V3, P899, DOI 10.1038/NCLIMATE1954; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haag T, 2009, GENETICA CONSERVACAO; Haines AM, 2006, BIOL CONSERV, V132, P424, DOI 10.1016/j.biocon.2006.04.035; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Lambeck RJ., 1997, CONSERV BIOL, P849; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; MILLER B., 2002, JAGUAR NUEVO MILENIO; Mona S, 2014, HEREDITY, V112, P291, DOI 10.1038/hdy.2013.105; Paula RC, 2011, SERIE ESPECIES AMEAC; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Placci G, 2003, BIODIVERSITY VISION, V116; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Redford KH, 2003, CONSERV BIOL, V17, P116, DOI 10.1046/j.1523-1739.2003.01467.x; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; Root Karen V., 2004, P491; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Wielgus RB, 2002, BIOL CONSERV, V106, P381, DOI 10.1016/S0006-3207(01)00265-8; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162377; Zanin M, 2015, EUR J WILDLIFE RES, V61, P529, DOI 10.1007/s10344-015-0924-6; Zeller, 2007, JAGUARS NEW MILLENNI, P1	46	20	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167372	10.1371/journal.pone.0167372	http://dx.doi.org/10.1371/journal.pone.0167372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973584	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300027
J	Koester, D; Schack, T				Koester, Dirk; Schack, Thomas			Action Priority: Early Neurophysiological Interaction of Conceptual and Motor Representations	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; LANGUAGE COMPREHENSION; PREHENSION MOVEMENTS; BRAIN POTENTIALS; WORKING-MEMORY; VISUAL INPUT; TIME-COURSE; SELECTIVE PERTURBATION; VOLUNTARY MOVEMENT	Handling our everyday life, we often react manually to verbal requests or instruction, but the functional interrelations of motor control and language are not fully understood yet, especially their neurophysiological basis. Here, we investigated whether specific motor representations for grip types interact neurophysiologically with conceptual information, that is, when reading nouns. Participants performed lexical decisions and, for words, executed a grasp-and-lift task on objects of different sizes involving precision or power grips while the electroencephalogram was recorded. Nouns could denote objects that require either a precision or a power grip and could, thus, be (in) congruent with the performed grasp. In a control block, participants pointed at the objects instead of grasping them. The main result revealed an event-related potential (ERP) interaction of grip type and conceptual information which was not present for pointing. Incongruent compared to congruent conditions elicited an increased positivity (100-200 ms after noun onset). Grip type effects were obtained in response-locked analyses of the grasping ERPs (100-300 ms at left anterior electrodes). These findings attest that grip type and conceptual information are functionally related when planning a grasping action but such an interaction could not be detected for pointing. Generally, the results suggest that control of behaviour can be modulated by task demands; conceptual noun information (i.e., associated action knowledge) may gain processing priority if the task requires a complex motor response.	[Koester, Dirk; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp Biomech, Bielefeld, Germany; [Koester, Dirk; Schack, Thomas] Univ Bielefeld, Cluster Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Schack, Thomas] Univ Bielefeld, Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Koester, D (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp Biomech, Bielefeld, Germany.; Koester, D (corresponding author), Univ Bielefeld, Cluster Excellence Cognit Interact Technol CITEC, Bielefeld, Germany.	dkoester@cit-ec.uni-bielefeld.de	Koester, Dirk/B-2438-2008	Koester, Dirk/0000-0003-3940-8559	Cluster of Excellence Cognitive Interaction Technology "CITEC" at Bielefeld University - German Research Foundation [EXC 277]	Cluster of Excellence Cognitive Interaction Technology "CITEC" at Bielefeld University - German Research Foundation	This work was funded by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (http://www.dfg.de) and performed by the Neurocognition and Action Research Group - Biomechanics (www.neurocognition.de) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel BD, 2013, NEUROIMAGE, V77, P1, DOI 10.1016/j.neuroimage.2013.03.058; Andres M, 2008, CURR DIR PSYCHOL SCI, V17, P313, DOI 10.1111/j.1467-8721.2008.00597.x; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Borghi AM, 2009, BRAIN RES, V1253, P117, DOI 10.1016/j.brainres.2008.11.064; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; CARNAHAN H, 1993, HUM MOVEMENT SCI, V12, P219, DOI 10.1016/0167-9457(93)90016-I; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Corballis MC, 1991, EVOLUTION GENERATIVE; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Dambacher M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005047; De Sanctis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065508; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Fiebach CJ, 2006, CORTEX, V42, P499, DOI 10.1016/S0010-9452(08)70386-1; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Freude G, 1987, Psychiatr Neurol Med Psychol (Leipz), V39, P449; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gibson J.J., 1986, ECOLOGICAL APPROACH; Girardi G, 2010, J EXP PSYCHOL HUMAN, V36, P330, DOI 10.1037/a0017180; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Glover S, 2002, EXP BRAIN RES, V146, P383, DOI 10.1007/s00221-002-1222-6; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Goldin-Meadow S, 1998, NATURE, V391, P279, DOI 10.1038/34646; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Gratton G., 1983, CLIN NEUROPHYSIOL, V55, P468, DOI DOI 10.1016/0013-4694(83)90135-9; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Heister J, 2011, PSYCHOL RUNDSCH, V62, P10, DOI 10.1026/0033-3042/a000029; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; HILLYARD SA, 1999, ATTENTION SPACE ACTI, P31; Horchak OV, 2014, COGN SYST RES, V29-30, P66, DOI 10.1016/j.cogsys.2013.09.002; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kaan E, 2002, J PSYCHOLINGUIST RES, V31, P165, DOI 10.1023/A:1014978917769; Koester D, 2004, J COGNITIVE NEUROSCI, V16, P1647, DOI 10.1162/0898929042568541; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; KUTAS M, 1980, BRAIN RES, V202, P95, DOI 10.1016/0006-8993(80)90646-0; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; Lindemann O, 2006, J EXP PSYCHOL HUMAN, V32, P633, DOI 10.1037/0096-1523.32.3.633; Logan SW, 2011, ACTA PSYCHOL, V137, P292, DOI 10.1016/j.actpsy.2011.03.009; Luck S.J., 2005, INTRO EVENT RELATED; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Miller GA, 1960, PLANS STRUCTURE BEHA; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; Moreau D, 2013, ACTA PSYCHOL, V142, P356, DOI 10.1016/j.actpsy.2013.01.011; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Naatanen R., 2018, ATTENTION BRAIN FUNC; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pastra K, 2012, PHILOS T R SOC B, V367, P103, DOI 10.1098/rstb.2011.0123; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; R Development Core Team, 2005, R LANG ENV STAT COMP; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Schack T, 2013, NEW IDEAS PSYCHOL, V31, P258, DOI 10.1016/j.newideapsych.2013.04.003; Sell AJ, 2011, BRAIN LANG, V117, P39, DOI 10.1016/j.bandl.2010.07.003; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spiegel MA, 2012, NEUROSCI LETT, V509, P82, DOI 10.1016/j.neulet.2011.12.033; Springer A, 2010, Q J EXP PSYCHOL, V63, P2141, DOI 10.1080/17470211003721659; STEKLIS HD, 1976, ANN NY ACAD SCI, V280, P445, DOI 10.1111/j.1749-6632.1976.tb25508.x; Thompson JJ, 2016, NEW IDEAS PSYCHOL, V43, P28, DOI 10.1016/j.newideapsych.2016.03.002; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; van Elk M, 2010, BIOL PSYCHOL, V85, P134, DOI 10.1016/j.biopsycho.2010.06.004; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weigelt M, 2009, ACTA PSYCHOL, V132, P68, DOI 10.1016/j.actpsy.2009.06.005; Westerholz J, 2014, NEUROSCI LETT, V575, P85, DOI 10.1016/j.neulet.2014.05.022; Westerholz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093116; Westerholz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068501; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	111	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165882	10.1371/journal.pone.0165882	http://dx.doi.org/10.1371/journal.pone.0165882			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973539	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300005
J	Monteiro, MLG; Marsico, ET; Soares, MS; Magalhaes, AO; Canto, ACVCS; Costa-Lima, BRC; Alvares, TS; Junior, CAC				Monteiro, Maria Lucia G.; Marsico, Eliane T.; Soares Junior, Manoel S.; Magalhaes, Amanda O.; Canto, Anna Carolina V. C. S.; Costa-Lima, Bruno R. C.; Alvares, Thiago S.; Conte Junior, Carlos A.			Nutritional Profile and Chemical Stability of Pasta Fortified with Tilapia (Oreochromis niloticus) Flour	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HEAT-TREATMENT; QUALITY CHARACTERISTICS; INACTIVATION KINETICS; MODIFIED ATMOSPHERE; KONJAC GLUCOMANNAN; PROTEIN OXIDATION; MAILLARD REACTION; WATER STATE; SHELF-LIFE	Physicochemical parameters of pasta enriched with tilapia (Oreochromis niloticus) flour were investigated. Five formulations were prepared with different concentrations of tilapia flour as partial substitute of wheat flour: pasta without tilapia flour (PTF0%), pasta with 6% (PTF6%), 12% (PTF12%), 17% (PTF17%), and 23% (PTF23%) of tilapia flour. The formulations were assessed for proximate composition, fatty acid and amino acid profile on day 1 whereas, instrumental color parameters (L*, a* and b* values), pH, water activity (a(w)), and lipid and protein oxidation were evaluated on days 1, 7, 14, and 21 of storage at 25 degrees C. Fortification with tilapia flour increased (p < 0.05) protein, lipid, ash, total essential amino acids, and total polyunsaturated fatty acids contents. In addition, supplementation of pasta with tilapia flour decreased (p < 0.05) lightness and water activity while redness, yellowness, pH values, and lipid oxidation were increased (p < 0.05) in a level-dependent manner. Nevertheless, all formulations were exhibited storage stability at 25 degrees C. In general, protein oxidation was greater (p < 0.05) in the pasta containing 12%, 17%, and 23% of tilapia flour than their counterparts, and the storage promoted an increase (p < 0.05) on the carbonyl content in all formulations. Thus, pasta with 6% of tilapia flour has the potential to be a technological alternative to food industry for the nutritional enrichment of traditional pasta with negligible negative effects on the chemical stability of the final product during 21 days at 25 degrees C.	[Monteiro, Maria Lucia G.; Marsico, Eliane T.; Canto, Anna Carolina V. C. S.; Costa-Lima, Bruno R. C.; Conte Junior, Carlos A.] Univ Fed Fluminense, Dept Food Technol, Rio De Janeiro, Brazil; [Soares Junior, Manoel S.; Magalhaes, Amanda O.] Univ Fed Goias, Sch Agron, Dept Food Engn, Goiania, Go, Brazil; [Alvares, Thiago S.] Univ Fed Rio de Janeiro, Inst Nutr, Rio De Janeiro, Brazil; [Conte Junior, Carlos A.] Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil	Universidade Federal Fluminense; Universidade Federal de Goias; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Monteiro, MLG (corresponding author), Univ Fed Fluminense, Dept Food Technol, Rio De Janeiro, Brazil.	mariaguerra@id.uff.br	Conte-Junior, Carlos A./J-5815-2014; Marsico, Eliane/AAQ-7766-2021; Júnior, Manoel Soares Soares/ABH-9440-2020; Alvares, Thiago/AAO-7782-2020; Alvares, Thiago/GSJ-3655-2022	Conte-Junior, Carlos A./0000-0001-6133-5080; Júnior, Manoel Soares Soares/0000-0001-8728-4592; Marsico, Eliane/0000-0001-9452-5462; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/111.673/2013, E-26/010.001954/2014, E-26/201.185/2014, E-26/110.094/2014, E-26/010.001961/2014, E-26/010.001911/2014, E-26/101.403/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [311361/2013-7, 401922/2013-8, 313917/2013-2, 442102/2014-3, 441987/2014-1]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) [E-26/101.403/2014]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant numbers E-26/111.673/2013; E-26/010.001954/2014; E-26/201.185/2014; E-26/110.094/2014; E-26/010.001961/2014; E-26/010.001911/2014 and E-26/101.403/2014 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - grant numbers 311361/2013-7, 401922/2013-8, 313917/2013-2, 442102/2014-3 and 441987/2014-1 Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) - grant number E-26/101.403/2014 (CAPES/FAPERJ E-45 - PAPDRJ/2013) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful for the financial support provided by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), grant numbers E-26/111.673/2013; E-26/010.001954/2014; E-26/201.185/2014; E-26/110.094/2014; E-26/010.001961/2014; E-26/010.001911/2014 and E-26/101.403/2014; as well as the Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq) grant numbers 311361/20137, 401922/2013-8, 313917/2013-2, 442102/2014-3 and 441987/2014-1; and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), grant number E-26/101.403/2014 (CAPES/FAPERJ E-45-PAPDRJ/2013).	Adeleke R. O., 2010, Pakistan Journal of Nutrition, V9, P535; AIDOO ES, 1973, CEREAL SCI TODAY, V18, P302; American Diabetes Association, 2014, GLYC IND DIAB; American Diabetes Association, 2014, PROT FOODS; AMSA, 2012, AMSA MEAT COLOR MEAS; Anbudhasan P, 2014, FISH TECHNOL, V51, P242; [Anonymous], 1973, MILLENNIUM ECOSYSTEM; AOAC, 2012, OFF METH AN AOAC; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonomi F, 2012, FOOD CHEM, V135, P348, DOI 10.1016/j.foodchem.2012.05.026; Bradley RL, 2010, FOOD ANALYSIS, FOURTH EDITION, P85, DOI 10.1007/978-1-4419-1478-1_6; Bustos MC, 2015, RSC ADV, V5, P30780, DOI 10.1039/c4ra11857j; Cavazza A, 2013, FOOD BIOPROCESS TECH, V6, P2721, DOI 10.1007/s11947-012-0906-6; Chelh I, 2007, MEAT SCI, V76, P210, DOI 10.1016/j.meatsci.2006.10.028; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; CHIOU SH, 1989, J CHROMATOGR-BIOMED, V491, P424, DOI 10.1016/S0378-4347(00)82861-3; Conforti FD, 2006, INT J FOOD SCI TECH, V41, P95, DOI 10.1111/j.1365-2621.2006.01410.x; Conte-Junior C. A., 2008, MODERN MULTIDISCIPLI, P356; Conte-Junior CA, 2007, REV COMPLUTENSE CIEN, V1, P482; de Oliveira IS, 2015, FOOD CONTROL, V50, P38, DOI 10.1016/j.foodcont.2014.08.018; De Pili T, 2014, ITAL J FOOD SCI, V26, P183; Devi N. L., 2013, International Food Research Journal, V20, P219; Dickinson E, 2008, SOFT MATTER, V4, P932, DOI 10.1039/b718319d; Distaam EM, 2001, CEREAL FOOD WORLD, V46, P522; Goes ESD, 2016, FOOD SCI TECH-BRAZIL, V36, P76, DOI 10.1590/1678-457X.0020; Doxastakis G, 2007, FOOD CHEM, V101, P57, DOI 10.1016/j.foodchem.2005.12.054; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Gaie-Levrel F, 2011, PHYS CHEM CHEM PHYS, V13, P7024, DOI 10.1039/c0cp02798g; Gatti R, 2010, J PHARMACEUT BIOMED, V53, P207, DOI 10.1016/j.jpba.2009.12.031; GomezGuillen C, 1997, FOOD CHEM, V58, P81, DOI 10.1016/S0308-8146(96)00217-8; Monteiro MLG, 2012, CIENC RURAL, V42, P737, DOI 10.1590/S0103-84782012000400027; Hall CA, 2005, J FOOD SCI, V70, pC483, DOI 10.1111/j.1365-2621.2005.tb11505.x; Hedegaard RV, 2013, WOODHEAD PUBL FOOD S, V255, P409, DOI 10.1533/9780857098672.2.409; Helrick K., 1990, OFF METH AN, V15 th ed.; Hong SR, 2012, STARCH-STARKE, V64, P511, DOI 10.1002/star.201100170; International Pasta Organization-Survey, 2014, WORLD PAST IND 2013; International Pasta Organization-Survey, 2013, WORLD PAST IND 2012; Jayasena V, 2010, J FOOD QUALITY, V33, P709, DOI 10.1111/j.1745-4557.2010.00353.x; Kadam SU, 2012, J TEXTURE STUD, V43, P268, DOI 10.1111/j.1745-4603.2011.00336.x; Karlsdottir MG, 2014, FOOD CHEM, V164, P476, DOI 10.1016/j.foodchem.2014.05.068; Kishino S, 2002, BIOSCI BIOTECH BIOCH, V66, P2283, DOI 10.1271/bbb.66.2283; Kumar SB, 2014, TRENDS FOOD SCI TECH, V35, P32, DOI 10.1016/j.tifs.2013.10.007; Laroque D, 2008, FOOD CHEM, V111, P1032, DOI 10.1016/j.foodchem.2008.05.033; Liu JJ, 2013, FOOD RES INT, V51, P437, DOI 10.1016/j.foodres.2013.01.002; Lodi A, 2008, FOOD CHEM, V110, P554, DOI 10.1016/j.foodchem.2008.02.032; Monteiro MLG, 2013, FOOD SCI NUTR, V1, P298, DOI 10.1002/fsn3.41; MARCONI E, 1995, AMINO ACIDS, V8, P201, DOI 10.1007/BF00806493; Marti A, 2014, LWT-FOOD SCI TECHNOL, V59, P1100, DOI 10.1016/j.lwt.2014.06.039; Mercier Y, 1998, MEAT SCI, V48, P301, DOI 10.1016/S0309-1740(97)00113-7; Monteiro MLG, 2014, FOOD SCI TECHNOL RES, V20, P571, DOI 10.3136/fstr.20.571; Monteiro MLG, 2012, J AQUACULTURE RES DE, V3, P1; Oliver CN, 1982, EXPERIENCES BIOCH PE, P233; Petenuci ME, 2010, CIENC AGROTEC, V34, P1279, DOI 10.1590/S1413-70542010000500028; Petitot M, 2009, TRENDS FOOD SCI TECH, V20, P521, DOI 10.1016/j.tifs.2009.06.005; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; del Pulgar JS, 2012, MEAT SCI, V90, P828, DOI 10.1016/j.meatsci.2011.11.024; Sandhu KS, 2008, LWT-FOOD SCI TECHNOL, V41, P1000, DOI 10.1016/j.lwt.2007.07.012; Schneedorferova I, 2015, FOOD CHEM, V176, P205, DOI 10.1016/j.foodchem.2014.12.058; Seda O.G.U.R., 2014, J FOOD NUTR RES, V2, P985, DOI [10.12691/jfnr-2-12-20, DOI 10.12691/JFNR-2-12-20]; Serventi L, 2009, J SCI FOOD AGR, V89, P73, DOI 10.1002/jsfa.3412; Shaviklo GR, 2010, J SCI FOOD AGR, V90, P2133, DOI 10.1002/jsfa.4062; Shogren RL, 2006, J FOOD SCI, V71, pS428, DOI 10.1111/j.1750-3841.2006.00061.x; Stephany M, 2016, LWT-FOOD SCI TECHNOL, V68, P36, DOI 10.1016/j.lwt.2015.11.052; Stevanato FB, 2010, J FOOD PROCESS PRES, V34, P373, DOI 10.1111/j.1745-4549.2009.00429.x; Svec I, 2008, CZECH J FOOD SCI, V26, P421, DOI 10.17221/83/2008-CJFS; Tang X, 2012, NUTRITION, V28, P1180, DOI 10.1016/j.nut.2012.03.011; Thachil MT, 2014, INT J FOOD SCI TECH, V49, P309, DOI 10.1111/ijfs.12333; USDA - United States Department of Agriculture, 2009, NAT NUTR DAT; Verardo V, 2009, FOOD CHEM, V114, P472, DOI 10.1016/j.foodchem.2008.09.074; Vhangani LN, 2013, FOOD CHEM, V137, P92, DOI 10.1016/j.foodchem.2012.09.030; WARMBIER HC, 1976, J FOOD SCI, V41, P981, DOI 10.1111/j.1365-2621.1976.tb14372.x; Wojtowicz A, 2014, LWT-FOOD SCI TECHNOL, V59, P1175, DOI 10.1016/j.lwt.2014.06.010; Wong CW, 2015, FOOD ENG SER, P41, DOI 10.1007/978-1-4939-2578-0_4; Wust J, 2016, FOOD FUNCT, V7, P2526, DOI [10.1039/c5fo01550b, 10.1039/C5FO01550B]; Xu B, 2016, J FOOD PROCESS ENG, V39, P247, DOI 10.1111/jfpe.12216; YIN MC, 1993, J FOOD SCI, V58, P1273, DOI 10.1111/j.1365-2621.1993.tb06164.x; Zhang M, 2016, CROP SCI, V56, P1; Zhang T, 2016, FOOD RES INT, V83, P152, DOI 10.1016/j.foodres.2016.03.007; Zhou ZK, 2007, FOOD RES INT, V40, P209, DOI 10.1016/j.foodres.2006.10.006	80	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168270	10.1371/journal.pone.0168270	http://dx.doi.org/10.1371/journal.pone.0168270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973565	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300072
J	Munafo, J; Wade, MG; Stergiou, N; Stoffregen, TA				Munafo, Justin; Wade, Michael G.; Stergiou, Nick; Stoffregen, Thomas A.			The Rim and the Ancient Mariner: The Nautical Horizon Affects Postural Sway in Older Adults	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; STANDING BODY SWAY; PERFORMANCE; MOTION; WOMEN; YOUNG; TIME; VARIABILITY; STABILITY; ATTENTION	On land, the spatial magnitude of postural sway (i.e., the amount of sway) tends to be greater when participants look at the horizon than when they look at nearby targets. By contrast, on ships at sea, the spatial magnitude of postural sway in young adults has been greater when looking at nearby targets and less when looking at the horizon. Healthy aging is associated with changes in the movement patterns of the standing body sway, and these changes typically are interpreted in terms of age-related declines in the ability to control posture. To further elucidate the mechanisms associated with these changes we investigated control of posture in a setting that poses substantial postural challenges; standing on a ship at sea. In particular, we explored postural sway on a ship at sea when older adults looked at the horizon or at nearby targets. We evaluated the kinematics of the center of pressure in terms of spatial magnitude (i.e., the amount of sway) and multifractality (a measure of temporal dynamics). We found that looking at the horizon significantly affected the multifractality of standing body, but did not systematically influence the spatial magnitude of sway. We discuss the results in terms of age-related changes in the perception and control of dynamic body orientation.	[Munafo, Justin; Wade, Michael G.; Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Stergiou, Nick] Univ Nebraska Omaha, Dept Biomech, Omaha, NE USA; [Stergiou, Nick] Univ Nebraska Omaha, Ctr Res Human Movement Variabil, Omaha, NE USA	University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Omaha; University of Nebraska System; University of Nebraska Omaha	Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021		University of Minnesota; University of Minnesota Diversity of Views and Experiences (DOVE) program; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH [P20GM109090, R15HD086828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD086828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); University of Minnesota Diversity of Views and Experiences (DOVE) program; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by a Grant in Aid of Research from the University of Minnesota. Justin Munafo's participation was supported by a fellowship from the University of Minnesota Diversity of Views and Experiences (DOVE) program. Nick Stergiou's participation was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090 and R15HD086828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We extend our thanks to Nathan Blessing and ISE. In addition, we thank Samuel Taylor Coleridge, for poetic inspiration. Dr. Stergiou is supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090 and R15HD086828).	Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Beer T., 1997, ENV OCEANOGRAPHY; Birren J. E., 1980, AGING 1980S PSYCHOL, P293; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cruise Lines International Association Inc, 2010, 2010 CLIA CRUIS MARK; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Jor'dan AJ, 2015, NEUROSCI LETT, V593, P101, DOI 10.1016/j.neulet.2015.03.014; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kelty-Stephen DG, 2013, ECOL PSYCHOL, V25, P1, DOI 10.1080/10407413.2013.753804; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; Koslucher F, 2016, EXP BRAIN RES, V234, P2709, DOI 10.1007/s00221-016-4675-8; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Merlo A, 2012, GAIT POSTURE, V36, P662, DOI 10.1016/j.gaitpost.2012.06.016; Munafo J, 2016, EXP BRAIN RES, V234, P2721, DOI 10.1007/s00221-016-4676-7; Munafo J, 2015, ECOL PSYCHOL, V27, P127, DOI 10.1080/10407413.2015.1027127; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Palatinus Z, 2014, J EXP PSYCHOL HUMAN, V40, P1808, DOI 10.1037/a0037247; PAULUS W, 1989, EXP BRAIN RES, V78, P243; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Redfern MS, 2007, J ANXIETY DISORD, V21, P704, DOI 10.1016/j.janxdis.2006.09.002; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Riccio G. E., 1993, VARIABILITY MOTOR CO; Riccio G. E., 1995, LOCAL APPL ECOLOGICA, P122; Roller CA, 2002, NEUROBIOL AGING, V23, P117, DOI 10.1016/S0197-4580(01)00264-0; Shimizu Y, 2002, FRACTALS, V10, P103, DOI 10.1142/S0218348X02001130; Simeonov P., 2001, INJURY PREVENT S1, V7, pi50, DOI DOI 10.1136/IP.7.SUPPL_1.I50; Stevens SC, 2002, MAR TECHNOL SNAME N, V39, P29; Stoffregen T. A., 2016, KINES REV, V5, P23, DOI DOI 10.1123/KR.2015-0049; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Stoffregen TA, 2011, ECOL PSYCHOL, V23, P19, DOI 10.1080/10407413.2011.539102; Sullivan EV, 2009, NEUROBIOL AGING, V30, P793, DOI 10.1016/j.neurobiolaging.2007.08.021; Thurner S, 2000, PHYS REV E, V62, P4018, DOI 10.1103/PhysRevE.62.4018; Turvey MT, 2014, J MOTOR BEHAV, V46, P143, DOI 10.1080/00222895.2013.798252; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Varlet M, 2015, EXP BRAIN RES, V233, P1607, DOI 10.1007/s00221-015-4235-7; Varlet M, 2014, J EXP PSYCHOL HUMAN, V40, P2310, DOI 10.1037/a0038197; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yu YW, 2013, GAIT POSTURE, V37, P103, DOI 10.1016/j.gaitpost.2012.06.021; Yu YW, 2010, AVIAT SPACE ENVIR MD, V81, P375, DOI 10.3357/ASEM.2638.2010	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166900	10.1371/journal.pone.0166900	http://dx.doi.org/10.1371/journal.pone.0166900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973576	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300015
J	Sun, XY; Yu, ZW; Cai, ZY; Yu, LY; Lv, YY				Sun, Xiaoyi; Yu, Zhenwei; Cai, Zhengyuan; Yu, Lingyan; Lv, Yuanyuan			Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-beta-Cyclodextrin Nanofibers for Ophthalmic Delivery	PLOS ONE			English	Article							IN-VIVO EVALUATION; OCULAR INSERTS; DRUG-RELEASE; SUSTAINED-RELEASE; ANTIFUNGAL DRUGS; CYCLOSPORINE-A; VITRO; STABILITY; FORMULATION; SOLUBILITY	Voriconazole (VRC) incorporated in composited polyvinyl alcohol (PVA)/hydroxypropyl-beta cyclodextrin (HP beta CD) blended nanofibers were produced via electrospinning for efficient ophthalmic delivery. The VRC loading capacity increased with increasing HP beta CD content. The optimal solution for electrospinning consisted of 8% (w/v) PVA, 4% (w/v) HP beta CD and 0.5% (w/v) VRC. The nanofibers exhibited bead- free average fiber diameters of 307 +/- 31 nm and VRC was released in vitro in a sustained manner. The VRC nanofibers were characterized by infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). The proton nuclear magnetic resonance (H-1-NMR) was used to analyze the molar ratio of HP beta CD/VRC in the nanofibers. Compared with a VRC solution, the nanofibers significantly prolonged the half life, and increased the bioavailability of VRC in rabbit tears. No obvious signs of irritation were observed after application in the conjunctival sac. VRC nanofibers are promising for ophthalmic drug delivery and further pharmacodynamics studies are needed.	[Sun, Xiaoyi; Cai, Zhengyuan; Lv, Yuanyuan] Zhejiang Univ City Coll, Dept Pharm, Huzhou St, Hangzhou, Zhejiang, Peoples R China; [Yu, Zhenwei] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Yu, Lingyan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University City College; Zhejiang University; Zhejiang University	Lv, YY (corresponding author), Zhejiang Univ City Coll, Dept Pharm, Huzhou St, Hangzhou, Zhejiang, Peoples R China.; Yu, ZW (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China.	zhenweiyu84@126.com; lvyy@zucc.edu.cn		YU, Zhenwei/0000-0002-3776-2290	Public Welfare Technology Research and Social Development Project of Zhejiang [2013C33234]; National Nature Science Foundation of China [81402872, 51303155]; Natural Science Foundation of Zhejiang Province of China [LQ16H120004, LY17H160002]; Health and Family Planning Commission of Zhejiang, China [2014RCA012]	Public Welfare Technology Research and Social Development Project of Zhejiang; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Health and Family Planning Commission of Zhejiang, China	This work was supported by Public Welfare Technology Research and Social Development Project of Zhejiang (2013C33234: http://www.zjkjt.gov.cn/ to ZWY),the National Nature Science Foundation of China (81402872 to XYS, 51303155 to YYL:http://www.nsfc.gov.cn/), Natural Science Foundation of Zhejiang Province of China (LQ16H120004 to LYY and LY17H160002 to XYS:http://www.zjnsf.gov.cn/), and Health and Family Planning Commission of Zhejiang, China (2014RCA012 to ZWY:http://www.zjwst.gov.cn/).	Amoros-Reboredo P, 2015, AM J HEALTH-SYST PH, V72, P479, DOI 10.2146/ajhp140127; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; DiDomenico B, 1999, CURR OPIN MICROBIOL, V2, P509, DOI 10.1016/S1369-5274(99)00009-0; DILUCCIO RC, 1994, J PHARM SCI, V83, P104, DOI 10.1002/jps.2600830124; Dupuis A, 2009, ANTIMICROB AGENTS CH, V53, P798, DOI 10.1128/AAC.01126-08; Duxfield L, 2015, DRUG DEV IND PHARM; Gower EW, 2010, OPHTHALMOLOGY, V117, P2263, DOI 10.1016/j.ophtha.2010.03.048; Goyal R., 2015, J CONTROL RELEASE; Hermans K, 2014, INT J PHARMACEUT, V472, P10, DOI 10.1016/j.ijpharm.2014.06.017; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Iyer Sandhya A, 2006, Eye Contact Lens, V32, P267, DOI 10.1097/01.icl.0000249595.27520.2e; Jain D, 2011, DRUG DEV IND PHARM, V37, P167, DOI 10.3109/03639045.2010.502533; Jayaraman P, 2015, ADV DRUG DELIVER REV, V94, P77, DOI 10.1016/j.addr.2015.09.007; Jeong S, 2009, ANTIMICROB AGENTS CH, V53, P541, DOI 10.1128/AAC.01123-08; Karn PR, 2014, INT J NANOMED, V9, P3791, DOI 10.2147/IJN.S65601; Kumar R, 2014, COLLOID SURFACE B, V117, P82, DOI 10.1016/j.colsurfb.2014.02.007; Lat Asma, 2011, Infect Drug Resist, V4, P43, DOI 10.2147/IDR.S12714; Li GX, 2015, INT J CLIN EXP MED, V8, P12949; Loftssona T, 1996, ADV DRUG DELIV REV, V36, P59; Luke DR, 2010, J PHARM SCI-US, V99, P3291, DOI 10.1002/jps.22109; Miletic T, 2013, CARBOHYD POLYM, V98, P122, DOI 10.1016/j.carbpol.2013.05.084; Morrison PWJ, 2013, MOL PHARMACEUT, V10, P756, DOI 10.1021/mp3005963; Nafee NA, 2003, INT J PHARMACEUT, V264, P1, DOI 10.1016/S0378-5173(03)00371-5; Negishi J, 2010, EUR J PHARM SCI, V41, P617, DOI 10.1016/j.ejps.2010.09.001; Nivoix Y, 2008, CLIN PHARMACOKINET, V47, P779, DOI 10.2165/0003088-200847120-00003; Pahuja P, 2014, CURR DRUG DELIV, V11, P223, DOI 10.2174/1567201810666131224105205; Pawar P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/341218; Peeters J, 2002, J PHARM SCI, V91, P1414, DOI 10.1002/jps.10126; de Sa FAP, 2015, COLLOID SURFACE B, V133, P331, DOI 10.1016/j.colsurfb.2015.06.036; Reynolds TD, 2002, DRUG DEV IND PHARM, V28, P457, DOI 10.1081/DDC-120003007; SAETTONE MF, 1995, ADV DRUG DELIVER REV, V16, P95, DOI 10.1016/0169-409X(95)00014-X; Schulze J, 2016, ACTA BIOMATER; Sebe I, 2015, INT J PHARMACEUT, V494, P516, DOI 10.1016/j.ijpharm.2015.08.054; Shivaprakash MR, 2011, MYCOSES, V54, pE583, DOI 10.1111/j.1439-0507.2010.01996.x; Shukr M, 2014, ARCH PHARM RES, V37, P882, DOI 10.1007/s12272-013-0317-x; Shukr MH, 2016, J MICROENCAPSUL, V33, P71, DOI 10.3109/02652048.2015.1128489; Siafaka PI, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030282; Sun XZ, 2013, CARBOHYD POLYM, V94, P147, DOI 10.1016/j.carbpol.2012.12.064; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Taepaiboon P, 2006, NANOTECHNOLOGY, V17, P2317, DOI 10.1088/0957-4484/17/9/041; Tonglairoum P, 2016, AAPS PHARM SCI TECH; Tonglairoum P, 2014, PHARM RES-DORDR, V31, P1893, DOI 10.1007/s11095-013-1291-1; Xu JK, 2010, J BIOMAT SCI-POLYM E, V21, P1023, DOI 10.1163/156856209X463690; Yang W, 2010, EUR J PHARM SCI, V39, P336, DOI 10.1016/j.ejps.2010.01.001	44	40	40	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167961	10.1371/journal.pone.0167961	http://dx.doi.org/10.1371/journal.pone.0167961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6ZW	27974859	Green Published, gold, Green Submitted			2022-12-26	WOS:000398960300001
J	Sampson, DM; Alonso-Caneiro, D; Chew, AL; Lamey, T; McLaren, T; De Roach, J; Chen, FK				Sampson, Danuta M.; Alonso-Caneiro, David; Chew, Avenell L.; Lamey, Tina; McLaren, Terri; De Roach, John; Chen, Fred K.			Enhanced Visualization of Subtle Outer Retinal Pathology by En Face Optical Coherence Tomography and Correlation with Multi-Modal Imaging	PLOS ONE			English	Article							LAYER SEGMENTATION; AUTOMATIC SEGMENTATION; OCT; IMAGES; DISEASE; THICKNESS	Purpose To present en face optical coherence tomography (OCT) images generated by graphsearch theory algorithm-based custom software and examine correlation with other imaging modalities. Methods En face OCT images derived from high density OCT volumetric scans of 3 healthy subjects and 4 patients using a custom algorithm (graph-search theory) and commercial software (Heidelberg Eye Explorer software (Heidelberg Engineering)) were compared and correlated with near infrared reflectance, fundus autofluorescence, adaptive optics flood-illumination ophthalmoscopy (AO-FIO) and microperimetry. Results Commercial software was unable to generate accurate en face OCT images in eyes with retinal pigment epithelium (RPE) pathology due to segmentation error at the level of Bruch's membrane (BM). Accurate segmentation of the basal RPE and BM was achieved using custom software. The en face OCT images from eyes with isolated interdigitation or ellipsoid zone pathology were of similar quality between custom software and Heidelberg Eye Explorer software in the absence of any other significant outer retinal pathology. En face OCT images demonstrated angioid streaks, lesions of acute macular neuroretinopathy, hydroxychloroquine toxicity and Bietti crystalline deposits that correlated with other imaging modalities. Conclusions Graph-search theory algorithm helps to overcome the limitations of outer retinal segmentation inaccuracies in commercial software. En face OCT images can provide detailed topography of the reflectivity within a specific layer of the retina which correlates with other forms of fundus imaging. Our results highlight the need for standardization of image reflectivity to facilitate quantification of en face OCT images and longitudinal analysis.	[Sampson, Danuta M.; Chew, Avenell L.; Lamey, Tina; De Roach, John; Chen, Fred K.] Univ Western Australia, Ctr Ophthalmol & Vis Sci, Crawley, WA, Australia; [Sampson, Danuta M.; Chew, Avenell L.; Chen, Fred K.] Lions Eye Inst, Nedlands, WA, Australia; [Alonso-Caneiro, David] Queensland Univ Technol, Sch Optometry & Vis Sci, Contact Lens & Visual Opt Lab, Brisbane, Qld, Australia; [Lamey, Tina; McLaren, Terri; De Roach, John] Sir Charles Gairdner Hosp, Dept Med Technol & Phys, Nedlands, WA, Australia; [Chen, Fred K.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; Queensland University of Technology (QUT); University of Western Australia; Royal Perth Hospital; University of Western Australia	Chen, FK (corresponding author), Univ Western Australia, Ctr Ophthalmol & Vis Sci, Crawley, WA, Australia.	fred.chen@lei.org.au	Sampson, Danuta/AAN-6075-2021; LAMEY, TINA/AAL-6401-2021; , Fred/B-8158-2013; Sampson, Danuta M/A-5873-2016	LAMEY, TINA/0000-0002-4608-4073; , Fred/0000-0003-2809-9930; Alonso-Caneiro, David/0000-0002-7754-6592; Sampson, Danuta M/0000-0003-4737-6606	Ophthalmic Research Institute of Australia; Global Ophthalmology Award Program Bayer; National Health & Medical Research Council [APP1054712, 37812900]; Retina Australia; Health Department of Western Australia	Ophthalmic Research Institute of Australia; Global Ophthalmology Award Program Bayer; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia; Health Department of Western Australia	This study was supported by the Ophthalmic Research Institute of Australia (DMS, FKC); Global Ophthalmology Award Program Bayer (FKC); National Health & Medical Research Council (Early Career Fellowship; APP1054712, FKC; Equipment Grant: 37812900, FKC); Retina Australia (FKC, JDR, TL, TM); and Health Department of Western Australia (FKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Affortit AS, 2015, RETINA-J RET VIT DIS, V35, P1049, DOI 10.1097/IAE.0000000000000362; Alonso-Caneiro D, 2013, BIOMED OPT EXPRESS, V4, P2795, DOI 10.1364/BOE.4.002795; Chen HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09269; Chen Q, 2014, RETINA-J RET VIT DIS, V34, P996, DOI 10.1097/IAE.0000000000000018; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; De Roach JN, 2013, CLIN EXP OPHTHALMOL, V41, P476, DOI 10.1111/ceo.12020; Fabritius T, 2009, OPT EXPRESS, V17, P15659, DOI 10.1364/OE.17.015659; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Francis AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145628; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Girkin C., 2005, ESSENTIAL HRT PRIMER, P1; Gliem Martin, 2013, Frontiers in Genetics, V4, P14, DOI 10.3389/fgene.2013.00014; Gorczynska I, 2009, BRIT J OPHTHALMOL, V93, P603, DOI 10.1136/bjo.2007.136101; Haeker M, 2007, PROC SPIE, V6512, DOI 10.1117/12.710231; Hariri AH, 2016, JAMA OPHTHALMOL, V134, P628, DOI 10.1001/jamaophthalmol.2016.0502; Heiferman MJ, 2015, RETINA-J RET VIT DIS, V35, P2593, DOI 10.1097/IAE.0000000000000666; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Issa PC, 2009, INVEST OPHTH VIS SCI, V50, P5913, DOI 10.1167/iovs.09-3541; Itoh Y, 2016, BRIT J OPHTHALMOL, V100, P295, DOI 10.1136/bjophthalmol-2015-307105; KLIEN BA, 1947, AM J OPHTHALMOL, V30, P955; Mansour AM, 2007, EUR J OPHTHALMOL, V17, P680, DOI 10.1177/112067210701700434; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mesiwala NK, 2015, J OPHTHALMIC INFLAMM, V5, DOI 10.1186/s12348-015-0053-0; Mishra A, 2009, OPT EXPRESS, V17, P23719, DOI 10.1364/OE.17.023719; Mohammad F, 2014, J OPHTHALMOL, V2014, P1; Muthiah MN, 2014, BRIT J OPHTHALMOL, V98, P1073, DOI 10.1136/bjophthalmol-2013-304615; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Novais EA, 2016, OSLI RETINA, V47, P201, DOI 10.3928/23258160-20160229-01; Pilotto E, 2015, INVEST OPHTH VIS SCI, V56, P8120, DOI 10.1167/iovs.15-17366; Pisano ED, 1998, J DIGIT IMAGING, V11, P193, DOI 10.1007/BF03178082; Puche N, 2014, GRAEF ARCH CLIN EXP, V252, P555, DOI 10.1007/s00417-013-2493-2; Read SA, 2015, RETINA-J RET VIT DIS, V35, P1223, DOI 10.1097/IAE.0000000000000464; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P6145, DOI 10.1167/iovs.12-10580; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi F, 2015, IEEE T MED IMAGING, V34, P441, DOI 10.1109/TMI.2014.2359980; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Toto L, 2013, CLIN EXP OPTOM, V96, P39, DOI 10.1111/j.1444-0938.2012.00784.x; Vermeer KA, 2014, BIOMED OPT EXPRESS, V5, P322, DOI 10.1364/BOE.5.000322; Vermeer KA, 2011, BIOMED OPT EXPRESS, V2, P1743, DOI 10.1364/BOE.2.001743; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Wojtkowski M, 2009, OPT EXPRESS, V17, P4189, DOI 10.1364/OE.17.004189; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Yazdanpanah A, 2011, IEEE T MED IMAGING, V30, P484, DOI 10.1109/TMI.2010.2087390	47	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168275	10.1371/journal.pone.0168275	http://dx.doi.org/10.1371/journal.pone.0168275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959968	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900053
J	Gershengorn, HB; Xu, YC; Chan, CW; Armony, M; Gong, MN				Gershengorn, Hayley B.; Xu, Yunchao; Chan, Carri W.; Armony, Mor; Gong, Michelle N.			The Impact of Adding a Physician Assistant to a Critical Care Outreach Team	PLOS ONE			English	Article							RAPID RESPONSE TEAMS; NURSE-PRACTITIONERS; INPATIENT; SYSTEMS; TIME	Rationale Hospitals are increasingly using critical care outreach teams (CCOTs) to respond to patients deteriorating outside intensive care units (ICUs). CCOT staffing is variable across hospitals and optimal team composition is unknown. Objectives To assess whether adding a critical care medicine trained physician assistant (CCM-PA) to a critical care outreach team (CCOT) impacts clinical and process outcomes. Methods We performed a retrospective study of two cohorts-one with a CCM-PA added to the CCOT (intervention hospital) and one with no staffing change (control hospital)-at two facilities in the same system. All adults in the emergency department and hospital for whom CCOT consultation was requested from October 1, 2012-March 16, 2013 (pre-intervention) and January 5-March 31, 2014 (post-intervention) were included. We performed difference-in-differences analyses comparing pre- to post-intervention periods in the intervention versus control hospitals to assess the impact of adding the CCM-PA to the CCOT. Measurements and Main Results Our cohort consisted of 3,099 patients (control hospital: 792 pre- and 595 post-intervention; intervention hospital: 1114 pre- and 839 post-intervention). Intervention hospital patients tended to be younger, with fewer comorbidities, but with similar severity of acute illness. Across both periods, hospital mortality (p = 0.26) and hospital length of stay (p = 0.64) for the intervention vs control hospitals were similar, but time-to-transfer to the ICU was longer for the intervention hospital (13.3-17.0 vs 11.5-11.6 hours, p = 0.006). Using the difference-in-differences approach, we found a 19.2% reduction (95 confidence interval: 6.7%-31.6%, p = 0.002) in the time-to-transfer to the ICU associated with adding the CCM-PA to the CCOT; we found no difference in hospital mortality (p = 0.20) or length of stay (p = 0.52). Conclusions Adding a CCM-PA to the CCOT was associated with a notable reduction in time-to-transfer to the ICU; hospital mortality and length of stay were not impacted.	[Gershengorn, Hayley B.; Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA; [Gershengorn, Hayley B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Xu, Yunchao; Armony, Mor] NYU, Stern Sch Business, Dept Informat Operat & Management Sci, New York, NY USA; [Chan, Carri W.] Columbia Business Sch, Div Decis Risk & Operat, New York, NY USA; [Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; Columbia University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Gershengorn, HB (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA.; Gershengorn, HB (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.	hgershen@montefiore.org	Chan, Carri W/J-3237-2016	Gershengorn, Hayley/0000-0002-7360-2489	National Science Foundation [CMII 1233547]; National Heart Lung Blood Institute [U01 HL122998, U01 HL123009, UH2 HL125119]	National Science Foundation(National Science Foundation (NSF)); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation (CMII 1233547) for CWC; National Heart Lung Blood Institute (U01 HL122998, U01 HL123009, UH2 HL125119) for MNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Alvarez AA, 2013, MED INTENSIVA, V37, P12, DOI 10.1016/j.medin.2012.08.006; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, 2013 AAPA ANN SURVEY; [Anonymous], 2011, AG HEALTHC RES QUAL; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Bing-Hua YU, 2014, AM J SURG, V208, P268, DOI 10.1016/j.amjsurg.2013.08.044; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Cretikos M A, 2005, Minerva Anestesiol, V71, P259; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; DUBAYBO BA, 1991, CHEST, V99, P89, DOI 10.1378/chest.99.1.89; Edelson DP, 2011, J HOSP MED, V6, P475, DOI 10.1002/jhm.886; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; Garland A, 2013, CHEST, V143, P214, DOI 10.1378/chest.12-1531; Gershengorn HB, 2012, AM J RESP CRIT CARE, V185, P600, DOI 10.1164/rccm.201107-1261CP; Gershengorn HB, 2011, CHEST; Harris Steve, 2015, Lancet, V385 Suppl 1, pS40, DOI 10.1016/S0140-6736(15)60355-5; Health Care Protocol: Rapid Response Team, 2011, HLTH CARE PROTOCOL R; Jones D, 2009, CRIT CARE, V13, DOI 10.1186/cc7996; Kapu AN, 2014, CRIT CARE NURSE, V34, P51, DOI 10.4037/ccn2014847; Kawar Eyad, 2011, JAAPA, V24, P36; Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c; Laurens NH, 2010, INT J NURS PRACT, V16, P533, DOI 10.1111/j.1440-172X.2010.01879.x; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; McNeill G, 2013, RESUSCITATION, V84, P1652, DOI 10.1016/j.resuscitation.2013.08.006; Morris DS, 2012, RESUSCITATION; Niven DJ, CRIT CARE MED, V201; Puymirat E, 2015, EUR HEART J ACUTE CA; Repasky TM, 2005, J EMERG NURS, V31, P376, DOI 10.1016/j.jen.2005.06.025; Rothberg MB, 2012, J HOSP MED, V7, P98, DOI 10.1002/jhm.953; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Society of Critical Care Medicine, 2014, COMP CRIT CAR PROF; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167959	10.1371/journal.pone.0167959	http://dx.doi.org/10.1371/journal.pone.0167959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942002	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600040
J	Huang, Y; Tang, W; Mu, Y; Li, XH; Liu, Z; Wang, YP; Li, MR; Li, Q; Dai, L; Liang, J; Zhu, J				Huang, Yan; Tang, Wen; Mu, Yi; Li, Xiaohong; Liu, Zheng; Wang, Yanping; Li, Mingrong; Li, Qi; Dai, Li; Liang, Juan; Zhu, Jun			The Sex Ratio at Birth for 5,338,853 Deliveries in China from 2012 to 2015: A Facility-Based Study	PLoS One			English	Article							MARRIAGE SQUEEZE; RECENT INCREASE; AGE	Objective The accuracy of a population-based sex ratio at birth (SRB) in China has long been questioned. To depict a more accurate profile, the present study used data from a national surveillance system for health facility births to explore the characteristics of SRB in China. Methods Data from China's National Maternal Near Miss Surveillance System between 2012 and 2015 were used. We restricted the analysis to live births of >= 28 completed gestational weeks or >= 1000 g birth weight. The strength of association between obstetric characteristics and SRB was examined using logistic regression, taking into account the sampling strategy and clustering of births within health facilities. Results There were 2,785,513 boys and 2,549,269 girls born alive between 2012 and 2015 in 441 health facilities. The SRB was 111.04 in 2012, 110.16 in 2013, 108.79 in 2014, and 109.53 in 2015. The SRB was high in the eastern region, especially in rural areas. The SRBs increased with mother's age and decreased with mother's education. The SRB in women who were pregnant for the first time was 104.30. The SRB in primipara was normal (104.35), but it was extremely high in non-primipara, especially for women with three or more parities (141.76); only 5.26% of live births fell within this group. The SRBs increased significantly by the number of parities, especially in the rural areas of the central region. After adjustment for sociodemographic factors, women with three or more parities were 1.39 (95% CI 1.34, 1.43) times more likely to give birth to a boy compared with primiparae who were pregnant for the first time. Conclusion Our analysis suggests that the SRB was lower than what was reported officially but higher than normal. The government should keep strengthening supervision to prevent sex-selection, especially in the wake of the two-child policy implemented in 2015.	[Huang, Yan] Sichuan Univ, West China Univ Hosp 2, Dept Nursing, Chengdu, Sichuan, Peoples R China; [Tang, Wen; Mu, Yi; Li, Xiaohong; Liu, Zheng; Wang, Yanping; Li, Mingrong; Li, Qi; Dai, Li; Liang, Juan; Zhu, Jun] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Natl Off Maternal & Child Hlth Surveillance China, West China Univ Hosp 2,Minist Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Liang, J; Zhu, J (corresponding author), Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Natl Off Maternal & Child Hlth Surveillance China, West China Univ Hosp 2,Minist Educ, Chengdu, Sichuan, Peoples R China.	liangjuan028@163.com; zhujun028@163.com		Li, Xiaohong/0000-0003-0336-7302	UNICEF; China Medical Board [11-065]; National "Twelfth Five-Year Plan for Science and Technology Support [2014BAI06B01]	UNICEF; China Medical Board; National "Twelfth Five-Year Plan for Science and Technology Support	The authors received support from the UNICEF, China Medical Board (11-065), and the National "Twelfth Five-Year Plan for Science and Technology Support (2014BAI06B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHAT PNM, 2002, ECON POLIT WEEKLY, V51, P5105; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Garenne M, 2008, HUM BIOL, V80, P473, DOI 10.3378/1534-6617-80.5.473; Gavalas V, 2015, J BIOSOC SCI, V47, P363, DOI 10.1017/S0021932014000182; Gong WG, 2013, REGIONAL VARIATIONS, V27, P32; Guilmoto CZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004624; He J, 2013, LIB RES, V43, P126; Health and Family Planning Commission of the People's Republic of China, CHIN OFF Q A NUM BIR; Health and Family Planning Commission of the People's Republic of China, CHIN SRB KEPT GOING; Health and Family Planning Commission of the People's Republic of China, NOT STRENGTH PREV ID; Hongyan Cui, 2013, POPULATION RES, V37, P10; Jia ZK, 2012, SOCIAL SCI, P22; Jiang QB, 2015, CHINESE J POPULATION, P60; Jiang QB, 2014, POPUL RES POLICY REV, V33, P189, DOI 10.1007/s11113-013-9283-8; Liu Haocheng, 2014, SHANGHAI MANAGEMENT, V36, P5; Liu LG, 2014, J CONTEMP CHINA, V23, P351, DOI 10.1080/10670564.2013.832541; Madhukar SD, 2013, NATURWISSENSCHAFTEN, V100, P559, DOI [10.1007/s00114-013-1052-3, DOI 10.1007/S00114-013-1052-3]; Ministry of Health China, NAT MAT NEAR MISS SU; Ministry of Human Resources and Social Security of the People's Republic of China, 2014, ANN REP DEV SOC INS; National Bureau of Statistics of China, CHIN EC REAL MOD STA; National Bureau of Statistics of China, STAT COMM PEOPL REP; Nie JB, 2011, BRIT MED BULL, V98, P7, DOI 10.1093/bmb/ldr015; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; Pham BN, 2010, J BIOSOC SCI, V42, P757, DOI 10.1017/S0021932010000398; Research Team of National Strategy on Population Development, 2007, GEN REP CHIN NAT STR, P45; ROSTRON J, 1977, ANN HUM GENET, V41, P205, DOI 10.1111/j.1469-1809.1977.tb01916.x; Sun QR, 2013, POPULATION DEV, V19, P95; The Central People's Government of the People's Republic of China, NAT POP CENS REG; Wang G, 2016, SCI PROGRAMMING-NETH, V2016, DOI 10.1155/2016/3676149; Wang Pei'an, VIC MIN NAT HLTH FAM; Wang SA, 2009, HEBEI ACAD J, P174; Wang XF, 2015, MED SOC, V28, P34; Xu L, 2008, POPULATION RES, V32, P79; Yang JH, 2009, POPULATION DEV, V15, P37; Yu GJ, 2014, J XIANGTAN U PHILOS, P112; Yu p, 2007, GANSU SOCIAL SCI, P189; ZENG Y, 1993, POPUL DEV REV, V19, P283; Zhai ZW, 2011, J FUJIAN JIANGXIA U, V1, P4; Zhao XF, 2014, J ANHUI VOCATIONAL C, V13, P7; Zhou XD, 2011, SOC SCI MED, V73, P1422, DOI 10.1016/j.socscimed.2011.07.033; Zhu J, 2016, LANCET GLOB HEALTH, V4, pE109, DOI 10.1016/S2214-109X(15)00271-5; Zhu XJ, 2010, NW POPULATION, V31, P8	43	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167575	10.1371/journal.pone.0167575	http://dx.doi.org/10.1371/journal.pone.0167575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941978	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600022
J	Vignesh, S; Dahms, HU; Muthukumar, K; Vignesh, G; James, RA				Vignesh, Sivanandham; Dahms, Hans-Uwe; Muthukumar, Krishnan; Vignesh, Gopalaswamy; James, Rathinam Arthur			Biomonitoring along the Tropical Southern Indian Coast with Multiple Biomarkers	PLOS ONE			English	Article							HEAVY-METALS; PATHOGENIC BACTERIA; POLLUTION INDICATOR; ESCHERICHIA-COLI; TRACE-ELEMENTS; WATER-QUALITY; SEDIMENTS; CONTAMINATION; SALMONELLA; PARAMETERS	We assessed the spatial and temporal variations of pollution indicators and geochemical and trace metal parameters (23 in total) from water and sediment (144 samples) of three different eco-niches (beach, fishing harbor, and estuary) in larger coastal cities of southern India (Cuddalore and Pondicherry) for one year. A total of 120 marine Pseudomonas isolates were challenged against different concentrations of copper solutions and 10 different antibiotics in heavy metal and antibiotic resistance approaches, respectively. The study shows that 4.16% of the isolates could survive in 250 mM of copper; 70% were resistant to minimum concentrations. Strains were resistant (98.4%) to at least one antibiotic in Cuddalore compared to the Pondicherry (78.4%) region. Pollution index (PI) (0-14.55) and antibiotic resistance index (ARI) (0.05-0.10) ratio indicated that high bacterial and antibiotic loads were released into the coastal environment. The degree of trace metal contamination in sediments were calculated by enrichment factor (EF), contamination factor (CF), pollution load index (PLI), and geo-accumulation index (Igeo). Statistical parameters like two-way analysis of variance (ANOVA), correlation, factor analysis and scatter matrix tools were employed between the 23 parameters in order to find sources, pathways, disparities and interactions of environmental pollutants. It indicates that geochemical and biological parameters were not strongly associated with each other (except a few) and were affected by different sources. Factor analysis elucidated, 'microbe-metal' interaction (Factor 1-48.86%), 'anthropogenic' factor (Factor 2-13.23%) and 'Pseudomonas-Cadmium' factor (Factor 3-11.74%), respectively.	[Vignesh, Sivanandham; Muthukumar, Krishnan; James, Rathinam Arthur] Bharathidasan Univ, Dept Marine Sci, Tiruchirappalli, Tamil Nadu, India; [Dahms, Hans-Uwe; James, Rathinam Arthur] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, 70 Lienhai Rd, Kaohsiung, Taiwan; [Vignesh, Gopalaswamy] Bharathidasan Univ, Dept Chem, Tiruchirappalli, Tamil Nadu, India; [Dahms, Hans-Uwe] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, 100 Shin Chuan 1st Rd, Kaohsiung, Taiwan	Bharathidasan University; National Sun Yat Sen University; Bharathidasan University; Kaohsiung Medical University	James, RA (corresponding author), Bharathidasan Univ, Dept Marine Sci, Tiruchirappalli, Tamil Nadu, India.; Dahms, HU; James, RA (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, 70 Lienhai Rd, Kaohsiung, Taiwan.; Dahms, HU (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, 100 Shin Chuan 1st Rd, Kaohsiung, Taiwan.	hansd@kmu.edu.tw; james.msbdu@gmail.com		Muthukumar, Krishnan/0000-0001-7826-8179	Department of Biotechnology (DBT), India [BT/PR 121814/2009]; MOST [MOST 104-2621-M-037-001]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); MOST	The authors would like to thank the Department of Biotechnology (DBT), India for finan-cial assistance (BT/PR 121814/2009) in carrying out this research. A grant from MOST to HUD is gratefully acknowledged (MOST 104-2621-M-037-001 to T.H. Shih). We also thank the Asia Pacific Ocean Research Center of the Department of Oceanography [No. 76211194] in the frame of KMU/NSYSU cooperation. The funders had no role in study design, data collection and analysis,	Abdelzaher AM, 2010, APPL ENVIRON MICROB, V76, P724, DOI 10.1128/AEM.02127-09; Ahlf W, 2001, J SOIL SEDIMENT, V1, P1; Alm EW, 2003, WATER RES, V37, P3978, DOI 10.1016/S0043-1354(03)00301-4; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; [Anonymous], 1996, HLTH CRIT OTH SUPP I; ARAUJO RM, 1989, J APPL BACTERIOL, V67, P213, DOI 10.1111/j.1365-2672.1989.tb03398.x; Ashbolt N, WATER SCI TECHNOLOGY, V27, P449; BIS, 2009, 2009252047C BIS FAD, V25, P1; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; BROOKS RR, 1967, TALANTA, V14, P809, DOI 10.1016/0039-9140(67)80102-4; Chapman PM, 2001, ENVIRON TOXICOL CHEM, V20, P3, DOI [10.1002/etc.5620200102, 10.1897/1551-5028(2001)020&lt;0003:ASCIE&gt;2.0.CO;2]; Clark A, 2003, ECOTOX ENVIRON SAFE, V56, P390, DOI 10.1016/S0147-6513(03)00098-8; Clark RB, 1992, MARINE POLLUTION; Dell'Anno A, 2003, WORLD J MICROB BIOT, V19, P93, DOI 10.1023/A:1022581632116; DeSanto RS, 1991, INORGANIC CONTAMINAN; FABIANO M, 1994, MAR POLLUT BULL, V28, P18, DOI 10.1016/0025-326X(94)90181-3; Fatoki OS, 2002, WATER S AFRICA, V2, P2; Finstein MS, POLLUTION MICROBIOLO, P127; George I, 2001, ESTUARIES, V24, P994, DOI 10.2307/1353012; Grande JA, 2003, MAR POLLUT BULL, V46, P475, DOI 10.1016/S0025-326X(02)00452-6; Harakeh S, 2006, ENVIRON POLLUT, V143, P269, DOI 10.1016/j.envpol.2005.11.027; Hassen A, 1998, BIORESOURCE TECHNOL, V64, P7, DOI 10.1016/S0960-8524(97)00161-2; HINTON M, 1985, J APPL BACTERIOL, V58, P27, DOI 10.1111/j.1365-2672.1985.tb01426.x; HOLMBERG SD, 1984, SCIENCE, V225, P833, DOI 10.1126/science.6382605; Kennish M.J., 1994, PRACTICAL HDB MARINE; Koukal B, 2004, ENVIRON POLLUT, V131, P163, DOI 10.1016/j.envpol.2004.01.014; Kumarasamy P., 2009, Research Journal of Microbiology, V4, P540; Langergraber G, 2005, ENVIRON INT, V31, P433, DOI 10.1016/j.envint.2004.08.006; Mandal P, 2012, ENVIRON MONIT ASSESS, V170, P661; Mazel D, 1999, CELL MOL LIFE SCI, V56, P742, DOI 10.1007/s000180050021; McLellan SL, 2001, APPL ENVIRON MICROB, V67, P4934, DOI 10.1128/AEM.67.10.4934-4938.2001; Mohandass C, 2010, ENVIRON MONIT ASSESS, V169, P639, DOI 10.1007/s10661-009-1203-3; Mustapha A, 2012, POL J ENVIRON STUD, V21, P1359; Nagvenkar GS, 2009, ENVIRON MONIT ASSESS, V155, P245, DOI 10.1007/s10661-008-0432-1; NAKAHARA H, 1977, NATURE, V266, P165, DOI 10.1038/266165a0; *NCCLS, 1998, M100S8 NCCLS; Ow D., 1993, DEV BIOL, V29, P213; Ramaiah N, 2004, CURR SCI INDIA, V87, P435; Salah E. A. M., 2012, Journal of Water Resource and Protection, V4, P1009, DOI 10.4236/jwarp.2012.412117; Santhiya G, 2011, MICROCHEM J, V99, P197, DOI 10.1016/j.microc.2011.05.004; STARZECKA A, 1993, ARCH HYDROBIOL, P71; Thuy HTT, 2000, ENVIRON GEOL, V39, P733, DOI 10.1007/s002540050487; TNPCB, 2000, REV, V2, P1; TOMLINSON DL, 1980, HELGOLANDER MEERESUN, V33, P566, DOI 10.1007/BF02414780; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; Vignesh S., 2013, SUSTAINABLE FUTURE E, P363, DOI [DOI 10.1007/978-3-642-32917-3-20, 10.1007/978-3-642-32917-3_20, DOI 10.1007/978-3-642-32917-3_20]; Vignesh S, 2015, ENVIRON PROCESS, V2, P125, DOI 10.1007/s40710-015-0058-6; Vignesh S, 2014, ENVIRON MONIT ASSESS, V186, P1875, DOI 10.1007/s10661-013-3501-z; Vignesh S, 2012, MAR POLLUT BULL, V64, P790, DOI 10.1016/j.marpolbul.2012.01.015; WHO, 1998, GUID DRINK WAT QUAL, V1; WHO, 2011, GUID DRINK WAT QUAL; World Health Organization (WHO), 2006, GUID SAF US WAST EXC, P182	52	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0154105	10.1371/journal.pone.0154105	http://dx.doi.org/10.1371/journal.pone.0154105			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941969	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600001
J	Al-Subari, K; Al-Baddai, S; Tome, AM; Volberg, G; Ludwig, B; Lang, EW				Al-Subari, Karema; Al-Baddai, Saad; Tome, Ana Maria; Volberg, Gregor; Ludwig, Bernd; Lang, Elmar W.			Combined EMD-sLORETA Analysis of EEG Data Collected during a Contour Integration Task	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; SOURCE LOCALIZATION; RESOLUTION; BRAIN; NOISE; DENSITY; SYSTEMS; NUMBER	Lately, Ensemble Empirical Mode Decomposition (EEMD) techniques receive growing interest in biomedical data analysis. Event-Related Modes (ERMs) represent features extracted by an EEMD from electroencephalographic (EEG) recordings. We present a new approach for source localization of EEG data based on combining ERMs with inverse models. As the first step, 64 channel EEG recordings are pooled according to six brain areas and decomposed, by applying an EEMD, into their underlying ERMs. Then, based upon the problem at hand, the most closely related ERM, in terms of frequency and amplitude, is combined with inverse modeling techniques for source localization. More specifically, the standardized low resolution brain electromagnetic tomography (sLORETA) procedure is employed in this work. Accuracy and robustness of the results indicate that this approach deems highly promising in source localization techniques for EEG data.	[Al-Subari, Karema; Al-Baddai, Saad; Lang, Elmar W.] Univ Regensburg, Inst Biophys, Dept Biol, Regensburg, Germany; [Al-Subari, Karema; Al-Baddai, Saad; Ludwig, Bernd] Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, Regensburg, Germany; [Tome, Ana Maria] Univ Aveiro, Inst Elect Engn & Elect, Dept Elect Engn Telecommun & Informat, Aveiro, Portugal; [Volberg, Gregor] Univ Regensburg, Inst Expt Psychol, Dept Psychol Pedag & Sport, Regensburg, Germany	University of Regensburg; University of Regensburg; Universidade de Aveiro; University of Regensburg	Al-Baddai, S (corresponding author), Univ Regensburg, Inst Biophys, Dept Biol, Regensburg, Germany.; Al-Baddai, S (corresponding author), Univ Regensburg, Inst Informat Sci, Dept Linguist Literature & Culture, Regensburg, Germany.	saad.al-baddai@ur.de		Lang, Elmar W./0000-0001-7440-0224; Volberg, Gregor/0000-0002-4427-2409; Tome, Ana Maria/0000-0002-1210-0266				Al-Baddai S, 2014, BIOMED SIGNAL PROCES, V13, P218, DOI 10.1016/j.bspc.2014.04.011; Al-Baddai S, 2015, BMVA, V2015, P1; Al-Baddai S, 2016, THESIS; Al-Baddai S, 2016, INFORM SCIENCES, V348, P305, DOI 10.1016/j.ins.2016.01.089; Al-Subari K, 2015, J NEUROSCI METH, V253, P193, DOI 10.1016/j.jneumeth.2015.06.020; Al-Subari K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119489; Aydin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093154; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Belardinelli P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051985; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Cho JH, 2015, NEUROIMAGE, V110, P60, DOI 10.1016/j.neuroimage.2015.01.043; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Durka PJ, 2005, J NEUROSCI METH, V148, P49, DOI 10.1016/j.jneumeth.2005.04.001; Edelman BJ, 2015, ENGINEERING-PRC, V1, P292, DOI [10.15302/J-ENG-2015078, 10.15302/j-eng-2015078]; FENDER DH, 1991, J CLIN NEUROPHYSIOL, V8, P381, DOI 10.1097/00004691-199110000-00003; Fender DH, 1987, METHODS ANAL BRAIN E; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Goetz T, 2016, J NEURAL EN IN PRESS; Gordon SM, 2015, J NEUROSCI METH, V256, P41, DOI 10.1016/j.jneumeth.2015.08.019; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; He B, 2002, CLIN NEUROPHYSIOL, V113, P227, DOI 10.1016/S1388-2457(01)00740-4; He B, 2013, ELECTROPHYSIOLOGICAL, P499; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Huang N.E., 1998, P ROYAL SOC LONDON S, V454, P903, DOI DOI 10.1098/RSPA.1998.0193; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jatoi MA, 2014, BIOMED SIGNAL PROCES, V11, P42, DOI 10.1016/j.bspc.2014.01.009; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V106, P127, DOI 10.1016/S0013-4694(97)00115-6; Lu W, 2003, NEUROCOMPUTING, V50, P271, DOI 10.1016/S0925-2312(01)00710-X; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Malony A, 2011, P MED MEETS VIRT REA; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD., 2007, ARXIV 07103341 MATH; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Rey RR, 2010, NEUROELECTROMAGNETIC, V38, P127; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Ryynanen ORM, 2004, IEEE T BIO-MED ENG, V51, P1547, DOI 10.1109/TBME.2004.828036; Ryynanen ORM, 2006, IEEE T BIO-MED ENG, V53, P1851, DOI 10.1109/TBME.2006.873744; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Sohrabpour A, 2015, CLIN NEUROPHYSIOL, V126, P472, DOI 10.1016/j.clinph.2014.05.038; Song J., 2013, FUNCT NEUROL REHABIL, V3, P275; Song J, 2015, J NEUROSCI METH, V256, P9, DOI 10.1016/j.jneumeth.2015.08.015; Staudigl T, 2013, CURR BIOL, V23, P1101, DOI 10.1016/j.cub.2013.04.074; Tadel F, COMPUTATIONAL INTELL; Tarantola A, 2005, INVERSE PROBLEM THEO, DOI DOI 10.1137/1.9780898717921; Vitali P, 2015, FUNCT NEUROL, V30, P9; Volberg G, 2016, VISUAL WORKING MEMOR; Volberg G, 2014, EXP PSYCHOL, V61, P331, DOI 10.1027/1618-3169/a000252; Volberg G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00264; Vorwerk J, BIOMED TECH; Wagner M, 2007, P 15 INT C BIOM VANC, P1300; Wang G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/459346; Wendel Katrina, 2009, Comput Intell Neurosci, P656092, DOI 10.1155/2009/656092; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang L, 2011, NEUROIMAGE, V56, P1908, DOI 10.1016/j.neuroimage.2011.03.043; Yu K, 2016, IEEE T BIO-MED ENG, V63, P1787, DOI 10.1109/TBME.2016.2591924	67	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167957	10.1371/journal.pone.0167957	http://dx.doi.org/10.1371/journal.pone.0167957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936219	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100238
J	Bieler, S; Waltenberger, H; Barrett, MP; McCulloch, R; Mottram, JC; Carrington, M; Schwaeble, W; McKerrow, J; Phillips, MA; Michels, PA; Buscher, P; Sanchez, JC; Bishop, R; Robinson, DR; Bangs, J; Ferguson, M; Nerima, B; Albertini, A; Michel, G; Radwanska, M; Ndung'u, JM				Bieler, Sylvain; Waltenberger, Harald; Barrett, Michael P.; McCulloch, Richard; Mottram, Jeremy C.; Carrington, Mark; Schwaeble, Wilhelm; McKerrow, James; Phillips, Margaret A.; Michels, Paul A.; Buscher, Philippe; Sanchez, Jean-Charles; Bishop, Richard; Robinson, Derrick R.; Bangs, James; Ferguson, Michael; Nerima, Barbara; Albertini, Audrey; Michel, Gerd; Radwanska, Magdalena; Ndung'u, Joseph Mathu			Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEINS; RAPID DIAGNOSTIC-TEST; BRUCEI-GAMBIENSE; SLEEPING SICKNESS; AGGLUTINATION-TEST; TRYPTECT CIATT(R); PROTEIN; GENE; RHODESIENSE; SERUM	Background Control and elimination of human African trypanosomiasis (HAT) can be accelerated through the use of diagnostic tests that are more accurate and easier to deploy. The goal of this work was to evaluate the immuno-reactivity of antigens and identify candidates to be considered for development of a simple serological test for the detection of Trypanosoma brucei gambiense or T. b. rhodesiense infections, ideally both. Methodology/Principal Findings The reactivity of 35 antigens was independently evaluated by slot blot and ELISA against sera from both T. b. gambiense and T. b. rhodesiense infected patients and controls. The antigens that were most reactive by both tests to T. b. gambiense sera were the membrane proteins VSG LiTat 1.3, VSG LiTat 1.5 and ISG64. Reactivity to T. b. rhodesiense sera was highest with VSG LiTat 1.3, VSG LiTat 1.5 and SRA, although much lower than with T. b. gambiense samples. The reactivity of all possible combinations of antigens was also calculated. When the slot blot results of 2 antigens were paired, a VSG LiTat 1.3-ISG75 combination performed best on T. b. gambiense sera, while a VSG LiTat 1.3-VSG LiTat 1.5 combination was the most reactive using ELISA. A combination of SRA and either VSG LiTat 1.3 or VSG LiTat 1.5 had the highest reactivity on T. b. rhodesiense sera according to slot blot, while in ELISA, pairing SRA with either GM6 or VSG LiTat 1.3 yielded the best results. Conclusions This study identified antigens that were highly reactive to T. b. gambiense sera, which could be considered for developing a serological test for gambiense HAT, either individually or in combination. Antigens with potential for inclusion in a test for T. b. rhodesiense HAT were also identified, but because their reactivity was comparatively lower, a search for additional antigens would be required before developing a test for this form of the disease.	[Bieler, Sylvain; Albertini, Audrey; Michel, Gerd; Radwanska, Magdalena; Ndung'u, Joseph Mathu] FIND, Geneva, Switzerland; [Waltenberger, Harald] Microcoat Biotechnol GmbH, Bernried, Germany; [Barrett, Michael P.; McCulloch, Richard; Mottram, Jeremy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Carrington, Mark] Univ Cambridge, Cambridge, England; [Schwaeble, Wilhelm] Univ Leicester, Leicester, Leics, England; [McKerrow, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Phillips, Margaret A.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Michels, Paul A.] Christian Duve Inst, Brussels, Belgium; [Buscher, Philippe] Inst Trop Med, Antwerp, Belgium; [Sanchez, Jean-Charles] Univ Geneva, Biomed Prote Res Grp, Geneva, Switzerland; [Bishop, Richard] Int Livestock Res Inst, Nairobi, Kenya; [Robinson, Derrick R.] Univ Bordeaux, CNRS, UMR 5234, Bordeaux, France; [Bangs, James] Univ Wisconsin Madison, Madison, WI USA; [Ferguson, Michael] Univ Dundee, Dundee, Scotland; [Nerima, Barbara] Univ Bern, Bern, Switzerland; [Nerima, Barbara] Makerere Univ, Kampala, Uganda; [McKerrow, James] Univ Calif San Diego, San Diego, CA 92103 USA; [Bangs, James] SUNY Buffalo, Buffalo, NY USA; [Radwanska, Magdalena] Univ Ghent, Global Campus, Inchon, South Korea	Foundation For Innovative New Diagnostics; University of Glasgow; University of Cambridge; University of Leicester; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; Institute of Tropical Medicine (ITM); University of Geneva; CGIAR; International Livestock Research Institute (ILRI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Wisconsin System; University of Wisconsin Madison; University of Dundee; University of Bern; Makerere University; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Ghent University	Bieler, S (corresponding author), FIND, Geneva, Switzerland.	sylvain.bieler@finddx.org	Carrington, Mark/N-3653-2019; Radwanska, Magdalena/Q-4279-2018; Michels, Paul A/A-5637-2009; Büscher, Philippe/B-9956-2012; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Radwanska, Magdalena/0000-0002-0797-6001; Michels, Paul A/0000-0003-3726-6104; Büscher, Philippe/0000-0002-1926-7472; Carrington, Mark/0000-0002-6435-7266; Ferguson, Michael/0000-0003-1321-8714; Mottram, Jeremy/0000-0001-5574-3766; Schwaeble, Wilhelm/0000-0001-8927-0864	Bill & Melinda Gates Foundation [39524]; National Institutes of Health [2R37AI034432]; National Institute of Allergy and Infectious Diseases [AI035739, AI056866]; Wellcome Trust [101842]; Sandler Foundation; Agence nationale de la recherche [ANR-11-LABX-0024]; Wellcome Trust Centre for Molecular Parasitology [104111/Z/14/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, R37AI034432, R01AI056866] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); Sandler Foundation; Agence nationale de la recherche(French National Research Agency (ANR)); Wellcome Trust Centre for Molecular Parasitology(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), grant 39524 (JMN); National Institutes of Health (https://www.nih.gov/), grant 2R37AI034432 (MAP); National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), grants AI035739 and AI056866 (JB); Wellcome Trust (https://wellcome.ac.uk/), grant 101842 (MF); The Sandler Foundation to University of California (JMK); Agence nationale de la recherche (http://www.agence-nationale-recherche.fr/), grant ANR-11-LABX-0024 (DRR); Wellcome Trust Centre for Molecular Parasitology (http://www.gla.ac.uk/researchinstitutes/iii/wtcmp/), grant 104111/Z/14/Z (MPB, RMC and JCM). The funders provided support in the form of salaries for authors JMN, SB, AA, GM, MR, MAP, JB, MF, JMK, DRR, MPB, RMC and JCM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW is an employee of MicroCoat Biotechnologie GmbH. This company was contracted by FIND to evaluate the reactivity of the antigens by slot blot and ELISA against sera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Asonganyi T, 1998, ANN TROP MED PARASIT, V92, P837, DOI 10.1080/00034989858871; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bart JM, 2015, CELL MICROBIOL, V17, P1523, DOI 10.1111/cmi.12454; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Buscher P, 2015, EXPERT REV MOL DIAGN, V15, P607, DOI 10.1586/14737159.2015.1027195; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Buza J, 1999, VET IMMUNOL IMMUNOP, V69, P1, DOI 10.1016/S0165-2427(99)00033-1; Capewell P, 2015, PARASITOLOGY, V142, pS108, DOI 10.1017/S0031182014000602; Capewell P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003686; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Cordeiro AT, 2009, BIOORGAN MED CHEM, V17, P2483, DOI 10.1016/j.bmc.2009.01.068; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; DEGREEF C, 1989, MOL BIOCHEM PARASIT, V36, P169, DOI 10.1016/0166-6851(89)90189-8; DIFFLEY P, 1983, J IMMUNOL, V131, P1983; Dobson R, 2011, MOL MICROBIOL, V81, P434, DOI 10.1111/j.1365-2958.2011.07703.x; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; EISENHART C, 1972, ANN MATH STAT, V43, P1035, DOI 10.1214/aoms/1177692458; Eyford BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071463; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Fyfe J, 2016, ACTA TROP; Gualdron-Lopez M, 2013, BBA-MOL CELL RES, V1833, P3076, DOI 10.1016/j.bbamcr.2013.08.008; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Jamonneau V, 2000, ACTA TROP, V76, P175, DOI 10.1016/S0001-706X(00)00095-4; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Caceres AJ, 2010, MOL BIOCHEM PARASIT, V169, P50, DOI 10.1016/j.molbiopara.2009.09.001; Lynch NJ, 2002, INT IMMUNOPHARMACOL, V2, P415, DOI 10.1016/S1567-5769(01)00165-5; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Malabanan MM, 2011, BIOCHEMISTRY-US, V50, P5767, DOI 10.1021/bi2005416; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mcnae IW, 2009, J MOL BIOL, V385, P1519, DOI 10.1016/j.jmb.2008.11.047; Mercaldi GF, 2012, FEBS J, V279, P2012, DOI 10.1111/j.1742-4658.2012.08586.x; Milne KG, 2001, MOL BIOCHEM PARASIT, V112, P301, DOI 10.1016/S0166-6851(00)00369-8; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Nantulya VM, 1997, T ROY SOC TROP MED H, V91, P551, DOI 10.1016/S0035-9203(97)90023-7; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Nzou SM, 2016, PARASITOL INT, V65, P121, DOI 10.1016/j.parint.2015.10.008; OKA M, 1988, MICROBIOL IMMUNOL, V32, P1175, DOI 10.1111/j.1348-0421.1988.tb01481.x; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Radwanska M, 2000, INFECT IMMUN, V68, P848, DOI 10.1128/IAI.68.2.848-860.2000; Roge S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003006; Rooney B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004271; Ruda GF, 2010, BIOORGAN MED CHEM, V18, P5056, DOI 10.1016/j.bmc.2010.05.077; Rudd SG, 2013, MOL CELL, V52, P554, DOI 10.1016/j.molcel.2013.10.034; Sanderson SJ, 2003, FEBS LETT, V542, P12, DOI 10.1016/S0014-5793(03)00327-2; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Schnekenburger M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00170; Schwede A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005259; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Sistrom M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147660; Sistrom M, 2014, GENOME BIOL EVOL, V6, P2811, DOI 10.1093/gbe/evu222; Sullivan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002087; Van Nieuwenhove L, 2013, TROP MED INT HEALTH, V18, P461, DOI 10.1111/tmi.12058; Van Nieuwenhove L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001682; Van Nieuwenhove LC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001189; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Whitley E, 2002, CRIT CARE, V6, P143; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104	66	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168074	10.1371/journal.pone.0168074	http://dx.doi.org/10.1371/journal.pone.0168074			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936225	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000389587100269
J	Dong, CJ; Chen, L; Feng, JY; Xu, J; Mahboob, S; Al-Ghanim, K; Li, XJ; Xu, P				Dong, Chuanju; Chen, Lin; Feng, Jingyan; Xu, Jian; Mahboob, Shahid; Al-Ghanim, Khalid; Li, Xuejun; Xu, Peng			Genome Wide Identification, Phylogeny, and Expression of Aquaporin Genes in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							LINKAGE MAP; DUPLICATION; EVOLUTION; DIVERSITY; CDNA; L.	Background Aquaporins (Aqps) are integral membrane proteins that facilitate the transport of water and small solutes across cell membranes. Among vertebrate species, Aqps are highly conserved in both gene structure and amino acid sequence. These proteins are vital for maintaining water homeostasis in living organisms, especially for aquatic animals such as teleost fish. Studies on teleost Aqps are mainly limited to several model species with diploid genomes. Common carp, which has a tetraploidized genome, is one of the most common aquaculture species being adapted to a wide range of aquatic environments. The complete common carp genome has recently been released, providing us the possibility for gene evolution of aqp gene family after whole genome duplication. Results In this study, we identified a total of 37 aqp genes from common carp genome. Phylogenetic analysis revealed that most of aqps are highly conserved. Comparative analysis was performed across five typical vertebrate genomes. We found that almost all of the aqp genes in common carp were duplicated in the evolution of the gene family. We postulated that the expansion of the aqp gene family in common carp was the result of an additional whole genome duplication event and that the aqp gene family in other teleosts has been lost in their evolution history with the reason that the functions of genes are redundant and conservation. Expression patterns were assessed in various tissues, including brain, heart, spleen, liver, intestine, gill, muscle, and skin, which demonstrated the comprehensive expression profiles of aqp genes in the tetraploidized genome. Significant gene expression divergences have been observed, revealing substantial expression divergences or functional divergences in those duplicated aqp genes post the latest WGD event. Conclusions To some extent, the gene families are also considered as a unique source for evolutionary studies. Moreover, the whole set of common carp aqp gene family provides an essential genomic resource for future biochemical, toxicological, physiological, and evolutionary studies in common carp.	[Dong, Chuanju; Chen, Lin; Li, Xuejun] Henan Normal Univ, Coll Fishery, Xinxiang, Henan, Peoples R China; [Dong, Chuanju; Feng, Jingyan] Shanghai Ocean Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Lin; Xu, Peng] Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China; [Feng, Jingyan; Xu, Jian; Xu, Peng] Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing, Peoples R China; [Feng, Jingyan; Xu, Jian; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Mahboob, Shahid] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan	Henan Normal University; Shanghai Ocean University; Xiamen University; Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; King Saud University; Government College University Faisalabad	Xu, P (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Fujian Collaborat Innovat Ctr Exploitat & Utiliza, Xiamen, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Aquat Genom, Beijing, Peoples R China.; Xu, P (corresponding author), Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng77@xmu.edu.cn	Xu, Jian/H-5349-2019; Xu, Peng/J-4018-2012; Rana, Shahid Mahboob/P-1131-2014	Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078; Rana, Shahid Mahboob/0000-0003-4969-5387	National Natural Science Foundation of China [31422057]; National High Technology Research and Development Program of China (863 program) [2011AA100401]; Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01, 2016GH02]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences; Deanship of Scientific Research at King Saud University(King Saud University)	This research was supported by grants from the National Natural Science Foundation of China (No. 31422057), the National High Technology Research and Development Program of China (863 program; 2011AA100401), and the Special Scientific Research Funds for Central Nonprofit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01 and 2016GH02). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Aparicio S, 2000, TRENDS GENET, V16, P54, DOI 10.1016/S0168-9525(99)01934-4; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Dong C, 2015, PLOS ONE, V10; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Gates MA, 1999, GENOME RES, V9, P334; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gong Z, 1998, NAT GENET, V18, P303; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Jiang LM, 2015, ACTA MATER, V90, P344, DOI 10.1016/j.actamat.2015.02.039; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Kondrashov FA, 2012, P ROYAL SOC LONDON B; Kumar S., 2016, MOL BIOL EVOLUTION; Li Y, 2011, MAR BIOTECHNOL, V13, P1183, DOI 10.1007/s10126-011-9404-5; Liu S. -R, 2013, PLOS ONE, V8; Loh YH, 2004, GENOME RES, V14, P1248, DOI 10.1101/gr.2400004; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Park JS, 2006, CANCER RES, V57, P3606; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Soukup S. W, 1974, TERATOLOGY, V9, P250, DOI DOI 10.1002/TERA.1420090224; Staniscuaski F, 2013, J INSECT PHYSIOL, V59, P1140, DOI 10.1016/j.jinsphys.2013.08.013; Sun XW, 2004, AQUACULTURE, V238, P165, DOI 10.1016/S0044-8486(03)00445-9; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tingaudsequeira A, 2010, BMC EVOLUTIONARY BIO, V10, P91; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-96; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2011, BMC GENOMICS, V12; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928	44	19	22	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166160	10.1371/journal.pone.0166160	http://dx.doi.org/10.1371/journal.pone.0166160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935978	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100019
J	Gladkikh, OL; Romanenko, SA; Lemskaya, NA; Serdyukova, NA; O'Brien, PCM; Kovalskaya, JM; Smorkatcheva, AV; Golenishchev, FN; Perelman, PL; Trifonov, VA; Ferguson-Smith, MA; Yang, FT; Graphodatsky, AS				Gladkikh, Olga L.; Romanenko, Svetlana A.; Lemskaya, Natalya A.; Serdyukova, Natalya A.; O'Brien, Patricia C. M.; Kovalskaya, Julia M.; Smorkatcheva, Antonina V.; Golenishchev, Feodor N.; Perelman, Polina L.; Trifonov, Vladimir A.; Ferguson-Smith, Malcolm A.; Yang, Fengtang; Graphodatsky, Alexander S.			Rapid Karyotype Evolution in Lasiopodomys Involved at Least Two Autosome - Sex Chromosome Translocations	PLOS ONE			English	Article							MICROTUS-MANDARINUS-MANDARINUS; ARVICOLINAE CRICETIDAE; GENOME HOMOLOGY; FIELD VOLE; RODENTIA; GENE; HETEROCHROMATIN; DIVERSITY; GREGALIS; ORIGIN	The generic status of Lasiopodomys and its division into subgenera Lasiopodomys (L. mandarinus, L. brandtii) and Stenocranius (L. gregalis, L. raddei) are not generally accepted because of contradictions between the morphological and molecular data. To obtain cytogenetic evidence for the Lasiopodomys genus and its subgenera and to test the autosome to sex chromosome translocation hypothesis of sex chromosome complex origin in L. mandarinus proposed previously, we hybridized chromosome painting probes from the field vole (Microtus agrestis, MAG) and the Arctic lemming (Dicrostonyx torquatus, DTO) onto the metaphases of a female Mandarin vole (L. mandarinus, 2n = 47) and a male Brandt's vole (L. brandtii, 2n = 34). In addition, we hybridized Arctic lemming painting probes onto chromosomes of a female narrow-headed vole (L. gregalis, 2n = 36). Cross-species painting revealed three cytogenetic signatures (MAG12/18, 17a/19, and 22/24) that could validate the genus Lasiopodomys and indicate the evolutionary affinity of L. gregalis to the genus. Moreover, all three species retained the associations MAG1bc/17b and 2/8a detected previously in karyotypes of all arvicolins studied. The associations MAG2a/8a/19b, 8b/21, 9b/23, 11/13b, 12b/18, 17a/19a ,and 5 fissions of ancestral segments appear to be characteristic for the subgenus Lasiopodomys. We also validated the autosome to sex chromosome translocation hypothesis on the origin of complex sex chromosomes in L. mandarinus. Two translocations of autosomes onto the ancestral X chromosome in L. mandarinus led to a complex of neo-X-1, neo-X-2, and neo-X-3 elements. Our results demonstrate that genus Lasiopodomys represents a striking example of rapid chromosome evolution involving both autosomes and sex chromosomes. Multiple reshuffling events including Robertsonian fusions, chromosomal fissions, inversions and heterochromatin expansion have led to the formation of modern species karyotypes in a very short time, about 2.4 MY.	[Gladkikh, Olga L.; Romanenko, Svetlana A.; Lemskaya, Natalya A.; Serdyukova, Natalya A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk, Russia; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Kovalskaya, Julia M.] Russian Acad Sci, Severtzov Inst Ecol & Evolut, Moscow, Russia; [Smorkatcheva, Antonina V.] St Petersburg State Univ, Dept Vertebrate Zool, St Petersburg, Russia; [Golenishchev, Feodor N.] Russian Acad Sci, Inst Zool, St Petersburg, Russia; [Yang, Fengtang] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England	Russian Academy of Sciences; Novosibirsk State University; University of Cambridge; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Saint Petersburg State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Wellcome Trust Sanger Institute	Romanenko, SA (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Romanenko, SA (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	rosa@mcb.nsc.ru	Golenishchev, Fedor/HDO-4568-2022; Graphodatsky, Alexander/B-4922-2010; Romanenko, Svetlana/N-2500-2015; Trifonov, Vladimir/E-4907-2012; Perelman, Polina/AAD-9030-2019; Serdyukova, Natalia/AAU-6393-2021; Perelman, Polina/N-8088-2015; Yang, Fan/GYU-4249-2022; Lemskaya, Natalya A./N-5609-2015	Graphodatsky, Alexander/0000-0002-8282-1085; Romanenko, Svetlana/0000-0002-0951-5209; Trifonov, Vladimir/0000-0003-0454-8359; Perelman, Polina/0000-0002-0982-5100; Serdyukova, Natalia/0000-0002-0409-1371; Perelman, Polina/0000-0002-0982-5100; Lemskaya, Natalya/0000-0002-3682-6125; Yang, Fengtang/0000-0002-3573-2354	Russian Science Foundation (RSF) [16-14-10009]; Federal Agency for Scientific Organizations (FASO Russia) [01201351185, 0310-2016-0002]; Russian Foundation for Basic Research (RFBR) [14-04-00451, 15-04-00962, 15-29-02384, 16-04-00983-a]; Russian Science Foundation [16-14-10009] Funding Source: Russian Science Foundation	Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Federal Agency for Scientific Organizations (FASO Russia); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The study was funded by the by the Russian Science Foundation (RSF, http://rscf.ru/) under project No. 16-14-10009 to ASG. This work was partially supported by the Programs of the Federal Agency for Scientific Organizations (FASO Russia, http://fano.gov.ru/) No. 01201351185 to FNG for the animals collection and No. 0310-2016-0002 for cell culture collection to ASG. Significant funding was also provided by the Russian Foundation for Basic Research (RFBR, http://www.rfbr.ru/) grants No. 14-04-00451 to SAR, No. 15-04-00962 and No. 15-29-02384 both to ASG, No. 16-04-00983-a to FNG for the animals and tissue cell collections.	Abramson N, 2011, NARROW HEADED VOLE L, P1; Abramson N, 2010, MOL PHYLOGENETICS, P18; Abramson N I, 2009, Dokl Biol Sci, V428, P458; Borodin PM, 2012, CHROMOSOME RES, V20, P259, DOI 10.1007/s10577-011-9261-0; Chen YQ, 2008, MAMM GENOME, V19, P61, DOI 10.1007/s00335-007-9076-7; Chen YQ, 2011, HEREDITAS, V148, P93, DOI 10.1111/j.1601-5223.2011.02207.x; Dupal TA, 2010, ZOOL ZH, V89, P850; Dupal TA, 2000, ZOOL ZH, V79, P851; Golenishchev F, 2002, THERILOGICHESKIE ISS, P17; Gornung E, 2011, CYTOGENET GENOME RES, V132, P144, DOI 10.1159/000321572; Graphodatsky A, 2001, CYTOGENET CELL GENET, V92, P243, DOI 10.1159/000056911; Graphodatsky A, 1981, GENETIKA, P1498; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 1998, HUM MOL GENET, V7, P1991, DOI 10.1093/hmg/7.13.1991; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; KOVALSKAYA YM, 1974, TSITOLOGIYA+, V16, P497; Lemskaya NA, 2010, CHROMOSOME RES, V18, P459, DOI 10.1007/s10577-010-9124-0; Lissovsky Andrey A., 2013, Russian Journal of Theriology, V12, P83; Liu H, 2010, NEUROGASTROENT MOTIL, V22, P1232, DOI 10.1111/j.1365-2982.2010.01586.x; Liu SY, 2012, SCI WORLD J, DOI 10.1100/2012/614263; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; MEZHZHERIN SV, 1993, GENETIKA+, V29, P28; Musser GG, 2005, MAMMAL SPECIES WORLD, P926; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Ohno S., 1967, BIOSCIENCE, P331; Pala I, 2012, HEREDITY, V108, P264, DOI 10.1038/hdy.2011.70; Pavlinov I.Y., 2012, MAMMALS RUSSIA TAXON; Petrova TV, 2015, J ZOOL SYST EVOL RES, V53, P97, DOI 10.1111/jzs.12082; Petrova TV, 2016, ZOOL SCR; Petrova TV, 2015, STRUCTURE MAMMALIAN, P64; Romanenko SA, 2012, CYTOGENET GENOME RES, V137, P233, DOI 10.1159/000339294; Romanenko SA, 2007, CHROMOSOME RES, V15, P891, DOI 10.1007/s10577-007-1171-9; Romanenko SA, 2016, CHROMOSOME RES, V24, P145, DOI 10.1007/s10577-015-9504-6; Romanenko SA, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0194-8; Schibler L, 1998, GENOME RES, V8, P901, DOI 10.1101/gr.8.9.901; SEABRIGH.M, 1971, LANCET, V2, P971; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Toder R, 1997, MAMM GENOME, V8, P418, DOI 10.1007/s003359900459; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Wang JY, 2014, CELL MOL LIFE SCI, V71, P4841, DOI 10.1007/s00018-014-1725-x; Wang JX, 2003, HEREDITAS, V138, P47, DOI 10.1034/j.1601-5223.2003.01615.x; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Zhou Q, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r98; Zhu B, 2003, HEREDITAS, V139, P90, DOI 10.1111/j.1601-5223.2003.01756.x; Zhu B, 1993, ACTA GENET SIN, P135; Zhu BC, 2006, HEREDITAS, V143, P130, DOI 10.1111/j.2006.0018-0661.01950.x	51	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167653	10.1371/journal.pone.0167653	http://dx.doi.org/10.1371/journal.pone.0167653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936177	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100141
J	Jandova, Z; Musilek, M; Vackova, Z; Kozakova, J; Krizova, P				Jandova, Zuzana; Musilek, Martin; Vackova, Zuzana; Kozakova, Jana; Krizova, Pavla			Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; CHANGING EPIDEMIOLOGY; ENGLAND; VACCINE; POPULATIONS; EMERGENCE; WALES; W135	Background This study presents antigenic and genetic characteristics of Neisseria meningitidis strains recovered from invasive meningococcal disease (IMD) in the Czech Republic in 1971-2015. Material and Methods A total of 1970 isolates from IMD, referred to the National Reference Laboratory for Meningococcal Infections in 1971-2015, were studied. All isolates were identified and characterized by conventional biochemical and serological tests. Most isolates (82.5%) were characterized by multilocus sequence typing method. Results In the study period 1971-2015, the leading serogroup was B (52.4%), most often assigned to clonal complexes cc32, cc41/44, cc18, and cc269. A significant percentage of strains were of serogroup C (41.4%), with high clonal homogeneity due to hyperinvasive complex cc11, which played an important role in IMD in the Czech Republic in the mid-1990s. Serogroup Y isolates, mostly assigned to cc23, and isolates of clonally homogeneous serogroup Whave also been recovered more often over the last years. Conclusion The incidence of IMD and distribution of serogroups and clonal complexes of N. meningitidis in the Czech Republic varied over time, as can be seen from the long-term monitoring, including molecular surveillance data. Data from the conventional and molecular IMD surveillance are helpful in refining the antimeningococcal vaccination strategy in the Czech Republic.	[Jandova, Zuzana; Musilek, Martin; Vackova, Zuzana; Kozakova, Jana; Krizova, Pavla] Natl Inst Publ Hlth, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic	Krizova, P (corresponding author), Natl Inst Publ Hlth, Natl Reference Lab Meningococcal Infect, Prague, Czech Republic.	pavla.krizova@szu.cz	Krizova, Pavla/M-6120-2015		Ministry of Health of the Czech Republic [15-34887A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This study was supported by the Ministry of Health of the Czech Republic, grant no. 15-34887A.; This study was supported by the Ministry of Health of the Czech Republic, grant no. 15-34887A. All rights reserved.	Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Campbell H, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21188; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Frosch M, 2006, HDB MENINGOCOCCAL DI; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Ibarz-Pavon AB, 2011, J INFECT DIS, V204, P1046, DOI 10.1093/infdis/jir466; Jandova Z, 2015, EPIDEMIOL MIKROBI IM, V64, P147; Krauland MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035699; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kriz P, 2011, EXPERT REV VACCINES, V10, P1477, DOI [10.1586/ERV.11.117, 10.1586/erv.11.117]; Krizova P, 2014, EPIDEMIOL MIKROBI IM, V63, P61; Ladhani SN, 2015, CLIN INFECT DIS, V60, P578, DOI 10.1093/cid/ciu881; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mustapha MM, 2016, VACCINE, V34, P1515, DOI 10.1016/j.vaccine.2016.02.014; Neri A, 2012, J PREV MED HYG, V53, P109; Nicolas P, 2001, EMERG INFECT DIS, V7, P849; Pollard AJ, 2004, EMERG INFECT DIS, V10, P1812, DOI 10.3201/eid1010.040335; Pollard Andrew J, 2004, Pediatr Infect Dis J, V23, pS274; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Skoczynska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071943; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; Toros B, 2014, EUROSURVEILLANCE, V19, P25; Toros B, 2015, J CLIN MICROBIOL, V53, P2154, DOI 10.1128/JCM.03524-14; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Vackova Z, 2015, EPIDEMIOL MIKROBI IM, V64, P222; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Vogel U, 2003, FRONT BIOSCI-LANDMRK, V8, pE14, DOI 10.2741/920; Watkins ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045349; Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167762	10.1371/journal.pone.0167762	http://dx.doi.org/10.1371/journal.pone.0167762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936105	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100178
J	Kim, BH; Shin, HY; Goto, JJ; Carp, RI; Choi, EK; Kim, YS				Kim, Boe-Hyun; Shin, Hae-Young; Goto, Joy J.; Carp, Richard I.; Choi, Eun-Kyoung; Kim, Yong-Sun			Cellular Prion Protein Combined with Galectin-3 and-6 Affects the Infectivity Titer of an Endogenous Retrovirus Assayed in Hippocampal Neuronal Cells	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; NUCLEOCAPSID PROTEIN; SENESCENCE-PRONE; SCRAPIE; MICE; LINE; PRPC; INTERACTS; BINDING; HIV-1	Prion diseases are infectious and fatal neurodegenerative diseases which require the cellular prion protein, PrPC, for development of diseases. The current study shows that the PrPC augments infectivity and plaque formation of a mouse endogenous retrovirus, MuLV. We have established four neuronal cell lines expressing mouse PrPC, PrP+/+; two express wild type PrPC (MoPrPwild) and the other two express mutant PrPC (MoPrPmut). Infection of neuronal cells from various PrP+/+ and PrP-/- (MoPrPKO) lines with MuLV yielded at least three times as many plaques in PrP+/+ than in PrP-/-. Furthermore, among the four PrP+/+ lines, one mutant line, P101L, had at least 2.5 times as many plaques as the other three PrP+/+ lines. Plaques in P101L were four times larger than those in other PrP+/+ lines. Colocalization of PrP and CAgag was seen in MuLV-infected PrP+/+ cells. In the PrP-MuLV interaction, the involvement of galectin-3 and -6 was observed by immunoprecipitation with antibody to PrPC. These results suggest that PrPC combined with galectin-3 and -6 can act as a receptor for MuLV. P101L, the disease form of mutant PrPC results suggest the genetic mutant form of PrPC may be more susceptible to viral infection.	[Kim, Boe-Hyun] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Shin, Hae-Young; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Goto, Joy J.] Calif State Univ Fresno, Dept Chem, Fresno, CA USA; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Staten Isl, NY USA	Icahn School of Medicine at Mount Sinai; Hallym University; California State University System; California State University Fresno; Institute for Basic Research in Developmental Disabilities	Choi, EK; Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	ekchoi@hallym.ac.kr; yskim@hallym.ac.kr		Kim, Boe-Hyun/0000-0003-2821-0467	National Research Foundation of Korea - Korean Government [NRF-2011K3A1A1003362, 2016R1A2B4013052]; Hallym University Specialization Fund [HRF-S-51]; Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute [A090960]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Hallym University Specialization Fund; Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute	This research was supported by the National Research Foundation of Korea Grant Funded by the Korean Government (NRF-2011K3A1A1003362), Hallym University Specialization Fund (HRF-S-51), and the National Research Foundation of Korea Grant Funded by the Korean Government (2016R1A2B4013052) and a grant of the Korea Healthcare technology R&D Project, the Korea Health Industry Development Institute (A090960).	Alais S, 2012, CELL MOL LIFE SCI, V69, P1331, DOI 10.1007/s00018-011-0879-z; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; ANDERSEN KB, 1994, J VIROL, V68, P3175, DOI 10.1128/JVI.68.5.3175-3182.1994; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carp RI, 1998, J GEN VIROL, V79, P2863, DOI 10.1099/0022-1317-79-11-2863; Carp RI, 1999, J GEN VIROL, V80, P5, DOI 10.1099/0022-1317-80-1-5; Carp RI, 2002, MECH AGEING DEV, V123, P575, DOI 10.1016/S0047-6374(01)00377-3; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Edenhofer F, 1996, J VIROL, V70, P4724, DOI 10.1128/JVI.70.7.4724-4728.1996; Ferrer I, 2011, TRANSL NEUROSCI, V2, P23, DOI 10.2478/s13380-011-0001-x; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kim BH, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-104; KURSCHNER C, 1995, MOL BRAIN RES, V30, P165, DOI 10.1016/0169-328X(95)00013-I; Kurschner C, 1996, MOL BRAIN RES, V37, P249, DOI 10.1016/0169-328X(95)00323-K; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Lee B, 2007, ANN NY ACAD SCI, V1102, P51, DOI 10.1196/annals.1408.004; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lotscher M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001158; Marriott DR, 1995, NEURAL CELL CULTURE, P85; Meeker HC, 1997, NEUROBIOL AGING, V18, P543, DOI 10.1016/S0197-4580(97)00041-9; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sakudo A, 2003, BIOCHEM BIOPH RES CO, V308, P660, DOI 10.1016/S0006-291X(03)01459-1; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Stanton JB, 2008, J VIROL, V82, P9839, DOI 10.1128/JVI.01137-08; Tranchant C, 1997, J NEUROL NEUROSUR PS, V63, P240, DOI 10.1136/jnnp.63.2.240; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Yano S, 2003, J HISTOCHEM CYTOCHEM, V51, P199, DOI 10.1177/002215540305100208	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167293	10.1371/journal.pone.0167293	http://dx.doi.org/10.1371/journal.pone.0167293			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936017	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100080
J	Kutty, RG; Xin, G; Schauder, DM; Cossette, SM; Bordas, M; Cui, WG; Ramchandran, R				Kutty, Raman G.; Xin, Gang; Schauder, David M.; Cossette, Stephanie M.; Bordas, Michelle; Cui, Weiguo; Ramchandran, Ramani			Dual Specificity Phosphatase 5 Is Essential for T Cell Survival	PLOS ONE			English	Article							NUCLEAR ERK ACTIVITY; GENE-FUNCTION; MEMORY; DUSP5; HYPERTROPHY; RESPONSES; RESOURCE	The mitogen-activated protein kinase (MAPK) pathway regulates many key cellular processes such as differentiation, apoptosis, and survival. The final proteins in this pathway, ERK1/2, are regulated by dual specificity phosphatase 5 (DUSP5). DUSP5 is a nuclear, inducible phosphatase with high affinity and fidelity for ERK1/2. By regulating the final step in the MAPK signaling cascade, DUSP5 exerts strong regulatory control over a central cellular pathway. Like other DUSPs, DUSP5 plays an important role in immune function. In this study, we have utilized new knockout mouse reagents to explore its function further. We demonstrate that global loss of DUSP5 does not result in any gross phenotypic changes. However, loss of DUSP5 affects memory/effector CD8(+) T cell populations in response to acute viral infection. Specifically, Dusp5(-/-) mice have decreased proportions of short-lived effector cells (SLECs) and increased proportions of memory precursor effector cells (MPECs) in response to infection. Further, we show that this phenotype is T cell intrinsic; a bone marrow chimera model restricting loss of DUSP5 to the CD8(+) T cell compartment displays a similar phenotype. Dusp5(-/-) T cells also display increased proliferation, increased apoptosis, and altered metabolic profiles, suggesting that DUSP5 is a pro-survival protein in T cells.	[Kutty, Raman G.; Cossette, Stephanie M.; Bordas, Michelle; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Dept Obstet & Gynecol,Div Neonatol,Childrens Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Kutty, Raman G.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Xin, Gang; Schauder, David M.; Cui, Weiguo] BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI USA; [Schauder, David M.; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Dept Obstet & Gynecol,Div Neonatol,Childrens Res, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu	Xin, Gang/N-5788-2018; Xin, Gang/AAX-7651-2020		National Institutes of Health, National Heart, Lung, and Blood Institute [HL090712, HL102745, HL112639]; American Cancer Society [6-004-26]; T32 training grant - National Institutes of Health, National Institute of General Medical Sciences [T32-GM080202]; Children's Hospital of Wisconsin; Department of Pediatrics grant; MCW; NIH [Al125741]; Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS [T32-GM080202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125741] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); T32 training grant - National Institutes of Health, National Institute of General Medical Sciences; Children's Hospital of Wisconsin; Department of Pediatrics grant; MCW; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Elser Doolittle Postdoctoral Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by: National Institutes of Health, National Heart, Lung, and Blood Institute, HL090712, [http://www.nhlbi.nih.gov] to RR; National Institutes of Health, National Heart, Lung, and Blood Institute, HL102745, [http/www.nhlbi.nih.gov] to RR; National Institutes of Health, National Heart, Lung, and Blood Institute, HL112639, [http.//www.nhlbi.nih.gov] to RR; American Cancer Society, 86-004-26, [http.www.cancer.org] to WC; Supported by T32 training grant - National Institutes of Health, National Institute of General Medical Sciences, T32-GM080202, [https://www.nigms.nih.gov/Pages/default.aspx] to RR; RK - Children's Hospital of Wisconsin; and Department of Pediatrics grant, MCW to RK. WC is supported by NIH grant Al125741. GX is supported by The Elizabeth Elser Doolittle Postdoctoral Fellowship. DMS is a member of the Medical Scientist Training Program at MCW, which is partially supported by a training grant from NIGMS T32-GM080202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2013, CROSSROADS INNATE AD, VIV, P107; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chowdhury FZ, 2011, BLOOD, V118, P3890, DOI 10.1182/blood-2011-05-357111; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Holmes DA, 2014, EMBO J; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jeong DG, 2007, PROTEINS, V66, P253, DOI 10.1002/prot.21224; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180; Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tanzola MB, 2006, MOL IMMUNOL, V43, P754, DOI 10.1016/j.molimm.2005.03.006; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007	29	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167246	10.1371/journal.pone.0167246	http://dx.doi.org/10.1371/journal.pone.0167246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936095	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100078
J	Lim, JY; Kim, CM; Rhee, JH; Kim, YR				Lim, Ju Young; Kim, Choon-Mee; Rhee, Joon Haeng; Kim, Young Ran			Effects of Pyrogallol on Growth and Cytotoxicity of Wild-Type and katG Mutant Strains of Vibrio vulnificus	PLOS ONE			English	Article							INFECTIONS; RESISTANCE; PATHOGEN; BACTERIA; REVEALS; DEATH; CELLS	Vibrio vulnificus is a causative agent of fatal septicemia and necrotic wound infection and the pathogen infection became an important public health problem in many counties. Vibrio vulnificus causes RtxA1 toxin-induced acute cell death. We tried to identify natural products that inhibit the acute cytotoxicity of V. vulnificus using a lactate hydrogenase assay. A polyphenol pyrogallol protected HeLa cells from V. vulnificus-induced cytotoxicity. Pyrogallol also decreased the growth of V. vulnificus; this inhibitory effect was more significant during log phase than stationary phase. To further elucidate the inhibitory mechanism, pyrogallol-induced toxicity was compared between a V. vulnificus catalase-peroxidase mutant (katG(-)) and the isogenic wild-type MO6-24/O strains. No growth was observed for the katG(-) mutant in the presence of pyrogallol (50 mu g/mL) even after 24 h, whereas the wild-type strain demonstrated growth recovery following a prolonged lag phase. Pyrogallol-mediated growth inhibition of the katG(-) mutant strain was partially rescued by exogenous catalase treatment. These results indicate that the mechanism by which pyrogallol inhibits the growth and cytotoxicity of V. vulnificus likely involves polyphenol-induced prooxidant damage. Taken together, these results suggest that pyrogallol has potential for development as a new paradigm drug to treat infectious diseases.	[Lim, Ju Young; Kim, Young Ran] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea; [Lim, Ju Young; Kim, Young Ran] Chonnam Natl Univ, Res Inst Drug Dev, Gwangju, South Korea; [Kim, Choon-Mee] Chosun Univ, Sch Med, Premed Sci, Gwangju, South Korea; [Rhee, Joon Haeng] Chonnam Natl Univ, Dept Microbiol, Clin Vaccine Res & Dev Ctr, Sch Med, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chosun University; Chonnam National University	Kim, YR (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea.; Kim, YR (corresponding author), Chonnam Natl Univ, Res Inst Drug Dev, Gwangju, South Korea.	kimyr@chonnam.ac.kr			Basic Science Research Program - Ministry of Education, Science, and Technology of South Korea [NRF-2015R1A2A2A01002919]	Basic Science Research Program - Ministry of Education, Science, and Technology of South Korea	This work was supported by the Basic Science Research Program (grant NRF-2015R1A2A2A01002919) that is funded by the Ministry of Education, Science, and Technology of South Korea, http://www.nrf.re.kr.	Baker-Austin C, 2009, MICROB ECOL, V57, P151, DOI 10.1007/s00248-008-9413-8; Baruah K, 2015, FREE RADICAL BIO MED, V89, P593, DOI 10.1016/j.freeradbiomed.2015.10.397; Chen CH, 2007, MOL NUTR FOOD RES, V51, P962, DOI 10.1002/mnfr.200600230; Kim BA, 2016, J INFECT DIS, V213, P131, DOI 10.1093/infdis/jiv362; Kim JR, 2010, EUR J PHARMACOL, V642, P163, DOI 10.1016/j.ejphar.2010.05.037; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kim YR, 2013, J INFECT DIS, V207, P1406, DOI 10.1093/infdis/jis746; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Na HS, 2011, FEMS IMMUNOL MED MIC, V63, P355, DOI 10.1111/j.1574-695X.2011.00855.x; Ni NT, 2008, BIOORG MED CHEM LETT, V18, P1567, DOI 10.1016/j.bmcl.2008.01.081; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Radu S, 1998, FEMS MICROBIOL LETT, V165, P139, DOI 10.1016/S0378-1097(98)00266-3; Rao NV, 2014, WORLD J MICROB BIOT, V30, P2205, DOI 10.1007/s11274-014-1640-1; REDDY GP, 1992, J BACTERIOL, V174, P2620, DOI 10.1128/JB.174.8.2620-2630.1992; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; TACKET CO, 1984, J INFECT DIS, V149, P558, DOI 10.1093/infdis/149.4.558; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2	21	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167699	10.1371/journal.pone.0167699	http://dx.doi.org/10.1371/journal.pone.0167699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936080	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100157
J	Ng, DHL; Wong, JGX; Thein, TL; Leo, YS; Lye, DC				Ng, Deborah H. L.; Wong, Joshua G. X.; Thein, Tun-Linn; Leo, Yee-Sin; Lye, David C.			The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue	PLOS ONE			English	Article							SHOCK SYNDROME; VIREMIA; INFECTION; SEVERITY; PATTERN; RISK	Dengue fever is gaining importance in Singapore with an increase in the number of cases and mortality in recent years. Although prolonged and saddleback fever have been reported in dengue fever, there are no specific studies on their significance in dengue. This study aims to examine the prevalence of prolonged and saddleback fever in dengue as well as their associations with dengue severity. A total of 2843 polymerase-chain reaction (PCR) confirmed dengue patients admitted to Tan Tock Seng Hospital from 2004 to 2008 were included in the study. Sixty-nine percent of them were male with a median age of 34 years. Prolonged fever (fever > 7 days duration) was present in 572 (20.1%) of patients. Dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS) and severe dengue (SD) were significantly more likely to occur in patients with prolonged fever. Mucosal bleeding, anorexia, diarrhea, abdominal pain, nausea or vomiting, lethargy, rash, clinical fluid accumulation, hepatomegaly, nosocomial infection, leukopenia, higher neutrophil count, higher hematocrit, higher alanine transaminase (ALT) and aspartate transaminase (AST), higher creatinine, lower protein and prolonged activated partial thromboplastin time (APTT) were significantly associated with prolonged fever but not platelet count or prothrombin time (PT). Saddleback fever was present in 165 (5.8%). Although DHF and SD were more likely to occur in patients in those with saddleback fever, DSS was not. Compared with prolonged fever, saddleback fever did not show many significant associations except for diarrhea, abdominal pain, clinical fluid accumulation, hematocrit and platelet change, and lower systolic blood pressure. This study demonstrates that prolonged fever may be associated with various warning signs and more severe forms of dengue (SD, DSS, DHF), while saddleback fever showed associations with DHF and SD but not DSS. The presence of prolonged or saddleback fever in dengue patients should therefore prompt detailed evaluation for complications of dengue, as well as early investigation to evaluate for development of nosocomial infection.	[Ng, Deborah H. L.; Wong, Joshua G. X.; Thein, Tun-Linn; Leo, Yee-Sin; Lye, David C.] Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore; [Leo, Yee-Sin; Lye, David C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Leo, Yee-Sin; Lye, David C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Leo, Yee-Sin] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ng, DHL (corresponding author), Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.	deborah.ng@mohh.com.sg	Thein, Tun-Linn/Y-9520-2018; Thein, Tun-Linn/K-5281-2019; Lye, David/ABF-4402-2021	Thein, Tun-Linn/0000-0002-5254-032X; Thein, Tun-Linn/0000-0002-5254-032X; Lye, David/0000-0003-0324-0205; Wong, Joshua/0000-0001-8268-5610; Ng, Deborah/0000-0002-5169-2401				Barkham TM, 2006, T ROY SOC TROP MED H, V100, P142, DOI 10.1016/j.trstmh.2005.05.015; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Ghosh Sanat Kumar, 2011, J Indian Med Assoc, V109, P790; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Lee IK, 2005, AM J TROP MED HYG, V72, P221, DOI 10.4269/ajtmh.2005.72.221; Lee LK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001676; Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576; Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123; Lum LCS, 2003, J PEDIATR-US, V143, P682, DOI 10.1067/S0022-3476(03)00503-1; Ministry of Health Singapore, 2005, COMM DIS SURV SING 2; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Ratageri Vinod H., 2005, Indian Journal of Pediatrics, V72, P705, DOI 10.1007/BF02724083; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Sideridis K, 2003, HEART LUNG, V32, P414, DOI 10.1016/S0147-9563(03)00105-5; Trayers FJ, 2008, MIL MED, V173, P1188, DOI 10.7205/MILMED.173.12.1188; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; World Health Organisation Special Programme for Research and Training in Tropical Diseases, 2000, WHO SPEC PORGR RES T; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167025	10.1371/journal.pone.0167025	http://dx.doi.org/10.1371/journal.pone.0167025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936002	Green Published, gold			2022-12-26	WOS:000389587100055
J	Sammer, D; Krause, K; Gube, M; Wagner, K; Kothe, E				Sammer, Dominik; Krause, Katrin; Gube, Matthias; Wagner, Katharina; Kothe, Erika			Hydrophobins in the Life Cycle of the Ectomycorrhizal Basidiomycete Tricholoma vaccinum	PLOS ONE			English	Article							FUNGUS PAXILLUS-INVOLUTUS; SCHIZOPHYLLUM-COMMUNE; PISOLITHUS-TINCTORIUS; RESOLUTION STRUCTURE; AERIAL HYPHAE; ORGANIC-ACIDS; RODLET LAYER; GENES; EXPRESSION; SEQUENCE	Hydrophobins-secreted small cysteine-rich, amphipathic proteins-foster interactions of fungal hyphae with hydrophobic surfaces, and are involved in the formation of aerial hyphae. Phylogenetic analyses of Tricholoma vaccinum hydrophobins showed a grouping with hydrophobins of other ectomycorrhizal fungi, which might be a result of co-evolution. Further analyses indicate angiosperms as likely host trees for the last common ancestor of the genus Tricholoma. The nine hydrophobin genes in the T. vaccinum genome were investigated to infer their individual roles in different stages of the life cycle, host interaction, asexual and sexual development, and with respect to different stresses. In aerial mycelium, hyd8 was up-regulated. In silico analysis predicted three packing arrangements, i.e., ring-like, plus-like and sheet-like structure for Hyd8; the first two may assemble to rodlets of hydrophobin covering aerial hyphae, whereas the third is expected to be involved in forming a two-dimensional network of hydrophobins. Metal stress induced hydrophobin gene hyd5. In early steps of mycorrhization, induction of hyd4 and hyd5 by plant root exudates and root volatiles could be shown, followed by hyd5 up-regulation during formation of mantle, Hartig' net, and rhizomorphs with concomitant repression of hyd8 and hyd9. During fruiting body formation, mainly hyd3, but also hyd8 were induced. Host preference between the compatible host Picea abies and the low compatibility host Pinus sylvestris could be linked to a stronger induction of hyd4 and hyd5 by the preferred host and a stronger repression of hyd8, whereas the repression of hyd9 was comparable between the two hosts.	[Sammer, Dominik; Krause, Katrin; Gube, Matthias; Wagner, Katharina; Kothe, Erika] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany; [Sammer, Dominik] Food GmbH Jena, Analyt & Consulting, Jena, Germany; [Gube, Matthias] Univ Gottingen, Dept Soil Sci Temperate Ecosyst, Gottingen, Germany; [Wagner, Katharina] Wacker Biotech GmbH, Jena, Germany	Friedrich Schiller University of Jena; University of Gottingen; Wacker Chemie	Krause, K (corresponding author), Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany.	Katrin.Krause@uni-jena.de		Gube, Matthias/0000-0001-5101-3096	International Leibnitz and Research School, Max Planck Society, Germany; German Research Foundation	International Leibnitz and Research School, Max Planck Society, Germany; German Research Foundation(German Research Foundation (DFG))	This research was supported by the International Leibnitz and Research School, Max Planck Society, Germany, and by the German Research Foundation with Graduate School 214 (www.dfg.de).	Ahonen-Jonnarth U, 2000, NEW PHYTOL, V146, P557, DOI 10.1046/j.1469-8137.2000.00653.x; [Anonymous], 2012, PCR PROTOCOLS GUIDE; Asiimwe T, 2012, MYCORRHIZA, V22, P471, DOI 10.1007/s00572-011-0424-9; Bailey TL, 2015, MEME SUITE; Bailey TL, 2009, MEME SUITE TOOLS MOT; BEEVER RE, 1979, J BACTERIOL, V140, P1063, DOI 10.1128/JB.140.3.1063-1070.1979; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chuang HW, 2009, FEMS MICROBIOL LETT, V293, P205, DOI 10.1111/j.1574-6968.2009.01533.x; Creevey C, CRANN SOFTWARE; de Vocht ML, 1998, BIOPHYS J, V74, P2059, DOI 10.1016/S0006-3495(98)77912-3; Ditengou FA, 2015, NAT COMMUN, V6279, P1; Dominguez C, 2003, HADDOCK PROTEIN PROT, DOI [10.1021/ja026939x, DOI 10.1021/JA026939X]; Erdmann S, 2012, EUKARYOT CELL, V11, P571, DOI 10.1128/EC.05214-11; Gasteiger E, PROTEIN IDENTIFICATI, DOI [10.1016/j.jmb.2004.05.028, DOI 10.1016/J.JMB.2004.05.028]; Hakanpaa J, 2006, ACTA CRYSTALLOGR D, V62, P356, DOI 10.1107/S0907444906000862; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004; Henke C, 2015, ENVIRON EXP BOT, V110, P56, DOI 10.1016/j.envexpbot.2014.09.009; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.arplant.42.1.553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacob C, 2004, FEBS LETT, V576, P423, DOI 10.1016/j.febslet.2004.09.028; Jarosz-Wilkolazka A, 2002, CELL BIOL INT, V26, P605, DOI 10.1006/cbir.2002.0887; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; Kallio JM, 2007, J BIOL CHEM, V282, P28733, DOI 10.1074/jbc.M704238200; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawabata T., 2003, MATRAS PROGRAM PROTE; Kothe E., 2013, AGR APPL, V2nd, P295, DOI [10.1007/978-3-642-36821-9_11, DOI 10.1007/978-3-642-36821-9_11]; Kottke I, 1987, TREES-STRUCT FUNCT, V1, P191, DOI 10.1007/BF00193562; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Krause K, 2006, J BASIC MICROB, V46, P387, DOI 10.1002/jobm.200610153; Kriegelsteiner GJ, 2001, GROSSPILZE BADEN WUR, V3; Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Linder MB, 2009, CURR OPIN COLLOID IN, V14, P356, DOI 10.1016/j.cocis.2009.04.001; Macindoe I, 2012, P NATL ACAD SCI USA, V109, pE804, DOI 10.1073/pnas.1114052109; Mankel A, 1999, MICROBIOL RES, V153, P377, DOI 10.1016/S0944-5013(99)80053-6; Mankel A, 2002, APPL ENVIRON MICROB, V68, P1408, DOI 10.1128/AEM.68.3.1408-1413.2002; Mankel A, 2000, J APPL BOT-ANGEW BOT, V74, P95; Meade A, 2014, BAYES TRAITS V2; Mgbeahuruike AC, 2013, MYCOLOGIA, V105, P1471, DOI 10.3852/13-077; Morris VK, 2013, J MOL BIOL, V425, P244, DOI 10.1016/j.jmb.2012.10.021; Moser M., 1958, Forstwissenschaftliches Zentralblatt, V77, P32, DOI 10.1007/BF01827194; Moser M., 1960, GATTUNG PHLEGMACIUM, V4, P440; Neumann G, 2007, RHIZOSPHERE BIOCH OR; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Pachlewski R, 1974, STUDIES SYMBIOTIC PR, V1, P228; Pfaffl MW, 2004, BIOSPEKTRUM, V01, P92; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Rajashekar B, 2007, NEW PHYTOL, V174, P399, DOI 10.1111/j.1469-8137.2007.02022.x; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; Raudaskoski M, 2015, MYCORRHIZA, V25, P243, DOI 10.1007/s00572-014-0607-2; RIGOU L, 1995, NEW PHYTOL, V130, P141, DOI 10.1111/j.1469-8137.1995.tb01824.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Tagu D, 1996, GENE, V168, P93, DOI 10.1016/0378-1119(95)00725-3; TAGU D, 1995, MOL PLANT MICROBE IN, V8, P781; van Wetter MA, 2000, MOL MICROBIOL, V36, P201, DOI 10.1046/j.1365-2958.2000.01848.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; Wadhwa K, 2012, J BASIC MICROB, V52, P613, DOI 10.1002/jobm.201100407; Wagner K, 2016, ENDOCYT CELL RES, V27, P47; Wagner K, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv120; Wang ZF, 2010, LANGMUIR, V26, P8491, DOI 10.1021/la101240e; WESSELS JGH, 1991, PLANT CELL, V3, P793; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiemken V, 2002, CURR OPIN PLANT BIOL, V5, P355, DOI 10.1016/S1369-5266(02)00269-8; WOSTEN HAB, 1993, PLANT CELL, V5, P1567; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yang J, 2015, I TASSER SUITE PROTE; Yu L, 2008, MICROBIOL-SGM, V154, P1677, DOI 10.1099/mic.0.2007/015263-0	75	24	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167773	10.1371/journal.pone.0167773	http://dx.doi.org/10.1371/journal.pone.0167773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936063	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100183
J	Silva, FH; Claudino, MA; Calmasini, FB; Alexandre, EC; Franco-Penteado, C; Burnett, AL; Antunes, E; Costa, FF				Silva, Fabio H.; Claudino, Mario A.; Calmasini, Fabiano B.; Alexandre, Eduardo C.; Franco-Penteado, Carla; Burnett, Arthur L.; Antunes, Edson; Costa, Fernando F.			Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; ERECTILE DYSFUNCTION; SIGNALING PATHWAY; PRIAPISM; DISEASE; MICE; MECHANISM; RESPONSES; THERAPY; TISSUE	Background Sickle cell disease patients display priapism that may progress to erectile dysfunction. However, little is known about the pathophysiological alterations of corpus cavernosum in sickle cell disease. Objective Thus, this study aimed to evaluate the functional and molecular alterations of sympathetic machinery and nitric oxide-cyclic guanosine monophosphate signaling pathway in Townes transgenic sickle cell disease mice. Methods Concentration-response curves to contractile (phenylephrine) and relaxant agents (acetylcholine and sodium nitroprusside) were obtained in corpus cavernosum strips from sickle and C57BL/6 (control) mice. Neurogenic contractions and nitrergic relaxations were obtained using electrical-field stimulation. Measurements of endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), phosphodiesterase-5 (PDE5) and a alpha(1A)-, alpha(1B)-and alpha(1D)-adrenoceptor mRNA expressions and reactive-oxygen species were performed. Tyrosine hydroxylase phosphorylated at Ser-31 and total tyrosine hydroxylase protein expressions in cavernosal tissues were also measured. Results The neurogenic contractions were higher in the sickle cell disease group, in association with elevated tyrosine hydroxylase phosphorylated at Ser-31 and total tyrosine hydroxylase protein expression, as well as increased tyrosine hydroxylase mRNA expression. Likewise, phenylephrine-induced contractions were greater in the sickle mice, whereas a alpha(1A)-, alpha(1B)-and alpha(1D)-adrenoceptor mRNA expression remained unchanged. Cavernosal relaxations to acetylcholine, sodium nitroprusside and EFS were higher in sickle mice, accompanied by decreased eNOS and nNOS, along with lower PDE5 mRNA expression. An increase of about 40% in reactive-oxygen species generation in corpus cavernosum from sickle mice was also detected. Conclusion Our study shows that decreased nitric oxide bioavailability in erectile tissue due to increased oxidative stress leads to both sympathetic hyperactivity and dysregulation of nitric oxide signaling in corpus cavernosum from Townes sickle mice.	[Silva, Fabio H.; Franco-Penteado, Carla; Costa, Fernando F.] Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Claudino, Mario A.] Univ Sao Francisco, Lab Multidisciplinary Res, Sch Med, Braganca Paulista, SP, Brazil; [Calmasini, Fabiano B.; Alexandre, Eduardo C.; Antunes, Edson] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Burnett, Arthur L.] James Buchanan Brady Urol Inst, Baltimore, MD USA; [Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA	Universidade Estadual de Campinas; Universidade Sao Francisco; Universidade Estadual de Campinas; Johns Hopkins University; Johns Hopkins Medicine	Silva, FH (corresponding author), Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	fabiohsilva87@gmail.com	Costa, Fernando F/D-1566-2012; Claudino, Mário A/D-5367-2014; SILVA, FABIO HENRIQUE/AAZ-8140-2020; Silva, Fábio/D-5412-2013; Calmasini, Fabiano/S-9691-2019; ANTUNES, EDSON/F-6731-2012	Costa, Fernando F/0000-0002-4632-572X; Silva, Fábio/0000-0003-3374-5570; Calmasini, Fabiano/0000-0002-7790-2550; Claudino, Mario Angelo/0000-0002-3590-9607; ANTUNES, EDSON/0000-0003-2201-8247	Sao Paulo Research Foundation (FAPESP) [2013/19781-2, 2014/00984-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), grant number: 2013/19781-2 and 2014/00984-3.; Fabio H. Silva and Fernando F. Costa thank Sao Paulo Research Foundation (FAPESP) for financial support (2013/19781-2, 2014/00984-3).	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Azadzoi KM, 2010, BJU INT, V105, P404, DOI 10.1111/j.1464-410X.2009.08717.x; Bonaventura D, 2008, NITRIC OXIDE-BIOL CH, V18, P287, DOI 10.1016/j.niox.2008.02.004; Burnett AL, 2005, CURR PHARM DESIGN, V11, P3987, DOI 10.2174/138161205774913381; Carson CC, 2005, BJU INT, V96, P257, DOI 10.1111/j.1464-410X.2005.05614.x; Cellek S, 1997, P NATL ACAD SCI USA, V94, P8226, DOI 10.1073/pnas.94.15.8226; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Hedlund F, 2000, J UROLOGY, V164, P868, DOI 10.1016/S0022-5347(05)67329-6; Kheirandish P, 2011, BJU INT, V108, P1068, DOI 10.1111/j.1464-410X.2011.10367.x; Kolo LL, 2004, AM J PHYSIOL-HEART C, V286, pH296, DOI 10.1152/ajpheart.00668.2003; Lagoda G, 2013, J UROLOGY, V189, P762, DOI 10.1016/j.juro.2012.08.198; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Macarthur H, 2011, ACTA PHYSIOL, V203, P37, DOI 10.1111/j.1748-1716.2010.02242.x; Morrison JFB, 2007, MOL CELL BIOCHEM, V295, P53, DOI 10.1007/s11010-006-9271-y; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Muniz JJ, 2015, LIFE SCI, V141, P44, DOI 10.1016/j.lfs.2015.09.017; Nakashima A, 2009, J NEURAL TRANSM, V116, P1355, DOI 10.1007/s00702-009-0227-8; Nangle MR, 2004, PFLUG ARCH EUR J PHY, V448, P139, DOI 10.1007/s00424-003-1232-7; Ning C, 2014, FASEB J, V28, P2725, DOI 10.1096/fj.13-247833; Nur E, 2011, AM J HEMATOL, V86, P484, DOI 10.1002/ajh.22012; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Salonia A, 2014, EUR UROL, V65, P480, DOI 10.1016/j.eururo.2013.11.008; SCHWARZ P, 1995, CIRC RES, V77, P841, DOI 10.1161/01.RES.77.4.841; Silva FH, 2014, AM J PHYSIOL-HEART C, V307, pH1393, DOI 10.1152/ajpheart.00708.2013; Silva FH, 2014, J SEX MED, V11, P2661, DOI 10.1111/jsm.12682; TAMURA M, 1995, J UROLOGY, V153, P530, DOI 10.1097/00005392-199502000-00077; Toque HA, 2011, BJU INT, V107, P1628, DOI 10.1111/j.1464-410X.2010.09704.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166291	10.1371/journal.pone.0166291	http://dx.doi.org/10.1371/journal.pone.0166291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935981	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100023
J	Stockman, VB; Ghamsari, L; Lasso, G; Honig, B; Shapira, SD; Wang, HH				Stockman, Victoria B.; Ghamsari, Lila; Lasso, Gorka; Honig, Barry; Shapira, Sagi D.; Wang, Harris H.			A High-Throughput Strategy for Dissecting Mammalian Genetic Interactions	PLOS ONE			English	Article							HUMAN-CELLS; RNA; CRISPR-CAS9; CAS9; NETWORKS; COMPLEX; VECTOR; SYSTEM; YEAST	Comprehensive delineation of complex cellular networks requires high -throughput interrogation of genetic interactions. To address this challenge, we describe the development of a multiplex combinatorial strategy to assess pairwise genetic interactions using CRISPR-Cas9 genome editing and next-generation sequencing. We characterize the performance of combinatorial genome editing and analysis using different promoter and gRNA designs and identified regions of the chimeric RNA that are compatible with next-generation sequencing preparation and quantification. This approach is an important step towards elucidating genetic networks relevant to human diseases and the development of more efficient Cas9based therapeutics.	[Stockman, Victoria B.; Ghamsari, Lila; Lasso, Gorka; Honig, Barry; Shapira, Sagi D.; Wang, Harris H.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA; [Ghamsari, Lila; Shapira, Sagi D.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10027 USA; [Lasso, Gorka; Honig, Barry] Columbia Univ, Dept Biochem, Med Ctr, New York, NY USA; [Wang, Harris H.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Shapira, SD; Wang, HH (corresponding author), Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10027 USA.; Shapira, SD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY 10027 USA.; Wang, HH (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.	ss4197@columbia.edu; hw2429@columbia.edu	Lasso, Gorka/GYV-3393-2022; Cabrera, Gorka Lasso/ABD-1962-2020	Cabrera, Gorka Lasso/0000-0001-5355-323X; Honig, Barry/0000-0002-1835-1031; Wang, Harris/0000-0003-2164-4318	NIH [1DP5OD009172-02, 1U01GM110714-01A1]; NSF [MCB-1453219]; Sloan Foundation [FR-2015-65795]; DARPA [W911NF-15-2-0065]; ONR [N00014-15-1-2704]; NIH R01 [GM109018-04]; NIH U54 [CA21852-07]; NATIONAL CANCER INSTITUTE [U54CA121852, U54CA209997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110714, R01GM109018, R01GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021764, DP5OD009172, S10OD012351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ONR(Office of Naval Research); NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH U54(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHW acknowledges funding from NIH (1DP5OD009172-02, 1U01GM110714-01A1), NSF (MCB-1453219), Sloan Foundation (FR-2015-65795), DARPA (W911NF-15-2-0065), and ONR (N00014-15-1-2704). SDS acknowledges funding from NIH R01 (GM109018-04) and NIH U54 (CA21852-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.H.W. acknowledges funding from NIH (1DP5OD009172-02, 1U01GM110714-01A1), NSF (MCB-1453219), Sloan Foundation (FR-2015-65795), DARPA (W911NF-15-2-0065), and ONR (N00014-15-1-2704). S.S. acknowledges funding from NIH R01 (GM109018-04) and NIH U54 (CA121852-07). We thank Beatrice Leitao, Nathan Johns and Jacky Cheung for technical assistance and members of the Shapira and Wang labs for helpful discussions. We additionally thank Michael Metzger and Stephen Goff for providing reagents including an eGFP cell line.	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	24	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167617	10.1371/journal.pone.0167617	http://dx.doi.org/10.1371/journal.pone.0167617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936040	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100131
J	Xiang, Y; Wang, XZ; He, LH; Wang, WY; Moran, W				Xiang, Yu; Wang, Xuezhi; He, Lihua; Wang, Wenyong; Moran, William			Spatial-Temporal Analysis of Environmental Data of North Beijing District Using Hilbert-HuangTransform	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; VARIABILITY; TEMPERATURE	Temperature, solar radiation and water are major important variables in ecosystem models which are measurable via wireless sensor networks (WSN). Effective data analysis is necessary to extract significant spatial and temporal information. In this work, information regarding the long term variation of seasonal field environment conditions is explored using Hilbert-Huang transform (HHT) based analysis on the wireless sensor network data collection. The data collection network, consisting of 36 wireless nodes, covers an area of 100 square kilometres in Yanqing, the northwest of Beijing CBD, in China and data collection involves environmental parameter observations taken over a period of three months in 2011. The analysis used the empirical mode decomposition (EMD/EEMD) to break a time sequence of data down to a finite set of intrinsic mode functions (IMFs). Both spatial and temporal properties of data explored by HHT analysis are demonstrated. Our research shows potential for better understanding the spatial-temporal relationships among environmental parameters using WSN and HHT.	[Xiang, Yu; He, Lihua; Wang, Wenyong] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China; [Wang, Xuezhi; Moran, William] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [He, Lihua] Guilin Univ Aerosp Technol, Sch Comp Sci & Engn, Guilin, Guangxi, Peoples R China	University of Electronic Science & Technology of China; Royal Melbourne Institute of Technology (RMIT); Guilin University of Aerospace Technology	Xiang, Y (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Sichuan, Peoples R China.	jcxiang@uestc.edu.cn	Xiang, Yu/P-5005-2016	Xiang, Yu/0000-0001-9622-7661				[Anonymous], 2004, P 2 INT C EMB NETW S, DOI DOI 10.1145/1031495.1031560; Barnhart BL, 2011, J ATMOS SOL-TERR PHY, V73, P1771, DOI 10.1016/j.jastp.2011.04.012; Biswas A, 2013, GEODERMA, V209, P57, DOI 10.1016/j.geoderma.2013.06.003; Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Feng HH, 2015, REMOTE SENS-BASEL, V7, P5398, DOI 10.3390/rs70505398; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Hu B, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007965; Hu W, 2014, CATENA, V113, P377, DOI 10.1016/j.catena.2013.08.024; Huang NE, 2005, INTERD MATH SCI, V5, P1; Huang NE, 2009, ADV DATA SCI ADAPT, V1, P177, DOI 10.1142/S1793536909000096; Jiang DD, 2016, IEEE ACCESS, V4, P3046, DOI 10.1109/ACCESS.2016.2573264; Langendoen K., 2006, P 20 IEEE INT PAR DI, P155; Li SN, 2016, IEEE ACCESS, V4, P4484, DOI 10.1109/ACCESS.2016.2600623; Lin Y., 2006, IEEE PERVAS COMPUT, V4, P65; Mandic DP, 2013, IEEE SIGNAL PROC MAG, V30, P74, DOI 10.1109/MSP.2013.2267931; Massei N, 2012, J HYDROL, V448, P119, DOI 10.1016/j.jhydrol.2012.04.052; Miralles DG, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053703; Morais R., 2005, P 5 EUR FED INF TECH, P845; Othman MF, 2012, PROCEDIA ENGINEER, V41, P1204, DOI 10.1016/j.proeng.2012.07.302; Ouyang ZT, 2014, ECOL COMPLEX, V19, P46, DOI 10.1016/j.ecocom.2014.04.005; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Urbanski S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000293; van Dijk Albert IJM, 2005, GLOBAL BIOGEOCHEMICA, V19; Wang ZH, 2015, IEEE COMMUN MAG, V53, P216, DOI 10.1109/MCOM.2015.7105668; Western AW, 1998, J HYDROL, V205, P20, DOI 10.1016/S0022-1694(97)00142-X; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Wu ZH, 2010, ADV DATA SCI ADAPT, V2, P397, DOI 10.1142/S1793536910000604; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Yang T, 2015, APPL RES CO IN PRESS; Yao XM, 2009, 2009 WRI INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND MOBILE COMPUTING: CMC 2009, VOL 2, P9, DOI 10.1109/CMC.2009.111; Zhou QP, 2014, SCI TOTAL ENVIRON, V496, P264, DOI 10.1016/j.scitotenv.2014.07.051; Zhu XD, 2010, J GEOGR SCI, V20, P803, DOI 10.1007/s11442-010-0812-7	33	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167662	10.1371/journal.pone.0167662	http://dx.doi.org/10.1371/journal.pone.0167662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936056	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100143
J	Yang, XL; Zhao, L; Li, SQ; Ma, SC; Yang, AN; Ning, D; Li, N; Jia, YX; Yang, XM; Li, GZ; Jiang, YD				Yang Xiaoling; Zhao Li; Li ShuQiang; Ma Shengchao; Yang Anning; Ding Ning; Li Nan; Jia Yuexia; Yang Xiaoming; Li Guizhong; Jiang Yideng			Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation	PLOS ONE			English	Article							ARGININE METHYLATION; DNA METHYLATION; HISTONE; PROTEIN; LYSINE; HYPOMETHYLATION; ATHEROSCLEROSIS; TRIMETHYLATION; HOMOCYSTEINE; EPIGENETICS	Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases, such as atherosclerosis. HHcy promotes atherogenesis by modifying the histone methylation patterns and miRNA regulation. In this study, we investigated the effects of homocysteine (Hcy) on the expression of enhancer of zeste homolog 2 (EZH2), and tested our hypothesis that Hcy-induced atherosclerosis is mediated by increased EZH2 expression, which is regulated by miR-92a. The levels of EZH2 and H3K27me3 were increased in the aorta of ApoE-/- mice fed a high-methionine diet for 16 weeks, whereas miR-92a expression was decreased. Over-expression of EZH2 increased H3K27me3 level and the accumulation of total cholesterol and triglycerides in the foam cells. Furthermore, upregulation of miR-92a reduced EZH2 expression in the foam cells. These data suggested that EZH2 plays a key role in Hcy-mediated lipid metabolism disorders, and that miR-92a may be a novel therapeutic target in Hcy-related atherosclerosis.	[Yang Xiaoling; Zhao Li; Li ShuQiang; Ma Shengchao; Yang Anning; Ding Ning; Li Nan; Jia Yuexia; Yang Xiaoming; Li Guizhong; Jiang Yideng] Ningxia Med Univ, Basic Med Sch, Key Lab Cardiocerebro Vasc Dis, Ningxia, Peoples R China; [Yang Xiaoling] Inst Med Sci Ningxia, Ningxia, Peoples R China	Ningxia Medical University	Jiang, YD (corresponding author), Ningxia Med Univ, Basic Med Sch, Key Lab Cardiocerebro Vasc Dis, Ningxia, Peoples R China.	yangxl@nxmu.edu.cn	Jiang, Yideng/Q-1329-2019		National Natural Science Foundation of China [81360027, 81360052, 81360053, 81460080]; Provincial Natural Science Foundation of Ningxia [NZ15209]; Education Department Foundation of Ningxia [NGY2015092, NGY2015084]; Ningxia Medical University Foundation [XY201505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Ningxia; Education Department Foundation of Ningxia; Ningxia Medical University Foundation	This work was supported in part by grants from the National Natural Science Foundation of China (81360027, 81360052, 81360053, 81460080), the Provincial Natural Science Foundation of Ningxia (NZ15209), the Education Department Foundation of Ningxia (NGY2015092, NGY2015084) and the Ningxia Medical University Foundation (XY201505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araldi E, 2015, CURR VASC PHARMACOL, V13, P291, DOI 10.2174/15701611113119990012; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Byrne K, 2014, ANIM GENET, V45, P427, DOI 10.1111/age.12145; Cao Y, 2014, EUR REV MED PHARMACO, V18, P3097; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Esse R, 2014, FASEB J, V28, P2686, DOI 10.1096/fj.13-246579; Esse R, 2013, BBA-MOL BASIS DIS, V1832, P1708, DOI 10.1016/j.bbadis.2013.05.013; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gurok U, 2007, EUR J NEUROSCI, V26, P1079, DOI 10.1111/j.1460-9568.2007.05734.x; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Inoue S, 2015, NUTRITION, V31, P366, DOI 10.1016/j.nut.2014.07.017; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Kalani A, 2013, MOL NEUROBIOL, V48, P157, DOI 10.1007/s12035-013-8421-y; Liang Y, 2014, SOC INDIC RES, V116, P307, DOI 10.1007/s11205-013-0280-4; Lillico R, 2016, J PROTEOMICS, V133, P125, DOI 10.1016/j.jprot.2015.12.018; Liu FH, 2015, INT J CLIN EXP PATHO, V8, P4972; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Luan Y, 2015, ORGANIC BIOMOLECULAR, V14, P631; Mishra PK, 2009, CELL BIOCHEM BIOPHYS, V55, P153, DOI 10.1007/s12013-009-9063-6; Pommier AJC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003483; Reynolds LM, 2015, CIRC-CARDIOVASC GENE, V8, P707, DOI 10.1161/CIRCGENETICS.115.001097; Tikoo K, 2015, BIOCHEM PHARMACOL, V93, P343, DOI 10.1016/j.bcp.2014.11.013; Watanabe K, 2015, CANCER MED-US, V4, P1573, DOI 10.1002/cam4.505; Wierda RJ, 2015, LIFE SCI, V129, P3, DOI 10.1016/j.lfs.2014.10.010; Yang XW, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/697170; Zhao Li, 2015, Shengli Xuebao, V67, P207; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457	28	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167744	10.1371/journal.pone.0167744	http://dx.doi.org/10.1371/journal.pone.0167744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936205	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100172
J	Dumartin, L; Alrawashdeh, W; Trabulo, SM; Radon, TP; Steiger, K; Feakins, RM; di Magliano, MP; Heeschen, C; Esposito, I; Lemoine, NR; Crnogorac-Jurcevic, T				Dumartin, L.; Alrawashdeh, W.; Trabulo, S. M.; Radon, T. P.; Steiger, K.; Feakins, R. M.; di Magliano, M. P.; Heeschen, C.; Esposito, I.; Lemoine, N. R.; Crnogorac-Jurcevic, T.			ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ANTERIOR GRADIENT 2; ONCOGENIC KRAS; CELLS; PROMOTES; INFLAMMATION; EXPRESSION; INDUCTION; OBESITY	The mechanisms of initiation of pancreatic ductal adenocarcinoma (PDAC) are still largely unknown. In the present study, we analysed the role of anterior gradient-2 (AGR2) in the earliest stages of pancreatic neoplasia. Immunohistochemical analysis of chronic pancreatitis (CP) and peritumoral areas in PDAC tissues showed that AGR2 was present in tubular complexes (TC) and early pancreatic intraepithelial neoplasia (PanINs). Moreover, AGR2 was also found in discrete subpopulations of non-transformed cells neighbouring these pre-neoplastic lesions. In primary cells derived from human patient-derived xenograft (PDX) model, flowcytometry revealed that AGR2 was overexpressed in pancreatic cancer stem cells (CSC) compared with non-stem cancer cells. In LSL-Kras(G12D); Pdx1-Cre (KC) mouse model Agr2 induction preceded the formation of pre-neoplastic lesions and their development was largely inhibited by Agr2 deletion in engineered LSL-Kras(G12D); Pdx1-Cre; Agr2(-/-)mice. In vitro, AGR2 expression was stimulated by tunicamycin-induced endoplasmic reticulum (ER) stress in both KRAS wild-type normal pancreas cells, as well as in KRAS mutated pancreatic cancer cells and was essential for ER homoeostasis. The unfolded protein response proteins GRP78, ATF6 and XBP1s were found expressed in CP and PDAC peritumoral tissues, but in contrast to AGR2, their expression was switched off during TC and PanIN formation. Real-time PCR and ELISA analyses showed that ER stress induced a pro-inflammatory phenotype in pancreatic normal, cancer and stellate cells. Moreover, AGR2 expression was inducible by paracrine transfer of ER stress and pro-inflammation between different pancreatic cell types. Our findings demonstrate that AGR2 induced in ER-stressed and inflammatory preneoplastic pancreas is a potential marker of cancer progenitor cells with an important functional role in PDAC initiation.	[Dumartin, L.; Alrawashdeh, W.; Radon, T. P.; Lemoine, N. R.; Crnogorac-Jurcevic, T.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Trabulo, S. M.; Heeschen, C.] Queen Mary Univ London, Barts Canc Inst, Ctr Stem Cells Canc & Ageing, London, England; [Steiger, K.] Tech Univ Munich, Inst Pathol, Munich, Germany; [Feakins, R. M.] Royal London Hosp, Dept Histopathol, London, England; [di Magliano, M. P.] Univ Michigan, Dept Surg Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Esposito, I.] Heinrich Heine Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany	University of London; Queen Mary University London; University of London; Queen Mary University London; Technical University of Munich; Barts Health NHS Trust; Royal London Hospital; University of Michigan System; University of Michigan; Heinrich Heine University Dusseldorf	Crnogorac-Jurcevic, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England.; Crnogorac-Jurcevic, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, John Vane Sci Ctr, Charterhouse Sq, London EC1M 6BQ, England.	t.c.jurcevic@qmul.ac.uk	Feakins, Roger/J-6782-2019; Guba, Markus/M-4309-2019; Feakins, Roger/AAO-5570-2020	Lemoine, Nick/0000-0001-8675-058X; Pasca di Magliano, Marina/0000-0001-9632-9035	CR-UK [A12008]; Cancer Research UK [12008] Funding Source: researchfish	CR-UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We would like to thank Profs David Tuveson and David Erle for providing us with KC and germline Agr2<SUP>-/-</SUP> transgenic mice, respectively and Prof Hemant Kocher for PS1 pancreatic stellate cells. We would also like to thank Julie Andow, Hagen Schmid and George Elia for their expert technical assistance. Grant Support: The work was supported by a grant A12008 from CR-UK (L. Dumartin, N.R. Lemoine and T. Crnogorac-Jurcevic).	Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kong B, 2018, GUT, V67, P146, DOI 10.1136/gutjnl-2015-310913; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Ma SR, 2015, ONCOTARGET, V6, P8807, DOI 10.18632/oncotarget.3556; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Morris JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095486; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Norris AM, 2013, ONCOGENE, V32, P3867, DOI 10.1038/onc.2012.394; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Pandol SJ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00008; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Ryu J, 2013, BIOCHEM BIOPH RES CO, V430, P610, DOI 10.1016/j.bbrc.2012.11.105; Sah RP, 2014, J BIOL CHEM, V289, P27551, DOI 10.1074/jbc.M113.528174; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545	46	51	55	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3094	3103		10.1038/onc.2016.459	http://dx.doi.org/10.1038/onc.2016.459			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	27941872	Green Published, hybrid			2022-12-26	WOS:000402617900003
J	Sarkar, M; Khare, V; Ghosh, MK				Sarkar, M.; Khare, V.; Ghosh, M. K.			The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis	ONCOGENE			English	Article							COLORECTAL-CANCER; BETA-CATENIN; RNA HELICASE; EXPRESSION; ACTIVATION; APOPTOSIS; TARGET; CELLS; TRANSFORMATION; PATHWAY	DEAD box RNA helicase p68 acts as a transcriptional coactivator of several oncogenic transcription factors apart from being a vital player of RNA metabolism. Signal transducer and activator of transcription 3 (Stat3) is a major oncogenic contributor of diverse cancers, including that of colon. Deciphering the mechanistic insights of coactivation of Stat3 transcriptional activity may aid in improved therapeutic strategies. Here we report for the first time a novel mechanism of alliance between p68 and Stat3 in stimulating transcriptional activity of Stat3. Interestingly, we observed that the expression of p68 and Stat3 bears strong positive correlation and significant colocalization in normal and colon carcinoma patient samples. We demonstrated that p68 directly interacts with Stat3 in HEK293 cells as well as multiple colon cancer cell lines. Additionally, p68 positively modulated both mRNA and protein expression levels of Stat3 target genes; promoter activity of Stat3 target gene Mcl-1 in multiple colon cancer cell lines. Also, p68 occupied the promoters of multiple Stat3 target genes in enhancing Stat3-dependent transcription. Moreover, the strong positive correlation between the abundance of p68 and Stat3 target genes in the same set of colon carcinoma samples further supported our observations. Enhanced expression levels of Stat3 target genes observed in primary tumors and metastatic lung nodules, generated in mice colorectal allograft model using syngeneic cells stably expressing p68, further reinforced our in vitro findings. Hence, this study unravels novel modes of p68-mediated oncogenesis through coactivation of Stat3 and enhancing Stat3 signaling.	[Sarkar, M.; Khare, V.; Ghosh, M. K.] IICB, CSIR, Canc Biol & Inflammatory Disorder Div, Signal Transduct Canc & Stem Cells Lab, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ghosh, MK (corresponding author), IICB, CSIR, Canc Biol & Inflammatory Disorder, Signal Transduct Canc & Stem Cells Lab, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com		Sarkar, Dr Moumita/0000-0002-7437-5353	CSIR, India [EMPOWER-OLP-002, MEDCHEM-BSC0108]; DST Nano Mission programme [SR/NM/NS-1058/2015]; CSIR-MAYO Clinic programme [MLP-0017]	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); DST Nano Mission programme; CSIR-MAYO Clinic programme	We thank Dr Frances V Fuller-Pace and Dr Kenneth M Yamada for gifting the pGS5-p68 construct and pGZ21dx vector, respectively. We also thank Dr Uttara Chatterjee (Park Clinic, India) for providing human normal colon and colon carcinoma samples, related pathological reports and helping in the data analysis. This work is supported by grants from CSIR, India (EMPOWER-OLP-002, MEDCHEM-BSC0108 and CSIR-MAYO Clinic programme: MLP-0017) and DST Nano Mission programme (SR/NM/NS-1058/2015) to Dr Mrinal K Ghosh.	Ahmed SF, 2015, MOL THER, V23, P255, DOI 10.1038/mt.2014.202; Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Bhattacharya S, 2015, CELL ONCOL, V38, P265, DOI 10.1007/s13402-015-0228-6; Bhattacharya S, 2014, FEBS J, V281, P3061, DOI 10.1111/febs.12843; Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.63; Dai TY, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0064-y; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Gordziel C, 2013, BRIT J CANCER, V109, P138, DOI 10.1038/bjc.2013.274; Guturi KKN, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0496-5; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Iwamoto M, 2000, CARCINOGENESIS, V21, P1935, DOI 10.1093/carcin/21.11.1935; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Langers AMJ, 2012, BRIT J CANCER, V106, P1495, DOI 10.1038/bjc.2012.80; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lee WS, 2015, AM J CANCER RES, V5, P101; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Said AH, 2014, CANCERS, V6, P366, DOI 10.3390/cancers6010366; Sarkar M, 2015, ONCOGENE, V34, P5843, DOI 10.1038/onc.2015.42; Sarkar M, 2016, FRONT BIOSCI-LANDMRK, V21, P225, DOI 10.2741/4386; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang YL, 2008, WORLD J GASTROENTERO, V14, P3069, DOI 10.3748/wjg.14.3069	43	17	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 1	2017	36	22					3080	3093		10.1038/onc.2016.449	http://dx.doi.org/10.1038/onc.2016.449			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EW6KA	27941883				2022-12-26	WOS:000402617900002
J	Kim, JW; Park, SY; You, YH; Ham, DS; Lee, SH; Yang, HK; Jeong, IK; Ko, SH; Yoon, KH				Kim, Ji-Won; Park, Shin-Young; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Jeong, In-Kyung; Ko, Seung-Hyun; Yoon, Kun-Ho			Suppression of ROS Production by Exendin-4 in PSC Attenuates the High Glucose-Induced Islet Fibrosis	PLOS ONE			English	Article							PANCREATIC STELLATE CELLS; ACTIVATION; IDENTIFICATION; HYPERGLYCEMIA; DYSFUNCTION; TGF-BETA-1; TOLERANCE; GROWTH; RATS; MASS	Pancreatic stellate cells (PSCs) play a major role to fibrotic islet destruction observed in diabetic patients and animal model of diabetes. Exendin-4 (Ex-4) is a potent insulinotropic agent and has been approved for the treatment of type 2 diabetes. However, there have been no reports demonstrating the effects of Ex-4 on pancreatic islet fibrosis. In this study, Ex-4 treatment clearly attenuated fibrotic islet destruction and improved glucose tolerance and islet survival. GLP-1 receptor expression was upregulated during activation and proliferation of PSCs by hyperglycemia. The activation of PKA pathway by Ex-4 plays a role in ROS production and angiotensin II (Ang II) production. Exposure to high glucose stimulated ERK activation and Ang II-TGF-beta 1 production in PSCs. Interestingly, Ex-4 significantly reduced Ang II and TGF-beta 1 production by inhibition of ROS production but not ERK phosphorylation. Ex-4 may be useful not only as an anti-diabetic agent but also as an anti-fibrotic agent in type 2 diabetes due to its ability to inhibit PSC activation and proliferation and improve islet fibrosis in OLETF rats.	[Kim, Ji-Won; Park, Shin-Young; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Ko, Seung-Hyun; Yoon, Kun-Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Ji-Won; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Yoon, Kun-Ho] Catholic Univ Korea, Catholic Res Inst Med Sci, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Jeong, In-Kyung] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Kyung Hee University	Yoon, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.; Yoon, KH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yoonk@catholic.ac.kr	Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019; Jeong, In-Kyung/AAI-6488-2020	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; Jeong, In-Kyung/0000-0001-7857-546X; Kim, Ji-Won/0000-0002-3806-4873	Korea Healthcare Technology R&D Project of the Ministry of Health, Welfare Family Affairs [HI14C3417]; Investigator Initiated Study Program of Merck; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013729]	Korea Healthcare Technology R&D Project of the Ministry of Health, Welfare Family Affairs; Investigator Initiated Study Program of Merck; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant from the Korea Healthcare Technology R&D Project (HI14C3417) of the Ministry of Health, Welfare & Family Affairs and the Investigator Initiated Study Program of Merck. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013729).	Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Hama K, 2004, BIOCHEM BIOPH RES CO, V315, P905, DOI 10.1016/j.bbrc.2004.01.155; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kim JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6022, DOI 10.2741/3133; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Kruse ML, 2000, REGUL PEPTIDES, V90, P47, DOI 10.1016/S0167-0115(00)00104-X; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Li WB, 2012, CELL PHYSIOL BIOCHEM, V30, P749, DOI 10.1159/000341454; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Ryu GR, 2013, BIOCHEM BIOPH RES CO, V439, P258, DOI 10.1016/j.bbrc.2013.08.046; Strauss A, 2008, TRANSPL P, V40, P533, DOI 10.1016/j.transproceed.2008.02.004; Weibel ER., 1978, PRACTICAL METHODS BI; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0163187	10.1371/journal.pone.0163187	http://dx.doi.org/10.1371/journal.pone.0163187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977690	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400001
J	Fairoozy, RH; White, J; Palmen, J; Kalea, AZ; Humphries, SE				Fairoozy, Roaa Hani; White, Jon; Palmen, Jutta; Kalea, Anastasia Z.; Humphries, Steve E.			Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RNA-POLYMERASE-II; DNA-BINDING; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSCRIPTIONAL ACTIVATION; COMMON POLYMORPHISM; SPLICING EFFICIENCY; PROMOTER; GENE; CHOLESTEROL	Background The Low-Density Lipoprotein Receptor (LDLR) SNP rs6511720 (G>T), located in intron-1 of the gene, has been identified in genome-wide association studies (GWAS) as being associated with lower plasma levels of LDL-C and a lower risk of coronary heart disease (CHD). Whether or not rs6511720 is itself functional or a marker for a functional variant elsewhere in the gene is not known. Methods The association of LDLR SNP rs6511720 with incidence of CHD and levels of LDL-C was determined by reference to CARDIoGRAM, C4D and Global lipids genetics consortium (GLGC) data. SNP annotation databases were used to identify possible SNP function and prioritization. Luciferase reporter assays in the liver cell line Huh7 were used to measure the effect of variant genotype on gene expression. Electrophoretic Mobility Shift Assays (EMSAs) were used to identify the Transcription Factors (TFs) involved in gene expression regulation. Results The phenotype-genotype analysis showed that the rs6511720 minor allele is associated with lower level of LDL-C [beta = -0.2209, p = 3.85 x10(-262)], and lower risk of CHD [log (OR) = 0.1155, p = 1.04 x 10(-7)]. Rs6511720 is in complete linkage. Rs6511720 is in complete linkage disequilibrium (LD) with three intron-1 SNPs (rs141787760, rs60173709, rs57217136). Luciferase reporter assays in Huh7 cells showed that the rare alleles of both rs6511720 and rs57217136 caused a significant increase in LDLR expression compared to the common alleles (+29% and +24%, respectively). Multiplex Competitor-EMSAs (MC-EMSA) identified that the transcription factor serum response element (SRE) binds to rs6511720, while retinoic acid receptor (RAR) and signal transducer and activator of transcription 1 (STAT1) bind to rs57217136. Conclusion Both LDLR rs6511720 and rs57217136 are functional variants. Both these minor alleles create enhancer-binding protein sites for TFs and may contribute to increased LDLR expression, which is consequently associated with reduced LDL-C levels and 12% lower CHD risk.	[Fairoozy, Roaa Hani; Palmen, Jutta; Kalea, Anastasia Z.; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London, England; [White, Jon] UCL, Genet Inst, Dept Genet Environm & Evolut, London, England	University of London; University College London; University of London; University College London	Fairoozy, RH (corresponding author), UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London, England.	roaa.fairoozy.12@ucl.ac.uk	Kalea, Anastasia Z./G-4053-2010	Kalea, Anastasia Z./0000-0001-5775-3984; Humphries, Stephen E/0000-0002-8221-6547	King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme [BRC105CMSH/5982]; BHF [BHFPG08/008]; National Institute for Health Research UCL Hospitals Biomedical Research Centre; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme; BHF(British Heart Foundation); National Institute for Health Research UCL Hospitals Biomedical Research Centre; British Heart Foundation(British Heart Foundation)	RHF is funded by King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia. AZK is funded by a National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme (BRC105CMSH/5982). SEH is a British Heart Foundation (BHF) Professor and he and JP are funded by BHF grant (grant numbers BHFPG08/008) and by the National Institute for Health Research UCL Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2002, HUM GENET, V111, P501, DOI 10.1007/s00439-002-0813-4; Anand SS, 2009, CIRC-CARDIOVASC GENE, V2, P16, DOI 10.1161/CIRCGENETICS.108.813709; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Boright AP, 1998, J HUM GENET, V43, P153, DOI 10.1007/s100380050060; Bradley DT, 2013, CIRC-CARDIOVASC GENE, V6, P498, DOI 10.1161/CIRCGENETICS.113.000165; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Castro-Oros I, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-17; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gao F, 2013, HUM MOL GENET, V22, P1424, DOI 10.1093/hmg/dds559; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khamis A, 2015, EUR J HUM GENET, V23, P790, DOI 10.1038/ejhg.2014.199; Lee JD, 2014, DNA CELL BIOL, V33, P869, DOI 10.1089/dna.2014.2577; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; Mozas P, 2002, J LIPID RES, V43, P13; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pak YK, 1996, BIOCHEM MOL BIOL INT, V38, P31; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Planas AM, 1997, J NEUROCHEM, V68, P1345; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Qin JZ, 2001, J INVEST DERMATOL, V117, P583, DOI 10.1046/j.0022-202x.2001.01436.x; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Ward LD, 2015, NUCL ACIDS RES; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	59	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167676	10.1371/journal.pone.0167676	http://dx.doi.org/10.1371/journal.pone.0167676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973560	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300038
J	Blanc, P; Dutronc, H; Peuchant, O; Dauchy, FA; Cazanave, C; Neau, D; Wirth, G; Pellegrin, JL; Morlat, P; Mercie, P; Tunon-de-Lara, JM; Doutre, MS; Pelissier, P; Dupon, M				Blanc, Peggy; Dutronc, Herve; Peuchant, Olivia; Dauchy, Frederic-Antoine; Cazanave, Charles; Neau, Didier; Wirth, Gaetane; Pellegrin, Jean-Luc; Morlat, Philippe; Mercie, Patrick; Tunon-de-Lara, Jose-Manuel; Doutre, Marie-Sylvie; Pelissier, Philippe; Dupon, Michel			Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study	PLOS ONE			English	Article							HIV-NEGATIVE PATIENTS; COMPLEX LUNG-DISEASE; PULMONARY-DISEASE; AVIUM COMPLEX; CLINICAL-MANIFESTATIONS; PROGNOSTIC-FACTORS; RISK-FACTORS; MORTALITY; XENOPI	Background Nontuberculous mycobacteria (NTM) are environmental organisms associated with a range of infections. Reports of NTM epidemiology are mainly focused on pulmonary infections and isolations, and extrapulmonary infections are less frequently described. Methods We conducted a retrospective study of NTM infections at the Bordeaux University Hospital, France, between January 2002 and December 2013. We used the microbiologic component of the American Thoracic Society/Infectious Diseases Society of America's pulmonary NTM disease criteria to define cases of pulmonary NTM, and patients with isolates from a normally sterile site were classified as having extrapulmonary disease. Results In our setting, 170 patients were included. Pulmonary cases predominated (54.1%), followed by skin and soft tissue infections (22.9%), disseminated cases (10.6%), lymphadenitis (7.7%), bone and joint infections (2.9%) and the remaining 1.8% catheter-related infections. Overall, 16 NTM species were isolated. Mycobacterium avium (31.8%) and M. intracellulare (20%) were the most common species identified, followed by M. marinum (13.5%), M. kansasii (10.6%), M. xenopi (9.4%), rapidly growing mycobacteria (9.4%) and other slowly growing mycobacteria (5.3%). In general, NTM isolates were largely prevalent in people older than 50 (62.4%); patients aged 1-10 year-old exclusively yielded M. avium from lymph nodes, almost cases having being diagnosed after 2007. Among the 121 patients with complete follow-up, 78 (64.5%), 24 (19.8%), and 19 (15.7%) were cured, experienced relapse, or died, respectively. Conclusion In our study, extrapulmonary NTM infections represented almost half of cases, consisting mainly in skin and soft tissue infections. The increase lymphadenitis cases in children after 2007 could be linked to the cessation of mandatory BCG vaccination in France. We observed similar cure rates (64%) between pulmonary and extrapulmonary infections.	[Blanc, Peggy; Dutronc, Herve; Dauchy, Frederic-Antoine; Cazanave, Charles; Neau, Didier; Dupon, Michel] Ctr Hosp Univ Bordeaux, Serv Malad Infect & Trop, Bordeaux, France; [Peuchant, Olivia] Ctr Hosp Univ Bordeaux, Lab Bacteriol, Bordeaux, France; [Peuchant, Olivia] Univ Bordeaux, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Peuchant, Olivia] INRA, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Pellegrin, Jean-Luc; Morlat, Philippe; Mercie, Patrick] Ctr Hosp Univ Bordeaux, Med Interna Serv, Bordeaux, France; [Tunon-de-Lara, Jose-Manuel] Ctr Hosp Univ Bordeaux, Serv Pneumol, Bordeaux, France; [Doutre, Marie-Sylvie] Ctr Hosp Univ Bordeaux, Serv Dermatol, Bordeaux, France; [Pelissier, Philippe] Ctr Hosp Univ Bordeaux, Serv Chirurgie Plast Reconstruct & Esthet Brules, Bordeaux, France	CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Peuchant, O (corresponding author), Ctr Hosp Univ Bordeaux, Lab Bacteriol, Bordeaux, France.; Peuchant, O (corresponding author), Univ Bordeaux, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France.; Peuchant, O (corresponding author), INRA, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France.	olivia.peuchant@u-bordeaux.fr	Dauchy, Frédéric-Antoine/T-4652-2019; Cazanave, Charles/AHE-5492-2022					Andrejak C, 2009, THORAX, V64, P291, DOI 10.1136/thx.2008.096842; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Atkins BL, 2014, CURR OPIN INFECT DIS, V27, P137, DOI 10.1097/QCO.0000000000000041; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; Carrillo MC, 2014, CAN ASSOC RADIOL J, V65, P207, DOI 10.1016/j.carj.2013.05.006; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Clinical and Laboratory Standards Institute, 2011, SUSC TEST MYC OTH AE; Dailloux M, 2006, EUR RESPIR J, V28, P1211, DOI 10.1183/09031936.00063806; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Fleshner M, 2016, INT J TUBERC LUNG D, V20, P582, DOI 10.5588/ijtld.15.0807; Gommans EPAT, 2015, RESP MED, V109, P137, DOI 10.1016/j.rmed.2014.10.013; Gonzalez-Santiago TM, 2015, DERMATOL CLIN, V33, P563, DOI 10.1016/j.det.2015.03.017; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Guglielmetti L, 2015, FUTURE MICROBIOL, V10, P1467, DOI 10.2217/fmb.15.64; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Ide S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128304; Jenkins PA, 2003, RESP MED, V97, P439, DOI 10.1053/rmed.2002.1444; Jimenez-Montero B, 2014, PEDIATR INFECT DIS J, V33, P28, DOI 10.1097/INF.0000000000000007; Kang HK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0823-1; Kotilainen H, 2015, EUR J CLIN MICROBIOL, V34, P1909, DOI 10.1007/s10096-015-2432-8; Lee BY, 2015, ANTIMICROB AGENTS CH, V59, P2972, DOI 10.1128/AAC.04577-14; Maugein J, 2005, EUR RESPIR J, V26, P1092, DOI 10.1183/09031936.05.00148604; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Rindi L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1380-y; Shah NM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1521-3; Smith GS, 2016, J INFECTION, V72, P678, DOI 10.1016/j.jinf.2016.03.008; Stout JE, 2016, INT J INFECT DIS, V45, P123, DOI 10.1016/j.ijid.2016.03.006; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; Tortoli E, 2012, INT J MYCOBACT, V1, P165, DOI 10.1016/j.ijmyco.2012.10.008; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Wallace RJ, 2014, J ANTIMICROB CHEMOTH, V69, P1945, DOI 10.1093/jac/dku062; Wassilew N, 2016, RESPIRATION, V91, P386, DOI 10.1159/000445906	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168290	10.1371/journal.pone.0168290	http://dx.doi.org/10.1371/journal.pone.0168290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959960	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900057
J	Carmeis, ACA; Crusciol, CAC; Guimaraes, TM; Calonego, JC; Mooney, SJ				Carmeis Filho, Antonio C. A.; Crusciol, Carlos A. C.; Guimaraes, Tiara M.; Calonego, Juliano C.; Mooney, Sacha J.			Impact of Amendments on the Physical Properties of Soil under Tropical Long-Term No Till Conditions	PLOS ONE			English	Article							CROP GRAIN PRODUCTION; PARTICULATE ORGANIC-MATTER; SURFACE APPLICATION; CARBON CONTENT; LIME; GYPSUM; MANAGEMENT; AGGREGATE; ACID; ROOT	Tropical regions have been considered the world's primary agricultural frontier; however, some physico-chemical deficiencies, such as low soil organic matter content, poor soil structure, high erodibility, soil acidity, and aluminum toxicity, have affected their productive capacity. Lime and gypsum are commonly used to improve soil chemical fertility, but no information exists about the long-term effects of these products on the physical attributes and C protection mechanisms of highly weathered Oxisols. A field trial was conducted in a sandy clay loam (kaolinitic, thermic Typic Haplorthox) under a no-tillage system for 12 years. The trial consisted of four treatments: a control with no soil amendment application, the application of 2.1 Mg ha (-1) phosphogypsum, the application of 2.0 Mg ha(-1) lime, and the application of lime + phosphogypsum (2.0 + 2.1 Mg ha(-1), respectively). Since the experiment was established in 2002, the rates have been applied three times (2002, 2004, and 2010). Surface liming effectively increased water-stable aggregates > 2.0 mm at a depth of up to 0.2 m; however, the association with phosphogypsum was considered a good strategy to improve the macroaggregate stability in subsoil layers (0.20 to 0.40 m). Consequently, both soil amendments applied together increased the mean weight diameter (MWD) and geometric mean diameter (GMD) in all soil layers, with increases of up to 118 and 89%, respectively, according to the soil layer. The formation and stabilization of larger aggregates contributed to a higher accumulation of total organic carbon (TOC) on these structures. In addition to TOC, the MWD and aggregate stability index were positively correlated with Ca2+ and Mg2+ levels and base saturation. Consequently, the increase observed in the aggregate size class resulted in a better organization of soil particles, increasing the macroporosity and reducing the soil bulk density and penetration resistance. Therefore, adequate soil chemical management plays a fundamental role in improving the soil's physical attributes in tropical areas under conservative management and highly affected by compaction caused by intensive farming.	[Carmeis Filho, Antonio C. A.; Crusciol, Carlos A. C.; Guimaraes, Tiara M.; Calonego, Juliano C.] Sao Paulo State Univ UNESP, Dept Crop Sci, Coll Agr Sci, Botucatu, SP, Brazil; [Mooney, Sacha J.] Univ Nottingham, Div Agr & Environm Sci, Nottingham, England	Universidade Estadual Paulista; University of Nottingham	Crusciol, CAC (corresponding author), Sao Paulo State Univ UNESP, Dept Crop Sci, Coll Agr Sci, Botucatu, SP, Brazil.	crusciol@fca.unesp.br	Calonego, Juliano/N-4011-2017; Calonego, Juliano C/AAD-9707-2020; Calonego, Juliano/AFS-1997-2022; Mooney, Sacha J/G-4020-2010	Calonego, Juliano C/0000-0002-8950-3231; Calonego, Juliano/0000-0002-8950-3231; /0000-0003-4673-1071	Sao Paulo Research Foundation (FAPESP) [2013/18462-0, 2014/16712-2]; National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the Sao Paulo Research Foundation (FAPESP, Proc. 2013/18462-0 and 2014/16712-2) for the financial support and the National Council for Scientific and Technological Development (CNPq) for an award for excellence in research to the second and third authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Sao Paulo Research Foundation (FAPESP, Proc. 2013/18462-0 and 2014/16712-2) for the financial support and the National Council for Scientific and Technological Development (CNPq) for an award for excellence in research to the second and third authors.	Abiven S, 2005, BIOL FERT SOILS, V42, P119, DOI 10.1007/s00374-005-0006-0; Alcarde JA, 2003, TOPICOS CIENCIA SOLO, P291; Baldock D., 1994, NATURE FARMING LOW I; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Bongiovanni MD, 2006, GEODERMA, V136, P660, DOI 10.1016/j.geoderma.2006.05.002; Briedis C, 2012, GEODERMA, V170, P80, DOI 10.1016/j.geoderma.2011.10.011; Caires EF, 2008, EUR J AGRON, V28, P57, DOI 10.1016/j.eja.2007.05.002; Caires EF, 2015, EUR J AGRON, V66, P41, DOI 10.1016/j.eja.2015.02.008; Caires EF, 2011, AGRON J, V103, P1804, DOI 10.2134/agronj2011.0192; Caires EF, 2005, AGRON J, V97, P791, DOI 10.2134/agronj2004.0207; Cantarella H, 1998, COMMUN SOIL SCI PLAN, V29, P1691, DOI 10.1080/00103629809370060; Carvalho MCS, 1997, PLANT SOIL, V192, P37, DOI 10.1023/A:1004285113189; Castro Filho C., 2002, Soil and Tillage Research, V65, P45, DOI 10.1016/S0167-1987(01)00275-6; Castro GSA, 2013, GEODERMA, V195, P234, DOI 10.1016/j.geoderma.2012.12.006; Chevallier T, 2004, AGR ECOSYST ENVIRON, V103, P375, DOI 10.1016/j.agee.2003.12.009; Correa JC, 2009, REV BRAS CIENC SOLO, V33, P263, DOI 10.1590/S0100-06832009000200004; Crusciol CAC, 2016, CATENA, V137, P87, DOI 10.1016/j.catena.2015.09.009; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Dube F, 2009, FOREST ECOL MANAG, V257, P1695, DOI 10.1016/j.foreco.2009.01.044; EDWARDS AP, 1967, J SOIL SCI, V18, P64, DOI 10.1111/j.1365-2389.1967.tb01488.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Embrapa Brazilian Agricultural Research Corporation, 1997, MAN METH SOIL AN; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Fageria NK, 2014, ADV AGRON, V128, P221, DOI 10.1016/B978-0-12-802139-2.00006-8; FARINA MPW, 1988, SOIL SCI SOC AM J, V52, P175, DOI 10.2136/sssaj1988.03615995005200010031x; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Garbuio FJ, 2011, SOIL SCI SOC AM J, V75, P1723, DOI 10.2136/sssaj2010.0291; Garcia RA, 2013, SOIL SCI SOC AM J, V77, P1724, DOI 10.2136/sssaj2012.0310; Hati KM, 2008, GEODERMA, V148, P173, DOI 10.1016/j.geoderma.2008.09.015; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Kemper W.D., 1965, SIZE DISTRIBUTION 1, P499; Kiehl EJ, EDAPHOLOGY MANUAL SO; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Lal R, 2000, SOIL SCI, V165, P191, DOI 10.1097/00010694-200003000-00002; Lehmann J, 2007, BIOGEOCHEMISTRY, V85, P45, DOI 10.1007/s10533-007-9105-3; Leys A, 2010, J HYDROL, V390, P143, DOI 10.1016/j.jhydrol.2010.06.034; Manna MC, 2007, SOIL TILL RES, V94, P397, DOI 10.1016/j.still.2006.08.013; Marsili A, 1998, SOIL TILL RES, V49, P185, DOI 10.1016/S0167-1987(98)00169-X; Martins MR, 2013, SOIL BIOL BIOCHEM, V58, P153, DOI 10.1016/j.soilbio.2012.11.011; Mbagwu JSC, 1989, SOIL TECHNOL, V2, P49, DOI DOI 10.1016/S0933-3630(89)80006-6; McCallum MH, 2004, AUST J EXP AGR, V44, P299, DOI 10.1071/EA03076; Mitchell JP, 2000, AGR WATER MANAGE, V45, P55, DOI 10.1016/S0378-3774(99)00070-0; MUNEER M, 1989, AUST J SOIL RES, V27, P411, DOI 10.1071/SR9890411; OGNER G, 1971, CAN J CHEMISTRY, V49, P1053, DOI 10.1139/v71-175; Pagliai M, 2004, SOIL TILL RES, V79, P131, DOI 10.1016/j.still.2004.07.002; Reichert JM, 2009, SOIL TILL RES, V102, P242, DOI 10.1016/j.still.2008.07.002; ROTH CH, 1991, GEODERMA, V48, P351, DOI 10.1016/0016-7061(91)90053-V; Ruhlmann J, 2006, GEODERMA, V130, P272, DOI 10.1016/j.geoderma.2005.01.024; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith K.A., 1991, SOIL ANAL PHYS METHO; Soil Survey Staff, 1999, SOIL TAX BAS SYST SO, V2, P436, DOI DOI 10.1111/J.1475-2743.2001.TB00008.X; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Tormena C. A., 1998, Revista Brasileira de Ciencia do Solo, V22, P573, DOI 10.1590/S0100-06831998000400002; Traore O, 2000, EUR J SOIL SCI, V51, P575, DOI 10.1111/j.1365-2389.2000.00348.x; Valzano FP, 2001, AUST J SOIL RES, V39, P1307, DOI 10.1071/SR99086; van Raij B., 2001, CHEM ANAL FERTILITY; van Raij B, 1997, RECOMMENDATIONS FERT	57	11	11	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167564	10.1371/journal.pone.0167564	http://dx.doi.org/10.1371/journal.pone.0167564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959897	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900010
J	Marrone, A; Re, N; Storchi, L				Marrone, Alessandro; Re, Nazzareno; Storchi, Loriano			The Effects of Ca2+ Concentration and E200K Mutation on the Aggregation Propensity of PrPC : A Computational Study	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; STRUCTURAL BASIS; SCRAPIE; BINDING; DISEASE; PROPAGATION; SIMILARITY; CONVERSION; MECHANISM; EPITOPE	The propensity of cellular prion protein to aggregation is reputed essential for the initiation of the amyloid cascade that ultimately lead to the accumulation of neurotoxic aggregates. In this paper, we extended and applied an already reported computational workflow [Proteins 2015; 83: 1751-1765] to elucidate in details the aggregation propensity of PrP protein systems including wild type, wild type treated at different [Ca2+] and E200K mutant. The application of the computational procedure to two segments of PrPC, i.e. 125-228 and 120-231, allowed to emphasize how the inclusion of complete C-terminus and last portion (120-126) of the neurotoxic segment 106-126 may be crucial to unveil significant and unexpected interaction properties. Indeed, the anchoring of N-terminus on H2 domain detected in the wild type resulted to be disrupted upon either E200K mutation or Ca2+ binding, and to unbury hydrophobic spots on the PrPC surface. A peculiar dinuclear Ca2+ binding motif formed by the C-terminus and the S2-H2 loop was detected for [Ca2+] > 5 mM and showed similarities with binding motifs retraced in other protein systems, thus suggesting a possible functional meaning for its formation. Therefore, we potentiated the computational procedure by including a tool that clusterize the minima of molecular interaction fields of a proteinand delimit the regions of space with higher hydrophobic or higher hydrophilic character, hence, more likely involved in the self-assembly process. Plausible models for the self-assembly of either the E200K mutated or Ca2+-bound PrPC were sketched and discussed. The present investigation provides for structure-based information and new prompts that may represent a startings point for future experimental or computational works on the PrPC aggregation.	[Marrone, Alessandro; Re, Nazzareno; Storchi, Loriano] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Storchi, Loriano] Mol Discovery Ltd, London, England	G d'Annunzio University of Chieti-Pescara	Marrone, A (corresponding author), Univ G dAnnunzio, Dept Pharm, Chieti, Italy.	amarrone@unich.it	Storchi, Loriano/K-3557-2018	Storchi, Loriano/0000-0001-5021-7759; Marrone, Alessandro/0000-0002-8311-8172	Molecular Discovery Limited, Middlesex, London, United Kingdom	Molecular Discovery Limited, Middlesex, London, United Kingdom	The authors received no specific funding for this work. Concerning the affiliation of Loriano Storchi (LS) to the commercial company Molecular Discovery Limited, Middlesex, London, United Kingdom, we declare that this funder provided support in the form of salaries for one author [LS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chen W, 2014, BIOPHYS J, V106, P1152, DOI 10.1016/j.bpj.2013.12.053; Chiovitti K, 2007, J NEUROCHEM, V103, P2597, DOI 10.1111/j.1471-4159.2007.04965.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chon NL, 2015, BIOCHEMISTRY-US, V54, P5696, DOI 10.1021/acs.biochem.5b00422; Corsaro A, 2011, INT J BIOCHEM CELL B, V43, P372, DOI 10.1016/j.biocel.2010.11.007; Cross S, 2010, DRUG DISCOV TODAY, V15, P23, DOI 10.1016/j.drudis.2008.12.006; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; Jones E., SCIPY OPEN SOURCE SC; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Li L, 2009, PROTEIN ENG DES SEL, V22, P523, DOI 10.1093/protein/gzp038; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paulis D, 2011, NEUROCHEM INT, V59, P168, DOI 10.1016/j.neuint.2011.04.008; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Simon ES, 2000, ANN NEUROL, V47, P257, DOI 10.1002/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U; Sorrentino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038314; Storchi L, 2015, PROTEINS, V83, P1751, DOI 10.1002/prot.24836; Ueyama N, 1999, INORG CHEM, V38, P4028, DOI 10.1021/ic9811042; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Voigtlander T, 2008, NEUROPATH APPL NEURO, V34, P435, DOI 10.1111/j.1365-2990.2007.00902.x; Wiseman F, 2005, BIOCHEM SOC T, V33, P1094, DOI 10.1042/BST20051094; Yagi H, 2015, J BIOL CHEM, V290, P25213, DOI 10.1074/jbc.M115.668384; Yamamoto N, 2014, J PHYS CHEM B, V118, P9826, DOI 10.1021/jp5034245; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168039	10.1371/journal.pone.0168039	http://dx.doi.org/10.1371/journal.pone.0168039			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959938	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900035
J	Tarazanova, M; Beerthuyzen, M; Siezen, R; Fernandez-Gutierrez, MM; de Jong, A; van der Meulen, S; Kok, J; Bachmann, H				Tarazanova, Mariya; Beerthuyzen, Marke; Siezen, Roland; Fernandez-Gutierrez, Marcela M.; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan; Bachmann, Herwig			Plasmid Complement of Lactococcus lactis NCDO712 Reveals a Novel Pilus Gene Cluster	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; HIGH-FREQUENCY CONJUGATION; COMPLETE GENOME SEQUENCE; EXPRESSION SYSTEM NICE; CELL-AGGREGATION; PHAGE RESISTANCE; NISIN RESISTANCE; NATURAL ISOLATE; SSP CREMORIS; IDENTIFICATION	Lactococcus lactis MG1363 is an important gram-positive model organism. It is a plasmid-free and phage-cured derivative of strain NCDO712. Plasmid-cured strains facilitate studies on molecular biological aspects, but many properties which make L. lactis an important organism in the dairy industry are plasmid encoded. We sequenced the total DNA of strain NCDO712 and, contrary to earlier reports, revealed that the strain carries 6 rather than 5 plasmids. A new 50-kb plasmid, designated pNZ712, encodes functional nisin immunity (nisCIP) and copper resistance (lcoRSABC). The copper resistance could be used as a marker for the conjugation of pNZ712 to L. lactis MG1614. A genome comparison with the plasmid cured daughter strain MG1363 showed that the number of single nucleotide polymorphisms that accumulated in the laboratory since the strains diverted more than 30 years ago is limited to 11 of which only 5 lead to amino acid changes. The 16-kb plasmid pSH74 was found to contain a novel 8-kb pilus gene cluster spaCB-spaA-srtC1-srtC2, which is predicted to encode a pilin tip protein SpaC, a pilus basal subunit SpaB, and a pilus backbone protein SpaA. The sortases SrtC1/SrtC2 are most likely involved in pilus polymerization while the chromosomally encoded SrtA could act to anchor the pilus to peptidoglycan in the cell wall. Overexpression of the pilus gene cluster from a multi-copy plasmid in L. lactis MG1363 resulted in cell chaining, aggregation, rapid sedimentation and increased conjugation efficiency of the cells. Electron microscopy showed that the over-expression of the pilus gene cluster leads to appendices on the cell surfaces. A deletion of the gene encoding the putative basal protein spaB, by truncating spaCB, led to more pilus-like structures on the cell surface, but cell aggregation and cell chaining were no longer observed. This is consistent with the prediction that spaB is involved in the anchoring of the pili to the cell.	[Tarazanova, Mariya; Beerthuyzen, Marke; Bachmann, Herwig] NIZO Food Res BV, Ede, Netherlands; [Tarazanova, Mariya; Beerthuyzen, Marke; Siezen, Roland; Fernandez-Gutierrez, Marcela M.; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan; Bachmann, Herwig] TI Food & Nutr, Wageningen, Netherlands; [Tarazanova, Mariya; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan] Univ Groningen, Mol Genet, Groningen, Netherlands; [Siezen, Roland] Radboud UMC, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Fernandez-Gutierrez, Marcela M.] Wageningen Univ, Host Microbe Interact Grp, Anim Sci, Wageningen, Netherlands	NIZO Food Research; Top Institute Food & Nutrition; University of Groningen; Radboud University Nijmegen; Wageningen University & Research	Bachmann, H (corresponding author), NIZO Food Res BV, Ede, Netherlands.; Bachmann, H (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Herwig.Bachmann@nizo.com	Bachmann, Herwig/ABE-6301-2021; Siezen, Roland J/P-5745-2015	Bachmann, Herwig/0000-0002-8224-0993; Fernandez-Gutierrez, Marcela M./0000-0001-5314-9659	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands) [FF001]; TIFN	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands); TIFN	This study was funded by the Top Institute Food & Nutrition (TIFN, Program FF001, Wageningen, The Netherlands). MB and HB are also employed by NIZO Food Research. TIFN provided support in the form of salaries for authors HB, MB, RS, AdJ, SvM, JK and HB. Neither NIZO food research nor TIFN had an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth S, 2014, FEMS MICROBIOL REV, V38, P1066, DOI 10.1111/1574-6976.12074; Ainsworth S, 2014, APPL ENVIRON MICROB, V80, P4341, DOI 10.1128/AEM.01070-14; ANDERSON DG, 1984, J BACTERIOL, V158, P954, DOI 10.1128/JB.158.3.954-962.1984; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bachmann H, 2012, GENOME RES, V22, P115, DOI 10.1101/gr.121285.111; Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Campelo AB, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-77; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Clarke M, 2008, P NATL ACAD SCI USA, V105, P17978, DOI 10.1073/pnas.0806786105; Coakley M, 1997, APPL ENVIRON MICROB, V63, P1434, DOI 10.1128/AEM.63.4.1434-1440.1997; Cozzi R, 2012, FASEB J, V26, P2008, DOI 10.1096/fj.11-196378; Cui YH, 2015, INT J MOL SCI, V16, P13172, DOI 10.3390/ijms160613172; DAVIES FL, 1981, J APPL BACTERIOL, V51, P325, DOI 10.1111/j.1365-2672.1981.tb01249.x; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEVOS WM, 1987, FEMS MICROBIOL LETT, V46, P281, DOI 10.1111/j.1574-6968.1987.tb02466.x; Le DTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079850; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Duan K, 1999, APPL MICROBIOL BIOT, V53, P36, DOI 10.1007/s002530051611; EFSTATHIOU JD, 1977, J BACTERIOL, V130, P257, DOI 10.1128/JB.130.1.257-265.1977; Fallico V, 2012, J DAIRY SCI, V95, P3593, DOI 10.3168/jds.2011-5255; Filloux A, 2010, J BACTERIOL, V192, P3243, DOI 10.1128/JB.00424-10; GASSON MJ, 1992, MOL MICROBIOL, V6, P3213, DOI 10.1111/j.1365-2958.1992.tb01776.x; GASSON MJ, 1980, J BACTERIOL, V143, P1260, DOI 10.1128/JB.143.3.1260-1264.1980; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gevers D, 2003, FEMS MICROBIOL LETT, V225, P125, DOI 10.1016/S0378-1097(03)00505-6; GODON JJ, 1994, MOL MICROBIOL, V12, P655, DOI 10.1111/j.1365-2958.1994.tb01053.x; Gorecki RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022238; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Khunajakr N, 1999, GENE, V229, P229, DOI 10.1016/S0378-1119(98)00395-3; KLAENHAMMER TR, 1985, J GEN MICROBIOL, V131, P1531; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Kojic M, 2005, CAN J MICROBIOL, V51, P305, DOI [10.1139/w05-009, 10.1139/W05-009]; Kojic M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-265; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Kuipers OP, 1997, TRENDS BIOTECHNOL, V15, P135, DOI 10.1016/S0167-7799(97)01029-9; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Bourgeois P, 2000, J BACTERIOL, V182, P2481, DOI 10.1128/JB.182.9.2481-2491.2000; LEENHOUTS KJ, 1991, APPL ENVIRON MICROB, V57, P2562, DOI 10.1128/AEM.57.9.2562-2567.1991; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Liu CQ, 2002, GENE, V297, P241, DOI 10.1016/S0378-1119(02)00918-6; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mantovani HC, 2001, APPL ENVIRON MICROB, V67, P808, DOI 10.1128/AEM.67.2.808-813.2001; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MCKAY LL, 1980, APPL ENVIRON MICROB, V40, P84, DOI 10.1128/AEM.40.1.84-91.1980; Meyrand M, 2013, MOL CELL PROTEOMICS, V12, P3935, DOI 10.1074/mcp.M113.029066; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Montville TJ, 1998, APPL MICROBIOL BIOT, V50, P511, DOI 10.1007/s002530051328; O'Driscoll J, 2006, J BACTERIOL, V188, P6629, DOI 10.1128/JB.00672-06; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rintahaka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113922; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; SING WD, 1991, J DAIRY SCI, V74, P1133, DOI 10.3168/jds.S0022-0302(91)78265-9; STEELE JL, 1986, APPL ENVIRON MICROB, V51, P57, DOI 10.1128/AEM.51.1.57-64.1986; Stentz R, 2004, MICROBIOL-SGM, V150, P2503, DOI 10.1099/mic.0.27149-0; STERKENBURG A, 1988, BIOCHIMIE, V70, P451, DOI 10.1016/0300-9084(88)90220-9; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; Taguchi F, 2011, MOL PLANT MICROBE IN, V24, P1001, DOI 10.1094/MPMI-02-11-0026; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; van der Meulen SB, 2016, RNA BIOL, V13, P353, DOI 10.1080/15476286.2016.1146855; VANBELKUM MJ, 1991, APPL ENVIRON MICROB, V57, P492, DOI 10.1128/AEM.57.2.492-498.1991; VANDERLELIE D, 1991, APPL ENVIRON MICROB, V57, P201, DOI 10.1128/AEM.57.1.201-206.1991; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; WALSH PM, 1981, J BACTERIOL, V146, P937, DOI 10.1128/JB.146.3.937-944.1981; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wegmann U, 2012, MICROBIOL-SGM, V158, P2936, DOI 10.1099/mic.0.062554-0; WELLS JM, 1993, J APPL BACTERIOL, V74, P629, DOI 10.1111/j.1365-2672.1993.tb05195.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	91	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167970	10.1371/journal.pone.0167970	http://dx.doi.org/10.1371/journal.pone.0167970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941999	Green Published, gold			2022-12-26	WOS:000392745600042
J	Bregante, M; Carpaneto, A; Piazza, V; Sbrana, F; Vassalli, M; Faimali, M; Gambale, F				Bregante, Monica; Carpaneto, Armando; Piazza, Veronica; Sbrana, Francesca; Vassalli, Massimo; Faimali, Marco; Gambale, Franco			Osmoregulated Chloride Currents in Hemocytes from Mytilus galloprovincialis	PLOS ONE			English	Article							POTASSIUM CHANNELS; ESSENTIAL COMPONENT; VOLUME REGULATION; ION CHANNELS; MUSSEL; TRANSMISSION; TRANSPORTERS; IMMUNOCYTE; ACTIVATION; VACUOLES	We investigated the biophysical properties of the transport mediated by ion channels in hemocytes from the hemolymph of the bivalve Mytilus galloprovincialis. Besides other transporters, mytilus hemocytes possess a specialized channel sensitive to the osmotic pressure with functional properties similar to those of other transport proteins present in vertebrates. As chloride fluxes may play an important role in the regulation of cell volume in case of modifications of the ionic composition of the external medium, we focused our attention on an inwardly-rectifying voltage-dependent, chloride-selective channel activated by negative membrane potentials and potentiated by the low osmolality of the external solution. The chloride channel was slightly inhibited by micromolar concentrations of zinc chloride in the bath solution, while the antifouling agent zinc pyrithione did not affect the channel conductance at all. This is the first direct electrophysiological characterization of a functional ion channel in ancestral immunocytes of mytilus, which may bring a contribution to the understanding of the response of bivalves to salt and contaminant stresses.	[Bregante, Monica; Carpaneto, Armando; Sbrana, Francesca; Vassalli, Massimo; Gambale, Franco] Natl Res Council Italy IBF, Inst Biophys, Genoa, Italy; [Piazza, Veronica; Faimali, Marco] Natl Res Council Italy ISMAR, Inst Marine Sci, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Gambale, F (corresponding author), Natl Res Council Italy IBF, Inst Biophys, Genoa, Italy.	gambale@ge.ibf.cnr.it	Faimali, Marco/AAK-5723-2021; Vassalli, Massimo/F-6762-2011; Faimali, Marco/B-7191-2008	Faimali, Marco/0000-0001-5558-3555; Vassalli, Massimo/0000-0002-3063-4376; Carpaneto, Armando/0000-0002-5060-3657; PIAZZA, VERONICA/0000-0003-0142-6057; Sbrana, Francesca/0000-0001-7500-7774	Italian "Progetti di Ricerca di Interesse Nazionale" [PRIN2010CSJX4F, PRIN 2015795S5W_003]; Compagnia di San Paolo Research Foundation [ROL 291]; RITMARE (Ricerca Italiana peril MARE) Flagship Project; National Research Programme - Italian Ministry of University and Research (MIUR)	Italian "Progetti di Ricerca di Interesse Nazionale"(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Compagnia di San Paolo Research Foundation(Compagnia di San Paolo); RITMARE (Ricerca Italiana peril MARE) Flagship Project; National Research Programme - Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	AC was supported by the Italian "Progetti di Ricerca di Interesse Nazionale" (PRIN2010CSJX4F and PRIN 2015795S5W_003), as well as the Compagnia di San Paolo Research Foundation (ROL 291). MF was supported by RITMARE (Ricerca Italiana peril MARE) Flagship Project, a National Research Programme funded by the Italian Ministry of University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A. C. was supported by the Italian "Progetti di Ricerca di Interesse Nazionale" (PRIN2010CSJX4F and PRIN 201579555W_003) as well as by Compagnia di San Paolo Research Foundation (ROL 291). M.F. was supported by RITMARE (Ricerca Habana peril MARE) Flagship Project, a National Research Programme funded by the Italian Ministry of University and Research (MIUR).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Astuya A, 2015, INT J MOL SCI, V16, P15235, DOI 10.3390/ijms160715235; Barber BJ, 2004, AQUAT LIVING RESOUR, V17, P449, DOI 10.1051/alr:2004052; Bose T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.23; Bott T.R., 1995, FOULING HEAT EXCHANG; Bregante M, 1997, EUR BIOPHYS J BIOPHY, V26, P381, DOI 10.1007/s002490050092; CAJARAVILLE MP, 1995, CELL STRUCT FUNCT, V20, P355, DOI 10.1247/csf.20.355; Calisi A, 2008, ENVIRON TOXICOL CHEM, V27, P1435, DOI 10.1897/07-396; Cao GZ, 2011, J MEMBRANE BIOL, V240, P111, DOI 10.1007/s00232-011-9349-7; Carpaneto A, 2003, J BIOCHEM BIOPH METH, V55, P179, DOI 10.1016/S0165-022X(02)00184-7; Carpaneto A, 1999, EXP BRAIN RES, V124, P193, DOI 10.1007/s002210050614; Carpaneto A, 2001, PLANTA, V213, P457, DOI 10.1007/s004250100519; Carpaneto A, 1999, FEBS LETT, V442, P129, DOI 10.1016/S0014-5793(98)01642-1; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Curtis TM, 1999, COMP BIOCHEM PHYS A, V124, P231, DOI 10.1016/S1095-6433(99)00118-X; Dash D., 2012, ISRN CHEM ENG, V2012, P1, DOI 10.5402/2012/730154; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; ERMOLAYEVA E, 1995, APPL ENVIRON MICROB, V61, P3385, DOI 10.1128/AEM.61.9.3385-3390.1995; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; FIORICAHOWELLS E, 1990, J PHARMACOL EXP THER, V252, P610; Gambale F, 1996, J MEMBRANE BIOL, V154, P69, DOI 10.1007/s002329900133; Hamer W. J., 1972, J PHYS CHEM REF DATA, V1, P1047, DOI DOI 10.1063/1.3253108; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kodirov SA, 2011, COMP BIOCHEM PHYS A, V160, P102, DOI 10.1016/j.cbpa.2011.06.014; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Le Foll F, 2010, FISH SHELLFISH IMMUN, V28, P372, DOI 10.1016/j.fsi.2009.11.011; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Lofts H, 2009, C03634 CEH; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Lowe S., 2000, ALIENS; Malagoli D, 2006, CELL BIOL INT, V30, P721, DOI 10.1016/j.cellbi.2006.05.003; Marcheselli M, 2011, AQUAT TOXICOL, V102, P39, DOI 10.1016/j.aquatox.2010.12.015; Marcheselli M, 2010, ENVIRON TOXICOL CHEM, V29, P2583, DOI 10.1002/etc.316; Metzger MJ, 2016, NATURE, V534, P705, DOI 10.1038/nature18599; Metzger MJ, 2015, CELL, V161, P255, DOI 10.1016/j.cell.2015.02.042; Murchison EP, 2016, NATURE, V534, P628, DOI 10.1038/nature18455; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Ottaviani E, 2011, ISJ-INVERT SURVIV J, V8, P1; Ottaviani E, 1998, ITAL J ZOOL, V65, P349, DOI 10.1080/11250009809386772; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Rajagopal S, 2003, WATER RES, V37, P329, DOI 10.1016/S0043-1354(02)00270-1; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; SILVA AL, 1994, J EXP BIOL, V194, P47; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOROED SM, 1994, J EXP BIOL, V186, P245; Torre A, 2013, TOXICOL IN VITRO, V27, P1260, DOI 10.1016/j.tiv.2013.02.017; Torre A, 2013, CELL BIOCHEM FUNCT, V31, P489, DOI 10.1002/cbf.2925; Turner A, 2010, MAR POLLUT BULL, V60, P159, DOI 10.1016/j.marpolbul.2009.12.004; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wickenden AD, 2009, CURR PHARM DESIGN, V15, P1773, DOI 10.2174/138161209788186326; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	63	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167972	10.1371/journal.pone.0167972	http://dx.doi.org/10.1371/journal.pone.0167972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936151	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000389587100242
J	Endow, JK; Agostinho, GRA; Baldwin, AJ; Roston, RL; Yamaguchi, T; Kamikubo, H; Inoue, K				Endow, Joshua K.; Rocha, Agostinho Gomes; Baldwin, Amy J.; Roston, Rebecca L.; Yamaguchi, Toshio; Kamikubo, Hironari; Inoue, Kentaro			Polyglycine Acts as a Rejection Signal for Protein Transport at the Chloroplast Envelope	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BETA-BARREL PROTEINS; INNER ENVELOPE; OUTER ENVELOPE; TRANSIT PEPTIDE; TRANSMEMBRANE DOMAIN; INTERMEMBRANE SPACE; MEMBRANE-PROTEINS; IMPORT APPARATUS; CHANNEL TOC75	PolyGly is present in many proteins in various organisms. One example is found in a transmembrane a-barrel protein, translocon at the outer-envelope-membrane of chloroplasts 75 (Toc75). Toc75 requires its N-terminal extension (t75) for proper localization. t75 comprises signals for chloroplast import (n75) and envelope sorting (c75) in tandem. n75 and c75 are removed by stromal processing peptidase and plastidic type I signal peptidase 1, respectively. PolyGly is present within c75 and its deletion or substitution causes mistargeting of Toc75 to the stroma. Here we have examined the properties of polyGly-dependent protein targeting using two soluble passenger proteins, the mature portion of the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase (mSS) and enhanced green fluorescent protein (EGFP). Both t75-mSS and t75-EGFP were imported into isolated chloroplasts and their n75 removed. Resultant c75-mSS was associated with the envelope at the intermembrane space, whereas c75-EGFP was partially exposed outside the envelope. Deletion of polyGly or substitution of tri-Ala for the critical tri-Gly segment within polyGly caused each passenger to be targeted to the stroma. Transient expression of t75-EGFP in Nicotiana benthamiana resulted in accumulation of c75-EGFP exposed at the surface of the chloroplast, but the majority of the EGFP passenger was found free in the cytosol with most of its c75 attachment removed. Results of circular dichroism analyses suggest that polyGly within c75 may form an extended conformation, which is disrupted by tri-Ala substitution. These data suggest that polyGly is distinct from a canonical stop-transfer sequence and acts as a rejection signal at the chloroplast inner envelope.	[Endow, Joshua K.; Rocha, Agostinho Gomes; Baldwin, Amy J.; Roston, Rebecca L.; Yamaguchi, Toshio; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, One Shields Ave, Davis, CA 95616 USA; [Kamikubo, Hironari] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan; [Rocha, Agostinho Gomes] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA; [Baldwin, Amy J.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Roston, Rebecca L.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Yamaguchi, Toshio] Niigata Univ Pharm & Appl Life Sci, Dept Microbiol, Fac Pharm, Niigata, Japan	University of California System; University of California Davis; Nara Institute of Science & Technology; Washington University (WUSTL); Cardiff University; University of Nebraska System; University of Nebraska Lincoln; Niigata University	Endow, JK (corresponding author), Univ Calif Davis, Dept Plant Sci, One Shields Ave, Davis, CA 95616 USA.	jkendow@ucdavis.edu	Roston, Rebecca/AAQ-5309-2020	Endow-Monteiro, Joshua/0000-0002-5845-0077; Roston, Rebecca/0000-0002-3063-5002; Baldwin, Amy/0000-0002-2162-3771; G Rocha, PhD, Agostinho/0000-0001-7134-7376	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [2003-02860]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-08ER15963]; Division of Molecular and Cellular Biosciences at the US National Science Foundation [1050602]	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Division of Molecular and Cellular Biosciences at the US National Science Foundation	The initial phase of this work involving preparation of some DNA constructs was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (grant no. 2003-02860) to KI. The assay using recombinant Plsp1 was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (grant no. DE-FG02-08ER15963) to KI. Performance of all other experiments and data analysis was supported by the Division of Molecular and Cellular Biosciences at the US National Science Foundation (grant no. 1050602) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Baldwin AJ, 2006, FEBS J, V273, P1547, DOI 10.1111/j.1742-4658.2006.05175.x; Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111; Bolter B, 2011, CHEMBIOCHEM, V12, P1655, DOI 10.1002/cbic.201100118; Breuers FKH, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00097; Brito M, 2005, CARCINOGENESIS, V26, P2046, DOI 10.1093/carcin/bgi168; Brockschmidt FF, 2007, J MOL ENDOCRINOL, V39, P1, DOI 10.1677/JME-06-0072; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Chiu CC, 2008, PLANT J, V56, P793, DOI 10.1111/j.1365-313X.2008.03638.x; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; Faux N, 2012, ADV EXP MED BIOL, V769, P26; Froehlich JE, 2001, J BIOL CHEM, V276, P31806, DOI 10.1074/jbc.M104652200; Froehlich JE, 2011, PLANT J, V68, P844, DOI 10.1111/j.1365-313X.2011.04735.x; Gutierrez-Carbonell E, 2014, J PROTEOME RES, V13, P2941, DOI 10.1021/pr500106s; Harvey CG, 2007, AM J MED GENET B, V144B, P355, DOI 10.1002/ajmg.b.30425; Hewitt VL, 2014, BBA-GEN SUBJECTS, V1840, P1246, DOI 10.1016/j.bbagen.2013.08.013; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Hsu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027258; Hsu SC, 2009, BIOSCI TRENDS, V3, P168; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Inoue K, 2001, EUR J BIOCHEM, V268, P4036, DOI 10.1046/j.1432-1327.2001.02316.x; Inoue K, 2006, PHYSIOL PLANTARUM, V127, P561, DOI 10.1111/j.1399-3054.2006.00690.x; Inoue K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00278; Inoue K, 2014, ADVAN PL BIO, V5, P305, DOI 10.1007/978-1-4939-1136-3_12; Inoue K, 2011, TRENDS PLANT SCI, V16, P550, DOI 10.1016/j.tplants.2011.06.005; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Kim DH, 2014, DEV CELL, V30, P598, DOI 10.1016/j.devcel.2014.07.026; Kim DH, 2013, TRAFFIC, V14, P613, DOI 10.1111/tra.12043; Kim HK, 1998, BRAIN RES BULL, V47, P35, DOI 10.1016/S0361-9230(98)00020-3; Klasek L, 2016, INT REV CEL MOL BIO, V323, P231, DOI 10.1016/bs.ircmb.2015.12.008; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kouranov A, 1999, J BIOL CHEM, V274, P25181, DOI 10.1074/jbc.274.35.25181; Lamppa G, 2004, CHLOROPLAST STROMAL; Lee J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00173; Li M, 2006, J CELL BIOL, V175, P249, DOI 10.1083/jcb.200605162; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; Marques JP, 2003, MOL GENET GENOMICS, V269, P381, DOI 10.1007/s00438-003-0846-y; Midorikawa T, 2014, PLANT J, V80, P592, DOI 10.1111/tpj.12655; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Muthan B, 2013, PLANT PHYSIOL, V163, P61, DOI 10.1104/pp.113.222513; Nada A, 2004, J CELL SCI, V117, P3975, DOI 10.1242/jcs.01265; Nakachi Y, 1997, MOL BIOL EVOL, V14, P1042, DOI 10.1093/oxfordjournals.molbev.a025710; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Pogson BJ, 2015, BBA-BIOENERGETICS, V1847, P1017, DOI 10.1016/j.bbabio.2015.02.003; Rolland N., 2009, V13, P41, DOI 10.1007/7089_2008_33; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Simm S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00011; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Tu SL, 2004, PLANT CELL, V16, P2078, DOI 10.1105/tpc.104.023952; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Viana AAB, 2010, J BIOL CHEM, V285, P12948, DOI 10.1074/jbc.M110.109744; WARD WW, 2005, BIOCH PHYS PROPERTIE, P39; Woody RW, 2009, J AM CHEM SOC, V131, P8234, DOI 10.1021/ja901218m; Zhang LD, 2006, GENOME, V49, P900, DOI 10.1139/G06-054	69	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167802	10.1371/journal.pone.0167802	http://dx.doi.org/10.1371/journal.pone.0167802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936133	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000389587100198
J	Gernaat, SAM; Isgum, I; de Vos, BD; Takx, RAP; Young-Afat, DA; Rijnberg, N; Grobbee, DE; van der Graaf, Y; de Jong, PA; Leiner, T; van den Bongard, DHJ; Pignol, JP; Verkooijen, HM				Gernaat, Sofie A. M.; Isgum, Ivana; de Vos, Bob D.; Takx, Richard A. P.; Young-Afat, Danny A.; Rijnberg, Noor; Grobbee, Diederick E.; van der Graaf, Yolanda; de Jong, Pim A.; Leiner, Tim; van den Bongard, Desiree H. J.; Pignol, Jean-Philippe; Verkooijen, Helena M.			Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; VALVE CALCIFICATIONS; PROGNOSTIC VALUE; HEART-DISEASE; EVENTS; PROGRESSION; PREDICTION; AGREEMENT; MDCT	Objectives Coronary artery calcium (CAC) is a strong and independent predictor of cardiovascular disease (CVD) risk. This study assesses reproducibility of automatic CAC scoring on radiotherapy planning computed tomography (CT) scans of breast cancer patients, and examines its association with traditional cardiovascular risk factors. Methods This study included 561 breast cancer patients undergoing radiotherapy between 2013 and 2015. CAC was automatically scored with an algorithm using supervised pattern recognition, expressed as Agatston scores and categorized into five categories (0, 1-10, 11-100, 101-400, >400). Reproducibility between automatic and manual expert scoring was assessed in 79 patients with automatically determined CAC above zero and 84 randomly selected patients without automatically determined CAC. Interscan reproducibility of automatic scoring was assessed in 294 patients having received two scans (82% on the same day). Association between CAC and CVD risk factors was assessed in 36 patients with CAC scores >100, 72 randomly selected patients with scores 1-100, and 72 randomly selected patients without CAC. Reliability was assessed with linearly weighted kappa and agreement with proportional agreement. Results 134 out of 561 (24%) patients had a CAC score above zero. Reliability of CVD risk categorization between automatic and manual scoring was 0.80 (95% Confidence Interval (CI): 0.74-0.87), and slightly higher for scans with breath-hold. Agreement was 0.79 (95% CI: 0.72-0.85). Interscan reliability was 0.61 (95% CI: 0.50-0.72) with an agreement of 0.84 (95% CI: 0.80-0.89). Ten out of 36 (27.8%) patients with CAC scores above 100 did not have other cardiovascular risk factors. Conclusions Automatic CAC scoring on radiotherapy planning CT scans is a reliable method to assess CVD risk based on Agatston scores. One in four breast cancer patients planned for radiotherapy have elevated CAC score. One in three patients with high CAC scores don't have other CVD risk factors and wouldn't have been identified as high risk.	[Gernaat, Sofie A. M.; Young-Afat, Danny A.; Grobbee, Diederick E.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands; [Isgum, Ivana; de Vos, Bob D.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Rijnberg, Noor] Acad Med Ctr, Devis Internal Med, Amsterdam, Netherlands; [van den Bongard, Desiree H. J.] Univ Med Ctr Utrecht, Dept Radiat Oncol, Utrecht, Netherlands; [Pignol, Jean-Philippe] Erasmus MC, Dept Radiat Oncol, Rotterdam, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Gernaat, SAM (corresponding author), Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr, Utrecht, Netherlands.	S.A.M.Gernaat@umcutrecht.nl	Takx, Richard/T-2852-2019	Takx, Richard/0000-0003-2252-3040; Pignol, Jean-Philippe/0000-0002-0253-8520; van den Bongard, Desiree/0000-0002-5549-324X; Gernaat, Sofie/0000-0001-7828-1138				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Brenner H, 1996, EPIDEMIOLOGY, V7, P199, DOI 10.1097/00001648-199603000-00016; Brunner G, 2010, INT J CARDIOVAS IMAG, V26, P829, DOI 10.1007/s10554-010-9608-1; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P12, DOI 10.1016/j.jcct.2010.11.004; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Chiles C, 2015, RADIOLOGY, V276, P82, DOI 10.1148/radiol.15142062; Cutter D, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-P3-13-06; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Jairam PM, 2014, RADIOLOGY, V272, P700, DOI 10.1148/radiol.14132211; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Kurkure U, 2010, INT J CARDIOVAS IMAG, V26, P817, DOI 10.1007/s10554-010-9607-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee YC, 2015, BREAST CANC RES TREA; Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045; Maher JE, 1999, MAYO CLIN PROC, V74, P347, DOI 10.4065/74.4.347; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Raggi P, 2001, AM J CARDIOL, V87, p27A; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Shahzad R, 2013, ACAD RADIOL, V20, P1, DOI 10.1016/j.acra.2012.07.018; Shaw LJ, 2006, EUR HEART J, V27, P968, DOI 10.1093/eurheartj/ehi750; Sobin L, 2009, TNM CLASSIFICATION M; Takx RAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091239; Taunk NK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00039; Taylor CW, 2015, CLIN ONCOL R COLL RA; Toutouzas K, 2013, NEW ENGL J MED, V368, P2524, DOI 10.1056/NEJMc1304601; van Hamersvelt RW, 2014, EUR RADIOL, V24, P1557, DOI 10.1007/s00330-014-3191-0; Vossen LM, 2015, NUTRIENTS, V7, P8905, DOI 10.3390/nu7115443; Willemink MJ, 2015, INT J CARDIOVAS IMAG, V31, P1243, DOI 10.1007/s10554-015-0664-4; Wolterink JM, 2015, IEEE T MED IMAGING, V34, P1867, DOI 10.1109/TMI.2015.2412651; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie Y., 2014, SPIE INT S MED IM 20, V9035	41	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167925	10.1371/journal.pone.0167925	http://dx.doi.org/10.1371/journal.pone.0167925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936125	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100232
J	Li, TX; Zhang, MJ; Lu, ZM; Herman, U; Mumbengegwi, D; Crittenden, J				Li, Tianxin; Zhang, Minjie; Lu, Zhongming; Herman, Uwizeyimana; Mumbengegwi, Dzivaidzo; Crittenden, John			Effects of Heavy Metals from Soil and Dust Source on DNA Damage of the Leymus chinensis Leaves in Coal-Mining Area in Northwest China	PLOS ONE			English	Article							CONTAMINATION; SEDIMENTS; PLANTS	Air and soil pollution from mining activities has been considered as a critical issue to the health of living organisms. However, few efforts have been made in distinguishing the main pathway of organism genetic damage by heavy metals related to mining activities. Therefore, we investigated the genetic damage of Leymus chinensis leaf cells, the air particulate matter (PM) contents, and concentrations of the main heavy metals (Pb, Cd, Cr, Hg) in soil and foliar dust samples collected from seven experiment points at the core mining area and one control point 20 kilometers away from the core mining area in Inner Mongolia in 2013. Comet assay was used to test the genetic damage of the Leymus chinensis leaf cells; the Tail DNA% and Tail Moment were used to characterize the genetic damage degree of the plant cells. The comet assay results showed that the cell genetic damage ratio was up to 77.0% in experiment points but was only 35.0% in control point. The control point also had the slight Tail DNA% and Tail Moment values than other experiment groups. The cell damage degree of the control group was 0.935 and experiment groups were 1.299-1.815. The geo-accumulation index and comperehensive pollution index(CPI) were used to characterize heavy metal pollution in foliar dust samples, and single factor pollution index and CPI were used to characterize the heavy metal pollution in soil samples. The CPIfoliar dust of control group was 0.36 and experiment groups were 1.45-2.57; the CPIsoil of control group was 0.04 and experiment groups were 0.07-0.12. The results of correlation analyze showed that Air Quality Index (AQI)-CPIfoliar dust(r = 0.955**)>Damage degree-CPIfoliar dust(r = 0.923**) >Damage degree-AQI(r = 0.908**)> Damage degree-CPIsoil (r = 0.824*). The present research proved that mining activity had a high level of positive correlation with organism genetic damage caused by heavy metals through comparing with the control point; soil and atmosphere were both the important action pathway for heavy metal induced genetic damage in mining area. Furthermore, heavy metal contents in foliar dust showed a higher positive correlation with genetic damage than when compared with soil. This means the heavy metal contents that L. chinensis absorbed through respiration from the atmosphere could make more serious genetic damage than when absorbed by root systems from soil in the mining area. This study can provide theoretical support for research on plant genetic damage mechanisms and exposure pathways induced by environmental pollution.	[Li, Tianxin; Zhang, Minjie; Herman, Uwizeyimana; Mumbengegwi, Dzivaidzo] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing, Peoples R China; [Lu, Zhongming; Crittenden, John] Georgia Inst Technol, Brook Byers Inst Sustainable Syst, Atlanta, GA 30332 USA; [Herman, Uwizeyimana] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lu, Zhongming; Crittenden, John] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	University of Science & Technology Beijing; University System of Georgia; Georgia Institute of Technology; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University System of Georgia; Georgia Institute of Technology	Li, TX (corresponding author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Beijing, Peoples R China.	tianxinli@ustb.edu.cn	Lu, Zhongming/M-8292-2018; Lu, Zhongming/S-2757-2019	Lu, Zhongming/0000-0002-4151-5065; Lu, Zhongming/0000-0002-4151-5065	National Basic Research Fund of the Chinese Ministry of Education [FRF-SD-12-008A]; Brook Byers Institute for Sustainable Systems; Hightower Chair; Georgia Research Alliance at the Georgia Institute of Technology; Emerging Frontiers & Multidisciplinary Activities [1441208] Funding Source: National Science Foundation	National Basic Research Fund of the Chinese Ministry of Education; Brook Byers Institute for Sustainable Systems; Hightower Chair; Georgia Research Alliance at the Georgia Institute of Technology; Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project is supported by the National Basic Research Fund of the Chinese Ministry of Education (No. FRF-SD-12-008A). The authors also appreciate support from the Brook Byers Institute for Sustainable Systems and the Hightower Chair and Georgia Research Alliance at the Georgia Institute of Technology.	Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0; Bian Z, 2010, MIN SCI TECHNOL, V20, P215, DOI DOI 10.1016/S1674-5264(09)60187-3; Clark MW, 2001, ENVIRON GEOL, V40, P655, DOI 10.1007/s002549900073; Cook AG, 2005, BIOL TRACE ELEM RES, V103, P1, DOI 10.1385/BTER:103:1:001; Deng HG, 2010, ENVIRON EARTH SCI, V60, P57, DOI 10.1007/s12665-009-0169-3; Escarre J, 2011, WATER AIR SOIL POLL, V216, P485, DOI 10.1007/s11270-010-0547-1; Feng JF, 2011, J ENVIRON SCI-CHINA, V23, P1158, DOI 10.1016/S1001-0742(10)60529-3; Gao Y, 2010, J ENVIRON SCI-CHINA, V22, P1040, DOI 10.1016/S1001-0742(09)60215-1; Ghrefat HA, 2011, ENVIRON MONIT ASSESS, V178, P95, DOI 10.1007/s10661-010-1675-1; Gjorgieva D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276417; Guerrero-Castilla A, 2014, MUTAT RES-GEN TOX EN, V762, P24, DOI 10.1016/j.mrgentox.2013.12.005; Khorasanipour M, 2011, APPL GEOCHEM, V26, P714, DOI 10.1016/j.apgeochem.2011.01.030; Li KX, 2015, J GEOGR SCI, V25, P1439, DOI 10.1007/s11442-015-1244-1; Li TX, 2015, INT J ENV RES PUB HE, V12, P12475, DOI 10.3390/ijerph121012475; [林健 Lin Jian], 2002, [环境与健康杂志, Journal of Environment and Health], V19, P119; Loska K, 2004, ENVIRON INT, V30, P159, DOI 10.1016/S0160-4120(03)00157-0; Lu XW, 2009, ATMOS ENVIRON, V43, P2489, DOI 10.1016/j.atmosenv.2009.01.048; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; Miler M, 2012, J GEOCHEM EXPLOR, V112, P152, DOI 10.1016/j.gexplo.2011.08.012; Monterroso C, 2014, APPL GEOCHEM, V44, P3, DOI 10.1016/j.apgeochem.2013.09.001; Ogunkunle CO, 2013, POL J ENVIRON STUD, V22, P487; Pan Luqing, 2011, Journal of Ocean University of China, V10, P177, DOI 10.1007/s11802-011-1809-2; Shi G, 2010, ENVIRON POLLUT, V158, P694, DOI 10.1016/j.envpol.2009.10.020; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Song SJ, 2012, ENVIRON POLLUT, V161, P215, DOI 10.1016/j.envpol.2011.10.014; Weimin C, 2012, APPL MECH MAT, V246-247, P608; [杨利民 Yang Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P16; Yin RJ, 2013, J ENVIRON QUAL, V42, P1724, DOI 10.2134/jeq2013.04.0150; Yiru Y, 2009, J PLANT RESOURCES EN	29	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166522	10.1371/journal.pone.0166522	http://dx.doi.org/10.1371/journal.pone.0166522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935969	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100032
J	McAuley, EM; Bertram, SM				McAuley, Emily M.; Bertram, Susan M.			Field Crickets Compensate for Unattractive Static Long-Distance Call Components by Increasing Dynamic Signalling Effort	PLOS ONE			English	Article							SEXUAL-SELECTION; CONDITION DEPENDENCE; FEMALE PREFERENCE; ORNAMENTS; BEHAVIOR; TEMPERATURE; EVOLUTION; TRAITS; AGE; COMMUNICATION	The evolution of multiple sexual signals presents a dilemma since individuals selecting a mate should pay attention to the most honest signal and ignore the rest; however, multiple signals may evolve if, together, they provide more information to the receiver than either one would alone. Static and dynamic signals, for instance, can act as multiple messages, providing information on different aspects of signaller quality that reflect condition at different time scales. While the nature of static signals makes them difficult or impossible for individuals to augment, dynamic signals are much more susceptible to temporary fluctuations in effort. We investigated whether male Texas field crickets, Gryllus texensis, that produce unattractive static signals compensate by dynamically increasing their calling effort. Our findings lend partial support to the compensation hypothesis, as males that called at unattractive carrier frequencies (a static trait) spent more time calling each night (a dynamic trait). Interestingly, this finding was most pronounced in males that called with attractive pulse characteristics (static traits) but did not occur in males that called with unattractive pulse characteristics. Males that signalled with unattractive pulse characteristics (duration and pause) spent less time calling through the night. Our correlative findings on wild caught males suggest that only males that signal with attractive pulse characteristics may be able to afford to pay the costs of both trait exaggeration and increased calling effort to compensate for poor carrier frequencies.	[McAuley, Emily M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Simon Fraser University; Carleton University	Bertram, SM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	sue.bertram@carleton.ca		Bertram, Susan/0000-0002-1822-3208	Natural Science and Engineering Research Council (NSERC) of Canada; NSERC	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an Natural Science and Engineering Research Council (NSERC) of Canada Discovery Grant to SB. NSERC also provided a Canada Graduate Scholarship to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Andersson Malte, 1994; Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; Bailey WJ, 2001, J EXP BIOL, V204, P2827; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Bertram SM, 2004, TECHNICAL ACOUSTICS, P1; Bertram SM, 2007, EVOL ECOL RES, V9, P975; Bertram SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074938, 10.1371/journal.pone.0069247]; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; Blankers T, 2015, J EVOLUTION BIOL, V28, P1656, DOI 10.1111/jeb.12686; Blankers T, 2015, J EVOLUTION BIOL, V28, P630, DOI 10.1111/jeb.12599; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; CICERAN M, 1994, CAN J ZOOL, V72, P38, DOI 10.1139/z94-006; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Copeland EK, 2012, P ROY SOC B-BIOL SCI, V279, P4740, DOI 10.1098/rspb.2012.1914; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; Eshel I, 2000, EVOL ECOL RES, V2, P509; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 2001, ANIM BEHAV, V62, P871, DOI 10.1006/anbe.2001.1825; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hedrick A, 2005, ANIM BEHAV, V70, P1121, DOI 10.1016/j.anbehav.2005.02.011; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HEDRICK AV, 1986, BEHAV ECOL SOCIOBIOL, V19, P73, DOI 10.1007/BF00303845; HEDRICK AV, 1988, AM NAT, V132, P267, DOI 10.1086/284849; Higgins LA, 2004, ANIM BEHAV, V68, P1139, DOI 10.1016/j.anbehav.2003.10.035; HILL KG, 1974, J COMP PHYSIOL, V93, P7, DOI 10.1007/BF00608756; Hoglund J, 1998, OIKOS, V83, P478, DOI 10.2307/3546675; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Kelly CD, 2015, PEERJ, V3, DOI 10.7717/peerj.1501; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kostarakos Konstantinos, 2009, Frontiers in Zoology, V6, P1; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; PFAU HK, 1994, J EXP BIOL, V195, P147; Polkki M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1002; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Thomson IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090409; VANWYK JW, 1995, J INSECT PHYSIOL, V41, P837, DOI 10.1016/0022-1910(95)00055-Y; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Zahavi A., 1977, P253; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZEH DW, 1988, AM NAT, V132, P454, DOI 10.1086/284863	70	6	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167311	10.1371/journal.pone.0167311	http://dx.doi.org/10.1371/journal.pone.0167311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936045	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100082
J	Sun, LW; Johnson, RD; Williams, V; Summerfelt, P; Dubra, A; Weinberg, DV; Stepien, KE; Fishman, GA; Carroll, J				Sun, Lynn W.; Johnson, Ryan D.; Williams, Vesper; Summerfelt, Phyllis; Dubra, Alfredo; Weinberg, David V.; Stepien, Kimberly E.; Fishman, Gerald A.; Carroll, Joseph			Multimodal Imaging of Photoreceptor Structure in Choroideremia	PLOS ONE			English	Article							OPTICAL-COHERENCE-TOMOGRAPHY; OUTER RETINAL TUBULATION; ADAPTIVE OPTICS; RETINITIS-PIGMENTOSA; GENE; DISRUPTION; MORPHOLOGY; MUTATION; METRICS; CLONING	Purpose Choroideremia is a progressive X-linked recessive dystrophy, characterized by degeneration of the retinal pigment epithelium (RPE), choroid, choriocapillaris, and photoreceptors. We examined photoreceptor structure in a series of subjects with choroideremia with particular attention to areas bordering atrophic lesions. Methods Twelve males with clinically-diagnosed choroideremia and confirmed hemizygous mutations in the CHM gene were examined. High-resolution images of the retina were obtained using spectral domain optical coherence tomography (SD-OCT) and both confocal and non-confocal split-detector adaptive optics scanning light ophthalmoscope (AOSLO) techniques. Results Eleven CHM gene mutations (3 novel) were identified; three subjects had the same mutation and one subject had two mutations. SD-OCT findings included interdigitation zone (IZ) attenuation or loss in 10/12 subjects, often in areas with intact ellipsoid zones; RPE thinning in all subjects; interlaminar bridges in the imaged areas of 10/12 subjects; and outer retinal tubulations (ORTs) in 10/12 subjects. Only split-detector AOSLO could reliably resolve cones near lesion borders, and such cones were abnormally heterogeneous in morphology, diameter and density. On split-detector imaging, the cone mosaic terminated sharply at lesion borders in 5/5 cases examined. Split-detector imaging detected remnant cone inner segments within ORTs, which were generally contiguous with a central patch of preserved retina. Conclusions Early IZ dropout and RPE thinning on SD-OCT are consistent with previously published results. Evidence of remnant cone inner segments within ORTs and the continuity of the ORTs with preserved retina suggests that these may represent an intermediate state of retinal degeneration prior to complete atrophy. Taken together, these results supports a model of choroideremia in which the RPE degenerates before photoreceptors.	[Sun, Lynn W.; Johnson, Ryan D.; Williams, Vesper; Summerfelt, Phyllis; Dubra, Alfredo; Weinberg, David V.; Stepien, Kimberly E.; Carroll, Joseph] Med Coll Wisconsin, Dept Ophthalmol & Visual Sci, Milwaukee, WI 53226 USA; [Dubra, Alfredo; Fishman, Gerald A.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Dubra, Alfredo; Carroll, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Dubra, Alfredo; Carroll, Joseph] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Carroll, Joseph] Chicago Lighthouse, Chicago, IL 60608 USA; [Dubra, Alfredo] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA; [Stepien, Kimberly E.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Medical College of Wisconsin; Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Carroll, J (corresponding author), Med Coll Wisconsin, Dept Ophthalmol & Visual Sci, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA.; Carroll, J (corresponding author), Chicago Lighthouse, Chicago, IL 60608 USA.	jcarroll@mcw.edu		Dubra, Alfredo/0000-0002-6506-9020	National Eye Institute of the National Institutes of Health [P30EY001931, R01EY017607]; Richard O. Schultz, MD / Ruth Works Professorship; Edward N. & Della L. Thome Memorial Foundation; Foundation Fighting Blindness; Thomas M. Aaberg Sr. Retina Research Fund; Gene and Ruth Posner Foundation; R.D. and Linda Peters Foundation; Research Facilities Improvement Program; National Center for Research Resources, NIH [C06RR016511]; NATIONAL EYE INSTITUTE [R01EY017607, P30EY001931] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Richard O. Schultz, MD / Ruth Works Professorship; Edward N. & Della L. Thome Memorial Foundation; Foundation Fighting Blindness(European Commission); Thomas M. Aaberg Sr. Retina Research Fund; Gene and Ruth Posner Foundation; R.D. and Linda Peters Foundation; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Numbers P30EY001931 & R01EY017607. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support comes from the Richard O. Schultz, MD / Ruth Works Professorship, The Edward N. & Della L. Thome Memorial Foundation, Foundation Fighting Blindness, the Thomas M. Aaberg Sr. Retina Research Fund, the Gene and Ruth Posner Foundation, and the R.D. and Linda Peters Foundation. This investigation was conducted in part in a facility constructed with support from the Research Facilities Improvement Program; grant number C06RR016511 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Chen YM, 2011, INVEST OPHTH VIS SCI, V52, P3281, DOI 10.1167/iovs.10-6538; Cooper RE, 2016, INVEST OPHTH VIS SCI, V57, P2992, DOI 10.1167/iovs.16-19072; Cooper RF, 2011, BIOMED OPT EXPRESS, V2, P2577, DOI 10.1364/BOE.2.002577; Coussa RG, 2012, OPHTHALMIC GENET, V33, P57, DOI 10.3109/13816810.2011.620056; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; DeLuca AM, 2013, INVEST OPHTHALMOL VI, V54, P3382; Dubis AM, 2014, INVEST OPHTH VIS SCI, V55, P7303, DOI 10.1167/iovs.14-14225; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1864, DOI 10.1364/BOE.2.001864; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; Dubra A, 2010, LECT NOTES COMPUT SC, V6204, P60, DOI 10.1007/978-3-642-14366-3_6; Duncan JL, 2007, INVEST OPHTH VIS SCI, V48, P3283, DOI 10.1167/iovs.06-1422; Duncan JL, 2011, INVEST OPHTH VIS SCI, V52, P1557, DOI 10.1167/iovs.10-6549; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; FLANNERY JG, 1990, INVEST OPHTH VIS SCI, V31, P229; Flatter JA, 2014, RETINA-J RET VIT DIS, V34, P2133, DOI 10.1097/IAE.0000000000000169; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Godara P, 2010, ARCH OPHTHALMOL-CHIC, V128, P253, DOI 10.1001/archophthalmol.2009.383; Heon E, 2016, INVEST OPHTH VIS SCI, V57, pOCT377, DOI 10.1167/iovs.15-18421; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Lazow MA, 2011, INVEST OPHTH VIS SCI, V52, P9581, DOI 10.1167/iovs.11-8554; Litts KM, 2016, INVEST OPHTH VIS SCI, V57, P2647, DOI 10.1167/iovs.16-19262; Litts KM, 2016, RETINA; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; McAllister JT, 2010, VISION RES, V50, P810, DOI 10.1016/j.visres.2010.02.003; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Michaelides M, 2011, INVEST OPHTH VIS SCI, V52, P4757, DOI 10.1167/iovs.10-6659; Morgan JIW, 2014, INVEST OPHTH VIS SCI, V55, P6381, DOI 10.1167/iovs.13-13454; Packer O., 2003, SCI COLOR, P41, DOI 10.1016/B978-044451251-2/50003-9; Razeen MM, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.6; RODRIGUES MM, 1984, OPHTHALMOLOGY, V91, P873; Rossi EA, 2011, EYE, V25, P301, DOI 10.1038/eye.2010.221; Scoles D, 2016, RETINA; Scoles D, 2016, RETINA-J RET VIT DIS, V36, P91, DOI 10.1097/IAE.0000000000000618; Scoles D, 2014, INVEST OPHTH VIS SCI, V55, P4244, DOI 10.1167/iovs.14-14542; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; Stepien KE, 2012, ARCH OPHTHALMOL-CHIC, V130, P400, DOI 10.1001/archopthalmol.2011.1490; Sun LW, 2016, INVEST OPHTH VIS SCI, V57, P2428, DOI 10.1167/iovs.15-18246; Syed N, 2001, OPHTHALMOLOGY, V108, P711, DOI 10.1016/S0161-6420(00)00643-6; Syed R, 2013, INVEST OPHTH VIS SCI, V54, P950, DOI 10.1167/iovs.12-10707; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tanna H, 2010, BRIT J OPHTHALMOL, V94, P372, DOI 10.1136/bjo.2009.163501; Tuten WS, 2012, OPTOMETRY VISION SCI, V89, P563, DOI 10.1097/OPX.0b013e3182512b98; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1041, DOI 10.1093/hmg/3.7.1041; Wilk MA, 2014, INVEST OPHTH VIS SCI, V55, P4186, DOI 10.1167/iovs.13-13217; Zweifel SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1596, DOI 10.1001/archophthalmol.2009.326	52	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167526	10.1371/journal.pone.0167526	http://dx.doi.org/10.1371/journal.pone.0167526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936069	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100115
J	Crosas-Molist, E; Bertran, E; Rodriguez-Hernandez, I; Herraiz, C; Cantelli, G; Fabra, A; Sanz-Moreno, V; Fabregat, I				Crosas-Molist, E.; Bertran, E.; Rodriguez-Hernandez, I.; Herraiz, C.; Cantelli, G.; Fabra, A.; Sanz-Moreno, V.; Fabregat, I.			The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination	ONCOGENE			English	Article							TGF-BETA; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; CELL INVASION; MIGRATION; ACTIVATION; EXPRESSION; METASTASIS; PLASTICITY; ADHESION	Epithelial to mesenchymal transition is a common event during tumour dissemination. However, direct epithelial to amoeboid transition has not been characterized to date. Here we provide evidence that cells from hepatocellular carcinoma (HCC), a highly metastatic cancer, undergo epithelial to amoeboid transition in physiological environments, such as organoids or three-dimensional complex matrices. Furthermore, the NADPH oxidase NOX4 inhibits this transition and therefore suppresses efficient amoeboid bleb-based invasion. Moreover, NOX4 expression is associated with E-cadherin levels and inversely correlated with invasive features. NOX4 is necessary to maintain parenchymal structures, increase cell-cell and cell-to-matrix adhesion, and impair actomyosin contractility and amoeboid invasion. Importantly, NOX4 gene deletions are frequent in HCC patients, correlating with higher tumour grade. Contrary to that observed in mesenchymal cell types, here NOX4 suppresses Rho and Cdc42 GTPase expression and downstream actomyosin contractility. In HCC patients, NOX4 expression inversely correlates with RhoC and Cdc42 levels. Moreover, low expression of NOX4 combined with high expression of either RhoC or Cdc42 is associated with worse prognosis. Therefore, loss of NOX4 increases actomyosin levels and favours an epithelial to amoeboid transition contributing to tumour aggressiveness.	[Crosas-Molist, E.; Bertran, E.; Fabra, A.; Fabregat, I.] Bellvitge Biomed Res Inst IDIBELL, Mol Oncol, Gran Via Hosp 199, Barcelona 08908, Spain; [Crosas-Molist, E.; Rodriguez-Hernandez, I.; Herraiz, C.; Cantelli, G.; Sanz-Moreno, V.] Kings Coll London, Tumour Plast Lab, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England; [Fabregat, I.] Univ Barcelona, Dept Ciencies Fisiol 2, Barcelona, Spain; [Herraiz, C.] Univ Murcia, Sch Med, Dept Biochem & Mol Biol, Murcia, Spain; [Herraiz, C.] IMIB Arrixaca, Murcia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of London; King's College London; University of Barcelona; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Fabregat, I (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Mol Oncol, Gran Via Hosp 199, Barcelona 08908, Spain.; Sanz-Moreno, V (corresponding author), Kings Coll London, Tumour Plast Lab, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	victoria.sanz_moreno@kcl.ac.uk; ifabregat@idibell.cat	Serrano, Cecilia Herraiz/H-2550-2015; Bertran, Esther/GZK-5458-2022; Fabregat, Isabel/H-7038-2015	Serrano, Cecilia Herraiz/0000-0001-6912-0738; Fabregat, Isabel/0000-0003-0136-8440; Sanz-Moreno, Victoria/0000-0002-5096-9456; Bertran Rodriguez, Esther/0000-0001-9356-7409; Cantelli, Gaia/0000-0003-2650-6280; Rodriguez-Hernandez, Irene/0000-0002-6487-452X	MINECO (FEDER funds), Spain [BFU2012-35538, SAF 2015-64149-R, PIE13/00022, ISCIII-RTICC RD12-0036-0029]; MINECO (European Regional Development Fund), Spain [BFU2012-35538, SAF 2015-64149-R, PIE13/00022, ISCIII-RTICC RD12-0036-0029]; AGAUR, Generalitat de Catalunya [2014SGR0334]; CRUK [c33043/A12065]; Royal Society [RG110591]; Fundacion Alfonso Martin Escudero; FEBS fellowship; MRC [C97993H]; European Cooperation in Science and Technology (COST Action) [BM1203/EU-ROS]; Cancer Research UK [24478, 12065] Funding Source: researchfish	MINECO (FEDER funds), Spain; MINECO (European Regional Development Fund), Spain; AGAUR, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); CRUK(Cancer Research UK); Royal Society(Royal Society of London); Fundacion Alfonso Martin Escudero; FEBS fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Cooperation in Science and Technology (COST Action)(European Cooperation in Science and Technology (COST)); Cancer Research UK(Cancer Research UK)	We acknowledge Pahini Pandya for critical reading of the manuscript. Grants to IF from MINECO (co-funded by FEDER funds and the European Regional Development Fund: a way to build Europe), Spain (Grant numbers: BFU2012-35538, SAF 2015-64149-R, PIE13/00022 and ISCIII-RTICC RD12-0036-0029) and the AGAUR, Generalitat de Catalunya (2014SGR0334). Grants to VS-M and EC-M from CRUK (c33043/A12065) and to VS-M from Royal Society (RG110591). EC-M. was founded by the FPU program (MECD, Spain), IR-H was supported by Fundacion Alfonso Martin Escudero, CH by a FEBS fellowship and GC from MRC (C97993H). IF group is also supported by the European Cooperation in Science and Technology (COST Action BM1203/EU-ROS).	Ahn J, 2012, J CELL SCI, V125, P1814, DOI 10.1242/jcs.101444; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Bertran E, 2013, HEPATOLOGY, V58, P2032, DOI 10.1002/hep.26597; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Boudreau HE, 2014, BRIT J CANCER, V110, P2569, DOI 10.1038/bjc.2014.165; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cantelli G, 2015, CURR BIOL, V25, P2899, DOI 10.1016/j.cub.2015.09.054; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Crosas-Molist E, 2015, REDOX BIOL, V6, P106, DOI 10.1016/j.redox.2015.07.005; Crosas-Molist E, 2014, FREE RADICAL BIO MED, V69, P338, DOI 10.1016/j.freeradbiomed.2014.01.040; de Rezende FF, 2012, FREE RADICAL BIO MED, V53, P521, DOI 10.1016/j.freeradbiomed.2012.05.032; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Fernandez I, 2015, ARTERIOSCL THROM VAS, V35, P1198, DOI 10.1161/ATVBAHA.114.305185; Fernando J, 2015, INT J CANCER, V136, pE161, DOI 10.1002/ijc.29097; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gregg JL, 2014, CANCER RES, V74, P3501, DOI 10.1158/0008-5472.CAN-13-2979; Ha SY, 2016, GUT LIVER, V10, P826, DOI 10.5009/gnl15543; Herraiz C, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv289; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Kim HJ, 2015, ONCOTARGET, V6, P16287, DOI 10.18632/oncotarget.3843; Lai KKY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002147; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li J, 2015, ONCOTARGET, V6, P1031, DOI 10.18632/oncotarget.2671; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Montenegro MF, 2015, FREE RADICAL BIO MED, V85, P288, DOI 10.1016/j.freeradbiomed.2015.05.011; Murray TVA, 2015, FREE RADICAL BIO MED, V89, P918, DOI 10.1016/j.freeradbiomed.2015.09.015; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Reichl P, 2012, CURR PHARM DESIGN, V18, P4135, DOI 10.2174/138161212802430477; Ruiz-Ontanon P, 2013, STEM CELLS, V31, P1075, DOI 10.1002/stem.1349; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2012, CURR BIOL, V22, pR449, DOI 10.1016/j.cub.2012.04.024; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Smith BN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020017; Stanley A, 2014, ANTIOXID REDOX SIGN, V20, P2026, DOI 10.1089/ars.2013.5713; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Valdivia A, 2015, CURR PHARM DESIGN, V21, P6009, DOI 10.2174/1381612821666151029112624; Yu JH, 2012, HEPATOLOGY, V56, P2375, DOI 10.1002/hep.25900; Zavattari P, 2015, HEPATOLOGY, V62, P851, DOI 10.1002/hep.27790	61	40	42	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3002	3014		10.1038/onc.2016.454	http://dx.doi.org/10.1038/onc.2016.454			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27941881	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000402000400008
J	Li, BB; Cheng, G; Zhang, DJ; Wei, DT; Qiao, L; Wang, XP; Che, XW				Li, Bingbing; Cheng, Gang; Zhang, Dajun; Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng; Che, Xianwei			Regional Brain Responses Are Biased Toward Infant Facial Expressions Compared to Adult Facial Expressions in Nulliparous Women	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; MATERNAL-BEHAVIOR; SEX-DIFFERENCES; HUMAN AMYGDALA; ATTACHMENT; MOTHERS; EMPATHY; FACES; REPRESENTATIONS; RECOGNITION	Recent neuroimaging studies suggest that neutral infant faces compared to neutral adult faces elicit greater activity in brain areas associated with face processing, attention, empathic response, reward, and movement. However, whether infant facial expressions evoke larger brain responses than adult facial expressions remains unclear. Here, we performed event-related functional magnetic resonance imaging in nulliparous women while they were presented with images of matched unfamiliar infant and adult facial expressions (happy, neutral, and uncomfortable/sad) in a pseudo-randomized order. We found that the bilateral fusiform and right lingual gyrus were overall more activated during the presentation of infant facial expressions compared to adult facial expressions. Uncomfortable infant faces compared to sad adult faces evoked greater activation in the bilateral fusiform gyrus, precentral gyrus, postcentral gyrus, posterior cingulate cortex-thalamus, and precuneus. Neutral infant faces activated larger brain responses in the left fusiform gyrus compared to neutral adult faces. Happy infant faces compared to happy adult faces elicited larger responses in areas of the brain associated with emotion and reward processing using a more liberal threshold of p < 0.005 uncorrected. Furthermore, the level of the test subjects' Interest-In-Infants was positively associated with the intensity of right fusiform gyrus response to infant faces and uncomfortable infant faces compared to sad adult faces. In addition, the Perspective Taking subscale score on the Interpersonal Reactivity Index-Chinese was significantly correlated with precuneus activity during uncomfortable infant faces compared to sad adult faces. Our findings suggest that regional brain areas may bias cognitive and emotional responses to infant facial expressions compared to adult facial expressions among nulliparous women, and this bias may be modulated by individual differences in Interest-In-Infants and perspective taking ability.	[Li, Bingbing; Zhang, Dajun; Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Li, Bingbing; Zhang, Dajun] Southwest Univ, Ctr Mental Hlth Educ, Chongqing, Peoples R China; [Cheng, Gang] Guizhou Normal Univ, Sch Educ Sci, Guiyang, Peoples R China; [Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Che, Xianwei] The Alfred, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Che, Xianwei] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	Southwest University - China; Southwest University - China; Guizhou Normal University; Monash University; Monash University	Zhang, DJ (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.; Zhang, DJ (corresponding author), Southwest Univ, Ctr Mental Hlth Educ, Chongqing, Peoples R China.	Zhangdj@swu.edu.cn		Cheng, Gang/0000-0002-6903-6381; Che, Xianwei/0000-0002-0039-7306				Best D.L., 2001, HDB CULTURE PSYCHOL, P195; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheng G, 2015, PERS INDIV DIFFER, V87, P39, DOI 10.1016/j.paid.2015.07.004; De Pisapia N, 2013, NEUROREPORT, V24, P142, DOI 10.1097/WNR.0b013e32835df4fa; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Fengfeng Z., 2010, CHIN J CLIN PSYCHOL, V18, P155; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Gang C, 2015, CHINESE MENTAL HLTH, V29, P406; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Harvey PO, 2013, SCHIZOPHRENIA BULL, V39, P617, DOI 10.1093/schbul/sbs042; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Lenzi D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01241; Lenzi D, 2013, HUM BRAIN MAPP, V34, P1399, DOI 10.1002/hbm.21520; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Montoya JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036270; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; MURPHY MR, 1981, SCIENCE, V213, P459, DOI 10.1126/science.7244642; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Pechtel Pia, 2013, Transl Dev Psychiatry, V1, DOI 10.3402/tdp.v1i0.19673; Peltola MJ, 2014, EMOTION, V14, P469, DOI 10.1037/a0035959; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Proverbio AM, 2011, J COGNITIVE NEUROSCI, V23, P3197, DOI 10.1162/jocn_a_00041; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Riem MME, 2012, ATTACH HUM DEV, V14, P533, DOI 10.1080/14616734.2012.727252; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; SLOTNICK BM, 1967, BEHAVIOUR, V29, P204, DOI 10.1163/156853967X00127; STAMM JS, 1955, J COMP PHYSIOL PSYCH, V48, P347, DOI 10.1037/h0042977; Stolier RM, 2016, NAT NEUROSCI; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Thompson-Booth C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109362; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	55	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166860	10.1371/journal.pone.0166860	http://dx.doi.org/10.1371/journal.pone.0166860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977692	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400008
J	Casarrubia, S; Sapienza, S; Fritz, H; Daghino, S; Rosenkranz, M; Schnitzler, JP; Martin, F; Perotto, S; Martino, E				Casarrubia, Salvatore; Sapienza, Sara; Fritz, Hema; Daghino, Stefania; Rosenkranz, Maaria; Schnitzler, Joerg-Peter; Martin, Francis; Perotto, Silvia; Martino, Elena			Ecologically Different Fungi Affect Arabidopsis Development: Contribution of Soluble and Volatile Compounds	PLOS ONE			English	Article							ERICOID MYCORRHIZAL FUNGI; LATERAL ROOT-FORMATION; PLANT-GROWTH; AUXIN TRANSPORT; ECTOMYCORRHIZAL FUNGI; FUSARIUM-OXYSPORUM; MODEL SYSTEM; L-GLUTAMATE; THALIANA; PINUS	Plant growth and development can be influenced by mutualistic and non-mutualistic microorganisms. We investigated the ability of the ericoid endomycorrhizal fungus Oidiodendron maius to influence growth and development of the non-host plant Arabidopsis thaliana. Different experimental setups (non-compartmented and compartmented co-culture plates) were used to investigate the influence of both soluble and volatile fungal molecules on the plant phenotype. O. maius promoted growth of A. thaliana in all experimental setups. In addition, a peculiar clumped root phenotype, characterized by shortening of the primary root and by an increase of lateral root length and number, was observed in A. thaliana only in the non-compartmented plates, suggesting that soluble diffusible molecules are responsible for this root morphology. Fungal auxin does not seem to be involved in plant growth promotion and in the clumped root phenotype because co-cultivation with O. maius did not change auxin accumulation in plant tissues, as assessed in plants carrying the DR5::GUS reporter construct. In addition, no correlation between the amount of fungal auxin produced and the plant root phenotype was observed in an O. maius mutant unable to induce the clumped root phenotype in A. thaliana. Addition of active charcoal, a VOC absorbant, in the compartmented plates did not modify plant growth promotion, suggesting that VOCs are not involved in this phenomenon. The low VOCs emission measured for O. maius further corroborated this hypothesis. By contrast, the addition of CO2 traps in the compartmented plates drastically reduced plant growth, suggesting involvement of fungal CO2 in plant growth promotion. Other mycorrhizal fungi, as well as a saprotrophic and a pathogenic fungus, were also tested with the same experimental setups. In the non-compartmented plates, most fungi promoted A. thaliana growth and some could induce the clumped root phenotype. In the compartmented plate experiments, a general induction of plant growth was observed for most other fungi, especially those producing higher biomass, further strengthening the role of a nonspecific mechanism, such as CO2 emission.	[Casarrubia, Salvatore; Sapienza, Sara; Daghino, Stefania; Perotto, Silvia; Martino, Elena] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Fritz, Hema; Martin, Francis; Martino, Elena] INRA Nancy, Champenoux, France; [Fritz, Hema; Martin, Francis; Martino, Elena] Lorraine Univ, Lab Excellence ARBRE, UMR 1136, Champenoux, France; [Rosenkranz, Maaria; Schnitzler, Joerg-Peter] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany	University of Turin; INRAE; Universite de Lorraine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Martino, E (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.; Martino, E (corresponding author), INRA Nancy, Champenoux, France.; Martino, E (corresponding author), Lorraine Univ, Lab Excellence ARBRE, UMR 1136, Champenoux, France.	elena.martino@unito.it	Daghino, Stefania/AAO-7718-2021; Rosenkranz, Maaria/B-3338-2013; Schnitzler, Joerg-Peter/C-5268-2011	Rosenkranz, Maaria/0000-0002-1421-112X; Schnitzler, Joerg-Peter/0000-0002-9825-867X; DAGHINO, Stefania/0000-0001-5722-1558; PEROTTO, Silvia/0000-0003-0121-1806; Martino, Elena/0000-0003-3446-2994	Italian MIUR; University of Turin; Laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]	Italian MIUR(Ministry of Education, Universities and Research (MIUR)); University of Turin; Laboratory of Excellence ARBRE	S.C. was supported by a PhD fellowship from the Italian MIUR. The authors acknowledge financial support from local funding of the University of Turin and from the Laboratory of Excellence ARBRE (ANR-11-LABX-0002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba S, 2009, MOL PLANT MICROBE IN, V22, P1412, DOI 10.1094/MPMI-22-11-1412; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Bent E, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P225, DOI 10.1007/0-387-23266-4_10; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Berta G, 1987, MYCORRHIZAE PHYSL GE, P673; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cairney JWG, 2003, EUR J SOIL SCI, V54, P735, DOI 10.1046/j.1351-0754.2003.0555.x; Chambers SM, 2008, FEMS MICROBIOL ECOL, V65, P263, DOI 10.1111/j.1574-6941.2008.00481.x; Crookshanks M, 1998, J EXP BOT, V49, P593, DOI 10.1093/jexbot/49.320.593; Daghino S, 2016, MYCORRHIZA, V26, P263, DOI 10.1007/s00572-015-0675-y; Ditengou FA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7279; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dovana F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143353; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Garnica-Vergara A, 2016, NEW PHYTOL, V209, P1496, DOI 10.1111/nph.13725; Gay G, 1986, N MYCORRHIZAE PHYSL; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gougoulias C, 2014, J SCI FOOD AGR, V94, P2362, DOI 10.1002/jsfa.6577; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Heller G, 2012, MYCORRHIZA, V22, P271, DOI 10.1007/s00572-011-0402-2; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; KAGEYAMA S.A., 2008, MYCORRHIZA STATE ART, P29, DOI DOI 10.1007/978-3-540-78826-3_2; Kai M, 2009, FEBS LETT, V583, P3473, DOI 10.1016/j.febslet.2009.09.053; Kaldorf M, 2000, PHYSIOL PLANTARUM, V109, P58, DOI 10.1034/j.1399-3054.2000.100109.x; Karabaghli-Degron C, 1998, NEW PHYTOL, V140, P723, DOI 10.1046/j.1469-8137.1998.00307.x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0080097]; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; Lopez-Bucio J, 2007, PLANT PHYSIOL, V145, P1703, DOI 10.1104/pp.107.107953; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Sanchez-Lopez AM, 2016, PLANT CELL ENVIRON, V39, P2592, DOI 10.1111/pce.12759; Martino E, 2000, MYCOL RES, V104, P338, DOI 10.1017/S0953756299001252; Martinuz A, 2015, PLANTA, V241, P1015, DOI 10.1007/s00425-014-2237-5; Minerdi D, 2011, FEMS MICROBIOL ECOL, V76, P342, DOI 10.1111/j.1574-6941.2011.01051.x; Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005; Murali Amruthesh KN, 2012, SCREENING PLANT GROW, V4, P30; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Niemi K, 2002, TREE PHYSIOL, V22, P1231, DOI 10.1093/treephys/22.17.1231; Orfanoudakis M, 2010, MYCORRHIZA, V20, P117, DOI 10.1007/s00572-009-0271-0; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Perotto S, 2012, FUNGAL ASS, P255; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Piechulla B, 2016, TRENDS PLANT SCI, V21, P541, DOI 10.1016/j.tplants.2016.05.001; Rai Mahendra, 2005, Electron. J. Biotechnol., V8, P1; Rincon A, 2003, TREE PHYSIOL, V23, P785, DOI 10.1093/treephys/23.11.785; Rommert AK, 2002, 7 INT MYC C U OSL; Ryu CM, 2005, PLANT SOIL, V268, P285, DOI 10.1007/s11104-004-0301-9; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Salas-Marina MA, 2011, J MICROBIOL BIOTECHN, V21, P686, DOI 10.4014/jmb.1101.01012; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sharples JM, 2000, NATURE, V404, P951, DOI 10.1038/35010193; Shi CL, 2010, MOL CELLS, V29, P251, DOI 10.1007/s10059-010-0032-0; Shi W-L, 2016, J EXP BOT; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Tranvan H, 2000, TREE PHYSIOL, V20, P123; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; Turjaman M, 2006, MYCORRHIZA, V16, P459, DOI 10.1007/s00572-006-0059-4; Villarreal-Ruiz L, 2004, NEW PHYTOL, V164, P183, DOI 10.1111/j.1469-8137.2004.01167.x; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Walch-Liu P, 2007, PLANT SIGNAL BEHAV, V2, P284, DOI 10.4161/psb.2.4.4016; Weikl F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22152; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2	74	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168236	10.1371/journal.pone.0168236	http://dx.doi.org/10.1371/journal.pone.0168236			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973595	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300068
J	Li, B; Luo, XM; Li, T; Zheng, CY; Ji, SM; Ma, YY; Zhang, SS; Zhou, XD				Li, Bing; Luo, Xiumei; Li, Tao; Zheng, Changyue; Ji, Shunmei; Ma, Yuanyuan; Zhang, Shuangshuang; Zhou, Xiaodong			Effects of Constant Flickering Light on Refractive Status, 5-HT and 5-HT2A Receptor in Guinea Pigs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RETINAL DOPAMINE; DEPRIVATION MYOPIA; SEROTONIN 5-HT2A; RAT RETINA; CELLS; CHICKENS; NEURONS; ERRORS; EPINEPHRINE	Purpose To investigate the effects of constant flickering light on refractive development, the role of serotonin (i.e. 5-hydroxytryptamine, 5-HT) and 5-HT2A receptor in myopia induced by flickering light in guinea pigs. Methods Forty-five guinea pigs were randomly divided into three groups: control, form deprivation myopia (FDM) and flickering light induced myopia (FLM) groups(n = 15 for each group). The right eyes of the FDM group were covered with semitransparent hemispherical plastic shells serving as eye diffusers. Guinea pigs in FLM group were raised with illumination of a duty cycle of 50% at a flash frequency of 0.5Hz. The refractive status, axial length (AL), corneal radius of curvature(CRC) were measured by streak retinoscope, A-scan ultrasonography and keratometer, respectively. Ultramicroscopy images were taken by electron microscopy. The concentrations of 5-HTin the retina, vitreous body and retinal pigment epithelium (RPE) were assessed by high performance liquid chromatography, the retinal 5-HT2A receptor expression was evaluated by immunohistofluorescence and western blot. Results The refraction of FDM and FLM eyes became myopic from some time point (the 4th week and the 6th week, respectively) in the course of the experiment, which was indicated by significantly decreased refraction and longer AL when compared with the controls (p<0.05). The concentrations of 5-HT in the retina, vitreous body and RPE of FDM and FLM eyes were significantly increased in comparison with those of control eyes (both p<0.05). Similar to FDM eyes, the expression of retinal 5-HT2A receptor in FLM eyes was significantly upregulated compared to that of control eyes (both p<0.05). Western blot analysis showed that retinal 5-HT2A receptor level elevated less in the FLM eyes than that in the FDM eyes. Moreover, the levels of norepinephrine and epinephrine in FDM and FLM groups generally decreased when compared with control groups (all p<0.05). Conclusions Constant flickering light could cause progressive myopia in guinea pigs. 5-HT and 5-HT2A receptor increased both in form deprivation myopia and flickering light induced myopia, indicating that 5-HT possibly involved in myopic development via binding to5-HT2A receptor.	[Li, Bing] Fudan Univ, Jinshan Hosp, Cent Lab, Shanghai, Peoples R China; [Luo, Xiumei; Li, Tao; Zheng, Changyue; Ji, Shunmei; Zhou, Xiaodong] Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Ma, Yuanyuan] Fudan Univ, Shanghai Med Coll, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Ma, Yuanyuan] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China; [Zhang, Shuangshuang] Fudan Univ, Jinshan Hosp, Dept Dermatol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zhou, XD (corresponding author), Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai, Peoples R China.	jinshantg@163.com	Zhang, Shuangshuang/GVS-0109-2022		Shanghai health and family planning committee funded projects of China [201640046]; Shanghai Municipal Natural Science Foundation of China [13ZR1405800]; Shanghai Municipality Health Bureau Youth Project [2013-121]	Shanghai health and family planning committee funded projects of China; Shanghai Municipal Natural Science Foundation of China; Shanghai Municipality Health Bureau Youth Project	This work was supported by Grants from the Shanghai health and family planning committee funded projects of China (No. 201640046), Shanghai Municipal Natural Science Foundation of China (13ZR1405800) and Shanghai Municipality Health Bureau Youth Project (2013-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; BARTMANN M, 1994, VISUAL NEUROSCI, V11, P199, DOI 10.1017/S0952523800001565; Bubar MJ, 2006, CURR TOP MED CHEM, V6, P1971, DOI 10.2174/156802606778522131; Chanut E, 2002, J NEUROCHEM, V83, P863, DOI 10.1046/j.1471-4159.2002.01194.x; Chidlow G, 1998, NEUROSCIENCE, V87, P675, DOI 10.1016/S0306-4522(98)00181-X; Cohen Y, 2008, VISION RES, V48, P2329, DOI 10.1016/j.visres.2008.07.010; Crewther SG, 2006, EXP EYE RES, V83, P322, DOI 10.1016/j.exer.2005.12.016; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Di Giovanni G, 2016, PROGR NEUROBIOLOGY; Di Y, 2013, INT J OPHTHALMOL-CHI, V6, P115, DOI 10.3980/j.issn.2222-3959.2013.02.01; George A, 2005, EXP EYE RES, V81, P616, DOI 10.1016/j.exer.2005.03.021; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; Grewal JS, 1999, AM J PHYSIOL-RENAL, V276, pF922, DOI 10.1152/ajprenal.1999.276.6.F922; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; HADJICONSTANTINOU M, 1983, J NEUROCHEM, V41, P1440, DOI 10.1111/j.1471-4159.1983.tb00843.x; HAMMANG JP, 1992, J COMP NEUROL, V316, P383, DOI 10.1002/cne.903160309; Han L, 2007, BRAIN RES BULL, V73, P273, DOI 10.1016/j.brainresbull.2007.04.005; Hidaka S, 2009, J INTEGR NEUROSCI, V8, P299, DOI 10.1142/S0219635209002198; Howell LL, 2015, PHARMACOL REV, V67, P176, DOI 10.1124/pr.114.009514; KATO S, 1982, J NEUROCHEM, V39, P493, DOI 10.1111/j.1471-4159.1982.tb03971.x; KELLAND MD, 1993, BRAIN RES BULL, V31, P539, DOI 10.1016/0361-9230(93)90121-Q; Liu Yan, 2005, J PREV MED CHIN PLA, V5, P415; Nash M, 1999, OPHTHALMIC RES, V31, P1, DOI 10.1159/000055506; NORTON TT, 1992, VISION RES, V32, P833, DOI 10.1016/0042-6989(92)90026-F; Ohngemach S, 1997, VISUAL NEUROSCI, V14, P493, DOI 10.1017/S0952523800012153; OSBORNE NN, 1982, NEUROCHEM INT, V4, P175, DOI 10.1016/0197-0186(82)90012-2; OSBORNE NN, 1981, J NEUROCHEM, V36, P17, DOI 10.1111/j.1471-4159.1981.tb02372.x; OSBORNE NN, 1983, NEUROSCI LETT, V39, P33, DOI 10.1016/0304-3940(83)90161-1; Pootanakit K, 1999, VISUAL NEUROSCI, V16, P221, DOI 10.1017/S0952523899162035; SCHAEFFEL F, 1995, VISION RES, V35, P1247, DOI 10.1016/0042-6989(94)00221-7; Schwahn HN, 1997, VISION RES, V37, P2661, DOI 10.1016/S0042-6989(97)00114-4; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; TSAI WH, 1987, NEUROSCIENCE, V22, P675, DOI 10.1016/0306-4522(87)90363-0; Wang F, 2011, CURR EYE RES, V36, P103, DOI 10.3109/02713683.2010.526750; Yang JW, 2010, INT J OPHTHALMOL-CHI, V3, P299, DOI 10.3980/j.issn.2222-3959.2010.04.05; Yu Y, 2011, OPHTHALMIC RES, V46, P80, DOI 10.1159/000323179; ZIFA E, 1992, PHARMACOL REV, V44, P401	37	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167902	10.1371/journal.pone.0167902	http://dx.doi.org/10.1371/journal.pone.0167902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959948	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900022
J	Luft, N; Wozniak, PA; Aschinger, GC; Fondi, K; Bata, AM; Werkmeister, RM; Schmidl, D; Witkowska, KJ; Bolz, M; Garhofer, G; Schmetterer, L				Luft, Nikolaus; Wozniak, Piotr A.; Aschinger, Gerold C.; Fondi, Klemens; Bata, Ahmed M.; Werkmeister, Rene M.; Schmidl, Doreen; Witkowska, Katarzyna J.; Bolz, Matthias; Garhoefer, Gerhard; Schmetterer, Leopold			Ocular Blood Flow Measurements in Healthy White Subjects Using Laser Speckle Flowgraphy	PLOS ONE			English	Article							OPTIC-NERVE HEAD; WAVE-FORM ANALYSIS; CENTRAL SEROUS CHORIORETINOPATHY; NORMAL-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; HUMAN RETINA; VELOCITY; CIRCULATION; PULSE; MICROCIRCULATION	Purpose To assess the feasibility and reliability of Laser Speckle Flowgraphy (LSFG) to measure ocular perfusion in a sample of healthy white subjects and to elucidate the age-dependence of the parameters obtained. Methods This cross-sectional study included 80 eyes of 80 healthy, non-smoking white subjects of Western European descent between 19 and 79 years of age. A commercial LSFG instrument was applied to measure ocular blood flow at the optic nerve head (ONH) three successive times before and after pharmacological pupil dilation. The mean blur rate (MBR), a measure of relative blood flow velocity, was obtained for different regions of the ONH. Eight parameters of ocular perfusion derived from the pulse-waveform analysis of MBR including blowout time (BOT) and falling rate (FR) were also recorded. Results Artifact-free LSFG images meeting the quality criteria for automated image analysis were obtainable in 93.8% without pupil dilation and in 98.8% with pharmacological pupil dilation. Measurements of MBR showed excellent repeatability with intraclass correlation coefficients >= 0.937 and were barely affected by pupil dilation. The majority of pulse-waveform derived variables exhibited equally high repeatability. MBR-related blood flow indices exhibited significant age dependence (p<0.001). FR (r = 0.747, p<0.001) and BOT (r = -0.714, p<0.001) most strongly correlated with age. Conclusions LSFG represents a reliable method for the quantitative assessment of ocular blood flow in white subjects. Our data affirms that the LSFG-derived variables FR and BOT may be useful biomarkers for age-related changes in ocular perfusion.	[Luft, Nikolaus; Wozniak, Piotr A.; Fondi, Klemens; Bata, Ahmed M.; Schmidl, Doreen; Witkowska, Katarzyna J.; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Luft, Nikolaus; Bolz, Matthias] Kepler Univ Hosp, Dept Ophthalmol, Linz, Austria; [Luft, Nikolaus] Ludwig Maximilians Univ Munchen, Univ Eye Hosp, Munich, Germany; [Wozniak, Piotr A.] Med Univ Warsaw, Dept Ophthalmol, Warsaw, Poland; [Aschinger, Gerold C.; Werkmeister, Rene M.; Schmidl, Doreen; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Aschinger, Gerold C.] Vienna Univ Technol, Inst Appl Phys, Vienna, Austria; [Schmetterer, Leopold] Singapore Eye Res Inst, Singapore, Singapore; [Schmetterer, Leopold] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Medical University of Vienna; Kepler University Hospital; University of Munich; Medical University of Warsaw; Medical University of Vienna; Technische Universitat Wien; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schmetterer, L (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.; Schmetterer, L (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.; Schmetterer, L (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Schmetterer, L (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	leopold.schmetterer@meduniwien.ac.at	Bata, Ahmed/AAH-1735-2020; Wozniak, Piotr/AAT-7394-2020; Bolz, Matthias/HCI-0622-2022	Bata, Ahmed/0000-0001-5228-762X; Wozniak, Piotr/0000-0002-0944-0438; Schmetterer, Leopold/0000-0002-7189-1707; Schmidl, Doreen/0000-0001-5664-7768; Bolz, Matthias/0000-0001-8691-5276; Werkmeister, Rene/0000-0002-5147-5714	NIDEK Co. Ltd.	NIDEK Co. Ltd.	This study was supported by an unrestricted grant from NIDEK Co. Ltd. (https://www.nidek-intl.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Baumann B, 2011, BIOMED OPT EXPRESS, V2, P1539, DOI 10.1364/BOE.2.001539; BRIERS JD, 1982, INVEST OPHTH VIS SCI, V22, P255; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cull G, 2013, INVEST OPHTH VIS SCI, V54, P4271, DOI 10.1167/iovs.13-12013; Doblhoff-Dier V, 2014, BIOMED OPT EXPRESS, V5, P630, DOI 10.1364/BOE.5.000630; FRANK O, 1990, J MOL CELL CARDIOL, V22, P255, DOI 10.1016/0022-2828(90)91460-O; Garhofer G, 2004, CURR EYE RES, V28, P351, DOI 10.1076/ceyr.28.5.351.28680; Garhofer G, 2012, INVEST OPHTH VIS SCI, V53, P698, DOI 10.1167/iovs.11-8624; Himori N, 2016, GRAEF ARCH CLIN EXP, V254, P333, DOI 10.1007/s00417-015-3203-z; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001256; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000519; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Kuroda Y, 2016, GRAEF ARCH CLIN EXP, V254, P963, DOI 10.1007/s00417-015-3247-0; Matsumoto T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/693056; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Murakami Y, 2015, ACTA OPHTHALMOL, V93, pE644, DOI 10.1111/aos.12693; Okamoto M, 2016, RETINA-J RET VIT DIS, V36, P805, DOI 10.1097/IAE.0000000000000800; Okuno T, 2002, JPN J OPHTHALMOL, V46, P170, DOI 10.1016/S0021-5155(01)00498-1; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Rina M, 2015, GRAEF ARCH CLIN EXP, V253, P2285, DOI 10.1007/s00417-015-3123-y; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Saito M, 2015, INVEST OPHTH VIS SCI, V56, P6515, DOI 10.1167/iovs.15-17246; Saito M, 2014, CLIN EXP OPHTHALMOL, V42, P139, DOI 10.1111/ceo.12143; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Shiba T, 2016, GRAEF ARCH CLIN EXP, V254, P1033, DOI 10.1007/s00417-015-3145-5; Shiba T, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/291687; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2015, CURR EYE RES, V40, P1055, DOI 10.3109/02713683.2014.971934; Shiga Y, 2014, INVEST OPHTH VIS SCI, V55, P3899, DOI 10.1167/iovs.14-14116; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Takayama J, 2009, EYE, V23, P827, DOI 10.1038/eye.2008.142; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Terai N, 2012, ACTA OPHTHALMOL, V90, pE524, DOI 10.1111/j.1755-3768.2012.02486.x; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P873, DOI 10.1167/iovs.13-13716; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wang YM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772871; Werkmeister RM, 2012, INVEST OPHTH VIS SCI, V53, P6062, DOI 10.1167/iovs.12-9514; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567	51	54	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168190	10.1371/journal.pone.0168190	http://dx.doi.org/10.1371/journal.pone.0168190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959905	gold, Green Published			2022-12-26	WOS:000392753900048
J	Mendonca, C; Mandelli, P; Pulkki, V				Mendonca, Catarina; Mandelli, Pietro; Pulkki, Ville			Modeling the Perception of Audiovisual Distance: Bayesian Causal Inference and Other Models	PLOS ONE			English	Article							AUDITORY-PERCEPTION; INTEGRATION; VENTRILOQUISM; CAPTURE; VISION; HUMANS; DEPTH	Studies of audiovisual perception of distance are rare. Here, visual and auditory cue interactions in distance are tested against several multisensory models, including a modified causal inference model. In this causal inference model predictions of estimate distributions are included. In our study, the audiovisual perception of distance was overall better explained by Bayesian causal inference than by other traditional models, such as sensory dominance and mandatory integration, and no interaction. Causal inference resolved with probability matching yielded the best fit to the data. Finally, we propose that sensory weights can also be estimated from causal inference. The analysis of the sensory weights allows us to obtain windows within which there is an interaction between the audiovisual stimuli. We find that the visual stimulus always contributes by more than 80% to the perception of visual distance. The visual stimulus also contributes by more than 50% to the perception of auditory distance, but only within a mobile window of interaction, which ranges from 1 to 4 m.	[Mendonca, Catarina; Pulkki, Ville] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland; [Mandelli, Pietro] Polytech Univ Milan, Sch Ind & Informat Engn, Milan, Italy	Aalto University; Polytechnic University of Milan	Mendonca, C (corresponding author), Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.	Catarina.Mendonca@aalto.fi	Pulkki, Ville/G-2394-2013; Mendonca, Catarina/L-8877-2013	Pulkki, Ville/0000-0003-3460-9677; Mendonca, Catarina/0000-0002-4333-898X	European Union [659114]; Academy of Finland [266239]	European Union(European Commission); Academy of Finland(Academy of Finland)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant No 659114 and by the Academy of Finland, decision No 266239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska Curie grant No 659114 and by the Academy of Finland, decision no 266239.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Andersen TS, 2005, NEUROSCI LETT, V380, P155, DOI 10.1016/j.neulet.2005.01.030; Anderson PW, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01097; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beierholm U, 2007, ADV NEURAL INFORM PR, P81; Bizley JK, 2016, TRENDS NEUROSCI, V39, P74, DOI 10.1016/j.tins.2015.12.007; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; Calcagno ER, 2012, PERCEPTION, V41, P175, DOI 10.1068/p7153; CHONG SC, 1975, PERCEPT PSYCHOPHYS, V18, P55, DOI DOI 10.3758/BF03199367; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GARDNER MB, 1968, J ACOUST SOC AM, V43, P163, DOI 10.1121/1.1910747; GARDNER MB, 1969, J ACOUST SOC AM, V45, P47, DOI 10.1121/1.1911372; GILINSKY AS, 1951, PSYCHOL REV, V58, P460, DOI 10.1037/h0061505; Kim HY, 2001, APPL ACOUST, V62, P245, DOI 10.1016/S0003-682X(00)00023-2; KONRAD PK, 2007, PLOS ONE, V2, pE943, DOI DOI 10.1371/JOURNAL.PONE.0000943; Laitinen Mikko-Ville, 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P337, DOI 10.1109/ASPAA.2009.5346545; LITTLE AD, 1992, PERCEPTION, V21, P405, DOI 10.1068/p210405; Mendonca C, 2011, EXP BRAIN RES, V213, P185, DOI 10.1007/s00221-011-2620-4; MERSHON DH, 1989, PERCEPTION, V18, P403, DOI 10.1068/p180403; MERSHON DH, 1975, PERCEPT PSYCHOPHYS, V18, P409, DOI 10.3758/BF03204113; Mershon Donald H, 1980, J AUDITORY RES; Moore DR, 1999, CURR BIOL, V9, pR361, DOI 10.1016/S0960-9822(99)80227-9; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Odegaard B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004649; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pulkki V, 2007, J AUDIO ENG SOC, V55, P503; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080096; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Van der Stoep N, 2016, EXP BRAIN RES, V234, P1175, DOI 10.1007/s00221-015-4248-2; Van der Stoep N, 2015, NEUROPSYCHOLOGIA, V70, P335, DOI 10.1016/j.neuropsychologia.2014.12.007; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2001, OPTOMETRY VISION SCI, V78, P270, DOI 10.1097/00006324-200105000-00009	45	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0165391	10.1371/journal.pone.0165391	http://dx.doi.org/10.1371/journal.pone.0165391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959919	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900002
J	Wen, SX; Chen, XL; Xu, FZ; Sun, HL				Wen, Shuxiang; Chen, Xiaoling; Xu, Fuzhou; Sun, Huiling			Validation of Reference Genes for Real-Time Quantitative PCR (qPCR) Analysis of Avibacterium paragallinarum	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION; NORMALIZATION; PASTEURELLA; TOOL; IDENTIFICATION	Real-time quantitative reverse transcription PCR (qRT-PCR) offers a robust method for measurement of gene expression levels. Selection of reliable reference gene(s) for gene expression study is conducive to reduce variations derived from different amounts of RNA and cDNA, the efficiency of the reverse transcriptase or polymerase enzymes. Until now reference genes identified for other members of the family Pasteurellaceae have not been validated for Avibacterium paragallinarum. The aim of this study was to validate nine reference genes of serovars A, B, and C strains of A. paragallinarum in different growth phase by qRT-PCR. Three of the most widely used statistical algorithms, geNorm, NormFinder and Delta CT method were used to evaluate the expression stability of reference genes. Data analyzed by overall rankings showed that in exponential and stationary phase of serovar A, the most stable reference genes were gyrA and atpD respectively; in exponential and stationary phase of serovar B, the most stable reference genes were atpD and recN respectively; in exponential and stationary phase of serovar C, the most stable reference genes were rpoB and recN respectively. This study provides recommendations for stable endogenous control genes for use in further studies involving measurement of gene expression levels.	[Wen, Shuxiang; Chen, Xiaoling; Xu, Fuzhou; Sun, Huiling] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Sun, HL (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China.	sunhuiling01@163.com			National Key Research and Development Program of China [2016YFD0500804]; National Natural Science Foundation of China [30871867]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 2016YFD0500804 from National Key Research and Development Program of China, and grant 30871867 from National Natural Science Foundation of China. There was no additional external funding received for this study. The funders (funding bodies) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Blackall PJ, 2005, INT J SYST EVOL MICR, V55, P353, DOI 10.1099/ijs.0.63357-0; Blackall PJ, 1999, CLIN MICROBIOL REV, V12, P627, DOI 10.1128/CMR.12.4.627; Blackall PJ, 1997, DIS POULTRY, P179; Bujold Adina R, 2015, BMC Res Notes, V8, P86, DOI 10.1186/s13104-015-1045-8; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Christensen H, 2004, VET MICROBIOL, V99, P13, DOI 10.1016/j.vetmic.2003.12.002; Gautier AL, 2005, J CLIN MICROBIOL, V43, P2307, DOI 10.1128/JCM.43.5.2307-2314.2005; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jacob TR, 2011, BIOTECHNOL LETT, V33, P1177, DOI 10.1007/s10529-011-0552-5; Jacobsen AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115592; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kuhnert P, 2006, MICROBIOL-SGM, V152, P2537, DOI 10.1099/mic.0.28991-0; Labandeira-Rey M, 2009, INFECT IMMUN, V77, P3402, DOI 10.1128/IAI.00292-09; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Norskov-Lauritsen N, 2005, INT J SYST EVOL MICR, V55, P449, DOI 10.1099/ijs.0.63325-0; PAGE LA, 1962, AM J VET RES, V23, P85; Petersen KD, 2001, MICROBIOL-SGM, V147, P2739, DOI 10.1099/00221287-147-10-2739; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Richardson J, 2005, J MED MICROBIOL, V54, P497, DOI 10.1099/jmm.0.45949-0; Sihto HM, 2014, FEMS MICROBIOL LETT, V356, P134, DOI 10.1111/1574-6968.12491; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167736	10.1371/journal.pone.0167736	http://dx.doi.org/10.1371/journal.pone.0167736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942007	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600028
J	Alam, AHMK; Hossain, ASMS; Khan, MA; Kabir, SR; Abu Reza, M; Rahman, MM; Islam, MS; Rahman, MAA; Rashid, M; Sadik, MG				Alam, A. H. M. Khurshid; Hossain, A. S. M. Sakhawat; Khan, Muhammad Ali; Kabir, Syed Rashel; Abu Reza, Md; Rahman, Md Mahbubur; Islam, Mohammad Saiful; Rahman, Md Aziz Abdur; Rashid, Mamunur; Sadik, Md Golam			The Antioxidative Fraction of White Mulberry Induces Apoptosis through Regulation of p53 and NF kappa B in EAC Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GROWTH-INHIBITION; PHASE ARREST; CYCLE ARREST; CANCER; EXTRACTS; TEA; CHEMILUMINESCENCE; INDUCTION; INSIGHTS	In this study, the antioxidative fraction of white mulberry (Morus alba) was found to have an apotogenic effect on Ehrlich's ascites carcinoma cell-induced mice (EAC mice) that correlate with upregulated p53 and downregulated NF kappa B signaling. The antioxidant activities and polyphenolic contents of various mulberry fractions were evaluated by spectrophotometry and the ethyl acetate fraction (EAF) was selected for further analysis. Strikingly, the EAF caused 70.20% tumor growth inhibition with S-phase cell cycle arrest, normalized blood parameters including red/white blood cell counts and suppressed the tumor weight of EAC mice compared with untreated controls. Fluorescence microscopy analysis of EAF-treated EAC cells revealed DNA fragmentation, cell shrinkage, and plasma membrane blebbing. These characteristic morphological features of apoptosis influenced us to further investigate pro-and anti-apoptotic signals in EAF-treated EAC mice. Interestingly, apoptosis correlated with the upregulation of p53 and its target genes PARP-1 and Bax, and also with the down-regulation of NF.B and its target genes Bcl-2 and Bcl-xL. Our results suggest that the tumor-suppressive effect of the antioxidative fraction of white mulberry is likely due to apoptosis mediated by p53 and NF kappa B signaling.	[Alam, A. H. M. Khurshid; Hossain, A. S. M. Sakhawat; Rahman, Md Mahbubur; Islam, Mohammad Saiful; Rahman, Md Aziz Abdur; Rashid, Mamunur; Sadik, Md Golam] Rajshahi Univ, Dept Pharm, Rajshahi, Bangladesh; [Khan, Muhammad Ali] Bangabandhu Sheikh Mujibur Rahman Sci & Technol U, Dept Pharm, Gopalganj, Bangladesh; [Kabir, Syed Rashel] Rajshahi Univ, Dept Biochem & Mol Biol, Rajshahi, Bangladesh; [Abu Reza, Md] Rajshahi Univ, Dept Genet Engn & Biotechnol, Rajshahi, Bangladesh	University of Rajshahi; Bangabandhu Sheikh Mujibur Rahman Science & Technology University; University of Rajshahi; University of Rajshahi	Alam, AHMK (corresponding author), Rajshahi Univ, Dept Pharm, Rajshahi, Bangladesh.	khurshid.jaist@gmail.com	Abu Reza/ABE-6824-2020; Abu Reza, M./P-6725-2019; Khan, Muhammad Ali/ABA-9088-2021; Sadik, Md. Golam/ABA-9831-2021; Kabir, Syed Rashel/I-6247-2015; Hossain, ABm Sharif/C-2446-2019	Khan, Muhammad Ali/0000-0002-6980-6112; Kabir, Syed Rashel/0000-0002-5708-014X; Hossain, ABm Sharif/0000-0002-6437-3864; Alam, AHM Khurshid/0000-0003-2690-6559	Department of Pharmacy, University of Rajshahi, Bangladesh	Department of Pharmacy, University of Rajshahi, Bangladesh	The authors acknowledge the Dean and Department of Pharmacy, University of Rajshahi, Bangladesh for financial support. We further acknowledge Ms. Jenelle Hyunji Lee and Mr. John Vaughen for comments on the manuscript. We acknowledge ICDDR'B, Bangladesh for FAGS analysis. We also thank Dr. AHM Mahabubur Rahman, Associate Professor,	AHMED H, 1988, J BIOSCIENCE, V13, P419, DOI 10.1007/BF02703454; Alam AHMK, 2010, CELL BIOL INT, V34, P631, DOI 10.1042/CBI20090332; [Anonymous], 2011, INT J PHARM PHARM SC; Arfan M, 2012, INT J MOL SCI, V13, P2472, DOI 10.3390/ijms13022472; Balasubramanian A, 2004, IRANIAN J PHARM THER, V4, P13; Bhattacharyya A, 2003, CARCINOGENESIS, V24, P75, DOI 10.1093/carcin/24.1.75; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bruchlausen F.V, 1979, N-S ARCH PHARMACOL, V308, P27; Chinni SR, 2001, ONCOGENE, V20, P2927, DOI 10.1038/sj.onc.1204365; Choi HY, 2000, PHYTOTHER RES, V14, P250, DOI 10.1002/1099-1573(200006)14:4&lt;250::AID-PTR587&gt;3.0.CO;2-J; Chon SU, 2009, EUR FOOD RES TECHNOL, V230, P231, DOI 10.1007/s00217-009-1165-2; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deepa M, 2013, NUTR CANCER, V65, P305, DOI 10.1080/01635581.2013.748924; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Durackova Z, 2010, PHYSIOL RES, V59, P459, DOI 10.33549/physiolres.931844; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gomes A, 2011, TOXICON, V58, P85, DOI 10.1016/j.toxicon.2011.05.008; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hussein MSh, 2010, J AM SCI, V6, P762; Islam S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-142; Jaganathan SK, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/989163; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kabir SR, 2013, PHYTOMEDICINE, V20, P1288, DOI 10.1016/j.phymed.2013.06.010; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khalid N, 2011, PAK J BOT, V43, P91; Khan Muhammad Ali, 2013, BMC Res Notes, V6, P24, DOI 10.1186/1756-0500-6-24; Khanam JA, 2010, J NATL SCI FOUND SRI, V38, P225, DOI 10.4038/jnsfsr.v38i4.2649; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; Kumari SR, 1998, CANCER RES, V58, P5075; Kwon HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-392; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; Li H, 2009, FOOD CHEM, V112, P454, DOI 10.1016/j.foodchem.2008.05.111; Liu F, 2000, LIFE SCI, V66, P725, DOI 10.1016/S0024-3205(99)00643-8; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Nagai T, 2005, FOOD CHEM, V91, P389, DOI 10.1016/j.foodchem.2004.04.016; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Naowaratwattana W, 2010, J MED FOOD, V13, P1045, DOI 10.1089/jmf.2010.1021; Nomura M, 2000, CARCINOGENESIS, V21, P1885, DOI 10.1093/carcin/21.10.1885; Oktay M, 2003, LEBENSM-WISS TECHNOL, V36, P263, DOI 10.1016/S0023-6438(02)00226-8; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Saxena A, 2010, CHEM-BIOL INTERACT, V188, P580, DOI 10.1016/j.cbi.2010.09.029; Scully C, 1993, Dent Update, V20, P95; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24049; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; SUR P, 1994, PLANTA MED, V60, P106, DOI 10.1055/s-2006-959427; Visconti R, 2009, CURR OPIN DRUG DISC, V12, P240; Wang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071144; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhang YX, 2000, CANCER RES, V60, P2025	63	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167536	10.1371/journal.pone.0167536	http://dx.doi.org/10.1371/journal.pone.0167536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936037	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100117
J	Gil-Cayuela, C; Rosello-LLeti, E; Ortega, A; Tarazon, E; Trivino, JC; Martinez-Dolz, L; Gonzalez-Juanatey, JR; Lago, F; Portoles, M; Rivera, M				Gil-Cayuela, Carolina; Rosello-LLeti, Esther; Ortega, Ana; Tarazon, Estefania; Carlos Trivino, Juan; Martinez-Dolz, Luis; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca; Portoles, Manuel; Rivera, Miguel			New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process	PLOS ONE			English	Article							VIII COLLAGEN; MOLECULAR-MECHANISMS; ARTERIAL INJURY; HEART-FAILURE; ATHEROSCLEROSIS; HYPERTROPHY; GUIDELINES; CELLS	Background In dilated cardiomyopathy (DCM), cardiac failure is accompanied by profound alterations of extracellular matrix associated with the progression of cardiac dilation and left ventricular (LV) dysfunction. Recently, we reported alterations of non-fibrillar collagen expression in ischemic cardiomyopathy linked to fibrosis and cardiac remodeling. We suspect that expression changes in genes coding for non-fibrillar collagens may have a potential role in DCM development. Objectives This study sought to analyze changes in the expression profile of non-fibrillar collagen genes in patients with DCM and to examine relationships between cardiac remodeling parameters and the expression levels of these genes. Methods and Results Twenty-three human left ventricle tissue samples were obtained from DCM patients (n = 13) undergoing heart transplantation and control donors (n = 10) for RNA sequencing analysis. We found increased mRNA levels of six non-fibrillar collagen genes, such as COL4A5, COL9A1, COL21A1, and COL23A1 (P < 0.05 for all), not previously described in DCM. Protein levels of COL8A1 and COL16A1 (P < 0.05 for both), were correspondingly increased. We also identified TGF-beta 1 significantly upregulated and related to both COL8A1 and COL16A1. Interestingly, we found a significant relationship between LV mass index and the gene expression level of COL8A1 (r = 0.653, P < 0.05). Conclusions In our research, we identified new non-fibrillar collagens with altered expression in DCM, being COL8A1 overexpression directly related to LV mass index, suggesting that they may be involved in the progression of cardiac dilation and remodeling.	[Gil-Cayuela, Carolina; Rosello-LLeti, Esther; Ortega, Ana; Tarazon, Estefania; Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp IIS La Fe, Hlth Inst, Cardiocirculatory Unit, Valencia, Spain; [Carlos Trivino, Juan] Genom Syst, Paterna, Valencia, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Portoles, M; Rivera, M (corresponding author), La Fe Univ Hosp IIS La Fe, Hlth Inst, Cardiocirculatory Unit, Valencia, Spain.	portoles_man@gva.es; miguelrivera492@gmail.com	PORTOLES, MANUEL/B-4789-2009; Tarazón, Estefanía/D-6950-2017; Dolz, Luis Martinez/X-4627-2018; Ortega, Ana AO/D-3027-2017; Roselló Lletí, Esther/ABG-8503-2020; Roselló-Lletí, Esther/B-2695-2017; Gil-Cayuela, Carolina/D-6996-2017; Ortega, Ana/AAG-5941-2020	PORTOLES, MANUEL/0000-0002-4415-7160; Tarazón, Estefanía/0000-0003-3466-2558; Dolz, Luis Martinez/0000-0001-5145-8191; Ortega, Ana AO/0000-0002-9763-0505; Roselló Lletí, Esther/0000-0003-2627-6104; Roselló-Lletí, Esther/0000-0003-2627-6104; Gil-Cayuela, Carolina/0000-0002-1106-7935; Ortega, Ana/0000-0002-9763-0505; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); RETICS, Madrid, Spain [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain; European Regional Development Fund (FEDER)(European Commission); RETICS, Madrid, Spain	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); and RETICS, Madrid, Spain [12/0042/0003]. The funders provided support in the form of salaries for authors CGC, ERL, AO, and ET, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section and also included in this letter.	Barnes MJ, 1999, EXP GERONTOL, V34, P513, DOI 10.1016/S0531-5565(99)00038-8; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Brower GL, 2001, AM J PHYSIOL-HEART C, V280, pH674, DOI 10.1152/ajpheart.2001.280.2.H674; CAMPBELL GR, 1990, ANN NY ACAD SCI, V598, P143, DOI 10.1111/j.1749-6632.1990.tb42286.x; CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116; Dray S., 2007, R NEWS, V7, P47; Fitzgerald J, 2001, FEBS LETT, V505, P275, DOI 10.1016/S0014-5793(01)02754-5; Gil-Cayuela C, 2015, J AM COLL CARDIOL, V65, P1265, DOI 10.1016/j.jacc.2015.01.029; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Hou GP, 2000, AM J PATHOL, V156, P467, DOI 10.1016/S0002-9440(10)64751-7; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kapelko V I, 2001, Exp Clin Cardiol, V6, P41; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler I, 2011, J AM SOC NEPHROL, V22, P649, DOI 10.1681/ASN.2010010098; Lopes J, 2013, AM J PATHOL, V182, P2241, DOI 10.1016/j.ajpath.2013.02.011; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; MEDUGORAC I, 1982, BASIC RES CARDIOL, V77, P589, DOI 10.1007/BF01908312; Monkawa T, 2002, J AM SOC NEPHROL, V13, P1172, DOI 10.1097/01.ASN.0000013162.29833.45; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Plenz GAM, 2003, ATHEROSCLEROSIS, V166, P1, DOI 10.1016/S0021-9150(01)00766-3; Ratzinger S, 2010, MATRIX BIOL, V29, P177, DOI 10.1016/j.matbio.2009.11.004; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Shamhart PE, 2010, J MOL CELL CARDIOL, V48, P530, DOI 10.1016/j.yjmcc.2009.06.017; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sibinga NES, 1997, CIRC RES, V80, P532, DOI 10.1161/01.RES.80.4.532; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tarazon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090157; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Watanabe T, 1998, JPN HEART J, V39, P753; WEBER KT, 1995, HERZ, V20, P81; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; Xu R, 2001, BIOCHEM BIOPH RES CO, V289, P264, DOI 10.1006/bbrc.2001.5970	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168130	10.1371/journal.pone.0168130	http://dx.doi.org/10.1371/journal.pone.0168130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936202	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100274
J	Griggio, M; Fracasso, G; Mahr, K; Hoi, H				Griggio, Matteo; Fracasso, Gerardo; Mahr, Katharina; Hoi, Herbert			Olfactory Assessment of Competitors to the Nest Site: An Experiment on a Passerine Species	PLOS ONE			English	Article							ODOR RECOGNITION; PROCELLARIIFORM SEABIRDS; KIN RECOGNITION; BIRDS; PREDATORS; SONGBIRD; SCENT; PREFERENCE; AVOIDANCE; NAVIGATION	Since most avian species have been considered anosmic or microsmatic, olfaction and associated behavioural patterns have hardly been investigated. Most importantly, empirical data on avian olfaction is not equally distributed among species. Initial investigations focused on species with relatively big olfactory bulbs because they were thought to have better olfactory capabilities. Hence, in this study we tested the ability of house sparrows (Passer domesticus) to use chemical cues as parameters to estimate nest features. House sparrows are a commonly used model species, but their olfactory capabilities have not been studied so far. We offered two different odours to males and females, namely the scent of mouse urine (Mus musculus domesticus), representing a possible competitor and a threat to eggs and hatchlings, and the odour of hay, representing a familiar and innocuous odour. The experiment was performed at the sunset to simulate a first inspection to new possible roosting or nesting sites. Interestingly, males but not females preferred to spend significantly more time in front of the hay odour, than in front of the scent of mouse urine. Our results strengthen the hypothesis that oscines can not only perceive odours but also use olfaction to assess the environment and estimate nest site quality.	[Griggio, Matteo; Fracasso, Gerardo] Univ Padua, Dipartimento Biol, Via U Bassi, Padua, Italy; [Mahr, Katharina; Hoi, Herbert] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria	University of Padua; University of Veterinary Medicine Vienna	Griggio, M (corresponding author), Univ Padua, Dipartimento Biol, Via U Bassi, Padua, Italy.	matteo.griggio@unipd.it	Fracasso, Gerardo/G-4082-2018	Fracasso, Gerardo/0000-0003-3384-4472; Griggio, Matteo/0000-0002-3298-2905				Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2013, ECOL LETT, V16, P1348, DOI 10.1111/ele.12177; Amo L, 2012, ANIM BEHAV, V84, P1483, DOI 10.1016/j.anbehav.2012.09.021; Amo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027576; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; [Anonymous], 1963, THE HOUSE SPARROW; BANG BG, 1968, AUK, V85, P55; BANG BG, 1960, NATURE, V188, P547, DOI 10.1038/188547a0; Blight LK, 1999, CONDOR, V101, P871, DOI 10.2307/1370079; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bonadonna F, 2004, SCIENCE, V306, P835, DOI 10.1126/science.1103001; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Bradley JE, 2003, AUK, V120, P1180, DOI 10.1642/0004-8038(2003)120[1180:RANPIO]2.0.CO;2; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; Clark L, 1991, BIRD PARASITE INTERA, P204; Corfield JR, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00102; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; CRAMP S, 1992, BIRDS W PALEARCTIC, V8; Degraaf RM, 1999, WILSON BULL, V111, P236; Dell'Ariccia G, 2013, J EXP BIOL, V216, P1430, DOI 10.1242/jeb.082826; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Godard RD, 2007, J AVIAN BIOL, V38, P128, DOI 10.1111/j.2007.0908-8857.03788.x; Griggio M, 2016, ECOL EVOL, V6, P493, DOI 10.1002/ece3.1903; Griggio M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-44; Griggio M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-261; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Haahr M., 1998, TRUE RANDOM NUMBER S; Hagelin JC, 2003, P ROY SOC B-BIOL SCI, V270, P1323, DOI 10.1098/rspb.2003.2379; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Johnson LS, 2011, J FIELD ORNITHOL, V82, P150, DOI 10.1111/j.1557-9263.2011.00317.x; Krause ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036615; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mehlhorn J, 2010, BRAIN BEHAV EVOLUT, V75, P63, DOI 10.1159/000295151; Nevitt GA, 2000, BIOL BULL-US, V198, P245, DOI 10.2307/1542527; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; PICMAN J, 1994, WILSON BULL, V106, P456; Roth TC, 2008, ANIM BEHAV, V76, P2021, DOI 10.1016/j.anbehav.2008.08.022; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thompson FR, 1999, AUK, V116, P259, DOI 10.2307/4089477; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Zidar J, 2012, ANIM BEHAV, V84, P547, DOI 10.1016/j.anbehav.2012.06.006	47	8	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167905	10.1371/journal.pone.0167905	http://dx.doi.org/10.1371/journal.pone.0167905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936093	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100228
J	Huckstepp, RTR; Llaudet, E; Gourine, AV				Huckstepp, Robert T. R.; Llaudet, Enrique; Gourine, Alexander V.			CO2-Induced ATP-Dependent Release of Acetylcholine on the Ventral Surface of the Medulla Oblongata	PLOS ONE			English	Article							BRAIN-STEM; CO2 CHEMOSENSITIVITY; VENTILATORY RESPONSE; MAMMALIAN BRAIN; ASTROCYTES; SENSITIVITY; NEURONS; CHEMORECEPTORS; INHIBITION; MECHANISMS	Complex mechanisms that detect changes in brainstem parenchymal PCO2/[H+] and trigger adaptive changes in lung ventilation are responsible for central respiratory CO2 chemosensitivity. Previous studies of chemosensory signalling pathways suggest that at the level of the ventral surface of the medulla oblongata (VMS), CO2-induced changes in ventilation are (at least in part) mediated by the release and actions of ATP and/or acetylcholine (ACh). Here we performed simultaneous real-time biosensor recordings of CO2-induced ATP and ACh release from the VMS in vivo and in vitro, to test the hypothesis that central respiratory CO2 chemosensory transduction involves simultaneous recruitment of purinergic and cholinergic signalling pathways. In anaesthetised and artificially ventilated rats, an increase in inspired CO2 triggered ACh release on the VMS with a peak amplitude of similar to 5 mu M. Release of ACh was only detected after the onset of CO2-induced activation of the respiratory activity and was markedly reduced (by similar to 70%) by ATP receptor blockade. In horizontal slices of the VMS, CO2-induced release of ATP was reliably detected, whereas CO2 or bath application of ATP (100 mu M) failed to trigger release of ACh. These results suggest that during hypercapnia locally produced ATP induces or potentiates the release of ACh (likely from the medullary projections of distal groups of cholinergic neurones), which may also contribute to the development and/or maintenance of the ventilatory response to CO2.	[Huckstepp, Robert T. R.; Gourine, Alexander V.] UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England; [Huckstepp, Robert T. R.; Llaudet, Enrique] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of London; University College London; University of Warwick	Huckstepp, RTR (corresponding author), UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England.; Huckstepp, RTR (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	R.Huckstepp@warwick.ac.uk	Huckstepp, Robert/L-2387-2018	Huckstepp, Robert/0000-0003-4410-3397; Llaudet, Enrique/0000-0003-1136-0602	Wellcome trust	Wellcome trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome trust awarded to AVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne D, 2000, J PHYSIOL-LONDON, V525, P567, DOI 10.1111/j.1469-7793.2000.00567.x; Daly M. D. B., 1997, MONOGRAPH PHYSL SOC; DEV NB, 1979, PFLUG ARCH EUR J PHY, V379, P19, DOI 10.1007/BF00622900; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; FUKUDA Y, 1979, PFLUG ARCH EUR J PHY, V379, P125, DOI 10.1007/BF00586938; Garg SK, 2015, J APPL PHYSIOL, V119, P670, DOI 10.1152/japplphysiol.00411.2015; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Gourine AV, 2009, TRENDS NEUROSCI, V32, P241, DOI 10.1016/j.tins.2009.03.002; Gourine AV, 2005, J PHYSIOL-LONDON, V568, P715, DOI 10.1113/jphysiol.2005.095968; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gourine AV, 2005, J NEUROSCI, V25, P1211, DOI 10.1523/JNEUROSCI.3763-04.2005; Gourine AV, 2003, J PHYSIOL-LONDON, V552, P197, DOI 10.1113/jphysiol.2003.045294; Guyenet PG, 2016, J PHYSIOL-LONDON, V594, P1529, DOI 10.1113/JP271480; Hawkins V, 2014, FASEB J S, V28; HEERINGA J, 1979, RESP PHYSIOL, V37, P365, DOI 10.1016/0034-5687(79)90082-3; Huckstepp RTR, 2015, J NEUROSCI, V35, P1052, DOI 10.1523/JNEUROSCI.2953-14.2015; Huckstepp RTR, 2011, J PHYSIOL-LONDON, V589, P5561, DOI 10.1113/jphysiol.2011.214759; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3921, DOI 10.1113/jphysiol.2010.192096; Kasymov V, 2013, J NEUROSCI, V33, P435, DOI 10.1523/JNEUROSCI.2813-12.2013; Kumar NN, 2015, SCIENCE, V348, P1255, DOI 10.1126/science.aaa0922; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; NATTIE EE, 1994, RESP PHYSIOL, V97, P63, DOI 10.1016/0034-5687(94)90012-4; Nattie E, 2011, J APPL PHYSIOL, V110, P1, DOI 10.1152/japplphysiol.01061.2010; Ramanantsoa N, 2011, J NEUROSCI, V31, P12880, DOI 10.1523/JNEUROSCI.1721-11.2011; Sobrinho CR, 2016, J PHYSIOL-LONDON, V594, P407, DOI 10.1113/JP271761; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Stornetta RL, 2013, BRAIN STRUCT FUNCT, V218, P455, DOI 10.1007/s00429-012-0408-3; Thomas T, 2000, J PHYSIOL-LONDON, V523, P441, DOI 10.1111/j.1469-7793.2000.00441.x; Thomas T, 1999, J PHYSIOL-LONDON, V517, P899, DOI 10.1111/j.1469-7793.1999.00899.x; Turovsky E, 2016, J NEUROSCI, V36, P10750, DOI 10.1523/JNEUROSCI.1281-16.2016; Turovsky E, 2015, J PHYSIOL-LONDON, V593, P3159, DOI 10.1113/JP270369; Wenker IC, 2012, J PHYSIOL-LONDON, V590, P2137, DOI 10.1113/jphysiol.2012.229666; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; WOOLF NJ, 1989, BRAIN RES BULL, V23, P519, DOI 10.1016/0361-9230(89)90197-4; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x	42	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167861	10.1371/journal.pone.0167861	http://dx.doi.org/10.1371/journal.pone.0167861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936179	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100219
J	Liao, M; Xiao, JJ; Zhou, LJ; Liu, Y; Wu, XW; Hua, RM; Wang, GR; Cao, HQ				Liao, Min; Xiao, Jin-Jing; Zhou, Li-Jun; Liu, Yang; Wu, Xiang-Wei; Hua, Ri-Mao; Wang, Gui-Rong; Cao, Hai-Qun			Insecticidal Activity of Melaleuca alternifolia Essential Oil and RNA-Seq Analysis of Sitophilus zeamais Transcriptome in Response to Oil Fumigation	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; PLANT ESSENTIAL OILS; CHEMICAL-COMPOSITION; FLOUR BEETLE; GENES; EXPRESSION; DETOXIFICATION; TOOL; ACETYLCHOLINESTERASE; SUSCEPTIBILITY	Background The cereal weevil, Sitophilus zeamais is one of the most destructive pests of stored cereals worldwide. Frequent use of fumigants for managing stored-product insects has led to the development of resistance in insects. Essential oils from aromatic plants including the tea oil plant, Melaleuca alternifolia may provide environmentally friendly alternatives to currently used pest control agents. However, little is known about molecular events involved in stored-product insects in response to plant essential oil fumigation. Results M. alternifolia essential oil was shown to possess the fumigant toxicity against S. zeamais. The constituent, terpinen-4-ol was the most effective compound for fumigant toxicity. M. alternifolia essential oil significantly inhibited the activity of three enzymes in S. zeamais, including two detoxifying enzymes, glutathione S-transferase (GST), and carboxylesterase (CarE), as well as a nerve conduction enzyme, acetylcholinesterase (AChE). Comparative transcriptome analysis of S. zeamais through RNA-Seq identified a total of 3,562 differentially expressed genes (DEGs), of which 2,836 and 726 were up-regulated and down-regulated in response to M. alternifolia essential oil fumigation, respectively. Based on gene ontology (GO) analysis, the majority of DEGs were involved in insecticide detoxification and mitochondrial function. Furthermore, an abundance of DEGs mapped into the metabolism pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database were associated with respiration and metabolism of xenobiotics, including cytochrome P450s, CarEs, GSTs, and ATP-binding cassette transporters (ABC transporters). Some DEGs mapped into the proteasome and phagosome pathway were found to be significantly enriched. These results led us to propose a model of insecticide action that M. alternifolia essential oil likely directly affects the hydrogen carrier to block the electron flow and interfere energy synthesis in mitochondrial respiratory chain. Conclusion This is the first study to perform a comparative transcriptome analysis of S. zeamais in response to M. alternifolia essential oil fumigation. Our results provide new insights into the insecticidal mechanism of M. alternifolia essential oil fumigation against S. zeamais and eventually contribute to the management of this important agricultural pest.	[Liao, Min; Xiao, Jin-Jing; Zhou, Li-Jun; Cao, Hai-Qun] Anhui Agr Univ, Sch Plant Protect, Hefei, Peoples R China; [Liu, Yang; Wang, Gui-Rong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Wu, Xiang-Wei; Hua, Ri-Mao; Cao, Hai-Qun] Prov Key Lab Agri Food Safety, Hefei, Peoples R China	Anhui Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Cao, HQ (corresponding author), Anhui Agr Univ, Sch Plant Protect, Hefei, Peoples R China.; Cao, HQ (corresponding author), Prov Key Lab Agri Food Safety, Hefei, Peoples R China.	haiquncao@163.com	Zhou, Li/GSE-4531-2022	Liu, Yang/0000-0002-3424-7111	National forestry public welfare profession scientific research special project of China [201404601]	National forestry public welfare profession scientific research special project of China	This work was supported by National forestry public welfare profession scientific research special project of China (NO. 201404601). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgaleil SAM, 2016, J PEST SCI, V89, P219, DOI 10.1007/s10340-015-0665-z; Abouseadaa HH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0570-x; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Altincicek B, 2013, PLOS ONE, V8, P11; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2014, BIOINFORMATICS; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athanassiou CG, 2015, J ECON ENTOMOL, V108, P1422, DOI 10.1093/jee/tov069; Azeez S, 2012, J MOL MODEL, V18, P151, DOI 10.1007/s00894-011-1035-2; Bajda S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2157-1; Balyan R, 2015, CHEM-BIOL INTERACT, V240, P208, DOI 10.1016/j.cbi.2015.08.011; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benjamini Y, 2001, ANN STAT, V29, P1165; Chen Y., 2016, SCI REPORTS, V6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coronado-Puchau M, 2013, NANO TODAY, V8, P461, DOI 10.1016/j.nantod.2013.08.008; Cunha V, 2016, ENVIRON SCI POLLUT R, V23, P10615, DOI 10.1007/s11356-016-6547-y; Dippel S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1141; Du ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21827; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Fong DKH, 2016, PSYCHOMETRIKA, V81, P161, DOI 10.1007/s11336-014-9437-6; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; Gong YH, 2016, ECOTOXICOLOGY, V25, P655, DOI 10.1007/s10646-016-1624-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haddi K, 2015, J ECON ENTOMOL, V108, P362, DOI 10.1093/jee/tou049; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Huang YZ, 2011, INSECT SCI, V18, P181, DOI 10.1111/j.1744-7917.2010.01358.x; Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Jagadeesan R, 2015, PEST MANAG SCI, V71, P1379, DOI 10.1002/ps.3940; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; Kang JS, 2013, PESTIC BIOCHEM PHYS, V105, P184, DOI 10.1016/j.pestbp.2013.02.001; Kavitha K, 2013, BIOCHIMIE, V95, P1629, DOI 10.1016/j.biochi.2013.05.004; Korkina L, 2016, EXPERT OPIN DRUG MET, V12, P377, DOI 10.1517/17425255.2016.1149569; Li SG, 2013, J PEST SCI, V86, P677, DOI 10.1007/s10340-013-0520-z; Lins RF, 2016, COLLOID SURFACE A, V497, P271, DOI 10.1016/j.colsurfa.2016.02.024; Mansour SA, 2015, IND CROP PROD, V76, P900, DOI 10.1016/j.indcrop.2015.08.004; Herrera JM, 2015, IND CROP PROD, V70, P435, DOI 10.1016/j.indcrop.2015.03.074; Matthews HJ, 2010, ARCH INSECT BIOCHEM, V75, P139, DOI 10.1002/arch.20376; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mostofa MG, 2015, PROTOPLASMA, V252, P461, DOI 10.1007/s00709-014-0691-3; Nascimento SS, 2015, INT J MOL SCI, V16, P547, DOI 10.3390/ijms16010547; Nouri-Ganbalani G, 2016, J ESSENT OIL BEAR PL, V19, P1234, DOI 10.1080/0972060X.2016.1178606; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129482; Pan L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155682; Papadopoulou D, 2008, INT J FOOD SCI TECH, V43, P1053, DOI 10.1111/j.1365-2621.2007.01562.x; Pegard A., 2015, Phytotherapie (Paris), V13, P384, DOI 10.1007/s10298-015-0966-7; Prophiro JS, 2012, PARASITOL RES, V110, P713, DOI 10.1007/s00436-011-2547-5; Rajashekar Y, 2014, J FOOD SCI TECH MYS, V51, P3494, DOI 10.1007/s13197-012-0884-8; Riazanski V, 2015, P NATL ACAD SCI USA, V112, pE6486, DOI 10.1073/pnas.1518966112; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuler MA, 2012, MOL ECOL, V21, P4157, DOI 10.1111/j.1365-294X.2012.05657.x; Sfara V, 2009, J MED ENTOMOL, V46, P511, DOI 10.1603/033.046.0315; Shelton D, 2002, PLANT SCI, V162, P9, DOI 10.1016/S0168-9452(01)00504-0; SINGER TP, 1994, BBA-BIOENERGETICS, V1187, P198, DOI 10.1016/0005-2728(94)90110-4; Tak JH, 2016, J PEST SCI, V89, P183, DOI 10.1007/s10340-015-0655-1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thompson BM, 2016, FLA ENTOMOL, V99, P67, DOI 10.1653/024.099.0112; Thomsen NA, 2013, INT J ANTIMICROB AG, V41, P343, DOI 10.1016/j.ijantimicag.2012.12.011; Wang GB, 2015, J INVERTEBR PATHOL, V128, P37, DOI 10.1016/j.jip.2015.04.001; Zhang JQ, 2013, CHEMOSPHERE, V93, P1207, DOI 10.1016/j.chemosphere.2013.06.081; Zhang MX, 2013, PESTIC BIOCHEM PHYS, V107, P44, DOI 10.1016/j.pestbp.2013.05.002	67	56	61	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167748	10.1371/journal.pone.0167748	http://dx.doi.org/10.1371/journal.pone.0167748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936192	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100174
J	Mecacci, F; Serena, C; Avagliano, L; Cozzolino, M; Baroni, E; Rambaldi, MP; Simeone, S; Castiglione, F; Taddei, GL; Bulfamante, G				Mecacci, Federico; Serena, Caterina; Avagliano, Laura; Cozzolino, Mauro; Baroni, Eleonora; Rambaldi, Marianna Pina; Simeone, Serena; Castiglione, Francesca; Taddei, Gian Luigi; Bulfamante, Gaetano			Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology	PLOS ONE			English	Article							FETAL-GROWTH; REACTION PATTERNS; RESTRICTION; DEATH; REPRODUCIBILITY; IDENTIFICATION; NOSOLOGY; AGE	Objective To investigate the proportion of stillbirths at term associated with abnormal growth using customized birth weight percentiles and to compare histological placental findings both in underweight stillborn fetuses and in live births. Methods A retrospective case-control study of 150 singleton term stillbirths. The livebirth control groups included 586 cases of low-risk pregnancies and 153 late fetal growth restriction fetuses. Stillbirths and livebirths from low-risk pregnancies were classified using customized standards for fetal weight at birth, as adequate for gestational age (AGA; 10-90th percentile), small (SGA; <10th percentile) or large for gestational age (LGA; > 90th percentile). Placental characteristics in stillbirth were compared with those from livebirths using four categories: inflammation, disruptive, obstructive and adaptive lesions. Results There was a higher rate of SGA (26% vs 6%, p<0.001) and LGA fetuses (10.6% vs 5.6%, p<0.05) in the stillbirth group. Among stillbirth fetuses, almost half of the SGA were very low birthweight (<= 3 degrees percentile) (12% vs 0.3%, p<0.001). The disruptive (7.3% vs 0.17%; p<0.001), obstructive (54.6% vs 7.5%; p<0.001) and adaptive (46.6% vs 35.8%; p<0.001) findings were significantly more common in than in livebirth-low risk. Placental characteristics of AGA and SGA stillbirth were compared with those of AGA and FGR livebirth. In stillbirths-SGA we found a higher number of disruptive (12.8% vs 0%; p<0.001), obstructive (58.9% vs 23.5%; p<0.001) and adaptive lesions (56.4% vs 49%; p 0.47) than in livebirth-FGR. Conclusion The assessment of fetal weight with customized curves can identify fetuses which have not reached their genetically determined growth potential and are therefore at risk for adverse outcomes. Placental evaluation in stillbirths can reveal chronic histological signs that might be useful to clinical assessment, especially in underweight fetuses.	[Mecacci, Federico; Serena, Caterina; Baroni, Eleonora; Rambaldi, Marianna Pina; Simeone, Serena] Careggi Hosp, Dept Sci Hlth Women & Children, Florence, Italy; [Avagliano, Laura; Bulfamante, Gaetano] Univ Milan, Dept Hlth Sci, Sch Med, San Paolo Hosp, Milan, Italy; [Cozzolino, Mauro] Univ Florence, Div Obstet & Gynaecol, Dept Biomed Expt & Clin Sci, Florence, Italy; [Castiglione, Francesca; Taddei, Gian Luigi] Careggi Hosp, Dept Biomed, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; San Paolo-Polo Universitaria Hospital; University of Milan; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Serena, C (corresponding author), Careggi Hosp, Dept Sci Hlth Women & Children, Florence, Italy.	caterinaserena79@gmail.com	Avagliano, Laura/AAM-3412-2021	AVAGLIANO, LAURA/0000-0002-7808-7578				American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113; [Anonymous], ULTRASOUND GUIDELINE; Avagliano L, 2013, PLACENTA, V34, P1091, DOI 10.1016/j.placenta.2013.09.004; Avagliano L, 2015, EARLY HUM DEV, V91, P339, DOI 10.1016/j.earlhumdev.2015.03.004; Avagliano L, 2012, J MATERN-FETAL NEO M, V25, P2789, DOI 10.3109/14767058.2012.705395; Avagliano L, 2010, HUM PATHOL, V41, P971, DOI 10.1016/j.humpath.2009.07.026; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; DIVON MY, 1986, AM J OBSTET GYNECOL, V155, P1197, DOI 10.1016/0002-9378(86)90144-4; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Flenady V, 2009, PSANZ CLIN PRACT GUI; Fretts R, 2010, CLIN OBSTET GYNECOL, V53, P588, DOI 10.1097/GRF.0b013e3181eb63fc; Gardosi J, 2014, PUBLIC HEALTH, V128, P698, DOI 10.1016/j.puhe.2014.06.022; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009; Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe; Langston C, 1997, ARCH PATHOL LAB MED, V121, P449; Monari F, 2012, EARLY HUM DEV, V88, P251, DOI 10.1016/j.earlhumdev.2011.08.013; Ptacek I, 2014, PLACENTA, V35, P552, DOI 10.1016/j.placenta.2014.05.011; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P443, DOI 10.1007/s10024-004-2020-x; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005; Serena C, 2013, J MATERN-FETAL NEO M, V26, P16, DOI 10.3109/14767058.2012.718389; Smith NA, 2014, ULTRASOUND OBST GYN, V44, P595, DOI 10.1002/uog.13333; SOGC clinical practice guideline, 2006, J OBSTET GYNAECOL CA, V28, P540; Stanek J, 2013, ARCH PATHOL LAB MED, V137, P706, DOI 10.5858/arpa.2011-0645-RA; Stanek J, 2012, PEDIATR DEVEL PATHOL, V15, P13, DOI 10.2350/11-03-1000-OA.1; Tellefsen CH, 2011, PEDIATR DEVEL PATHOL, V14, P99, DOI 10.2350/10-07-0870-OA.1; Waldenstrom U, 2015, OBSTET GYNECOL, V126, P355, DOI 10.1097/AOG.0000000000000947	29	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166514	10.1371/journal.pone.0166514	http://dx.doi.org/10.1371/journal.pone.0166514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936018	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100031
J	Moruzzi, S; Udali, S; Ruzzenente, A; Guglielmi, A; Guarini, P; Martinelli, N; Conci, S; Mazzi, F; Pattini, P; Tammen, SA; Olivieri, O; Pizzolo, F; Choi, SW; Friso, S				Moruzzi, Sara; Udali, Silvia; Ruzzenente, Andrea; Guglielmi, Alfredo; Guarini, Patrizia; Martinelli, Nicola; Conci, Simone; Mazzi, Filippo; Pattini, Patrizia; Tammen, Stephanie A.; Olivieri, Oliviero; Pizzolo, Francesca; Choi, Sang-Woon; Friso, Simonetta			The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; ACUTE LYMPHOBLASTIC-LEUKEMIA; NEURAL-TUBE DEFECTS; COLORECTAL-CANCER; METHIONINE SYNTHASE; METABOLIZING GENES; TOTAL HOMOCYSTEINE; BREAST-CANCER; COLON-CANCER; METHYLENETETRAHYDROFOLATE REDUCTASE	Polymorphisms within one-carbon metabolism genes have been largely studied in relation to cancer risk for the function of this pathway in nucleotide synthesis and DNA methylation. Aims of this study were to explore the possible link among several common functional gene polymorphisms within one-carbon metabolism and survival rate in primary liver cancers, i.e., hepatocellular carcinoma and cholangiocarcinoma, and to assess the additional effect of global DNA methylation on survival rate and mortality risk. Forty-seven primary liver cancer patients were genotyped for ten polymorphisms: DHFR 19bp ins/del, TS 2rpt-3rpt, MTHFD1 1958G>A, MTHFR 677C>T, MTR 2756A>G, MTRR 66A>G, RFC1 80G>A, SHMT1 1420C>T, BHMT 716 A>G, TC II 776C>G. Methylation was determined in peripheral blood mononuclear cells (PBMCs) DNA as methylcytosine (mCyt) content using LC/MS/MS. Among the polymorphisms analysed, the RFC1 80G>A (rs1051266) influenced the survival rate in primary liver cancers. The RFC1 80AA was associated to a significantly reduced survival rate (22.2%) as compared to both GG and GA genotypes (61.5% and 76% respectively, p = 0.005). When the cancer patients were stratified according to the mCyt median value as high (>5.34%) or low (<= 5.34%), the concomitant presence of AA genotype and low mCyt level led to a significantly worse survival rate as compared to the G allele carriership (p<0.0001) with a higher Hazard Ratio (HR = 6.62, p = 0.001). The subjects carrying the AA genotype in association with high mCyt did not show a significant difference in survival rate as compared with the G allele carriers (p = 0.919). The RFC1 80G>A polymorphism influenced the survival rate, and the presence of RFC1 80AA genotype with low global methylation in PBMCs DNA was associated with poorer prognosis and higher mortality risk, therefore highlighting novel molecular signatures potentially helpful to define prognostic markers for primary liver cancers.	[Moruzzi, Sara; Udali, Silvia; Guarini, Patrizia; Martinelli, Nicola; Mazzi, Filippo; Pattini, Patrizia; Olivieri, Oliviero; Pizzolo, Francesca; Friso, Simonetta] Univ Verona, Dept Med, Sch Med, Verona, Italy; [Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone] Univ Verona, Sch Med, Dept Surg, Verona, Italy; [Tammen, Stephanie A.; Choi, Sang-Woon] Tufts Univ, Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Choi, Sang-Woon] CHA Univ, Chaum Life Ctr, Seoul, South Korea	University of Verona; University of Verona; Tufts University; Pochon Cha University	Friso, S (corresponding author), Univ Verona, Dept Med, Sch Med, Verona, Italy.	simonetta.friso@univr.it	Friso, Simonetta/K-4715-2016; Olivieri, Oliviero/A-9126-2008; conci, simone/AAB-6516-2022; Pizzolo, Francesca/AAF-6581-2020; Ruzzenente, Andrea/R-5850-2019	Olivieri, Oliviero/0000-0001-8209-9056; conci, simone/0000-0001-7110-1974; Pizzolo, Francesca/0000-0003-4419-3994; Ruzzenente, Andrea/0000-0001-6911-563X; Mazzi, Filippo/0000-0001-5623-2108				Leyva-Vazquez MA, 2012, J INVEST MED, V60, P1064, DOI 10.2310/JIM.0b013e31826803c1; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BRIGLE KE, 1995, J BIOL CHEM, V270, P22974, DOI 10.1074/jbc.270.39.22974; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928; Deroo LA, 2014, CARCINOGENESIS, V35, P333, DOI 10.1093/carcin/bgt342; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; DeVos L, 2008, AM J CLIN NUTR, V88, P1149, DOI 10.1093/ajcn/88.4.1149; DIXON KH, 1994, J BIOL CHEM, V269, P17; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Friso S, 2013, CANCER EPIDEM BIOMAR, V22, P348, DOI 10.1158/1055-9965.EPI-12-0859; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Gotze T, 2007, CANCER LETT, V251, P228, DOI 10.1016/j.canlet.2006.11.021; Han SS, 2012, CANCER EPIDEM BIOMAR, V21, P417, DOI 10.1158/1055-9965.EPI-11-0782; Hazra A, 2007, CARCINOGENESIS, V28, P1510, DOI 10.1093/carcin/bgm062; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hol FA, 1998, CLIN GENET, V53, P119; Jacques PF, 2003, ATHEROSCLEROSIS, V166, P49, DOI 10.1016/S0021-9150(02)00204-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jang MJ, 2014, GENE, V533, P558, DOI 10.1016/j.gene.2013.09.056; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Klerk M, 2003, THROMB RES, V110, P87, DOI 10.1016/S0049-3848(03)00341-4; Kotsopoulos J, 2008, BREAST CANCER RES TR, V112, P585, DOI 10.1007/s10549-008-9895-6; Laverdiere C, 2002, BLOOD, V100, P3832, DOI 10.1182/blood.V100.10.3832; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; Ma DWL, 2005, CANCER RES, V65, P887; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Galbiatti ALS, 2012, MOL BIOL REP, V39, P635, DOI 10.1007/s11033-011-0781-7; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; Ulrich CM, 2002, CANCER RES, V62, P3361; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Winkelmayer WC, 2003, KIDNEY INT, V63, P2280, DOI 10.1046/j.1523-1755.2003.00025.x; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Xu XR, 2008, CANCER EPIDEM BIOMAR, V17, P2109, DOI 10.1158/1055-9965.EPI-07-2900; Yates Z, 2005, LIFE SCI, V77, P2735, DOI 10.1016/j.lfs.2005.02.029; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	54	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167534	10.1371/journal.pone.0167534	http://dx.doi.org/10.1371/journal.pone.0167534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936032	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100116
J	Yoshinaga, T; Uwabe, K; Naito, S; Higashino, K; Nakano, T; Numata, Y; Kihara, A				Yoshinaga, Tomoyo; Uwabe, Kenichiro; Naito, Shoichi; Higashino, Kenichi; Nakano, Toru; Numata, Yoshito; Kihara, Akio			AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CHRONIC KIDNEY-DISEASE; CANNABINOID RECEPTOR 1; GROWTH FACTOR-BETA; TGF-BETA; MOLECULAR-MECHANISMS; FIBROSIS; MYOFIBROBLASTS; SYSTEM; GPR55	Epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells is one of the causative mechanisms of kidney fibrosis. In our study, we screened lipophilic compounds using a lipid library including approximately 200 lipids to identify those that suppressed EMT induced by a transforming growth factor (TGF)-beta 1 stimulus. Initial screening was performed with the immortalized HK-2 renal tubule epithelial cell line. The most promising compounds were further tested in RPTEC primary renal tubule epithelial cells. We found that the synthetic lipid AM251 suppressed two hallmark events associated with EMT, the upregulation of collagen 1A1 (COL1A1) and downregulation of E-cadherin. Though AM251 is known to act as an antagonist for the cannabinoid receptor type 1 (CB1) and an agonist for the G protein-coupled receptor 55 (GRP55), the suppression of EMT by AM251 was not mediated through either receptor. Microarray analyses revealed that AM251 inhibited induction of several EMT transcription factors such as SNAIL1, which is the key inducer of EMT, and the AP-1 transcription factors FOSB and JUNB. Activation of SMAD2/3 and p38 mitogen-activated protein kinase (MAPK) was inhibited by AM251, with greater inhibition of the latter, indicating that AM251 acted upstream of SMAD/p38 MAPK in the TGF-beta signaling pathway. Our findings regarding the effects of AM251 on the TGF-beta signaling pathway may inform development of a novel therapeutic agent suppressing EMT, thus preventing kidney fibrosis.	[Yoshinaga, Tomoyo; Kihara, Akio] Hokkaido Univ, Grad Sch Life Sci, Biochem Lab, Sapporo, Hokkaido, Japan; [Yoshinaga, Tomoyo; Naito, Shoichi; Higashino, Kenichi] Shionogi & Co Ltd, Biomarker R&D Dept, Toyonaka, Osaka, Japan; [Uwabe, Kenichiro] Shionogi & Co Ltd, Global Innovat Off, Div Pharmaceut Res, Toyonaka, Osaka, Japan; [Nakano, Toru] Shionogi & Co Ltd, Corp GxP Compliance Off, Toyonaka, Osaka, Japan; [Numata, Yoshito] Shionogi & Co Ltd, Drug Discovery Dis Lab, Sapporo, Hokkaido, Japan; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido, Japan	Hokkaido University; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Biochem Lab, Sapporo, Hokkaido, Japan.; Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Shionogi Co., Ltd.	Shionogi Co., Ltd.	Shionogi & Co., Ltd., funded the work presented in this manuscript but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jenkin KA, 2015, J ENDOCRINOL, V225, P113, DOI 10.1530/JOE-15-0004; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kargl J, 2013, J PHARMACOL EXP THER, V346, P54, DOI 10.1124/jpet.113.204180; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lecru L, 2015, KIDNEY INT, V88, P72, DOI 10.1038/ki.2015.63; Lin CL, 2014, J MOL MED, V92, P779, DOI 10.1007/s00109-014-1125-6; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Ovadya Y, 2015, NAT MED, V21, P975, DOI 10.1038/nm.3938; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sebe A, 2008, NEPHROL DIAL TRANSPL, V23, P1537, DOI 10.1093/ndt/gfm789; Skaper SD, 2012, PHILOS T R SOC B, V367, P3193, DOI 10.1098/rstb.2012.0313; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	35	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167848	10.1371/journal.pone.0167848	http://dx.doi.org/10.1371/journal.pone.0167848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936102	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100215
J	Han, XB; Shen, LQ; Wang, QJ; Cen, XF; Wang, J; Wu, M; Li, P; Zhao, W; Zhang, Y; Zhao, GP				Han, Xiaobiao; Shen, Liqiang; Wang, Qijun; Cen, Xufeng; Wang, Jin; Wu, Meng; Li, Peng; Zhao, Wei; Zhang, Yu; Zhao, Guoping			Cyclic AMP Inhibits the Activity and Promotes the Acetylation of Acetyl-CoA Synthetase through Competitive Binding to the ATP/AMP Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP; acetyl-CoA synthetase; acetylation; crystal structure; post-translational modification	COENZYME-A SYNTHETASE; ESCHERICHIA-COLI; RECEPTOR PROTEIN; RESPONSE REGULATOR; CAMP; ACTIVATION; IDENTIFICATION; TRANSCRIPTION; GROWTH; CHEY	The high-affinity biosynthetic pathway for converting acetate to acetyl-coenzyme A (acetyl-CoA) is catalyzed by the central metabolic enzyme acetyl-coenzymeAsynthetase (Acs), which is finely regulated both at the transcriptional level via cyclic AMP (cAMP)-driven trans-activation and at the post-translational level via acetylation inhibition. In this study, we discovered that cAMP directly binds to Salmonella enterica Acs (SeAcs) and inhibits its activity in a substrate-competitive manner. In addition, cAMP binding increases SeAcs acetylation by simultaneously promoting Pat-dependent acetylation and inhibiting CobB-dependent deacetylation, resulting in enhanced SeAcs inhibition. A crystal structure study and site-directed mutagenesis analyses confirmed that cAMP binds to the ATP/AMP pocket of SeAcs, and restrains SeAcs in an open conformation. The cAMP contact residues are well conserved from prokaryotes to eukaryotes, suggesting a general regulatory mechanism of cAMP on Acs.	[Han, Xiaobiao; Cen, Xufeng; Wang, Jin; Li, Peng; Zhao, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Shen, Liqiang; Zhang, Yu; Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol,Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China; [Wang, Qijun] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China; [Wu, Meng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhao, Guoping] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Guoping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Han, Xiaobiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, W (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Zhang, Y; Zhao, GP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol,Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China.; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China.; Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	wzhao@sibs.ac.cn; zhang-yu@sibs.ac.cn; gpzhao@sibs.ac.cn	Wang, Jin/P-5458-2019; Zhang, Yu/AAV-5722-2021	Wang, Jin/0000-0003-4008-9284; Zhang, Yu/0000-0002-1778-8389; Zhao, Wei/0000-0002-2422-8398; Li, Peng/0000-0001-8262-7330; Zhao, Guo-Ping/0000-0002-7621-6620	Natural Science Foundation for Youth Grant [31400039]; Postdoctoral Science Foundation of China Grant [2012M510787]; Chinese Thousand Talents Program	Natural Science Foundation for Youth Grant; Postdoctoral Science Foundation of China Grant; Chinese Thousand Talents Program	This work was supported by Natural Science Foundation for Youth Grant 31400039, Postdoctoral Science Foundation of China Grant 2012M510787, and the Chinese Thousand Talents Program grant. The authors declare no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barak R, 2004, J MOL BIOL, V342, P383, DOI 10.1016/j.jmb.2004.07.020; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Browning DF, 2004, MOL MICROBIOL, V51, P241, DOI 10.1046/j.1365-2958.2003.03824.x; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; DARI R, 1988, J BACTERIOL, V170, P65, DOI 10.1128/jb.170.1.65-70.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; MAKMAN RS, 1965, J BIOL CHEM, V240, P1309; Malecki J, 2000, J BIOL CHEM, V275, P8480, DOI 10.1074/jbc.275.12.8480; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; SUTHERLA.EW, 1969, DIABETES, V18, P797, DOI 10.2337/diab.18.12.797; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAKIO K, 1982, P NATL ACAD SCI-BIOL, V79, P2544, DOI 10.1073/pnas.79.8.2544; Tucker AC, 2014, J BIOL CHEM, V289, P36249, DOI 10.1074/jbc.M114.613901; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Villarreal JM, 2011, MICROBIOL-SGM, V157, P636, DOI 10.1099/mic.0.046045-0; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yan JS, 2008, J MOL BIOL, V376, P1260, DOI 10.1016/j.jmb.2007.12.070; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	50	11	11	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1374	1384		10.1074/jbc.M116.753640	http://dx.doi.org/10.1074/jbc.M116.753640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974467	Green Published, hybrid			2022-12-26	WOS:000393339800019
J	Lee, LM; Ji, M; Sinha, M; Dong, MB; Ren, X; Wang, YL; Lowell, CA; Ghosh, S; Locksley, RM; DeFranco, AL				Lee, Linda M.; Ji, Ming; Sinha, Meenal; Dong, Matthew B.; Ren, Xin; Wang, Yanli; Lowell, Clifford A.; Ghosh, Sankar; Locksley, Richard M.; DeFranco, Anthony L.			Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9	PLOS ONE			English	Article							HOUSE-DUST MITE; MEDIATED ALLERGIC INFLAMMATION; DENDRITIC CELLS; TYPE-2 IMMUNITY; STRUCTURAL CELLS; EPITHELIAL-CELLS; TH2 RESPONSES; REPORTER MICE; IN-VIVO; INNATE	Excessive type 2 helper T cell responses to environmental antigens can cause immunopathology such as asthma and allergy, but how such immune responses are induced remains unclear. We studied this process in the airways by immunizing mice intranasally with the antigen ovalbumin together with either of two Toll-like receptor (TLR) ligands. We found the TLR5 ligand flagellin promoted a type 2 helper T cell response, whereas, a TLR9 ligand CpG oligodeoxyribonucleotide (ODN) promoted a type 1 helper T cell response. CpG ODN induced mRNA encoding interleukin (IL)-12 p40, whereas, flagellin caused IL-33 secretion and induced mRNAs encoding IL-1 and thymic stromal lymphopoietin (TSLP). By using mice deficient in the TLR and IL-1R signaling molecule, myeloid differentiation primary response 88 (MyD88), in conventional dendritic cells (cDCs) and alveolar macrophages (AMs), and by cell sorting different lung populations after 2 hours of in vivo stimulation, we characterized the cell types that rapidly produced inflammatory cytokines in response to TLR stimulation. CpG ODN was likely recognized by TLR9 on cDCs and AMs, which made mRNA encoding IL-12. IL-12 was necessary for the subsequent innate and adaptive interferon-gamma production. In contrast, flagellin stimulated multiple cells of hematopoietic and non-hematopoietic origin, including AMs, DCs, monocytes, and lung epithelial cells. AMs were largely responsible for IL-1a, whereas lung epithelial cells made TSLP. Multiple hematopoietic cells, including AMs, DCs, and monocytes contributed to other cytokines, including IL-1 beta and TNF alpha. MyD88-dependent signals, likely through IL-1R and IL-33R, and MyD88-independent signals, likely from TSLP, were necessary in cDCs for promotion of the early IL-4 response by CD4 T cells in the draining lymph node. Thus, the cell types that responded to TLR ligands were a critical determinant of the innate cytokines produced and the character of the resulting adaptive immune response in the airways.	[Lee, Linda M.; Ji, Ming; Dong, Matthew B.; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lee, Linda M.; DeFranco, Anthony L.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Sinha, Meenal; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ren, Xin; Wang, Yanli; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; DeFranco, AL (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	Anthony.DeFranco@ucsf.edu	Sinha, Meenal/B-7158-2016	Sinha, Meenal/0000-0002-4008-4080; Lee, Linda/0000-0002-8106-1360	National Institutes of Health [PO1AI078869, T32AI007334, P30 DK063720]; University of California San Francisco Graduate Student Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R21AI117378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Graduate Student Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was in part supported by National Institutes of Health grants: PO1AI078869 (CAL, RML, ALD), T32AI007334 (LML), and P30 DK063720 (Diabetes Research Center Grant). LML was in part supported by the University of California San Francisco Graduate Student Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Chen L, 2006, J IMMUNOL, V177, P2373, DOI 10.4049/jimmunol.177.4.2373; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fougeron D, 2015, VACCINE, P1; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Honko AN, 2004, INFECT IMMUN, V72, P6676, DOI 10.1128/IAI.72.11.6676-6679.2004; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; MacDonald A. S., 2008, EXP MED, V205, P13; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; McAlees JW, 2014, MUCOSAL IMMUNOL; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakano H, 2013, METHODS MOL BIOL, V1032, P19, DOI 10.1007/978-1-62703-496-8_2; O'Neill LAJ, 2008, IMMUNOL REV, P10, DOI [10.1111/j.1600-065X.2008.00701.x, DOI 10.1111/J.1600-065X.2008.00701.X]; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pesce I, 2010, J INNATE IMMUN, V2, P144, DOI 10.1159/000254948; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulke S, 2011, J ALLERGY CLIN IMMUN, V128, P1340, DOI 10.1016/j.jaci.2011.07.036; Schulke S, 2010, MOL IMMUNOL, V48, P341, DOI 10.1016/j.molimm.2010.07.006; Shim JU, 2016, J ALLERGY CLIN IMMUN, V137, P426, DOI 10.1016/j.jaci.2015.07.010; Sinha M, 2015, AM J RESP CELL MOL B, P1; Smith K.D., 2003, NAT IMMUNOL, V5, P451, DOI DOI 10.1038/NI1011; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Suzuki K, 2005, AM J RESP CRIT CARE, V171, P707, DOI 10.1164/rccm.200408-1078OC; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	67	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167693	10.1371/journal.pone.0167693	http://dx.doi.org/10.1371/journal.pone.0167693			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977701	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400029
J	Doughty, CE; Wolf, A				Doughty, Christopher E.; Wolf, Adam			Detecting 3D Vegetation Structure with the Galileo Space Probe: Can a Distant Probe Detect Vegetation Structure on Earth?	PLOS ONE			English	Article							DISK-AVERAGED SPECTRA; BIDIRECTIONAL REFLECTANCE; PLANETARY CHARACTERISTICS; EXTRASOLAR PLANETS; SIGNATURES; LIFE; PHOTOSYNTHESIS; DETECTABILITY; COEVOLUTION; ATMOSPHERE	Sagan et al. (1993) used the Galileo space probe data and first principles to find evidence of life on Earth. Here we ask whether Sagan et al. (1993) could also have detected whether life on Earth had three-dimensional structure, based on the Galileo space probe data. We reanalyse the data from this probe to see if structured vegetation could have been detected in regions with abundant photosynthetic pigments through the anisotropy of reflected short-wave radiation. We compare changing brightness of the Amazon forest (a region where Sagan et al. (1993) noted a red edge in the reflectance spectrum, indicative of photosynthesis) as the planet rotates to a common model of reflectance anisotropy and found measured increase of surface reflectance of 0.019 +/- 0.003 versus a 0.007 predicted from only anisotropic effects. We hypothesize the difference was due to minor cloud contamination. However, the Galileo dataset had only a small change in phase angle (sun-satellite position) which reduced the observed anisotropy signal and we demonstrate that theoretically if the probe had a variable phase angle between 0-20 degrees, there would have been a much larger predicted change in surface reflectance of 0.1 and under such a scenario three-dimensional vegetation structure on Earth could possibly have been detected. These results suggest that anisotropic effects may be useful to help determine whether exoplanets have three-dimensional vegetation structure in the future, but that further comparisons between empirical and theoretical results are first necessary.	[Doughty, Christopher E.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Wolf, Adam] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Northern Arizona University; Princeton University	Doughty, CE (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.	chris.doughty@nau.edu						Anglada-Escude A G, 2016, NATURE; [Anonymous], 1877, DIFFERENT FORMS FLOW; Arnold L, 2002, ASTRON ASTROPHYS, V392, P231, DOI 10.1051/0004-6361:20020933; Bacour C, 2005, REMOTE SENS ENVIRON, V98, P80, DOI 10.1016/j.rse.2005.06.008; BELTON MJS, 1992, SPACE SCI REV, V60, P413, DOI 10.1007/BF00216864; Bicheron P, 2000, J GEOPHYS RES-ATMOS, V105, P26669, DOI 10.1029/2000JD900380; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Breon FM, 1997, IEEE T GEOSCI REMOTE, V35, P479, DOI 10.1109/36.563289; Breon FM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001094; Doughty CE, 2010, ASTROBIOLOGY, V10, P869, DOI 10.1089/ast.2010.0495; Ford EB, 2001, NATURE, V412, P885, DOI 10.1038/35091009; Fujii Y, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/184; Fujii Y, 2010, ASTROPHYS J, V715, P866, DOI 10.1088/0004-637X/715/2/866; Hall O, 2005, IEEE GEOSCI REMOTE S, V2, P177, DOI 10.1109/LGRS.2004.842447; Kenny R, 2001, GEOL SOC AM BULL, V113, P650, DOI 10.1130/0016-7606(2001)113<0650:SIVITN>2.0.CO;2; Kiang NY, 2007, ASTROBIOLOGY, V7, P486; Kiang NY, 2007, ASTROBIOLOGY, V7, P252, DOI 10.1089/ast.2006.0108; LI XW, 1992, IEEE T GEOSCI REMOTE, V30, P276, DOI 10.1109/36.134078; Lucht W, 2000, IEEE T GEOSCI REMOTE, V38, P977, DOI 10.1109/36.841980; Maignan F, 2004, REMOTE SENS ENVIRON, V90, P210, DOI 10.1016/j.rse.2003.12.006; Montanes-Rodriguez P, 2006, ASTROPHYS J, V651, P544, DOI 10.1086/507694; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Robinson TD, 2010, ASTROPHYS J LETT, V721, pL67, DOI 10.1088/2041-8205/721/1/L67; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Schaepman-Strub G, 2006, REMOTE SENS ENVIRON, V103, P27, DOI 10.1016/j.rse.2006.03.002; Seager S, 2005, ASTROBIOLOGY, V5, P372, DOI 10.1089/ast.2005.5.372; Tenenbaum P, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/6; Tinetti G, 2006, ASTROBIOLOGY, V6, P34, DOI 10.1089/ast.2006.6.34; Tinetti G, 2006, ASTROBIOLOGY, V6, P881, DOI 10.1089/ast.2006.6.881; Wolf A, 2010, REMOTE SENSING ENV	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167188	10.1371/journal.pone.0167188	http://dx.doi.org/10.1371/journal.pone.0167188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973530	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300019
J	Queliconi, BB; Kowaltowski, AJ; Gottlieb, RA				Queliconi, Bruno B.; Kowaltowski, Alicia J.; Gottlieb, Roberta A.			Bicarbonate Increases Ischemia-Reperfusion Damage by Inhibiting Mitophagy	PLOS ONE			English	Article							CORONARY ENDOTHELIAL-CELLS; MITOCHONDRIAL FRAGMENTATION; SUPEROXIDE-DISMUTASE; IN-VIVO; HEART; INJURY; PROTEASOME; APOPTOSIS; AUTOPHAGY; TRANSPORT	During an ischemic event, bicarbonate and CO2 concentration increase as a consequence of O-2 consumption and lack of blood flow. This event is important as bicarbonate/CO2 is determinant for several redox and enzymatic reactions, in addition to pH regulation. Until now, most work done on the role of bicarbonate in ischemia-reperfusion injury focused on pH changes; although reperfusion solutions have a fixed pH, cardiac resuscitation protocols commonly employ bicarbonate to correct the profound acidosis associated with respiratory arrest. However, we previously showed that bicarbonate can increase tissue damage and protein oxidative damage independent of pH. Here we show the molecular basis of bicarbonate- induced reperfusion damage: the presence of bicarbonate selectively impairs mitophagy, with no detectable effect on autophagy, proteasome activity, reactive oxygen species production or protein oxidation. We also show that inhibition of autophagy reproduces the effects of bicarbonate in reperfusion injury, providing additional evidence in support of this mechanism. This phenomenon is especially important because bicarbonate is widely used in resuscitation protocols after cardiac arrest, and while effective as a buffer, may also contribute to myocardial injury.	[Queliconi, Bruno B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil; [Queliconi, Bruno B.; Gottlieb, Roberta A.] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Universidade de Sao Paulo; Cedars Sinai Medical Center	Gottlieb, RA (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	Roberta.Gottlieb@cshs.org	Kowaltowski, Alicia J/H-8698-2012	Queliconi, Bruno Barros/0000-0001-7361-5573	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51906-1]; Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina [13/07937-8]; Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); NIH [P01 HL112730]; FAPESP [2009/50168-0, 2013/07292-7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL112730] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina; Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 10/51906-1) (AJK), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (13/07937-8) (AJK), Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma) (AJK, BBQ), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma) (AJK), and NIH P01 HL112730 (RAG). BBQ was a doctoral student supported by two FAPESP grants (2009/50168-0 and 2013/07292-7).	Alka K, 2014, IUBMB LIFE, V66, P596, DOI 10.1002/iub.1315; Andres AM, 2016, AM J PHYSIOL-HEART C, V311, pH219, DOI 10.1152/ajpheart.00041.2016; Andres AM, 2015, J MOL CELL CARDIOL, V78, P62, DOI 10.1016/j.yjmcc.2014.10.003; Andres AM, 2013, ANTIOXID REDOX SIGNA, V11; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; da Cunha FM, 2011, FREE RADICAL BIO MED, V51, P664, DOI 10.1016/j.freeradbiomed.2011.05.035; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dorn GW, 2015, CIRC RES, V116, P225, DOI 10.1161/CIRCRESAHA.114.305672; Duda T, 2015, J BIOL CHEM, V290, P11052, DOI 10.1074/jbc.M115.650408; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Facundo HTF, 2006, FREE RADICAL BIO MED, V40, P469, DOI 10.1016/j.freeradbiomed.2005.08.041; Gottlieb RA, 2015, SCIENCE, V350, P1162, DOI 10.1126/science.aad8222; Gottlieb RA, 2011, AUTOPHAGY, V7, P1573, DOI 10.4161/auto.7.12.18175; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Heijnen BHM, 2002, J APPL PHYSIOL, V93, P319, DOI 10.1152/japplphysiol.01112.2001; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Inserte J, 2008, CARDIOVASC RES, V77, P782, DOI 10.1093/cvr/cvm082; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kobayashi S, 2014, BIOCH BIOPHYS ACTA D; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kumar S, 2007, J CELL MOL MED, V11, P798, DOI 10.1111/j.1582-4934.2007.00053.x; Kumar S, 2011, CARDIOVASC RES, V89, P392, DOI 10.1093/cvr/cvq330; Lima ML, 2012, REV BRAS CIR CARDIOV, V27, P110, DOI 10.5935/1678-9741.20120016; Liochev SI, 2002, J BIOL CHEM, V277, P34674, DOI 10.1074/jbc.M204726200; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Meiltz A, 1998, J MOL CELL CARDIOL, V30, P327, DOI 10.1006/jmcc.1997.0595; Nozik-Grayck E, 2003, AM J PHYSIOL-HEART C, V285, pH2327, DOI 10.1152/ajpheart.00507.2003; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Perry CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016288; Pierce JD, 2016, J INFUS MURS, V39, P40, DOI 10.1097/NAN.0000000000000149; Queiroz RF, 2013, BIOCHEM J, V455, P37, DOI 10.1042/BJ20130180; Queliconi BB, 2013, FREE RADICAL BIO MED, V55, P46, DOI 10.1016/j.freeradbiomed.2012.11.007; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	48	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167678	10.1371/journal.pone.0167678	http://dx.doi.org/10.1371/journal.pone.0167678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973540	Green Submitted, gold, Green Published			2022-12-26	WOS:000392754300039
J	Esapa, CT; Piret, SE; Nesbit, MA; Loh, NY; Thomas, G; Croucher, PI; Brown, MA; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Piret, Sian E.; Nesbit, M. Andrew; Loh, Nellie Y.; Thomas, Gethin; Croucher, Peter I.; Brown, Matthew A.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			Mice with an N-Ethyl-N-Nitrosourea (ENU) Induced Tyr209Asn Mutation in Natriuretic Peptide Receptor 3 (NPR3) Provide a Model for Kyphosis Associated with Activation of the MAPK Signaling Pathway	PLOS ONE			English	Article							MOUSE MODEL; VERTEBRAL SEGMENTATION; SCHEUERMANN-DISEASE; SKELETAL GROWTH; GENE; MUTAGENESIS; DYSPLASIA; ETIOLOGY; DWARFISM	Non-syndromic kyphosis is a common disorder that is associated with significant morbidity and has a strong genetic involvement; however, the causative genes remain to be identified, as such studies are hampered by genetic heterogeneity, small families and various modes of inheritance. To overcome these limitations, we investigated 12 week old progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) using phenotypic assessments including dysmorphology, radiography, and dual-energy X-ray absorptiometry. This identified a mouse with autosomal recessive kyphosis (KYLB). KYLB mice, when compared to unaffected littermates, had: thoraco-lumbar kyphosis, larger vertebrae, and increased body length and increased bone area. In addition, female KYLB mice had increases in bone mineral content and plasma alkaline phosphatase activity. Recombination mapping localized the Kylb locus to a 5.5Mb region on chromosome 15A1, which contained 51 genes, including the natriuretic peptide receptor 3 (Npr3) gene. DNA sequence analysis of Npr3 identified a missense mutation, Tyr209Asn, which introduced an N-linked glycosylation consensus sequence. Expression of wild-type NPR3 and the KYLB-associated Tyr209Asn NPR3 mutant in COS-7 cells demonstrated the mutant to be associated with abnormal N-linked glycosylation and retention in the endoplasmic reticulum that resulted in its absence from the plasma membrane. NPR3 is a decoy receptor for C-type natriuretic peptide (CNP), which also binds to NPR2 and stimulates mitogen-activated protein kinase (MAPK) signaling, thereby increasing the number and size of hypertrophic chondrocytes. Histomorphometric analysis of KYLB vertebrae and tibiae showed delayed endochondral ossification and expansion of the hypertrophic zones of the growth plates, and immunohistochemistry revealed increased p38 MAPK phosphorylation throughout the growth plates of KYLB vertebrae. Thus, we established a model of kyphosis due to a novel NPR3 mutation, in which loss of plasma membrane NPR3 expression results in increased MAPK pathway activation, causing elongation of the vertebrae and resulting in kyphosis.	[Esapa, Christopher T.; Piret, Sian E.; Nesbit, M. Andrew; Loh, Nellie Y.; Thakker, Rajesh V.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Esapa, Christopher T.; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, MRC Mammalian Genet Unit, Harwell, Berks, England; [Esapa, Christopher T.; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, Mary Lyon Ctr, Harwell, Berks, England; [Thomas, Gethin; Brown, Matthew A.] Queensland Univ Technol, Translat Res Inst, Princess Alexandra Hosp, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia; [Nesbit, M. Andrew] Univ Ulster, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland; [Thomas, Gethin] Charles Sturt Univ, Wagga Wagga, NSW, Australia	University of Oxford; MRC Harwell; MRC Harwell; Queensland University of Technology (QUT); Garvan Institute of Medical Research; Ulster University; Charles Sturt University	Thakker, RV (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211; Cox, Roger/0000-0001-7170-5014; Piret, Sian/0000-0002-3586-7654; Thomas, Gethin/0000-0001-9081-3686; Croucher, Peter/0000-0002-7102-2413	Medical Research Council UK [G0600702, G9825289, G1000467]; European Union [Health-F2-2008-200800]; Medical Research Council [MC_U142661184, MC_U142684172, G0600702] Funding Source: researchfish; MRC [G0600702, MC_U142684172, MC_U142661184] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council UK, http://www.mrc.ac.uk (Grant numbers G0600702, G9825289, G1000467) (CTE, SEP, MAN, NYL, SDMB, RDC, RVT) and the European Union Framework 7, https://ec.europa.eu/research/fp7/index_en.cfm (Grant number Health-F2-2008-200800) (CTE, MAN, NYL, RVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Agoston H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-18; ANDERSEN J, 1991, J BONE JOINT SURG BR, V73, P859, DOI 10.1302/0301-620X.73B5.1894681; Axenovich TI, 2001, AM J MED GENET, V100, P275, DOI 10.1002/ajmg.1290; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; CARR AJ, 1990, J BONE JOINT SURG BR, V72, P144, DOI 10.1302/0301-620X.72B1.2298775; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Dauphinee SM, 2013, G3-GENES GENOM GENET, V3, P1753, DOI 10.1534/g3.113.007310; Esapa CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122650; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; FINDLAY A, 1989, J MED GENET, V26, P400, DOI 10.1136/jmg.26.6.400; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hough TA, 2007, J BONE MINER RES, V22, P1397, DOI 10.1359/jbmr.070515; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; MCKENZIE L, 1992, J MED GENET, V29, P41, DOI 10.1136/jmg.29.1.41; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Piret SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045217; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Scheuermann H., 1920, UGESKRIFT LAEGER, V82, P385; Serin E, 2006, FIRAT TIP DERGISI, V11, P213; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stricker SJ, 2002, INT PEDIAT, V17, P135; THEVENON A, 1987, SPINE, V12, P744, DOI 10.1097/00007632-198710000-00005; Toye AA, 2004, DIABETES, V53, P1577, DOI 10.2337/diabetes.53.6.1577; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Xin D, 2011, P INT C COMP PROBL S, P1; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167916	10.1371/journal.pone.0167916	http://dx.doi.org/10.1371/journal.pone.0167916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959934	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900023
J	Qian, JY; Chopp, M; Liu, ZW				Qian, Jian-Yong; Chopp, Michael; Liu, Zhongwu			Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPA	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; FACTOR GENE-EXPRESSION; BONE-MARROW; PLASMINOGEN-ACTIVATOR; STEM-CELLS; ISCHEMIC-STROKE; GROWTH-FACTOR; FUNCTIONAL RECOVERY; IN-VITRO	We reported that mesenchymal stromal cells (MSCs) enhance neurological recovery from experimental stroke and increase tissue plasminogen activator (tPA) expression in astrocytes. Here, we investigate mechanisms by which tPA mediates MSC enhanced axonal outgrowth. Primary murine neurons and astrocytes were isolated from wild-type (WT) and tPA-knockout (KO) cortices of embryos. Mouse MSCs (WT) were purchased from Cognate Inc. Neurons (WT or KO) were seeded in soma side of Xona microfluidic chambers, and astrocytes (WT or KO) and/or MSCs in axon side. The chambers were cultured as usual (normoxia) or subjected to oxygen deprivation. Primary neurons (seeded in plates) were cocultured with astrocytes and/or MSCs (in inserts) for Western blot. In chambers, WT axons grew significantly longer than KO axons and exogenous tPA enhanced axonal outgrowth. MSCs increased WT axonal outgrowth alone and synergistically with WT astrocytes at both normoxia and oxygen deprivation conditions. The synergistic effect was inhibited by U0126, an ERK inhibitor, and receptor associated protein (RAP), a low density lipoprotein receptor related protein 1 (LRP1) ligand antagonist. However, MSCs exerted neither individual nor synergistic effects on KO axonal outgrowth. Western blot showed that MSCs promoted astrocytic tPA expression and increased neuronal tPA alone and synergistically with astrocytes. Also, MSCs activated neuronal ERK alone and synergistically with astrocytes, which was inhibited by RAP. We conclude: (1) MSCs promote axonal outgrowth via neuronal tPA and synergistically with astrocytic tPA; (2) neuronal tPA is critical to observe the synergistic effect of MSC and astrocytes on axonal outgrowth; and (3) tPA mediates MSC treatment-induced axonal outgrowth through the LRP1 receptor and ERK.	[Qian, Jian-Yong; Chopp, Michael; Liu, Zhongwu] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48063 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, ZW (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zwliu@neuro.hfh.edu		Liu, Zhongwu/0000-0002-8571-8112	National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [R01NS066041, R01AG037506]; American Heart Association [15GRNT25560025]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health under award numbers R01NS066041 (ZL) and R01AG037506 (MC), and American Heart Association 15GRNT25560025 (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts MJ, 2013, NEUROLOGY, V80, P514, DOI 10.1212/WNL.0b013e31827b1b7c; Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barzilay R, 2013, EUR NEUROPSYCHOPHARM, V23, P1115, DOI 10.1016/j.euroneuro.2012.10.002; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bhasin A, 2011, CEREBROVASC DIS EXTR, V1, P93, DOI 10.1159/000333381; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1994, J BIOL CHEM, V269, P18521; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2010, PRESS, px; CRUTCHER KA, 1986, CRIT REV NEUROBIOL, V2, P297; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; EDGAR D, 1985, J CELL SCI, P107; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fang MC, 2010, J HOSP MED, V5, P406, DOI 10.1002/jhm.689; Filous A.R., 2016, PROG NEUROBIOL; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Goto JJ, 2002, J MOL NEUROSCI, V19, P37, DOI 10.1007/s12031-002-0008-4; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Gutierrez-Fernandez M, 2015, EXPERT OPIN BIOL TH, V15, P873, DOI 10.1517/14712598.2015.1040386; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Hu SQ, 2015, CNS NEUROSCI THER, V21, P520, DOI 10.1111/cns.12401; Ibrahim F, 2016, J STROKE CEREBROVASC; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; LEPRINCE P, 1991, J NEUROCHEM, V57, P665, DOI 10.1111/j.1471-4159.1991.tb03798.x; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Prasad JM, 2015, J BIOL CHEM, V290, P17262, DOI 10.1074/jbc.M115.660084; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Taylor Anne M., 2011, Critical Reviews in Biomedical Engineering, V39, P185, DOI 10.1615/CritRevBiomedEng.v39.i3.20; Vizard TN, 2015, NEUROSCI LETT, V603, P77, DOI 10.1016/j.neulet.2015.07.019; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Wind T, 2002, BIOL CHEM, V383, P21, DOI 10.1515/BC.2002.003; WOLF BB, 1992, AM J PATHOL, V141, P37; Wozniak W, 1993, Folia Morphol (Warsz), V52, P173; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang Y., 2016, MOL NEUROBIOL; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	70	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168345	10.1371/journal.pone.0168345	http://dx.doi.org/10.1371/journal.pone.0168345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959956	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900060
J	Xiao, Q; Zhang, BH; Deng, X; Wu, J; Wang, H; Wang, YG; Wang, WX				Xiao, Qin; Zhang, Baihua; Deng, Xiang; Wu, Jie; Wang, Hui; Wang, Yonggang; Wang, Wenxiang			The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; SURVIVAL; CANCER; RECURRENCE; CHEMOKINES; OUTCOMES	Background The pretreatment neutrophil-to-lymphocyte ratio (NLR) is an independent predictor of prognosis in various malignancies, but its predictive capacity in basaloid squamous cell carcinoma of the esophagus (BSCCE) remains unclear. We aim to determine the value of the inflammation-related factors, including the NLR, neutrophil-to-monocyte ratio (NMR), and albumin levels, in predicting BSCCE prognosis. Methods We retrospectively analyzed the records of 121 patients with pathologically diagnosed BSCCE that underwent a curative esophagectomy from January 2007 to December 2014. Univariate and multivariate analyses were used to identify prognostic factors for overall survival (OS) and recurrence-free survival (RFS). Results The preoperative NLR was correlated with the tumor length and NMR. In OS univariate analyses, a high NLR (>1.77), high NMR (>12.31), and low albumin (<= 40.0 g/L) level were significantly associated with a poorer survival in BSCCE. The median OS was significantly greater in low NLR (<= 1.77) than in the high NLR (>1.77) patients (51.0 vs. 31.0 months; P = 0.008). In multivariate analyses, only the NLR was an independent prognostic factor for OS (hazard ratio (HR), 2.030; 95% confidence interval (CI), 1.262-3.264; P = 0.003). A high NLR was also an independent predictor of a poorer RFS in BSCCE (HR, 2.222; 95% CI, 1.407-3.508; P = 0.001); the median RFS for low (<= 1.77) and high (>1.77) NLR patients was 44.0 months and 14.0 months, respectively. NLR remained a strong prognostic indicator for OS in stage I/II patients and a preoperative NLR>1.77 was predictive of a poor RFS in both stage I/II and stage III patients. Conclusions We show that the preoperative NLR, a convenient and cost-effective biomarker, may serve as a prognostic indicator for BSCCE patients following curative surgery.	[Xiao, Qin; Wang, Hui] Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Radiat Oncol,Key Lab Transla, Changsha, Hunan, Peoples R China; [Zhang, Baihua; Deng, Xiang; Wu, Jie; Wang, Wenxiang] Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Thorac Surg 2, Changsha, Hunan, Peoples R China; [Wang, Yonggang] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Thorac Surg, Beijing, Peoples R China; [Wang, Yonggang] Peking Union Med Coll, Beijing, Peoples R China	Central South University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, H (corresponding author), Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Radiat Oncol,Key Lab Transla, Changsha, Hunan, Peoples R China.	wanghui710327@163.com						Baba Y, 2015, ANN SURG ONCOL, V22, P3659, DOI 10.1245/s10434-015-4445-z; Cho KJ, 2000, HISTOPATHOLOGY, V36, P331; Duan H, 2015, WORLD J GASTROENTERO, V21, P5591, DOI 10.3748/wjg.v21.i18.5591; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-58; Hamilton SR, 2000, WHO CLASSIFICATION T; Huang ZZ, 2001, CHINESE MED J-PEKING, V114, P1084; Imamhasan A, 2012, HUM PATHOL, V43, P2012, DOI 10.1016/j.humpath.2012.02.010; Ji WH, 2016, DIS ESOPHAGUS, V29, P403, DOI 10.1111/dote.12322; Kumagai Y, 2013, INT SURG, V98, P455, DOI 10.9738/CC195; Lam KY, 2001, J PATHOL, V195, P435, DOI 10.1002/path.984; Li TJ, 2004, ARCH PATHOL LAB MED, V128, P1124; Liu JY, 2015, BRIT J CANCER, V113, P747, DOI 10.1038/bjc.2015.290; Liu JY, 2015, ONCOTARGET, V6, P24978, DOI 10.18632/oncotarget.4617; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Saito T, 2015, INT J CLIN EXP PATHO, V8, P2267; Saito T, 2014, VIRCHOWS ARCH, V464, P135, DOI 10.1007/s00428-014-1538-1; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato-Kuwabara Y, 2016, TUMOR BIOL, V37, P6691, DOI 10.1007/s13277-015-4551-3; Sharaiha RZ, 2011, ANN SURG ONCOL, V18, P3362, DOI 10.1245/s10434-011-1754-8; Toyokawa T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2696-0; TSANG WYW, 1991, HISTOPATHOLOGY, V19, P35, DOI 10.1111/j.1365-2559.1991.tb00892.x; Tsubochi H, 2000, ANTICANCER RES, V20, P1205; WAIN SL, 1986, HUM PATHOL, V17, P1158, DOI 10.1016/S0046-8177(86)80422-1; Wang JB, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-7; Wang SC, 2016, ANN SURG, V263, P292, DOI 10.1097/SLA.0000000000001189; Yang X, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S77099; Yang YG, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-662-48676-4_1; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-5; Yuan DW, 2014, J SURG ONCOL, V110, P333, DOI 10.1002/jso.23651; Zhang BH, 2013, ASIAN PAC J CANCER P, V14, P1889, DOI 10.7314/APJCP.2013.14.3.1889; Zhao WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31394	32	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168299	10.1371/journal.pone.0168299	http://dx.doi.org/10.1371/journal.pone.0168299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959959	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900058
J	Dentovskaya, SV; Platonov, ME; Svetoch, TE; Kopylov, PK; Kombarova, TI; Ivanov, SA; Shaikhutdinova, RZ; Kolombet, LV; Chauhan, S; Ablamunits, VG; Motin, VL; Uversky, VN; Anisimov, AP				Dentovskaya, Svetlana V.; Platonov, Mikhail E.; Svetoch, Tat'yana E.; Kopylov, Pavel Kh.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Shaikhutdinova, Rima Z.; Kolombet, Lyubov' V.; Chauhan, Sadhana; Ablamunits, Vitaly G.; Motin, Vladimir L.; Uversky, Vladimir N.; Anisimov, Andrey P.			Two Isoforms of Yersinia pestis Plasminogen Activator Pla: Intraspecies Distribution, Intrinsic Disorder Propensity, and Contribution to Virulence	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; FLEA-BORNE TRANSMISSION; MEMBRANE-PROTEIN OMPA; UNSTRUCTURED PROTEINS; ESCHERICHIA-COLI; SURFACE PROTEASE; PESTOIDES-F; WEB SERVER; SEQUENCE; BINDING	It has been shown previously that several endemic Y. pestis isolates with limited virulence contained the I259 isoform of the outer membrane protease Pla, while the epidemic highly virulent strains possessed only the T259 Pla isoform. Our sequence analysis of the pla gene from 118 Y. pestis subsp. microtus strains revealed that the I259 isoform was present exclusively in the endemic strains providing a convictive evidence of more ancestral origin of this isoform. Analysis of the effects of the I259T polymorphism on the intrinsic disorder propensity of Pla revealed that the I259T mutation slightly increases the intrinsic disorder propensity of the C-terminal tail of Pla and makes this protein slightly more prone for disorder-based protein-protein interactions, suggesting that the T259 Pla could be functionally more active than the I259 Pla. This assumption was proven experimentally by assessing the coagulase and fibrinolytic activities of the two Pla isoforms in human plasma, as well as in a direct fluorometric assay with the Pla peptide substrate. The virulence testing of Pla-negative or expressing the I259 and T259 Pla isoforms Y. pestis subsp. microtus and subsp. pestis strains did not reveal any significant difference in LD50 values and dose-dependent survival assays between them by using a subcutaneous route of challenge of mice and guinea pigs or intradermal challenge of mice. However, a significant decrease in time-todeath was observed in animals infected with the epidemic T259 Pla-producing strains as compared to the parent Pla-negative variants. Survival curves of the endemic I259 Pla(+) strains fit between them, but significant difference in mean time to death post infection between the Pla(-) strains and their I259 Pla(+) variants could be seen only in the isogenic set of subsp. pestis strains. These findings suggest an essential role for the outer membrane protease Pla evolution in Y. pestis bubonic infection exacerbation that is necessary for intensification of epidemic process from endemic natural focality with sporadic cases in men to rapidly expanding epizootics followed by human epidemic outbreaks, local epidemics or even pandemics.	[Dentovskaya, Svetlana V.; Platonov, Mikhail E.; Svetoch, Tat'yana E.; Kopylov, Pavel Kh.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Shaikhutdinova, Rima Z.; Kolombet, Lyubov' V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ablamunits, Vitaly G.] St Petersburg Med Pediat Univ, St Petersburg, Russia; [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Anisimov, AP (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia.	a-p-anisimov@yandex.ru	Dentovskaya, Svetlana/F-4623-2017; Shaykhutinova, Rima/ABG-3321-2021; Anisimov, Andrey P./H-5257-2012; Svetoch, Tatyana/ABG-3315-2021; Michael, Platonov/GZG-8615-2022; Platonov, Mikhail E/S-1209-2016; Motin, Vladimir L/O-1535-2013; Ivanov, Sergey/GSD-3061-2022; Uversky, Vladimir N./F-4515-2011	Dentovskaya, Svetlana/0000-0002-1996-8949; Shaykhutinova, Rima/0000-0002-6985-6822; Anisimov, Andrey P./0000-0002-5499-7999; Uversky, Vladimir N./0000-0002-4037-5857; Platonov, Mihail/0000-0003-3946-1755; Govorunov, Igor/0000-0002-6366-1223; Motin, Vladimir/0000-0002-4762-457X	Russian Science Foundation [14-15-00599]	Russian Science Foundation(Russian Science Foundation (RSF))	This research and PKK, MEP, TIK, SAI, RZS, LVK, SVD, and APA were supported by the Russian Science Foundation (Ru) (grant 14-15-00599; http://www.rscf.ru/en/).; We thank Dr. Stephan Willias (UTMB) for his contribution for statistical analysis of the Pla activity by the fluorometric assay. The work was supported by the Russian Science Foundation (grant no. 14-15-00599).	Agarkov A, 2008, BIOORG MED CHEM LETT, V18, P427, DOI 10.1016/j.bmcl.2007.09.104; Anisimov A. P., 2002, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P3; Anisimov AP, 2009, J MED MICROBIOL, V58, P26, DOI 10.1099/jmm.0.005678-0; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bahmanyar M, 1976, PLAGUE MANUAL; BEESLEY ED, 1967, J BACTERIOL, V94, P19, DOI 10.1128/JB.94.1.19-26.1967; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; DOMARADSKII I V, 1987, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eddy JL, 2016, J THROMB HAEMOST, V14, P1833, DOI 10.1111/jth.13408; Eddy JL, 2015, INFECT IMMUN, V83, P4837, DOI 10.1128/IAI.01086-15; Eren E, 2010, STRUCTURE, V18, P809, DOI 10.1016/j.str.2010.03.013; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Gonzalez RJ, 2015, INFECT IMMUN, V83, P2855, DOI 10.1128/IAI.00140-15; Guinet F, 2003, ADV EXP MED BIOL, V529, P73; Guinet F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005222; Guinet F, 2012, ADV EXP MED BIOL, V954, P211, DOI 10.1007/978-1-4614-3561-7_26; Haiko J, 2010, J BACTERIOL, V192, P4553, DOI 10.1128/JB.00458-10; Haiko J, 2009, J BACTERIOL, V191, P4758, DOI 10.1128/JB.00489-09; Haiko J, 2009, INNATE IMMUN-LONDON, V15, P67, DOI 10.1177/1753425909102559; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kiefer D, 2012, VECTOR-BORNE ZOONOT, V12, P183, DOI 10.1089/vbz.2011.0748; Koebnik R, 1999, J MOL BIOL, V285, P1801, DOI 10.1006/jmbi.1998.2405; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Korenberg EI, 2010, BIOL BULL+, V37, P665, DOI 10.1134/S1062359010070010; Korhonen TK, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00035; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Kutyrev V, 1999, INFECT IMMUN, V67, P1359, DOI 10.1128/IAI.67.3.1359-1367.1999; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lane MC, 2013, J MED MICROBIOL, V62, P1124, DOI 10.1099/jmm.0.056275-0; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lawrenz MB, 2013, MOL MICROBIOL, V89, P276, DOI 10.1111/mmi.12273; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oyston PCF, 2005, ANTON LEEUW INT J G, V87, P171, DOI 10.1007/s10482-004-4619-3; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Platonov M E, 2013, Mol Gen Mikrobiol Virusol, P3; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; SODEINDE OA, 1988, INFECT IMMUN, V56, P2743, DOI 10.1128/IAI.56.10.2743-2748.1988; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Sun YC, 2014, CELL HOST MICROBE, V15, P578, DOI 10.1016/j.chom.2014.04.003; Tiner BL, 2015, INFECT IMMUN, V83, P1318, DOI 10.1128/IAI.02778-14; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2012, J MOL BIOL, V418, P267, DOI 10.1016/j.jmb.2012.02.034; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Valls SM, 2010, J THROMB HAEMOST, V8, P2232; van Lier CJ, 2015, MICROB PATHOGENESIS, V80, P27, DOI 10.1016/j.micpath.2015.02.005; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zhang SS, 2008, J BIOL CHEM, V283, P31511, DOI 10.1074/jbc.M804646200; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zimbler DL, 2016, INFECT IMMUN, V84, P365, DOI 10.1128/IAI.01168-15; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487	99	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168089	10.1371/journal.pone.0168089	http://dx.doi.org/10.1371/journal.pone.0168089			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936190	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100272
J	Dueker, ND; Beecham, A; Wang, LY; Blanton, SH; Guo, SR; Rundek, T; Sacco, RL				Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.; Guo, Shengru; Rundek, Tatjana; Sacco, Ralph L.			Rare Variants in NOD1 Associated with Carotid Bifurcation Intima-Media Thickness in Dominican Republic Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ARTERY INTIMA; SUBCLINICAL ATHEROSCLEROSIS; LINKAGE ANALYSIS; ISCHEMIC-STROKE; RISK; HERITABILITY; HEART; GENES	Cardiovascular disorders including ischemic stroke (IS) and myocardial infarction (MI) are heritable; however, few replicated loci have been identified. One strategy to identify loci influencing these complex disorders is to study subclinical phenotypes, such as carotid bifurcation intima-media thickness (bIMT). We have previously shown bIMT to be heritable and found evidence for linkage and association with common variants on chromosome 7p for bIMT. In this study, we aimed to characterize contributions of rare variants (RVs) in 7p to bIMT. To achieve this aim, we sequenced the 1 LOD unit down region on 7p in nine extended families from the Dominican Republic (DR) with strong evidence for linkage to bIMT. We then performed the family-based sequence kernel association test (famSKAT) on genes within the 7p region. Analyses were restricted to single nucleotide variants (SNVs) with population based minor allele frequency (MAF) <5%. We first analyzed all exonic RVs and then the subset of only non-synonymous RVs. There were 68 genes in our analyses. Nucleotide-binding oligomerization domain (NOD1) was the most significantly associated gene when analyzing exonic RVs (famSKAT p = 9.2x10(-4); number of SNVs = 14). We achieved suggestive replication of NOD1 in an independent sample of twelve extended families from the DR (p = 0.055). Our study provides suggestive statistical evidence for a role of rare variants in NOD1 in bIMT. Studies in mice have shown Nod1 to play a role in heart function and atherosclerosis, providing biologic plausibility for a role in bIMT thus making NOD1 an excellent bIMT candidate.	[Dueker, Nicole D.; Beecham, Ashley; Wang, Liyong; Blanton, Susan H.; Guo, Shengru] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Wang, Liyong; Blanton, Susan H.; Sacco, Ralph L.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Rundek, Tatjana; Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Rundek, Tatjana; Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Sacco, RL (corresponding author), Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA.; Sacco, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Sacco, RL (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	rsacco@med.miami.edu	Sacco, Ralph/Y-9278-2019; Blanton, Susan Halloran/ABF-1323-2021		National Institutes of Health [R01NS040807, R37NS29992, R01NS047655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health R01NS040807, R37NS29992, and R01NS047655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bis JC, 2014, CIRC-CARDIOVASC GENE, V7, P359, DOI 10.1161/CIRCGENETICS.113.000116; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Bowden DW, 2010, HUM MOL GENET, V19, P4112, DOI 10.1093/hmg/ddq327; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Cvjetkovic N, 2015, MOL GENET GENOM MED, V3, P440, DOI 10.1002/mgg3.155; Duan S., 2012, ABSTRACT APPL ANAL, V2012, P1, DOI DOI 10.1109/SPC0M.2012.6290252; Elkind MSV, 2006, STROKE, V37, P13, DOI 10.1161/01.STR.0000195048.86810.5b; Eyre S, 2011, ARTHRITIS RHEUM-US, V63, P1522, DOI 10.1002/art.30315; Fenstad MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012993; Fernandez-Velasco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045260; Fox CS, 2004, AM J HUM GENET, V74, P253, DOI 10.1086/381559; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Iwakiri T, 2012, ATHEROSCLEROSIS, V225, P359, DOI 10.1016/j.atherosclerosis.2012.10.033; Kanno S, 2015, J IMMUNOL, V194, P773, DOI 10.4049/jimmunol.1302841; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lange LA, 2002, STROKE, V33, P1876, DOI 10.1161/01.STR.0000019909.71547.AA; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liao YC, 2008, STROKE, V39, P3159, DOI 10.1161/STROKEAHA.108.522789; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lu MF, 2005, NAT IMMUNOL, V6, P989, DOI 10.1038/ni1246; Melton PE, 2013, CIRC-CARDIOVASC GENE, V6, P211, DOI 10.1161/CIRCGENETICS.113.000079; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Procino G, 2011, AM J HYPERTENS, V24, P822, DOI 10.1038/ajh.2011.47; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Saad M, 2014, GENET EPIDEMIOL, V38, P1, DOI 10.1002/gepi.21776; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sacco RL, 2007, ETHNIC DIS, V17, P351; Sacco RL, 2009, STROKE, V40, P2307, DOI 10.1161/STROKEAHA.109.554121; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Shanahan CM, 1999, J VASC RES, V36, P353, DOI 10.1159/000025674; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tiszlavicz Z, 2009, EUR J NEUROL, V16, P1224, DOI 10.1111/j.1468-1331.2009.02698.x; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; Wang LY, 2015, HUM GENET, V134, P1127, DOI 10.1007/s00439-015-1592-z; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wijsman EM, 2012, HUM GENET, V131, P1555, DOI 10.1007/s00439-012-1190-2; Xiang AH, 2002, ARTERIOSCL THROM VAS, V22, P843, DOI 10.1161/01.ATV.0000015329.15481.E8; Zeller T, 2012, CLIN CHEM, V58, P92, DOI 10.1373/clinchem.2011.170431	49	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167202	10.1371/journal.pone.0167202	http://dx.doi.org/10.1371/journal.pone.0167202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936005	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100072
J	Franca, SL; Lima, SS; Vieira, JRS				Franca, Sergio Lobato; Lima, Sandra Souza; Dos Santos Vieira, Jose Ricardo			Metabolic Syndrome and Associated Factors in Adults of the Amazon Region	PLOS ONE			English	Article							RISK-FACTORS; OBESITY; PREVALENCE; POPULATION; HEALTH; MEN	Metabolic syndrome (MS) plays a key role in the origin of cardiovascular diseases. Studies on the MS in Brazil are recent, and its epidemiology in more isolated regions such as the Amazon is still unknown. The study aimed to estimate the prevalence of MS and associated factors in adults of the Brazilian Amazon. This study was conducted in 2012-2013. It is a cross-sectional population-based study, involving 787 adults randomly selected from the urban area of four cities in the state of Para A, in the Brazilian Eastern Amazon. The participants underwent anthropometric measurements, laboratory examination, and were questioned about their lifestyle. MS was defined by the Joint Interim Statement criteria, using the multiple logistic regression to investigate the potential association of risk factors with the presence of MS. The overall prevalence of MS was 34.1% (95% CI = 30.8-37.4), increasing linearly with the increasing body mass index and age. From 40-49 years of age, MS was observed in about half of the women (46.0%), while men only experienced a high prevalence in the fifth decade of life (43.3%). The low HDL-c (64.4%) and abdominal obesity (58.9%) were higher in women (p < 0.001), while for men, high blood pressure was significantly higher (p < 0.001). Individuals aged 40-59 years old (odds ratio [OR] = 3.35 [95% CI = 2.30-4.90]), >= 60 years old (OR = 5.80 [3.63-9.27]), overweight (OR = 4.17 [2.77-6.29]), and obese (OR = 8.82 [5.56-13.98]) were more likely to have MS. The study population experienced high cardiometabolic risk, requiring government efforts to control MS and related risk factors, especially obesity.	[Franca, Sergio Lobato; Lima, Sandra Souza; Dos Santos Vieira, Jose Ricardo] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil	Universidade Federal do Para	Vieira, JRS (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	jrvieira@ufpa.br			Amazon Foundation for Support of Studies and Research of Para (FAPESPA) [014/2012]	Amazon Foundation for Support of Studies and Research of Para (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	This work is part of a multicenter study entitled "Epidemiological Markers in the Health of the Marajo Archipelago", which was funded by the Amazon Foundation for Support of Studies and Research of Para (FAPESPA) (Project No 014/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; de Oliveira BFA, 2013, CAD SAUDE PUBLICA, V29, P1617, DOI [10.1590/S0102-311X2013001200014, 10.1590/0102-311X00146212]; Martins MSAS, 2010, ARQ BRAS CARDIOL, V94, P639, DOI 10.1590/S0066-782X2010005000028; [Anonymous], 2011, REV BRAS CARDIOL; [Anonymous], CENS DEM 2010 INF MU; Ayres M, 2011, BIOESTAT 5 3 APLICAC; Bettelheim A., 2013, INTRO GEN ORGANIC BI; Bezerra APM, 2013, DEMETRA, V8, P63; Brasil, 2015, VIGITEL BRAS VIG FAT; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Conceicao L, 2010, 5 C PESQ IN RED NORT; de Oliveira A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-141; Dean A, 1996, EPI INFO VERSION 6 W; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dutra ES, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-20; Escobar FA, 2009, CADERNOS UNIFOA, V11, P69; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Franca F. C. O, 2012, AN SEM AL CULT BAH 2; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gomes R, 2007, CAD SAUDE PUBLICA, V23, P565, DOI 10.1590/S0102-311X2007000300015; Governo do estado do Para, 2012, IND QUAL AMB MUN REG; Haab RS., 2012, REV BRAS MED FAM COM, V7, P90, DOI [10.5712/rbmfc7(23)237, DOI 10.5712/RBMFC7(23)237]; Hausenloy DJ, 2008, HEART, V94, P706, DOI 10.1136/hrt.2007.125401; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2010 CAR PO; Instituto Brasileiro de Geografia e Estatistica (BR), 2013, PROJ LEV CLASS USO T; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Lopez-Jaramillo P, 2014, ARQ BRAS ENDOCRINOL, V58, P205, DOI 10.1590/0004-2730000003019; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Mady C, 2008, ARQ BRAS CARDIOL, V91, P46; Mancini MC, 2010, TRATADO DE OBESIDADE, P253; Mariath AB, 2007, CAD SAUDE PUBLICA, V23, P897, DOI 10.1590/S0102-311X2007000400017; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Milici NA, 2010, P ROM ACAD, V1, P13; Moreira GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105056; Muñoz Contreras Angélica M, 2013, Colomb. Med., V44, P57; Oliveira AG, 2015, J AMAZON HLTH SCI, V1, P1, DOI DOI 10.1016/JJTRANGE0.2015.01.001; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Papakonstantinou E, 2013, CURR VASC PHARMACOL, V11, P858, DOI 10.2174/15701611113116660176; Peralta N, 2008, CAMPOS, V9, P109; Rodrigo CP, 2013, NUTR HOSP, V28, P21, DOI 10.3305/nh.2013.28.sup5.6915; Ponce-Garcia Isabel, 2015, PLoS One, V10, pe0127369, DOI 10.1371/journal.pone.0127369; Portinho J.A., 2012, INT J NUTROLOGY, V5, P15, DOI [10.1055/s-0040-1701423, DOI 10.1055/S-0040-1701423]; Programa das Nacoes Unidas para o Desenvolvimento (BR), ATL BRAS 2013 RANK R; Rocha E, 2012, REV PORT CARDIOL, V31, P637, DOI 10.1016/j.repc.2012.07.001; Salas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105581; Silva DAS, 2013, EUR J NUTR, V52, P237, DOI 10.1007/s00394-012-0314-8; Schelbert KB, 2009, PRIMARY CARE, V36, P271, DOI 10.1016/j.pop.2009.01.009; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Silva AR, 2013, MATURITAS, V76, P64, DOI DOI 10.1016/J.MATURITAS.2013.05.015; Silva RJ, 2012, SEGUR ALIMENT NUTR, V19, P1; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Spalding A, 2009, J CLIN HYPERTENS, V11, P755, DOI 10.1111/j.1751-7176.2009.00191.x; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Universidade Federal do Para, 2012, REL AN TERR MAR; Vidigal FD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1198; World Health Organization,, 1998, WHO TECHN REP SER; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091578; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	64	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167320	10.1371/journal.pone.0167320	http://dx.doi.org/10.1371/journal.pone.0167320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936021	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100084
J	Lu, ZM; Pan, Q; Wang, LH; Wen, XM				Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming			Overload Control for Signaling Congestion of Machine Type Communications in 3GPP Networks	PLOS ONE			English	Article								Because of the limited resources on radio access channels of third generation partnership projection (3GPP) network, one of the most challenging tasks posted by 3GPP cellular-based machine type communications (MTC) is congestion due to massive requests for connection to radio access network (RAN). In this paper, an overload control algorithm in 3GPP RAN is proposed, which proactively disperses the simultaneous access attempts in evenly distributed time window. Through periodic reservation strategy, massive access requests of MTC devices are dispersed in time, which reduces the probability of confliction of signaling. By the compensation and prediction mechanism, each device can communicate with MTC server with dynamic load of air interface. Numerical results prove that proposed method makes MTC applications friendly to 3GPP cellular network.	[Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming] Beijing Key Lab Network Syst Architecture & Conve, Beijing, Peoples R China; [Lu, Zhaoming; Pan, Qi; Wang, Luhan; Wen, Xiangming] Beijing Lab Adv Informat Network, Beijing, Peoples R China; [Lu, Zhaoming; Wang, Luhan; Wen, Xiangming] Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China; [Lu, Zhaoming; Wang, Luhan; Wen, Xiangming] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Lu, ZM (corresponding author), Beijing Key Lab Network Syst Architecture & Conve, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Lab Adv Informat Network, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China.; Lu, ZM (corresponding author), Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China.	lzy_0372@163.com	Pan, Qi/K-3532-2019	Pan, Qi/0000-0003-3354-0559	 [D151100000115002]		This work was supported by Grant number: D151100000115002, URL: http://www.bjkw.gov.cn/n8785584/index.html; Author who received the funding: Xiangming Wen.	[Anonymous], 2011, 37868 3GPP TR; [Anonymous], 2014, 43868 3GPP TR; [Anonymous], 2012, 23888 3GPP TR; Cheng MY, 2012, IEEE COMMUN MAG, V50, P38, DOI 10.1109/MCOM.2012.6211484; Gotsis AG, 2013, T EMERG TELECOMMUN T, V24, P378, DOI 10.1002/ett.2629; Hasan M, 2013, IEEE COMMUN MAG, V51, P86, DOI 10.1109/MCOM.2013.6525600; Ho C, IEEE WIRELESS COMMUN, V1, P209; Ksentini A, 2012, IEEE NETWORK, V26, P54, DOI 10.1109/MNET.2012.6375894; Larmo A, 2012, IEEE GLOBE WORK, P1626, DOI 10.1109/GLOCOMW.2012.6477829; Lee KD, 2011, IEEE GLOBE WORK, P373, DOI 10.1109/GLOCOMW.2011.6162474; Lien SY, 2012, IEEE T WIREL COMMUN, V11, P27, DOI 10.1109/TWC.2011.111611.110350; Lien SY, 2011, IEEE COMMUN MAG, V49, P66, DOI 10.1109/MCOM.2011.5741148; Service Requirements for Machine- Type Communications (MTC), 2011, 22368 3GPP TS	13	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167380	10.1371/journal.pone.0167380	http://dx.doi.org/10.1371/journal.pone.0167380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936011	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100089
J	Nakhaeizadeh, H; Amin, E; Nakhaei-Rad, S; Dvorsky, R; Ahmadian, MR				Nakhaeizadeh, Hossein; Amin, Ehsan; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Ahmadian, Mohammad Reza			The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; GTPASE-ACTIVATING PROTEINS; SWITCH I-REGION; K-RAS; H-RAS; R-RAS; N-RAS; SIGNAL-TRANSDUCTION; BCL-XL; RAF-1	RAS effectors specifically interact with the GTP-bound form of RAS in response to extracellular signals and link them to downstream signaling pathways. The molecular nature of effector interaction by RAS is well-studied but yet still incompletely understood in a comprehensive and systematic way. Here, structure-function relationships in the interaction between different RAS proteins and various effectors were investigated in detail by combining our in vitro data with in silico data. Equilibrium dissociation constants were determined for the binding of HRAS, KRAS, NRAS, RRAS1 and RRAS2 to both the RAS binding (RB) domain of CRAF and PI3K alpha, and the RAS association (RA) domain of RASSF5, RALGDS and PLC epsilon, respectively, using fluorescence polarization. An interaction matrix, constructed on the basis of available crystal structures, allowed identification of hotspots as critical determinants for RAS-effector interaction. New insights provided by this study are the dissection of the identified hotspots in five distinct regions (R1 to R5) in spite of high sequence variability not only between, but also within, RB/RA domain-containing effectors proteins. Finally, we propose that intermolecular beta-sheet interaction in R1 is a central recognition region while R3 may determine specific contacts of RAS versus RRAS isoforms with effectors.	[Nakhaeizadeh, Hossein; Amin, Ehsan; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Fac Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Fac Med, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Amin, Ehsan/GPC-5382-2022; Dvorsky, Radovan/ABE-3042-2020; Nakhaeirad, Saeideh/AAV-1771-2020	Nakhaeirad, Saeideh/0000-0001-8966-8960; Amin, Ehsan/0000-0003-2995-8864	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 [SFB 974]; International Research Training Group 1902 "Intra- and interorgan communication of the cardiovascular system" [IRTG 1902]; German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe) [01GM1519D]; European Network on Noonan Syndrome and Related Disorders (NSEuroNet) [01GM16026]	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974(German Research Foundation (DFG)); International Research Training Group 1902 "Intra- and interorgan communication of the cardiovascular system"; German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe)(Federal Ministry of Education & Research (BMBF)); European Network on Noonan Syndrome and Related Disorders (NSEuroNet)	This study was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration", the International Research Training Group 1902 (IRTG 1902) "Intra- and interorgan communication of the cardiovascular system", the German Federal Ministry of Education and Research (BMBF) - German Network of RASopathy Research (GeNeRARe; fund number 01GM1519D), and the European Network on Noonan Syndrome and Related Disorders (NSEuroNet; fund number 01GM16026).	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Amin E, 2016, J BIOL CHEM; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Baljuls A, 2013, MOL BIOSYST, V9, P551, DOI 10.1039/c2mb25393c; Beeram M, 2005, J CLIN ONCOL, V23, P6771, DOI 10.1200/JCO.2005.08.036; Beeram Muralidhar, 2003, Clin Adv Hematol Oncol, V1, P476; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boettner B, 2001, METHOD ENZYMOL, V332, P151; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Calvo F, 2009, MOL BIOL CELL, V20, P4289, DOI 10.1091/mbc.E09-03-0212; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Cirstea IC, 2013, HUM MOL GENET, V22, P262, DOI 10.1093/hmg/dds426; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; de la Vega M, 2010, J BIOL CHEM, V285, P12028, DOI 10.1074/jbc.M109.081448; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Donninger H, 2016, SEM CELL DEV BIOL; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Erijman A, 2016, MINI-REV MED CHEM, V16, P370, DOI 10.2174/1389557515666151001141838; Feig LA, 2002, CURR BIOL, V12, pR259, DOI 10.1016/S0960-9822(02)00787-X; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Furuhjelm J, 2003, J CELL SCI, V116, P3729, DOI 10.1242/jcs.00689; Gentry LR, 2014, BBA-MOL CELL RES, V1843, P2976, DOI 10.1016/j.bbamcr.2014.09.004; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; Gutierrez-Erlandsson S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-127; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Knyphausen P, 2016, BIOL CHEM; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; LINNEMANN T, 1999, THE JOURNAL OF BIOLO, V274, P13556; Lissewski C, 2015, AM J MED GENET A, V167, P2685, DOI 10.1002/ajmg.a.37155; Lu S, 2016, CHEM SOC REV; Lynch SJ, 2015, J CELL PHYSIOL, V230, P610, DOI 10.1002/jcp.24779; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nakhaei-Rad S, 2016, J BIOL CHEM, V291, P8399, DOI 10.1074/jbc.M115.700088; Nakhaei-Rad S, 2015, J BIOL CHEM, V290, P15892, DOI 10.1074/jbc.M115.640607; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nussinov R, 2015, EXPERT REV PROTEOMIC, V12, P669, DOI 10.1586/14789450.2015.1100079; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Ostrem JM, 2016, NAT REV DRUG DISCOV; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Parker JA, 2015, MOL CANCER RES, V13, P595, DOI 10.1158/1541-7786.MCR-14-0535; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qamra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072473; Raines RT, 2015, METHODS MOL BIOL, V1278, P323, DOI 10.1007/978-1-4939-2425-7_19; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rodriguez-Viciana P, 2006, CANCER CELL, V9, P243, DOI 10.1016/j.ccr.2006.03.025; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Shima Fumi, 2013, Enzymes, V34 Pt. B, P1, DOI 10.1016/B978-0-12-420146-0.00001-9; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Sydor JR, 1999, FEBS LETT, V452, P375, DOI 10.1016/S0014-5793(99)00633-X; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Vandal G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084745; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Wurtzel JGT, 2015, BIOCHEM BIOPH RES CO, V467, P785, DOI 10.1016/j.bbrc.2015.10.064; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; Zheng ZY, 2012, ONCOGENE, V31, P4630, DOI 10.1038/onc.2011.607; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061	118	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167145	10.1371/journal.pone.0167145	http://dx.doi.org/10.1371/journal.pone.0167145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936046	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100066
J	Sharif, S; Nakatani, Y; Wise, L; Corbett, M; Real, NC; Stuart, GS; Lateef, Z; Krause, K; Mercer, AA; Fleming, SB				Sharif, Saeed; Nakatani, Yoshio; Wise, Lyn; Corbett, Michael; Real, Nicola C.; Stuart, Gabriella S.; Lateef, Zabeen; Krause, Kurt; Mercer, Andrew A.; Fleming, Stephen B.			A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin	PLOS ONE			English	Article							ORF VIRUS; CYTOKINE SYNTHESIS; DENDRITIC CELLS; PARAPOXVIRUS; INFECTION; MIGRATION; POXVIRUS; INTERLEUKIN-10; RECEPTOR; SITES	Bovine papular stomatitis virus (BPSV) is a Parapoxvirus that induces acute pustular skin lesions in cattle and is transmissible to humans. Previous studies have shown that BPSV encodes a distinctive chemokine-binding protein (CBP). Chemokines are critically involved in the trafficking of immune cells to sites of inflammation and infected tissue, suggesting that the CBP plays a role in immune evasion by preventing immune cells reaching sites of infection. We hypothesised that the BPSV-CBP binds a wide range of inflammatory chemokines particularly those involved in BPSV skin infection, and inhibits the recruitment of immune cells from the blood into inflamed skin. Molecular analysis of the purified protein revealed that the BPSV-CBP is a homodimeric polypeptide with a MW of 82.4 kDa whilst a comprehensive screen of inflammatory chemokines by surface plasmon resonance showed high affinity binding to a range of chemokines within the CXC, CC and XC subfamilies. Structural analysis of BPSV-CBP, based on the crystal structure of orf virus CBP, provided a probable explanation for these chemokine specificities at a molecular level. Functional analysis of the BPSV-CBP using transwell migration assays demonstrated that it potently inhibited chemotaxis of murine neutrophils and monocytes in response to CXCL1, CXCL2 as well as CCL2, CCL3 and CCL5 chemokines. In order to examine the effects of CBP in vivo, we used murine skin models to determine its impact on inflammatory cell recruitment such as that observed during BPSV infection. Intradermal injection of BPSV-CBP blocked the influx of neutrophils and monocytes in murine skin in which inflammation was induced with lipopolysaccharide. Furthermore, intradermal injection of BPSV-CBP into injured skin, which more closely mimics BPSV lesions, delayed the influx of neutrophils and reduced the recruitment of MHC-II+ immune cells to the wound bed. Our findings suggest that the CBP could be important in pathogenesis of BPSV infections.	[Sharif, Saeed; Nakatani, Yoshio; Wise, Lyn; Corbett, Michael; Real, Nicola C.; Stuart, Gabriella S.; Lateef, Zabeen; Mercer, Andrew A.; Fleming, Stephen B.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Krause, Kurt] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago; University of Otago	Fleming, SB (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	stephen.fleming@otago.ac.nz	Mercer, Andrew A/G-6635-2015	Lateef, Zabeen/0000-0001-5987-7665; Mercer, Andrew/0000-0003-3697-1071; Wise, Lyn/0000-0003-0646-8424	Health Research Council of New Zealand; University of Otago Special Health Research Scholarship; Health Research Council Explorer Grant; Maurice Wilkins Centre	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago Special Health Research Scholarship; Health Research Council Explorer Grant; Maurice Wilkins Centre	This research was supported by funding from the Health Research Council of New Zealand and the University of Otago Special Health Research Scholarship. Yoshio Nakatani was funded by a Health Research Council Explorer Grant and the Maurice Wilkins Centre.; This research was supported by funding from the Health Research Council of New Zealand and the University of Otago Special Health Research Scholarship. Yoshio Nakatani was funded by a Health Research Council Explorer Grant and the Maurice Wilkins Centre. The authors would like to thank Norihito Ueda and Ellena Whelan (Department of Microbiology & Immunology, University of Otago) for cloning of the BPSV-CBP gene, Michelle Wilson (Department of Microbiology & Immunology, University of Otago) for FAGS technical assistance, Amanda Fisher, Janine Neill, Sharon White and Alisha Shaw (Histology Unit, Department Pathology, University of Otago) for histological processing, and Marcel Hijnen (Biacore product specialist) for SPR technical support.	Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Bennett JR, 2016, VIRUS RES, V213, P230, DOI 10.1016/j.virusres.2015.12.015; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bosio CF, 2012, INFECT IMMUN, V80, P4034, DOI 10.1128/IAI.00606-12; BOWMAN KF, 1981, JAMA-J AM MED ASSOC, V246, P2813, DOI 10.1001/jama.246.24.2813; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Buttner M, 2002, J VET MED B, V49, P7, DOI 10.1046/j.1439-0450.2002.00539.x; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Costes B, 2005, J GEN VIROL, V86, P3209, DOI 10.1099/vir.0.81388-0; Counago RM, 2015, STRUCTURE, V23, P1199, DOI 10.1016/j.str.2015.04.023; Dal Pozzo F, 2011, J CLIN MICROBIOL, V49, P4397, DOI 10.1128/JCM.05281-11; de Sant'Ana FJF, 2012, J VET DIAGN INVEST, V24, P442, DOI 10.1177/1040638711434799; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Fenner F, 1987, CHAPTER 21 POXVIRIDA, P387; Fleming S. B., 2007, GENUS PARAPOXVIRUS P, P127; Fleming SB, 1997, J VIROL, V71, P4857, DOI 10.1128/JVI.71.6.4857-4861.1997; Fleming SB, 2015, VIRUSES-BASEL, V7, P1505, DOI 10.3390/v7031505; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Gaines P, 2005, J LEUKOCYTE BIOL, V77, P669, DOI 10.1189/jlb.1004567; Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R; Grimsey NL, 2012, J BIOMOL SCREEN, V17, P386, DOI 10.1177/1087057111428985; Haig DM, 2002, VIRUS RES, V88, P3, DOI 10.1016/S0168-1702(02)00117-X; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Huang T, 2015, ARCH VIROL, V160, P1527, DOI 10.1007/s00705-015-2394-2; Iketani Y, 2002, MICROBIOL IMMUNOL, V46, P285, DOI 10.1111/j.1348-0421.2002.tb02697.x; Imlach W, 2002, J GEN VIROL, V83, P1049, DOI 10.1099/0022-1317-83-5-1049; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lalani AS, 1997, J LEUKOCYTE BIOL, V62, P570, DOI 10.1002/jlb.62.5.570; Lateef Z, 2003, J GEN VIROL, V84, P1101, DOI 10.1099/vir.0.18978-0; Lateef Z, 2010, CELL MICROBIOL, V12, P665, DOI 10.1111/j.1462-5822.2009.01425.x; Lateef Z, 2009, J GEN VIROL, V90, P1477, DOI 10.1099/vir.0.009589-0; Lee S, 2015, STROKE, V46, P537, DOI 10.1161/STROKEAHA.114.007298; Leire E, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-28; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mattar EH, 2015, CYTOKINE GROWTH FACT; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nelson CA, 2015, VIRUSES-BASEL, V7, P4873, DOI 10.3390/v7092848; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; PYE D, 1990, AUST VET J, V67, P182, DOI 10.1111/j.1751-0813.1990.tb07751.x; Robinson AJ, 1992, RECOMBINANT POXVIRUS, V96, P285; Roess AA, 2013, ZOONOSES PUBLIC HLTH, V60, P543, DOI 10.1111/zph.12036; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Rziha HJ, 2003, J GEN VIROL, V84, P1111, DOI 10.1099/vir.0.18850-0; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schwartzkopff F, 2012, INNATE IMMUN-LONDON, V18, P124, DOI 10.1177/1753425910388833; Seet BT, 2003, P NATL ACAD SCI USA, V100, P15137, DOI 10.1073/pnas.2336648100; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; Sentsui H, 1999, VET MICROBIOL, V70, P143, DOI 10.1016/S0378-1135(99)00138-8; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Straschewski S, 2011, J VIROL, V85, P5150, DOI 10.1128/JVI.02100-10; Sun J, 2007, AM J PHYSIOL-CELL PH, V293, pC696, DOI 10.1152/ajpcell.00060.2007; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; Wallace AE, 2009, CANCER RES, V69, P5726, DOI 10.1158/0008-5472.CAN-09-0390; Wise L, 2007, J GEN VIROL, V88, P1677, DOI 10.1099/vir.0.82765-0; Wise LM, 2014, WOUND REPAIR REGEN, V22, P356, DOI 10.1111/wrr.12169; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Zhou LB, 1996, EUR J IMMUNOL, V26, P120, DOI 10.1002/eji.1830260119	73	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168007	10.1371/journal.pone.0168007	http://dx.doi.org/10.1371/journal.pone.0168007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936239	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100250
J	Xu, L; He, JZ; Kaiser, A; Graber, N; Schlager, L; Ritze, Y; Scholz, H				Xu, Li; He, Jianzheng; Kaiser, Andrea; Graeber, Nikolas; Schlaeger, Laura; Ritze, Yvonne; Scholz, Henrike			A Single Pair of Serotonergic Neurons Counteracts Serotonergic Inhibition of Ethanol Attraction in Drosophila	PLOS ONE			English	Article							ADULT DROSOPHILA; PLACE PREFERENCE; OLFACTORY CENTER; COCAINE REWARD; ANTENNAL LOBE; TRANSPORTER; MELANOGASTER; EXPRESSION; DOPAMINE; AVERSION	Attraction to ethanol is common in both flies and humans, but the neuromodulatory mechanisms underlying this innate attraction are not well understood. Here, we dissect the function of the key regulator of serotonin signaling-the serotonin transporter-in innate olfactory attraction to ethanol in Drosophila melanogaster. We generated a mutated version of the serotonin transporter that prolongs serotonin signaling in the synaptic cleft and is targeted via the Gal4 system to different sets of serotonergic neurons. We identified four serotonergic neurons that inhibit the olfactory attraction to ethanol and two additional neurons that counteract this inhibition by strengthening olfactory information. Our results reveal that compensation can occur on the circuit level and that serotonin has a bidirectional function in modulating the innate attraction to ethanol. Given the evolutionarily conserved nature of the serotonin transporter and serotonin, the bidirectional serotonergic mechanisms delineate a basic principle for how random behavior is switched into targeted approach behavior.	[Xu, Li; He, Jianzheng; Kaiser, Andrea; Graeber, Nikolas; Schlaeger, Laura; Scholz, Henrike] Albertus Magnus Univ Cologne, Zool, Cologne, Germany; [Ritze, Yvonne; Scholz, Henrike] Julius Maximillian Univ Wurzburg, Inst Genet & Neurobiol, Wurzburg, Germany	University of Cologne; University of Wurzburg	Scholz, H (corresponding author), Albertus Magnus Univ Cologne, Zool, Cologne, Germany.; Scholz, H (corresponding author), Julius Maximillian Univ Wurzburg, Inst Genet & Neurobiol, Wurzburg, Germany.	henrike.scholz@uni-koeln.de	Scholz, Henrike/ABE-1063-2020		Chinese Academy of Science; German Science Foundation; Thyssen Stiftung [DFG656-7, SFB1340]; BMBF-SysMedAlc; PhD CSC fellowships	Chinese Academy of Science(Chinese Academy of Sciences); German Science Foundation(German Research Foundation (DFG)); Thyssen Stiftung; BMBF-SysMedAlc; PhD CSC fellowships	Financial support was provided by the Chinese Academy of Science, the German Science Foundation, and Thyssen Stiftung. DFG656-7 to HS, SFB1340 to HS, Thyssen Stiftung to HS, BMBF-SysMedAlc to HS; PhD CSC fellowships to LX and JH.	Albin SD, 2015, CURR BIOL, V25, P2435, DOI 10.1016/j.cub.2015.08.005; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; Chang AS, 1998, BIOCHEM BIOPH RES CO, V249, P416, DOI 10.1006/bbrc.1998.9158; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; Devineni Anita V, 2010, Commun Integr Biol, V3, P357; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Ellen CW, 2012, J MOL HISTOL, V43, P401, DOI 10.1007/s10735-012-9401-7; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Giang T, 2011, J NEUROGENET, V25, P17, DOI 10.3109/01677063.2011.553002; Gupta N, 2012, J NEUROSCI, V32, P8138, DOI 10.1523/JNEUROSCI.1066-12.2012; Haynes PR, 2015, ELIFE, V4, DOI 10.7554/eLife.03868; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liang L, 2013, NEURON, V79, P917, DOI 10.1016/j.neuron.2013.06.014; Liang L, 2010, SCI CHINA LIFE SCI, V53, P472, DOI 10.1007/s11427-010-0099-z; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Matsutani S, 2008, ANAT SCI INT, V83, P218, DOI 10.1111/j.1447-073X.2007.00223.x; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Park JB, 2006, INT J INNOVATIONS EN, V1, P1, DOI DOI 10.1038/NATURE04788; Park SK, 2006, J NEUROBIOL, V66, P452, DOI 10.1002/neu.20222; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Singh AP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003452; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Strutz A, 2014, ELIFE, V3, DOI 10.7554/eLife.04147; Su CY, 2014, CURR OPIN NEUROBIOL, V29, P9, DOI 10.1016/j.conb.2014.04.008; Tanaka NK, 2012, J COMP NEUROL, V520, P4131, DOI 10.1002/cne.23149; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167518	10.1371/journal.pone.0167518	http://dx.doi.org/10.1371/journal.pone.0167518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936023	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100113
J	van Rosmalen, M; Janssen, BMG; Hendrikse, NM; van der Linden, AJ; Pieters, PA; Wanders, D; de Greef, TFA; Merkx, M				van Rosmalen, Martijn; Janssen, Brian M. G.; Hendrikse, Natalie M.; van der Linden, Ardjan J.; Pieters, Pascal A.; Wanders, Dave; de Greef, Tom F. A.; Merkx, Maarten			Affinity Maturation of a Cyclic Peptide Handle for Therapeutic Antibodies Using Deep Mutational Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPUTATIONAL DESIGN; SURFACE DISPLAY; YEAST DISPLAY; PROTEIN; SITE; MUTAGENESIS; GENERATION; STABILITY; EVOLUTION; STRATEGY	Meditopes are cyclic peptides that bind in a specific pocket in the antigen-binding fragment of a therapeutic antibody such as cetuximab. Provided their moderate affinity can be enhanced, meditope peptides could be used as specific non-covalent and paratope-independent handles in targeted drug delivery, molecular imaging, and therapeutic drug monitoring. Here we show that the affinity of a recently reported meditope for cetuximab can be substantially enhanced using a combination of yeast display and deep mutational scanning. Deep sequencing was used to construct a fitness landscape of this protein-peptide interaction, and four mutations were identified that together improved the affinity for cetuximab 10-fold to 15 nM. Importantly, the increased affinity translated into enhanced cetuximab-mediated recruitment to EGF receptor-overexpressing cancer cells. Although in silico Rosetta simulations correctly identified positions that were tolerant to mutation, modeling did not accurately predict the affinity-enhancing mutations. The experimental approach reported here should be generally applicable and could be used to develop meditope peptides with low nano-molar affinity for other therapeutic antibodies.	[Merkx, Maarten] Eindhoven Univ Technol, Biol Chem Lab, POB 513 STO 3-22, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Dept Biomed Engn, ICMS, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Merkx, M (corresponding author), Eindhoven Univ Technol, Biol Chem Lab, POB 513 STO 3-22, NL-5600 MB Eindhoven, Netherlands.	m.merkx@tue.nl	Merkx, Maarten/E-7009-2011	de Greef, Tom/0000-0002-9338-284X; Hendrikse, Natalie/0000-0001-8644-3408; Pieters, Pascal/0000-0003-2032-0100	European Research Council (ERC) [ERC-2011-StG 280255]; ERC Proof-of-Concept Grant [ERC-2013-PoC 632274]; NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners	European Research Council (ERC)(European Research Council (ERC)); ERC Proof-of-Concept Grant; NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners	This work was supported by European Research Council (ERC) Starting Grant ERC-2011-StG 280255, ERC Proof-of-Concept Grant ERC-2013-PoC 632274, and NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Avery KN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07817; Beerli RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131177; BJORCK L, 1988, J IMMUNOL, V140, P1194; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Donaldson JM, 2013, P NATL ACAD SCI USA, V110, P17456, DOI 10.1073/pnas.1307309110; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Forsyth CM, 2013, MABS-AUSTIN, V5, P523, DOI 10.4161/mabs.24979; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Harris DT, 2016, J BIOL CHEM, V291, P24566, DOI 10.1074/jbc.M116.748681; Hui JZ, 2015, BIOCONJUGATE CHEM, V26, P1456, DOI 10.1021/acs.bioconjchem.5b00275; Janssen BMG, 2013, CHEM SCI, V4, P1442, DOI 10.1039/c3sc22033h; Kabat E. A., 1991, SEQUENCES PROTEINS I, P662; Kadonosono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103397; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Koenig P, 2015, J BIOL CHEM, V290, P21773, DOI 10.1074/jbc.M115.662783; Kornberger P, 2014, MABS-AUSTIN, V6, P354, DOI 10.4161/mabs.27444; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kowalsky CA, 2015, J BIOL CHEM, V290, P26457, DOI 10.1074/jbc.M115.676635; Lee Y, 2016, ANAL CHEM, V88, P9503, DOI 10.1021/acs.analchem.6b02071; Mazzucchelli S, 2010, ACS NANO, V4, P5693, DOI 10.1021/nn101307r; Mishra P, 2016, CELL REP, V15, P588, DOI 10.1016/j.celrep.2016.03.046; Muguruma K, 2016, BIOCONJUGATE CHEM, V27, P1606, DOI 10.1021/acs.bioconjchem.6b00149; Murelli RP, 2009, J AM CHEM SOC, V131, P17090, DOI 10.1021/ja906844e; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Reich L, 2015, J MOL BIOL, V427, P2135, DOI 10.1016/j.jmb.2014.09.025; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rosenthal ME, 2012, MED HYPOTHESES, V79, P138, DOI 10.1016/j.mehy.2012.04.013; Shin H, 2015, INT J MOL SCI, V16, P23094, DOI 10.3390/ijms160923094; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith SN, 2015, METHODS MOL BIOL, V1319, P95, DOI 10.1007/978-1-4939-2748-7_6; Sochaj AM, 2015, BIOTECHNOL ADV, V33, P775, DOI 10.1016/j.biotechadv.2015.05.001; Starita Lea M, 2015, Cold Spring Harb Protoc, V2015, P711, DOI 10.1101/pdb.top077503; Strauch EM, 2014, P NATL ACAD SCI USA, V111, P675, DOI 10.1073/pnas.1313605111; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; van Geel R, 2015, BIOCONJUGATE CHEM, V26, P2233, DOI 10.1021/acs.bioconjchem.5b00224; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Williams J. C., 2014, U. S. Patent, Patent No. [US 8658774 B2, 8658774]; Xu ZH, 2012, J IMMUNOL, V189, P4470, DOI 10.4049/jimmunol.1201813; Yao HZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020194; Zouali M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00063; Zouali Moncef, 2007, Chem Immunol Allergy, V93, P92, DOI 10.1159/000100860	58	15	15	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1477	1489		10.1074/jbc.M116.764225	http://dx.doi.org/10.1074/jbc.M116.764225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974464	Green Published, hybrid			2022-12-26	WOS:000393339800028
J	Legramante, JM; Morciano, L; Lucaroni, F; Gilardi, F; Caredda, E; Pesaresi, A; Coscia, M; Orlando, S; Brandi, A; Giovagnoli, G; Di Lecce, VN; Visconti, G; Palombi, L				Legramante, Jacopo M.; Morciano, Laura; Lucaroni, Francesca; Gilardi, Francesco; Caredda, Emanuele; Pesaresi, Alessia; Coscia, Massimo; Orlando, Stefano; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito N.; Visconti, Giuseppe; Palombi, Leonardo			Frequent Use of Emergency Departments by the Elderly Population When Continuing Care Is Not Well Established	PLOS ONE			English	Article							OLDER-ADULTS; HOSPITAL ADMISSIONS; RISK; ACCESS; MODEL	Introduction The elderly, who suffer from multiple chronic diseases, represent a substantial proportion of Emergency Department (ED) frequent users, thus contributing to ED overcrowding, although they could benefit from other health care facilities, if those were available. The aim of this study was to evaluate and characterize hospital visits of older patients (age 65 or greater) to the ED of a university teaching hospital in Rome from the 1st of January to the 31st of December 2014, in order to identify clinical and social characteristics potentially associated with "elderly frequent users". Material and Methods A retrospective study was performed during the calendar year 2014 (1st January 2014-31st December 2014) analyzing all ED admissions to the University Hospital of Rome Tor Vergata. Variables collected included age, triage code, arrival data, discharge diagnosis, and visit outcome. We performed a risk analysis using univariate binary logistic regression models. Results A total number of 38,016 patients accessed the ED, generating 46,820 accesses during the study period, with an average of 1.23 accesses for patient. The elderly population represented a quarter of the total ED population and had an increased risk of frequent use (OR 1.5: CI 1.4-1.7) and hospitalization (OR 3.8: CI 3.7-4). Moreover, they showed a greater diagnostic complexity, as demonstrated by the higher incidence of yellow and red priority codes compared to other ED populations (OR 3.1: CI 2.9-3.2). Discussion Older patients presented clinical and social characteristics related to the definition of "elderly frail frequent users". The fact that a larger number of hospitalizations occurred in such patients is indirect evidence of frailty in this specific population, suggesting that hospital admissions may be an inappropriate response to frailty, especially when continued care is not established. Conclusion Enhancement of continuity of care, establishment of a tracking system for those who are at greater risk of visiting the ED and evaluating fragile individuals should be the highest priority in addressing ED frequent usage by the elderly.	[Legramante, Jacopo M.] Univ Roma Tor Vergata, Fdn Policlin Tor Vergata, Dept Med Syst, Rome, Italy; [Morciano, Laura; Lucaroni, Francesca; Gilardi, Francesco; Caredda, Emanuele; Pesaresi, Alessia; Coscia, Massimo; Orlando, Stefano; Palombi, Leonardo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Visconti, Giuseppe] Fdn Policlin Tor Vergata, Sanit Director, Rome, Italy; [Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito N.] Fdn Policlin Tor Vergata, Emergengy Dept, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Palombi, L (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.	Leonardo.palombi@gmail.com	Gilardi, Francesco/AAA-1999-2020; Orlando, Stefano/AAU-2937-2021; Caredda, Emanuele/AAB-5230-2020	Orlando, Stefano/0000-0001-9706-4075; Caredda, Emanuele/0000-0002-2828-6202; Gilardi, Francesco/0000-0002-4038-6003				Affleck A, 2013, CAN J EMERG MED, V15, P359; Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Ciccone MM, 2013, CLIN AUDIT, V2013, P49; de Stampa M, 2014, ARCH GERONTOL GERIAT, V58, P350, DOI 10.1016/j.archger.2014.01.005; Deschodt M, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0055-7; Di Bari M, 2012, J GERONTOL A-BIOL, V67, P544, DOI 10.1093/gerona/glr209; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Ellis G, 2014, CLIN INTERV AGING, V9, P2033, DOI 10.2147/CIA.S29662; Ercoli L, 2015, MINERVA PEDIATR, V67, P11; Franchi C, 2017, AGING CLIN EXP RES, V29, P319, DOI 10.1007/s40520-016-0550-5; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Hastings SN, 2014, J AM GERIATR SOC, V62, P711, DOI 10.1111/jgs.12746; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; LaCalle EJ, 2013, J EMERG MED, V44, P1167, DOI 10.1016/j.jemermed.2012.11.042; Latham LP, 2014, CAN GERIATR J, V17, P118, DOI 10.5770/cgj.17.108; Lowthian JA, 2012, MED J AUSTRALIA, V196, P128, DOI 10.5694/mja11.10955; Ondler C, 2014, AM J EMERG MED, V32, P1215, DOI 10.1016/j.ajem.2014.07.013; Oredsson S, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-43; Palmer E, 2014, CAN FAM PHYSICIAN, V60, pE223; Palombi Leonardo, 2013, Ig Sanita Pubbl, V69, P105; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Raven MC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-270; Salvi F, 2011, G GERONTOL, V59, P179; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Sona A, 2012, EUR J PUBLIC HEALTH, V22, P76, DOI 10.1093/eurpub/ckr008; Tricco AC, 2014, CAN MED ASSOC J, V186, pE568, DOI 10.1503/cmaj.140289; van der Linden MC, 2014, INT J EMERG MED, V7, DOI 10.1186/1865-1380-7-9; Vinton DT, 2014, EMERG MED J, V31, P526, DOI 10.1136/emermed-2013-202407; Wajnberg A, 2012, J EMERG MED, V43, P376, DOI 10.1016/j.jemermed.2011.06.056; Waldner A, 2014, REDEFINING FREQUENT; Yim VWT, 2009, INT J EMERG MED, V2, P19, DOI 10.1007/s12245-009-0087-x	35	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165939	10.1371/journal.pone.0165939	http://dx.doi.org/10.1371/journal.pone.0165939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973563	Green Submitted, gold, Green Published			2022-12-26	WOS:000392754300006
J	Maguilla, E; Escudero, M				Maguilla, Enrique; Escudero, Marcial			Cryptic Species Due to Hybridization: A Combined Approach to Describe a New Species (Carex: Cyperaceae)	PLOS ONE			English	Article							DIVERSIFICATION RATES; DELIMITATION; PHYLOGENY; EVOLUTION; POPULATIONS; SYSTEMATICS; BOUNDARIES; SEQUENCES; RICHNESS; ZONES	Disappearance of diagnostic morphological characters due to hybridization is considered to be one of the causes of the complex taxonomy of the species-rich (ca. 2000 described species) genus Carex (Cyperaceae). Carex furva s.l. belongs to section Glareosae. It is an endemic species from the high mountains of the Iberian Peninsula (Spain and Portugal). Previous studies suggested the existence of two different, cryptic taxa within C. furva s.l. Intermediate morphologies found in the southern Iberian Peninsula precluded the description of a new taxa. We aimed to determine whether C. furva s.l. should be split into two different species based on the combination of morphological and molecular data. We sampled ten populations across its full range and performed a morphological study based on measurements on herbarium specimens and silica-dried inflorescences. Both morphological and phylogenetic data support the existence of two different species within C. furva s.l. Nevertheless, intermediate morphologies and sterile specimens were found in one of the southern populations (Sierra Nevada) of C. furva s.l., suggesting the presence of hybrid populations in areas where both supposed species coexist. Hybridization between these two putative species has blurred morphological and genetic limits among them in this hybrid zone. We have proved the utility of combining molecular and morphological data to discover a new cryptic species in a scenario of hybridization. We now recognize a new species, C. lucennoiberica, endemic to the Iberian Peninsula (Sierra Nevada, Central system and Cantabrian Mountains). On the other hand, C. furva s.s. is distributed only in Sierra Nevada, where it may be threatened by hybridization with C. lucennoiberica. The restricted distribution of both species and their specific habitat requirements are the main limiting factors for their conservation.	[Maguilla, Enrique] Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain; [Escudero, Marcial] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	Universidad Pablo de Olavide; University of Sevilla	Maguilla, E (corresponding author), Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain.	emagsal@gmail.com	Lirio, Antonio Marcial Escudero/H-2099-2015; Maguilla, Enrique/A-9738-2016	Lirio, Antonio Marcial Escudero/0000-0002-2541-5427; Maguilla, Enrique/0000-0002-8245-3024				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bauer AM, 2011, P ROY SOC B-BIOL SCI, V278, P490, DOI 10.1098/rspb.2010.1330; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; CAYOUETTE J, 1992, BOT REV, V58, P351, DOI 10.1007/BF02858773; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Cracraft J., 1989, P28; Cronquist A., 1988, EVOLUTION CLASSIFICA; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards DL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2765; Egorova T.V., 1999, SEDGES CAREX L RUSSI; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Escudero M, 2012, MOL PHYLOGENET EVOL, V63, P650, DOI 10.1016/j.ympev.2012.02.005; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Escudero M, 2013, AM J BOT, V100, P2403, DOI 10.3732/ajb.1300162; Escudero M, 2009, PLANT SYST EVOL, V279, P163, DOI 10.1007/s00606-009-0156-x; Gay J, 1839, ANN SCI NAT BOT 2, V11, P179; Gopalan, 2015, PLOS ONE, V10, P1; Govaerts R, 2007, ROYAL BOT GARDENS; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Jimenez-Mejias P, 2016, SYST BOT, V41, P500, DOI 10.1600/036364416X692497; Jimenez-Mejias P, 2014, SYST BOT, V39, P117, DOI 10.1600/036364414X677973; Jimenez-Mejias P, 2012, SYST BOT, V37, P382, DOI 10.1600/036364412X635449; Jimenez-Mejias P, 2011, AM J BOT, V98, P1855, DOI 10.3732/ajb.1100120; Judd W. S., 2007, PLANT SYSTEMATICS PH; Kauserud H, 2007, MOL ECOL, V16, P389, DOI 10.1111/j.1365-294X.2006.03129.x; Kukenthal G., 1909, PFLANZENREICH 4, V20; KUKKONEN I, 1988, AQUAT BOT, V30, P5, DOI 10.1016/0304-3770(88)90003-4; Lamer JT, 2014, MOL ECOL RESOUR, V14, P79, DOI 10.1111/1755-0998.12152; Latch EK, 2006, J WILDLIFE MANAGE, V70, P485, DOI 10.2193/0022-541X(2006)70[485:AHIWPU]2.0.CO;2; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Luceno M., 2008, FLORA IBERICA, P146; Luceno M., 1986, AN JARDIN BOT MADRID, V42, P427; Luceno Modesto, 2015, Acta Botanica Malacitana, V40, P217; Maguilla E, 2015, AM J BOT, V102, P1128, DOI 10.3732/ajb.1500169; Marino IAM, 2015, J HERED, V106, P123, DOI 10.1093/jhered/esu064; Martin-Bravo S, 2013, S AFR J BOT, V87, P85, DOI 10.1016/j.sajb.2013.03.014; Martin-Bravo S, 2009, FOLIA GEOBOT, V44, P399, DOI 10.1007/s12224-009-9052-y; MAYR E, 1969, Biological Journal of the Linnean Society, V1, P311, DOI 10.1111/j.1095-8312.1969.tb00123.x; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Roalson EH, 2001, SYST BOT, V26, P318; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thiers B., 2015, INDEX HERBARIORUM GL; TOIVONEN H, 1980, ANN BOT FENN, V17, P91; Toivonen H., 1981, ACTA BOT FENN, V116, P1; Toivonen H., 2002, FLORA N AM, P311; Valcarcel V, 2010, AM J BOT, V97, P1555, DOI 10.3732/ajb.1000115; Wang ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107101; Watanabe MT, 2015, PLOS ONE, V10, P1; Waterway MJ, 2015, BOT J LINN SOC, V179, P1, DOI 10.1111/boj.12298; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; Webb PB, 1838, ITER HISPANIENSE, V5; Yang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136373; Yang RC, 2016, EXP PARASITOL, V163, P16, DOI 10.1016/j.exppara.2016.01.013	63	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166949	10.1371/journal.pone.0166949	http://dx.doi.org/10.1371/journal.pone.0166949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973589	Green Published, gold			2022-12-26	WOS:000392754300017
J	Ning, DF; Liang, YC; Liu, ZD; Xiao, JF; Duan, AW				Ning, Dongfeng; Liang, Yongchao; Liu, Zhandong; Xiao, Junfu; Duan, Aiwang			Impacts of Steel-Slag-Based Silicate Fertilizer on Soil Acidity and Silicon Availability and Metals-Immobilization in a Paddy Soil	PLOS ONE			English	Article							IN-SITU REMEDIATION; POLLUTED SOILS; SEQUENTIAL EXTRACTION; HEAVY-METALS; RICE; CADMIUM; ACCUMULATION; MECHANISMS; AMENDMENTS; COMPONENTS	Slag-based silicate fertilizer has been widely used to improve soil silicon-availability and crop productivity. A consecutive early rice-late rice rotation experiment was conducted to test the impacts of steel slag on soil pH, silicon availability, rice growth and metals-immobilization in paddy soil. Our results show that application of slag at a rate above higher or equal to 1 600 mg plant-available SiO2 per kg soil increased soil pH, dry weight of rice straw and grain, plant-available Si concentration and Si concentration in rice shoots compared with the control treatment. No significant accumulation of total cadmium (Cd) and lead (Pb) was noted in soil; rather, the exchangeable fraction of Cd significantly decreased. The cadmium concentrations in rice grains decreased significantly compared with the control treatment. In conclusion, application of steel slag reduced soil acidity, increased plant-availability of silicon, promoted rice growth and inhibited Cd transport to rice grain in the soil-plant system.	[Ning, Dongfeng; Liu, Zhandong; Xiao, Junfu; Duan, Aiwang] Chinese Acad Agr Sci, Inst Farmland Irrigat Res, Minist Agr, Key Lab Crop Water Use & Regulat, Xinxiang, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Ning, DF (corresponding author), Chinese Acad Agr Sci, Inst Farmland Irrigat Res, Minist Agr, Key Lab Crop Water Use & Regulat, Xinxiang, Peoples R China.	smile_0808@163.com	Liang, Yongchao/S-9281-2019; Liang, Yongchao/D-5809-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	National Natural Science Foundation of China [51509249]; 12th Five-year Key Programs, China [2013BAB03B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Key Programs, China	The National Natural Science Foundation of China entitled "Immobilization of heavy metals in a contaminated paddy soil using nano-slag-based silicon fertilizer and ecological assessment" (Approved No. 51509249), The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration," China (2013BAB03B02).; This work was jointly supported by The National Natural Science Foundation of China entitled "Immobilization of heavy metals in a contaminated paddy soil using nano-slag-based silicon fertilizer and ecological assessment" (Approved No. 51509249), The 12 th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration", China (2013BAB03B02)	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8; Bocharnikova E. A., 2010, Russian Agricultural Sciences, V36, P446, DOI 10.3103/S1068367410060157; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Cooke J, 2011, TRENDS PLANT SCI, V16, P61, DOI 10.1016/j.tplants.2010.10.003; Dai WeiMin, 2005, Chinese Journal of Rice Science, V19, P460; Dallagnol LJ, 2009, PHYTOPATHOLOGY, V99, P116, DOI 10.1094/PHYTO-99-1-0116; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; DEREN CW, 1994, CROP SCI, V34, P733, DOI 10.2135/cropsci1994.0011183X003400030024x; Duan JM, 2014, CHEM ENG J, V246, P160, DOI 10.1016/j.cej.2014.02.056; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Friesl W, 2003, J PLANT NUTR SOIL SC, V166, P191, DOI 10.1002/jpln.200390028; Fuentes A, 2004, J HAZARD MATER, V108, P161, DOI 10.1016/j.jhazmat.2004.02.014; Gray CW, 2006, ENVIRON POLLUT, V142, P530, DOI 10.1016/j.envpol.2005.10.017; Gu HH, 2011, CHEMOSPHERE, V83, P1234, DOI 10.1016/j.chemosphere.2011.03.014; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gutierrez J, 2010, BIOL FERT SOILS, V46, P617, DOI 10.1007/s00374-010-0470-z; Hamon RE, 2002, ENVIRON SCI TECHNOL, V36, P3991, DOI 10.1021/es025558g; Haynes RJ, 2013, J PLANT NUTR SOIL SC, V176, P238, DOI 10.1002/jpln.201200372; Kaasalainen M, 2003, ENVIRON POLLUT, V126, P225, DOI 10.1016/S0269-7491(03)00191-X; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P329, DOI 10.1080/00380768.1997.10414757; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P351, DOI 10.1080/00380768.1997.10414759; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Li P, 2008, J ENVIRON SCI, V20, P449, DOI 10.1016/S1001-0742(08)62078-1; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; LIANG YC, 1994, COMMUN SOIL SCI PLAN, V25, P2285, DOI 10.1080/00103629409369189; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Lombi E, 2003, ENVIRON SCI TECHNOL, V37, P979, DOI 10.1021/es026083w; Lu R.K, 2000, ANAL METHOD SOIL AGR; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma TS, 1994, SOIL, V26, P154; Maiz I, 2000, ENVIRON POLLUT, V110, P3, DOI 10.1016/S0269-7491(99)00287-0; Meena V. D., 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P505, DOI 10.1007/s40011-013-0270-y; Nanayakkara UN, 2008, PLANT DIS, V92, P870, DOI 10.1094/PDIS-92-6-0870; Ning DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102681; Pueyo M, 2008, ENVIRON POLLUT, V152, P330, DOI 10.1016/j.envpol.2007.06.020; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Rodrigues FA, 2001, PLANT DIS, V85, P827, DOI 10.1094/PDIS.2001.85.8.827; Sauve S, 1998, SOIL SCI SOC AM J, V62, P618, DOI 10.2136/sssaj1998.03615995006200030010x; Savant NK, 1997, ADV AGRON, V58, P151; Seebold KW, 2001, PHYTOPATHOLOGY, V91, P63, DOI 10.1094/PHYTO.2001.91.1.63; Song A, 2009, J HAZARD MATER, V172, P74, DOI 10.1016/j.jhazmat.2009.06.143; Tsakiridis PE, 2008, J HAZARD MATER, V152, P805, DOI 10.1016/j.jhazmat.2007.07.093; Wu SP, 2007, BUILD ENVIRON, V42, P2580, DOI 10.1016/j.buildenv.2006.06.008; Xu XH, 2014, ECOTOX ENVIRON SAFE, V108, P161, DOI 10.1016/j.ecoenv.2014.07.001; Xue YJ, 2009, J HAZARD MATER, V162, P973, DOI 10.1016/j.jhazmat.2008.05.131; Zhang CC, 2008, ENVIRON EXP BOT, V62, P300, DOI 10.1016/j.envexpbot.2007.10.024; Zhang XP, 1982, SOIL, V14, P185; Zhu GL, 2010, IRON STEEL SCRAP, V1, P12; Zhuo L, 2012, ENVIRON SCI POLLUT R, V19, P2842, DOI 10.1007/s11356-012-0790-7	53	52	55	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168163	10.1371/journal.pone.0168163	http://dx.doi.org/10.1371/journal.pone.0168163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973585	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300060
J	Strullu-Derrien, C; Goral, T; Longcore, JE; Olesen, J; Kenrick, P; Edgecombe, GD				Strullu-Derrien, Christine; Goral, Tomasz; Longcore, Joyce E.; Olesen, Jorgen; Kenrick, Paul; Edgecombe, Gregory D.			A New Chytridiomycete Fungus Intermixed with Crustacean Resting Eggs in a 407-Million-Year- Old Continental Freshwater Environment	PLOS ONE			English	Article							DEVONIAN RHYNIE CHERT; RHIZOPHYDIALES CHYTRIDIOMYCOTA; GREEN-ALGA; LAND PLANT; FOOD-WEB; SCOTLAND; ABERDEENSHIRE; EVOLUTION; HORNEOPHYTON; MICROFUNGUS	The 407-million-year-old Rhynie Chert (Scotland) contains the most intact fossilised remains of an early land-based ecosystem including plants, arthropods, fungi and other microorganisms. Although most studies have focused on the terrestrial component, fossilised freshwater environments provide critical insights into fungal-algal interactions and the earliest continental branchiopod crustaceans. Here we report interactions between an enigmatic organism and an exquisitely preserved fungus. The fungal reproductive structures are intermixed with exceptionally well-preserved globular spiny structures interpreted as branchiopod resting eggs. Confocal laser scanning microscopy enabled us to reconstruct the fungus and its possible mode of nutrition, the affinity of the resting eggs, and their spatial associations. The new fungus (Cultoraquaticus trewini gen. et sp. nov) is attributed to Chytridiomycota based on its size, consistent formation of papillae, and the presence of an internal rhizoidal system. It is the most pristine fossil Chytridiomycota known, especially in terms of rhizoidal development and closely resembles living species in the Rhizophydiales. The spiny resting eggs are attributed to the crustacean Lepidocaris rhyniensis, dating branchiopod adaptation to life in ephemeral pools to the Early Devonian. The new fungal interaction suggests that, as in modern freshwater environments, chytrids were important to the mobilisation of nutrients in early aquatic foodwebs.	[Strullu-Derrien, Christine; Kenrick, Paul; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London, England; [Goral, Tomasz] Nat Hist Museum, Imaging & Anal Ctr, Cromwell Rd, London, England; [Longcore, Joyce E.] Univ Maine, Sch Biol & Ecol, 5722 Deering Hall, Orono, ME USA; [Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum, Univ Pk, Copenhagen, Denmark	Natural History Museum London; Natural History Museum London; University of Maine System; University of Maine Orono; University of Copenhagen	Strullu-Derrien, C (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London, England.	c.strullu-derrien@nhm.ac.uk	Strullu-Derrien, Christine/P-4543-2019; Olesen, Jørgen/A-3353-2013	Strullu-Derrien, Christine/0000-0003-1131-9546; Olesen, Jørgen/0000-0001-9582-7083; Edgecombe, Gregory/0000-0002-9591-8011; Kenrick, Paul/0000-0002-3626-5460	Marie Curie Intra-European Fellowship for Career Development [SYMBIONTS GA-2011-298735]; FP7 SYNTHESYS grant of the European Commission [NL-TAF 3245]	Marie Curie Intra-European Fellowship for Career Development; FP7 SYNTHESYS grant of the European Commission	This work was supported by a Marie Curie Intra-European Fellowship for Career Development (SYMBIONTS GA-2011-298735) and a FP7 SYNTHESYS grant (NL-TAF 3245) of the European Commission to C.S.-D for data collection and analysis.	Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; BARR DJS, 1984, CAN J BOT, V62, P1171, DOI 10.1139/b84-161; Barr DJS, 2001, MYCOTA, V7, P93; Bruner E, 2013, HYDROBIOLOGIA, V705, P1, DOI 10.1007/s10750-012-1343-2; CANTER HILDA M., 1949, TRANS BRIT MYCOL SOC, V32, P69; Crous PW, 2004, STUD MYCOL, P19; Fayers SR, 2003, T ROY SOC EDIN-EARTH, V93, P355; FORSTER H, 1990, MYCOLOGIA, V82, P306, DOI 10.2307/3759901; FRYER G, 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P103; Fryer G, 2009, ZOOL J LINN SOC-LOND, V155, P513, DOI 10.1111/j.1096-3642.2008.00455.x; Gueriau P, 2016, CURR BIOL, V26, P383, DOI 10.1016/j.cub.2015.12.039; Habgood KS, 2004, T ROY SOC EDIN-EARTH, V94, P371, DOI 10.1017/S0263593300000754; HASS H, 1994, AM J BOT, V81, P29, DOI 10.2307/2445559; Haug C, 2014, ATLAS OF CRUSTACEAN LARVAE, P36; Haug C, 2012, PALAEONTOL ELECTRON, V15; ILLMAN WI, 1984, MYCOLOGIA, V76, P545, DOI 10.2307/3793338; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Karling John S., 1946, LLOYDIA [CINCINNATI], V9, P1; Karling JS, 1977, CHYTRIDIOMYCETARUM I; Krings M, 2007, NEW PHYTOL, V174, P648, DOI 10.1111/j.1469-8137.2007.02008.x; Krings M, 2014, NOVA HEDWIGIA, V99, P403, DOI 10.1127/0029-5035/2014/0205; Krings Michael, 2009, Zitteliana Reihe A, V48-49, P165; Letcher PM, 2008, MYCOL RES, V112, P759, DOI 10.1016/j.mycres.2008.01.025; Letcher PM, 2006, MYCOL RES, V110, P898, DOI 10.1016/j.mycres.2006.06.011; Letcher PM, 2012, TAXONOMIC SUMMARY RH; Mark DF, 2013, J GEOL SOC LONDON, V170, P701, DOI 10.1144/jgs2011-110; MARTIN JW, 1992, MICROSCOPIC ANATOMY, V9, P25; Olesen Jorgen, 2009, Arthropod Systematics & Phylogeny, V67, P3; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; REMY W, 1994, AM J BOT, V81, P690, DOI 10.2307/2445647; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rice CM, 2002, J GEOL SOC LONDON, V159, P203, DOI 10.1144/0016-764900-181; Schopf JW, 2011, TOP GEOBIOL, V32, P457, DOI 10.1007/978-90-481-8643-3_13; Schopf JW, 2009, PRECAMBRIAN RES, V173, P39, DOI 10.1016/j.precamres.2009.02.007; Schram FR, 2001, EVOL DEV, V3, P343, DOI 10.1046/j.1525-142X.2001.01038.x; Scourfield DJ, 1926, PHILOS T R SOC LON B, V214, P153, DOI 10.1098/rstb.1926.0005; Scourfield DJ., 1940, ZOOLOGICAL J LINNEAN, V152, P290; Shi CS, 2013, AM J BOT, V100, P1626, DOI 10.3732/ajb.1300027; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Stalpers J., MYCOBANK ENGINE RELA; Strullu-Derrien C, 2015, BOT J LINN SOC, V179, P201, DOI 10.1111/boj.12307; Strullu-Derrien C, 2014, NEW PHYTOL, V203, P964, DOI 10.1111/nph.12805; Talyor T.N., 2015, FOSSIL FUNGI; TAYLOR TN, 1994, NATURE, V367, P601, DOI 10.1038/367601a0; Taylor TN, 2004, T ROY SOC EDIN-EARTH, V94, P457, DOI 10.1017/S026359330000081X; TAYLOR TN, 1992, MYCOLOGIA, V84, P901, DOI 10.2307/3760288; TAYLOR TN, 1992, AM J BOT, V79, P1233, DOI 10.2307/2445050; TAYLOR TN, 1992, NATURE, V357, P493, DOI 10.1038/357493a0; Trewin NH, 2004, T R SOC EDINB EARTH, V94	51	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167301	10.1371/journal.pone.0167301	http://dx.doi.org/10.1371/journal.pone.0167301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973602	Green Published, gold			2022-12-26	WOS:000392754300023
J	Assadi, G; Vesterlund, L; Bonfiglio, F; Mazzurana, L; Cordeddu, L; Schepis, D; Mjosberg, J; Ruhrmann, S; Fabbri, A; Vukojevic, V; Percipalle, P; Salomons, FA; Laurencikiene, J; Torkvist, L; Halfvarson, J; D'Amato, M				Assadi, Ghazaleh; Vesterlund, Liselotte; Bonfiglio, Ferdinando; Mazzurana, Luca; Cordeddu, Lina; Schepis, Danika; Mjosberg, Jenny; Ruhrmann, Sabrina; Fabbri, Alessia; Vukojevic, Vladana; Percipalle, Piergiorgio; Salomons, Florian A.; Laurencikiene, Jurga; Torkvist, Leif; Halfvarson, Jonas; D'Amato, Mauro			Functional Analyses of the Crohn's Disease Risk Gene LACC1	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; LEPROSY; LOCI; MICE	Background Genetic variation in the Laccase (multicopper oxidoreductase) domain-containing 1 (LACC1) gene has been shown to affect the risk of Crohn's disease, leprosy and, more recently, ulcerative colitis and juvenile idiopathic arthritis. LACC1 function appears to promote fatty-acid oxidation, with concomitant inflammasome activation, reactive oxygen species production, and anti-bacterial responses in macrophages. We sought to contribute to elucidating LACC1 biological function by extensive characterization of its expression in human tissues and cells, and through preliminary analyses of the regulatory mechanisms driving such expression. Methods We implemented Western blot, quantitative real-time PCR, immunofluorescence microscopy, and flow cytometry analyses to investigate fatty acid metabolism-immune nexus (FAMIN; the LACC1 encoded protein) expression in subcellular compartments, cell lines and relevant human tissues. Gene-set enrichment analyses were performed to initially investigate modulatory mechanisms of LACC1 expression. A small-interference RNA knockdown in vitro model system was used to study the effect of FAMIN depletion on peroxisome function. Results FAMIN expression was detected in macrophage-differentiated THP-1 cells and several human tissues, being highest in neutrophils, monocytes/macrophages, myeloid and plasmacytoid dendritic cells among peripheral blood cells. Subcellular co-localization was exclusively confined to peroxisomes, with some additional positivity for organelle endomembrane structures. LACC1 co-expression signatures were enriched for genes involved in peroxisome proliferator-activated receptors (PPAR) signaling pathways, and PPAR ligands downregulated FAMIN expression in in vitro model systems. Conclusion FAMIN is a peroxisome-associated protein with primary role(s) in macrophages and other immune cells, where its metabolic functions may be modulated by PPAR signaling events. However, the precise molecular mechanisms through which FAMIN exerts its biological effects in immune cells remain to be elucidated.	[Assadi, Ghazaleh; Vesterlund, Liselotte; Bonfiglio, Ferdinando; Cordeddu, Lina; D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mazzurana, Luca; Mjosberg, Jenny] Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden; [Schepis, Danika] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Rheumatol Unit, Stockholm, Sweden; [Ruhrmann, Sabrina; Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Fabbri, Alessia] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Rome, Italy; [Percipalle, Piergiorgio] New York Univ Abu Dhabi, Biol Program, Abu Dhabi, U Arab Emirates; [Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Salomons, Florian A.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Laurencikiene, Jurga] Karolinska Inst, Dept Med Huddinge, Lipid Lab, Stockholm, Sweden; [Torkvist, Leif] Karolinska Univ Hosp, Gastroctr, Stockholm, Sweden; [Halfvarson, Jonas] Univ Orebro, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden; [D'Amato, Mauro] Basque Fdn Sci, BioDonostia Hlth Res Inst, San Sebastian & IKERBASQUE, Bilbao, Spain	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Istituto Superiore di Sanita (ISS); Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University; Basque Foundation for Science; Instituto de Investigacion Sanitaria Biodonostia	Assadi, G (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	ghazaleh.assadi@ki.se	Vukojevic, Vladana B/AAY-3144-2021; D'Amato, Mauro/F-2450-2010; Bonfiglio, Ferdinando/ABE-5834-2021; RICE, GREGORY E/F-2412-2010; D'Amato, Mauro/B-5050-2019; Fabbri, Alessia/AAA-4594-2019; Halfvarson, Jonas/AAU-4687-2020; Bonfiglio, Ferdinando/AAP-4424-2020	D'Amato, Mauro/0000-0003-2743-5197; Bonfiglio, Ferdinando/0000-0003-2488-3867; RICE, GREGORY E/0000-0001-7177-0246; D'Amato, Mauro/0000-0003-2743-5197; Fabbri, Alessia/0000-0002-3075-3367; Bonfiglio, Ferdinando/0000-0003-2488-3867; , Jurga/0000-0002-7032-2924; Vesterlund, Liselotte/0000-0003-3547-9288; Vukojevic, Vladana/0000-0003-0873-5653; Mjosberg, Jenny/0000-0002-1119-0976	Swedish Research Council, Vetenskapsradet (VR); Karolinska Institutet KID PhD fellowship	Swedish Research Council, Vetenskapsradet (VR)(Swedish Research Council); Karolinska Institutet KID PhD fellowship	This study was supported by funds from the Swedish Research Council, Vetenskapsradet (VR; http://www.vr.se/) to MDA. GA is the recipient of a Karolinska Institutet KID PhD fellowship.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assadi G, 2016, GENES IMMUN, V17, P261, DOI 10.1038/gene.2016.17; Bayley R, 2015, ANN RHEUM DIS, V74, P1588, DOI 10.1136/annrheumdis-2013-204796; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cable S, 1994, STUDIES PEROXISOMES, V39, P2177; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goel A, 2014, GUT, V63, pA179, DOI 10.1136/gutjnl-2014-307263.385; Goncalves P, 2015, INFLAMM BOWEL DIS, V21, P453, DOI 10.1097/MIB.0000000000000209; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hontecillas R, 2011, MUCOSAL IMMUNOL, V4, P304, DOI 10.1038/mi.2010.75; Hruz T, 2008, GENEVESTIGATOR, V2008; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ning K, 2015, HUM MOL GENET, V24, P4147, DOI 10.1093/hmg/ddv142; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rogovin VV, 2001, COMPOSITION NEUTROPH, V28, P396; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; Skieceviciene J, 2013, INFLAMM BOWEL DIS, V19, P2349, DOI 10.1097/MIB.0b013e3182a3eaeb; Sugawara K, 2005, GASTROENTEROLOGY, V128, P351, DOI 10.1053/j.gastro.2004.11.001; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; Xiong JH, 2016, INT J DERMATOL, V55, P65, DOI 10.1111/ijd.12981; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	35	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168276	10.1371/journal.pone.0168276	http://dx.doi.org/10.1371/journal.pone.0168276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959965	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900054
J	Posod, A; Komazec, IO; Kager, K; Peglow, UP; Griesmaier, E; Schermer, E; Wurtinger, P; Baumgartner, D; Kiechl-Kohlendorfer, U				Posod, Anna; Komazec, Irena Odri; Kager, Katrin; Peglow, Ulrike Pupp; Griesmaier, Elke; Schermer, Elisabeth; Wuertinger, Philipp; Baumgartner, Daniela; Kiechl-Kohlendorfer, Ursula			Former Very Preterm Infants Show an Unfavorable Cardiovascular Risk Profile at a Preschool Age	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; LOW-BIRTH-WEIGHT; METABOLIC SYNDROME; CHILDREN; INSULIN; ADOLESCENTS; ADULTHOOD; MORTALITY; GROWTH; HEART	Cardiovascular disease is the leading cause of death worldwide. Evidence points towards an unfavorable cardiovascular risk profile of former preterm infants in adolescence and adulthood. The aim of this study was to determine whether cardiovascular risk predictors are detectable in former very preterm infants at a preschool age. Five-to seven-year-old children born at < 32 weeks' gestational age were included in the study. Same-aged children born at term served as controls. Basic data of study participants were collected by means of follow-up databases and standardized questionnaires. At study visit, anthropometric data, blood pressure readings and aortic intima-media thickness were assessed. Blood samples were obtained after an overnight fast. In comparison to children born at term, former preterm infants had higher systolic and diastolic blood pressure readings (odds ratio [95% confidence interval] per 1-SD higher blood pressure level 3.2 [2.0-5.0], p< 0.001 and 1.6 [1.1 - 1.2], p = 0.008), fasting glucose levels (OR [95% CI] 5.2 [2.7-10.1], p< 0.001), homeostasis model assessment index (OR [95% CI] 1.6 [1.0-2.6], p = 0.036), and cholesterol levels (OR [95% CI] 2.1 [1.3-3.4], p = 0.002). Systolic prehypertension (23.7% vs. 2.2%; OR [95% CI] 13.8 [3.1-60.9], p = 0.001), elevated glucose levels (28.6% vs. 5.9%; OR [95% CI] 6.4 [1.4 - 28.8], p = 0.016), and hypercholesterolemia (77.4% vs. 52.9%; OR [95% CI] 3.0 [1.3-7.1], p = 0.010) were significantly more prevalent in the preterm group. As former very preterm infants display an unfavorable cardiovascular risk profile already at a preschool age, implementation of routine cardiovascular follow-up programs might be warranted.	[Posod, Anna; Komazec, Irena Odri; Kager, Katrin; Peglow, Ulrike Pupp; Griesmaier, Elke; Kiechl-Kohlendorfer, Ursula] Med Univ Innsbruck, Dept Pediat Pediat Neonatol 2, Innsbruck, Austria; [Komazec, Irena Odri; Schermer, Elisabeth; Baumgartner, Daniela] Med Univ Innsbruck, Dept Pediat Pediat Pediat Cardiol Pulmonol Allerg, Innsbruck, Austria; [Wuertinger, Philipp] Univ Innsbruck Hosp, Cent Inst Med & Chem Lab Diag, Innsbruck, Austria; [Baumgartner, Daniela] Med Univ Graz, Dept Pediat Clin, Clin Div Cardiol, Graz, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Graz	Kiechl-Kohlendorfer, U (corresponding author), Med Univ Innsbruck, Dept Pediat Pediat Neonatol 2, Innsbruck, Austria.	ursula.kohlendorfer@i-med.ac.at	Posod, Anna/AAE-8951-2020	Baumgartner, Daniela/0000-0001-8141-2426; Kiechl-Kohlendorfer, Ursula/0000-0003-0433-6196	Anniversary Fund of the Austrian National Bank [14570]; Austrian Heart Foundation; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMVIT [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMWFW [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Wirtschaftsagentur Wien [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Standortagentur Tirol [843536]	Anniversary Fund of the Austrian National Bank; Austrian Heart Foundation; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMVIT; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMWFW; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Wirtschaftsagentur Wien; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Standortagentur Tirol	This study was supported by the Anniversary Fund of the Austrian National Bank (Project No. 14570) (UK-K) and the Austrian Heart Foundation (UK-K). UK-K is also supported by the excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" (K-Project No. 843536) funded by BMVIT, BMWFW, Wirtschaftsagentur Wien and Standortagentur Tirol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Bracewell MA, 2008, ARCH DIS CHILD-FETAL, V93, pF108, DOI 10.1136/adc.2007.118596; Breukhoven PE, 2012, J CLIN ENDOCR METAB, V97, P1294, DOI 10.1210/jc.2011-2621; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Darendeliler F, 2008, CLIN ENDOCRINOL, V68, P773, DOI 10.1111/j.1365-2265.2007.03119.x; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Maric-Bilkan C, 2016, HYPERTENSION, V67, P802, DOI 10.1161/HYPERTENSIONAHA.115.06967; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Peplies J, 2014, INT J OBESITY, V38, pS39, DOI 10.1038/ijo.2014.134; Piyasena C, 2014, ARCH DIS CHILD-FETAL, V99, pF29, DOI [10.1136/archdischild-2014-306742, 10.1136/archdischild-2013-304101]; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Saigal S, 2006, PEDIATR RES, V60, P751, DOI 10.1203/01.pdr.0000246201.93662.8e; Shimizu T, 2014, PEDIATR CARDIOL, V35, P121, DOI 10.1007/s00246-013-0750-0; Sipola-Leppanen M, 2015, CURR OPIN LIPIDOL, V26, P282, DOI 10.1097/MOL.0000000000000190; Sipola-Leppanen M, 2014, PEDIATRICS, V134, pE1072, DOI 10.1542/peds.2013-4186; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Thornburg KL, 2015, J DEV ORIG HLTH DIS, V6, P366, DOI 10.1017/S2040174415001300; Truthmann J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-133; Wabitsch M, 2014, KONSENSBASIERTE S2 L	30	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168162	10.1371/journal.pone.0168162	http://dx.doi.org/10.1371/journal.pone.0168162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959909	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900043
J	Yamazaki, R; Nishiyama, O; Sano, H; Iwanaga, T; Higashimoto, Y; Kume, H; Tohda, Y				Yamazaki, Ryo; Nishiyama, Osamu; Sano, Hiroyuki; Iwanaga, Takashi; Higashimoto, Yuji; Kume, Hiroaki; Tohda, Yuji			Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; REQUIRING HOSPITALIZATION; ACUTE EXACERBATION; FIBROSIS; DIAGNOSIS; RISK; STANDARDIZATION; GUIDELINES; MANAGEMENT; CULTURE	Many patients with idiopathic pulmonary fibrosis (IPF) undergo hospitalizations due to pulmonary infections. We retrospectively investigated the characteristics of hospitalizations due to pulmonary infection in patients with IPF to elucidate causative pathogens and mortality. We reviewed patients with IPF who were admitted between January 2008 and December 2014 for pulmonary infections including pneumonia and bronchitis. The causative pathogen, the relationship between the site of pneumonia and existing IPF radiological patterns on high-resolution chest CT, and predictors of mortality were evaluated. Forty-eight IPF patients were hospitalized a totally of 81 times due to pulmonary infection during the study period. In the 48 first-time admissions after IPF diagnosis, causative pathogens were detected in 20 patients (41.6%). The most common pathogen was Haemophilus influenzae (14.5%) followed by Pseudomonas aeruginosa (4.1%), Staphylococcus aureus (4.1%), Branhamella catarrhalis (4.1%), and Klebsiella pneumoniae (4.1%). Among all 81 admissions, the most common pathogen was P. aeruginosa (12.3%), followed by H. influenzae (8.6%), S. aureus (6.1%) and Escherichia coli (4.9%). No relationship was observed between the detected pathogen and the site of pneumonia. The 30-day and hospital mortality rates were 14.5% and 18.7%, respectively. Pneumonia severity index on admission was significantly associated with both 30-day and hospital mortality. In conclusion, IPF patients hospitalized for pulmonary infections had high 30-day and hospital mortality. In contrast to community-acquired pneumonia, the causative pathogens mainly consisted of gram-negative bacteria. The PSI score may be a significant predictor of mortality. These results provide information for empiric antibiotic selection when treating IPF patients with pulmonary infections.	[Yamazaki, Ryo; Nishiyama, Osamu; Sano, Hiroyuki; Iwanaga, Takashi; Higashimoto, Yuji; Kume, Hiroaki; Tohda, Yuji] Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan		Nishiyama, O (corresponding author), Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan.	nishiyama_o@yahoo.co.jp	Higashimoto, Yuji/AAW-2703-2021	Nishiyama, Osamu/0000-0002-9163-9605				Andruska A, 2015, CHEST, V148, P103, DOI 10.1378/chest.14-2129; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Brown AW, 2015, CHEST, V147, P173, DOI 10.1378/chest.13-2424; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Durheim MT, 2015, LANCET RESP MED, V3, P388, DOI 10.1016/S2213-2600(15)00093-4; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vazquez E, 2004, ARCH INTERN MED, V164, P1807, DOI 10.1001/archinte.164.16.1807; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Hirama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024474; Ishida T, 1998, CHEST, V114, P1588, DOI 10.1378/chest.114.6.1588; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyashita N, 2008, MED SCI MONITOR, V14, pCR171; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Zalacain R, 2003, EUR RESPIR J, V21, P294, DOI 10.1183/09031936.03.00064102	24	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168164	10.1371/journal.pone.0168164	http://dx.doi.org/10.1371/journal.pone.0168164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959904	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900044
J	Kumar, S; Archak, S; Tyagi, RK; Kumar, J; Vikas, VK; Jacob, SR; Srinivasan, K; Radhamani, J; Parimalan, R; Sivaswamy, M; Tyagi, S; Yadav, M; Kumari, J; Deepali; Sharma, S; Bhagat, I; Meeta, M; Bains, NS; Chowdhury, AK; Saha, BC; Bhattacharya, PM; Kumari, J; Singh, MC; Gangwar, OP; Prasad, P; Bharadwaj, SC; Gogoi, R; Sharma, JB; Kumar, GMS; Saharan, MS; Bag, M; Roy, A; Prasad, TV; Sharma, RK; Dutta, M; Sharma, I; Bansal, KC				Kumar, Sundeep; Archak, Sunil; Tyagi, R. K.; Kumar, Jagdish; Vikas, V. K.; Jacob, Sherry R.; Srinivasan, Kalyani; Radhamani, J.; Parimalan, R.; Sivaswamy, M.; Tyagi, Sandhya; Yadav, Mamata; Kumari, Jyotisna; Deepali; Sharma, Sandeep; Bhagat, Indoo; Meeta, Madhu; Bains, N. S.; Chowdhury, A. K.; Saha, B. C.; Bhattacharya, P. M.; Kumari, Jyoti; Singh, M. C.; Gangwar, O. P.; Prasad, P.; Bharadwaj, S. C.; Gogoi, Robin; Sharma, J. B.; Kumar, Sandeep G. M.; Saharan, M. S.; Bag, Manas; Roy, Anirban; Prasad, T. V.; Sharma, R. K.; Dutta, M.; Sharma, Indu; Bansal, K. C.			Evaluation of 19,460 Wheat Accessions Conserved in the Indian National Genebank to Identify New Sources of Resistance to Rust and Spot Blotch Diseases	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; STEM-RUST; STRIPE-RUST; BIPOLARIS-SOROKINIANA; LEAF; GENES; MICROSATELLITE; REGION; UG99; IDENTIFICATION	A comprehensive germplasm evaluation study of wheat accessions conserved in the Indian National Genebank was conducted to identify sources of rust and spot blotch resistance. Genebank accessions comprising three species of wheat-Triticum aestivum, T. durum and T. dicoccum were screened sequentially at multiple disease hotspots, during the 2011-14 crop seasons, carrying only resistant accessions to the next step of evaluation. Wheat accessions which were found to be resistant in the field were then assayed for seedling resistance and profiled using molecular markers. In the primary evaluation, 19,460 accessions were screened at Wellington (Tamil Nadu), a hotspot for wheat rusts. We identified 4925 accessions to be resistant and these were further evaluated at Gurdaspur (Punjab), a hotspot for stripe rust and at Cooch Behar (West Bengal), a hotspot for spot blotch. The second round evaluation identified 498 accessions potentially resistant to multiple rusts and 868 accessions potentially resistant to spot blotch. Evaluation of rust resistant accessions for seedling resistance against seven virulent pathotypes of three rusts under artificial epiphytotic conditions identified 137 accessions potentially resistant to multiple rusts. Molecular analysis to identify different combinations of genetic loci imparting resistance to leaf rust, stem rust, stripe rust and spot blotch using linked molecular markers, identified 45 wheat accessions containing known resistance genes against all three rusts as well as a QTL for spot blotch resistance. The resistant germplasm accessions, particularly against stripe rust, identified in this study can be excellent potential candidates to be employed for breeding resistance into the background of high yielding wheat cultivars through conventional or molecular breeding approaches, and are expected to contribute toward food security at national and global levels.	[Kumar, Sundeep; Archak, Sunil; Tyagi, R. K.; Jacob, Sherry R.; Srinivasan, Kalyani; Radhamani, J.; Parimalan, R.; Tyagi, Sandhya; Yadav, Mamata; Kumari, Jyotisna; Deepali; Sharma, Sandeep; Kumari, Jyoti; Singh, M. C.; Bag, Manas; Roy, Anirban; Prasad, T. V.; Sharma, R. K.; Dutta, M.; Bansal, K. C.] Natl Bur Plant Genet Resources, ICAR, Pusa Campus, New Delhi, India; [Kumar, Jagdish; Vikas, V. K.; Sivaswamy, M.] Indian Agr Res Inst, Reg Stn, ICAR, Wellington, Tamil Nadu, India; [Bhagat, Indoo] Punjab Agr Univ, Reg Stn, Gurdaspur, Punjab, India; [Meeta, Madhu; Bains, N. S.] Punjab Agr Univ, Ludhiana, Punjab, India; [Chowdhury, A. K.; Saha, B. C.; Bhattacharya, P. M.] North Bengal Agr Univ, Cooch Behar, Cooch Behar, W Bengal, India; [Gangwar, O. P.; Prasad, P.; Bharadwaj, S. C.] Indian Inst Wheat & Barley Res, Reg Stn, ICAR, Flowerdale, Himachal Prades, India; [Gogoi, Robin; Sharma, J. B.] Indian Agr Res Inst, ICAR, New Delhi, India; [Kumar, Sandeep G. M.] Indian Agr Res Inst, Reg Stn, ICAR, Katrain, Himachal Prades, India; [Saharan, M. S.; Sharma, Indu] Indian Inst Wheat & Barley Res, ICAR, Karnal, Haryana, India; [Kumar, Jagdish] Natl Inst Biot Stress Management, ICAR, Raipur, Madhya Pradesh, India; [Bag, Manas] Cent Rice Res Inst, ICAR, Cuttack, Orissa, India; [Roy, Anirban] Indian Agr Res Inst, ICAR, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Punjab Agricultural University; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Biotic Stresses Management; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Bansal, KC (corresponding author), Natl Bur Plant Genet Resources, ICAR, Pusa Campus, New Delhi, India.	kailashbansal@hotmail.com	Gogoi, Robin/AAF-7155-2019; Saharan, Mahender/AAI-9831-2020; Bhardwaj, Subhash Chander/U-2644-2017; Bag, Manas Kumar/ABA-4776-2021; Gangwar, Om Prakash/ABA-5954-2021; Prasad, Pramod/M-4679-2017	Bhardwaj, Subhash Chander/0000-0002-4070-8412; Bag, Manas Kumar/0000-0002-5429-2497; Prasad, Pramod/0000-0003-4091-1119; SHARMA, SANDEEP/0000-0002-5795-8899; ARCHAK, SUNIL/0000-0002-9146-2993; TYAGI, SANDHYA/0000-0002-8168-017X	National Innovations on Climate Resilient Agriculture (NICRA)	National Innovations on Climate Resilient Agriculture (NICRA)	The work was funded by a sponsored research component of National Innovations on Climate Resilient Agriculture (NICRA) given to ICAR-NBPGR (http//www.nicra-icar.in/nicrarevised/index.php/spnsored-competative-grants/list-of-projects).	Bansal UK, 2008, WHEAT GENET S, V1, P188; Bonman JM, 2007, CROP SCI, V47, P1955, DOI 10.2135/cropsci2007.01.0028; BROWDER LE, 1973, PHYTOPATHOLOGY, V63, P524, DOI 10.1094/Phyto-63-524; Caldwell RM, 1968, P 3 INT WHEAT GEN S, P263; Chakraborty S, 2011, EUPHYTICA, V179, P19, DOI 10.1007/s10681-010-0324-7; Chand R, 2003, Z PFLANZENK PFLANZEN, V110, P27; Chaurasia S, 1999, GENET RESOUR CROP EV, V46, P469, DOI 10.1023/A:1008797232108; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chowdhury A.K., 2013, J WHEAT RES, V5, P1; CIMMYT, 2013, RES BATTL WHEAT SPOT; Curtis BC, 2002, MACPHERSON HG BREAD, P1; Daetwyler HD, 2014, THEOR APPL GENET, V127, P1795, DOI 10.1007/s00122-014-2341-8; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUBIN HJ, 1998, P INT WORKSH HELM DI, P182; Duveiller E., 1998, HELMINTHOSPORIUM BLI, P162; Duveiller E, 2007, EUPHYTICA, V157, P417, DOI 10.1007/s10681-007-9380-z; Duveiller E, 2012, CABI PLANT PROT SER, P120, DOI 10.1079/9781845938185.0120; Eisa M, 2013, EUR J PLANT PATHOL, V137, P805, DOI 10.1007/s10658-013-0290-8; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Elouafi I, 2001, HEREDITAS, V135, P255, DOI 10.1111/j.1601-5223.2001.t01-1-00255.x; Eyal Z., 1987, SEPTORIA DIS WHEAT C; FAOSTAT, 2016, FAOSTAT AGR DAT, P1; Hadi Bux, 2012, Australian Journal of Crop Science, V6, P116; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; Hiebert CW, 2007, THEOR APPL GENET, V115, P877, DOI 10.1007/s00122-007-0604-3; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Iftikhar S, 2012, PAK J BOT, V44, P361; Jin Y, 2006, PLANT DIS, V90, P476, DOI 10.1094/PD-90-0476; Johnson R, 1998, BREEDING STRATEGIES, P63; Joshi AK, 2007, FIELD CROP RES, V103, P53, DOI 10.1016/j.fcr.2007.04.010; Joshi AK, 2011, EUPHYTICA, V179, P187, DOI 10.1007/s10681-010-0314-9; Joshi AK, 2004, PLANT BREEDING, V123, P213, DOI 10.1111/j.1439-0523.2004.00954.x; Kolmer JA, 2007, AUST J AGR RES, V58, P631, DOI 10.1071/AR07057; Kolmer JA, 2008, CROP SCI, V48, P1841, DOI 10.2135/cropsci2007.08.0474; Kumar J, 2014, INDIAN J AGR SCI, V84, P112; Kumar J, 2011, J WHEAT RES, V3, P8; Kumar U, 2010, MOL BREEDING, V26, P477, DOI 10.1007/s11032-009-9388-2; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Mago R, 2005, THEOR APPL GENET, V111, P496, DOI 10.1007/s00122-005-2039-z; Mago R, 2011, THEOR APPL GENET, V122, P735, DOI 10.1007/s00122-010-1482-7; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh R A, 2010, CATALOGUE GENE SYM S; Mikhailova L. A., 2004, Archives of Phytopathology and Plant Protection, V37, P161, DOI 10.1080/03235400310001631909; Nagarajan S., 1975, Cereal Rusts Bulletin, V3, P29; Nagarajan S, 1985, DIS DISTRIBUTION EPI, V2; Nagarajan S., 1998, PROC INT WORKSHOP HE, P52; Nazari K, 2009, PLANT DIS, V93, DOI 10.1094/PDIS-93-3-0317B; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Parlevliet J. E., 1985, CEREAL RUSTS, V2, P501; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Roder MS, 1998, GENETICS, V149, P2007; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; Saari E.E., 1998, HELMINTHOSPORIUM BLI, P37; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Simons K, 2011, THEOR APPL GENET, V122, P649, DOI 10.1007/s00122-010-1444-0; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; Singh RP, 2002, WHEAT RUSTS BREAD WH, P227; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stakman EC, 1962, USDA ARS E617, P1; Thomas J, 2010, CROP SCI, V50, P2310, DOI 10.2135/cropsci2010.02.0065; Tiwari V, 2012, CROP IMPROVEMENT, VI; Tomar SMS, 2014, INDIAN J GENET PL BR, V74, P129, DOI 10.5958/0975-6906.2014.00150.3; Tyagi S, 2014, MOL BREEDING, V34, P167, DOI 10.1007/s11032-014-0027-1; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Vanderplank JE., 1968, DIS RESISTANCE PLANT; Vikas VK, 2014, GENETIC RESOURCES CR, V61; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	76	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167702	10.1371/journal.pone.0167702	http://dx.doi.org/10.1371/journal.pone.0167702			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942031	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600026
J	Long, LC; Rosen, SB; Brennan, A; Moyo, F; Sauls, C; Evans, D; Modi, SL; Sanne, I; Fox, MP				Long, Lawrence C.; Rosen, Sydney B.; Brennan, Alana; Moyo, Faith; Sauls, Celeste; Evans, Denise; Modi, Shookdev L.; Sanne, Ian; Fox, Matthew P.			Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa	PLOS ONE			English	Article							POSITIVE PATIENTS; CARE; JOHANNESBURG; DELIVERY; NURSES; ACCESS; MODEL	Background In 2010 South Africa revised its HIV treatment guidelines to allow the initiation and management of patients on antiretroviral therapy (ART) by nurses, rather than solely doctors, under a program called NIMART (Nurse Initiated and Managed Antiretroviral Therapy). We compared the outcomes and costs of NIMART between the two major public sector HIV treatment delivery models in use in South Africa today, primary health clinics and hospital-based HIV clinics. Methods and findings The study was conducted at one hospital-based outpatient HIV clinic and one primary health clinic (PHC) in Gauteng Province. A retrospective cohort of adult patients initiated on ART at the PHC was propensity-score matched to patients initiated at the hospital outpatient clinic. Each patient was assigned a 12-month outcome of alive and in care or died/lost to follow up. Costs were estimated from the provider perspective for the 12 months after ART initiation. The proportion of patients alive and in care at 12 months did not differ between the PHC (76.5%) and the hospital-based site (74.2%). The average annual cost per patient alive and in care at 12 months after ART initiation was significantly lower at the PHC (US$238) than at the hospital outpatient clinic (US$428). Conclusions Initiating and managing ART patients at PHCs under NIMART is producing equally good outcomes as hospital-based HIV clinic care at much lower cost. Evolution of hospital-based clinics into referral facilities that serve complicated patients, while investing most program expansion resources into PHCs, may be a preferred strategy for achieving treatment coverage targets.	[Long, Lawrence C.; Rosen, Sydney B.; Brennan, Alana; Moyo, Faith; Sauls, Celeste; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence C.; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence C.; Rosen, Sydney B.; Moyo, Faith; Sauls, Celeste; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Rosen, Sydney B.; Brennan, Alana; Sanne, Ian; Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Modi, Shookdev L.; Sanne, Ian] Right Care, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Boston University; Boston University	Long, LC (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa.; Long, LC (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.; Long, LC (corresponding author), Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	llong@heroza.org	Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	Rosen, Sydney/0000-0002-6560-2964; Brennan, Alana/0000-0002-7746-0668; Long, Lawrence/0000-0003-4986-4988	United States Agency for International Development (USAID) [674-A-00-09-00018-00, 674-A-12-00029]; USAID [674-A-12-00029, 674-A-12-00020]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	LL, MPF, AB, FM, CS, DE and SBR were funded for this work by United States Agency for International Development (USAID) through the following agreements: 674-A-00-09-00018-00 & 674-A-12-00029. IS was funded for this work by USAID through the following agreement: 674-A-12-00029. SLM was funded for this work by USAID through the following agreement: 674-A-12-00020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author's views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	[Anonymous], 2004, NAT ANT TREATM GUID; Barton GR, 2013, TROP MED INT HEALTH, V18, P769, DOI 10.1111/tmi.12093; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bergstralh E, 2014, VMATCH SAS MACRO MAY; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Cameron D, 2012, SAMJ S AFR MED J, V102, P98, DOI 10.7196/SAMJ.5195; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Grimsrud A, 2014, TROP MED INT HEALTH, V19, P1029, DOI 10.1111/tmi.12346; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Meyer-Rath G, 2015, S AFRICAS INVESTMENT; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; Monyatsi G., 2011, S AFR MED J, V102, P34; Moshabela Mosa, 2011, Afr J AIDS Res, V10, P393, DOI 10.2989/16085906.2011.646654; Motsoaledi A., 2010, HLTH BUDGET SPEECH; *NAT DEP HLTH SOUT, 2010, CLIN GUID MAN HIV AI; Nyasulu JCY, 2013, SAMJ S AFR MED J, V103, P232, DOI [10.7196/SAMJ.6380, 10.7196/samj.6380]; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Umar NA, 2011, J PUBLIC HLTH AFRICA, V2; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168118	10.1371/journal.pone.0168118	http://dx.doi.org/10.1371/journal.pone.0168118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942005	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600052
J	Benfatto, MN; Seimyr, GO; Ygge, J; Pansell, T; Rydberg, A; Jacobson, C				Benfatto, Mattias Nilsson; Seimyr, Gustaf Oqvist; Ygge, Jan; Pansell, Tony; Rydberg, Agneta; Jacobson, Christer			Screening for Dyslexia Using Eye Tracking during Reading	PLOS ONE			English	Article							BINOCULAR COORDINATION; SWEDISH POPULATION; MOVEMENTS; CLASSIFICATION; FIXATIONS; STUDENTS; MODEL	Dyslexia is a neurodevelopmental reading disability estimated to affect 5-10% of the population. While there is yet no full understanding of the cause of dyslexia, or agreement on its precise definition, it is certain that many individuals suffer persistent problems in learning to read for no apparent reason. Although it is generally agreed that early intervention is the best form of support for children with dyslexia, there is still a lack of efficient and objective means to help identify those at risk during the early years of school. Here we show that it is possible to identify 9-10 year old individuals at risk of persistent reading difficulties by using eye tracking during reading to probe the processes that underlie reading ability. In contrast to current screening methods, which rely on oral or written tests, eye tracking does not depend on the subject to produce some overt verbal response and thus provides a natural means to objectively assess the reading process as it unfolds in real-time. Our study is based on a sample of 97 high-risk subjects with early identified word decoding difficulties and a control group of 88 low-risk subjects. These subjects were selected from a larger population of 2165 school children attending second grade. Using predictive modeling and statistical resampling techniques, we develop classification models from eye tracking records less than one minute in duration and show that the models are able to differentiate high-risk subjects from low-risk subjects with high accuracy. Although dyslexia is fundamentally a language-based learning disability, our results suggest that eye movements in reading can be highly predictive of individual reading ability and that eye tracking can be an efficient means to identify children at risk of long-term reading difficulties.	[Benfatto, Mattias Nilsson; Seimyr, Gustaf Oqvist; Ygge, Jan; Pansell, Tony; Rydberg, Agneta] Karolinska Inst, Marianne Bernadotte Ctr, Div Ophthalmol & Vis, Dept Clin Neurosci, Stockholm, Sweden; [Jacobson, Christer] Linnaeus Univ, Dept Pedag, Vaxjo, Sweden	Karolinska Institutet; Linnaeus University	Benfatto, MN (corresponding author), Karolinska Inst, Marianne Bernadotte Ctr, Div Ophthalmol & Vis, Dept Clin Neurosci, Stockholm, Sweden.	mattias.nilsson@ki.se	Pansell, Tony/L-9487-2017	Nilsson, Mattias/0000-0002-8616-5273	Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA); Promobilia Foundation	Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA)(Vinnova); Promobilia Foundation	This work was supported by The Ulla and Ingemar Dahlberg Foundation; Sweden's Innovation Agency (VINNOVA), http://www.vinnova.se/; and The Promobilia Foundation, http://www.promobilia.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Passe N, 2006, DYSLEXIA, V12, P256, DOI 10.1002/dys.318; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Benson PJ, 2012, BIOL PSYCHIAT, V72, P716, DOI 10.1016/j.biopsych.2012.04.019; Bucci MP, 2008, GRAEF ARCH CLIN EXP, V246, P417, DOI 10.1007/s00417-007-0723-1; Clifton Charles Jr., 2007, P341, DOI 10.1016/B978-008044980-7/50017-3; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Ellis AW, 1984, READING WRITING DYSL; ELTERMAN RD, 1980, J LEARN DISABIL, V13, P11, DOI 10.1177/002221948001300104; Fouganthine A., 2012, THESIS; Ghassemi E, 2013, J EYE MOVEMENT RES, V6; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; Jacobson C, 1998, THESIS; Jainta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018694; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027105; Long L, 2007, J ADOLESC ADULT LIT, V51, P124, DOI 10.1598/JAAL.51.2.4; OLSON RK, 1983, EYE MOVEMENTS READIN, P467; PAVLIDIS GT, 1981, NEUROPSYCHOLOGIA, V19, P57, DOI 10.1016/0028-3932(81)90044-0; Pennington BF, 2012, J ABNORM PSYCHOL, V121, P212, DOI 10.1037/a0025823; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Platt J, 1998, ADV KERNEL METHODS S, V185, P208; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1981, J EXP PSYCHOL HUMAN, V7, P167, DOI 10.1037/0096-1523.7.1.167; Rayner K, 2003, PSYCHOL SCI, V14, P385, DOI 10.1111/1467-9280.24483; Rayner K., 2012, PSYCHOL READING, V2nd, DOI [10.4324/9780203155158, DOI 10.4324/9780203155158]; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Riddick B., 1996, LIVING DYSLEXIA SOCI; RODGERS B, 1983, BRIT J EDUC PSYCHOL, V53, P369, DOI 10.1111/j.2044-8279.1983.tb02570.x; Rubino C A, 1973, Cortex, V9, P217; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; SBU, 2014, DYSL CHILDR AD TESTS; Shaywitz BA, 2004, BIOL PSYCHIAT, V55, P926, DOI 10.1016/j.biopsych.2003.12.019; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Siegel Linda S, 2006, Paediatr Child Health, V11, P581; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Tseng PH, 2013, J NEUROL, V260, P275, DOI 10.1007/s00415-012-6631-2; Vapnik V., 1998, STAT LEARNING THEORY; Vaughn S, 2010, SCHOOL PSYCHOL REV, V39, P3; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; YGGE J, 1993, ACTA OPHTHALMOL, V71, P10; YGGE J, 1993, ACTA OPHTHALMOL, V71, P1	52	79	79	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165508	10.1371/journal.pone.0165508	http://dx.doi.org/10.1371/journal.pone.0165508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936148	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100011
J	Chen, CC; Hsu, YC; Lee, CT; Hsu, CC; Tai, CM; Wang, WL; Tseng, CH; Hsu, CT; Lin, JT; Chang, CY				Chen, Chih-Cheng; Hsu, Yao-Chun; Lee, Ching-Tai; Hsu, Chia-Chang; Tai, Chi-Ming; Wang, Wen-Lun; Tseng, Cheng-Hao; Hsu, Chao-Tien; Lin, Jaw-Town; Chang, Chi-Yang			Central Obesity and H-pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; CHINESE POPULATION; GENERAL-POPULATION; ABDOMINAL OBESITY; PREVALENCE; ASSOCIATION; SYMPTOMS; METAANALYSIS; DEFINITION	Background and Aim The prevalence rates of Barrett's esophagus (BE) in western countries are higher than Asian ones, but little is known about their difference among risk factors of BE. The aim of this study is to investigate the associations of various risk factors including central obesity, body mass index (BMI), metabolic syndrome and H. pylori infection, with BE. Methods A total of 161 subjects with BE were enrolled and compared to age-and gender-matched controls randomly sampled (1: 4) from check-up center in same hospital. Central obesity was defined by waist circumference (female>80cm; male> 90cm), metabolic syndrome by the modified National Cholesterol Education Program Adult Treatment Panel III criteria in Taiwan. Independent risk factors for BE were identified by multiple logistic regression analyses. Results The mean age for BE was 53.8 +/- 13.7 years and 75.8% was male. H. pylori infection status was detected by the rapid urease test with the prevalence of 28.4% and 44.4% in the BE patients and controls, respectively. The univariate logistic regression analyses showed the risk was associated with higher waist circumference (odds ratio [OR], 2.53; 95% confidence interval [CI], 1.78-3.60), metabolic syndrome (OR, 2.02; 95% CI, 1.38-2.96) and negative H. pylori infection (OR, 0.50; 95% CI, 0.34-0.74). However, multivariate logistic regression analyses revealed that BE associated with higher waist circumference (adjusted OR, 2.79; 95% CI, 1.89-4.12) and negative H. pylori infection (adjusted OR, 0.46; 95% CI, 0.30-0.70). Conclusions Central obesity is associated with a higher risk of BE whereas H. pylori infection with a lower risk in an ethnic Chinese population.	[Chen, Chih-Cheng; Hsu, Yao-Chun; Lee, Ching-Tai; Hsu, Chia-Chang; Tai, Chi-Ming; Wang, Wen-Lun; Tseng, Cheng-Hao; Lin, Jaw-Town; Chang, Chi-Yang] I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsu, Chao-Tien] I Shou Univ, E Da Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town; Chang, Chi-Yang] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hsu, Yao-Chun; Lin, Jaw-Town; Chang, Chi-Yang] Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Fu Jen Catholic University; Fu Jen Catholic University	Chang, CY (corresponding author), I Shou Univ, E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Chang, CY (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.; Chang, CY (corresponding author), Fu Jen Catholic Univ, Big Data Res Ctr, New Taipei, Taiwan.	chiyang1112@gmail.com	CHEN, CHIH-CHENG/L-6568-2019; Wang, Wen-Lun/AAJ-1281-2020; Lee, Ching-Tai/AAI-2048-2021	CHEN, CHIH-CHENG/0000-0003-0266-1534; 				Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-56; Amano Y, 2006, SCAND J GASTROENTERO, V41, P873, DOI 10.1080/00365520500535485; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Cameron AJ, 1999, AM J GASTROENTEROL, V94, P2054; Campos GMR, 2001, ARCH SURG-CHICAGO, V136, P1267, DOI 10.1001/archsurg.136.11.1267; Chang CY, 2009, AM J GASTROENTEROL, V104, P13, DOI 10.1038/ajg.2008.43; Chen Q. Y., 2006, PRIMARY MEDICAL CARE, V21, P367; Cook MB, 2008, AM J GASTROENTEROL, V103, P292, DOI 10.1111/j.1572-0241.2007.01621.x; Corley DA, 2008, GUT, V57, P727, DOI 10.1136/gut.2007.132068; Corley DA, 2007, GASTROENTEROLOGY, V133, P34, DOI 10.1053/j.gastro.2007.04.046; Dore MP, 2016, SCAND J GASTROENTERO, P1; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; El-Serag HB, 2006, SCAND J GASTROENTERO, V41, P887, DOI 10.1080/00365520500535402; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fischbach LA, 2014, AM J GASTROENTEROL, V109, P357, DOI 10.1038/ajg.2013.443; International Diabetes Federation, IDF CONS WORLDW DEF; Kendall BJ, 2016, CLIN GASTROENTEROL H, V14, P1412, DOI 10.1016/j.cgh.2016.05.032; Kubo A, 2013, GUT, V62, P1684, DOI 10.1136/gutjnl-2012-303753; Mathew P, 2011, J GASTROEN HEPATOL, V26, P1151, DOI 10.1111/j.1440-1746.2011.06714.x; Peng S, 2009, ENDOSCOPY, V41, P1011, DOI 10.1055/s-0029-1215291; Rajendra S, 2004, DIGEST DIS SCI, V49, P237, DOI 10.1023/B:DDAS.0000017444.30792.94; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Seidel D, 2009, DIS ESOPHAGUS, V22, P564, DOI 10.1111/j.1442-2050.2009.00967.x; Shaheen NJ, 2016, AM J GASTROENTEROL, V111, P30, DOI 10.1038/ajg.2015.322; Sharifi A, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/696294; Shaw MJ, 2001, AM J GASTROENTEROL, V96, P52; Shiota S, 2015, CLIN GASTROENTEROL H, V13, P1907, DOI 10.1016/j.cgh.2015.07.050; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Toruner M, 2004, J GASTROEN HEPATOL, V19, P535, DOI 10.1111/j.1440-1746.2003.03342.x; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Watari J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-143; Wu JCY, 2007, GASTROENTEROLOGY, V132, P883, DOI 10.1053/j.gastro.2006.12.032; Xiong LS, 2010, J DIGEST DIS, V11, P83, DOI 10.1111/j.1751-2980.2010.00419.x; Yilmaz Nevin, 2006, Turk J Gastroenterol, V17, P79; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; Zhang HZ, 2012, CHIN J CANCER, V31, P281, DOI 10.5732/cjc.011.10390	38	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167815	10.1371/journal.pone.0167815	http://dx.doi.org/10.1371/journal.pone.0167815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936223	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100204
J	Deiss, R; Bower, RJ; Co, E; Mesner, O; Sanchez, JL; Masel, J; Ganesan, A; Macalino, GE; Agan, BK				Deiss, Robert; Bower, Richard J.; Co, Edgie; Mesner, Octavio; Sanchez, Jose L.; Masel, Jennifer; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.			The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the US Military	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; GONORRHEA; SOLDIERS; SYSTEM; SURVEILLANCE; INSTALLATION; PREVALENCE; PERSONNEL; RATES; RISK	Background Numerous studies have found higher rates of sexually transmitted infections (STIs) among military personnel than the general population, but the cumulative risk of acquiring STIs throughout an individual's military career has not been described. Methods Using ICD-9 diagnosis codes, we analyzed the medical records of 100,005 individuals from all service branches, divided in equal cohorts (n = 6,667) between 1997 and 2011. As women receive frequent STI screening compared to men, these groups were analyzed separately. Incidence rates were calculated for pathogen-specific STIs along with syndromic diagnoses. Descriptive statistics were used to characterize the individuals within each accession year cohort; repeat infections were censored. Results The total sample included 29,010 females and 70,995 males. The STI incidence rates (per 100 person-years) for women and men, respectively, were as follows: chlamydia (3.5 and 0.7), gonorrhea (1.1 and 0.4), HIV (0.04 and 0.07) and syphilis (0.14 and 0.15). During the study period, 22% of women and 3.3% of men received a pathogen-specific STI diagnosis; inclusion of syndromic diagnoses increased STI prevalence to 41% and 5.5%, respectively. In multivariate analyses, factors associated with etiologic and syndromic STIs among women included African American race, younger age and fewer years of education. In the overall sample, increasing number of years of service was associated with an increased likelihood of an STI diagnosis (p<0.001 for trend). Conclusion In this survey of military personnel, we found very high rates of STI acquisition throughout military service, especially among women, demonstrating that STI-related risk is significant and ongoing throughout military service. Lower STI incidence rates among men may represent under-diagnosis and demonstrate a need for enhancing male-directed screening and diagnostic interventions.	[Deiss, Robert; Mesner, Octavio; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Deiss, Robert; Mesner, Octavio; Ganesan, Anuradha; Macalino, Grace E.; Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Deiss, Robert; Bower, Richard J.] Naval Med Ctr San Diego, San Diego, CA USA; [Co, Edgie] William Beaumont Army Med Ctr, El Paso, TX 79920 USA; [Sanchez, Jose L.] Def Hlth Agcy, Publ Hlth Div, Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA; [Masel, Jennifer; Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Navy; Naval Medical Center San Diego; William Beaumont Army Medical Center; Walter Reed National Military Medical Center	Deiss, R (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.; Deiss, R (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.; Deiss, R (corresponding author), Naval Med Ctr San Diego, San Diego, CA USA.	rgdeiss@gmail.com	Co, Edgie-Mark/P-6825-2019	Agan, Brian/0000-0002-5114-1669	Department of Defense, National Institute of Allergic and Infectious Diseases; DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center [IDCRP-069]; Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-Al-5072];  [C0689-12-HS]	Department of Defense, National Institute of Allergic and Infectious Diseases; DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center; Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); 	This work was supported by the Department of Defense, National Institute of Allergic and Infectious Diseases. Support for this work (IDCRP-069) was provided by the DoD Global Emerging Infections Surveillance and Response System (GEIS) Division of the Armed Forces Health Surveillance Center, award C0689-12-HS, and the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-Al-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous WK, 2011, MIL MED, V176, P705, DOI 10.7205/MILMED-D-10-00218; Armed Forces Health Surveillance Center, 2013, MSMR, V20, P5; Armed Forces Health Surveillance Center (AFHSC), 2010, MED SURVEILLANCE MON, V17, P2; Barnett SD, 2001, SEX TRANSM INFECT, V77, P33, DOI 10.1136/sti.77.1.33; Berry-Caban CS, 2011, J VACCINES VACCIN; Brodine SK, 1998, J INFECT DIS, V178, P1202, DOI 10.1086/515685; Gaydos CA, 2000, CLIN INFECT DIS, V30, P719, DOI 10.1086/313758; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Goyal V, 2012, J WOMENS HEALTH, V21, P1155, DOI 10.1089/jwh.2012.3605; Hakre S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-181; Jenkins PR, 2000, CLIN INFECT DIS, V30, P730, DOI 10.1086/313743; Jordan NN, 2011, MIL MED, V176, P312, DOI 10.7205/MILMED-D-10-00212; Masel J, 2015, SEX TRANSM DIS, V42, P253, DOI 10.1097/OLQ.0000000000000277; Nsouli-Maktabi Hala, 2013, MSMR, V20, P17; Rasnake Mark S, 2005, Mil Med, V170, P61; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Sena AC, 2000, CLIN INFECT DIS, V30, P742, DOI 10.1086/313742; Shen-Gunther J, 2011, GYNECOL ONCOL, V123, P272, DOI 10.1016/j.ygyno.2011.07.094; Sutton TL, 2003, SEX TRANSM DIS, V30, P901, DOI 10.1097/01.OLQ.0000091136.14932.8B; US Centers for Disease Control and Prevention (CDC), 2000, CHLAM SCREEN PERC RE; Zenilman JM, 1999, SEX TRANSM DIS, V26, P75, DOI 10.1097/00007435-199902000-00002; Zenilman JM, 2002, SEX TRANSM INFECT, V78, P40, DOI 10.1136/sti.78.1.40	22	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167892	10.1371/journal.pone.0167892	http://dx.doi.org/10.1371/journal.pone.0167892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936092	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100223
J	Karakulah, G; Kurtoglu, KY; Unver, T				Karakulah, Gokhan; Kurtoglu, Kuaybe Yucebilgili; Unver, Turgay			PeTMbase: A Database of Plant Endogenous Target Mimics (eTMs)	PLOS ONE			English	Article							LONG NONCODING RNAS; MICRORNAS; STRESS; ROLES	MicroRNAs (miRNA) are small endogenous RNA molecules, which regulate target gene expression at post-transcriptional level. Besides, miRNA activity can be controlled by a newly discovered regulatory mechanism called endogenous target mimicry (eTM). In target mimicry, eTMs bind to the corresponding miRNAs to block the binding of specific transcript leading to increase mRNA expression. Thus, miRNA-eTM-target-mRNA regulation modules involving a wide range of biological processes; an increasing need for a comprehensive eTM database arose. Except miRSponge with limited number of Arabidopsis eTM data no available database and/or repository was developed and released for plant eTMs yet. Here, we present an online plant eTM database, called PeTMbase (http://petmbase.org), with a highly efficient search tool. To establish the repository a number of identified eTMs was obtained utilizing from high-throughput RNA-sequencing data of 11 plant species. Each transcriptome libraries is first mapped to corresponding plant genome, then long non-coding RNA (lncRNA) transcripts are characterized. Furthermore, additional lncRNAs retrieved from GREENC and PNRD were incorporated into the lncRNA catalog. Then, utilizing the lncRNA and miRNA sources a total of 2,728 eTMs were successfully predicted. Our regularly updated database, PeTMbase, provides high quality information regarding miRNA: eTM modules and will aid functional genomics studies particularly, on miRNA regulatory networks.	[Karakulah, Gokhan; Unver, Turgay] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey; [Kurtoglu, Kuaybe Yucebilgili] Istanbul Medeniyet Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Dokuz Eylul University; Istanbul Medeniyet University	Karakulah, G; Unver, T (corresponding author), Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst iBG Izmir, Izmir, Turkey.	gokhan.karakulah@deu.edu.tr; turgay.unver@deu.edu.tr	Unver, Turgay/B-4819-2009; Kurtoglu, Kuaybe Yucebilgili/AAE-9731-2020; Karakulah, Gokhan/N-1342-2018	Unver, Turgay/0000-0001-6760-443X; Karakulah, Gokhan/0000-0001-6706-1375	Turkish Academy of Science (TUBA)	Turkish Academy of Science (TUBA)(Turkish Academy of Sciences)	This work was supported by Turkish Academy of Science (TUBA) with grant type GEBIP.	Banks IR, 2012, PLANT SIGNAL BEHAV, V7, P1188, DOI 10.4161/psb.21299; Chen DJ, 2012, NUCLEIC ACIDS RES, V40, pD1187, DOI 10.1093/nar/gkr823; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta PK, 2015, CURR SCI INDIA, V108, P1624; Ivashuta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021330; Jin JJ, 2013, BIOINFORMATICS, V29, P1068, DOI 10.1093/bioinformatics/btt107; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kurtoglu KY, 2014, FUNCT INTEGR GENOMIC, V14, P363, DOI 10.1007/s10142-013-0357-9; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Liu X, 2015, GENOM PROTEOM BIOINF, V13, P137, DOI 10.1016/j.gpb.2015.02.003; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Poole Rebecca L., 2007, V406, P179; Quek XC, 2014, NUCLEIC ACIDS RES; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Szczesniak MW, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv201; Team RC, 2015, R LANG ENV STAT COMP; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang P, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav098; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu HJ, 2013, PLANT PHYSIOL, V161, P1875, DOI 10.1104/pp.113.215962; Yan J, 2012, PLANT CELL, V24, P415, DOI 10.1105/tpc.111.094144; Ye CY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00743; Yi X, 2015, NUCLEIC ACIDS RES, V43, pD982, DOI 10.1093/nar/gku1162; Zhang H, 2013, MOL BIOL REP, V40, P6245, DOI 10.1007/s11033-013-2736-7; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	34	38	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167698	10.1371/journal.pone.0167698	http://dx.doi.org/10.1371/journal.pone.0167698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936097	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100156
J	Kattke, MD; Chan, AH; Duong, A; Sexton, DL; Sawaya, MR; Cascio, D; Elliot, MA; Clubb, RT				Kattke, Michele D.; Chan, Albert H.; Duong, Andrew; Sexton, Danielle L.; Sawaya, Michael R.; Cascio, Duilio; Elliot, Marie A.; Clubb, Robert T.			Crystal Structure of the Streptomyces coelicolor Sortase E1 Transpeptidase Provides Insight into the Binding Mode of the Novel Class E Sorting Signal	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; CELL-WALL; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; ACCURATE DOCKING; LIGATION; SITE; DATABASE	Many species of Gram-positive bacteria use sortase transpeptidases to covalently affix proteins to their cell wall or to assemble pili. Sortase-displayed proteins perform critical and diverse functions for cell survival, including cell adhesion, nutrient acquisition, and morphological development, among others. Based on their amino acid sequences, there are at least six types of sortases (class A to F enzymes); however, class E enzymes have not been extensively studied. Class E sortases are used by soil and freshwater-dwelling Actinobacteria to display proteins that contain a non-canonical LAXTG sorting signal, which differs from 90% of known sorting signals by substitution of alanine for proline. Here we report the first crystal structure of a class E sortase, the 1.93 angstrom resolution structure of the SrtE1 enzyme from Streptomyces coelicolor. The active site is bound to a tripeptide, providing insight into the mechanism of substrate binding. SrtE1 possesses beta 3/beta 4 and beta 6/beta 7 active site loops that contact the LAXTG substrate and are structurally distinct from other classes. We propose that SrtE1 and other class E sortases employ a conserved tyrosine residue within their beta 3/beta 4 loop to recognize the amide nitrogen of alanine at position P3 of the sorting signal through a hydrogen bond, as seen here. Incapability of hydrogen-bonding with canonical proline-containing sorting signals likely contributes to class E substrate specificity. Furthermore, we demonstrate that surface anchoring of proteins involved in aerial hyphae formation requires an N-terminal segment in SrtE1 that is presumably positioned within the cytoplasm. Combined, our results reveal unique features within class E enzymes that enable them to recognize distinct sorting signals, and could facilitate the development of substrate-based inhibitors of this important enzyme family.	[Kattke, Michele D.; Sawaya, Michael R.; Cascio, Duilio] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Kattke, Michele D.] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA; [Chan, Albert H.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Duong, Andrew; Sexton, Danielle L.; Elliot, Marie A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Duong, Andrew; Sexton, Danielle L.; Elliot, Marie A.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Yale University; McMaster University; McMaster University; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Clubb, RT (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA USA.	rclubb@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043	Canadian Institutes of Health Research [MOP-137004]; National Institutes of Health [R01 AI52217, P41 GM103403, S10 RR029205, AI52217]; U.S. Department of Energy Office of Science, Office of Biological and Environmental Research [DE-FC02-02ER63421, DE-AC02-06CH11357]; UCLA Eugene V. Cota-Robles Fellowship; UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); UCLA Eugene V. Cota-Robles Fellowship; UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program; DOE Office of Science(United States Department of Energy (DOE)); Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) under award number MOP-137004 and the National Institutes of Health (https://www.nih.gov/) under award number R01 AI52217, P41 GM103403 and S10 RR029205. This work was also partially supported by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research program under award number DE-FC02-02ER63421 and DE-AC02-06CH11357. MDK was supported by a UCLA Eugene V. Cota-Robles Fellowship and a UCLA Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Michael Collazo from the UCLA-DOE Institute Macromolecular Crystallization Core Technology Facility, as well as M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, F. Murphy, S. Banerjee, K. Perry, and D. Neau at NECAT beamline 24-ID-C of the Argonne National Laboratory APS for assistance with X-ray data collection. The Pilatus 6M detector on 24-ID-C beam line is supported by grants from the National Center for Research Resources (5P41RR015301-10), the National Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health, and the National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant Program (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This material is based upon work supported by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research under award number DE-FC02-02ER63421, the National Institutes of Health under award number AI52217, and the Canadian Institutes of Health Research under award number MOP-137004. We would also like to thank David Capstick, Christina Di Berardo, and Kanishk Jain for their technical assistance. M.D.K. was supported by the Eugene V. Cota-Robles Fellowship through the UCLA Graduate Division and the Philip Whitcome Pre-doctoral Fellowship in Molecular Biology through the UCLA Molecular Biology Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amer BR, 2016, J BIOMOL NMR, V64, P197, DOI 10.1007/s10858-016-0019-z; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Case D.A., 2022, AMBER; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Dorr BM, 2014, P NATL ACAD SCI; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Duong A, 2016, LIQUID CHROMATOGRAPH, P99; Duong A, 2012, MOL MICROBIOL, V83, P992, DOI 10.1111/j.1365-2958.2012.07983.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fitzgerald-Hughes D, 2012, FEMS IMMUNOL MED MIC, V65, P399, DOI 10.1111/j.1574-695X.2012.00954.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ritzefeld M, 2014, CHEM-EUR J, V20, P8516, DOI 10.1002/chem.201402072; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schmohl L, 2014, CURR OPIN CHEM BIOL, V22, P122, DOI 10.1016/j.cbpa.2014.09.020; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Scott JR, SURFACE PROTEINS GRA; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Suryadinata R, 2015, ACTA CRYST, V71; Ta HT, 2012, TRENDS CARDIOVAS MED, V22, P105, DOI 10.1016/j.tcm.2012.07.004; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Tubert-Brohman I, 2013, J CHEM INF MODEL, V53, P1689, DOI 10.1021/ci400128m; van't Hof W, 2015, BIOL CHEM, V396, P283, DOI 10.1515/hsz-2014-0260; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	60	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167763	10.1371/journal.pone.0167763	http://dx.doi.org/10.1371/journal.pone.0167763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936128	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100179
J	Ortner, CNM; Ste Marie, M; Corno, D				Ortner, Catherine Nicole Marie; Ste Marie, Mark; Corno, Daniela			Cognitive Costs of Reappraisal Depend on Both Emotional Stimulus Intensity and Individual Differences in Habitual Reappraisal	PLOS ONE			English	Article							SEX-DIFFERENCES; CONSEQUENCES; METAANALYSIS; DISTRACTION; ABILITY; MEMORY	Recent models of emotion regulation suggest that the cognitive costs of reappraisal depend on stimulus intensity and habitual reappraisal. In the current experiment, we tested these hypotheses by manipulating the intensity of unpleasant and pleasant images, which participants reappraised, viewed, or suppressed their emotions to. To assess cognitive costs, we measured participants' performance on a concurrent simple reaction time task. Participants also reported on their everyday use of reappraisal and suppression. Higher intensity stimuli were associated with greater cognitive costs of reappraisal, for unpleasant, but not pleasant pictures. Also, greater habitual reappraisal predicted lower cognitive costs of reappraisal and greater reductions in subjective feelings. Results support the role of stimulus intensity and habitual use of reappraisal in predicting the cognitive costs of reappraisal.	[Ortner, Catherine Nicole Marie; Ste Marie, Mark; Corno, Daniela] Thompson Rivers Univ, Kamloops, BC, Canada		Ortner, CNM (corresponding author), Thompson Rivers Univ, Kamloops, BC, Canada.	cortner@tru.ca	Corno, Daniela/T-7217-2019	Ortner, Catherine/0000-0002-2250-3608	Social Sciences and Humanities Research Council of Canada [430-2014-00626]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada, http://www.sshrc.crsh.gc.ca/, Grant number 430-2014-00626. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; Denny BT, 2014, EMOTION, V14, P425, DOI 10.1037/a0035276; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Gardener EKT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073475; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Hopp H, 2011, COGNITION EMOTION, V25, P532, DOI 10.1080/02699931.2010.532606; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Kalokerinos E. K., 2014, EMOTION; Lang P.J., 2008, A8 U FLOR; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Nelis D, 2011, PSYCHOL BELG, V51, P49, DOI 10.5334/pb-51-1-49; Ortner CNM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062750; Ortner CNM, 2013, MOTIV EMOTION, V37, P346, DOI 10.1007/s11031-012-9310-9; Parvaz MA, 2012, COGN AFFECT BEHAV NE, V12, P730, DOI 10.3758/s13415-012-0107-9; Pe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069071; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Richards JM, 1999, PERS SOC PSYCHOL B, V25, P1033, DOI 10.1177/01461672992511010; Riediger M, 2011, EMOTION, V11, P656, DOI 10.1037/a0022756; Riediger M, 2009, PSYCHOL SCI, V20, P1529, DOI 10.1111/j.1467-9280.2009.02473.x; Shafir R, 2016, SOC COGN AFFECT NEUR; Sheppes G, 2007, PERS SOC PSYCHOL B, V33, P1518, DOI 10.1177/0146167207305537; Sheppes G, 2014, J EXP PSYCHOL GEN, V143, P163, DOI 10.1037/a0030831; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Sheppes G, 2009, INT J PSYCHOPHYSIOL, V71, P91, DOI 10.1016/j.ijpsycho.2008.06.006; Sheppes G, 2008, EMOTION, V8, P870, DOI 10.1037/a0013711; Smith JC, 2005, BIOL PSYCHOL, V69, P247, DOI 10.1016/j.biopsycho.2004.09.001; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; Troy AS, 2010, EMOTION, V10, P783, DOI 10.1037/a0020262; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Weber H, 2014, COGNITION EMOTION, V28, P345, DOI 10.1080/02699931.2013.832152	38	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167253	10.1371/journal.pone.0167253	http://dx.doi.org/10.1371/journal.pone.0167253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936022	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100079
J	Qi, L; Xiong, Y; Xiao, BZ; Tang, WG; Ling, H; Long, J; Xiao, DY; Zhao, H; Ye, S; Chen, S; Yu, Z; Li, Q				Qi, Li; Xiong, Yu; Xiao, Bangzhong; Tang, Wenge; Ling, Hua; Long, Jiang; Xiao, Dayong; Zhao, Han; Ye, Sheng; Chen, Shuang; Yu, Zhen; Li, Qin			Epidemiological and Virological Characteristics of Influenza in Chongqing, China, 2011-2015	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; MORTALITY; SEASONALITY; PNEUMONIA; ILLNESS; VIRUSES	Background Chongqing is the largest municipality and located in Southwestern of China, with over 30 million registered inhabitants. There are few reports regarding the epidemiology of influenza in Chongqing. The objective of the paper is to explore the epidemiology of influenza in Chongqing, in order to provide scientific basis for prevention and control of influenza. Methodology /Principal Findings From 2011 to 2015, we collected information on influenza-like illness (ILI) patients fulfilling the case definition, and took nasalpharyngeal or throat swabs specimens from ILI cases per week at the 7 sentinel hospitals. Specimens were tested by reverse transcription-polymerase chain reaction(RT-PCR) for influenza. Descriptive epidemiology was applied to analyze the epidemiology and etiology of influenza. A total of 9,696,212 cases were enrolled, of which 111,589 were ILI. Of those 24,868 samples from ILI cases, 13.3% (3,314/24,868) tested positive for influenza virus (65.7% influenza A, 34.1% influenza B, and 0.2% influenza A and B co-infection). Among the influenza A viruses, 71.3% were seasonal influenza A (H3N2) and 28.7% were influenza A(H1N1)pdm09. No cases of seasonal A(H1N1) were detected. The isolation rate was highest in children aged 5-14 years old. Influenza activity consistently peaked during January-March in 2011-2015, and June-July in 2012, 2014 and 2015. Conclusions Influenza is an important public health problem among ILI patients in Chongqing, especially among school-aged children. It might be beneficial to prioritize influenza vaccination for school-aged children and implement the school-based intervention to prevent and mitigating influenza outbreaks in Chongqing, particularly during the seasonal peaks.	[Qi, Li; Xiong, Yu; Xiao, Bangzhong; Tang, Wenge; Ling, Hua; Long, Jiang; Xiao, Dayong; Zhao, Han; Ye, Sheng; Chen, Shuang; Yu, Zhen; Li, Qin] Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Qi, Li] 8,Changjiang 2nd Rd, Chongqing, Peoples R China		Li, Q (corresponding author), Chongqing Municipal Ctr Dis Control & Prevent, Chongqing, Peoples R China.	qili19812012@126.com			Chinese Center for Disease Control and Prevention; Chongqing Health and Family Planning Commission	Chinese Center for Disease Control and Prevention; Chongqing Health and Family Planning Commission	Our study was funded by the Chinese Center for Disease Control and Prevention (http://www.chinaivdc.cn/cnic/en/) and Chongqing Health and Family Planning Commission (http://www.cqwsjsw.gov.cn/).	Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Bennet R, 2016, VACCINE, V34, P3298, DOI 10.1016/j.vaccine.2016.04.082; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Arango AE, 2015, INFLUENZA OTHER RESP, V9, P1, DOI 10.1111/irv.12271; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI 10.1111/ajt.13505; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nguyen HT, 2009, VACCINE, V28, P398, DOI 10.1016/j.vaccine.2009.09.139; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Oliveira WK, 2009, EUROSURVEILLANCE, V14, P16; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tarnagda Z, 2014, INFLUENZA OTHER RESP, V8, P524, DOI 10.1111/irv.12259; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Wang H, 2014, VACCINE, V32, P973, DOI 10.1016/j.vaccine.2013.12.013; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; WHO, WHO REC SURV STAND S; Yaka P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-34; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	27	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167866	10.1371/journal.pone.0167866	http://dx.doi.org/10.1371/journal.pone.0167866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936139	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100221
J	Kasho, K; Tanaka, H; Sakai, R; Katayama, T				Kasho, Kazutoshi; Tanaka, Hiroyuki; Sakai, Ryuji; Katayama, Tsutomu			Cooperative DnaA Binding to the Negatively Supercoiled datA Locus Stimulates DnaA-ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI REPLICATION ORIGIN; OSMOTIC-STRESS RESPONSE; INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; CHROMOSOMAL REPLICATION; INITIATION COMPLEX; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN-BINDING; IN-VITRO	Timely initiation of replication in Escherichia coli requires functional regulation of the replication initiator, ATP-DnaA. The cellular level of ATP-DnaA increases just before initiation, after which its level decreases through hydrolysis of DnaA-bound ATP, yielding initiation-inactive ADP-DnaA. Previously, we reported a novel DnaA-ATP hydrolysis system involving the chromosomal locus datA and named it datA-dependent DnaA-ATP hydrolysis (DDAH). The datA locus contains a binding site for a nucleoid-associating factor integration host factor (IHF) and a cluster of three known DnaA-binding sites, which are important for DDAH. However, the mechanisms underlying the formation and regulation of the datA-IHF.DnaA complex remain unclear. We now demonstrate that a novel DnaA box within datA is essential for ATP-DnaA complex formation and DnaA-ATP hydrolysis. Specific DnaA residues, which are important for interaction with bound ATP and for head-to-tail inter-DnaA interaction, were also required for ATP-DnaA-specific oligomer formation on datA. Furthermore, we show that negative DNA supercoiling of datA stabilizes ATP-DnaA oligomers, and stimulates datA-IHF interaction and DnaA-ATP hydrolysis. Relaxation of DNA supercoiling by the addition of novobiocin, a DNA gyrase inhibitor, inhibits datA function in cells. On the basis of these results, we propose a mechanistic model of datA-IHF.DnaA complex formation and DNA supercoiling-dependent regulation for DDAH.	[Kasho, Kazutoshi; Tanaka, Hiroyuki; Sakai, Ryuji; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Tanaka, Hiroyuki] Hisamitsu Pharmaceut Co, Tosu, Saga 8410017, Japan	Kyushu University; Hisamitsu Pharmaceutical Co Ltd	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Kasho, Kazutoshi/0000-0003-0326-0740; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 15K18479, 26291004, 26650127, 16H00775]; Japan Society for the Promotion of Science; Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development) [26122, 28247]; Grants-in-Aid for Scientific Research [15K18479, 16H00775, 26291004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research KAKENHI 15K18479, 26291004, 26650127, and 16H00775 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science and by the Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development) (no. 26122 and 28247) and English/Japanese Proofreading Expenses Support. The authors declare that they have no conflict of interest of this article.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aeling KA, 2006, J BIOL CHEM, V281, P39236, DOI 10.1074/jbc.M606363200; BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Cagliero C, 2013, NUCLEIC ACIDS RES, V41, P315, DOI 10.1093/nar/gks988; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; COZZARELLI NR, 1980, SCIENCE, V207, P953, DOI 10.1126/science.6243420; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donczew R, 2014, J MOL BIOL, V426, P2769, DOI 10.1016/j.jmb.2014.05.018; Dorman CJ, 1996, TRENDS MICROBIOL, V4, P214, DOI 10.1016/0966-842X(96)30015-2; DRLICA K, 1988, J BACTERIOL, V170, P4983, DOI 10.1128/jb.170.10.4983-4985.1988; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; HOLLOMAN WK, 1976, P NATL ACAD SCI USA, V73, P3910, DOI 10.1073/pnas.73.11.3910; Inoue Y, 2016, GENES CELLS, V21, P1015, DOI 10.1111/gtc.12395; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kasho K, 2014, NUCLEIC ACIDS RES, V42, P13134, DOI 10.1093/nar/gku1051; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Leonard AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00545; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2005, J BACTERIOL, V187, P3913, DOI 10.1128/JB.187.12.3913-3920.2005; Morigen M, 2014, MICROBIOL-SGM, V160, P703, DOI 10.1099/mic.0.074898-0; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noguchi Y, 2015, J BIOL CHEM, V290, P20295, DOI 10.1074/jbc.M115.662601; Nozaki S, 2009, GENES CELLS, V14, P329, DOI 10.1111/j.1365-2443.2008.01269.x; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Okumura H, 2012, NUCLEIC ACIDS RES, V40, P220, DOI 10.1093/nar/gkr716; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Riber L, 2016, FRONT MOL BIOSCI, V3, DOI [10.3389/fmollb.2016.00029, 10.3389/fmolb.2016.00029]; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Sheridan SD, 1998, J BIOL CHEM, V273, P21298, DOI 10.1074/jbc.273.33.21298; SKARSTAD K, 1989, MOL GEN GENET, V218, P50, DOI 10.1007/BF00330564; SKARSTAD K, 1994, BBA-GENE STRUCT EXPR, V1217, P111, DOI 10.1016/0167-4781(94)90025-6; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Smulczyk-Krawczyszyn A, 2006, J BACTERIOL, V188, P6184, DOI 10.1128/JB.00528-06; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; Su'etsugu M, 2003, GENES CELLS, V8, P731, DOI 10.1046/j.1365-2443.2003.00671.x; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Teter B, 2000, PLASMID, V43, P73, DOI 10.1006/plas.1999.1443; Teyssier C, 1996, BIOCHEMISTRY-US, V35, P7954, DOI 10.1021/bi952414o; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; von Freiesleben U, 2000, MOL MICROBIOL, V37, P1087, DOI 10.1046/j.1365-2958.2000.02060.x; VONFREISLEBEN U, 1992, RES MICROBIOL, V143, P655, DOI 10.1016/0923-2508(92)90060-2; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x	64	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1251	1266		10.1074/jbc.M116.762815	http://dx.doi.org/10.1074/jbc.M116.762815			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941026	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000393339800010
J	Chaplinska, M; Gerritsma, S; Dini-Andreote, F; Salles, JF; Wertheim, B				Chaplinska, Mariia; Gerritsma, Sylvia; Dini-Andreote, Francisco; Salles, Joana Falcao; Wertheim, Bregje			Bacterial Communities Differ among Drosophila melanogaster Populations and Affect Host Resistance against Parasitoids	PLOS ONE			English	Article							GEOGRAPHICAL VARIATION; WOLBACHIA INFECTION; GUT MICROBIOTA; EVOLUTION; INCOMPATIBILITY; HOMEOSTASIS; DIVERSITY; HEMOCYTES; DEFENSE; CELLS	In Drosophila, diet is considered a prominent factor shaping the associated bacterial community. However, the host population background (e.g. genotype, geographical origin and founder effects) is a factor that may also exert a significant influence and is often overlooked. To test for population background effects, we characterized the bacterial communities in larvae of six genetically differentiated and geographically distant D. melanogaster lines collected from natural populations across Europe. The diet for these six lines had been identical for ca. 50 generations, thus any differences in the composition of the microbiome originates from the host populations. We also investigated whether induced shifts in the microbiome D in this case by controlled antibiotic administration D alters the hosts' resistance to parasitism. Our data revealed a clear signature of population background on the diversity and composition of D. melanogaster microbiome that differed across lines, even after hosts had been maintained at the same diet and laboratory conditions for over 4 years. In particular, the number of bacterial OTUs per line ranged from 8 to 39 OTUs. Each line harboured 2 to 28 unique OTUs, and OTUs that were highly abundant in some lines were entirely missing in others. Moreover, we found that the response to antibiotic treatment differed among the lines and significantly altered the host resistance to the parasitoid Asobara tabida in one of the six lines. Wolbachia, a widespread intracellular endosymbiont associated with parasitoid resistance, was lacking in this line, suggesting that other components of the Drosophila microbiome caused a change in host resistance. Collectively, our results revealed that lines that originate from different population backgrounds show significant differences in the established Drosophila microbiome, outpacing the long-term effect of diet. Perturbations on these naturally assembled microbiomes to some degree influenced the hosts' resistance against natural parasites.	[Chaplinska, Mariia; Gerritsma, Sylvia; Wertheim, Bregje] Univ Groningen, Groningen Inst Evolutionary Life Sci, Evolutionary Genet Dev & Behav, Groningen, Netherlands; [Dini-Andreote, Francisco; Salles, Joana Falcao] Univ Groningen, Groningen Inst Evolutionary Life Sci, Genom Res Ecol & Evolut Nat, Groningen, Netherlands	University of Groningen; University of Groningen	Wertheim, B (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Evolutionary Genet Dev & Behav, Groningen, Netherlands.	b.wertheim@rug.nl	Wertheim, Bregje/B-6436-2009; Salles, Joana Falcao/AAG-7070-2020; Dini-Andreote, Francisco/M-6176-2017; Falcao Salles, Joana/A-7313-2008	Wertheim, Bregje/0000-0001-8555-1925; Salles, Joana Falcao/0000-0003-4317-7263; Dini-Andreote, Francisco/0000-0002-6654-0769; Falcao Salles, Joana/0000-0003-4317-7263	VIDI grant from the Netherlands Organisation for Scientific Research [854.08.008]	VIDI grant from the Netherlands Organisation for Scientific Research	This work was supported by a VIDI grant to BW [grant number: 854.08.008] from the Netherlands Organisation for Scientific Research (URL: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Begon M., 1982, GENET BIOL DROSOPHIL, P345; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bourtzis K, 1996, GENETICS, V144, P1063; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Crawley M.J., 2007, R BOOK; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gerritsma S., 2015, THESIS; Gerritsma S, 2013, J INSECT PHYSIOL, V59, P148, DOI 10.1016/j.jinsphys.2012.09.017; Guyenot E, 1913, CR SOC BIOL, V74, P97; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; KRAAIJEVELD AR, 1995, EVOL ECOL, V9, P10, DOI 10.1007/BF01237692; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lize A, 2014, ISME J, V8, P469, DOI 10.1038/ismej.2013.157; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060459; Markus R, 2015, J INNATE IMMUN, V7, P340, DOI 10.1159/000369618; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salazar-Jaramillo L, 2014, GENOME BIOL EVOL, V6, P273, DOI 10.1093/gbe/evu012; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; [Team RDC R Development Core Team R Team RDC], 2011, R LANG ENV STAT COMP, P409; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Xie J, 2014, HEREDITY, V112, P399, DOI 10.1038/hdy.2013.118; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	59	18	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167726	10.1371/journal.pone.0167726	http://dx.doi.org/10.1371/journal.pone.0167726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973604	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300043
J	Gao, JQ; Chen, T; Zhao, DQ; Zheng, JP; Liu, ZJ				Gao, Junqing; Chen, Tao; Zhao, Deqiang; Zheng, Jianpu; Liu, Zongjun			Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; CRYSTALLINE NANOPARTICLES; PROTECTIVE ROLE; BILOBA LEAVES; BREAST-CANCER; MELATONIN; DELIVERY; EXTRACT	The aim of this study was to evaluate the effect of Ginkgolide B (GB) on doxorubicin (DOX) induced cardiotoxicity in vitro and in vivo. Rat cardiomyocyte cell line H9c2 was pretreated with GB and subsequently subjected to doxorubicin treatment. Cell viability and cell apoptosis were assessed by MTT assay and Hoechst staining, respectively. Reactive oxygen species (ROS), Akt phosphorylation and intracellular calcium were equally determined in order to explore the underlying molecular mechanism. To verify the in vivo therapeutic effect of GB, we established a mouse model of cardiotoxicity and determined left ventricle ejection fraction (LVEF) and left ventricular mass (LVM). The in vitro experimental results indicated that pretreatment with GB significantly decreases the viability and apoptosis of H9c2 cells by decreasing ROS and intracellular calcium levels and activating Akt phosphorylation. In the in vivo study, we recorded an improved LVEF and a decreased LVM in the group of cardiotoxic rats treated with GB. Altogether, our findings anticipate that GB exerts a cardioprotective effect through possible regulation of the ROS, Akt and calcium pathways. The findings suggest that combination of GB with DOX in chemotherapy could help avoid the cardiotoxic side effects of GB.	[Gao, Junqing; Chen, Tao; Zhao, Deqiang; Zheng, Jianpu; Liu, Zongjun] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Zheng, JP; Liu, ZJ (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China.	liuzongjun028@sina.com; zhengjianpu_p@163.com	郜, 俊清/GXM-4013-2022	郜, 俊清/0000-0001-8795-885X	national natural science foundation of China [81303145]; science and technology committee foundation of Shanghai [124119b1600]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); science and technology committee foundation of Shanghai	This work was supported by the national natural science foundation of China (81303145); and science and technology committee foundation of Shanghai (124119b1600).	Asensio-Lopez MC, 2013, FREE RADICAL BIO MED, V57, P188, DOI 10.1016/j.freeradbiomed.2012.09.009; Baghbani F, 2016, INT J BIOL MACROMOL, V93, P512, DOI 10.1016/j.ijbiomac.2016.09.008; Baliutyte G, 2012, J CARDIOVASC PHARM, V59, P450, DOI 10.1097/FJC.0b013e318249171d; Cao Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/674219; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chan BY, 2016, FASEB J S, V30, P742; Chen XR, 2014, J PINEAL RES, V57, P168, DOI 10.1111/jpi.12153; Chen YL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/970490; Dias QC, 2016, INT BRAZ J UROL, V42, P942, DOI 10.1590/S1677-5538.IBJU.2015.0381; Dong QH, 2014, BRIT J PHARMACOL, V171, P4440, DOI 10.1111/bph.12795; Durham K, 2014, ARTERIOSCL THROM VAS, V34; Escarcega-Gonzalez CE, 2016, BIOCH RES INT, V2016; Fernandes RS, 2016, BIOMED PHARMACOTHER, V84, P252, DOI 10.1016/j.biopha.2016.09.032; Ghibu S, 2012, BIOCHIMIE, V94, P932, DOI 10.1016/j.biochi.2011.02.015; Govender J, 2014, J PINEAL RES, V57, P367, DOI 10.1111/jpi.12176; Granados-Principal S, 2014, BIOCHEM PHARMACOL, V90, P25, DOI 10.1016/j.bcp.2014.04.001; Guenancia C, 2015, TOXICOL APPL PHARM, V284, P152, DOI 10.1016/j.taap.2015.02.015; Hao EK, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00261; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Iqbal M, 2008, PHARMACOL REP, V60, P382; Jagetia G.C., 2014, J MOL BIOCH, V3, P34; Jay SM, 2013, CIRCULATION, V128, P152, DOI 10.1161/CIRCULATIONAHA.113.002203; Kaur N, 2015, J NEUROSCI RES, V93, P938, DOI 10.1002/jnr.23565; Khan MA, 2014, CURR CLIN PHARMACOL, V9, P288, DOI 10.2174/1574884709999140606162053; Kumar S, 2012, TEXAS HEART I J, V39; Lamberti M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/240642; Ludke A, 2012, MOL CELL BIOCHEM, V360, P215, DOI 10.1007/s11010-011-1059-z; Lv SX, 2013, ACTA BIOMATER, V9, P9330, DOI 10.1016/j.actbio.2013.08.015; Mahmoud F, 2000, JPN J PHARMACOL, V83, P241, DOI 10.1254/jjp.83.241; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Pallerla S, 2017, EUR J MED CHEM, V125, P914, DOI 10.1016/j.ejmech.2016.10.015; Parimoo HA, 2014, TOXICON, V81, P1, DOI 10.1016/j.toxicon.2014.01.013; Ponnusamy L, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-4571; Potemski P, 2006, PHARMACOL REP, V58, P966; Qi XY, 2004, ACTA PHARMACOL SIN, V25, P203; Sin TK, 2015, J PHYSIOL-LONDON, V593, P1887, DOI 10.1113/jphysiol.2014.270101; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064526; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Swarnakar NK, 2014, NANOMED-NANOTECHNOL, V10, P1231, DOI 10.1016/j.nano.2014.03.003; Swarnakar NK, 2014, PHARM RES-DORDR, V31, P1219, DOI 10.1007/s11095-013-1244-8; Tahover E, 2015, ANTI-CANCER DRUG, V26, P241, DOI 10.1097/CAD.0000000000000182; Varshosaz J, 2016, INT J BIOL MACROMOL, V93, P1192, DOI 10.1016/j.ijbiomac.2016.07.025; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Wang Z, 2016, PHYTOMEDICINE, V23, P621, DOI 10.1016/j.phymed.2016.03.005; Xia SH, 2008, PANCREAS, V37, P170, DOI 10.1097/MPA.0b013e3181661b07; Xiang SL, 2015, J PINEAL RES, V59, P60, DOI 10.1111/jpi.12239; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227; Xu CN, 2016, BIOMATER SCI-UK, V4, P1646, DOI 10.1039/c6bm00601a; Yang Y, 2004, GUT, V53, P877, DOI 10.1136/gut.2003.024893; Yang Y, 2014, J PINEAL RES, V57, P357, DOI 10.1111/jpi.12175; Yu LM, 2015, J PINEAL RES, V59, P420, DOI 10.1111/jpi.12272; Yu LM, 2015, J PINEAL RES, V59, P376, DOI 10.1111/jpi.12269; Yu XH, 2013, ACTA BIOCH BIOPH SIN, V45, P817, DOI 10.1093/abbs/gmt082; Yuan WL, 2009, ACTA BIOCH BIOPH SIN, V41, P625, DOI 10.1093/abbs/gmp050; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhang Zhi-Xiong, 2003, Shengli Xuebao, V55, P24	60	26	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168219	10.1371/journal.pone.0168219	http://dx.doi.org/10.1371/journal.pone.0168219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973574	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300066
J	Enos, RT; Velazquez, KT; Carson, MS; McClellan, JL; Nagarkatti, P; Nagarkatti, M; Davis, JM; Murphy, EA				Enos, Reilly T.; Velazquez, Kandy T.; Carson, Meredith S.; McClellan, Jamie L.; Nagarkatti, Prakash; Nagarkatti, Mitzi; Davis, J. Mark; Murphy, E. Angela			A Low Dose of Dietary Quercetin Fails to Protect against the Development of an Obese Phenotype in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-LIVER-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; SATURATED FAT; C57BL/6J MICE; RATS; INFLAMMATION; CANCER	The purpose of this study was to examine the effect of a 40% high-fat diet (HFD) supplemented with a dietary attainable level of quercetin (0.02%) on body composition, adipose tissue (AT) inflammation, Non-Alcoholic Fatty-Liver Disease (NAFLD), and metabolic outcomes. Diets were administered for 16 weeks to C57BL/6J mice (n = 10/group) beginning at 4 weeks of age. Body composition and fasting blood glucose, insulin, and total cholesterol concentrations were examined intermittently. AT and liver mRNA expression (RT-PCR) of inflammatory mediators (F4/80, CD206 (AT only), CD11c (AT only) TLR-2 (AT only), TLR-4 (AT only), MCP-1, TNF-alpha, IL-6 (AT only), and IL-10 (AT only)) were measured along with activation of NF kappa B-p65, and JNK (western blot). Hepatic lipid accumulation, gene expression (RT-PCR) of hepatic metabolic markers (ACAC1, SREBP-1, PPAR-gamma), protein content of Endoplasmic Reticulum (ER) Stress markers (BiP, phosphorylated and total EIF2 alpha, phosphorylated and total IRE1 alpha, CHOP), and hepatic oxidative capacity were assessed (western blot). Quercetin administration had no effect at mitigating increases in visceral AT, AT inflammation, hepatic steatosis, ER Stress, decrements in hepatic oxidative capacity, or the development of insulin resistance and hypercholesterolemia. In conclusion, 0.02% quercetin supplementation is not an effective therapy for attenuating HFD-induced obesity development. It is likely that a higher dose of quercetin supplementation is needed to elicit favorable outcomes in obesity.	[Enos, Reilly T.; Velazquez, Kandy T.; Carson, Meredith S.; McClellan, Jamie L.; Nagarkatti, Prakash; Nagarkatti, Mitzi; Murphy, E. Angela] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Davis, J. Mark] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Murphy, EA (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Angela.Murphy@uscmed.sc.edu	Enos, Reilly/AFO-4814-2022; davis, j mark/AAD-9575-2021	Enos, Reilly/0000-0001-5571-4586; Nagarkatti, Prakash/0000-0003-2663-0759	NIH/NCI [R21CA175636]; NIH/NCCIH [K01AT007824]; NATIONAL CANCER INSTITUTE [R21CA175636] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K01AT007824, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R21CA175636 (NIH/NCI) and K01AT007824 (NIH/NCCIH) to EAM. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, PPAR RES, V2012, DOI 10.1155/2012/912351; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Arias N, 2016, EUR J NUTR, V55, P341, DOI 10.1007/s00394-015-0854-9; Arias N, 2015, J PHYSIOL BIOCHEM, V71, P569, DOI 10.1007/s13105-015-0403-2; Carson JA, 2002, J APPL PHYSIOL, V93, P242, DOI 10.1152/japplphysiol.01212.2001; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Enos RT, 2015, NUTR RES, V35, P449, DOI 10.1016/j.nutres.2015.04.003; Enos RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094897; Enos RT, 2014, J NUTR BIOCHEM, V25, P600, DOI 10.1016/j.jnutbio.2014.01.011; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grotto D, 2010, NUTR CLIN PRACT, V25, P603, DOI 10.1177/0884533610386234; Henagan TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089365; Hoek-van den Hil EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051588; Jung CH, 2012, PHYTOTHER RES; Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687; Jung JY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-18; Kim CS, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0030-5; Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murphy EA, 2011, NUTR CANCER, V63, P421, DOI 10.1080/01635581.2011.535954; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Steiner JL, 2014, CANCER BIOL THER, V15, P1456, DOI 10.4161/15384047.2014.955444; Stewart LK, 2009, DIABETOLOGIA, V52, P514, DOI 10.1007/s00125-008-1252-0; Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wein S, 2010, EUR J PHARM SCI, V41, P16, DOI 10.1016/j.ejps.2010.05.004; Wein SA, 2015, J NUTR BIOCHEM, V26, P1660, DOI 10.1016/j.jnutbio.2015.08.010; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Ying HZ, 2013, FOOD CHEM TOXICOL, V52, P53, DOI 10.1016/j.fct.2012.10.030; Ying HZ, 2012, FOOD CHEM TOXICOL; Zhang LF, 2010, J AGR FOOD CHEM, V58, P7252, DOI 10.1021/jf101192k; Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768	47	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167979	10.1371/journal.pone.0167979	http://dx.doi.org/10.1371/journal.pone.0167979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959936	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900029
J	Tian, X; Zhong, L; von Cramon-Taubadel, S; Tu, HK; Wang, H				Tian, Xu; Zhong, Li; von Cramon-Taubadel, Stephan; Tu, Huakang; Wang, Hui			Restaurants in the Neighborhood, Eating Away from Home and BMI in China	PLOS ONE			English	Article							BODY-MASS INDEX; FAST-FOOD RESTAURANT; OUT-OF-HOME; DIETARY CHANGE; CONSUMPTION; OBESITY; ASSOCIATION; WEIGHT; ADULTS; RISK	Background To investigate the association between environmental risk factors, eating away from home, and increasing BMI of Chinese adults. Methods Participants were selected from the recent four waves (2004, 2006, 2009, and 2011) of the China Health and Nutrition Survey (CHNS). 10633 participants, including 5084 men and 5549 women, were used in the analysis. 24-h dietary recall data for three consecutive days with information on the time and place of consumption were collected. Nearby restaurants were measured by the number of fast food outlets, indoor restaurants, and food stands in the neighborhood. Random effects multivariable regression was used to assess associations between these variables. Results People living in neighborhoods with large numbers of indoor restaurants are more likely to eat away from home (p<0.05). Higher frequency of eating away from home is positively associated with BMI, but this effect is only significant for men (p<0.05). Moreover, while eating dinner or breakfast away from home contributes to BMI increase for men (p<0.05), no such association is found for lunch. Conclusion Eating dinner and breakfast away from home is positively associated with BMI for Chinese men. Labeling energy and portion size for the dishes served in indoor restaurants is recommended in China.	[Tian, Xu; Zhong, Li] Nanjing Agr Univ, China Ctr Food Secur Studies, Coll Econ & Management, Nanjing, Peoples R China; [von Cramon-Taubadel, Stephan] Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Tu, Huakang] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wang, Hui] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; University of Gottingen; University of Texas System; UTMD Anderson Cancer Center; Nanjing Medical University	Wang, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	huiwang@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [71473123, 81402741]; Natural Science Foundation Jiangsu Province [BK20140904]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; Carolina Population Centre, University of North Carolina at Chapel Hill; National Institutes of Health (NIH) [R01-HD30880, DK056350, R01-HD38700]; Fogarty International Centre, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; Carolina Population Centre, University of North Carolina at Chapel Hill; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was sponsored by the National Natural Science Foundation of China (NSFC) (Project ID: 71473123&81402741), and BK20140904 from Natural Science Foundation Jiangsu Province, as well as "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)." We also thank the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; the Carolina Population Centre, University of North Carolina at Chapel Hill; the National Institutes of Health (NIH; R01-HD30880, DK056350, and R01-HD38700); and the Fogarty International Centre, NIH, for their financial contribution toward the CHNS data collection and analysis files since 1989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JF, 2012, CHINA AGR ECON REV, V4, P18, DOI 10.1108/17561371211196757; Bai JF, 2010, CHINA ECON REV, V21, P432, DOI 10.1016/j.chieco.2010.04.003; Batis C, 2014, BR J NUTR, V111, P1441; Bezerra IN, 2009, PUBLIC HEALTH NUTR, V12, P2037, DOI 10.1017/S1368980009005710; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Burns C, 2002, PUBLIC HEALTH NUTR, V5, P441, DOI 10.1079/PHN2001316; Butzlaff Iris, 2016, UNDERSTANDING DRIVER; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; Dong XX, 2010, AGRIC AGRIC SCI PROC, V1, P271, DOI 10.1016/j.aaspro.2010.09.034; Du WW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004528; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; Gordon-Larsen P, 2014, OBES REV, V15, P37, DOI 10.1111/obr.12121; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Insik M, 2004, CHINA ECON REV, V15, P457; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Liu HY, 2015, FOOD POLICY, V51, P97, DOI 10.1016/j.foodpol.2014.12.011; Liu J, 2014, FOOD POLICY, V49, P323, DOI 10.1016/j.foodpol.2014.09.007; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; Marin-Guerrero AC, 2008, BRIT J NUTR, V100, P1142, DOI 10.1017/S0007114508966137; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naska A, 2011, INT J OBESITY, V35, P416, DOI 10.1038/ijo.2010.142; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Orfanos P, 2009, EUR J CLIN NUTR, V63, pS239, DOI 10.1038/ejcn.2009.84; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; REDMAN BJ, 1980, AM J AGR ECON, V62, P234, DOI 10.2307/1239690; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Tian X, 2015, FOOD POLICY, V53, P67, DOI 10.1016/j.foodpol.2015.04.006; Tian X, 2013, FRONT ECON CHINA, V8, P186, DOI 10.3868/s060-002-013-0009-9; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth; Wu Y, 2009, CVD PREVENTION CONTR, V1, P19, DOI DOI 10.1016/J.CVDPC.2008.11.003; Xu HW, 2013, J EPIDEMIOL COMMUN H, V67, P271, DOI 10.1136/jech-2012-201157; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	21	25	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167721	10.1371/journal.pone.0167721	http://dx.doi.org/10.1371/journal.pone.0167721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959893	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900014
J	Baljin, B; Baldan, G; Chimeddorj, B; Tulgaa, K; Gunchin, B; Sandag, T; Pfeffer, K; MacKenzie, CR; Wendel, AF				Baljin, Bayaraa; Baldan, Ganbaatar; Chimeddorj, Battogtokh; Tulgaa, Khosbayar; Gunchin, Batbaatar; Sandag, Tsogtsaikhan; Pfeffer, Klaus; MacKenzie, Colin R.; Wendel, Andreas F.			Faecal Carriage of Gram-Negative Multidrug-Resistant Bacteria among Patients Hospitalized in Two Centres in Ulaanbaatar, Mongolia	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; SEQUENCE TYPING SCHEME; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; HIGH PREVALENCE; MULTIPLEX PCR; RISK-FACTORS; CTX-M; GENES; COMMUNITY	Gram-negative multidrug-resistant organisms (GN-MDRO) producing beta-lactamases (ESBL, plasmid-mediated AmpC beta-lactamases and carbapenemases) are increasingly reported throughout Asia. The aim of this surveillance study was to determine the rate of bacterial colonization in patients from two hospitals in the Mongolian capital Ulaanbaatar. Rectal swabs were obtained from patients referred to the National Traumatology and Orthopaedics Research Centre (NTORC) or the Burn Treatment Centre (BTC) between July and September 2014, on admission and again after 14 days. Bacteria growing on selective chromogenic media (CHROMagar ESBL/KPC) were identified by MALDI-ToF MS. We performed susceptibility testing by disk diffusion and PCR (bla(IMP-1), bla(VIM), bla(GES), bla(NDM), bla(KPC), bla(OXA-48), bla(GIM-1), bla(OXA-23), bla(OXA-24/40), bla(OXA-51), bla(OXA-58), bla(OXA-143), bla(OXA-235), bla(CTX-M), bla(SHV) bla(TEM) and plasmid-mediated bla(AmpC)). Carbapenemase-producing isolates were additionally genotyped by PFGE and MLST. During the study period 985 patients in the NTORC and 65 patients in the BTC were screened on admission. The prevalence of GN-MDRO-carriage was 42.4% and 69.2% respectively (p< 0.001). Due to the different medical specialities the two study populations differed significantly in age (p< 0.029) and gender (p< 0.001) with younger and more female patients in the burn centre (BTC). We did not observe a significant difference in colonization rate in the respective age groups in the total study population. In both centres most carriers were colonized with CTX-M-producing E. coli, followed by CTX-M-producing K. pneumoniae and CTX-M-producing E. cloacae. 158 patients from the NTORC were re-screened after 14 days of whom 99 had acquired a new GN-MDRO (p< 0.001). Carbapenemases were detected in both centres in four OXA-58-producing A. baumannii isolates (ST642) and six VIM-2-producing P. aeruginosa isolates (ST235). This study shows a high overall prevalence of GN-MDRO in the study population and highlights the importance of routine surveillance, appropriate infection control practice and antibiotic prescribing policies to prevent further spread especially of carbapenemases.	[Baljin, Bayaraa; Baldan, Ganbaatar; Chimeddorj, Battogtokh; Gunchin, Batbaatar; Sandag, Tsogtsaikhan] Mongolian Natl Univ Med Sci, Sch Biomed, Dept Microbiol & Immunol, Ulaanbaatar, Mongolia; [Tulgaa, Khosbayar] Mongolian Natl Univ Med Sci, Sch Biomed, Dept Mol Biol & Genet, Ulaanbaatar, Mongolia; [Pfeffer, Klaus; MacKenzie, Colin R.; Wendel, Andreas F.] Heinrich Heine Univ, Univ Hosp, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany	Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Heinrich Heine University Dusseldorf	Wendel, AF (corresponding author), Heinrich Heine Univ, Univ Hosp, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	Andreas.Wendel@med.uni-duesseldorf.de	MacKenzie, Colin R/E-9368-2011; San, Tsogt/AAX-6434-2020	MacKenzie, Colin R/0000-0001-7732-2698; San, Tsogt/0000-0003-4916-5108; Baljin, Bayaraa/0000-0002-2750-0588; Batbaatar, Gunchin/0000-0002-6678-7569; Tulgaa, Khosbayar/0000-0001-6288-9624	Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany; ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland; DAAD-PAGEL program [54448058]	Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany; ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland; DAAD-PAGEL program	This work was supported by the Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany, in collaboration with the ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland. and by the DAAD-PAGEL program (54448058).	Azzopardi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095042; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; EUCAST, EUCAST GUID DET RES; Evans BA, 2008, CLIN MICROBIOL INFEC, V14, P268, DOI 10.1111/j.1469-0691.2007.01919.x; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ider BE, 2010, J HOSP INFECT, V75, P209, DOI 10.1016/j.jhin.2010.02.022; Kao CY, 2016, J MICROBIOL IMMUNOL, V49, P692, DOI 10.1016/j.jmii.2015.05.009; Kao CY, 2014, INFECT GENET EVOL, V28, P313, DOI 10.1016/j.meegid.2014.10.024; Kao CY, 2014, INFECT GENET EVOL, V25, P66, DOI 10.1016/j.meegid.2014.04.012; Khandarmaa TO, 2012, BURNS, V38, P751, DOI 10.1016/j.burns.2011.11.006; Khorsandi M, 2015, ANN ROY COLL SURG, V97, P298, DOI 10.1308/003588415X14181254789169; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Nakajima Rie, 2010, South Med Rev, V3, P19; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Sun Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113121; Swayne RL, 2011, INT J ANTIMICROB AG, V38, P35, DOI 10.1016/j.ijantimicag.2011.03.010; Takehara K, 2016, MATERN CHILD HLTH J, V20, P1072, DOI 10.1007/s10995-015-1893-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Wendel AF, 2013, ANTIMICROB AGENTS CH, V57, P5162, DOI 10.1128/AAC.00118-13; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhang HN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00239; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0	36	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168146	10.1371/journal.pone.0168146	http://dx.doi.org/10.1371/journal.pone.0168146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942042	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600056
J	Embry, AE; Mohammadi, H; Niu, XY; Liu, LP; Moe, B; Miller-Little, WA; Lu, CY; Bruggeman, LA; McCulloch, CA; Janmey, PA; Miller, RT				Embry, Addie E.; Mohammadi, Hamid; Niu, Xinying; Liu, Liping; Moe, Borren; Miller-Little, William A.; Lu, Christopher Y.; Bruggeman, Leslie A.; McCulloch, Christopher A.; Janmey, Paul A.; Miller, R. Tyler			Biochemical and Cellular Determinants of Renal Glomerular Elasticity	PLOS ONE			English	Article							VIMENTIN INTERMEDIATE-FILAMENTS; ACTIN CYTOSKELETON; NEPHROTIC SYNDROME; CELLS; PODOCYTES; STRESS; MECHANISMS; MUTATIONS; DYNAMICS; ADHESION	The elastic properties of renal glomeruli and their capillaries permit them to maintain structural integrity in the presence of variable hemodynamic forces. Measured by micro-indentation, glomeruli have an elastic modulus (E, Young's modulus) of 2.1 kPa, and estimates from glomerular perfusion studies suggest that the E of glomeruli is between 2 and 4 kPa. F-actin depolymerization by latrunculin, inhibition of acto-myosin contractility by blebbistatin, reduction in ATP synthesis, and reduction of the affinity of adhesion proteins by EDTA reduced the glomerular E to 1.26, 1.7, 1.5, and 1.43 kPa, respectively. Actin filament stabilization with jasplakinolide and increasing integrin affinity with Mg2+ increased E to 2.65 and 2.87 kPa, respectively. Alterations in glomerular E are reflected in commensurate changes in F/G actin ratios. Disruption of vimentin intermediate filaments by withaferin A reduced E to 0.92 kPa. The E of decellularized glomeruli was 0.74 kPa, indicating that cellular components of glomeruli have dominant effects on their elasticity. The E of glomerular basement membranes measured by magnetic bead displacement was 2.4 kPa. Podocytes and mesangial cells grown on substrates with E values between 3 and 5 kPa had actin fibers and focal adhesions resembling those of podocytes in vivo. Renal ischemia and ischemia-reperfusion reduced the E of glomeruli to 1.58 kPa. These results show that the E of glomeruli is between 2 and 4 kPa. E of the GBM, 2.4 kPa, is consistent with this value, and is supported by the behavior of podocytes and mesangial cells grown on variable stiffness matrices. The podocyte cytoskeleton contributes the major component to the overall E of glomeruli, and a normal E requires ATP synthesis. The reduction in glomerular E following ischemia and in other diseases indicates that reduced glomerular E is a common feature of many forms of glomerular injury and indicative of an abnormal podocyte cytoskeleton.	[Embry, Addie E.; Niu, Xinying; Liu, Liping; Moe, Borren; Miller-Little, William A.; Lu, Christopher Y.; Miller, R. Tyler] UT Southwestern Med Sch, Nephrol & Med, Dallas, TX 75390 USA; [Mohammadi, Hamid; McCulloch, Christopher A.] Univ Toronto, Ctr Matrix Biol, Toronto, ON, Canada; [Bruggeman, Leslie A.] Case Western Reserve Univ, Metrohlth Med Ctr, Nephrol, Cleveland, OH USA; [Janmey, Paul A.] Univ Penn, Inst Med & Engn, Physiol & Biophys, Philadelphia, PA 19104 USA; [Miller, R. Tyler] Dallas VAMC, Med, Dallas, TX 75216 USA; [Moe, Borren] Univ Toronto, Engn, Toronto, ON, Canada; [Miller-Little, William A.] MSTP Case Western Reserve Univ, Cleveland, OH USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; Case Western Reserve University; MetroHealth System; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; Case Western Reserve University	Miller, RT (corresponding author), UT Southwestern Med Sch, Nephrol & Med, Dallas, TX 75390 USA.; Miller, RT (corresponding author), Dallas VAMC, Med, Dallas, TX 75216 USA.	tyler.miller@utsouthwestern.edu	liu, li/HGC-0900-2022		National Institute of Health [RO1 DK083592, DK095832]; Charles and Jane Pak Foundation; Center for Mineral Metabolism and Clinical Research; U.T. Southwestern O'Brien Center for Kidney Disease; Veterans Affairs Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592, R01DK097836, R01DK095832] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Jane Pak Foundation; Center for Mineral Metabolism and Clinical Research; U.T. Southwestern O'Brien Center for Kidney Disease; Veterans Affairs Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institute of Health grants RO1 DK083592 (RTM and PAJ), DK095832 (LAB) the Charles and Jane Pak Foundation and Center for Mineral Metabolism and Clinical Research, and the U.T. Southwestern O'Brien Center for Kidney Disease, and the Veterans Affairs Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Bargana-Mohan P, 2015, PLOS ONE, V17; BRENNER BM, 1971, J CLIN INVEST, V50, P1776, DOI 10.1172/JCI106667; Brown Elizabeth J, 2010, Nat Genet, V42, P72, DOI 10.1038/ng.505; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Chen YM, 2013, J AM SOC NEPHROL, V24, P1223, DOI 10.1681/ASN.2012121149; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cortes P, 1996, AM J PHYSIOL-RENAL, V270, pF356, DOI 10.1152/ajprenal.1996.270.2.F356; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; DANIELS BS, 1992, AM J PHYSIOL, V262, pF919, DOI 10.1152/ajprenal.1992.262.6.F919; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; DWORKIN LD, 1984, J CLIN INVEST, V73, P1448, DOI 10.1172/JCI111349; Endlich N, 2006, EUR J CELL BIOL, V85, P229, DOI 10.1016/j.ejcb.2005.09.006; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Ferrell N, 2015, AM J PHYSIOL-RENAL, V308, pF588, DOI 10.1152/ajprenal.00290.2014; Perez MF, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0146588, 10.1371/journal.pone.0165590]; Gladilin E, 2014, J BIOMECH, V47, P2598, DOI 10.1016/j.jbiomech.2014.05.020; GRANTHAM JJ, 1987, KIDNEY INT, V32, P187, DOI 10.1038/ki.1987.191; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Kamgoue A, 2007, J BIOMECH ENG-T ASME, V129, P523, DOI 10.1115/1.2746374; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kinnunen AI, 2011, J BIOL CHEM, V286, P7755, DOI 10.1074/jbc.M110.166132; KRIZ W, 1994, KIDNEY INT, V45, P369, DOI 10.1038/ki.1994.47; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miller RT, 2015, CURR OPIN NEPHROL HY, V24, P393, DOI 10.1097/MNH.0000000000000138; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Mohammadi H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1074; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; O'Tool JF, 2007, JASN, V18, p136A; Perez-Liva M., 2016, 2016 Global Medical Engineering Physics Exchanges/Pan-American Health Care Exchanges (GMEPE/PAHCE), P1, DOI 10.1109/GMEPE-PAHCE.2016.7504651; RACUSEN LC, 1984, AM J PATHOL, V114, P157; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Smithies O, 2003, P NATL ACAD SCI USA, V100, P4108, DOI 10.1073/pnas.0730776100; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Steenhard BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050745; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010	56	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167924	10.1371/journal.pone.0167924	http://dx.doi.org/10.1371/journal.pone.0167924			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942003	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600038
J	Volpe, NL; Robinson, WD; Frey, SJK; Hadley, AS; Betts, MG				Volpe, Noelia L.; Robinson, W. Douglas; Frey, Sarah J. K.; Hadley, Adam S.; Betts, Matthew G.			Tropical Forest Fragmentation Limits Movements, but Not Occurrence of a Generalist Pollinator Species	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MATRIX COMPOSITION; BIRD MOVEMENTS; HOME-RANGE; BEHAVIOR; DISPERSAL; LANDSCAPE; SONGBIRDS; NETWORKS; KEYSTONE	Habitat loss and fragmentation influence species distributions and therefore ecological processes that depend upon them. Pollination may be particularly susceptible to fragmentation, as it depends on frequent pollinator movement. Unfortunately, most pollinators are too small to track efficiently which has precluded testing the hypothesis that habitat fragmentation reduces or eliminates pollen flow by disrupting pollinator movement. We used radio-telemetry to examine space use of the green hermit hummingbird (Phaethornis guy), an important 'hub' pollinator of understory flowering plants across substantial portions of the neotropics and the primary pollinator of a keystone plant which shows reduced pollination success in fragmented landscapes. We found that green hermits strongly avoided crossing large stretches of non-forested matrix and preferred to move along stream corridors. Forest gaps as small as 50 m diminished the odds of movement by 50%. Green hermits occurred almost exclusively inside the forest, with the odds of occurrence being 8 times higher at points with >95% canopy cover compared with points having <5% canopy cover. Nevertheless, surprisingly. the species occurred in fragmented landscapes with low amounts of forest (similar to 30% within a 2 km radius). Our results indicate that although green hermits are present even in landscapes with low amounts of tropical forest, movement within these landscapes ends up strongly constrained by forest gaps. Restricted movement of pollinators may be an underappreciated mechanism for widespread declines in pollination and plant fitness in fragmented landscapes, even when in the presence of appropriate pollinators.	[Volpe, Noelia L.; Robinson, W. Douglas] Oregon State Univ, Dept Fisheries & Wildlife, 104 Nash Hall, Corvallis, OR 97331 USA; [Frey, Sarah J. K.; Hadley, Adam S.; Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Betts, MG (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	matt.betts@oregonstate.edu	Frey, Sarah/AAZ-2404-2021; Frey, Sarah/D-5685-2013; Hadley, Adam/G-8391-2012; Betts, Matthew G/Q-2978-2019	Frey, Sarah/0000-0002-4343-0700; Hadley, Adam/0000-0002-8344-3354; Betts, Matthew G/0000-0002-7100-2551	National Science Foundation [DEB-1050954, DEB-1457837]; Bob and Phyllis Mace Professorship; Division Of Environmental Biology [1457837] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Bob and Phyllis Mace Professorship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partly funded by the National Science Foundation grants DEB-1050954 awarded to M.G.B. and W.D.R., and DEB-1457837 awarded to M.G.B. and A.S.H (http//www.nsf.gov), as well as the Bob and Phyllis Mace Professorship to W.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2012, ANIM CONSERV, V15, P658, DOI 10.1111/j.1469-1795.2012.00562.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Betts MG, 2006, ECOL APPL, V16, P1076, DOI 10.1890/1051-0761(2006)016[1076:IEOFOF]2.0.CO;2; Betts MG, 2015, P NATL ACAD SCI USA, V112, P3433, DOI 10.1073/pnas.1419522112; Beyer H. L, 2012, GEOSPATIAL MODELLING; Borgella R, 2001, BIOTROPICA, V33, P90, DOI 10.1111/j.1744-7429.2001.tb00160.x; Bosschieter L, 2010, ARDEA, V98, P383, DOI 10.5253/078.098.0312; Brosi BJ, 2008, CONSERV LETT, V1, P27, DOI 10.1111/j.1755-263X.2008.00004.x; Desrochers A, 2010, ECOGRAPHY, V33, P921, DOI 10.1111/j.1600-0587.2009.06061.x; Diekotter T, 2007, OIKOS, V116, P1588, DOI [10.1111/j.2007.0030-1299.15963.x, 10.1111/j.0030-1299.2007.15963.x]; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hadley AS, 2014, ECOLOGY, V95, P2202, DOI 10.1890/13-0929.1; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hadley AS., 2016, CURR LANDSC ECOL REP, V1, P55, DOI [10.1007/s40823-016-0007-8, DOI 10.1007/S40823-016-0007-8]; HEINRICH B, 1972, SCIENCE, V176, P597, DOI 10.1126/science.176.4035.597; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; Kormann U, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2347; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kucharick S, 2001, J ECOL RES, V3, P27; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Lloyd H, 2011, RESTOR ECOL, V19, P74, DOI 10.1111/j.1526-100X.2009.00542.x; Magrach A, 2012, CONSERV BIOL, V26, P238, DOI 10.1111/j.1523-1739.2011.01818.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Rettie WJ, 1999, CAN J ZOOL, V77, P1175, DOI 10.1139/cjz-77-8-1175; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Schuepp C, 2014, P R SOC LOND B, V281; Smith JNM, 2002, TRENDS ECOL EVOL, V17, P397, DOI 10.1016/S0169-5347(02)02576-4; Smith MJ, 2011, LANDSCAPE ECOL, V26, P709, DOI 10.1007/s10980-011-9595-1; SNOW BK, 1974, IBIS, V116, P278, DOI 10.1111/j.1474-919X.1974.tb00125.x; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Volpe NL, 2014, ECOL APPL, V24, P2122, DOI 10.1890/13-2168.1; Wilson RF, 2007, WILDLIFE RES, V34, P177, DOI 10.1071/WR06114; Zuur Alain F., 2009, P1	53	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167513	10.1371/journal.pone.0167513	http://dx.doi.org/10.1371/journal.pone.0167513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941984	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600020
J	Akhdar, H; El Shamieh, S; Musso, O; Desert, R; Joumaa, W; Guyader, D; Aninat, C; Corlu, A; Morel, F				Akhdar, Hanane; El Shamieh, Said; Musso, Orlando; Desert, Romain; Joumaa, Wissam; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice			The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals	PLOS ONE			English	Article							CANCER-RISK; ENDOSTATIN PRECURSOR; COLLAGEN-XVIII; POLYMORPHISMS; CELLS; PROGRESSION; EXPRESSION; SOFTWARE; GENOTYPE; M1	Glutathione S-transferases (GSTs) detoxify toxic molecules by conjugation with reduced glutathione and regulate cell signaling. Single nucleotide polymorphisms (SNPs) of GST genes have been suggested to affect GST functions and thus to increase the risk of human hepatocellular carcinoma (HCC). As GSTA1 is expressed in hepatocytes and the rs3957 357C>T (TT) SNP is known to downregulate GSTA1 mRNA expression, the aims of this study were: (i) to explore the relationship between the TT SNP in GSTA1 and the occurrence of HCC; (ii) to measure GSTA1 mRNA expression in HCCs. For that purpose, we genotyped non-tumor-tissue-derived DNA from 48 HCC patients and white-blood-cell-derived DNA from 37 healthy individuals by restriction fragment length polymorphism (RFLP). In addition, expression of GSTA1 mRNA was assessed by real-time PCR in 18 matching pairs of HCCs and non-tumor livers. Survival analysis was performed on an annotated microarray dataset containing 247 HCC patients (GSE14520). The GSTA1 TT genotype was more frequent in HCC than in non-HCC patients (27% versus 5%, respectively), suggesting that individuals carrying this genotype could be associated with 2-fold higher risk of developing HCCs (odds ratio = 2.1; p = 0.02). Also, we found that GSTA1 mRNA expression was lower in HCCs than in non-tumor livers. HCCs expressing the highest GSTA1 mRNA levels were the smallest in size (R = -0.67; p = 0.007), expressed the highest levels of liver-enriched genes such as ALB (albumin, R = -0.67; p = 0.007) and COL18A1 (procollagen type XVIII, R = -0.50; p = 0.03) and showed the most favorable disease-free (OR = 0.54; p<0.001) and overall (OR = 0.56; p = 0.006) outcomes. Moreover, GSTA1 was found within a 263-gene network involved in well-differentiated hepatocyte functions. In conclusion, HCCs are characterized by two GSTA1 features: the TT SNP and reduced GSTA1 gene expression in a context of hepatocyte de-differentiation.	[Akhdar, Hanane; Musso, Orlando; Desert, Romain; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice] INSERM, UMR991, Rennes, France; [Akhdar, Hanane; Musso, Orlando; Desert, Romain; Guyader, Dominique; Aninat, Caroline; Corlu, Anne; Morel, Fabrice] Univ Rennes 1, Rennes, France; [El Shamieh, Said; Joumaa, Wissam] Beirut Arab Univ, Fac Hlth Sci, Dept Med Lab Technol, Beirut, Lebanon; [El Shamieh, Said] INSERM, UMR1122, Nancy, France; [Guyader, Dominique] CHU Rennes, Serv Malad Foie, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Beirut Arab University; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes	Akhdar, H; Musso, O; Corlu, A (corresponding author), INSERM, UMR991, Rennes, France.; Akhdar, H; Musso, O; Corlu, A (corresponding author), Univ Rennes 1, Rennes, France.	hanane.akhdar@liu.edu.lb; orlando.musso@inserm.fr; anne.corlu@inserm.fr	Shamieh, Said El/J-6343-2019; Musso, Orlando/N-5756-2017; Corlu, Anne/U-8030-2018; Aninat, Caroline/AAL-8446-2020	Shamieh, Said El/0000-0002-8522-0445; Corlu, Anne/0000-0002-7370-0564; Aninat, Caroline/0000-0002-9008-0686; Musso, Orlando/0000-0001-8881-6925	INSERM; CNRS; University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne; Agence Nationale de la Recherche; Institut National du Cancer; Fondation pour la Recherche Medcale and Contrat de Plan Etat Region; Conseil National de la Recherche Scientifique du Liban	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne(Region Bretagne); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medcale and Contrat de Plan Etat Region; Conseil National de la Recherche Scientifique du Liban	This research was supported by INSERM; CNRS; University of Rennes 1; la Ligue Contre le Cancer (Comites d'Ille-et-Vilaine et des COtes d'Armor) France; Region Bretagne; Agence Nationale de la Recherche; Institut National du Cancer; Fondation pour la Recherche Medcale and Contrat de Plan Etat Region 2007-2013 projet CanceropOle. Hanane Akhdar was the recipient of a fellowship from the Conseil National de la Recherche Scientifique du Liban. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, CARCINOGENESIS, V27, P1876, DOI 10.1093/carcin/bgl038; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen KJ, 2014, TUMOR BIOL, V35, P213, DOI 10.1007/s13277-013-1026-2; Choudhury JH, 2015, TUMOUR BIOL; Coles BF, 2005, METHOD ENZYMOL, V401, P9, DOI 10.1016/S0076-6879(05)01002-5; Davies A, 2014, CLIN PHARMACOL THER, V96, P694, DOI 10.1038/clpt.2014.176; Deng QW, 2015, J BUON, V20, P287; Desert R, 2016, INT J BIOCH CELL BIO; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu MM, 2014, BIOMED REP, V2, P898, DOI 10.3892/br.2014.319; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kadouri L, 2008, BRIT J CANCER, V98, P2006, DOI 10.1038/sj.bjc.6604394; Klusek Justyna, 2014, Contemp Oncol (Pozn), V18, P219, DOI 10.5114/wo.2014.41388; Kruger M, 2015, CLIN ORAL INVESTIG; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lei ZY, 2015, INT J CLIN EXP MED, V8, P377; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057043; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Musso O, 2001, CANCER RES, V61, P45; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Osman AM, 2010, REPROD TOXICOL, V30, P322, DOI 10.1016/j.reprotox.2010.05.084; Pajaud J, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/137676; Pan CG, 2014, ONCOL RES TREAT, V37, P164, DOI 10.1159/000361083; Panczyk M, 2014, WORLD J GASTROENTERO, V20, P9775, DOI 10.3748/wjg.v20.i29.9775; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Ramsay EE, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00181; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014; Song K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048924; Villanueva A, 2015, HEPATOLOGY, V61, P1945, DOI 10.1002/hep.27732; Wang B, 2010, SCI CHINA MATH, V53, P1, DOI 10.1007/s11425-010-0014-x; Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061	40	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167543	10.1371/journal.pone.0167543	http://dx.doi.org/10.1371/journal.pone.0167543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936036	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100119
J	Campbell, LG; Shukla, K; Sneck, ME; Chaplin, C; Mercer, KL				Campbell, Lesley G.; Shukla, Kruti; Sneck, Michelle E.; Chaplin, Colleen; Mercer, Kristin L.			The Effect of Altered Soil Moisture on Hybridization Rate in a Crop-Wild System (Raphanus spp.)	PLOS ONE			English	Article							CLIMATE-CHANGE; FLORAL DISPLAY; GENE FLOW; RADISH; POPULATIONS; WEEDY; INTROGRESSION; EVOLUTION; HYBRIDS; TRAITS	Since plant mating choices are flexible and responsive to the environment, rates of spontaneous hybridization may vary across ecological clines. Developing a robust and predictive framework for rates of plant gene flow requires assessing the role of environmental sensitivity on plant reproductive traits, relative abundance, and pollen vectors. Therefore, across a soil moisture gradient, we quantified pollinator movement, life-history trait variation, and unidirectional hybridization rates from crop (Raphanus sativus) to wild (Raphanus raphanistrum) radish populations. Both radish species were grown together in relatively dry (no rain), relatively wet (double rain), or control soil moisture conditions in Ohio, USA. We measured wild and crop radish life-history, phenology and pollinator visitation patterns. To quantify hybridization rates from crop-to-wild species, we used a simply inherited morphological marker to detect F-1 hybrid progeny. Although crop-to-wild hybridization did not respond to watering treatments, the abundance of hybrid offspring was higher in fruits produced late in the period of phenological overlap, when both species had roughly equal numbers of open flowers. Therefore, the timing of fruit production and its relationship to flowering overlap may be more important to hybrid zone formation in Raphanus spp. than soil moisture or pollen vector movements.	[Campbell, Lesley G.; Shukla, Kruti; Chaplin, Colleen] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Campbell, Lesley G.; Sneck, Michelle E.] Rice Univ, Dept Biosci, Houston, TX USA; [Mercer, Kristin L.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	Toronto Metropolitan University; Rice University; University System of Ohio; Ohio State University	Mercer, KL (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mercer.97@osu.edu			Shell Center for Sustainability; Rice University; Ohio State University; Natural Sciences and Engineering Research Council Discovery grant [402305-2011]; Ryerson University	Shell Center for Sustainability; Rice University; Ohio State University(Ohio State University); Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ryerson University	Funds from Shell Center for Sustainability (to K. Whitney), Rice University (to LGC), Ohio State University (to KLM), Natural Sciences and Engineering Research Council Discovery grant (#402305-2011 to LGC), and Ryerson University (to LGC) supported this work.	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Anjum SA, 2011, AFR J AGR RES, V6, P2026; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bates B.C., 2008, CLIMATE CHANGE WATER; Bleeker W, 2001, MOL ECOL, V10, P2013, DOI 10.1046/j.1365-294X.2001.01341.x; Bolmgren K, 2005, INT J PLANT SCI, V166, P663, DOI 10.1086/430097; Borror DJ, 1981, INTRO STUDY INSECTS; BROCHMANN C, 1984, NORD J BOT, V4, P729, DOI 10.1111/j.1756-1051.1984.tb02001.x; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Campbell DR, 2013, AM J BOT, V100, P1322, DOI 10.3732/ajb.1200473; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Campbell LG, 2015, INT J PLANT SCI, V176, P393, DOI 10.1086/680683; Campbell LG, 2009, NEW PHYTOL, V184, P806, DOI 10.1111/j.1469-8137.2009.03036.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chunco AJ, 2014, ECOL EVOL, V4, P2019, DOI 10.1002/ece3.1052; CLEGG MT, 1980, BIOSCIENCE, V30, P814, DOI 10.2307/1308373; CONNER J, 1993, EVOLUTION, V47, P704, DOI 10.1111/j.1558-5646.1993.tb02128.x; Conner JK, 1996, EVOLUTION, V50, P1127, DOI [10.2307/2410653, 10.1111/j.1558-5646.1996.tb02353.x]; CRUZAN MB, 1994, HEREDITY, V72, P95, DOI 10.1038/hdy.1994.12; Cummings CL, 2002, OECOLOGIA, V130, P274, DOI 10.1007/s004420100806; De La Torre A, 2015, HEREDITY, V115, P153, DOI 10.1038/hdy.2015.19; Duminil J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-195; ECKHART VM, 1991, EVOL ECOL, V5, P370, DOI 10.1007/BF02214154; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Field DL, 2008, J ECOL, V96, P1198, DOI 10.1111/j.1365-2745.2008.01434.x; Field DL, 2011, MOL ECOL, V20, P2367, DOI 10.1111/j.1365-294X.2011.05054.x; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Gomez C, 2016, ECOL EVOL; Halpin PN, 1997, ECOL APPL, V7, P828; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Hegde SG, 2006, EVOLUTION, V60, P1187, DOI 10.1111/j.0014-3820.2006.tb01197.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; IPCC, 2012, MAN RISKS EXTR EV DI; Kennedy BF, 2008, OECOLOGIA, V155, P469, DOI 10.1007/s00442-007-0924-7; KLINGER T, 1991, CONSERV BIOL, V5, P531, DOI 10.1111/j.1523-1739.1991.tb00360.x; Lee TN, 1998, AM J BOT, V85, P333, DOI 10.2307/2446325; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116411; Ma X, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-164; Marques I, 2007, AM J BOT, V94, P1352, DOI 10.3732/ajb.94.8.1352; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Meehl GA, 2007, CLIM DYNAM, V29, P779, DOI 10.1007/s00382-007-0268-3; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Mimura M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0209-9; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; PANETSOS CA, 1968, GENETICA, V38, P243, DOI 10.1007/BF01507462; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pertl M, 2002, HEREDITY, V89, P212, DOI 10.1038/sj.hdy.6800131; Pirimova N, 2015, AM J UNDERGRADUATE R, V12, P63; Prentis PJ, 2007, NEW PHYTOL, V176, P902, DOI 10.1111/j.1469-8137.2007.02217.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Sanchez-Guillen RA, 2015, BIOL REV; Schiegg K, 2002, P ROY SOC B-BIOL SCI, V269, P1153, DOI 10.1098/rspb.2002.1966; Schwarzbach AE, 2001, AM J BOT, V88, P270, DOI 10.2307/2657018; Sedlacek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047415; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Snow AA, 2010, NEW PHYTOL, V186, P537, DOI 10.1111/j.1469-8137.2009.03172.x; Snow AA, 2005, CROP FERALITY AND VOLUNTEERISM, P193, DOI 10.1201/9781420037999.ch13; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Snow AA, 2001, ECOL APPL, V11, P934, DOI 10.1890/1051-0761(2001)011[0934:FOHBWA]2.0.CO;2; STANTON ML, 1987, AM J BOT, V74, P178, DOI 10.2307/2444019; Teitel Z, 2016, WEED RES, V56, P149, DOI 10.1111/wre.12194; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	74	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166802	10.1371/journal.pone.0166802	http://dx.doi.org/10.1371/journal.pone.0166802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936159	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100044
J	Christenson, A; Johansson, E; Reynisdottir, S; Torgerson, J; Hemmingsson, E				Christenson, Anne; Johansson, Eva; Reynisdottir, Signy; Torgerson, Jarl; Hemmingsson, Erik			Women's Perceived Reasons for Their Excessive Postpartum Weight Retention: A Qualitative Interview Study	PLOS ONE			English	Article							LOW-INCOME OVERWEIGHT; PREGNANT-WOMEN; RISK-FACTORS; GAIN; DEPRESSION; OUTCOMES; ANXIETY; OBESITY; STRESS; IMPACT	Introduction Obesity in Sweden has doubled to 14% over the last 20 years. New strategies for treatment and prevention are needed. Excessive gestational weight gain has been found to contribute substantially to obesity, and there is a consistent association between postpartum weight retention and obesity later in life. We aimed to explore what factors women perceive as reasons for having substantial postpartum weight retention, to identify areas for new and improved interventions. Methods Qualitative interview study (semi-structured) using an emergent design. Fifteen women, with a postpartum weight retention >= 10 kg, were interviewed by a trained cognitive therapist. Eight women had pre-pregnancy BMI below 30 kg/m(2). Interviews were transcribed verbatim and data analysed using inductive manifest content analysis. Salient text passages were extracted, shortened, coded and clustered into categories. Results Participants reported no knowledge of current gestational weight gain recommendations or of risks for adverse pregnancy outcomes with excessive weight gain or postpartum weigh retention. Excessive eating emerged as a common strategy to provide relief of psychological, emotional and physical discomfort, such as depression and morning sickness. Women perceived medical staff as being unconcerned about weight, and postpartum weight loss support was scarce or absent. Some women reported eating more due to a belief that breastfeeding would automatically lead to weight loss. Conclusion There is a need to raise awareness about risks with unhealthy gestational weight development and postpartum weight retention in women of childbearing age. The common strategy to cope with psychological, emotional or physical discomfort by eating is an important factor to target with intervention. The postpartum year is a neglected period where additional follow-up on weight and weight loss support is strongly indicated.	[Christenson, Anne; Reynisdottir, Signy] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Obes Ctr, Stockholm, Sweden; [Johansson, Eva] Karolinska Inst, Dept Publ Hlth Sci IHCAR, Stockholm, Sweden; [Torgerson, Jarl] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hemmingsson, Erik] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Christenson, A (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Obes Ctr, Stockholm, Sweden.	anne.christenson@ki.se		Hemmingsson, Erik/0000-0001-7335-3796				Anderson CK, 2015, J NUTR EDUC BEHAV, V47, P404, DOI 10.1016/j.jneb.2015.05.011; Atkinson L, 2016, BRIT J HLTH PSYCHOL; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bogaerts A, 2013, OBSTET GYNECOL, V122, P999, DOI 10.1097/AOG.0b013e3182a7f63e; Bogaerts AFL, 2013, OBESITY, V21, P1942, DOI 10.1002/oby.20352; Braden A, 2016, J BEHAV MED; Brownfoot FC, 2016, BJOG-INT J OBSTET GY, V123, P254, DOI 10.1111/1471-0528.13735; Chang MW, 2015, MATERN CHILD HLTH J, V19, P1060, DOI 10.1007/s10995-014-1605-x; Cnattingius S, 2016, LANCET, V387, P558, DOI 10.1016/S0140-6736(15)00990-3; Duthie EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-231; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Falah-Hassani K, 2016, J AFFECT DISORDERS, V198, P142, DOI 10.1016/j.jad.2016.03.010; Finch LE, 2015, APPETITE, V95, P239, DOI 10.1016/j.appet.2015.07.017; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harris HE, 1999, J PSYCHOSOM OBST GYN, V20, P65, DOI 10.3109/01674829909075579; Hartley E, 2015, WOMEN BIRTH, V28, pE99, DOI 10.1016/j.wombi.2015.04.004; Institute of Medicine Committee on Nutritional Status During Pregnancy and Lactation, 1990, NUTR PREGN 1; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Krakowiak P, 2015, MATERN CHILD HLTH J, V19, P1925, DOI 10.1007/s10995-015-1723-0; Liamputtong P, 2009, HEALTH PROMOT J AUST, V20, P133, DOI 10.1071/HE09133; Lindholm ES, 2010, ACTA OBSTET GYN SCAN, V89, P840, DOI 10.3109/00016340903428370; Linne Y, 2003, ACTA OBSTET GYN SCAN, V82, P318, DOI 10.1034/j.1600-0412.2003.00150.x; Lopez-Olmedo N, 2016, MATERN CHILD HLTH J, V20, P270, DOI 10.1007/s10995-015-1826-7; Mannan M, 2013, NUTR REV, V71, P343, DOI 10.1111/nure.12034; Neville CE, 2014, INT J OBESITY, V38, P577, DOI 10.1038/ijo.2013.132; Ohlendorf JM, 2015, J ADV NURS, V71, P1833, DOI 10.1111/jan.12640; Olander EK, 2016, WOMEN BIRTH, V29, pE67, DOI 10.1016/j.wombi.2015.11.005; Olander EK, 2011, SEX REPROD HEALTHC, V2, P43, DOI 10.1016/j.srhc.2010.10.004; Ostbye T, 2010, PREV MED, V51, P368, DOI 10.1016/j.ypmed.2010.07.017; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Phillips J, 2014, BRIT J HEALTH PSYCH, V19, P751, DOI 10.1111/bjhp.12074; Rasmussen KM, 2009, CURR OPIN OBSTET GYN, V21, P521, DOI 10.1097/GCO.0b013e328332d24e; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Redding JQRCA, 2008, ENCY EPIDEMIOLOGY; Samura Tirah, 2016, Glob Adv Health Med, V5, P87, DOI 10.7453/gahmj.2015.094; SBU, 2002, OB PROBL INT; SCB, 2015, STAT; Skouteris H, 2016, BRIT J HEALTH PSYCH, V21, P31, DOI 10.1111/bjhp.12154; Smith DM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-157; Staneva AA, 2015, MIDWIFERY, V31, P563, DOI 10.1016/j.midw.2015.03.015; Sui Zhixian, 2013, Australas Med J, V6, P565, DOI 10.4066/AMJ.2013.1881; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; van Strien T, 2016, APPETITE, V100, P216, DOI 10.1016/j.appet.2016.02.034; Vesco KK, 2016, OBESITY, V24, P2042, DOI 10.1002/oby.21597; Villamor E, 2016, OBESITY SILVER SPRI; Waring ME, 2014, BIRTH-ISS PERINAT C, V41, P353, DOI 10.1111/birt.12131; Wennberg AL, 2014, SEX REPROD HEALTHC, V5, P107, DOI 10.1016/j.srhc.2014.07.001; Xiao RS, 2014, J PSYCHOSOM RES, V77, P351, DOI 10.1016/j.jpsychores.2014.09.016	50	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167731	10.1371/journal.pone.0167731	http://dx.doi.org/10.1371/journal.pone.0167731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936110	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100166
J	Consoli, P; Esposito, V; Battaglia, P; Altobelli, C; Perzia, P; Romeo, T; Canese, S; Andaloro, F				Consoli, Pierpaolo; Esposito, Valentina; Battaglia, Pietro; Altobelli, Chiara; Perzia, Patrizia; Romeo, Teresa; Canese, Simonepietro; Andaloro, Franco			Fish Distribution and Habitat Complexity on Banks of the Strait of Sicily (Central Mediterranean Sea) from Remotely-Operated Vehicle (ROV) Explorations	PLOS ONE			English	Article							SPECIES-DIVERSITY; VISUAL CENSUSES; NORTH-ATLANTIC; PREY REFUGES; DYNAMICS; CORAL; ASSEMBLAGES; CIRCULATION; PREDATION; ABUNDANCE	The Strait of Sicily was recognized internationally as an "Ecologically or Biologically Significant Area" by the Contracting Parties of the Convention on Biological Diversity in 2014. However, basic aspects of its fish diversity are still unknown and most of the information comes from traditional trawl surveys. This paper provides the first detailed description, using a Remotely Operated Vehicle (ROV), of the composition and depth distribution of the demersal fish assemblages found on banks of the Strait of Sicily and the related habitat complexity from 35 to 240 m depth. A total of 24 families and 52 fish species were recorded and depth was consistently associated with a significant proportion of the variation of the fish assemblage. The highest species richness was observed at the shallowest depth layer (0-50 m) and significantly decreased, remaining almost constant, in deeper layers. Similarly the highest abundance was recorded at 0-50 m, where C. julis represented the most abundant species, and decreased progressively throughout the whole depth gradient. Although the factor habitat complexity explained only a small proportion of the fish assemblage variation, significant differences among different degrees of habitat complexity were observed, together with a general positive trend for species richness and abundance with increasing habitat complexity. The ROV also allowed us to observe some rare or poorly known fish species such as Scorpaenodes arenai, Hyporthodus haifensis, Myliobatis aquila, Gadella maraldi, Epinephelus caninus and Lappanella fasciata. These findings show that banks serve as reservoirs for fish abundance and biodiversity and that immediate environmental conservation and management actions represent a priority not only for Italy but also for other countries which share the same area.	[Consoli, Pierpaolo; Esposito, Valentina; Battaglia, Pietro; Romeo, Teresa] ISPRA, Lab Ittiol & Eol Marina, Milazzo, Italy; [Altobelli, Chiara; Perzia, Patrizia; Andaloro, Franco] ISPRA, STS Palermo, Dipartimento Uso Sostenibile Risorse 4, Palermo, Italy; [Canese, Simonepietro] ISPRA, Dipartimento Tutela Habitat & Biodiversita Marina, Rome, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; Italian Institute for Environmental Protection & Research (ISPRA)	Consoli, P (corresponding author), ISPRA, Lab Ittiol & Eol Marina, Milazzo, Italy.	pierpaolo.consoli@isprambiente.it	Consoli, Pierpaolo/C-9265-2017; Esposito, Valentina/AAE-3561-2019; Battaglia, Pietro/X-2180-2019; Canese, Simonepietro/AAA-5499-2019; Romeo, Teresa/AAA-1711-2020; Consoli, Pierpaolo/AAD-5604-2019; Perzia, Patrizia/GSI-4575-2022	Consoli, Pierpaolo/0000-0001-8135-3876; Esposito, Valentina/0000-0001-7595-8369; Battaglia, Pietro/0000-0003-1822-7775; Canese, Simonepietro/0000-0001-6049-4506; Consoli, Pierpaolo/0000-0001-8135-3876; Perzia, Patrizia/0000-0001-6143-349X	D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia	D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia	This project was financed by D.R.A. Assessorato Territorio Ambiente Regione Siciliana-Asse 3 Linea di intervento 3.2.1.2 of POR FESR Sicilia 2007-2013 aimed to assess the marine biodiversity in Sicily. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla Ameer, 2008, MARITIME TRAFFIC EFF; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Andaloro F, 2013, HELGOLAND MAR RES, V67, P241, DOI 10.1007/s10152-012-0319-y; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Astraldi M, 2001, J PHYS OCEANOGR, V31, P3457, DOI 10.1175/1520-0485(2001)031<3457:DWDATS>2.0.CO;2; Barbagallo Rosi, 2015, Biodiversity Journal, V6, P115; Battaglia P, 2015, ITAL J ZOOL, V82, P454, DOI 10.1080/11250003.2015.1028485; BELL JD, 1983, J APPL ECOL, V20, P357, DOI 10.2307/2403513; Beranger K, 2004, DEEP-SEA RES PT II, V51, P411, DOI 10.1016/j.dsr2.2003.08.004; Bo M, 2014, MAR ECOL-EVOL PERSP, V35, P332, DOI 10.1111/maec.12089; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Canese S, 2015, P 1 MED S CONS DARK; Civile D, 2016, GEOL MAG, V153, P160, DOI 10.1017/S0016756815000485; Civile D, 2015, GLOBAL PLANET CHANGE, V125, P36, DOI 10.1016/j.gloplacha.2014.12.003; Colantoni P, 1985, GIORNALE GEOLOGIA, V47, P2; Colloca F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119590; Consoli P, 2015, J MAR BIOL ASSOC UK, V95, P17, DOI 10.1017/S0025315414000940; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Deidun A, 2015, ITAL J ZOOL, V82, P271, DOI 10.1080/11250003.2014.986544; Falzone G, 2009, GEOITALIA, V29; Fiorentino F, 2004, MEDSUDMED TECHNICAL, V2, P50; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Frontier S, 1986, EVALUATION OPTIMISAT; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garofalo G, 2007, HYDROBIOLOGIA, V580, P117, DOI 10.1007/s10750-006-0460-1; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; Garofalo G., 2004, GIS SPATIAL ANAL FIS, V2, P101; Garofalo G, 2008, GCPRER010ITAMSMTD19; GIBSON RN, 1972, J ANIM ECOL, V41, P189, DOI 10.2307/3512; Gorley C.K., 2006, GETTING STARTED PRIM; GOSLINE WA, 1965, ECOLOGY, V46, P823, DOI 10.2307/1934015; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Gristina M, 2006, FISH RES, V81, P60, DOI 10.1016/j.fishres.2006.05.010; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Holtzhausen JA, 2016, MYLIOBATIS AQUILA IU; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Lodolo E, 2015, J ARCHAEOL SCI-REP, V3, P398, DOI 10.1016/j.jasrep.2015.07.003; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACPHERSON E, 1994, MAR ECOL PROG SER, V114, P211, DOI 10.3354/meps114211; Magnussen E, 2002, MAR ECOL PROG SER, V238, P211, DOI 10.3354/meps238211; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MERRETT NR, 1991, J MAR BIOL ASSOC UK, V71, P329, DOI 10.1017/S0025315400051638; Misic C, 2012, DEEP-SEA RES PT I, V67, P1, DOI 10.1016/j.dsr.2012.04.012; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Morato T, 2013, BIOGEOSCIENCES, V10, P3039, DOI 10.5194/bg-10-3039-2013; Ohman MC, 1998, ENVIRON BIOL FISH, V53, P19, DOI 10.1023/A:1007445226928; Omrani H, 2016, PROG OCEANOGR, V140, P54, DOI 10.1016/j.pocean.2015.10.007; Oral N, 2008, MARITIME TRAFFIC EFF; Porteiro FM, 2013, DEEP-SEA RES PT II, V98, P114, DOI 10.1016/j.dsr2.2013.09.015; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Ross SW, 2015, DEEP-SEA RES PT I, V103, P137, DOI 10.1016/j.dsr.2015.06.004; Ross SW, 2009, MAR ECOL-EVOL PERSP, V30, P74, DOI 10.1111/j.1439-0485.2008.00260.x; Rovere M., 2015, ATLAS MEDITERRANEAN; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; Schultz AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096798; StatSoft inc, 2010, STAT WIND VERS 10 CO; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027	62	30	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167809	10.1371/journal.pone.0167809	http://dx.doi.org/10.1371/journal.pone.0167809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936221	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100201
J	Ho, GJ; Liew, SM; Ng, CJ; Shunmugam, RH; Glasziou, P				Ho, Gah Juan; Liew, Su May; Ng, Chirk Jenn; Shunmugam, Ranita Hisham; Glasziou, Paul			Development of a Search Strategy for an Evidence Based Retrieval Service	PLOS ONE			English	Article							BIBLIOGRAPHIC DATABASES; INFORMATION; QUALITY	Background Physicians are often encouraged to locate answers for their clinical queries via an evidence-based literature search approach. The methods used are often not clearly specified. Inappropriate search strategies, time constraint and contradictory information complicate evidence retrieval. Aims Our study aimed to develop a search strategy to answer clinical queries among physicians in a primary care setting Methods Six clinical questions of different medical conditions seen in primary care were formulated. A series of experimental searches to answer each question was conducted on 3 commonly advocated medical databases. We compared search results from a PICO (patients, intervention, comparison, outcome) framework for questions using different combinations of PICO elements. We also compared outcomes from doing searches using text words, Medical Subject Headings (MeSH), or a combination of both. All searches were documented using screenshots and saved search strategies. Results Answers to all 6 questions using the PICO framework were found. A higher number of systematic reviews were obtained using a 2 PICO element search compared to a 4 element search. A more optimal choice of search is a combination of both text words and MeSH terms. Despite searching using the Systematic Review filter, many non-systematic reviews or narrative reviews were found in PubMed. There was poor overlap between outcomes of searches using different databases. The duration of search and screening for the 6 questions ranged from 1 to 4 hours. Conclusion This strategy has been shown to be feasible and can provide evidence to doctors' clinical questions. It has the potential to be incorporated into an interventional study to determine the impact of an online evidence retrieval system.	[Ho, Gah Juan; Liew, Su May; Ng, Chirk Jenn; Shunmugam, Ranita Hisham] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	Universiti Malaya; Bond University	Liew, SM (corresponding author), Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia.	su_mayliew@um.edu.my	Glasziou, Paul/A-7832-2008; Hisham Shunmugam, Ranita/F-5073-2011; LIEW, Su May/B-8852-2010; NG, CHIRK JENN/C-1344-2010	Glasziou, Paul/0000-0001-7564-073X; Hisham Shunmugam, Ranita/0000-0002-3356-2291; LIEW, Su May/0000-0003-2865-7955; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya Research Grant (UMRG) [RP037A-15HTM]	University of Malaya Research Grant (UMRG)	This work was supported by the University of Malaya Research Grant (UMRG) under the Grant Number RP037A-15HTM, which was received by SML. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoritsas T, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0125-9; Agoritsas T, 2012, J MED INTERNET RES, V14, P389, DOI 10.2196/jmir.2021; Alper BS, 2001, J FAM PRACTICE, V50, P960; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Booth A, 2006, HEALTH INFO LIBR J, V23, P229, DOI 10.1111/j.1471-1842.2006.00663.x; Brettle AJ, 2001, B MED LIBR ASSOC, V89, P353; Cheng GYT, 2004, J MED LIBR ASSOC, V92, P445; Clark E, 2006, INT J QUAL HEALTH C, V18, P165, DOI 10.1093/intqhc/mzl007; Del Mar CB, 2001, MED J AUSTRALIA, V175, P134, DOI 10.5694/j.1326-5377.2001.tb143060.x; Gehanno JF, 1998, OCCUP ENVIRON MED, V55, P562, DOI 10.1136/oem.55.8.562; Glasziou P, 2008, EVIDENCE BASED PRACT, P24; Grandage KK, 2002, J MED LIBR ASSOC, V90, P298; Greenhalgh T, 2002, BRIT MED J, V324, P524, DOI 10.1136/bmj.324.7336.524; Huang Xiaoli, 2006, AMIA Annu Symp Proc, P359; Jankowski TA, 2008, MED LIB ASS ESSENTIA, P131; Lefebvre C, 2011, COCHRANE COLLABORATI; McGowan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003785; Montori VM, 2002, EVID BASED MED, V7, P104; Perrier L, 2014, J AM MED INFORM ASSN, V21, P1118, DOI 10.1136/amiajnl-2014-002825; Prorok JC, 2012, J CLIN EPIDEMIOL, V65, P1289, DOI 10.1016/j.jclinepi.2012.05.003; Royle PL, 2005, DIABETIC MED, V22, P1386, DOI 10.1111/j.1464-5491.2005.01645.x; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sanders S, 2005, BRIT MED J, V330, P1162, DOI 10.1136/bmj.330.7501.1162; Savoie I, 2003, INT J TECHNOL ASSESS, V19, P168, DOI 10.1017/S0266462303000163; Schwartz K, 2003, FAM MED, V35, P251; Slawson DC, 1997, BRIT MED J, V314, P947, DOI 10.1136/bmj.314.7085.947; Straus S.E., 2004, BMJ-BRIT MED J, V329, P1029, DOI DOI 10.1136/BMJ.329.7473; Straus SE, 2005, EVIDENCE BASED MED P; Tsafnat G, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-74; Walton J, PRIORY MED J; Wilczynski NL, 2013, J AM MED INFORM ASSN, V20, P363, DOI 10.1136/amiajnl-2012-001075	31	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167170	10.1371/journal.pone.0167170	http://dx.doi.org/10.1371/journal.pone.0167170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935993	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100069
J	Hu, J; Zhu, MM; Liu, KH; Fan, H; Zhao, WF; Mao, Y; Zhang, YG				Hu, Jing; Zhu, Manman; Liu, Kehai; Fan, Hua; Zhao, Wenfang; Mao, Yuan; Zhang, Yaguang			A Biodegradable Polyethylenimine-Based Vector Modified by Trifunctional Peptide R18 for Enhancing Gene Transfection Efficiency In Vivo	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; DELIVERY; DNA; CHITOSAN; VITRO; PEI; NANOSPHERES; DERIVATIVES; PARTICLES; COMPLEXES	Lack of capacity to cross the nucleus membrane seems to be one of the main reasons for the lower transfection efficiency of gene vectors observed in vivo study than in vitro. To solve this problem, a new non-viral gene vector was designed. First, a degradable polyethylenimine (PEI) derivate was synthesized by crosslinking low-molecular-weight (LMW) PEI with N-octyl-N-quaternary chitosan (OTMCS), and then adopting a designed trifunctional peptide (RGDC-TAT-NLS) with good tumor targeting, cell uptake and nucleus transport capabilities to modify OTMCS-PEI. The new gene vector was termed as OTMCS-PEI-R18 and characterized in terms of its chemical structure and biophysical parameters. Gene transfection efficiency and nucleus transport mechanism of this vector were also evaluated. The polymer showed controlled degradation and remarkable buffer capabilities with the particle size around 100-300 nm and the zeta potential ranged from 5 mV to 40 mV. Agraose gel electrophoresis showed that OTMCS-PEI-R18 could effectively condensed plasmid DNA at a ratio of 1.0. Besides, the polymer was stable in the presence of sodium heparin and could resist digestion by DNase I at a concentration of 63U DNase I/DNA. OTMCS-PEI-R18 also showed much lower cytotoxicity and better transfection rates compared to polymers OTMCS-PEI-R13, OTMCS-PEI and PEI 25 KDa in vitro and in vivo. Furthermore, OTMCS-PEI-R18/DNA complexes could accumulate in the nucleus well soon and not rely on mitosis absolutely due to the newly incorporated ligand peptide NLS with the specific nuclear delivery pathway indicating that the gene delivery system OTMCS-PEI-R18 could reinforce gene transfection efficiency in vivo.	[Hu, Jing; Zhu, Manman; Liu, Kehai; Zhao, Wenfang; Mao, Yuan; Zhang, Yaguang] Shanghai Ocean Univ, Dept Biopharmaceut, Coll Food Sci & Technol, Shanghai, Peoples R China; [Fan, Hua] Charite Univ Med Berlin, Inst Lab Med, Campus Virchow Klinikum, Berlin, Germany	Shanghai Ocean University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Liu, KH (corresponding author), Shanghai Ocean Univ, Dept Biopharmaceut, Coll Food Sci & Technol, Shanghai, Peoples R China.	khliu@shou.edu.cn			National Natural Science Foundation of China [81001024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, Grant number: 81001024, http://www.letpub.com.cn/?page=grant&name=&person=%E5%88%98%E5% 85%8B%E6%B5%B7&no=&company=&addcomment_s1-0&addcomment_ s2= 0&addcomment_s3_0&money1=&money2=&startTime=2011&endTime=2015&subcategory= &searchsubmit=true&submit.x=69&submit.y= 22&submit=advSearch#fundlisttable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation, China (81001024).	And HR, 1998, ANAL CHEM, V70, P131; Arocena M, 2006, CELL BIOL INT, V30, P1007, DOI 10.1016/j.cellbi.2006.07.008; Aufort M, 2009, EUR J MED CHEM, V44, P3394, DOI 10.1016/j.ejmech.2009.02.022; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Dailey LA, 2004, J CONTROL RELEASE, V100, P425, DOI 10.1016/j.jconrel.2004.08.031; Deng R, 2009, J CONTROL RELEASE, V140, P40, DOI 10.1016/j.jconrel.2009.07.009; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Eguchi A, 2005, J CONTROL RELEASE, V104, P507, DOI 10.1016/j.jconrel.2005.02.019; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Guo ST, 2011, BIOMATERIALS, V32, P4283, DOI 10.1016/j.biomaterials.2011.02.034; Hao JG, 2009, ARCH PHARM RES, V32, P1045, DOI 10.1007/s12272-009-1710-3; Hyndman L, 2004, J CONTROL RELEASE, V99, P435, DOI 10.1016/j.jconrel.2004.07.023; Ito T, 2010, BIOMATERIALS, V31, P2912, DOI 10.1016/j.biomaterials.2009.12.032; Javeed A, 2009, EUR J PHARM SCI, V38, P283, DOI 10.1016/j.ejps.2009.08.009; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021; Lee DE, 2010, APPL RADIAT ISOTOPES, V68, P1896, DOI 10.1016/j.apradiso.2010.04.029; Levchenko TS, 2003, METHOD ENZYMOL, V372, P339; Lin EH, 2011, BIOMATERIALS, V32, P1978, DOI 10.1016/j.biomaterials.2010.11.026; Liu CC, 2012, INT J NANOMED, V7, P5339, DOI 10.2147/IJN.S36179; Liu HM, 2014, BIOMATERIALS, V35, P5407, DOI 10.1016/j.biomaterials.2014.03.040; Lv H, 2014, INT J NANOMED, V9, P1311, DOI 10.2147/IJN.S59726; Ma K, 2009, BIOMATERIALS, V30, P6109, DOI 10.1016/j.biomaterials.2009.07.036; Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/S0939-6411(03)00155-3; Martin ME, 2007, AAPS J, V9, pE18, DOI 10.1208/aapsj0901003; Meng Y, 2016, BIOMATERIALS, V100, P134, DOI 10.1016/j.biomaterials.2016.05.033; Ping Y, 2013, BIOMATERIALS, V34, P6482, DOI 10.1016/j.biomaterials.2013.03.071; Reschel T, 2002, J CONTROL RELEASE, V81, P201, DOI 10.1016/S0168-3659(02)00045-7; Solak Y, 2010, MED HYPOTHESES, V74, P314, DOI 10.1016/j.mehy.2009.08.041; Talsma SS, 2006, J CONTROL RELEASE, V112, P271, DOI 10.1016/j.jconrel.2006.02.008; Trentin D, 2005, J CONTROL RELEASE, V102, P263, DOI 10.1016/j.jconrel.2004.09.029; Yang J., 2010, EURASIP J J IMAGE VI, V2010, P2, DOI DOI 10.1371/J0URNAL.PGEN.1000955; You J, 2013, BIOMATERIALS, V34, P4510, DOI 10.1016/j.biomaterials.2013.02.069; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91	35	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166673	10.1371/journal.pone.0166673	http://dx.doi.org/10.1371/journal.pone.0166673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935984	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100040
J	Jeon, MJ; Song, DE; Jung, CK; Kim, WG; Kwon, H; Lee, YM; Sung, TY; Yoon, JH; Chung, KW; Hong, SJ; Baek, JH; Lee, JH; Kim, TY; Shong, YK; Kim, WB				Jeon, Min Ji; Song, Dong Eun; Jung, Chan Kwon; Kim, Won Gu; Kwon, Hyemi; Lee, Yu-Mi; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon; Baek, Jung Hwan; Lee, Jeong Hyun; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae			Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; UNDETERMINED SIGNIFICANCE; MALIGNANCY; MANAGEMENT; ASPIRATION; LESIONS; RISK	Background The follicular variant of papillary thyroid cancer (FVPTC), especially the encapsulated non-invasive subtype, is a controversial entity. Recent study suggested using 'non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)' for these indolent carcinomas. We evaluated the impact of reclassification from non-invasive encapsulated FVPTCs (EFVPTCs) to NIFTPs in the diagnosis of thyroid nodules with architectural atypia. Methods We reviewed 1301 thyroid nodules with architectural atypia in core needle biopsy (CNB) specimens obtained from March 2012 to February 2013. Nodules were classified into atypia of undetermined significance with architectural atypia (AUS-A, 984, 76%) or follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN, 317, 24%). Among them, diagnostic surgery was performed in 384 nodules (30%). Results In total, 160 nodules (42%) presented final malignant diagnoses including 39 non-invasive encapsulated FVPTCs (10%). The malignancy rate was estimated to be 7-35% in AUS-A nodules and 28-49% in FN/SFN nodules. After reclassification, the malignancy rate was much decreased and estimated to be 5-24% in AUS-A nodules, and 23-39% in FN/SFN nodules. Thyroid nodules with final malignant diagnoses were significantly more likely to have a FN/SFN CNB diagnosis, malignant US features and concomitant nuclear atypia in CNB specimens. However, these factors could not differentiate NIFTPs from other malignancies. Conclusions After reclassification of non-invasive EFVPTCs to NIFTPs, the malignancy rate of thyroid nodules with architectural atypia in CNB specimens was decreased. However, there were no preoperative factors differentiating other malignancies from NIFTPs. The presence of malignant US features or concomitant nuclear atypia might help clinicians deciding diagnostic surgery but, these features also might indicate NIFTPs.	[Jeon, Min Ji; Kim, Won Gu; Kwon, Hyemi; Kim, Tae Yong; Shong, Young Kee; Kim, Won Bae] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Jung, Chan Kwon] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea; [Lee, Yu-Mi; Sung, Tae-Yon; Yoon, Jong Ho; Chung, Ki-Wook; Hong, Suck Joon] Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea; [Baek, Jung Hwan; Lee, Jeong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Baek, Jung Hwan; Lee, Jeong Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Catholic University of Korea; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, DE (corresponding author), Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea.	hipuha@hanmail.net	Kim, Tae Yong/C-1272-2009; Jung, Chan Kwon/C-7578-2014	Kim, Tae Yong/0000-0003-4982-4441; Jung, Chan Kwon/0000-0001-6843-3708; Shong, Young Kee/0000-0002-7911-9471	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2016-633]	Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This study was supported by a grant (No. 2016-633) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SH, 2015, THYROID, V25, P897, DOI 10.1089/thy.2014.0606; Choi YJ, 2014, THYROID, V24, P494, DOI 10.1089/thy.2012.0635; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Faquin WC, 2015, CANC CYTOPATHOLOGY; Ha EJ, 2015, KOREAN J RADIOL, V16, P749, DOI 10.3348/kjr.2015.16.4.749; Ho AS, 2014, THYROID, V24, P832, DOI 10.1089/thy.2013.0317; Jang EK, 2015, CLIN ENDOCRINOL, V83, P968, DOI 10.1111/cen.12674; Jung CK, 2015, J PATHOL TRANSL MED, V49, P288, DOI 10.4132/jptm.2015.06.04; Kamaya A, 2015, J ULTRAS MED, V34, P767, DOI 10.7863/ultra.34.5.767; Kwak JY, 2013, ENDOCRINOL METAB, V28, P81, DOI 10.3803/EnM.2013.28.2.81; Macias CA, 2015, ANN SURG ONCOL, V22, P1527, DOI 10.1245/s10434-014-4190-8; Maletta F, 2016, HUMAN PATHOLOGY; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Nikiforov YE, 2016, JAMA ONCOLOGY; Strickland KC, 2015, THYROID, V25, P987, DOI 10.1089/thy.2014.0612; Suh CH, 2016, THYROID, V26, P395, DOI 10.1089/thy.2015.0404; Thompson LD, 2016, MODERN PATHOLOGY OFF; Yoon RG, 2014, THYROID, V24, P1612, DOI 10.1089/thy.2014.0140	18	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167756	10.1371/journal.pone.0167756	http://dx.doi.org/10.1371/journal.pone.0167756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936121	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100175
J	Kalsi, G; Euesden, J; Coleman, JRI; Ducci, F; Aliev, F; Newhouse, SJ; Liu, XH; Ma, XH; Wang, YC; Collier, DA; Asherson, P; Li, T; Breen, G				Kalsi, Gursharan; Euesden, Jack; Coleman, Jonathan R. I.; Ducci, Francesca; Aliev, Fazil; Newhouse, Stephen J.; Liu, Xiehe; Ma, Xiaohong; Wang, Yingcheng; Collier, David A.; Asherson, Philip; Li, Tao; Breen, Gerome			Genome-Wide Association of Heroin Dependence in Han Chinese	PLOS ONE			English	Article							OPIOID RECEPTOR GENE; DENDRITIC SPINES; ACTIN CYTOSKELETON; RHO-GTPASES; STRUCTURAL PLASTICITY; DRUG-ADDICTION; ABUSE; POLYMORPHISMS; RISK; VARIANTS	Drug addiction is a costly and recurring healthcare problem, necessitating a need to understand risk factors and mechanisms of addiction, and to identify new biomarkers. To date, genome-wide association studies (GWAS) for heroin addiction have been limited; moreover they have been restricted to examining samples of European and African-American origin due to difficulty of recruiting samples from other populations. This is the first study to test a Han Chinese population; we performed a GWAS on a homogeneous sample of 370 Han Chinese subjects diagnosed with heroin dependence using the DSM-IV criteria and 134 ethnically matched controls. Analysis using the diagnostic criteria of heroin dependence yielded suggestive evidence for association between variants in the genes CCDC42 (coiled coil domain 42; p = 2.8x10(-7)) and BRSK2 (BR serine/threonine 2; p = 4.110(-6)). In addition, we found evidence for risk variants within the ARHGEF10 (Rho guanine nucleotide exchange factor 10) gene on chromosome 8 and variants in a region on chromosome 20q13, which is gene-poor but has a concentration of mRNAs and predicted miRNAs. Gene-based association analysis identified genome-wide significant association between variants in CCDC42 and heroin addiction. Additionally, when we investigated shared risk variants between heroin addiction and risk of other addiction-related and psychiatric phenotypes using polygenic risk scores, we found a suggestive relationship with variants predicting tobacco addiction, and a significant relationship with variants predicting schizophrenia. Our genome wide association study of heroin dependence provides data in a novel sample, with functionally plausible results and evidence of genetic data of value to the field.	[Kalsi, Gursharan; Coleman, Jonathan R. I.; Ducci, Francesca; Newhouse, Stephen J.; Collier, David A.; Asherson, Philip; Breen, Gerome] Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Euesden, Jack] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Aliev, Fazil] Karabuk Univ, Dept Actuarial Sci & Risk Management, Fac Business, Karabuk, Turkey; [Newhouse, Stephen J.; Liu, Xiehe; Ma, Xiaohong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Liu, Xiehe; Ma, Xiaohong; Wang, Yingcheng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Psychiat Lab, Chengdu, Sichuan, Peoples R China; [Collier, David A.] Lilly UK, Windlesham, Surrey, England; [Li, Tao] Sichuan Univ, Sch Med, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China	University of London; King's College London; University of Bristol; Karabuk University; Sichuan University; Sichuan University; Sichuan University	Breen, G (corresponding author), Kings Coll London, MRC SGDP Ctr, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	gerome.breen@kcl.ac.uk	Breen, Gerome D/A-5540-2010; Aliev, Fazil/D-7172-2013; Coleman, Jonathan/T-9412-2019; Breen, Gerome/Y-2706-2019; Collier, David/D-1649-2011	Breen, Gerome D/0000-0003-2053-1792; Aliev, Fazil/0000-0001-8357-4699; Coleman, Jonathan/0000-0002-6759-0944; Breen, Gerome/0000-0003-2053-1792; Li, Tao/0000-0003-3831-901X; Ma, Xiaohong/0000-0003-2627-9946; Asherson, Philip/0000-0003-2667-2254; Collier, David/0000-0003-4087-1559; Kalsi, Gursharan/0000-0002-5156-7176	European Union [302040]; Lilly UK; MRC [MC_UU_12013/5] Funding Source: UKRI; Medical Research Council [1242800, MC_UU_12013/5] Funding Source: researchfish	European Union(European Commission); Lilly UK(Eli Lilly); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under the REA grant agreement no 302040. Lilly UK, provided support in the form of salaries for authors DAC and GB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baas S, 2011, DEVELOPMENT, V138, P553, DOI 10.1242/dev.055376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Coleman JR, 2015, BRIEF FUNCT GENOMICS; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ekenstedt KJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004635; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Euesden J., 2014, BIOINFORMATICS; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gao F, 2011, BIOCHEM BIOPH RES CO, V412, P450, DOI 10.1016/j.bbrc.2011.07.114; Gelernter J, 2014, BIOL PSYCHIAT, V76, P66, DOI 10.1016/j.biopsych.2013.08.034; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hou QF, 2009, NEUROSCI LETT, V464, P127, DOI 10.1016/j.neulet.2009.08.004; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Levran O, 2012, HUM GENET, V131, P823, DOI 10.1007/s00439-012-1172-4; Li CY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040002; Li T, 2000, AM J MED GENET, V96, P616, DOI 10.1002/1096-8628(20001009)96:5<616::AID-AJMG6>3.0.CO;2-7; Li T, 2000, ADDICT BIOL, V5, P181, DOI 10.1080/13556210050003775; Li T, 2002, AM J MED GENET, V114, P329, DOI 10.1002/ajmg.10200; Li T, 1997, MOL PSYCHIATR, V2, P413, DOI 10.1038/sj.mp.4000310; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lilley BN, 2014, P NATL ACAD SCI USA, V111, P1138, DOI 10.1073/pnas.1321990111; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loh EW, 2007, AM J MED GENET B, V144B, P439, DOI 10.1002/ajmg.b.30429; Lotsch J, 2005, TRENDS MOL MED, V11, P82, DOI 10.1016/j.molmed.2004.12.006; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Nelson EC, 2015, MOL PSYCHIAT; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nielsen DA, 2008, MOL PSYCHIATR, V13, P417, DOI 10.1038/sj.mp.4002147; Nielsen DA, 2010, PSYCHIAT GENET, V20, P207, DOI 10.1097/YPG.0b013e32833a2106; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rothenfluh A, 2013, CURR OPIN NEUROBIOL, V23, P507, DOI 10.1016/j.conb.2013.01.027; Schwantes-An TH, 2016, BEHAV GENET, V46, P151, DOI 10.1007/s10519-015-9737-3; Shao CH, 2006, PSYCHOPHARMACOLOGY, V186, P185, DOI 10.1007/s00213-006-0375-6; Shen HW, 2011, P NATL ACAD SCI USA, V108, P19407, DOI 10.1073/pnas.1112052108; Shi JX, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9026; SILMAN AJ, 1990, LANCET, V335, P1078; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Szeto CYK, 2001, NEUROREPORT, V12, P1103, DOI 10.1097/00001756-200105080-00011; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Vink JM, 2014, ADDICTION, V109, P1141, DOI 10.1111/add.12491; Wang TY, 2013, PROG NEURO-PSYCHOPH, V43, P134, DOI 10.1016/j.pnpbp.2012.12.011; Xu K, 2002, AM J MED GENET, V110, P45, DOI 10.1002/ajmg.10374; Xu K, 2004, ARCH GEN PSYCHIAT, V61, P597, DOI 10.1001/archpsyc.61.6.597; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x	74	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167388	10.1371/journal.pone.0167388	http://dx.doi.org/10.1371/journal.pone.0167388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936112	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100090
J	Li, HX; Liao, Y; Wang, YL; Liu, P; Sun, CF; Chen, YH; Tang, CS; Jin, HF; Du, JB				Li, Hongxia; Liao, Ying; Wang, Yuli; Liu, Ping; Sun, Chufan; Chen, Yonghong; Tang, Chaoshu; Jin, Hongfang; Du, Junbao			Baroreflex Sensitivity Predicts Short-Term Outcome of Postural Tachycardia Syndrome in Children	PLOS ONE			English	Article							CHRONIC ORTHOSTATIC INTOLERANCE; QUALITY-OF-LIFE; BLOOD-PRESSURE; SYNDROME POTS; NEUROCARDIOGENIC SYNCOPE; MIDODRINE HYDROCHLORIDE; HEART-RATE; ADOLESCENTS; MANAGEMENT; EXERCISE	Objective The study was designed to examine if baroreflex sensitivity (BRS) could predict the short-term outcome of postural tachycardia syndrome (POTS) in children. Methods Seventy-seven children subjects were included in the study. Among them, 45 children were in the POTS group and another 32 healthy children were in the control group. A ninety-day clinical follow-up was conducted and the symptom score before and after the follow-up was calculated for POTS patients by using POTS score system. Hemodynamics and continuous BRS monitoring were recorded by Finapres Medical System-FMS (FinometerPRO, FMS Company, Netherlands). According to the symptom score change during follow-up period, POTS patients were further divided into subgroup A (n = 24) with symptom score decreased by at least two points and subgroup B (n = 21) with symptom score decreased by less than two points. The predictive value of BRS in the short-term outcome of POTS in children was analyzed using receiver-operating characteristic (ROC) curve. Results BRS of POTS children was significantly higher than that of the healthy children (18.76 +/- 9.96 ms/mmHg vs 10 +/- 5.42 ms/mmHg, P<0.01). It was higher in subgroup B than that of subgroup A (24.7 +/- 9.9 ms/mmHg vs 13.5 +/- 6.6 ms/mmHg, P < 0.01). BRS was positively correlated with HR change in POTS Group (r = 0.304, P < 0.05). Area under curve (AUC) was 0.855 (95% of confidence interval 0.735-0.975), and BRS of 17.01 ms/mmHg as a cut-off value yielded the predictive sensitivity of 85.7% and specificity of 87.5%. Conclusions BRS is a useful index to predict the short-term outcome of POTS in children.	[Li, Hongxia; Liao, Ying; Wang, Yuli; Liu, Ping; Sun, Chufan; Chen, Yonghong; Jin, Hongfang; Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Tang, Chaoshu] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Du, Junbao] Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China	Peking University; Peking University	Du, JB (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China.; Du, JB (corresponding author), Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China.	junbaodu1@126.com		Jin, Hongfang/0000-0002-1606-8988	Major Basic Research Project of China [2012BA103B03]	Major Basic Research Project of China	Major Basic Research Project of China (2012BA103B03); JD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2007, POSTGRAD MED J, V83, P478, DOI 10.1136/pgmj.2006.055046; Bagai K, 2011, J CLIN SLEEP MED, V7, P204; Benrud-Larson LM, 2002, MAYO CLIN PROC, V77, P531, DOI 10.4065/77.6.531; Bogert LWJ, 2005, CLIN SCI, V109, P493, DOI 10.1042/CS20050094; Convertino VA, 1997, AVIAT SPACE ENVIR MD, V68, P838; Ector H, 1998, PACE, V21, P193, DOI 10.1111/j.1540-8159.1998.tb01087.x; Fu Q, 2010, J AM COLL CARDIOL, V55, P2858, DOI 10.1016/j.jacc.2010.02.043; Furlan R, 1998, CIRCULATION, V98, P2154, DOI 10.1161/01.CIR.98.20.2154; Galbreath MM, 2011, CLIN AUTON RES, V21, P73, DOI 10.1007/s10286-010-0091-5; Grubb BP, 2008, CIRCULATION, V117, P2814, DOI 10.1161/CIRCULATIONAHA.107.761643; Harrington F, 2000, J HYPERTENS, V18, P1629, DOI 10.1097/00004872-200018110-00014; Ianaka H, 2009, PEDIATR INT, V511, P69; Jarjour IT, 2013, SEMIN PEDIATR NEUROL, V20, P18, DOI 10.1016/j.spen.2013.01.001; Kanjwal Y, 2003, PACE, V26, P1747, DOI 10.1046/j.1460-9592.2003.t01-1-00262.x; Kimpinski K, 2012, MAYO CLIN PROC, V87, P746, DOI 10.1016/j.mayocp.2012.02.020; Langewouters GJ, 1998, J MED ENG TECHNOL, V22, P37, DOI 10.3109/03091909809009997; Liao Y, 2010, AM J CARDIOL, V106, P378, DOI 10.1016/j.amjcard.2010.03.034; Lin J, 2015, PLOS ONE, V26; Lin J, 2014, CARDIOL YOUNG, V24, P792, DOI 10.1017/S1047951114000316; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Ma W, 2003, SHANGHAI MED J S, V26, P73; Medow MS, 2005, CIRCULATION, V112, P2611, DOI 10.1161/CIRCULATIONAHA.104.526764; Mizumaki K, 2011, J ARRYTHM, V27, P289; Mustafa HI, 2012, CIRC-ARRHYTHMIA ELEC, V5, P173, DOI 10.1161/CIRCEP.111.965343; Numata T, 2000, JPN CIRC J, V64, P406, DOI 10.1253/jcj.64.406; Ojha A, 2011, J PEDIATR-US, V158, P119, DOI 10.1016/j.jpeds.2010.07.005; Parati G, 1996, Arq Bras Cardiol, V67, P131; Raamat R, 2009, MED ENG PHYS, V31, P522, DOI 10.1016/j.medengphy.2008.10.002; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2007, AM J MED SCI, V334, P57, DOI 10.1097/MAJ.0b013e318063c6c0; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Remmen JJ, 2006, CLIN SCI, V111, P153, DOI 10.1042/CS20050372; Robertson D, 1999, AM J MED SCI, V317, P75, DOI 10.1097/00000441-199902000-00001; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sidhu B, 2013, BMJ CASE REP, V16, P2013; Singer W, 2012, J PEDIATR-US, V160, P222, DOI 10.1016/j.jpeds.2011.08.054; Sousa A, 2012, CLIN AUTON RES, V22, P151, DOI 10.1007/s10286-011-0155-1; Stewart JM, 2000, PEDIATR RES, V48, P218, DOI 10.1203/00006450-200008000-00016; Stewart JM, 2004, J PEDIATR-US, V145, P725, DOI 10.1016/j.jpeds.2004.06.084; Stewart JM, 2004, AM J PHYSIOL-HEART C, V286, pH1216, DOI 10.1152/ajpheart.00738.2003; Wieling W, 2004, HEART, V90, P1094, DOI 10.1136/hrt.2003.022996; Winker R, 2005, HYPERTENSION, V45, P391, DOI 10.1161/01.HYP.0000156540.25707.af; Winker R, 2004, WIEN KLIN WOCHENSCHR, V116, P40; Yan JY, 2014, INT J PEDIAT, V41, P195, DOI DOI 10.3760/cma.j.issn.1673-4408.2014.02.024; Yang JY, 2013, J PEDIATR-US, V163, P1169, DOI 10.1016/j.jpeds.2013.04.039; Zhang FW, 2012, J AM COLL CARDIOL, V60, P315, DOI 10.1016/j.jacc.2012.04.025; Zhang Qing-you, 2005, Zhonghua Er Ke Za Zhi, V43, P165; Zhao J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007356; Zhu L, 2011, CHIN J APPL CLIN PED, V26, P684	49	16	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167525	10.1371/journal.pone.0167525	http://dx.doi.org/10.1371/journal.pone.0167525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936059	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100114
J	Luczkiewicz, P; Daszkiewicz, K; Chroscielewski, J; Witkowski, W; Winklewski, PJ				Luczkiewicz, Piotr; Daszkiewicz, Karol; Chroscielewski, Jacek; Witkowski, Wojciech; Winklewski, Pawel J.			The Influence of Articular Cartilage Thickness Reduction on Meniscus Biomechanics	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; MAGNETIC-RESONANCE IMAGES; CONTACT STRESS; KNEE OSTEOARTHRITIS; BONE; JOINT; SHAPE; GEOMETRY; PLANE	Objective Evaluation of the biomechanical interaction between meniscus and cartilage in medial compartment knee osteoarthritis. Methods The finite element method was used to simulate knee joint contact mechanics. Three knee models were created on the basis of knee geometry from the Open Knee project. We reduced the thickness of medial cartilages in the intact knee model by approximately 50% to obtain a medial knee osteoarthritis (OA) model. Two variants of medial knee OA model with congruent and incongruent contact surfaces were analysed to investigate the influence of congruency. A nonlinear static analysis for one compressive load case was performed. The focus of the study was the influence of cartilage degeneration on meniscal extrusion and the values of the contact forces and contact areas. Results In the model with incongruent contact surfaces, we observed maximal compressive stress on the tibial plateau. In this model, the value of medial meniscus external shift was 95.3% greater, while the contact area between the tibial cartilage and medial meniscus was 50% lower than in the congruent contact surfaces model. After the non-uniform reduction of cartilage thickness, the medial meniscus carried only 48.4% of load in the medial compartment in comparison to 71.2% in the healthy knee model. Conclusions We have shown that the change in articular cartilage geometry may significantly reduce the role of meniscus in load transmission and the contact area between the meniscus and cartilage. Additionally, medial knee OA may increase the risk of meniscal extrusion in the medial compartment of the knee joint.	[Luczkiewicz, Piotr] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland; [Daszkiewicz, Karol; Chroscielewski, Jacek; Witkowski, Wojciech] Gdansk Univ Technol, Fac Civil & Environm Engn, Dept Mech Mat, Gdansk, Poland; [Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Winklewski, Pawel J.] Pomeranian Univ Slupsk, Inst Hlth Sci, Slupsk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Luczkiewicz, P (corresponding author), Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland.	plucz@gumed.edu.pl	Chróścielewski, Jacek/N-5959-2018; Witkowski, Wojciech/E-3550-2017; Luczkiewicz, Piotr/AAC-2970-2020	Chróścielewski, Jacek/0000-0002-7648-2785; Witkowski, Wojciech/0000-0003-2832-7892; Luczkiewicz, Piotr/0000-0001-8988-1251; Daszkiewicz, Karol/0000-0002-0522-7752; Winklewski, Pawel/0000-0002-1671-2163	Faculty of Civil and Environmental Engineering, Gdansk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Faculty of Civil and Environmental Engineering, Gdansk University of Technology; Medical University of Gdansk, Gdansk University of Technology	Abaqus calculations were carried out at the Academic Computer Center in Gdansk. Karol Daszkiewicz is supported with grants for the development of young scientists from the Faculty of Civil and Environmental Engineering, Gdansk University of Technology. The study was financed by Medical University of Gdansk, Gdansk University of Technology and private donation from Dr Luczkiewicz.	[Anonymous], AB 6 14 2 US MAN; Arno S, 2012, KNEE, V19, P896, DOI 10.1016/j.knee.2012.04.005; Bae JY, 2012, MED BIOL ENG COMPUT, V50, P53, DOI 10.1007/s11517-011-0840-1; Baek J, 2016, TISSUE ENGINEERING P; Bao HRC, 2013, J ORTHOP SCI, V18, P256, DOI 10.1007/s00776-012-0334-5; Blanc R, 2012, MED IMAGE ANAL, V16, P1156, DOI 10.1016/j.media.2012.04.004; Burkhart TA, 2013, J BIOMECH, V46, P1477, DOI 10.1016/j.jbiomech.2013.03.022; D'Angeli V, 2014, J BIOMECH, V47, P1198, DOI 10.1016/j.jbiomech.2014.01.045; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2010, BEST PRACT RES CL RH, V24, P39, DOI 10.1016/j.berh.2009.08.008; Englund M, 2009, RADIOL CLIN N AM, V47, P703, DOI 10.1016/j.rcl.2009.03.003; Erdemir A, OPEN KNEE 3 DIMENSIO; Erdemir Ahmet, 2013, J Med Device, V7, P0409101; Erdemir A, 2016, J KNEE SURG, V29, P107, DOI 10.1055/s-0035-1564600; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Gardiner JC, 2003, J ORTHOP RES, V21, P1098, DOI 10.1016/S0736-0266(03)00113-X; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Hauch KN, 2010, J BIOMECH, V43, P463, DOI 10.1016/j.jbiomech.2009.09.043; Holzapfel G.A., 2001, NONLINEAR SOLID MECH; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hunziker EB, 2016, J ORTHOPAEDIC RES; Jung KA, 2010, RHEUMATOL INT, V30, P1325, DOI 10.1007/s00296-009-1153-7; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Laxafoss E, 2013, SKELETAL RADIOL, V42, P531, DOI 10.1007/s00256-012-1509-z; Li G, 2001, J BIOMECH ENG-T ASME, V123, P341, DOI 10.1115/1.1385841; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Luczkiewicz P, 2015, J BIOMECH, V48, P1356, DOI 10.1016/j.jbiomech.2015.03.002; Marques J, 2013, MAGN RESON MED, V70, P568, DOI 10.1002/mrm.24477; McAlindon TE, 2015, ARTHRITIS RHEUMATOL, V67, P1987, DOI 10.1002/art.39177; Meakin JR, 2003, KNEE, V10, P33, DOI 10.1016/S0968-0160(02)00106-0; Pena E, 2006, INT J NUMER METH ENG, V68, P836, DOI 10.1002/nme.1726; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Pena E, 2005, CLIN BIOMECH, V20, P498, DOI 10.1016/j.clinbiomech.2005.01.009; Segal NA, 2012, OSTEOARTHR CARTILAGE, V20, P1120, DOI 10.1016/j.joca.2012.05.013; Shepherd DET, 1999, RHEUMATOLOGY, V38, P124, DOI 10.1093/rheumatology/38.2.124; Walker PS, 2015, J BIOMECH, V48, P1383, DOI 10.1016/j.jbiomech.2015.02.055; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Wenger A, 2013, ARTHRITIS RHEUM-US, V65, P1804, DOI 10.1002/art.37947; Yang NH, 2010, J APPL BIOMECH, V26, P432, DOI 10.1123/jab.26.4.432; Yao J, 2006, J BIOMECH ENG-T ASME, V128, P399, DOI 10.1115/1.2191077	43	7	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167733	10.1371/journal.pone.0167733	http://dx.doi.org/10.1371/journal.pone.0167733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936066	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100168
J	Modi, S; Cavanaugh, JS; Shiraishi, RW; Alexander, HL; McCarthy, KD; Burmen, B; Muttai, H; Heilig, CM; Nakashima, AK; Cain, KP				Modi, Surbhi; Cavanaugh, Joseph S.; Shiraishi, Ray W.; Alexander, Heather L.; McCarthy, Kimberly D.; Burmen, Barbara; Muttai, Hellen; Heilig, Chad M.; Nakashima, Allyn K.; Cain, Kevin P.			Performance of Clinical Screening Algorithms for Tuberculosis Intensified Case Finding among People Living with HIV in Western Kenya	PLOS ONE			English	Article							INFECTED PREGNANT-WOMEN; ANTIRETROVIRAL THERAPY; ACTIVE TUBERCULOSIS; DIAGNOSIS	Objective To assess the performance of symptom-based screening for tuberculosis (TB), alone and with chest radiography among people living with HIV (PLHIV), including pregnant women, in Western Kenya. Design Prospective cohort study Methods PLHIV from 15 randomly-selected HIV clinics were screened with three clinical algorithms [World Health Organization (WHO), Ministry of Health (MOH), and "Improving Diagnosis of TB in HIV-infected persons" (ID-TB/HIV) study], underwent chest radiography (unless pregnant), and provided two or more sputum specimens for smear microscopy, liquid culture, and Xpert MTB/RIF. Performance of clinical screening was compared to laboratory results, controlling for the complex design of the survey. Results Overall, 738 (85.6%) of 862 PLHIV enrolled were included in the analysis. Estimated TB prevalence was 11.2% (95% CI, 9.9-12.7). Sensitivity of the three screening algorithms was similar [WHO, 74.1% (95% CI, 64.1-82.2); MOH, 77.5% (95% CI, 68.6-84.5); and IDTB/HIV, 72.5% (95% CI, 60.9-81.7)]. Sensitivity of the WHO algorithm was significantly lower among HIV-infected pregnant women [28.2% (95% CI, 14.9-46.7)] compared to nonpregnant women [78.3% (95% CI, 67.3-86.4)] and men [77.2% (95% CI, 68.3-84.2)]. Chest radiography increased WHO algorithm sensitivity and negative predictive value to 90.9% (95% CI, 86.4-93.9) and 96.1% (95% CI, 94.4-97.3), respectively, among asymptomatic men and non-pregnant women. Conclusions Clinical screening missed approximately 25% of laboratory-confirmed TB cases among all PLHIV and more than 70% among HIV-infected pregnant women. National HIV programs should evaluate the feasibility of laboratory-based screening for TB, such as a single Xpert MTB/RIF test for all PLHIV, especially pregnant women, at enrollment in HIV services.	[Modi, Surbhi; Shiraishi, Ray W.; Alexander, Heather L.; Nakashima, Allyn K.] United States Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA 30333 USA; [Cavanaugh, Joseph S.; McCarthy, Kimberly D.; Heilig, Chad M.; Cain, Kevin P.] CDC, Div TB Eliminat, Atlanta, GA 30333 USA; [Burmen, Barbara] Ctr Global Hlth Res, Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Burmen, Barbara] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Muttai, Hellen; Cain, Kevin P.] CDC, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Modi, S (corresponding author), United States Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Atlanta, GA 30333 USA.	smodi@cdc.gov	Muttai, Hellen/ABH-7164-2020	Shiraishi, Ray/0000-0001-7640-0666; Burmen, Barbara/0000-0002-4382-2747; Heilig, Charles/0000-0003-1075-1310	U.S. President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention [5U19GH000041]; United States Agency for International Development	U.S. President's Emergency Plan for AIDS Relief through Centers for Disease Control and Prevention; United States Agency for International Development(United States Agency for International Development (USAID))	Primary funding for this study was provided by the U.S. President's Emergency Plan for AIDS Relief through Cooperative Agreement 5U19GH000041 from the Centers for Disease Control and Prevention to the Kenya Medical Research Institute. Additional funding was provided by the United States Agency for International Development. Approval for study design was obtained from the U.S. President's Emergency Plan for AIDS Relief Public Health Evaluation Scientific Committee. The funders had no role in data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cavanaugh JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152364; Division of Leprosy Tuberculosis and Lung Diseases, 2009, GUID MAN LEPR TUB; Getahun H, 2012, J INFECT DIS, V205, pS216, DOI 10.1093/infdis/jis009; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V57, pE77, DOI 10.1097/QAI.0b013e31821ac9c1; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Kenya National AIDS and STI Control Programme, 2011, GUID ANT THER KEN; Kenya National AIDS and STI Control Programme, 2005, PROGR NAASC; Kenya National AIDS and STI Control Programme Ministry of Public Health and Sanitation Kenya, 2008, GUID HIV TEST COUNS; Khan FA, 2014, AIDS, V28, P1463, DOI 10.1097/QAD.0000000000000278; Kosgei RJ, 2013, PUBLIC HEALTH ACTION, V3, P294, DOI 10.5588/pha.13.0073; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; LaCourse SM, 2016, JAIDS-J ACQ IMM DEF, V71, P219, DOI 10.1097/QAI.0000000000000826; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-231; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, INT J TUBERC LUNG D, V13, P1186; Rangaka MX, 2012, CLIN INFECT DIS, V55, P1698, DOI 10.1093/cid/cis775; Siddiqui S.H., 2006, MGIT PROCEDURE MANUA; Sugarman J, 2014, LANCET GLOB HEALTH, V2, pE710, DOI 10.1016/S2214-109X(14)70330-4; Swindells S, 2013, INT J TUBERC LUNG D, V17, P532, DOI 10.5588/ijtld.12.0737; Turnbull ER, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/565049; UNAIDS, 2014, AIDS CHANG EV FACT S; UNAIDS, 2014, THE GAP REP; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHO POL UPD XPERT MT; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	33	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167685	10.1371/journal.pone.0167685	http://dx.doi.org/10.1371/journal.pone.0167685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936146	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100150
J	Nikfarjam, F; Beyer, K; Konig, A; Hofmann, M; Butting, M; Valesky, E; Kippenberger, S; Kaufmann, R; Heidemann, D; Bernd, A; Zoller, NN				Nikfarjam, Frangis; Beyer, Kim; Koenig, Anke; Hofmann, Matthias; Butting, Manuel; Valesky, Eva; Kippenberger, Stefan; Kaufmann, Roland; Heidemann, Detlef; Bernd, August; Zoeller, Nadja Nicole			Influence of Biodentine (R) - A Dentine Substitute - On Collagen Type I Synthesis in Pulp Fibroblasts In Vitro	PLOS ONE			English	Article							TRICALCIUM SILICATE CEMENTS; MINERAL TRIOXIDE AGGREGATE; GROWTH-FACTOR-II; STEM-CELLS; GENE-EXPRESSION; ALVEOLAR BONE; MTA; DIFFERENTIATION; BIOMINERALIZATION; BIOCOMPATIBILITY	Preserving a patient's own teeth even in a difficult situation is nowadays preferable to surgical intervention and therefore promotes development of suitable dental repair materials. Biodentine (R), a mineral trioxide aggregate substitute, has been used to replace dentine in a bioactive and biocompatible manner in both the dental crown and the root. The aim of our study was to evaluate the influence of Biodentine (R) on pulp fibroblasts in vitro. For this study, one to five Biodentine (R) discs with a diameter of 5.1 mm were incubated in DMEM. To obtain Biodentine (R) suspensions the media were collected and replaced with fresh medium every 24h for 4 days. Primary pulp cells were isolated from freshly extracted wisdom teeth of 20-23 year old patients and incubated with the Biodentine (R) suspensions. Proliferation, cell morphology, cell integrity and cell viability were monitored. To evaluate the effect of Biodentine (R) on collagen type I synthesis, the secretion of the N-terminal domain of pro-collagen type I (P1NP) and the release of transforming growth factor-beta 1 (TGF-beta 1) were quantified. None of the Biodentine (R) suspensions tested influenced cell morphology, proliferation or cell integrity. The cell viability varied slightly depending on the suspension used. However, the concentrations of P1NP of all pulp fibroblast cultures treated for 24h with the moderate to high Biodentine (R) concentration containing suspensions of day 1 were reduced to 5% of the control. Furthermore, a significant TGF-beta 1 reduction was observed after treatment with these suspensions. It could be shown that Biodentine (R) is biocompatible. However, dissolved particles of the moderate to high concentrated Biodentine (R) suspensions 24h after mixing induce a significant reduction of TGF-beta 1 release and reduce the secretion of collagen type I of primary pulp fibroblasts.	[Nikfarjam, Frangis; Beyer, Kim; Koenig, Anke; Hofmann, Matthias; Butting, Manuel; Valesky, Eva; Kippenberger, Stefan; Kaufmann, Roland; Bernd, August; Zoeller, Nadja Nicole] Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany; [Nikfarjam, Frangis; Beyer, Kim; Heidemann, Detlef] Goethe Univ Frankfurt, Ctr Dent & Oral Med Carolinum, Dept Operat Dent, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Zoller, NN (corresponding author), Goethe Univ Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany.	Nadja.Zoeller@kgu.de		Hofmann, Matthias/0000-0003-4107-7197				A Saberi Eshagh, 2016, J Dent Res Dent Clin Dent Prospects, V10, P75, DOI 10.15171/joddd.2016.012; Aleksova P, 2013, CONTRIBUTIONS MACEDO, V34, P159; ANDUJAR MB, 1991, DEVELOPMENT, V111, P691; BEGUEKIRN C, 1992, INT J DEV BIOL, V36, P491; Bidar Maryam, 2014, J Dent Res Dent Clin Dent Prospects, V8, P134, DOI 10.5681/joddd.2014.025; Blum IR, 2011, EUR J PROSTHODONT RE, V19, P56, DOI 10.1922/EJPRD_973Blum06; Cornelio AL, 2015, INT ENDODONTIC J; Cuadros-Fernandez C, 2015, CLIN ORAL INVESTIGAT; Du R, 2013, J ENDODONT, V39, P1023, DOI 10.1016/j.joen.2013.03.002; Dujic J, 2009, INT J CANCER, V124, P1422, DOI 10.1002/ijc.23997; Fayazi Sara, 2011, Indian J Dent Res, V22, P190, DOI 10.4103/0970-9290.84278; Guven G, 2007, MED PRIN PRACT, V16, P454, DOI 10.1159/000107751; Hakki SS, 2012, INT ENDOD J, V45, P240, DOI 10.1111/j.1365-2591.2011.01968.x; HELDER MN, 1993, MATRIX, V13, P415, DOI 10.1016/S0934-8832(11)80047-8; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Kenchappa Mallikarjuna, 2015, J Indian Soc Pedod Prev Dent, V33, P250, DOI 10.4103/0970-4388.160404; Khedmat Sedigheh, 2014, Restor Dent Endod, V39, P149, DOI 10.5395/rde.2014.39.3.149; Kim Jia, 2016, Restor Dent Endod, V41, P29, DOI 10.5395/rde.2016.41.1.29; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Kucukkaya S, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/9203932; Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x; Lee BN, 2014, J ENDODONT, V40, P1217, DOI 10.1016/j.joen.2014.01.036; Lee BN, 2012, J ENDODONT, V38, P1627, DOI 10.1016/j.joen.2012.09.004; Leiendecker AP, 2012, J ENDODONT, V38, P829, DOI 10.1016/j.joen.2012.01.004; Malkondu O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160951; Margunato S, 2015, J ENDODONT, V41, P1646, DOI 10.1016/j.joen.2015.05.012; Mayard-Pons ML, 2015, J DIABETES COMPLICAT, V29, P993, DOI 10.1016/j.jdiacomp.2015.09.007; Michel A, 2016, CLIN ORAL INVESTIGAT; Mizuno M, 2003, J CELL BIOCHEM, V88, P1112, DOI 10.1002/jcb.10466; Mullaguri H, 2016, J ENDODONT, V42, P766, DOI 10.1016/j.joen.2016.02.009; Nagy-Bota MCM, 2014, ROM J MORPHOL EMBRYO, V55, P43; Nayak Gurudutt, 2014, Restor Dent Endod, V39, P120, DOI 10.5395/rde.2014.39.2.120; Niranjani K, 2015, J CLIN DIAGN RES, V9, pZC35, DOI 10.7860/JCDR/2015/13153.5823; Nowicka A, 2015, J ENDODONT, V41, P1234, DOI 10.1016/j.joen.2015.03.017; Oncel Torun Z, 2015, INT ENDOD J, V48, P986, DOI 10.1111/iej.12393; Pelliccioni GA, 2004, J MATER SCI-MATER M, V15, P167, DOI 10.1023/B:JMSM.0000011819.26935.47; Perard M, 2013, J MATER SCI-MATER M, V24, P1527, DOI 10.1007/s10856-013-4908-3; Peters OA, 2015, INT ENDODONTIC J; Poggio Claudio, 2014, Ann Stomatol (Roma), V5, P69; Poggio C, 2015, ARH HIG RADA TOKSIKO, V66, P181, DOI 10.1515/aiht-2015-66-2589; Raskin A, 2012, J ADHES DENT, V14, P535, DOI 10.3290/j.jad.a25690; Rathinam E, 2015, J ENDODONT, V41, P1805, DOI 10.1016/j.joen.2015.07.015; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soydan SS, 2015, HUM EXP TOXICOL, V34, P1073, DOI 10.1177/0960327115569808; STRONG DD, 1991, J BONE MINER RES, V6, P15; Tomson P. L., 2016, INT ENDODONTIC J; Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010; Tziafas D, 1998, ARCH ORAL BIOL, V43, P431, DOI 10.1016/S0003-9969(98)00026-0; Utneja Shivani, 2015, Restor Dent Endod, V40, P1, DOI 10.5395/rde.2015.40.1.1; Villat C, 2010, DENT MATER, V26, P1127, DOI 10.1016/j.dental.2010.07.013; Widbiller M, 2016, CLIN ORAL INVEST, V20, P237, DOI 10.1007/s00784-015-1515-3; Widbiller M, 2016, CLIN ORAL INVESTIGAT; Willershausen I, 2013, ARCH ORAL BIOL, V58, P1232, DOI 10.1016/j.archoralbio.2013.04.002; Zanini M, 2012, J ENDODONT, V38, P1220, DOI 10.1016/j.joen.2012.04.018; Zoller NN, 2008, TOXICOL IN VITRO, V22, P747, DOI 10.1016/j.tiv.2007.11.022	56	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167633	10.1371/journal.pone.0167633	http://dx.doi.org/10.1371/journal.pone.0167633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936042	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100136
J	O'Dea, KP; Porter, JR; Tirlapur, N; Katbeh, U; Singh, S; Handy, JM; Takata, M				O'Dea, Kieran P.; Porter, John R.; Tirlapur, Nikhil; Katbeh, Umar; Singh, Suveer; Handy, Jonathan M.; Takata, Masao			Circulating Microvesicles Are Elevated Acutely following Major Burns Injury and Associated with Clinical Severity	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; EXTRACELLULAR VESICLES; EMERGING ROLE; SEPSIS; HYPERCOAGULABILITY; GENERATION; COMPLEXES; BLOOD	Microvesicles are cell-derived signaling particles emerging as important mediators and biomarkers of systemic inflammation, but their production in severe burn injury patients has not been described. In this pilot investigation, we measured circulating microvesicle levels following severe burns, with severe sepsis patients as a comparator group. We hypothesized that levels of circulating vascular cell-derived microvesicles are elevated acutely following burns injury, mirroring clinical severity due to the early onset and prevalence of systemic inflammatory response syndrome (SIRS) in these patients. Blood samples were obtained from patients with moderate to severe thermal injury burns, with severe sepsis, and from healthy volunteers. Circulating microvesicles derived from total leukocytes, granulocytes, monocytes, and endothelial cells were quantified in plasma by flow cytometry. All circulating microvesicle subpopulations were elevated in burns patients on day of admission (day 0) compared to healthy volunteers (leukocyte-microvesicles: 3.5-fold, p = 0.005; granulocyte-microvesicles: 12.8-fold, p< 0.0001; monocyte-microvesicles: 20.4-fold, p< 0.0001; endothelial-microvesicles: 9.6-fold, p = 0.01), but decreased significantly by day 2. Microvesicle levels were increased with severe sepsis, but less consistently between patients. Leukocyte- and granulocyte-derived microvesicles on day 0 correlated with clinical assessment scores and were higher in burns ICU non-survivors compared to survivors (leukocyte MVs 4.6 fold, p = 0.002; granulocyte MVs 4.8 fold, p = 0.003). Mortality prediction analysis of area under receiver operating characteristic curve was 0.92 (p = 0.01) for total leukocyte microvesicles and 0.85 (p = 0.04) for granulocyte microvesicles. These findings demonstrate, for the first time, acute increases in circulating microvesicles following burns injury in patients and point to their potential role in propagation of sterile SIRS-related pathophysiology.	[O'Dea, Kieran P.; Porter, John R.; Tirlapur, Nikhil; Katbeh, Umar; Singh, Suveer; Handy, Jonathan M.; Takata, Masao] Imperial Coll London, Sect Anaesthet Pain Med & Intens Care, Dept Surg Canc, London, England; [Porter, John R.; Singh, Suveer; Handy, Jonathan M.] Chelsea & Westminster Hosp, Intens Care Unit, London, England	Imperial College London; Imperial College London	Takata, M (corresponding author), Imperial Coll London, Sect Anaesthet Pain Med & Intens Care, Dept Surg Canc, London, England.	m.takata@imperial.ac.uk			Chelsea and Westminster Health Charity, London, UK [1067412]; Chelsea and Westminster Health Charity, London, UK; National Institute for Health Research [ACF-2014-21-019] Funding Source: researchfish	Chelsea and Westminster Health Charity, London, UK; Chelsea and Westminster Health Charity, London, UK; National Institute for Health Research(National Institute for Health Research (NIHR))	Chelsea and Westminster Health Charity, London, UK http://www.cwplus.org.uk/ CW+ 2016 Registered charity number 1067412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Richard Keays (FRCA, FFICM), Dr Michelle Hayes (FRCA, FFICM), Dr Marcela Vizcaychipi (MD, PhD) and the staff at Chelsea and Westminster Hospital Intensive Care Unit. This work was supported by grants from the Chelsea and Westminster Health Charity, London, UK.	Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; Augustine D, 2014, CIRC RES, V114, P109, DOI 10.1161/CIRCRESAHA.114.301904; Blot S, 2009, BRIT J SURG, V96, P111, DOI 10.1002/bjs.6329; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Cabrera-Benitez NE, 2015, CRIT CARE MED; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Clayton M C, 1995, J Burn Care Rehabil, V16, P451, DOI 10.1097/00004630-199507000-00013; Curry N, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25625; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Farina JA, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/715645; GOLDIE AS, 1995, JAMA-J AM MED ASSOC, V274, P172, DOI 10.1001/jama.274.2.172; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Johnson BL, 2014, ENDOCR METAB IMMUNE, V14, P210, DOI 10.2174/1871530314666140722083717; Joop K, 2001, THROMB HAEMOSTASIS, V85, P810; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; LACELLE P, 1990, BLOOD, V75, P470; Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223; Lorincz AM, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25465; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Lu Rommel P, 2013, J Trauma Acute Care Surg, V74, P1474, DOI 10.1097/TA.0b013e3182923193; Markiewicz Margaret, 2013, J Aging Res, V2013, P734509, DOI 10.1155/2013/734509; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; Midura EF, 2016, SHOCK, V45, P82, DOI 10.1097/SHK.0000000000000460; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nieuwland R, 1997, CIRCULATION, V96, P3534; Nomellini V, 2008, J LEUKOCYTE BIOL, V83, P1493, DOI 10.1189/jlb.1007672; Ogura H, 2004, J TRAUMA, V56, P823, DOI 10.1097/01.TA.0000084517.39244.46; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Reid VL, 2012, BRIT J ANAESTH, V109, P503, DOI 10.1093/bja/aes321; Sheridan RL, 1998, BURNS, V24, P307, DOI 10.1016/S0305-4179(97)00062-4; TOBIASEN J, 1982, ANN EMERG MED, V11, P260, DOI 10.1016/S0196-0644(82)80096-6; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P37, DOI 10.1097/TA.0b013e3182984911; Venet F, 2007, CRIT CARE MED, V35, P1910, DOI 10.1097/01.CCM.0000275271.77350.B6	39	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167801	10.1371/journal.pone.0167801	http://dx.doi.org/10.1371/journal.pone.0167801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936199	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100197
J	Taylor, CE; Machtinger, ET; Geden, CJ; Kramer, M				Taylor, Caitlin E.; Machtinger, Erika T.; Geden, Christopher J.; Kramer, Matthew			Manure Preferences and Postemergence Learning of Two Filth Fly Parasitoids, Spalangia cameroni and Muscidifurax raptor (Hymenoptera: Pteromalidae)	PLOS ONE			English	Article							PATCH TIME ALLOCATION; DIADEGMA-SEMICLAUSUM HYMENOPTERA; HOUSE-FLIES DIPTERA; STABLE FLIES; HOST-SEEKING; MORMONIELLA-VITRIPENNIS; ZARAPTOR HYMENOPTERA; BIOLOGICAL-CONTROL; MUSCA-DOMESTICA; MUSCIDAE	The efficiency of host-seeking behavior is crucial to the reproductive performance of female parasitoids. Initially, parasitoids may use chemical information garnered from the microhabitat in which they emerge to locate hosts. Spalangia cameroni and Muscidifurax raptor are commercially available parasitoids of filth flies. Postemergence exposure to a specific manure may provide a way to increase parasitism in specific microhabitats found at livestock facilities upon release. In this study, female parasitoids of both species were exposed to equine manure, bovine manure, or clean pupae. Females from each emergence exposure were tested in a two-choice arena (house fly hosts in bovine manure versus clean pupae, equine manure versus clean pupae, and equine manure versus bovine manure) for progeny production. There was a detectable but small effect of postemergence exposure on S. cameroni, but it was not sufficient to reverse innate preferences. Females consistently produced more progeny in hosts found in any manure over clean pupae, and in equine manure over bovine manure. The effect of postemergence exposure on M. raptor was also detectable but small. Females produced equal numbers of progeny in bovine manure versus clean pupae, as opposed to preferring to oviposit in clean pupae as with all other treatments. Preferences by M. raptor were overall less marked than for S. cameroni; indeed most of the variability observed for this species did not result from the treatment design. Residual host mortality was also detectably altered by exposure in both species, but the effect was small. Thus, postemergence exposure did not consistently and effectively manipulate these parasitoids to producing progeny in different exposure manures, suggesting that microhabitat preferences are largely determined by other factors.	[Taylor, Caitlin E.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Machtinger, Erika T.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Geden, Christopher J.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Kramer, Matthew] USDA ARS, Stat Grp, Beltsville, MD USA; [Machtinger, Erika T.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Machtinger, ET (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.; Machtinger, ET (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA.	erika.machtinger@ars.usda.gov	Geden, Christopher J/J-5413-2016; Machtinger, Erika/B-4197-2016	Machtinger, Erika/0000-0002-6492-0901				Abram PK, 2016, BIOL CONTROL, V98, P52, DOI 10.1016/j.biocontrol.2016.04.002; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boivin G, 2004, OECOLOGIA, V138, P640, DOI 10.1007/s00442-003-1469-z; Boone CK, 2009, CAN ENTOMOL, V141, P172, DOI 10.4039/n09-004; CAMPBELL ROBERT W., 1963, CANADIAN ENTOMOL, V95, P337; CAUBET Y, 1991, ANIM BEHAV, V42, P977, DOI 10.1016/S0003-3472(05)80150-2; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CRESPO DIANA C., 2002, Neotrop. entomol., V31, P141, DOI 10.1590/S1519-566X2002000100019; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; DRIESSEN G, 1995, J ANIM ECOL, V64, P117, DOI 10.2307/5832; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; EDWARDS RL, 1954, BEHAVIOUR, V7, P88, DOI 10.1163/156853955X00049; Geden CJ, 2006, ENVIRON ENTOMOL, V35, P75, DOI 10.1603/0046-225X-35.1.75; Geden CJ, 2002, ENVIRON ENTOMOL, V31, P411, DOI 10.1603/0046-225X-31.2.411; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Goubault M, 2005, BEHAV ECOL, V16, P693, DOI 10.1093/beheco/ari043; Hogsette J. A., 1981, Patterson, R. S. (Chairman): Status of biological control of filth flies. Proceedings of a workshop. February 4-5, 1981, University of Florida, Gainesville., P105; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; JONES RL, 1971, SCIENCE, V173, P842, DOI 10.1126/science.173.3999.842; Kapongo JP, 2007, HORTSCIENCE, V42, P1400, DOI 10.21273/HORTSCI.42.6.1400; Kaufman PE, 2002, J APPL POULTRY RES, V11, P90, DOI 10.1093/japr/11.1.90; Kaufman PE, 2001, J ECON ENTOMOL, V94, P593, DOI 10.1603/0022-0493-94.2.593; KESTER KM, 1991, J INSECT BEHAV, V4, P727, DOI 10.1007/BF01052227; Laing J, 1937, J ANIM ECOL, V6, P298, DOI 10.2307/1186; LASHOMB J, 1987, CAN ENTOMOL, V119, P75, DOI 10.4039/Ent11975-1; LEE CN, 1990, ENVIRON ENTOMOL, V19, P1296, DOI 10.1093/ee/19.5.1296; Lentz-Ronning AJ, 2013, J INSECT BEHAV, V26, P165, DOI 10.1007/s10905-012-9345-5; Li X., 2002, ACTA ENTOMOL SINICA, V46, P749; Machtinger ET, 2015, ENVIRON ENTOMOL, V44, P330, DOI 10.1093/ee/nvu063; Machtinger ET, 2013, BIOL CONTROL, V65, P130, DOI 10.1016/j.biocontrol.2013.01.004; Machtinger ET, 2015, ENV ENTOMOL; Machtinger ET, 2016, NEOTROP ENTOMOL; MANDEVILLE JD, 1990, ANN ENTOMOL SOC AM, V83, P1203, DOI 10.1093/aesa/83.6.1203; McKay T, 2003, J KANSAS ENTOMOL SOC, V76, P31; McKay T, 1999, CAN ENTOMOL, V131, P743, DOI 10.4039/Ent131743-6; Pitzer JB, 2011, J ECON ENTOMOL, V104, P1108, DOI 10.1603/EC10227; Potting RPJ, 1997, ANIM BEHAV, V53, P1211, DOI 10.1006/anbe.1996.0382; R Core Team, 2021, R LANGUAGE ENV STAT; RUEDA LM, 1985, ENVIRON ENTOMOL, V14, P217, DOI 10.1093/ee/14.3.217; Rutz DA, 1990, BIOCONTROL ARTHRO BI; SHEEHAN W, 1989, J INSECT BEHAV, V2, P743, DOI 10.1007/BF01049398; Skovgard H, 2004, B ENTOMOL RES, V94, P555, DOI 10.1079/BER2004322; STAFFORD KC, 1984, ENVIRON ENTOMOL, V13, P228, DOI 10.1093/ee/13.1.228; STRAND MR, 1986, J INSECT PHYSIOL, V32, P389, DOI 10.1016/0022-1910(86)90052-1; Thiel A, 2006, ANIM BIOL, V56, P233, DOI 10.1163/157075606777304212; Tormos JJ, 2002, B ENTOMOL RES, V102, P51; Turlings Ted C. J., 1993, P51; Van Dijken MJ, 1998, ECOL ENTOMOL, V23, P265, DOI 10.1046/j.1365-2311.1998.00130.x; VET LEM, 1983, NETH J ZOOL, V33, P225, DOI 10.1163/002829683X00101; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vet Louise E.M., 1995, P65; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VINSON SB, 1975, ENTOMOL EXP APPL, V18, P443, DOI 10.1007/BF00304647; WAAGE JK, 1979, J ANIM ECOL, V48, P353, DOI 10.2307/4166; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; Wajnberg E, 1999, J ANIM ECOL, V68, P121, DOI 10.1046/j.1365-2656.1999.00270.x; Wang XG, 2005, J INSECT BEHAV, V18, P171, DOI 10.1007/s10905-005-0473-z; Wang XG, 2004, J INSECT BEHAV, V17, P761, DOI 10.1023/B:JOIR.0000048987.10357.a6; Wang XG, 2003, J INSECT BEHAV, V16, P279, DOI 10.1023/A:1023924103884; Weinzierl RA, 1998, J ECON ENTOMOL, V91, P1114, DOI 10.1093/jee/91.5.1114; WYLIE H. G., 1958, CANADIAN ENT, V90, P597	65	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167893	10.1371/journal.pone.0167893	http://dx.doi.org/10.1371/journal.pone.0167893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936090	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100224
J	Tavares, CDJ; Giles, DH; Stancu, G; Chitjian, CA; Ferguson, SB; Wellmann, RM; Kaoud, TS; Ghose, R; Dalby, KN				Tavares, Clint D. J.; Giles, David H.; Stancu, Gabriel; Chitjian, Catrina A.; Ferguson, Scarlett B.; Wellmann, Rebecca M.; Kaoud, Tamer S.; Ghose, Ranajeet; Dalby, Kevin N.			Signal Integration at Elongation Factor 2 Kinase THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calmodulin (CaM); phosphorylation; translation; translation elongation factor; CaMK-III; S500D; Ser-500; Thr-348; eEF-2K	MR 100,000 SUBSTRATE; FACTOR-II KINASE; MAMMALIAN-CELLS; PROTEIN-KINASES; RABBIT RETICULOCYTES; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; CHAIN ELONGATION; ALPHA-KINASES; ACTIVATION	Eukaryotic elongation factor 2 kinase (eEF-2K), the only calmodulin (CaM)-dependent member of the unique -kinase family, impedes protein synthesis by phosphorylating eEF-2. We recently identified Thr-348 and Ser-500 as two key autophosphorylation sites within eEF-2K that regulate its activity. eEF-2K is regulated by Ca2+ ions and multiple upstream signaling pathways, but how it integrates these signals into a coherent output, i.e. phosphorylation of eEF-2, is unclear. This study focuses on understanding how the post-translational phosphorylation of Ser-500 integrates with Ca2+ and CaM to regulate eEF-2K. CaM is shown to be absolutely necessary for efficient activity of eEF-2K, and Ca2+ is shown to enhance the affinity of CaM toward eEF-2K. Ser-500 is found to undergo autophosphorylation in cells treated with ionomycin and is likely also targeted by PKA. In vitro, autophosphorylation of Ser-500 is found to require Ca2+ and CaM and is inhibited by mutations that compromise binding of phosphorylated Thr-348 to an allosteric binding pocket on the kinase domain. A phosphomimetic Ser-500 to aspartic acid mutation (eEF-2K S500D) enhances the rate of activation (Thr-348 autophosphorylation) by 6-fold and lowers the EC50 for Ca2+/CaM binding to activated eEF-2K (Thr-348 phosphorylated) by 20-fold. This is predicted to result in an elevation of the cellular fraction of active eEF-2K. In support of this mechanism, eEF-2K knock-out MCF10A cells reconstituted with eEF-2K S500D display relatively high levels of phospho-eEF-2 under basal conditions. This study reports how phosphorylation of a regulatory site (Ser-500) integrates with Ca2+ and CaM to influence eEF-2K activity.	[Tavares, Clint D. J.; Chitjian, Catrina A.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Tavares, Clint D. J.; Giles, David H.; Stancu, Gabriel; Chitjian, Catrina A.; Ferguson, Scarlett B.; Wellmann, Rebecca M.; Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY 10016 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Tavares, CDJ (corresponding author), Harvard Med Sch, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Tavares, CDJ (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Dalby, KN (corresponding author), Univ Texas Austin, Div Chem Biol & Med Chem, Coll Pharm, 107 West Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA.	clinttavares@utexas.edu; dalby@austin.utexas.edu	Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019	Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725	Welch Foundation [F-1390]; National Institutes of Health [GM59802]; NSF Division of Molecular and Cellular Biosciences Award [1657192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Division of Molecular and Cellular Biosciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Welch Foundation Grant F-1390 and National Institutes of Health Grant GM59802 (to K.N.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NSF Division of Molecular and Cellular Biosciences Award 1657192.	Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Cheng Y, 2016, ONCOGENE, V35, P6293, DOI 10.1038/onc.2016.166; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; DUMONTMISCOPEIN A, 1994, FEBS LETT, V356, P283, DOI 10.1016/0014-5793(94)01272-5; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Hovland R, 1999, FEBS LETT, V444, P97, DOI 10.1016/S0014-5793(99)00039-3; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lee K, 2016, STRUCTURE, V24, P1441, DOI 10.1016/j.str.2016.06.015; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Meric-Bernstam F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3343; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Moore CEJ, 2015, MOL CELL BIOL, V35, P1788, DOI 10.1128/MCB.01457-14; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1987, J BIOL CHEM, V262, P14265; PALFREY HC, 1987, J BIOL CHEM, V262, P9785; Pandey K, 2014, J PHYS CHEM B, V118, P5059, DOI 10.1021/jp501641r; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; Pigott CR, 2012, BIOCHEM J, V442, P105, DOI 10.1042/BJ20111536; Pon CK, 2016, FASEB J, V30, P1144, DOI 10.1096/fj.15-277798; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; RYAZANOV AG, 1988, BIOCHIMIE, V70, P619, DOI 10.1016/0300-9084(88)90245-3; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; TANAKA M, 1977, J BIOCHEM-TOKYO, V82, P1035, DOI 10.1093/oxfordjournals.jbchem.a131774; Tang SQ, 2017, CELL MOL IMMUNOL, V14, P180, DOI 10.1038/cmi.2015.59; Tavares CDJ, 2014, J BIOL CHEM, V289, P23901, DOI 10.1074/jbc.M114.577148; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Tekedereli I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041171; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 2014, MOL CELL BIOL, V34, P4088, DOI 10.1128/MCB.01035-14; Wiseman SL, 2013, J BIOL CHEM, V288, P17803, DOI 10.1074/jbc.M113.477182; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525	62	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2032	2045		10.1074/jbc.M116.753277	http://dx.doi.org/10.1074/jbc.M116.753277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956550	Green Published, hybrid			2022-12-26	WOS:000395515600040
J	Otero-Muras, I; Banga, JR				Otero-Muras, Irene; Banga, Julio R.			Design Principles of Biological Oscillators through Optimization: Forward and Reverse Analysis	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; CIRCADIAN-RHYTHMS; NETWORK; MOTIFS; ROBUST; ALGORITHM; DYNAMICS; NOISE; TIME	From cyanobacteria to human, sustained oscillations coordinate important biological functions. Although much has been learned concerning the sophisticated molecular mechanisms underlying biological oscillators, design principles linking structure and functional behavior are not yet fully understood. Here we explore design principles of biological oscillators from a multiobjective optimization perspective, taking into account the trade-offs between conflicting performance goals or demands. We develop a comprehensive tool for automated design of oscillators, based on multicriteria global optimization that allows two modes: (i) the automatic design (forward problem) and (ii) the inference of design principles (reverse analysis problem). From the perspective of synthetic biology, the forward mode allows the solution of design problems that mimic some of the desirable properties appearing in natural oscillators. The reverse analysis mode facilitates a systematic exploration of the design space based on Pareto optimality concepts. The method is illustrated with two case studies: the automatic design of synthetic oscillators from a library of biological parts, and the exploration of design principles in 3-gene oscillatory systems.	[Otero-Muras, Irene; Banga, Julio R.] Spanish Natl Res Council, CSIC, IIM, BioProc Engn Grp, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Otero-Muras, I (corresponding author), Spanish Natl Res Council, CSIC, IIM, BioProc Engn Grp, Vigo, Spain.	ireneotero@iim.csic.es	Banga, Julio R./A-8388-2008; Otero-Muras, Irene/K-3832-2014; Banga, Julio R./ABD-8629-2020	Banga, Julio R./0000-0002-4245-0320; Otero-Muras, Irene/0000-0003-2895-997X; Banga, Julio R./0000-0002-4245-0320	MINECO [DPI2014-55276-C5-2-R]	MINECO(Spanish Government)	This work was supported by MINECO (and the European Regional Development Fund) project SYNBIOFACTORY (grant number DPI2014-55276-C5-2-R).	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ananthasubramaniam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104761; Ananthasubramaniam B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003565; Angione C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15147; Bandaru S, 2015, LECT NOTES COMPUT SC, V9018, P79, DOI 10.1007/978-3-319-15934-8_6; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Cao YS, 2015, NAT PHYS, V11, P772, DOI 10.1038/NPHYS3412; d'Eysmond T, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056005; de Hijas-Liste GM, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-1; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Egea JA, 2010, COMPUT OPER RES, V37, P315, DOI 10.1016/j.cor.2009.05.003; El Samad H, 2005, P 16 IFAC WORLD C PR; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Exler O, 2007, OPTIM LETT, V1, P269, DOI 10.1007/s11590-006-0026-1; Exler O, 2008, COMPUT CHEM ENG, V32, P1877, DOI 10.1016/j.compchemeng.2007.10.008; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gaspard P, 2002, J STAT PHYS, V106, P57, DOI 10.1023/A:1013167928166; Gaspard P, 2002, J CHEM PHYS, V117, P8905, DOI 10.1063/1.1513461; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gonze D, 2002, J CHEM PHYS, V116, P10997, DOI 10.1063/1.1475765; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Gonze D, 2009, CELL SCI REV, V5; Granada AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059464; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hasegawa Y, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1020; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Higuera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041122; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Loinger A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051917; Mantzaris NV, 2007, BIOPHYS J, V92, P4271, DOI 10.1529/biophysj.106.100271; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Min B, 2010, J KOREAN PHYS SOC, V56, P911, DOI 10.3938/jkps.56.911; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Munteanu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05003; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oh YG, 2009, BIOTECHNOL PROGR, V25, P999, DOI 10.1002/btpr.193; Otero-Muras I, 2016, BIOINFORMATICS, V32, P3360, DOI 10.1093/bioinformatics/btw415; Otero-Muras I, 2014, LECT NOTES COMPUT SC, V8859, P225, DOI 10.1007/978-3-319-12982-2_16; Otero-Muras I, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0113-3; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Rodrigo G, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr616; Rodrigo G, 2010, BIOCHIMIE, V92, P746, DOI 10.1016/j.biochi.2010.04.003; Rougemont J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100130; Schluter M, 2009, COMPUT OPER RES, V36, P2217, DOI 10.1016/j.cor.2008.08.015; Schuster P, 2012, COMPLEXITY, V18, P5, DOI 10.1002/cplx.21426; Sendin JOH, 2010, IET SYST BIOL, V4, P236, DOI 10.1049/iet-syb.2009.0045; Sendin JOH, 2006, IND ENG CHEM RES, V45, P8594, DOI 10.1021/ie0605433; Sendin JOH, 2009, ADV SOFT COMP, V49, P197; Sendin OH, 2006, MATH COMP MODEL DYN, V12, P469, DOI 10.1080/13873950600723442; Seoane LF, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032807; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Szekely P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003163; Taneda A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0706-x; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Troein C, 2009, CURR BIOL, V19, P1961, DOI 10.1016/j.cub.2009.09.024; Tsai TYC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001788; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; van Dorp M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012722; Woods ML, 2016, ACS SYNTH BIOL, V5, P459, DOI 10.1021/acssynbio.5b00179	70	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166867	10.1371/journal.pone.0166867	http://dx.doi.org/10.1371/journal.pone.0166867			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977695	Green Submitted, Green Published, gold			2022-12-26	WOS:000391217400009
J	Malmberg, C; Yuen, PK; Spaak, J; Cars, O; Tangden, T; Lagerback, P				Malmberg, Christer; Yuen, Pikkei; Spaak, Johanna; Cars, Otto; Tangden, Thomas; Lagerback, Pernilla			A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; IN-VITRO; VANCOMYCIN	Background Appropriate antibiotic therapy is critical in the management of severe sepsis and septic shock to reduce mortality, morbidity and health costs. New methods for rapid antibiotic susceptibility testing are needed because of increasing resistance rates to standard treatment. Aims The purpose of this study was to evaluate the performance of a novel microfluidic method and the potential to directly apply this method on positive blood cultures. Methods Minimum inhibitory concentrations (MICs) of ciprofloxacin, ceftazidime, tigecycline and/or vancomycin for Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Staphylococcus aureus were determined using a linear antibiotic concentration gradient in a microfluidic assay. Bacterial growth along the antibiotic gradient was monitored using automated time-lapse photomicrography and growth inhibition was quantified by measuring greyscale intensity changes in the images. In addition to pure culture MICs, vancomycin MICs were determined for S. aureus from spiked and clinical blood cultures following a short centrifugation step. The MICs were compared with those obtained with the Etest and for S. aureus and vancomycin also with macrodilution. Results The MICs obtained with the microfluidic assay showed good agreement internally as well as with the Etest and macrodilution assays, although some minor differences were noted between the methods. The time to possible readout was within the range of 2 to 5 h. Conclusions The examined microfluidic assay has the potential to provide rapid and accurate MICs using samples from positive clinical blood cultures and will now be tested using other bacterial species and antibiotics.	[Malmberg, Christer; Yuen, Pikkei; Cars, Otto; Tangden, Thomas; Lagerback, Pernilla] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Malmberg, Christer; Spaak, Johanna] Gradientech AB, Uppsala, Sweden	Uppsala University	Malmberg, C; Yuen, PK (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.; Malmberg, C; Yuen, PK (corresponding author), Gradientech AB, Uppsala, Sweden.	christer.malmberg@medsci.uu.se; pikkei.yuen@medsci.uu.se		Wistrand-Yuen, Pikkei/0000-0002-2309-5394	AFA Insurance; Vinnova grant [2014-03512]	AFA Insurance; Vinnova grant(Vinnova)	This work was supported by AFA Insurance (PL OC) (https://www.afaforsakring.se/) and Vinnova grant 2014-03512 (OC TT) (http://www.vinnova.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deresinski S, 2009, J INFECT DIS, V199, P605, DOI 10.1086/596630; Fraser A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14561858.CD004785.pub3; Hegde SS, 2010, J ANTIMICROB CHEMOTH, V65, P725, DOI 10.1093/jac/dkq028; Hou ZN, 2014, LAB CHIP, V14, P3409, DOI 10.1039/c4lc00451e; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Prakash V, 2008, ANTIMICROB AGENTS CH, V52, P4528, DOI 10.1128/AAC.00904-08; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Udekwu KI, 2009, J ANTIMICROB CHEMOTH; van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	16	25	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167356	10.1371/journal.pone.0167356	http://dx.doi.org/10.1371/journal.pone.0167356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27974860	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300025
J	Stern, JA; Markova, S; Ueda, Y; Kim, JB; Pascoe, PJ; Evanchik, MJ; Green, EM; Harris, SP				Stern, Joshua A.; Markova, Svetlana; Ueda, Yu; Kim, Jae B.; Pascoe, Peter J.; Evanchik, Marc J.; Green, Eric M.; Harris, Samantha P.			A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							SUBAORTIC STENOSIS; HUMAN-DISEASE; ANIMAL-MODEL; CATS; PREVALENCE; MUTATIONS; DYNAMICS; THERAPY	Hypertrophic cardiomyopathy (HCM) is an inherited disease of the heart muscle characterized by otherwise unexplained thickening of the left ventricle. Left ventricular outflow tract (LVOT) obstruction is present in approximately two-thirds of patients and substantially increases the risk of disease complications. Invasive treatment with septal myectomy or alcohol septal ablation can improve symptoms and functional status, but currently available drugs for reducing obstruction have pleiotropic effects and variable therapeutic responses. New medical treatments with more targeted pharmacology are needed, but the lack of preclinical animal models for HCM with LVOT obstruction has limited their development. HCM is a common cause of heart failure in cats, and a subset exhibit systolic anterior motion of the mitral valve leading to LVOT obstruction. MYK-461 is a recently-described, mechanistically novel small molecule that acts at the sarcomere to specifically inhibit contractility that has been proposed as a treatment for HCM. Here, we use MYK-461 to test whether direct reduction in contractility is sufficient to relieve LVOT obstruction in feline HCM. We evaluated mixed-breed cats in a research colony derived from a Maine Coon/mixed-breed founder with naturally-occurring HCM. By echocardiography, we identified five cats that developed systolic anterior motion of the mitral valve and LVOT obstruction both at rest and under anesthesia when provoked with an adrenergic agonist. An IV MYK-461 infusion and echocardiography protocol was developed to serially assess contractility and LVOT gradient at multiple MYK-461 concentrations. Treatment with MYK-461 reduced contractility, eliminated systolic anterior motion of the mitral valve and relieved LVOT pressure gradients in an exposure-dependent manner. Our findings provide proof of principle that acute reduction in contractility with MYK-461 is sufficient to relieve LVOT obstruction. Further, these studies suggest that feline HCM will be a valuable translational model for the study of disease pathology, particularly LVOT obstruction.	[Stern, Joshua A.; Ueda, Yu] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Markova, Svetlana; Kim, Jae B.; Evanchik, Marc J.; Green, Eric M.] MyoKardia Inc, San Francisco, CA 94080 USA; [Pascoe, Peter J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Harris, Samantha P.] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ 85719 USA; [Kim, Jae B.] Alnylam Pharmaceut, Cambridge, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Green, EM (corresponding author), MyoKardia Inc, San Francisco, CA 94080 USA.; Harris, SP (corresponding author), Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ 85719 USA.	egreen@myokardia.com; samharris@email.arizona.edu	Ueda, Yu/I-2694-2019	Pascoe, Peter/0000-0002-7401-2253; Stern, Joshua/0000-0001-5611-5745; Green, Eric/0000-0001-7874-9482	NIH [R21HL093603]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R21HL093603 to SPH and an unrestricted gift from MyoKardia, Inc (www.myokardia.com). Authors from MyoKardia were involved in study design, data collection and analysis and preparation of the manuscript.	Alfares AA, 2015, RESULTS CLIN GENETIC, P1; Boon J.A., 2011, VET ECHOCARDIOGRAPHY, V2nd ed.; BRAUNWALD E, 1964, CIRCULATION, V30, P3; FOX PR, 1995, CIRCULATION, V92, P2645, DOI 10.1161/01.CIR.92.9.2645; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Kim LK, 2016, JAMA CARDIOL, V1, P324, DOI 10.1001/jamacardio.2016.0252; Kittleson MD, 2015, J VET CARDIOL, V17, pS53, DOI 10.1016/j.jvc.2015.03.001; Kittleson MD, 1999, CIRCULATION, V99, P3172, DOI 10.1161/01.CIR.99.24.3172; Kooiker KB, 2016, ARCH BIOCH BIOPHYS; LELE SS, 1995, CIRCULATION, V92, P2886, DOI 10.1161/01.CIR.92.10.2886; Liebregts M, 2015, JACC-HEART FAIL, V3, P896, DOI 10.1016/j.jchf.2015.06.011; Maron BJ, 2015, J VET CARDIOL, V17, pS6, DOI 10.1016/j.jvc.2015.03.007; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Meurs KM, 2005, HUM MOL GENET, V14, P3587, DOI 10.1093/hmg/ddi386; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; MORROW AG, 1965, AM J CARDIOL, V16, P540, DOI 10.1016/0002-9149(65)90031-7; NATHAN D, 1977, CHEST, V71, P746, DOI 10.1378/chest.71.6.746; Olivotto Iacopo, 2013, Glob Cardiol Sci Pract, V2013, P243, DOI 10.5339/gcsp.2013.31; Ommen SR, 2005, J AM COLL CARDIOL, V46, P470, DOI 10.1016/j.jacc.2005.02.090; Payne JR, 2015, J VET CARDIOL, V17, pS244, DOI 10.1016/j.jvc.2015.03.008; Ro R, 2014, J AM COLL CARDIOL, V64, P1984, DOI 10.1016/j.jacc.2014.04.090; Sedehi D, 2014, J CARDIOL; Sherrid MV, 2013, CIRC-HEART FAIL, V6, P694, DOI 10.1161/CIRCHEARTFAILURE.112.000122; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; STEWART S, 1968, CIRCULATION, V37, P8, DOI 10.1161/01.CIR.37.1.8; Veselka J, 2016, EUR HEART J, V37, P1517, DOI 10.1093/eurheartj/ehv693; WILSON WS, 1967, AM HEART J, V73, P4, DOI 10.1016/0002-8703(67)90303-1	34	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168407	10.1371/journal.pone.0168407	http://dx.doi.org/10.1371/journal.pone.0168407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973580	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300081
J	You, I; Sharma, V; Atiquzzaman, M; Choo, KKR				You, Ilsun; Sharma, Vishal; Atiquzzaman, Mohammed; Choo, Kim-Kwang Raymond			GDTN: Genome-Based Delay Tolerant Network Formation in Heterogeneous 5G Using Inter-UA Collaboration	PLOS ONE			English	Article								With a more Internet-savvy and sophisticated user base, there are more demands for interactive applications and services. However, it is a challenge for existing radio access networks (e.g. 3G and 4G) to cope with the increasingly demanding requirements such as higher data rates and wider coverage area. One potential solution is the inter-collaborative deployment of multiple radio devices in a 5G setting designed to meet exacting user demands, and facilitate the high data rate requirements in the underlying networks. These heterogeneous 5G networks can readily resolve the data rate and coverage challenges. Networks established using the hybridization of existing networks have diverse military and civilian applications. However, there are inherent limitations in such networks such as irregular breakdown, node failures, and halts during speed transmissions. In recent years, there have been attempts to integrate heterogeneous 5G networks with existing ad hoc networks to provide a robust solution for delay-tolerant transmissions in the form of packet switched networks. However, continuous connectivity is still required in these networks, in order to efficiently regulate the flow to allow the formation of a robust network. Therefore, in this paper, we present a novel network formation consisting of nodes from different network maneuvered by Unmanned Aircraft (UA). The proposed model utilizes the features of a biological aspect of genomes and forms a delay tolerant network with existing network models. This allows us to provide continuous and robust connectivity. We then demonstrate that the proposed network model has an efficient data delivery, lower overheads and lesser delays with high convergence rate in comparison to existing approaches, based on evaluations in both real-time testbed and simulation environment.	[You, Ilsun] Soonchunhyang Univ, Dept Informat Secur Engn, Asan 31538, South Korea; [Sharma, Vishal] Thapar Univ, Dept Comp Sci & Engn, Patiala 147004, Punjab, India; [Atiquzzaman, Mohammed] Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA	Soonchunhyang University; Thapar Institute of Engineering & Technology; University of Oklahoma System; University of Oklahoma - Norman; University of Texas System; University of Texas at San Antonio (UTSA)	Sharma, V (corresponding author), Thapar Univ, Dept Comp Sci & Engn, Patiala 147004, Punjab, India.	vishal_sharma2012@hotmail.com	Atiquzzaman, Mohammed/G-4059-2017; Sharma, Vishal/E-5834-2017; Choo, Kim-Kwang Raymond/A-3634-2009; You, Ilsun/AAR-7793-2021	Atiquzzaman, Mohammed/0000-0001-9440-7669; Sharma, Vishal/0000-0001-7470-6506; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; 	Ministry of Science, ICT and Future Planning, Korea; Soonchunhyang University Research Fund; Ministry of Science, ICT and Future Planning; Cross-Ministry Giga KOREA Project; Soonchunhyang University	Ministry of Science, ICT and Future Planning, Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); Soonchunhyang University Research Fund; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Cross-Ministry Giga KOREA Project(Giga Korea Co.); Soonchunhyang University	This work was supported by 'The Cross-Ministry Giga KOREA Project' grant from the Ministry of Science, ICT and Future Planning, Korea. In addition, it was partially supported by the Soonchunhyang University Research Fund. 1) Funder: the Ministry of Science, ICT and Future Planning (KR), Website of Funder: http://english.msip.go.kr/index.do, Grant Number: The Cross-Ministry Giga KOREA Project, Recipient: Ilsun You. 2) Funder: Soonchunhyang University (KR), Website of Funder: https://homepage.sch.ac.kr/english/, Grant Number: the Soonchunhyang University Research Fund, Recipient: Ilsun You. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg J., 2011, Proceedings of the 2011 9th IEEE International Conference on Industrial Informatics (INDIN 2011), P410, DOI 10.1109/INDIN.2011.6034912; [Anonymous], 2003, ACM SIGMOBILE, DOI DOI 10.1145/961268.961272; Bums B, 2008, AD HOC NETW, V6, P600, DOI 10.1016/j.adhoc.2007.05.002; Burgess J, 2006, IEEE INFOCOM SER, P1688, DOI 10.1109/infocom.2006.228; Chen JM, 2010, IEEE T IND ELECTRON, V57, P4219, DOI 10.1109/TIE.2010.2043038; Figueiras J, 2011, MOBILE POSITIONING T, DOI [10.1002/9780470663035, DOI 10.1002/9780470663035]; Gil-Castineira F, 2008, IEEE T IND ELECTRON, V55, P3307, DOI 10.1109/TIE.2008.927972; Han B, 2012, IEEE T MOBILE COMPUT, V11, P821, DOI 10.1109/TMC.2011.101; Hui P, 2011, IEEE T MOBILE COMPUT, V10, P1576, DOI 10.1109/TMC.2010.246; Jain R., 2008, ART COMPUTER SYSTEMS; Jones EPC, 2007, IEEE T MOBILE COMPUT, V6, P943, DOI 10.1109/TMC.2007.1016; Khanesar MA, 2015, IEEE T FUZZY SYST, V23, P205, DOI 10.1109/TFUZZ.2014.2362549; Ludwig A, 2010, GAUSS MARKOV LOSS P; Pereira PR, 2012, IEEE COMMUN SURV TUT, V14, P1166, DOI 10.1109/SURV.2011.081611.00102; Prasad A, 2015, 2015 IEEE 26TH ANNUAL INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1740, DOI 10.1109/PIMRC.2015.7343580; Ramasamy S, 2015, INT CONF UNMAN AIRCR, P765, DOI 10.1109/ICUAS.2015.7152360; Rao WX, 2015, IEEE T MOBILE COMPUT, V14, P755, DOI 10.1109/TMC.2014.2330296; Ridley M., 2000, GENOME; Rubinstein MG, 2009, IEEE COMMUN MAG, V47, P128, DOI 10.1109/MCOM.2009.5307476; Schoeneich RO, 2016, INT J DISTRIB SENS N, V12, DOI 10.1177/1550147716662755; Sharma V, 2014, IT CONVERGENCE PRACT, V2, P24; Sharma V, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND COMMUNICATION SYSTEMS (ICECS), P1551, DOI 10.1109/ECS.2015.7124849; Sharma V, 2015, J INTELL ROBOT SYST, V77, P629, DOI 10.1007/s10846-014-0091-0; Shuai ZB, 2014, IEEE T VEH TECHNOL, V63, P591, DOI 10.1109/TVT.2013.2279843; Soares VNGJ, 2014, INFORM FUSION, V15, P102, DOI 10.1016/j.inffus.2011.11.003; Soares VNGJ, 2009, IEEE SYMP COMP COMMU, P122, DOI 10.1109/ISCC.2009.5202332; Spyropoulos T, 2008, IEEE ACM T NETWORK, V16, P63, DOI 10.1109/TNET.2007.897962; Stewart MF, 2016, 2016 INT C COMP NETW, P1; Tenne D, 2002, IEEE T AERO ELEC SYS, V38, P1072, DOI 10.1109/TAES.2002.1039425; Tian CP, 2014, 2014 IEEE 12TH INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING (DASC)/2014 IEEE 12TH INTERNATIONAL CONFERENCE ON EMBEDDED COMPUTING (EMBEDDEDCOM)/2014 IEEE 12TH INTERNATIONAL CONF ON PERVASIVE INTELLIGENCE AND COMPUTING (PICOM), P485, DOI 10.1109/DASC.2014.93; Vahdat A., 2000, EPIDEMIC ROUTING PAR; Yilmaz ONC, 2014, 2014 11TH INTERNATIONAL SYMPOSIUM ON WIRELESS COMMUNICATIONS SYSTEMS (ISWCS), P6, DOI 10.1109/ISWCS.2014.6933310; You L, 2015, AD HOC NETW, V24, P228, DOI 10.1016/j.adhoc.2014.09.004; Yu C, 2016, INT J COMMUN SYST, V29, P2416, DOI 10.1002/dac.3030	35	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167913	10.1371/journal.pone.0167913	http://dx.doi.org/10.1371/journal.pone.0167913			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973618	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300047
J	Waheeb, W; Ghazali, R; Herawan, T				Waheeb, Waddah; Ghazali, Rozaida; Herawan, Tutut			Ridge Polynomial Neural Network with Error Feedback for Time Series Forecasting	PLOS ONE			English	Article							LEARNING ALGORITHM; EXCHANGE-RATE; PREDICTION; FUZZY; HYBRID; NONSTATIONARY; MODEL	Time series forecasting has gained much attention due to its many practical applications. Higher-order neural network with recurrent feedback is a powerful technique that has been used successfully for time series forecasting. It maintains fast learning and the ability to learn the dynamics of the time series over time. Network output feedback is the most common recurrent feedback for many recurrent neural network models. However, not much attention has been paid to the use of network error feedback instead of network output feedback. In this study, we propose a novel model, called Ridge Polynomial Neural Network with Error Feedback (RPNN-EF) that incorporates higher order terms, recurrence and error feedback. To evaluate the performance of RPNN-EF, we used four univariate time series with different forecasting horizons, namely star brightness, monthly smoothed sunspot numbers, daily Euro/Dollar exchange rate, and Mackey-Glass time-delay differential equation. We compared the forecasting performance of RPNN-EF with the ordinary Ridge Polynomial Neural Network (RPNN) and the Dynamic Ridge Polynomial Neural Network (DRPNN). Simulation results showed an average 23.34% improvement in Root Mean Square Error (RMSE) with respect to RPNN and an average 10.74% improvement with respect to DRPNN. That means that using network errors during training helps enhance the overall forecasting performance for the network.	[Waheeb, Waddah; Ghazali, Rozaida] Univ Tun Hussein Onn Malaysia, Fac Comp Sci & Informat Technol, Batu Pahat, Johor, Malaysia; [Waheeb, Waddah] Hodeidah Univ, Dept Comp Sci, Hodeidah, Yemen; [Herawan, Tutut] Univ Malaya, Dept Informat Syst, Kuala Lumpur, Malaysia; [Herawan, Tutut] Univ Teknol Yogyakarta, Dept Comp Sci, Yogyakarta, Indonesia; [Herawan, Tutut] AMCS Res Ctr, Yogyakarta, Indonesia	University of Tun Hussein Onn Malaysia; Hodeidah University; Universiti Malaya	Waheeb, W (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Comp Sci & Informat Technol, Batu Pahat, Johor, Malaysia.; Waheeb, W (corresponding author), Hodeidah Univ, Dept Comp Sci, Hodeidah, Yemen.	waddah.waheeb@gmail.com	Saeed, Waddah/E-9179-2015; Herawan, Tutut/AAB-6534-2021; Ghazali, Rozaida/D-3985-2013	Saeed, Waddah/0000-0002-2280-4427; Herawan, Tutut/0000-0001-9262-9137; Ghazali, Rozaida/0000-0003-0119-0873	Universitas Teknologi Yogyakarta Research Grant [07/UTY-R/SK/0/X/2013]	Universitas Teknologi Yogyakarta Research Grant	This work was supported by Universitas Teknologi Yogyakarta Research Grant 07/UTY-R/SK/0/X/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by Universitas Teknologi Yogyakarta Research Grant 07/UTY-R/SK/0/X/2013.	Abarbanel HDI., 1996, ANAL OBSERVED CHAOTI, DOI [10.1007/978-1-4612-0763-4, DOI 10.1007/978-1-4612-0763-4]; Aizenberg I, 2012, SOFT COMPUT, V16, P563, DOI 10.1007/s00500-011-0755-7; Al-Jumeily D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105766; Antweiler Werner, PACIFIC EXCHANGE RAT; Atiya AF., 1988, NEURAL INFORMATION P, P22; Behera NKS, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION CONTROL AND COMPUTING TECHNOLOGIES (ICACCCT), P1110, DOI 10.1109/ICACCCT.2014.7019270; Bouaziz S, 2013, NEUROCOMPUTING, V117, P107, DOI 10.1016/j.neucom.2013.01.024; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; Cheng R, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/572592; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Dash PK, 1997, IEEE T POWER SYST, V12, P675, DOI 10.1109/59.589648; Dhahri H, 2006, IEEE IJCNN, P2938; Dhahri H, 2008, STUD COMPUT INTELL, V129, P461; Diebold F. X., 2004, ELEMENTS FORECASTING; Dong YL, 2014, IEEE IJCNN, P157, DOI 10.1109/IJCNN.2014.6889431; Dunis C.L., 2002, TRADING REGULATION, P211, DOI DOI 10.1002/F0R.935; Feng GR, 2009, IEEE T NEURAL NETWOR, V20, P1352, DOI 10.1109/TNN.2009.2024147; Ghazali R, 2008, NEURAL COMPUT APPL, V17, P311, DOI 10.1007/s00521-007-0132-8; Ghazali R, 2011, EXPERT SYST APPL, V38, P3765, DOI 10.1016/j.eswa.2010.09.037; Ghazali R, 2009, NEUROCOMPUTING, V72, P2359, DOI 10.1016/j.neucom.2008.12.005; Ghosh J., 1993, International Journal of Neural Systems, V3, P323, DOI 10.1142/S0129065792000255; Gonzalez PA, 2005, ENERG BUILDINGS, V37, P595, DOI 10.1016/j.enbuild.2004.09.006; Graves D, 2009, NEUROCOMPUTING, V72, P1668, DOI 10.1016/j.neucom.2008.07.009; Haykin S., 2009, NEURAL NETWORKS LEAR; Hongwei Wang, 2012, 2012 Third International Conference on Intelligent Control and Information Processing (ICICIP 2012), P298, DOI 10.1109/ICICIP.2012.6391564; Huang SC, 2010, EXPERT SYST APPL, V37, P8590, DOI 10.1016/j.eswa.2010.06.001; Husaini NA, 2011, COMM COM INF SC, V151, P547; Hussain AJ, 2003, NEUROCOMPUTING, V55, P363, DOI 10.1016/S0925-2312(02)00629-X; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kitagawa G., 2010, INTRO TIME SERIES MO; Lanza PAG, 2002, ENG APPL ARTIF INTEL, V15, P459, DOI 10.1016/S0952-1976(02)00089-1; Leclercq E, 2005, NEUROCOMPUTING, V63, P25, DOI 10.1016/j.neucom.2004.04.007; Lin CJ, 2009, IEEE T SYST MAN CY C, V39, P55, DOI 10.1109/TSMCC.2008.2002333; Lin CM, 2015, IEEE T SYST MAN CY-S, V45, P1281, DOI 10.1109/TSMC.2015.2389752; Lohani AK, 2012, J HYDROL, V442, P23, DOI 10.1016/j.jhydrol.2012.03.031; Mahmud MS, 2015, SOFT COMPUT, P1; Makridakis S., 1998, FORECASTING METHODS; Nakanishi J, 2004, NEURAL NETWORKS, V17, P1453, DOI 10.1016/j.neunet.2004.05.003; Panda C, 2007, J POLICY MODEL, V29, P227, DOI 10.1016/j.jpolmod.2006.01.005; Parsapoor Mahboobeh, 2013, International Journal of Reasoning-based Intelligent Systems, V5, P113; Sabahi K, 2009, ENERG CONVERS MANAGE, V50, P938, DOI 10.1016/j.enconman.2008.12.028; Samarasinghe S., 2006, NEURAL NETWORKS APPL; Sermpinis G, 2012, DECIS SUPPORT SYST, V54, P316, DOI 10.1016/j.dss.2012.05.039; Sermpinis G, 2012, EXPERT SYST APPL, V39, P8865, DOI 10.1016/j.eswa.2012.02.022; SHIN Y, 1995, IEEE T NEURAL NETWOR, V6, P610, DOI 10.1109/72.377967; Shoorehdeli MA, 2009, APPL SOFT COMPUT, V9, P833, DOI 10.1016/j.asoc.2008.11.001; Tan JYB, 2012, ENG LET, V20, P203; Voutriaridis C, 2003, PROCEEDINGS EC-VIP-MC 2003, VOLS 1 AND 2, P519; Waheeb W, 2 INT C SOF IN PRESS; Wan DS, 2009, ICICTA: 2009 SECOND INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL I, PROCEEDINGS, P63, DOI 10.1109/ICICTA.2009.24; Wang HW, 2011, ASIAN J CONTROL, V13, P576, DOI 10.1002/asjc.355; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Wong WK, 2010, EUR J OPER RES, V207, P807, DOI 10.1016/j.ejor.2010.05.022; YABUTA T, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P740, DOI 10.1109/ROBOT.1991.131673; Yu L, 2009, APPL SOFT COMPUT, V9, P563, DOI 10.1016/j.asoc.2008.08.001; Yu X, 2014, NEUROCOMPUTING, V129, P437, DOI 10.1016/j.neucom.2013.09.015; Yuanquan Wen, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P458, DOI 10.1109/FSKD.2009.133; Zhang hui, 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P93, DOI 10.1109/FSKD.2012.6233957	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							0167248	10.1371/journal.pone.0167248	http://dx.doi.org/10.1371/journal.pone.0167248			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959927	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900007
J	Choi, H; Shin, JH; Kim, ES; Park, SJ; Bae, IH; Jo, YK; Jeong, IY; Kim, HJ; Lee, Y; Park, HC; Jeon, HB; Kim, KW; Lee, TR; Cho, DH				Choi, Hyunjung; Shin, Ji Hyun; Kim, Eun Sung; Park, So Jung; Bae, Il-Hong; Jo, Yoon Kyung; Jeong, In Young; Kim, Hyoung-June; Lee, Youngjin; Park, Hea Chul; Jeon, Hong Bae; Kim, Ki Woo; Lee, Tae Ryong; Cho, Dong-Hyung			Primary Cilia Negatively Regulate Melanogenesis in Melanocytes and Pigmentation in a Human Skin Model	PLoS One			English	Article							SONIC HEDGEHOG; INTRAFLAGELLAR TRANSPORT; KIDNEY-DISEASE; MELANOMA-CELLS; PROTEIN; GLI2; DIFFERENTIATION; CILIOGENESIS; HAIR	The primary cilium is an organelle protruding from the cell body that senses external stimuli including chemical, mechanical, light, osmotic, fluid flow, and gravitational signals. Skin is always exposed to the external environment and responds to external stimuli. Therefore, it is possible that primary cilia have an important role in skin. Ciliogenesis was reported to be involved in developmental processes in skin, such as keratinocyte differentiation and hair formation. However, the relation between skin pigmentation and primary cilia is largely unknown. Here, we observed that increased melanogenesis in melanocytes treated with a melanogenic inducer was inhibited by a ciliogenesis inducer, cytochalasin D, and serumfree culture. However, these inhibitory effects disappeared in GLI2 knockdown cells. In addition, activation of sonic hedgehog (SHH)-smoothened (Smo) signaling pathway by a Smo agonist, SAG inhibited melanin synthesis in melanocytes and pigmentation in a human skin model. On the contrary, an inhibitor of primary cilium formation, ciliobrevin A1, activated melanogenesis in melanocytes. These results suggest that skin pigmentation may be regulated partly by the induction of ciliogenesis through Smo-GLI2 signaling.	[Choi, Hyunjung; Shin, Ji Hyun; Kim, Eun Sung; Park, So Jung; Jo, Yoon Kyung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Gerontol, Yongin, Gyeonggi Do, South Korea; [Choi, Hyunjung; Bae, Il-Hong; Kim, Hyoung-June; Lee, Youngjin; Lee, Tae Ryong] AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea; [Jeong, In Young; Park, Hea Chul] Korea Univ, Dept Med Sci, Ansan Hosp, Ansan, Gyeonggi Do, South Korea; [Jeon, Hong Bae] MEDIPOST Corp, Biomed Res Inst, Seongnam, Gyeonggi Do, South Korea; [Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju, Gangwon Do, South Korea	Kyung Hee University; Korea University; Korea University Medicine (KU Medicine); MEDIPOST; Yonsei University	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Gerontol, Yongin, Gyeonggi Do, South Korea.; Lee, TR (corresponding author), AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea.	trlee@amorepacific.com; dhcho@khu.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515; Bae, Il-Hong/0000-0003-0535-8303	National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2013R1A1A1058361]; AmorePacific Corporation; MEDIPOST corporation	National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea; AmorePacific Corporation; MEDIPOST corporation	This study was supported by grants from the National Research Foundation (NRF-2013R1A1A1058361), Ministry of Science, ICT and Future Planning, Republic of Korea. All Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The AmorePacific Corporation (HC, IHB, HJK, YL, TRL) and MEDIPOST corporation (HBJ) provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balafa C, 2005, EXP DERMATOL, V14, P363, DOI 10.1111/j.0906-6705.2005.00287.x; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chang H, 2012, PIGM CELL MELANOMA R, V25, P765, DOI 10.1111/pcmr.12002; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Choi H, 2014, EXP DERMATOL, V23, P172, DOI 10.1111/exd.12343; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gazea M, 2016, DEV BIOL, V409, P55, DOI 10.1016/j.ydbio.2015.10.033; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Ji J, 2008, INT J CANCER, V122, P50, DOI 10.1002/ijc.23023; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kleene SJ, 2014, BIOSCIENCE, V64, P1092, DOI 10.1093/biosci/biu181; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lee CS, 2013, EXP DERMATOL, V22, P762, DOI 10.1111/exd.12248; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Snedecor ER, 2015, J INVEST DERMATOL, V135, P1456, DOI 10.1038/jid.2015.22; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200	34	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168025	10.1371/journal.pone.0168025	http://dx.doi.org/10.1371/journal.pone.0168025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941997	gold, Green Submitted, Green Published			2022-12-26	WOS:000392745600047
J	Lee, YB; Lee, SE; Jun, JE; Jee, JH; Bae, JC; Jin, SM; Kim, JH				Lee, You-Bin; Lee, Seung-Eun; Jun, Ji Eun; Jee, Jae Hwan; Bae, Ji Cheol; Jin, Sang-Man; Kim, Jae Hyeon			Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome	PLOS ONE			English	Article							HEME OXYGENASE-1; HEART-DISEASE; RISK; MEN; ACTIVATION; OUTCOMES; SYSTEM; CELLS	Aim Serum bilirubin level was negatively associated with the prevalence of metabolic syndrome (MetS) in previous cross-sectional studies. However, bilirubin variance preceding the development of MetS has yet to be investigated. We aimed to determine the effect of change in bilirubin concentration on the risk of incident MetS in healthy Korean adults. Methods We conducted a retrospective longitudinal study of subjects who had undergone at least four yearly health check-ups between 2006 and 2012. Of 24,185 total individuals who received annual check-ups, 11,613 non-MetS participants with a baseline bilirubin level not exceeding 34.2 mu mol/l were enrolled. We evaluated the association between percent change in bilirubin and risk of incident MetS. Results During 55,407 person-years of follow-up, 2,439 cases of incident MetS developed (21.0%). Baseline serum bilirubin level clearly showed no association with the development of MetS in men but an independent significant inverse association in women which attenuated (hence may be mediated) by elevated homeostatic model assessment index 2 for insulin resistance (HOMA2-IR). However, increased risk for incident MetS was observed in higher percent change in bilirubin quartiles, with hazard ratios of 2.415 (95% CI 2.094-2.785) in men and 2.156 (95% CI 1.738-2.675) in women in the fourth quartile, compared to the lowest quartile, after adjusting for age, smoking status, medication history, alanine aminotransferase, uric acid, estimated glomerular filtration rate, fasting glucose, baseline diabetes mellitus prevalence, systolic blood pressure, waist circumference, and body mass index. The hazard ratios per one standard deviation increase in percent change in bilirubin as a continuous variable were 1.277 (95% CI 1.229-1.326) in men and 1.366 (95% CI 1.288-1.447) in women. Conclusions Increases in serum bilirubin concentration were positively associated with a higher risk of incident MetS. Serum bilirubin increment might be a sensitive marker for the development of MetS.	[Lee, You-Bin; Lee, Seung-Eun; Jun, Ji Eun; Jin, Sang-Man; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Endocrinol & Metab,Dept Med, Changwon Si, Gyeongsangnam D, South Korea; [Kim, Jae Hyeon] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.; Kim, JH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea.	jaehyeon@skku.edu	Jin, Sang-Man/AFO-5933-2022	Lee, You-Bin/0000-0003-4058-1738				Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Barbagallo I, 2014, CURR PHARM DESIGN, V20, P4970; BREIMER LH, 1995, CLIN CHEM, V41, P1504; Chung JO, 2015, INTERNAL MED, V54, P141, DOI 10.2169/internalmedicine.54.2858; Giral P, 2010, ATHEROSCLEROSIS, V210, P607, DOI 10.1016/j.atherosclerosis.2009.12.026; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Kappas A, 2004, PEDIATRICS, V113, P119, DOI 10.1542/peds.113.1.119; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Kunutsor SK, 2015, ARTERIOSCL THROM VAS, V35, P716, DOI 10.1161/ATVBAHA.114.304929; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Lee MJ, 2014, DIABETES METAB, V40, P305, DOI 10.1016/j.diabet.2014.04.006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Onat A, 2015, EXP CLIN ENDOCR DIAB, V123, P11, DOI 10.1055/s-0034-1385922; Onat A, 2016, J INVEST MED, V64, P392, DOI 10.1136/jim-2015-000003; Onat A, 2013, INT J CARDIOL, V168, P4500, DOI 10.1016/j.ijcard.2013.06.119; Onat A, 2012, OBESITY, V20, P842, DOI 10.1038/oby.2011.136; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; WU TW, 1994, LIFE SCI, V54, pPL477, DOI 10.1016/0024-3205(94)90140-6	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168253	10.1371/journal.pone.0168253	http://dx.doi.org/10.1371/journal.pone.0168253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936224	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100284
J	Saad, SM; Randhawa, G; Pang, D				Saad, Sadiq M.; Randhawa, Gurch; Pang, Dong			Absence of Association between Behavior Problems in Childhood and Hypertension in Midlife	PLOS ONE			English	Article							BLOOD-PRESSURE; BIRTH-WEIGHT; TIME; RISK	Background It is known that behavior in childhood is associated with certain physical and mental health problems in midlife. However, there is limited evidence on the role of childhood behavior problems in the development of hypertension in adulthood. The present study aimed to examine whether behavior problems in childhood influenced the risk of hypertension in midlife in the United Kingdom 1958 birth cohort. Methods The 1958 British birth cohort comprised 17,638 individuals born in the first week of March 1958 in the United Kingdom. Behavior problems were assessed at 7, 11, and 16 years of age by parents and teachers. At age 45, blood pressure was measured and hypertension was recorded if blood pressure was >= 140/90 mm Hg or if the participants were informed by their health professionals that they had high blood pressure. Behavioral information was reported according to the Rutter Children's Behaviour Questionnaire (RCBQ) and the Bristol Social Adjustment Guide (BSAG). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to examine behavior problems in childhood in relation to hypertension at 45 years of age according to logistic regression analysis, with adjustment for sex, social class in childhood and adulthood, childhood cognition, birth weight, gestational age at birth, body mass index (BMI), smoking, alcohol consumption, and physical activity. Results Behavior problems reported by parents at 7, 11, and 16 years were not associated with hypertension in midlife (OR, 0.93; 95% CI, 0.81, 1.07; OR, 0.95; 95% CI, 0.81, 1.11; OR, 0.98; 95% CI, 0.85, 1.12, respectively). Similarly, teacher-reported behavior problems at 7, 11, and 16 years were not associated with hypertension in midlife (OR, 0.92; 95% CI, 0.72, 1.18; OR, 0.92; 95% CI, 0.84, 1.02; OR, 1.03; 95% CI, 0.92, 1.15, respectively). Further separate analyses showed similar results for males and females. Conclusion There is no association between behavior problems in childhood and hypertension in midlife.	[Saad, Sadiq M.; Randhawa, Gurch; Pang, Dong] Univ Bedfordshire, Inst Hlth Res, Luton, Beds, England	University of Bedfordshire	Pang, D (corresponding author), Univ Bedfordshire, Inst Hlth Res, Luton, Beds, England.	dong.pang@beds.ac.uk	QQ, Simon/D-3888-2014	randhawa, gurch/0000-0002-2289-5859				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Babor TF., 2001, AUDIT ALCOHOL USE DI; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chalmers J, 1999, J HYPERTENS, V17, P151; Colman I, 2009, BMJ-BRIT MED J, V338, DOI [10.1136/bmj.a2981, 10.1136/bmj.b777]; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; Jokela M, 2009, J CHILD PSYCHOL PSYC, V50, P1541, DOI 10.1111/j.1469-7610.2009.02122.x; Jokela M, 2009, J AM ACAD CHILD PSY, V48, P19, DOI 10.1097/CHI.0b013e31818b1c76; Kintscher U, 2013, EUROINTERVENTION, V9, pR12, DOI 10.4244/EIJV9SRA3; Klein John M., 2009, Psico-USF, V14, P157; Moore VM, 1999, J HYPERTENS, V17, P883, DOI 10.1097/00004872-199917070-00003; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; OPCS [Office of Population Censuses and Surveys], 1991, STAND OCC CLASS; Pang D, 2010, RHEUMATOLOGY, V49, P1882, DOI 10.1093/rheumatology/keq052; PICKERING GW, 1952, BRIT MED BULL, V8, P305, DOI 10.1093/oxfordjournals.bmb.a074193; Rosenman RH, 1966, PREVENTION ISCHEMIC; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Rutter M., 1970, ED HLTH BEHAV; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sourander A, 2007, J AM ACAD CHILD PSY, V46, P1148, DOI 10.1097/chi.0b013e31809861e9; Starr JM, 2004, J HYPERTENS, V22, P893, DOI 10.1097/00004872-200405000-00009; Stata C, 2013, STAT REL 13 DAT AN S; Stott D. H., 1987, SOCIAL ADJUSTMENT CH; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VEERMAN DP, 1994, HYPERTENSION, V24, P120, DOI 10.1161/01.HYP.24.1.120; von Stumm S, 2011, J CHILD PSYCHOL PSYC, V52, P992, DOI 10.1111/j.1469-7610.2011.02373.x; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	33	1	1	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167831	10.1371/journal.pone.0167831	http://dx.doi.org/10.1371/journal.pone.0167831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936147	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100211
J	Shabnam, N; Sharmila, P; Kim, H; Pardha-Saradhi, P				Shabnam, Nisha; Sharmila, P.; Kim, Hyunook; Pardha-Saradhi, P.			Light Mediated Generation of Silver Nanoparticles by Spinach Thylakoids/Chloroplasts	PLOS ONE			English	Article							GREEN SYNTHESIS; LEAVES; FATE	The unique potential of chloroplasts/thylakoids to harness light energy to transport electrons from H2O to various entities was exploited for reduction of Ag+ to generate nanoparticles (NPs). Spinach thylakoids/chloroplasts turned AgNO3 solutions brown in light, but not in dark. Besides showing Ag-NPs specific surface plasmon resonance band, these brown solutions showed presence of 5-30 nm crystalline NPs composed of Ag. Powder X-ray diffraction (PXRD) analysis revealed that Ag-NPs were biphasic composed of face-centered cubic Ag-0 and cubic Ag2O. X-ray photoelectron spectroscopy (XPS) data further corroborated the presence of Ag2O in Ag-NPs. Limited formation of Ag-NPs in dark and increased generation of Ag-0/Ag2O-NPs with increase in light intensity (photon flux density) by thylakoids/chloroplasts, established the role of light-harvesting photosynthetic machinery in generation of Ag-0/Ag2O-NPs. Potential of thylakoids/chloroplasts to generate Ag-NPs from Ag+ on exposure to red and blue wavelength regions of visible light of electromagnetic spectrum, further confirmed the involvement of photosynthetic electron transport in reduction of Ag+ and generation of Ag-NPs. While light energy mediated photosynthetic electron transport donates energized electrons extracted from H2O to Ag+ to form Ag-0-NPs, O-2 released as a by-product during photolysis of H2O oxidizes Ag-0 to form Ag2O-NPs. Our findings furnish a novel, simple, economic and green method that can be exploited for commercial production of Ag-0/Ag2O-NPs.	[Shabnam, Nisha; Pardha-Saradhi, P.] Univ Delhi, Dept Environm Studies, Delhi, India; [Sharmila, P.] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Kim, Hyunook] Univ Seoul, Dept Energy & Environm Syst Engn, Seoul, South Korea	University of Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Seoul	Pardha-Saradhi, P (corresponding author), Univ Delhi, Dept Environm Studies, Delhi, India.; Kim, H (corresponding author), Univ Seoul, Dept Energy & Environm Syst Engn, Seoul, South Korea.	h_kim@uos.ac.kr; ppsaradhi@gmail.com	Kim, Hyunook/C-9316-2012; Shabnam, Nisha/J-7470-2019	Kim, Hyunook/0000-0003-1256-480X; Shabnam, Nisha/0000-0002-1855-8497	Department of Biotechnology, Ministry of Science and Technology [BT/Bio-CARe/02/604/2011-12]; University of Delhi (IN) [RC/2015/9677]; Korea Environmental Industry and Technology Institute [2015001790002]; University Grants Commission [3625]	Department of Biotechnology, Ministry of Science and Technology; University of Delhi (IN); Korea Environmental Industry and Technology Institute; University Grants Commission(University Grants Commission, India)	Support was provided by: the Department of Biotechnology, Ministry of Science and Technology (Award Number: BT/Bio-CARe/02/604/2011-12, Recipient: P.Sharmila); University of Delhi (IN) (Award Number: RC/2015/9677, Recipient: P.Pardha-Saradhi, Ph.D.); Korea Environmental Industry and Technology Institute (Award Number: 2015001790002, Recipient: Hyunook Kim); and University Grants Commission (Award Number: 3625(NET-DEC.2012), Recipient: Nisha Shabnam). The funding received during this specific study had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ATAL N, 1991, PLANT CELL PHYSIOL, V32, P943, DOI 10.1093/oxfordjournals.pcp.a078181; Beattie IR, 2011, METALLOMICS, V3, P628, DOI 10.1039/c1mt00044f; Dahoumane SA, 2012, J NANOPART RES, V14, P17; Duncan DB, 1955, BIOMETRICS, V39, P205; Li C, 2012, INT J NANOMED, V7, P5995, DOI 10.2147/IJN.S38043; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P7027, DOI 10.1021/es204608d; Merzlyak MN, 2009, PHOTOSYNTH RES, V102, P31, DOI 10.1007/s11120-009-9481-8; Mohan S, 2014, CARBOHYD POLYM, V106, P469, DOI 10.1016/j.carbpol.2014.01.008; Pardha-Saradhi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106715; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Sarkar D, 2013, ACS APPL MATER INTER, V5, P331, DOI 10.1021/am302136y; Shabnam N, 2016, FUNCT PLANT BIOL, V43, P346, DOI 10.1071/FP15293; Shabnam N, 2015, PHOTOSYNTH RES, V125, P305, DOI 10.1007/s11120-014-0051-3; Shabnam N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085242; Shabnam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071123; Sharma VK, 2014, ADV COLLOID INTERFAC, V204, P15, DOI 10.1016/j.cis.2013.12.002; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Sicard C, 2010, J MATER CHEM, V20, P9342, DOI 10.1039/c0jm01735c; Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6; Terfa MT, 2013, PHYSIOL PLANTARUM, V148, P146, DOI 10.1111/j.1399-3054.2012.01698.x; Thanh NTK, 2014, CHEM REV, V114, P7610, DOI 10.1021/cr400544s; Yamal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061750	22	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167937	10.1371/journal.pone.0167937	http://dx.doi.org/10.1371/journal.pone.0167937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936248	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100234
J	Wang, LS; Lee, CT; Su, WL; Huang, SC; Wang, SC				Wang, Lung-Shuo; Lee, Chun-Ting; Su, Wei-Lieh; Huang, Shih-Che; Wang, Shu-Chi			Delonix regia Leaf Extract (DRLE): A Potential Therapeutic Agent for Cardioprotection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; DOWN-REGULATES ENOS; ANTIINFLAMMATORY ACTIVITY; PHENOLIC-COMPOUNDS; HEART-FAILURE; FLAVONOIDS; HYPERTROPHY; RAT; ANTIOXIDANTS	Delonix regia (Boj. Ex. Hook) is a flowering plant in the pea family found in tropical areas and its leaves are used informally to treat diseases in folk medicine. However, the cardioprotective effects in this plant are still unclear. In this study, we found that the Delonix regia leaf extract (DRLE) (400 mg/kg/d) can reduce the mortality rate in an isoproterenol (ISO)-induced heart injury and hypertrophy mouse model. Decreased serum levels of creatine phosphokinase, LDH, GOT, TNF-alpha and increased nitric oxide levels were found in DRLE-treated ISO-injured mice. In the in vitro study, the porcine coronary artery exhibited vasodilation effect induced by DRLE in a dose-dependent manner. In the DRLE toxic test, overdose of DRLE showed the high safety in normal mice and may have the ability to remove the metabolic wastes in blood. In conclusion, we demonstrated for the first time that DRLE has the cardioprotective effects by activating the vasodilation through NO pathway and preventing the myocyte injury via inhibition of TNF-alpha pathway. We suggest that DRLE may act as a promising novel herbal medicine for cardioprotection.	[Wang, Lung-Shuo] Tainan Sin Lau Hosp, Dept Chinese Med, Tainan, Taiwan; [Lee, Chun-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Su, Wei-Lieh] Kaohsiung Med Univ, Dept Occupat Therapy, Kaohsiung, Taiwan; [Huang, Shih-Che; Wang, Shu-Chi] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Huang, Shih-Che] E DA Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Shu-Chi] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Kaohsiung Medical University; I Shou University; E-Da Hospital; I Shou University	Wang, SC (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Wang, SC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.	wansuchi@isu.edu.tw			Intramural Industry-University Collaboration Projects in I-Shou university; E-Da hospital, Kaohsiung, Taiwan [ISU-103-INT-05E]	Intramural Industry-University Collaboration Projects in I-Shou university; E-Da hospital, Kaohsiung, Taiwan	This study was sponsored by the Intramural Industry-University Collaboration Projects in I-Shou university and E-Da hospital, Kaohsiung, Taiwan (ISU-103-INT-05E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Ahmed J, 2011, PHYTOPHARMACOL, V5, P118; Alves MJ, 2013, J APPL MICROBIOL, V115, P346, DOI 10.1111/jam.12196; Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Arul V., 1999, Journal of Pharmacy and Pharmacology, V51, P252; Azab SS, 2013, MED CHEM RES, V22, P4269, DOI 10.1007/s00044-012-0420-4; Barros L, 2009, FOOD CHEM TOXICOL, V47, P1076, DOI 10.1016/j.fct.2009.01.039; Bi FangJie, 2012, African Journal of Biotechnology, V11, P9270; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Bouic P J, 1999, Altern Med Rev, V4, P170; Bouic PJD, 2002, DRUG DISCOV TODAY, V7, P775, DOI 10.1016/S1359-6446(02)02343-7; Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301; Condorelli G, 2002, FASEB J, V16, P1732, DOI 10.1096/fj.02-0419com; Fatmawaty, 2013, Journal of Natural Products (India), V6, P61; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Ganapathy P, 2014, J ACAD IND RES, V3, P209; Geetha T, 2001, J ETHNOPHARMACOL, V76, P77, DOI 10.1016/S0378-8741(01)00175-1; Gomes A, 2012, BIOFACTORS, V38, P378, DOI 10.1002/biof.1033; Grassi D, 2010, NUTRIENTS, V2, P889, DOI 10.3390/nu2080889; Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057; Huang CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364741; Huang SC, 2010, NEUROGASTROENT MOTIL, V22, P1009, DOI 10.1111/j.1365-2982.2010.01513.x; Huang SC, 2011, REGUL PEPTIDES, V167, P246, DOI 10.1016/j.regpep.2011.02.007; Husain A, 2012, AM J PHARMTECH RES, V2, P380; Izzi V, 2012, FRONT BIOSCI-LANDMRK, V17, P2396, DOI 10.2741/4061; Jahan I, 2010, ACTA PHARMACEUT, V60, P207, DOI 10.2478/v10007-010-0018-7; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; LAKSHMI V, 1987, NATL ACAD SCI LETT, V10, P197; Lee MC, 2013, SCAND J GASTROENTERO, V48, P205, DOI 10.3109/00365521.2012.741615; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li XB, 2012, J PHARM PHARMACOL, V64, P1107, DOI 10.1111/j.2042-7158.2012.01502.x; Loizou S, 2010, MOL NUTR FOOD RES, V54, P551, DOI 10.1002/mnfr.200900012; Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033; Maity P, 2009, INDIAN J EXP BIOL, V47, P849; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; Modi A, 2016, CHIN J NAT MEDICINES, V14, P31, DOI 10.3724/SP.J.1009.2016.00031; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ozaki M, 2002, CIRC J, V66, P851, DOI 10.1253/circj.66.851; Ragasa CY, 2011, MANILA J SCI, V7, P7; Rahman M, 2011, AFR J TRADIT COMPLEM, V8, P34; Rani P. M. J., 2011, African Journal of Biochemistry Research, V5, P341; Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534; Rosenthal K, 2003, RODENT REFERENCE RAN; Sack MN, 2000, CARDIOVASC RES, V45, P688, DOI 10.1016/S0008-6363(99)00228-X; Sama K, 2011, INT J PHARM LIFE SCI, V2, P42; Shabir G, 2011, MOLECULES, V16, P7302, DOI 10.3390/molecules16097302; Shanmukha I, 2011, INT J CHEMTECH RES, V3, P280; Shewale VD, 2012, ADV PHARM SCI, V2012, P1; Shiramane RS, 2011, INT J RES PHARM CHEM, V1, P2231; Shiramane RS, 2011, INT J RES PHARM CHEM, V2, P234; Siasos G, 2013, CURR MED CHEM, V20, P2641, DOI 10.2174/0929867311320210003; Song F, 2013, J ETHNOPHARMACOL, V150, P125, DOI 10.1016/j.jep.2013.08.019; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Takaki Miyako, 2012, Pathophysiology, V19, P163, DOI 10.1016/j.pathophys.2012.04.004; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; WEXLER BC, 1978, AM HEART J, V96, P70, DOI 10.1016/0002-8703(78)90128-X; White RE, 2005, AM J PHYSIOL-HEART C, V289, pH1468, DOI 10.1152/ajpheart.01173.2004; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yang AL, 2011, CHINESE J PHYSIOL, V54, P87, DOI 10.4077/CJP.2011.AMM011	64	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167768	10.1371/journal.pone.0167768	http://dx.doi.org/10.1371/journal.pone.0167768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936072	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100181
J	Bogoevska, V; Wolters-Eisfeld, G; Hofmann, BT; El Gammal, AT; Mercanoglu, B; Gebauer, F; Vashist, YK; Bogoevski, D; Perez, D; Gagliani, N; Izbicki, JR; Bockhorn, M; Gungor, C				Bogoevska, V.; Wolters-Eisfeld, G.; Hofmann, B. T.; El Gammal, A. T.; Mercanoglu, B.; Gebauer, F.; Vashist, Y. K.; Bogoevski, D.; Perez, D.; Gagliani, N.; Izbicki, J. R.; Bockhorn, M.; Guengoer, C.			HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer	ONCOGENE			English	Article							ARYL-HYDROCARBON RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; N-WASP; PROTEIN; GROWTH; TRANSCRIPTION; NETWORK; TARGETS	Colorectal cancer (CRC) is a complex disease with still unsatisfactory prognosis even in western societies, although substantial progress has been made in pre-screening programs, surgical techniques and targeted therapy options. Mediator of motility-1 (Memo-1) was previously recognized as an important effector of cell migration downstream of receptor tyrosine kinase signaling in breast cancer. This study identified Memo-1 as frequently overexpressed in CRC and established a close link between extracellular HER2 activation, AhR/ARNT transcriptional activity and Memo-1 expression. Dissection of the hMemo-1 gene promoter using reporter assays and chromatin IP techniques revealed recruitment of Aryl hydrocarbon receptor (AhR)/Aryl hydrocarbon receptor nuclear-translocator (ARNT) complex, which positively influenced Memo-1 expression in cancer cells. We found that Memo-1 depletion negatively influenced the cellular actin network and that its expression is required for HER2-mediated cell migration and invasion. Moreover, analyses of Memo-1 expression in primary CRC revealed correlation with clinical parameters that point to Memo-1 as a new prognostic factor of aggressive disease in CRC patients. Altogether, these observations demonstrate that Memo-1 is an important downstream regulator of HER2-driven CRC cell migration and invasion through connecting extracellular signals from membrane to the cytoskeletal actin network.	[Bogoevska, V.] Cardiologicum Hamburg Res & Study Ctr, Hamburg, Germany; [Bogoevska, V.; Wolters-Eisfeld, G.; Hofmann, B. T.; El Gammal, A. T.; Mercanoglu, B.; Gebauer, F.; Vashist, Y. K.; Bogoevski, D.; Perez, D.; Gagliani, N.; Izbicki, J. R.; Bockhorn, M.; Guengoer, C.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Expt Oncol, Martinistr 52, D-20246 Hamburg, Germany; [Vashist, Y. K.] Kantonsspital Aarau AG, Sect Visceral Surg, Dept Surg, Aarau, Switzerland; [Gagliani, N.] Univ Med Ctr, Dept Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Kantonsspital Aarau AG (KSA); University of Hamburg; University Medical Center Hamburg-Eppendorf	Gungor, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Expt Oncol, Martinistr 52, D-20246 Hamburg, Germany.	c.guengoer@uke.de	Vashist, Yogesh/AFH-9205-2022; Vashist, Yogesh/AAF-3529-2022; Wolters-Eisfeld, Gerrit/H-8333-2019; Vashist, Yogesh/ABE-4001-2020	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Perez, Daniel/0000-0002-3154-7311; Gagliani, Nicola/0000-0001-8514-1395	'Roggenbuck Foundation', Hamburg, Germany	'Roggenbuck Foundation', Hamburg, Germany	We thank A Heinecke, P Merkert and P Schroder for excellent technical assistance and Dr M Linnebacher for providing primary CRC cells. This work (CG) was partially funded by the 'Roggenbuck Foundation', Hamburg, Germany.	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Atlas E, 2003, MOL CANCER RES, V1, P165; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Carvajal-Gonzalez JM, 2009, MOL BIOL CELL, V20, P1715, DOI 10.1091/mbc.E08-05-0451; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Feng SL, 2013, BBA-REV CANCER, V1836, P197, DOI 10.1016/j.bbcan.2013.05.001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Heppner BI, 2014, BRIT J CANCER, V111, P1977, DOI 10.1038/bjc.2014.483; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang K, 2013, J BIOL CHEM, V288, P24590, DOI 10.1074/jbc.M113.467837; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Lai DW, 2014, ONCOTARGET, V5, P7788, DOI 10.18632/oncotarget.2307; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; MacDonald G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004870; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052485; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Momeny M, 2015, ONCOTARGET, V6, P3932, DOI 10.18632/oncotarget.2846; Oberlander M, 2013, LANGENBECK ARCH SURG, V398, P251, DOI 10.1007/s00423-012-1043-4; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Rawnaq T, 2014, MOL CANCER RES, V12, P670, DOI 10.1158/1541-7786.MCR-13-0467; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Romiti A, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0496-z; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Ross JS, 2001, CANCER INVEST, V19, P554, DOI 10.1081/CNV-100103852; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Stier S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/271246; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Yang MH, 2011, LEUKEMIA LYMPHOMA, V52, P298, DOI 10.3109/10428194.2010.538776; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zegers Mirjam M, 2014, Small GTPases, V5, pe28997, DOI 10.4161/sgtp.28997; Zhao S, 2013, CANCER LETT, V330, P41, DOI 10.1016/j.canlet.2012.11.021	39	16	17	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2394	2404		10.1038/onc.2016.390	http://dx.doi.org/10.1038/onc.2016.390			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27941874				2022-12-26	WOS:000400268900006
J	Liao, SH; Hu, HQ; Wang, T; Tu, XM; Li, ZY				Liao, Shanhui; Hu, Huiqing; Wang, Tao; Tu, Xiaoming; Li, Ziyin			The Protein Neddylation Pathway in Trypanosoma brucei FUNCTIONAL CHARACTERIZATION AND SUBSTRATE IDENTIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT ZONE FILAMENT; UBIQUITIN-LIKE PROTEIN; FLAGELLUM ATTACHMENT; CELL-CYCLE; CENTROSOME DUPLICATION; MODIFIER NEDD8; IN-VIVO; COMPLEX; LIGASE; CDT1	Protein posttranslational modifications such as neddylation play crucial roles in regulating protein function. Only a few neddylated substrates have been validated to date, and the role of neddylation remains poorly understood. Here, using Trypanosoma brucei as the model organism, we investigated the function and substrates of TbNedd8. TbNedd8 is distributed throughout the cytosol but enriched in the nucleus and the flagellum. Depletion of TbNedd8 by RNAi abolished global protein ubiquitination, caused DNA re-replication in postmitotic cells, impaired spindle assembly, and compromised the flagellum attachment zone filament, leading to flagellum detachment. Through affinity purification and mass spectrometry, we identified 70 TbNedd8-conjugated and -associated proteins, including known Nedd8-conjugated and -associated proteins, putative TbNedd8 conjugation system enzymes, proteins of diverse biological functions, and proteins of unknown function. Finally, we validated six Cullins as bona fide TbNedd8 substrates and identified the TbNedd8 conjugation site in three Cullins. This work lays the foundation for understanding the roles of protein neddylation in this early divergent parasitic protozoan.	[Liao, Shanhui; Tu, Xiaoming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Liao, Shanhui; Hu, Huiqing; Wang, Tao; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Wang, Tao] Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Tu, XM (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.; Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	xmtu@ustc.edu.cn; ziyin.li@uth.tmc.edu	Liao, Shanhui/N-1628-2018; Tu, Xiaoming/G-5090-2018	Liao, Shanhui/0000-0002-5083-667X; Li, Ziyin/0000-0002-3960-9716	National Natural Science Foundation of China [31270780, U1332137, 21272090, 31500601]; Fundamental Research Funds for the Central Universities [WK2070000020]; National Institutes of Health [R01AI101437, R01AI118736]; Chinese Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 31270780, U1332137, and 21272090 (to X. T.) and 31500601 (to S. L.), Fundamental Research Funds for the Central Universities Grant WK2070000020 (to X. T.), and National Institutes of Health Grants R01AI101437 and R01AI118736 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a scholarship from the Chinese Scholarship Council.	Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Hu HQ, 2012, J CELL SCI, V125, P4126, DOI 10.1242/jcs.106534; Hu L, 2012, MOL MICROBIOL, V83, P565, DOI 10.1111/j.1365-2958.2011.07951.x; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Koopmann R, 2009, AUTOPHAGY, V5, P1085, DOI 10.4161/auto.5.8.9611; Korzeniewski N, 2009, CANCER RES, V69, P6668, DOI 10.1158/0008-5472.CAN-09-1284; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; Li TW, 2006, ARCH BIOCHEM BIOPHYS, V453, P70, DOI 10.1016/j.abb.2006.03.002; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EXP CELL RES, V312, P3504, DOI 10.1016/j.yexcr.2006.07.022; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu Y, 2013, MOL MICROBIOL, V90, P130, DOI 10.1111/mmi.12352; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Norman JA, 2006, BIOCHEMISTRY-US, V45, P3014, DOI 10.1021/bi052435a; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; SASSE R, 1988, J CELL SCI, V90, P577; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X; Woods K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052846; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Zhang W, 2009, PROTEINS, V75, P781, DOI 10.1002/prot.22371; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	51	18	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1081	1091		10.1074/jbc.M116.766741	http://dx.doi.org/10.1074/jbc.M116.766741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956554	hybrid, Green Published			2022-12-26	WOS:000392318700027
J	Chen, Y; Hora, B; DeMarco, T; Shah, SA; Ahmed, M; Sanchez, AM; Su, C; Carter, M; Stone, M; Hasan, R; Hasan, Z; Busch, MP; Denny, TN; Gao, F				Chen, Yue; Hora, Bhavna; DeMarco, Todd; Shah, Sharaf Ali; Ahmed, Manzoor; Sanchez, Ana M.; Su, Chang; Carter, Meredith; Stone, Mars; Hasan, Rumina; Hasan, Zahra; Busch, Michael P.; Denny, Thomas N.; Gao, Feng			Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan	PLOS ONE			English	Article							INJECTION-DRUG USERS; INFECTION; DYNAMICS; GENOMES	A number of HIV-1 subtypes are identified in Pakistan by characterization of partial viral gene sequences. Little is known whether new recombinants are generated and how they disseminate since whole genome sequences for these viruses have not been characterized. Near full-length genome (NFLG) sequences were obtained by amplifying two overlapping half genomes or next generation sequencing from 34 HIV-1-infected individuals in Pakistan. Phylogenetic tree analysis showed that the newly characterized sequences were 16 subtype As, one subtype C, and 17 A/G recombinants. Further analysis showed that all 16 subtype A1 sequences (47%), together with the vast majority of sequences from Pakistan from other studies, formed a tight subcluster (A1a) within the subtype A1 clade, suggesting that they were derived from a single introduction. More in-depth analysis of 17 A/G NFLG sequences showed that five shared similar recombination breakpoints as in CRF02 (15%) but were phylogenetically distinct from the prototype CRF02 by forming a tight subcluster (CRF02a) while 12 (38%) were new recombinants between CRF02a and A1a or a divergent A1b viruses. Unique recombination patterns among the majority of the newly characterized recombinants indicated ongoing recombination. Interestingly, recombination breakpoints in these CRF02/A1 recombinants were similar to those in prototype CRF02 viruses, indicating that recombination at these sites more likely generate variable recombinant viruses. The dominance and fast dissemination of new CRF02a/A1 recombinants over prototype CRF02 suggest that these recombinant have more adapted and may become major epidemic strains in Pakistan.	[Chen, Yue; Hora, Bhavna; DeMarco, Todd; Sanchez, Ana M.; Su, Chang; Carter, Meredith; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Shah, Sharaf Ali; Ahmed, Manzoor] Bridge Consultants Fdn, Karachi, Pakistan; [Stone, Mars; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Hasan, Rumina; Hasan, Zahra] Aga Khan Univ, Dept Pathol, Karachi, Pakistan; [Hasan, Rumina; Hasan, Zahra] Aga Khan Univ, Dept Microbiol, Karachi, Pakistan	Duke University; Vitalant; Vitalant Research Institute; Aga Khan University; Aga Khan University	Gao, F (corresponding author), Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	fgao@duke.edu		Hasan, Zahra/0000-0001-7580-372X	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) [HHSN272201000045C, HHSN272200800014C]	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL)	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) (HHSN272201000045C and HHSN272200800014C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093415; Andrew Rambaut TTL, 2016, VIRUS EVOLUTION, V2, P1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Baqi S, 1999, INT J STD AIDS, V10, P300, DOI 10.1258/0956462991914159; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Kijak GH, 2010, AIDS RES HUM RETROV, V26, P1317, DOI 10.1089/aid.2010.0127; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; National AIDS Control Program MoNHS, 2015, PAK GLOB AIDS RESP P; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rajabali A, 2008, LANCET INFECT DIS, V8, P511, DOI 10.1016/S1473-3099(08)70183-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez AM, 2014, J IMMUNOL METHODS; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Sanchez ana M., 2016, PLOS ONE; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Siddiqui AUR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000154; Simonyan V, 2014, GENES-BASEL, V5, P957, DOI 10.3390/genes5040957; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yousaf MZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-401	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167839	10.1371/journal.pone.0167839	http://dx.doi.org/10.1371/journal.pone.0167839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973597	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300045
J	Davis, SE; Maftei, M; Mallory, ML				Davis, Shanti E.; Maftei, Mark; Mallory, Mark L.			Migratory Connectivity at High Latitudes: Sabine's Gulls (Xema sabini) from a Colony in the Canadian High Arctic Migrate to Different Oceans	PLOS ONE			English	Article							RHODOSTETHIA-ROSEA; RADAR OBSERVATIONS; PAGOPHILA-EBURNEA; BIRD MIGRATION; EVOLUTION; TRACKING; ROUTES; GEOLOCATION; POPULATION; PHILOPATRY	The world's Arctic latitudes are some of the most recently colonized by birds, and an understanding of the migratory connectivity of circumpolar species offers insights into the mechanisms of range expansion and speciation. Migratory divides exist for many birds, however for many taxa it is unclear where such boundaries lie, and to what extent these affect the connectivity of species breeding across their ranges. Sabine's gulls (Xema sabini) have a patchy, circumpolar breeding distribution and overwinter in two ecologically similar areas in different ocean basins: the Humboldt Current off the coast of Peru in the Pacific, and the Benguela Current off the coasts of South Africa and Namibia in the Atlantic. We used geolocators to track Sabine's gulls breeding at a colony in the Canadian High Arctic to determine their migratory pathways and wintering sites. Our study provides evidence that birds from this breeding site disperse to both the Pacific and Atlantic oceans during the non-breeding season, which suggests that a migratory divide for this species exists in the Nearctic. Remarkably, members of one mated pair wintered in opposite oceans. Our results ultimately suggest that colonization of favorable breeding habitat may be one of the strongest drivers of range expansion in the High Arctic.	[Davis, Shanti E.; Maftei, Mark; Mallory, Mark L.] High Arctic Gull Res Grp, Victoria, BC, Canada; [Davis, Shanti E.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Mallory, Mark L.] Acadia Univ, Dept Biol, Wolfville, NS, Canada	Memorial University Newfoundland; Acadia University	Davis, SE (corresponding author), High Arctic Gull Res Grp, Victoria, BC, Canada.; Davis, SE (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	shanti.davis@gmail.com			Canadian Wildlife Federation; Natural Sciences and Engineering Research Council of Canada; Northern Scientific Training Program; Acadia University; Memorial University of Newfoundland	Canadian Wildlife Federation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Scientific Training Program; Acadia University; Memorial University of Newfoundland	Financial support was received from Canadian Wildlife Federation (MM http://www.cwf-fcf.org); Natural Sciences and Engineering Research Council of Canada (MLM, SD, and I. Jones, http://www.nserc-crsng.gc.ca/); Northern Scientific Training Program (SD, MM https://nstp-pfsn.fluidreview.com/); Acadia University (MLM http://www2.acadiau.ca/); and Memorial University of Newfoundland (SD www.mun.ca). Logistical support was provided by Natural Resources Canada (Polar Continental Shelf Project, MLM, http://www.nrcan.gc.ca/the-north/polar-continental-shelf-program/polar-shelf/10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1999, P ROY SOC B-BIOL SCI, V266, P2499, DOI 10.1098/rspb.1999.0952; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1999, ARCTIC, V52, P346; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Alvarado AH, 2014, ECOL EVOL, V4, P3456, DOI 10.1002/ece3.1205; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Beyer HL, 2012, SPATIAL ECOLOGY LCC; BLOMQVIST S, 1981, ARCTIC, V34, P122; Bub H, 1991, BIRD TRAPPING BIRD B; CHAPMAN SE, 1969, IBIS, V111, P615, DOI 10.1111/j.1474-919X.1969.tb02576.x; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Day Robert H., 2001, Birds of North America, V593, P1; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; Edwards Darryl B., 2011, Wader Study Group Bulletin, V118, P134; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Fifield DA, 2014, ORNITHOL MONOGR, P1; Fijn RC, 2013, E ANTARCTICA ARDEA, V101, P1; Freitas C., 2012, ARGOSFILTER ARGOS LO, P1; Gilg O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064614; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2010, SCIENCE, V327, P276, DOI 10.1126/science.1184964; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Gudmundsson GA, 2002, ARCTIC, V55, P21; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hedenstrom A, 1998, ARCTIC, V51, P283; Henningsson SS, 2008, J BIOGEOGR, V35, P781, DOI 10.1111/j.1365-2699.2007.01845.x; Henningsson SS, 2005, P ROY SOC B-BIOL SCI, V272, P2251, DOI 10.1098/rspb.2005.3221; Hobson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129340; Irwin Darren E., 2005, P27; Kerr KCR, 2013, ECOL EVOL, V3, P1915, DOI 10.1002/ece3.597; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Kraaijeveld K, 2000, ARDEA, V88, P193; Lambert K., 1972, CAN FIELD NAT, V87, P57; Lotek Wireless, 2010, LAT 2900 SER NAN LIG, P1; Macdonald C. A., 2013, Animal Migration, V1, P23, DOI 10.2478/ami-2012-0003; Maftei M, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.25055; Mallory ML, 2012, POLAR BIOL, V35, P335, DOI 10.1007/s00300-011-1079-x; Marra P. P., 2011, ENVIROMENTAL LAW, V41, P317; Mehl KR, 2004, CONDOR, V106, P241, DOI 10.1650/7356; Morrison RIG, 2006, ARDEA, V94, P607; Mosbech A, 2006, ARDEA, V94, P651; Muller MS, 2015, ANIM BEHAV, V102, P267, DOI 10.1016/j.anbehav.2015.02.005; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; Rogacheva E.V., 1987, P9; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Stenhouse IJ, 2005, CONDOR, V107, P416, DOI 10.1650/7627; Stenhouse IJ, 2001, CONDOR, V103, P98, DOI 10.1650/0010-5422(2001)103[0098:RBOSSG]2.0.CO;2; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Webster Michael S., 2005, P199; Yannic G, 2016, POLAR BIOL, V39, P221, DOI 10.1007/s00300-015-1775-z	56	16	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166043	10.1371/journal.pone.0166043	http://dx.doi.org/10.1371/journal.pone.0166043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973614	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300007
J	von Byern, J; Dorrer, V; Merritt, DJ; Chandler, P; Stringer, I; Marchetti-Deschmann, M; McNaughton, A; Cyran, N; Thiel, K; Noeske, M; Grunwald, I				von Byern, Janek; Dorrer, Victoria; Merritt, David J.; Chandler, Peter; Stringer, Ian; Marchetti-Deschmann, Martina; McNaughton, Andrew; Cyran, Norbert; Thiel, Karsten; Noeske, Michael; Grunwald, Ingo			Characterization of the Fishing Lines in Titiwai (=Arachnocampa luminosa Skuse, 1890) from New Zealand and Australia	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; VISCOUS CAPTURE THREADS; GLOW-WORM; CIRCADIAN BIOLUMINESCENCE; MALPIGHIAN TUBULES; GLYCOPROTEIN GLUE; INSECT SILK; EGG STALKS; DIPTERA; MYCETOPHILIDAE	Animals use adhesive secretions in a plethora of ways, either for attachment, egg anchorage, mating or as either active or passive defence. The most interesting function, however, is the use of adhesive threads to capture prey, as the bonding must be performed within milliseconds and under unsuitable conditions (movement of prey, variable environmental conditions, unfavourable attack angle, etc.) to be nonetheless successful. In the following study a detailed characterization of the prey capture system of the world-renowned glowworm group Arachnocampa from the macroscopic to the ultrastructural level is performed. The data reveal that the adhesive droplets consist mostly of water and display hygroscopic properties at varying humidity levels. The droplet core of Arachnocampa luminosa includes a certain amount of the elements sodium, sulphur and potassium (beside carbon, oxygen and nitrogen), while a different element composition is found in the two related species A. richardsae and A. tasmaniensis. Evidence for lipids, carbohydrates and proteins was negative on the histochemical level, however X-ray photoelectron spectroscopy confirm the presence of peptides within the droplet content. Different to earlier assumptions, the present study indicates that rather than oxalic acid, urea or uric acid are present in the adhesive droplets, presumably originating from the gut. Comparing the capture system in Arachnocampa with those of orb-spiders, large differences appear not only regarding the silky threads, but also, in the composition, hygroscopic properties and size of the mucous droplets.	[von Byern, Janek] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [von Byern, Janek; Cyran, Norbert] Univ Vienna, Fac Life Sci, Core Facil Cell Imaging Ultrastruct Res, Vienna, Austria; [Dorrer, Victoria; Marchetti-Deschmann, Martina] Tech Univ Wien, Inst Chem Technol & Analyt, Vienna, Austria; [Merritt, David J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Chandler, Peter] Spellbound Cave, Waitomo, New Zealand; [Stringer, Ian] Dept Conservat, Wellington, New Zealand; [McNaughton, Andrew] Univ Otago, Otago Ctr Confocal Microscopy, Sch Med Sci, Dept Anat, Otago, New Zealand; [Thiel, Karsten; Noeske, Michael; Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat, Dept Adhes Bonding Technol & Surfaces, Bremen, Germany	Ludwig Boltzmann Institute; University of Vienna; Technische Universitat Wien; University of Queensland; University of Otago; Fraunhofer Gesellschaft	von Byern, J (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.; von Byern, J (corresponding author), Univ Vienna, Fac Life Sci, Core Facil Cell Imaging Ultrastruct Res, Vienna, Austria.	vByern@freenet.de	Grunwald, Ingo/C-5662-2012; Noeske, Michael/AAB-9123-2020; Merritt, David J/D-2318-2010; Marchetti-Deschmann, Martina/AAO-9614-2020	Noeske, Michael/0000-0002-5417-6808; Merritt, David J/0000-0002-8573-7508; Marchetti-Deschmann, Martina/0000-0002-8060-7851; von Byern, Janek/0000-0001-7243-0438	Austrian Science Foundation FWF [AP 24531-B17]	Austrian Science Foundation FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation FWF (Project No. AP 24531-B17).	Baker C. H., 2003, Australian Entomologist, V30, P45; Baker CG., 2004, THESIS; Baker CH, 2002, WILDLIFE TOURISM RES, V21, P1; Baker CH, 2008, MEMOIRS QUEENSLAND M, V55, P11; Baker CH, 2008, MOL PHYLOGENET EVOL, V48, P506, DOI 10.1016/j.ympev.2008.04.037; Bauer F, 2012, BIOMACROMOLECULES, V13, P3730, DOI 10.1021/bm301199d; Bauer F, 2012, ANGEW CHEM INT EDIT, V51, P6521, DOI 10.1002/anie.201200591; Betz O, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P111, DOI 10.1007/978-3-7091-0286-2_8; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; BRADLEY TJ, 1985, COMPREHENSIVE INSECT, V4, P421; Broadley RA, 2012, NZ ENTOMOL, V35, P1, DOI 10.1080/00779962.2012.649689; Broadley R.A., 2009, BIOLUMINESCENCE FOCU, P325; Broadley RA, 2001, INVERTEBR BIOL, V120, P170, DOI 10.1111/j.1744-7410.2001.tb00121.x; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; CRAIG R, 1960, ANNU REV ENTOMOL, V5, P53, DOI 10.1146/annurev.en.05.010160.000413; Doran B., 2004, THESIS; Edwards FW, 1933, P LINN SOC LONDON, P3; Edwards FW, 1924, J NAT HIST, V9, P175; Fu C, 2009, J CHEM SOC CHEM COMM, V43, P6515; FULTON B. B., 1941, ANN ENT SOC AMERICA, V34, P289; FULTON B. B., 1939, JOUR ELISHA MITCHELL SCI SOC, V55, P289; GATENBY J. BRONTE, 1960, TUATARA, V8, P86; GATENBY J. BRONTE, 1960, TRANS ROY SOC NEW ZEALAND, V88, P149; GATENBY J. BRONTE, 1959, TRANS ROY SOC NEW ZEALAND, V87, P291; GREEN LFB, 1979, TISSUE CELL, V11, P457, DOI 10.1016/0040-8166(79)90056-9; GREEN LFB, 1980, TISSUE CELL, V12, P141, DOI 10.1016/0040-8166(80)90057-9; GREEN LFB, 1979, TISSUE CELL, V11, P673, DOI 10.1016/0040-8166(79)90024-7; HARRISON RA, 1966, PAC INSECTS, V8, P877; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hudson GV, 1891, T P NEW ZEAL I, V23, P43; Hudson GV, 1886, T P NZ I, V19, P62; Hudson GV., 1886, ENTOMOL MON MAG, V23, P99; Humphries T., 1889, APPENDICES J HOUSE R, VIII, pH; Hutton FW, 1901, T ROYAL SOC NZ, V34, P179; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; KENCHINGTON W, 1983, J INSECT PHYSIOL, V29, P355, DOI 10.1016/0022-1910(83)90037-9; Kermode L, 1974, NZ SPELEOL B, V5, P313; LEE J, 1976, PHOTOCHEM PHOTOBIOL, V24, P279, DOI 10.1111/j.1751-1097.1976.tb06823.x; MATILE L, 1981, ANN SOC ENTOMOL FR, V17, P99; May BM, 2013, NZ SPELEOLOGICAL B, V3, P169; Maynard AJ, 2013, INTEGR COMP BIOL, V53, P154, DOI 10.1093/icb/ict011; Merritt DJ, 2011, J BIOL RHYTHM, V26, P34, DOI 10.1177/0748730410391947; Merritt DJ, 2001, NEWCAVES CHRONICLES, V16, P42; Merritt DJ, 2009, BIOLUMINESCENCE FOCU, P291; Merritt DJ, 2005, WAITOMO CAVES MUSEUM, P1; Meyer-Rochow VB, 2007, LUMINESCENCE, V22, P251, DOI 10.1002/bio.955; Meyer-Rochow VB, 1990, NZ GLOWWORM; Meyrick E, 1886, ENTOMOLOGISTS MONTHL, V22, P266; Neuenfeldt M, 2015, INSECT MOL BIOL ECOL, P376; Opell BD, 2010, J EXP BIOL, V213, P339, DOI 10.1242/jeb.036947; Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682; Opell BD, 2015, J ARACHNOL, V43, P152; Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822; Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996; Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064; Opell BD, 2009, ZOOLOGY, V112, P16, DOI 10.1016/j.zool.2008.04.002; Osten-Sacken CR, 1884, ENTOMOLOGISTS MONTHE, V23, P133; PANT R, 1978, BIOCHEM J, V174, P341, DOI 10.1042/bj1740341; Petrie E. M., 2007, HDB ADHESIVES SEALAN; Piper R., 2007, EXTRAORDINARY ANIMAL; PUGSLEY C, 1984, J ROY SOC NEW ZEAL, V14, P387, DOI 10.1080/03036758.1984.10421739; Pugsley C., 1982, U AUCKLAND NEWS, V12, P7; PUGSLEY CW, 1983, NEW ZEAL ENTOMOL, V7, P419; Pugsley CW, 1980, THESIS; Purchas AG., 1871, T N Z I, V4, P388; RAMSAY JA, 1958, J EXP BIOL, V35, P871; Rasines G, 2015, CARBON, V83, P262, DOI 10.1016/j.carbon.2014.11.015; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDS AOLA M., 1960, TRANS ROY SOC NEW ZEALAND, V88, P559; RICHARDS AOLA M., 1964, STUD SPELEOL, V1, P38; Rudall K. M., 1962, COMP BIOCH, P397; SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781; Schulz S, 2001, LIPIDS, V36, P637, DOI 10.1007/s11745-001-0768-7; Skuse FAA, 1890, P LINNEAN SOC N S WA, V2, P677; Stellwagen SD, 2014, J EXP BIOL, V217, P1563, DOI 10.1242/jeb.097816; STRINGER I. A. N., 1967, TANE, V13, P107; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Teuschl AH, 2014, TISSUE ENG PART C-ME, V20, P431, DOI [10.1089/ten.tec.2013.0278, 10.1089/ten.TEC.2013.0278]; Tillinghast EK, 1993, BIOMOLECULAR MAT, P9; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; Townley Mark A., 2013, P283; Viviani VR, 2002, PHOTOCHEM PHOTOBIOL, V75, P22, DOI 10.1562/0031-8655(2002)075<0022:TBDTNA>2.0.CO;2; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; von Byern J, 2015, ZOOLOGY, V118, P334, DOI 10.1016/j.zool.2015.04.003; Walker AA, 2015, COMP BIOCHEM PHYS B, V187, P78, DOI 10.1016/j.cbpb.2015.05.008; Walker AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030408; Willis RE, 2011, J COMP PHYSIOL B, V181, P477, DOI 10.1007/s00360-010-0533-3; Zahl P. A., 1971, National Geographic Mag, V140, P45	91	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0162687	10.1371/journal.pone.0162687	http://dx.doi.org/10.1371/journal.pone.0162687			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973586	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300002
J	Amaradasa, BS; Everhart, SE				Amaradasa, B. Sajeewa; Everhart, Sydney E.			Effects of Sublethal Fungicides on Mutation Rates and Genomic Variation in Fungal Plant Pathogen, Sclerotinia sclerotiorum	PLOS ONE			English	Article							UNDERSTANDING MOLECULAR-MECHANISMS; PHYTOPATHOGENIC FUNGI; R-PACKAGE; RESISTANCE; POPULATIONS; EVOLUTION; AFLP; MICROSATELLITES; ANTIBIOTICS; STROBILURIN	Pathogen exposure to sublethal doses of fungicides may result in mutations that may represent an important and largely overlooked mechanism of introducing new genetic variation into strictly clonal populations, including acquisition of fungicide resistance. We tested this hypothesis using the clonal plant pathogen, Sclerotinia sclerotiorum. Nine susceptible isolates were exposed independently to five commercial fungicides with different modes of action: boscalid (respiration inhibitor), iprodione (unclear mode of action), thiophanate methyl (inhibition of microtubulin synthesis) and azoxystrobin and pyraclostrobin (quinone outside inhibitors). Mycelium of each isolate was inoculated onto a fungicide gradient and sub-cultured from the 50-100% inhibition zone for 12 generations and experiment repeated. Mutational changes were assessed for all isolates at six neutral microsatellite (SSR) loci and for a subset of isolates using amplified fragment length polymorphisms (AFLPs). SSR analysis showed 12 of 85 fungicide-exposed isolates had a total of 127 stepwise mutations with 42 insertions and 85 deletions. Most stepwise deletions were in iprodione-and azoxystrobin- exposed isolates (n = 40/85 each). Estimated mutation rates were 1.7 to 60-fold higher for mutated loci compared to that expected under neutral conditions. AFLP genotyping of 33 isolates (16 non-exposed control and 17 fungicide exposed) generated 602 polymorphic alleles. Cluster analysis with principal coordinate analysis (PCoA) and discriminant analysis of principal components (DAPC) identified fungicide-exposed isolates as a distinct group from non-exposed control isolates (PhiPT = 0.15, P = 0.001). Dendrograms based on neighbor-joining also supported allelic variation associated with fungicide-exposure. Fungicide sensitivity of isolates measured throughout both experiments did not show consistent trends. For example, eight isolates exposed to boscalid had higher EC50 values at the end of the experiment, and when repeated, only one isolate had higher EC50 while most isolates showed no difference. Results of this support the hypothesis that sublethal fungicide stress increases mutation rates in a largely clonal plant pathogen under in vitro conditions. Collectively, this work will aid our understanding how non-lethal fungicide exposure may affect genomic variation, which may be an important mechanism of novel trait emergence, adaptation, and evolution for clonal organisms.	[Amaradasa, B. Sajeewa; Everhart, Sydney E.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Everhart, SE (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	everhart@unl.edu		Everhart, Sydney/0000-0002-5773-1280	North Central Soybean Research Program [639K623]; Layman Award [2446]; University of Nebraska-Lincoln	North Central Soybean Research Program; Layman Award; University of Nebraska-Lincoln	Funding for this research was provided by the North Central Soybean Research Program (#639K623) to SEE, a Layman Award (#2446) to SEE and start-up funds from the University of Nebraska-Lincoln to SEE.	Ajouz S, 2010, FUNGAL BIOL-UK, V114, P949, DOI 10.1016/j.funbio.2010.09.004; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Avenot HF, 2010, CROP PROT, V29, P643, DOI 10.1016/j.cropro.2010.02.019; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Beckerman JL, 2015, PEST MANAG SCI, V71, P331, DOI 10.1002/ps.3715; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Mesa-Arango AC, 2014, ANTIMICROB AGENTS CH, V58, P6627, DOI 10.1128/AAC.03570-14; Chen FP, 2015, FUNGAL GENET BIOL, V85, P38, DOI 10.1016/j.fgb.2015.10.006; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; DAVIDSE LC, 1986, ANNU REV PHYTOPATHOL, V24, P43, DOI 10.1146/annurev.py.24.090186.000355; DEKKER J, 1976, ANNU REV PHYTOPATHOL, V14, P405, DOI 10.1146/annurev.py.14.090176.002201; Dettman JR, 2004, GENETICS, V168, P1231, DOI 10.1534/genetics.104.029322; Duan YB, 2012, PESTIC BIOCHEM PHYS, V103, P101, DOI 10.1016/j.pestbp.2012.04.004; Ekins MG, 2011, AUSTRALAS PLANT PATH, V40, P99, DOI 10.1007/s13313-010-0018-6; Everhart SE, 2016, ANN REP BEAN IMPROV, V59, P131; Fernandez-Ortuno D, 2008, INT MICROBIOL, V11, P1, DOI 10.2436/20.1501.01.38; Forster H, 2004, PHYTOPATHOLOGY, V94, P163, DOI 10.1094/PHYTO.2004.94.2.163; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gressel J, 2011, PEST MANAG SCI, V67, P253, DOI 10.1002/ps.2071; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; KOHLI Y, 1995, MOL ECOL, V4, P69, DOI 10.1111/j.1365-294X.1995.tb00193.x; Kohli Y, 1998, FUNGAL GENET BIOL, V23, P139, DOI 10.1006/fgbi.1997.1026; Kohn LM, 2008, FUNGAL GENET BIOL, V45, P613, DOI 10.1016/j.fgb.2007.09.013; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; MILGROOM MG, 1988, PHYTOPATHOLOGY, V78, P565, DOI 10.1094/Phyto-78-565; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petzoldt R., 1996, ANN REP BEAN IMPROV, V39, P142; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Schnabel G., 2014, Modern fungicides and antifungal compounds VII. Proceedings of the 17th International Reinhardsbrunn Symposium, April 21-25 2013, Friedrichroda, Germany, P263; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Shapiro RS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004678; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STEADMAN JR, 1983, PLANT DIS, V67, P346, DOI 10.1094/PD-67-346; Sweet MJ, 2012, ADV APPL MICROBIOL, V81, P169, DOI 10.1016/B978-0-12-394382-8.00005-8; Troncoso-Rojas R., 2013, African Journal of Microbiology Research, V7, P838; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Wang Y, 2015, PLANT PATHOL, V64, P101, DOI 10.1111/ppa.12246; Wang Y., 2014, BIOMED RES INT, V2014; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Wright S, 1978, VARIABILITY NATURAL, V4; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	61	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168079	10.1371/journal.pone.0168079	http://dx.doi.org/10.1371/journal.pone.0168079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959950	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900037
J	Guerrini, V; Subbian, S; Santucci, P; Canaan, S; Gennaro, ML; Pozzi, G				Guerrini, Valentina; Subbian, Selvakumar; Santucci, Pierre; Canaan, Stephane; Gennaro, Maria Laura; Pozzi, Gianni			Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage	PLOS ONE			English	Article							GROWTH; ALIGNMENT	Isolates of the human pathogen Mycobacterium tuberculosis recovered from clinical samples exhibit genetic heterogeneity. Such variation may result from the stressful environment encountered by the pathogen inside the macrophage, which is the host cell tubercle bacilli parasitize. To study the evolution of the M. tuberculosis genome during growth inside macrophages, we developed a model of intracellular culture in which bacteria were serially passaged in macrophage-like THP-1 cells for about 80 bacterial generations. Genome sequencing of single bacterial colonies isolated before and after the infection cycles revealed that M. tuberculosis developed mutations at a rate of about 5.7 x 10(-9) /bp/generation, consistent with mutation rates calculated during in vivo infection. Analysis of mutant growth in macrophages and in mice showed that the mutations identified after the cyclic infection conferred no advantage to the mutants relative to wild-type. Furthermore, activity testing of the recombinant protein harboring one of these mutations showed that the presence of the mutation did not affect the enzymatic activity. The serial infection protocol developed in this work to study M. tuberculosis genome microevolution can be applied to exposure to stressors to determine their effect on genome remodeling during intra-macrophage growth.	[Guerrini, Valentina; Subbian, Selvakumar; Gennaro, Maria Laura] Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07102 USA; [Guerrini, Valentina; Pozzi, Gianni] Univ Siena, Dept Med Biotechnol, Lab Mol Microbiol & Biotechnol, Siena, Italy; [Santucci, Pierre; Canaan, Stephane] Aix Marseille Univ, CNRS, Lab Enzymol Interfaciale & Physiol Lipolyse, Marseille, France	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Siena; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gennaro, ML (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07102 USA.	marila.gennaro@rutgers.edu	Pozzi, Gianni/Q-2713-2018	Pozzi, Gianni/0000-0002-9557-4714; SANTUCCI, Pierre/0000-0002-6291-3425; Subbian, Selvakumar/0000-0003-2021-8632; Gennaro, Maria Laura/0000-0003-4801-3567	NIH [HL106788, AI104615]; European Community's Seventh Framework Programme (FP7) [FP7-223681]; Ministere Francais de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community's Seventh Framework Programme (FP7); Ministere Francais de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The work was funded in part by NIH grants HL106788 and AI104615 to MLG and in part by European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681 (TB PAN-NET) to GP. PS's PhD fellowship was financed by the Ministere Francais de l'Enseignement Superieur et de la Recherche. We are also grateful for the support from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Garcia de Viedma D, 2004, J CLIN MICROBIOL, V42, P3415, DOI 10.1128/JCM.42.8.3415-3418.2004; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Giovannini D, 2012, MICROB PATHOGENESIS, V53, P135, DOI 10.1016/j.micpath.2012.06.002; Guerrini V., 2016, NEW MICROBIOL, V39; Guerrini V, 2013, TUBERCULOSIS, V93, P405, DOI 10.1016/j.tube.2013.02.017; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Martin A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-73; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Medie FM, 2011, PROTEIN EXPRES PURIF, V75, P172, DOI 10.1016/j.pep.2010.08.015; Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459; Mitra A, 2008, TUBERCULOSIS, V88, P566, DOI 10.1016/j.tube.2008.06.004; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; O'Neill MB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005257; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; REZAPOV BR, 1991, TERAPEVT ARKH, V63, P155; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167989	10.1371/journal.pone.0167989	http://dx.doi.org/10.1371/journal.pone.0167989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959952	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900031
J	Martin, V; Perales, C; Fernandez-Algar, M; Dos Santos, HG; Garrido, P; Pernas, M; Parro, V; Moreno, M; Garcia-Perez, J; Alcami, J; Toran, JL; Abia, D; Domingo, E; Briones, C				Martin, Veronica; Perales, Celia; Fernandez-Algar, Maria; Dos Santos, Helena G.; Garrido, Patricia; Pernas, Maria; Parro, Victor; Moreno, Miguel; Garcia-perez, Javier; Alcami, Jose; Luis Toran, Jose; Abia, David; Domingo, Esteban; Briones, Carlos			An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENERATION SEQUENCING DATA; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; CLINICAL-IMPLICATIONS; DIPEPTIDE INSERTION; TREATMENT-NAIVE; MEMORY GENOMES; RNA VIRUSES; VARIANTS	The response of human immunodeficiency virus type 1 (HIV-1) quasispecies to antiretroviral therapy is influenced by the ensemble of mutants that composes the evolving population. Low-abundance subpopulations within HIV-1 quasispecies may determine the viral response to the administered drug combinations. However, routine sequencing assays available to clinical laboratories do not recognize HIV-1 minority variants representing less than 25% of the population. Although several alternative and more sensitive genotyping techniques have been developed, including next-generation sequencing (NGS) methods, they are usually very time consuming, expensive and require highly trained personnel, thus becoming unrealistic approaches in daily clinical practice. Here we describe the development and testing of a HIV-1 genotyping DNA microarray that detects and quantifies, in majority and minority viral subpopulations, relevant mutations and amino acid insertions in 42 codons of the pol gene associated with drug-and multidrug-resistance to protease (PR) and reverse transcriptase (RT) inhibitors. A customized bioinformatics protocol has been implemented to analyze the microarray hybridization data by including a new normalization procedure and a stepwise filtering algorithm, which resulted in the highly accurate (96.33%) detection of positive/negative signals. This microarray has been tested with 57 subtype B HIV-1 clinical samples extracted from multi-treated patients, showing an overall identification of 95.53% and 89.24% of the queried PR and RT codons, respectively, and enough sensitivity to detect minority subpopulations representing as low as 5-10% of the total quasispecies. The developed genotyping platform represents an efficient diagnostic and prognostic tool useful to personalize antiviral treatments in clinical practice.	[Martin, Veronica; Perales, Celia; Dos Santos, Helena G.; Abia, David; Domingo, Esteban] CSIC UAM, CBMSO, Campus Cantoblanco, Madrid, Spain; [Perales, Celia; Domingo, Esteban; Briones, Carlos] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Perales, Celia] Univ Autonoma Barcelona, VHIR HUVH, Liver Unit, Internal Med,Lab Malalties Hepat, Barcelona, Spain; [Fernandez-Algar, Maria; Parro, Victor; Moreno, Miguel; Briones, Carlos] CSIC INTA, CAB, Dept Mol Evolut, Madrid, Spain; [Garrido, Patricia; Pernas, Maria; Luis Toran, Jose] SLU, Biotherapix, Parque Tecnol Madrid, Madrid, Spain; [Garcia-perez, Javier; Alcami, Jose] Inst Salud Carlos III, AIDS Immunopathogenesis Unit, Madrid, Spain; [Martin, Veronica] Inst Nacl Invest Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Dos Santos, Helena G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Garrido, Patricia] Sygnis Biotech, Parque Cient Madrid,Campus Cantoblanco, Madrid, Spain; [Pernas, Maria] Inst Salud Carlos III, Madrid, Spain; [Luis Toran, Jose] CSIC, Spanish Natl Ctr Biotechnol CNB, Campus Cantoblanco, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Instituto de Salud Carlos III; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); State University System of Florida; Florida International University; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Briones, C (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.; Briones, C (corresponding author), CSIC INTA, CAB, Dept Mol Evolut, Madrid, Spain.	cbriones@cab.inta-csic.es	Briones, Carlos/G-3689-2016; Martin, Veronica/M-9641-2019; Martín, Verónica/H-2776-2015; Pernas, Maria/E-3998-2018; Moreno, Miguel/E-9552-2010; García-Pérez, Javier/F-9248-2019; Alcami, Pepe/T-2242-2018; Domingo, Esteban/K-3937-2014	Briones, Carlos/0000-0003-2213-8353; Martin, Veronica/0000-0003-1486-1656; Martín, Verónica/0000-0003-1486-1656; Pernas, Maria/0000-0003-2966-0160; Moreno, Miguel/0000-0002-6065-4095; García-Pérez, Javier/0000-0001-7551-7803; Alcami, Pepe/0000-0003-0023-7377; Perales Viejo, Celia Belen/0000-0003-1618-1937; Parro, Victor/0000-0003-3738-0724; Abia, David/0000-0003-0401-7590; Domingo, Esteban/0000-0002-0573-1676	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2010-20696]; Ministerio de Economia y Competitividad (MINECO) [BIO2013-47228-R, SAF2014-52400-R]; Comunidad Autanoma de Madrid (PLATESA) [52013/ABI-2906]; Biotherapix, S.L.U.; FEDER funds from the European Union; Institute de Salud Carlos III (ISCIII); MICINN [RyC2010-06516, AGL2015-64290-R]; Miguel Servet program of the ISCIII [CP14/00121]; European Regional Development Fund (ERDF); Spanish National Research Council (CSIC)	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Comunidad Autanoma de Madrid (PLATESA); Biotherapix, S.L.U.; FEDER funds from the European Union(European Commission); Institute de Salud Carlos III (ISCIII); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Miguel Servet program of the ISCIII; European Regional Development Fund (ERDF)(European Commission); Spanish National Research Council (CSIC)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN grant BIO2010-20696 to CB), Ministerio de Economia y Competitividad (MINECO grants BIO2013-47228-R to CB and SAF2014-52400-R to ED), Comunidad Autanoma de Madrid (PLATESA, grant 52013/ABI-2906 to ED), Biotherapix, S.L.U. and FEDER funds from the European Union. Work at CIBERehd is funded by the Institute de Salud Carlos III (ISCIII). MICINN provided funding for VM under grants RyC2010-06516 and AGL2015-64290-R. CP is supported by Miguel Servet program of the ISCIII (CP14/00121), co-financed by the European Regional Development Fund (ERDF). Funding for open access charge: Spanish National Research Council (CSIC). The funders provided support in the form of salaries and research materials for authors [MICINN and MINECO for VM, CP, MF-A, HGDS, VP, MM, DA, ED and CB; ISCIII for CP, JG-P and JA; Biotherapix, S.L.U. for PG, MP and JLT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baldwin C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-78; Barnett V., 1994, OUTLIERS STAT DATA; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bolsewicz K, 2015, AIDS CARE, V27, P1429, DOI 10.1080/09540121.2015.1114992; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Briones C, 2000, VIRUS RES, V66, P13, DOI 10.1016/S0168-1702(99)00120-3; Briones C, 2003, J MOL BIOL, V331, P213, DOI 10.1016/S0022-2836(03)00661-2; Briones C, 2008, AIDS REV, V10, P93; Briones C, 2006, GENE, V384, P129, DOI 10.1016/j.gene.2006.07.037; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Casadella M, 2015, J ANTIMICROB CHEMOTH, V70, P2885, DOI 10.1093/jac/dkv202; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Combe M, 2014, FUTURE VIROL, V9, P605, DOI 10.2217/FVL.14.41; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Fernandez N, 2011, NUCLEIC ACIDS RES, V39, P8572, DOI 10.1093/nar/gkr560; Fernandez N, 2011, VIROLOGY, V409, P251, DOI 10.1016/j.virol.2010.10.013; FORGY EW, 1965, BIOMETRICS, V21, P768; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Gega A, 2011, FUTURE VIROL, V6, P17, DOI 10.2217/FVL.10.77; Gibson RM, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0401-5; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gupta S, 2014, VIRUSES-BASEL, V6, P3428, DOI 10.3390/v6093428; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Mackay D. J., 2003, INFORM THEORY INFERE, P284, DOI [10.2277/0521642981, DOI 10.2277/0521642981]; Martell M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh088; Martin V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-117; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Masimba P, 2014, TROP MED INT HEALTH, V19, P664, DOI 10.1111/tmi.12289; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; Mayers D, 1998, J INFECT DIS, V177, P1730, DOI 10.1086/517433; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Monge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090710; Nishizawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135941; Ojosnegros S, 2011, VIRUS RES, V162, P203, DOI 10.1016/j.virusres.2011.09.018; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Quan Y, 2009, J INFECT DIS, V200, P1479, DOI 10.1086/606117; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Romero-Lopez C, 2014, NUCLEIC ACIDS RES, V42, P567, DOI 10.1093/nar/gkt841; Romero-Lopez C, 2012, NUCLEIC ACIDS RES, V40, P11697, DOI 10.1093/nar/gks927; Ruiz-Jarabo CM, 2002, J MOL BIOL, V315, P285, DOI 10.1006/jmbi.2001.5232; Ruiz-Jarabo CM, 2000, J VIROL, V74, P3543, DOI 10.1128/JVI.74.8.3543-3547.2000; Samuel R, 2014, AIDS REV, V16, P187; Schanne M, 2008, ANAL BIOANAL CHEM, V391, P1661, DOI 10.1007/s00216-007-1775-0; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Vahey M, 1999, J CLIN MICROBIOL, V37, P2533, DOI 10.1128/JCM.37.8.2533-2537.1999; Vandamme AM, 2011, AIDS REV, V13, P77; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Wilson JW, 2000, J CLIN MICROBIOL, V38, P3022, DOI 10.1128/JCM.38.8.3022-3028.2000; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zoufaly A, 2015, J ANTIMICROB CHEMOTH, V70, P922, DOI 10.1093/jac/dku470	76	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166902	10.1371/journal.pone.0166902	http://dx.doi.org/10.1371/journal.pone.0166902			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959928	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900005
J	Radibratovic, M; Minic, S; Stanic-Vucinic, D; Nikolic, M; Milcic, M; Velickovic, TC				Radibratovic, Milica; Minic, Simeon; Stanic-Vucinic, Dragana; Nikolic, Milan; Milcic, Milos; Velickovic, Tanja Cirkovic			Stabilization of Human Serum Albumin by the Binding of Phycocyanobilin, a Bioactive Chromophore of Blue-Green Alga Spirulina: Molecular Dynamics and Experimental Study	PLOS ONE			English	Article							DRUG-BINDING; CONFORMATIONAL FLEXIBILITY; THERMAL-DENATURATION; CIRCULAR-DICHROISM; BILIRUBIN-BINDING; AQUEOUS-SOLUTION; PROTEINS; SIMULATIONS; STABILITY; CHEMISTRY	Phycocyanobilin (PCB) binds with high affinity (2.2 x 10 6 M-1 at 25 degrees C) to human serum albumin (HSA) at sites located in IB and IIA subdomains. The aim of this study was to examine effects of PCB binding on protein conformation and stability. Using 300 ns molecular dynamics (MD) simulations, UV-VIS spectrophotometry, CD, FT-IR, spectrofluorimetry, thermal denaturation and susceptibility to trypsin digestion, we studied the effects of PCB binding on the stability and rigidity of HSA, as well as the conformational changes in PCB itself upon binding to the protein. MD simulation results demonstrated that HSA with PCB bound at any of the two sites showed greater rigidity and lower overall and individual domain flexibility compared to free HSA. Experimental data demonstrated an increase in the a-helical content of the protein and thermal and proteolytic stability upon ligand binding. PCB bound to HSA undergoes a conformational change to a more elongated conformation in the binding pockets of HSA. PCB binding to HSA stabilizes the structure of this flexible transport protein, making it more thermostable and resistant to proteolysis. The results from this work explain at molecular level, conformational changes and stabilization of HSA structure upon ligand binding. The resultant increased thermal and proteolytic stability of HSA may provide greater longevity to HSA in plasma.	[Radibratovic, Milica] Univ Belgrade, Ctr Chem, Inst Chem Technol & Met, Belgrade, Serbia; [Minic, Simeon; Stanic-Vucinic, Dragana; Nikolic, Milan; Velickovic, Tanja Cirkovic] Univ Belgrade, Fac Chem, Ctr Excellence Mol Food Sci, Belgrade, Serbia; [Nikolic, Milan] Univ Belgrade, Fac Chem, Dept Biochem, Belgrade, Serbia; [Milcic, Milos] Univ Belgrade, Fac Chem, Dept Inorgan Chem, Belgrade, Serbia; [Milcic, Milos] Univ Belgrade, Fac Chem, Ctr Computat Chem & Bioinformat, Belgrade, Serbia; [Velickovic, Tanja Cirkovic] Ghent Univ Global Campus, Incheon, South Korea; [Velickovic, Tanja Cirkovic] Univ Ghent, Fac Biosci Engn, Ghent, Belgium	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; Ghent University; Ghent University	Velickovic, TC (corresponding author), Univ Belgrade, Fac Chem, Dept Inorgan Chem, Belgrade, Serbia.	mmilcic@chem.bg.ac.rs; tcirkov@chem.bg.ac.rs	Nikolić, Milan R/P-6923-2016; Radibratovic, Milica/ABG-6145-2021; Milcic, Milos/Q-8238-2016; Stanic-Vucinic, Dragana/J-7897-2016; Cirkovic Velickovic, Tanja/R-6751-2016	Nikolić, Milan R/0000-0003-0932-889X; Radibratovic, Milica/0000-0003-4708-6633; Milcic, Milos/0000-0002-0082-5278; Stanic-Vucinic, Dragana/0000-0003-2576-3074; Minic, Simeon/0000-0002-7053-1216; Cirkovic Velickovic, Tanja/0000-0003-2559-5234	Ministry of Education, Science and Technological Development of the Republic of Serbia [01172024]; FP7 RegPot project FCUB ERA [256716]	Ministry of Education, Science and Technological Development of the Republic of Serbia; FP7 RegPot project FCUB ERA	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 01172024) and FP7 RegPot project FCUB ERA GA No. 256716. The EC does not share responsibility for the content of the article.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Barreca D, 2016, BIOCH BIOPHYS ACTA; Buono S, 2014, FOOD FUNCT, V5, P1669, DOI [10.1039/C4FO00125G, 10.1039/c4fo00125g]; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Guizado TRC, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2450-y; Datta S, 2014, J PHYS CHEM B, V118, P6071, DOI 10.1021/jp501547r; Dong AC, 1997, ARCH BIOCHEM BIOPHYS, V347, P213, DOI 10.1006/abbi.1997.0349; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Goller AH, 2005, CHEMPHYSCHEM, V6, P1259, DOI 10.1002/cphc.200400667; Goller AH, 2001, CHEMPHYSCHEM, V2, P665, DOI 10.1002/1439-7641(20011119)2:11<665::AID-CPHC665>3.0.CO;2-O; Goncharova I, 2013, BIOPHYS CHEM, V180, P55, DOI 10.1016/j.bpc.2013.06.004; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hou HN, 2008, J PHARMACEUT BIOMED, V47, P134, DOI 10.1016/j.jpba.2007.12.029; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallubai M, 2015, MOL BIOSYST, V11, P1172, DOI 10.1039/c4mb00635f; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JH, 2008, J MOL STRUCT, V885, P64, DOI 10.1016/j.molstruc.2007.10.020; LOHNER K, 1994, J PHARMACEUT BIOMED, V12, P1501, DOI 10.1016/0731-7085(94)00094-8; LOU J, 1973, Z NATURFORSCH C, VC 28, P511; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARKUS G, 1967, J BIOL CHEM, V242, P4402; McCarty MF, 2007, J MED FOOD, V10, P566, DOI 10.1089/jmf.2007.621; Minic SL, 2015, RSC ADV, V5, P61787, DOI 10.1039/c5ra05534b; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SJODIN T, 1977, BIOCHIM BIOPHYS ACTA, V494, P61, DOI 10.1016/0005-2795(77)90135-0; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; TERRY MJ, 1993, J BIOL CHEM, V268, P26099; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu PH, 2009, J MOL STRUC-THEOCHEM, V894, P9, DOI 10.1016/j.theochem.2008.09.034; Yamamoto T, 2006, J MOL STRUCT, V782, P60, DOI 10.1016/j.molstruc.2005.01.024; Zaidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071422; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	39	23	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167973	10.1371/journal.pone.0167973	http://dx.doi.org/10.1371/journal.pone.0167973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959940	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900028
J	Zhang, ZY; Ravassa, S; Yang, WY; Petit, T; Pejchinovski, M; Zurbig, P; Lopez, B; Wei, FF; Pontillo, C; Thijs, L; Jacobs, L; Gonzalez, A; Koeck, T; Delles, C; Voigt, JU; Verhamme, P; Kuznetsova, T; Diez, J; Mischak, H; Staessen, JA				Zhang, Zhen-Yu; Ravassa, Susana; Yang, Wen-Yi; Petit, Thibault; Pejchinovski, Martin; Zuerbig, Petra; Lopez, Begona; Wei, Fang-Fei; Pontillo, Claudia; Thijs, Lutgarde; Jacobs, Lotte; Gonzalez, Arantxa; Koeck, Thomas; Delles, Christian; Voigt, Jens-Uwe; Verhamme, Peter; Kuznetsova, Tatiana; Diez, Javier; Mischak, Harald; Staessen, Jan A.			Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population	PLOS ONE			English	Article							HEART-FAILURE; HYPERTENSIVE PATIENTS; DILATED CARDIOMYOPATHY; CROSS-LINKING; MYOCARDIAL FIBROSIS; FILLING PRESSURES; PROTEOME ANALYSIS; BLOOD-PRESSURE; DYSFUNCTION; ECHOCARDIOGRAPHY	Current knowledge on the pathogenesis of diastolic heart failure predominantly rests on case-control studies involving symptomatic patients with preserved ejection fraction and relying on invasive diagnostic procedures including endomyocardial biopsy. Our objective was to gain insight in serum and urinary biomarkers reflecting collagen turnover and associated with asymptomatic diastolic LV dysfunction. We randomly recruited 782 Flemish (51.3% women; 50.5 years). We assessed diastolic LV function from the early and late diastolic peak velocities of the transmitral blood flow and of the mitral annulus. By sequencing urinary peptides, we identified 70 urinary collagen fragments. In serum, we measured carboxyterminal propeptide of procollagen type 1 (PICP) as marker of collagen I synthesis and tissue inhibitor of matrix metalloproteinase type 1 (TIMP-1), an inhibitor of collagen-degrading enzymes. In multivariable-adjusted analyses with Bonferroni correction, we expressed effect sizes per 1-SD in urinary collagen I (uCI) or collagen III (uCIII) fragments. In relation to uCI fragments, e' decreased by 0.183 cm/s (95% confidence interval, 0.017 to 0.350; p = 0.025), whereas E/e' increased by 0.210 (0.067 to 0.353; p = 0.0012). E/e' decreased with uCIII by 0.168 (0.021 to 0.316; p = 0.018). Based on age-specific echocardiographic criteria, 182 participants (23.3%) had subclinical diastolic LV dysfunction. Partial least squares discriminant analysis contrasting normal vs. diastolic LV dysfunction confirmed the aforementioned associations with the uCI and uCIII fragments. PICP and TIMP-1 increased in relation to uCI (p<0.0001), whereas these serum markers decreased with uCIII (p <= 0.0006). Diastolic LV dysfunction was associated with higher levels of TIMP-1 (653 vs. 696 ng/mL; p = 0.013). In a general population, the non-invasively assessed diastolic LV function correlated inversely with uCI and serum markers of collagen I deposition, but positively with uCIII. These observations generalise previous studies in patients to randomly recruited people, in whom diastolic LV function ranged from normal to subclinical impairment, but did not encompass overt diastolic heart failure.	[Zhang, Zhen-Yu; Yang, Wen-Yi; Petit, Thibault; Wei, Fang-Fei; Thijs, Lutgarde; Jacobs, Lotte; Kuznetsova, Tatiana; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium; [Ravassa, Susana; Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Ctr Appl Med, Program Cardiovasc Dis, Pamplona, Spain; [Ravassa, Susana; Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Inst Invest Sanitaria Navarra, Pamplona, Spain; [Pejchinovski, Martin; Zuerbig, Petra; Pontillo, Claudia; Koeck, Thomas; Mischak, Harald] Mosa Diagnost & Therapeut AG, Hannover, Germany; [Delles, Christian] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Voigt, Jens-Uwe] Univ Leuven, KU Leuven, Dept Cardiovasc Dis, Res Unit Cardiol, Leuven, Belgium; [Verhamme, Peter] Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Diez, Javier] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, Pamplona, Spain; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands	KU Leuven; University of Navarra; University of Glasgow; KU Leuven; KU Leuven; University of Navarra; Maastricht University	Staessen, JA (corresponding author), Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium.; Staessen, JA (corresponding author), Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands.	jan.staessen@med.kuleuven.be	Díez, Javier/D-7014-2017; Kuznetsova, Tatiana/ABI-5662-2020; Ravassa, Susana/I-2567-2017; Yang, Wenyi/ABA-5526-2021; Staessen, Jan A/A-1065-2011; Zhang, Zhenyu/GZL-8479-2022; González, Arantxa/D-6860-2017	Díez, Javier/0000-0002-3414-6919; Kuznetsova, Tatiana/0000-0003-4293-4576; Ravassa, Susana/0000-0001-5926-5677; Staessen, Jan A/0000-0002-3026-1637; Zhang, Zhenyu/0000-0002-3785-7417; González, Arantxa/0000-0001-5986-6528; Lopez Salazar, Begona/0000-0001-8508-698X; Yang, Wen-Yi/0000-0003-1279-0866; Verhamme, Anne/0000-0002-2201-1865; Zurbig, Petra/0000-0003-3465-2173; Voigt, Jens-Uwe/0000-0002-0575-1888; Thijs, Lutgarde/0000-0002-8108-2356; Mischak, Harald/0000-0003-0323-0306; Pejchinovski, Martin/0000-0002-8029-5800	European Union [HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE]; European Research Council [2011-294713-EPLORE, 713601-uPROPHET]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013, 11Z0916N]	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO)	The European Union (HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE) and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13, G.088013, and 11Z0916N) currently support the Studies Coordinating Centre in Leuven. The funders provide support in the form of salaries for authors (ZYZ, WYY, TP, FFW, LT, LJ), but did not have any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Aoki T, 2011, CIRC J, V75, P2605, DOI 10.1253/circj.CJ-11-0568; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gonzalez A, 2010, HYPERTENSION, V55, P1418, DOI 10.1161/HYPERTENSIONAHA.109.149112; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Grammer JB, 2005, BASIC RES CARDIOL, V100, P288, DOI 10.1007/s00395-005-0515-x; HESS OM, 1981, CIRCULATION, V63, P360, DOI 10.1161/01.CIR.63.2.360; Izawa H, 2005, CIRCULATION, V112, P2940, DOI 10.1161/CIRCULATIONAHA.105.571653; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Kloch-Badelek M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-10; Kuznetsova T, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002882; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; Lazar C, 2016, J PROTEOME RES, V15, P1116, DOI 10.1021/acs.jproteome.5b00981; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; Longobardo L, 2014, EUR HEART J-CARD IMG, V15, P1, DOI 10.1093/ehjci/jet116; Lopez B, 2001, CIRCULATION, V104, P286, DOI 10.1161/01.CIR.104.3.286; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Lopez B, 2016, J AM COLL CARDIOL, V67, P251, DOI 10.1016/j.jacc.2015.10.063; Lopez B, 2015, J AM COLL CARDIOL, V65, P2449, DOI 10.1016/j.jacc.2015.04.026; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Meleth S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-7; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Velagaleti RS, 2012, ARTERIOSCLER THROMB, V30, P2283; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Wei FF, 2016, EBIOMEDICINE, V4, P162, DOI 10.1016/j.ebiom.2016.01.011; Wei S, 1999, J CARD FAIL, V5, P117, DOI 10.1016/S1071-9164(99)90034-9; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Yang WY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0272-2; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	49	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167582	10.1371/journal.pone.0167582	http://dx.doi.org/10.1371/journal.pone.0167582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959898	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000392753900011
J	Kotter, T; Ritter, J; Katalinic, A; Voltmer, E				Koetter, Thomas; Ritter, Johanna; Katalinic, Alexander; Voltmer, Edgar			Predictors of Participation of Sophomore Medical Students in a Health-Promoting Intervention: An Observational Study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; STRESS REDUCTION; DEPRESSION SCALE; HOSPITAL ANXIETY; CONTROLLED-TRIAL; BEHAVIOR; EXPERIENCES; RELAXATION; PATTERNS	Medical students and doctors have to be particularly stress-resilient, as both medical education and practice are considered very stressful. Specific stressors can lead to increased risks of developing, for example, depression, anxiety and burnout. Relaxation techniques have proven to be effective for the prevention of these outcomes in student populations. However, only a very few medical students practice relaxation techniques regularly early on in their studies. Furthermore, it is unclear which students make use of stress-management offers and hence whether vulnerable students are generally reachable. Therefore, the aim of our study was to explore predictors of participating in a voluntary stress management course for sophomore medical students. One cohort of freshmen at a German medical school was surveyed at the end of the freshman year [t1] and at the end of the sophomore year [t2]. In addition to sociodemographic information, we captured perceived study stress, self-rated general health and mental health and dimensions of study-related behaviour and experience as potential predictors of participation at t1. During the sophomore year, we offered the participants a progressive muscle relaxation (PMR) beginners' course. At t2, we registered participation status. We used binary logistic regression analyses in order to assess correlations between potential predictors and participation. About one third of the whole class took part in the course. The main reason for non-participation was "no time". Being female and higher levels of anxiety were the strongest predictors of course participation. Career ambition (the higher, the less likely to participate) and emotional distancing (the higher, the more likely to participate) were further significant predictors. Future interventions should be attractive to both male and female medical students. Ideally, for every hour of stress management teaching, the curriculum should be cut by at least the same amount of time.	[Koetter, Thomas; Ritter, Johanna; Katalinic, Alexander] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Voltmer, Edgar] Friedensau Adventist Univ, Dept Hlth Sci, Mockern, Germany	University of Lubeck	Kotter, T (corresponding author), Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany.	thomas.koetter@uksh.de	Katalinic, Alexander/D-2512-2010	Katalinic, Alexander/0000-0003-0490-1554	Lubeck Medical School [E18-2011]	Lubeck Medical School	This research was supported by a grant from Lubeck Medical School (bit.ly/1pcsaZk) received by TK (E18-2011).	Aster-Schenck I, 2010, GMS Z MED AUSBILD, V27, DOI DOI 10.3205/ZMA000698; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; CARLSON CR, 1993, J CONSULT CLIN PSYCH, V61, P1059, DOI 10.1037/0022-006X.61.6.1059; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; de Vibe M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-107; Dehghan-nayeri N, 2011, COMPLEMENT THER MED, V19, P194, DOI 10.1016/j.ctim.2011.06.002; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; General Medical Council, 2014, STAT MED ED PRACT UK; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Ishak W, 2013, CLIN TEACH, V10, P242, DOI 10.1111/tct.12014; Jordan S, 2013, BUNDESGESUNDHEITSBLA, V56, P878, DOI 10.1007/s00103-013-1664-y; Kjeldstadli Kari, 2006, BMC Med Educ, V6, P48, DOI 10.1186/1472-6920-6-48; Kotter T, 2015, PERSPECT MED EDUC, V4, P128, DOI 10.1007/s40037-015-0189-5; Kotter T, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-134; Kotter Thomas, 2013, GMS Z Med Ausbild, V30, pDoc22, DOI 10.3205/zma000865; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; McGrady A, 2012, APPL PSYCHOPHYS BIOF, V37, P253, DOI 10.1007/s10484-012-9198-x; Moffat KJ, 2004, MED EDUC, V38, P482, DOI 10.1046/j.1365-2929.2004.01814.x; NOTMAN MT, 1984, COMPR PSYCHIAT, V25, P355, DOI 10.1016/0010-440X(84)90068-3; Quince TA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001519; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Schaarschmidt U., 2008, ARBEITSBEZOGENES VER; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Snaith R, 2011, HOSP ANXIETY DEPRESS; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; van Dijk I, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0302-9; VITALIANO PP, 1984, J NERV MENT DIS, V172, P730, DOI 10.1097/00005053-198412000-00006; Voltmer E, 2012, MED TEACH, V34, P840, DOI 10.3109/0142159X.2012.706339; Voltmer E, 2010, MED TEACH, V32, pE422, DOI 10.3109/0142159X.2010.496008; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Warnecke E, 2011, MED EDUC, V45, P381, DOI 10.1111/j.1365-2923.2010.03877.x; Wild K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114967; Woolf Katherine, 2007, BMC Med Educ, V7, P50, DOI 10.1186/1472-6920-7-50; World Health Organization, HLTH INT SURV INT HA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168104	10.1371/journal.pone.0168104	http://dx.doi.org/10.1371/journal.pone.0168104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942029	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600051
J	Li, HY; Zheng, L; Mo, YQ; Gong, Q; Jiang, AH; Zhao, J				Li, Huanyin; Zheng, Lan; Mo, Yanqing; Gong, Qi; Jiang, Aihua; Zhao, Jing			Voltage-Dependent Anion Channel 1(VDAC1) Participates the Apoptosis of the Mitochondrial Dysfunction in Desminopathy	PLoS One			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; SUBCELLULAR-LOCALIZATION; BCL-XL; BOUND HEXOKINASE; CELL-DEATH; BAX; BCL-X(L); PROTEIN; VDAC; ATF2	Desminopathies caused by the mutation in the gene coding for desmin are genetically protein aggregation myopathies. Mitochondrial dysfunction is one of pathological changes in the desminopathies at the earliest stage. The molecular mechanisms of mitochondria dysfunction in desminopathies remain exclusive. VDAC1 regulates mitochondrial uptake across the outer membrane and mitochondrial outer membrane permeabilization (MOMP). Relationships between desminopathies and Voltage-dependent anion channel 1 (VDAC1) remain unclear. Here we successfully constructed the desminopathy rat model, evaluated with conventional stains, containing hematoxylin and eosin (HE), Gomori Trichrome (MGT), (PAS), red oil (ORO), NADH-TR, SDH staining and immunohistochemistry. Immunofluorescence results showed that VDAC1 was accumulated in the desmin highly stained area of muscle fibers of desminopathy patients or desminopathy rat model compared to the normal ones. Meanwhile apoptosis related proteins bax and ATF2 were involved in desminopathy patients and desminopathy rat model, but not bcl-2, bcl-xl or HK2. VDAC1 and desmin are closely relevant in the tissue splices of deminopathies patients and rats with desminopathy at protein lever. Moreover, apoptotic proteins are also involved in the desminopathies, like bax, ATF2, but not bcl-2, bcl-xl or HK2. This pathological analysis presents the correlation between VDAC1 and desmin, and apoptosis related proteins are correlated in the desminopathy. Furthermore, we provide a rat model of desminopathy for the investigation of desmin related myopathy.	[Li, Huanyin; Zheng, Lan; Mo, Yanqing; Gong, Qi; Jiang, Aihua; Zhao, Jing] Fudan Univ, Shanghai Minhang Hosp, Dept Internal Neurol, Cent Hosp Minhang Dist, Shanghai, Peoples R China	Fudan University	Zhao, J (corresponding author), Fudan Univ, Shanghai Minhang Hosp, Dept Internal Neurol, Cent Hosp Minhang Dist, Shanghai, Peoples R China.	zjmzx16f@126.com			Minhang District Natural Science Foundation Project, ShangHai, China [2016MHZ20]	Minhang District Natural Science Foundation Project, ShangHai, China	This work was supported by Minhang District Natural Science Foundation Project in 2016 (2016MHZ20), ShangHai, China.	Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Berger AJ, 2003, CANCER RES, V63, P8103; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Capetanaki Y, 2015, CURR OPIN CELL BIOL, V32, P113, DOI 10.1016/j.ceb.2015.01.004; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Cheng QL, 2011, FEBS LETT, V585, P328, DOI 10.1016/j.febslet.2010.12.008; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Dong Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158672; Ferrer Isidre, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000793; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Hong D, 2011, NEUROPATH APPL NEURO, V37, P257, DOI 10.1111/j.1365-2990.2010.01112.x; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Joanne P, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-4; Kim JE, 2014, BIOCHEM BIOPH RES CO, V447, P184, DOI 10.1016/j.bbrc.2014.03.124; Kostareva A, 2008, J MUSCLE RES CELL M, V29, P25, DOI 10.1007/s10974-008-9139-8; Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P1221, DOI 10.1517/14728222.2013.833607; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Liu ZY, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0188-y; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Monaco G, 2015, J BIOL CHEM, V290, P9150, DOI 10.1074/jbc.M114.622514; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Panickar KS, 2005, NEUROSCIENCE, V135, P73, DOI 10.1016/j.neuroscience.2005.02.052; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sugawara M, 2000, NEUROLOGY, V55, P986, DOI 10.1212/WNL.55.7.986; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vela L, 2015, CURR OPIN PHARMACOL, V23, P74, DOI 10.1016/j.coph.2015.05.014; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Wang TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090780; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015	49	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167908	10.1371/journal.pone.0167908	http://dx.doi.org/10.1371/journal.pone.0167908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941998	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600037
J	Wang, XH; Liu, XY; Li, LY; Zhang, FM; Hu, M; Ren, FJ; Chi, LL; Linhardt, RJ				Wang, Xiaohua; Liu, Xinyue; Li, Lingyun; Zhang, Fuming; Hu, Min; Ren, Fuji; Chi, Lianli; Linhardt, Robert J.			GlycCompSoft: Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data	PLoS One			English	Article							MASS-SPECTROMETRY	Low molecular weight heparins are complex polycomponent drugs that have recently become amenable to top-down analysis using liquid chromatography-mass spectrometry. Even using open source deconvolution software, DeconTools, and automatic structural assignment software, GlycReSoft, the comparison of two or more low molecular weight heparins is extremely time-consuming, taking about a week for an expert analyst and provides no guarantee of accuracy. Efficient data processing tools are required to improve analysis. This study uses the programming language of Microsoft Excel (TM) Visual Basic for Applications to extend its standard functionality for macro functions and specific mathematical modules for mass spectrometric data processing. The program developed enables the comparison of top-down analytical glycomics data on two or more low molecular weight heparins. The current study describes a new program, GlycCompSoft, which has a low error rate with good time efficiency in the automatic processing of large data sets. The experimental results based on three lots of Lovenox (R), Clexane (R) and three generic enoxaparin samples show that the run time of GlycCompSoft decreases from 11 to 2 seconds when the data processed decreases from 18000 to 1500 rows.	[Wang, Xiaohua; Hu, Min; Ren, Fuji] Hefei Univ Technol, Sch Comp & Informat, Anhui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China; [Wang, Xiaohua; Liu, Xinyue; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Liu, Xinyue; Chi, Lianli] Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Peoples R China; [Li, Lingyun] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Ren, Fuji] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima, Japan	Hefei University of Technology; Rensselaer Polytechnic Institute; Shandong University; State University of New York (SUNY) System; Wadsworth Center; Tokushima University	Wang, XH (corresponding author), Hefei Univ Technol, Sch Comp & Informat, Anhui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China.; Wang, XH; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.	xh_wang@hfut.edu.cn; linhar@rpi.edu	wang, xiao/HGB-7081-2022; Liu, Xinyue/AAR-6887-2021; Chi, Lianli/B-9149-2015	wang, xiao/0000-0002-4088-3341; Liu, Xinyue/0000-0002-0934-4155; Chi, Lianli/0000-0003-1126-1022	National Institutes of Health [HL125371, GM38060, GM090127, HL096972, HL10172]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125371, R01HL096972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090127, R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Grants from the National Institutes of Health in the form of Grants HL125371, GM38060, GM090127, HL096972, and HL10172.	[Anonymous], 2015, DECONTOOLS DECON2LS, V11, P17; Apte A, 2010, METHODS MOL BIOL, V600, P269, DOI 10.1007/978-1-60761-454-8_19; Bennett L, 2015, 5 INVALUABLE TECHNIQ, V6, P30; Cai WX, 2016, EXPERT REV PROTEOMIC, V13, P717, DOI 10.1080/14789450.2016.1209414; Cox R, 2007, REGULAR EXPRESSION M, P1; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kronewitter SR, 2012, PROTEOMICS, V12, P2523, DOI 10.1002/pmic.201100273; Li DY, 2014, CARBOHYD POLYM, V99, P339, DOI 10.1016/j.carbpol.2013.08.074; Li GY, 2014, ANAL CHEM, V86, P6626, DOI 10.1021/ac501301v; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Linhardt RJ, 1999, SEMINARS THROMBOSIS; Linhardt RJ., 1991, CHEM IND; Maxwell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045474; Slysz G.W., 2010, P 58 ASMS C MASS SPE; Thaysen-Andersen M, 2014, BBA-PROTEINS PROTEOM, V1844, P1437, DOI 10.1016/j.bbapap.2014.05.002; Tu CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160160; Xiao ZP, 2011, J MED CHEM, V54, P603, DOI 10.1021/jm101381k; Xu XH, 2015, CARBOHYD RES, V407, P26, DOI 10.1016/j.carres.2015.01.016	18	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167727	10.1371/journal.pone.0167727	http://dx.doi.org/10.1371/journal.pone.0167727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942011	Green Published, gold			2022-12-26	WOS:000392745600027
J	Yang, CC; Su, FC; Yang, PC; Lin, HT; Guo, LY				Yang, Chia-Chi; Su, Fong-Chin; Yang, Po-Ching; Lin, Hwai-Ting; Guo, Lan-Yuen			Characteristics of the Motor Units during Sternocleidomastoid Isometric Flexion among Patients with Mechanical Neck Disorder and Asymptomatic Individuals	PLoS One			English	Article							SURFACE EMG SIGNALS; EXPERIMENTAL MUSCLE PAIN; UPPER TRAPEZIUS MUSCLE; VOLUNTARY CONTRACTIONS; CERVICAL-SPINE; FIRING RATE; RECRUITMENT THRESHOLD; DISCHARGE RATES; CEREBRAL-PALSY; SYNCHRONIZATION	Mechanical neck disorder is a widespread and non-neurological musculoskeletal condition resulting from modern lifestyles. Presently, the fundamental electrophysiological properties of the motor units of the sternocleidomastoid muscles and the characteristics of the short-term synchronization of the motor unit in patients with neck pain are ambiguous. This study therefore aims to clarify the fundamental electrophysiological properties of the motor units of the sternocleidomastoid muscles in patients with mechanical neck disorder and in asymptomatic individuals. We further investigated whether alterations in the degree of motor unit short-term synchronization occur. The surface electrophysiological signals of the bilateral sternal heads of the sternocleidomastoid muscles of twelve patients with mechanical neck disorder and asymptomatic individuals were detected at 25% of the maximum voluntary contraction during cervical isometric flexion and then decomposed into individual motor unit action potential trains. We found that the patients with mechanical neck disorder showed significantly higher initial and mean firing rates of the sternocleidomastoid muscles and displayed substantially lower motor unit short-term synchronization values compared with the asymptomatic subjects. Consequently, these convincing findings support the assertion that patients with mechanical neck disorder display altered neuromuscular control strategies, such as the reinforcement of motor unit recruitment firing rates in the sternocleidomastoid muscles. The motor units of these patients also revealed neural recruitment strategies with relatively poor efficiency when executing the required motor tasks.	[Yang, Chia-Chi; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Yang, Po-Ching; Lin, Hwai-Ting; Guo, Lan-Yuen] Kaohsiung Med Univ, Dept Sports Med, Coll Med, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University	Guo, LY (corresponding author), Kaohsiung Med Univ, Dept Sports Med, Coll Med, Kaohsiung, Taiwan.	yuen@kmu.edu.tw	, 郭藍遠/AAY-8243-2021; Lin, Hwai-Ting/D-5123-2009; Guo, Lan-Yuen/C-7439-2009; SU, FONG-CHIN/C-8094-2011	, 郭藍遠/0000-0002-6256-355X; Guo, Lan-Yuen/0000-0002-6256-355X; SU, FONG-CHIN/0000-0002-3870-4842	National Health Research Institutes, Taiwan [NHRI-EX103-10204EI]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work is financially supported by National Health Research Institutes, Taiwan. (NHRI-EX103-10204EI, http//english.nhri.org.tw/NHRI_WEB/nhriw001Action.do) Grant Recipient: LYG.	Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; Bernard B., 1997, MUSCULOSKELETAL DISO; Binder MD, 1990, SEGMENTAL MOTOR SYST; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Chiu TTW, 2002, CLIN REHABIL, V16, P851, DOI 10.1191/0269215502cr550oa; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; DATTA AK, 1991, J PHYSIOL-LONDON, V432, P401, DOI 10.1113/jphysiol.1991.sp018391; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; DE LUCA CJ, 1993, J NEUROPHYSIOL, V70, P2010, DOI 10.1152/jn.1993.70.5.2010; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Defreitas JM, 2014, MUSCLE NERVE, V49, P575, DOI 10.1002/mus.23978; Falla D, 2008, EXP BRAIN RES, V191, P363, DOI 10.1007/s00221-008-1530-6; Falla D, 2004, DISABIL REHABIL, V26, P712, DOI 10.1080/09638280410001704287; Falla D, 2003, CLIN NEUROPHYSIOL, V114, P488, DOI 10.1016/S1388-2457(02)00418-2; Falla D, 2004, SPINE, V29, P1436, DOI 10.1097/01.BRS.0000128759.02487.BF; Falla D, 2010, CLIN NEUROPHYSIOL, V121, P744, DOI 10.1016/j.clinph.2009.12.029; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Farina D, 2004, J NEUROPHYSIOL, V91, P1250, DOI 10.1152/jn.00620.2003; FARMER SF, 1990, J PHYSIOL-LONDON, V428, P467, DOI 10.1113/jphysiol.1990.sp018222; FARMER SF, 1993, J PHYSIOL-LONDON, V463, P83, DOI 10.1113/jphysiol.1993.sp019585; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Gazzoni M, 2004, J NEUROSCI METH, V136, P165, DOI 10.1016/j.jneumeth.2004.01.002; Gibbs J, 1999, DEV MED CHILD NEUROL, V41, P465, DOI 10.1017/S0012162299001012; GOGIA PP, 1991, SPINE, V16, P1135, DOI 10.1097/00007632-199110000-00001; Guo LY, 2012, J BACK MUSCULOSKELET, V25, P47, DOI 10.3233/BMR-2012-0309; Hagen KB, 1997, SPINE, V22, P1501, DOI 10.1097/00007632-199707010-00015; Hanten WP, 2000, ARCH PHYS MED REHAB, V81, P62, DOI 10.1053/apmr.2000.0810062; Holtermann A, 2005, J ELECTROMYOGR KINES, V15, P131, DOI 10.1016/j.jelekin.2004.09.003; Johnston V, 2008, SPINE, V33, P555, DOI 10.1097/BRS.0b013e3181657d0d; Jordan A, 1997, J MANIP PHYSIOL THER, V20, P468; Kallenberg LAC, 2006, EUR J APPL PHYSIOL, V96, P203, DOI 10.1007/s00421-004-1215-1; Kallenberg LAC, 2011, MUSCLE NERVE, V43, P112, DOI 10.1002/mus.21803; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V327, P105, DOI 10.1113/jphysiol.1982.sp014223; Kleine BU, 2008, J ELECTROMYOGR KINES, V18, P652, DOI 10.1016/j.jelekin.2007.01.010; Kleine BU, 2007, J ELECTROMYOGR KINES, V17, P535, DOI 10.1016/j.jelekin.2006.05.003; Kleine BU, 2000, MUSCLE NERVE, V23, P1005, DOI 10.1002/1097-4598(200007)23:7<1005::AID-MUS2>3.0.CO;2-2; Korhonen T, 2003, OCCUP ENVIRON MED, V60, P475, DOI 10.1136/oem.60.7.475; Lee HJ, 2004, SPINE, V29, P33, DOI 10.1097/01.BRS.0000103944.10408.BA; Lukacs M, 2005, CLIN NEUROPHYSIOL, V116, P1566, DOI 10.1016/j.clinph.2005.04.005; Madeleine P, 2006, CLIN NEUROPHYSIOL, V117, P2436, DOI 10.1016/j.clinph.2006.06.753; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Rau G, 1997, J ELECTROMYOGR KINES, V7, P233, DOI 10.1016/S1050-6411(97)00007-2; Rose J, 2005, DEV MED CHILD NEUROL, V47, P329, DOI 10.1017/S0012162205000629; Schmied A, 1999, CLIN NEUROPHYSIOL, V110, P960, DOI 10.1016/S1388-2457(99)00032-2; SCHMIED A, 1994, J PHYSIOL-LONDON, V480, P369, DOI 10.1113/jphysiol.1994.sp020367; SEARS TA, 1976, J PHYSIOL-LONDON, V263, P357, DOI 10.1113/jphysiol.1976.sp011635; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; Sjolander Per, 2002, J Electromyogr Kinesiol, V12, P167, DOI 10.1016/S1050-6411(02)00017-2; Standring S., 2016, GRAYS ANATOMY ANATOM, V41; Stock MS, 2012, MUSCLE NERVE, V45, P100, DOI 10.1002/mus.22266; UHLIG Y, 1995, J ORTHOP RES, V13, P240, DOI 10.1002/jor.1100130212; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Yang CC, 2014, EUR SPINE J, V23, P1743, DOI 10.1007/s00586-014-3413-9; Yang CC, 2012, SENSORS-BASEL, V12, P17463, DOI 10.3390/s121217463; Zazula D, 2005, COMPUT METH PROG BIO, V80, pS51, DOI 10.1016/S0169-2607(05)80006-9	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167737	10.1371/journal.pone.0167737	http://dx.doi.org/10.1371/journal.pone.0167737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941995	gold, Green Submitted, Green Published			2022-12-26	WOS:000392745600029
J	Chang, NY; Chan, YJ; Ding, ST; Lee, YH; HuangFu, WC; Liu, IH				Chang, Nai-Yun; Chan, Yen-Ju; Ding, Shih-Torng; Lee, Yen-Hua; HuangFu, Wei-Chun; Liu, I-Hsuan			Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis	PLOS ONE			English	Article							ACYL-COENZYME; APOLIPOPROTEIN-E; EMBRYONIC-DEVELOPMENT; SYNCYTIAL LAYER; SAC MEMBRANE; HUMAN LIVER; ACAT2; COA; EXPRESSION; CELLS	To elucidate whether Sterol O-acyltransferase (Soat) mediates the absorption and transportation of yolk lipids to the developing embryo, zebrafish soat1 and soat2 were cloned and studied. In the adult zebrafish, soat1 was detected ubiquitously while soat2 mRNA was detected specifically in the liver, intestine, brain and testis. Whole mount in situ hybridization demonstrated that both soat1 and soat2 expressed in the yolk syncytial layer, hatching gland and developing cardiovascular as well as digestive systems, suggesting that Soats may play important roles in the lipid trafficking and utilization during embryonic development. The enzymatic activity of zebrafish Soat2 was confirmed by Oil Red O staining in the HEK293 cells overexpressing this gene, and could be quenched by Soat2 inhibitor Pyripyropene A (PPPA). The zebrafish embryos injected with PPPA or morpholino oligo against soat2 in the yolk showed significantly larger yolk when compared with wild-type embryos, especially at 72 hpf, indicating a slower rate of yolk consumption. Our result indicated that zebrafish Soat2 is catalytically active in synthesizing cholesteryl esters and contributes to the yolk cholesterol trafficking during zebrafish embryogenesis.	[Chang, Nai-Yun; Chan, Yen-Ju; Ding, Shih-Torng; Lee, Yen-Hua; Liu, I-Hsuan] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, I-Hsuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; Taipei Medical University; National Taiwan University	Liu, IH (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, IH (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan.	ihliu@ntu.edu.tw	Liu, I-Hsuan/D-9043-2017	Liu, I-Hsuan/0000-0002-4524-3263; Lee, Yen-Hua/0000-0001-8812-6094	Ministry of Science and Technology, Taiwan [105-2628-B-002-005-MY4, 104R7602D2]; Ministry of Science and Technology of Taiwan, ROC [103-2321-B-400-010, 103-2321-B-001-050]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan, ROC	This work was financially supported by Ministry of Science and Technology, Taiwan (105-2628-B-002-005-MY4; https://www.most.gov.tw/) and National Taiwan University (104R7602D2; http://www.ntu.edu.tw/) to IHL. The funding agencies had no role on in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Ju-Ahng Lee for the reviewing and revising of this manuscript, Dr. Jeff Shyh-Jye Lee for helpful discussion, and Ms. Ke-Hsuan Wei for the zebrafish husbandry. The authors would also like to acknowledge the materials and services provided by Taiwan Zebrafish Core Facility at ZeTH (103-2321-B-400-010) and Academia Sinica (103-2321-B-001-050), which are supported by Ministry of Science and Technology of Taiwan, ROC.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; An SJ, 2006, FEBS LETT, V580, P2741, DOI 10.1016/j.febslet.2006.04.035; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Carvalho L, 2010, TRENDS CELL BIOL, V20, P586, DOI 10.1016/j.tcb.2010.06.009; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 2010, BIOCHEMISTRY-US, V49, P9957, DOI 10.1021/bi1013936; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; Chang YC, 2013, AMINO ACIDS, V44, P615, DOI 10.1007/s00726-012-1386-8; Das A, 2009, BIOCHEMISTRY AND MOL; Das A, 2008, J BIOL CHEM, V283, P10453, DOI 10.1074/jbc.M709460200; Ding ST, 2000, POULTRY SCI, V79, P1460, DOI 10.1093/ps/79.10.1460; Dove DE, 2006, ATHEROSCLEROSIS, V186, P267, DOI 10.1016/j.atherosclerosis.2005.08.005; falseZhao X.-P., 2009, FOUNDRY TECHNOL, V30, P745; Guo ZM, 2001, J LIPID RES, V42, P1282; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Karasinska JM, 2011, NAT REV NEUROL, V7, P561, DOI 10.1038/nrneurol.2011.132; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lee RG, 2000, J LIPID RES, V41, P1991; Leung CF, 1998, DEV GROWTH DIFFER, V40, P313; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Llaverias G, 2002, EUR J PHARMACOL, V451, P11, DOI 10.1016/S0014-2999(02)02152-0; Matsuda D, 2015, J ANTIBIOT, V68, P27, DOI 10.1038/ja.2014.91; Miyares RL, 2014, DIS MODEL MECH, V7, P915, DOI 10.1242/dmm.015800; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Ohshiro T, 2015, J PHARMACOL EXP THER, V355, P297, DOI 10.1124/jpet.115.227348; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Rodriguez A, 2002, ATHEROSCLEROSIS, V161, P45, DOI 10.1016/S0021-9150(01)00620-7; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Schwend T, 2011, J LIPID RES, V52, P1328, DOI 10.1194/jlr.M012377; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; SHAND JH, 1993, LIPIDS, V28, P621, DOI 10.1007/BF02536056; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Spady DK, 2000, J BIOL CHEM, V275, P27005; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhan Y, 2016, ORG BIOMOL CHEM, V14, P747, DOI 10.1039/c5ob02019k; Zhang J, 2014, CIRC RES, V115, P826, DOI 10.1161/CIRCRESAHA.115.304378; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	55	10	10	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167644	10.1371/journal.pone.0167644	http://dx.doi.org/10.1371/journal.pone.0167644			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936201	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100139
J	Heiss-Blanquet, S; Fayolle-Guichard, F; Lombard, V; Hebert, A; Coutinho, PM; Groppi, A; Barre, A; Henrissat, B				Heiss-Blanquet, Senta; Fayolle-Guichard, Francoise; Lombard, Vincent; Hebert, Agnes; Coutinho, Pedro M.; Groppi, Alexis; Barre, Aurelien; Henrissat, Bernard			Composting-Like Conditions Are More Efficient for Enrichment and Diversity of Organisms Containing Cellulase-Encoding Genes than Submerged Cultures	PLOS ONE			English	Article							ENZYME DISCOVERY; PLANT BIOMASS; DNA; HYDROLASES; CONVERSION; DYNAMICS; GENOMES; SOIL	Cost-effective biofuel production from lignocellulosic biomass depends on efficient degradation of the plant cell wall. One of the major obstacles for the development of a cost-efficient process is the lack of resistance of currently used fungal enzymes to harsh conditions such as high temperature. Adapted, thermophilic microbial communities provide a huge reservoir of potentially interesting lignocellulose-degrading enzymes for improvement of the cellulose hydrolysis step. In order to identify such enzymes, a leaf and wood chip compost was enriched on a mixture of thermo-chemically pretreated wheat straw, poplar and Miscanthus under thermophile conditions, but in two different set-ups. Unexpectedly, metagenome sequencing revealed that incubation of the lignocellulosic substrate with compost as inoculum in a suspension culture resulted in an impoverishment of putative cellulase-and hemicellulase-encoding genes. However, mimicking composting conditions without liquid phase yielded a high number and diversity of glycoside hydrolase genes and an enrichment of genes encoding cellulose binding domains. These identified genes were most closely related to species from Actinobacteria, which seem to constitute important players of lignocellulose degradation under the applied conditions. The study highlights that subtle changes in an enrichment set-up can have an important impact on composition and functions of the microcosm. Composting-like conditions were found to be the most successful method for enrichment in species with high biomass degrading capacity.	[Heiss-Blanquet, Senta; Fayolle-Guichard, Francoise; Hebert, Agnes] IFP Energies Nouvelles, Dept Biotechnol, Rueil Malmaison, France; [Lombard, Vincent; Coutinho, Pedro M.; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Groppi, Alexis; Barre, Aurelien] Univ Bordeaux, Ctr Genom Fonct Bordeaux, Bordeaux, France; [Lombard, Vincent; Coutinho, Pedro M.; Henrissat, Bernard] INRA, AFMB, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Hebert, Agnes] Univ Evry Val Essonne, CNRS FRE 3561, Inst Syst & Synthet Biol, Evry, France	IFP Energies Nouvelles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Heiss-Blanquet, S (corresponding author), IFP Energies Nouvelles, Dept Biotechnol, Rueil Malmaison, France.	Senta.Blanquet@ifpen.fr	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Lombard, Vincent/0000-0002-9684-7067; Barre, annick/0000-0002-1360-8491; Groppi, Alexis/0000-0002-3341-8281	Agence Nationale de Recherche (ANR) [ANR-12-BIO-ME-006-01]	Agence Nationale de Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Agence Nationale de Recherche (ANR), Grant number: ANR-12-BIO-ME-006-01 (http://www.agence-nationale-recherche.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Brethauer S, 2015, CHIMIA, V69, P572, DOI 10.2533/chimia.2015.572; Courtois S, 2001, ENVIRON MICROBIOL, V3, P431, DOI 10.1046/j.1462-2920.2001.00208.x; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; Cairo JPLF, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-50; Gladden JM, 2011, APPL ENVIRON MICROB, V77, P5804, DOI 10.1128/AEM.00032-11; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Jimenez DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13845; Jimenez DJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-92; Le Digabel Y, 2013, APPL MICROBIOL BIOT, V97, P10531, DOI 10.1007/s00253-013-4803-3; Liguori R, 2013, APPL MICROBIOL BIOT, V97, P6129, DOI 10.1007/s00253-013-5014-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopez-Gonzalez JA, 2013, BIORESOURCE TECHNOL, V146, P574, DOI 10.1016/j.biortech.2013.07.122; Martins LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061928; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mhuantong W, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0200-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mori T, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-365; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Reddy A. P., 2013, PLoS ONE, V8, pe77985, DOI 10.1371/journal.pone.0077985; Rosewarne CP, 2011, MICROB ECOL, V61, P448, DOI 10.1007/s00248-010-9745-z; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Thompson CE, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-65; van der Lelie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036740; VANSOEST PJ, 1973, P NUTR SOC, V32, P123, DOI 10.1079/PNS19730029; Wang C, 2016, BIOTECHNOLOGY BIOFUE, V22; Wei H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-20; Wongwilaiwalin S, 2013, APPL MICROBIOL BIOT, V97, P8941, DOI 10.1007/s00253-013-4699-y; Ximenes E, 2011, ENZYME MICROB TECH, V48, P54, DOI 10.1016/j.enzmictec.2010.09.006	35	7	7	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167216	10.1371/journal.pone.0167216	http://dx.doi.org/10.1371/journal.pone.0167216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936240	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100074
J	Vieira, VMNCS; Engelen, AH; Huanel, OR; Guillemin, ML				Vieira, Vasco M. N. C. S.; Engelen, Aschwin H.; Huanel, Oscar R.; Guillemin, Marie-Laure			Linear-In-The-Parameters Oblique Least Squares (LOLS) Provides More Accurate Estimates of Density-Dependent Survival	PLOS ONE			English	Article							BIPHASIC LIFE-CYCLES; PLANT SIZE; RHODOPHYTA; TETRASPOROPHYTES; SIGNIFICANCES; GAMETOPHYTES; TEMPERATURE; POPULATIONS; MAZZAELLA; DYNAMICS	Survival is a fundamental demographic component and the importance of its accurate estimation goes beyond the traditional estimation of life expectancy. The evolutionary stability of isomorphic biphasic life-cycles and the occurrence of its different ploidy phases at uneven abundances are hypothesized to be driven by differences in survival rates between haploids and diploids. We monitored Gracilaria chilensis, a commercially exploited red alga with an isomorphic biphasic life-cycle, having found density-dependent survival with competition and Allee effects. While estimating the linear-in-the-parameters survival function, all model I regression methods (i.e, vertical least squares) provided biased line-fits rendering them inappropriate for studies about ecology, evolution or population management. Hence, we developed an iterative two-step non-linear model II regression (i.e, oblique least squares), which provided improved line-fits and estimates of survival function parameters, while robust to the data aspects that usually turn the regression methods numerically unstable.	[Vieira, Vasco M. N. C. S.] Univ Tecn Lisboa, Inst Super Tecn, MARETEC, Ave Rovisco Pais, Lisbon, Portugal; [Engelen, Aschwin H.] Univ Algarve, CIMAR Lab Associado, FCT, CCMAR,Ctr Marine Sci, Campus Gambelas, Faro, Portugal; [Huanel, Oscar R.; Guillemin, Marie-Laure] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Fac Ciencias, Valdivia, Chile; [Guillemin, Marie-Laure] UPMC Univ Paris VI, Sorbonne Univ, CNRS,CS, UMI 3614,Evolutionary Biol & Ecol Algae,Stn Biol, Pl G Tessier, Roscoff, France	Universidade de Lisboa; Instituto Superior Tecnico; Universidade do Algarve; Universidad Austral de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Vieira, VMNCS (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, MARETEC, Ave Rovisco Pais, Lisbon, Portugal.	vasco.vieira@tecnico.ulisboa.pt	Engelen, Aschwin H/M-3432-2013	Engelen, Aschwin H/0000-0002-9579-9606; Vieira, Vasco/0000-0001-9858-6254	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1090360]; European Regional Development Funds of the Competitiveness Factors Operational Programme-COMPETE; national funds of the Foundation for Science and Technology (FCT) [UID/EEA/50009/2013]; FCT [SFRH/BPD/63703/2009, SFRH/BPD/107878/2015]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Regional Development Funds of the Competitiveness Factors Operational Programme-COMPETE; national funds of the Foundation for Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Research on Gracilaria chilensis was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/fondecyt-program/) under grant number 1090360. VV was funded by European Regional Development Funds (http://ec.europa.eu/regional_policy/en/funding/erdf/) of the Competitiveness Factors Operational Programme-COMPETE and national funds of the Foundation for Science and Technology (FCT-www.fct.pt) under the project UID/EEA/50009/2013. AHE was supported by fellowships SFRH/BPD/63703/2009 and SFRH/BPD/107878/2015 of the FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cragg JG, 1997, RAND J ECON, V28, pS71, DOI 10.2307/3087456; Creed JC, 1998, J PHYCOL, V34, P39, DOI 10.1046/j.1529-8817.1998.340039.x; Vieira VMNDD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092602; Vieira VMNCS, 2012, J PHYCOL, V48, P1012, DOI 10.1111/j.1529-8817.2012.01192.x; Vieira VMNDD, 2010, J PHYCOL, V46, P1128, DOI 10.1111/j.1529-8817.2010.00924.x; Draper NR, 1992, P KANS STAT U C APPL, P1; Engel C, 2001, J ECOL, V89, P436, DOI 10.1046/j.1365-2745.2001.00567.x; Garza-Sanchez F, 2000, BOT MAR, V43, P205, DOI 10.1515/BOT.2000.022; Gillard J. W., 2005, METHOD MOMENTS ESTIM; Gillard J, 2010, REVSTAT-STAT J, V8, P57; Gonzalez J, 1996, AQUACULTURE, V143, P91, DOI 10.1016/0044-8486(95)01203-6; Guillemin M-L, 2012, J APPL PHYCOL; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; Jackson JE, 1991, USERS GUIDE PRINCIPA; Kamiya M, 2002, PHYCOLOGIA, V41, P107, DOI 10.2216/i0031-8884-41-2-107.1; Keeley ER, 2003, OIKOS, V102, P543, DOI 10.1034/j.1600-0706.2003.12035.x; King MR, 2010, NUMERICAL STAT METHO; LONSDALE WM, 1983, J ECOL, V71, P285, DOI 10.2307/2259977; Mudge B, 2003, J MAR BIOL ASSOC UK, V83, P701, DOI 10.1017/S0025315403007665h; Rincon PA, 2002, ECOLOGY, V83, P1808, DOI 10.2307/3071766; SCHIEL DR, 1985, J ECOL, V73, P199, DOI 10.2307/2259778; Scrosati R, 1998, J PHYCOL, V34, P228, DOI 10.1046/j.1529-8817.1998.340228.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Sokal R. R., 1981, BIOMETRY; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; Oppliger LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039289; Vieira Vasco M. N. C. S., 2013, Computational Ecology and Software, V3, P44; Vieira VMNCS, 2012, J BIOL DYNAM, V6, P1067, DOI 10.1080/17513758.2012.721901; Vieira VMNCS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119670; VIEIRA VMNCS, 2013, COMPUT ECOL SOFTW, V3, P102; Vieira VMNCS., 2016, ANN RES REV BIOL, V10, P1, DOI [10.9734/arrb/2016/25219, DOI 10.9734/ARRB/2016/25219]; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167418	10.1371/journal.pone.0167418	http://dx.doi.org/10.1371/journal.pone.0167418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936048	gold, Green Published			2022-12-26	WOS:000389587100095
J	Yang, J; Du, XL; Li, ST; Wang, BY; Wu, YY; Chen, ZL; Lv, M; Shen, YW; Wang, X; Dong, DF; Li, D; Wang, F; Li, EX; Yi, M; Yang, J				Yang, Jiao; Du, Xiang Lin; Li, Shu Ting; Wang, Bi Yuan; Wu, Yin Ying; Chen, Zhe Ling; Lv, Meng; Shen, Yan Wei; Wang, Xin; Dong, Dan Feng; Li, Dan; Wang, Fan; Li, En Xiao; Yi, Min; Yang, Jin			Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients	PLOS ONE			English	Article							PRIMARY TUMOR SITE; MOLECULAR-FEATURES; PROSPECTIVE COHORT; NATIONWIDE COHORT; MISMATCH REPAIR; RECTAL-CANCER; SURVIVAL; STAGE; METASTASIS; PREDICTOR	Background It has been suggested that colorectal cancer be regarded as several subgroups defined according to tumor location rather than as a single entity. The current study aimed to identify the most useful method for grouping colorectal cancer by tumor location according to both baseline and survival characteristics. Methods Cases of pathologically confirmed colorectal adenocarcinoma diagnosed from 2000 to 2012 were identified from the Surveillance, Epidemiology, and End Results database and categorized into three groups: right colon cancer (RCC), left colon cancer (LCC), and rectal cancer (ReC). Adjusted hazard ratios for known predictors of disease-specific survival (DSS) in colorectal cancer were obtained using a Cox proportional hazards regression model. Results The study included 57847 patients: 43.5% with RCC, 37.7% with LCC, and 18.8% with ReC. Compared with LCC and ReC, RCC was more likely to affect old patients and women, and to be at advanced stage, poorly differentiated or un-differentiated, and mucinous. Patients with LCC or ReC had better DSS than those with RCC in subgroups including stage III or IV disease, age <= 70 years and non-mucinous adenocarcinoma. Conversely, patients with LCC or ReC had worse DSS than those with RCC in subgroups including age >70 years and mucinous adenocarcinoma. Conclusions RCC differed from both LCC and ReC in several clinicopathologic characteristics and in DSS. It seems reasonable to group colorectal cancer into right-sided (i.e., proximal) and left-sided (i.e., distal) ones.	[Yang, Jiao; Li, Shu Ting; Wang, Bi Yuan; Wu, Yin Ying; Chen, Zhe Ling; Lv, Meng; Shen, Yan Wei; Wang, Xin; Dong, Dan Feng; Li, Dan; Wang, Fan; Li, En Xiao; Yi, Min; Yang, Jin] Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China; [Du, Xiang Lin] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Yi, M; Yang, J (corresponding author), Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Shaanxi Provinc, Peoples R China.; Yi, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.	myi@mdanderson.org; yangjin@mail.xjtu.edu.cn	Yi, Min/J-8963-2017; Chen, Zheling/L-6089-2019	Yi, Min/0000-0001-8662-6546; 				Agesen TH, 2012, GUT, V61, P1560, DOI 10.1136/gutjnl-2011-301179; Alves Izabela Sinara Silva, 2016, J Gastrointest Cancer, V47, P278, DOI 10.1007/s12029-016-9829-1; Bernstein AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135959; Bretthauer M, 2016, JAMA INTERN MED, V176, P894, DOI 10.1001/jamainternmed.2016.0960; Brule SY, 2015, EUR J CANCER, V51, P1405, DOI 10.1016/j.ejca.2015.03.015; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chen Jeffrey, 2016, Hosp Pract (1995), V44, P120, DOI 10.1080/21548331.2016.1200949; Chen KH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2358-2; de Kort S, 2016, EUR J GASTROEN HEPAT, V28, P896, DOI 10.1097/MEG.0000000000000626; Erning v. RE, 2015, JNCI J NATL CANC I; Ghazi S, 2012, J GASTROENTEROL, V47, P619, DOI 10.1007/s00535-011-0520-9; Graziano F, 2016, PHARMACOGENOMICS J; Huh JW, 2014, J SURG ONCOL, V109, P848, DOI 10.1002/jso.23592; Jayasekara H, 2016, INT J CANCER, V139, P1081, DOI 10.1002/ijc.30153; Keeler BD, 2016, ANN MED SURG, V6, P6, DOI 10.1016/j.amsu.2015.12.052; Korphaisarn K, 2015, WORLD J GASTROENTERO, V21, P926, DOI 10.3748/wjg.v21.i3.926; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; Moretto R, 2016, ONCOLOGIST, V21, P988, DOI 10.1634/theoncologist.2016-0084; Nash GM, 2009, DIS COLON RECTUM, V52, P577, DOI 10.1007/DCR.0b013e3181a0adbd; Nayani R, 2015, CURR COLORECT CANC R, V11, P408, DOI 10.1007/s11888-015-0302-5; Plummer JM, 2016, ANN MED SURG, V6, P26, DOI 10.1016/j.amsu.2016.01.018; Price TJ, 2015, CANCER-AM CANCER SOC, V121, P830, DOI 10.1002/cncr.29129; Pugh SA, 2015, ANN SURG; Rotondano G, 2015, DIGEST LIVER DIS, V47, P512, DOI 10.1016/j.dld.2015.03.005; Sideris M, 2015, ANTICANCER RES, V35, P2345; Steffen A, 2014, MED J AUSTRALIA, V201, P523, DOI 10.5694/mja14.00197; Tarantino I, 2015, ANN SURG ONCOLOGY; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; TEIXEIRA Yolanda, 2015, Arq. Gastroenterol., V52, P293, DOI 10.1590/S0004-28032015000400008; Vaish V, 2016, GENE CHROMOSOME CANC, V55, P577, DOI 10.1002/gcc.22361; Vulcan A, 2015, BRIT J NUTR, V114, P959, DOI 10.1017/S0007114515002743; Wang MJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002350; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Wong HL, 2016, CLIN COLORECTAL CANC, V15, pE9, DOI 10.1016/j.clcc.2016.02.007; Xu S Z, 2016, Zhonghua Yi Xue Za Zhi, V96, P1578, DOI 10.3760/cma.j.issn.0376-2491.2016.20.007; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; You YN, 2007, ANN SURG, V245, P726, DOI 10.1097/01.sla.0000252590.95116.4f; Zhang Jian, 2016, Zhonghua Wei Chang Wai Ke Za Zhi, V19, P780	39	43	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167540	10.1371/journal.pone.0167540	http://dx.doi.org/10.1371/journal.pone.0167540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936129	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100118
J	Yao, CH; Carlisi, C; Li, YN; Chen, D; Ding, JF; Feng, YL				Yao, Chunhe; Carlisi, Cristina; Li, Yuning; Chen, Da; Ding, Jianfu; Feng, Yong-Lai			Interaction Potency of Single-Walled Carbon Nanotubes with DNAs: A Novel Assay for Assessment of Hazard Risk	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; STRANDED-DNA; IN-VITRO; CYTOTOXICITY; CELLS; NANOMATERIALS; ADSORPTION; TOXICITY; EXPOSURE; DELIVERY	Increasing use of single-walled carbon nanotubes (SWCNTs) necessitates a novel method for hazard risk assessment. In this work, we investigated the interaction of several types of commercial SWCNTs with single-stranded (ss) and double-stranded (ds) DNA oligonucleotides (20-mer and 20 bp). Based on the results achieved, we proposed a novel assay that employed the DNA interaction potency to assess the hazard risk of SWCNTs. It was found that SWCNTs in different sizes or different batches of the same product number of SWCNTs showed dramatically different potency of interaction with DNAs. In addition, the same SWCNTs also exerted strikingly different interaction potency with ss-versus ds-DNAs. The interaction rates of SWCNTs with DNAs were investigated, which could be utilized as the indicator of potential hazard for acute exposure. Compared to solid SWCNTs, the SWCNTs dispersed in liquid medium (2% sodium cholate solution) exhibited dramatically different interaction potency with DNAs. This indicates that the exposure medium may greatly influence the subsequent toxicity and hazard risk produced by SWCNTs. Based on the findings of dose-dependences and time-dependences from the interactions between SWCNTs and DNAs, a new chemistry based assay for hazard risk assessment of nanomaterials including SWCNTs has been presented.	[Yao, Chunhe; Carlisi, Cristina; Feng, Yong-Lai] Hlth Canada, Exposure & Biomonitoring Div, Environm Hlth Sci & Res Bur, Environm & Radiat Hlth Sci Directorate,Hlth Envir, Ottawa, ON, Canada; [Li, Yuning] Univ Waterloo, Dept Chem Engn, Dept Chem, Waterloo, ON, Canada; [Li, Yuning] Univ Waterloo, WIN, Waterloo, ON, Canada; [Chen, Da] Southern Illinois Univ, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA; [Chen, Da] Southern Illinois Univ, Dept Zool, Carbondale, IL 62901 USA; [Ding, Jianfu] Natl Res Council Canada, Secur & Disrupt Technol, Ottawa, ON, Canada	Health Canada; University of Waterloo; University of Waterloo; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; National Research Council Canada	Feng, YL (corresponding author), Hlth Canada, Exposure & Biomonitoring Div, Environm Hlth Sci & Res Bur, Environm & Radiat Hlth Sci Directorate,Hlth Envir, Ottawa, ON, Canada.	yong-lai.feng@canada.ca	Li, Yuning/G-4546-2010; Chen, Da/F-5821-2014	Li, Yuning/0000-0003-3679-8133; Chen, Da/0000-0001-5563-0091	Natural Sciences and Engineering Research Council (NSERC) Canada; Health Canada; Canadian Government under the Chemicals Management Plan (CMP); NSERC Canada	Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Health Canada; Canadian Government under the Chemicals Management Plan (CMP); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Dr. Yao is grateful to Natural Sciences and Engineering Research Council (NSERC) Canada and Health Canada for financial support in the form of post-doctoral fellowship. The Canadian Government under the Chemicals Management Plan (CMP) financially supported this project.; We are grateful to NSERC Canada and Health Canada for financial support in the form of post-doctoral fellowship to Chunhe Yao. The Canadian Government under the Chemicals Management Plan (CMP) financially supported this project.	Berges MG, 2013, NANOMATERIALS, P25; Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s; Bianco A, 2003, ADV MATER, V15, P1765, DOI 10.1002/adma.200301646; Cancino J, 2013, TOXICOL LETT, V219, P18, DOI 10.1016/j.toxlet.2013.02.009; Cui H, 2000, J APPL PHYS, V88, P6072, DOI 10.1063/1.1320024; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Du J, 2013, ENV TOXIC PHARM; Feng YL, 2009, ENVIRON TOXICOL CHEM, V28, P2044, DOI 10.1897/09-015.1; Gavina JMA, 2011, J ENVIRON MONITOR, V13, P3145, DOI 10.1039/c1em10511f; Geys J, 2010, TOXICOL IN VITRO, V24, P620, DOI 10.1016/j.tiv.2009.10.007; Hayashida T, 2013, COLLOID SURFACE B, V101, P49, DOI 10.1016/j.colsurfb.2012.06.018; Heller DA, 2006, SCIENCE, V311, P508, DOI 10.1126/science.1120792; Hughes ME, 2007, NANO LETT, V7, P1191, DOI 10.1021/nl062906u; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kato Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00733; Liu ZD, 2011, ANAL CHIM ACTA, V706, P171, DOI 10.1016/j.aca.2011.08.032; Lu G, 2005, NANO LETT, V5, P897, DOI 10.1021/nl050354u; Manshian BB, 2013, NANOTOXICOLOGY, V7, P144, DOI 10.3109/17435390.2011.647928; Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688; Mayo ML, 2012, J PHYS CHEM LETT, V3, P2790, DOI 10.1021/jz3011145; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Ong LC, 2016, ARCH TOXICOL, V90, P103, DOI 10.1007/s00204-014-1376-6; Raffa V, 2010, NANOMEDICINE-UK, V5, P89, DOI 10.2217/NNM.09.95; Rajendra J, 2005, CHEM-EUR J, V11, P4841, DOI 10.1002/chem.200500093; Ren HX, 2010, MATER TODAY, V13, P6, DOI 10.1016/S1369-7021(10)70002-X; Saito R, 1998, PHYS PROPERTIES CARB; Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/713853956; Speit Gunter, 2006, Methods Mol Biol, V314, P275; Thomas SP, 2013, ARAB J SCI ENG, V38, P457, DOI 10.1007/s13369-012-0324-0; Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049; Vashist SK, 2011, BIOTECHNOL ADV, V29, P169, DOI 10.1016/j.biotechadv.2010.10.002; Walter D, 2001, J THERM ANAL CALORIM, V63, P733, DOI 10.1023/A:1010187921227; Weizmann Y, 2011, J AM CHEM SOC, V133, P3238, DOI 10.1021/ja109180d; Yan H, 2006, CHEMOSPHERE, V62, P142, DOI 10.1016/j.chemosphere.2005.03.075; Yun Y, 2012, J NANOMEDIC BIOTHERA, V2, P2, DOI DOI 10.4172/2155-983X.1000104; Zheng D, 2009, BIOELECTROCHEMISTRY, V74, P240, DOI 10.1016/j.bioelechem.2008.08.006; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	40	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167796	10.1371/journal.pone.0167796	http://dx.doi.org/10.1371/journal.pone.0167796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936089	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100195
J	Cheng, D; Zhao, YJ; Wang, SW; Zhang, F; Russo, M; McMahon, SB; Zhu, JY				Cheng, De; Zhao, Yuanjun; Wang, Shuwen; Zhang, Fan; Russo, Mariano; McMahon, Steven B.; Zhu, Jiyue			Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes	FASEB JOURNAL			English	Article							CATALYTIC SUBUNIT HTERT; REVERSE-TRANSCRIPTASE GENE; NORMAL HUMAN-CELLS; HISTONE DEACETYLATION; COMPARATIVE BIOLOGY; HUMAN CANCER; LIFE-SPAN; C-MYC; ACTIVATION; ROLES	The human telomerase reverse transcriptase (hTERT) gene is repressed in most somatic cells, whereas the expression of the mouse mTert gene is widely detected. To understand the mechanisms of this human-specific repression, we constructed bacterial artificial chromosome(BAC) reporters using human and mouse genomic DNAs encompassing the TERT genes and neighboring loci. Upon chromosomal integration, the hTERT, but not the mTert, reporter was stringently repressed in telomerase-negative human cells in a histone deacetylase (HDAC)-dependent manner, replicating the expression of their respective endogenous genes. In chimeric BACs, the mTert promoter became strongly repressed in the human genomic context, but the hTERT promoter was highly active in the mouse genomic context. Furthermore, an unrelated herpes simplex virus-thymidine kinase (HSV-TK) promoter was strongly repressed in the human, but not in the mouse, genomic context. These results demonstrated that the repression of hTERT gene was dictated by distal elements and its chromatin environment. This repression depended on class I HDACs and involved multiple corepressor complexes, including HDAC1/2-containing Sin3B, nucleosome remodeling and histone deacetylase (NuRD), and corepressor of RE1 silencing transcription factor (CoREST) complexes. Together, our data indicate that the lack of telomerase expression in most human somatic cells results from its repressive genomic environment, providing new insight into the mechanism of long-recognized differential telomerase regulation in mammalian species.-Cheng, D., Zhao, Y., Wang, S., Zhang, F., Russo, M., McMahon, S. B., Zhu, J. Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes.	[Cheng, De; Wang, Shuwen; Zhang, Fan; Zhu, Jiyue] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, PBS 323, POB 1495, Spokane, WA 99210 USA; [Zhao, Yuanjun; Russo, Mariano] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, University Pk, PA 16802 USA; [McMahon, Steven B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Jefferson University	Zhu, JY (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, PBS 323, POB 1495, Spokane, WA 99210 USA.	jiyue.zhu@wsu.edu	zhu, ji/HDM-1538-2022; Zhang, Fan/AAB-1175-2020	ZHANG, FAN/0000-0002-7186-6317; McMahon, Steven/0000-0002-3405-1768	NIH Institute of General Medical Sciences [R01GM071725]; Spokane County Health Sciences and Services Authority (Spokane, WA, USA);  [R21OD021432]; NATIONAL CANCER INSTITUTE [R01CA164834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071725] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD021432] Funding Source: NIH RePORTER	NIH Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spokane County Health Sciences and Services Authority (Spokane, WA, USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Weidong Wang [U.S. National Institutes of Health (NIH) National Institute on Aging] for the generous gift of CHD3 and -4 antibodies. This work was supported by NIH Institute of General Medical Sciences Grant R01GM071725, and Grant R21OD021432 from the Office of the Director (both to J.Z.); and the Spokane County Health Sciences and Services Authority (Spokane, WA, USA). The authors declare no conflicts of interest.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cheng D, 2015, J BIOL CHEM, V290, P30193, DOI 10.1074/jbc.M115.662221; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Cobrinik D, 2013, GENE CHROMOSOME CANC, V52, P1150, DOI 10.1002/gcc.22110; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Devereux TR, 1999, CANCER RES, V59, P6087; Fujimoto K, 2000, NUCLEIC ACIDS RES, V28, P2557, DOI 10.1093/nar/28.13.2557; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Gunes C, 2000, CANCER RES, V60, P2116; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Heidenreich B, 2014, CURR OPIN GENET DEV, V24, P30, DOI 10.1016/j.gde.2013.11.005; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jia WW, 2011, FASEB J, V25, P979, DOI 10.1096/fj.10-173989; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lewis KA, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00083; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Nagel I, 2010, BLOOD, V116, P1317, DOI 10.1182/blood-2009-09-240440; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Takakura M, 1999, CANCER RES, V59, P551; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang SW, 2007, MOL BIOL CELL, V18, P669, DOI 10.1091/mbc.E06-09-0840; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Wang SW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp511; Wang SW, 2009, NUCLEIC ACIDS RES, V37, P2618, DOI 10.1093/nar/gkp125; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721; Zhao Yuanjun, 2011, Int J Biochem Mol Biol, V2, P199; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698; Zhu JY, 2010, PROTEIN CELL, V1, P22, DOI 10.1007/s13238-010-0014-1; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	45	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1165	+		10.1096/fj.201601111R	http://dx.doi.org/10.1096/fj.201601111R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27940549	Green Published			2022-12-26	WOS:000395671200029
J	Morgenstern, J; Fleming, T; Schumacher, D; Eckstein, V; Freichel, M; Herzig, S; Nawroth, P				Morgenstern, Jakob; Fleming, Thomas; Schumacher, Dagmar; Eckstein, Volker; Freichel, Marc; Herzig, Stephan; Nawroth, Peter			Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; CRISPR; Cas; diabetes; enzyme kinetics; glycation; toxicity; aldose reductase; diabetic neuropathy; glyoxalase system; methylglyoxal	GLYCATION END-PRODUCTS; ALDOSE REDUCTASE INHIBITOR; DIABETIC-NEUROPATHY; NITRIC-OXIDE; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; METHYLGLYOXAL; SYSTEM; COMPLICATIONS; PROTEINS	The glyoxalase system is a highly specific enzyme system existing in all mammalian cells that is responsible for the detoxification of dicarbonyl species, primarily methylglyoxal (MG). It has been implicated to play an essential role in preventing the increased formation of advanced glycation end products under certain pathological conditions. We have established the first glyoxalase 1 knock-out model (GLO1(-/-)) in mammalian Schwann cells using the CRISPR/Cas9 technique to investigate compensatory mechanisms. Neither elevated concentrations of MG nor associated protein modifications were observed in GLO1(-/-) cells. Alternative detoxification of MG in GLO1(-/-) is achieved by increased catalytic efficiency of aldose reductase toward hemithioacetal (product of glutathione and MG), which is most likely caused by S-nitrosylation of aldose reductase. The hemithioacetal is mainly converted into lactaldehyde, which is paralleled by a loss of reduced glutathione. Inhibition of aldose reductase in GLO1(-/-) cells is associated with an increased sensitivity against MG, elevated intracellular MG levels, associated modifications, as well as increased oxidative stress. Our data suggest that aldose reductase can compensate for the loss of GLO1. This might be of clinical importance within the context of neuronal diseases caused by an impaired glyoxalase system and elevated levels of dicarbonyl species, such as MG.	[Morgenstern, Jakob; Fleming, Thomas; Nawroth, Peter] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Eckstein, Volker] Univ Heidelberg Hosp, Dept Med 5, Neuenheimer Feld 410, Heidelberg, Germany; [Schumacher, Dagmar; Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany; [Herzig, Stephan; Nawroth, Peter] German Inst Diabet & Canc IDC, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Fleming, Thomas; Herzig, Stephan; Nawroth, Peter] German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Morgenstern, J (corresponding author), Univ Heidelberg Hosp, Dept Internal Med & Clin Chem, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	jakob.morgenstern@med.uni-heidelberg.de		Morgenstern, Jakob/0000-0001-7227-8958	Deutsche Forschungsgemeinschaft [SFB1118]; GRK [1874-DIAMICOM]; DietmarHopp Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); GRK(German Research Foundation (DFG)); DietmarHopp Foundation	This work was supported in whole or part by Deutsche Forschungsgemeinschaft Grants SFB1118 and GRK 1874-DIAMICOM and The DietmarHopp Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Baba SP, 2009, CHEM-BIOL INTERACT, V178, P250, DOI 10.1016/j.cbi.2008.11.007; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beilin E, 2008, J PHARMACEUT BIOMED, V46, P316, DOI 10.1016/j.jpba.2007.10.022; Belanger M, 2011, J NEUROSCI, V31, P18338, DOI 10.1523/JNEUROSCI.1249-11.2011; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; CLELLAND JD, 1990, J LABELLED COMPD RAD, V28, P1455, DOI 10.1002/jlcr.2580281215; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Freeman OJ, 2016, DIABETES, V65, P228, DOI 10.2337/db15-0835; Giacco F, 2014, DIABETES, V63, P291, DOI 10.2337/db13-0316; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hidmark A, 2014, EXP CLIN ENDOCR DIAB, V122, P201, DOI 10.1055/s-0034-1367023; Hu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087096; Izaguirre G, 1998, COMP BIOCHEM PHYS B, V119, P747, DOI 10.1016/S0305-0491(98)00051-0; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Kaiserova K, 2008, J BIOL CHEM, V283, P9101, DOI 10.1074/jbc.M709671200; KERN TS, 1982, HISTOCHEM J, V14, P507, DOI 10.1007/BF01011860; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; MCLELLAN AC, 1989, MECH AGEING DEV, V48, P63, DOI 10.1016/0047-6374(89)90026-2; Mizisin Andrew P, 2014, Handb Clin Neurol, V126, P401, DOI 10.1016/B978-0-444-53480-4.00029-1; Peters AS, 2016, J VASC SURG, V64, P990, DOI 10.1016/j.jvs.2016.04.025; PHILLIPS SA, 1993, BIOCHEM PHARMACOL, V46, P805, DOI 10.1016/0006-2952(93)90488-I; Qu Z, 2014, J PROTEOME RES, V13, P3200, DOI 10.1021/pr401179v; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Rabbani N, 2014, DIABETES, V63, P50, DOI 10.2337/db13-1606; RAE C, 1990, EUR J BIOCHEM, V193, P83, DOI 10.1111/j.1432-1033.1990.tb19307.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramirez MA, 2008, PHARMACOTHERAPY, V28, P646, DOI 10.1592/phco.28.5.646; Schemmel KE, 2010, J DIABETES COMPLICAT, V24, P354, DOI 10.1016/j.jdiacomp.2009.07.005; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Skapare E, 2013, J DIABETES COMPLICAT, V27, P262, DOI 10.1016/j.jdiacomp.2012.12.002; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Su Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-134; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Turkseven Saadet, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P109, DOI 10.1515/jbcpp-2013-0095; Vander Jagt D. L., 1989, GLUTATHIONE CHEM B A, P598; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Vander Jagt DL, 2001, CHEM-BIOL INTERACT, V130, P549, DOI 10.1016/S0009-2797(00)00298-2; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; Watabe, 2014, J MOL GENET MED S, VS1, P12; Xue MZ, 2016, DIABETES, V65, P2282, DOI 10.2337/db16-0153; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648	62	52	53	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3224	3238		10.1074/jbc.M116.760132	http://dx.doi.org/10.1074/jbc.M116.760132			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	27956549	Green Published, hybrid			2022-12-26	WOS:000395538800015
J	Bien, SA; Wojcik, GL; Zubair, N; Gignoux, CR; Martin, AR; Kocarnik, JM; Martin, LW; Buyske, S; Haessler, J; Walker, RW; Cheng, I; Graff, M; Xia, L; Franceschini, N; Matise, T; James, R; Hindorff, L; Le Marchand, L; North, KE; Haiman, CA; Peters, U; Loos, RJF; Kooperberg, CL; Bustamante, CD; Kenny, EE; Carlson, CS				Bien, Stephanie A.; Wojcik, Genevieve L.; Zubair, Niha; Gignoux, Christopher R.; Martin, Alicia R.; Kocarnik, Jonathan M.; Martin, Lisa W.; Buyske, Steven; Haessler, Jeffrey; Walker, Ryan W.; Cheng, Iona; Graff, Mariaelisa; Xia, Lucy; Franceschini, Nora; Matise, Tara; James, Regina; Hindorff, Lucia; Le Marchand, Loic; North, Kari E.; Haiman, Christopher A.; Peters, Ulrike; Loos, Ruth J. F.; Kooperberg, Charles L.; Bustamante, Carlos D.; Kenny, Eimear E.; Carlson, Christopher S.		PAGE Study	Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array	PLOS ONE			English	Article							SPLICING EFFICIENCY; POLYMORPHISM; GENE; DESIGN; MDR1; SNP	Investigating genetic architecture of complex traits in ancestrally diverse populations is imperative to understand the etiology of disease. However, the current paucity of genetic research in people of African and Latin American ancestry, Hispanic and indigenous peoples in the United States is likely to exacerbate existing health disparities for many common diseases. The Population Architecture using Genomics and Epidemiology, Phase II (PAGE II), Study was initiated in 2013 by the National Human Genome Research Institute to expand our understanding of complex trait loci in ethnically diverse and well characterized study populations. To meet this goal, the Multi-Ethnic Genotyping Array (MEGA) was designed to substantially improve fine-mapping and functional discovery by increasing variant coverage across multiple ethnicities at known loci for metabolic, cardiovascular, renal, inflammatory, anthropometric, and a variety of lifestyle traits. Studying the frequency distribution of clinically relevant mutations, putative risk alleles, and known functional variants across multiple populations will provide important insight into the genetic architecture of complex diseases and facilitate the discovery of novel, sometimes population-specific, disease associations. DNA samples from 51,650 self-identified African ancestry (17,328), Hispanic/Latino (22,379), Asian/Pacific Islander (8,640), and American Indian (653) and an additional 2,650 participants of either South Asian or European ancestry, and other reference panels have been genotyped on MEGA by PAGE II. MEGA was designed as a new resource for studying ancestrally diverse populations. Here, we describe the methodology for selecting trait-specific content for use in multi-ethnic populations and how enriching MEGA for this content may contribute to deeper biological understanding of the genetic etiology of complex disease.	[Bien, Stephanie A.; Zubair, Niha; Kocarnik, Jonathan M.; Haessler, Jeffrey; Peters, Ulrike; Kooperberg, Charles L.; Carlson, Christopher S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Wojcik, Genevieve L.; Gignoux, Christopher R.; Martin, Alicia R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martin, Lisa W.] George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC 20052 USA; [Buyske, Steven; Matise, Tara] Rutgers State Univ, Dept Genet, Sch Arts & Sci, Piscataway, NJ USA; [Walker, Ryan W.; Loos, Ruth J. F.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Walker, Ryan W.; Loos, Ruth J. F.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA USA; [Graff, Mariaelisa; Franceschini, Nora; North, Kari E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Xia, Lucy; Haiman, Christopher A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [James, Regina] NICHHD, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Le Marchand, Loic] Univ Hawaii, Dept Epidemiol Program, Ctr Canc, Honolulu, HI 96822 USA; [Peters, Ulrike; Carlson, Christopher S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Stanford University; George Washington University; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cancer Prevention Institute of California; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cancer Research Center of Hawaii; University of Hawaii System; University of Washington; University of Washington Seattle	Carlson, CS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	sbien@fredhutch.org; ccarlson@fredhutch.org	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; Kocarnik, Jonathan/0000-0001-8084-1608; Bustamante, Carlos D./0000-0002-4187-7920; Bien, Stephanie/0000-0002-8713-4583; Buyske, Steven/0000-0001-8539-5416; Martin, Alicia/0000-0003-0241-3522	National Human Genome Research Institute (NHGRI); National Institutes of Health [U01HG004803, U01HG004802, U01HG004790, U01HG004801]; NHGRI PAGE II program [U01HG004802]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; NHGRI PAGE program [U01HG004803, U01HG004790]; National Heart, Lung, and Blood Institute (NHLBI); US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-85079]; National Institute of Neurological Disorders and Stroke; National Center for Research Resources [M01-RR00425]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; National Center on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; Office of Dietary Supplements; Andrea and Charles Bronfman Philantropies;  [N01-HC-85086];  [N01-HC-35129];  [N01-HC-15103];  [N01 HC-55222];  [N01-HC-75150];  [N01-HC-45133];  [U01HL080295];  [R01 HL087652];  [N01-HC65233];  [N01-HC65234];  [N01-HC65235];  [N01-HC65236];  [N01-HC65237];  [U01 HL65520];  [U01 HL41642];  [U01 HL41652];  [U01 HL41654];  [U01 HL65521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, T32HD049311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007397, U01HG007376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI PAGE II program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI PAGE program; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrea and Charles Bronfman Philantropies; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture using Genomics and Epidemiology (PAGE) Study is a collaboration between the Multi-Ethnic Cohort Study (MEC), the Women's Health Initiative (WHI), the Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) consortium, which comprises the Atherosclerosis Risk in Communities (ARIC) Study, the Coronary Artery Risk Development in Young Adults (CARDIA) Study, the Cardiovascular Health Study (CHS), the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), and the Strong Heart Study (SHS). A complete list of members of the PAGE consortium can be found at [http://www.pagestudy.org]. PAGE II is funded by the National Human Genome Research Institute (NHGRI) and is supported by National Institutes of Health grants U01HG004803 (CALiCo), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center). Characterization of epidemiological architecture in the Multiethnic Cohort Study is funded through the NHGRI PAGE II program (grant U01HG004802). The Multiethnic Cohort Study is funded by the National Cancer Institute (grants R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). Funding for the study of the epidemiology of putative genetic variants in the WHI is provided through the NHGRI PAGE program (grant U01HG004790). The WHI is funded by the National Heart, Lung, and Blood Institute (NHLBI) and the US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. (The authors thank the WHI investigators and staff for their dedication). A full listing of WHI investigators can be found at [http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf]. Funding for the CALiCo consortium was provided through the NHGRI PAGE program (grant U01HG004803). The ARIC Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The CARDIA Study is supported by the following NHLBI contracts: N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, and N01-HC-45205. The Cardiovascular Health Study is supported by contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grants U01HL080295 and R01 HL087652 from the NHLBI, with an additional contribution from the National Institute of Neurological Disorders and Stroke. Genome-wide association study DNA handling and genotyping in the Cardiovascular Health Study was supported in part by National Center for Research Resources grant M01-RR00425 to the Cedars-Sinai General Clinical Research Center genotyping core and by National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The HCHS/SOL is supported by NHLBI contracts N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, and N01-HC65237.; The following institutes/centers/offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: the National Center on Minority Health and Health Disparities, the National Institute on Deafness and Other Communication Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The Strong Heart Study is supported by NHLBI grants U01 HL65520, U01 HL41642, U01 HL41652, U01 HL41654, and U01 HL65521. (The opinions expressed in this paper are those of the author(s) and do not necessarily reflect the views of the Indian Health Service). Funding for the BioMe Biobank program is supported by the Andrea and Charles Bronfman Philantropies. We thank the participants in the BioMe Biobank for their invaluable contribution to biomedical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bruun GH, 2013, MOL GENET METAB, V110, P122, DOI 10.1016/j.ymgme.2013.06.005; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Gignoux C. R., 2016, 65 ANN M AM SOC HUM; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Haeussler M, 2011, BIOINFORMATICS, V27, P980, DOI 10.1093/bioinformatics/btr043; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Huo DZ, 2007, JAMA-J AM MED ASSOC, V298, P2910, DOI 10.1001/jama.298.24.2910; Johnston H. R., 2015, 65 ANN M AM SOC HUM; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Landrum MJ, 2015, NUCL ACIDS RES; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Ohtsuki T, 2008, SCHIZOPHR RES, V101, P9, DOI 10.1016/j.schres.2008.01.027; Papp AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031930; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Suhy A, 2014, BIOCHEM BIOPH RES CO, V443, P1270, DOI 10.1016/j.bbrc.2013.12.127; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wojcik G. L., 2015, TAG SNP SELECTION LO; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	30	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167758	10.1371/journal.pone.0167758	http://dx.doi.org/10.1371/journal.pone.0167758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973554	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300044
J	Hjelmgren, O; Gellerman, K; Kjelldahl, J; Lindahl, P; Bergstrom, GML				Hjelmgren, Ola; Gellerman, Karl; Kjelldahl, Josefin; Lindahl, Per; Bergstrom, Goran M. L.			Increased Vascularization in the Vulnerable Upstream Regions of Both Early and Advanced Human Carotid Atherosclerosis	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; PLAQUE NEOVASCULARIZATION; CELLULAR COMPOSITION; ANGIOGENESIS; HYPOXIA; MECHANISMS; EXPRESSION; DISORDERS; DIRECTION; ARTERIES	Background Vascularization of atherosclerotic plaques has been linked to plaque vulnerability. The aim of this study was to test if the vascularization was increased in upstream regions of early atherosclerotic carotid plaques and also to test if the same pattern of vascularization was seen in complicated, symptomatic plaques. Methods We enrolled 45 subjects with early atherosclerotic lesions for contrast enhanced ultrasound and evaluated the percentage of plaque area in a longitudinal ultrasound section which contained contrast agent. Contrast-agent uptake was evaluated in both the upstream and downstream regions of the plaque. We also collected carotid endarterectomy specimens from 56 subjects and upstream and downstream regions were localized using magnetic resonance angiography and analyzed using histopathology and immunohistochemistry. Results Vascularization was increased in the upstream regions of early carotid plaques compared with downstream regions (30% vs. 23%, p = 0.033). Vascularization was also increased in the upstream regions of advanced atherosclerotic lesions compared with downstream regions (4.6 vs. 1.4 vessels/mm(2), p = 0.001) and was associated with intra-plaque hemorrhage and inflammation. Conclusions Vascularization is increased in the upstream regions of both early and advanced plaques and is in advanced lesions mainly driven by inflammation.	[Hjelmgren, Ola; Gellerman, Karl; Kjelldahl, Josefin; Lindahl, Per; Bergstrom, Goran M. L.] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden; [Hjelmgren, Ola; Bergstrom, Goran M. L.] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Hjelmgren, O (corresponding author), Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden.; Hjelmgren, O (corresponding author), Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden.	ola.hjelmgren@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722; Hjelmgren, Ola/0000-0002-8639-6928	Swedish Heart and Lung Foundation [20110350]; Sahlgrenska university hospital LUA/ALF [70370]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska university hospital LUA/ALF	This work was supported by the Swedish Heart and Lung Foundation grant number: 20110350, Sahlgrenska university hospital LUA/ALF (agreement concerning research and education of doctors) number: 70370.	Bokemark L, 2002, DIABETIC MED, V19, P144, DOI 10.1046/j.1464-5491.2002.00664.x; Chen F, 2005, CORONARY ARTERY DIS, V16, P191, DOI 10.1097/00019501-200505000-00009; Cicha I, 2011, STROKE, V42, P3502, DOI 10.1161/STROKEAHA.111.627265; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; Dirksen MT, 1998, CIRCULATION, V98, P2000, DOI 10.1161/01.CIR.98.19.2000; Fagerberg B, 2010, J VASC RES, V47, P221, DOI 10.1159/000255965; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Giannoni MF, 2009, EUR J VASC ENDOVASC, V37, P722, DOI 10.1016/j.ejvs.2008.12.028; Helderman F, 2007, CURR OPIN LIPIDOL, V18, P527, DOI 10.1097/MOL.0b013e3282ef7716; Hjelmgren O, 2013, EUR J VASC ENDOVASC, V46, P21, DOI 10.1016/j.ejvs.2013.03.023; Hoogi A, 2011, AM J ROENTGENOL, V196, P431, DOI 10.2214/AJR.10.4522; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Jeziorska M, 1999, J PATHOL, V188, P189; Lovett JK, 2004, CIRCULATION, V110, P2190, DOI 10.1161/01.CIR.0000144307.82502.32; Lovett JK, 2003, CEREBROVASC DIS, V16, P369, DOI 10.1159/000072559; Luque A, 2008, FRONT BIOSCI, V13, P6483, DOI 10.2741/3168; Moreno PR, 2012, ANN NY ACAD SCI, V1254, P7, DOI 10.1111/j.1749-6632.2012.06497.x; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Shah F, 2007, VASC MED, V12, P291, DOI 10.1177/1358863X07083363; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stromberg S, 2015, EUR J VASC ENDOVASC, V49, P137, DOI 10.1016/j.ejvs.2014.11.004; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829; Xue YJ, 2008, ACTA RADIOL, V49, P558, DOI 10.1080/02841850801918548; Yilmaz A, 2007, EXP MOL PATHOL, V82, P245, DOI 10.1016/j.yexmp.2006.10.008	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166918	10.1371/journal.pone.0166918	http://dx.doi.org/10.1371/journal.pone.0166918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973542	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300016
J	Kuroki, S; Hagura, N; Nishida, S; Haggard, P; Watanabe, J				Kuroki, Scinob; Hagura, Nobuhiro; Nishida, Shin'ya; Haggard, Patrick; Watanabe, Junji			Sanshool on The Fingertip Interferes with Vibration Detection in a Rapidly-Adapting (RA) Tactile Channel	PLOS ONE			English	Article							MECHANORECEPTIVE AFFERENTS; MECHANICAL FREQUENCY; DETECTION THRESHOLDS; SENSORY NEURONS; HUMAN HAND; VIBROTACTILE; CAPACITY; EVENTS; MICROSTIMULATION; DISCRIMINATION	An Asian spice, Szechuan pepper (sanshool), is well known for the tingling sensation it induces on the mouth and on the lips. Electrophysiological studies have revealed that its active ingredient can induce firing of mechanoreceptor fibres that typically respond to mechanical vibration. Moreover, a human behavioral study has reported that the perceived frequency of sanshool-induced tingling matches with the preferred frequency range of the tactile rapidly adapting (RA) channel, suggesting the contribution of sanshool-induced RA channel firing to its unique perceptual experience. However, since the RA channel may not be the only channel activated by sanshool, there could be a possibility that the sanshool tingling percept may be caused in whole or in part by other sensory channels. Here, by using a perceptual interference paradigm, we show that the sanshool-induced RA input indeed contributes to the human tactile processing. The absolute detection thresholds for vibrotactile input were measured with and without sanshool application on the fingertip. Sanshool significantly impaired detection of vibrations at 30 Hz (RA channel dominant frequency), but did not impair detection of higher frequency vibrations at 240 Hz (Pacinian-corpuscle (PC) channel dominant frequency) or lower frequency vibrations at 1 Hz (slowly adapting 1 (SA1) channel dominant frequency). These results show that the sanshool induces a peripheral RA channel activation that is relevant for tactile perception. This anomalous activation of RA channels may contribute to the unique tingling experience of sanshool.	[Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Tokyo, Kanagawa, Japan; [Hagura, Nobuhiro; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Hagura, Nobuhiro] Natl Inst Commun & Technol, Ctr Informat & Neural Networks CiNet, 1-4 Yamadaoka, Suita, Osaka, Japan	Nippon Telegraph & Telephone Corporation; University of London; University College London; National Institute of Information & Communications Technology (NICT) - Japan	Kuroki, S (corresponding author), NTT Corp, NTT Commun Sci Labs, Tokyo, Kanagawa, Japan.; Hagura, N (corresponding author), UCL, Inst Cognit Neurosci, London, England.; Hagura, N (corresponding author), Natl Inst Commun & Technol, Ctr Informat & Neural Networks CiNet, 1-4 Yamadaoka, Suita, Osaka, Japan.	kuroki.shinobu@lab.ntt.co.jp; n.hagura@gmail.com		Kuroki, Scinob/0000-0002-7585-0099; Haggard, Patrick/0000-0001-7798-793X	JSPS KAKENHI [JP 15H05915]; JSPS Postdoctoral fellowships; KAKENHI [JP 26119535]; NTT Communication Science Laboratories; Nippon Telegraph and Telephone Corporation; Grants-in-Aid for Scientific Research [15H05915, 16H01524] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Postdoctoral fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NTT Communication Science Laboratories; Nippon Telegraph and Telephone Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 15H05915. NH was supported by JSPS Postdoctoral fellowships for research abroad and KAKENHI Grant Number JP 26119535. NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation, provides support in the form of salaries for authors SK, SN, and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta RD, 2006, CLIN ORAL INVEST, V10, P17, DOI 10.1007/s00784-005-0005-4; BARLOW SM, 1987, EXP NEUROL, V96, P253, DOI 10.1016/0014-4886(87)90044-6; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; BOLANOWSKI SJ, 1982, J NEUROPHYSIOL, V48, P836, DOI 10.1152/jn.1982.48.3.836; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; CAUNA N, 1961, J COMP NEUROL, V117, P309, DOI 10.1002/cne.901170304; Efron B., 1993, MONOGRAPHS STAT APPL; Gescheider G. A., 2009, INFORM PROCESSING CH; Gescheider GA, 1995, J ACOUST SOC AM, V98, P3188, DOI 10.1121/1.413808; GESCHEIDER GA, 1985, J ACOUST SOC AM, V78, P534, DOI 10.1121/1.392475; Hagura N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1680; Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Julius David, 2005, Harvey Lect, V101, P89; Klein AH, 2011, J NEUROPHYSIOL, V105, P1701, DOI 10.1152/jn.00922.2010; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; LABS SM, 1978, SENS PROCESS, V2, P231; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037/0096-1523.23.6.1680; Lennertz RC, 2010, J NEUROSCI, V30, P4353, DOI 10.1523/JNEUROSCI.4666-09.2010; Morioka M, 2005, SOMATOSENS MOT RES, V22, P69, DOI 10.1080/08990220500084644; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1958, DOI 10.1271/bbb.69.1958; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Tommerdahl M, 2005, BRAIN RES, V1057, P1, DOI 10.1016/j.brainres.2005.04.031; Trulsson M, 2010, J NEUROPHYSIOL, V103, P1741, DOI 10.1152/jn.01146.2009; Tsunozaki M, 2013, J PHYSIOL-LONDON, V591, P3325, DOI 10.1113/jphysiol.2013.252106; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; Vazquez Y, 2013, P NATL ACAD SCI USA, V110, pE2635, DOI 10.1073/pnas.1309728110; VERRILLO RT, 1966, PSYCHON SCI, V4, P135; Weber AI, 2013, P NATL ACAD SCI USA, V110, P17107, DOI 10.1073/pnas.1305509110; WEBER DL, 1978, J ACOUST SOC AM, V64, P1392, DOI 10.1121/1.382105; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Yamashita T, 1999, ACTA ORTHOP SCAND, V70, P137, DOI 10.3109/17453679909011251	40	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165842	10.1371/journal.pone.0165842	http://dx.doi.org/10.1371/journal.pone.0165842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935970	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100017
J	Ramratnam, M; Salama, G; Sharma, RK; Wang, DWR; Smith, SH; Banerjee, SK; Huang, XN; Gifford, LM; Pruce, ML; Gabris, BE; Saba, S; Shroff, SG; Ahmad, F				Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Smith, Stephen H.; Banerjee, Sanjay K.; Huang, Xueyin N.; Gifford, Lindsey M.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Shroff, Sanjeev G.; Ahmad, Ferhaan			Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization	PLOS ONE			English	Article							HEART-FAILURE; MOUSE HEARTS; MODEL; TRANSIENTS; PROTEINS	Most studies of the mechanisms leading to hereditary dilated cardiomyopathy (DCM) have been performed in reconstituted in vitro systems. Genetically engineered murine models offer the opportunity to dissect these mechanisms in vivo. We generated a gene-targeted knock-in murine model of the autosomal dominant Arg141Trp (R141W) mutation in Tnnt2, which was first described in a human family with DCM. Mice heterozygous for the mutation (Tnnt2(R141W/+)) recapitulated the human phenotype, developing left ventricular dilation and reduced contractility. There was a gene dosage effect, so that the phenotype in Tnnt2(R141W/+) mice was attenuated by transgenic overexpression of wildtype Tnnt2 mRNA transcript. Male mice exhibited poorer survival than females. Biomechanical studies on skinned fibers from Tnnt2(R141W/+) hearts showed a significant decrease in pCa(50) (-log[Ca2+] required for generation of 50% of maximal force) relative to wildtype hearts, indicating Ca2+ desensitization. Optical mapping studies of Langendorff-perfused Tnnt2(R141W/+) hearts showed marked increases in diastolic and peak systolic intracellular Ca2+ ([Ca2+] i), and prolonged systolic rise and diastolic fall of [Ca2+] i. Perfused Tnnt2(R141W/+) hearts had slower intrinsic rates in sinus rhythm and reduced peak heart rates in response to isoproterenol. Tnnt2(R141W/+) hearts exhibited a reduction in phosphorylated phospholamban relative to wildtype mice. However, crossing Tnnt2(R141W/+) mice with phospholamban knockout (Pln(-/-)) mice, which exhibit increased Ca2+ transients and contractility, had no effect on the DCM phenotype. We conclude that the Tnnt2(R141W) mutation causes a Ca2+ desensitization and mice adapt by increasing Ca2+-transient amplitudes, which impairs Ca2+ handling dynamics, metabolism and responses to beta-adrenergic activation.	[Ramratnam, Mohun] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI USA; [Ramratnam, Mohun] William S Middleton Mem Vet Adm Med Ctr, Med Serv, Cardiol Sect, Madison, WI USA; [Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Banerjee, Sanjay K.; Huang, Xueyin N.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Ahmad, Ferhaan] Univ Pittsburgh, UPMC Heart & Vasc Inst, Pittsburgh, PA 15260 USA; [Ramratnam, Mohun; Salama, Guy; Sharma, Ravi K.; Wang, David Wen Rui; Banerjee, Sanjay K.; Huang, Xueyin N.; Pruce, Michele L.; Gabris, Bethann E.; Saba, Samir; Ahmad, Ferhaan] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA; [Smith, Stephen H.; Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Gifford, Lindsey M.; Ahmad, Ferhaan] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Gifford, Lindsey M.; Ahmad, Ferhaan] Univ Iowa, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Banerjee, Sanjay K.] Translat Hlth Sci & Technol Inst, Gurgaon, India	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Ahmad, F (corresponding author), Univ Pittsburgh, UPMC Heart & Vasc Inst, Pittsburgh, PA 15260 USA.; Ahmad, F (corresponding author), Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA 15260 USA.; Ahmad, F (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.; Ahmad, F (corresponding author), Univ Iowa, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA.	ferhaan-ahmad@uiowa.edu	Salama, Guy/GWQ-9862-2022	Ahmad, Ferhaan/0000-0003-2877-4641; Banerjee, Sanjay k/0000-0002-0044-0984; Banerjee, Sanjay/0000-0002-0008-0480	National Heart, Lung, and Blood Institute (US) [U01 HL108642]; Ferhaan Ahmad National Heart, Lung, and Blood Institute (US) [R21 HL1098121]; Ferhaan Ahmad American Heart Association (US) [053531N, 0725359U]	National Heart, Lung, and Blood Institute (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ferhaan Ahmad National Heart, Lung, and Blood Institute (US); Ferhaan Ahmad American Heart Association (US)	National Heart, Lung, and Blood Institute (US) Award Number: U01 HL108642 vertical bar Recipient: Ferhaan Ahmad National Heart, Lung, and Blood Institute (US) Award Number: R21 HL1098121 vertical bar Recipient: Ferhaan Ahmad American Heart Association (US) Award Number: Scientist Development Grant 053531N vertical bar Recipient: Ferhaan Ahmad American Heart Association (US) Award Number: 0725359U vertical bar Recipient: Sanjay Banerjee	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Baker LC, 2004, AM J PHYSIOL-HEART C, V287, pH1771, DOI 10.1152/ajpheart.00234.2004; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Banerjee SK, 2007, BIOCHEM BIOPH RES CO, V360, P381, DOI 10.1016/j.bbrc.2007.06.067; Banerjee SK, 2010, J MOL CELL CARDIOL, V49, P683, DOI 10.1016/j.yjmcc.2010.06.003; Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190; BANERJEE SK, 2009, BIOCH BIOPHYS ACTA; Bozkurt B., 2007, CARDIOVASCULAR MED, P1233; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI [10.1161/CIRCULATIONAHA.105, DOI 10.1161/CIRCULATIONAHA.105]; del Nido PJ, 1998, AM J PHYSIOL-HEART C, V274, pH728, DOI 10.1152/ajpheart.1998.274.2.H728; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Du XJ, 2004, CARDIOVASC RES, V63, P510, DOI 10.1016/j.cardiores.2004.03.027; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Gollapudi SK, 2015, AM J PHYSIOL-HEART C, V308, pH884, DOI 10.1152/ajpheart.00528.2014; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; Lombardi R, 2008, CARDIOVASC RES, V79, P109, DOI 10.1093/cvr/cvn078; London B, 2003, AM J PHYSIOL-HEART C, V284, pH431, DOI 10.1152/ajpheart.00431.2002; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Pemberton CJ, 2007, J HYPERTENS, V25, P2008, DOI 10.1097/HJH.0b013e3282ef5632; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Ramratnam M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000899; Redwood C, 2000, CIRC RES, V86, P1146; Ruiz-Hurtado G, 2012, CARDIOVASC RES; Salama G., 2009, CURR PROTOC CYTOM; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sommese RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083403; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Zhang LT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-40	42	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167681	10.1371/journal.pone.0167681	http://dx.doi.org/10.1371/journal.pone.0167681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936050	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100148
J	Reetzke, R; Lam, BPW; Xie, ZL; Sheng, L; Chandrasekaran, B				Reetzke, Rachel; Lam, Boji Pak-Wing; Xie, Zilong; Sheng, Li; Chandrasekaran, Bharath			Effect of Simultaneous Bilingualism on Speech Intelligibility across Different Masker Types, Modalities, and Signal-to-Noise Ratios in School-Age Children	PLOS ONE			English	Article							AUDIOVISUAL PERCEPTION; SOCIOECONOMIC-STATUS; ATTENTIONAL CONTROL; EXECUTIVE FUNCTION; ADVERSE CONDITIONS; LANGUAGE; RECOGNITION; VOCABULARY; EFFICIENCY; LISTENERS	Recognizing speech in adverse listening conditions is a significant cognitive, perceptual, and linguistic challenge, especially for children. Prior studies have yielded mixed results on the impact of bilingualism on speech perception in noise. Methodological variations across studies make it difficult to converge on a conclusion regarding the effect of bilingualism on speech-in-noise performance. Moreover, there is a dearth of speech-in-noise evidence for bilingual children who learn two languages simultaneously. The aim of the present study was to examine the extent to which various adverse listening conditions modulate differences in speech-in-noise performance between monolingual and simultaneous bilingual children. To that end, sentence recognition was assessed in twenty-four school-aged children (12 monolinguals; 12 simultaneous bilinguals, age of English acquisition <= 3 yrs.). We implemented a comprehensive speech-in-noise battery to examine recognition of English sentences across different modalities (audio-only, audiovisual), masker types (steady-state pink noise, two-talker babble), and a range of signal-to-noise ratios (SNRs; 0 to -16 dB). Results revealed no difference in performance between monolingual and simultaneous bilingual children across each combination of modality, masker, and SNR. Our findings suggest that when English age of acquisition and socioeconomic status is similar between groups, monolingual and bilingual children exhibit comparable speech-in-noise performance across a range of conditions analogous to everyday listening environments.	[Reetzke, Rachel; Lam, Boji Pak-Wing; Xie, Zilong; Sheng, Li; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Cognit Neurosci, Austin, TX 78712 USA; [Sheng, Li] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Delaware	Chandrasekaran, B (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.; Chandrasekaran, B (corresponding author), Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA.; Chandrasekaran, B (corresponding author), Univ Texas Austin, Cognit Neurosci, Austin, TX 78712 USA.	bchandra@utexas.edu		Sheng, Li/0000-0001-7092-6798; Reetzke, Rachel/0000-0003-1307-540X; Chandrasekaran, Bharath/0000-0002-3673-9435; Xie, Zilong/0000-0002-6851-7554	University of Texas at Austin Academic Excellence Funding; University of Texas at Austin Undergraduate Research Fellowship	University of Texas at Austin Academic Excellence Funding; University of Texas at Austin Undergraduate Research Fellowship	This project was supported through University of Texas at Austin Academic Excellence Funding to BC, and a University of Texas at Austin Undergraduate Research Fellowship to Nicole Tsao (mentored by LS and RR).; The authors thank the children and parents who made this study possible. The authors would also like to thank Nicole Tsao, Rachel Tessmer, and other members of the SoundBrain Laboratory and the Language Learning and Bilingualism Laboratory for assistance with stimulus generation, participant recruitment, and data collection. This project was supported through University of Texas at Austin Academic Excellence Funding to BC, and a University of Texas at Austin Undergraduate Research Fellowship to Nicole Tsao (mentored by LS and RR).	[Anonymous], 2014, J ACOUSTICAL SOC AM, V135, pEL88, DOI [10.1121/1.4862879, DOI 10.1121/1.4862879]; Baker M, 2014, J SPEECH LANG HEAR R, V57, P327, DOI 10.1044/1092-4388(2013/12-0287); Baskent D, 2016, J ACOUST SOC AM, V139, pEL51, DOI 10.1121/1.4942628; Bell NL, 2001, J CLIN PSYCHOL, V57, P417, DOI 10.1002/jclp.1024; Besson M., 2007, RESTORATIVE NEUROLOG, V25, P399; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bialystok E, 2014, PSYCHOL AGING, V29, P696, DOI 10.1037/a0037254; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2010, BILING-LANG COGN, V13, P525, DOI 10.1017/S1366728909990423; Bialystok E, 2009, BILING-LANG COGN, V12, P3, DOI 10.1017/S1366728908003477; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Blumenfeld H. K., 2007, LANG COGNITIVE PROC, V22, P633, DOI 10.1080/01690960601000746; Boebinger D, 2015, J ACOUST SOC AM, V137, P378, DOI 10.1121/1.4904537; Boersma Paul, 2002, GLOT INT, V5, P341; Bradley JS, 1999, J ACOUST SOC AM, V106, P1820, DOI 10.1121/1.427932; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Brungart DS, 2009, J ACOUST SOC AM, V125, P4006, DOI 10.1121/1.3117686; Burfin S, 2014, FRONT PSYCHOL, P5; Calandruccio L, 2014, J SPEECH LANG HEAR R, V57, P1089, DOI 10.1044/2013_JSLHR-H-12-0378; Calandruccio L, 2014, AM J AUDIOL, V23, P158, DOI 10.1044/2014_AJA-13-0055; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Calvo A, 2014, COGNITION, V130, P278, DOI 10.1016/j.cognition.2013.11.015; Chen YC, 2009, J ACOUST SOC AM, V126, P858, DOI 10.1121/1.3158823; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; Crandell C. C., 1996, AM J AUDIOL, V5, P47, DOI [10.1044/1059-0889.0503.47, DOI 10.1044/1059-0889.0503.47]; Cunningham J, 2001, CLIN NEUROPHYSIOL, V112, P758, DOI 10.1016/S1388-2457(01)00465-5; Fallon M, 2000, J ACOUST SOC AM, V108, P3023, DOI 10.1121/1.1323233; Fuller CD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00179; Gollan TH, 2005, MEM COGNITION, V33, P1220, DOI 10.3758/BF03193224; Gullifer JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00278; Gutierrez-Clellen VF, 2003, APPL PSYCHOLINGUIST, V24, P267, DOI 10.1017/S0142716403000158; Hazan V, 2006, J ACOUST SOC AM, V119, P1740, DOI 10.1121/1.2166611; Hazan V, 2010, SPEECH COMMUN, V52, P996, DOI 10.1016/j.specom.2010.05.003; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hollingshead AB, 2001, YALE J SOCIOLOGY, P21; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kapa LL, 2013, COGNITIVE DEV, V28, P233, DOI 10.1016/j.cogdev.2013.01.011; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krizman J, 2015, NEUROSCI LETT, V585, P48, DOI 10.1016/j.neulet.2014.11.011; Krizman J, 2014, BRAIN LANG, V128, P34, DOI 10.1016/j.bandl.2013.11.006; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Kuhnis J, 2014, J OF COGNITIVE; Leibold LJ, 2013, J SPEECH LANG HEAR R, V56, P1144, DOI 10.1044/1092-4388(2012/12-0011); LINDBLOM B, 1990, AAC (Augmentative and Alternative Communication), V6, P220, DOI 10.1080/07434619012331275504; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI DOI 10.1017/S1366728903001068; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson P, 2005, LANG SPEECH HEAR SER, V36, P219, DOI 10.1044/0161-1461(2005/022); NICOLADIS E, 1997, J SPEECH LANGUAGE PA, V0021; Paap KR, 2016, CORTEX, V74, P305, DOI 10.1016/j.cortex.2015.09.010; PAPSO CF, 1989, EAR HEARING, V10, P235, DOI 10.1097/00003446-198908000-00004; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; PLOMP R, 1979, J ACOUST SOC AM, V66, P1333, DOI 10.1121/1.383554; Pons F, 2015, PSYCHOL SCI; Pons F, 2009, P NATL ACAD SCI USA, V106, P10598, DOI 10.1073/pnas.0904134106; Portocarrero JS, 2007, ARCH CLIN NEUROPSYCH, V22, P415, DOI 10.1016/j.acn.2007.01.015; Poulin-Dubois D, 2011, J EXP CHILD PSYCHOL, V108, P567, DOI 10.1016/j.jecp.2010.10.009; Rogers CL, 2006, APPL PSYCHOLINGUIST, V27, P465, DOI 10.1017/S014271640606036X; Ronnberg J, 2013, EASE LANGUAGE UNDERS; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Ross LA, 2011, EUR J NEUROSCI, V33, P2329, DOI 10.1111/j.1460-9568.2011.07685.x; Ruggles DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086980; Schafer EC, 2012, EAR HEARING, V33, pE32, DOI 10.1097/AUD.0b013e318258c616; Schellenberg EG, 2008, TRENDS COGN SCI, V12, P45, DOI 10.1016/j.tics.2007.11.005; Sebastian-Galles N, 2012, PSYCHOL SCI, V23, P994, DOI 10.1177/0956797612436817; Shi LF, 2015, AM J AUDIOL, V24, P53, DOI 10.1044/2014_AJA-14-0041; Shi LF, 2010, J SPEECH LANG HEAR R, V53, P821, DOI 10.1044/1092-4388(2010/09-0081); Shin HB, 2011, FED FOR C APRIL; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Smayda KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152773; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Swaminathan J, 2015, SCI REPORTS, V5; Team RC R, 2013, R LANG ENV STAT COMP; Thordardottir E, 2011, INT J BILINGUAL, V15, P426, DOI 10.1177/1367006911403202; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Van Engen KJ, 2014, J SPEECH LANG HEAR R, V57, P1908, DOI 10.1044/JSLHR-H-13-0076; Van Engen KJ, 2010, LANG SPEECH, V53, P510, DOI 10.1177/0023830910372495; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Wang Y, 2008, J ACOUST SOC AM, V124, P1716, DOI 10.1121/1.2956483; Wang Y, 2009, J PHONETICS, V37, P344, DOI 10.1016/j.wocn.2009.04.002; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Werker JF, 2009, PHILOS T R SOC B, V364, P3649, DOI 10.1098/rstb.2009.0105; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Xie ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114439; Yi HG, 2013, J ACOUST SOC AM, V134, pEL387, DOI 10.1121/1.4822320	92	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							0168048	10.1371/journal.pone.0168048	http://dx.doi.org/10.1371/journal.pone.0168048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936212	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100262
J	Williams, AN; Evans, LH; Herron, JE; Wilding, EL				Williams, Angharad N.; Evans, Lisa H.; Herron, Jane E.; Wilding, Edward L.			On the Antecedents of an Electrophysiological Signature of Retrieval Mode	PLOS ONE			English	Article							EPISODIC MEMORY; PREFRONTAL CORTEX; TASK-SET; BRAIN; INSIGHTS	It has been proposed that people employ a common set of sustained operations (retrieval mode) when preparing to remember different kinds of episodic information. In two experiments, however, there was no evidence for the pattern of brain activity commonly assumed to index these operations. In both experiments event-related potentials (ERPs) were recorded time-locked to alternating preparatory cues signalling that participants should prepare for different retrieval tasks. One cue signalled episodic retrieval: remember the location where the object was presented in a prior study phase. The other signalled semantic retrieval: identify the location where the object is most commonly found (Experiment 1) or identify the typical size of the object (Experiment 2). In both experiments, only two trials of the same task were completed in succession. This enabled ERP contrasts between 'repeat' trials (the cue on the preceding trial signalled the same retrieval task), and 'switch' trials (the cue differed from the preceding trial). There were differences between the ERPs elicited by the preparatory task cues in Experiment 1 only: these were evident only on switch trials and comprised more positive-going activity over right-frontal scalp for the semantic than for the episodic task. These findings diverge from previous outcomes where the activity differentiating cues signalling preparation for episodic or semantic retrieval has been restricted to right-frontal scalp sites, comprising more positive-going activity for the episodic than for the semantic task. While these findings are consistent with the view that there is not a common set of operations engaged when people prepare to remember different kinds of episodic information, an alternative account is offered here, which is that these outcomes are a consequence of structural and temporal components of the experiment designs.	[Williams, Angharad N.; Evans, Lisa H.; Herron, Jane E.] Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales; [Williams, Angharad N.] Cardiff Univ, Sch Med, IPMCN, Cardiff, S Glam, Wales; [Williams, Angharad N.] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Wilding, Edward L.] Univ Nottingham, Sch Psychol, Nottingham, England	Cardiff University; Cardiff University; Cardiff University; University of Nottingham	Williams, AN (corresponding author), Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales.; Williams, AN (corresponding author), Cardiff Univ, Sch Med, IPMCN, Cardiff, S Glam, Wales.; Williams, AN (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales.	WilliamsAN@cardiff.ac.uk	Herron, Jane/L-1340-2013; Wilding, Edward/ABC-8750-2021	Herron, Jane/0000-0002-2443-0713; Wilding, Edward/0000-0002-9495-1418; Evans, Lisa/0000-0002-3874-4676; Williams, Angharad Nia/0000-0001-9363-8537	School of Psychology at Cardiff University; Wellcome Trust [106278/Z/14/Z]; BBSRC [BB/E009921/1] Funding Source: UKRI	School of Psychology at Cardiff University; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AW was supported by a PhD studentship from the School of Psychology at Cardiff University. JH is supported by the Wellcome Trust (106278/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, CANADIAN PSYCHOL; Azimian-Faridani N, 2004, PSYCHON B REV, V11, P926, DOI 10.3758/BF03196723; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Duzel E, 2001, HUM BRAIN MAPP, V13, P104, DOI 10.1002/hbm.1028; Evans LH, 2012, COGN NEUROSCI-UK, V3, P168, DOI 10.1080/17588928.2012.662217; Evans LH, 2015, NEUROIMAGE, V108, P435, DOI 10.1016/j.neuroimage.2014.12.068; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herron JE, 2006, NEUROIMAGE, V32, P863, DOI 10.1016/j.neuroimage.2006.03.046; Herron JE, 2004, NEUROIMAGE, V22, P1554, DOI 10.1016/j.neuroimage.2004.04.011; Hicks JL, 1998, J EXP PSYCHOL LEARN, V24, P1105, DOI 10.1037/0278-7393.24.5.1105; Johnson JD, 2006, J COGNITIVE NEUROSCI, V18, P1531, DOI 10.1162/jocn.2006.18.9.1531; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Monsell S, 2003, MEM COGNITION, V31, P327, DOI 10.3758/BF03194391; Morcom AM, 2002, NEUROREPORT, V13, P149, DOI 10.1097/00001756-200201210-00034; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Peynircioglu Z.F., 1988, PRACTICAL ASPECTS ME, V2, P518; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2012, DOI 10.1073/pnas.91.6.2012; Verde MF, 2004, PSYCHON B REV, V11, P560, DOI 10.3758/BF03196611; Verde MF, 2003, J EXP PSYCHOL LEARN, V29, P739, DOI 10.1037/0278-7393.29.5.739; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Wasserman L., 2004, ALL STAT CONCISE COU, V26; WATKINS MJ, 1990, J EXP PSYCHOL LEARN, V16, P1012, DOI 10.1037/0278-7393.16.6.1012; Werkle-Bergner M, 2005, COGNITIVE BRAIN RES, V24, P599, DOI 10.1016/j.cogbrainres.2005.03.011; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Wilckens KA, 2011, NEUROIMAGE, V55, P1384, DOI 10.1016/j.neuroimage.2010.12.059; Wilding EL, 2006, CLIN EEG NEUROSCI, V37, P315, DOI 10.1177/155005940603700409; Wilding EL, 2001, NEUROREPORT, V12, P3613, DOI 10.1097/00001756-200111160-00048	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167574	10.1371/journal.pone.0167574	http://dx.doi.org/10.1371/journal.pone.0167574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936062	gold, Green Accepted, Green Published			2022-12-26	WOS:000389587100127
J	Saxe, F; Weichold, S; Reinecke, A; Lisec, J; Doring, A; Neumetzler, L; Burgert, I; Eder, M				Saxe, Friederike; Weichold, Susann; Reinecke, Antje; Lisec, Jan; Doering, Anett; Neumetzler, Lutz; Burgert, Ingo; Eder, Michaela			Age Effects on Hypocotyl Mechanics	PLOS ONE			English	Article							PLANT-CELL WALLS; ARABIDOPSIS; GROWTH; NANOINDENTATION; ELONGATION; CELLULOSE	Numerous studies deal with composition and molecular processes involved in primary cell wall formation and alteration in Arabidopsis. However, it still remains difficult to assess the relation between physiological properties and mechanical function at the cell wall level. The thin and fragile structure of primary cell walls and their large biological variability, partly related to structural changes during growth, make mechanical experiments challenging. Since, to the best of our knowledge, there is no reliable data in the literature about how the properties of the fully elongated zone of hypocotyls change with age. We studied in a series of experiments on two different seed batches the tensile properties the region below the growth zone of 4 to 7 day old etiolated Arabidopsis hypocotyls. Additionally, we analysed geometrical parameters, hypocotyl density and cellulose content as individual traits and their relation to tissue mechanics. No significant differences of the mechanical parameters of the non-growing region between 5-7 day old plants could be found whereas in 4 day old plants both tensile stiffness and ultimate tensile stress were significantly lower than in the older plants. Furthermore hypocotyl diameters and densities remain almost the same for 5, 6 and 7 day old seedlings. Naturally, hypocotyl lengths increase with age. The evaluation whether the choice-age or length D influences the mechanical properties showed that both are equally applicable sampling parameters. Additionally, our detailed study allows for the estimation of biological variability, connections between mechanics and hypocotyl age could be established and complement the knowledge on biochemistry and genetics affecting primary plant cell wall growth. The application of two different micromechanical devices for testing living Arabidopsis hypocotyls allows for emphasizing and discussing experimental limitations and for presenting a wide range of possibilities to address current and future questions related to plant cell wall mechanics, synthesis and growth in combination with molecular biology methodologies.	[Saxe, Friederike; Weichold, Susann; Reinecke, Antje; Burgert, Ingo; Eder, Michaela] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Saxe, Friederike] Humboldt Univ, Cluster Excellence Image Knowledge Gestaltung, Berlin, Germany; [Lisec, Jan; Doering, Anett; Neumetzler, Lutz] Max Planck Inst Mol Plant Physiol, Plant Cell Wall Grp, Potsdam, Germany; [Lisec, Jan] Charite, Mol Krebsforschungszentrum MKFZ, Berlin, Germany; [Doering, Anett] Targenomix GmbH, Potsdam, Germany; [Burgert, Ingo] Fed Inst Technol, Inst Bldg Mat, Zurich, Switzerland; [Burgert, Ingo] Swiss Fed Labs Mat Sci & Technol, Appl Wood Mat Lab, Dubendorf, Switzerland	Max Planck Society; Humboldt University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Saxe, F; Eder, M (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.; Saxe, F (corresponding author), Humboldt Univ, Cluster Excellence Image Knowledge Gestaltung, Berlin, Germany.	friederike.saxe@mpikg.mpg.de; michaela.eder@mpikg.mpg.de		Lisec, Jan/0000-0003-1220-2286; Eder, Michaela/0000-0002-1461-1668				Abasolo W, 2009, MOL PLANT, V2, P990, DOI 10.1093/mp/ssp065; Burgert I, 2003, HOLZFORSCHUNG, V57, P661, DOI 10.1515/HF.2003.099; Burgert I., 2006, CHARACT CELLUL CELL, V30, P7; Burgert I, 2009, INTEGR COMP BIOL, V49, P69, DOI 10.1093/icb/icp026; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204; Cosgrove DJ, 2011, METHODS MOL BIOL, V715, P291, DOI 10.1007/978-1-61779-008-9_20; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Fratzl P., 2007, THE EXPANDING CELL, P191; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gindl W, 2004, APPL PHYS A-MATER, V79, P2069, DOI 10.1007/s00339-004-2864-y; Kohler L, 2002, PLANTA, V215, P33, DOI 10.1007/s00425-001-0718-9; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; PRESTON RD, 1982, PLANTA, V155, P356, DOI 10.1007/BF00429465; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Saxe F, 2015, METHODS MOL BIOL, V1242, P211, DOI 10.1007/978-1-4939-1902-4_18; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Wimmer R, 1997, WOOD SCI TECHNOL, V31, P131, DOI 10.1007/s002260050022; Yakubov GE, 2016, J EXP BOT, V67, P2799, DOI 10.1093/jxb/erw117; Yuan S, 2001, PLANT PHYSIOL, V127, P324, DOI 10.1104/pp.127.1.324	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167808	10.1371/journal.pone.0167808	http://dx.doi.org/10.1371/journal.pone.0167808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977698	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400033
J	Soltau, I; Mudersbach, E; Geissen, M; Schwedhelm, E; Winkler, MS; Geffken, M; Peine, S; Schoen, G; Debus, ES; Larena-Avellaneda, A; Daum, G				Soltau, Irina; Mudersbach, Eileen; Geissen, Markus; Schwedhelm, Edzard; Winkler, Martin S.; Geffken, Maria; Peine, Sven; Schoen, Gerhard; Debus, E. Sebastian; Larena-Avellaneda, Axel; Daum, Guenter			Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SPHINGOSINE 1-PHOSPHATE; SERUM SPHINGOSINE-1-PHOSPHATE; LYMPHOCYTE EGRESS; HUMAN PLATELETS; PLASMA; HDL; RELEASE; INFLAMMATION; SEPSIS	Background and Objectives Atherosclerotic changes of arteries are the leading cause for deaths in cardiovascular disease and greatly impair patient's quality of life. Sphingosine-1-phosphate (S1P) is a signaling sphingolipid that regulates potentially pro-as well as anti-atherogenic processes. Here, we investigate whether serum-S1P concentrations are associated with peripheral artery disease (PAD) and carotid stenosis (CS). Methods and Results Serum was sampled from blood donors (controls, N = 174) and from atherosclerotic patients (N = 132) who presented to the hospital with either clinically relevant PAD (N = 102) or CS (N = 30). From all subjects, serum-S1P was measured by mass spectrometry and blood parameters were determined by routine laboratory assays. When compared to controls, atherosclerotic patients before invasive treatment to restore blood flow showed significantly lower serum-S1P levels. This difference cannot be explained by risk factors for atherosclerosis (old age, male gender, hypertension, hypercholesteremia, obesity, diabetes or smoking) or comorbidities (Chronic obstructive pulmonary disease, kidney insufficiency or arrhythmia). Receiver operating characteristic curves suggest that S1P has more power to indicate atherosclerosis (PAD and CS) than high density lipoprotein-cholesterol (HDL-C). In 35 patients, serum-S1P was measured again between one and six months after treatment. In this group, serum-S1P concentrations rose after treatment independent of whether patients had PAD or CS, or whether they underwent open or endovascular surgery. Post-treatment S1P levels were highly associated to platelet numbers measured pre-treatment. Conclusions Our study shows that PAD and CS in humans is associated with decreased serum-S1P concentrations and that S1P may possess higher accuracy to indicate these diseases than HDL-C.	[Soltau, Irina; Geissen, Markus; Debus, E. Sebastian; Larena-Avellaneda, Axel; Daum, Guenter] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr, Clin & Polyclin Vasc Med, Hamburg, Germany; [Mudersbach, Eileen; Schwedhelm, Edzard] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Winkler, Martin S.] Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Hamburg, Germany; [Geffken, Maria; Peine, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Transfus Med, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Geissen, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr, Clin & Polyclin Vasc Med, Hamburg, Germany.	m.geissen@uke.de	Winkler, Martin Sebastian/AGZ-1086-2022		Forderverein des Universitaren Herzzentrums Hamburg e.V.; Dorit & Alexander Otto foundation	Forderverein des Universitaren Herzzentrums Hamburg e.V.; Dorit & Alexander Otto foundation	We thank the Forderverein des Universitaren Herzzentrums Hamburg e.V. and the Dorit & Alexander Otto foundation for their generous laboratory equipment funds. We thank Astrid Becker and Sina Noorzad for technical and organizational help.	Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Brown Todd M, 2008, Curr Cardiol Rep, V10, P497, DOI 10.1007/s11886-008-0078-1; Bundes_aerztekammer, 2010, RICHTL GEW BLUT BLUT; Coldewey SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27594; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Deutschman DH, 2003, AM HEART J, V146, P62, DOI 10.1016/S0002-8703(03)00118-2; Frej C, 2016, J CELL MOL MED; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hovingh GK, 2015, CURR OPIN LIPIDOL, V26, P127, DOI 10.1097/MOL.0000000000000161; Ibrahimi P, 2013, ATHEROSCLEROSIS, V231, P323, DOI 10.1016/j.atherosclerosis.2013.09.035; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Magnoni M, 2015, J CARDIOL, V65, P261, DOI 10.1016/j.jjcc.2015.01.004; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Ono Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-20; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; RCore Team, 2016, R LANG ENV STAT COMP; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Shimizu T, 2007, CIRC RES, V101, P995, DOI 10.1161/CIRCRESAHA.107.159228; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; Sugiura T, 2012, CORONARY ARTERY DIS, V23, P234, DOI 10.1097/MCA.0b013e328351ab0a; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Winkler MS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1089-0; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	39	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168302	10.1371/journal.pone.0168302	http://dx.doi.org/10.1371/journal.pone.0168302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973607	Green Submitted, gold, Green Published			2022-12-26	WOS:000392754300075
J	Yasuda, T; Ura, T; Taniguchi, M; Yoshida, H				Yasuda, Takuwa; Ura, Takehiro; Taniguchi, Masaru; Yoshida, Hisahiro			Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy	PLOS ONE			English	Article							TRANSDERMAL DRUG-DELIVERY; DERMAL DENDRITIC CELLS; INFLUENZA VACCINE; EPICUTANEOUS IMMUNOTHERAPY; MICRONEEDLE ARRAYS; ATOPIC-DERMATITIS; IMMUNE-RESPONSES; BARRIER FUNCTION; STRATUM-CORNEUM; LYMPH-NODE	Skin is protected by a tough but flexible multilayered barrier and is a front line for immune responses against invading particles. For many years now, skin has been a tissue where certain vaccines are injected for the prevention of infectious disease, however, the detailed mechanisms of the skin immune response are not yet well understood. Using thin and small injection needles, we carefully injected OVA into a restricted region of mouse skin, i.e., intradermal (ID), and examined the antibody response in comparison with subcutaneous (SC) injection or epicutaneous patch administration of OVA. Epicutaneous patches induced a high IgE response against OVA, but IgG production was low. High IgG production was induced by both ID and SC injection, moreover, ID injection induced higher IgG production without any adjutants. Furthermore, OVA-specific IgE production was diminished by ID injection. We found that ID injection could efficiently stimulate skin resident DCs, drive Th1-biased conditions and diminish IgE production. The ID injection response was regulated by Langerin(+) dermal DCs, because OVA was taken up mainly by these cells and, after transiently deleting them, the IgE response was no longer diminished and IgG1 production was enhanced. We also tested whether ID injection might be an effective allergy treatment by attempting to inhibit ongoing IgE production in mice with experimentally induced high serum IgE levels. Multiple ID injections of OVA were shown to prevent elevation of serum OVA-specific IgE after repeated allergen challenge. In contrast, SC OVA injection could only transiently inhibit the OVA-specific IgE production. These findings indicated that ID injection results in higher induction of antigen-specific IgG, and thus may be useful for vaccine delivery with little or no adjuvant components. Moreover, the observed diminishment of IgE and induction of Th1-biased immune responses suggest that ID may be a useful injection route for allergy immunotherapy.	[Yasuda, Takuwa; Yoshida, Hisahiro] RIKEN Res Ctr Integrat Med Sci IMS, Immunogenet Lab, Yokohama, Kanagawa, Japan; [Ura, Takehiro] Terumo Co Ltd, Hosp Co R&D Dept, Nakai, Kanagawa, Japan; [Taniguchi, Masaru] RIKEN Res Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa, Japan	RIKEN; Terumo Corporation; RIKEN	Yasuda, T (corresponding author), RIKEN Res Ctr Integrat Med Sci IMS, Immunogenet Lab, Yokohama, Kanagawa, Japan.	takuwa@riken.jp			Terumo Corporation	Terumo Corporation	One of the authors (TU) is employee of Terumo Corporation. About the Funding Statement, Terumo Corporation provided support in the form of salary for author [TU] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Alvarez-Roman R, 2004, J CONTROL RELEASE, V99, P53, DOI 10.1016/j.jconrel.2004.06.015; Anaya JM, 2015, CLIN EXP RHEUMATOL, V33, P545; Ansaldi F, 2011, EXPERT OPIN BIOL TH, V11, P415, DOI 10.1517/14712598.2011.557658; Arakane R, 2015, VACCINE, V33, P6650, DOI 10.1016/j.vaccine.2015.10.088; Arakane R, 2015, VACCINE, V33, P6340, DOI 10.1016/j.vaccine.2015.09.010; Batard T, 2015, ALLERGY; Beyer K, 2012, J ALLERGY CLIN IMMUN, V129, P1179, DOI 10.1016/j.jaci.2012.03.037; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Ferrari L, 2011, RES VET SCI, V90, P64, DOI 10.1016/j.rvsc.2010.04.026; Flacher V, 2012, J IMMUNOL, V188, P2146, DOI 10.4049/jimmunol.1004120; Gorse GJ, 2013, VACCINE, V31, P2358, DOI 10.1016/j.vaccine.2013.03.008; Grunewald SM, 2001, INT ARCH ALLERGY IMM, V125, P322, DOI 10.1159/000053833; Guimaraes LE, 2015, PHARMACOL RES, V100, P190, DOI 10.1016/j.phrs.2015.08.003; Herz U, 1998, CLIN EXP ALLERGY, V28, P625; Jakasa I, 2011, J INVEST DERMATOL, V131, P540, DOI 10.1038/jid.2010.307; Jin GH, 2012, J DERMATOL SCI, V67, P181, DOI 10.1016/j.jdermsci.2012.06.005; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Matsushima H, 2003, J DERMATOL SCI, V32, P223, DOI 10.1016/S0923-1811(03)00106-3; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Naito S, 2012, VACCINE, V30, P1191, DOI 10.1016/j.vaccine.2011.11.111; Nishifuji K, 2013, VET DERMATOL, V24, P60, DOI 10.1111/j.1365-3164.2012.01090.x; Okubo Kimihiro, 2010, Journal of Nippon Medical School, V77, P285, DOI 10.1272/jnms.77.285; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Ptak W, 2002, INT ARCH ALLERGY IMM, V128, P8, DOI 10.1159/000057998; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Rotiroti G, 2012, J ALLERGY CLIN IMMUN, V130, P918, DOI 10.1016/j.jaci.2012.06.052; Rutkowski K, 2012, POSTGRAD MED J, V88, P458, DOI 10.1136/postgradmedj-2011-130634; Saad Abdel Hakim, 2006, Journal of the Egyptian Society of Parasitology, V36, P867; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Simon L, 2009, J PHARM SCI-US, V98, P187, DOI 10.1002/jps.21408; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Suzuki Yusuke, 2011, Allergology International, V60, P11, DOI 10.2332/allergolint.10-RAI-0281; Tanizaki H, 2015, J DERMATOL SCI, V79, P310, DOI 10.1016/j.jdermsci.2015.06.010; Tarnow K, 2004, APPL NURS RES, V17, P275, DOI 10.1016/S0897-1897(04)00079-5; Tozuka M, 2016, J DERMATOL SCI, V82, P38, DOI 10.1016/j.jdermsci.2015.11.008; Tsang P, 2014, VACCINE, V32, P2507, DOI 10.1016/j.vaccine.2013.09.074; Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wang G, 2007, CLIN EXP ALLERGY, V37, P151, DOI 10.1111/j.1365-2222.2006.02621.x; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007; Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j	47	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167952	10.1371/journal.pone.0167952	http://dx.doi.org/10.1371/journal.pone.0167952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973543	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300050
J	Liao, NB; Zhong, JJ; Zhang, RH; Ye, XQ; Zhang, YJ; Wang, WJ; Wang, YX; Chen, SG; Liu, DH; Liu, RH				Liao, Ningbo; Zhong, Jianjun; Zhang, Ronghua; Ye, Xingqian; Zhang, Yanjun; Wang, Wenjun; Wang, Yuexia; Chen, Shiguo; Liu, Donghong; Liu, Ruihai			Protein-Bound Polysaccharide from Corbicula fluminea Inhibits Cell Growth in MCF-7 and MDA-MB-231 Human Breast Cancer Cells	PLOS ONE			English	Article							FRESH-WATER CLAM; AQUEOUS EXTRACT; EDIBLE MUSHROOM; APOPTOSIS; ANTIOXIDANT; LINES; PROLIFERATION; COMPONENTS; SULFATE; RATS	A novel protein-bound polysaccharide, CFPS-1, isolated from Corbicula fluminea, is composed predominantly of mannose (Man) and glucose (Glc) in a molar ratio of 3.1: 12.7. The polysaccharide, with an average molecular weight of about 283 kDa, also contains 10.8% protein. Atomic force microscopy, high-performance liquid chromatography, Fourier transform infrared spectroscopy, gas chromatography/mass spectrometry, and nuclear magnetic resonance spectroscopy analyses revealed that CFPS-1 has a backbone of 1,6-linked and 1,4,6-linked-alpha-D-Glc, which is terminated with a 1-linked-alpha-D-Man residue at the O-4 position of 1,4,6-linked-alpha-D-Glc, in a molar ratio of 3: 1: 1. Preliminary in vitro bioactivity tests revealed that CFPS-1 effectively and dose-dependently inhibits human breast cancer MCF7 and MDA-MB-231 cell growth, with an IC50 of 243 +/- 6.79 and 1142 +/- 14.84 mu g/mL, respectively. In MCF-7, CFPS-1 produced a significant up-regulation of p53, p21, Bax and cleaved caspase-7 and down-regulation of Cdk4, cyclin D1, Bcl-2 and caspase-7. These effects resulted in cell cycle blockade at the S-phase and apoptosis induction. In contrast, in MDA-MB-231, with limited degree of change in cell cycle distribution, CFPS-1 increases the proportion of cells in apoptotic sub-G1 phase executed by down-regulation of Bcl-2 and caspase-7 and up-regulation of Bax and cleaved caspase-7. This study extends our understanding of the anticancer mechanism of C. fluminea protein-bound polysaccharide.	[Liao, Ningbo; Zhang, Ronghua; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China; [Zhong, Jianjun; Ye, Xingqian; Wang, Wenjun; Chen, Shiguo; Liu, Donghong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuexia] Zhejiang Acad Sci & Technol Inspect & Quarantine, Hangzhou, Zhejiang, Peoples R China; [Liu, Donghong] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Ruihai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University; Zhejiang University; Cornell University	Liu, DH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, DH (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, RH (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	dhliu@zju.edu.cn; rl23@cornell.edu	CHEN, SHIGUO/AGP-0850-2022; Liu, Rui Hai/AAE-4865-2019; Liao, Ningbo/ACM-4512-2022	Liu, Rui Hai/0000-0002-7018-7929; Zhong, Jian-Jun/0000-0002-0693-255X; CHEN, SHIGUO/0000-0001-8470-7983	National Natural Science Foundation of China [31371872]; Public Projects of Zhejiang Province [2015C32017]; Program of Health and Medicine Science in Zhejiang Province [2015RCA003]; Major Science and Technology Special Projects of Zhejiang, China [2013C03045-1]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Projects of Zhejiang Province; Program of Health and Medicine Science in Zhejiang Province; Major Science and Technology Special Projects of Zhejiang, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This research was sponsored by the National Natural Science Foundation of China (NO. 31371872), http://fund.sciencenet.cn/index.php/ item/view/207237/, the Public Projects of Zhejiang Province (NO. 2015C32017), http://www.zjkjt.gov.cn/news/node01/detail0101/2015/0101_61846. htm, the Program of Health and Medicine Science in Zhejiang Province (NO. 2015RCA003), http://www.doc88.com/p-6572488490711.html, Major Science and Technology Special Projects of Zhejiang, China (NO. 2013C03045-1) and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, http://www.decmin.com/zj_view.asp?id=919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Chakraborty I, 2004, CARBOHYD RES, V339, P2249, DOI 10.1016/j.carres.2004.07.013; Chijimatsu T, 2008, BIOSCI BIOTECH BIOCH, V72, P2566, DOI 10.1271/bbb.80257; Chresta CM, 1996, CANCER RES, V56, P1834; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Dalonso N, 2012, FOOD CHEM, V134, P1804, DOI 10.1016/j.foodchem.2012.03.088; Darby SC, 2013, NEW ENGL J MED, V15, P425; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gonzaga MLC, 2005, CARBOHYD POLYM, V60, P43, DOI 10.1016/j.carbpol.2004.11.022; Han Peng, 2009, Xiamen Daxue Xuebao (Ziran Kexue Ban), V48, P576; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu CL, 2010, AM J CHINESE MED, V38, P881, DOI 10.1142/S0192415X10008329; Huang YT, 2006, FOOD CHEM TOXICOL, V44, P1261, DOI 10.1016/j.fct.2006.02.001; Kidd P M, 2000, Altern Med Rev, V5, P4; Kuwata H, 1998, BBA-PROTEIN STRUCT M, V1429, P129, DOI 10.1016/S0167-4838(98)00224-6; Li CI, 2013, BREAST CANCER RES TR, V137, P579, DOI 10.1007/s10549-012-2365-1; Liao NB, 2013, FOOD FUNCT, V4, P539, DOI 10.1039/c2fo30178d; Martin-Algarra S, 2009, EUR J CANCER, V45, P732, DOI 10.1016/j.ejca.2008.12.005; Miranda CL, 1999, FOOD CHEM TOXICOL, V37, P271, DOI 10.1016/S0278-6915(99)00019-8; Ohira SI, 2006, J CHROMATOGR A, V1121, P280, DOI 10.1016/j.chroma.2006.05.074; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pang XB, 2007, CARBOHYD POLYM, V70, P291, DOI 10.1016/j.carbpol.2007.04.010; Pramanik M, 2005, CARBOHYD RES, V340, P629, DOI 10.1016/j.carres.2004.12.032; Qiao DL, 2010, CARBOHYD POLYM, V82, P1184, DOI 10.1016/j.carbpol.2010.06.048; Qiu Ping-ping, 2009, Xiamen Daxue Xuebao (Ziran Kexue Ban), V48, P406; Rout D, 2004, MED CHEM RES, V13, P509, DOI 10.1007/s00044-004-0050-6; SCHMITZ U, 1990, BIOCHEMISTRY-US, V29, P2357, DOI 10.1021/bi00461a021; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Tsai JS, 2006, PROCESS BIOCHEM, V41, P2276, DOI 10.1016/j.procbio.2006.05.023; Vaculova A, 2008, METHOD ENZYMOL, V442, P157, DOI 10.1016/S0076-6879(08)01408-0; Xiao J, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.22; Yanez J, 2004, NUTR CANCER, V49, P191, DOI 10.1207/s15327914nc4902_11; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177; You LJ, 2010, FOOD CHEM, V120, P810, DOI 10.1016/j.foodchem.2009.11.018; Yu XL, 2013, CARBOHYD POLYM, V92, P269, DOI 10.1016/j.carbpol.2012.09.045; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zhu Wen, 2004, Journal of Fishery Sciences of China, V11, P349; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	44	17	18	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167889	10.1371/journal.pone.0167889	http://dx.doi.org/10.1371/journal.pone.0167889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959954	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900021
J	Pecchinenda, A; Petrucci, M				Pecchinenda, Anna; Petrucci, Manuel			Emotion Unchained: Facial Expression Modulates Gaze Cueing under Cognitive Load	PLOS ONE			English	Article							WORKING-MEMORY LOAD; EYE GAZE; SELECTIVE ATTENTION; SPATIAL ATTENTION; SOCIAL ATTENTION; FACES; DIRECTION; PERCEPTION; FEARFUL; ANXIETY	Direction of eye gaze cues spatial attention, and typically this cueing effect is not modulated by the expression of a face unless top-down processes are explicitly or implicitly involved. To investigate the role of cognitive control on gaze cueing by emotional faces, participants performed a gaze cueing task with happy, angry, or neutral faces under high (i.e., counting backward by 7) or low cognitive load (i.e., counting forward by 2). Results show that high cognitive load enhances gaze cueing effects for angry facial expressions. In addition, cognitive load reduces gaze cueing for neutral faces, whereas happy facial expressions and gaze affected object preferences regardless of load. This evidence clearly indicates a differential role of cognitive control in processing gaze direction and facial expression, suggesting that under typical conditions, when we shift attention based on social cues from another person, cognitive control processes are used to reduce interference from emotional information.	[Pecchinenda, Anna; Petrucci, Manuel] Sapienza Univ Rome, Dept Psychol, Rome, Italy	Sapienza University Rome	Pecchinenda, A (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.	anna.pecchinenda@uniroma1.it		Pecchinenda, Anna/0000-0001-9139-5295	Sapienza University [C26A14JFTP, C26A15H5KA]	Sapienza University	AP was funded by Sapienza University grant C26A14JFTP and grant C26A15H5KA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Baddeley AD, 2009, J MEM LANG, V61, P438, DOI 10.1016/j.jml.2009.05.004; Bayless SJ, 2011, VIS COGN, V19, P483, DOI 10.1080/13506285.2011.552895; Bayliss AP, 2007, COGNITION, V104, P644, DOI 10.1016/j.cognition.2006.07.012; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bobak AK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01258; Brosch T, 2011, NEUROPSYCHOLOGIA, V49, P1779, DOI 10.1016/j.neuropsychologia.2011.02.056; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Cohen N, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00033; Dawel A, 2015, DEVELOPMENTAL SCI, V18, P219, DOI 10.1111/desc.12203; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Fichtenholtz HM, 2009, SOC NEUROSCI-UK, V4, P317, DOI 10.1080/17470910902809487; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Friesen CK, 2011, COGNITION EMOTION, V25, P73, DOI 10.1080/02699931003672381; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Harding IH, 2016, CEREB CORTEX, V26, P557, DOI 10.1093/cercor/bhu208; Hayward DA, 2013, EXP BRAIN RES, V231, P405, DOI 10.1007/s00221-013-3705-z; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Holmes A, 2014, COGN AFFECT BEHAV NE, V14, P827, DOI 10.3758/s13415-013-0212-4; Holmes A, 2010, SOC NEUROSCI-UK, V5, P285, DOI 10.1080/17470910903422819; Hori E, 2005, PHYSIOL BEHAV, V84, P397, DOI 10.1016/j.physbeh.2005.01.002; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jellema T, 2011, VIS COGN, V19, P616, DOI 10.1080/13506285.2011.569775; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanske P, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00042; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Lachat F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050499; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Lassalle A, 2013, SOC NEUROSCI-UK, V8, P583, DOI 10.1080/17470919.2013.835750; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Law AS, 2010, VIS COGN, V18, P1420, DOI 10.1080/13506285.2010.496579; Love J., 2015, JASP VERSION 0 7; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mathews A, 2003, VIS COGN, V10, P823, DOI 10.1080/13506280344000095; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Okon-Singer H, 2007, EMOTION, V7, P147, DOI 10.1037/1528-3542.7.1.147; Pecchinenda A., 2013, ABSTRACTS PSYCHONOMI, V18; Pecchinenda A, 2008, EMOTION, V8, P628, DOI 10.1037/a0013437; Pecchinenda A, 2007, EUR J COGN PSYCHOL, V19, P898, DOI 10.1080/09541440601095388; Pecchinenda A, 2015, NEUROPSYCHOLOGIA, V68, P1, DOI 10.1016/j.neuropsychologia.2014.12.023; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Petrucci M., 2016, COGNITION EMOTION; Picardo R, 2016, PLOSONE; Putman P, 2006, EMOTION, V6, P94, DOI 10.1037/1528-3542.6.1.94; Ramon M, 2010, NEUROPSYCHOLOGIA, V48, P933, DOI 10.1016/j.neuropsychologia.2009.11.014; Rao KV, 2013, Q J EXP PSYCHOL, V66, P1881, DOI 10.1080/17470218.2013.828314; Rhodes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049317; Rigato S, 2013, INT J BEHAV DEV, V37, P154, DOI 10.1177/0165025412472410; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schneider W., 2002, E PRIME USERS GUIDE; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tipples J, 2005, J EXP PSYCHOL HUMAN, V31, P843, DOI 10.1037/0096-1523.31.5.843; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287	68	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168111	10.1371/journal.pone.0168111	http://dx.doi.org/10.1371/journal.pone.0168111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959925	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900038
J	Tian, C; Harris, BS; Johnson, KR				Tian, Cong; Harris, Belinda S.; Johnson, Kenneth R.			Ectopic Mineralization and Conductive Hearing Loss in Enpp1(asj) Mutant Mice, a New Model for Otitis Media and Tympanosclerosis	PLOS ONE			English	Article							GENERALIZED ARTERIAL CALCIFICATION; VASCULAR CALCIFICATION; KNOCKOUT MOUSE; MIDDLE-EAR; USH1C GENE; MUTATION; DEAFNESS; OSTEOMALACIA; DISEASE; INFANCY	Otitis media (OM), inflammation of the middle ear, is a common cause of hearing loss in children and in patients with many different syndromic diseases. Studies of the human population and mouse models have revealed that OM is a multifactorial disease with many environmental and genetic contributing factors. Here, we report on otitis media-related hearing loss in asj (ages with stiffened joints) mutant mice, which bear a point mutation in the Enpp1 gene. Auditory-evoked brainstem response (ABR) measurements revealed that around 90% of the mutant mice (Enpp1(asj/asj)) tested had moderate to severe hearing impairment in at least one ear. The ABR thresholds were variable and generally elevated with age. We found otitis media with effusion (OME) in all of the hearing-impaired Enpp1(asj/asj) mice by anatomic and histological examinations. The volume and inflammatory cell content of the effusion varied among the asj mutant mice, but all mutants exhibited a thickened middle ear epithelium with fibrous polyps and more mucin-secreting goblet cells than controls. Other abnormalities observed in the Enpp1 mutant mice include over-ossification at the round window ridge, thickened and over-calcified stapedial artery, fusion of malleus and incus, and white patches on the inside of tympanic membrane, some of which are typical symptoms of tympanosclerosis. An excessive yellow discharge was detected in the outer ear canal of older asj mutant mice, with 100% penetrance by 5 months of age, and contributes to the progressive nature of the hearing loss. This is the first report of hearing loss and ear pathology associated with an Enpp1 mutation in mice. The Enpp1 asj mutant mouse provides a new animal model for studying tympanosclerotic otitis and otitis media with effusion, and also provides a specific model for the hearing loss recently reported to be associated with human ENPP1 mutations causing generalized arterial calcification of infancy and hypophosphatemic rickets.	[Tian, Cong; Harris, Belinda S.; Johnson, Kenneth R.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Tian, Cong] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	Jackson Laboratory; University of Maine System; University of Maine Orono	Tian, C (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	cong.tian@maine.edu	Tian, Cong/E-6300-2012		National Institutes of Health [R01 DC004301, P40 OD010972, P30 CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 DC004301 (KRJ), P40 OD010972 (The Jackson Laboratory Mouse Mutant Resource), and P30 CA034196 (The Jackson Laboratory Shared Services).	Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Bowman MAH, 2012, TRENDS CARDIOVAS MED, V22, P93, DOI 10.1016/j.tcm.2012.07.002; Brachet C, 2014, HORM RES PAEDIAT, V81, P63, DOI 10.1159/000354661; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058156; DAVIES M, 1984, ANN INTERN MED, V100, P230, DOI 10.7326/0003-4819-100-2-230; DIAMOND MK, 1989, J MORPHOL, V200, P71, DOI 10.1002/jmor.1052000109; Goycoolea MV, 1997, MICROSC RES TECHNIQ, V36, P201, DOI 10.1002/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.0.CO;2-R; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Han FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043010; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Harris BS WJ, 2012, AGES STIFF ENED JOIN; Hilton JM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r90; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P79, DOI 10.1016/j.ijporl.2012.09.037; Li Q, 2014, ELECTRON J DIFFER EQ; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Lin Jizhen, 2012, Int J Otolaryngol, V2012, P745325, DOI 10.1155/2012/745325; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Mata M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0420-1; Morava E, 2011, J CLIN ENDOCR METAB, V96, pE189, DOI 10.1210/jc.2010-1539; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Noben-Trauth K, 2011, J BIOL CHEM, V286, P3079, DOI 10.1074/jbc.M110.184598; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; OMALLEY SP, 1988, CLIN RADIOL, V39, P528, DOI 10.1016/S0009-9260(88)80224-1; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Tateossian H, 2013, HUM MOL GENET, V22, P2553, DOI 10.1093/hmg/ddt103; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thys M, 2009, OTOL NEUROTOL, V30, P1021, DOI 10.1097/MAO.0b013e3181a86509; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; WEIR N, 1977, J LARYNGOL OTOL, V91, P717, DOI 10.1017/S0022215100084255; Yamada S, 2014, AM J PHYSIOL-RENAL, V306, pF1418, DOI 10.1152/ajprenal.00633.2013; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022622; Zhang Y, 2012, AM J PATHOL, V181, P761, DOI 10.1016/j.ajpath.2012.05.031; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	40	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168159	10.1371/journal.pone.0168159	http://dx.doi.org/10.1371/journal.pone.0168159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959908	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900042
J	Arbogast, P; Flamant, F; Godement, P; Glosmann, M; Peichl, L				Arbogast, Patrick; Flamant, Frederic; Godement, Pierre; Gloesmann, Martin; Peichl, Leo			Thyroid Hormone Signaling in the Mouse Retina	PLOS ONE			English	Article							CONE OPSIN EXPRESSION; DEVELOPMENTAL EXPRESSION; TYPE-3 DEIODINASE; RECEPTOR-ALPHA; PHOTORECEPTOR; HYPOTHYROIDISM; CELLS; KNOCKOUT; PIGMENTS	Thyroid hormone is a crucial regulator of gene expression in the developing and adult retina. Here we sought to map sites of thyroid hormone signaling at the cellular level using the transgenic FINDT3 reporter mouse model in which neurons express beta-galactosidase (beta-gal) under the control of a hybrid Gal4-TR alpha receptor when triiodothyronine (T3) and cofactors of thyroid receptor signaling are present. In the adult retina, nearly all neurons of the ganglion cell layer (GCL, ganglion cells and displaced amacrine cells) showed strong beta-gal labeling. In the inner nuclear layer (INL), a minority of glycineric and GABAergic amacrine cells showed beta-gal labeling, whereas the majority of amacrine cells were unlabeled. At the level of amacrine types, beta-gal labeling was found in a large proportion of the glycinergic AII amacrines, but only in a small proportion of the cholinergic/GABAergic 'starburst' amacrines. At postnatal day 10, there also was a high density of strongly beta-gal-labeled neurons in the GCL, but only few amacrine cells were labeled in the INL. There was no labeling of bipolar cells, horizontal cells and Muller glia cells at both stages. Most surprisingly, the photoreceptor somata in the outer nuclear layer also showed no beta-gal label, although thyroid hormone is known to control cone opsin expression. This is the first record of thyroid hormone signaling in the inner retina of an adult mammal. We hypothesize that T3 levels in photoreceptors are below the detection threshold of the reporter system. The topographical distribution of beta-gal-positive cells in the GCL follows the overall neuron distribution in that layer, with more T3-signaling cells in the ventral than the dorsal half-retina.	[Arbogast, Patrick; Peichl, Leo] Max Planck Inst Brain Res, Max von Laue Str, Frankfurt, Germany; [Flamant, Frederic; Godement, Pierre] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, 46 Allee Italie, Lyon 07, France; [Gloesmann, Martin] Univ Vet Med, VetCore Imaging, Vet Pl 1, Vienna, Austria; [Peichl, Leo] Ernst Strungmann Inst Neurosci, Deutschordenstr, Frankfurt, Germany	Max Planck Society; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Veterinary Medicine Vienna	Peichl, L (corresponding author), Max Planck Inst Brain Res, Max von Laue Str, Frankfurt, Germany.; Peichl, L (corresponding author), Ernst Strungmann Inst Neurosci, Deutschordenstr, Frankfurt, Germany.	leo.peichl@brain.mpg.de	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft [PE 38/16-2]; Agence Nationale de la Recherche [ANR15 CE14-0011-01]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de) grant PE 38/16-2 to LP, and by Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) grant Thyromut2 (ANR15 CE14-0011-01) to FF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Flamant F, 1998, DEV BIOL, V197, P1, DOI 10.1006/dbio.1998.8872; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Gamborino MJ, 2001, OPHTHALMIC RES, V33, P283, DOI 10.1159/000055682; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hernandez A, 2010, ENDOCRINOLOGY, V151, P5550, DOI 10.1210/en.2010-0450; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma WB, 2002, J HISTOCHEM CYTOCHEM, V50, P1421, DOI 10.1177/002215540205001015; Mader M, 2006, MOL VIS, V12, P915; Navegantes LCC, 1996, BRAZ J MED BIOL RES, V29, P665; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Pinazo-Duran MD, 2005, OPHTHALMIC RES, V37, P225, DOI 10.1159/000086863; Quignodon L, 2004, J MOL ENDOCRINOL, V33, P467, DOI 10.1677/jme.1.01570; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; SJOBERG M, 1992, DEVELOPMENT, V114, P39; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Thut CJ, 2001, DEV BIOL, V231, P63, DOI 10.1006/dbio.2000.0140; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	51	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168003	10.1371/journal.pone.0168003	http://dx.doi.org/10.1371/journal.pone.0168003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942035	Green Published, gold			2022-12-26	WOS:000392745600045
J	Carter, HE; Schofield, DJ; Shrestha, R				Carter, Hannah E.; Schofield, Deborah J.; Shrestha, Rupendra			The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model	PLOS ONE			English	Article							ECONOMIC BURDEN	Aim To estimate the productivity costs of premature mortality due to cancer in Australia, in aggregate and for the 26 most prevalent cancer sites. Methods A human capital approach was adopted to estimate the long term impacts of Australian cancer deaths in 2003. Using population mortality data, the labour force participation and the present value of lifetime income (PVLI) forgone due to premature mortality was estimated based on individual characteristics at the time of death including age, sex and socioeconomic status. Outcomes were modelled to the year 2030 using economic data from a national microsimulation model. A discount rate of 3% was applied and costs were reported in 2016 Australian dollars. Results Premature deaths from cancer in 2003 resulted in 88,000 working years lost and a cost of $4.2 billion in the PVLI forgone. Costs were close to three times higher in males than females due to the higher number of premature deaths in men, combined with higher levels of workforce participation and income. Lung, colorectal and brain cancers accounted for the highest proportion of costs, while testicular cancer was the most costly cancer site per death. Conclusions The productivity costs of premature mortality due to cancer are significant. These results provide an economic measure of the cancer burden which may assist decision makers in allocating scare resources amongst competing priorities.	[Carter, Hannah E.; Schofield, Deborah J.; Shrestha, Rupendra] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of Sydney	Carter, HE (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.	hannah.carter@qut.edu.au		Carter, Hannah/0000-0002-0046-4126; Shrestha, Rupendra/0000-0001-5455-0735; Schofield, Deborah/0000-0002-1658-494X	Australian Research Council; Australian Research Council (ARC)/Linkage Projects (LP) [100100158]	Australian Research Council(Australian Research Council); Australian Research Council (ARC)/Linkage Projects (LP)(Australian Research Council)	Work associated with this manuscript was funded by an Australian Research Council grant: Long term economic impacts of disease on older workers to 2030: Costs to government and individuals and opportunities for intervention; Schofield D, Vos E, Grobler M, Percival R, Kelly S, Passey M, Kelly S, Vos E, Percival R; Australian Research Council (ARC)/Linkage Projects (LP) 100100158 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2013, PROST CANC AUSTR; [Anonymous], 2015, AUSTR BURD DIS STUD; Australian Bureau of Statistics, 2015, AV WEEKL EARN; Australian Bureau of Statistics, 2003, DEATHS; Australian Bureau of Statistics, 2015, WAG PRIC IND; Australian Bureau of Statistics, 2015, CONS PRIC IND; Australian Bureau of Statistics, 2016, LAB FORC; Begg S., 2007, BURDEN DIS INJURY AU; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Branton PE, 2008, LANCET ONCOL, V9, P82, DOI 10.1016/S1470-2045(08)70007-X; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526; Carter HE, 2014, INT J MOCROSIMULATIO, V7, P33; Carter HE, 2016, AUSTR NZ J IN PRESS; Cobb-Clark D., 2001, AUSTR EC REV, V34, P467; Dear RF, 2011, MED J AUSTRALIA, V194, P387, DOI 10.5694/j.1326-5377.2011.tb03027.x; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287; Hanly Paul A, 2014, BMC Cancer, V14, P224, DOI 10.1186/1471-2407-14-224; International Statistical Classification of Diseases and Related Health Problems, 2003, 10 REV VERS 2003; Keegan M., 2007, HILDA SURV RES C MEL; Kelly S., 2007, APPSIM SELECTION MAI; Kim SG, 2008, EUR J CANCER CARE, V17, P136, DOI 10.1111/j.1365-2354.2007.00818.x; Koopmanschap MA, 1996, MED CARE, V34, pDS59; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Max W, 2003, GYNECOL ONCOL, V88, P96, DOI 10.1016/S0090-8258(02)00101-4; Max W, 2009, BREAST CANCER RES TR, V116, P201, DOI 10.1007/s10549-008-0149-4; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; Ortiz-Ortiz KJ, 2010, P R HEALTH SCI J, V29, P241; Pennec S, 2007, 5 U CANB NAT CTR SOC; Rice DP, 1966, ESTIMATING COST OF I; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; WOODEN M, 2002, MERCER MELBOURNE I Q, V0003; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	37	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167521	10.1371/journal.pone.0167521	http://dx.doi.org/10.1371/journal.pone.0167521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942032	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600021
J	Jamalabadi, MYA; Bidokhti, AAA; Rah, HK; Vaezi, S; Hooshmand, P				Jamalabadi, M. Y. Abdollahzadeh; Bidokhti, Amin Ali Akbari; Rah, Hamid Khak; Vaezi, Siavash; Hooshmand, Payam			Numerical Investigation of Oxygenated and Deoxygenated Blood Flow through a Tapered Stenosed Arteries in Magnetic Field	PLoS One			English	Article							NON-NEWTONIAN BLOOD; ENTROPY GENERATION ANALYSIS; STENOTIC CONDITIONS; FLUID MODEL; NANOPARTICLES; SUSPENSION; SIMULATION; NANOFLUID; WATER; TUBE	Current paper is focused on transient modeling of blood flow through a tapered stenosed arteries surrounded a by solenoid under the presence of heat transfer. The oxygenated and deoxygenated blood are considered here by the Newtonian and Non-Newtonian fluid (power law and Carreau-Yasuda) models. The governing equations of bio magnetic fluid flow for an incompressible, laminar, homogeneous, non-Newtonian are solved by finite volume method with SIMPLE algorithm for structured grid. Both magnetization and electric current source terms are well thought-out in momentum and energy equations. The effects of fluid viscosity model, Hartmann number, and magnetic number on wall shear stress, shearing stress at the stenosis throat and maximum temperature of the system are investigated and are optimized. The current study results are in agreement with some of the existing findings in the literature and are useful in thermal and mechanical design of spatially varying magnets to control the drug delivery and biomagnetic fluid flows through tapered arteries.	[Jamalabadi, M. Y. Abdollahzadeh] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea; [Bidokhti, Amin Ali Akbari; Vaezi, Siavash] Sharif Univ Technol, Dept Mech Engn, Azadi St, Tehran, Iran; [Rah, Hamid Khak] Islamic Azad Univ, Shiraz Branch, Dept Mech Engn, Shiraz, Iran; [Hooshmand, Payam] Islamic Azad Univ, Sanandaj Branch, Dept Mech Engn, Sanandaj, Iran	Dongguk University; Sharif University of Technology; Islamic Azad University; Islamic Azad University	Jamalabadi, MYA (corresponding author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.	abdollahzadeh@dongguk.edu	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/M-5838-2015	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/0000-0002-4423-1025				a-Medvidova M, INT J NUMERICAL METH, V56, P1409; Abdollahzadeh Jamalabadi M. Y., 2014, INT J SCI BASIC APPL, V14, P18; Abdollahzadeh Jamalabadi M Y, 2015, J CHEM PHARM RES, V7, P788; Abdollahzadeh Jamalabadi M Y, 2016, J HYDRODYNAMICS B, V2, P850; Abdollahzadeh Jamalabadi M Y, NUMERICAL INVESTIGAT, V18, P203; Abdollahzadeh Jamalabadi M Y, 2016, J CHEM PHARM RES, V8, P428; Akbar N.S., 2016, J APPL FLUID MECH, V9; Akbar NS, 2016, COMPUT METH PROG BIO, V132, P45, DOI 10.1016/j.cmpb.2016.04.022; Akbar NS, 2016, COMPUT METH PROG BIO, V130, P22, DOI 10.1016/j.cmpb.2016.03.003; Akbar NS, 2016, INT J EXERGY, V19, P41, DOI 10.1504/IJEX.2016.074266; Akbar NS, 2016, INT J BIOMATH, V9, DOI 10.1142/S1793524516500029; Akbar NS, 2015, PHYSICA E, V72, P70, DOI 10.1016/j.physe.2015.04.017; Akbar NS, 2015, ENTROPY-SWITZ, V17, P1411, DOI 10.3390/e17031411; Akbar NS, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500041; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Chakravarty S, 2000, INT J NONLIN MECH, V35, P779, DOI 10.1016/S0020-7462(99)00059-1; Edmund Eand Callaghan S H, 1960, D465 NAT AER SPAC AD; El-Dabe N.T., 2015, J APPL MATH PHYS, V3, P649, DOI [10.4236/jamp.2015.36078, DOI 10.4236/JAMP.2015.36078]; Ellahi R, 2014, APPL MATH INFORM SCI, V8, P1567, DOI 10.12785/amis/080410; HALDAR K, 1985, B MATH BIOL, V47, P545, DOI 10.1007/BF02460013; HIGASHI T, 1993, BLOOD, V82, P1328; Husain I, 2014, LECT NOTES ELECTR EN, V307, P55, DOI 10.1007/978-3-319-03967-1_5; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; Ishikawa T, 1998, FLUID DYN RES, V22, P251, DOI 10.1016/S0169-5983(97)00041-5; Jamalabadi MYA, 2016, ENTOMOL APPL SCI LET, V3, P52; Jamalabadi MYA, 2015, CHEM ENG RES DES, V102, P407, DOI 10.1016/j.cherd.2015.07.015; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Kumar Mandal P, 2007, INT J COMPUT MATH, V84, P1059; LOU Z, 1993, J BIOMECH, V26, P37, DOI 10.1016/0021-9290(93)90611-H; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Mann FC, 1938, SURGERY, V4, P249; Mathur P., 2013, ADV APPL MATH BIOSCI, V4, P1; Medhavi A, 2015, 2 PHASE ARTERIAL BLO; MISRA JC, 1993, J BIOMECH, V26, P1129, DOI 10.1016/S0021-9290(05)80011-9; Mosayebidorcheh S, 2015, J BRAZILIAN SOC 0826; Pontrelli G, 2001, P I MECH ENG H, V215, P1, DOI 10.1243/0954411011533445; Prakash O, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500102; Sankar A R, 2013, INT J APPL INNOVATIO, V2, P30; Sankar DS, 2011, J MECH SCI TECHNOL, V25, P2573, DOI 10.1007/s12206-011-0728-x; Sarifuddin, 2008, Journal of Medical Engineering & Technology, V32, P385, DOI 10.1080/03091900601164820; Shahidian A, 2009, IEEE T MAGN, V45, P2667, DOI 10.1109/TMAG.2009.2018954; SHUKLA JB, 1980, B MATH BIOL, V42, P283, DOI 10.1007/BF02460787; Siauw W, MED ENG PHYS, V22, P265; Srivastava V, 2015, RESPONSE COMPOSITE S; Srivastava V.P., 2015, J SCI TECHNOL, V4, P5; SRIVASTAVA VP, 1995, RHEOL ACTA, V34, P406, DOI 10.1007/BF00367155; Tanwar V K, 2012, APPL MATH SCI, V6, P5959; Tzirtzilakis EE, 2008, PHYSICA D, V237, P66, DOI 10.1016/j.physd.2007.08.006; Tzirtzilakis EE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1978807; Varshney G, 2010, INT J ENG SCI TECHNO, V2; Walker AM, 2014, ANN BIOMED ENG, V42, P97, DOI 10.1007/s10439-013-0893-4; Wang DN, 2009, COMPUT MATH APPL, V58, P1030, DOI 10.1016/j.camwa.2009.02.020; Xenos M., 2013, ADV DYN SYST APPL, V8, P427; Zaman A, 2015, AIP ADV, V5, DOI 10.1063/1.4916043	55	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167393	10.1371/journal.pone.0167393	http://dx.doi.org/10.1371/journal.pone.0167393			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941986	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600014
J	Kuuliala, K; Kuuliala, A; Koivuniemi, R; Kautiainen, H; Repo, H; Leirisalo-Repo, M				Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Kautiainen, Hannu; Repo, Heikki; Leirisalo-Repo, Marjatta			STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis	PLOS ONE			English	Article							CITRULLINATED PROTEIN ANTIBODIES; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; DISEASE-ACTIVITY; CLINICAL-RESPONSE; INTERFERON-GAMMA; FACTOR-ALPHA; EXPRESSION; THERAPY; IL-4	Objective To find novel predictors of treatment response to disease-modifying antirheumatic drugs (DMARDs), we studied activation of STAT (signal transducers and activators of transcription) 6 and 1 in circulating leukocytes of patients with rheumatoid arthritis (RA). Methods 19 patients with untreated recent-onset RA, 16 patients with chronic RA irresponsive to synthetic DMARDs and 37 healthy volunteers provided blood samples for whole blood flow cytometric determination of intracellular STAT6 and STAT1 phosphorylation, expressed as relative fluorescence units, in response to IL-4 and IFN-gamma, respectively. Phosphorylation was restudied and treatment response (according to European League Against Rheumatism) determined after 1-year treatment with synthetic DMARDs in recent-onset RA and with biological DMARD in synthetic DMARD-irresponsive RA. Estimation-based exact logistic regression was used to investigate relation of baseline variables to treatment response. 95% confidence intervals of means were estimated by bias-corrected bootstrapping and the significance between baseline and follow-up values was calculated by permutation test. Results At baseline, levels of phosphorylated STAT6 (pSTAT6) induced by IL-4 in monocytes were higher in those who achieved good treatment response to synthetic DMARDs than in those who did not among patients with untreated RA (OR 2.74, 95% CI 1.05 to 9.47), and IFN-gamma-stimulated lymphocyte pSTAT1 levels were higher in those who achieved good treatment response to a biological drug than in those who did not among patients with chronic RA (OR 3.91, 95% CI 1.12 to 20.68). During follow-up, in recent-onset RA patients with good treatment response to synthetic DMARDS, the lymphocyte pSTAT6 levels decreased (p = 0.011), and, consequently, the ratio of pSTAT1/pSTAT6 in lymphocytes increased (p = 0.042). Conclusion Cytokine-stimulated STAT6 and STAT1 phosphorylation in circulating leukocytes was associated with treatment response to DMARDs in this pilot study. The result, if confirmed in larger studies, may aid in developing personalized medicine in RA.	[Kuuliala, Krista; Kuuliala, Antti; Repo, Heikki] Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland; [Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Kautiainen, Hannu; Repo, Heikki; Leirisalo-Repo, Marjatta] Univ Helsinki, Helsinki, Finland; [Koivuniemi, Riitta; Leirisalo-Repo, Marjatta] Helsinki Univ Hosp, Rheumatol, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Gen Practice, Helsinki, Finland; [Kautiainen, Hannu] Kuopio Univ Hosp, Unit Primary Hlth Care, Kuopio, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Kuuliala, K (corresponding author), Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland.; Kuuliala, K (corresponding author), Univ Helsinki, Helsinki, Finland.	krista.kuuliala@gmail.com		Kuuliala, Antti/0000-0002-3190-207X	Paulo Foundation; Finnish Cultural Foundation; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	This work was supported by Paulo Foundation and Finnish Cultural Foundation (to KK); Helsinki University Central Hospital Research Funds (to MLR and HR); and Finska Lakaresallskapet (to MLR and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Bobbio-Pallavicini F, 2007, ANN RHEUM DIS, V66, P302, DOI 10.1136/ard.2006.060608; Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497; Cooper DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028918; Couderc M, 2013, ARTHRIT CARE RES, V65, P648, DOI 10.1002/acr.21865; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Ermann J, 2015, NAT REV RHEUMATOL, V11, P541, DOI 10.1038/nrrheum.2015.71; Fabris M, 2012, AUTOIMMUN REV, V11, P315, DOI 10.1016/j.autrev.2010.06.012; Finnegan A, 2002, J IMMUNOL, V169, P3345, DOI 10.4049/jimmunol.169.6.3345; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Gonzalez-Alvaro I, 2015, CURR PHARM DESIGN, V21, P170; Gremese E, 2012, J RHEUMATOL, V39, P2276, DOI 10.3899/jrheum.120153; Hakala Markku, 2009, Duodecim, V125, P2131; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huang Z, 2005, J IMMUNOL, V174, P1332, DOI 10.4049/jimmunol.174.3.1332; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Kawashima M, 2005, ANN RHEUM DIS, V64, P415, DOI 10.1136/ard.2004.022731; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Knudsen LS, 2008, J RHEUMATOL, V35, P1277; Kuuliala K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137385; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Muller-Ladner U, 2000, J IMMUNOL, V164, P3894, DOI 10.4049/jimmunol.164.7.3894; Nandakumar KS, 2006, EUR J IMMUNOL, V36, P1608, DOI 10.1002/eji.200535633; Nissinen R, 2004, ANN RHEUM DIS, V63, P681, DOI 10.1136/ard.2003.008599; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oberprieler NG, 2011, CELL SIGNAL, V23, P14, DOI 10.1016/j.cellsig.2010.07.009; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Ortiz MA, 2015, CLIN IMMUNOL, V158, P174, DOI 10.1016/j.clim.2015.03.025; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Puolakka K, 2005, ARTHRITIS RHEUM, V52, P36, DOI 10.1002/art.20716; Romao VC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-17; Rudwaleit M, 2000, ANN RHEUM DIS, V59, P311, DOI 10.1136/ard.59.4.311; Sanchez-Guajardo V, J IMMUNOL; Scarsi M, 2011, J RHEUMATOL, V38, P2105, DOI 10.3899/jrheum.110386; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Szalay B, 2014, CLIN RHEUMATOL, V33, P175, DOI 10.1007/s10067-013-2352-x; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van Lent PLEM, 2002, OSTEOARTHR CARTILAGE, V10, P234, DOI 10.1053/joca.2001.0501; Walker JG, 2006, ANN RHEUM DIS, V65, P1558, DOI 10.1136/ard.2005.050385; Wermeling F, 2013, P NATL ACAD SCI USA, V110, P13487, DOI 10.1073/pnas.1312525110; Yeh WI, 2014, J NEUROIMMUNOL, V267, P20, DOI 10.1016/j.jneuroim.2013.12.001; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	52	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167975	10.1371/journal.pone.0167975	http://dx.doi.org/10.1371/journal.pone.0167975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942004	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600043
J	Che, L; Xu, MM; Yang, ZG; Xu, SY; Che, LQ; Lin, Y; Fang, ZF; Feng, B; Li, J; Chen, DW; Wu, D				Che, Long; Xu, Mengmeng; Yang, Zhenguo; Xu, Shengyu; Che, Lianqiang; Lin, Yan; Fang, Zhengfeng; Feng, Bin; Li, Jian; Chen, Daiwen; Wu, De			Detection of Placental Proteomes at Different Uterine Positions in Large White and Meishan Gilts on Gestational Day 90	PLOS ONE			English	Article							WITHIN-LITTER VARIATION; BIRTH-WEIGHT; FETAL; PROTEIN; GROWTH; RESTRICTION; GLUCOSE; PERFORMANCE; METABOLISM; EXPRESSION	Within-litter uniformity in pigs is a major factor affecting piglet survival and growth performance. We know that Meishan (MS) gilts have higher piglet survival rate than Large White (LW) gilts because their foetal weight is less varied. To understand the molecular basis for placental nutritional transport during the late stages of gestation in LW and MS, we employed the isobaric tags for relative and absolute quantification (iTRAQ) method to investigate alterations in the placental proteomes of LW and MS gilts on gestational day 90. Investigation of foetal weight at different uterine positions revealed that the foetal and placental weights as well as the foetal concentration of glucose were significantly higher in LW gilts positioned towards the utero-tubal junction than in those positioned toward the cervix; however, no such differences were observed in MS gilts, and MS gilts had a greater uniformity in foetal weight on day 90 of gestation. Comparisons of the proteomes between placentas positioned toward the cervix and those positioned toward the utero-tubal junction identified 38 differentially expressed proteins in the two breeds. These proteins play a central role in nutrient transport and metabolism, as well as in transcriptional and translational regulation. Of particular interest is the finding that the placentas of LW gilts showed 14 differential expression of proteins mainly related to lipid transport and energy metabolism (including solute carrier family 27, mitochondrial trifunctional protein, and NADH dehydrogenase [ ubiquinone] flavoprotein 2), but only 2 proteins in MS gilts. In contrast, the differentially expressed proteins in MS gilts were primarily involved in transcriptional and translational regulation (such as ribosome-sec61 and 40S ribosomal protein S23), with a few related to glucose and coenzyme transport and metabolism (including glucose transport protein and ferrochelatase). Our results revealed that placental lipid and energy metabolism might play a crucial role in the regulation of foetal weight, based on uterine position in two distinct pig breeds. These findings provide a deeper understanding of placental efficiency that can be utilized to provide a new method to enhance the efficiency of livestock production.	[Che, Long; Xu, Mengmeng; Yang, Zhenguo; Xu, Shengyu; Che, Lianqiang; Lin, Yan; Fang, Zhengfeng; Feng, Bin; Li, Jian; Chen, Daiwen; Wu, De] Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, Minist Educ China, Yaan Shi, Sichuan Sheng, Peoples R China	Ministry of Education, China; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, Minist Educ China, Yaan Shi, Sichuan Sheng, Peoples R China.	sow_nutrition@sina.com	Xu, Shengyu/AFN-8288-2022	Xu, Shengyu/0000-0002-4415-8542	Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; National Basic Research Program of China (973 Program) [2012CB124701]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT13083) and the National Basic Research Program of China (973 Program) (2012CB124701). The funder, De Wu, had a role in conceived and designed the experiments and contributed reagents/materials/analysis tools.	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; BAZER FW, 1988, J REPROD FERTIL, V84, P37, DOI 10.1530/jrf.0.0840037; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Biensen NJ, 1998, J ANIM SCI, V76, P2169; BOILEAU P, 1995, J CLIN INVEST, V96, P309, DOI 10.1172/JCI118036; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Dai Y, 2012, ENDOCRINOLOGY, V153, P4216, DOI 10.1210/en.2012-1206; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Haggarty P, 1997, PLACENTA, V18, P635, DOI 10.1016/S0143-4004(97)90004-7; Han YK, 2009, ANIM SCI J, V80, P57, DOI 10.1111/j.1740-0929.2008.00604.x; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Hu L, 2015, BRIT J NUTR, V114, P53, DOI 10.1017/S0007114515001579; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Johnson RK, 1999, J ANIM SCI, V77, P541; Kim S W, 2009, J Anim Sci, V87, pE123, DOI 10.2527/jas.2008-1452; Kim S. W., 2013, J ANIM SCI BIOTECHNO, V4, P26, DOI DOI 10.1186/2049-1891-4-26; Kimura RE, 1991, LIPID METABOLISM FET, P291; KNOPP R H, 1981, Clinical Obstetrics and Gynecology, V24, P21, DOI 10.1097/00003081-198103000-00006; Knopp RH, 1997, ANN NY ACAD SCI, V817, P251, DOI 10.1111/j.1749-6632.1997.tb48212.x; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; LEE GJ, 1995, ANIM SCI, V60, P269, DOI 10.1017/S1357729800008432; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Major CA, 1998, AM J OBSTET GYNECOL, V179, P1038, DOI 10.1016/S0002-9378(98)70211-X; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PERE MC, 1995, J ANIM SCI, V73, P2994; Quesnel H, 2014, J ANIM SCI, V92, P1445, DOI 10.2527/jas.2013-6701; Ramadoss J, 2012, REPROD TOXICOL, V34, P538, DOI 10.1016/j.reprotox.2012.08.008; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; Wilson ME, 1998, SELECTION LITTER SIZ; Wise T, 1997, J ANIM SCI, V75, P2197; Wu GY, 2012, PAEDIATR PERINAT EP, V26, P4, DOI 10.1111/j.1365-3016.2012.01291.x; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010	44	10	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167799	10.1371/journal.pone.0167799	http://dx.doi.org/10.1371/journal.pone.0167799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936087	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100196
J	Chen, I; Chau, G; Wang, J; Clarke, W; Marzinke, MA; Cummings, V; Breaud, A; Laeyendecker, O; Fields, SD; Griffith, S; Scott, HM; Shoptaw, S; del Rio, C; Magnus, M; Mannheimer, S; Tieu, HV; Wheeler, DP; Mayer, KH; Koblin, BA; Eshleman, SH				Chen, Iris; Chau, Gordon; Wang, Jing; Clarke, William; Marzinke, Mark A.; Cummings, Vanessa; Breaud, Autumn; Laeyendecker, Oliver; Fields, Sheldon D.; Griffith, Sam; Scott, Hyman M.; Shoptaw, Steven; del Rio, Carlos; Magnus, Manya; Mannheimer, Sharon; Hong-Van Tieu; Wheeler, Darrell P.; Mayer, Kenneth H.; Koblin, Beryl A.; Eshleman, Susan H.			Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061)	PLOS ONE			English	Article							RESOLUTION MELTING ASSAY; GENETIC DIVERSITY; SEQUENCE DIVERSITY; ENV; EVOLUTION; VIREMIA; GAG	Background HIV populations often diversify in response to selective pressures, such as the immune response and antiretroviral drug use. We analyzed HIV diversity in Black men who have sex with men who were enrolled in the HIV Prevention Trials Network 061 study. Methods A high resolution melting (HRM) diversity assay was used to measure diversity in six regions of the HIV genome: two in gag, one in pot, and three in env. HIV diversity was analyzed for 146 men who were HIV infected at study enrollment, including three with acute infection and 13 with recent infection (identified using a multi-assay algorithm), and for 21 men who seroconverted during the study. HIV diversification was analyzed in a paired analysis for 62 HIV-infected men using plasma samples from the enrollment and 12-month (end of study) visits. Results Men with acute or recent infection at enrollment and seroconverters had lower median HRM scores (lower HIV diversity) than men with non-recent infection in all six regions analyzed. In univariate analyses, younger age, higher CD4 cell count, and HIV drug resistance were associated with lower median HRM scores in multiple regions; ARV drug detection was marginally associated with lower diversity in the po/region. In multivariate analysis, acute or recent infection (all six regions) and HIV drug resistance (both gag regions) were associated with lower median HRM scores. Diversification in the pol region over 12 months was greater for men with acute or recent infection, higher CD4 cell count, and lower HIV viral load at study enrollment. Conclusions HIV diversity was significantly associated with duration of HIV infection, and lower gag diversity was observed in men who had HIV drug resistance. HIV po/diversification was more pronounced in men with acute or recent infection, higher CD4 cell count, and lower HIV viral load.	[Chen, Iris; Clarke, William; Marzinke, Mark A.; Cummings, Vanessa; Breaud, Autumn; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Chau, Gordon; Wang, Jing] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIA, Baltimore, MD USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Fields, Sheldon D.] Charles R Drew Univ Med & Sci, Mervyn M Dymally Sch Nursing, 1621 E 120th St, Los Angeles, CA 90059 USA; [Griffith, Sam] Sci Facilitat Dept, FHI 360, Durham, NC USA; [Scott, Hyman M.] Bridge HIV, San Francisco Dept Publ Hlth, San Francisco, CA USA; [Shoptaw, Steven] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA; [del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Magnus, Manya] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Mannheimer, Sharon] Columbia Univ, Dept Med, Harlem Hosp, Mailman Sch Publ Hlth, New York, NY USA; [Hong-Van Tieu; Koblin, Beryl A.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Wheeler, Darrell P.] SUNY Albany, Sch Social Welf, Albany, NY 12222 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Med Sch, Dept Med, Boston, MA USA	Johns Hopkins University; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Charles R. Drew University of Medicine & Science; FHI 360; San Francisco Department of Public Health; University of California System; University of California Los Angeles; Emory University; Rollins School Public Health; George Washington University; Columbia University; New York Blood Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Shoptaw, Steven/0000-0002-3583-0026; Laeyendecker, Oliver/0000-0002-6429-4760	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Child Health and Human Development (NICH/HD); National Institute of Drug Abuse (NIDA); National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services [UM1-A1068613, R01-A1095068]; Division of Intramural Research, NIAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095068, UM1AI069412, UM1AI069424, UM1AI068613, ZIAAI000361, UM1AI069470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, T32MH019105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development (NICH/HD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services; Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The HIV Prevention Trials Network (HPTN) is funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Child Health and Human Development (NICH/HD), National Institute of Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), Office of AIDS Research, National Institutes of Health (NIH), Department of Health and Human Services (UM1-A1068613), and R01-A1095068 (Eshleman). Additional support was provided by the Division of Intramural Research, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Carter CC, 2015, VIROLOGY, V474, P34, DOI 10.1016/j.virol.2014.10.019; Chen I, 2015, JAIDS-J ACQ IMM DEF, V69, P446, DOI 10.1097/QAI.0000000000000633; Chen I, 2014, JAIDS-J ACQ IMM DEF, V67, P405, DOI 10.1097/QAI.0000000000000298; Chen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081213; Cousins MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051359; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Hong SL, 2009, MICROBIOL IMMUNOL, V53, P535, DOI 10.1111/j.1348-0421.2009.00153.x; James MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057350; James MM, 2012, PEDIATR INFECT DIS J, V31, pE222, DOI 10.1097/INF.0b013e3182678c3f; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Marzinke MA, 2014, CLIN INFECT DIS, V58, P117, DOI 10.1093/cid/cit672; Mayer KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087298; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Richman Douglas D, 2004, Trans Am Clin Climatol Assoc, V115, P289; Sagar M, 2006, AIDS RES HUM RETROV, V22, P430, DOI 10.1089/aid.2006.22.430; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; Williamson S, 2003, MOL BIOL EVOL, V20, P1318, DOI 10.1093/molbev/msg144; Zanini F, 2015, ELIFE, V4, DOI 10.7554/eLife.11282	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167629	10.1371/journal.pone.0167629	http://dx.doi.org/10.1371/journal.pone.0167629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936098	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100134
J	Khaddaj-Mallat, R; Sirois, C; Sirois, M; Rizcallah, E; Marouan, S; Morin, C; Rousseau, E				Khaddaj-Mallat, Rayan; Sirois, Chantal; Sirois, Marco; Rizcallah, Edmond; Marouan, Sofia; Morin, Caroline; Rousseau, Eric			Pro-Resolving Effects of Resolvin D-2 in LTD4 and TNF-alpha Pre-Treated Human Bronchi	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; CA2+ SENSITIVITY; CYSTEINYL-LEUKOTRIENES; D2; INFLAMMATION; RESOLUTION; RECEPTOR; ACTIVATION; MEDIATORS; HISTAMINE	Inflammation is a major burden in respiratory diseases, resulting in airway hyperresponsiveness. Our hypothesis is that resolution of inflammation may represent a long-term solution in preventing human bronchial dysfunctions. The aim of the present study was to assess the anti-inflammatory effects of RvD(2), a member of the D-series resolving family, with concomitant effects on ASM mechanical reactivity. The role and mode of action of RvD(2) were assessed in an in vitro model of human bronchi under pro-inflammatory conditions, induced either by 1 mu M LTD4 or 10 ng/ml TNF-alpha pre-treatment for 48h. TNF-alpha and LTD4 both induced hyperreactivity in response to pharmacological stimuli. Enhanced 5-Lipoxygenase (5-LOX) and cysteinyl leukotriene receptor 1 (CysLTR1) detection was documented in LTD4 or TNF-alpha pre-treated human bronchi when compared to control (untreated) human bronchi. In contrast, RvD(2) treatments reversed 5-LOX/beta-actin and CysLTR1/beta-actin ratios and decreased the phosphorylation levels of AP-1 subunits (c-Fos, c-Jun) and p38-MAP kinase, while increasing the detection of the ALX/FPR2 receptor. Moreover, various pharmacological agents revealed the blunting effects of RvD(2) on LTD4 or TNF-alpha induced hyper-responsiveness. Combined treatment with 300 nM RvD(2) and 1 mu M WRW4 (an ALX/FPR2 receptor inhibitor) blunted the pro-resolving and broncho-modulatory effects of RvD(2). The present data provide new evidence regarding the role of RvD(2) in a human model of airway inflammation and hyperrresponsiveness.	[Khaddaj-Mallat, Rayan; Rousseau, Eric] Univ Sherbrooke, Dept Obstet Gynecol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Sirois, Chantal; Sirois, Marco] CHUS Felurimont, Serv Thorac Surg, Sherbrooke, PQ, Canada; [Rizcallah, Edmond; Marouan, Sofia] Univ Sherbrooke, Dept Pathol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Morin, Caroline] Univ Montreal, Nursery Sch, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Montreal	Rousseau, E (corresponding author), Univ Sherbrooke, Dept Obstet Gynecol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada.	Eric.Rousseau@USherbrooke.ca	Khaddaj-Mallat, Rayan/W-8228-2019; Rizcallah, Edmond/AAI-3986-2021	Khaddaj-Mallat, Rayan/0000-0002-8850-6342; 	Canadian Institute of Health Research (CIHR) [MOP-111112]; Health Respiratory Training Program of Quebec	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Health Respiratory Training Program of Quebec	This work was initially supported by the Canadian Institute of Health Research (CIHR) grant MOP-111112 to ER, who is a member of the Respiratory Health Network of the FRQS: www.rsr-frqs.ca. RKM is a recipient of a Ph.D. studentship from the Health Respiratory Training Program of Quebec formerly supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Accomazzo MR, 2001, AM J RESP CRIT CARE, V163, P266, DOI 10.1164/ajrccm.163.1.9912019; Al-Zaubai N, 2014, J PHARMACOL EXP THER, V351, P172, DOI 10.1124/jpet.114.214403; BARNES PJ, 1987, AM REV RESPIR DIS, V135, pS26; Basil MC, 2016, NAT REV IMMUNOL; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Carbajal V, 2005, AM J PHYSIOL-LUNG C, V288, pL84, DOI 10.1152/ajplung.00446.2003; Casale Thomas B, 2003, Postgrad Med, V113, P7, DOI 10.3810/pgm.02.2003.suppl25.131; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Clarke DL, 2009, PULM PHARMACOL THER, V22, P426, DOI 10.1016/j.pupt.2008.12.003; ELLIS JL, 1994, AM J RESP CRIT CARE, V149, P118, DOI 10.1164/ajrccm.149.1.8111568; Figueroa DJ, 2001, AM J RESP CRIT CARE, V163, P226, DOI 10.1164/ajrccm.163.1.2003101; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Giudetti AM, 2012, PROSTAG OTH LIPID M, V99, P57, DOI 10.1016/j.prostaglandins.2012.09.006; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; HUBER M, 1988, EUR J IMMUNOL, V18, P2085, DOI 10.1002/eji.1830181233; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kankaanranta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090298; Khaddaj Mallat R, 2016, PHARM RES P IN PRESS; Khaddaj-Mallat R, 2015, PROSTAG OTH LIPID M, V121, P145, DOI 10.1016/j.prostaglandins.2015.04.005; Khaddaj-Mallat R, 2015, PFLUG ARCH EUR J PHY, V467, P1591, DOI 10.1007/s00424-014-1584-1; Kumar A, 2016, NUTR RES REV, V29, P1, DOI 10.1017/S0954422415000116; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; Lee IT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/791231; Lin HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107890; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; Morin C, 2006, CAN J PHYSIOL PHARM, V84, P1029, DOI 10.1139/Y06-048; Morin C, 2011, AM J RESP CELL MOL, V45, P366, DOI 10.1165/rcmb.2010-0156OC; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ono E, 2014, AM J RESP CRIT CARE, V190, P886, DOI 10.1164/rccm.201403-0544OC; Parameswaran K, 2007, AM J RESP CELL MOL, V37, P240, DOI 10.1165/rcmb.2006-0172OC; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shinohara M, 2016, J ATHEROSCLER THROMB; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Suzuki M, 2003, J ASTHMA, V40, P395, DOI 10.1081/JAS-120018709; Tulic MK, 2002, SEMIN RESP CRIT CARE, V23, P347, DOI 10.1055/s-2002-34330; Uddin M, 2011, PROG LIPID RES, V50, P75, DOI 10.1016/j.plipres.2010.09.002	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167058	10.1371/journal.pone.0167058	http://dx.doi.org/10.1371/journal.pone.0167058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935998	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100057
J	Khalil, S; El-Badri, N; El-Mokhtaar, M; Al-Mofty, S; Farghaly, M; Ayman, R; Habib, D; Mousa, N				Khalil, Sabreen; El-Badri, Nagwa; El-Mokhtaar, Mohamed; Al-Mofty, Saif; Farghaly, Mohamed; Ayman, Radwa; Habib, Dina; Mousa, Noha			A Cost-Effective Method to Assemble Biomimetic 3D Cell Culture Platforms	PLOS ONE			English	Article							HUMAN AMNIOTIC MEMBRANE; MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; SURFACE RECONSTRUCTION; EPITHELIAL-CELLS; EXPANSION; PROTEINS; MATRIX; NICHE; FATE	Developing effective stem cell based therapies requires the design of complex in vitro culture systems for more accurate representation of the stem cell niche. Attempts to improve conventional cell culture platforms include the use of biomaterial coated culture plates, sphere culture, microfluidic systems and bioreactors. Most of these platforms are not cost-effective, require industrial technical expertise to fabricate, and remain too simplistic compared to the physiological cell niche. The human amniotic membrane (hAM) has been used successfully in clinical grafting applications due to its unique biological composition and regenerative properties. In this study, we present a combinatorial platform that integrates the hAM with biomolecular, topographic and mechanical cues in one versatile model. Methods We utilized the hAM to provide the biological and the three dimensional (3D) topographic components of the prototype. The 3D nano-roughness of the hAM was characterized using surface electron microscopy and surface image analysis (ImageJ and SurfaceJ). We developed additional macro-scale and micro-scale versions of the platform which provided additional shear stress factors to simulate the fluid dynamics of the in vivo extracellular fluids. Results Three models of varying complexities of the prototype were assembled. A well-defined 3D surface modulation of the hAM in comparable to commercial 3D biomaterial culture substrates was achieved without complex fabrication and with significantly lower cost. Performance of the prototype was demonstrated through culture of primary human umbilical cord mononuclear blood cells (MNCs), human bone marrow mesenchymal stem cell line (hBMSC), and human breast cancer tissue. Conclusion This study presents methods of assembling an integrated, flexible and low cost biomimetic cell culture platform for diverse cell culture applications.	[Khalil, Sabreen; El-Badri, Nagwa; Al-Mofty, Saif; Farghaly, Mohamed; Ayman, Radwa] Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med, Giza, Egypt; [El-Badri, Nagwa; Al-Mofty, Saif; Mousa, Noha] Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt; [El-Mokhtaar, Mohamed] Assiut Univ, Dept Microbiol & Immunol, Fac Med, Assiut, Egypt; [Habib, Dina] Assiut Univ, Dept Obstet & Gynecol, Fac Med, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	El-Badri, N (corresponding author), Zewail City Sci & Technol, Ctr Excellence Stem Cells & Regenerat Med, Giza, Egypt.; El-Badri, N; Mousa, N (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Giza, Egypt.	nelbadri@zewailcity.edu.eg; noha.mousa@utoronto.ca	El-Mokhtar, Mohamed A./AAP-4906-2020; El-Mofty, saif El-din/ABE-3017-2021	El-Mokhtar, Mohamed A./0000-0003-1943-8419; Farghaly, Mohamed/0000-0002-0428-9185; Elmofty, saif/0000-0001-7708-7413	Science and Technology Development Fund STDF Egypt [5300]	Science and Technology Development Fund STDF Egypt(Science and Technology Development Fund (STDF))	Funded by Science and Technology Development Fund STDF (governmental funding) Egypt, grant #5300.	Ahmed O, 2014, BIOM ENG C CIBEC 201; Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29; DAVIS GE, 1987, SCIENCE, V236, P1106, DOI 10.1126/science.3576223; Pena Janethe Deolinda de Oliveira, 2007, Arq. Bras. Oftalmol., V70, P756, DOI 10.1590/S0004-27492007000500006; Eberwein P, 2015, STEM CELLS, V33, P916, DOI 10.1002/stem.1886; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hardy JG, 2015, BIOENGINEERING-BASEL, V2, P15, DOI 10.3390/bioengineering2010015; ISKI P, 2012, CENTRAL EUROPEAN J I, V37, P114; Jerman UD, 2014, TISSUE ENG PART C-ME, V20, P317, DOI [10.1089/ten.TEC.2013.0298, 10.1089/ten.tec.2013.0298]; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kang NH, 2012, CANCER GENE THER, V19, P517, DOI 10.1038/cgt.2012.30; Kang NH, 2012, INT J ONCOL, V40, P2022, DOI 10.3892/ijo.2012.1372; KIM JC, 1995, CORNEA, V14, P473; Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mamede AC, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0702-z; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Mamede AC, 2014, J MEMBRANE BIOL, V247, P357, DOI 10.1007/s00232-014-9642-3; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Mrugala A, 2015, INT WOUND J; Nourazarian S.M, 2015, BULL ENVIRON PHARMAC, V4, P61; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Peirovi H, 2012, J VASC SURG, V56, P1098, DOI 10.1016/j.jvs.2012.02.036; Pham PV, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-56; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003; Rocha SCM, 2015, BIOCH PROPERTIES AMN, P19; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444; Stock SJ, 2007, AM J OBSTET GYNECOL, V196, P255, DOI 10.1016/j.ajog.2006.10.908; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; Ueta M, 2002, CLIN EXP IMMUNOL, V129, P464, DOI 10.1046/j.1365-2249.2002.01945.x; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; WELLS WJC, 1946, BRIT MED J, V2, P624, DOI 10.1136/bmj.2.4477.624-c; Westekemper H, 2016, BRIT J OPHTHALMOLOGY; Yam GHF, 2013, INVEST OPHTH VIS SCI, V54	43	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167116	10.1371/journal.pone.0167116	http://dx.doi.org/10.1371/journal.pone.0167116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935982	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100062
J	Lin, R; Zhang, YX; Yan, DJ; Liao, XP; Wang, XS; Fu, YX; Cai, WW				Lin, Rong; Zhang, Yunxia; Yan, Dongjing; Liao, Xiaoping; Wang, Xianshou; Fu, Yunxin; Cai, Wangwei			Genetic Association Analysis of Common Variants in FOXO3 Related to Longevity in a Chinese Population	PLOS ONE			English	Article							LONG-LIVED INDIVIDUALS; EXTREME LONGEVITY; CENTENARIANS; METAANALYSIS; LOCI	Recent studies suggested that forkhead box class O3 (FOXO3) functions as a key regulator for the insulin/insulin-like growth factor-1signaling pathway that influence aging and longevity. This study aimed to comprehensively elucidate the association of common genetic variants in FOXO3 with human longevity in a Chinese population. Eighteen single-nucleotide polymorphisms (SNPs) in FOXO3 were successfully genotyped in 616 unrelated long-lived individuals and 846 younger controls. No nominally significant effects were found. However, when stratifying by gender, four SNPs (rs10499051, rs7762395, rs4946933 and rs3800230) previously reported to be associated with longevity and one novel SNP (rs4945815) showed significant association with male longevity (P-values: 0.007-0.032), but all SNPs were not associated with female longevity. Correspondingly, males carrying the G-G-T-G haplotype of rs10499051, rs7762395, rs4945815 and rs3800230 tended to have longer lifespan than those carrying the most common haplotype A-G-C-T (odds ratio = 2.36, 95% confidence interval = 1.20-4.63, P = 0.013). However, none of the associated SNPs and haplotype remained significant after Bonferroni correction. In conclusion, our findings revealed that the FOXO3 variants we tested in our population of Chinese men and women were associated with longevity in men only. None of these associations passed Bonferroni correction. Bonferroni correction is very stringent for association studies. We therefore believe the effects of these nominally significant variants on human longevity will be confirmed by future studies.	[Lin, Rong] Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China; [Zhang, Yunxia; Yan, Dongjing; Cai, Wangwei] Hainan Med Coll, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Liao, Xiaoping] Hainan Med Coll, Affiliated Hosp 1, Dept Neurol, Haikou, Hainan, Peoples R China; [Wang, Xianshou] Hainan Med Coll, Specialized Biotechnol Lab, Haikou, Hainan, Peoples R China; [Fu, Yunxin] Univ Texas Hlth Sci Ctr Houston, Div Biostat, Houston, TX 77030 USA; [Fu, Yunxin] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Fu, Yunxin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China	Hainan Medical University; Hainan Medical University; Hainan Medical University; Hainan Medical University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Yunnan University	Lin, R (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.; Cai, WW (corresponding author), Hainan Med Coll, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China.	xianronglin@gmail.com; caiww591020@163.com	Lin, Rong/AAY-3001-2020	Lin, Rong/0000-0001-9161-6844	National Natural Science Foundation of China [31460290, 81460184, 31660309]; Department of Science and Technology of Hainan Province [KJHZ2013-16, ZDXM20090805]; Research Start-Up Fund in Hainan Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Hainan Province; Research Start-Up Fund in Hainan Medical College	This study was supported by grants from the National Natural Science Foundation of China (31460290, 81460184 and 31660309), (http://www.nsfc.gov.cn/), Department of Science and Technology of Hainan Province (KJHZ2013-16 and ZDXM20090805) (http://dost.hainan.gov.cn/), and the Research Start-Up Fund in Hainan Medical College for Dr.Lin (http://www.hainmc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bao JM, 2014, ASIAN J ANDROL, V16, P446, DOI 10.4103/1008-682X.123673; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Chen X, 2012, J THROMB HAEMOST, V10, P1508, DOI 10.1111/j.1538-7836.2012.04815.x; Daumer C, 2014, AGE, V36, P911, DOI 10.1007/s11357-013-9578-z; Donlon TA, 2012, J GERONTOL A-BIOL, V67, P1132, DOI 10.1093/gerona/gls067; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franceschi C, 2000, AGING-CLIN EXP RES, V12, P77, DOI 10.1007/BF03339894; He YH, 2014, AGING-US, V6, P944, DOI 10.18632/aging.100703; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Li N, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/4583147; Li XiangJuan, 2010, Journal of Environment and Health, V27, P54; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nygaard M, 2014, EXP GERONTOL, V57, P41, DOI 10.1016/j.exger.2014.04.018; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Soerensen M, 2015, AGING CELL, V14, P60, DOI 10.1111/acel.12295; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sun L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09852; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox BJ, 2016, AGING CELL, V15, P617, DOI 10.1111/acel.12452; Xm F, 2013, POPUL J, V35, P14; Yunfeng LI, 2009, CHINA MINING MAGAZIN, V8, P1, DOI DOI 10.1093/HMG/DDP459; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zeng Y, 2010, J GERONTOL A-BIOL, V65, P1285, DOI 10.1093/gerona/glq156	33	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167918	10.1371/journal.pone.0167918	http://dx.doi.org/10.1371/journal.pone.0167918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936216	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100231
J	Lind, T; Gustafson, AM; Calounova, G; Hu, LJ; Rasmusson, A; Jonsson, KB; Wernersson, S; Aring;brink, M; Andersson, G; Larsson, S; Melhus, H; Pejler, G				Lind, Thomas; Gustafson, Ann-Marie; Calounova, Gabriela; Hu, Lijuan; Rasmusson, Annica; Jonsson, Kenneth B.; Wernersson, Sara; Abrink, Magnus; Andersson, Goran; Larsson, Sune; Melhus, Hakan; Pejler, Gunnar			Increased Bone Mass in Female Mice Lacking Mast Cell Chymase	PLOS ONE			English	Article							INDOLENT SYSTEMIC MASTOCYTOSIS; INFLAMMATION; OSTEOPOROSIS; INHIBITOR; DIFFERENTIATION; OSTEOBLAST; PROTEASE-4; HAMSTERS; TISSUE; ACCUMULATION	Here we addressed the potential impact of chymase, a mast-cell restricted protease, on mouse bone phenotype. We show that female mice lacking the chymase Mcpt4 acquired a persistent expansion of diaphyseal bone in comparison with wild type controls, reaching a 15% larger diaphyseal cross sectional area at 12 months of age. Mcpt4(-/-) mice also showed increased levels of a bone anabolic serum marker and higher periosteal bone formation rate. However, they were not protected from experimental osteoporosis, suggesting that chymase regulates normal bone homeostasis rather than the course of osteoporosis. Further, the absence of Mcpt4(-/-) resulted in age-dependent upregulation of numerous genes important for bone formation but no effects on osteoclast activity. In spite of the latter, Mcpt4(-/-) bones had increased cortical porosity and reduced endocortical mineralization. Mast cells were found periosteally and, notably, bone-proximal mast cells in Mcpt4(-/-) mice were degranulated to a larger extent than in wild type mice. Hence, chymase regulates degranulation of bone mast cells, which could affect the release of mast cell-derived factors influencing bone remodelling. Together, these findings reveal a functional impact of mast cell chymase on bone. Further studies exploring the possibility of using chymase inhibitors as a strategy to increase bone volume may be warranted.	[Lind, Thomas; Gustafson, Ann-Marie; Hu, Lijuan; Rasmusson, Annica; Melhus, Hakan] Univ Uppsala Hosp, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden; [Gustafson, Ann-Marie; Calounova, Gabriela; Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Jonsson, Kenneth B.; Larsson, Sune] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Wernersson, Sara; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Andersson, Goran] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University; Uppsala University Hospital; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska University Hospital	Lind, T (corresponding author), Univ Uppsala Hosp, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden.	thomas.lind@medsci.uu.se	, kenneth/GPF-8006-2022; Åbrink, Magnus/AAK-8346-2020; Wernersson, Sara/D-4580-2011; Wernersson, Sara/N-8830-2019	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Abrink, Magnus/0000-0002-1335-3927; Lind, Thomas/0000-0003-2791-688X; Rasmusson, Annica/0000-0002-7228-7755	Uppsala Bio-X; Svenska Lakaresallskapet; Medicinska forskningsradet	Uppsala Bio-X; Svenska Lakaresallskapet; Medicinska forskningsradet	The funders of this study were: Uppsala Bio-X, Svenska Lakaresallskapet and Medicinska forskningsradet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AS, 2006, CLIN CHEM LAB MED, V44, P672, DOI 10.1515/CCLM.2006.117; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Blair HC, 1999, VIRCHOWS ARCH, V435, P50, DOI 10.1007/s004280050394; Bot I, 2011, CARDIOVASC RES, V89, P244, DOI 10.1093/cvr/cvq260; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Chen H, 2004, HISTOL HISTOPATHOL, V19, P677, DOI 10.14670/HH-19.677; Chiappetta N, 2006, SEMIN ARTHRITIS RHEU, V36, P32, DOI 10.1016/j.semarthrit.2006.03.004; Dhillon RS, 2013, J BONE MINER RES, V28, P586, DOI 10.1002/jbmr.1765; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Farber CR, 2011, J BONE MINER RES, V26, P2174, DOI 10.1002/jbmr.436; FEIK SA, 1979, PATHOLOGY, V11, P641, DOI 10.3109/00313027909059044; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2015, ADV IMMUNOL, V126, P45, DOI 10.1016/bs.ai.2014.11.002; Gannon FH, 2001, HUM PATHOL, V32, P842, DOI 10.1053/hupa.2001.26464; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Guillaume N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.018; He AN, 2013, CURR PHARM DESIGN, V19, P1114; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hoshino F, 2003, J CARDIOVASC PHARM, V41, pS11; Houde M, 2016, LIFE SCI, V159, P71, DOI 10.1016/j.lfs.2016.03.018; Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439; Imada T, 2002, JPN J PHARMACOL, V90, P214, DOI 10.1254/jjp.90.214; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Jarvinen TLN, 2015, J INTERN MED, V277, P662, DOI 10.1111/joim.12366; Johnzon CF, 2016, AM J PATHOL, V186, P4, DOI 10.1016/j.ajpath.2015.06.024; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Lesclous P, 2001, CALCIFIED TISSUE INT, V68, P297, DOI 10.1007/BF02390837; Lin L, 2011, J BIOL CHEM, V286, P37358, DOI 10.1074/jbc.M111.272401; Lind T, 2012, CALCIFIED TISSUE INT, V90, P219, DOI 10.1007/s00223-011-9561-6; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Maryanoff BE, 2010, AM J RESP CRIT CARE, V181, P247, DOI 10.1164/rccm.200904-0627OC; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nyman JS, 2011, J BONE MINER RES, V26, P1252, DOI 10.1002/jbmr.326; Okamoto Y, 2002, JPN J PHARMACOL, V90, P94, DOI 10.1254/jjp.90.94; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; RAMESH BL, 2005, BONE, V36, P555, DOI DOI 10.1016/J.B0NE.2004.12.005; Rossini M, 2014, IMMUNOL ALLERGY CLIN, V34, P383, DOI 10.1016/j.iac.2014.01.011; Rossini M, 2011, BONE, V49, P880, DOI 10.1016/j.bone.2011.07.004; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Scandiuzzi L, 2010, J IMMUNOL, V185, P624, DOI 10.4049/jimmunol.0902129; Seitz S, 2013, OSTEOPOROSIS INT, V24, P2325, DOI 10.1007/s00198-013-2305-x; Sun JS, 2009, CIRCULATION, V120, P973, DOI 10.1161/CIRCULATIONAHA.109.849679; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tsunemi K, 2004, J PHARMACOL EXP THER, V309, P879, DOI 10.1124/jpet.103.063974; Turner RT, 2010, J BONE MINER RES, V25, P1637, DOI 10.1002/jbmr.49; van der Veer E, 2012, ALLERGY, V67, P431, DOI 10.1111/j.1398-9995.2011.02780.x; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wu LA, 2016, J CELL PHYSIOL, V231, P1189, DOI 10.1002/jcp.25266; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167964	10.1371/journal.pone.0167964	http://dx.doi.org/10.1371/journal.pone.0167964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936149	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100241
J	Liu, XL; Liu, CJ				Liu, Xinlun; Liu, Chunji			Effects of Drought-Stress on Fusarium Crown Rot Development in Barley	PLOS ONE			English	Article							ESTIMATING DISEASE LOSSES; HEAD BLIGHT; BREAD WHEAT; RESISTANCE; SEVERITY	Fusarium crown rot (FCR), caused by various Fusarium species, is a chronic disease of cereals in many semi-arid regions worldwide. To clarify what effects drought-stress may have on FCR development, visual assessment, histological analysis and quantitative PCR were used to analyse the infection process of F. pseudograminearum in barley. This study observed for the first time that the severity of FCR symptom reflects the quantity of pathogens in infected tissues of barley under both drought-stressed and well-watered conditions. Drought-stress prolongs the initial infection phase but enhances the proliferation and spread of Fusarium pathogens after the initial infection phase. Under drought-stressed conditions, the invading hyphae were frequently observed to re-emerge from stomata and invade again the surrounding epidermis cells. Under the well-watered conditions, however, very few hyphae re-emerged from stomata and most infection was caused by hyphae intracellularly grown. It was also observed that drought-stress increased the length and density of trichomes dramatically especially in the susceptible genotypes, and that the length and density of trichomes were positively related to fungal biomass of F. pseudograminearum in plants.	[Liu, Xinlun] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Xinlun; Liu, Chunji] CSIRO Agr & Food, St Lucia, Qld, Australia; [Liu, Chunji] Univ Western Australia, Sch Plant Biol, Perth, WA, Australia	Northwest A&F University - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Liu, XL (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, XL (corresponding author), CSIRO Agr & Food, St Lucia, Qld, Australia.	liuxinlun@nwafu.edu.cn	Liu, Chunji/B-5243-2009		Northwest AF University; China Scholarship Council; Grains Research and Development Corporation, Australia [CSP00149]	Northwest AF University; China Scholarship Council(China Scholarship Council); Grains Research and Development Corporation, Australia(Grains R&D Corp)	XL is grateful to the Northwest A&F University and the China Scholarship Council for funding her visit to CSIRO Agriculture & Food. Work reported in this paper is supported by the Grains Research and Development Corporation, Australia (CSP00149). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Bai ZY, 2015, J PHYTOPATHOL, V163, P91, DOI 10.1111/jph.12283; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Clement JA, 1998, EUR J PLANT PATHOL, V104, P323, DOI 10.1023/A:1008681618351; COOK RJ, 1980, PLANT DIS, V64, P102, DOI 10.1094/PD-64-1061; DODMAN RL, 1987, AUST J AGR RES, V38, P475; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Fernandez MR, 2009, CAN J PLANT PATHOL, V31, P96, DOI 10.1080/07060660909507577; Hulburt DJ, 2004, J ECON ENTOMOL, V97, P621, DOI 10.1603/0022-0493-97.2.621; Knight NL, 2013, AUSTRALAS PLANT PATH, V42, P609, DOI 10.1007/s13313-013-0225-z; Knight NL, 2013, PLANT PATHOL, V62, P679, DOI 10.1111/j.1365-3059.2012.02663.x; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Liu YX, 2012, J PHYTOPATHOL, V160, P412, DOI 10.1111/j.1439-0434.2012.01920.x; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PAPENDICK RI, 1974, PHYTOPATHOLOGY, V64, P358, DOI 10.1094/Phyto-64-358; Paulitz TC, 2002, CAN J PLANT PATHOL, V24, P416; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rittenour WR, 2010, MOL PLANT PATHOL, V11, P361, DOI [10.1111/J.1364-3703.2010.00609.X, 10.1111/j.1364-3703.2010.00609.x]; Schafer P, 2004, MOL PLANT MICROBE IN, V17, P366, DOI 10.1094/MPMI.2004.17.4.366; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	28	18	19	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167304	10.1371/journal.pone.0167304	http://dx.doi.org/10.1371/journal.pone.0167304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936004	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100081
J	Rossi, S; Sanchez-Sarmiento, AM; Vanstreels, RET; dos Santos, RG; Prioste, FES; Gattamorta, MA; Grisi, JHH; Matushima, ER				Rossi, Silmara; Sanchez-Sarmiento, Angelica Maria; Thijl Vanstreels, Ralph Eric; dos Santos, Robson Guimaraes; Setim Prioste, Fabiola Eloisa; Gattamorta, Marco Aurelio; Hildebrand Grisi-Filho, Jose Henrique; Matushima, Eliana Reiko			Challenges in Evaluating the Severity of Fibropapillomatosis: A Proposal for Objective Index and Score System for Green Sea Turtles (Chelonia mydas) in Brazil	PLOS ONE			English	Article							CARETTA-CARETTA; HERPESVIRUS; SPIRORCHIDIASIS; ASSOCIATION; INFECTION	Fibropapillomatosis (FP) is a neoplastic disease that affects marine turtles worldwide, especially green sea turtles (Chelonia mydas). FP tumors can develop on the body surface of marine turtles and also internally in the oral cavity and viscera. Depending on their quantity, size and anatomical distribution, these tumors can interfere with hydrodynamics and the ability to feed, hence scoring systems have been proposed in an attempt to quantify the clinical manifestation of FP. In order to establish a new scoring system adapted to geographic regions, we examined 214 juvenile green sea turtles with FP caught or rescued at Brazilian feeding areas, counted their 7466 tumors and classified them in relation to their size and anatomical distribution. The patterns in quantity, size and distribution of tumors revealed interesting aspects in the clinical manifestation of FP in specimens studied in Brazil, and that FP scoring systems developed for other areas might not perform adequately when applied to sea turtles on the Southwest Atlantic Ocean. We therefore propose a novel method to evaluate the clinical manifestation of FP: fibropapillomatosis index (FPI) that provides the Southwest Atlantic fibropapillomatosis score (FPSswA). In combination, these indexing and scoring systems allow for a more objective, rapid and detailed evaluation of the severity of FP in green sea turtles. While primarily designed for the clinical manifestation of FP currently witnessed in our dataset, this index and the score system can be adapted for other areas and compare the characteristics of the disease across regions. In conclusion, scoring systems to classify the severity of FP can assist our understanding on the environmental factors that modulate its development and its impacts on the individual and population health of green sea turtles.	[Rossi, Silmara; Setim Prioste, Fabiola Eloisa; Gattamorta, Marco Aurelio; Matushima, Eliana Reiko] Univ Sao Paulo, Res Grp Fibropapillomatosis Sea Turtles, Sao Paulo, SP, Brazil; [Sanchez-Sarmiento, Angelica Maria; Thijl Vanstreels, Ralph Eric; Setim Prioste, Fabiola Eloisa; Matushima, Eliana Reiko] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, Lab Patol Comparada Anim Selvagens LAPCOM, Sao Paulo, SP, Brazil; [dos Santos, Robson Guimaraes] Univ Fed Alagoas, Inst Ciencias Biol & Saude, Maceio, AL, Brazil; [Gattamorta, Marco Aurelio] FMU, Sao Paulo, SP, Brazil; [Hildebrand Grisi-Filho, Jose Henrique] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, LEB, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo	Rossi, S (corresponding author), Univ Sao Paulo, Res Grp Fibropapillomatosis Sea Turtles, Sao Paulo, SP, Brazil.	smara.rossi@gmail.com	Grisi-Filho, Jose/Q-3106-2019; Rossi, Silmara/AAS-3371-2020; Grisi-Filho, Jose/J-2523-2012; Sánchez-Sarmiento, Angélica María/AAH-9474-2020; Santos, Robson Guimaraes/E-7183-2010; Sanchez-Sarmiento, Angélica María/B-8764-2019	Grisi-Filho, Jose/0000-0002-3263-2147; Grisi-Filho, Jose/0000-0002-3263-2147; Sánchez-Sarmiento, Angélica María/0000-0001-6818-4609; Santos, Robson Guimaraes/0000-0001-5240-6799; Sanchez-Sarmiento, Angélica María/0000-0001-6818-4609	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2009/53956-9, 2010/01781-8, 2011/04565-7, 2012/14319-6]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/01781-8, 2011/04565-7, 2012/14319-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (www.fapesp.br): process number 2009/53956-9 (RETV), 2010/01781-8 (SR), 2011/04565-7 (AMSS), 2012/14319-6 (ERM); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES (www.capes.gov.br): RGS, FESP, MAG.; We would like to thank to Projeto TAMAR-ICMBio, Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) and Comissao de Etica no Uso de Animais (FMVZ-USP). We are indebted to Jose Luiz Cataro-Dias, Jorge Oyakawa and Ticiana Zwarg. Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2010/01781-8, 2011/04565-7, 2012/14319-6) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Adnyana W, 1997, AUST VET J, V75, P737, DOI 10.1111/j.1751-0813.1997.tb12258.x; Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; Alfaro-Nunez A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0206-z; [Anonymous], 2021, LANG ENV STAT COMP; BALAZS G.H., 1991, RES PLAN MARINE TURT, P47; Balazs George H., 1997, Marine Turtle Newsletter, V76, P1; Baptistotte C, 2007, THESIS; Borrowman KM, 2008, PREVALENCE SEVERITY; BRITO F. L. C., 2004, MARINE TURTLE NEWSLE, V106, P12; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Chaloupka M, 2009, J WILDLIFE DIS, V45, P1138, DOI 10.7589/0090-3558-45.4.1138; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; dos Santos RG, 2010, DIS AQUAT ORGAN, V89, P87, DOI 10.3354/dao02178; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; Gamer M, 2012, IRR VARIOUS COEFFICI; George Robert H., 1997, P363; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; Herbst LH, 1998, J WILDLIFE DIS, V34, P496, DOI 10.7589/0090-3558-34.3.496; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; Hirama Shigetomo, 2007, Florida Scientist, V70, P435; Hirth H.F., 1997, BIOL REPORT; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Mascarenhas Rita, 2008, Marine Turtle Newsletter, P3; NORTON TM, 1990, J WILDLIFE DIS, V26, P265, DOI 10.7589/0090-3558-26.2.265; Page-Karjian A, 2015, DIS AQUAT ORGAN, V115, P185, DOI 10.3354/dao02878; Page-Karjian A, 2014, J ZOO WILDLIFE MED, V45, P507, DOI 10.1638/2013-0132R1.1; Patricio AR, 2012, J GEN VIROL, V93, P1035, DOI 10.1099/vir.0.038950-0; PRITCHARD P.C.H., 2000, TECNICAS INVESTIGACI, P23; Quackenbush SL, 2001, VIROLOGY, V287, P105, DOI 10.1006/viro.2001.1023; Rodenbusch CR, 2014, DIS AQUAT ORGAN, V111, P207, DOI 10.3354/dao02782; Rossi S, 2009, PESQUISA VET BRASIL, V29, P974, DOI 10.1590/S0100-736X2009001200004; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Spotila JR, 2004, SEA TURTLES COMPLETE; Tapia AC, 2004, THESIS; Torezani E, 2010, J MAR BIOL ASSOC UK, V90, P233, DOI 10.1017/S0025315409990579; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; WOOD F, 1993, HERPETOL J, V3, P84; Work TM, 2009, J GEN VIROL, V90, P1943, DOI 10.1099/vir.0.011650-0; Work TM, 1999, J WILDLIFE DIS, V35, P804, DOI 10.7589/0090-3558-35.4.804; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2003, DIS AQUAT ORGAN, V53, P41, DOI 10.3354/dao053041; Work TM, 2014, VET PATHOL, V52, P1; Zwarg T, 2014, PESQUI VET BRASIL, V34, P682, DOI 10.1590/S0100-736X2014000700013	47	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167632	10.1371/journal.pone.0167632	http://dx.doi.org/10.1371/journal.pone.0167632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936118	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100135
J	Vito, A; Alarabi, H; Czorny, S; Beiraghi, O; Kent, J; Janzen, N; Genady, AR; Alkarmi, SA; Rathmann, S; Naperstkow, Z; Blacker, M; Llano, L; Berti, PJ; Valliant, JF				Vito, Alyssa; Alarabi, Hussain; Czorny, Shannon; Beiraghi, Omid; Kent, Jeff; Janzen, Nancy; Genady, Afaf R.; Alkarmi, Salma A.; Rathmann, Stephanie; Naperstkow, Zoya; Blacker, Megan; Llano, Lisset; Berti, Paul J.; Valliant, John F.			A Tc-99m-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives	PLOS ONE			English	Article							ALDER CLICK CHEMISTRY; BACTERIAL-INFECTIONS; CO-LIGANDS; TC-99M; BONE; RADIOPHARMACEUTICALS; BISPHOSPHONATE; PEPTIDES; LIGATION; STRATEGY	A convenient strategy to radiolabel a hydrazinonicotonic acid (HYNIC)-derived tetrazine with Tc-99m was developed, and its utility for creating probes to image bone metabolism and bacterial infection using both active and pretargeting strategies was demonstrated. The Tc-99m-labelled HYNIC-tetrazine was synthesized in 75% yield and exhibited high stability in vitro and in vivo. A trans-cyclooctene (TCO)-labelled bisphosphonate (TCO-BP) that binds to regions of active calcium metabolism was used to evaluate the utility of the labelled tetrazine for bioorthogonal chemistry. The pretargeting approach, with Tc-99m-HYNIC-tetrazine administered to mice one hour after TCO-BP, showed significant uptake of radioactivity in regions of active bone metabolism (knees and shoulders) at 6 hours post-injection. For comparison, TCO-BP was reacted with Tc-99m-HYNIC-tetrazine before injection and this active targeting also showed high specific uptake in the knees and shoulders, whereas control Tc-99m-HYNIC-tetrazine alone did not. A TCO-vancomycin derivative was similarly employed for targeting Staphylococcus aureus infection in vitro and in vivo. Pretargeting and active targeting strategies showed 2.5- and 3-fold uptake, respectively, at the sites of a calf-muscle infection in a murine model, compared to the contralateral control muscle. These results demonstrate the utility of the Tc-99m-HYNIC-tetrazine for preparing new technetium radiopharmaceuticals, including those based on small molecule targeting constructs containing TCO, using either active or pretargeting strategies.	[Vito, Alyssa; Alarabi, Hussain; Czorny, Shannon; Beiraghi, Omid; Kent, Jeff; Janzen, Nancy; Genady, Afaf R.; Alkarmi, Salma A.; Rathmann, Stephanie; Naperstkow, Zoya; Llano, Lisset; Berti, Paul J.; Valliant, John F.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Genady, Afaf R.] Tanta Univ, Dept Chem, Fac Sci, Tanta, Egypt; [Blacker, Megan; Valliant, John F.] McMaster Univ, Ctr Probe Dev & Commercializat, Hamilton, ON, Canada; [Berti, Paul J.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; Egyptian Knowledge Bank (EKB); Tanta University; McMaster University; McMaster University	Valliant, JF (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.; Valliant, JF (corresponding author), McMaster Univ, Ctr Probe Dev & Commercializat, Hamilton, ON, Canada.	valliant@mcmaster.ca		Alarabi Hussain, Hussain/0000-0003-2027-719X	Natural Sciences and Engineering Research Council of Canada (NSERC) [227514, 227511]; Canadian Cancer Society (CCS) [703857]; Canadian Institutes for Health Research (CIHR) [493840-16]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding was provided by the following government and cancer research agencies within Canada through standard, peer-reviewed research grants: 1)The Natural Sciences and Engineering Research Council of Canada (NSERC) [www.nserc-crsng.gc.ca] research grants: #227514 held by JFV and #227511 held by PJB. 2)The Canadian Cancer Society (CCS) [www.cancer.ca] grant #703857 held by JFV. 3)The Canadian Institutes for Health Research (CIHR) [www.cihr-irsc.gc.ca] grant #493840-16 held by JFV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Amato I, 2009, CHEM ENG NEWS, V87, P58, DOI 10.1021/cen-v087n036.p058; [Anonymous], 2003, HDB RADIOPHARMACEUTI; BABICH JW, 1995, NUCL MED BIOL, V22, P25, DOI 10.1016/0969-8051(94)00081-T; Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102; CALAME W, 1991, J NUCL MED, V32, P468; Chung HJ, 2011, ACS NANO, V5, P8834, DOI 10.1021/nn2029692; Cole LE, 2016, ADV DRUG DELIVER REV, V99, P12, DOI 10.1016/j.addr.2015.10.005; Decristoforo C, 1999, NUCL MED BIOL, V26, P389, DOI 10.1016/S0969-8051(98)00118-8; Devaraj NK, 2012, P NATL ACAD SCI USA, V109, P4762, DOI 10.1073/pnas.1113466109; Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t; Garcia MF, 2016, BIOORGAN MED CHEM, V24, P1209, DOI 10.1016/j.bmc.2016.01.046; Garcia MF, 2015, ANTI-CANCER AGENT ME, V15, P122; Herth MM, 2013, CHEM COMMUN, V49, P3805, DOI 10.1039/c3cc41027g; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Karver MR, 2011, BIOCONJUGATE CHEM, V22, P2263, DOI 10.1021/bc200295y; Kluba CA, 2013, MOLECULES, V18, P3206, DOI 10.3390/molecules18033206; Li ZB, 2010, CHEM COMMUN, V46, P8043, DOI 10.1039/c0cc03078c; Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006; Maresca KP, 2012, INORG CHIM ACTA, V389, P168, DOI 10.1016/j.ica.2012.03.002; Meszaros LK, 2011, DALTON T, V40, P6260, DOI 10.1039/c0dt01608j; Ning XH, 2014, ANGEW CHEM INT EDIT, V53, P14096, DOI 10.1002/anie.201408533; Ogawa K, 2006, J NUCL MED, V47, P2042; Rieder U, 2014, ANGEW CHEM INT EDIT, V53, P9168, DOI 10.1002/anie.201403580; Rosch F, 2011, DALTON T, V40, P6104, DOI 10.1039/c0dt01504k; Rossin R, 2010, ANGEW CHEM INT EDIT, V49, P3375, DOI 10.1002/anie.200906294; Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z; Sohaib M, 2014, J LABELLED COMPD RAD, V57, P652, DOI 10.1002/jlcr.3235; Su ZF, 2003, NUCL MED BIOL, V30, P141, DOI 10.1016/S0969-8051(02)00390-6; Sugawara Y, 1999, EUR J NUCL MED, V26, P333, DOI 10.1007/s002590050395; Surfraz MBU, 2009, J INORG BIOCHEM, V103, P971, DOI 10.1016/j.jinorgbio.2009.04.007; WANG TST, 1980, J NUCL MED, V21, P767; Welling MM, 2015, BIOCONJUGATE CHEM, V26, P839, DOI 10.1021/acs.bioconjchem.5b00062; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036; Zeglis BM, 2013, J NUCL MED, V54, P1389, DOI 10.2967/jnumed.112.115840; Zeglis BM, 2011, BIOCONJUGATE CHEM, V22, P2048, DOI 10.1021/bc200288d	37	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167425	10.1371/journal.pone.0167425	http://dx.doi.org/10.1371/journal.pone.0167425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936007	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100096
J	White, T; Westgate, K; Wareham, NJ; Brage, S				White, Tom; Westgate, Kate; Wareham, Nicholas J.; Brage, Soren			Estimation of Physical Activity Energy Expenditure during Free-Living from Wrist Accelerometry in UK Adults	PLOS ONE			English	Article							COMBINED HEART-RATE; VALIDITY; SENSOR	Background Wrist-worn accelerometers are emerging as the most common instrument for measuring physical activity in large-scale epidemiological studies, though little is known about the relationship between wrist acceleration and physical activity energy expenditure (PAEE). Methods 1695 UK adults wore two devices simultaneously for six days; a combined sensor and a wrist accelerometer. The combined sensor measured heart rate and trunk acceleration, which was combined with a treadmill test to yield a signal of individually-calibrated PAEE. Multi-level regression models were used to characterise the relationship between the two time-series, and their estimations were evaluated in an independent holdout sample. Finally, the relationship between PAEE and BMI was described separately for each source of PAEE estimate (wrist acceleration models and combined-sensing). Results Wrist acceleration explained 44-47% between-individual variance in PAEE, with RMSE between 34-39 J.min(-1).kg(-1). Estimations agreed well with PAEE in cross-validation (mean bias [95% limits of agreement]: 0.07 [-70.6: 70.7]) but overestimated in women by 3% and underestimated in men by 4%. Estimation error was inversely related to age (-2.3 J.min(-1).kg(-1) per 10y) and BMI (-0.3 J.min(-1).kg(-1) per kg/m(2)). Associations with BMI were similar for all PAEE estimates (approximately -0.08 kg/m(2) per J.min(-1).kg(-1)). Conclusions A strong relationship exists between wrist acceleration and PAEE in free-living adults, such that irrespective of the objective method of PAEE assessment, a strong inverse association between PAEE and BMI was observed.	[White, Tom; Westgate, Kate; Wareham, Nicholas J.; Brage, Soren] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	University of Cambridge	Brage, S (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	Brage, Soren/C-6415-2013	Brage, Soren/0000-0002-1265-7355; White, Thomas/0000-0001-8456-0803	Medical Research Council [MC_UU_12015/3]; MedImmune; MRC [MC_UU_12015/3, MC_UU_12015/1, MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_UU_12015/1, MC_U106179473, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MedImmune(AstraZenecaMedimmune); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Medical Research Council (MC_UU_12015/3), and Tom White is the recipient of a studentship from MedImmune. The funders had no role in the design, conduct, analysis, and decision to publish results from this study.	Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; O'Connor L, 2015, BRIT J NUTR, V114, P1286, DOI 10.1017/S000711451500269X; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Troiano R, 2012, P 8 INT C DIET ACT M; UK Biobank, 2009, CAT 2 ENH PHEN BAS A; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661	20	55	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167472	10.1371/journal.pone.0167472	http://dx.doi.org/10.1371/journal.pone.0167472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936024	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100104
J	Yang, J; Lu, C; Wei, J; Guo, Y; Liu, W; Luo, L; Fisch, G; Li, X				Yang, J.; Lu, C.; Wei, J.; Guo, Y.; Liu, W.; Luo, L.; Fisch, G.; Li, X.			Inhibition of KPNA4 attenuates prostate cancer metastasis	ONCOGENE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TNF-ALPHA; ANDROGEN RECEPTOR; BREAST-CANCER; IMPORTIN ALPHA-3; MACROPHAGES; EXPRESSION; CELLS; ACTIVATION	Prostate cancer (PCa) is a common cancer in men. Although current treatments effectively palliate symptoms and prolong life, the metastatic PCa remains incurable. It is important to find biomarkers and targets to improve metastatic PCa diagnosis and treatment. Here we report a novel correlation between karyopherin alpha 4 (KPNA4) and PCa pathological stages. KPNA4 mediates the cytoplasm-to- nucleus translocation of transcription factors, including nuclear factor kappa B, although its role in PCa was largely unknown. We find that knockdown of KPNA4 reduces cell migration in multiple PCa cell lines, suggesting a role of KPNA4 in PCa progression. Indeed, stable knockdown of KPNA4 significantly reduces PCa invasion and distant metastasis in mouse models. Functionally, KPNA4 alters tumor microenvironment in terms of macrophage polarization and osteoclastogenesis by modulating tumor necrosis factor (TNF)-alpha and -beta. Further, KPNA4 is proved as a direct target of miR-708, a tumor-suppressive microRNA. We disclose the role of miR-708-KPNA4-TNF axes in PCa metastasis and KPNA4's potential as a novel biomarker for PCa metastasis.	[Yang, J.; Lu, C.; Guo, Y.; Liu, W.; Luo, L.; Li, X.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, Room 901D,345 East 24th St, New York, NY 10010 USA; [Wei, J.] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Obstet & Gynaecol, Tongji Hosp, Wuhan, Peoples R China; [Fisch, G.] CUNY, Baruch Coll, Dept Stat & Comp Informat Syst, New York, NY 10021 USA; [Li, X.] NYU, Langone Med Ctr, Dept Urol, New York, NY USA	New York University; Huazhong University of Science & Technology; City University of New York (CUNY) System; Baruch College (CUNY); New York University; NYU Langone Medical Center	Li, X (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, Room 901D,345 East 24th St, New York, NY 10010 USA.	xl15@nyu.edu	Yang, Jian/E-1051-2015	Li, Xin/0000-0002-7414-5734	NIH [R01CA180277, R03CA172894]; NYU CTSA [1UL1TR001445, 1KL2TR001446, 1TL1TR001447]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA180277, R03CA172894] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU CTSA; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIH grants R01CA180277 and R03CA172894 to Xin Li, and in part by the NYU CTSA grant numbers 1UL1TR001445, 1KL2TR001446 and 1TL1TR001447 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. We thank Dr Deepak Saxena (New York University, New York, NY, USA) for the proofreading.	Abravanel DL, 2015, J CLIN INVEST, V125, P2484, DOI 10.1172/JCI74883; Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Agrawal T, 2012, J CLIN IMMUNOL, V32, P1093, DOI 10.1007/s10875-012-9696-x; Ahluwalia A, 2014, AM J PHYSIOL-GASTR L, V306, pG338, DOI 10.1152/ajpgi.00382.2013; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bertrand F, 2015, CANCER RES, V75, P2619, DOI 10.1158/0008-5472.CAN-14-2524; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Chen PC, 2014, ONCOTARGET, V5, P1595, DOI 10.18632/oncotarget.1570; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fang LY, 2013, CANCER RES, V73, P5633, DOI 10.1158/0008-5472.CAN-12-3228; Feng FY, 2016, P NATL ACAD SCI USA, V113, P473, DOI 10.1073/pnas.1522938113; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Gerondalds S, 2014, NAT IMMUNOL, V15, P15, DOI 10.1038/ni.2785; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hu X, 2014, J IMMUNOL, V192, P1320, DOI 10.4049/jimmunol.1203195; Ikenberg K, 2014, J PATHOL, V234, P239, DOI 10.1002/path.4390; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Jin R, 2015, ONCOGENE, V34, P3700, DOI 10.1038/onc.2014.302; Jin RJ, 2014, CANCER RES, V74, P2763, DOI 10.1158/0008-5472.CAN-13-2543; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Ke G, 2013, ONCOGENE, V32, P3019, DOI 10.1038/onc.2012.323; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Liang JQ, 2015, AM J CANCER RES, V5, P1124; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mak P, 2015, ONCOTARGET, V6, P40247, DOI 10.18632/oncotarget.5377; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Nadiminty N, 2010, CANCER RES, V70, P3309, DOI 10.1158/0008-5472.CAN-09-3703; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rachidi Saleh M, 2013, PLoS One, V8, pe57911, DOI 10.1371/journal.pone.0057911; Ryu S, 2013, CANCER CELL, V23, P63, DOI 10.1016/j.ccr.2012.11.019; Sachan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068247; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Sakai M, 2010, ANTICANCER RES, V30, P851; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Wang HQ, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-4; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu AX, 2015, ONCOL LETT, V10, P1402, DOI 10.3892/ol.2015.3472; Yang J, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.18; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Zadran S, 2013, P NATL ACAD SCI USA, V110, P19160, DOI 10.1073/pnas.1316991110; Zhang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065896; Zins K, 2007, CANCER RES, V67, P1038, DOI 10.1158/0008-5472.CAN-06-2295; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	66	30	31	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2868	2878		10.1038/onc.2016.440	http://dx.doi.org/10.1038/onc.2016.440			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27941876	Green Accepted			2022-12-26	WOS:000401697800009
J	Abbott, RK; Silva, M; Labuda, J; Thayer, M; Cain, DW; Philbrook, P; Sethumadhavan, S; Hatfield, S; Ohta, A; Sitkovsky, M				Abbott, Robert K.; Silva, Murillo; Labuda, Jasmine; Thayer, Molly; Cain, Derek W.; Philbrook, Phaethon; Sethumadhavan, Shalini; Hatfield, Stephen; Ohta, Akio; Sitkovsky, Michail			The GS Protein-coupled A2a Adenosine Receptor Controls T Cell Help in the Germinal Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; CENTER B-CELLS; FOLLICULAR HELPER; IMMUNE-RESPONSES; DENDRITIC CELLS; HYPOXIA; DIFFERENTIATION; INFLAMMATION; CONFINEMENT	T follicular helper (TFH) cells have been shown to be critically required for the germinal center (GC) reaction where B cells undergo class switch recombination and clonal selection to generate high affinity neutralizing antibodies. However, detailed knowledge of the physiological cues within the GC microenvironment that regulate T cell help is limited. The cAMP-elevating, Gs protein-coupled A2a adenosine receptor (A2aR) is an evolutionarily conserved receptor that limits and redirects cellular immunity. However, the role of A2aR in humoral immunity and B cell differentiation is unknown. We hypothesized that the hypoxic microenvironment within the GC facilitates an extracellular adenosine-rich milieu, which serves to limit TFH frequency and function, and also promotes immunosuppressive T follicular regulatory cells (TFR). In support of this hypothesis, we found that following immunization, mice lacking A2aR (A2aRKO) exhibited a significant expansion of T follicular cells, as well as increases in TFH to TFR ratio, GCT cell frequency, GC B cell frequency, and class switching of GC B cells to IgG1. Transfer of CD4 T cells from A2aRKO or wild type donors into T cell-deficient hosts revealed that these increases were largely T cell-intrinsic. Finally, injection of A2aR agonist, CGS21680, following immunization suppressed T follicular differentiation, GC B cell frequency, and class switching of GC B cells to IgG1. Taken together, these observations point to a previously unappreciated role of GS protein-coupled A2aR in regulating humoral immunity, which may be pharmacologically targeted during vaccination or pathological states in which GC-derived autoantibodies contribute to the pathology.	[Abbott, Robert K.; Silva, Murillo; Labuda, Jasmine; Thayer, Molly; Philbrook, Phaethon; Sethumadhavan, Shalini; Hatfield, Stephen; Ohta, Akio; Sitkovsky, Michail] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; [Cain, Derek W.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	Northeastern University; Duke University	Abbott, RK; Sitkovsky, M (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave,Mugar Bldg,Rm 312, Boston, MA 02115 USA.	robertkabbott@gmail.com; m.sitkovsky@neu.edu	Silva, Murillo/I-4863-2017	Silva, Murillo/0000-0003-4668-6290; Abbott, Robert/0000-0003-0335-1175	National Institutes of Health [U19 AI 091693, R01 CA 111985]; NATIONAL CANCER INSTITUTE [R01CA111985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants U19 AI 091693 and R01 CA 111985 (to M. Sitkovsky). The authors R. K. A., S. H., and M. Sitkovsky have filed a patent partially based on this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Bullen JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0583; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hatfield SM, 2014, J MOL MED, V92, P1283, DOI 10.1007/s00109-014-1189-3; Hynes Thomas R, 2015, J Mol Signal, V10, P2, DOI 10.5334/1750-2187-10-2; Iskandrian AE, 2007, J NUCL CARDIOL, V14, P645, DOI 10.1016/j.nuclcard.2007.06.114; Iyer SS, 2013, EUR J IMMUNOL, V43, P3219, DOI 10.1002/eji.201343469; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Muppidi JR, 2015, J EXP MED, V212, P2213, DOI 10.1084/jem.20151250; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navarro G, 2016, NEUROPHARMACOLOGY, V104, P161, DOI 10.1016/j.neuropharm.2015.07.024; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ohta A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00304; Preite S, 2015, EUR J IMMUNOL, V45, P3010, DOI 10.1002/eji.201545920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thompson CA, 2008, AM J HEALTH-SYST PH, V65, P890, DOI 10.2146/news080038; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067	42	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1211	1217		10.1074/jbc.C116.764043	http://dx.doi.org/10.1074/jbc.C116.764043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974461	Green Published, hybrid			2022-12-26	WOS:000393339800006
J	Mori, H; Kubo, M; Nishimura, R; Osako, T; Arima, N; Okumura, Y; Okido, M; Yamada, M; Kai, M; Kishimoto, J; Miyazaki, T; Oda, Y; Otsuka, T; Nakamura, M				Mori, Hitomi; Kubo, Makoto; Nishimura, Reiki; Osako, Tomofumi; Arima, Nobuyuki; Okumura, Yasuhiro; Okido, Masayuki; Yamada, Mai; Kai, Masaya; Kishimoto, Junji; Miyazaki, Tetsuyuki; Oda, Yoshinao; Otsuka, Takao; Nakamura, Masafumi			BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; DEPENDENT PROBE AMPLIFICATION; PRIMARY THERAPY; NEOADJUVANT CHEMOTHERAPY; CLINICAL-FEATURES; AMERICAN-SOCIETY; BASAL-LIKE; PHASE-II; HIGHLIGHTS; SUBTYPES	Background Triple-negative breast cancer (TNBC) is a heterogeneous tumor that encompasses many different subclasses of the disease. In this study, we assessed BRCAness, defined as the shared characteristics between sporadic and BRCA1-mutated tumors, in a large cohort of TNBC cases. Methods The BRCAness of 262 patients with primary TNBCs resected between January 2004 and December 2014 was determined through the isolation of DNA from tumor tissue. Classification of BRCAness was performed using multiple ligation-dependent probe amplification (MLPA). The tumor subtypes were determined immunohistochemically using resected specimens. Results Of the 262 TNBCs, the results of the MLPA assays showed that 174 (66.4%) tumors had BRCAness. Patients with BRCAness tumors were younger than patients with non-BRCAness tumors (P = 0.003). There was no significant difference between the two groups regarding their pathological stages. The BRCAness group had a significantly shorter recurrence- free survival (RFS) compared with the non-BRCAness group (P = 0.04) and had a shorter overall survival (OS) although this did not reach statistical significance. Adjuvant treatments with anthracycline-based regimens provided significantly greater benefits to the BRCAness group (P = 0.003 for RFS, and P = 0.03 for OS). Multivariate Cox proportional hazard model analysis showed that BRCAness was an independent negative prognostic factor, and the anthracycline-based adjuvant chemotherapy was an independent positive prognostic factor for both RFS and OS in TNBC. Conclusions The 66.4% patients of TNBCs showed BRCAness. BRCAness is essential as a biomarker in the subclassification of TNBCs and might be of use for predicting their prognosis. Furthermore, this biomarker might be a predictive factor for the effectiveness of anthracycline-based adjuvant chemotherapy for patients with TNBCs.	[Mori, Hitomi; Kubo, Makoto; Yamada, Mai; Kai, Masaya; Otsuka, Takao; Nakamura, Masafumi] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan; [Nishimura, Reiki; Osako, Tomofumi] Kumamoto Shinto Gen Hosp, Breast Ctr, Kumamoto, Japan; [Arima, Nobuyuki] Kumamoto Shinto Gen Hosp, Dept Pathol, Kumamoto, Japan; [Okumura, Yasuhiro] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Okido, Masayuki] Hamanomachi Hosp, Dept Surg, Fukuoka, Japan; [Kishimoto, Junji] Kyushu Univ, Dept Res & Dev Next Generat Med, Fac Med Sci, Fukuoka, Japan; [Miyazaki, Tetsuyuki; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kubo, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan.	mkubo@tumor.med.kyushu-u.ac.jp		Mori, Hitomi/0000-0002-5416-5869	Japan Society for the Promotion of Science, KAKENHI; Ministry of Education, Culture, Sports, Science and Technology, Japan [20591550]; World premier COE	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); World premier COE	This work was supported by the Japan Society for the Promotion of Science, KAKENHI, and by the budget demand from Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant number 20591550, https://www.jsps.go.jp/j-grantsinaid/ to Makoto Kubo, and by World premier COE (core of excellence) formation for the treatment and research of pancreatic cancer (there is no grant number), http://www.mext.go.jp/en/ to Takao Otsuka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Byrski T, 2009, BREAST CANCER RES TR, V115, P359, DOI 10.1007/s10549-008-0128-9; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Conforti R, 2007, ANN ONCOL, V18, P1477, DOI 10.1093/annonc/mdm209; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gerratana L, 2016, CANCER TREAT REV, V48, P34, DOI 10.1016/j.ctrv.2016.06.004; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Miyoshi Y, 2010, BREAST CANCER-TOKYO, V17, P103, DOI 10.1007/s12282-009-0152-6; Oonk AMM, 2012, ANN ONCOL, V23, P2301, DOI 10.1093/annonc/mdr621; Petrelli F, 2014, BREAST CANCER RES TR, V144, P223, DOI 10.1007/s10549-014-2876-z; Prat A, 2014, BRIT J CANCER, V111, P1532, DOI 10.1038/bjc.2014.444; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; Telli ML, 2015, J CLIN ONCOL, V33, P1895, DOI 10.1200/JCO.2014.57.0085; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Vollebergh MA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3655; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167016	10.1371/journal.pone.0167016	http://dx.doi.org/10.1371/journal.pone.0167016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977696	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400011
J	Lesieur, V; Martin, JF; Weaver, DK; Hoelmer, KA; Smith, DR; Morrill, WL; Kadiri, N; Peairs, FB; Cockrell, DM; Randolph, TL; Waters, DK; Bon, MC				Lesieur, Vincent; Martin, Jean-Francois; Weaver, David K.; Hoelmer, Kim A.; Smith, David R.; Morrill, Wendell L.; Kadiri, Nassera; Peairs, Frank B.; Cockrell, Darren M.; Randolph, Terri L.; Waters, Debra K.; Bon, Marie-Claude			Phylogeography of the Wheat Stem Sawfly, Cephus cinctus Norton (Hymenoptera: Cephidae): Implications for Pest Management	PLOS ONE			English	Article							COMPLETE MITOGENOMES; POPULATION-STRUCTURE; BIOLOGICAL-CONTROL; PYGMEUS L.; EVOLUTION; SOFTWARE; RESISTANCE; INFERENCE; GENETICS; CLUSTERS	The wheat stem sawfly, Cephus cinctus Norton (Hymenoptera: Cephidae), is a key pest of wheat in the northern Great Plains of North America, and damage resulting from this species has recently expanded southward. Current pest management practices are inadequate and uncertainty regarding geographic origin, as well as limited data on population structure and dynamics across North America impede progress towards more informed management. We examined the genetic divergence between samples collected in North America and northeastern Asia, the assumed native range of C. cinctus using two mitochondrial regions (COI and 16S). Subsequently, we characterized the structure of genetic diversity in the main wheat producing areas in North America using a combination of mtDNA marker and microsatellites in samples collected both in wheat fields and in grasses in wildlands. The strong genetic divergence observed between North American samples and Asian congeners, in particular the synonimized C. hyalinatus, did not support the hypothesis of a recent American colonization by C. cinctus. Furthermore, the relatively high genetic diversity both with mtDNA and microsatellite markers offered additional evidence in favor of the native American origin of this pest. The genetic diversity of North American populations is structured into three genetic clusters and these are highly correlated with geography. Regarding the recent southern outbreaks in North America, the results tend to exclude the hypothesis of recent movement of damaging wheat stem sawfly populations from the northern area. The shift in host plant use by local populations appears to be the most likely scenario. Finally, the significance of these findings is discussed in the context of pest management.	[Lesieur, Vincent; Bon, Marie-Claude] USDA ARS, European Biol Control Lab, 810 Ave Campus Agropolis, Montferrier Sur Lez, France; [Lesieur, Vincent; Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, 755 Ave Campus Agropolis, Montferrier Sur Lez, France; [Weaver, David K.; Morrill, Wendell L.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Hoelmer, Kim A.] USDA ARS, Beneficial Insects Introduct Res Unit, Newark, DE USA; [Smith, David R.] Smithsonian Inst, Systemat Entomol Lab, USDA ARS, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kadiri, Nassera] Univ Paul Valery Montpellier 3, UMR CEFE 5175, Lab Zoogeog, Dept Biol Ecol Environm, Route Mende, Montpellier 5, France; [Peairs, Frank B.; Cockrell, Darren M.; Randolph, Terri L.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Waters, Debra K.] USDA ARS, Northern Plains Agr Res Lab, Sidney, MT USA	Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Colorado State University; United States Department of Agriculture (USDA)	Lesieur, V (corresponding author), USDA ARS, European Biol Control Lab, 810 Ave Campus Agropolis, Montferrier Sur Lez, France.; Lesieur, V (corresponding author), Montpellier SupAgro, UMR CBGP, 755 Ave Campus Agropolis, Montferrier Sur Lez, France.	vincent.lesieur@supagro.fr	Martin, Jean-Francois/M-9426-2017; Peairs, Frank B./R-5493-2018; Martin, Jean-Francois/AAD-3883-2019	Martin, Jean-Francois/0000-0001-9176-4476; Peairs, Frank B./0000-0002-6591-7958; Martin, Jean-Francois/0000-0001-9176-4476				Beauzay, 2010, INTEGRATED PEST MANA; Benson RB, 1950, T ACTIONS SOC BRIT E; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Bertheau C, 2013, MOL ECOL, V22, P3318, DOI 10.1111/mec.12296; Bon M-C, 2015, ANN ENTOMOLOGICAL SO; Budak M, 2011, ZOOKEYS, P363, DOI 10.3897/zookeys.130.1466; Castel G, 2014, VIRUSES-BASEL, V6, P1112, DOI 10.3390/v6031112; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen S, 2004, J AGR URBAN ENTOMOLO, V2, P1; Criddle N., 1922, W WHEAT STEM SAWFLY, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIS E. G., 1955, Bi-Monthly Bulletin. North Dakota Agricultural Experiment Station, V18, P63; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duan Y, 2013, PLOS ONE, V8; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flagel LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-195; Fletcher J., 1896, W WHEAT STEM SAWFLY, P147; Fresia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076168; Fu YX, 1997, GENETICS, V147, P915; GOUDET J., 2001, FSTAT VERSION 2 9 3; Hartel KD, 2003, MOL ECOL NOTES, V3, P85, DOI 10.1046/j.1471-8286.2003.00359.x; Hitchcock AS, 1971, MANUAL GRASSES US; Hoddle MS, 2015, INSECTS, V6, P13, DOI 10.3390/insects6010013; Hoelmer KA, 2004, J AGR URBAN ENTOMOL, V21, P223; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Irell B, 2011, WHEAT STEM SAWFLY NE; Ivie MA, 1996, CAN ENTOMOL, V128, P347, DOI 10.4039/Ent128347-2; Ivie Michael A., 2001, American Entomologist, V47, P84; Johnson JR, 2007, GRASSLAND PLANTS S D; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kergoat GJ, 2015, ZOOL J LINN SOC-LOND, V175, P244, DOI 10.1111/zoj.12275; Kirk H, 2013, EVOL APPL, V6, P842, DOI 10.1111/eva.12071; Korkmaz EM, 2016, GENE, V576, P404, DOI 10.1016/j.gene.2015.10.050; Korkmaz EM, 2015, GENE, V558, P254, DOI 10.1016/j.gene.2014.12.069; Korkmaz EM, 2011, TURK J BIOL, V35, P713, DOI 10.3906/biy-1003-65; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langella O., 1999, POPULATIONS 1 2 32; Leasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104385; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lou KF, 1998, J HERED, V89, P329, DOI 10.1093/jhered/89.4.329; MACKAY MARGARET ROWLATT, 1955, CANADIAN JOUR ZOOL, V33, P161, DOI 10.1139/z55-011; McCullough C., 2016, DISPERSAL SAMPLING W; Michaud JP, 2013, WHEAT STEM SAWFLY; Middlekauff W. W., 1969, Bull. Calif. Insect. Surv., V11, P1; Modica MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102160; Norton E, 1872, T AM ENTOMOL SOC, V4, P77, DOI DOI 10.2307/25076265; Peairs FB, 2014, TR1407 COL AGR EXP S; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Mendoza J, 2006, ENVIRON ENTOMOL, V35, P1222, DOI 10.1603/0046-225X(2006)35[1222:TARHEO]2.0.CO;2; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Pritchard JK, 2000, GENETICS, V155, P945; Rand TA, 2015, CAN ENTOMOL, P1; Rand TA, 2016, BIOCONTROL SCI TECHN, V26, P61, DOI 10.1080/09583157.2015.1076377; Rand TA, 2014, AGR ECOSYST ENVIRON, V186, P135, DOI 10.1016/j.agee.2014.01.022; Rombaut A., 2012, FIGTREE V1 4 TREE FI; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seamans, 1928, VALUE TRAP CROPS CON, P59; Shanower TG, 2004, J AGR URBAN ENTOMOL, V21, P197; Silva TL, 2015, MOL ECOL RESOUR, V15, P652, DOI 10.1111/1755-0998.12335; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith DR, 2005, P ENTOMOL SOC WASH, V107, P864; Smith DR, 2002, P ENTOMOL SOC WASH, V104, P479; Smith DR., 1979, PRESS, V1, P1198; Steinfeld D., 2011, NATIV PLANTS J, V12, P269, DOI [10.3368/npj.12.3.269, DOI 10.3368/NPJ.12.3.269]; TAJIMA F, 1989, GENETICS, V123, P585; Talbert LE, 2014, PLANT BREEDING, V133, P427, DOI 10.1111/pbr.12184; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varella AC, 2015, CROP SCI, V55, P2046, DOI 10.2135/cropsci2014.12.0852; Wallace L.E., 1966, STEM SAWFLIES EC IMP; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Whitfield JB, 1998, MOL BIOL EVOL, V15, P1728, DOI 10.1093/oxfordjournals.molbev.a025899; Wilkinson K. M., 2008, Native Plants Journal, V9, P267, DOI 10.2979/NPJ.2008.9.3.267; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	82	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168370	10.1371/journal.pone.0168370	http://dx.doi.org/10.1371/journal.pone.0168370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959958	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900061
J	Lukhele, BW; Techasrivichien, T; Suguimoto, SP; Musumari, PM; El-saaidi, C; Haumba, S; Tagutanazvo, OB; Ono-Kihara, M; Kihara, M				Lukhele, Bhekumusa Wellington; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Musumari, Patou Masika; El-saaidi, Christina; Haumba, Samson; Tagutanazvo, Oslinah Buru; Ono-Kihara, Masako; Kihara, Masahiro			Structural and Behavioral Correlates of HIV Infection among Pregnant Women in a Country with a Highly Generalized HIV Epidemic: A Cross-Sectional Study with a Probability Sample of Antenatal Care Facilities in Swaziland	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUAL RISK; REPRODUCTIVE HEALTH; POVERTY; FAMILY; MEN; COMMUNICATION; DETERMINANTS; PARTNERSHIPS; ASSOCIATION	Introduction HIV disproportionately affects women in Sub-Saharan Africa. Swaziland bears the highest HIV prevalence of 41% among pregnant women in this region. This heightened HIV-epidemic reflects the importance of context-specific interventions. Apart from routine HIV surveillance, studies that examine structural and behavioral factors associated with HIV infection among women may facilitate the revitalization of existing programs and provide insights to inform context-specific HIV prevention interventions. Methods and Findings This cross-sectional study employed a two-stage random cluster sampling in ten antenatal health care facilities in the Hhohho region of Swaziland in August and September 2015. Participants were eligible for the study if they were 18 years or older and had tested for HIV. Self-administered tablet-based questionnaires were used to assess HIV risk factors. Of all eligible pregnant women, 827 (92.4%) participated, out of which 297 (35.9%) were self-reportedly HIV positive. Among structural factors, family function was not significantly associated with self-reported HIV positive status, while lower than high school educational attainment (AOR, 1.65; CI, 1.14-3.38; P = 0.008), and income below minimum wage (AOR, 1.81; CI, 1.09-3.01; P = 0.021) were significantly associated with self-reported HIV positive status. Behavioral factors significantly associated with reporting a positive HIV status included; >= 2 lifetime sexual partners (AOR, 3.16; CI, 2.00-5.00; P< 0.001), and ever cohabited (AOR, 2.39; CI, 1.66-3.43; P = 0.00). The most cited reason for having multiple sexual partners was financial gain. HIV/AIDS-related knowledge level was high but not associated to self-reported HIV status (P = 0.319). Conclusions Structural and behavioral factors showed significant association with self-reported HIV infection among pregnant women in Swaziland while HIV/AIDS-related knowledge and family function did not. This suggests that HIV interventions should be reinforced taking into consideration these findings. The findings also suggest the importance of future research sensitive to the Swazi and African sociocultural contexts, especially research for family function.	[Lukhele, Bhekumusa Wellington; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Musumari, Patou Masika; El-saaidi, Christina; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan; [Haumba, Samson] Univ Res Co LLC, Ctr Human Serv, Mbabane, Eswatini; [Tagutanazvo, Oslinah Buru] Univ Swaziland, Dept Midwifery Sci, Fac Hlth Sci, Mbabane, Eswatini	Kyoto University; Kyoto University	Lukhele, BW (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	bhekie.l@gmail.com	el-saaidi, christina/AGS-1983-2022	Suguimoto, S. Pilar/0000-0002-8447-9172; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X				Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2005, GLOB COAL WOM AIDS E, P4; Armistead L, 2014, HEALTH PSYCHOL, V33, P668, DOI 10.1037/hea0000067; Bell CC, 2008, J NATL MED ASSOC, V100, P936, DOI 10.1016/S0027-9684(15)31408-5; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Central Intelligence Agency, 2011, WORLD FACTB COUNTR C; Central Statistical Office, 2015, SWAZ MULT IND CLUST; Central Statistical Office (CSO) [Swaziland] and Macro Internationa Inc, 2007, SWAZ DEM HLTH SURV 2; Central Statistical Office UNICEF., 2011, SWAZ MULT IND CLUST; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; Creswell J, 2003, HDB MIXED METHODS DE, P209; Crosby RA, 2003, ARCH PEDIAT ADOL MED, V157, P169, DOI 10.1001/archpedi.157.2.169; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; FHI/Impact Behavioural Surveillance Surveys (BSS), 2000, GUID REP BEH SURV PO; Fielding-Miller R, 2016, SOC SCI MED, V148, P25, DOI 10.1016/j.socscimed.2015.11.024; Fielding-Miller R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-79; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Fry K., 2014, MEASURING EQUITY NAT; Hammond RJ, 2010, SOCIOLOGY FAMILY; Handa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085473; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Heywood W, 2015, ARCH SEX BEHAV, V44, P531, DOI 10.1007/s10508-014-0374-3; Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1; International Labour Office, 2005, BRIEF OCTOBER 2005 H; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, WOM OUT LOUD WOM LIV, P1; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kish L, 1965, SURVEY SAMPLING; Lama TT, 2016, PREV SCI, V17, P227, DOI 10.1007/s11121-015-0607-2; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Magadi MA, 2013, AIDS BEHAV, V17, P1645, DOI 10.1007/s10461-012-0217-y; Markham CM, 2010, J ADOLESCENT HEALTH, V46, pS23, DOI 10.1016/j.jadohealth.2009.11.214; Masanjala W, 2007, SOC SCI MED, V64, P1032, DOI 10.1016/j.socscimed.2006.10.009; Mbirimtengerenji ND, 2007, CROAT MED J, V48, P605; Mercer CH, 2013, AM J EPIDEMIOL, V178, P249, DOI 10.1093/aje/kws467; Michael Kohn S, 2015, SAMPLE SIZE CALCULAT; Ministry of Health, 2013, SERV AV MAPP REP 201; Ministry of Health Swaziland, 2011, 12 NAT HIV SER WOM A; Mngadi S, 2009, SWAZILAND HIV PREVEN; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; National AIDS Control Council, 2014, KEN AIDS STRAT FRAM, P1; National Emergency Response Council on HIV/AIDS, 2011, SWAZ HEARS ETHN STUD; NERCHA, 2014, EXT NAT MULT HIV AID; Nkhambule M, 2008, HIV PREVENTION MULTI; Olson DH, 2004, FAMILY ADAPTABILITY; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Paul S., 2008, SAMPLING POPULATIONS; Pequegnat W, 2012, FAMILY AND HIV/AIDS: CULTURAL AND CONTEXTUAL ISSUES IN PREVENTION AND TREATMENT, P1, DOI 10.1007/978-1-4614-0439-2; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Republic of Namibia Ministry of Health and Social Services, 2015, NAM AIDS RESP PROGR; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Ruark A, 2014, AJAR-AFR J AIDS RES, V13, P133, DOI 10.2989/16085906.2014.927781; Sacolo HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067289; Sawers L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17431; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Statistics South Africa, 2015, S AFR MID POP EST 20; Stephen B. H., 2007, DESIGNING CLIN RES; Sullivan PS, 2005, PUBLIC HEALTH REP, V120, P230, DOI 10.1177/003335490512000304; Techasrivichien T, 2016, ARCH SEX BEHAV, V45, P367, DOI 10.1007/s10508-014-0429-5; The World Bank, HIV AIDS ED; Thoma BC, 2014, AIDS BEHAV, V18, P1604, DOI 10.1007/s10461-014-0717-z; UNAIDS, 2014, AIDS EPIDEMIOLOGY, P1; UNAIDS, 2013, ACC ANT THER AFR 201, P1; UNDP Swaziland, 2007, SWAZ HUM DEV REP HIV; UNICEF, 2013, STATISTICS; Voisin DR, 2002, AM J ORTHOPSYCHIAT, V72, P294, DOI 10.1037/0002-9432.722.294; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wamoyi J, 2015, CULT HEALTH SEX, V17, P718, DOI 10.1080/13691058.2014.992044; Wamoyi J, 2014, AJAR-AFR J AIDS RES, V13, P169, DOI 10.2989/16085906.2014.945387; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; Whiteside A, 2003, WHAT IS DRIVING HIV; World Health Organization, 2014, World Health Organ Tech Rep Ser, P1	79	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168140	10.1371/journal.pone.0168140	http://dx.doi.org/10.1371/journal.pone.0168140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942014	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600054
J	Bassani, GA; Lonati, C; Brambilla, D; Rapido, F; Valenza, F; Gatti, S				Bassani, Giulia Alessandra; Lonati, Caterina; Brambilla, Daniela; Rapido, Francesca; Valenza, Franco; Gatti, Stefano			Ex Vivo Lung Perfusion in the Rat: Detailed Procedure and Videos	PLOS ONE			English	Article							EXPERIMENTAL-MODEL; DONOR LUNGS; TRANSPLANTATION; PRESERVATION; INCREASE; VENTILATION; EXPRESSION; EXPERIENCE; IMPROVE; INJURY	Ex vivo lung perfusion (EVLP) is a promising procedure for evaluation, reconditioning, and treatment of marginal lungs before transplantation. Small animal models can contribute to improve clinical development of this technique and represent a substantial platform for bio-molecular investigations. However, to accomplish this purpose, EVLP models must sustain a prolonged reperfusion without pharmacological interventions. Currently available protocols only partly satisfy this need. The aim of the present research was accomplishment and optimization of a reproducible model for a protracted rat EVLP in the absence of anti-inflammatory treatment. A 180 min, uninjured and untreated perfusion was achieved through a stepwise implementation of the protocol. Flow rate, temperature, and tidal volume were gradually increased during the initial reperfusion phase to reduce hemodynamic and oxidative stress. Low flow rate combined with open atrium and protective ventilation strategy were applied to prevent lung damage. The videos enclosed show management of the most critical technical steps. The stability and reproducibility of the present procedure were confirmed by lung function evaluation and edema assessment. The meticulous description of the protocol provided in this paper can enable other laboratories to reproduce it effortlessly, supporting research in the EVLP field.	[Bassani, Giulia Alessandra; Lonati, Caterina; Brambilla, Daniela; Gatti, Stefano] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg Res Ctr, Milan, Italy; [Bassani, Giulia Alessandra; Lonati, Caterina; Valenza, Franco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz & Emergenza Urgen, Milan, Italy; [Rapido, Francesca; Valenza, Franco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Bassani, GA (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg Res Ctr, Milan, Italy.; Bassani, GA (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz & Emergenza Urgen, Milan, Italy.	giulia.bassani@outlook.it	Gatti, Stefano/AAE-3281-2022; Gatti, Stefano/M-1780-2015; Fernandes, Paulo Manuel Pego/AAC-8319-2020; lonati, caterina/GVT-5843-2022; Bassani, Giulia A./AAC-3634-2022; Pego-Fernandes, Paulo Manuel/C-2756-2012; lonati, caterina/ABI-1503-2020; lonati, caterina/M-3748-2015	Gatti, Stefano/0000-0003-2209-4338; Gatti, Stefano/0000-0003-2209-4338; Fernandes, Paulo Manuel Pego/0000-0001-7243-5343; Bassani, Giulia A./0000-0001-9196-6975; Pego-Fernandes, Paulo Manuel/0000-0001-7243-5343; lonati, caterina/0000-0001-7855-7851; Brambilla, Daniela/0000-0002-9669-278X	Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico; MILTA (Milano Liver Transplant Association)	Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico; MILTA (Milano Liver Transplant Association)	This work was supported by the Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico and MILTA (Milano Liver Transplant Association) paid publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075592; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Cypel M, 2011, CURR OPIN ORGAN TRAN, V16, P469, DOI 10.1097/MOT.0b013e32834ab15a; Cypel M, 2008, J HEART LUNG TRANSPL, V27, P1319, DOI 10.1016/j.healun.2008.09.003; Dacho C, 2013, IN VIVO, V27, P49; Fehrenbach H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-60; Hirata T, 2001, RESPIRATION, V68, P292, DOI 10.1159/000050513; Hodyc D, 2008, J HEART LUNG TRANSPL, V27, P890, DOI 10.1016/j.healun.2008.05.019; Ibrahim AM, 2016, J LAPAROENDOSC ADV S, V26, P240, DOI 10.1089/lap.2016.0100; Ingemansson R, 2009, ANN THORAC SURG, V87, P255, DOI 10.1016/j.athoracsur.2008.09.049; Inokawa H, 2006, ANN THORAC SURG, V82, P1219, DOI 10.1016/j.athoracsur.2006.05.004; Laumonier T, 2003, TRANSPLANTATION, V76, P838, DOI 10.1097/01.TP.0000078898.28399.0A; Liu MY, 2000, AM J PHYSIOL-LUNG C, V278, pL1071, DOI 10.1152/ajplung.2000.278.5.L1071; Markou T, 2014, J THORAC CARDIOV SUR, V148, P2335, DOI 10.1016/j.jtcvs.2014.04.037; Silva CAM, 2010, INTERACT CARDIOV TH, V11, P46, DOI 10.1510/icvts.2009.222018; Motoyama H, 2013, J HEART LUNG TRANSPL, V32, P505, DOI 10.1016/j.healun.2013.02.007; Nelson K, 2015, JOVE-J VIS EXP, DOI 10.3791/52309; Nelson Kevin, 2014, World J Exp Med, V4, P7, DOI 10.5493/wjem.v4.i2.7; Noda K, 2014, EUR J CARDIO-THORAC, V45, pE54, DOI 10.1093/ejcts/ezt598; Parker JC, 1998, J APPL PHYSIOL, V85, P1753, DOI 10.1152/jappl.1998.85.5.1753; Pego-Fernandes PM, 2010, TRANSPL P, V42, P444, DOI 10.1016/j.transproceed.2010.01.016; Pego-Fernandes PM, 2010, J BRAS PNEUMOL, V36, P490, DOI 10.1590/S1806-37132010000400015; Pierre L, 2013, PERFUSION-UK, V28, P322, DOI 10.1177/0267659113479424; Reeb J, 2016, CLIN TRANSPLANT, V30, P183, DOI 10.1111/ctr.12680; Russell WMS., 1959, MED J AUSTRALIA; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Valenza F, 2000, CRIT CARE MED, V28, P3697, DOI 10.1097/00003246-200011000-00027; Valenza F, 2016, AM J TRANSPLANT, V16, P1312, DOI 10.1111/ajt.13612; Valenza F, 2012, TRANSPL P, V44, P1826, DOI 10.1016/j.transproceed.2012.06.023; Valenza F, 2014, TRANSPL INT; Valenza F, 2012, J HEART LUNG TRANSPL, V31, P524, DOI 10.1016/j.healun.2012.02.001	33	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167898	10.1371/journal.pone.0167898	http://dx.doi.org/10.1371/journal.pone.0167898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936178	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100226
J	Haller, S; Montandon, ML; Lazeyras, F; Scheffler, M; Meckel, S; Herrmann, FR; Giannakopoulos, P; Kovari, E				Haller, Sven; Montandon, Marie-Louise; Lazeyras, Francois; Scheffler, Max; Meckel, Stephan; Herrmann, Francois R.; Giannakopoulos, Panteleimon; Koevari, Eniko			Radiologic-Histopathologic Correlation of Cerebral Microbleeds Using Pre-Mortem and Post-Mortem MRI	PLOS ONE			English	Article							7.0-TESLA MAGNETIC-RESONANCE; CEREBROVASCULAR DISEASES; CORTICAL MICROINFARCTS; VASCULAR DEMENTIA; BRAINS; IRON; PREVALENCE; IMAGES; FOCI	Introduction Cerebral microbleeds (CMB), also known as cerebral microhemorrhages, are small areas of susceptibility on brain magnetic resonance imaging (MRI), that are increasingly detected due to the higher availability of high-field MRI systems and dedicated pulse sequences. The prevalence of CMBs increases in cases with cognitive decline. The current investigation assessed the poorly investigated radiologic-histopathologic correlation of CMBs on MRI. Methods The local ethical committee approved the current investigation. We retrospectively assessed a consecutive series of 1303 autopsy cases hospitalized in Geneva University Hospitals between 2000-2014. Of 112 cases with pre-mortem T2* sequences, we included 25 cases (mean age 77.3 +/- 9.6, 9 females) with at least one CMB. We compared pre-mortem CMBs with targeted histopathology and post-mortem MRI. Results 25 cases had 31 CMB lesions detected by pre-mortem MRI. 25 additional CMB were detected on histopathology. 4 CMBs on pre-mortem MRI were false positives, resulting in a total of 52 CMBs. 27 CMBs on pre-mortem MRI were confirmed on histopathology, corresponding to a sensitivity or true positive rate of 51.9% (95% CI 37.6 +/- 66.0%). The false negative rate of pre-mortem MRI was 48.1% (95% CI 4.0 +/- 62.4%). Post-mortem MRI showed only 3 cases with additional CMBs. Overall, pre-mortem MRI significantly underestimated CMBs (p = 0.0001). Conclusions Routine clinical brain MRI underestimates the prevalence of CMBs by approximately 50%, and 12% of radiologic pre-mortem MRI CMBs were false positives. Post-mortem MRI confirmed that this discordance is not explained by microbleeds occurring after the pre-mortem MRI.	[Haller, Sven] Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland; [Haller, Sven; Montandon, Marie-Louise; Herrmann, Francois R.; Giannakopoulos, Panteleimon; Koevari, Eniko] Med Sch Univ, Geneva, Switzerland; [Haller, Sven] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Haller, Sven; Meckel, Stephan] Univ Hosp Freiburg, Dept Neuroradiol, Freiburg, Germany; [Lazeyras, Francois; Scheffler, Max] Univ Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Herrmann, Francois R.] Univ Hosp Geneva, Dept Internal Med Rehabil & Geriatr, Div Geriatr, Geneva, Switzerland; [Giannakopoulos, Panteleimon] Univ Hosp Geneva, Geneva, Switzerland	Uppsala University; University of Freiburg; University of Geneva; University of Geneva; University of Geneva	Haller, S (corresponding author), Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland.; Haller, S (corresponding author), Med Sch Univ, Geneva, Switzerland.; Haller, S (corresponding author), Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden.; Haller, S (corresponding author), Univ Hosp Freiburg, Dept Neuroradiol, Freiburg, Germany.	sven.haller@gmail.com	HERRMANN, Francois/M-7390-2019; Haller, Sven/AAY-2564-2020; Meckel, Stephan/I-5810-2018; HERRMANN, Francois R/B-6710-2011	HERRMANN, Francois/0000-0003-1312-1517; Haller, Sven/0000-0001-7433-0203; Meckel, Stephan/0000-0001-6468-4526; HERRMANN, Francois R/0000-0003-1312-1517	Swiss National Foundation [SNF 320030_159990/1, SNF 320030_159990]; Association Suisse pour la Recherche Alzheimer, Geneva	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Association Suisse pour la Recherche Alzheimer, Geneva	This work is supported in part by Swiss National Foundation Grant SNF 320030_159990/1 and an unrestricted grant from the Association Suisse pour la Recherche Alzheimer, Geneva.; This work was supported by Swiss National Foundation grant SNF 320030_159990.	Akoudad S, 2015, CIRCULATION, V132, P509, DOI 10.1161/CIRCULATIONAHA.115.016261; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; De Reuck J, 2015, AGING DIS, V6, P437, DOI 10.14336/AD.2015.0429; De Reuck J, 2014, J NEUROL SCI, V346, P85, DOI 10.1016/j.jns.2014.07.061; De Reuck J, 2012, EUR J NEUROL, V19, P1355, DOI 10.1111/j.1468-1331.2012.03776.x; De Reuck J, 2011, CEREBROVASC DIS, V31, P511, DOI 10.1159/000324391; De Reuck JL, 2014, EUR J NEUROL, V21, P1026, DOI 10.1111/ene.12432; De Reuck J, 2014, FOLIA NEUROPATHOL, V52, P421, DOI 10.5114/fn.2014.47843; De Reuck JL, 2015, EUR NEUROL, V74, P158, DOI 10.1159/000441057; De Reuck JL, 2015, CEREBROVASC DIS, V39, P138, DOI 10.1159/000371488; De Reuck JL, 2013, ALZ DIS ASSOC DIS, V27, P162, DOI 10.1097/WAD.0b013e318256ecd8; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Goos JDC, 2011, STROKE, V42, P1894, DOI 10.1161/STROKEAHA.110.599837; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haller S, 2013, EUR RADIOL, V23, P3393, DOI 10.1007/s00330-013-2957-0; Haller S, 2010, RADIOLOGY, V257, P764, DOI 10.1148/radiol.10100612; Kikuta K, 2007, NEUROL MED-CHIR, V47, P564, DOI 10.2176/nmc.47.564; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Kovari E, 2015, ACTA NEUROPATHOL COM, P349; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Tanskanen M, 2012, FRONT NEUROL, P3103; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; Uetani H, 2013, AM J NEURORADIOL, V34, P984, DOI 10.3174/ajnr.A3332; van Veluw SJ, 2015, J CEREBR BLOOD F MET, V35, P676, DOI 10.1038/jcbfm.2014.258	31	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167743	10.1371/journal.pone.0167743	http://dx.doi.org/10.1371/journal.pone.0167743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936213	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100171
J	Low, LL; Liu, N; Wang, SJ; Thumboo, J; Ong, MEH; Lee, KH				Low, Lian Leng; Liu, Nan; Wang, Sijia; Thumboo, Julian; Ong, Marcus Eng Hock; Lee, Kheng Hock			Predicting 30-Day Readmissions in an Asian Population: Building a Predictive Model by Incorporating Markers of Hospitalization Severity	PLOS ONE			English	Article							RISK-FACTORS; MEDICAL PATIENTS; CARE PROGRAM; INDEX; REHOSPITALIZATION; PERFORMANCE; VALIDATION; DERIVATION; MORTALITY; ICD-9-CM	Background To reduce readmissions, it may be cost-effective to consider risk stratification, with targeting intervention programs to patients at high risk of readmissions. In this study, we aimed to derive and validate a prediction model including several novel markers of hospitalization severity, and compare the model with the LACE index (Length of stay, Acuity of admission, Charlson comorbidity index, Emergency department visits in past 6 months), an established risk stratification tool. Method This was a retrospective cohort study of all patients >= 21 years of age, who were admitted to a tertiary hospital in Singapore from January 1, 2013 through May 31, 2015. Data were extracted from the hospital's electronic health records. The outcome was defined as unplanned readmissions within 30 days of discharge from the index hospitalization. Candidate predictive variables were broadly grouped into five categories: Patient demographics, social determinants of health, past healthcare utilization, medical comorbidities, and markers of hospitalization severity. Multivariable logistic regression was used to predict the outcome, and receiver operating characteristic analysis was performed to compare our model with the LACE index. Results 74,102 cases were enrolled for analysis. Of these, 11,492 patient cases (15.5%) were readmitted within 30 days of discharge. A total of fifteen predictive variables were strongly associated with the risk of 30-day readmissions, including number of emergency department visits in the past 6 months, Charlson Comorbidity Index, markers of hospitalization severity such as 'requiring inpatient dialysis during index admission, and 'treatment with intravenous furosemide 40 milligrams or more' during index admission. Our predictive model outperformed the LACE index by achieving larger area under the curve values: 0.78 (95% confidence interval [CI]: 0.77-0.79) versus 0.70 (95% CI: 0.69-0.71). Conclusion Several factors are important for the risk of 30-day readmissions, including proxy markers of hospitalization severity.	[Low, Lian Leng; Lee, Kheng Hock] Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore; [Low, Lian Leng; Lee, Kheng Hock] Duke NUS Med Sch, Family Med Program, Singapore, Singapore; [Liu, Nan; Thumboo, Julian] Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore; [Liu, Nan] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Wang, Sijia] Integrated Hlth Informat Syst, Singapore, Singapore; [Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; Singapore General Hospital; Singapore General Hospital; National University of Singapore	Low, LL (corresponding author), Singapore Gen Hosp, Dept Family Med & Continuing Care, Singapore, Singapore.; Low, LL (corresponding author), Duke NUS Med Sch, Family Med Program, Singapore, Singapore.; Liu, N (corresponding author), Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore.; Liu, N (corresponding author), Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore.	low.lian.leng@singhealth.com.sg; liu.nan@singhealth.com.sg	Liu, Nan/L-9529-2013; Low, Lian Leng/M-2853-2016; Liu, Nan/HCS-2632-2022	Low, Lian Leng/0000-0003-4228-2862; Liu, Nan/0000-0003-3610-4883	Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant [HSRNIG14nov002]; SingHealth Foundation Health Services Research (Ageing) Grant [SHF/HSRAg004/2015]	Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant; SingHealth Foundation Health Services Research (Ageing) Grant	This study was supported by Singapore Ministry of Health (MOH) Health Services Research New Investigator Grant HSRNIG14nov002 and the SingHealth Foundation Health Services Research (Ageing) Grant SHF/HSRAg004/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaudeen N, 2011, J HOSP MED, V6, P54, DOI 10.1002/jhm.805; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; Choudhry Shahid A, 2013, Online J Public Health Inform, V5, P219, DOI 10.5210/ojphi.v5i2.4726; Cooksley T, 2015, QJM; Cotter PE, 2012, AGE AGEING, V41, P784, DOI 10.1093/ageing/afs073; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fiest KM, 2014, BMC PSYCHIATRY, V14, P1; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Graham KL, 2015, ANN INTERN MED, V162, P741, DOI 10.7326/M14-2159; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lim E, 2011, BMC HEALTH SERV RES, V2011, P1; Low LL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/169870; Low LL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0750-2; Luthi JC, 2003, INT J QUAL HEALTH C, V15, P413, DOI 10.1093/intqhc/mzg055; Luthi JC, 2004, QUAL SAF HEALTH CARE, V13, P46, DOI 10.1136/qshc.2003.006999; Ministry of Health, 2010, CHRONIC DIS; Ministry of Health Singapore, 2012, HLTH FACTS SING HEAL; Neupane B, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-22; Onukwugha E, 2011, MED CARE, V49, P215, DOI 10.1097/MLR.0b013e31820192a5; Pederson JL, 2016, J HOSP MED; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Smith DM, 1996, J GEN INTERN MED, V11, P762, DOI 10.1007/BF02598996; Taha M, 2014, INT J QUAL HEALTH C, V26, P271, DOI 10.1093/intqhc/mzu038; Tan SY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-366; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wee SL, 2014, J AM GERIATR SOC, V62, P747, DOI 10.1111/jgs.12750; Zhou HQ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011060	45	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167413	10.1371/journal.pone.0167413	http://dx.doi.org/10.1371/journal.pone.0167413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936053	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100093
J	Su, D; Wang, XT; Campbell, MR; Porter, DK; Pittman, GS; Bennett, BD; Wan, M; Englert, NA; Crowl, CL; Gimple, RN; Adamski, KN; Huang, ZQ; Murphy, SK; Bell, DA				Su, Dan; Wang, Xuting; Campbell, Michelle R.; Porter, Devin K.; Pittman, Gary S.; Bennett, Brian D.; Wan, Ma; Englert, Neal A.; Crowl, Christopher L.; Gimple, Ryan N.; Adamski, Kelly N.; Huang, Zhiqing; Murphy, Susan K.; Bell, Douglas A.			Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; DNA METHYLATION; CIGARETTE-SMOKING; IMMUNE-SYSTEM; EXPRESSION; MTSS1; DIFFERENTIATION; LANDSCAPE; FREQUENCY; CANCER	Tobacco smoke exposure dramatically alters DNA methylation in blood cells and may mediate smoking-associated complex diseases through effects on immune cell function. However, knowledge of smoking effects in specific leukocyte subtypes is limited. To better characterize smoking-associated methylation changes in whole blood and leukocyte subtypes, we used Illumina 450K arrays and Reduced Representation Bisulfite Sequencing (RRBS) to assess genome-wide DNA methylation. Differential methylation analysis in whole blood DNA from 172 smokers and 81 nonsmokers revealed 738 CpGs, including 616 previously unreported CpGs, genome-wide significantly associated with current smoking (p < 1.2x10(-7), Bonferroni correction). Several CpGs (MTSS1, NKX6-2, BTG2) were associated with smoking duration among heavy smokers (>22 cigarettes/day, n = 86) which might relate to long-term heavy-smoking pathology. In purified leukocyte subtypes from an independent group of 20 smokers and 14 nonsmokers we further examined methylation and gene expression for selected genes among CD14+ monocytes, CD15+ granulocytes, CD19 + B cells, and CD2+ T cells. In 10 smokers and 10 nonsmokers we used RRBS to fine map differential methylation in CD4+ T cells, CD8+ T cells, CD14+, CD15+, CD19+, and CD56+ natural killer cells. Distinct cell-type differences in smoking-associated methylation and gene expression were identified. AHRR (cg05575921), ALPPL2 (cg21566642), GFI1 (cg09935388), IER3 (cg06126421) and F2RL3 (cg03636183) showed a distinct pattern of significant smoking-associated methylation differences across cell types: granulocytes> monocytes >> B cells. In contrast GPR15 (cg19859270) was highly significant in T and B cells and ITGAL (cg09099830) significant only in T cells. Numerous other CpGs displayed distinctive cell-type responses to tobacco smoke exposure that were not apparent in whole blood DNA. Assessing the overlap between these CpG sites and differential methylated regions (DMRs) with RRBS in 6 cell types, we confirmed cell-type specificity in the context of DMRs. We identified new CpGs associated with current smoking, pack-years, duration, and revealed unique profiles of smoking-associated DNA methylation and gene expression among immune cell types, providing potential clues to hematopoietic lineage-specific effects in disease etiology.	[Su, Dan; Wang, Xuting; Campbell, Michelle R.; Porter, Devin K.; Pittman, Gary S.; Wan, Ma; Englert, Neal A.; Crowl, Christopher L.; Gimple, Ryan N.; Adamski, Kelly N.; Bell, Douglas A.] NIEHS, Environm Genom Grp, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Bennett, Brian D.] NIEHS, Integrated Bioinformat, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Huang, Zhiqing; Murphy, Susan K.] Duke Univ, Sch Med, Durham, NC 27708 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Bell, DA (corresponding author), NIEHS, Environm Genom Grp, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	BELL1@niehs.nih.gov	su, dan/GYJ-1940-2022; Bell, Douglas A/C-7687-2019; Murphy, Susan/R-3903-2019; Gimple, Ryan/AAU-8944-2020	Bell, Douglas A/0000-0001-7700-0840; Murphy, Susan/0000-0001-8298-7272; Wang, Xuting/0000-0001-6781-8008; Gimple, Ryan/0000-0002-7189-3243	Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health [Z01-ES100475]; NIH/FDA Intramural Center for Tobacco Research; NIEHS Clinical Research Unit and Hematology Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES046008, ZICES102445] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health; NIH/FDA Intramural Center for Tobacco Research; NIEHS Clinical Research Unit and Hematology Core; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was funded by the Intramural Research Program of National Institute of Environmental Health Sciences-National Institutes of Health (Z01-ES100475) (www.niehs.nih.gov) and a grant from NIH/FDA Intramural Center for Tobacco Research (https://prevention.nih.gov/tobacco-regulatory-science-program) to D.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIEHS Clinical Research Unit and Hematology Core for support and the NIEHS Molecular Genetics Core, NIH Intramural Sequencing Center, and NCI DCEG Center for Genomics Research for methylation analysis.	Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bauer M, 2016, CLIN EPIGENETICS, V8, DOI [10.1186/s13148-015-0113-1, 10.1186/s13148-016-0249-7]; BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223; Birney E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006105; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Breton CV, 2014, PLOS ONE, V9; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Flanagan JM, 2015, CANCER EPIDEM BIOMAR, V24, P221, DOI 10.1158/1055-9965.EPI-14-0767; Fox J, 2011, R COMPANION APPL REG, P449; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; JONES IM, 1993, CANCER EPIDEM BIOMAR, V2, P249; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kayser G, 2015, BRIT J CANCER, V112, P866, DOI 10.1038/bjc.2015.2; Kim S, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/015021; Koestler DC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0943-7; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lunn RM, 1999, CANCER RES, V59, P2557; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mertz KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4465; Michaud DS, 2015, CANCER EPIDEM BIOMAR, V24, P1811, DOI 10.1158/1055-9965.EPI-15-0681; Monick MM, 2012, AM J MED GENET B, V159B, P141, DOI 10.1002/ajmg.b.32021; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nguyen LP, 2015, NAT IMMUNOL, V16, P207, DOI 10.1038/ni.3079; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Phelan JD, 2010, CURR OPIN HEMATOL, V17, P300, DOI 10.1097/MOH.0b013e32833a06f8; Philibert RA, 2012, EPIGENETICS-US, V7, P1331, DOI 10.4161/epi.22520; PHILLIPS DH, 1988, NATURE, V336, P790, DOI 10.1038/336790a0; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Reynolds LM, 2015, CIRC-CARDIOVASC GENE, V8, P707, DOI 10.1161/CIRCGENETICS.115.001097; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Smith MR, 2003, ATHEROSCLEROSIS, V169, P331, DOI 10.1016/S0021-9150(03)00200-4; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sun YV, 2013, HUM GENET, V132, P1027, DOI 10.1007/s00439-013-1311-6; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wiencke JK, 2016, EPIGENETICS-US, V11, P363, DOI 10.1080/15592294.2016.1163454; Zeilinger S, 2013, PLOS ONE, V8; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	55	69	73	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166486	10.1371/journal.pone.0166486	http://dx.doi.org/10.1371/journal.pone.0166486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935972	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100029
J	Wang, LH; Dong, F; Reinach, PS; He, DD; Zhao, XT; Chen, XY; Hu, DN; Yan, DS				Wang, Lihua; Dong, Feng; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng			MicroRNA-182 Suppresses HGF/SF-Induced Increases in Retinal Pigment Epithelial Cell Proliferation and Migration through Targeting c-Met	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MESENCHYMAL TRANSITION; VITREORETINOPATHY; DISEASE; DETACHMENT; PHYSIOLOGY; P53	As increases in hepatocyte growth factor/scatter factor (HGF/SF) induce retinal pigment epithelial (RPE) migration and proliferation into the vitreous cavity and contribute to proliferative vitreoretinopathy (PVR) development, we determined if changes in miR-182 expression affect such behavioral changes. We found that miR-182 expression was less in PVR clinical samples than in primary RPE cells whereas c-Met was upregulated. Ectopic miR-182 inhibited RPE cell proliferation, cell cycle, and migration. Bioinformatic analysis identified c-Met as a miR-182 target, which was confirmed with the luciferase reporter assay. Transfection of miR-182 into RPE cells induced c-Met downregulation, which led to reduced cell proliferation and migration through declines in p-Akt formation. MiR-182 downregulation along with c-Met upregulation in PVR tissues suggest that these two opposing effects play important roles in PVR development. As ectopic miR-182 expression suppressed RPE cell proliferation and migration, strategies to selectively upregulate miR-182 expression in a clinical setting may provide a novel option to treat this disease.	[Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Yan, Dongsheng] Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China; [Wang, Lihua; Reinach, Peter S.; He, Dandan; Zhao, Xiaoting; Chen, Xiaoyan; Hu, Dan-Ning; Yan, Dongsheng] Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Hu, Dan-Ning] New York Med Coll, New York Eye & Ear Infirm, Tissue Culture Ctr, New York, NY USA; [Dong, Feng] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College; Zhejiang University	Yan, DS (corresponding author), Wenzhou Med Univ, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.; Yan, DS (corresponding author), Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Wenzhou, Zhejiang, Peoples R China.; Yan, DS (corresponding author), Minist Hlth Peoples Republ China, Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China.	dnaprotein@hotmail.com	chen, xia/GXM-5435-2022; Reinach, Peter/AAI-3582-2021; Yan, Dongsheng/B-1861-2018; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Yan, Dongsheng/0000-0003-0551-2219; wang, lihua/0000-0001-6133-7940	973 Project from the Ministry of Science and Technology of China [2012CB722303]; Wenzhou Municipal Science-technology Program Project of China [Y20130164]; Science Foundation of Wenzhou Medical University [QTJ11020]	973 Project from the Ministry of Science and Technology of China(National Basic Research Program of China); Wenzhou Municipal Science-technology Program Project of China; Science Foundation of Wenzhou Medical University	This work was supported, in part, by the 973 Project (2012CB722303) from the Ministry of Science and Technology of China, Wenzhou Municipal Science-technology Program Project of China (Y20130164), and Science Foundation of Wenzhou Medical University (QTJ11020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Briggs MC, 2000, INVEST OPHTH VIS SCI, V41, P3085; Cai N, 2012, INT J OPHTHALMOL-CHI, V5, P675, DOI 10.3980/j.issn.2222-3959.2012.06.05; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen XY, 2014, INT J MOL MED, V33, P1195, DOI 10.3892/ijmm.2014.1688; Chen Zhenna, 2015, Mol Vis, V21, P706; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou Q, 2013, INVEST OPHTH VIS SCI, V54, P6481, DOI 10.1167/iovs.13-11873; Hu DN, 2002, INT J TOXICOL, V21, P465, DOI 10.1080/10915810290169891; Jun JH, 2016, INVEST OPHTH VIS SCI, V57, P12, DOI 10.1167/iovs.15-17111; Kasaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040771; Kim Ivana K, 2002, Ophthalmol Clin North Am, V15, P81; Kwon OW, 2016, DEV OPHTHALMOL, V55, P154, DOI 10.1159/000438972; Lashkari K, 1999, INVEST OPHTH VIS SCI, V40, P149; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACHEMER R, 1978, AM J OPHTHALMOL, V85, P181, DOI 10.1016/S0002-9394(14)75946-X; Murad N, 2014, FEBS J, V281, P5251, DOI 10.1111/febs.13066; Nair AR, 2005, CELL CYCLE, V4, P697, DOI 10.4161/cc.4.5.1672; Pastor JC, 2015, PROLIFERATIVE VITREO; Pennock S, 2014, AM J PATHOL, V184, P3052, DOI 10.1016/j.ajpath.2014.07.026; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Tamiya S, 2016, EXP EYE RES, V142, P26, DOI 10.1016/j.exer.2015.02.008; Tosi GM, 2014, J CELL PHYSIOL, V229, P1577, DOI 10.1002/jcp.24606; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681; Yang S, 2015, DISCOV MED, V20, P207	36	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167684	10.1371/journal.pone.0167684	http://dx.doi.org/10.1371/journal.pone.0167684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936052	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100149
J	Wang, Y; Sun, T; Li, TT; Wang, M; Yang, GX; He, GY				Wang, Yan; Sun, Tao; Li, Tingting; Wang, Meng; Yang, Guangxiao; He, Guangyuan			A CBL-Interacting Protein Kinase TaCIPK2 Confers Drought Tolerance in Transgenic Tobacco Plants through Regulating the Stomatal Movement	PLOS ONE			English	Article							CIPK GENE FAMILIES; ARABIDOPSIS-THALIANA; CALCIUM SENSORS; SIGNALING NETWORK; STRESS TOLERANCE; SALT STRESS; ECTOPIC EXPRESSION; OSMOTIC-STRESS; ABSCISIC-ACID; K+ CHANNEL	In plants, the CBL-CIPK signaling pathways play key roles in the response to abiotic stresses. However, functional studies of CIPKs in the important staple crop wheat are very rare. In this study, we identified a CIPKgene from wheat, designated TaCIPK2. Expression analysis results showed that TaCIPK2 could be up-regulated in wheat leaves by polyethylene glycol, abscisic acid and H2O2 treatments. Subcellular localization analyses revealed that TaCIPK2 was present in whole wheat epidermal cells. A yeast two-hybrid assay indicated that TaCIPK2 interacted with TaCBL1, 2, 3 and 4 in vitro. Transgenic tobacco plants over-expressing TaCIPK2 exhibited increased drought tolerance, indicated by a larger proportion of green cotyledons and higher survival rates under the osmotic and drought stress conditions compared with control plants. Additionally, physiological index analyses revealed that the transgenic tobacco plants had lower water loss rates and ion leakage, accumulated less malondialdehyde and H2O2, and had higher catalase and superoxide dismutase activities than the control plants. The transgenic plants also exhibited faster stomatal closure following exposure to osmotic stress conditions. The seed germination rates and stomatal aperture of TaC/PK2-overexpressing tobacco plants decreased after exogenous abscisic acid treatment was applied, implying that the transgenic tobacco plants were more sensitive to exogenous abscisic acid than the control plants. Our results indicate that TaCIPK2 plays a positive regulatory role in drought stress responses in transgenic tobacco plants.	[Wang, Yan; Sun, Tao; Li, Tingting; Wang, Meng; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys,Chinese Minist Educ, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan, Peoples R China	Huazhong University of Science & Technology	He, GY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys,Chinese Minist Educ, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan, Peoples R China.	hegy@hust.edu.cn			National Genetically Modified New Varieties of Major Projects of China [2016ZX08010004-004]; International S & T Cooperation Key Projects of MoST [2009DFB30340]; Research Fund for the Doctoral Program of Higher Education of China [2012014211075]	National Genetically Modified New Varieties of Major Projects of China; International S & T Cooperation Key Projects of MoST; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Genetically Modified New Varieties of Major Projects of China (2016ZX08010004-004), International S & T Cooperation Key Projects of MoST (grant No. 2009DFB30340) and Research Fund for the Doctoral Program of Higher Education of China (Grant no. 2012014211075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Genetically Modified New Varieties of Major Projects of China (2016ZX08010004-004), International S & T Cooperation Key Projects of MoST (grant No. 2009DFB30340) and Research Fund for the Doctoral Program of Higher Education of China (Grant no. 2012014211075).	Abdula SE, 2016, PLANT MOL BIOL REP, V34, P501, DOI 10.1007/s11105-015-0939-x; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Chen XF, 2011, J GENET GENOMICS, V38, P77, DOI 10.1016/j.jcg.2011.01.005; Chen XJ, 2014, INT J MOL SCI, V15, P14819, DOI 10.3390/ijms150814819; Deng XM, 2013, PHYSIOL PLANTARUM, V149, P367, DOI 10.1111/ppl.12046; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Guo Y, 2004, PLANT CELL, V16, P435, DOI 10.1105/tpc.019174; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huang CJ, 2013, PHYSIOL PLANTARUM, V149, P297, DOI 10.1111/ppl.12031; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Laanemets K, 2013, PLANT PHYSIOL, V163, P504, DOI 10.1104/pp.113.220343; Li J, 2014, PLANT CELL, V26, P3387, DOI 10.1105/tpc.114.123455; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li RF, 2012, PLANT CELL ENVIRON, V35, P1582, DOI 10.1111/j.1365-3040.2012.02511.x; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu L., 2013, J FOOD SCI ENG, V3, P161; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mahs A, 2013, MOL PLANT, V6, P1149, DOI 10.1093/mp/sst095; Nieves-Cordones M, 2012, PLANT CELL PHYSIOL, V53, P423, DOI 10.1093/pcp/pcr194; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Piao HL, 2010, MOL CELLS, V30, P19, DOI 10.1007/s10059-010-0084-1; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Reilly C A, 2001, Curr Protoc Toxicol, VChapter 2, DOI 10.1002/0471140856.tx0204s00; SANO H, 1994, P NATL ACAD SCI USA, V91, P2582, DOI 10.1073/pnas.91.7.2582; Sun T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0657-4; Sun YD, 2015, PLANT CELL REP, V34, P1295, DOI 10.1007/s00299-015-1787-8; Tai FJ, 2016, PLANT CELL TISS ORG, V124, P459, DOI 10.1007/s11240-015-0906-0; Tang RJ, 2015, P NATL ACAD SCI USA, V112, P3134, DOI 10.1073/pnas.1420944112; Verslues PE, 2007, MOL CELL BIOL, V27, P7771, DOI 10.1128/MCB.00429-07; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang HF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-8; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5	44	24	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167962	10.1371/journal.pone.0167962	http://dx.doi.org/10.1371/journal.pone.0167962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936160	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100239
J	Yang, Z; Zhao, Q; Gao, YA; Zhang, W				Yang, Zhe; Zhao, Qing; Gao, Yun-An; Zhang, Wei			Combined Oral and Intravenous Immunization Stimulates Strong IgA Responses in Both Systemic and Mucosal Compartments	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; IMMUNE-RESPONSES; CHOLERA-TOXIN; INTRANASAL IMMUNIZATION; VACCINE; EXPRESSION; ANTIGEN; PRIME; SERUM; MICE	To investigate the influence of immunization routes onIgG, IgA and IgM production in systemic and mucosal compartments, we immunized mice with keyhole limpet hemocyanin (KLH) via oral, intranasal (i.n.) or subcutaneous (s.c.) routes alone or combined with the intravenous (i.v.) route. We found that administering antigen intravenously could affect antibody production and formation of antibody secreting cells (ASCs) depending on the immunization route previously used. Combined oral/i.v. immunization but not s.c./i.v. immunization caused a great increase of IgA ASCs in the spleen and enhanced IgA production in the small intestine and serum. Combined i.n./i.v. immunization could also increase IgA ASCs in the spleen and enhance IgA production in serum but had no effect on IgA production in the small intestine. Oral/i.v. immunization caused increase of IgG ASCs in both the spleen and bone marrow. In comparison, combined i.n./i.v. and s.c./i.v. immunization could increase IgG ASCs in the spleen but not in bone marrow. Intravenous administration of KLH in mice that had been immunized via oral, i.n. or s.c. routes caused some increase of IgM ASCs in the spleen but not in bone marrow. In conclusion, combined oral and i.v. administration of an antigen can induce fast and strong immune responses, especially for IgA, in both systemic and mucosal compartments.	[Yang, Zhe; Zhao, Qing; Gao, Yun-An; Zhang, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol,Sch Basic Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol,Sch Basic Med, Beijing, Peoples R China.	zw83423@hotmail.com			Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences	This work was partially supported by a grant for Young Lecturers from Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. QZ received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific fundings for our work, the additional cost of our work supported by the funding from our laboratory.	Agnello D, 2013, J IMMUNOL, V190, P4836, DOI 10.4049/jimmunol.1202979; Batra A, 2007, NEPHROL DIAL TRANSPL, V22, P2540, DOI 10.1093/ndt/gfm228; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Bouvet JP, 2002, TRENDS IMMUNOL, V23, P209, DOI 10.1016/S1471-4906(02)02186-5; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; Bruhl P, 1998, AIDS RES HUM RETROV, V14, P401, DOI 10.1089/aid.1998.14.401; Chadwick S, 2009, EXPERT OPIN BIOL TH, V9, P427, DOI [10.1517/14712590902849224 , 10.1517/14712590902849224]; Chen DX, 2001, J VIROL, V75, P7956, DOI 10.1128/JVI.75.17.7956-7965.2001; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Eriksson K, 1998, INFECT IMMUN, V66, P5889, DOI 10.1128/IAI.66.12.5889-5896.1998; Gloudemans AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059822; Goodsell A, 2008, IMMUNOLOGY, V123, P378, DOI 10.1111/j.1365-2567.2007.02702.x; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GRISCELLI C, 1969, J EXP MED, V130, P1427, DOI 10.1084/jem.130.6.1427; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; HAQ JA, 1991, INFECT IMMUN, V59, P3094, DOI 10.1128/IAI.59.9.3094-3100.1991; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Israel ZR, 1999, AIDS RES HUM RETROV, V15, P1121, DOI 10.1089/088922299310412; Jertborn M, 2001, INFECT IMMUN, V69, P4125, DOI 10.1128/IAI.69.6.4125-4128.2001; Johansson EL, 2004, VACCINE, V22, P984, DOI 10.1016/j.vaccine.2003.09.002; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Kanellos TS, 2000, IMMUNOL LETT, V74, P215, DOI 10.1016/S0165-2478(00)00257-1; Kantele A, 1999, VACCINE, V17, P229, DOI 10.1016/S0264-410X(98)00193-5; Koga T, 2000, J IMMUNOL, V165, P5352, DOI 10.4049/jimmunol.165.9.5352; Kowalczyk DW, 2001, VACCINE, V19, P3583, DOI 10.1016/S0264-410X(01)00070-6; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lee CK, 1999, VACCINE, V17, P3072, DOI 10.1016/S0264-410X(99)00144-9; LEHNER T, 1994, J VIROL, V68, P1624, DOI 10.1128/JVI.68.3.1624-1632.1994; Mantis NJ, 2001, VACCINE, V19, P3990, DOI 10.1016/S0264-410X(01)00115-3; MARX PA, 1993, SCIENCE, V260, P1323, DOI 10.1126/science.8493576; McCluskie MJ, 2000, MOL MED, V6, P867, DOI 10.1007/BF03401824; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mestecky J, 1989, CURR TOP MICROBIOL I, V146, P1; Mestecky J, 2013, ANNU REV PATHOL-MECH, V8, P217, DOI 10.1146/annurev-pathol-011110-130216; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Ogra Pearay L., 1996, P3, DOI 10.1016/B978-012410580-5/50002-9; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; QUIDING M, 1991, J CLIN INVEST, V88, P143, DOI 10.1172/JCI115270; QuidingJarbrink M, 1997, J CLIN INVEST, V99, P1281, DOI 10.1172/JCI119286; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tanaka N, 2007, VACCINE, V25, P2680, DOI 10.1016/j.vaccine.2006.10.014; Yanagita M, 1999, J IMMUNOL, V162, P3559; Yu HH, 2011, CLIN REV ALLERG IMMU, V41, P198, DOI 10.1007/s12016-010-8232-0	49	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168037	10.1371/journal.pone.0168037	http://dx.doi.org/10.1371/journal.pone.0168037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936222	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100258
J	Chan, CM; Macdonald, CD; Litherland, GJ; Wilkinson, DJ; Skelton, A; Europe-Finner, GN; Rowan, AD				Chan, Chun Ming; Macdonald, Christopher D.; Litherland, Gary J.; Wilkinson, David J.; Skelton, Andrew; Europe-Finner, G. Nicholas; Rowan, Andrew D.			Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); arthritis; cell signaling; chondrocyte; inflammation; matrix metalloproteinase (MMP)	MATRIX-METALLOPROTEINASE 13; TUMOR-NECROSIS-FACTOR; HUMAN OSTEOARTHRITIC CHONDROCYTES; CARTILAGE COLLAGEN BREAKDOWN; ONCOSTATIN-M; GENE-EXPRESSION; RESPONSE ELEMENT; PARATHYROID-HORMONE; PROINFLAMMATORY CYTOKINES; INTERSTITIAL COLLAGENASE	Irreversible breakdown of cartilage extracellular matrix (ECM) by the collagenase matrix metalloproteinase 13 (MMP13) represents a key event in osteoarthritis (OA) progression. Although inflammation is most commonly associated with inflammatory joint diseases, it also occurs in OA and is thus relevant to the prevalent tissue destruction. Here, inflammation generates a cFOS AP-1 early response that indirectly affects MMP13 gene expression. To ascertain a more direct effect on prolonged MMP13 production we examined the potential molecular events occurring between the rapid, transient expression of cFOS and the subsequent MMP13 induction. Importantly, we show MMP13 mRNA expression is mirrored by nascent hnRNA transcription. Employing ChIP assays, cFOS recruitment to the MMP13 promoter occurs at an early stage prior to gene transcription and that recruitment of transcriptional initiation markers also correlated with MMP13 expression. Moreover, protein synthesis inhibition following early FOS expression resulted in a significant decrease in MMP13 expression thus indicating a role for different regulatory factors modulating expression of the gene. Subsequent mRNA transcriptome analyses highlighted several genes induced soon after FOS that could contribute to MMP13 expression. Specific small interfering RNA-mediated silencing highlighted that ATF3 was as highly selective for MMP13 as cFOS. Moreover, ATF3 expression was AP-1(cFOS/cJUN)-dependent and expression levels were maintained after the early transient cFOS response. Furthermore, ATF3 bound the proximal MMP13 AP-1 motif in stimulated chondrocytes at time points that no longer supported binding of FOS. Consequently, these findings support roles for both cFOS (indirect) and ATF3 (direct) in effecting MMP13 transcription in human chondrocytes.	[Chan, Chun Ming; Macdonald, Christopher D.; Litherland, Gary J.; Wilkinson, David J.; Skelton, Andrew; Europe-Finner, G. Nicholas; Rowan, Andrew D.] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Macdonald, Christopher D.] Arthrit Res UK, 41 Portland Pl,4th Floor, London W1B 1QH, England; [Litherland, Gary J.] Univ West Scotland, Sch Sci & Sport, Inst Biomed & Environm Hlth Res, Paisley Campus, Paisley PA1 2BE, Renfrew, Scotland; [Skelton, Andrew] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Europe-Finner, G. Nicholas] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; University of West Scotland; Newcastle University - UK; Newcastle University - UK	Rowan, AD (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	drew.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Litherland, Gary/0000-0001-5264-0219; Wilkinson, David/0000-0002-6262-3575	Nuffield Foundation (Oliver Bird Rheumatism Programme); JGW Patterson Foundation; United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award; Arthritis Research Campaign [18726, 19322, 19485]	Nuffield Foundation (Oliver Bird Rheumatism Programme); JGW Patterson Foundation; United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award; Arthritis Research Campaign(Versus Arthritis)	This work was supported by the Nuffield Foundation (Oliver Bird Rheumatism Programme), the JGW Patterson Foundation, Arthritis Research Campaign Grants 18726, 19322, and 19485, and a United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Dept. of Health.	AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Durigova M, 2011, EUR CELLS MATER, V21, P31, DOI 10.22203/eCM.v021a03; Fukasawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30918; Gellersen B, 1997, MOL ENDOCRINOL, V11, P97, DOI 10.1210/me.11.1.97; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hai T, 1999, GENE EXPRESSION, V7, P321; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Iezaki T, 2016, J PATHOL, V239, P426, DOI 10.1002/path.4739; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Little CB, 2005, OSTEOARTHR CARTILAGE, V13, P162, DOI 10.1016/j.joca.2004.10.014; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nilsson M, 1997, CELL GROWTH DIFFER, V8, P913; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Radwan M, 2013, ARTHRITIS RHEUM-US, V65, P1290, DOI 10.1002/art.37868; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Rowan AD, 2008, EXPERT OPIN THER TAR, V12, P1, DOI 10.1517/14728222.12.1.1; Schmucker AC, 2012, J BIOL CHEM, V287, P1189, DOI 10.1074/jbc.M111.264077; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Thalayasingam N, 2011, BEST PRACT RES CL RH, V25, P549, DOI 10.1016/j.berh.2011.10.004; Uchida M, 2001, J BONE MINER RES, V16, P221, DOI 10.1359/jbmr.2001.16.2.221; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Yue CM, 2008, PHYSIOL GENOMICS, V35, P231, DOI 10.1152/physiolgenomics.90218.2008; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574	50	32	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1625	1636		10.1074/jbc.M116.756601	http://dx.doi.org/10.1074/jbc.M116.756601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956552	Green Published, hybrid			2022-12-26	WOS:000395515600008
J	Beaudoin, G; Rafanoharana, S; Boissiere, M; Wijaya, A; Wardhana, W				Beaudoin, Guillaume; Rafanoharana, Serge; Boissiere, Manuel; Wijaya, Arief; Wardhana, Wahyu			Completing the Picture: Importance of Considering Participatory Mapping for REDD plus Measurement, Reporting and Verification (MRV)	PLOS ONE			English	Article							LAND-COVER; FOREST; GIS; ACCURACY; BENEFITS	Remote sensing has been widely used for mapping land cover and is considered key to monitoring changes in forest areas in the REDD+ Measurement, Reporting and Verification (MRV) system. But Remote Sensing as a desk study cannot capture the whole picture; it also requires ground checking. Therefore, complementing remote sensing analysis using participatory mapping can help provide information for an initial forest cover assessment, gain better understanding of how local land use might affect changes, and provide a way to engage local communities in REDD+. Our study looked at the potential of participatory mapping in providing complementary information for remotely sensed maps. The research sites were located in different ecological and socio-economic contexts in the provinces of Papua, West Kalimantan and Central Java, Indonesia. Twenty-one maps of land cover and land use were drawn with local community participation during focus group discussions in seven villages. These maps, covering a total of 270,000ha, were used to add information to maps developed using remote sensing, adding 39 land covers to the eight from our initial desk assessment. They also provided additional information on drivers of land use and land cover change, resource areas, territory claims and land status, which we were able to correlate to understand changes in forest cover. Incorporating participatory mapping in the REDD+ MRV protocol would help with initial remotely sensed land classifications, stratify an area for ground checks and measurement plots, and add other valuable social data not visible at the RS scale. Ultimately, it would provide a forum for local communities to discuss REDD+ activities and develop a better understanding of REDD+.	[Beaudoin, Guillaume; Rafanoharana, Serge; Boissiere, Manuel; Wijaya, Arief] Ctr Int Forestry Res CIFOR, Jl CIFOR, Bogor, Indonesia; [Boissiere, Manuel] Ctr Cooperat Int Rech Agron Dev CIRAD, Campus Baillarguet, Montpellier 6, France; [Wardhana, Wahyu] GadjahMada Univ UGM, Fac Forestry, Jl Agro Bulaksumur 1, Sleman Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); CIRAD	Boissiere, M (corresponding author), Ctr Int Forestry Res CIFOR, Jl CIFOR, Bogor, Indonesia.; Boissiere, M (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Campus Baillarguet, Montpellier 6, France.	m.boissiere@cgiar.org	; Wijaya, Arief/L-8405-2015	BOISSIERE, Manuel/0000-0002-2552-7664; Wijaya, Arief/0000-0001-6165-0144	U.S. Agency for International Development (USAID) [MTO069018]; Norwegian Agency for Development (NORAD) [GLO-3945, QZA 12/0882]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development (NORAD)(CGIAR)	The authors acknowledge the U.S. Agency for International Development (USAID) grant number MTO069018 and the Norwegian Agency for Development (NORAD) grant number GLO-3945, QZA 12/0882 for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulharis R., 2014, FIG C 2014 ENG CHALL; [Anonymous], 2011, USITC PUBL; [Anonymous], 2013, GOFC GOLD SOURC METH; Asner G, 2014, HIGH RESOLUTION CARB; Torres AB, 2014, FORESTS, V5, P1815, DOI 10.3390/f5081815; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Brown G, 2014, LANDSCAPE URBAN PLAN, V122, P196, DOI 10.1016/j.landurbplan.2013.11.007; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Chambers R, 2006, ELECTR J INF SYS DEV, V25; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Chhatre A, 2012, CURR OPIN ENV SUST, V4, P654, DOI 10.1016/j.cosust.2012.08.006; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Gaillard JC, 2013, APPL GEOGR, V45, P158, DOI 10.1016/j.apgeog.2013.09.009; Graham K., 2009, CARBON CLIMATE LAW R, V3, P303; Hansen M C, 2013, SCIENCE, V342, P2011; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Hossain M S, 2007, J SOCIAL SCI HUMANIT, V13, P413; Joseph S., 2013, ENVIRON RES LETT, V8, P34; Kauffman JB, 2010, WETLANDS, V30, P1077, DOI 10.1007/s13157-010-0114-y; Knowles T., 2010, CTR PATHWAYS IMPLEME, P141; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Mapedza E, 2003, APPL GEOGR, V23, P1, DOI 10.1016/S0143-6228(02)00070-X; MATHER AS, 1992, AREA, V24, P367; Meta P., 2005, MAPPING COMMUNITIES, P29; Minang P. A., 2014, CLIM POLICY, P1; [Ministry of Forestry Direction general of Forestry Planning Kemetrian Kehutanan Direktorat Jenderal Planologi Kehutanan], 2012, KEM KEH DIR JEND PLA; Minter T., 2014, HUMAN ECOLOGY; Naidoo G, 2010, TREES-STRUCT FUNCT, V24, P667, DOI 10.1007/s00468-010-0436-7; NGENDAKUMANA S, 2013, ISRN FORESTRY, V2013; Padmanaba M., 2012, PROJECT REPORT; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Rambaldi G., 2006, PARTICIPATORY LEARNI, V54, P106; Resosudarmo IAP, 2014, WORLD DEV, V55, P68, DOI 10.1016/j.worlddev.2013.01.015; Richards J.A., 1999, REMOTE SENSING DIGIT, DOI [DOI 10.1007/978-3-642-30062-2, 10.1007/978-3-662-03978-6, DOI 10.1007/978-3-662-03978-6]; Richards S. J., 2002, RAP B BILOIGICAL ASS, V25; Rindfuss R.R., 1998, PEOPLE PIXELS LINKIN, P1, DOI [10.17226/5963, DOI 10.17226/5963]; Rindfuss RR, 2004, REMOTE SENSING IMAGE, V6, P379; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Salvini G, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074004; Sheil D, 2002, EXPLORING BIOL DIVER, P1, DOI [10.17528/cifor/001021, DOI 10.17528/CIFOR/001021]; Sheil D, 2015, ECOL SOC, V20, DOI 10.5751/ES-07625-200239; UNFCCC, 2010, OUTC WORK HOC WORK G; Vergara-Asenjo G, 2015, CONSERV LETT, V8, P432, DOI 10.1111/conl.12161; Wertz-Kanounnikoff S., 2009, REALISING REDD NATL, P13; World Agroforestry Centre, 2011, WORLD AGR CTR ACC LO; Zhang ZM, 2013, J NAT CONSERV, V21, P225, DOI 10.1016/j.jnc.2012.12.006	55	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166592	10.1371/journal.pone.0166592	http://dx.doi.org/10.1371/journal.pone.0166592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977685	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400004
J	Graham, JB; Muir, D				Graham, James B.; Muir, David			Chondroitinase C Selectively Degrades Chondroitin Sulfate Glycosaminoglycans that Inhibit Axonal Growth within the Endoneurium of Peripheral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; NEURITE OUTGROWTH; BASEMENT-MEMBRANE; MONOCLONAL-ANTIBODIES; EXTRACELLULAR-MATRIX; DEGENERATED NERVE; REGENERATION; PROTEOGLYCAN; GRAFTS; ABC	The success of peripheral nerve regeneration is highly dependent on the regrowth of axons within the endoneurial basal lamina tubes that promote target-oriented pathfinding and appropriate reinnervation. Restoration of nerve continuity at this structural level after nerve transection injury by direct repair and nerve grafting remains a major surgical challenge. Recently, biological approaches that alter the balance of growth inhibitors and promoters in nerve have shown promise to improve appropriate axonal regeneration and recovery of peripheral nerve function. Chondroitin sulfate proteoglycans (CSPGs) are known inhibitors of axonal growth. This growth inhibition is mainly associated with a CSPG's glycosaminoglycan chains. Enzymatic degradation of these chains with chondroitinase eliminates this inhibitory activity and, when applied in vivo, can improve the outcome of nerve repair. To date, these encouraging findings were obtained with chondroitinase ABC (a pan-specific chondroitinase). The aim of this study was to examine the distribution of CSPG subtypes in rodent, rabbit, and human peripheral nerve and to test more selective biological enzymatic approaches to improve appropriate axonal growth within the endoneurium and minimize aberrant growth. Here we provide evidence that the endoneurium, but not the surrounding epineurium, is rich in CSPGs that have glycosaminoglycan chains readily degraded by chondroitinase C. Biochemical studies indicate that chondroitinase C has degradation specificity for 6-sulfated glycosaminoglycans found in peripheral nerve. We found that chondroitinase C degrades and inactivates inhibitory CSPGs within the endoneurium but not so much in the surrounding nerve compartments. Cryoculture bioassays (neurons grown on tissue sections) show that chondroitinase C selectively and significantly enhanced neuritic growth associated with the endoneurial basal laminae without changing growth-inhibiting properties of the surrounding epineurium. Interestingly, chondroitinase ABC treatment increased greatly the growth-promoting properties of the epineurial tissue whereas chondroitinase C had little effect. Our evidence indicates that chondroitinase C effectively degrades and inactivates inhibitory CSPGs present in the endoneurial Schwann cell basal lamina and does so more specifically than chondroitinase ABC. These findings are discussed in the context of improving nerve repair and regeneration and the growth-promoting properties of processed nerve allografts.	[Graham, James B.; Muir, David] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Graham, JB (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.	jbgraham@ufl.edu			United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award [DM090175]; National Institutes of Health; National Center for Research Resources Clinical and Translational Science Award [TL1 TR000066]	United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by: United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award DM090175 (DM) and National Institutes of Health and National Center for Research Resources Clinical and Translational Science Award TL1 TR000066 (JBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius E, 1998, J NEUROSCI, V18, P328; ASHER R, 1991, J NEUROSCI RES, V28, P410, DOI 10.1002/jnr.490280314; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; Bianchetti L, 2012, J CELL MOL MED, V16, P483, DOI 10.1111/j.1582-4934.2011.01344.x; BLAKESLEY RW, 1977, ANAL BIOCHEM, V82, P580, DOI 10.1016/0003-2697(77)90197-X; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x; CARBONETTO S, 1987, J NEUROSCI, V7, P610; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; DANIELSEN N, 1994, BRAIN RES, V666, P250, DOI 10.1016/0006-8993(94)90779-X; English AW, 2005, J COMP NEUROL, V490, P427, DOI 10.1002/cne.20678; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; EVANS PJ, 1995, MUSCLE NERVE, V18, P1128, DOI 10.1002/mus.880181009; Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859; Graham JB, 2007, EXP NEUROL, V203, P185, DOI 10.1016/j.expneurol.2006.08.004; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hamai A, 1997, J BIOL CHEM, V272, P9123; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Krekoski CA, 2001, J NEUROSCI, V21, P6206, DOI 10.1523/JNEUROSCI.21-16-06206.2001; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; MICHELACCI YM, 1976, J BIOL CHEM, V251, P1154; Muir D, 2010, EXP NEUROL, V223, P102, DOI 10.1016/j.expneurol.2009.05.038; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Neubauer D, 2007, EXP NEUROL, V207, P163, DOI 10.1016/j.expneurol.2007.06.006; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; POOLE CA, 1991, J HISTOCHEM CYTOCHEM, V39, P1175, DOI 10.1177/39.9.1717545; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Sattelle BM, 2015, BIOMACROMOLECULES; SCOTT JE, 1972, HISTOCHEMISTRY, V32, P191, DOI 10.1007/BF00306028; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]; Tsuda H, 1999, EUR J BIOCHEM, V262, P127, DOI 10.1046/j.1432-1327.1999.00348.x; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	45	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167682	10.1371/journal.pone.0167682	http://dx.doi.org/10.1371/journal.pone.0167682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973564	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300040
J	Kinoshita, T; Mori, J; Okuda, N; Imaizumi, H; Iwasaki, M; Shimizu, M; Miyamoto, H; Akalwa, K; Semba, K; Sonoda, S; Sakamoto, T; Mitamura, Y				Kinoshita, Takamasa; Mori, Junya; Okuda, Natsuki; Imaizumi, Hiroko; Iwasaki, Masanori; Shimizu, Miho; Miyamoto, Hirotomo; Akalwa, Kei; Semba, Kentaro; Sonoda, Shozo; Sakamoto, Taiji; Mitamura, Yoshinori			Effects of Exercise on the Structure and Circulation of Choroid in Normal Eyes	PLOS ONE			English	Article							BLOOD-FLOW REGULATION; OPTIC-NERVE HEAD; LASER SPECKLE; INTRAOCULAR-PRESSURE; COHERENCE TOMOGRAPHY; ISOMETRIC-EXERCISE; DYNAMIC EXERCISE; STROMAL AREAS; AXIAL LENGTH; THICKNESS	Aims To determine the effects of dynamic exercise on the circulation and the luminal and stromal areas of the choroid in normal eyes. Methods This was a prospective interventional study of 38 eyes of 38 normal subjects enrolled by invitation. The systolic and diastolic blood pressures, heart rate, intraocularpressure, mean ocular perfusion pressure (MOPP), choroidal blood velocity, and enhanced depth imaging optical coherence tomographic (EDI-OCT) images were recorded before, and immediately after mild dynamic exercise. The same measurements were recorded after 10 min of rest. The choroidal blood velocity was measured bylaser speckle flowgraphy, and the mean blur rate was used for the evaluations. The horizontal EDI-OCT images of the subfoveal choroid were converted to binary images. The central choroidal thickness (CCT), total cross sectional choroidal area, luminal areas, stromal areas, and the ratio of luminal area to total choroidal area (L/C ratio) were determined from these images. Results The systolic and diastolic blood pressures, heart rate, MOPP, and the mean blur rate were significantly increased immediately after the exercise and significantly decreased 10 minutes after the exercise. There wereno significant changes in the mean CCT, the mean total choroidal area, the mean luminal and stromal areas, and the mean L/C ratio after the exercise. Conclusions Our results suggest that a rest period is needed before measurements of blood flow velocity but not necessary for the EDI-OCT imaging to determine the choroidal thickness and area.	[Kinoshita, Takamasa; Akalwa, Kei; Semba, Kentaro; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan; [Kinoshita, Takamasa; Mori, Junya; Okuda, Natsuki; Imaizumi, Hiroko; Iwasaki, Masanori; Shimizu, Miho; Miyamoto, Hirotomo] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Tokushima University; Sapporo City General Hospital; Kagoshima University	Kinoshita, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan.	knst129@gmail.com	Kinoshita, Takamasa/S-9174-2019; Iwasaki, Masanori/GQH-9944-2022	Kinoshita, Takamasa/0000-0002-0465-2140; 	Ministry of Education, Culture, Sports, Science and Technology, Japan [16K11288]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grant-in-aid 16K11288 (to YM) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. URL: http://www.mext.go.ip/ english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwassia AA, 2013, RETINA-J RET VIT DIS, V33, P160, DOI 10.1097/IAE.0b013e3182618c22; ASHKENAZI I, 1992, INVEST OPHTH VIS SCI, V33, P2874; BILL A, 1990, EYE, V4, P319, DOI 10.1038/eye.1990.43; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; CHRISTENSEN NJ, 1983, ANNU REV PHYSIOL, V45, P139, DOI 10.1146/annurev.ph.45.030183.001035; Cicek A, 2016, INT OPHTHALMOL; Egawa M, 2016, BRIT J OPHTHALMOL, V100, P1646, DOI 10.1136/bjophthalmol-2015-307734; Egawa M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0127-7; Fuchsjager-Mayrl G, 2003, INVEST OPHTH VIS SCI, V44, P728, DOI 10.1167/iovs.02-0372; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; Harris A, 1996, GRAEF ARCH CLIN EXP, V234, P440, DOI 10.1007/BF02539410; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HONG J, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PONE.0104294; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Iwata A, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0014-2; Jablonski MM, 2007, INVEST OPHTH VIS SCI, V48, P479, DOI 10.1167/iovs.06-0972; Jones H, 2006, HYPERTENSION, V47, P778, DOI 10.1161/01.HYP.0000206421.09642.b5; Kawano H, 2016, GRAEF ARCH CLIN EXP, V254, P421, DOI 10.1007/s00417-016-3283-4; Kinoshita T, 2017, BRIT J OPHTHALMOL, V101, P360, DOI 10.1136/bjophthalmol-2016-308594; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; LEIGHTON DA, 1970, BRIT J OPHTHALMOL, V54, P599, DOI 10.1136/bjo.54.9.599; LI X, 2016, INVEST OPHTH VIS SCI, V57, pCT189, DOI DOI 10.1167/IOVS.15-18449; Lovasik JV, 2003, INVEST OPHTH VIS SCI, V44, P2126, DOI 10.1167/iovs.02-0825; Luksch A, 2003, INVEST OPHTH VIS SCI, V44, P734, DOI 10.1167/iovs.02-0177; Lutjen-Drecoll E, 2006, EXP EYE RES, V82, P357, DOI 10.1016/j.exer.2005.09.015; MacDonald JR, 2002, J HUM HYPERTENS, V16, P225, DOI 10.1038/sj.jhh.1001377; MASTER AM, 1968, AM HEART J, V75, P809, DOI 10.1016/0002-8703(68)90042-2; Nemeth J, 2002, GRAEF ARCH CLIN EXP, V240, P835, DOI 10.1007/s00417-002-0552-1; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; PALATINI P, 1994, CLIN SCI, V87, P275, DOI 10.1042/cs0870275; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Portmann N, INVEST OPHTHALMOL VI, V53, P7068; Read SA, 2011, EYE, V25, P767, DOI 10.1038/eye.2011.54; Sayin N, 2015, INDIAN J OPHTHALMOL, V63, P445, DOI 10.4103/0301-4738.159884; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Suzuki T, 2003, AM J OPHTHALMOL, V136, P62, DOI 10.1016/S0002-9394(03)00149-1; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; WENER J, 1953, CAN MED ASSOC J, V68, P368	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168336	10.1371/journal.pone.0168336	http://dx.doi.org/10.1371/journal.pone.0168336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973598	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300077
J	Seth, C; Mas, C; Conod, A; Mueller, J; Siems, K; Kuciak, M; Borges, I; Altaba, ARI				Seth, Chandan; Mas, Christophe; Conod, Arwen; Mueller, Jens; Siems, Karsten; Kuciak, Monika; Borges, Isabel; Altaba, Ariel Ruiz I.			Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; STEM-CELLS; INHIBITION; GROWTH; ACTIVATION; EXPRESSION; WITHAFERIN; PROMOTES; BINDING; ARREST	The WNT-TCF signaling pathway participates in adult tissue homeostasis and repair, and is hyperactive in a number of human diseases including cancers of the colon. Whereas to date there are no antagonists approved for patient use, a potential problem for their sustained use is the blockade of WNT signaling in healthy tissues, thus provoking potentially serious co-lateral damage. Here we have screened a library of plant and microorganism small molecules for novel WNT signaling antagonists and describe withanolide F as a potent WNT-TCF response blocker. This steroidal lactone inhibits TCF-dependent colon cancer xenograft growth and mimics the effects of genetic blockade of TCF and of ivermectin, a previously reported WNT-TCF blocker. However, withanolide F is unique in that it imposes a long-lasting repression of tumor growth, WNT-TCF targets and cancer stem cell clonogenicity after drug treatment. These findings are paralleled by its modulation of chromatin regulators and its alteration of overall H3K4me1 levels. Our results open up the possibility to permanently repress essential signaling responses in cancer cells through limited treatments with small molecules.	[Seth, Chandan; Mas, Christophe; Conod, Arwen; Kuciak, Monika; Borges, Isabel; Altaba, Ariel Ruiz I.] CMU, Dept Med Genet & Dev, 1 Rue Michel Servet, Geneva, Switzerland; [Mueller, Jens; Siems, Karsten] Analyticon Discovery, Biotech Campus Potsdam Hermannswerder, Potsdam, Germany	University of Geneva	Altaba, ARI (corresponding author), CMU, Dept Med Genet & Dev, 1 Rue Michel Servet, Geneva, Switzerland.	Ariel.RuizAltaba@unige.ch		Seth Nanda, Chandan/0000-0002-3955-8808; Mas, Christophe/0000-0002-7585-1091; Ruiz i Altaba, Ariel/0000-0003-2292-3933	European Union; Analyticon Discovery; Swiss Cancer League; National Swiss Science Foundation; Departement d'Instruction Publique de Geneve; Analyticon Discovery Gmbh	European Union(European Commission); Analyticon Discovery; Swiss Cancer League; National Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Departement d'Instruction Publique de Geneve; Analyticon Discovery Gmbh	This work was funded by European Union ITN grants CAPPELLA and HEALING to ARA (Universite de Geneve) and Analyticon Discovery, and by the Swiss Cancer League, National Swiss Science Foundation and the Departement d'Instruction Publique de Geneve to ARA. Analyticon Discovery Gmbh provided support in the form of funds for small molecule sample preparation and analyses and salaries for authors JM and KS. Analyticon was in charge of providing extracts and small molecules and the discussion of the initial screen and project, as well as ongoing discussion on small molecules and their effects. As a company, it did not have additional roles in data collection and analysis, decision to publish, or preparation of the manuscript other than JM and KS providing insight and comments on the ms. The specific roles of these authors are articulated in the 'author contributions' section.	Abdeljebbar LH, 2007, HELV CHIM ACTA, V90, P346, DOI 10.1002/hlca.200790041; Amin H, 2016, MOL CARCINOGEN, V55, P864, DOI 10.1002/mc.22328; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Beg M, 2014, PHYTOMEDICINE, V21, P406, DOI 10.1016/j.phymed.2013.10.009; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chevillard-Briet M, 2014, HUM MOL GENET, V23, P2120, DOI 10.1093/hmg/ddt604; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Duquet A, 2014, EMBO MOL MED, V6, P882, DOI 10.15252/emmm.201303799; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; Fu Y, 2013, EMBO MOL MED, V5, P737, DOI 10.1002/emmm.201202218; Fuentes RG, 2015, NAT PROD REP, V32, P1622, DOI 10.1039/c5np00074b; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Gu MC, 2014, INVEST NEW DRUG, V32, P68, DOI 10.1007/s10637-013-9987-y; Abdeljebbar LH, 2009, THERAPIE, V64, P121, DOI 10.2515/therapie/2009015; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ihsan-ul-Haq, 2013, J NAT PROD, V76, P22, DOI 10.1021/np300534x; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kwon M, 2014, INT J CANCER, V135, P48, DOI 10.1002/ijc.28662; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lorente-Trigos A, 2010, J MOL CELL BIOL, V2, P318, DOI 10.1093/jmcb/mjq035; Melotti A, 2014, EMBO MOL MED, V6, P1263, DOI 10.15252/emmm.201404084; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; Panagopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063663; Parody JP, 2010, GROWTH FACTORS, V28, P166, DOI 10.3109/08977190903547863; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Sarkar S, 2014, ENDOCR-RELAT CANCER, V21, P113, DOI 10.1530/ERC-13-0315; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Singh N, 2011, AFR J TRADIT COMPLEM, V8, P208, DOI 10.4314/ajtcam.v8i5S.9; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168170	10.1371/journal.pone.0168170	http://dx.doi.org/10.1371/journal.pone.0168170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973612	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300062
J	Zhang, YL; Liao, ZT; Wei, QJ; Pan, YF; Wang, XW; Cao, SY; Guo, ZS; Wu, YQ; Rong, J; Jin, O; Xu, ML; Lin, ZM; Gu, JR				Zhang, Yanli; Liao, Zetao; Wei, Qiujing; Pan, Yunfeng; Wang, Xinwei; Cao, Shuangyan; Guo, Zishi; Wu, Yuqiong; Rong, Ju; Jin, Ou; Xu, Manlong; Lin, Zhiming; Gu, Jieruo			A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENETIC-SUSCEPTIBILITY; MHC; ASSOCIATION; HLA-B27; ERAP1; MAPS	Objectives To screen susceptibility loci for ankylosing spondylitis (AS) using an affected-only linkage analysis based on high-density single nucleotide polymorphisms (SNPs) in a genome-wide manner. Patients and Methods AS patients from ten families with Cantonese origin of China were enrolled in the study. Blood samples were genotyped using genomic DNA derived from peripheral blood leukocytes by Illumina HumanHap 610-Quad SNP Chip. Genotype data were generated using the Illumina BeadStudio 3.2 software. PLINK package was used to remove non-autosomal SNPs and to further eliminate markers of typing errors. An affected-only linkage analysis was carried out using both non-parametric and parametric linkage analyses, as implemented in MERLIN. Result Seventy-eight AS patients (48 males and 30 females, mean age: 39 +/- 6 years) were enrolled in the study. The mean age of onset was 23 +/- 10 years and mean duration of disease was 16.7 +/- 12.2 years. Iritis (2/76, 2.86%), dactylitis (5/78, 6.41%), hip joint involvement (9/78, 11.54%), peripheral arthritis (22/78, 28.21%), inflammatory back pain (IBP) (69/78, 88.46%) and HLA-B27 positivity (70/78, 89.74%) were observed in these patients. Using non-parameter linkage analysis, we found one susceptibility locus for AS, IBP and HLA-B27 in 6p21 respectively, spanning about 13.5Mb, 20.9Mb and 21.2Mb, respectively No significant results were found in the other clinical trait groups including dactylitis, hip involved and arthritis. The identical susceptibility locus region spanning above 9.44Mb was detected in AS IBP and HLA-B27 by the parametric linkage analysis. Conclusion Our genome-wide SNP linkage analysis in ten families with ankylosing spondylitis suggests a susceptibility locus on 6p21 in AS, which is a risk locus for IBP in AS patients.	[Zhang, Yanli; Liao, Zetao; Wei, Qiujing; Pan, Yunfeng; Wang, Xinwei; Cao, Shuangyan; Guo, Zishi; Wu, Yuqiong; Rong, Ju; Jin, Ou; Xu, Manlong; Lin, Zhiming; Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Lin, ZM; Gu, JR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China.	lzm-zj99@163.com; gujieruo@163.com			Sun Yat-Sen University [5010]; National Natural Science Foundation for the youth NSFY of China [81302583]; Guangdong Natural Science Funds for Distinguished Young Scholar [2014A030306039]; High-level personnel of special support program for Technology Innovative Talents; Top Young of Guangdong Province [2015TQ01R516]; Fundamental Research Funds for the Central Universities [16ykzd05]; Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University; Pearl River Nova Program of Guangzhou [201610010005]	Sun Yat-Sen University; National Natural Science Foundation for the youth NSFY of China; Guangdong Natural Science Funds for Distinguished Young Scholar; High-level personnel of special support program for Technology Innovative Talents; Top Young of Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University; Pearl River Nova Program of Guangzhou	This study was supported by 5010 Subject (2007) of Sun Yat-Sen University, National Natural Science Foundation for the youth NSFY of China (Grant No. 81302583), Guangdong Natural Science Funds for Distinguished Young Scholar (Grant No. 2014A030306039), High-level personnel of special support program for Technology Innovative Talents and the Top Young of Guangdong Province (Grant No. 2015TQ01R516), The Fundamental Research Funds for the Central Universities (16ykzd05), Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University and Pearl River Nova Program of Guangzhou (Grant No.201610010005).; We thank Prof. David Tak Yan Yu, Rheumatology Division, University of California at Los Angeles, for assistance and comments on our study. This study was supported by 5010 Subject (2007) of Sun Yat-Sen University, National Natural Science Foundation for the youth NSFY of China (Grant No.81302583), Guangdong Natural Science Funds for Distinguished Young Scholar (Grant No.2014A030306039), High-level personnel of special support program for Technology Innovative Talents and the Top Young of Guangdong Province (Grant No.2015TQ01R516), The Fundamental Research Funds for the Central Universities (16ykzd05), Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University and Pearl River Nova Program of Guangzhou (Grant No. 201610010005). (Si File)	Abecasis Goncalo, 2007, Nat Genet, V39, P153, DOI 10.1038/ng0207-153; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Breban M, 2006, JOINT BONE SPINE, V73, P355, DOI 10.1016/j.jbspin.2005.11.010; Brionez TF, 2008, CURR OPIN RHEUMATOL, V20, P384, DOI 10.1097/BOR.0b013e32830460fe; Brown MA, 2008, RHEUMATOLOGY, V47, P132, DOI 10.1093/rheumatology/kem269; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2016, NAT REV RHEUMATOL, V12, P81, DOI 10.1038/nrrheum.2015.133; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Dick KJ, 2008, NEUROLOGY, V71, P248, DOI 10.1212/01.wnl.0000319610.29522.8a; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Gu J, 2009, J MED GENET, V46, P657, DOI 10.1136/jmg.2009.066456; Keith Michael P, 2012, Am J Orthop (Belle Mead NJ), V41, pE166; Laval SH, 2001, AM J HUM GENET, V68, P918, DOI 10.1086/319509; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peretz A, 2007, Rev Med Brux, V28, P290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reveille JD, 2006, BEST PRACT RES CL RH, V20, P601, DOI 10.1016/j.berh.2006.03.004; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Reveille JD, 2010, J RHEUMATOL, V37, P2624, DOI 10.3899/jrheum.100891; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Zhang G, 2004, ARTHRITIS RHEUM-US, V50, P2246, DOI 10.1002/art.20308	30	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166888	10.1371/journal.pone.0166888	http://dx.doi.org/10.1371/journal.pone.0166888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973620	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300014
J	Boczkowska, M; Lapinski, B; Kordulasinska, I; Dostatny, DF; Czembor, JH				Boczkowska, Maja; Lapinski, Boguslaw; Kordulasinska, Izabela; Dostatny, Denise F.; Czembor, Jerzy H.			Promoting the Use of Common Oat Genetic Resources through Diversity Analysis and Core Collection Construction	PLOS ONE			English	Article							AVENA-SATIVA L.; POPULATION-STRUCTURE; POWDERY MILDEW; GRAIN-YIELD; DNA POLYMORPHISM; AFLP MARKERS; TEST WEIGHT; CROWN RUST; RESISTANCE; CULTIVARS	The assessment of diversity and population structure and construction of a core collection is beneficial for the efficient use and management of germplasm. A unique collection of common oat landraces, cultivated in the temperate climate of central Europe until the end of the twentieth century, is preserved in the Polish gene bank. It consists of 91 accessions that have never been used in breeding programs. In order to optimise the use of this genetic resource, we aimed to: (1) determine genetic and agro-morphological diversity, (2) identify internal genetic variation of the tested accessions, (3) form a core collection and (4) recognise the accessions useful for breeding programs or re-release for cultivation. The collection was screened using ISSR markers (1520 loci) and eight agro-morphological traits. Uniquely, we performed molecular studies based on 24 individuals of every accession instead of bulk samples. Therefore, assessment of the degree of diversity within each population and the identification of overlapping gene pools were possible. The observed internal diversity (Nei unbiased coefficient) was in the range of 0.17-0.31. Based on combined genetic and agromorphological data, we established the core collection composed of 21 landraces. Due to valuable compositions of important traits, some accessions were also identified as useful for breeding programs. The population structure and principal coordinate analysis revealed two major clusters. Based on the previous results, the accessions classified within the smaller one were identified as obsolete varieties instead of landraces. Our results show that the oat landraces are, in general, resistant to local races of diseases, well adapted to local conditions and, in some cases, yielding at the level of modern varieties. Therefore, in situ conservation of the landraces in the near future may be satisfactory for both farmers and researchers in terms of the genetic resources preservation.	[Boczkowska, Maja; Lapinski, Boguslaw; Kordulasinska, Izabela; Dostatny, Denise F.; Czembor, Jerzy H.] Natl Ctr Plant Genet Resources, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Radzikow, Poland	Institute of Plant Breeding & Acclimatization	Boczkowska, M (corresponding author), Natl Ctr Plant Genet Resources, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Radzikow, Poland.	m.boczkowska@ihar.edu.pl	Czembor, Jerzy H./I-8188-2015; Boczkowska, Maja/J-3654-2019; Dostatny, Denise/AAG-6582-2021	Boczkowska, Maja/0000-0001-8691-410X; Dostatny, Denise/0000-0002-6544-1531; Czembor, Jerzy H./0000-0002-3997-3868	Ministry of Agriculture and Rural Development of Poland [3-1-02-0-08, 3-1-02-0-13, PW 1.2, 3-1-03-0-08, 3-1-03-0-23]	Ministry of Agriculture and Rural Development of Poland	This work was supported by the Ministry of Agriculture and Rural Development of Poland in the form of the Multi-annual programs: 2015-2020:Creation of scientific basis for biological improvement and plant genetic resources protection as source of innovation and support of sustainable agriculture and national food security (Project No. 3-1-02-0-08; 3-1-02-0-13, PW 1.2); 2008-2013:Improving Plants for Sustainable agro-ecosystems, High quality food and crop production for non-food purposes (Project No. 3-1-03-0-08; 3-1-03-0-23).	Achleitner A, 2008, THEOR APPL GENET, V117, P1041, DOI 10.1007/s00122-008-0843-y; Adhikari TB, 2003, PHYTOPATHOLOGY, V93, P1158, DOI 10.1094/PHYTO.2003.93.9.1158; Baohong G, 2003, CEREAL RES COMMUN, V31, P339; Boczkowska M, 2016, ANN APPL BIOL, V169, P155, DOI 10.1111/aab.12289; Boczkowska M, 2014, GENET RESOUR CROP EV, V61, P927, DOI 10.1007/s10722-014-0087-4; Boczkowska M, 2013, GENET RESOUR CROP EV, V60, P2157, DOI 10.1007/s10722-013-9984-1; Boczkowska M, 2015, CEREAL RES COMMUN; Breseghello F, 2013, J AGR FOOD CHEM, V61, P8277, DOI 10.1021/jf305531j; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EGISET, 2015, DAT NAT CTR PLANT GE; Ersts PJ, 2016, GEOGRAPHIC DISTANCE; EXCOFFIER L, 1992, GENETICS, V131, P479; FAO, 2010, 2 FAO; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Frey K. J., 1982, Plant improvement and somatic cell genetics, P43; Fu YB, 2004, CAN J PLANT SCI, V84, P23; Fu YB, 2003, CROP SCI, V43, P1989, DOI 10.2135/cropsci2003.1989; Gollin D, 2000, AM J AGR ECON, V82, P812, DOI 10.1111/0002-9092.00083; Gorny A., 2005, OUTLINE CERALS GENET; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Gregova E, 1999, GENET RESOUR CROP EV, V46, P521, DOI 10.1023/A:1008751815445; Hagenblad J, 2012, GENET RESOUR CROP EV, V59, P1185, DOI 10.1007/s10722-011-9754-x; Hammami R, 2014, PLANT SYST EVOL, V300, P2029, DOI 10.1007/s00606-014-1021-0; Herrmann M, 1996, EUPHYTICA, V89, P405; Holland JB, 2002, THEOR APPL GENET, V105, P113, DOI 10.1007/s00122-001-0845-5; Holland JB, 2001, CROP SCI, V41, P1041, DOI 10.2135/cropsci2001.4141041x; Hsam SLK, 2014, J APPL GENET, V55, P155, DOI 10.1007/s13353-014-0196-y; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES IT, 1987, ANN APPL BIOL, V110, P591, DOI 10.1111/j.1744-7348.1987.tb04178.x; Karp A, 1997, MOL TOOLS SCREENING; Khan MK, 2014, GENET RESOUR CROP EV, V61, P1001, DOI 10.1007/s10722-014-0114-5; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; KOLB FL, 1990, CROP SCI, V30, P1023, DOI 10.2135/cropsci1990.0011183X003000050014x; LAWES DA, 1965, PLANT PATHOL, V14, P125, DOI 10.1111/j.1365-3059.1965.tb00295.x; LEATH S, 1991, PLANT DIS, V75, P807, DOI 10.1094/PD-75-0807; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Loskutov IG, 2001, RUSS J GENET+, V37, P467, DOI 10.1023/A:1016697812009; MANTEL N, 1967, CANCER RES, V27, P209; Montilla-Bascon G, 2013, PLANT MOL BIOL REP, V31, P1305, DOI 10.1007/s11105-013-0598-8; MUEHLBAU.FJ, 1971, CROP SCI, V11, P375, DOI 10.2135/cropsci1971.0011183X001100030019x; Newton AC, 2010, AGRON SUSTAIN DEV, V30, P237, DOI 10.1051/agro/2009032; Nikoloudakis N, 2008, THEOR APPL GENET, V117, P273, DOI 10.1007/s00122-008-0772-9; Nowosielska Dorota, 2008, Plant Breeding and Seed Science, V58, P11; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Pawlisch PE, 1962, CROP SCI, P231; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PETR FC, 1966, CROP SCI, V6, P259, DOI 10.2135/cropsci1966.0011183X000600030013x; PIXLEY KV, 1991, CROP SCI, V31, P36, DOI 10.2135/cropsci1991.0011183X003100010008x; Roldan-Ruiz I, 2000, MOL BREEDING, V6, P125, DOI 10.1023/A:1009680614564; Schwarzbach E., 1988, EUROPEAN HDB PLANT D; Siripoonwiwat W, 1996, J QUANTITATIVE TRAIT, P2; Sucher Nikolaus J, 2012, Methods Mol Biol, V862, P13, DOI 10.1007/978-1-61779-609-8_2; TAKEDA K, 1977, EUPHYTICA, V26, P309, DOI 10.1007/BF00026992; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; UPOV, 1994, INT CONV PROT NEW VA; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Wang HF, 2012, THEOR APPL GENET, V124, P789, DOI 10.1007/s00122-011-1750-1; Winkler LR, 2016, FRONT PLANT SCI, P7; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhu S, 2003, CROP SCI, V43, P358, DOI 10.2135/cropsci2003.0358; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	67	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167855	10.1371/journal.pone.0167855	http://dx.doi.org/10.1371/journal.pone.0167855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959891	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900019
J	Yadav, KK; Datta, S; Naglot, A; Bora, A; Hmuaka, V; Bhagyawant, S; Gogoi, HK; Veer, V; Raju, PS				Yadav, Kamlesh K.; Datta, Sibnarayan; Naglot, Ashok; Bora, Ajitabh; Hmuaka, Vanlal; Bhagyawant, Sameer; Gogoi, Hemanta K.; Veer, Vijay; Raju, P. Srinivas			Diversity of Cultivable Midgut Microbiota at Different Stages of the Asian Tiger Mosquito, Aedes albopictus from Tezpur, India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; SP NOV.; GUT MICROBIOTA; POPULATION-DYNAMICS; BACTERIAL DIVERSITY; SYMBIOTIC BACTERIA; VECTOR; CHIKUNGUNYA; DIPTERA; MALARIA	Aedes aegypti and Ae. albopictus are among the most important vectors of arboviral diseases, worldwide. Recent studies indicate that diverse midgut microbiota of mosquitoes significantly affect development, digestion, metabolism, and immunity of their hosts. Midgut microbiota has also been suggested to modulate the competency of mosquitoes to transmit arboviruses, malaria parasites etc. Interestingly, the midgut microbial flora is dynamic and the diversity changes with the development of vectors, in addition to other factors such as species, sex, life-stage, feeding behavior and geographical origin. The aim of the present study was to investigate the midgut bacterial diversity among larva, adult male, sugar fed female and blood fed female Ae. albopictus collected from Tezpur, Northeastern India. Based on colony morphological characteristics, we selected 113 cultivable bacterial isolates for 16S rRNA gene sequence based molecular identification. Of the 113 isolates, we could identify 35 bacterial species belonging to 18 distinct genera under four major phyla, namely Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes. Phyla Proteobacteria and Firmicutes accounted for majority (80%) of the species, while phylum Actinobacteria constituted 17% of the species. Bacteroidetes was the least represented phylum, characterized by a single species-Chryseobacterium rhizoplanae, isolated from blood fed individuals. Dissection of midgut microbiota diversity at different developmental stages of Ae. albopictus will be helpful in better understanding mosquito-borne diseases, and for designing effective strategies to manage mosquito-borne diseases.	[Yadav, Kamlesh K.; Datta, Sibnarayan; Naglot, Ashok; Bora, Ajitabh; Hmuaka, Vanlal; Gogoi, Hemanta K.; Veer, Vijay; Raju, P. Srinivas] DRDO, Def Res Lab, Div Biotechnol, Tezpur, India; [Bhagyawant, Sameer] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India	Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL); Jiwaji University Gwalior	Yadav, KK (corresponding author), DRDO, Def Res Lab, Div Biotechnol, Tezpur, India.	kamalbiotech.yadav@gmail.com	Datta, S./E-7036-2010; Yadav, Kamlesh/O-2071-2017	Datta, S./0000-0001-6953-1510; Yadav, Kamlesh/0000-0003-3871-9937; DHANGRAH, VINOD KUMAR/0000-0002-7954-6326				Abdul-Ghani R, 2012, ACTA TROP, V121, P71, DOI 10.1016/j.actatropica.2011.11.001; Alam SI, 2006, INT J SYST EVOL MICR, V56, P715, DOI 10.1099/ijs.0.63808-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401; Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806; CDC, SURV CONTR AED AEG A; Chandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080453; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Chavshin AR, 2013, SYMBIOSIS, V60, P17, DOI 10.1007/s13199-013-0231-5; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clarke K. R., 2001, CHANGES MARINE COMMU; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004; Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223; Diaz-Nieto LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153133; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Finney CAM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004646; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; HaraKudo Y, 1997, MICROB PATHOGENESIS, V22, P31, DOI 10.1006/mpat.1996.0088; Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Kampfer P, 2015, ANTON LEEUW INT J G, V107, P533, DOI 10.1007/s10482-014-0349-3; Kim HJ, 2011, J MICROBIOL, V49, P1044, DOI 10.1007/s12275-011-1548-5; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Laffineur K, 2003, J CLIN MICROBIOL, V41, P2242, DOI 10.1128/JCM.41.5.2242-2246.2003; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Metchnikoff E, 1908, CR HEBD ACAD SCI, V147, P579; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Moro CV, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-70; Mourya D. T., 2002, Dengue Bulletin, V26, P190; Oakeson KF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00392-16; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051; Rueda LM, 2004, PICRORIAL KEYS IDENT; Sambrook J., 2001, MOL CLONING LAB MANU; Shivaji S, 2009, INT J SYST EVOL MICR, V59, P2977, DOI 10.1099/ijs.0.002527-0; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TW, 1998, J AM MOSQUITO CONTR, V14, P72; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Soto-Rodriguez SA, 2013, J APPL MICROBIOL, V115, P654, DOI 10.1111/jam.12280; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; World Health Organization, 2016, ZIK SIT REP NEUR SYN; Yadav KK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1252-0; Yadav KK, 2015, INT J MICROBIOL RES, V2; Zhu DC, 2016, INT J SYST EVOL MICR, V66, P1857, DOI 10.1099/ijsem.0.000957; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	82	30	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167409	10.1371/journal.pone.0167409	http://dx.doi.org/10.1371/journal.pone.0167409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941985	Green Published, Green Submitted, gold			2022-12-26	WOS:000392745600015
J	Annarapu, GK; Singhal, R; Gupta, A; Chawla, S; Batra, H; Seth, T; Guchhait, P				Annarapu, Gowtham K.; Singhal, Rashi; Gupta, Avinash; Chawla, Sheetal; Batra, Harish; Seth, Tulika; Guchhait, Prasenjit			HbS Binding to GP1b alpha Activates Platelets in Sickle Cell Disease	PLOS ONE			English	Article							INTRAVASCULAR HEMOLYSIS; HEMOGLOBIN; MECHANISM; ADAMTS-13	Intravascular hemolysis increases the risk of thrombosis in hemolytic disorders. Our previous study showed that the binding of adult hemoglobin (HbA) to glycoprotein (GP) 1b alpha induced the activation of platelets. The elevated plasma Hb or platelet surface bound Hb positively correlated with platelet activation in patients with paroxysmal nocturnal hemoglobinuria (PNH). Furthermore, this study shows that the sickle Hb [HbS, occurs due to single nucleotide polymorphism at A>T of beta-globin gene of Hb and causes sickle cell disease (SCD)] also bound to GP1b alpha and activated platelets in a concentration-dependent manner. The HbS bound to glycocalicin (extramembranous part of GP1ba) with K-D similar to 10.46 +/- 3 mu M. HbS induced phosphorylation of signaling adapter proteins, such as Lyn, PI3K, Akt and ERK in platelets, and also increased the surface expression of platelet activation markers such as P-selectin (10.7 fold) and PAC1 binding (10.4 fold) in platelet surface in a concentration-dependent manner. HbS also increased the platelet microparticle-generation (4.7 fold) and thrombus-formation (4.3 fold) in a concentration-dependent manner. An elevated level of extracellular Hb in plasma correlated directly with platelet activation markers such as P-selectin (r = 0.7947), PAC1 binding (r = 0.5914) on platelet surface and plasma levels of platelet-derived microparticles (r = 0.7834) in patients with SCD. Our study therefore suggests that the HbS-induced platelet activation may play a crucial role in intravascular clot formation observed in SCD patients characterized by high propensity to vascular occlusion and hypercoagulable states.	[Annarapu, Gowtham K.; Singhal, Rashi; Gupta, Avinash; Chawla, Sheetal; Guchhait, Prasenjit] Natl Capital Reg Biotech Sci Cluster, Dis Biol Lab, Reg Ctr Biotechnol, Faridabad, India; [Annarapu, Gowtham K.; Singhal, Rashi] Manipal Univ, Dept Biotechnol, Manipal, Karnataka, India; [Batra, Harish; Seth, Tulika] All India Inst Med Sci, Dept Med Hematol, New Delhi, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Manipal Academy of Higher Education (MAHE); All India Institute of Medical Sciences (AIIMS) New Delhi	Guchhait, P (corresponding author), Natl Capital Reg Biotech Sci Cluster, Dis Biol Lab, Reg Ctr Biotechnol, Faridabad, India.	prasenjit@rcb.res.in	Annarapu, Gowtham K/N-5829-2017	Annarapu, Gowtham K/0000-0002-6761-0976				[Anonymous], 2008, REPORT SICKLE CELL D; [Anonymous], 2006, WHO REPORT SICKLE CE; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Chirico EN, 2015, SPORTS MED; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200; Du XP, 2007, CURR OPIN HEMATOL, V14, P262, DOI 10.1097/MOH.0b013e3280dce51a; Gowtham K, 2016, PLOS ONE; Helms CC, 2013, J THROMB HAEMOST, V11, P2148, DOI 10.1111/jth.12422; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Singhal R, 2015, HAEMATOLOGICA, V100, P1526, DOI 10.3324/haematol.2015.132183; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Zhang D, 2016, BLOOD; Zhou Z, 2012, CURR VASC PHARMACOL, V10, P756, DOI 10.2174/157016112803520738; Zhou Z, 2009, THROMB HAEMOSTASIS, V101, P1070, DOI 10.1160/TH08-10-0677	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167899	10.1371/journal.pone.0167899	http://dx.doi.org/10.1371/journal.pone.0167899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936141	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100227
J	Azuma, K; Uchiyama, I; Tanigawa, M; Bamba, I; Azuma, M; Takano, H; Yoshikawa, T; Sakabe, K				Azuma, Kenichi; Uchiyama, Iwao; Tanigawa, Mari; Bamba, Ikuko; Azuma, Michiyo; Takano, Hirohisa; Yoshikawa, Toshikazu; Sakabe, Kou			Association of Odor Thresholds and Responses in Cerebral Blood Flow of the Prefrontal Area during Olfactory Stimulation in Patients with Multiple Chemical Sensitivity	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; IDENTIFICATION TEST; AIRBORNE CHEMICALS; GENERAL-POPULATION; EPISODIC MEMORY; BRAIN; PROVOCATION; DYSFUNCTION; COMPONENTS; EXPOSURE	Multiple chemical sensitivity (MCS) is a disorder characterized by nonspecific and recurrent symptoms from various organ systems associated with exposure to low levels of chemicals. Patients with MCS process odors differently than controls do. Previously, we suggested that this odor processing was associated with increased regional cerebral blood flow (rCBF) in the prefrontal area during olfactory stimulation using near-infrared spectroscopic (NIRS) imaging. The aim of this study was to investigate the association of odor thresholds and changes in rCBF during olfactory stimulation at odor threshold levels in patients with MCS. We investigated changes in the prefrontal area using NIRS imaging and a T&T olfactometer during olfactory stimulation with two different odorants (sweet and fecal) at three concentrations (zero, odor recognition threshold, and normal perceived odor level) in 10 patients with MCS and six controls. The T&T olfactometer threshold test and subjective assessment of irritating and hedonic odors were also performed. The results indicated that the scores for both unpleasant and pungent odors were significantly higher for those for sweet odors at the normal perceived level in patients with MCS than in controls. The brain responses at the recognition threshold (fecal odor) and normal perceived levels (sweet and fecal odors) were stronger in patients with MCS than in controls. However, significant differences in the odor detection and recognition thresholds and odor intensity score between the two groups were not observed. These brain responses may involve cognitive and memory processing systems during past exposure to chemicals. Further research regarding the cognitive features of sensory perception and memory due to past exposure to chemicals and their associations with MCS symptoms is needed.	[Azuma, Kenichi] Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Basic Res Div, Sick House Med Sci Lab, Kyoto, Japan; [Uchiyama, Iwao] Hyakumanben Clin, Outpatient Dept Sick House Syndrome, Kyoto, Japan; [Tanigawa, Mari] Louis Pasteur Ctr Med Res, Clin Immune Funct Lab, Basic Res Div, Kyoto, Japan; [Tanigawa, Mari] Hyakumanben Clin, Div Internal Med, Kyoto, Japan; [Bamba, Ikuko] Tokyo Gakugei Univ, Fac Educ, Home Econ, Koganei, Tokyo, Japan; [Azuma, Michiyo] Kio Univ, Fac Hlth Sci, Dept Human Environm Design, Koryo, Nara, Japan; [Takano, Hirohisa] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Kyoto, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Dept Internal Med, Kyoto, Japan; [Sakabe, Kou] Tokai Univ, Dept Anat & Cellular Biol, Sch Med, Isehara, Kanagawa, Japan	Kindai University (Kinki University); Tokyo Gakugei University; Kyoto University; Kyoto Prefectural University of Medicine; Tokai University	Azuma, K (corresponding author), Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka, Japan.; Azuma, K (corresponding author), Louis Pasteur Ctr Med Res, Basic Res Div, Sick House Med Sci Lab, Kyoto, Japan.	kenazuma@med.kindai.ac.jp		Azuma, Kenichi/0000-0002-6382-9807	Japan Ministry of the Environment [H25-5962]; Japan Ministry of Health, Labour and Welfare [H25-008]; Grants-in-Aid for Scientific Research [16K09116] Funding Source: KAKEN	Japan Ministry of the Environment(Ministry of the Environment, Japan); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by a health science research grant (H25-5962) from the Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by a health science research grant (H25-5962) from the Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. We express our sincere appreciation to the staff members of the Hyakumanben Clinic for their assistance in data collection.	Alessandrini M, 2016, BRAIN TOPOGR, V29, P243, DOI 10.1007/s10548-015-0453-3; Andersson L, 2014, J PSYCHOSOM RES, V77, P401, DOI 10.1016/j.jpsychores.2014.09.014; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; Azuma K, 2015, ENVIRON HEALTH PREV, V20, P185, DOI 10.1007/s12199-015-0448-4; Azuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080567; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Berg ND, 2009, INT ARCH OCC ENV HEA, V82, P509, DOI 10.1007/s00420-008-0352-y; Bornschein S, 2008, CLIN TOXICOL, V46, P443, DOI 10.1080/15563650701742438; Chiaravalloti A, 2015, EUR J NUCL MED MOL I, V42, P733, DOI 10.1007/s00259-014-2969-2; CULLEN MR, 1987, OCCUP MED, V2, P655; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Dantoft TM, 2015, CURR RHEUMATOL REV, V11, P167, DOI 10.2174/157339711102150702111101; Das-Munshi J, 2006, J ALLERGY CLIN IMMUN, V118, P1257, DOI 10.1016/j.jaci.2006.07.046; DOTY RL, 1994, PERCEPT PSYCHOPHYS, V56, P701, DOI 10.3758/BF03208363; ENGEN T, 1987, AM SCI, V75, P497; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; Hasegawa Maki, 2009, JAPANESE J ALLERGY, V58, p112 ; Hashimoto Y, 2004, CHEM SENSES, V29, P565, DOI 10.1093/chemse/bjh061; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; HINTON PB, 1993, B PSYCHONOMIC SOC, V31, P595, DOI 10.3758/BF03337365; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; IKEDA K, 1988, J LARYNGOL OTOL, V102, P1111, DOI 10.1017/S0022215100107467; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kondo H, 1998, AM J RHINOL, V12, P353, DOI 10.2500/105065898780182390; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Saive AL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00240; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Skovbjerg S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/304314; Sorg BA, 1999, CRIT REV NEUROBIOL, V13, P283, DOI 10.1615/CritRevNeurobiol.v13.i3.30; STAUDENMAYER H, 1993, REGUL TOXICOL PHARM, V18, P44, DOI 10.1006/rtph.1993.1043; TAKAGI SF, 1987, ANN NY ACAD SCI, V510, P113; Tanida M, 2004, NEUROSCI LETT, V369, P69, DOI 10.1016/j.neulet.2004.07.076; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Winder C, 2002, TOXICOL LETT, V128, P85, DOI 10.1016/S0378-4274(01)00536-7; Yoshida T, 2012, JPN SOC OCCUP MED TR, V60, P11; ZUSHO H, 1983, Rhinology (Utrecht), V21, P281; Zusho H, 1981, Auris Nasus Larynx, V8, P19; 1999, ARCH ENVIRON HEALTH, V54, P147, DOI DOI 10.1080/00039899909602251	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168006	10.1371/journal.pone.0168006	http://dx.doi.org/10.1371/journal.pone.0168006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936122	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100249
J	Cloonan, KR; Andreadis, SS; Chen, HB; Jenkins, NE; Baker, TC				Cloonan, Kevin R.; Andreadis, Stefanos S.; Chen, Haibin; Jenkins, Nina E.; Baker, Thomas C.			Attraction, Oviposition and Larval Survival of the Fungus Gnat, Lycoriella ingenua, on Fungal Species Isolated from Adults, Larvae, and Mushroom Compost	PLOS ONE			English	Article							MALI DIPTERA; SCIARID FLY; DROSOPHILA-MELANOGASTER; PERMETHRIN RESISTANCE; PENICILLIUM-CITRINUM; AURIPILA; INSECTICIDES; IDENTIFICATION; VOLATILES; ALLERGEN	We previously showed that the females of the mushroom sciarid, Lycoriella ingenua (Dufour, 1839) (Diptera: Sciaridae), one of the most severe pests of the cultivated white button mushroom, Agaricus bisporus (J. E. Lange) Emil J. Imbach (Agaricales: Agaricaceae), are attracted to the mushroom compost that mushrooms are grown on and not to the mushrooms themselves. We also showed that females are attracted to the parasitic green mold, Trichoderma aggressivum. In an attempt to identify what is in the mushroom compost that attracts female L. ingenua, we isolated several species of fungi from adult males and females, third instar larvae, and mushroom compost itself. We then analyzed the attraction of females to these substrates using a static-flow two choice olfactometer, as well as their oviposition tendencies in another type of assay under choice and no-choice conditions. We also assessed the survival of larvae to adulthood when first instar larvae were placed on each of the isolated fungal species. We found that female flies were attracted most to the mycoparasitic green mold, T. aggressivum, to Penicilium citrinum isolated from adult female bodies, and to Scatylidium thermophilium isolated from the mushroom compost. Gravid female flies laid the most eggs on T. aggressivum, Aspergillus flavus isolated from third instar larval frass, Aspergillus fumigatus isolated from adult male bodies, and on P. citrinum. This egg-laying trend remained consistent under no-choice conditions as females aged. First instar larvae developed to adulthood only on S. thermophilium and Chaetomium sp. isolated from mushroom compost, and on P. citrinum. Our results indicate that the volatiles from a suite of different fungal species act in tandem in the natural setting of mushroom compost, with some first attracting gravid female flies and then others causing them to oviposit. The ecological context of these findings is important for creating an optimal strategy for using possible semiochemicals isolated from these fungal species to better monitor and control this pestiferous mushroom fly species.	[Cloonan, Kevin R.; Andreadis, Stefanos S.; Jenkins, Nina E.; Baker, Thomas C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Chen, Haibin] Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wenzhou Medical University	Baker, TC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	tcb10@psu.edu	Andreadis, Stefanos/GWR-2360-2022		United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant [2012-51181-19912]	United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant	United States Department of Agriculture/National Institute of Food and Agriculture/Specialty Crop Research Initiative Grant number 2012-51181-19912 URL: https://nifa.usda.gov/program/specialty crop-research initiative-sal The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis SS, 2015, FRONTIERS ECOLOGY EV, V3; Andreadis SS, 2015, J CHEM ECOL, V41, P1127, DOI 10.1007/s10886-015-0650-2; Bartlett GR, 1997, PESTIC BIOCHEM PHYS, V58, P173, DOI 10.1006/pest.1997.2306; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Binns E. S, 1980, ENTOMOLOGISTS MONTHL, V115, P77; BINNS ES, 1980, ANN APPL BIOL, V96, P143, DOI 10.1111/j.1744-7348.1980.tb02973.x; Bogart HGG, MYCOPATHOLOGIA, V122, P21; Braun SE, 2012, ENTOMOL EXP APPL, V145, P89, DOI 10.1111/j.1570-7458.2012.01315.x; BREWER KK, 1989, J ECON ENTOMOL, V82, P17, DOI 10.1093/jee/82.1.17; CANTELO WW, 1979, J ECON ENTOMOL, V72, P703, DOI 10.1093/jee/72.5.703; CANTELO WW, 1983, J ECON ENTOMOL, V76, P1433, DOI 10.1093/jee/76.6.1433; CANTELO WW, 1988, J ECON ENTOMOL, V81, P195, DOI 10.1093/jee/81.1.195; Cloonan KR, 2016, ENTOMOL EXP APPL, V159, P298, DOI 10.1111/eea.12439; Cloyd RA, 2008, FLORICULTURE ORNAMEN; Cloyd RA, 2009, HORTSCIENCE, V44, P1366, DOI 10.21273/HORTSCI.44.5.1366; Davis TS, 2011, MICROB ECOL, V61, P626, DOI 10.1007/s00248-010-9773-8; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Fakruddin M, 2015, SPRINGERPLUS, P4; Frouz J, 2002, GLOBAL CHANGE BIOL, V8, P339, DOI 10.1046/j.1354-1013.2001.00474.x; Frouz J, 2001, PEDOBIOLOGIA, V45, P329, DOI 10.1078/0031-4056-00090; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Gotoh T, 1999, JPN J APPL ENTOMOL Z, V43, P181, DOI 10.1303/jjaez.43.181; GREWAL PS, 1993, ANN APPL BIOL, V123, P695, DOI 10.1111/j.1744-7348.1993.tb04939.x; HAUSMANN SM, 1989, J ECON ENTOMOL, V82, P426, DOI 10.1093/jee/82.2.426; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Hussey N.W., 1968, MUSHROOM GROWERS ASS, V236, P338; HUSSEY NW, 1968, ANN APPL BIOL, V62, P395, DOI 10.1111/j.1744-7348.1968.tb05451.x; Jess S, 2009, PEST MANAG SCI, V65, P1195, DOI 10.1002/ps.1809; KIELBASA R, 1980, PENN AES BULL, P1; Kielbasa R, 1981, MELSHEIMER ENTOMOLOG, V31, P15; Kimura H.N. Shashi, 2013, Journal of Biopesticides, V6, P133; KOSTELC JG, 1980, J CHEM ECOL, V6, P1, DOI 10.1007/BF00987522; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Lai HY, 2002, INT ARCH ALLERGY IMM, V127, P181, DOI 10.1159/000053862; LLEWELLYN GC, 1983, J FOOD SAFETY, V5, P113, DOI 10.1111/j.1745-4565.1983.tb00463.x; Mehelis N, 1995, BIOL MANAGEMENT MUSH; Nasir H, 2003, ARCH INSECT BIOCHEM, V52, P175, DOI 10.1002/arch.10079; Ramirez-Camejo LA, 2014, MED MYCOL, V52, P211, DOI 10.1093/mmy/myt008; Sakai Renata Kazuko, 2007, Revista Universidade Rural Serie Ciencias da Vida, V27, P161; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Shamshad A, 2009, J APPL ENTOMOL, V133, P484, DOI 10.1111/j.1439-0418.2008.01362.x; Shirvani-Farsani N, 2013, J PEST SCI, V86, P591, DOI 10.1007/s10340-013-0486-x; Srivoramas T, 2012, INT J PARASITOL RES, V4, P4; Stotefeld L, 2015, CHEMOECOLOGY, V25, P271, DOI 10.1007/s00049-015-0197-2; STRAATSMA G, 1994, APPL ENVIRON MICROB, V60, P454, DOI 10.1128/AEM.60.2.454-458.1994; Su NY, 1999, EUR J BIOCHEM, V261, P115, DOI 10.1046/j.1432-1327.1999.00242.x; Tibbles LL, 2005, ENTOMOL EXP APPL, V116, P73, DOI 10.1111/j.1570-7458.2005.00272.x; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; USDA, 2014, SPEC CROPS MUSHR PRO; Wetzel HA, 1982, SIGNIFICANT PESTS CO; White P. F., 1989, Mushroom Science, V12, P851; WHITE PF, 1986, ANN APPL BIOL, V109, P11, DOI 10.1111/j.1744-7348.1986.tb03179.x; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Yang Y, 2015, APPL ENTOMOL ZOOL, V50, P443, DOI 10.1007/s13355-015-0351-x; Zhang L, 2014, BIORESOURCE TECHNOL, V171, P274, DOI 10.1016/j.biortech.2014.08.079	57	11	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167074	10.1371/journal.pone.0167074	http://dx.doi.org/10.1371/journal.pone.0167074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936070	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100058
J	Kunwar, RM; Baral, K; Paudel, P; Acharya, RP; Thapa-Magar, KB; Cameron, M; Bussmann, RW				Kunwar, Ripu M.; Baral, Kedar; Paudel, Prashant; Acharya, Ram P.; Thapa-Magar, Khum B.; Cameron, Mary; Bussmann, Rainer W.			Land-Use and Socioeconomic Change, Medicinal Plant Selection and Biodiversity Resilience in Far Western Nepal	PLOS ONE			English	Article							TIMBER FOREST PRODUCTS; TRADITIONAL MEDICINE; DADELDHURA DISTRICT; MAPUCHE COMMUNITY; CLIMATE-CHANGE; KNOWLEDGE; CONSERVATION; ETHNOBOTANY; VEGETATION; MANAGEMENT	Indigenous plant use-systems have evolved under, and constantly adapted to human and non-human impacts. In the last decades however, increasing socioeconomic and cultural transformations, including land-use change, outmigration, globalized markets, the introduction of new species, and climate change have led to a decreasing availability of indigenous resources, and are ultimately leading to a reduction of local use-knowledge. Participant observations, discussions, walks-in-the-woods, semi-structured interviews and informal meetings were carried out in 12 villages of far western Nepal between 2011 and 2015 to assess how sociocultural changes have affected the sustenance of indigenous systems and local biodiversity, when compared to studies carried out in the previous decades. Our findings show that there were no statistically significant differences in subject variable means, but differences were relatively important to plant parts-use and plant growth-forms (p = 0.183 and 0.088 respectively). Cissampelos pareira, Acorus calamus, Calotropis gigantea were found to have the greatest relative importance, whereas Ageratina adenophora, Melia azedarach, Carum carvi were most important based on use values. Among them, C. pareira and A. adenophora were introduced. The spatial distribution of species collected for medicine showed that all habitats were important for collection however, habitats close to villages were more favored. The use of non-indigenous and easily available species and more accessible habitats is becoming more prevalent as primary forests become increasingly overexploited, indigenous species become limited, and sociocultural cause of land use change expand. The utilization of indigenous and non-indigenous species and nearby habitats, although possibly affecting the quality of medicinal species, nonetheless reveals the dynamism of indigenous medicines as an adaptive asset mitigating human and non-human environmental changes.	[Kunwar, Ripu M.] Florida Atlantic Univ, Dept Geosci, Boca Raton, FL 33431 USA; [Baral, Kedar] Dist Forest Off, Baitadi, Nepal; [Paudel, Prashant] Georg August Univ, Trop & Int Forestry Program, Gottingen, Germany; [Acharya, Ram P.] Pract Solut, Kathmandu, Nepal; [Thapa-Magar, Khum B.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY USA; [Cameron, Mary] Florida Atlantic Univ, Dept Anthropol, Boca Raton, FL 33431 USA; [Bussmann, Rainer W.] Missouri Bot Garden, William L Brown Ctr, St Louis, MO USA	State University System of Florida; Florida Atlantic University; University of Gottingen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida Atlantic University; Missouri Botanical Gardens	Kunwar, RM (corresponding author), Florida Atlantic Univ, Dept Geosci, Boca Raton, FL 33431 USA.	rkunwar@fau.edu	Kunwar, Ripu M/A-2242-2012; Kunwar, Ripu/AAR-8887-2021; Bussmann, Rainer W/A-6105-2010	Kunwar, Ripu/0000-0002-9303-0932; Bussmann, Rainer W/0000-0002-3524-5273; Paudel, Prashant/0000-0003-0982-4818	William L Brown Center, Missouri Botanical Garden, Garden Club of America; AS Catham Fellowship from US and Rufford Foundation UK	William L Brown Center, Missouri Botanical Garden, Garden Club of America; AS Catham Fellowship from US and Rufford Foundation UK	William L Brown Center, Missouri Botanical Garden, Garden Club of America and AS Catham Fellowship from US and Rufford Foundation UK provided partial financial supports.	Adnan M HD, 2011, ECON BOT, V66, P344; Alcorn J. B., 1984, Huastec Mayan ethnobotany.; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alves R. R. N., 2007, Journal of Ethnobiology and Ethnomedicine, V3; [Anonymous], MILLENN ECOSYST ASSE, DOI DOI 10.1017/CBO9781107415324.004; [Anonymous], 2007, EX SUMM INT PAN CLIM; [Anonymous], 2010, KAILASH SACRED LANDS; [Anonymous], 2012, BOT EXPLORATION DARC; ANYINAM C, 1995, SOC SCI MED, V40, P321, DOI 10.1016/0277-9536(94)E0098-D; Arbonnier M., 2000, ARBRES ARBUSTES LIAN, P541; Arnold JEM, 2001, ECOL ECON, V39, P437, DOI 10.1016/S0921-8009(01)00236-1; Balick Michael J., 1996, PLANTS PEOPLE CULTUR; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bhandari G., 2013, International Journal of Plant, Animal and Environmental Sciences, V3, P247; Bhandari G, 2013, EFFECTS RAINFALL YIE, P205; BHATTARAI NK, 1992, ECON BOT, V46, P257, DOI 10.1007/BF02866624; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; Bista S, 2006, ENVIRON CONSERV, V33, P244, DOI 10.1017/S0376892906003195; Burlakoti C., 2008, MED PLANTS NEPAL ANT, P187; Byg A, 2010, HUM ECOL, V38, P177, DOI 10.1007/s10745-009-9300-z; Cadena-Gonzalez AL, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-23; Cameron M, 1993, EDGE AUSPICIOUS PRAC, P367; Cameron MM, 1996, HUM ORGAN, V55, P84, DOI 10.17730/humo.55.1.g206551211750h58; Cameron MM., 2010, CULTURE ENV HIMALAYA, P40; CBS, 2012, NAT POP HOUS CENS 20, V1, P1; Chand PB, 1987, BANKO JANAKARI, V1, P20; Chazdon RL, 1999, CONSERV BIOL, V13, P1312, DOI 10.1046/j.1523-1739.1999.98352.x; Chettri N, 2008, P INT MOUNT BIOD C, P201; Clarke R. C., 2007, Journal of Industrial Hemp, V12, P19, DOI 10.1300/J237v12n02_03; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; da Silva TC, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-6-3.4-1-12; De Albuquerque UP, 2007, J ETHNOPHARMACOL, V114, P325, DOI 10.1016/j.jep.2007.08.017; Albuquerque UP, 2007, J ETHNOPHARMACOL, V113, P156, DOI 10.1016/j.jep.2007.05.025; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; Devkota R., 2003, BOT ORIENTALIS, P135; DFO, 2015, MED PLANT TRAD DAT; Diamond J., 1997, GUNS GEMS STEEL FATE; Dolan JR, 2016, ISME J, V10, P2174, DOI 10.1038/ismej.2016.19; Ebbell B, 1937, PAPYRUS EBERS GREATE; Estomba D, 2006, J ETHNOPHARMACOL, V103, P109, DOI 10.1016/j.jep.2005.07.015; Etuk EU, 2009, AFR J PHARM PHARMACO, V3, P496; Farooquee NA, 1996, ENVIRON CONSERV, V23, P75, DOI 10.1017/S0376892900038273; Fassil H, 2003, WE DO WHAT WE KNOW L; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Folmar S., 2007, HIMALAYA, V27, P41; Fortier J., 2009, KINGS FOREST CULTURA, P232; Galeano G, 2000, ECON BOT, V54, P358, DOI 10.1007/BF02864787; Garbyal SS, 2005, CURR SCI INDIA, V88, P722; Geissler PW, 2002, J ETHNOPHARMACOL, V83, P39, DOI 10.1016/S0378-8741(02)00191-5; Giday M, 2003, J ETHNOPHARMACOL, V85, P43, DOI 10.1016/S0378-8741(02)00359-8; GOLDSTEIN MC, 1983, MT RES DEV, V3, P61, DOI 10.2307/3673129; GoN, 2015, HAMR BAN OUR FOR; GoN, 2011, NEP POP REP 2011; GOTTLIEB OR, 1995, BIOTROPICA, V27, P401, DOI 10.2307/2388927; Harlan H, 1992, TECHNOMETRICS; Harris H, 2010, PLANTS HLTH HEALING, P53; Hodgson Burnett Frances, 1911, THE SECRET GARDEN; HU SY, 1990, J ARNOLD ARBORETUM, V71, P487; Hutchen AR, 1992, HDB NATIVE AM HERBS; ISE, 2008, INT SOC ETHN COD ETH; Janes Craig R, 2002, Anthropol Med, V9, P267, DOI 10.1080/13648470216337; Janni KD, 2004, ECON BOT, V58, pS274, DOI 10.1663/0013-0001(2004)58[S274:EBITKP]2.0.CO;2; Jones L, 2011, GLOBAL ENVIRON CHANG, V21, P1262, DOI 10.1016/j.gloenvcha.2011.06.002; Joshi K, 2008, MED PLANTS NEPAL ANT, P178; Kala CP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-32; Khuankaew S, 2014, J ETHNOPHARMACOL, V151, P829, DOI 10.1016/j.jep.2013.11.033; Kohn Eduardo O., 1992, Journal of Ethnobiology, V12, P141; Kumar M, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-32; Kunwar R.M., 2003, HIMALAYAN J SCI, V1, P129, DOI DOI 10.3126/HJS.V1I2.213; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Kunwar RM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/792789; Kunwar RM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-24; Kunwar RM, 2012, J MT SCI-ENGL, V9, P589, DOI 10.1007/s11629-012-2315-8; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Ladio AH, 2003, BIODIVERS CONSERV, V12, P937, DOI 10.1023/A:1022873725432; Ladio AH, 2001, HUM ECOL, V29, P367, DOI 10.1023/A:1013199103440; Lanning, 2012, HLTH IS WEALTH HLTH; Lilleso J.-P.-B., 2005, MAP POTENTIAL VEGETA; Lulekal E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-63; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maharjan KL JN, 2007, POVERTY ANAL BAITADI; Malik ZA, 2015, J ETHNOPHARMACOL, V172, P133, DOI 10.1016/j.jep.2015.06.002; Manandhar NP, 1998, J ETHNOPHARMACOL, V60, P199, DOI 10.1016/S0378-8741(97)00150-5; Mander M., 1998, MARKETING INDIGENOUS, P1; Manzardo A E, 1976, Contrib Nepalese Stud, V3, P83; Manzardo A.E., 1977, CONTRIB NEPAL STUD, V4, P63; Maren IE, 2014, ENVIRON CONSERV, V41, P73, DOI 10.1017/S0376892913000258; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Milliken W, 1996, ECON BOT, V50, P10, DOI 10.1007/BF02862108; Moerman DE, 2003, J ETHNOPHARMACOL, V87, P51, DOI 10.1016/S0378-8741(03)00105-3; Molares S, 2009, J ETHNOPHARMACOL, V122, P251, DOI 10.1016/j.jep.2009.01.003; MUNTHE J, 1983, NATURE, V303, P331, DOI 10.1038/303331a0; Mutchnick PA, 1997, GUATEMALA EC BOT, V51, P158; Palmer CT, 2004, ECON BOT, V58, pS280, DOI 10.1663/0013-0001(2004)58[S280:TIORIP]2.0.CO;2; Pandey GD, 1989, NITYANANDA SMARAK SA, P546; Pant S.R., 2004, BOT ORIENT, P79; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parrotta J. A., 2001, Healing plants of peninsular India, DOI 10.1079/9780851995014.0000; Peretti JH, 1998, ENVIRON VALUE, V7, P183, DOI 10.3197/096327198129341537; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Pirker H, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-44; Poertner E, 2011, CRIT ASIAN STUD, V43, P23, DOI 10.1080/14672715.2011.537850; Polunin A, 1984, FLOWERS OF HIMALAYA; Pradhan K., 1998, ANC NEPAL, V107, P15; Prance G. T., 1998, Plants for food and medicine. Proceedings of the joint conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London, UK, 1-6 July 1996., P185; Quinlan MB, 2002, J ETHNOPHARMACOL, V80, P75, DOI 10.1016/S0378-8741(02)00002-8; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Reyes-Garcia V, 2006, ECON BOT, V60, P62, DOI 10.1663/0013-0001(2006)60[62:CPAEVO]2.0.CO;2; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; SALICK J, 1995, ECOL APPL, V5, P878, DOI 10.2307/2269339; Salick J, 1999, BIODIVERS CONSERV, V8, P797, DOI 10.1023/A:1008853413930; Salick J, 2014, J ETHNOBIOL, V34, P276, DOI 10.2993/0278-0771-34.3.276; Santoro FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119826; Shrestha S, 2001, ANC NEPAL, P1; SINGH MP, 1979, ECON BOT, V33, P185, DOI 10.1007/BF02858287; Soldati GT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364564; Stainton A, 1988, FLOWERS HIMALAYA SUP; Stepp JR, 2001, J ETHNOPHARMACOL, V75, P19, DOI 10.1016/S0378-8741(00)00385-8; Thomas E, 2008, HUM ECOL, V36, P861, DOI 10.1007/s10745-008-9208-z; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Toledo B. Arias, 2007, Journal of Ethnobiology, V27, P218; TOLEDO VM, 1995, INTERCIENCIA, V20, P177; Trudgen MS, 2012, P ROY SOC B-BIOL SCI, V279, P4115, DOI 10.1098/rspb.2012.1545; Turner NJ, 2009, GLOBAL ENVIRON CHANG, V19, P180, DOI 10.1016/j.gloenvcha.2009.01.005; Uddin K, 2015, LANDSCAPE URBAN PLAN, V141, P1, DOI 10.1016/j.landurbplan.2015.04.003; UNWFP, 2006, UNWFP FOOD SEC B, V38, P1; Vandebroek I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037643; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; Voeks RA, 1996, ECON BOT, V50, P381, DOI 10.1007/BF02866520; Wang WM, 2013, PALAEOWORLD, V22, P86, DOI 10.1016/j.palwor.2013.08.001; Weckerle CS, 2006, ECON BOT, V60, P3, DOI 10.1663/0013-0001(2006)60[3:PKOTSI]2.0.CO;2; Xu JC, 2004, BIODIVERS CONSERV, V13, P959, DOI 10.1023/B:BIOC.0000014464.80847.02; Zomer RJ, 2013, ENV STRATIFICATION K	133	23	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167812	10.1371/journal.pone.0167812	http://dx.doi.org/10.1371/journal.pone.0167812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936247	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100202
J	Newman, MA; Zebeli, Q; Velde, K; Grull, D; Molnar, T; Kandler, W; Metzler-Zebeli, BU				Newman, M. A.; Zebeli, Q.; Velde, K.; Gruell, D.; Molnar, T.; Kandler, W.; Metzler-Zebeli, B. U.			Enzymatically Modified Starch Favorably Modulated Intestinal Transit Time and Hindgut Fermentation in Growing Pigs	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; RESISTANT STARCH; DIETARY FIBER; WEANED PIGS; GASTROINTESTINAL-TRACT; NONSTARCH POLYSACCHARIDES; NUTRIENT DIGESTIBILITY; BACTERIAL-POPULATIONS; BODY-WEIGHT; HUMAN-COLON	Aside from being used as stabilizing agents in many processed foods, chemically modified starches may act as functional dietary ingredients. Therefore, development of chemically modified starches that are less digestible in the upper intestinal segments and promote fermentation in the hindgut receives considerable attention. This study aimed to investigate the impact of an enzymatically modified starch (EMS) on nutrient flow, passage rate, and bacterial activity at ileal and post-ileal level. Eight ileal-cannulated growing pigs were fed 2 diets containing 72% purified starch (EMS or waxy cornstarch as control) in a cross-over design for 10 d, followed by a 4-d collection of feces and 2-d collection of ileal digesta. On d 17, solid and liquid phase markers were added to the diet to determine ileal digesta flow for 8 h after feeding. Reduced small intestinal digestion after the consumption of the EMS diet was indicated by a 10%-increase in ileal flow and fecal excretion of dry matter and energy compared to the control diet (P< 0.05). Moreover, EMS feeding reduced ileal transit time of both liquid and solid fractions compared to the control diet (P< 0.05). The greater substrate flow to the large intestine with the EMS diet increased the concentrations of total and individual short-chain fatty acids (SCFA) in feces (P< 0.05). Total bacterial 16S rRNA gene abundance was not affected by diet, whereas the relative abundance of the Lactobacillus group decreased (P< 0.01) by 50% and of Enterobacteriaceae tended (P< 0.1) to increase by 20% in ileal digesta with the EMS diet compared to the control diet. In conclusion, EMS appears to resemble a slowly digestible starch by reducing intestinal transit and increasing SCFA in the distal large intestine.	[Newman, M. A.; Zebeli, Q.] Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Newman, M. A.; Zebeli, Q.; Metzler-Zebeli, B. U.] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Velde, K.] Univ Vet Med, Dept Compan Anim & Horses, Equine Univ Clin, Vienna, Austria; [Gruell, D.; Molnar, T.] Agrana Res & Innovat Ctr GmbH, Tulln, Austria; [Kandler, W.] Univ Nat Resources & Life Sci, IFA Tulln, Dept Agrobiotechnol, Ctr Analyt Chem, Vienna, Austria; [Metzler-Zebeli, B. U.] Univ Vet Med, Univ Clin Swine, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna	Metzler-Zebeli, BU (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria.; Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Univ Clin Swine, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at			Austrian Research Promotion Agency (FFG) [836447]; Agrana Research & Innovation Center GmbH	Austrian Research Promotion Agency (FFG); Agrana Research & Innovation Center GmbH	This project was funded by the Austrian Research Promotion Agency (FFG), BRIDGE programme (no. 836447-"Healthy Carbohydrates"), http://www.ffg.at/en/bridge. Agrana Research & Innovation Center GmbH provided support in the form of salaries for authors [DG, TM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bird AR, 2007, BRIT J NUTR, V97, P134, DOI 10.1017/S0007114507250433; Bird AR, 2009, DIGEST DIS SCI, V54, P947, DOI 10.1007/s10620-008-0451-3; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; CUMMINGS JH, 1980, CAN MED ASSOC J, V123, P1109; da Silva CS, 2014, ANIMAL, V8, P1402, DOI 10.1017/S1751731114001116; da Silva CS, 2012, PHYSIOL BEHAV, V107, P218, DOI 10.1016/j.physbeh.2012.07.001; Englyst KN, 2003, BRIT J NUTR, V89, P329, DOI 10.1079/BJN2002786; Gerrits WJJ, 2012, J NUTR, V142, P238, DOI 10.3945/jn.111.147496; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Han JA, 2007, CARBOHYD POLYM, V67, P366, DOI 10.1016/j.carbpol.2006.06.011; Heo JM, 2014, J ANIM SCI, V92, P3906, DOI 10.2527/jas.2013-7289; Hooda S, 2011, BRIT J NUTR, V106, P664, DOI 10.1017/S0007114511000985; Khan IUH, 2007, J MICROBIOL METH, V69, P480, DOI 10.1016/j.mimet.2007.02.016; Khol-Parisini A, 2015, ANIM FEED SCI TECH, V210, P74, DOI 10.1016/j.anifeedsci.2015.09.028; LI S, 1993, J ANIM PHYSIOL AN N, V70, P26, DOI [10.1111/j.1439-0396.1993.tb00303.x, 10.1111/j.1439-0396.1993.tb00314.x]; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; McCleary BV, 2010, J AOAC INT, V93, P221; Metzler BU, 2008, J ANIM SCI, V86, P1544, DOI 10.2527/jas.2007-0267; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P3351, DOI 10.2527/jas.2010-2906; Metzler-Zebeli BU, 2015, APPL ENVIRON MICROB, V81, P8489, DOI 10.1128/AEM.02756-15; Metzler-Zebeli BU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130553; Metzler-Zebeli BU, 2013, APPL ENVIRON MICROB, V79, P7264, DOI 10.1128/AEM.02691-13; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Morais MB, 1996, PEDIATR RES, V39, P872, DOI 10.1203/00006450-199605000-00022; Moran AW, 2010, BRIT J NUTR, V104, P647, DOI 10.1017/S0007114510000954; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; NRC, 2012, NUTRIENT REQUIREMENT; PHILLIPS J, 1995, AM J CLIN NUTR, V62, P121; POND WG, 1986, J ANIM SCI, V63, P1140, DOI 10.2527/jas1986.6341140x; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Stein HH, 1998, J ANIM SCI, V76, P1433; Suarez-Belloch J, 2013, SPAN J AGRIC RES, V11, P780, DOI 10.5424/sjar/2013113-3958; Sun Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00779; Sun Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00877; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; van Kempen TATG, 2010, J NUTR, V140, P1227, DOI 10.3945/jn.109.120584; VDLUFA, 2007, METHODENBUCH BUCH II; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wilfart A, 2007, BRIT J NUTR, V98, P54, DOI 10.1017/S0007114507682981; Zaman SA, 2015, CRIT REV BIOTECHNOL, V7, P1	48	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167784	10.1371/journal.pone.0167784	http://dx.doi.org/10.1371/journal.pone.0167784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936165	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100187
J	Oh, SY; Lee, JY; Park, KA; Oh, SY				Oh, Shin Yeop; Lee, Ju-Yeun; Park, Kyung-Ah; Oh, Sei Yeul			Long-Term Changes in Refractive Error and Clinical Evaluation in Partially Accommodative Esotropia after Surgery	PLOS ONE			English	Article							CONGENITAL ESOTROPIA; CHILDREN; OUTCOMES; GROWTH	We investigate the changes in refractive error and clinical evaluation in partially accommodative esotropia (PAET) after surgery. A total of 68 patients PAET who received at least 2 years of follow-up after surgery were enrolled in this study. We performed a retrospective study in patients who underwent unilateral or bilateral medial rectus recession for a non-accommodative component of PAET between January 2005 and March 2013. Patients were divided into groups according to the presence of dominancy (dominant, non-dominant, alternative eye), and presence of amblyopia (amblyopic, fellow, normal eye). Changes and changing pattern in SE refractive error were analyzed in all patients and compared between groups. Patients were divided into two groups, those weaned off of hyperopic glasses and those who continued using them, then factors that significantly influenced the continued use of glasses were analyzed. The changes and changing pattern in SE refractive error according to time after operation and presence of amblyopia or dominancy. The mean length of follow-up was 4.89 +/- 1.74 years after surgery and the mean change in SE refractive error rate per year was -0.284 +/- 0.411 diopters (D). The pattern of changes in the mean SE refractive error for those with dominant, non-dominant, and alternative eyes was not significantly different (p = 0.292). The pattern of changes in the mean SE refractive error for those with amblyopic, fellow, and normal eyes was significantly different (p = 0.0002). Patients were successfully weaned off of hyperopic glasses at an average age of 9.41 +/- 2.74 years. The average SE refractive error in the group weaned off of hyperopic glasses was significantly lower than that in the group maintained on hyperopic glasses (p = 0.0002). The change of SE refractive error in amblyopic eyes decreased less than that in fellow or normal eyes, which may be correlated with the presence of amblyopia. Patients with a smaller esodeviated angle without hyperopic correction, a lower degree of hyperopia, and who were older at the time of disease onset were discontinued from hyperopic glasses sooner after surgery.	[Oh, Shin Yeop] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Changwon Hosp, Chang Won, South Korea; [Lee, Ju-Yeun; Park, Kyung-Ah; Oh, Sei Yeul] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Samsung Med Ctr, Seoul, South Korea.	syoh@skku.edu						BAKER JD, 1980, AM J OPHTHALMOL, V90, P11, DOI 10.1016/S0002-9394(14)75070-6; Berk AT, 2004, J AAPOS, V8, P384, DOI 10.1016/j.jaapos.2004.02.001; Birch EE, 2008, EYE LOND, V24, P1814; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Brian G. Mohney, 2011, OPHTHALMOLOGY, V118, P581, DOI [10.1016/j.ophtha.2010.07.017, DOI 10.1016/J.OPHTHA.2010.07.017]; Burtolo C, 2002, J PEDIAT OPHTH STRAB, V39, P209, DOI 10.3928/0191-3913-20020701-08; Cho YA, 2009, ACTA OPHTHALMOL, V87, P532, DOI 10.1111/j.1755-3768.2008.01255.x; Donders FC, 1864, ANOMALIES ACCOMMODAT, V22, P292; Elham AT, 2015, STRABISMUS, V23, P111, DOI [10.3109/09273972.2015.1058401, DOI 10.3109/09273972.2015.1058401]; Fujikado T, 1997, GRAEF ARCH CLIN EXP, V235, P320, DOI 10.1007/BF01739642; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Ing MR, 1995, OPHTHALMOLOGY, V102, P2041, DOI 10.1016/S0161-6420(95)30756-7; Kutluturk I, 2014, J PEDIAT OPHTH STRAB, V51, P171, DOI 10.3928/01913913-20140305-01; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; Lambert SR, 2003, J AAPOS, V7, P7, DOI 10.1016/S1091-8531(02)42010-1; LEPARD CW, 1975, AM J OPHTHALMOL, V80, P485, DOI 10.1016/0002-9394(75)90212-3; Lowery R Scott, 2006, Compr Ophthalmol Update, V7, P145; Mulvihill A, 2000, BRIT J OPHTHALMOL, V84, P746, DOI 10.1136/bjo.84.7.746; NASTRI G, 1984, DOC OPHTHALMOL, V56, P265, DOI 10.1007/BF00159077; Parks MM, 1987, CLIN OPHTHALMOLOGY, P1; Repka MX, 1989, BINOC VIS, V4, P5; Rutstein RP, 1998, OPTOMETRY VISION SCI, V75, P97, DOI 10.1097/00006324-199802000-00013; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; SWAN KC, 1983, OPHTHALMOLOGY, V90, P1141; Varma R, 2010, OPHTHALMOLOGY, V117, P140, DOI 10.1016/j.ophtha.2009.06.009; VONNOORDEN GK, 1990, AM J OPHTHALMOL, V110, P287, DOI 10.1016/S0002-9394(14)76346-9; WRIGHT KW, 1994, ARCH OPHTHALMOL-CHIC, V112, P913, DOI 10.1001/archopht.1994.01090190061022	27	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166695	10.1371/journal.pone.0166695	http://dx.doi.org/10.1371/journal.pone.0166695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936115	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100041
J	Shi, CL; Guo, Y; Lv, YC; Nanding, A; Shi, TF; Qin, HD; He, JJ				Shi, Chenlei; Guo, Yong; Lv, Yichen; Nanding, Abiyasi; Shi, Tiefeng; Qin, Huadong; He, Jianjun			Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAF(V600E) Mutational Status and Expression of Angiogenic Factors	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; TALL CELL VARIANT; UNFAVORABLE PROGNOSIS; CARCINOMA; GROWTH; CANCER; OVEREXPRESSION; PROTEINS	Objective To investigate the clinicopathological characteristics of papillary thyroid microcarcinoma (PTMC) for surgery by comparing the difference between PTMC and larger papillary thyroid carcinoma (LPTC). Methods We analyzed the differences in the clinicopathological characteristics, prognosis, B-type RAF kinase (BRAF)(V600E) mutational status and expression of angiogenic factors, including pigment epithelium-derived factor (PEDF), Vascular Endothelial Growth Factor (VEGF), and hypoxia-inducible factor alpha subunit (HIF-1 alpha), between PTMC and LPTC by retrospectively reviewing the records of 251 patients with papillary thyroid carcinoma, 169 with PTMC, and 82 with LPTC (diameter >1 cm). Results There were no significant differences in the gender, age, multifocality, Hashimoto's thyroiditis, TNM stage, PEDF protein expression, rate of recurrence, or mean follow-up duration between patients with PTMC or LPTC. The prevalence of extrathyroidal invasion (EI), lymph node metastasis (LNM), and BRAF mutation in patients with PTMC was significantly lower than in patients with LPTC. In addition, in PTMC patients with EI and/or LNM and/or positive BRAF (high-risk PTMC patients), the prevalence of extrathyroidal invasion, Hashimoto's disease, lymph node metastasis, tumor TNM stage, PEDF positive protein expression, the rate of recurrent disease, and the mRNA expression of anti-angiogenic factors was almost as high as in patients with larger PTC, but with no significant difference. Conclusions Extrathyroid invasion, lymph node metastases, and BRAF(V600E) mutation were the high risk factors of PTMC. PTMC should be considered for the same treatment strategy as LPTC when any of these factors is found. Particularly, PTMC with BRAF(V600E) gene mutations needed earlier surgical treatment. In addition, the high cell subtype of PTMC with BRAF(V600E) gene mutation is recommended for total thyroidectomy in primary surgery to reduce the risk of recurrence.	[Shi, Chenlei; He, Jianjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian, Peoples R China; [Shi, Chenlei; Lv, Yichen; Shi, Tiefeng; Qin, Huadong] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg 4, Harbin, Peoples R China; [Guo, Yong] Heze Municipal Hosp, Dept Breast & Thyroid, Heze, Shandong, Peoples R China; [Nanding, Abiyasi] Harbin Med Univ, Affiliated Hosp 3, Dept Pathol, Harbin, Peoples R China	Xi'an Jiaotong University; Harbin Medical University; Harbin Medical University	He, JJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian, Peoples R China.	chinahjjjj@163.com			Programs of Science and Technology of Heilongjiang Educational Committee [12541490]	Programs of Science and Technology of Heilongjiang Educational Committee	This research was supported by the Programs of Science and Technology of Heilongjiang Educational Committee (12541490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bernstein J, 2013, THYROID, V23, P1525, DOI 10.1089/thy.2013.0154; Birner P, 2000, CANCER RES, V60, P4693; Brito JP, 2014, CURR OPIN ENDOCRINOL, V21, P405, DOI 10.1097/MED.0000000000000094; Brown RL, 2011, J CANCER, V2, P193, DOI 10.7150/jca.2.193; Browne M, 2006, PEDIATR RES, V60, P282, DOI 10.1203/01.pdr.0000232789.86632.91; Castro MR, 2015, CANCER-AM CANCER SOC, V121, P3364, DOI 10.1002/cncr.29468; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Ghossein RA, 2007, THYROID, V17, P655, DOI 10.1089/thy.2007.0061; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; Ito Y, 2004, WORLD J SURG, V28, P1115, DOI 10.1007/s00268-004-7644-5; Koperek O, 2013, VIRCHOWS ARCH, V463, P795, DOI 10.1007/s00428-013-1484-3; Koperek O, 2011, J PATHOL, V225, P63, DOI 10.1002/path.2926; Lan L, 2013, INT J ONCOL, V43, P113, DOI 10.3892/ijo.2013.1913; Lee JH, 2007, CANCER, V1, P38; Lian YZ, 2011, INT J LAB MED, V32, P644; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Ming J, 2015, INT J CLIN EXP PATHO, V8, P15155; Park YJ, 2010, HEAD NECK-J SCI SPEC, V32, P38, DOI 10.1002/hed.21142; Paterson ICM, 1999, CLIN ONCOL-UK, V11, P245, DOI 10.1053/clon.1999.9057; Pelizzo MR, 2004, NUCL MED COMMUN, V25, P547, DOI 10.1097/01.mnm.0000126625.17166.36; Sapio MR, 2006, EUR J ENDOCRINOL, V154, P341, DOI 10.1530/eje.1.02072; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Shi CL, 2015, GENET MOL RES, V14, P7377, DOI 10.4238/2015.July.3.13; Shi Chenlei, 2015, Zhonghua Zhong Liu Za Zhi, V37, P123; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Stratmann M, 2012, CHIRURG, V83, P646, DOI 10.1007/s00104-011-2216-3; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; Udelsman R, 1999, Adv Surg, V33, P1; [汪杰 WANG Jie], 2011, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V28, P1102; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Yang HS, 2009, CANCER SCI, V100, P2419, DOI 10.1111/j.1349-7006.2009.01332.x; Yang J, 2010, CANCER BIOL THER, V9, P967, DOI 10.4161/cbt.9.12.11635; Yoon JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002435; Zhang Y, 2011, ONCOL REP, V26, P681, DOI 10.3892/or.2011.1318	38	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167414	10.1371/journal.pone.0167414	http://dx.doi.org/10.1371/journal.pone.0167414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936049	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100094
J	Yates, NJ; Robertson, D; Rodger, J; Martin-Iverson, MT				Yates, Nathanael J.; Robertson, Donald; Rodger, Jennifer; Martin-Iverson, Mathew T.			Effects of Neonatal Dexamethasone Exposure on Adult Neuropsychiatric Traits in Rats	PLOS ONE			English	Article							SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; PRENATAL STRESS; STARTLE REFLEX; POSTNATAL DEXAMETHASONE; BRONCHOPULMONARY DYSPLASIA; DOPAMINE HYPOTHESIS; OBJECT RECOGNITION; LOCOMOTOR RESPONSE; NUCLEUS-ACCUMBENS	The effects of early life stress in utero or in neonates has long-term consequences on hypothalamic-pituitary-adrenal (HPA) stress axis function and neurodevelopment. These effects extend into adulthood and may underpin a variety of mental illnesses and be related to various developmental and cognitive changes. We examined the potential role of neonatal HPA axis activation on adult psychopathology and dopamine sensitivity in the mature rat using neonatal exposure to the synthetic glucocorticoid receptor agonist and stress hormone, dexamethasone. We utilized a comprehensive battery of assessments for behaviour, brain function and gene expression to determine if elevated early life HPA activation is associated with adult-onset neuropsychiatric traits. Dexamethasone exposure increased startle reactivity under all conditions tested, but decreased sensitivity of sensorimotor gating to dopaminergic disruption-contrasting with what is observed in several neuropsychiatric diseases. Under certain conditions there also appeared to be mild long-term changes in stress and anxiety-related behaviours with neonatal dexamethasone exposure. Electrophysiology revealed that there were no consistent neuropsychiatric abnormalities in auditory processing or resting state brain function with dexamethasone exposure. However, neonatal dexamethasone altered auditory cortex glucocorticoid activation, and auditory cortex synchronization. Our results indicate that neonatal HPA axis activation by dexamethasone alters several aspects of adult brain function and behaviour and may induce long-term changes in emotional stress-reactivity. However, neonatal dexamethasone exposure is not specifically related to any particular neuropsychiatric disease.	[Yates, Nathanael J.; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Fac Sci, Crawley, WA, Australia; [Robertson, Donald] Univ Western Australia, Fac Sci, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Martin-Iverson, Mathew T.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Med & Pharmacol, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Yates, NJ (corresponding author), Univ Western Australia, Sch Anim Biol, Fac Sci, Crawley, WA, Australia.	nathanael.yates@uwa.edu.au	Rodger, Jennifer/H-5735-2014; Yates, Nathanael J/K-8358-2018	Rodger, Jennifer/0000-0003-3413-4229; Yates, Nathanael J/0000-0003-2742-6952; Martin-Iverson, Mathew/0000-0003-4855-6748				Abduljawad KAJ, 1997, J PSYCHOPHARMACOL, V11, P29, DOI 10.1177/026988119701100110; ALONSO SJ, 1994, PHARMACOL BIOCHEM BE, V49, P353, DOI 10.1016/0091-3057(94)90433-2; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Brabham T, 2000, AM J PHYSIOL-REG I, V279, pR1899, DOI 10.1152/ajpregu.2000.279.5.R1899; Braff DL, 2010, CURR TOP BEHAV NEURO, V4, P349, DOI 10.1007/7854_2010_61; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Broberg BV, 2010, BEHAV BRAIN RES, V213, P142, DOI 10.1016/j.bbr.2010.04.026; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Buchmann AF, 2014, PSYCHOPHARMACOLOGY, V231, P3089, DOI 10.1007/s00213-014-3484-7; BUCHSBAUM MS, 1977, SCHIZOPHRENIA BULL, V3, P93, DOI 10.1093/schbul/3.1.93; CADOR M, 1993, NEUROSCIENCE, V56, P981, DOI 10.1016/0306-4522(93)90144-5; CAPASSO A, 1995, PROG NEURO-PSYCHOPH, V19, P1063, DOI 10.1016/0278-5846(95)00197-2; Cheong JLY, 2014, J PEDIATR-US, V164, P737, DOI 10.1016/j.jpeds.2013.10.083; Chitty K, 2014, PSYCHOPHARMACOLOGY, V231, P2327, DOI 10.1007/s00213-013-3395-z; Claessens SEF, 2012, HORM BEHAV, V62, P433, DOI 10.1016/j.yhbeh.2012.07.011; Clunas NJ, 2005, PSYCHIAT RES, V136, P17, DOI 10.1016/j.psychres.2005.05.009; Cole MA, 2000, PSYCHONEUROENDOCRINO, V25, P151, DOI 10.1016/S0306-4530(99)00045-1; Lopes-de-Morais AAC, 2014, BRAIN RES, V1591, P93, DOI 10.1016/j.brainres.2014.09.075; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; deKloet ER, 1996, CELL MOL NEUROBIOL, V16, P345; Denys D, 2004, J CLIN PSYCHIAT, V65, P11; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Ellenbroek BA, 2003, CLIN NEUROSCI RES, V3, P297, DOI 10.1016/S1566-2772(03)00090-2; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Felszeghy K, 1996, J NEUROENDOCRINOL, V8, P493, DOI 10.1046/j.1365-2826.1996.04822.x; Felszeghy K, 2000, J NEUROENDOCRINOL, V12, P1014, DOI 10.1046/j.1365-2826.2000.00551.x; Ferguson SA, 2001, NEUROTOXICOL TERATOL, V23, P57, DOI 10.1016/S0892-0362(00)00115-X; Ferguson SA, 1999, NEUROTOXICOL TERATOL, V21, P71, DOI 10.1016/S0892-0362(98)00029-4; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; FRIDE E, 1988, LIFE SCI, V42, P1059, DOI 10.1016/0024-3205(88)90561-9; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 1997, J AM ACAD CHILD PSY, V36, P925, DOI 10.1097/00004583-199707000-00014; Grillon C, 2008, PSYCHOPHARMACOLOGY, V199, P421, DOI 10.1007/s00213-007-1019-1; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Heckers S, 2000, BIOL PSYCHIAT, V48, P651, DOI 10.1016/S0006-3223(00)00919-7; HENRY C, 1995, BRAIN RES, V685, P179, DOI 10.1016/0006-8993(95)00430-X; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; Holstein DH, 2010, J AFFECT DISORDERS, V126, P188, DOI 10.1016/j.jad.2010.02.122; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Ichinohashi Y, 2013, EARLY HUM DEV, V89, P283, DOI 10.1016/j.earlhumdev.2012.10.007; Jancsik V, 1999, BRAIN RES, V831, P200, DOI 10.1016/S0006-8993(99)01445-6; Kamphuis PJGH, 2002, NEUROENDOCRINOLOGY, V76, P158, DOI 10.1159/000064526; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Koenig JI, 2006, HORM BEHAV, V50, P602, DOI 10.1016/j.yhbeh.2006.06.027; Koenig JI, 2002, NEUROPSYCHOPHARMACOL, V27, P309; Kohl S, 2013, J PSYCHIATR RES, V47, P445, DOI 10.1016/j.jpsychires.2012.11.018; Leao P, 2007, SYNAPSE, V61, P40, DOI 10.1002/syn.20341; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Li SX, 2014, NEUROBIOL DIS, V62, P124, DOI 10.1016/j.nbd.2013.09.004; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Martin-Iverson M, 2003, J PSYCHOPHARMACOLOGY; Martin-Iverson MT, 2000, PSYCHOPHARMACOLOGY, V151, P38, DOI 10.1007/s002130000483; McArthur S, 2016, BRAIN STRUCT FUNCT, V221, P2459, DOI 10.1007/s00429-015-1049-0; Menshanov PN, 2014, BEHAV BRAIN RES, V271, P43, DOI 10.1016/j.bbr.2014.05.053; MUKUNDAN CR, 1986, BIOL PSYCHIAT, V21, P1097, DOI 10.1016/0006-3223(86)90295-7; Nagano M, 2008, NEUROSCI RES, V60, P364, DOI 10.1016/j.neures.2007.12.005; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Onland W, 2009, PEDIATRICS, V123, P367, DOI 10.1542/peds.2008-0016; Papakostas GI, 2006, EUR NEUROPSYCHOPHARM, V16, P391, DOI 10.1016/j.euroneuro.2005.12.002; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010; Raikkonen K, 2011, STRESS, V14, P590, DOI 10.3109/10253890.2011.602147; Rajagopal L, 2014, CURR PHARM DESIGN, V20, P5104; Ralph RJ, 1999, J NEUROSCI, V19, P4627; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Roberts AD, 2004, NEUROTOXICOL TERATOL, V26, P169, DOI 10.1016/j.ntt.2003.12.003; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Sabeti M, 2009, J ART INTELL MED, V47, P263; Scholes KE, 2010, PSYCHOPHYSIOLOGY, V47, P223, DOI 10.1111/j.1469-8986.2009.00927.x; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Shinwell ES, 2000, ARCH DIS CHILD-FETAL, V83, pF177, DOI 10.1136/fn.83.3.F177; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Struber N, 2014, NEUROSCI BIOBEHAV R, V38, P17, DOI 10.1016/j.neubiorev.2013.10.015; Sun W, 2005, NEUROSCI LETT, V374, P63, DOI 10.1016/j.neulet.2004.10.032; SWERDLOW NR, 1990, PSYCHOPHARMACOLOGY, V100, P413, DOI 10.1007/BF02244616; SWERDLOW NR, 1992, PSYCHOPHARMACOLOGY, V108, P189, DOI 10.1007/BF02245306; TANDON R, 1991, BIOL PSYCHIAT, V29, P953, DOI 10.1016/0006-3223(91)90353-N; Teale P, 2003, BIOL PSYCHIAT, V54, P1149, DOI 10.1016/S0006-3223(03)00411-6; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Watson JB, 1999, DEV PSYCHOPATHOL, V11, P457, DOI 10.1017/S0954579499002151; Webster M, 2002, MOL PSYCHIAT; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wrobel A, 2005, PHARMACOL REP, V57, P451; Yachi K, 2007, BRAIN RES, V1159, P141, DOI 10.1016/j.brainres.2007.05.024	92	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167220	10.1371/journal.pone.0167220	http://dx.doi.org/10.1371/journal.pone.0167220			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936175	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100075
J	Li, L; Newton, PT; Bouderlique, T; Sejnohova, M; Zikmund, T; Kozhemyakina, E; Xie, M; Krivanek, J; Kaiser, J; Qian, H; Dyachuk, V; Lassar, AB; Warman, ML; Barenius, B; Adameyko, I; Chagin, AS				Li, Lei; Newton, Phillip T.; Bouderlique, Thibault; Sejnohova, Marie; Zikmund, Tomas; Kozhemyakina, Elena; Xie, Meng; Krivanek, Jan; Kaiser, Jozef; Qian, Hong; Dyachuk, Vyacheslav; Lassar, Andrew B.; Warman, Matthew L.; Barenius, Bjorn; Adameyko, Igor; Chagin, Andrei S.			Superficial cells are self-renewing chondrocyte progenitors, which form the articular cartilage in juvenile mice	FASEB JOURNAL			English	Article						superficial zone; bone; adult stem cells; regeneration; osteoarthritis	STEM-CELLS; IN-VIVO; FATE; POPULATION; EXPRESSION; THYMIDINE; JOINT; BROMODEOXYURIDINE; DIFFERENTIATION; OSTEOARTHRITIS	Articular cartilage has little regenerative capacity. Recently, genetic lineage tracing experiments have revealed chondrocyte progenitors at the articular surface. We further characterized these progenitors by using in vivo genetic approaches. Histone H2B-green fluorescent protein retention revealed that superficial cells divide more slowly than underlying articular chondrocytes. Clonal genetic tracing combined with immunohistochemistry revealed that superficial cells renew their number by symmetric division, express mesenchymal stem cell markers, and generate chondrocytes via both asymmetric and symmetric differentiation. Quantitative analysis of cellular kinetics, in combination with phosphotungstic acid- enhanced micro-computed tomography, showed that superficial cells generate chondrocytes and contribute to the growth and reshaping of articular cartilage. Furthermore, we found that cartilage renewal occurs as the progeny of superficial cells fully replace fetal chondrocytes during early postnatal life. Thus, superficial cells are self-renewing progenitors that are capable of maintaining their own population and fulfilling criteria of unipotent adult stem cells. Furthermore, the progeny of these cells reconstitute adult articular cartilage de novo, entirely substituting fetal chondrocytes.	[Li, Lei; Newton, Phillip T.; Bouderlique, Thibault; Xie, Meng; Adameyko, Igor; Chagin, Andrei S.] Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartz vag 2, S-17177 Stockholm, Sweden; [Qian, Hong] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Sodersjukhuset, Stockholm, Sweden; [Dyachuk, Vyacheslav] Karolinska Inst, Dept Neurosci, Sodersjukhuset, Stockholm, Sweden; [Barenius, Bjorn] Karolinska Inst, Dept Clin Sci & Educ, Orthopaed Sect, Sodersjukhuset, Stockholm, Sweden; [Sejnohova, Marie; Zikmund, Tomas; Kaiser, Jozef] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Kozhemyakina, Elena; Lassar, Andrew B.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Krivanek, Jan; Adameyko, Igor] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, Vienna, Austria; [Warman, Matthew L.] Boston Childrens Hosp, Orthoped Res Labs, Boston, MA USA	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Brno University of Technology; Harvard University; Harvard Medical School; Medical University of Vienna; Harvard University; Boston Children's Hospital	Chagin, AS (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartz vag 2, S-17177 Stockholm, Sweden.	andrei.chagin@ki.se	Krivanek, Jan/AAH-5871-2021; Kaiser, Jozef/D-6800-2012; Dyachuk, Vyacheslav/U-9115-2019; Kaiser, Jozef/P-4872-2019; Li, Lei/AAT-9135-2020; Zikmund, Tomas/G-9491-2014; Barenius, Björn/GQB-4107-2022; Chagin, Andrei/F-4080-2014; Qian, Hong/D-5588-2014	Krivanek, Jan/0000-0002-7590-187X; Kaiser, Jozef/0000-0002-7397-125X; Dyachuk, Vyacheslav/0000-0001-8100-7367; Bouderlique, Thibault/0000-0002-3926-990X; Adameyko, Igor/0000-0001-5471-0356; Chagin, Andrei/0000-0002-2696-5850; Newton, Phillip/0000-0003-2142-1798; Li, Lei/0000-0002-8026-3665; Qian, Hong/0000-0002-2512-9199; Zikmund, Tomas/0000-0003-2948-5198	Swedish Research Council [2016-02835, 2015-03387]; Karolinska Institutet; King Gustaf V's 80-year Jubileum Foundation; Swedish Foundation for Rheumatism; Chinese Scholarship Council; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard; EMBO long-term postdoctoral fellowship; StratNeuro; Bertil Hallsten Research Foundation; Ake Wiberg Foundation; Central European Institute of Technology 2020 project [LQ1601]; Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); King Gustaf V's 80-year Jubileum Foundation; Swedish Foundation for Rheumatism; Chinese Scholarship Council(China Scholarship Council); Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard; EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); StratNeuro; Bertil Hallsten Research Foundation; Ake Wiberg Foundation; Central European Institute of Technology 2020 project; Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II	The authors thank Susan Mackem (U.S. National Institutes of Health) for Col2-CreERt mouse strain, Bara Szarowska (Karolinska Institutet) for phosphotungstic acid contrasting, and Eugeniy Ivashkin (Karolinska Institutet) for assistance with Imaris software. This work was supported by The Swedish Research Council [2016-02835 (to A.S.C.), 2015-03387 (to V.D.)], Karolinska Institutet (including a FoAss extension grant, KID grant, Ulla och Gustaf af Ugglas Foundation and Karolinska Institutet Foundation for Rheumatism Research), King Gustaf V's 80-year Jubileum Foundation, and the Swedish Foundation for Rheumatism. L.L. was supported by the Chinese Scholarship Council; P.T.N. was supported by Stiftelsen Frimurare Barnhuset i Stockholm and Sallskapet Barnavard; M.X. was supported by EMBO long-term postdoctoral fellowship; V.D. was supported by StratNeuro; and I.A. was supported by Bertil Hallsten Research Foundation and Ake Wiberg Foundation. Tomographic analysis (M.S., T.Z., and Jo.K.) was carried out in connection with the Central European Institute of Technology 2020 project (LQ1601), with financial support from the Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II. The authors declare no conflicts of interest.	ARCHER CW, 1994, ANN RHEUM DIS, V53, P624, DOI 10.1136/ard.53.10.624; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Driskell I, 2015, STEM CELLS, V33, P988, DOI 10.1002/stem.1910; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Hall B. K., 2015, BONES CARTILAGE DEV; HOLLIBAUGH JT, 1988, MAR ECOL PROG SER, V43, P19, DOI 10.3354/meps043019; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kaucka M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600060; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kolb B, 1999, J NEUROSCI, V19, P2337; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; MANKIN HJ, 1962, J BONE JOINT SURG AM, V44, P682, DOI 10.2106/00004623-196244040-00008; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; POLLARD DR, 1976, J EMBRYOL EXP MORPH, V35, P169; PRIBYLOVA E, 1971, Folia Morphologica (Prague), V19, P233; Ray A, 2015, DEVELOPMENT, V142, P1169, DOI 10.1242/dev.110940; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Schoedel KB, 2016, BLOOD, V128, P2285, DOI 10.1182/blood-2016-03-706010; Shwartz Y, 2016, CELL REP, V15, P2577, DOI 10.1016/j.celrep.2016.05.055; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STOCKWELL RA, 1967, J ANAT, V101, P753; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tesarova M, 2016, J INSTRUM, V11, DOI 10.1088/1748-0221/11/03/C03006; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Zhang MJ, 2016, J CLIN INVEST, V126, P2893, DOI 10.1172/JCI83676	49	61	65	2	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1067	+		10.1096/fj.201600918R	http://dx.doi.org/10.1096/fj.201600918R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27965322	Green Published			2022-12-26	WOS:000395671200021
J	Roehrich, AD; Bordignon, E; Mode, S; Shen, DK; Liu, X; Pain, M; Murillo, I; Martinez-Argudo, I; Sessions, RB; Blocker, AJ				Roehrich, A. Dorothea; Bordignon, Enrica; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.			Steps for Shigella Gatekeeper Protein MxiC Function in Hierarchical Type III Secretion Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cellular regulation; electron paramagnetic resonance (EPR); Gram-negative bacteria; molecular genetics; protein secretion; type III secretion system (T3SS); MxiC; Shigella	SYSTEM NEEDLE TIP; B-CELL EPITOPES; YERSINIA-PESTIS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; GENE-EXPRESSION; YOP SECRETION; FLEXNERI; IPAB; APPARATUS	Type III secretion systems are complex nanomachines used for injection of proteins from Gram-negative bacteria into eukaryotic cells. Although they are assembled when the environmental conditions are appropriate, they only start secreting upon contact with a host cell. Secretion is hierarchical. First, the pore-forming translocators are released. Second, effector proteins are injected. Hierarchy between these protein classes is mediated by a conserved gatekeeper protein, MxiC, in Shigella. As its molecular mechanism of action is still poorly understood, we used its structure to guide site-directed mutagenesis and to dissect its function. We identified mutants predominantly affecting all known features of MxiC regulation as follows: secretion of translocators, MxiC and/or effectors. Using molecular genetics, we then mapped at which point in the regulatory cascade the mutants were affected. Analysis of some of these mutants led us to a set of electron paramagnetic resonance experiments that provide evidence that MxiC interacts directly with IpaD. We suggest how this interaction regulates a switch in its conformation that is key to its functions.	[Roehrich, A. Dorothea; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Med Sci Bldg, Bristol BS8 1TD, Avon, England; [Roehrich, A. Dorothea; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Fac Med & Vet Sci, Med Sci Bldg, Bristol BS8 1TD, Avon, England; [Bordignon, Enrica] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; [Martinez-Argudo, Isabel] Univ Castilla La Mancha, Area Genet, Fac Ciencias Ambientales & Bioquim, E-45071 Toledo, Spain; [Roehrich, A. Dorothea] Testo AG, Testostr 1, D-79853 Lenzkirch, Germany	University of Bristol; University of Bristol; Free University of Berlin; Universidad de Castilla-La Mancha	Blocker, AJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England.	ariel.blocker@bristol.ac.uk	Martinez, Isabel/R-4803-2019	Martinez, Isabel/0000-0001-5067-1791; Blocker, Ariel/0000-0002-8705-2641; Sessions, Richard/0000-0003-0320-0895; Bordignon, Enrica/0000-0003-2450-5161	Centenary Postgraduate Fund at the University of Bristol; United Kingdom Wellcome Trust [WT088266]; UK Medical Research Council [MR-J002097-1]; Universite Pierre et Marie Curie (Paris 6); MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [MR/J002097/1] Funding Source: researchfish	Centenary Postgraduate Fund at the University of Bristol; United Kingdom Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universite Pierre et Marie Curie (Paris 6); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Studentship from the Centenary Postgraduate Fund at the University of Bristol (to A.D.R.), Project Grant WT088266 from the United Kingdom Wellcome Trust (to A.J.B. and I.M.A.), Project Grant MR-J002097-1 from the UK Medical Research Council (to A.J.B., also supporting D.S. and M.P.), and two short Master 1-Level work-experience scholarships from the Universite Pierre et Marie Curie (Paris 6) (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Archuleta TL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004498; Archuleta TL, 2011, J BIOL CHEM, V286, P33992, DOI 10.1074/jbc.M111.258426; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; Birket SE, 2007, BIOCHEMISTRY-US, V46, P8128, DOI 10.1021/bi700099c; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bordignon Enrica, 2013, Methods Mol Biol, V974, P329, DOI 10.1007/978-1-62703-275-9_15; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burkinshaw BJ, 2015, ACTA CRYSTALLOGR F, V71, P1300, DOI 10.1107/S2053230X15016064; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Jackson MW, 1998, J BACTERIOL, V180, P4912, DOI 10.1128/JB.180.18.4912-4921.1998; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Johnson S, 2006, ACTA CRYSTALLOGR F, V62, P865, DOI 10.1107/S1744309106027047; Joseph SS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00001; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kosek M, 2010, CURR OPIN INFECT DIS, V23, P475, DOI 10.1097/QCO.0b013e32833da204; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lee PC, 2014, P NATL ACAD SCI USA, V111, pE2027, DOI 10.1073/pnas.1402658111; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Roehrich A. D., 2013, THESIS; Roehrich AD, 2013, MOL MICROBIOL, V87, P690, DOI 10.1111/mmi.12124; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155141; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Wang DP, 2008, SYNLETT, P69, DOI 10.1055/s-2007-992409; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wei HL, 2012, MOL MICROBIOL, V85, P195, DOI 10.1111/j.1365-2958.2012.08119.x; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	57	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1705	1723		10.1074/jbc.M116.746826	http://dx.doi.org/10.1074/jbc.M116.746826			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974466	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000395515600014
J	De Nardis, C; Lossl, P; van den Biggelaar, M; Madoori, PK; Leloup, N; Mertens, K; Heck, AJR; Gros, P				De Nardis, Camilla; Lossl, Philip; van den Biggelaar, Maartje; Madoori, Pramod K.; Leloup, Nadia; Mertens, Koen; Heck, Albert J. R.; Gros, Piet			Recombinant Expression of the Full-length Ectodomain of LDL Receptor-related Protein 1 (LRP1) Unravels pHdependent Conformational Changes and the Stoichiometry of Binding with Receptor- associated Protein ( RAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CRITICAL LYSINE RESIDUES; NMR SOLUTION STRUCTURE; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; MASS-SPECTROMETRY; HUMAN ALPHA(2)-MACROGLOBULIN; MOLECULAR CHAPERONE; 39-KDA PROTEIN; CROSS-LINKING	LDL receptor-related protein 1 (LRP1) is a highly modular protein and the largest known mammalian endocytic receptor. LRP1 binds and internalizes many plasma components, playing multiple crucial roles as a scavenger and signaling molecule. One major challenge to studying LRP1 has been that it is difficult to express such a large, highly glycosylated, and cysteinerich protein, limiting structural studies to LRP1 fragments. Here, we report the first recombinant expression of the complete 61 domains of the full-length LRP1 ectodomain. This advance was achieved with a multistep cloning approach and by using DNA dilutions to improve protein yields. We investigated the binding properties of LRP1 using receptor-associated protein (RAP) as a model ligand due to its tight binding interaction. The LRP1 conformation was studied in its bound and unbound state using mass spectrometry, small-angle X-ray scattering, and negative-stain electron microscopy at neutral and acidic pH. Our findings revealed a pH-dependent release of the ligand associated with a conformational change of the receptor. In summary, this investigation of the complete LRP1 ectodomain significantly advances our understanding of this important receptor and provides the basis for further elucidating the mechanism of action of LRP1 in a whole and integrated system.	[De Nardis, Camilla; Madoori, Pramod K.; Leloup, Nadia; Gros, Piet] Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Netherlands Prote Ctr, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [van den Biggelaar, Maartje; Mertens, Koen] Sanquin Res, Dept Plasma Proteins, NL-1006 AN Amsterdam, Netherlands; [Mertens, Koen] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@uu.nl	Leloup, Nadia/W-9748-2019; Gros, Piet/AAD-6452-2019; Heck, Albert/D-7098-2011	Leloup, Nadia/0000-0002-1504-3690; Gros, Piet/0000-0002-7782-2585; Heck, Albert/0000-0002-2405-4404; Lossl, Philip/0000-0001-5062-7723	ManiFold project in the European Union [317371]; BioStruct-X in the European Union [283570]; Roadmap Initiative Proteins@Work - Netherlands Organisation for Scientific Research (NWO) [184.032.201]; Landsteiner Foundation for Blood Transfusion Research (LSBR) [1517]	ManiFold project in the European Union; BioStruct-X in the European Union; Roadmap Initiative Proteins@Work - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Transfusion Research (LSBR)	This work was supported by the ManiFold project (Grant 317371) and the BioStruct-X (Grant 283570) embedded in the European Union's Seventh Framework Programme (FP7/2007-2013), the Roadmap Initiative Proteins@Work (Project 184.032.201) funded by The Netherlands Organisation for Scientific Research (NWO), and The Landsteiner Foundation for Blood Transfusion Research (LSBR Fellowship 1517 (to M. v. d. B)). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Bloem E, 2015, BIOCHEM J, V468, P65, DOI 10.1042/BJ20140977; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DELAIN E, 1994, ANN NY ACAD SCI, V737, P202, DOI 10.1111/j.1749-6632.1994.tb44313.x; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Halff EF, 2014, PROTEIN EXPRES PURIF, V99, P27, DOI 10.1016/j.pep.2014.03.010; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Lazic A, 2006, ARCH BIOCHEM BIOPHYS, V450, P167, DOI 10.1016/j.abb.2006.04.007; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Lossl P, 2016, ACS CENTRAL SCI, V2, P445, DOI 10.1021/acscentsci.6b00053; Lossl P, 2016, EMBO J, V35, P2634, DOI 10.15252/embj.201694818; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Snijder J, 2014, J AM CHEM SOC, V136, P7295, DOI 10.1021/ja502616y; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827	55	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					912	924		10.1074/jbc.M116.758862	http://dx.doi.org/10.1074/jbc.M116.758862			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956551	Green Published, hybrid			2022-12-26	WOS:000392318700013
J	Canela-Xandri, O; Rawlik, K; Woolliams, JA; Tenesa, A				Canela-Xandri, Oriol; Rawlik, Konrad; Woolliams, John A.; Tenesa, Albert			Improved Genetic Profiling of Anthropometric Traits Using a Big Data Approach	PLOS ONE			English	Article							COMPLEX TRAITS; PREDICTION; ASSOCIATION	Genome-wide association studies (GWAS) promised to translate their findings into clinically beneficial improvements of patient management by tailoring disease management to the individual through the prediction of disease risk. However, the ability to translate genetic findings from GWAS into predictive tools that are of clinical utility and which may inform clinical practice has, so far, been encouraging but limited. Here we propose to use a more powerful statistical approach, the use of which has traditionally been limited due to computational requirements and lack of sufficiently large individual level genotyped cohorts, but which improve the prediction of multiple medically relevant phenotypes using the same panel of SNPs. As a proof of principle, we used a shared panel of 319,038 common SNPs with MAF > 0.05 to train the prediction models in 114,264 unrelated White-British individuals for height and four obesity related traits (body mass index, basal metabolic rate, body fat percentage, and waist-to-hip ratio). We obtained prediction accuracies that ranged between 46% and 75% of the maximum achievable given the captured heritable component. For height, this represents an improvement in prediction accuracy of up to 68% (184% more phenotypic variance explained) over SNPs reported to be robustly associated with height in a previous GWAS meta-analysis of similar size. Across-population predictions in White non-British individuals were similar to those in White-British whilst those in Asian and Black individuals were informative but less accurate. We estimate that the genotyping of circa 500,000 unrelated individuals will yield predictions between 66% and 82% of the SNP-heritability captured by common variants in our array. Prediction accuracies did not improve when including rarer SNPs or when fitting multiple traits jointly in multivariate models.	[Canela-Xandri, Oriol; Rawlik, Konrad; Woolliams, John A.; Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Western Gen Hosp, MRC IGMM, MRC HGU, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Tenesa, A (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Tenesa, A (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC IGMM, MRC HGU, Edinburgh, Midlothian, Scotland.	Albert.Tenesa@ed.ac.uk	PAN, ZEQIANG/X-6341-2018	Tenesa, Albert/0000-0003-4884-4475	Medical Research Council [MR/K014781/1, MR/N003179/1]; BBSRC; Medical Research Council Human Genetics Unit; BBSRC [BBS/E/D/20211554, BBS/E/R/00001618, BBS/E/R/00001610, BBS/E/D/20211553] Funding Source: UKRI; MRC [MR/K014781/1, MR/N003179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/R/00001610, BBS/B/05710, BBS/E/R/00000673, BBS/E/D/20211553, BBS/E/R/00001618] Funding Source: researchfish; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was mainly supported by the Medical Research Council (http://www.mrc.ac.uk/) [grant numbers MR/K014781/1 and MR/N003179/1] and The Roslin Institute Strategic Grant funding from the BBSRC (http://www.bbsrc.ac.uk/). AT also acknowledges funding from the Medical Research Council Human Genetics Unit (https://www.hgu.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Biesecker BB, 1999, NAT GENET, V22, P133, DOI 10.1038/9641; Canela-Xandri O, 2015, NAT COMMUN IN PRESS; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Meuwissen THE, 2001, GENETICS, V157, P1819; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schrodi SJ, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00162, 10.3389/fmicb.2014.00144]; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	18	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166755	10.1371/journal.pone.0166755	http://dx.doi.org/10.1371/journal.pone.0166755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977676	Green Published, Green Submitted, gold			2022-12-26	WOS:000391217400006
J	Hirasawa, K; Moriya, S; Miyahara, K; Kazama, H; Hirota, A; Takemura, J; Abe, A; Inazu, M; Hiramoto, M; Tsukahara, K; Miyazawa, K				Hirasawa, Kazuhiro; Moriya, Shota; Miyahara, Kana; Kazama, Hiromi; Hirota, Ayako; Takemura, Jun; Abe, Akihisa; Inazu, Masato; Hiramoto, Masaki; Tsukahara, Kiyoaki; Miyazawa, Keisuke			Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines	PLOS ONE			English	Article							PROTEIN VCP; STRESS; CANCER; EXPRESSION; APOPTOSIS; DEATH; TUMOR; CLARITHROMYCIN; BEVACIZUMAB; TRANSPORTER	Autophagy, a self-digestive system for cytoplasmic components, is required to maintain the amino acid pool for cellular homeostasis. We previously reported that the macrolide antibiotics azithromycin (AZM) and clarithromycin (CAM) have an inhibitory effect on autophagy flux, and they potently enhance the cytocidal effect of various anticancer reagents in vitro. This suggests that macrolide antibiotics can be used as an adjuvant for cancer chemotherapy. Since cancer cells require a larger metabolic demand than normal cells because of their exuberant growth, upregulated autophagy in tumor cells has now become the target for cancer therapy. In the present study, we examined whether macrolides exhibit cytotoxic effect under an amino acid-starving condition in head and neck squamous cancer cell lines such as CAL 27 and Detroit 562 as models of solid tumors with an upregulated autophagy in the central region owing to hypovascularity. AZM and CAM induced cell death under the amino acid-depleted (AAD) culture condition in these cell lines along with CHOP upregulation, although they showed no cytotoxicity under the complete culture medium. CHOP knockdown by siRNA in the CAL 27 cells significantly suppressed macrolide-induced cell death under the AAD culture condition. CHOP-/- murine embryonic fibroblast (MEF) cell lines also attenuated AZM-induced cell death compared with CHOP+/+ MEF cell lines. Using a tet-off atg5 MEF cell line, knockout of atg5, an essential gene for autophagy, also induced cell death and CHOP in the AAD culture medium but not in the complete culture medium. This suggest that macrolide-induced cell death via CHOP induction is dependent on autophagy inhibition. The cytotoxicity of macrolide with CHOP induction was completely cancelled by the addition of amino acids in the culture medium, indicating that the cytotoxicity is due to the insufficient amino acid pool. These data suggest the possibility of using macrolides for "tumor-starving therapy	[Hirasawa, Kazuhiro; Tsukahara, Kiyoaki] Tokyo Med Univ, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Moriya, Shota; Kazama, Hiromi; Hirota, Ayako; Takemura, Jun; Abe, Akihisa; Hiramoto, Masaki; Miyazawa, Keisuke] Tokyo Med Univ, Dept Biochem, Tokyo, Japan; [Miyahara, Kana] Tokyo Med Univ, Dept Breast Surg, Tokyo, Japan; [Inazu, Masato] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Miyazawa, K (corresponding author), Tokyo Med Univ, Dept Biochem, Tokyo, Japan.	miyazawa@tokyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26460478]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860398]; Tokyo Medical University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Medical University	This study was supported by funds provided through a MEXT-supported program of the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology (no. 26460478, http://www.mext.go.jp/), and a Grant-in-Aid for Young Scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 25860398, http://www.mext.go.jp/) and a Research Grant from Tokyo Medical University to SM.	Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cho H, 2015, AURIS NASUS LARYNX, V42, P396, DOI 10.1016/j.anl.2015.02.009; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Goodsell DS, 2003, STEM CELLS, V21, P118, DOI 10.1634/stemcells.21-1-118; Guo XL, 2013, J MOL MED, V91, P473, DOI 10.1007/s00109-012-0966-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Herberman RB, 2002, SEMIN ONCOL, V29, P27, DOI 10.1053/sonc.2002.33079; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu S, 2012, INT J ONCOL, V40, P1029, DOI 10.3892/ijo.2011.1317; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Mukai S, 2016, INT J ONCOL, V48, P45, DOI 10.3892/ijo.2015.3237; Nujic K, 2012, EUR J PHARMACOL, V677, P163, DOI 10.1016/j.ejphar.2011.12.022; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sassa K, 1999, ANTIMICROB AGENTS CH, V43, P67, DOI 10.1128/AAC.43.1.67; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; van Nuffel AMT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.513; Wang ZY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju215; Wasik AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.106; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yatsunami J, 1997, RES EXP MED, V197, P189, DOI 10.1007/s004330050068; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0164529	10.1371/journal.pone.0164529	http://dx.doi.org/10.1371/journal.pone.0164529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977675	Green Published, gold, Green Submitted			2022-12-26	WOS:000391217400002
J	Bailey, LD; van de Pol, M				Bailey, Liam D.; van de Pol, Martijn			climwin: An R Toolbox for Climate Window Analysis	PLOS ONE			English	Article							REPRODUCTIVE TRAITS; RESPONSES; WEATHER; PLASTICITY; MODEL; DATE	When studying the impacts of climate change, there is a tendency to select climate data from a small set of arbitrary time periods or climate windows (e.g., spring temperature). However, these arbitrary windows may not encompass the strongest periods of climatic sensitivity and may lead to erroneous biological interpretations. Therefore, there is a need to consider a wider range of climate windows to better predict the impacts of future climate change. We introduce the R package climwin that provides a number of methods to test the effect of different climate windows on a chosen response variable and compare these windows to identify potential climate signals. climwin extracts the relevant data for each possible climate window and uses this data to fit a statistical model, the structure of which is chosen by the user. Models are then compared using an information criteria approach. This allows users to determine how well each window explains variation in the response variable and compare model support between windows. climwin also contains methods to detect type I and II errors, which are often a problem with this type of exploratory analysis. This article presents the statistical framework and technical details behind the climwin package and demonstrates the applicability of the method with a number of worked examples.	[Bailey, Liam D.; van de Pol, Martijn] Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT, Australia; [van de Pol, Martijn] Netherlands Inst Ecol NIOOKNAW, Dept Anim Ecol, Wageningen, Netherlands	Australian National University	Bailey, LD (corresponding author), Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT, Australia.	liam.bailey@anu.edu.au	KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; van de Pol, Martijn/0000-0003-4102-4079; Bailey, Liam D./0000-0002-8226-9454	Australian Postgraduate Award scholarship; Australian Research Council [FT120100204]	Australian Postgraduate Award scholarship; Australian Research Council(Australian Research Council)	LDB was supported by an Australian Postgraduate Award scholarship and MvdP by the Australian Research Council (http:www.arc.gov.au/; FT120100204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Briga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16600; Brommer JE, 2008, P ROY SOC B-BIOL SCI, V275, P687, DOI 10.1098/rspb.2007.0951; Burnham KP, 2003, MODEL SELECTION MULT; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cayton HL, 2015, ECOLOGY, V96, P1473, DOI 10.1890/15-0131.1; Cayuela H, 2016, GLOBAL CHANGE BIOL, V22, P2676, DOI 10.1111/gcb.13290; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Husby A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000585; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Kruuk LEB, 2015, GLOBAL CHANGE BIOL, V21, P2929, DOI 10.1111/gcb.12926; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts AMI, 2008, INT J BIOMETEOROL, V52, P463, DOI 10.1007/s00484-007-0141-4; Roberts AMI, 2015, GLOBAL CHANGE BIOL, V21, P2603, DOI 10.1111/gcb.12896; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Stopher KV, 2014, ECOLOGY, V95, P3124; Teller BJ, 2016, METHODS ECOL EVOL, V7, P171, DOI 10.1111/2041-210X.12486; Therneau T., 2015, PACKAGE SURVIVAL ANA; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; van de Pol M, 2011, AM NAT, V177, P698, DOI 10.1086/659101; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167980	10.1371/journal.pone.0167980	http://dx.doi.org/10.1371/journal.pone.0167980			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973534	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000392754300052
J	Liang, ZG; Chen, XQ; Niu, ZJ; Chen, KH; Li, L; Qu, S; Su, F; Zhao, W; Li, Y; Pan, XB; Zhu, XD				Liang, Zhong-Guo; Chen, Xiao-Qian; Niu, Zhi-Jie; Chen, Kai-Hua; Li, Ling; Qu, Song; Su, Fang; Zhao, Wei; Li, Ye; Pan, Xin-Bin; Zhu, Xiao-Dong			Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							7TH EDITION; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; CANCER; IMRT	Objective The aim of this study was to compare the 2008 Chinese and the 7th edition of the American Joint Committee on Cancer (AJCC) staging systems for nasopharyngeal carcinoma and to provide proposals for updating T and N staging systems of the present staging system. Methods Between January 2007 and December 2012, a cohort of 752 patients with biopsy-proven, newly diagnosed, non-metastatic nasopharyngeal carcinoma who were treated with intensity-modulated radiotherapy were retrospectively analysed. Prognoses were compared by T stage, N stage, and clinical stage according to the two staging systems for overall survival (OS), local relapse-free survival (LRFS), and distant metastasis-free survival (DMFS). Results In terms of both the T and N staging systems, the two current staging systems were comparable in predicting OS. The T classification of the 2008 Chinese staging system was better in predicting LRFS, while the N classification of the 7th edition AJCC staging system was superior in predicting DMFS. In the modern era of intensity-modulated radiotherapy, the staging system should be updated by down-staging the current stage T2 to T1, and it might be rational to merge subcategories N1 and N2. Conclusions The two current staging systems each had advantages in predicting prognosis. It seems reasonable to downstage T2 to T1 and to merge N1 and N2.	[Liang, Zhong-Guo; Chen, Xiao-Qian; Niu, Zhi-Jie; Chen, Kai-Hua; Li, Ling; Qu, Song; Su, Fang; Zhao, Wei; Li, Ye; Pan, Xin-Bin; Zhu, Xiao-Dong] Guangxi Med Univ, Affiliated Tumor Hosp, Canc Inst Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China	Guangxi Medical University	Zhu, XD (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Canc Inst Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China.	zhuxdonggxmu@126.com			Fund of Guangxi Science [0832229]; Major Research Projects of Guangxi Universities [201101ZD004]; Key Project of Guangxi Heath Care [2011076]; Youth Science Fund of Guangxi Medical University [201515]	Fund of Guangxi Science; Major Research Projects of Guangxi Universities; Key Project of Guangxi Heath Care; Youth Science Fund of Guangxi Medical University	This work was sponsored by the Fund of Guangxi Science (no. 0832229), Major Research Projects of Guangxi Universities (no. 201101ZD004), the Key Project of Guangxi Heath Care (no. 2011076), and the Youth Science Fund of Guangxi Medical University (no. 201515), http://www.gxsti.net.cn/zwgk/kjxmgl/xmysgg/612843.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KH, 2016, ONCOTARGET; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Ee VPC, 2013, ASIAN PAC J CANCER P, V14, P2243, DOI 10.7314/APJCP.2013.14.4.2243; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee AWM, 2012, ORAL ONCOL, V48, P1007, DOI 10.1016/j.oraloncology.2012.03.022; Liang SB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-260; Liang Z, 2014, CURR ONCOL, V21, pE408, DOI 10.3747/co.21.1777; [林少俊 Lin Shaojun], 2015, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V24, P275; Liu XW, 2014, CHIN J CANCER, V33, P511, DOI 10.5732/cjc.014.10017; Mao YP, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0016-8; Pan J, 2013, J RADIOL ONCOL, V2, P233, DOI 10.1007/s13566-013-0088-5; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Pan JJ, 2015, AM J CLIN ONCOL-CANC, V38, P189, DOI 10.1097/COC.0b013e31828f5c96; Qiu WZ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0076-9; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Su Z, 2016, TUMOR BIOL, V37, P4429, DOI 10.1007/s13277-015-4266-5; Wu Z, 2014, J CANCER RES CLIN, V140, P69, DOI 10.1007/s00432-013-1542-x; Xu TT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001457; [曾雷 Zeng Lei], 2015, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V24, P285; Zhang L, 2016, ONCOTARGET, V7, P6221, DOI 10.18632/oncotarget.6754; Zhang SX, 2014, BIO-MED MATER ENG, V24, P1117, DOI 10.3233/BME-130911; Zhou GQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22326; Zong JF, 2015, ORAL ONCOL, V51, P254, DOI 10.1016/j.oraloncology.2014.10.012	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168470	10.1371/journal.pone.0168470	http://dx.doi.org/10.1371/journal.pone.0168470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973544	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300082
J	Kojima, R; Kobayashi, S; Satuito, CGP; Katsuyama, I; Ando, H; Seki, Y; Senda, T				Kojima, Ryuji; Kobayashi, Seiji; Satuito, Cyril Glenn Perez; Katsuyama, Ichiro; Ando, Hirotomo; Seki, Yasuyuki; Senda, Tetsuya			A Method for Evaluating the Efficacy of Antifouling Paints Using Mytilus galloprovincialis in the Laboratory in a Flow-Through System	PLOS ONE			English	Article							BLUE MUSSEL; LARVAL SETTLEMENT; SCREENING METHOD; METAMORPHOSIS; SUBSTANCES; RECRUITMENT; SUCCESSION; ATTACHMENT; PATTERNS; SURVIVAL	A laboratory test with a flow-through system was designed and its applicability for testing antifouling paints of varying efficacies was investigated. Six different formulations of antifouling paints were prepared to have increasing contents (0 to 40 wt.%) of Cu2O, which is the most commonly used antifouling substance, and each formulation of paint was coated on just one surface of every test plate. The test plates were aged for 45 days by rotating them at a speed of 10 knots inside a cylinder drum. A behavioral test was then conducted using five mussels (Mytilus galloprovincialis) that were pasted onto the coated surface of each aged test plate. The number of the byssus threads produced by each mussel generally decreased with increasing Cu2O content of the paint. The newly designed method was considered valid owing to the high consistency of its results with observations from the field experiment.	[Kojima, Ryuji; Ando, Hirotomo; Senda, Tetsuya] Natl Maritime Res Inst, Dept Marine Environm & Engine Syst, Mitaka, Tokyo, Japan; [Kobayashi, Seiji; Katsuyama, Ichiro] Japan NUS Co Ltd, Dept Environm Risk Consulting, Shinjuku Ku, Tokyo, Japan; [Satuito, Cyril Glenn Perez] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki, Japan; [Seki, Yasuyuki] Chugoku Marine Paints Ltd, Hiroshima R&D Ctr, Otake, Hiroshima, Japan	National Maritime Research Institute; Japan NUS; Nagasaki University	Kojima, R (corresponding author), Natl Maritime Res Inst, Dept Marine Environm & Engine Syst, Mitaka, Tokyo, Japan.	kojima@nmri.go.jp	Satuito, Cyril Glenn/AAA-5753-2020	Satuito, Cyril Glenn/0000-0002-9287-2660	Japan NUS Co., Ltd.; Chugoku Marine Paints, Ltd.; Nippon Foundation [20011965347, 2000070441C99]	Japan NUS Co., Ltd.; Chugoku Marine Paints, Ltd.; Nippon Foundation(Nippon Foundation)	Japan NUS Co., Ltd. provided support in the form of salaries for authors [SK and IK], and Chugoku Marine Paints, Ltd. provided support in the form of salaries for author [YS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the Nippon Foundation, Project ID: 20011965347, Continued project ID: 2000070441C99.	Aldred N, 2006, J R SOC INTERFACE, V3, P37, DOI 10.1098/rsif.2005.0074; Allan J.A., 1976, Journal moll Stud, V42, P279; [Anonymous], 2007, 151812 ISO; Archambault P, 1999, J EXP MAR BIOL ECOL, V238, P161, DOI 10.1016/S0022-0981(98)00146-4; Arias S, 1999, EUROPEAN COATINGS H, V1571, P122; ASTM Method, 2003, SYSTEMS; Bao WY, 2007, MAR BIOL, V150, P565, DOI 10.1007/s00227-006-0383-4; BAYNE BL, 1964, J ANIM ECOL, V33, P513, DOI 10.2307/2569; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Briand JF, 2009, BIOFOULING, V25, P297, DOI 10.1080/08927010902745316; BROWN CH, 1952, Q J MICROSC SCI, V93, P487; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Campbell Marnie L, 2011, Biofouling, V27, P631, DOI 10.1080/08927014.2011.593715; Carl C, 2011, BIOFOULING, V27, P859, DOI 10.1080/08927014.2011.605943; Carl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052358; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Carrington E, 2004, AM MALACOL BULL, V18, P135; Coutts ADM, 2004, NEW ZEAL J MAR FRESH, V38, P215, DOI 10.1080/00288330.2004.9517232; Coutts ADM, 2010, MAR POLLUT BULL, V60, P1533, DOI 10.1016/j.marpolbul.2010.04.015; Coutts ADM, 2010, BIOFOULING, V26, P1, DOI 10.1080/08927010903174599; Da Gama BAP, 2003, BIOFOULING, V19, P161, DOI 10.1080/0892701031000089534; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; Dobretsov S, 2006, BIOFOULING, V22, P43, DOI 10.1080/08927010500504784; Dobretsov SV, 1999, BIOFOULING, V14, P153, DOI 10.1080/08927019909378406; ECHA, 2014, TRANS GUID BIOC PROD; Etoh H, 1996, NIPPON SUISAN GAKK, V62, P796; Filgueira LGPR, 2007, AQUAC RES, V38, P1679, DOI 10.1111/j.1365-2109.2007.01820.x; Finnie AA, 2006, BIOFOULING, V22, P279, DOI 10.1080/08927010600898862; HARADA A, 1984, AGR BIOL CHEM TOKYO, V48, P641, DOI 10.1080/00021369.1984.10866197; Haslbeck E., 2005, J PROTECT COAT LININ, V2005, P34; Haslbeck EG, 1992, SNAME A, V3A, P1; Hayashi Y., 1996, J MAR BIOTECHNOL, V4, P127; Hopkins Grant A, 2010, Biofouling, V26, P613, DOI 10.1080/08927014.2010.502963; INA K, 1989, AGR BIOL CHEM TOKYO, V53, P3319, DOI 10.1080/00021369.1989.10869811; Ina K, 1990, KAGAKU TO SEIBUTU, V2, P132; Japanese Standard Association, 1983, K5630 JIS; KETCHUM BH, 1945, IND ENG CHEM, V37, P456, DOI 10.1021/ie50425a021; KITAJIMA F, 1995, FISHERIES SCI, V61, P578, DOI 10.2331/fishsci.61.578; Kojima R, 2014, J SHIPPING OCEAN ENG, V4, P214; Martin-Rodriguez AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123652; MCGRATH D, 1988, MAR ECOL PROG SER, V47, P103, DOI 10.3354/meps047103; Ohba T, 1999, SESSILE ORGANISMS, V15, P9; Okamura Hideo, 2009, Sessile Organisms, V26, P33; Otani M, 2007, BIOFOULING, V23, P277, DOI 10.1080/08927010701315089; PINEDA J, 1994, MAR ECOL PROG SER, V107, P125, DOI 10.3354/meps107125; Piola RF, 2009, BIOFOULING, V25, P633, DOI 10.1080/08927010903063065; Ralston EA, 2014, BIOFOULING, V30, P459, DOI 10.1080/08927014.2014.894984; Richmond M.D., 1991, Biofouling, V3, P151; Sakaguchi I., 2007, ATTACHING ORGANISMS, P100; SATUITO CG, 1995, FISHERIES SCI, V61, P223, DOI 10.2331/fishsci.61.223; Satuito CG, 2005, BIOFOULING, V21, P217, DOI 10.1080/08927010500375300; Satuito CG, 1993, OEBALIA S, V16, P479; Schultz MP, 2007, BIOFOULING, V23, P331, DOI 10.1080/08927010701461974; Seki Y, 2014, P INT S MAR ENG ISME, P15; Sera Y, 2000, MAR BIOTECHNOL, V2, P314; The CEPE Antifouling Working Group, 2011, EFF EV ANT PROD COND, P1; Thomason JC, 2000, BIOFOULING, V16, P323, DOI 10.1080/08927010009378455; Toupoint N, 2012, ECOLOGY, V93, P1922, DOI 10.1890/11-1292.1; UNDERWOOD AJ, 1994, J MAR BIOL ASSOC UK, V74, P563, DOI 10.1017/S0025315400047676; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; Wang C, 2012, BIOFOULING, V28, P249, DOI 10.1080/08927014.2012.671303; Yebra DM, 2006, BIOFOULING, V22, P33, DOI 10.1080/08927010500519097	62	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168172	10.1371/journal.pone.0168172	http://dx.doi.org/10.1371/journal.pone.0168172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959916	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900045
J	Rickert, E; Wahl, M; Link, H; Richter, H; Pohnert, G				Rickert, Esther; Wahl, Martin; Link, Heike; Richter, Hannes; Pohnert, Georg			Seasonal Variations in Surface Metabolite Composition of Fucus vesiculosus and Fucus serratus from the Baltic Sea	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; FATTY-ACIDS; CHEMICAL-COMPOSITION; SECONDARY METABOLITES; ASCOPHYLLUM-NODOSUM; PHENOLIC-COMPOUNDS; MARINE MACROALGAE; CITRIC-ACID; TEMPERATURE; GROWTH	Perennial macroalgae within the genus Fucus are known to exude metabolites through their outer thallus surface. Some of these metabolites have pro-and/or antifouling properties. Seasonal fluctuations of natural fouling pressure and chemical fouling control strength against micro-and macrofoulers have previously been observed in Fucus, suggesting that control strength varies with threat. To date, a study on the seasonal composition of surface associated metabolites, responsible for much of the fouling control, has not been done. We sampled individuals of the two co-occurring species F. vesiculosus and F. serratus at monthly intervals (six per species and month) during a one-year field study. We analysed the chemical composition of surface associated metabolites of both Fucus species by means of gas chromatography- mass spectrometry (GC-MS) to describe temporal patterns in chemical surface composition. Additionally, we correlated abiotic and biotic parameters recorded monthly within the sampled habitat with the variation in the chemical surface landscape of Fucus. Our study revealed that the chemical surface composition of both Fucus species exhibits substantial seasonal differences between spring/summer and autumn/winter months. Light and temperature explained most of the seasonal variability in surface metabolite composition of both Fucus species. A strong summerly up-regulation of eighteen saccharides and two hydroxy acids in F. vesiculosus as well as of four fatty acids and two saccharides in F. serratus was observed. We discuss how these up-regulated molecules may have a complex effect on associated microfoulers, both promoting or decreasing fouling depending on metabolite and bacterial identity. These seasonal shifts in the surface metabolome seem to exert a compound control of density and composition of the Fucus associated biofilm.	[Rickert, Esther; Wahl, Martin] Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Marine Ecol, Div Benth Ecol, Kiel, Germany; [Link, Heike] Univ Kiel, Inst Ecosyst Res, Kiel, Germany; [Richter, Hannes; Pohnert, Georg] Friedrich Schiller Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Friedrich Schiller University of Jena	Rickert, E (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Marine Ecol, Div Benth Ecol, Kiel, Germany.	erickert@geomar.de	Wahl, Martin/D-2038-2016; Pohnert, Georg/D-3721-2013	Wahl, Martin/0000-0001-8703-3857; Pohnert, Georg/0000-0003-2351-6336; Link, Heike/0000-0002-8484-845X	German Research Foundation (DFG) [WA 708/24-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the German Research Foundation (DFG) under the project number: WA 708/24-1 (http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Diaz RT, 2006, MAR BIOL, V148, P459, DOI 10.1007/s00227-005-0102-6; Abdullah MI, 2004, J MAR BIOL ASSOC UK, V84, P887, DOI 10.1017/S002531540401015Xh; Amade P, 1998, AQUAT TOXICOL, V43, P287, DOI 10.1016/S0166-445X(98)00054-X; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; CARLSON DJ, 1984, LIMNOL OCEANOGR, V29, P1077, DOI 10.4319/lo.1984.29.5.1077; Colvard NB, 2014, J EXP MAR BIOL ECOL, V458, P6, DOI 10.1016/j.jembe.2014.05.001; Culioli G, 2002, BIOCHEM SYST ECOL, V30, P61, DOI 10.1016/S0305-1978(01)00071-0; DALY CG, 1982, J CLIN PERIODONTOL, V9, P386, DOI 10.1111/j.1600-051X.1982.tb02049.x; DAVISON IR, 1987, BRIT PHYCOL J, V22, P77, DOI 10.1080/00071618700650101; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; de Nys R, 1998, MAR ECOL PROG SER, V162, P79, DOI 10.3354/meps162079; De Rosa S, 2001, Z NATURFORSCH C, V56, P1008; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Dworjanyn SA, 2006, MAR ECOL PROG SER, V318, P153, DOI 10.3354/meps318153; Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; FLEURENCE J, 1994, J APPL PHYCOL, V6, P527, DOI 10.1007/BF02182406; Fong P, 2004, AQUAT BOT, V78, P83, DOI 10.1016/j.aquabot.2003.09.006; Goecke F, 2012, GAYANA BOT, V69, P376, DOI 10.4067/S0717-66432012000200016; Gorley C.K., 2006, GETTING STARTED PRIM; Grosser K, 2012, BIOFOULING, V28, P687, DOI 10.1080/08927014.2012.700306; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Hellio C, 2004, MAR BIOTECHNOL, V6, P67, DOI 10.1007/s10126-003-0020-x; ILVESSALO H, 1989, MAR BIOL, V101, P115, DOI 10.1007/BF00393484; In YW, 2013, J FOOD SAFETY, V33, P79, DOI 10.1111/jfs.12025; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kamenarska Z, 2004, BOT MAR, V47, P215, DOI 10.1515/BOT.2004.022; Kamenarska Z, 2002, Z NATURFORSCH C, V57, P584; Khotimchenko SV, 1998, PHYTOCHEMISTRY, V49, P2363, DOI 10.1016/S0031-9422(98)00240-4; Khotimchenko SV, 2002, BOT MAR, V45, P17, DOI 10.1515/BOT.2002.003; Lachnit T, 2013, FEMS MICROBIOL ECOL, V84, P411, DOI 10.1111/1574-6941.12071; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lehvo A, 2001, BOT MAR, V44, P345, DOI 10.1515/BOT.2001.044; LONGSTRETH DJ, 1980, PLANT PHYSIOL, V65, P541, DOI 10.1104/pp.65.3.541; Marechal JP, 2004, J EXP MAR BIOL ECOL, V313, P47, DOI 10.1016/j.jembe.2004.07.016; Ferrer-Luque CM, 2010, J ENDODONT, V36, P1673, DOI 10.1016/j.joen.2010.06.009; MASINI RJ, 1995, AQUAT BOT, V49, P239, DOI 10.1016/0304-3770(94)00432-L; McGaw LJ, 2002, FITOTERAPIA, V73, P431, DOI 10.1016/S0367-326X(02)00120-X; Menendez M, 2002, SCI MAR, V66, P355, DOI 10.3989/scimar.2002.66n4355; MIZUTA H, 1992, NIPPON SUISAN GAKK, V58, P2345; Nejrup LB, 2013, EUR J PHYCOL, V48, P295, DOI 10.1080/09670262.2013.830778; Nelson MM, 2002, BOT MAR, V45, P58, DOI 10.1515/BOT.2002.007; Nygard CA, 2008, EUR J PHYCOL, V43, P253, DOI 10.1080/09670260802172627; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Nylund GM, 2010, FEMS MICROBIOL ECOL, V71, P84, DOI 10.1111/j.1574-6941.2009.00791.x; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Pavia H, 2000, HYDROBIOLOGIA, V440, P299, DOI 10.1023/A:1004152001370; Persson F, 2011, BIOFOULING, V27, P579, DOI 10.1080/08927014.2011.589001; PREGNALL AM, 1983, MAR BIOL, V73, P37, DOI 10.1007/BF00396283; RAGAN MA, 1978, J EXP MAR BIOL ECOL, V34, P245, DOI 10.1016/S0022-0981(78)80006-9; Raikar SV, 2001, INDIAN J MAR SCI, V30, P98; Rickert E, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2970-3; Rickert E, 2015, BIOFOULING, V31, P363, DOI 10.1080/08927014.2015.1041020; Saha M, 2012, BIOFOULING, V28, P593, DOI 10.1080/08927014.2012.698615; Saha M, 2011, BIOFOULING, V27, P423, DOI 10.1080/08927014.2011.580841; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; SAND-JENSEN K, 1977, Aquatic Botany, V3, P55, DOI 10.1016/0304-3770(77)90004-3; Sebastianes FLS, 2012, CURR MICROBIOL, V65, P622, DOI 10.1007/s00284-012-0206-4; Seidel V, 2004, INT J ANTIMICROB AG, V23, P613, DOI 10.1016/j.ijantimicag.2003.11.008; SIEBURTH J M, 1969, Journal of Experimental Marine Biology and Ecology, V3, P290, DOI 10.1016/0022-0981(69)90052-5; Sneed JM, 2011, BIOFOULING, V27, P347, DOI 10.1080/08927014.2011.576317; Sneed JM, 2011, FEMS MICROBIOL ECOL, V75, P242, DOI 10.1111/j.1574-6941.2010.01005.x; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; TERRADOS J, 1992, J EXP MAR BIOL ECOL, V162, P199, DOI 10.1016/0022-0981(92)90201-K; TUGWELL S, 1989, J EXP MAR BIOL ECOL, V129, P219, DOI 10.1016/0022-0981(89)90104-4; Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6; Wada S, 2007, J EXP MAR BIOL ECOL, V349, P344, DOI 10.1016/j.jembe.2007.05.024; Wahl M, 2010, MAR ECOL PROG SER, V411, P33, DOI 10.3354/meps08644; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; WHEELER WN, 1983, J PHYCOL, V19, P92, DOI 10.1111/j.0022-3646.1983.00092.x; Wyatt KH, 2014, FRESHWATER BIOL, V59, P407, DOI 10.1111/fwb.12273; Yff BTS, 2002, J ETHNOPHARMACOL, V79, P101, DOI 10.1016/S0378-8741(01)00380-4	76	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168196	10.1371/journal.pone.0168196	http://dx.doi.org/10.1371/journal.pone.0168196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959901	Green Published, Green Accepted, gold			2022-12-26	WOS:000392753900049
J	Cha, E; Lee, KM; Park, KD; Park, KS; Lee, KW; Kim, SM; Lee, J				Cha, Eunju; Lee, Kang Mi; Park, Ki Duk; Park, Kyung Seok; Lee, Kwang-Woo; Kim, Sung-Min; Lee, Jaeick			Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack	PLoS One			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; MULTIPLE-SCLEROSIS; HUMAN BRAIN; CHOLESTEROL HOMEOSTASIS; DIAGNOSTIC-CRITERIA; OXIDATION-PRODUCTS; CELL-DEATH; OXYSTEROLS; PLASMA; 27-HYDROXYCHOLESTEROL	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system (CNS). Hydroxycholesterols (OHCs), metabolites of CNS cholesterol, are involved in diverse cellular responses to inflammation and demyelination, and may also be involved in the pathogenesis of NMO. We aimed to develop a sensitive and reliable method for the quantitative analysis of three major OHCs (24S-, 25-, and 27-OHCs), and to evaluate their concentration in the cerebrospinal fluid (CSF) and serum of patients with NMO. The levels of the three OHCs in the serum and CSF were measured using liquid chromatography-silver ion coordination ionspray tandem mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry with picolinyl ester derivatization, respectively. The linear range was 5-250 ng/mL for 24S- and 27-OHC, and 0.5-25 ng/mL for 25-OHC in serum, and was 0.1-5 ng/mL for 24S- and 27-OHC, and 0.03-1 ng/mL for 25-OHC in CSF. Precision and accuracy were 0.5%-14.7% and 92.5%-109.7%, respectively, in serum, and were 0.8%-7.7% and 94.5%-119.2%, respectively, in CSF. Extraction recovery was 82.7%-90.7% in serum and 68.4%-105.0% in CSF. When analyzed in 26 NMO patients and 23 control patients, the 25-OHC (0.54 +/- 0.96 ng/mL vs. 0.09 +/- 0.04 ng/mL, p = 0.032) and 27-OHC (2.68 +/- 3.18 ng/mL vs. 0.68 +/- 0.25 ng/mL, p = 0.005) were increased in the CSF from NMO patients. When we measured the OHCCSF index that controls the effects of blood-brain barrier disruption on the level of OHC in the CSF, the 27-OHCCSF index was associated with disability (0.723; 95% confidence interval (CI) -0.181, 0.620; p = 0.002), while the 24-OHCCSF index (0.518; 95% CI -1.070, 38.121; p = 0.040) and 25-OHCCSF index (0.677; 95% CI-4.313, 18.532; p = 0.004) were associated with the number of white blood cells in the CSF of NMO patients. Our results imply that OHCs in the CNS could play a role in the pathogenesis of NMO.	[Cha, Eunju; Lee, Kang Mi; Lee, Jaeick] Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea; [Park, Ki Duk] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea; [Park, Kyung Seok] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Gyeonggi Do, South Korea; [Lee, Kwang-Woo; Kim, Sung-Min] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University (SNU)	Lee, J (corresponding author), Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea.; Kim, SM (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	sueh916@gmail.com; jaeicklee@kist.re.kr			National Research foundation fund [2014R1A1A2055741]; intramural grant from Korea Institute of Science and Technology (KIST)	National Research foundation fund(National Research Foundation of Korea); intramural grant from Korea Institute of Science and Technology (KIST)	This work was supported by grant NO. "2014R1A1A2055741" from the National Research foundation fund. Ag+CIS work was supported by an intramural grant from Korea Institute of Science and Technology (KIST).	Bayer E, 1999, ANGEW CHEM INT EDIT, V38, P992, DOI 10.1002/(SICI)1521-3773(19990401)38:7<992::AID-ANIE992>3.0.CO;2-K; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bruck W, 2012, ANN NEUROL, V72, P385, DOI 10.1002/ana.23621; Burkard I, 2004, J LIPID RES, V45, P776, DOI 10.1194/jlr.D300036-JLR200; Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062; Crick PJ, 2015, STEROIDS, V99, P172, DOI 10.1016/j.steroids.2015.02.021; DeBarber AE, 2008, ANAL BIOCHEM, V381, P151, DOI 10.1016/j.ab.2008.05.037; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Eibinger G, 2013, EXP CELL RES, V319, P1828, DOI 10.1016/j.yexcr.2013.03.025; Emanuelsson I, 2012, NEUROSCI LETT, V525, P44, DOI 10.1016/j.neulet.2012.07.057; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Freemantle E, 2013, INT J NEUROPSYCHOPH, V16, P1241, DOI 10.1017/S1461145712001587; Gilardi F, 2009, NEUROSCIENCE, V164, P530, DOI 10.1016/j.neuroscience.2009.08.003; Griffiths WJ, 2009, J CHROMATOGR B, V877, P2778, DOI 10.1016/j.jchromb.2009.05.017; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Hirayama T, 2009, HEPATOL RES, V39, P149, DOI 10.1111/j.1872-034X.2008.00450.x; Honda A, 2008, J LIPID RES, V49, P2063, DOI 10.1194/jlr.D800017-JLR200; Honda A, 2009, J LIPID RES, V50, P350, DOI 10.1194/jlr.D800040-JLR200; Iuliano L, 2015, STEROIDS, V99, P189, DOI 10.1016/j.steroids.2015.01.026; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang XT, 2007, RAPID COMMUN MASS SP, V21, P141, DOI 10.1002/rcm.2820; Kim SM, 2011, J NEUROL, V258, P2176, DOI 10.1007/s00415-011-6086-x; Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4; Koarai A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-63; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; Leoni V, 2013, BIOCHEM PHARMACOL, V86, P26, DOI 10.1016/j.bcp.2013.03.015; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Makoukji J, 2011, J NEUROSCI, V31, P9620, DOI 10.1523/JNEUROSCI.0761-11.2011; Matysik S, 2013, BIOCHIMIE, V95, P489, DOI 10.1016/j.biochi.2012.09.015; Mendiara I, 2012, J SEP SCI, V35, P3308, DOI 10.1002/jssc.201200519; Menendez-Carreno M, 2008, J CHROMATOGR B, V864, P61, DOI 10.1016/j.jchromb.2008.01.036; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Misu T, 2009, J NEUROL NEUROSUR PS, V80, P575, DOI 10.1136/jnnp.2008.150698; Ogundare M, 2010, J BIOL CHEM, V285, P4666, DOI 10.1074/jbc.M109.086678; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Pittock SJ, 2008, SEMIN NEUROL, V28, P95, DOI 10.1055/s-2007-1019131; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ratelade J, 2012, ACTA NEUROPATHOL, V123, P861, DOI 10.1007/s00401-012-0986-4; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Schott HF, 2015, STEROIDS, V99, P139, DOI 10.1016/j.steroids.2015.02.006; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; SMITH LL, 1972, J NEUROCHEM, V19, P899, DOI 10.1111/j.1471-4159.1972.tb01406.x; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tiwari-Woodruff S, 2009, J NEUROL SCI, V286, P81, DOI 10.1016/j.jns.2009.04.023; Umetani M, 2011, TRENDS ENDOCRIN MET, V22, P130, DOI 10.1016/j.tem.2011.01.003; VANBEEK TA, 1995, PHYTOCHEM ANALYSIS, V6, P1, DOI 10.1002/pca.2800060102; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Zhang H, 2013, J CLIN INVEST, V123, P2306, DOI 10.1172/JCI67554	64	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167819	10.1371/journal.pone.0167819	http://dx.doi.org/10.1371/journal.pone.0167819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942009	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600033
J	Kollitz, EM; Zhang, GZ; Hawkins, MB; Whitfield, GK; Reif, DM; Kullman, SW				Kollitz, Erin M.; Zhang, Guozhu; Hawkins, Mary Beth; Whitfield, G. Kerr; Reif, David M.; Kullman, Seth W.			Evolutionary and Functional Diversification of the Vitamin D Receptor-Lithocholic Acid Partnership	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; BILE-ACIDS; CRYSTAL-STRUCTURE; GENOME; INSIGHTS; SALT; PXR; BIOTRANSFORMATIONS; CHEMISTRY	The evolution, molecular behavior, and physiological function of nuclear receptors are of particular interest given their diverse roles in regulating essential biological processes. The vitamin D receptor (VDR) is well known for its canonical roles in calcium homeostasis and skeletal maintenance. Additionally, VDR has received an increased amount of attention due to the discovery of numerous non-calcemic functions, including the detoxification of lithocholic acid. Lithocholic acid is a toxic metabolite of chenodeoxycholic acid, a primary bile acid. The partnership between the VDR and lithocholic acid has been hypothesized to be a recent adaptation that evolved to mediate the detoxification and elimination of lithocholic acid from the gut. This partnership is speculated to be limited to higher vertebrates (birds and mammals), as lower vertebrates do not synthesize the parent compound of lithocholic acid. However, the molecular functions associated with the observed insensitivity of basal VDRs to lithocholic acid have not been explored. Here we characterize canonical nuclear receptor functions of VDRs from select species representing key nodes in vertebrate evolution and span a range of bile salt phenotypes. Competitive ligand binding assays revealed that the receptor's affinity for lithocholic acid is highly conserved across species, suggesting that lithocholic acid affinity is an ancient and non-adaptive trait. However, transient transactivation assays revealed that lithocholic acid-mediated VDR activation might have evolved more recently, as the non-mammalian receptors did not respond to lithocholic acid unless exogenous coactivator proteins were co-expressed. Subsequent functional assays indicated that differential lithocholic acid-mediated receptor activation is potentially driven by differential protein-protein interactions between VDR and nuclear receptor coregulator proteins. We hypothesize that the vitamin D receptor-lithocholic acid partnership evolved as a by-product of natural selection on the ligand-receptor partnership between the vitamin D receptor and the native VDR ligand: 1 alpha, 25-dihydroxyvitamin D-3, the biologically active metabolite of vitamin D-3.	[Kollitz, Erin M.; Kullman, Seth W.] North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA; [Kollitz, Erin M.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Guozhu; Reif, David M.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA; [Hawkins, Mary Beth; Reif, David M.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA; [Whitfield, G. Kerr] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	University of North Carolina; North Carolina State University; Duke University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Arizona	Kullman, SW (corresponding author), North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA.	swkullma@ncsu.edu		Kullmam, Seth/0000-0002-6029-2266; Kollitz, Erin/0000-0003-1769-1496; Reif, David/0000-0001-7815-6767	National Science Foundation [IOS818799]; NIEHS [T32-ES007046]; North Carolina State University; Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES025128, T32ES007329] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); North Carolina State University; Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Foundation Grant #IOS818799, NIEHS Training Grant #T32-ES007046, The Disseration Completion Grant from North Carolina State University, and the Stan and Judy Fellowship from Mount Desert Island Biological Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Belorusova AY, 2014, J MED CHEM, V57, P4710, DOI 10.1021/jm5002524; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; BURMESTER JK, 1988, P NATL ACAD SCI USA, V85, P1005, DOI 10.1073/pnas.85.4.1005; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Ekins S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-103; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Goto T, 2003, J LIPID RES, V44, P1643, DOI 10.1194/jlr.M300155-JLR200; Hagey LR, 2013, ADV NUTR, V4, P29, DOI 10.3945/an.112.003061; Hagey LR, 2010, ZOOL SCI, V27, P565, DOI 10.2108/zsj.27.565; Hagey LR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P308, DOI 10.1086/649966; Haussler MR, 2016, VITAM HORM, V100, P165, DOI 10.1016/bs.vh.2015.11.005; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Howarth DL, 2010, AQUAT TOXICOL, V98, P245, DOI 10.1016/j.aquatox.2010.02.020; Ikura T, 2016, VITAM HORM, V100, P117, DOI 10.1016/bs.vh.2015.10.004; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kollitz EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122853; Kollitz EM, 2014, ENDOCRINOLOGY, V155, P4641, DOI 10.1210/en.2014-1505; Kozoni V, 2000, CARCINOGENESIS, V21, P999, DOI 10.1093/carcin/21.5.999; Krasowski Matthew D, 2005, Nucl Recept, V3, P2, DOI 10.1186/1478-1336-3-2; Krasowski MD, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-5; Krasowski MD, 2011, MOL CELL ENDOCRINOL, V334, P39, DOI 10.1016/j.mce.2010.06.016; Krasowski MD, 2005, MOL ENDOCRINOL, V19, P1720, DOI 10.1210/me.2004-0427; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Masuno H, 2013, J LIPID RES, V54, P2206, DOI 10.1194/jlr.M038307; Matsubara T, 2008, DRUG METAB DISPOS, V36, P2058, DOI 10.1124/dmd.108.021501; Motulsky H, 2005, FITTING MODELS BIOLO; Mukhopadhyay S, 2004, CURR SCI INDIA, V87, P1666; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; Ploner A, 2012, R PACKAGE VERSION 26; R Core Team, 2021, R LANGUAGE ENV STAT; Reschly EJ, 2006, CURR DRUG METAB, V7, P349, DOI 10.2174/138920006776873526; Reschly EJ, 2008, J LIPID RES, V49, P1577, DOI 10.1194/jlr.M800138-JLR200; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Singarapu KK, 2011, BIOCHEMISTRY-US, V50, P11025, DOI 10.1021/bi201637p; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298	50	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168278	10.1371/journal.pone.0168278	http://dx.doi.org/10.1371/journal.pone.0168278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942020	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600062
J	Pillai, SM; Sereda, NH; Hoffman, ML; Valley, EV; Crenshaw, TD; Park, YK; Lee, JY; Zinn, SA; Govoni, KE				Pillai, Sambhu M.; Sereda, Nicole H.; Hoffman, Maria L.; Valley, Ellen V.; Crenshaw, Thomas D.; Park, Young-Ki; Lee, Ji-Young; Zinn, Steven A.; Govoni, Kristen E.			Effects of Poor Maternal Nutrition during Gestation on Bone Development and Mesenchymal Stem Cell Activity in Offspring	PLOS ONE			English	Article							MUSCLE DEVELOPMENT; GROWTH; DIFFERENTIATION; MASS; UNDERNUTRITION; METABOLISM; EXPRESSION; PLASTICITY; ADIPOSITY; PATHWAYS	Poor maternal nutrition impairs overall growth and development of offspring. These changes can significantly impact the general health and production efficiency of offspring. Specifically, poor maternal nutrition is known to reduce growth of bone and muscle, and increase adipose tissue. Mesenchymal stem cells (MSC) are multipotent stem cells which contribute to development of these tissues and are responsive to changes in the maternal environment. The main objective was to evaluate the effects of poor maternal nutirtion during gestation on bone and MSC function in offspring. Thirty-six ewes were fed 100%, 60%, or 140% of energy requirements [NRC, 1985] beginning at day 31 +/- 1.3 of gestation. Lambs from ewes fed 100% (CON), 60% (RES) and 140% (OVER) were euthanized within 24 hours of birth (1 day; n = 18) or at 3 months of age (n = 15) and bone and MSC samples were collected. Dual X-ray absorptiometry was performed on bones obtained from day 1 and 3 months. Proliferation, differentiation, and metabolic activity were determined in the MSC isolated from lambs at day 1. Data were analyzed using mixed procedure in SAS. Maternal diet negatively affected offspring MSC by reducing proliferation 50% and reducing mitochondrial metabolic activity. Maternal diet did not alter MSC glycolytic activity or differentiation in culture. Maternal diet tended to decrease expression of P2Y purinoreceptor 1, but did not alter expression of other genes involved in MSC proliferation and differentiation. Maternal diet did not alter bone parameters in offspring. In conclusion, poor maternal diet may alter offspring growth through reduced MSC proliferation and metabolism. Further studies evaluating the potential molecular changes associated with altered proliferation and metabolism in MSC due to poor maternal nutrition are warranted.	[Pillai, Sambhu M.; Sereda, Nicole H.; Hoffman, Maria L.; Valley, Ellen V.; Zinn, Steven A.; Govoni, Kristen E.] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Crenshaw, Thomas D.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Park, Young-Ki; Lee, Ji-Young] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA	University of Connecticut; University of Wisconsin System; University of Wisconsin Madison; University of Connecticut	Govoni, KE (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	kristen.govoni@uconn.edu	Crenshaw, Thomas/H-1073-2013	Crenshaw, Thomas/0000-0001-8886-0264	University of Connecticut Research Funds (UCRF); Storrs Agricultural Experiment Station	University of Connecticut Research Funds (UCRF); Storrs Agricultural Experiment Station	Funded by University of Connecticut Research Funds (UCRF) and Storrs Agricultural Experiment Station.	Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Caplan AI, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/628767; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; Devlin MJ, 2012, BONE, V50, P444, DOI 10.1016/j.bone.2011.06.019; Du M, 2011, J ANIM SCI, V89, P583, DOI 10.2527/jas.2010-3386; Du M, 2010, MEAT SCI, V86, P103, DOI 10.1016/j.meatsci.2010.04.027; Eastell R, 2002, P NUTR SOC, V61, P173, DOI 10.1079/PNS2002160; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; FIOROTTO ML, 1995, OBES RES, V3, P131, DOI 10.1002/j.1550-8528.1995.tb00130.x; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Glynn ERA, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-40; Hoffman ML, 2016, J ANIM SCI, V94, P3093, DOI 10.2527/jas.2016-0570; Hoffman ML, 2016, J ANIM SCI, V94, P789, DOI 10.2527/jas.2015-9933; Hoffman ML, 2014, DOMEST ANIM ENDOCRIN, V49, P39, DOI 10.1016/j.domaniend.2014.05.002; HU CX, 2016, INT J MOL SCI, V17; Impact of Pregnancy Nutrition on Offspring Bone Development, 2015, 112 ABB NUTR RES C; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jousse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104896; Kaebisch C, 2015, COMPUT STRUCT BIOTEC, V13, P75, DOI 10.1016/j.csbj.2014.11.003; Knights M, 2001, J ANIM SCI, V79, P1120; Lanham SA, 2008, OSTEOPOROSIS INT, V19, P147, DOI 10.1007/s00198-007-0443-8; Lanham SA, 2008, OSTEOPOROSIS INT, V19, P157, DOI 10.1007/s00198-007-0448-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyublinskaya OG, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/502105; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mehta G, 2002, CALCIFIED TISSUE INT, V71, P493, DOI 10.1007/s00223-001-2104-9; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399; Oreffo ROC, 2003, BONE, V33, P100, DOI 10.1016/S8756-3282(03)00166-2; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Raja JS, 2016, ANIMAL, P1; Reagan MR, 2016, NAT REV RHEUMATOL, V12, P154, DOI 10.1038/nrrheum.2015.160; Reed SA, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-43; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; Sawada Rumi, 2006, J Artif Organs, V9, P179, DOI 10.1007/s10047-006-0338-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	44	14	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168382	10.1371/journal.pone.0168382	http://dx.doi.org/10.1371/journal.pone.0168382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942040	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600065
J	Choi, YM; Yeo, HK; Park, YW; Lee, JY				Choi, Yong Mi; Yeo, Hyun Ku; Park, Young Woo; Lee, Jae Young			Structural Analysis of Thymidylate Synthase from Kaposi's Sarcoma-Associated Herpesvirus with the Anticancer Drug Raltitrexed	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; DNA-SEQUENCES; 5-FLUOROURACIL; AUTOREGULATION; IDENTIFICATION; INDUCTION; MECHANISM; DELETION; TOMUDEX	Kaposi's sarcoma-associated herpesvirus (KSHV) is a highly infectious human herpesvirus that causes Kaposi's sarcoma. KSHV encodes functional thymidylate synthase, which is a target for anticancer drugs such as raltitrexed or 5-fluorouracil. Thymidylate synthase catalyzes the conversion of 2'-deoxyuridine-5'-monophosphate (dUMP) to thymidine-5'-mono-phosphate (dTMP) using 5,10-methylenetetrahydrofolate (mTHF) as a co-substrate. The crystal structures of thymidylate synthase from KSHV (apo), complexes with dUMP (binary), and complexes with both dUMP and raltitrexed (ternary) were determined at 1.7 angstrom, 2.0 angstrom, and 2.4 angstrom, respectively. While the ternary complex structures of human thymidylate synthase and E. co/ithymidylate synthase had a closed conformation, the ternary complex structure of KSHV thymidylate synthase was observed in an open conformation, similar to that of rat thymidylate synthase. The complex structures of KSHV thymidylate synthase did not have a covalent bond between the sulfhydryl group of Cys219 and C6 atom of dUMP, unlike the human thymidylate synthase. The catalytic Cys residue demonstrated a dual conformation in the apo structure, and its sulfhydryl group was oriented toward the C6 atom of dUMP with no covalent bond upon ligand binding in the complex structures. These structural data provide the potential use of antifolates such as raltitrexed as a viral induced anticancer drug and structural basis to design drugs for targeting the thymidylate synthase of KSHV.	[Choi, Yong Mi; Yeo, Hyun Ku; Park, Young Woo; Lee, Jae Young] Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea	Dongguk University	Lee, JY (corresponding author), Dongguk Univ Seoul, Dept Life Sci, Goyang Si, Gyeonggi Do, South Korea.	jylee001@dongguk.edu			National Research Foundation of Korea [2014R1A1A1A050 08017]; Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC [710003-03]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC	This work was supported by the National Research Foundation of Korea / 2014R1A1A1A050 08017 / (www.nrf.re.kr/) to JYL and the Ministry for Food, Agriculture, Forestry and Fisheries, Korea / ARC; 710003-03, (www.ipet.re.kr/) to JYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog R, 2001, PROTEIN SCI, V10, P988, DOI 10.1110/ps.47601; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SH, 2004, BBA-PROTEINS PROTEOM, V1696, P15, DOI 10.1016/j.bbapap.2003.09.005; Brunn ND, 2014, BIOSCIENCE REP, V34, P905, DOI 10.1042/BSR20140137; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Chu E, 1996, Cancer Treat Res, V87, P175; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Chu E, 1999, MOL CELL BIOL, V19, P1582; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fox KM, 1999, PROTEIN SCI, V8, P538; Gaspar G, 2002, J VIROL, V76, P10530, DOI 10.1128/JVI.76.20.10530-10532.2002; Hew K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143947; Jackman AL, 1996, INVEST NEW DRUG, V14, P305, DOI 10.1007/BF00194534; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Longley DB, 2002, CANCER RES, V62, P2644; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRY KM, 1993, BIOCHEMISTRY-US, V32, P7116, DOI 10.1021/bi00079a007; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Sotelo-Mundo RR, 1999, BIOCHEMISTRY-US, V38, P1087, DOI 10.1021/bi981881d; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168019	10.1371/journal.pone.0168019	http://dx.doi.org/10.1371/journal.pone.0168019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936107	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100255
J	Fadda, A; Bartschi, M; Hemphill, A; Widmer, HR; Zurbriggen, A; Perona, P; Vidondo, B; Oevermann, A				Fadda, A.; Bartschi, M.; Hemphill, A.; Widmer, H. R.; Zurbriggen, A.; Perona, P.; Vidondo, B.; Oevermann, A.			Primary Postnatal Dorsal Root Ganglion Culture from Conventionally Slaughtered Calves	PLOS ONE			English	Article							SATELLITE GLIAL-CELLS; E-CADHERIN EXPRESSION; NERVE GROWTH-FACTOR; PRIMARY AFFERENT NEURONS; PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; SCHWANN-CELLS; IN-VITRO; IMMUNOHISTOCHEMICAL CHARACTERIZATION; SPINAL GANGLIA	Neurological disorders in ruminants have an important impact on veterinary health, but very few host-specific in vitro models have been established to study diseases affecting the nervous system. Here we describe a primary neuronal dorsal root ganglia (DRG) culture derived from calves after being conventionally slaughtered for food consumption. The study focuses on the in vitro characterization of bovine DRG cell populations by immunofluorescence analysis. The effects of various growth factors on neuron viability, neurite outgrowth and arborisation were evaluated by morphological analysis. Bovine DRG neurons are able to survive for more than 4 weeks in culture. GF supplementation is not required for neuronal survival and neurite outgrowth. However, exogenously added growth factors promote neurite outgrowth. DRG cultures from regularly slaughtered calves represent a promising and sustainable host specific model for the investigation of pain and neurological diseases in bovines.	[Fadda, A.; Bartschi, M.; Zurbriggen, A.; Oevermann, A.] Univ Bern, Vetsuisse Fac, Div Neurol Sci, Bern, Switzerland; [Fadda, A.] Univ Bern, Theodor Kocher Inst, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Hemphill, A.] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Widmer, H. R.] Univ Hosp, Neuroctr & Regenerat Neurosci Cluster, Bern, Switzerland; [Widmer, H. R.] Univ Bern, Bern, Switzerland; [Perona, P.] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland; [Vidondo, B.] Univ Bern, Vetsuisse Fac, VPHI, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Edinburgh; University of Bern	Oevermann, A (corresponding author), Univ Bern, Vetsuisse Fac, Div Neurol Sci, Bern, Switzerland.	anna.oevermann@vetsuisse.unibe.ch	Widmer, Hans Rudolf/O-5172-2017	Widmer, Hans Rudolf/0000-0003-3378-8765; Vidondo, Beatriz/0000-0001-9693-2301; Oevermann, Anna/0000-0002-3569-8547; Hemphill, Andrew/0000-0002-0622-2128	Swiss National Foundation (SNF) [CRSII3_147692]; Charlotte and Ernst Frauchiger-Reyher Foundation	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Charlotte and Ernst Frauchiger-Reyher Foundation	This work was financially supported by a Swiss National Foundation (SNF) Sinergia grant (CRSII3_147692). The professorship of Anna Oevermann for comparative neuropathology is funded by the Charlotte and Ernst Frauchiger-Reyher Foundation.; This work was financially supported by a Swiss National Foundation (SNF) Sinergia grant (CRSII3_147692). The professorship of Anna Oevermann for comparative neuropathology is funded by the Charlotte and Ernst Frauchiger-Reyher foundation.	Arce V, 1998, J NEUROSCI, V18, P1440; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Barabas ME, 2014, J BIOL CHEM, V289, P34241, DOI 10.1074/jbc.M114.570101; Bauer A, 2014, J VIROL, V88, P14172, DOI 10.1128/JVI.02254-14; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Christie K, 2015, MOL CELL NEUROSCI, V67, P1, DOI 10.1016/j.mcn.2015.05.001; Colangelo AM, 2005, P NATL ACAD SCI USA, V102, P18658, DOI 10.1073/pnas.0508734102; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; de Lahunta A., 2015, VET NEUROANATOMY CLI, V4th ed; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; DEKONINCK P, 1993, J NEUROSCI, V13, P577; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Forgie A, 1999, MOL CELL NEUROSCI, V13, P430, DOI 10.1006/mcne.1999.0760; Franco NH, 2014, LAB ANIM-UK, V48, P50, DOI 10.1177/0023677213498717; Frey E, 2015, EXP NEUROL, V263, P350, DOI 10.1016/j.expneurol.2014.10.012; Gavazzi I, 1999, EUR J NEUROSCI, V11, P3405, DOI 10.1046/j.1460-9568.1999.00756.x; Gerhauser I, 2012, VET REC, V170, DOI 10.1136/vr.100255; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; GRILLO MA, 1963, J CELL BIOL, V16, P430, DOI 10.1083/jcb.16.2.430; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Hatzig SV, 2015, J EXP BOT, V66, P5617, DOI 10.1093/jxb/erv235; Hemphill Andrew, 1997, P227; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Huang TY, 2005, BRAIN RES, V1036, P42, DOI 10.1016/j.brainres.2004.12.021; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kalous A, 2010, NEUROSCIENCE, V166, P107, DOI 10.1016/j.neuroscience.2009.12.019; Khan AA, 2009, BIOMED RES-INDIA, V20, P45; Kobayashi S, 2005, SPINE, V30, P276, DOI 10.1097/01.brs.0000152377.72468.f4; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kushnir R, 2011, NEUROPHARMACOLOGY, V61, P739, DOI 10.1016/j.neuropharm.2011.05.019; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Madarame H, 2011, NEUROPATH APPL NEURO, V37, P753, DOI 10.1111/j.1365-2990.2011.01183.x; Madduri S, 2009, NEUROSCI RES, V65, P88, DOI 10.1016/j.neures.2009.06.003; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; MERIGHI A, 1990, ANAT EMBRYOL, V181, P271; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332; Muratori L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/860546; Nascimento RS, 2008, BRAZ J MED BIOL RES, V41, P1011, DOI 10.1590/S0100-879X2008005000051; Owen Davina E, 2012, Methods Mol Biol, V846, P179, DOI 10.1007/978-1-61779-536-7_16; PANNESE E, 1975, J COMP NEUROL, V160, P463, DOI 10.1002/cne.901600404; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Paveliev M, 2004, MOL CELL NEUROSCI, V25, P453, DOI 10.1016/j.mcn.2003.11.010; Peng YR, 2009, NEURON, V61, P71, DOI 10.1016/j.neuron.2008.11.015; Pierce LM, 2006, AM J OBSTET GYNECOL, V195, P987, DOI 10.1016/j.ajog.2006.02.042; PRICE J, 1985, J NEUROSCI, V5, P2051; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Russo D, 2010, MICROSC RES TECHNIQ, V73, P128, DOI 10.1002/jemt.20764; Scolnick JA, 2008, NEURON, V57, P847, DOI 10.1016/j.neuron.2008.01.027; SHIMAMURA K, 1992, DEV BIOL, V152, P242, DOI 10.1016/0012-1606(92)90132-Z; SHOLL DA, 1953, J ANAT, V87, P387; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Valtcheva MV, 2016, NAT PROTOC, V11, P1877, DOI 10.1038/nprot.2016.111; Voigt T, 2004, MICROSC RES TECHNIQ, V63, P149, DOI 10.1002/jemt.20023; Winzer P, 2015, ANTIMICROB AGENTS CH, V59, P6361, DOI 10.1128/AAC.01236-15; Wong AW, 2015, MOL CELL NEUROSCI, V65, P125, DOI 10.1016/j.mcn.2015.03.004; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168228	10.1371/journal.pone.0168228	http://dx.doi.org/10.1371/journal.pone.0168228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936156	Green Published, gold			2022-12-26	WOS:000389587100281
J	Kim, SH; Hyun, JW; Joung, A; Lee, SH; Kim, HJ				Kim, Su-Hyun; Hyun, Jae-Won; Joung, AeRan; Lee, Sang Hyun; Kim, Ho Jin			Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis	PLOS ONE			English	Article							ABNORMALITIES; AQUAPORIN-4	We aimed to investigate the frequency of asymptomatic acute brain MRI abnormalities accompanying optic neuritis (ON) or myelitis in neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-Ab). We reviewed 324 brain MRI scans that were obtained during acute attacks of ON or myelitis, in 165 NMOSD patients with AQP4-Ab. We observed that acute asymptomatic NMOSD-typical brain lesions accompanied 27 (8%) acute attacks of ON or myelitis in 24 (15%) patients. The most common asymptomatic brain abnormalities included edematous corpus callosum lesions (n = 17), followed by lesions on the internal capsule and/or cerebral peduncle lesions (n = 9), periependymal surfaces of the fourth ventricle (n = 5), large deep white matter lesions (n = 4), periependymal cerebral lesions surrounding the lateral ventricles (n = 3), and hypothalamic lesions (n = 1). If asymptomatic NMOSD-typical brain abnormalities were considered as evidence for DIS, while also assuming that the AQP4-IgG status was unknown, the median time to diagnosis using the 2015 diagnosis criteria for NMOSD was shortened from 28 months to 6 months (p = 0.008). Asymptomatic acute NMOSD-typical brain lesions can be accompanied by an acute attack of ON or myelitis. Identifying these asymptomatic brain lesions may help facilitate earlier diagnosis of NMOSD.	[Kim, Su-Hyun; Hyun, Jae-Won; Joung, AeRan; Kim, Ho Jin] Natl Canc Ctr, Dept Neurol, Res Inst & Hosp, Go Yang, South Korea; [Lee, Sang Hyun] Natl Canc Ctr, Dept Radiol, Res Inst & Hosp, Go Yang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, HJ (corresponding author), Natl Canc Ctr, Dept Neurol, Res Inst & Hosp, Go Yang, South Korea.	hojinkim@ncc.re.kr			National Research Foundation of Korea [NRF-2016R1D1A1A09916480]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by the National Research Foundation of Korea (Grant No. NRF-2016R1D1A1A09916480).	Bichuetti DB, 2008, ARQ NEURO-PSIQUIAT, V66, P1, DOI 10.1590/S0004-282X2008000100001; Cabrera-Gomez JA, 2007, MULT SCLER, V13, P186, DOI 10.1177/1352458506070725; Chavarro VS, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000286; Ito S, 2009, ANN NEUROL, V66, P425, DOI 10.1002/ana.21753; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Kim SH, 2012, NEUROLOGY, V78, P1179, DOI 10.1212/WNL.0b013e31824f8069; Kim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108320; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Kim W, 2011, MULT SCLER J, V17, P1107, DOI 10.1177/1352458511404917; Matthews L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137715; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Zandona ME, 2014, MULT SCLER J, V20, P1908, DOI 10.1177/1352458514528763	13	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167783	10.1371/journal.pone.0167783	http://dx.doi.org/10.1371/journal.pone.0167783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936193	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100186
J	Leber, A; Bassaganya-Riera, J; Tubau-Juni, N; Zoccoli-Rodriguez, V; Viladomiu, M; Abedi, V; Lu, PY; Hontecillas, R				Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Viladomiu, Monica; Abedi, Vida; Lu, Pinyi; Hontecillas, Raquel			Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC INFLAMMATION; COLON EXPLANTS; IFN-GAMMA; M-CSF; IL-10; MACROPHAGES; MONOCYTES; COLITIS; CX3CR1	Immune responses to Helicobacter pylori are orchestrated through complex balances of host-bacterial interactions, including inflammatory and regulatory immune responses across scales that can lead to the development of the gastric disease or the promotion of beneficial systemic effects. While inflammation in response to the bacterium has been reasonably characterized, the regulatory pathways that contribute to preventing inflammatory events during H. pylori infection are incompletely understood. To aid in this effort, we have generated a computational model incorporating recent developments in the understanding of H. pylori-host interactions. Sensitivity analysis of this model reveals that a regulatory macrophage population is critical in maintaining high H. pylori colonization without the generation of an inflammatory response. To address how this myeloid cell subset arises, we developed a second model describing an intracellular signaling network for the differentiation of macrophages. Modeling studies predicted that LANCL2 is a central regulator of inflammatory and effector pathways and its activation promotes regulatory responses characterized by IL-10 production while suppressing effector responses. The predicted impairment of regulatory macrophage differentiation by the loss of LANCL2 was simulated based on multiscale linkages between the tissue-level gastric mucosa and the intracellular models. The simulated deletion of LANCL2 resulted in a greater clearance of H. pylori, but also greater IFN gamma responses and damage to the epithelium. The model predictions were validated within a mouse model of H. pylori colonization in wild-type (WT), LANCL2 whole body KO and myeloid-specific LANCL2-/- (LANCL2(Myeloid)) mice, which displayed similar decreases in H. pylori burden, CX3CR1+ IL-10-producing macrophages, and type 1 regulatory (Tr1) T cells. This study shows the importance of LANCL2 in the induction of regulatory responses in macrophages and T cells during H. pylori infection.	[Leber, Andrew; Bassaganya-Riera, Josep; Tubau-Juni, Nuria; Zoccoli-Rodriguez, Victoria; Viladomiu, Monica; Abedi, Vida; Lu, Pinyi; Hontecillas, Raquel] Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hontecillas, R (corresponding author), Virginia Tech, Biocomplex Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA 24061 USA.	rmagarzo@vt.edu	Lu, Pinyi/U-4513-2017; Viladomiu, Monica/GNM-6447-2022	Zoccoli-Rodriguez, Victoria/0000-0002-5487-6521; Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136139; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bassaganya-Riera J, 2007, AM J CLIN NUTR, V85, P824, DOI 10.1093/ajcn/85.3.824; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Caruso R, 2007, J IMMUNOL, V178, P5957, DOI 10.4049/jimmunol.178.9.5957; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Crowe SE, 2005, CURR OPIN GASTROEN, V21, P32; Das L, 2016, BIOCH J; Erreni M, 2016, J IMMUNOL, V196, P902, DOI 10.4049/jimmunol.1501335; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Fixe P, 1998, CYTOKINE, V10, P32, DOI 10.1006/cyto.1997.0249; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Hontecillas Raquel, 2012, ESPEN J, V7, pe189; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hsu P, 2015, J IMMUNOL, V195, P3665, DOI 10.4049/jimmunol.1402898; Hussain K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00071; Jarry A, 2008, J CLIN INVEST, V118, P1132, DOI 10.1172/JCI32140; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Kent E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-91; Kim JE, 2015, IMMUNE NETW, V15, P269, DOI 10.4110/in.2015.15.6.269; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kronsteiner B, 2016, GUT MICROBES, V7, P3, DOI 10.1080/19490976.2015.1116673; Leber A, 2016, J THEOR BIOL, V398, P74, DOI 10.1016/j.jtbi.2016.02.036; Leber A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134849; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Li H, 2016, DIG DIS SCI; Lim JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002609; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lu PY, 2014, CURR DRUG TARGETS, V15, P565, DOI 10.2174/1389450115666140313123714; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Ma X., 2015, F1000RES, V4, DOI 10.12688/f1000research.7010.1; MARSHALL BJ, 1984, LANCET, V1, P1311; Mayer H, 2001, GENE, V269, P73, DOI 10.1016/S0378-1119(01)00463-2; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Michalkiewicz J, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/176726; Nelson DE, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130131; Oghumu S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00560; Pan D, 2013, CYTOKINE, V64, P30, DOI 10.1016/j.cyto.2013.06.312; Papadakis KA, 2015, AM J PHYSIOL-GASTR L, V309, pG900, DOI 10.1152/ajpgi.00309.2015; Philipson CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137839; Randle SJ, 2016, CURR PROTEIN PEPT SC; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schneider KM, 2015, HEPATOLOGY, V62, P1405, DOI 10.1002/hep.27982; Schulz C, 2016, DIGEST DIS, V34, P210, DOI 10.1159/000443353; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tighe RM, 2016, J IMMUNOL, V196, P2424, DOI 10.4049/jimmunol.1600002; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; WING EJ, 1985, J IMMUNOL, V135, P2052; XIE QW, 1994, J BIOL CHEM, V269, P4705; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Zeng M, 2014, MOL BIOL CELL, V25, P3954, DOI 10.1091/mbc.E14-01-0004; Zhou PF, 2004, AM J PHYSIOL-GASTR L, V287, pG599, DOI 10.1152/ajpgi.00063.2004; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	65	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167440	10.1371/journal.pone.0167440	http://dx.doi.org/10.1371/journal.pone.0167440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936058	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100098
J	de Almeida, MLM; Feringer, WH; Carvalho, JRG; Rodrigues, IM; Jordao, LR; Fonseca, MG; de Rezende, ASC; Neto, AD; Weese, JS; da Costa, MC; Lemos, EGD; Ferraz, GD				Mendes de Almeida, Maria Luiza; Feringer Junior, Walter Heinz; Garcia Carvalho, Julia Ribeiro; Rodrigues, Isadora Mestriner; Jordao, Lilian Rezende; Fonseca, Mayara Goncalves; Carneiro de Rezende, Adalgiza Souza; de Queiroz Neto, Antonio; Scott Weese, J.; da Costa, Marcio Carvalho; de Macedo Lemos, Eliana Gertrudes; Ferraz, Guilherme de Camargo			Intense Exercise and Aerobic Conditioning Associated with Chromium or L-Carnitine Supplementation Modified the Fecal Microbiota of Fillies	PLOS ONE			English	Article							GUT MICROBIOTA	Recent studies performed in humans and rats have reported that exercise can alter the intestinal microbiota. Athletic horses perform intense exercise regularly, but studies characterizing horse microbiome during aerobic conditioning programs are still limited. Evidence has indicated that this microbial community is involved in the metabolic homeostasis of the host. Research on ergogenic substances using new sequencing technologies have been limited to the intestinal microbiota and there is a considerable demand for scientific studies that verify the effectiveness of these supplements in horses. L-carnitine and chromium are potentially ergogenic substances for athletic humans and horses since they are possibly able to modify the metabolism of carbohydrates and lipids. This study aimed to assess the impact of acute exercise and aerobic conditioning, associated either with L-carnitine or chromium supplementation, on the intestinal microbiota of fillies. Twelve "Mangalarga Marchador" fillies in the incipient fitness stage were distributed into four groups: control (no exercise), exercise, L-carnitine (10g/day) and chelated chromium (10mg/day). In order to investigate the impact of acute exercise or aerobic conditioning on fecal microbiota all fillies undergoing the conditioning program were analyzed as a separate treatment. The fillies underwent two incremental exercise tests before and after training on a treadmill for 42 days at 70 -80% of the lactate threshold intensity. Fecal samples were obtained before and 48 h after acute exercise (incremental exercise test). Bacterial populations were characterized by sequencing the V4 region of the 16S rRNA gene using the MiSeq Illumina platform, and 5,224,389 sequences were obtained from 48 samples. The results showed that, overall, the two most abundant phyla were Firmicutes (50.22%) followed by Verrucomicrobia (15.13%). The taxa with the highest relative abundances were unclassified Clostridiales (17.06%) and "5 genus incertae sedis" from the phylum Verrucomicrobia (12.98%). There was a decrease in the phylum Chlamydiae and in the genus Mycobacterium after the second incremental exercise test. Intense exercise changed the community's structure and aerobic conditioning was associated with changes in the composition and structure of the intestinal bacterial population of fillies. The intra-group comparison showed that chromium or L-carnitine induced moderate changes in the fecal microbiota of fillies, but the microbiota did not differ from the control group, which was exercised with no supplementation. Fecal pH correlated positively with Simpson's index, while plasma pH correlated negatively. Our results show that exercise and aerobic conditioning can change in the microbiota and provide a basis for further studies enrolling a larger number of horses at different fitness levels to better understand the effects of exercise and training on the intestinal microbiota of horses.	[Mendes de Almeida, Maria Luiza; de Macedo Lemos, Eliana Gertrudes] UNESP Univ Estadual Paulista, Dept Technol, Fac Ciencias Agr & Vet, Lab Bioquim Microrganismos & Plantas, Jaboticabal, SP, Brazil; [Feringer Junior, Walter Heinz; Garcia Carvalho, Julia Ribeiro; Rodrigues, Isadora Mestriner; Fonseca, Mayara Goncalves; de Queiroz Neto, Antonio; Ferraz, Guilherme de Camargo] UNESP Univ Estadual Paulista, Dept Anim Morphol & Physiol, Fac Ciencias Agr & Vet, Lab Farmacol & Fisiol Exercicio Equino LAFEQ, Jaboticabal, SP, Brazil; [Jordao, Lilian Rezende; Fonseca, Mayara Goncalves; Carneiro de Rezende, Adalgiza Souza] Univ Fed Minas Gerais, Dept Anim Sci, Escola Vet, Belo Horizonte, MG, Brazil; [Scott Weese, J.; da Costa, Marcio Carvalho] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; University of Guelph	Ferraz, GD (corresponding author), UNESP Univ Estadual Paulista, Dept Anim Morphol & Physiol, Fac Ciencias Agr & Vet, Lab Farmacol & Fisiol Exercicio Equino LAFEQ, Jaboticabal, SP, Brazil.	gferraz@fcav.unesp.br	Ferraz, Guilherme/ADE-4760-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; LEMOS, ELIANA GM/A-3604-2008; Ferraz, Guilherme/G-4954-2012; Carvalho, Júlia/ABA-8392-2020	de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; LEMOS, ELIANA GM/0000-0002-1119-7748; Ferraz, Guilherme/0000-0002-6463-6628; Costa, Marcio/0000-0001-5067-7501; REZENDE, ADALGIZA SOUZA CANEIRO/0000-0001-8447-610X; Ribeiro Garcia de Carvalho, Julia/0000-0002-6593-511X; de Rezende Jordao, Lilian/0000-0001-8522-6460	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/14703-3, 2013/15215-2]; National Scientific and Technological Development Council (CNPq) [EditalMCT/CNPq14/2012, 482811/2012-9]; Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador- ABCCMM)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Scientific and Technological Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador- ABCCMM)	The authors are thankful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), process numbers 2013/14703-3 and 2013/15215-2. Thanks are also due to the National Scientific and Technological Development Council (CNPq) (EditalMCT/CNPq14/2012, Process number 482811/2012-9) Brazilian Association of Mangalarga Marchador Horse Breeders (Associacao Brasileira de Criadores do Cavalo Mangalarga Marchador-ABCCMM) for their operational and financial support.	Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; [Anonymous], 2007, NUTR REQUIREMENTS HO, V6th; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Bunge J, 2011, BIOCOMPUTING, V2011, P121, DOI DOI 10.1142/9789814335058_; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Cole J.R., 2013, NUCL ACIDS RES; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa M. C., 2015, EQUINE VET J; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Ferraz GC, 2010, EQUINE VET J, V42, P191, DOI 10.1111/j.2042-3306.2010.00278.x; Ferraz GC, 2008, AM J VET RES, V69, P1670, DOI 10.2460/ajvr.69.12.1670; Fonseca MG, 2015, LIVEST SCI, V177, P165, DOI 10.1016/j.livsci.2015.03.014; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Harlow BE, 2013, VET MICROBIOL, V166, P225, DOI 10.1016/j.vetmic.2013.05.003; Hold GL, 2014, GUT, V63, P1838, DOI 10.1136/gutjnl-2014-307305; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Janabi AHD, 2016, COMP EXERC PHYSIOL, V12, P119, DOI 10.3920/CEP160015; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; O'Sullivan O, 2015, GUT MICROBES, V6, P131, DOI 10.1080/19490976.2015.1011875; Pagan JD, 1995, EQUINE NUTR PHYSL SO, V14, P96; Proudman CJ, 2015, EQUINE VET J, V47, P580, DOI 10.1111/evj.12324; Rivero JLL, 2002, EQUINE VET J, V34, P269; Robergs RA, 2006, AM J PHYSIOL-REG I, V291, pR238, DOI 10.1152/ajpregu.00081.2006; van den Berg M, 2013, J EQUINE VET SCI, V33, P215, DOI 10.1016/j.jevs.2012.06.004; Weese JS, 2014, EQUINE VET J, V46, P654, DOI 10.1111/evj.12295	33	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167108	10.1371/journal.pone.0167108	http://dx.doi.org/10.1371/journal.pone.0167108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935992	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100061
J	Sorkac, A; Alcantara, IC; Hart, AC				Sorkac, Altar; Alcantara, Ivan C.; Hart, Anne C.			In Vivo Modelling of ATP1A3 G316S-Induced Ataxia in C-elegans Using CRISPR/Cas9-Mediated Homologous Recombination Reveals Dominant Loss of Function Defects	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MUTATIONS; GENOME; EXPRESSION; DISORDERS; INSIGHTS; GENE	The NIH Undiagnosed Diseases Program admitted a male patient with unclassifiable late onset ataxia-like symptoms. Exome sequencing revealed a heterozygous de novo mutation converting glycine 316 to serine in ATP1A3, which might cause disease. ATP1A3 encodes the Na+/K+ ATPase pump a3-subunit. Using CRISPR/Cas9-mediated homologous recombination for genome editing, we modelled this putative disease-causing allele in Caenorhabditis elegans, recreating the patient amino acid change in eat-6, the orthologue of ATP1A3. The impact of the mutation on eat-6 function at the neuromuscular junction was examined using two behavioural assays: rate of pharyngeal pumping and sensitivity to aldicarb, a drug that causes paralysis over time via the inhibition of acetylcholinesterase. The patient allele decreased pumping rates and caused hypersensitivity to aldicarb. Animals heterozygous for the allele exhibited similar defects, whereas loss of function mutations in eat-6 were recessive. These results indicate that the mutation is dominant and impairs the neuromuscular function. Thus, we conclude that the de novo G316S mutation in ATP1A3 likely causes or contributes to patient symptoms. More broadly, we conclude that, for conserved genes, it is possible to rapidly and easily model human diseases in C. elegans using CRIPSR/Cas9 genome editing.	[Sorkac, Altar; Alcantara, Ivan C.; Hart, Anne C.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Hart, AC (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	anne_hart@brown.edu			National Institutes of Health (NIH) [P01 NS066888]; Brown Institute for Brain Science Suna Kirac Fund for Brain Science; Brown University Karen T. Romer Undergraduate Teaching and Research Awards; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Institute for Brain Science Suna Kirac Fund for Brain Science; Brown University Karen T. Romer Undergraduate Teaching and Research Awards; NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the National Institutes of Health (NIH) grant P01 NS066888 (ACH, project fund), Brown Institute for Brain Science Suna Kirac Fund for Brain Science (AS, fellowship), and Brown University Karen T. Romer Undergraduate Teaching and Research Awards (ICA, summer fellowship). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Hart Laboratory members for helpful discussions. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health (NIH) grant P01 NS066888 (ACH), Brown Institute for Brain Science Suna Kirac Fund for Brain Science (AS), Brown University Karen T. Romer Undergraduate Teaching and Research Awards (ICA).	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; AVERY L, 1993, GENETICS, V133, P897; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Davis MW, 1995, J NEUROSCI, V15, P8408; DECARVALHO A, 2004, NEURON, V43, P169, DOI [DOI 10.1016/J.NEUR0N.2004.06.028, 10.1016/j.neuron.2004.06.028]; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Dimitriadi M, 2010, NEUROBIOL DIS, V40, P4, DOI 10.1016/j.nbd.2010.05.012; Doi M, 2008, MOL CELL NEUROSCI, V38, P548, DOI 10.1016/j.mcn.2008.05.003; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Govorunova EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010368; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Shima Y, 1998, BIOCHEM BIOPH RES CO, V248, P778, DOI 10.1006/bbrc.1998.8981; Sweadner KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151429; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350	24	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167963	10.1371/journal.pone.0167963	http://dx.doi.org/10.1371/journal.pone.0167963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936181	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100240
J	Su, HC; Liang, YA; Lai, YJJ; Chiu, YL; Barndt, RB; Shiao, F; Chang, HHD; Lu, DD; Huang, N; Tseng, CC; Wang, JK; Lee, MS; Johnson, MD; Huang, SM; Lin, CY				Su, Hui Chen; Liang, Yan A.; Lai, Ying-Jung J.; Chiu, Yi-Lin; Barndt, Robert B.; Shiao, Frank; Chang, Hsiang-Hua D.; Lu, Dajun D.; Huang, Nanxi; Tseng, Chun-Che; Wang, Jehng-Kang; Lee, Ming-Shyue; Johnson, Michael D.; Huang, Shih-Ming; Lin, Chen-Yong			Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner	PLOS ONE			English	Article							EPIDERMAL BARRIER FUNCTION; BREAST-CANCER CELLS; SERINE-PROTEASE; EPITHELIAL-CELLS; PROTEOLYTIC CASCADE; MOLECULAR-CLONING; IN-VITRO; PH; HAI-1; INHIBITOR	The membrane-associated serine proteases matriptase and prostasin are believed to function in close partnership. Their zymogen activation has been reported to be tightly coupled, either as a matriptase-initiated proteolytic cascade or through a mutually dependent mechanism involving the formation of a reciprocal zymogen activation complex. Here we show that this putative relationship may not apply in the context of human matriptase and prostasin. First, the tightly coupled proteolytic cascade between matriptase and prostasin might not occur when modest matriptase activation is induced by sphingosine 1-phospahte in human mammary epithelial cells. Second, prostasin is not required and/or involved in matriptase autoactivation because matriptase can undergo zymogen activation in cells that do not endogenously express prostasin. Third, matriptase is not required for and/or involved in prostasin activation, since activated prostasin can be detected in cells expressing no endogenous matriptase. Finally, matriptase and prostasin both undergo zymogen activation through an apparently un-coupled mechanism in cells endogenously expressing both proteases, such as in Caco-2 cells. In these human enterocytes, matriptase is detected primarily in the zymogen form and prostasin predominantly as the activated form, either in complexes with protease inhibitors or as the free active form. The negligible levels of prostasin zymogen with high levels of matriptase zymogen suggests that the reciprocal zymogen activation complex is likely not the mechanism for matriptase zymogen activation. Furthermore, high level prostasin activation still occurs in Caco-2 variants with reduced or absent matriptase expression, indicating that matriptase is not required and/or involved in prostasin zymogen activation. Collectively, these data suggest that any functional relationship between natural endogenous human matriptase and prostasin does not occur at the level of zymogen activation.	[Su, Hui Chen] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Liang, Yan A.; Lai, Ying-Jung J.; Chiu, Yi-Lin; Barndt, Robert B.; Shiao, Frank; Chang, Hsiang-Hua D.; Lu, Dajun D.; Huang, Nanxi; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang; Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Lee, Ming-Shyue] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan	Chi Mei Hospital; Georgetown University; National Defense Medical Center; National Taiwan University	Lin, CY (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.; Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	shihming@mail.ndmctsgh.edu.tw; lincy@georgetown.edu	Chiu, Yilin/ABC-3746-2021; Lin, Chen/GRR-2799-2022	Chiu, Yilin/0000-0002-1827-6924; Liang, Yan/0000-0002-6195-0961; Tseng, Chun-che/0000-0001-9637-4127; LEE, MING-SHYUE/0000-0002-8673-5088	National Cancer Institute (NCI) [RO1 CA 123223]; Department of Defense, Taiwan [MAB104-026]; Chi-Mei Medical Center [CMNDMC10312]; NIH/NCI NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Taiwan(United States Department of Defense); Chi-Mei Medical Center; NIH/NCI NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to M. D. Johnson and C.-Y. Lin), Grant (MAB104-026) from the Department of Defense, Taiwan (to J.-K. Wang), and Grant CMNDMC10312 from Chi-Mei Medical Center (to S.-M. Huang). We acknowledge the assistance provided by the Lombardi Comprehensive Cancer Center Tissue Culture and Microscopy and Imaging Shared Resources that are supported in part by NIH/NCI NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YW, 2016, J INVEST DERMATOL, V83, P34; CHERNEW I, 1962, J CLIN INVEST, V41, P1945, DOI 10.1172/JCI104652; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Frns S, 2011, J BIOL CHEM, V286, P5793, DOI [10.1074/jbc.M110.186874, DOI 10.1074/JBC.M110.186874]; Hachem JP, 2003, J INVEST DERMATOL, V121, P345, DOI 10.1046/j.1523-1747.2003.12365.x; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; KORTING HC, 1990, ACTA DERM-VENEREOL, V70, P429; Lai CH, 2016, BIOL OPEN, V5, P1380, DOI 10.1242/bio.019745; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; Mauro T, 1998, ARCH DERMATOL RES, V290, P215, DOI 10.1007/s004030050293; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093899; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167894	10.1371/journal.pone.0167894	http://dx.doi.org/10.1371/journal.pone.0167894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936035	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100225
J	Bhat, N; Park, J; Zoghbi, HY; Arthur, JSC; Zaret, KS				Bhat, Neha; Park, Jeehye; Zoghbi, Huda Y.; Arthur, J. Simon C.; Zaret, Kenneth S.			The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; STRESS-INDUCED PHOSPHORYLATION; HISTONE H3; TRANSCRIPTION FACTOR; INSULIN GENE; BETA-CELLS; EXPRESSION; DIFFERENTIATION; PROGENITORS; PDX-1	Type I diabetes is caused by loss of insulin-secreting beta cells. To identify novel, pharmacologically-targetable histone-modifying proteins that enhance beta cell production from pancreatic progenitors, we performed a screen for histone modifications induced by signal transduction pathways at key pancreatic genes. The screen led us to investigate the temporal dynamics of ser-28 phosphorylated histone H3 (H3S28ph) and its upstream kinases, MSK1 and MSK2 (MSK1/2). H3S28ph and MSK1/2 were enriched at the key endocrine and acinar promoters in E12.5 multipotent pancreatic progenitors. Pharmacological inhibition of MSK1/2 in embryonic pancreatic explants promoted the specification of endocrine fates, including the beta-cell lineage, while depleting acinar fates. Germline knockout of both Msk isoforms caused enhancement of alpha cells and a reduction in acinar differentiation, while monoallelic loss of Msk1 promoted beta cell mass. Our screen of chromatin state dynamics can be applied to other developmental contexts to reveal new pathways and approaches to modulate cell fates.	[Bhat, Neha; Zaret, Kenneth S.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Perelman Sch Med, Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Park, Jeehye; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Jeehye; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, Med Res Council, Prot Phosphorylat Unit, Dundee, Scotland; [Bhat, Neha] Yale Univ, Dept Internal Med, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Dundee; Yale University	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Perelman Sch Med, Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Arthur, Simon/0000-0002-8135-1958; Zoghbi, Huda/0000-0002-0700-3349	NIH [R37GM36477]; UPenn Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036477, R37GM036477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPenn Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by NIH R37GM36477 to K.S.Z. and the UPenn Institute for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ann O'Brien Jenkins and Naomi Takenaka for help with sample preparation, Justin Becker and Makiko Iwafuchi-Doi for comments on the manuscript, and Eileen Hulme for help in manuscript preparation. The research was supported by NIH R37GM36477 to K.S.Z. and the UPenn Institute for Regenerative Medicine.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bennett LB, 2010, EPIGENOMICS-UK, V2, P53, DOI 10.2217/EPI.09.43; Cai WL, 2014, NUCLEIC ACIDS RES, V42, P5456, DOI 10.1093/nar/gku173; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Choi HS, 2005, J BIOL CHEM, V280, P13545, DOI 10.1074/jbc.M410521200; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hale MA, 2014, DEVELOPMENT, V141, P3123, DOI 10.1242/dev.109405; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kellner WA, 2012, GENOME RES, V22, P1081, DOI 10.1101/gr.136929.111; Kobayashi H, 2002, BIOCHEM BIOPH RES CO, V293, P691, DOI 10.1016/S0006-291X(02)00278-4; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Metzger DE, 2012, DEVELOPMENT, V139, P1447, DOI 10.1242/dev.072892; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; WESSEL GM, 1986, J HISTOCHEM CYTOCHEM, V34, P703, DOI 10.1177/34.6.3084626; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	72	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166703	10.1371/journal.pone.0166703	http://dx.doi.org/10.1371/journal.pone.0166703			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973548	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300012
J	Sasaki, CT; Toman, J; Vageli, D				Sasaki, Clarence T.; Toman, Julia; Vageli, Dimitra			The In Vitro Effect of Acidic-Pepsin on Nuclear Factor KappaB Activation and Its Related Oncogenic Effect on Normal Human Hypopharyngeal Cells	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; STAT3 SIGNALING PATHWAYS; NECK-CANCER; EPITHELIAL-CELLS; HEAD; CARCINOMA; GROWTH; CARCINOGENESIS; PH; P53	Background Extra-esophageal carcinogenesis has been widely discussed in relation to the chronic effects of laryngopharyngeal reflux and most prominently with pepsin historically central to this discussion. With refluxate known to include gastric (pepsin) and duodenal (bile) fluids, we recently demonstrated the mechanistic role of NF-kappa B in mediating the preneoplastic effects of acidic-bile. However, the role of pepsin in promoting hypopharyngeal premalignant events remains historically unclear. Here, we investigate the in vitro effect of acidic-pepsin on the NF-kappa B oncogenic pathway to better define its potential role in hypopharyngeal neoplasia. Methods Human hypopharyngeal primary cells (HHPC) and keratinocytes (HHK) were repetitively exposed to physiologic pepsin concentrations (0.1 mg/ml) at pH 4.0, 5.0 and 7.0. Cellular localization of phospho-NF-kappa B and bcl-2 was determined using immunofluorescence and western blotting. NF-kappa B transcriptional activity was tested by luc reporter and qPCR. Analysis of DNA content of pepsin treated HHK and HHPC was performed using Fluorescence-activated- cell sorting assay. To explore a possible dose related effect, pepsin concentration was reduced from 0.1 to 0.05 and 0.01 mg/ml. Results At physiologic concentration, acidic-pepsin (0.1 mg/ml at pH 4.0) is lethal to most normal hypopharyngeal cells. However, in surviving cells, no NF-kappa B transcriptional activity is noted. Acidic-pepsin fails to activate the NF-kappa B or bcl-2, TNF-alpha, EGFR, STAT3, and wnt5a but increases the Tp53 mRNAs, in both HHPC and HHK. Weakly acidic-pepsin (pH 5.0) and neutral-pepsin (pH 7.0) induce mild activation of NF-kappa B with increase in TNF-alpha mRNAs, without oncogenic transcriptional activity. Lower concentrations of pepsin at varying pH do not produce NF-kappa B activity or transcriptional activation of the analyzed genes. Conclusion Our findings in vitro do not support the role of acidic-pepsin in NF-kappa B related hypopharyngeal carcinogenesis.	[Sasaki, Clarence T.; Toman, Julia; Vageli, Dimitra] Yale Sch Med, Dept Surg, Yale Larynx Lab, New Haven, CT 06510 USA	Yale University	Sasaki, CT (corresponding author), Yale Sch Med, Dept Surg, Yale Larynx Lab, New Haven, CT 06510 USA.	clarence.sasaki@yale.edu		Vageli, Dimitra/0000-0002-9852-5790	Charles W. Ohse Award of Yale School of Medicine; Virginia Alden Wright Fund	Charles W. Ohse Award of Yale School of Medicine; Virginia Alden Wright Fund	This study was supported in part by the Charles W. Ohse Award of Yale School of Medicine and the Virginia Alden Wright Fund.	Adams J, 2000, ARCH OTOLARYNGOL, V126, P405, DOI 10.1001/archotol.126.3.405; Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Altman KW, 2011, LARYNGOSCOPE, V121, P717, DOI 10.1002/lary.21429; Ayazi S, 2010, J AM COLL SURGEONS, V210, P345, DOI 10.1016/j.jamcollsurg.2009.12.006; Campos LA, 2003, FEBS LETT, V538, P89, DOI 10.1016/S0014-5793(03)00152-2; Del Negro A, 2008, ACTA CIR BRAS, V23, P337, DOI 10.1590/S0102-86502008000400007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Fan YH, 2013, PROTEIN CELL, V4, P176, DOI 10.1007/s13238-013-2084-3; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; GRANDIS JR, 1993, CANCER RES, V53, P3579; Gregory N., 2006, GI MOTILITY ONLINE; Hashibe M, 2007, AM J EPIDEMIOL, V165, P814, DOI 10.1093/aje/kwk066; Herbella FAM, 2015, WORLD J GASTROENTERO, V21, P815, DOI 10.3748/wjg.v21.i3.815; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Guzman-de la Garza FJ, 2013, CLINICS, V68, P1034, DOI 10.6061/clinics/2013(07)23; Jegu J, 2013, ORAL ONCOL, V49, P9, DOI 10.1016/j.oraloncology.2012.06.018; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Johnston N, 2009, ANN OTO RHINOL LARYN, V118, P677, DOI 10.1177/000348940911800913; Jordan RCK, 1996, ORAL ONCOL, V32B, P394, DOI 10.1016/S0964-1955(96)00033-4; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klein JD, 2010, CANCER BIOL THER, V9, P1; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Langevin SM, 2013, CANCER EPIDEM BIOMAR, V22, P1061, DOI 10.1158/1055-9965.EPI-13-0183; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; MARKS F, 1993, ENVIRON HEALTH PERSP, V101, P95, DOI 10.2307/3431849; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; PEARSON JP, 1986, GUT, V27, P243, DOI 10.1136/gut.27.3.243; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Qin L, 2015, ONCOTARGET, V6, P10239, DOI 10.18632/oncotarget.3518; Sasaki CT, 2016, HEAD NECK-J SCI SPEC, V38, pE1381, DOI 10.1002/hed.24231; Sasaki CT, 2000, ANN OTO RHINOL LARYN, V109, P2, DOI 10.1177/0003489400109S1001; Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Sen T, 2011, J BIOL CHEM, V286, P43204, DOI 10.1074/jbc.M111.257105; Sereg-Bahar M, 2015, RADIOL ONCOL, V49, P59, DOI 10.2478/raon-2014-0020; Shkeir O, 2013, HEAD NECK-J SCI SPEC, V35, P1542, DOI 10.1002/hed.23191; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Sriuranpong V, 2003, CANCER RES, V63, P2948; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Ulualp SO, 1999, OTOLARYNG HEAD NECK, V120, P672, DOI 10.1053/hn.1999.v120.a91774; Vageli DP, 2016, ONCOTARGET, V7, P5892, DOI 10.18632/oncotarget.6824; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walner DL, 1998, ARCH OTOLARYNGOL, V124, P551, DOI 10.1001/archotol.124.5.551; Wassenaar E, 2011, SURG ENDOSC, V25, P3870, DOI 10.1007/s00464-011-1813-z; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015	50	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168269	10.1371/journal.pone.0168269	http://dx.doi.org/10.1371/journal.pone.0168269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973541	gold, Green Submitted, Green Published			2022-12-26	WOS:000392754300071
J	Tobio, A; Alfonso, A; Madera-Salcedo, I; Botana, LM; Blank, U				Tobio, Araceli; Alfonso, Amparo; Madera-Salcedo, Iris; Botana, Luis M.; Blank, Ulrich			Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model	PLOS ONE			English	Article							OKADAIC ACID; MAST-CELLS; TOXICITY; HOMOYESSOTOXINS; EXOCYTOSIS; RECEPTORS; MECHANISM	Yessotoxins (YTXs) are a group of marine toxins produced by the dinoflagellates Protoceratium reticulatum, Lingulodinium polyedrum and Gonyaulax spinifera. They may have medical interest due to their potential role as anti-allergic but also anti-cancer compounds. However, their biological activities remain poorly characterized. Here, we show that the small molecular compound YTX causes a slight but significant reduction of the ability of mast cells to degranulate. Strikingly, further examination revealed that YTX had a marked and selective cytotoxicity for the RBL-2H3 mast cell line inducing apoptosis, while primary bone marrow derived mast cells were highly resistant. In addition, YTX exhibited strong cytotoxicity against the human B-chronic lymphocytic leukaemia cell line MEC1 and the murine melanoma cell line B16F10. To analyse the potential role of YTX as an anti-cancer drug in vivo we used the well-established B16F10 melanoma preclinical mouse model. Our results demonstrate that a few local application of YTX around established tumours dramatically diminished tumour growth in the absence of any significant toxicity as determined by the absence of weight loss and haematological alterations. Our data support that YTX may have a minor role as an anti-allergic drug, but reveals an important potential for its use as an anti-cancer drug.	[Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] INSERM, UMRS 1149, Paris, France; [Tobio, Araceli; Alfonso, Amparo; Botana, Luis M.] Univ Santiago de Compostela, Fac Vet, Dept Farmacol, Lugo, Spain; [Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] CNRS, Ctr Rech Inflammat, ERL, Paris, France; [Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] Univ Paris Diderot, Sorbonne Paris Cite, Lab Excellence INFLAMEX, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Santiago de Compostela; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Blank, U (corresponding author), INSERM, UMRS 1149, Paris, France.	ulrich.blank@inserm.fr	TOBIO, ARACELI/AAF-9718-2019; López, Luis M. Botana/AAJ-7111-2021; Madera-Salcedo, Iris/D-8981-2017; TOBIO, ARACELI/P-4157-2015; Alfonso, Amparo/GLN-2591-2022	TOBIO, ARACELI/0000-0002-7445-2507; López, Luis M. Botana/0000-0003-2153-6608; Madera-Salcedo, Iris/0000-0002-0741-9248; Alfonso Rancano, Maria Amparo/0000-0003-1572-9016; Blank, Ulrich/0000-0002-2661-2983	Fundacion Juana de Vega, Spain; ANR France [ANR-12-ISV3-0006-01]; Conacyt Mexico [Conacyt-ANR 188565]; Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX; DHU Fire; COST Action of the European Community [BM1007]	Fundacion Juana de Vega, Spain; ANR France(French National Research Agency (ANR)); Conacyt Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Investissements d'Avenir programme(French National Research Agency (ANR)); Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX; DHU Fire; COST Action of the European Community	Dr. Araceli Tobio Ageitos was supported by a postdoctoral fellowship from Fundacion Juana de Vega, Spain. Dr. Iris Madera-Salcedo was supported by an International collaboration grant between ANR France (ANR-12-ISV3-0006-01) and Conacyt Mexico (Conacyt-ANR 188565). This research project has been supported by the Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX, and DHU Fire. This work was also supported by the COST Action BM1007 (Mast cells and basophils-targets for innovative therapies) of the European Community.	Alexander J., 2009, EFSA J, V1306, P1; Alfonso A, 2003, BIOCHEM PHARMACOL, V65, P193, DOI 10.1016/S0006-2952(02)01454-5; Alfonso A, 2016, MAR DRUGS, V14, DOI 10.3390/md14020030; [Anonymous], 2014, ADV MOL TOXICOLOGY; Aune T, 2002, TOXICON, V40, P77, DOI 10.1016/S0041-0101(01)00192-1; Aune T., 1989, BIOACT MOL, P461; BANIYASH M, 1981, CANCER RES, V41, P433; Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; BOTANA LM, 1994, J LEUKOCYTE BIOL, V55, P798, DOI 10.1002/jlb.55.6.798; Draisci R, 1999, TOXICON, V37, P1187, DOI 10.1016/S0041-0101(98)00254-2; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fernandez-Araujo A, 2014, INT J BIOCHEM CELL B, V53, P89, DOI 10.1016/j.biocel.2014.04.028; Fernandez-Araujo A, 2015, TOXICOLOGY; Fernandez-Araujo A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00124; Galli SJ, 2016, AM J PATHOL, V186, P212, DOI 10.1016/j.ajpath.2015.07.025; Huo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012705; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kobayashi T, 2014, AM J PATHOL, V184, P3120, DOI 10.1016/j.ajpath.2014.07.003; Korsnes MS, 2011, TOXICOL IN VITRO, V25, P1764, DOI 10.1016/j.tiv.2011.09.005; Korsnes MS, 2015, TOXICOL IN VITRO; Lai YW, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0970-3; Lee SH, 2015, MOL MED REP, V12, P2777, DOI 10.3892/mmr.2015.3675; Leira F, 2002, TOXICOL IN VITRO, V16, P23, DOI 10.1016/S0887-2333(01)00095-9; Liu YJ, 2016, ONCOL LETT, V11, P1251, DOI 10.3892/ol.2015.4025; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Ogino Hiroyuki, 1997, Natural Toxins, V5, P255, DOI 10.1002/(SICI)1522-7189(1997)5:6<255::AID-NT6>3.0.CO;2-P; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pfirsch-Maisonnas S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001309; Pistocchi R, 2012, MAR DRUGS, V10, P140, DOI 10.3390/md10010140; Satake Masayuki, 1997, Natural Toxins, V5, P164; Sos ML, 2014, CELL REP, V8, P1037, DOI 10.1016/j.celrep.2014.07.010; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Talebian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031442; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tobio A, 2012, J CELL BIOCH; Tobio A, 2015, IMMUNOPHARM IMMUNOT, V37, P380, DOI 10.3109/08923973.2015.1064132; Tobio A, 2014, ANTICANCER RES, V34, P3347; Tubaro A, 2008, TOXICON, V51, P1225, DOI 10.1016/j.toxicon.2008.02.011; Tubaro A, 2004, TOXICON, V43, P439, DOI 10.1016/j.toxicon.2004.02.015; Tubaro A, 2003, TOXICON, V41, P783, DOI 10.1016/S0041-0101(03)00032-1; Tubaro A, 2010, TOXICON, V56, P163, DOI 10.1016/j.toxicon.2009.07.038; Vandercappellen J, 2010, MOL CANCER RES, V8, P322, DOI 10.1158/1541-7786.MCR-09-0176; Wang DY, 2015, ONCOLOGY, V29; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Yang LP, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-75	47	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167572	10.1371/journal.pone.0167572	http://dx.doi.org/10.1371/journal.pone.0167572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973568	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300033
J	Wang, RH; Yuan, XY; Meng, LH; Zhu, BZ; Zhu, HL; Luo, YB; Fu, DQ				Wang, Rui-Heng; Yuan, Xin-Yu; Meng, Lan-Huan; Zhu, Ben-Zhong; Zhu, Hong-liang; Luo, Yun-Bo; Fu, Da-Qi			Transcriptome Analysis Provides a Preliminary Regulation Route of the Ethylene Signal Transduction Component, SlEIN2, during Tomato Ripening	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GENE FAMILY; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; BINDING PROTEINS; FRUIT; ARABIDOPSIS; RECEPTOR; EIN2; EXPRESSION	Ethylene is crucial in climacteric fruit ripening. The ethylene signal pathway regulates several physiological alterations such as softening, carotenoid accumulation and sugar level reduction, and production of volatile compounds. All these physiological processes are controlled by numerous genes and their expression simultaneously changes at the onset of ripening. Ethylene insensitive 2 (EIN2) is a key component for ethylene signal transduction, and its mutation causes ethylene insensitivity. In tomato, silencing SlEIN2 resulted in a non-ripening phenotype and low ethylene production. RNA sequencing of SlEIN2-silenced and wild type tomato, and differential gene expression analyses, indicated that silencing SlEIN2 caused changes in more than 4,000 genes, including those related to photosynthesis, defense, and secondary metabolism. The relative expression level of 28 genes covering ripening- associated transcription factors, ethylene biosynthesis, ethylene signal pathway, chlorophyll binding proteins, lycopene and aroma biosynthesis, and defense pathway, showed that SlEIN2 influences ripening inhibitor (RIN) in a feedback loop, thus controlling the expression of several other genes. SlEIN2 regulates many aspects of fruit ripening, and is a key factor in the ethylene signal transduction pathway. Silencing SlEIN2 ultimately results in lycopene biosynthesis inhibition, which is the reason why tomato does not turn red, and this gene also affects the expression of several defense-associated genes. Although SlEIN2-silenced and green wild type fruits are similar in appearance, their metabolism is significantly different at the molecular level.	[Wang, Rui-Heng; Yuan, Xin-Yu; Meng, Lan-Huan; Zhu, Ben-Zhong; Zhu, Hong-liang; Luo, Yun-Bo; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, Beijing, Peoples R China	China Agricultural University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, Beijing, Peoples R China.	daqifu@cau.edu.cn			National Nature Science Foundation of China [31571898, 31572173]; Education Foundation of Da Bei Nong Group [1061-2413001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Foundation of Da Bei Nong Group	This work was supported by the National Nature Science Foundation of China (grants No. 31571898 and No. 31572173) and the Education Foundation of Da Bei Nong Group (No. 1061-2413001). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams-Phillips L, 2004, PLANT MOL BIOL, V54, P387, DOI 10.1023/B:PLAN.0000036371.30528.26; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Awad MA, 2002, SCI HORTIC-AMSTERDAM, V93, P257, DOI 10.1016/S0304-4238(01)00333-8; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Bewley JD, 2000, J EXP BOT, V51, P529, DOI 10.1093/jexbot/51.344.529; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Fu DQ, 2006, MOL CELLS, V21, P153; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Gao L, 2016, THEOR APPL GENET, V129, P717, DOI 10.1007/s00122-015-2660-4; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Klee HJ, 2002, J EXP BOT, V53, P2057, DOI 10.1093/jxb/erf062; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Nadakuduti SS, 2014, PLANT J, V78, P1022, DOI 10.1111/tpj.12529; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Phan TD, 2007, PLANT PHYSIOL, V144, P1960, DOI 10.1104/pp.107.096347; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sakuraba Y, 2015, MOL CELLS, V38, P390, DOI 10.14348/molcells.2015.0039; Senthil-Kumar M, 2014, NAT PROTOC, V9, P1549, DOI 10.1038/nprot.2014.092; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; Tieman DM, 1999, PLANT PHYSIOL, V120, P165, DOI 10.1104/pp.120.1.165; Trivedi PK, 2004, PLANT SCI, V167, P1351, DOI 10.1016/j.plantsci.2004.07.005; Velez-Ramirez AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5549; Wang J, 2007, DNA SEQUENCE, V18, P33, DOI 10.1080/10425170600986738; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Yokotani N, 2009, J EXP BOT, V60, P3433, DOI 10.1093/jxb/erp185; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021	57	13	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168287	10.1371/journal.pone.0168287	http://dx.doi.org/10.1371/journal.pone.0168287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973616	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300073
J	BitMansour, A; Pop, LM; Vitetta, ES				BitMansour, Andrew; Pop, Laurentiu M.; Vitetta, Ellen S.			The Role of Regulatory B Cell-Like Malignant Cells and T-reg Cells in the Mouse Model of BCL1 Tumor Dormancy	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FOSTERS IMMUNE PRIVILEGE; CANCER DORMANCY; HODGKIN-LYMPHOMA; B10 CELLS; INDUCTION; RESPONSES; ANTIBODY; BLOOD; STATE	Cancer dormancy is a clinical state in which residual tumor cells persist for long periods of time but do not cause detectable disease. In the mouse B cell lymphoma model (BCL1), dormancy can be induced and maintained by immunizing mice with a soluble form of the IgM expressed on the surface of the tumor cells. Immunization induces an anti-idiotype antibody response that maintains dormancy. Mice with dormant tumor have low numbers of BCL1 cells in their spleens that divide and are killed at the same rate. When the anti-Id antibodies wane, the tumor cells grow rapidly and kill the host. Spleens from tumor-bearing mice contain both effector (CD4(+) and CD8(+)) and regulatory T cells (Tregs). In other tumor models, it has been reported that Tregs promote tumor progression by preventing effector cells from killing the tumor. In this report, we demonstrate that the tumor site with rapidly dividing BCL1 cells has fewer Tregs than the tumor site harboring dormant BCL1 cells. In both cases, the Tregs were equally suppressive in vitro. In spleens from mice with actively growing tumor, CD8(+) but not CD4(+) T cells were virtually absent. In vitro analysis demonstrated a tumor-mediated elimination of CD8(+) T cells that was contact dependent and involved the caspase-3 pathway. Most importantly, we found that the BCL1 cells expressed characteristics of B10 regulatory B cells, i.e., they were CD1d hi CD5(+) and secreted high levels of IL-10. These BCL1 tumor cells can inhibit anti-tumor immune responses by depleting CD8(+) effector T cells.	[Vitetta, Ellen S.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Ctr Canc Immunobiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vitetta, ES (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	Ellen.Vitetta@utsouthwestern.edu	Pop, Laurentiu/N-5416-2019		Cancer Immunobiology Center; Horchow Foundation; Patigian Chair	Cancer Immunobiology Center; Horchow Foundation; Patigian Chair	The studies described were supported by the Cancer Immunobiology Center, the Horchow Foundation and the Patigian Chair.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00292; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Farrar JD, 1999, J IMMUNOL, V162, P2842; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; GRONOWICZ ES, 1980, J IMMUNOL, V125, P976; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kim WY, 2009, ANN ONCOL, V20, P1688, DOI 10.1093/annonc/mdp056; KROLICK KA, 1979, IMMUNOL REV, V48, P81, DOI 10.1111/j.1600-065X.1979.tb00299.x; Layton JE, 1982, B AND T CELL TUMORS, P369; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; Maksimow M, 2003, BLOOD, V101, P4022, DOI 10.1182/blood-2002-06-1904; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pop LM, 2005, J IMMUNOTHER, V28, P525, DOI 10.1097/01.cji.0000175493.05852.5a; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; RACILA E, 1995, J EXP MED, V181, P1539, DOI 10.1084/jem.181.4.1539; Saito T, 2000, CLIN CANCER RES, V6, P1351; SIU H, 1986, J IMMUNOL, V137, P1376; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tsukamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7702; Tutt AL, 2002, J IMMUNOL, V168, P2720, DOI 10.4049/jimmunol.168.6.2720; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Uhr JT, 2001, SEMIN CANCER BIOL, V11, P277, DOI 10.1006/scbi.2001.0383; UHR JW, 1991, CANCER RES, V51, pS5045; Vitetta ES, 1997, BLOOD, V89, P4425, DOI 10.1182/blood.V89.12.4425; VITETTA ES, 1979, J IMMUNOL, V122, P1649; Woo EY, 2001, CANCER RES, V61, P4766; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; YEFENOF E, 1993, P NATL ACAD SCI USA, V90, P1829, DOI 10.1073/pnas.90.5.1829	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167618	10.1371/journal.pone.0167618	http://dx.doi.org/10.1371/journal.pone.0167618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959896	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900012
J	Bredow, M; Vanderbeld, B; Walker, VK				Bredow, Melissa; Vanderbeld, Barbara; Walker, Virginia K.			Knockdown of Ice-Binding Proteins in Brachypodium distachyon Demonstrates Their Role in Freeze Protection	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; III ANTIFREEZE PROTEIN; COLD-ACCLIMATION; GENE ENCODES; WINTER RYE; RECRYSTALLIZATION INHIBITION; BITTERSWEET NIGHTSHADE; ELECTROLYTE LEAKAGE; RECEPTOR KINASE; EXPRESSION	Sub-zero temperatures pose a major threat to the survival of cold-climate perennials. Some of these freeze-tolerant plants produce ice-binding proteins (IBPs) that offer frost protection by restricting ice crystal growth and preventing expansion-induced lysis of the plasma membranes. Despite the extensive in vitro characterization of such proteins, the importance of IBPs in the freezing stress response has not been investigated. Using the freeze-tolerant grass and model crop, Brachypodium distachyon, we characterized putative IBPs (BdIRIs) and generated the first 'IBP-knockdowns'. Seven IBP sequences were identified and expressed in Escherichia coli, with all of the recombinant proteins demonstrating moderate to high levels of ice-recrystallization inhibition (IRI) activity, low levels of thermal hysteresis (TH) activity (0.03-0.09 degrees C at 1 mg/mL) and apparent adsorption to ice primary prism planes. Following plant cold acclimation, IBPs purified from wild-type B. distachyon cell lysates similarly showed high levels of IRI activity, hexagonal ice-shaping, and low levels of TH activity (0.15 degrees C at 0.5 mg/mL total protein). The transfer of a microRNA construct to wild-type plants resulted in the attenuation of IBP activity. The resulting knockdown mutant plants had reduced ability to restrict ice-crystal growth and a 63% reduction in TH activity. Additionally, all transgenic lines were significantly more vulnerable to electrolyte leakage after freezing to -10 degrees C, showing a 13-22% increase in released ions compared to wild-type. IBP-knockdown lines also demonstrated a significant decrease in viability following freezing to -8 degrees C, with some lines showing only two-thirds the survival seen in control lines. These results underscore the vital role IBPs play in the development of a freeze-tolerant phenotype and suggests that expression of these proteins in frost-susceptible plants could be valuable for the production of more winter-hardy crops.	[Bredow, Melissa; Vanderbeld, Barbara; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Walker, Virginia K.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Bredow, M (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	11mb95@queensu.ca			NSERC Discovery Grant [388335]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the NSERC Discovery Grant(http://www.nserc-crsng.gc.ca/index_eng.asp) to Virginia K. Walker (#388335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Dr. P.L. Davies for use of the Clifton Nanolitre Osmometer and Dr. J. Wan, Dr. S. Yang and Dr. K. Joslin from Performance Plants Inc. for the empty vector control plants used in this study. This work was funded by the NSERC Discovery Grant to Dr. V.K. Walker.	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Antikainen M, 1997, PHYSIOL PLANTARUM, V99, P423, DOI 10.1034/j.1399-3054.1997.990310.x; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; Bredow M, 2016, PLANT BIOTECH J; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; BURCHAM TS, 1984, BIOPOLYMERS, V23, P1379, DOI 10.1002/bip.360230720; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Colton-Gagnon K, 2014, ANN BOT-LONDON, V113, P681, DOI 10.1093/aob/mct283; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; Doucet D, 2002, EUR J BIOCHEM, V269, P38, DOI 10.1046/j.0014-2956.2001.02628.x; DUMAN JG, 1994, BBA-PROTEIN STRUCT M, V1206, P129, DOI 10.1016/0167-4838(94)90081-7; Fei Yun-Biao, 1994, Acta Botanica Sinica, V36, P649; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; GRIFFITH M, 1992, PLANT PHYSIOL, V100, P593, DOI 10.1104/pp.100.2.593; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R, 2014, PLOS ONE; Gupta R, 2012, J PROTEOME RES, V11, P2684, DOI 10.1021/pr200944z; Hays LM, 1996, P NATL ACAD SCI USA, V93, P6835, DOI 10.1073/pnas.93.13.6835; Hirano Y, 2008, CRYOBIOLOGY, V57, P46, DOI 10.1016/j.cryobiol.2008.05.006; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huang T, 2002, PLANT MOL BIOL, V48, P339, DOI 10.1023/A:1014062714786; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jinn TL, 2000, GENE DEV, V14, P108; Khanna HK, 2006, PLANT CELL REP, V25, P1336, DOI 10.1007/s00299-006-0191-9; KNIGHT CA, 1994, J CRYST GROWTH, V143, P301, DOI 10.1016/0022-0248(94)90071-X; Kontogiorgos V, 2007, J FOOD BIOCHEM, V31, P139, DOI 10.1111/j.1745-4514.2007.00112.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Lauersen KJ, 2011, CRYOBIOLOGY, V62, P194, DOI 10.1016/j.cryobiol.2011.03.003; Li C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-65; Lu CF, 2000, PROG BIOCHEM BIOPHYS, V27, P555; MARENTES E, 1993, PHYSIOL PLANTARUM, V87, P499, DOI 10.1111/j.1399-3054.1993.tb02499.x; Middleton AJ, 2014, METHODS MOL BIOL, V1166, P255, DOI 10.1007/978-1-4939-0844-8_19; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Muthukumaran J, 2011, J BIOINFORM SEQ ANAL, V3, P70; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; Pudney PDA, 2003, ARCH BIOCHEM BIOPHYS, V410, P238, DOI 10.1016/S0003-9861(02)00697-5; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Sandve SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-245; Sasaki K, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00116; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; SCOTT GK, 1985, P NATL ACAD SCI USA, V82, P2613, DOI 10.1073/pnas.82.9.2613; Smallwood M, 1999, BIOCHEM J, V340, P385, DOI 10.1042/0264-6021:3400385; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; URRUTIA ME, 1992, BIOCHIM BIOPHYS ACTA, V1121, P199, DOI 10.1016/0167-4838(92)90355-H; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Worrall D, 1998, SCIENCE, V282, P115, DOI 10.1126/science.282.5386.115; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Yu S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00622; Yu YL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-20; Zhang C, 2007, J AGR FOOD CHEM, V55, P7654, DOI 10.1021/jf0715065; Zhang CZ, 2010, PLANTA, V232, P155, DOI 10.1007/s00425-010-1163-4; Zhang DQ, 2004, PROTEIN EXPRES PURIF, V35, P257, DOI 10.1016/j.pep.2004.01.019; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902	66	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167941	10.1371/journal.pone.0167941	http://dx.doi.org/10.1371/journal.pone.0167941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959937	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900026
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Executive Functions, Time Organization and Quality of Life among Adults with Learning Disabilities	PLOS ONE			English	Article							WORKING-MEMORY; ACADEMIC-ACHIEVEMENT; CHILDREN; PERFORMANCE; BRAIN; DEFINITION; HEALTH; ADOLESCENTS; INHIBITION; ABILITIES	Purpose This study compared the executive functions, organization in time and perceived quality of life (QoL) of 55 adults with learning disabilities (LD) with those of 55 matched controls (mean age 30 years). Furthermore, relationships and predictive relationships between these variables among the group with LD were examined. Methods All participants completed the Behavioral Rating Inventory of Executive Functions (BRIEFA), the Time Organization and Participation (TOPS, A-C) and the World Health Organization Quality of Life (WHOQOL) questionnaires. Chi-square tests, independent t-tests and MANOVA were used to examine group differences in each of the subscales scores and ratings of each instrument. Pearson correlations and regression predictive models were used to examine the relationships between the variables in the group with LD. Results Adults with LD had significantly poorer executive functions (BRIEF-A), deficient organization in time abilities (TOPS A-B), accompanied with negative emotional response (TOPS-C), and lower perceived QoL (physical, psychological, social and environmental) in comparison to adults without LD. Regression analysis revealed that Initiation (BRIEF-A) significantly predicted approximately 15% of the participants' organization in time abilities (TOPS A, B scores) beyond group membership. Furthermore, initiation, emotional control (BRIEF-A subscales) and emotional responses following unsuccessful organization of time (TOPS-C) together accounted for 39% of the variance of psychological QoL beyond the contribution of group membership. Conclusions Deficits in initiation and emotional executive functions as well as organization in time abilities and emotional responses to impairments in organizing time affect the QoL of adults with LD and thus should be considered in further research as well as in clinical applications.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel	University of Haifa	Sharfi, K (corresponding author), Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel.	kineretsharfi@gmail.com			Israeli Ministry of Science and Technology [3-8634]	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This study was funded by the Israeli Ministry of Science and Technology, grant number 3-8634. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all those who participated for their cooperation and interest in the study and to the Israeli Ministry of Science and Technology for their support. The ethics committee for human subject research in the faculty of social welfare and health sciences at Haifa University approved this study in October 2010 (confirmation No. 170/10). An informed consent was signed by each participant and afterwards the subjects' personal identifiers were kept separately from the data.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bailey CE, 2007, ANN NY ACAD SCI, V1118, P122, DOI 10.1196/annals.1412.011; Barkley R.A., 1994, ADHD REPORT, V2, P1; Barkley RA, 2011, J PSYCHOPATHOL BEHAV, V33, P137, DOI 10.1007/s10862-011-9217-x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Brod M, 2006, QUAL LIFE RES, V15, P117, DOI 10.1007/s11136-005-8325-z; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Brown TE, 2010, POSTGRAD MED, V122, P42, DOI 10.3810/pgm.2010.09.2200; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Cortiella C., 2014, STATE LEARNING DISAB; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Farnworth L., 2003, J OCCUP SCI, V10, P150, DOI [DOI 10.1080/14427591.2003.9686523, https://doi.org/10.1080/14427591.2003.9686523]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felce D, 1997, QUALITY LIFE PEOPLE, P56; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Godard J, 2011, PSYCHIAT RES, V190, P244, DOI 10.1016/j.psychres.2011.06.014; Greenhill LL., 2000, LEARNING DISABILITIE; Grinblat N, 2012, THESIS; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Karande S, 2009, J TROP PEDIATRICS, V55, P160, DOI 10.1093/tropej/fmn099; Katz N, 2011, COGNITION OCCUPATION, P13; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; Koven NS, 2010, PERS INDIV DIFFER, V49, P24, DOI 10.1016/j.paid.2010.02.034; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; LACHMAN ME, 1993, INT J BEHAV DEV, V16, P131, DOI 10.1177/016502549301600203; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; Morrison F. J., 2010, CHILD DEV INTERSECTI, DOI DOI 10.1037/12059-011; Peleg O, 2009, LEARN DISABILITY Q, V32, P11, DOI 10.2307/25474659; Pyne JM, 1997, PSYCHOPHARMACOL BULL, V33, P23; Rosenblum S, 2013, RES DEV DISABIL, V34, P218, DOI 10.1016/j.ridd.2012.07.011; Rosenblum S, 2012, NEUROPSYCHOL REHABIL, V22, P65, DOI 10.1080/09602011.2011.640465; Rosenblum S, 2010, RES DEV DISABIL, V31, P502, DOI 10.1016/j.ridd.2009.10.016; Rotenberg-Shpigelman S., 2008, ISRAELI J OCCUPATION, V17, pH77; Roth RM., 2005, BRIEF A BEHAV RATING; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharfi K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106657, 10.1371/journal.pone.0108691]; Sharma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125693; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Stern A, 2013, J ATTEN DISORD, P1; SWANSON HL, 1994, J LEARN DISABIL-US, V27, P34, DOI 10.1177/002221949402700107; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Theofilou P, 2013, EUR J PSYCHOL, V9, P150, DOI 10.5964/ejop.v9i1.337; Toll SWM, 2011, J LEARN DISABIL-US, V44, P521, DOI 10.1177/0022219410387302; Vasic N, 2008, NEUROPSYCHOLOGIA, V46, P640, DOI 10.1016/j.neuropsychologia.2007.09.002; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization (WHO), 2004, WHO QUAL LIF QUEST W	62	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166939	10.1371/journal.pone.0166939	http://dx.doi.org/10.1371/journal.pone.0166939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959913	Green Submitted, Green Published, gold			2022-12-26	WOS:000392753900006
J	Allaway, D; Gilham, MS; Colyer, A; Jonsson, TJ; Swanson, KS; Morris, PJ				Allaway, David; Gilham, Matthew S.; Colyer, Alison; Jonsson, Thomas J.; Swanson, Kelly S.; Morris, Penelope J.			Metabolic Profiling Reveals Effects of Age, Sexual Development and Neutering in Plasma of Young Male Cats	PLOS ONE			English	Article							FOOD-INTAKE; BODY-COMPOSITION; GENE-EXPRESSION; RETINOIC ACID; GONADECTOMY; FELININE; WEIGHT; TESTOSTERONE; ENERGY; OVARIOHYSTERECTOMY	Neutering is a significant risk factor for obesity in cats. The mechanisms that promote neuter-associated weight gain are not well understood but following neutering, acute changes in energy expenditure and energy consumption have been observed. Metabolic profiling (GC-MS and UHPLC-MS-MS) was used in a longitudinal study to identify changes associated with age, sexual development and neutering in male cats fed a nutritionally-complete dry diet to maintain an ideal body condition score. At eight time points, between 19 and 52 weeks of age, fasted blood samples were taken from kittens neutered at either 19 weeks of age (Early Neuter (EN), n = 8) or at 31 weeks of age (Conventional Neuter (CN), n = 7). Univariate and multivariate analyses were used to compare plasma metabolites (n = 370) from EN and CN cats. Age was the primary driver of variance in the plasma metabolome, including a developmental change independent of neuter group between 19 and 21 weeks in lysolipids and fatty acid amides. Changes associated with sexual development and its subsequent loss were also observed, with differences at some time points observed between EN and CN cats for 45 metabolites (FDR p< 0.05). Pathway Enrichment Analysis also identified significant effects in 20 pathways, dominated by amino acid, sterol and fatty acid metabolism. Most changes were interpretable within the context of male sexual development, and changed following neutering in the CN group. Felinine metabolism in CN cats was the most significantly altered pathway, increasing during sexual development and decreasing acutely following neutering. Felinine is a testosterone-regulated, felid-specific glutathione derivative secreted in urine. Alterations in tryptophan, histidine and tocopherol metabolism observed in peripubertal cats may be to support physiological functions of glutathione following diversion of S-amino acids for urinary felinine secretion.	[Allaway, David; Gilham, Matthew S.; Colyer, Alison; Morris, Penelope J.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Jonsson, Thomas J.] Metabolon Inc, Durham, NC USA; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; Metabolon; University of Illinois System; University of Illinois Urbana-Champaign	Allaway, D (corresponding author), WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England.	david.allaway@effem.com		Allaway, David/0000-0003-4602-8933; Swanson, Kelly/0000-0001-5518-3076	Mars Petcare UK	Mars Petcare UK	I have read the journal's policy and the authors of this manuscript have the following competing interests: The study was funded by Mars Petcare UK, the employer of DA, MSG, AC & PJM. The study was initiated when KSS was on a sabbatical at WALTHAM (Mars Petcare). These affiliations and funding does not alter our adherence to PLOS ONE policies on sharing data and materials.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Alexander LG, 2011, BRIT J NUTR, V106, pS19, DOI 10.1017/S0007114511001851; Allaway D, 2013, METABOLOMICS, V9, P1096, DOI 10.1007/s11306-013-0527-8; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Beckmann M, 2010, BRIT J NUTR, V103, P1127, DOI 10.1017/S000711450999300X; Belsito KR, 2009, J ANIM SCI, V87, P594, DOI 10.2527/jas.2008-0887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bretz F., 2016, MULTIPLE COMP USING; Butterwick RF, 2001, AM J VET RES, V62, P331, DOI 10.2460/ajvr.2001.62.331; Cave NJ, 2007, NEW ZEAL VET J, V55, P113, DOI 10.1080/00480169.2007.36752; Cave NJ, 2007, J ANIM PHYSIOL AN N, V91, P400, DOI 10.1111/j.1439-0396.2006.00667.x; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Colyer A, 2011, BRIT J NUTR, V106, pS146, DOI 10.1017/S000711451100081X; Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fettman MJ, 1997, RES VET SCI, V62, P131, DOI 10.1016/S0034-5288(97)90134-X; Flynn MF, 1996, J AM VET MED ASSOC, V209, P1572; Gabbay V, 2010, J CHILD PSYCHOL PSYC, V51, P935, DOI 10.1111/j.1469-7610.2010.02245.x; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Hagen-Plantinga EA, 2014, J ANIM PHYSIOL AN N, V98, P491, DOI 10.1111/jpn.12097; Hoenig M, 2002, AM J VET RES, V63, P634, DOI 10.2460/ajvr.2002.63.634; Hogarth CA, 2012, ANIM REPROD, V9, P742; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; JONES DB, 1989, EUR J CLIN INVEST, V19, P438, DOI 10.1111/j.1365-2362.1989.tb00256.x; Joyce A, 2011, J FELINE MED SURG, V13, P3, DOI 10.1016/j.jfms.2010.11.005; Kanchuk ML, 2003, J NUTR, V133, P1866, DOI 10.1093/jn/133.6.1866; Kanchuk ML, 2002, J NUTR, V132, p1730S, DOI 10.1093/jn/132.6.1730S; Kasimanickam VR, 2013, THERIOGENOLOGY, V79, P10, DOI 10.1016/j.theriogenology.2012.09.001; Kratz EM, 2014, REPROD FERT DEVELOP, V28, P507; Lloyd AJ, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0997-6; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; MANNING BD, 1975, LIFE SCI, V17, P225, DOI 10.1016/0024-3205(75)90507-X; MENENDEZPELAEZ A, 1988, P SOC EXP BIOL MED, V187, P287; Metges CC, 2000, AM J PHYSIOL-ENDOC M, V278, pE868, DOI 10.1152/ajpendo.2000.278.5.E868; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Murray JK, 2008, VET REC, V163, P381, DOI 10.1136/vr.163.13.381; Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137; Nguyen PG, 2004, AM J VET RES, V65, P1708, DOI 10.2460/ajvr.2004.65.1708; NRC, 2006, NUTR REQ DOGS CATS, V2; PALEKAR AG, 1974, P NATL ACAD SCI USA, V71, P293, DOI 10.1073/pnas.71.2.293; Penafiel R, 2004, AMINO ACIDS, V26, P53, DOI 10.1007/s00726-003-0034-8; Rohrbach BW, 2001, J AM VET MED ASSOC, V218, P1111, DOI 10.2460/javma.2001.218.1111; Rutherfurd KJ, 2002, J BIOL CHEM, V277, P114, DOI 10.1074/jbc.M107728200; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Scarlett JM, 1998, J AM VET MED ASSOC, V212, P1725; SCHNEIDER R, 1983, J NATL CANCER I, V70, P971; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P372, DOI 10.2460/javma.2004.224.372; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STOZICKY F, 1991, ACTA PAEDIATR SCAND, V80, P1139, DOI 10.1111/j.1651-2227.1991.tb11801.x; Stubbs WP, 1996, J AM VET MED ASSOC, V209, P1864; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Tarttelin MF, 1998, PHYSIOL BEHAV, V65, P83, DOI 10.1016/S0031-9384(98)00132-2; Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8; Vester BM, 2009, ANIMAL, V3, P1287, DOI 10.1017/S1751731109004868; Viant MR, 2007, METABOLOMICS, V3, P453, DOI 10.1007/s11306-007-0092-0; Wei A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089557; Zoran DL, 2010, VET CLIN N AM-SMALL, V40, P221, DOI 10.1016/j.cvsm.2009.10.009	65	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168144	10.1371/journal.pone.0168144	http://dx.doi.org/10.1371/journal.pone.0168144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942045	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600055
J	Bjursell, M; Ryberg, E; Wu, TT; Greasley, PJ; Bohlooly-Y, M; Hjorth, S				Bjursell, Mikael; Ryberg, Erik; Wu, Tingting; Greasley, Peter J.; Bohlooly-Y, Mohammad; Hjorth, Stephan			Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation	PLOS ONE			English	Article							CANNABINOID RECEPTOR GPR55; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; POTENTIAL ROLE; MICE; EXPRESSION; OBESITY; IDENTIFICATION; PHARMACOLOGY; HOMEOSTASIS; C57BL/6J	The G-protein coupled receptor 55 (GPR55) is activated by cannabinoids and non-cannabinoid molecules and has been speculated to play a modulatory role in a large variety of physiological and pathological processes, including in metabolically perturbed states. We therefore generated male mice deficient in the gene coding for the cannabinoid/lysophosphatidylinositol (LPI) receptor Gpr55 and characterized them under normal dietary conditions as well as during high energy dense diet feeding followed by challenge with the CB1 receptor antagonist/GPR55 agonist rimonabant. Gpr55 deficient male mice (Gpr55 KO) were phenotypically indistinguishable from their wild type (WT) siblings for the most part. However, Gpr55 KO animals displayed an intriguing nocturnal pattern of motor activity and energy expenditure (EE). During the initial 6 hours of the night, motor activity was significantly elevated without any significant effect observed in EE. Interestingly, during the last 6 hours of the night motor activity was similar but EE was significantly decreased in the Gpr55 KO mice. No significant difference in motor activity was detected during daytime, but EE was lower in the Gpr55 KO compared to WT mice. The aforementioned patterns were not associated with alterations in energy intake, daytime core body temperature, body weight (BW) or composition, although a non-significant tendency to increased adiposity was seen in Gpr55 KO compared to WT mice. Detailed analyses of daytime activity in the Open Field paradigm unveiled lower horizontal activity and rearing time for the Gpr55 KO mice. Moreover, the Gpr55 KO mice displayed significantly faster reaction time in the tail flick test, indicative of thermal hyperalgesia. The BW-decreasing effect of rimonabant in mice on long-term cafeteria diet did not differ between Gpr55 KO and WT mice. In conclusion, Gpr55 deficiency is associated with subtle effects on diurnal/nocturnal EE and motor activity behaviours but does not appear per se critically required for overall metabolism or behaviours.	[Bjursell, Mikael; Wu, Tingting; Bohlooly-Y, Mohammad] AstraZeneca R&D, Discovery Sci Transgen, Molndal, Sweden; [Ryberg, Erik] AstraZeneca R&D, Cardiovasc & Metab Dis CVMD Innovat Med & Early D, Molndal, Sweden; [Greasley, Peter J.] AstraZeneca R&D, CVMD Translat Med Unit, Early Clin Dev, Molndal, Sweden; [Hjorth, Stephan] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; University of Gothenburg	Hjorth, S (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.	Stephan.Hjorth@gu.se	Hjorth, Stephan/AAO-4298-2021	Hjorth, Stephan/0000-0002-6980-3691				Balenga NA, 2014, BRIT J PHARMACOL, V171, P5387, DOI 10.1111/bph.12850; Balenga NAB, 2011, ADV PHARMACOL, V62, P251, DOI 10.1016/B978-0-12-385952-5.00004-X; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Imbernon M, 2014, MOL CELL ENDOCRINOL, V383, P159, DOI 10.1016/j.mce.2013.12.011; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Liu B, 2015, PHARMACOL THERAPEUT, V145, P35, DOI 10.1016/j.pharmthera.2014.06.007; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; Moran BM, 2016, ACTA DIABETOL, V53, P177, DOI 10.1007/s00592-015-0826-9; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Naderi N, 2012, NEUROCHEM RES, V37, P778, DOI 10.1007/s11064-011-0672-2; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Perez-Gomez E, 2013, ONCOGENE, V32, P2534, DOI 10.1038/onc.2012.278; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Shore DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00069; Simcocks AC, 2014, DRUG DISCOV TODAY, V19, P1145, DOI 10.1016/j.drudis.2013.12.005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314	34	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167965	10.1371/journal.pone.0167965	http://dx.doi.org/10.1371/journal.pone.0167965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941994	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600041
J	Carton, D; Nitsch, V; Meinzer, D; Wollherr, D				Carton, Daniel; Nitsch, Verena; Meinzer, Dominik; Wollherr, Dirk			Towards Assessing the Human Trajectory Planning Horizon	PLOS ONE			English	Article							COLLISION-AVOIDANCE; OBSTACLE AVOIDANCE; LOCOMOTION; MOVEMENT; DYNAMICS; STEP; PATH; ARM	Mobile robots are envisioned to cooperate closely with humans and to integrate seamlessly into a shared environment. For locomotion, these environments resemble traversable areas which are shared between multiple agents like humans and robots. The seamless integration of mobile robots into these environments requires accurate predictions of human locomotion. This work considers optimal control and model predictive control approaches for accurate trajectory prediction and proposes to integrate aspects of human behavior to improve their performance. Recently developed models are not able to reproduce accurately trajectories that result from sudden avoidance maneuvers. Particularly, the human locomotion behavior when handling disturbances from other agents poses a problem. The goal of this work is to investigate whether humans alter their trajectory planning horizon, in order to resolve abruptly emerging collision situations. By modeling humans as model predictive controllers, the influence of the planning horizon is investigated in simulations. Based on these results, an experiment is designed to identify, whether humans initiate a change in their locomotion planning behavior while moving in a complex environment. The results support the hypothesis, that humans employ a shorter planning horizon to avoid collisions that are triggered by unexpected disturbances. Observations presented in this work are expected to further improve the generalizability and accuracy of prediction methods based on dynamic models.	[Carton, Daniel; Meinzer, Dominik; Wollherr, Dirk] Tech Univ Munich, Chair Automat Control Engn, Theresienstr 90, D-80333 Munich, Germany; [Nitsch, Verena] Univ Bundeswehr Munchen, Human Factors Inst, Werner Heisenberg Weg 39, D-85577 Neubiberg, Germany	Technical University of Munich; Bundeswehr University Munich	Carton, D (corresponding author), Tech Univ Munich, Chair Automat Control Engn, Theresienstr 90, D-80333 Munich, Germany.	dc@tum.de	Wollherr, Dirk/C-3925-2011	Wollherr, Dirk/0000-0003-2810-6790	ERC Advanced Grant SHRINE [267877]; Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	ERC Advanced Grant SHRINE; Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	This work is supported in part within the ERC Advanced Grant SHRINE Agreement No. 267877 (www.shrine-project.eu) and in part by the Technische Universitat Munchen - Institute for Advanced Study (www.tum-ias.de), funded by the German Excellence Initiative.	Ahmadi-Pajouh MA, 2007, MED HYPOTHESES, V68, P1411, DOI 10.1016/j.mehy.2006.06.060; Albrecht S, 2012, INT C MATH MOD, P158; Allgower F., 1999, Advances in Control. Highlights of ECC'99, P391; Arechavaleta G., 2006, PROCEEDING IEEERAS E, P158, DOI [DOI 10.1109/BIOROB.2006.1639077, 10.1109/BIOROB.2006.1639077, DOI 10.1109/BI0R0B.2006.1639077]; Arechavaleta G, 2008, IEEE T ROBOT, V24, P5, DOI 10.1109/TRO.2008.915449; Bascetta L, 2011, IEEE INT C INT ROBOT, P2971, DOI 10.1109/IROS.2011.6048287; Basili P, 2013, GAIT POSTURE, V37, P385, DOI 10.1016/j.gaitpost.2012.08.003; Bitgood S, 2006, ENVIRON BEHAV, V38, P394, DOI 10.1177/0013916505280081; Buss M., 1999, Advances in Control. Highlights of ECC'99, P65; Carton D, 2012, INT S EXP ROB, P199, DOI [DOI 10.1007/978-3-319-00065-7_15, 10.1007/978-3-319-00065-7_15]; Dragan A., 2013, ROBOTICS SCI SYSTEMS, DOI [10.15607/RSS.2013.IX.024, DOI 10.15607/RSS.2013.IX.024]; Elnager A, 2001, 2001 IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, P414, DOI 10.1109/CIRA.2001.1013236; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Ferrer G, 2011, ACMIEEE INT CONF HUM, P135, DOI 10.1145/1957656.1957698; Fink PW, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134.1227136; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Goffman E., 1971, RELATIONS PUBLIC MIC; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Hoogendoorn S, 2003, OPTIM CONTR APPL MET, V24, P153, DOI 10.1002/oca.727; Houska B, 2011, OPTIM CONTR APPL MET, V32, P298, DOI 10.1002/oca.939; Huber M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089589; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Karamouzas I, 2010, LECT NOTES ARTIF INT, V6356, P180, DOI 10.1007/978-3-642-15892-6_19; Kruse T, 2014, ACMIEEE INT CONF HUM, P350, DOI 10.1145/2559636.2559662; Kruse T, 2012, 2012 IEEE WORKSHOP ON ADVANCED ROBOTICS AND ITS SOCIAL IMPACTS (ARSO), P83, DOI 10.1109/ARSO.2012.6213404; Kuderer M., 2012, ROBOTICS SCI SYSTEMS; Lasota PA, 2015, HUM FACTORS, V57, P21, DOI 10.1177/0018720814565188; Lefevre S, 2014, ROBOMECH J, V1, P1, DOI [DOI 10.1186/S40648-014-0001-Z, 10.1186/s40648-014-0001-z]; Mainprice J, 2015, IEEE INT CONF ROBOT, P885, DOI 10.1109/ICRA.2015.7139282; Mombaur K, 2010, AUTON ROBOT, V28, P369, DOI 10.1007/s10514-009-9170-7; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Nilsson NJ, 1984, SHAKEY THE ROBOT, P325; Olivier AH, 2013, GAIT POSTURE, V38, P751, DOI 10.1016/j.gaitpost.2013.03.017; Olivier AH, 2012, GAIT POSTURE, V36, P399, DOI 10.1016/j.gaitpost.2012.03.021; OLSON PL, 1986, HUM FACTORS, V28, P91, DOI 10.1177/001872088602800110; Ondrej J, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778860; Papadopoulos AV, 2013, IEEE INT C INT ROBOT, P1676, DOI 10.1109/IROS.2013.6696574; Papadopoulos AV, 2014, IFAC P, V47, P12299, DOI [10.3182/20140824-6-ZA-1003.01898, DOI 10.3182/20140824-6-ZA-1003.01898]; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Pham QC, 2009, J NEUROPHYSIOL, V102, P2800, DOI 10.1152/jn.00284.2009; Puydupin-Jamin AS, 2012, IEEE INT CONF ROBOT, P531, DOI 10.1109/ICRA.2012.6225317; Reich BD, 1997, IRCS TECHNICAL REPOR, P51; Schulz D, 2001, IEEE INT CONF ROBOT, P1665, DOI 10.1109/ROBOT.2001.932850; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; Stuart S, 2014, WORLD C INT SOC POST; Tastan B, 2011, PERVASIVE MOB COMPUT, V7, P319, DOI 10.1016/j.pmcj.2011.02.003; Vielledent S, 2001, NEUROSCI LETT, V305, P65, DOI 10.1016/S0304-3940(01)01798-0; Weinrich C, 2013, IEEE INT CONF ROBOT, P376, DOI 10.1109/ICRA.2013.6630603; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150; WOLFINGER NH, 1995, J CONTEMP ETHNOGR, V24, P323, DOI 10.1177/089124195024003004; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Ziebart BD, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3931, DOI 10.1109/IROS.2009.5354147	53	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167021	10.1371/journal.pone.0167021	http://dx.doi.org/10.1371/journal.pone.0167021			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936015	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100054
J	Hu, WH; Yu, JY; Liu, HW; Zhang, XS; Wang, Y				Hu, Wenhao; Yu, Jiayi; Liu, Huawei; Zhang, Xuesong; Wang, Yan			Shape Osteotomy in Ankylosing Spondylitis, a Prospective Case Series with Minimum 2 Year Follow-Up	PLOS ONE			English	Article							THORACOLUMBAR KYPHOSIS; KYPHOTIC DEFORMITY; SURGICAL-TREATMENT; SAGITTAL BALANCE; SPINAL OSTEOTOMY; WEDGE OSTEOTOMY; ALIGNMENT; IMPACT; ANGLE	The aim of the study is to evaluate the efficacy of a spinal osteotomy technique, Y shape osteotomy, for correcting kyphosis in AS patients planned preoperatively with computer software-assistance. 36 consecutive AS patients with thoracolumbar kyphosis were treated with one-stage posterior Y shape osteotomy and preoperative surgical planning was done with the aid of the Surgimap Spine. Radiological parameters of simulation and immediate postoperation were documented. Clinical and radiological results were evaluated in the preoperative, the early postoperative periods and during the last follow-up. The lumbar lordosis was found as 40.7 +/- 4.1 degrees in the surgical planning and 49.7 +/- 3.9 degrees postoperatively (p< 0.01). PI-LL was 3.8 +/- 0.9 degrees in the simulation procedure and 6.6 +/- 1.5 degrees postoperatively (p< 0.01). At the final follow-up, Global sagittal balance was restored and Both Oswestry Disability Index and Scoliosis Research Society scores improved largely. In conclusion, Y shape osteotomy is a safe and effective treatment option for AS patients with kyphosis deformity.	[Hu, Wenhao; Liu, Huawei; Zhang, Xuesong; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Yu, Jiayi] Peking Univ, Dept Renal Canc & Melanoma, Canc Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Zhang, XS; Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China.	tonnyzhang301@sina.com; yanwang301spine@sina.com						Akbar M, 2013, NEUROSURG CLIN N AM, V24, P163, DOI 10.1016/j.nec.2012.12.007; Arun R, 2011, EUR SPINE J, V20, P2252, DOI 10.1007/s00586-011-1894-3; Blondel B, 2012, NEUROSURGERY, V71, P341, DOI 10.1227/NEU.0b013e31825d20c0; Bridwell KH, 2003, SPINE, V28, P2093, DOI 10.1097/01.BRS.0000090891.60232.70; Crawford CH, 2015, SPINE, V40, P377, DOI 10.1097/BRS.0000000000000761; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Kiaer T, 2010, EUR SPINE J, V19, P57, DOI 10.1007/s00586-009-1104-8; Kubiak EN, 2005, J AM ACAD ORTHOP SUR, V13, P267, DOI 10.5435/00124635-200507000-00006; Lafage V, 2012, EUR SPINE J, V21, P698, DOI 10.1007/s00586-011-1967-3; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Mehdian H, 2015, SPINE J, V15, P771, DOI 10.1016/j.spinee.2015.01.014; MOLL JMH, 1987, SCAND J RHEUMATOL, P12; Murrey DB, 2002, SPINE, V27, P2338, DOI 10.1097/00007632-200211010-00006; Qian BP, 2012, SPINE, V37, P1415, DOI 10.1097/BRS.0b013e318250dc95; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Schwab FJ, 2012, J NEUROSURG-SPINE, V16, P539, DOI 10.3171/2012.2.SPINE11120; Smith JS, 2013, SPINE, V38, P1663, DOI 10.1097/BRS.0b013e31829ec563; Smith-Petersen M N, 1969, Clin Orthop Relat Res, V66, P6; Song K, 2013, SPINE, V38, pE616, DOI 10.1097/BRS.0b013e31828b3299; Suk KS, 2003, SPINE, V28, P2001, DOI 10.1097/01.BRS.0000083239.06023.78; Suk SI, 2005, SPINE, V30, pE703, DOI 10.1097/01.brs.0000188190.90034.be; THOMASEN E, 1985, CLIN ORTHOP RELAT R, P142, DOI 10.1097/00003086-198504000-00019; Van Royen BJ, 1999, ANN RHEUM DIS, V58, P399, DOI 10.1136/ard.58.7.399; Wang Y, 2009, EUR SPINE J, V18, P1436, DOI 10.1007/s00586-009-1067-9; Xi YM., 2013, EUR J ORTHOP SURG TR, V23 suppl 1, pS59, DOI DOI 10.1007/S00590-013-1168-3; Zhang X, 2016, BONE JOINT J, V98B, P672, DOI 10.1302/0301-620X.98B5.35726; Zheng GQ, 2014, SPINE, V39, P1055, DOI 10.1097/BRS.0000000000000346	28	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167792	10.1371/journal.pone.0167792	http://dx.doi.org/10.1371/journal.pone.0167792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936020	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100193
J	Islam, FMA; Bhowmik, JL; Islam, SZ; Renzaho, AMN; Hiller, JE				Islam, Fakir M. Amirul; Bhowmik, Jahar L.; Islam, Silvia Z.; Renzaho, Andre M. N.; Hiller, Janet E.			Factors Associated with Disability in Rural Bangladesh: Bangladesh Population-Based Diabetes and Eye Study (BPDES)	PLOS ONE			English	Article							FREE LIFE EXPECTANCY; PREVALENCE; ADULTS; DISEASES; HEALTH	Background To assess factors associated with disability in a rural district of Bangladesh. Methods Using a population-based systematic sampling technique, data were collected from 3104 adults aged >= 30 years from the Banshgram union of Narail district. Data collected included an interviewer administered questionnaire to report physical disabilities including impairment that prevents engagement with paid work, visual, hearing, and mobility as well as mental disabilities. Socio-demographic and anthropometric factors including educational attainment and body mass index, as well as clinical factors such as blood pressure, and fasting blood glucose were also collected. Binary and multinomial logistic regression techniques were used to explore the association of various socio-demographic and clinical factors with disability. Results The mean (SD), minimum and maximum ages of the participants were 51 (12), 30 and 89 years. Of total participants, 65% were female. The prevalence of disability varied from 29.1% for visual impairment (highest) to 16.5% for hearing, 14.7% for movement difficulties and 1.6% (lowest) for any other disability that prevented engagement with paid work. Overall, the prevalence of a single disability was 28.6% and that of two or more disabilities was 14.7%. Older age, gender (female), lower socio-economic status (SES), and hypertension were associated with a higher prevalence of most of the disability components. The prevalence of hearing problems (24.5% vs. 13.3%, p<0.001) and movement difficulties (24.9% vs. 13.0%, p<0.001) was significantly higher among lower-income participants than their higher-income counterparts after controlling for age. Prevalence of visual impairment (54.6% vs. 9.2%, p<0.001), hearing (32.2% vs. 6.7%, p<0.001) and movement difficulties (29.2% vs. 5.5%, p<0.001) were significantly higher in people of aged 60 years or older than those aged 30-34 years. After multivariate adjustment, the prevalence of single disability (prevalence risk ratio [PRR] 1.25, 95% CI: 1.09-1.42, p<0.001), and multiple disabilities (PRR 1.41, 95% CI 1.14-1.73, p<0.001) was higher among females than males. The prevalence of single disability and multiple disabilities was respectively 21% (PRR 1.21, 95% CI: 1.02-1.42, p<0.001) and 88% (PRR 1.88, 95% CI: 1.38-2.54, p<0.001) higher among participants with low educational attainment (primary level or less) than those with at least a secondary level of education. Conclusions In rural Bangladesh, the prevalence of disability is high. Public health programs should target those of low SES, older age, and female participants and aim to provide necessary supports in order to bridge disability-related inequities.	[Islam, Fakir M. Amirul; Bhowmik, Jahar L.] Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Hawthorn Campus, Hawthorn, Vic, Australia; [Islam, Fakir M. Amirul; Islam, Silvia Z.] Org Rural Community Dev, Dariapur, Narail, Bangladesh; [Islam, Silvia Z.] RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia; [Renzaho, Andre M. N.] Univ Western Sydney, Sch Social Sci & Psychol, Humanitarian & Dev Studies, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hiller, Janet E.] Swinburne Univ Technol, Fac Hlth Arts & Design, Sch Hlth Sci, Hawthorn Campus, Hawthorn, Vic, Australia; [Hiller, Janet E.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia	Swinburne University of Technology; Royal Melbourne Institute of Technology (RMIT); Western Sydney University; Monash University; Swinburne University of Technology; University of Adelaide	Islam, FMA (corresponding author), Swinburne Univ Technol, Dept Stat Data Sci & Epidemiol, Fac Hlth Arts & Design, Hawthorn Campus, Hawthorn, Vic, Australia.; Islam, FMA (corresponding author), Org Rural Community Dev, Dariapur, Narail, Bangladesh.	fislam@swin.edu.au	Bhowmik, Jahar/T-2289-2017; Islam, Fakir M Amirul/P-6665-2015; Hiller, Janet E./A-5633-2008; Renzaho, Andre M.N./AAH-7679-2021	Bhowmik, Jahar/0000-0001-9697-1968; Islam, Fakir M Amirul/0000-0003-3897-3302; Hiller, Janet E./0000-0002-8532-4033; RENZAHO, ANDRE/0000-0002-6844-0833	ARC Future Fellowship [FT 110100345]	ARC Future Fellowship(Australian Research Council)	AMNR is supported by an ARC Future Fellowship (FT 110100345).	Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Altman B.M., 2016, INT MEASUREMENT DISA; Andrade FCD, 2010, J GERONTOL B-PSYCHOL, V65, P381, DOI 10.1093/geronb/gbp119; [Anonymous], 2003, REP DIS PERS; [Anonymous], 2001, DISABILITY AND DEVEL, P12; [Anonymous], 2012, DIS GLANC 2012 STREN; [Anonymous], SEER CANC STAT REV; [Anonymous], 2011, POP HOUS; Bangladesh Bureau of Statistics, 2010, POP HOUS CENS; Basgram Union Parisad Office, 2011, EL LIST; Chakrabarti R, 2015, BANGLADESH J MED SCI, V14, P367, DOI 10.3329/bjms.v14i4.25767; Chappell NL, 2010, INT ENCY REHABILITAT; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Hairi NN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-492; Hasan MT, 2014, J INTERPERS VIOLENCE, V29, P3105, DOI 10.1177/0886260514534525; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Huq NL, 2013, DISABILITY CBR INCLU, V24, P37, DOI DOI 10.5463/DCID.V24I3.174; IDF, 2012, INT DIAB ATL; International SS, 2003, SUMM REP BANGL NAT B; Islam FMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133043; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Islam FM, 2015, J HUM HYPERTENS; Islam FM, 2015, J DIABETES; Islam Shiekh Mohammed Shariful, 2015, Glob Cardiol Sci Pract, V2015, P43, DOI 10.5339/gcsp.2015.43; Jagger C, 2007, J GERONTOL A-BIOL, V62, P408, DOI 10.1093/gerona/62.4.408; Kumar S Ganesh, 2008, Indian J Psychiatry, V50, P21, DOI 10.4103/0019-5545.39754; Marella M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2202-7; McGuire LC, 2006, AM J GERIAT PSYCHIAT, V14, P36, DOI 10.1097/01.JGP.0000192502.10692.d6; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Organization WH, 2016, GLOBAL STATUS REPORT; Rashed AMT, 2005, DISABILITY BANGLADES, P1; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538; Tareque MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103681; Tareque MI, 2013, J AGING HEALTH, V25, P1299, DOI 10.1177/0898264313501388; The Economist, 2012, ECONOMIST; USTUN TB, 2010, MANUAL WHO DISABILIT; Wang Z, 2013, J STAT SOFTW, V55, P5, DOI [10.18637/jss.v055.i05, DOI 10.18637/jss.v055.i05]; WHO (World Health Organization), 2011, WORLD INEQUALITY REP; Zheng XY, 2011, B WORLD HEALTH ORGAN, V89, P788, DOI 10.2471/BLT.11.089730	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165625	10.1371/journal.pone.0165625	http://dx.doi.org/10.1371/journal.pone.0165625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936096	gold, Green Published			2022-12-26	WOS:000389587100013
J	Jeon, I; Cho, ES; Kim, JH; Kim, DJ; Yu, JS; Chung, JJ				Jeon, Inhwan; Cho, Eun-Suk; Kim, Joo Hee; Kim, Dae Jung; Yu, Jeong-Sik; Chung, Jae-Joon			Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis	PLOS ONE			English	Article							IMPROVE CONSPICUOUSNESS; CLINICAL-EVALUATION; CONTRAST AGENT; LESIONS; GADOXETATE; MARKERS; SAFETY; IMAGES	Objectives To compare 10-minute (min) delayed hepatocyte phase imaging (HPI) using a 30 degrees flip angle (FA) (10m-FA30) and 20-min delayed HPI using a 10 degrees FA (20m-FA10) or 30 degrees FA (20m-FA30) in Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis or cirrhosis, in terms of lesion-to-liver contrast-to-noise ratio (CNR) for hepatocellular carcinoma (HCC) and detection sensitivity for focal hepatic lesions (FHLs). Materials and Methods One hundred and four patients with 168 HCCs and 55 benign FHLs who underwent Gd-EOB-DTPA-enhanced MRI with 10m-FA30, 20m-FA10, and 20m-FA30 were enrolled. Patients were divided into two groups according to the Child-Pugh classification: group A with chronic hepatitis or Child-Pugh A cirrhosis and group B with Child-Pugh B or C cirrhosis. Lesion-to-liver CNR for HCCs was compared between 10m-FA30 and 20m-FA10 or 20m-FA30 for each group. The presence of FHLs was evaluated using a four-point scale by two independent reviewers, and the detection sensitivity was analyzed. Results In group A, the CNR for HCCs (n = 86) on 10m-FA30 (165.8 +/- 99.7) was significantly higher than that on 20m-FA10 (113.4 +/- 71.4) and lower than that of 20m-FA30 (210.2 +/- 129.3). However, there was no significant difference in the sensitivity of FHL detection between 10m-FA30 (mean 95.0% for two reviewers) and 20m-FA10 (94.7%) or 20m-FA30 (94.7%). In group B, the CNR (54.0 +/- 36.4) for HCCs (n = 57) and the sensitivity (94.2%) of FHL detection for 10m-FA30 were significantly higher than those for 20m-FA10 (41.8 +/- 36.4 and 80.8%, respectively) and were not different from those for 20m-FA30 (62.7 +/- 44.4 and 93.3%, respectively). Conclusion The diagnostic performance of 10m-FA30 was similar to or higher than 20m-FA10 or 20m-FA30 in both groups A and B. This finding indicates that 10m-FA30 could replace 20-min delayed HPI regardless of patient liver function and reduce the delay time by 10 minutes.	[Jeon, Inhwan; Cho, Eun-Suk; Kim, Joo Hee; Yu, Jeong-Sik; Chung, Jae-Joon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Dae Jung] CHA Univ, Dept Radiol, CHA Bundang Med Ctr, Seongnam Si, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Cho, ES (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	jjondol@yuhs.ac		Cho, Eun-Suk/0000-0002-0007-9869; Chung, Jae-Joon/0000-0002-7447-1193; Yu, Jeong-Sik/0000-0002-8171-5838; KIM, JOO HEE/0000-0001-5383-3602				Bartolozzi C, 2001, EUR RADIOL, V11, P1374, DOI 10.1007/s003300100845; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1; Cho ES, 2015, AM J ROENTGENOL, V204, P69, DOI 10.2214/AJR.13.11903; Grazioli Luigi, 2010, J Gastrointest Cancer, V41, P221, DOI 10.1007/s12029-010-9145-0; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Haradome H, 2012, J MAGN RESON IMAGING, V35, P132, DOI 10.1002/jmri.22805; Horton KM, 1999, RADIOGRAPHICS, V19, P431, DOI 10.1148/radiographics.19.2.g99mr04431; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Jeong HT, 2012, J MAGN RESON IMAGING, V35, P635, DOI 10.1002/jmri.22880; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Kim S, 2013, AM J ROENTGENOL, V200, P90, DOI 10.2214/AJR.12.8722; Kim YK, 2010, INVEST RADIOL, V45, P740, DOI 10.1097/RLI.0b013e3181e943a7; Kudo M, 2008, INTERVIROLOGY, V51, P17, DOI 10.1159/000122595; Lee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139863; Lee JM, 2011, ABDOM IMAGING, V36, P282, DOI 10.1007/s00261-011-9692-2; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Motosugi U, 2009, EUR RADIOL, V19, P2623, DOI 10.1007/s00330-009-1467-6; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Sofue K, 2011, EUR RADIOL, V21, P2336, DOI 10.1007/s00330-011-2197-0; Tamada T, 2013, J MAGN RESON IMAGING, V37, P1093, DOI 10.1002/jmri.23903; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Tschirch FTC, 2008, EUR RADIOL, V18, P1577, DOI 10.1007/s00330-008-0929-6; van Kessel CS, 2012, EUR RADIOL, V22, P2153, DOI 10.1007/s00330-012-2486-2; Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; Verloh N, 2013, EUR J RADIOL, V82, P1710, DOI 10.1016/j.ejrad.2013.05.033; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167701	10.1371/journal.pone.0167701	http://dx.doi.org/10.1371/journal.pone.0167701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936106	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100158
J	Patchett, AL; Darby, JM; Tovar, C; Lyons, AB; Woods, GM				Patchett, Amanda L.; Darby, Jocelyn M.; Tovar, Cesar; Lyons, A. Bruce; Woods, Gregory M.			The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines	PLOS ONE			English	Article							RESPONSE MODIFIER IMIQUIMOD; NF-KAPPA-B; TASMANIAN DEVIL; SARCOPHILUS-HARRISII; DENDRITIC CELLS; CANCER-CELLS; IMMUNE-RESPONSES; ER STRESS; IN-VITRO; TRANSMISSIBLE CANCER	The survival of the Tasmanian devil (Sarcophilus harrisii) is threatened by devil facial tumour disease (DFTD). This transmissible cancer is usually fatal, and no successful treatments have been developed. In human studies, the small immunomodulatory molecule imiquimod is a successful immunotherapy, activating anti-tumour immunity via stimulation of toll-like receptor-7 (TLR7) signaling pathways. In addition, imiquimod is a potent inducer of apoptosis in human tumour cell lines via TLR7 independent mechanisms. Here we investigate the potential of imiquimod as a DFTD therapy through analysis of treated DFTD cell lines and Tasmanian devil fibroblasts. WST-8 proliferation assays and annexin V apoptosis assays were performed to monitor apoptosis, and changes to the expression of pro- and anti-apoptotic genes were analysed using qRT-PCR. Our results show that DFTD cell lines, but not Tasmanian devil fibroblasts, are sensitive to imiquimod-induced apoptosis in a time and concentration dependent manner. Induction of apoptosis was accompanied by down-regulation of the anti-apoptotic BCL2 and BCLXL genes, and up-regulation of the pro-apoptotic BIM gene. Continuous imiquimod treatment was required for these effects to occur. These results demonstrate that imiquimod can deregulate DFTD cell growth and survival in direct and targeted manner. In vivo, this may increase DFTD vulnerability to imiquimod-induced TLR7-mediated immune responses. Our findings have improved the current knowledge of imiquimod action in tumour cells for application to both DFTD and human cancer therapy.	[Patchett, Amanda L.; Darby, Jocelyn M.; Tovar, Cesar; Woods, Gregory M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Lyons, A. Bruce; Woods, Gregory M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Patchett, AL (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	amanda.patchett@utas.edu.au	Patchett, Amanda L/A-7468-2015	Patchett, Amanda L/0000-0002-8424-4680; Darby, Jocelyn/0000-0002-1819-6000; Lyons, Alan/0000-0002-8508-5853	Australian Research Council [LP130100218]; Save The Tasmanian Devil Program Appeal	Australian Research Council(Australian Research Council); Save The Tasmanian Devil Program Appeal	GW is supported by funding from the Australian Research Council (LP130100218). URL: http://www.arc.gov.au/. AP is supported by a scholarship from the Save The Tasmanian Devil Program Appeal. URL: http://www.tassiedevil.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2012, CLIN CANCER RES, V18, P6748, DOI 10.1158/1078-0432.CCR-12-1149; Almomen A, 2016, PHARM RES-DORDR, V33, P2209, DOI 10.1007/s11095-016-1957-6; Barnetson RSC, 2004, CLIN EXP DERMATOL, V29, P639, DOI 10.1111/j.1365-2230.2004.01614.x; El-Khattouti A, 2016, J CELL MOL MED, V20, P266, DOI 10.1111/jcmm.12718; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Han JH, 2013, INT J ONCOL, V42, P2087, DOI 10.3892/ijo.2013.1898; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Howson LJ, 2014, ANAT REC, V297, P925, DOI 10.1002/ar.22904; Huang SW, 2010, BRIT J DERMATOL, V163, P310, DOI 10.1111/j.1365-2133.2010.09827.x; Huang SW, 2016, J DERMATOL SCI, V81, P182, DOI 10.1016/j.jdermsci.2015.12.011; Huang SW, 2014, ONCOTARGET, V5, P1363, DOI 10.18632/oncotarget.1734; Huang SW, 2012, J DERMATOL SCI, V65, P170, DOI 10.1016/j.jdermsci.2011.11.001; Huang SJ, 2009, J INVEST DERMATOL, V129, P2676, DOI 10.1038/jid.2009.151; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Jiang J, 2016, MOL MED REP, V13, P393, DOI 10.3892/mmr.2015.4524; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Kreiss A, 2015, VACCINE, V33, P3016, DOI 10.1016/j.vaccine.2015.01.039; Kreiss A, 2008, DEV COMP IMMUNOL, V32, P544, DOI 10.1016/j.dci.2007.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Nyberg WA, 2016, BIOCHEM BIOPH RES CO, V473, P789, DOI 10.1016/j.bbrc.2016.03.080; Ooi T, 2006, BRIT J DERMATOL, V154, P72, DOI 10.1111/j.1365-2133.2005.06932.x; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Patchett AL, 2015, DEV COMP IMMUNOL, V53, P123, DOI 10.1016/j.dci.2015.07.003; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Phalen DN, 2015, VET J, V206, P312, DOI 10.1016/j.tvjl.2015.10.013; Phalen DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065133; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Schon MP, 2004, J INVEST DERMATOL, V122, P1266, DOI 10.1111/j.0022-202X.2004.22528.x; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; Sohn KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095337; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Urosevic M, 2005, J NATL CANCER I, V97, P1143, DOI 10.1093/jnci/dji207; Vacchelli E, 2012, ONCOIMMUNOLOGY, V1, P894, DOI 10.4161/onci.20931; Vidal D, 2004, BRIT J DERMATOL, V151, P656, DOI 10.1111/j.1365-2133.2004.06094.x; Wagner TL, 1999, CELL IMMUNOL, V191, P10, DOI 10.1006/cimm.1998.1406; Wang ST, 2015, J DERMATOL SCI, V78, P108, DOI 10.1016/j.jdermsci.2015.02.008; Wolf IH, 2007, AM J DERMATOPATH, V29, P237, DOI 10.1097/01.dad.0000211531.33670.94; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Yi JY, 2009, BIOCHEM BIOPH RES CO, V386, P455, DOI 10.1016/j.bbrc.2009.06.046	51	10	11	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168068	10.1371/journal.pone.0168068	http://dx.doi.org/10.1371/journal.pone.0168068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936237	Green Published, gold			2022-12-26	WOS:000389587100268
J	Xiao, XR; Hong, YH; Xia, W; Feng, SP; Zhou, X; Fu, XM; Zang, J; Xiao, Y; Niu, XL; Li, CX; Chen, YH				Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua			Transcriptome Analysis of Ceriops tagal in Saline Environments Using RNA-Sequencing	PLOS ONE			English	Article							SALT STRESS; ABIOTIC STRESS; H+-ATPASE; TOLERANCE; ARABIDOPSIS; PROLINE; EXPRESSION; MANGROVES; GENES; TOOL	Identification of genes involved in mangrove species' adaptation to salt stress can provide valuable information for developing salt-tolerant crops and understanding the molecular evolution of salt tolerance in halophiles. Ceriops tagal is a salt-tolerant mangrove tree growing in mudflats and marshes in tropical and subtropical areas, without any prior genome information. In this study, we assessed the biochemical and transcriptional responses of C. tagal to high salt treatment (500 mmol/L NaCl) by hydroponic experiments and RNA-seq. In C. tagal root tissues under salt stress, proline accumulated strongly from 3 to 12 h of treatment; meanwhile, malondialdehyde content progressively increased from 0 to 9 h, then dropped to lower than control levels by 24 h. These implied that C. tagal plants could survive salt stress through biochemical modification. Using the Illumina sequencing platform, approximately 27.39 million RNA-seq reads were obtained from three salt-treated and control (untreated) root samples. These reads were assembled into 47,111 transcripts with an average length of 514 bp and an N50 of 632 bp. Approximately 78% of the transcripts were annotated, and a total of 437 genes were putative transcription factors. Digital gene expression analysis was conducted by comparing transcripts from the untreated control to the three salt treated samples, and 7,330 differentially expressed transcripts were identified. Using k-means clustering, these transcripts were divided into six clusters that differed in their expression patterns across four treatment time points. The genes identified as being up-or downregulated are involved in salt stress responses, signal transduction, and DNA repair. Our study shows the main adaptive pathway of C. tagal in saline environments, under short-term and long-term treatments of salt stress. This provides vital clues as to which genes may be candidates for breeding salt-tolerant crops and clarifying molecular mechanisms of salt tolerance in C. tagal. The expression levels of 20 candidate genes measured by RNA-Seq were validated via qRT-PCR. Eighteen genes showed consistent expression patterns in RNA-Seq and qRT-PCR results, suggesting that the RNA-seq dataset was dependable for gene expression pattern analysis.	[Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Xiao, Xiaorong; Hong, Yuhui; Xia, Wei; Feng, Shipeng; Zhou, Xi; Fu, Xiumei; Zang, Jian; Xiao, Yong; Niu, Xiaolei; Li, Chunxia; Chen, Yinhua] Hainan Univ, Coll Agr, Haikou, Peoples R China	Hainan University; Hainan University	Li, CX; Chen, YH (corresponding author), Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China.; Li, CX; Chen, YH (corresponding author), Hainan Univ, Coll Agr, Haikou, Peoples R China.	chun_xia_li@126.com; yhchen@hainu.edu.cn	chen, yh/GRF-5587-2022	Zhou, Xi/0000-0002-6943-5585; Feng, Shipeng/0000-0002-3365-9990	National Natural Science foundation of China [31260345, 31060040]; Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China [201403075]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China	The study was supported by a grant from National Natural Science foundation of China (31260345, 31060040) and the Special Fund for Agro-scientific Research in the Public Interest of the People's Republic of China (Grant No. 201403075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31260345, 31060040). We thank Beidong Liu for manuscript revision and our thanks also go to Beijing Genomics Institute at Shenzhen for technical assistance in data analysis. The authors have no conflicts of interest to declare	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BALL MC, 1984, PLANT PHYSIOL, V74, P1, DOI 10.1104/pp.74.1.1; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; DOWNTON WJS, 1982, AUST J PLANT PHYSIOL, V9, P519, DOI 10.1071/PP9820519; Eckardt Nancy A., 2007, PLANT CELL, V19, P2970; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Huang YL, 2008, GENETICA, V133, P47, DOI 10.1007/s10709-007-9182-1; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jo Y, 2015, GENOM DATA, V6, P271, DOI 10.1016/j.gdata.2015.10.013; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Low R, 1996, PLANT PHYSIOL, V110, P259, DOI 10.1104/pp.110.1.259; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oikawa S, 1996, BIOCHEMISTRY-US, V35, P4584, DOI 10.1021/bi9527000; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parida AK, 2010, TREES-STRUCT FUNCT, V24, P199, DOI 10.1007/s00468-010-0417-x; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; RATAJCZAK R, 1994, PLANT CELL ENVIRON, V17, P1101, DOI 10.1111/j.1365-3040.1994.tb02008.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samanta S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00757; Slack JL, 2001, J MOL DIAGN, V3, P141, DOI 10.1016/S1525-1578(10)60665-4; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang Haibo, 2014, Plant Omics, V7, P178; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zang J, 2013, J TROPICAL BIOL, V4, P160	42	7	7	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167551	10.1371/journal.pone.0167551	http://dx.doi.org/10.1371/journal.pone.0167551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936168	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100122
J	Montassar, F; Darche, M; Blaizot, A; Augustin, S; Conart, JB; Millet, A; Elayeb, M; Sahel, JA; Goazigo, ARL; Sennlaub, F; Marrakchi, N; Messadi, E; Guillonneau, X				Montassar, Fadoua; Darche, Marie; Blaizot, Amandine; Augustin, Sebastien; Conart, Jean-Baptiste; Millet, Aurelie; Elayeb, Mohamed; Sahel, Jose-Alain; Goazigo, Annabelle Reaux-Le; Sennlaub, Florian; Marrakchi, Naziha; Messadi, Erij; Guillonneau, Xavier			Lebecetin, a C-type lectin, inhibits choroidal and retinal neovascularization	FASEB JOURNAL			English	Article						integrins; snake venom; retinopathy; angiogenesis; macular degeneration	OXYGEN-INDUCED RETINOPATHY; INTEGRIN ALPHA-5-BETA-1; MACULAR DEGENERATION; MOUSE MODEL; IN-VITRO; ANGIOGENESIS; ANTAGONIST; ALPHA(V)BETA(3); RANIBIZUMAB; ACTIVATION	Angiogenesis is a cause of visual impairment and blindness in the wet form of age-related macular degeneration and in ischemic retinopathies. Current therapies include use of anti-VEGF agents to reduce choroidal neovascularization (CNV) and edema. These treatments are effective in most cases, but spontaneous or acquired resistance to anti-VEGF and possible adverse effects of long-term VEGF inhibition in the retina and choroid highlight a need for additional alternative therapies. Integrins alpha v beta 3 and alpha v beta 5, which regulate endothelial cell proliferation and stabilization, have been implicated in ocular angiogenesis. Lebecetin (LCT) is a 30-kDa heterodimeric C-type lectin that is isolated from Macrovipera lebetina venom and interacts with alpha 5 beta 1-and alpha v-containing integrins. We previously showed that LCT inhibits human brain microvascular endothelial cell adhesion, migration, proliferation, and tubulogenesis. To evaluate the inhibitory effect of LCT on ocular angiogenesis, we cultured aortic and choroidal explants in the presence of LCT and analyzed the effect of LCT on CNV in the mouse CNV model and on retinal neovascularization in the oxygen-induced retinopathy model. Our data demonstrate that a single injection of LCT efficiently reduced CNV and retinal neovascularization in these models.	[Montassar, Fadoua; Darche, Marie; Blaizot, Amandine; Augustin, Sebastien; Conart, Jean-Baptiste; Sahel, Jose-Alain; Goazigo, Annabelle Reaux-Le; Sennlaub, Florian; Guillonneau, Xavier] Sorbonne Univ, Univ Pierre & Marie Curie, Ctr Natl Rech Sci, INSERM,Inst Vis, Paris, France; [Montassar, Fadoua; Millet, Aurelie; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11IPT08, Tunis, Tunisia; [Montassar, Fadoua] Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage	Guillonneau, X (corresponding author), INSERM, Inst Vis, Unit Mixte Rech S968, 17 Rue Moreau, F-75012 Paris, France.	xavier.guillonneau@inserm.fr	Goazigo, Annabelle Reaux-Le/F-2753-2017; Guillonneau, xavier/E-3995-2017; Sennlaub, Florian/F-2756-2017; guillonneau, xavier/AAF-9495-2021; Sahel, Jose-Alain/F-3172-2017; Conart, Jean-Baptiste/AAD-8547-2019	Goazigo, Annabelle Reaux-Le/0000-0003-3855-9523; Guillonneau, xavier/0000-0001-7379-3935; Sennlaub, Florian/0000-0003-4412-1341; guillonneau, xavier/0000-0001-7379-3935; Sahel, Jose-Alain/0000-0002-4831-1153; Michaelides, Michel/0000-0002-1552-7046	INSERM; Labex Lifesenses; Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France); Institute Pasteur International Network; Carnot	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Labex Lifesenses; Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France); Institute Pasteur International Network; Carnot	This work was supported by grants from INSERM, Labex Lifesenses, Carnot, Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France), and the Institute Pasteur International Network. The authors declare no conflicts of interest.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bishop PN, 2015, EXP EYE RES, V133, P30, DOI 10.1016/j.exer.2014.10.021; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chavakis E, 2002, DIABETOLOGIA, V45, P262, DOI 10.1007/s00125-001-0727-z; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Dominguez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132644; Eghoj MS, 2012, BRIT J OPHTHALMOL, V96, P21, DOI 10.1136/bjo.2011.203893; Forooghian F, 2009, RETINA-J RET VIT DIS, V29, P723, DOI 10.1097/IAE.0b013e3181a2c1c3; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kovach JL, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/786870; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Launay PS, 2016, NEUROBIOL DIS, V88, P16, DOI 10.1016/j.nbd.2015.12.017; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; Martinez-Zapata MJ, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD008721.PUB2; Nakajima T, 2014, MOL VIS, V20, P864; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3475; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Salehi-Had H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018864; Santulli RJ, 2008, J PHARMACOL EXP THER, V324, P894, DOI 10.1124/jpet.107.131656; Sarray S, 2003, BBA-PROTEINS PROTEOM, V1651, P30, DOI 10.1016/S1570-9639(03)00232-2; Sarray S, 2007, MATRIX BIOL, V26, P306, DOI 10.1016/j.matbio.2007.01.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069552; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takagi H, 2002, JPN J OPHTHALMOL, V46, P270, DOI 10.1016/S0021-5155(02)00482-3; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Zahn G, 2009, ARCH OPHTHALMOL-CHIC, V127, P1329, DOI 10.1001/archophthalmol.2009.265	55	13	14	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1107	+		10.1096/fj.201600351R	http://dx.doi.org/10.1096/fj.201600351R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27974593	Green Submitted			2022-12-26	WOS:000395671200024
J	Raja, V; Joshi, AS; Li, GL; Maddipati, KR; Greenberg, ML				Raja, Vaishnavi; Joshi, Amit S.; Li, Guiling; Maddipati, Krishna Rao; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Perturbation of Acetyl-CoA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE BYPASS; SUPPRESSES TEMPERATURE SENSITIVITY; COENZYME-A SYNTHETASE; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; SUPEROXIDE-DISMUTASE; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN; YEAST FRATAXIN; UP-REGULATION	Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, plays an important role in mitochondrial processes and bioenergetics. CL is synthesized de novo and undergoes remodeling in the mitochondrial membranes. Perturbation of CL remodeling leads to the rare X-linked genetic disorder Barth syndrome, which shows disparities in clinical presentation. Touncover biochemical modifiers that exacerbate CL deficiency, we carried out a synthetic genetic array screen to identify synthetic lethal interactions with the yeast CL synthase mutant crd1 Delta. The results indicated that crd1 Delta is synthetically lethal with mutants in pyruvate dehydrogenase (PDH), which catalyzes the conversion of pyruvate to acetyl-CoA. Acetyl-CoA levels were decreased in the mutant. The synthesis of acetylCoA depends primarily on the PDH-catalyzed conversion of pyruvate in the mitochondria and on the PDH bypass in the cytosol, which synthesizes acetyl-CoA from acetate. Consistent with perturbation of the PDH bypass, crd1 Delta cells grown on acetate as the sole carbon source exhibited decreased growth, decreased acetyl-CoA, and increased intracellular acetate levels resulting from decreased acetyl-CoA synthetase activity. PDH mRNA and protein levels were up-regulated in crd1 Delta cells, but PDH enzyme activity was not increased, indicating that PDH up-regulation did not compensate for defects in the PDH bypass. These findings demonstrate for the first time that CL is required for acetyl-CoA synthesis, which is decreased in CL-deficient cells as a result of a defective PDH bypass pathway.	[Raja, Vaishnavi; Joshi, Amit S.; Li, Guiling; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Maddipati, Krishna Rao] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol,Bioact Lipids Res Program, Detroit, MI 48202 USA; [Joshi, Amit S.] NIDDK, NIH, Bethesda, MD 20892 USA; [Li, Guiling] Jimei Univ, Coll Food & Biol Engn, Xiamen 361021, Fujian, Peoples R China	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Jimei University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X	National Institutes of Health [HL117880]; Barth Syndrome Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL117880, the Barth Syndrome Foundation (to M. L. G.), and the Graduate School of Wayne State University (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alrob OA, 2014, BIOCHEM SOC T, V42, P1043, DOI 10.1042/BST20140094; Armando JW, 2012, LETT APPL MICROBIOL, V54, P140, DOI 10.1111/j.1472-765X.2011.03184.x; Avidan O, 2015, J EXP BOT, V66, P7287, DOI 10.1093/jxb/erv424; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; BARTH KH, 1981, PEDIATRICS, V67, P675; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BISACCIA F, 1984, BIOCHIM BIOPHYS ACTA, V766, P386, DOI 10.1016/0005-2728(84)90254-8; Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.3.CO;2-F; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; BRIQUET M, 1977, BIOCHIM BIOPHYS ACTA, V459, P290, DOI 10.1016/0005-2728(77)90029-9; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; DESTEENSMA HY, 1990, EUR J BIOCHEM, V191, P769, DOI 10.1111/j.1432-1033.1990.tb19186.x; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Dickinson FM, 1996, BIOCHEM J, V315, P393, DOI 10.1042/bj3150393; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; GUEST JR, 1989, ANN N Y ACAD SCI, V573, P76; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; Joshi AS, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow019; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kozak BU, 2014, MBIO, V5, DOI 10.1128/mBio.01696-14; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; Meaden PG, 1997, YEAST, V13, P1319, DOI 10.1002/(SICI)1097-0061(199711)13:14<1319::AID-YEA183>3.0.CO;2-T; MIRAN SG, 1993, P NATL ACAD SCI USA, V90, P1252, DOI 10.1073/pnas.90.4.1252; NALECZ MJ, 1991, BIOCHIM BIOPHYS ACTA, V1079, P87, DOI 10.1016/0167-4838(91)90028-X; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; PAQUIN CE, 1986, MOL CELL BIOL, V6, P70, DOI 10.1128/MCB.6.1.70; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Remize F, 2000, APPL ENVIRON MICROB, V66, P3151, DOI 10.1128/AEM.66.8.3151-3159.2000; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Saffi J, 2006, REDOX REP, V11, P179, DOI 10.1179/135100006X116691; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trotter PJ, 2001, ANNU REV NUTR, V21, P97, DOI 10.1146/annurev.nutr.21.1.97; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Vorapreeda T, 2012, MICROBIOL-SGM, V158, P217, DOI 10.1099/mic.0.051946-0; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	80	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1092	1102		10.1074/jbc.M116.753624	http://dx.doi.org/10.1074/jbc.M116.753624			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27941023	Green Published, hybrid			2022-12-26	WOS:000392318700028
J	Calixto, CPG; Simpson, CG; Waugh, R; Brown, JWS				Calixto, Cristiane P. G.; Simpson, Craig G.; Waugh, Robbie; Brown, John W. S.			Alternative Splicing of Barley Clock Genes in Response to Low Temperature	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ARABIDOPSIS CIRCADIAN CLOCK; NONSENSE-MEDIATED DECAY; MESSENGER-RNAS; GROWTH-STAGES; DECIMAL CODE; PLANT-GROWTH; SR PROTEINS; TRANSCRIPTOME; LANDSCAPE	Alternative splicing (AS) is a regulated mechanism that generates multiple transcripts from individual genes. It is widespread in eukaryotic genomes and provides an effective way to control gene expression. At low temperatures, AS regulates Arabidopsis clock genes through dynamic changes in the levels of productive mRNAs. We examined AS in barley clock genes to assess whether temperature-dependent AS responses also occur in a monocotyledonous crop species. We identify changes in AS of various barley core clock genes including the barley orthologues of Arabidopsis AtLHY and AtPRR7 which showed the most pronounced AS changes in response to low temperature. The AS events modulate the levels of functional and translatable mRNAs, and potentially protein levels, upon transition to cold. There is some conservation of AS events and/or splicing behaviour of clock genes between Arabidopsis and barley. In addition, novel temperature-dependent AS of the core clock gene HvPPD-H1 (a major determinant of photoperiod response and AtPRR7 orthologue) is conserved in monocots. HvPPD-H1 showed a rapid, temperature-sensitive isoform switch which resulted in changes in abundance of AS variants encoding different protein isoforms. This novel layer of low temperature control of clock gene expression, observed in two very different species, will help our understanding of plant adaptation to different environments and ultimately offer a new range of targets for plant improvement.	[Calixto, Cristiane P. G.; Waugh, Robbie; Brown, John W. S.] Univ Dundee, James Hutton Inst, Div Plant Sci, Sch Life Sci, Dundee, Scotland; [Simpson, Craig G.; Waugh, Robbie; Brown, John W. S.] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	James Hutton Institute; University of Dundee; James Hutton Institute	Brown, JWS (corresponding author), Univ Dundee, James Hutton Inst, Div Plant Sci, Sch Life Sci, Dundee, Scotland.; Brown, JWS (corresponding author), James Hutton Inst, Cell & Mol Sci, Dundee, Scotland.	j.w.s.brown@dundee.ac.uk	Calixto, Cristiane P./L-7471-2017	Calixto, Cristiane P./0000-0002-9935-9325; Simpson, Craig/0000-0002-1723-1492	Biotechnology and Biological Sciences Research Council [BB/G024979/1]; Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); BBSRC [BB/G024979/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council [BB/G024979/1 - European Research Area network (ERA-NET) Plant Genomics (Plant Alternative Splicing and Abiotic Stress)] Dr. John W. S. Brown; Scottish Government Rural and Environment Science and Analytical Services division (RESAS) Dr. John W. S. Brown; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Dr Cristiane P. G. Calixto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boothby TC, 2013, DEV CELL, V24, P517, DOI 10.1016/j.devcel.2013.01.015; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Bushnell WR, 2010, PHYTOPATHOLOGY, V100, P33, DOI 10.1094/PHYTO-100-1-0033; Calixto CPG, 2015, J MOL EVOL, V80, P108, DOI 10.1007/s00239-015-9665-0; Carvalho RF, 2016, PLANT CELL, V28, P1910, DOI 10.1105/tpc.16.00301; Carvalho RF, 2013, PROTOPLASMA, V250, P639, DOI 10.1007/s00709-012-0448-9; Chamala S, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00033; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Darracq A, 2013, NEW PHYTOL, V199, P252, DOI 10.1111/nph.12238; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Duque P, 2011, PLANT SIGNAL BEHAV, V6, P49, DOI 10.4161/psb.6.1.14063; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Filichkin SA, 2015, MOL PLANT, V8, P207, DOI 10.1016/j.molp.2014.10.011; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; FRANCKOWIAK JD, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050037x; Franckowiak JD, 2007, BARLEY GENETICS NEWS, P247; Gohring J, 2014, PLANT CELL, V26, P754, DOI 10.1105/tpc.113.118075; Haydon MJ, 2013, SEMIN CELL DEV BIOL, V24, P414, DOI 10.1016/j.semcdb.2013.03.007; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Ito S, 2003, PLANT CELL PHYSIOL, V44, P1237, DOI 10.1093/pcp/pcg136; James AB, 2012, PLANT SIGNAL BEHAV, V7, P1219, DOI 10.4161/psb.21491; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kaur P, 2008, FUNCT INTEGR GENOMIC, V8, P375, DOI 10.1007/s10142-008-0085-8; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Mandadi KK, 2015, PLANT CELL, V27, P71, DOI 10.1105/tpc.114.133991; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McClung C Robertson, 2014, F1000Prime Rep, V6, P2, DOI 10.12703/P6-2; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Nicolas M, 2015, CURR BIOL, V25, P1799, DOI 10.1016/j.cub.2015.05.053; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Petrillo E, 2014, SCIENCE, V344, P427, DOI 10.1126/science.1250322; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Romanowski A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00437; Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schlaen RG, 2015, P NATL ACAD SCI US; Seo PJ, 2014, PLANT CELL, V26, P79, DOI 10.1105/tpc.113.119842; Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044; Shikata H, 2014, P NATL ACAD SCI USA, V111, P18781, DOI 10.1073/pnas.1407147112; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhang R, 2016, BIORXIV; Zhang RX, 2015, NEW PHYTOL, V208, P96, DOI 10.1111/nph.13545	79	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168028	10.1371/journal.pone.0168028	http://dx.doi.org/10.1371/journal.pone.0168028			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959947	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900033
J	Honda, T; Baba, T; Fujimoto, K; Goto, T; Nagao, K; Harada, M; Honda, E; Ichikawa, T				Honda, Tsuyoshi; Baba, Takuro; Fujimoto, Keiko; Goto, Takaharu; Nagao, Kan; Harada, Masafumi; Honda, Eiichi; Ichikawa, Tetsuo			Characterization of Swallowing Sound: Preliminary Investigation of Normal Subjects	PLOS ONE			English	Article							CERVICAL AUSCULTATION; BOLUS VOLUME; DYSPHAGIA; GENDER; VIDEOFLUOROSCOPY; RELIABILITY; VALIDITY; AGE	Objective The purpose of this study was to characterize the swallowing sound and identify the process of sound generation during swallowing in young healthy adults. Methods Thirty-three healthy volunteers were enrolled and allocated into three experimental groups. In experiment 1, a microphone was attached to one of eight cervical sites in 20 subjects, participants swallowed 5 ml water, and the sound waveform was recorded. In experiment 2, 10 subjects swallowed either 0, 5, 10, or 15 ml water during audio recording. In addition, participants consumed the 5 ml bolus in two different cervical postures. In experiment 3, the sound waveform and videofluoroscopy were simultaneously recorded while the three participants consumed 5 ml iopamidol solution. The duration and peak intensity ratio of the waveform were analyzed in all experimental groups. Results The acoustic analysis of the waveforms and videofluoroscopy suggested that the swallowing sound could be divided into three periods, each associated with a stage of the swallowing movement: the oral phase comprising posterior tongue and hyoid bone movement; the pharyngeal phase comprising larynx movement, hyoid bone elevation, epiglottis closure, and passage of the bolus through the esophagus orifice; and the repositioning phase comprising the return of the hyoid bone and larynx to their resting positions, and reopening of the epiglottis. Conclusion Acoustic analysis of swallowing sounds and videofluoroscopy suggests that the swallowing sound could be divided into three periods associated with each process of the swallowing movement: the oral phase comprising the posterior movement of the tongue and hyoid bone; the pharyngeal phase comprising the laryngeal movement, hyoid bone elevation, epiglottis closure, and the bolus passage to the esophagus orifice; and the repositioning phase comprising the repositioning of the hyoid bone and larynx, and reopening of the epiglottis.	[Honda, Tsuyoshi; Baba, Takuro; Fujimoto, Keiko; Goto, Takaharu; Nagao, Kan; Ichikawa, Tetsuo] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Prosthodont, Tokushima, Japan; [Harada, Masafumi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Radiol, Tokushima, Japan; [Honda, Eiichi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Radiol, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Ichikawa, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Prosthodont, Tokushima, Japan.	ichi@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304				Antunes EB, 2012, GERODONTOLOGY, V29, P247, DOI 10.1111/j.1741-2358.2012.00638.x; Boiron M, 1997, DYSPHAGIA, V12, P86, DOI 10.1007/PL00009524; Borr C, 2007, DYSPHAGIA, V22, P225, DOI 10.1007/s00455-007-9078-3; Bosma J F, 1976, Front Oral Physiol, V2, P78; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Cichero JAY, 2002, ANN OTO RHINOL LARYN, V111, P623, DOI 10.1177/000348940211100710; Dantas RO, 2009, DYSPHAGIA, V24, P280, DOI 10.1007/s00455-008-9202-z; HAMLET S L, 1992, Dysphagia, V7, P160, DOI 10.1007/BF02493450; Hammoudi K, 2014, DYSPHAGIA, V29, P468, DOI 10.1007/s00455-014-9529-6; Hirano K, 2001, J JPN STOMATOL SOC, V47, P93; Honda T, 2015, J ORAL HLTH BIOSCI, V28, P21; Horiguchi S., 2011, JMAJ - Japan Medical Association Journal, V54, P31; Karaho T., 1999, J JPN BRONCHOESOPHAG, V50, P396; Leslie P, 2004, DYSPHAGIA, V19, P231, DOI 10.1007/s00455-004-0007-4; LOGEMANN J, 1983, EVALUATION TREATMENT, P113; MACKOWIAK RC, 1967, P SOC EXP BIOL MED, V125, P1149; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Ohyado S, 2013, JPN J GERODONTOLOGY, V28, P331; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823, DOI 10.1016/0016-5085(92)90013-O; SELLEY W G, 1990, Dysphagia, V4, P227, DOI 10.1007/BF02407270; Smith HA, 1998, AGE AGEING, V29, P99; Takahashi K, 2001, JPN J HEAD NECK CANC, V27, P198; Takahashi Koji, 1994, Dysphagia, V9, P54; Teismann IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019987; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Youmans SR, 2011, DYSPHAGIA, V26, P374, DOI 10.1007/s00455-010-9323-z; ZENNER PM, 1995, DYSPHAGIA, V10, P27, DOI 10.1007/BF00261276	28	5	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168187	10.1371/journal.pone.0168187	http://dx.doi.org/10.1371/journal.pone.0168187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959902	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900047
J	Holdsworth, WL; LaPlant, KE; Bell, DC; Jahn, MM; Mazourek, M				Holdsworth, William L.; LaPlant, Kyle E.; Bell, Duane C.; Jahn, Molly M.; Mazourek, Michael			Cultivar-Based Introgression Mapping Reveals Wild Species-Derived Pm-0, the Major Powdery Mildew Resistance Locus in Squash	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; CUCURBITA-PEPO; SPHAEROTHECA-FULIGINEA; PODOSPHAERA-XANTHII; DISEASE RESISTANCE; GENOME ASSOCIATION; SUMMER SQUASH; PUMPKIN; POLYMORPHISMS; EVOLUTION	Powdery mildew is a major fungal disease on squash and pumpkin (Cucurbita spp.) in the US and throughout the world. Genetic resistance to the disease is not known to occur naturally within Cucurbita pepo and only infrequently in Cucurbita moschata, but has been achieved in both species through the introgression of a major resistance gene from the wild species Cucurbita okeechobeensis subsp. martinezii. At present, this gene, Pm-0, is used extensively in breeding, and is found in nearly all powdery mildew-resistant C. pepo and C. moschata commercial cultivars. In this study, we mapped C. okeechobeensis subsp. martinezii-derived single nucleotide polymorphism (SNP) alleles in a set of taxonomically and morphologically diverse and resistant C. pepo and C. moschata cultivars bred at Cornell University that, by common possession of Pm-0, form a shared-trait introgression panel. High marker density was achieved using genotyping-by-sequencing, which yielded over 50,000 de novo SNP markers in each of the three Cucurbita species genotyped. A single 516.4 kb wild-derived introgression was present in all of the resistant cultivars and absent in a diverse set of heirlooms that predated the Pm-0 introgression. The contribution of this interval to powdery mildew resistance was confirmed by association mapping in a C. pepo cultivar panel that included the Cornell lines, heirlooms, and 68 additional C. pepo cultivars and with an independent F-2 population derived from C. okeechobeensis subsp. martinezii x C. moschata. The interval was refined to a final candidate interval of 76.4 kb and CAPS markers were developed inside this interval to facilitate marker-assisted selection.	[Holdsworth, William L.; LaPlant, Kyle E.; Mazourek, Michael] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14853 USA; [Holdsworth, William L.; Bell, Duane C.] Rupp Seeds Inc, Wauseon, OH USA; [Jahn, Molly M.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Mazourek, M (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14853 USA.	mm284@cornell.edu		Jahn, Molly/0000-0003-0181-0374	USDA National Institute of Food and Agriculture, Plant Breeding and Education [2010-85117-20551]; USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative [2013-67013-21232]; Rupp Seeds Inc; Rupp Seeds Inc.; Calvin Noyes Keeney Endowment for Plant Breeding; Cornell University; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative [2015-51181-24285]	USDA National Institute of Food and Agriculture, Plant Breeding and Education; USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative; Rupp Seeds Inc; Rupp Seeds Inc.; Calvin Noyes Keeney Endowment for Plant Breeding; Cornell University; USDA National Institute of Food and Agriculture Specialty Crop Research Initiative	Support for William Holdsworth was provided by USDA National Institute of Food and Agriculture, Plant Breeding and Education Grant No. 2010-85117-20551 and the USDA National Institute of Food and Agriculture, Agriculture and Food Research Initiative Competitive Grant No. 2013-67013-21232 and was later employed by Rupp Seeds Inc. (a company that develops and distributes powdery mildew-resistant squash and pumpkin cultivars) during the time in which the manuscript was edited and in review. Duane Bell was employed by Rupp Seeds Inc and received salary support during which time he generated and phenotyped the C. okeechobeensis subsp. martinezii PI 532363 x C. moschata 'Burpee's Butterbush' F2 population. Rupp Seeds Inc. contributed resources for the analysis of the F2 population and support in the form of salaries for authors WLH and DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Support for Kyle LaPlant was provided by the Calvin Noyes Keeney Endowment for Plant Breeding. Funding for the association analysis was provided via new faculty startup funds from Cornell University. Funding for marker development was provided by USDA National Institute of Food and Agriculture Specialty Crop Research Initiative Grant No. 2015-51181-24285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIJI AA, 1983, J AM SOC HORTIC SCI, V108, P360; [Anonymous], SEQ VERS 4 9 SEQ AN; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Coffey MD, 2006, PHYTOPATHOLOGY, V96, pS25; Cohen R, 2003, EUPHYTICA, V130, P433, DOI 10.1023/A:1023082612420; COHEN R, 1993, PLANT PATHOL, V42, P510, DOI 10.1111/j.1365-3059.1993.tb01530.x; COHEN R, 2002, CUCURBITACEAE 2002, P181; Coleman C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-89; Contin M., 1978, THESIS CORNELL U ITH; Coolong T, 2011, HORTTECHNOLOGY, V21, P533, DOI 10.21273/HORTTECH.21.5.533; Cornell University Experiment Station, 1999, PLANT VAR PROT BUGL; De Mendiburu F, 2009, HERRAMIENTA ANALISIS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fernandez-Pozo N, 2014, NUCL ACIDS RES; Ferriol Maria, 2008, V1, P317; Formisano G, 2010, PLANT GENET RESOUR-C, V8, P198, DOI 10.1017/S1479262110000183; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gong L, 2008, GENOME, V51, P878, DOI 10.1139/G08-072; Gong L, 2008, THEOR APPL GENET, V117, P37, DOI 10.1007/s00122-008-0750-2; Gong L, 2013, GENET RESOUR CROP EV, V60, P1531, DOI 10.1007/s10722-012-9940-5; Gong L, 2012, THEOR APPL GENET, V124, P875, DOI 10.1007/s00122-011-1752-z; Gonzalez AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010495; Hoberman R, 2009, GENOME RES, V19, P1542, DOI 10.1101/gr.092072.109; Hultengren R., 2016, BREEDING RES ED NEED; Jahn M, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P239; Kim KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145665; Knstkova E, 2005, ACTA HORTIC, P510; Kyle M, 1995, INT S CUC 94 EV ENH; Lawson V, 2005, EVALUATION OF WINTER; Lebeda A, 1996, GENET RESOUR CROP EV, V43, P79, DOI 10.1007/BF00126944; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; McCreight J. D., 2004, Cucurbit Genetics Cooperative, P8; Mcgrath MT, 2007, PHYTOPATHOLOGY, V97, pS73; Mcgrath MT, 2009, PHYTOPATHOLOGY, V99, pS194; MCGRATH MT, 1994, MYCOLOGIA, V86, P517, DOI 10.2307/3760745; McGrath MT, 1996, PLANT DIS, V80, P1044, DOI 10.1094/PD-80-1044; McGrath MT, 2008, POWDERY MILDEW RESIS; McGrath MT, 2010, POWDERY MILDEW RESIS; McGrath MT, 2005, GUIDELINES MANAGING; Menda N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0287-2; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Navazio J., 2012, CUCURBITACEAE ORGANI, P207; NEE M, 1990, ECON BOT, V44, P56, DOI 10.1007/BF02860475; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; OBRIEN RG, 1988, AUST J EXP AGR, V28, P417, DOI 10.1071/EA9880417; PARIS H. S., 2005, HORTSCIENCE ALEXANDR, V40, P1630; Paris Harry S., 2008, V1, P351; Paris HS, 2003, THEOR APPL GENET, V106, P971, DOI 10.1007/S00122-002-1157-0; Paris HS, 2002, EUPHYTICA, V124, P121, DOI 10.1023/A:1015623013740; Perez-Garcia A, 2009, MOL PLANT PATHOL, V10, P153, DOI 10.1111/j.1364-3703.2008.00527.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Core Team, 2013, R LANG ENV STAT COMP; Reuscher S, 2015, 1 ANN TASSEL HACKATH; RHODES A. M., 1964, PLANT DIS REPTR, V48, P54; RHODES A. M., 1959, PROC AMER SOC HORT SCI, V74, P546; Robinson RW., 1997, CUCURBITS; SITTERLY WR, 1972, ANNU REV PHYTOPATHOL, V10, P471, DOI 10.1146/annurev.py.10.090172.002351; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; SOWELL G JR, 1973, Hortscience, V8, P492; Srichumpa P, 2005, PLANT PHYSIOL, V139, P885, DOI 10.1104/pp.105.062406; Staub JE., 1996, COMPENDIUM CUCURBIT, P66; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANDERBEEK JG, 1992, THEOR APPL GENET, V84, P106, DOI 10.1007/BF00223988; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wang QM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100949, 10.1371/journal.pone.0110209]; WHITAKER TW, 1956, AM NAT, V90, P171, DOI 10.1086/281923; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110; Zhang B, 1995, PLANT CELL, V7, P2241, DOI 10.1105/tpc.7.12.2241; Zhang Q, 2013, patent, Patent No. [US 20130283463 A1, 20130283463]; Zhou J, 2010, ACTA HORTIC	79	22	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167715	10.1371/journal.pone.0167715	http://dx.doi.org/10.1371/journal.pone.0167715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936008	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100161
J	Jalan-Sakrikar, N; De Assuncao, TM; Lu, J; Almada, LL; Lomberk, G; Fernandez-Zapico, ME; Urrutia, R; Huebert, RC				Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Almada, Luciana L.; Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul; Huebert, Robert C.			Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SONIC HEDGEHOG; LIVER; DIFFERENTIATION; EZH2; PROLIFERATION; HEPATOCYTES; ACTIVATION; EXPRESSION; BIOLOGY	Background & Aims Developmental morphogens play an important role in coordinating the ductular reaction and portal fibrosis occurring in the setting of cholangiopathies. However, little is known about how membrane signaling events in ductular reactive cells (DRCs) are transduced into nuclear transcriptional changes to drive cholangiocyte maturation and matrix deposition. Therefore, the aim of this study was to investigate potential mechanistic links between cell signaling events and epigenetic regulators in DRCs. Methods Using directed differentiation of induced pluripotent stem cells (iPSC), isolated DRCs, and in vivo models, we examine the mechanisms whereby sonic hedgehog (Shh) overcomes an epigenetic barrier in biliary precursors and promotes both cholangiocyte maturation and deposition of fibronectin (FN). Results We demonstrate, for the first time, that Gli1 influences the differentiation state and fibrogenic capacity of iPSC-derived hepatic progenitors and isolated DRCs. We outline a novel pathway wherein Shh-mediated Gli1 binding in key cholangiocyte gene promoters overcomes an epigenetic barrier conferred by the polycomb protein, enhancer of zeste homolog 2 (EZH2) and initiates the transcriptional program of cholangiocyte maturation. We also define previously unknown functional Gli1 binding sites in the promoters of cytokeratin (CK)7, CK19, and FN. Our in vivo results show that EZH2 KO mice fed the choline-deficient, ethanolamine supplemented (CDE) diet have an exaggerated cholangiocyte expansion associated with more robust ductular reaction and increased peri-portal fibrosis. Conclusion We conclude that Shh/Gli1 signaling plays an integral role in cholangiocyte maturation in vitro by overcoming an EZH2-dependent epigenetic barrier and this mechanism also promotes biliary expansion in vivo.	[Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Lomberk, Gwen; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Jalan-Sakrikar, Nidhi; De Assuncao, Thiago M.; Lu, Jie; Lomberk, Gwen; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin & Mayo Fdn, Schultze Ctr Novel Therapeut, Rochester, MN USA; [Lomberk, Gwen; Fernandez-Zapico, Martin E.; Urrutia, Raul; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.; Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN 55905 USA.; Huebert, RC (corresponding author), Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA.	huebert.robert@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Jalan-Sakrikar, Nidhi/S-8653-2019	Lomberk, Gwen/0000-0001-5463-789X; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121	Loan Repayment Program from the National Institutes of Health; Regenerative Medicine Minnesota; Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; Gilead Sciences; Mayo Clinic Center for Regenerative Medicine;  [DK100575];  [DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, K08DK100575, P30DK084567] Funding Source: NIH RePORTER	Loan Repayment Program from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Medicine Minnesota; Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; Gilead Sciences(Gilead Sciences); Mayo Clinic Center for Regenerative Medicine; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK100575, DK084567, and the Loan Repayment Program from the National Institutes of Health; by Regenerative Medicine Minnesota; by the Department of Gastroenterology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China; by Gilead Sciences; and by the Mayo Clinic Center for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Alvaro D, 2008, MOL ASPECTS MED, V29, P50, DOI 10.1016/j.mam.2007.09.007; Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237; De Assuncao TM, 2015, LAB INVEST, V95, P684, DOI 10.1038/labinvest.2015.51; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Ding XL, 2014, STEM CELLS DEV, V23, P931, DOI 10.1089/scd.2013.0267; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Fausther Michel, 2013, Curr Pathobiol Rep, V1, P225; Greenbaum LE, 2008, J CLIN INVEST, V118, P3263, DOI 10.1172/JCI37189; Greenbaum LE, 2011, INT J BIOCHEM CELL B, V43, P222, DOI 10.1016/j.biocel.2009.11.006; Grzenda A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-3; Halilbasic E, 2015, DIGEST DIS, V33, P149, DOI 10.1159/000440827; Hanaoka J, 2013, SURG TODAY, V43, P300, DOI 10.1007/s00595-012-0248-z; Hirose Y, 2009, EXP CELL RES, V315, P2648, DOI 10.1016/j.yexcr.2009.06.018; Kang NL, 2015, MOL CANCER RES, V13, P604, DOI 10.1158/1541-7786.MCR-14-0542; Karantanos T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00172; Koike H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104776; Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131; McCabe MT, 2014, EPIGENOMICS-UK, V6, P341, DOI [10.2217/EPI.14.23, 10.2217/epi.14.23]; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Nakamura N, 2012, CELL REPROGRAM, V14, P171, DOI 10.1089/cell.2011.0064; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Omenetti A, 2008, GUT, V57, P1275, DOI 10.1136/gut.2008.148619; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Omenetti A, 2009, HEPATOLOGY, V50, P518, DOI 10.1002/hep.23019; Razumilava N, 2014, J HEPATOL, V60, P599, DOI 10.1016/j.jhep.2013.11.005; Sahin MB, 2008, LIVER TRANSPLANT, V14, P333, DOI 10.1002/lt.21380; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Sasaki M, 2015, HISTOL HISTOPATHOL, V30, P267, DOI 10.14670/HH-30.267; Shin DH, 2013, COMPR PHYSIOL, V3, P799, DOI 10.1002/cphy.c120022; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka M, 2012, METHODS MOL BIOL, V826, P25, DOI 10.1007/978-1-61779-468-1_3; Tanimizu N, 2014, DEVELOPMENT, V141, P4448, DOI 10.1242/dev.113654; Tanimizu N, 2014, ORGANOGENESIS, V10, P208, DOI 10.4161/org.27591; Tian AG, 2015, J CELL BIOL, V208, P807, DOI 10.1083/jcb.201409025; Wong TY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2809192; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yin J, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/272313; Yovchev Mladen I, 2013, Methods Mol Biol, V976, P37, DOI 10.1007/978-1-62703-317-6_4; Yu Y, 2012, LIVER TRANSPLANT, V18, P9, DOI 10.1002/lt.22467; Zeybel M, 2013, J HEPATOL, V59, P1349, DOI 10.1016/j.jhep.2013.05.039	47	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168266	10.1371/journal.pone.0168266	http://dx.doi.org/10.1371/journal.pone.0168266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936185	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100286
J	Muller, A; Berkmann, JC; Scheerer, P; Biebermann, H; Kleinau, G				Mueller, Anne; Berkmann, Julia Catherine; Scheerer, Patrick; Biebermann, Heike; Kleinau, Gunnar			Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED RECEPTOR; HUMAN THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; NEUROTENSIN RECEPTOR; ACTIVATION; DOMAIN; GPR83; GPCR; IDENTIFICATION	The murine G-protein coupled receptor 83 (mGPR83) is expressed in the hypothalamus and was previously suggested to be involved in the regulation of metabolism. The neuropeptide PEN has been recently identified as a potent GPR83 ligand. Moreover, GPR83 constitutes functionally relevant hetero-oligomers with other G-protein coupled receptors (GPCR) such as the ghrelin receptor (GHSR) or GPR171. Previous deletion studies also revealed that the long N-terminal extracellular receptor domain (eNDo) of mGPR83 may act as an intra-molecular ligand, which participates in the regulation of basal signaling activity, which is a key feature of GPCR function. Here, we investigated particular amino acids at the eNDo of human GPR83 (hGPR83) by side-directed mutagenesis to identify determinants of the internal ligand. These studies were accompanied by structure homology modeling to combine functional insights with structural information. The capacity for hetero-oligomer formation of hGPR83 with diverse family A GPCRs such as the melanocortin-4 receptor (MC4R) was also investigated, with a specific emphasis on the impact of the eNDo on oligomerization and basal signaling properties. Finally, we demonstrate that hGPR83 exhibits an unusual basal signaling for different effectors, which also supports signaling promiscuity. hGPR83 interacts with a variety of hypothalamic GPCRs such as the MC4R or GHSR. These interactions are not dependent on the ectodomain and most likely occur at interfaces constituted in the transmembrane regions. Moreover, several amino acids at the transition between the eNDo and transmembrane helix 1 were identified, where mutations lead also to biased basal signaling modulation.	[Mueller, Anne; Berkmann, Julia Catherine; Biebermann, Heike; Kleinau, Gunnar] Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Scheerer, Patrick] Charite Univ Med Berlin, Grp Prot Xray Crystallog & Signal Transduct, Inst Med Phys & Biophys, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kleinau, G (corresponding author), Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany.	gunnar.kleinau@charite.de	Kleinau, Gunnar/GPX-6330-2022	Muller, Anne/0000-0002-6256-8860; Berkmann, Julia Catherine/0000-0002-5869-504X; Biebermann, Heike/0000-0002-2024-7778; Scheerer, Patrick/0000-0001-5028-2075	Else Kroner-Fresenius-Stiftung (EKFS) [2014_A114]; Deutsche Forschungsgemeinschaft DFG [BI 893/2-2, SFB740-B6, SFB1078-B6, D3/E3-1]; Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED) [WP19]	Else Kroner-Fresenius-Stiftung (EKFS); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED)	This work is supported by the Else Kroner-Fresenius-Stiftung (EKFS) project 2014_A114 to GK and HB, by the Deutsche Forschungsgemeinschaft DFG (BI 893/2-2 to HB; SFB740-B6 and SFB1078-B6 to PS; DFG - Cluster of Excellence UniCat 'Unifying Concepts in Catalysis' Research Field D3/E3-1 to PS) and by the Helmholtz Alliance, "Imaging and Curing Environmental Metabolic Diseases" (ICEMED), WP19 to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgeier A, 1997, MOL CELL ENDOCRINOL, V127, P81, DOI 10.1016/S0303-7207(96)03996-2; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bakker RA, 2004, J PHARMACOL EXP THER, V311, P131, DOI 10.1124/jpet.104.067041; Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Biebermann Heike, 2012, Handb Exp Pharmacol, P47, DOI 10.1007/978-3-642-24716-3_3; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brezillon S, 2001, BRAIN RES, V921, P21, DOI 10.1016/S0006-8993(01)03068-2; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; De Moerlooze L, 2000, CYTOGENET CELL GENET, V90, P146, DOI 10.1159/000015650; DeVree BT, 2016, NATURE, V535, P182, DOI 10.1038/nature18324; Dubins JS, 2012, METABOLISM, V61, P1486, DOI 10.1016/j.metabol.2012.03.015; Elsner A, 2006, PEPTIDES, V27, P372, DOI 10.1016/j.peptides.2005.02.027; Garland SL, 2013, J BIOMOL SCREEN; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gomes I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0694; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Huang J., 2013, ADV MECH ENG, V2013, P1, DOI DOI 10.1038/NSMB; Kenakin T, 2005, TRENDS PHARMACOL SCI, V26, P603, DOI 10.1016/j.tips.2005.10.007; Kleinau G, 2016, J MOL ENDOCRINOL; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Krumm BE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8895; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Laugwitz KL, 1996, P NATL ACAD SCI USA, V93, P116, DOI 10.1073/pnas.93.1.116; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Martin AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138463; Muller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053347; Muller TD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2968; Muller Anne, 2014, BMC Res Notes, V7, P913, DOI 10.1186/1756-0500-7-913; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piechowski CL, 2013, J MOL ENDOCRINOL, V51, P109, DOI 10.1530/JME-13-0061; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Sah R, 2007, PEPTIDES, V28, P302, DOI 10.1016/j.peptides.2006.11.013; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schoneberg T, 2016, PHARMACOL RES, V108, P9, DOI 10.1016/j.phrs.2016.03.027; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tao YX, 2014, PROG MOL BIOL TRANSL, V121, P1, DOI 10.1016/B978-0-12-800101-1.00001-6; Tao YX, 2014, PREFACE ADV PHARM, V70, pix, DOI [DOI 10.1016/B978-0-12-417197-8.10000-8, 10.1016/B978-0-12-417197-8.10000-8]; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Van Sande J, 2006, J CLIN ENDOCR METAB, V91, P1099, DOI 10.1210/jc.2005-1324; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yanagawa M, 2011, J BIOL CHEM, V286, P22971, DOI 10.1074/jbc.M110.206870; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhou XE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.21	64	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168260	10.1371/journal.pone.0168260	http://dx.doi.org/10.1371/journal.pone.0168260			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936173	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100285
J	Ota, S; Nishimura, M; Murakami, Y; Birukawa, NK; Yoneda, A; Nishita, H; Fujita, R; Sato, Y; Minomi, K; Kajiwara, K; Miyazaki, M; Uchiumi, M; Mikuni, S; Tamura, Y; Mizuguchi, T; Imamura, M; Meguro, M; Kimura, Y; Hirata, K; Niitsu, Y				Ota, Shigenori; Nishimura, Miyuki; Murakami, Yuya; Birukawa, Naoko Kubo; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Sato, Yasushi; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono; Uchiumi, Maki; Mikuni, Shintaro; Tamura, Yasuaki; Mizuguchi, Toru; Imamura, Masafumi; Meguro, Makoto; Kimura, Yasutoshi; Hirata, Koichi; Niitsu, Yoshiro			Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy	PLOS ONE			English	Article							COLLAGEN-SPECIFIC CHAPERONE; A-COUPLED LIPOSOMES; BETA-CELLS; ADULT-MOUSE; ACINAR-CELL; ENDOCRINE; EXOCRINE; RATS; PROGENITORS; FIBROSIS	Background and objectives Mechanism of regeneration of remnant pancreas after partial pancreatectomy (PX) is still unknown. In this study, effect of siRNA against the collagen specific chaperone, HSP47, which inhibits collagen secretion from activated pancreas stellate cells (aPSCs), and induces their apoptosis, on regeneration of remnant pancreas was determined. Methods Pancreatectomy was performed according to established methods. Proliferation of cells was assessed by BrdU incorporation. Immunostaining of HSP47 was employed to identify PSCs. Progenitor cells were identified by SOX9 staining. Acinar cells were immunostained for amylase. Co-culture of acinar cells with aPSCs were carried out in a double chamber with a cell culture insert. siRNA HSP47 encapsulated in vitamin A-coupled liposome (VA-lip siRNA HSP47) was delivered to aPSCs by iv injection. Results In remnant pancreas of 90% PX rat, new areas of foci were located separately from duodenal areas with normal pancreatic features. After PX, BrdU uptake of acinar cells and islet cells significantly increased, but was suppressed by treatment with VA-lip siRNA HSP47. BrdU uptake by acinar cells was augmented by co-culturing with aPSCs and the augmentation was nullified by siRNA HSP47. BrdU uptake by progenitor cells in foci area was slightly enhanced by the same treatment. New area which exhibited intermediate features between those of duodenal and area of foci, emerged after the treatment. Conclusion aPSCs play a crucial role in regeneration of remnant pancreas, proliferation of acinar and islet cells after PX through the activity of secreted collagen. Characterization of new area emerged by siRNA HSP47 treatment as to its origin is a future task.	[Ota, Shigenori; Nishimura, Miyuki; Murakami, Yuya; Birukawa, Naoko Kubo; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono; Niitsu, Yoshiro] Sapporo Med Univ, Dept Mol Target Explorat, Sapporo, Hokkaido, Japan; [Ota, Shigenori; Mizuguchi, Toru; Imamura, Masafumi; Meguro, Makoto; Kimura, Yasutoshi; Hirata, Koichi] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Yoneda, Akihiro; Uchiumi, Maki; Mikuni, Shintaro; Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Dept Mol Therapeut, Sapporo, Hokkaido 060, Japan; [Nishita, Hiroki; Minomi, Kenjiro; Kajiwara, Keiko; Miyazaki, Miyono] Hokkaido Univ, Nitto Denko Corp, Corp Business Dev Div, Hokkaido Lab Mol Therapeut, Sapporo, Hokkaido 060, Japan; [Sato, Yasushi] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Hokkaido University; Nitto Denko Corporation; Sapporo Medical University	Niitsu, Y (corresponding author), Sapporo Med Univ, Dept Mol Target Explorat, Sapporo, Hokkaido, Japan.	niitsu@sapmed.ac.jp	今村, 将史/AAC-7369-2022	Sato, Yasushi/0000-0002-6776-4609	KAKENHI-PROJECT [25861207]	KAKENHI-PROJECT	The author received support from KAKENHI-PROJECT; Project Number was 25861207, https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25861207/. Research Category was Grant-in-Aid for Encouragement of Young Scientists (B). The author was principal Investigator. Investigator ID was 90457705. Project Fiscal Year was 2013-04-01 - 2015-03-31 (Estimated).	Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Birukawa NK, 2014, J BIOL CHEM, V289, P20209, DOI 10.1074/jbc.M113.544494; Bonner-Weir S, 1993, DIABETES; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; Ko SBH, 2010, GASTROENTEROLOGY, V138, P1988, DOI 10.1053/j.gastro.2010.01.001; LEHV M, 1968, AM J PATHOL, V53, P513; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Migliorini A, 2014, MOL METAB, V3, P268, DOI 10.1016/j.molmet.2014.01.010; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; PEARSON KW, 1977, GASTROENTEROLOGY, V72, P469; Sato N, 1998, DIGEST DIS SCI, V43, P2616, DOI 10.1023/A:1026686824173; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoneda S, 2013, J CLIN ENDOCR METAB, V98, P2053, DOI 10.1210/jc.2012-3832; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Ziv O, 2013, DEV CELL, V26, P3, DOI 10.1016/j.devcel.2013.06.013	28	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165747	10.1371/journal.pone.0165747	http://dx.doi.org/10.1371/journal.pone.0165747			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935983	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100015
J	Volpin, F; Casaos, J; Sesen, J; Mangraviti, A; Choi, J; Gorelick, N; Frikeche, J; Lott, T; Felder, R; Scotland, SJ; Eisinger-Mathason, TSK; Brem, H; Tyler, B; Skuli, N				Volpin, F.; Casaos, J.; Sesen, J.; Mangraviti, A.; Choi, J.; Gorelick, N.; Frikeche, J.; Lott, T.; Felder, R.; Scotland, S. J.; Eisinger-Mathason, T. S. K.; Brem, H.; Tyler, B.; Skuli, N.			Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic	ONCOGENE			English	Article							INITIATION-FACTOR 4E; ACUTE MYELOID-LEUKEMIA; ADJUVANT TEMOZOLOMIDE; STEM-CELLS; INHIBITION; EIF4E; TRANSLATION; TARGET; TUMORS; RADIOTHERAPY	The median survival for glioblastoma patients is similar to 15 months despite aggressive surgery and radio-chemotherapy approaches. Thus, developing new therapeutics is necessary to improve the treatment of these invasive brain tumors, which are known to show high levels of the eukaryotic initiation factor, eIF4E, a potent oncogene. Ribavirin, the only clinically approved drug known to target eIF4E, is an anti-viral molecule currently used in hepatitis C treatment. Here, we report the effect of ribavirin on proliferation, cell cycle, cell death and migration of several human and murine glioma cell lines, as well as human glioblastoma stem-like cells, in vitro. In addition, we tested ribavirin efficacy in vivo, alone and in combination with temozolomide and radiation. Our work showed that ribavirin inhibits glioma cell growth and migration, and increases cell cycle arrest and cell death, potentially through modulation of the eIF4E, EZH2 and ERK pathways. We also demonstrate that ribavirin treatment in combination with temozolomide or irradiation increases cell death in glioma cells. Finally and most importantly, ribavirin treatment in vivo significantly enhances chemoradiotherapy efficacy and improves survival of rats and mice orthotopically implanted with gliosarcoma tumors or glioma stem-like cells, respectively. On the basis of these results, we propose that ribavirin represents a new therapeutic option for glioblastoma patients as an enhancer of the cytotoxic effects of temozolomide and radiotherapy.	[Volpin, F.; Casaos, J.; Sesen, J.; Mangraviti, A.; Choi, J.; Gorelick, N.; Frikeche, J.; Lott, T.; Felder, R.; Scotland, S. J.; Brem, H.; Tyler, B.; Skuli, N.] Johns Hopkins Univ, Dept Neurosurg, Hunterian Neurosurg Res Lab, Johns Hopkins Sch Med, Baltimore, MD USA; [Sesen, J.; Skuli, N.] CRCT, INSERM U1037, Toulouse, France; [Eisinger-Mathason, T. S. K.] Univ Penn, Dept Pathol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Pennsylvania; Pennsylvania Medicine	Skuli, N (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Hunterian Brain Tumor Lab, 1550 Orleans St,Koch Canc Res Bldg, Baltimore, MD 21231 USA.	nicolas.skuli@inserm.fr		Skuli, Sarah/0000-0001-7711-0732; FRIKECHE, Jihane/0000-0003-1291-6908; Gorelick, Noah/0000-0003-1313-1061; Mangraviti, Antonella/0000-0003-2843-0718	INSERM [U1037SPDOTSKULI]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank the Hunterian Neurosurgical Research Laboratory, Dr Thomas Simon for helpful comments, and Mr and Mrs Peter Jennison and Mr and Mrs Josh Fidler for their kind and generous support. This work was supported by INSERM (Grant number: U1037SPDOTSKULI).	Alimova I, 2013, NEURO-ONCOLOGY, V15, P149, DOI 10.1093/neuonc/nos285; Assouline S, 2015, HAEMATOLOGICA, V100, pE7, DOI 10.3324/haematol.2014.111245; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bertolini F, 2015, NAT REV CLIN ONCOL, V12, P732, DOI 10.1038/nrclinonc.2015.169; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; Chen DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087281; Colombo G, 2011, ANTIVIR RES, V92, P408, DOI 10.1016/j.antiviral.2011.09.012; Dadgostari S, 2004, DRUG CHEM TOXICOL, V27, P191, DOI 10.1081/DCT-200031953; De La Cruz-Hernandez E, 2015, ONCOL REP, V33, P2384, DOI 10.3892/or.2015.3816; Dubois L, 2009, INT J RADIAT ONCOL, V73, P1219, DOI 10.1016/j.ijrobp.2008.12.003; EGGLESTON M, 1987, INFECT CONT HOSP EP, V8, P215, DOI 10.1017/S0195941700065978; Fan TY, 2014, INT J CLIN EXP PATHO, V7, P6662; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Gu X, 2005, APPL IMMUNOHISTO M M, V13, P178, DOI 10.1097/01.pai.0000135615.07325.a2; Harvie P, 1996, J ACQ IMMUN DEF SYND, V12, P451, DOI 10.1097/00042560-199608150-00003; Hayman TJ, 2012, CANCER RES, V72, P2362, DOI 10.1158/0008-5472.CAN-12-0329; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Jeulin H, 2009, ANTIVIR RES, V81, P261, DOI 10.1016/j.antiviral.2008.12.006; Kentsis A, 2005, RNA, V11, P1762, DOI 10.1261/rna.2238705; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Kokeny S, 2009, ANTICANCER RES, V29, P1971; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Loustaud-Ratti V, 2016, WORLD J HEPATOL, V8, P123, DOI 10.4254/wjh.v8.i2.123; Mangraviti A, 2016, BIOMATERIALS, V100, P53, DOI 10.1016/j.biomaterials.2016.05.025; McGirt MJ, 2009, J NEUROSURG, V110, P583, DOI 10.3171/2008.5.17557; Mijatovic S, 2005, CELL MOL LIFE SCI, V62, P589, DOI 10.1007/s00018-005-4425-8; Myung JK, 2014, INT J CLIN EXP PATHO, V7, P1977; Narayana K, 2002, MUTAT RES-GEN TOX EN, V521, P179, DOI 10.1016/S1383-5718(02)00239-5; Ogino A, 2014, ONCOL LETT, V8, P2469, DOI 10.3892/ol.2014.2569; Olah E, 2006, ADV ENZYME REGUL, V46, P176, DOI 10.1016/j.advenzreg.2006.01.002; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Papanagnou P, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9020024; Pettersson F, 2015, CANCER RES, V75, P1102, DOI 10.1158/0008-5472.CAN-14-1996; Pettersson F, 2014, EXPERT OPIN THER TAR, V18, P1035, DOI 10.1517/14728222.2014.937426; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Richard SM, 2015, J CANCER RES THER, V11, P336, DOI 10.4103/0973-1482.157317; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Savary K, 2013, ONCOGENE, V32, P5409, DOI 10.1038/onc.2013.67; SCHEIDEL LM, 1987, VIROLOGY, V158, P1, DOI 10.1016/0042-6822(87)90230-3; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Sesen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123721; Sesen J, 2014, INT J MOL SCI, V15, P2172, DOI 10.3390/ijms15022172; Shi FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136746; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tamburini J, 2009, CELL CYCLE, V8, P3893, DOI 10.4161/cc.8.23.10091; Vallee S, 2000, EUR J PHARMACOL, V404, P49, DOI 10.1016/S0014-2999(00)00596-3; Vignon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068425; Wicks RT, 2015, NEURO-ONCOLOGY, V17, P70, DOI 10.1093/neuonc/nou143; Zambon AC, 2010, CYTOM PART A, V77A, P564, DOI 10.1002/cyto.a.20890; Zekri ARN, 2014, J ADV RES, V5, P27, DOI 10.1016/j.jare.2012.11.002; Zhang W, 2014, GENET MOL BIOL, V37, P716, DOI 10.1590/S1415-47572014000500015; Zopf S, 2016, WORLD J HEPATOL, V8, P139, DOI 10.4254/wjh.v8.i3.139	63	33	33	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3037	3047		10.1038/onc.2016.457	http://dx.doi.org/10.1038/onc.2016.457			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27941882				2022-12-26	WOS:000402000400011
J	Zhu, W; Gliddon, BL; Jarman, KE; Moretti, PAB; Tin, T; Parise, LV; Woodcock, JM; Powell, JA; Ruszkiewicz, A; Pitman, MR; Pitson, SM				Zhu, W.; Gliddon, B. L.; Jarman, K. E.; Moretti, P. A. B.; Tin, T.; Parise, L. V.; Woodcock, J. M.; Powell, J. A.; Ruszkiewicz, A.; Pitman, M. R.; Pitson, S. M.			CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1	ONCOGENE			English	Article							BREAST-CANCER; CYTOPLASMIC DOMAIN; BINDING PROTEIN; PHOSPHORYLATION; CELLS; IDENTIFICATION; TRANSLOCATION; ACTIVATION; PATHWAYS; SURVIVAL	CIB1 (calcium and integrin binding protein 1) is a small intracellular protein with numerous interacting partners, and hence has been implicated in various cellular functions. Recent studies have revealed emerging roles of CIB1 in regulating cancer cell survival and angiogenesis, although the mechanisms involved have remained largely undefined. In investigating the oncogenic function of CIB1, we initially found that CIB1 is widely up-regulated across a diverse range of cancers, with this upregulation frequently correlating with oncogenic mutations of KRas. Consistent with this, we found that ectopic expression of oncogenic KRas and HRas in cells resulted in elevated CIB1 expression. We previously described the Ca2+-myristoyl switch function of CIB1, and its ability to facilitate agonist-induced plasma membrane localisation of sphingosine kinase 1 (SK1), a location where SK1 is known to elicit oncogenic signalling. Thus, we examined the role this may play in oncogenesis. Consistent with these findings, we demonstrated here that over-expression of CIB1 by itself is sufficient to drive localisation of SK1 to the plasma membrane and enhance the membrane-associated enzymatic activity of SK1, as well as its oncogenic signalling. We subsequently demonstrated that elevated levels of CIB1 resulted in full neoplastic transformation, in a manner dependent on SK1. In agreement with our previous findings that SK1 is a downstream mediator of oncogenic signalling by Ras, we found that targeting CIB1 also inhibited neoplastic growth of cells induced by oncogenic Ras, suggesting an important pro-tumorigenic role for CIB1. Thus, we have demonstrated for the first time a role for CIB1 in neoplastic transformation, and revealed a novel mechanism facilitating oncogenic signalling by Ras and SK1.	[Zhu, W.; Gliddon, B. L.; Jarman, K. E.; Moretti, P. A. B.; Tin, T.; Woodcock, J. M.; Powell, J. A.; Ruszkiewicz, A.; Pitman, M. R.; Pitson, S. M.] Univ South Australia, Ctr Canc Biol, SA Pathol Bldg,Frome Rd, Adelaide, SA 5000, Australia; [Zhu, W.; Gliddon, B. L.; Jarman, K. E.; Moretti, P. A. B.; Tin, T.; Woodcock, J. M.; Powell, J. A.; Ruszkiewicz, A.; Pitman, M. R.; Pitson, S. M.] SA Pathol, SA Pathol Bldg,Frome Rd, Adelaide, SA 5000, Australia; [Zhu, W.; Jarman, K. E.; Pitson, S. M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Parise, L. V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Powell, J. A.; Pitson, S. M.] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of South Australia; SA Pathology; University of Adelaide; University of North Carolina; University of North Carolina Chapel Hill; University of Adelaide	Pitson, SM (corresponding author), Univ South Australia, Ctr Canc Biol, SA Pathol Bldg,Frome Rd, Adelaide, SA 5000, Australia.; Pitson, SM (corresponding author), SA Pathol, SA Pathol Bldg,Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@unisa.edu.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740; Powell, jason/0000-0001-8493-9178; Gliddon, Briony/0000-0003-3928-7478; Moretti, Paul/0000-0002-3523-1496; Pitman, Melissa/0000-0002-9587-3837; Woodcock, Joanna/0000-0001-5127-9687; Zhu, Layla/0000-0002-6413-699X	Fay Fuller Foundation [1004695]; National Health and Medical Research Council of Australia [508098, 1042589]; University of Adelaide Graduate Research and Research Training Scheme Scholarships, an Australian Postgraduate Award and Royal Adelaide Hospital (RAH) Dawes Scholarship; RAH Research Foundation Early Career Fellowship; Imperial Cancer Research Fund, London; Institute for Molecular Bioscience, Brisbane; Osaka University;  [NIH 1R01HL092544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092544] Funding Source: NIH RePORTER	Fay Fuller Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide Graduate Research and Research Training Scheme Scholarships, an Australian Postgraduate Award and Royal Adelaide Hospital (RAH) Dawes Scholarship; RAH Research Foundation Early Career Fellowship; Imperial Cancer Research Fund, London; Institute for Molecular Bioscience, Brisbane; Osaka University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fay Fuller Foundation, Project Grant (1004695) and Senior Research Fellowships (508098 and 1042589) from the National Health and Medical Research Council of Australia (to SMP), NIH 1R01HL092544 (to LVP), University of Adelaide Graduate Research and Research Training Scheme Scholarships (to WZ), an Australian Postgraduate Award and Royal Adelaide Hospital (RAH) Dawes Scholarship (to KEJ) and a RAH Research Foundation Early Career Fellowship (to MRP). We thank J Downward (Imperial Cancer Research Fund, London) and R Parton (Institute for Molecular Bioscience, Brisbane) for providing the H- and KRas plasmids, respectively, and M Okabe (Osaka University) for providing the pCX-EGFP plasmid. Some of the data shown are based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Adams DR, 2016, TRENDS BIOCHEM SCI, V41, P395, DOI 10.1016/j.tibs.2016.02.007; Al-Jehani RM, 1998, J NATL CANCER I, V90, P540, DOI 10.1093/jnci/90.7.540; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Armacki M, 2014, ONCOGENE, V33, P1167, DOI 10.1038/onc.2013.43; Black JL, 2015, BREAST CANCER RES TR, V152, P337, DOI 10.1007/s10549-015-3458-4; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; French KJ, 2003, CANCER RES, V63, P5962; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gault CR, 2012, J BIOL CHEM, V287, P31794, DOI 10.1074/jbc.M112.385765; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Heffernan-Stroud LA, 2013, ADV CANCER RES, V117, P201, DOI 10.1016/B978-0-12-394274-6.00007-8; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Leisner TM, 2013, ONCOGENE, V32, P4017, DOI 10.1038/onc.2012.408; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Meyer T, 1999, NAT CELL BIOL, V1, pE93, DOI 10.1038/12090; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagayoshi Y, 2014, ANN SURG ONCOL, V21, P459, DOI 10.1245/s10434-014-3574-0; Naik MU, 2009, J THROMB HAEMOST, V7, P1906, DOI 10.1111/j.1538-7836.2009.03581.x; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Naik MU, 2011, INT J CANCER, V128, P587, DOI 10.1002/ijc.25388; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitman MR, 2015, ONCOTARGET, V6, P7065, DOI 10.18632/oncotarget.3178; Pitman Melissa R, 2012, Methods Mol Biol, V874, P21, DOI 10.1007/978-1-61779-800-9_2; Pitman MR, 2011, INT J BIOCHEM CELL B, V43, P342, DOI 10.1016/j.biocel.2010.11.001; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Tong JR, 2011, J BIOSCIENCES, V36, P659, DOI 10.1007/s12038-011-9101-6; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yamniuk AP, 2006, CALCIUM BINDING PROT, V1, P150; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17	48	23	23	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 4	2017	36	18					2619	2627		10.1038/onc.2016.428	http://dx.doi.org/10.1038/onc.2016.428			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET9AN	27941888	Green Accepted, Green Submitted			2022-12-26	WOS:000400597300012
J	Wang, GX; Yu, JY; Wen, L; Zhang, L; Mou, KJ; Zhang, D				Wang, Guang-xian; Yu, Jiao-yan; Wen, Li; Zhang, Lei; Mou, Ke-jie; Zhang, Dong			Risk Factors for the Rupture of Middle Cerebral Artery Bifurcation Aneurysms Using CT Angiography	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; MANAGEMENT; MORPHOLOGY; GROWTH; RATIO	Background and Purpose To investigate the clinical and morphological characteristics associated with risk factors for the rupture of bifurcation-type middle cerebral artery aneurysms (MCAAs). Methods A total of 169 consecutive patients with 177 bifurcation-type MCAAs were reviewed from August 2011 to January 2016. Based on the clinical and morphologic characteristics findings, the risk factors of aneurysm rupture were assessed using statistical methods. Results Age, cerebral atherosclerosis, no hypertension, hypertension grade 2 and coronary artery disease (CAD) were negatively correlated with aneurysm rupture. The mean diameter (MD) of the parent and two daughter arteries was negatively correlated with rupture. Aneurysms with irregularity, depth, width, maximum size, aspect ratio, depth-to-width ratio, bottleneck factor, and size ratio were positively correlated with rupture. The multivariate logistic regression model revealed that irregular shape (odds ratio (OR) 2.697) and aspect ratio (OR 3.723) were significantly and positively correlated with rupture, while cerebral atherosclerosis (OR 0.033), CAD (OR 0.080), and MD (OR 0.201) were negatively correlated with rupture. Receiver operating characteristic analysis revealed that the threshold value of the aspect ratio and MD were 0.96 and 2.43 mm, respectively. Conclusions Cerebral atherosclerosis and CAD are protective factors against rupture. Morphological characteristics such as an aneurysm with an irregular shape, a high aspect ratio (> 0.96) and a small MD (< 2.43 mm) are likely better predictors of rupture.	[Wang, Guang-xian; Yu, Jiao-yan; Wen, Li; Zhang, Lei; Zhang, Dong] Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China; [Mou, Ke-jie] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhang, D (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China.	xqzhangdong@163.com						Bacigaluppi S, 2014, NEUROSURG REV, V37, P1, DOI 10.1007/s10143-013-0501-y; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Castro MA, 2009, AM J NEURORADIOL, V30, P297, DOI 10.3174/ajnr.A1323; Dashti R, 2007, SURG NEUROL, V67, P6, DOI 10.1016/j.surneu.2006.08.027; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Elsharkawy A, 2013, NEUROSURGERY, V73, P825, DOI 10.1227/NEU.0000000000000116; Elsharkawy A, 2013, NEUROSURGERY, V73, P94, DOI 10.1227/01.neu.0000429842.61213.d5; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Heit JJ, 2015, J NEUROINTERV SURG; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Kang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142330; Kang HG, 2015, STROKE, V46, P3093, DOI 10.1161/STROKEAHA.115.011351; Lall RR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS0921; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Lindekleiv H, 2011, NEUROLOGY, V76, P637, DOI 10.1212/WNL.0b013e31820c30d3; Mackey J, 2012, J NEUROSURG, V117, P60, DOI 10.3171/2012.4.JNS111822; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Mehan WA, 2014, J NEUROINTERV SURG, V6, P761, DOI 10.1136/neurintsurg-2013-010944; Nader-Sepahi A, 2004, NEUROSURGERY, V54, P1343, DOI 10.1227/01.NEU.0000124482.03676.8B; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Prat R, 2007, CLIN NEUROL NEUROSUR, V109, P431, DOI 10.1016/j.clineuro.2007.03.005; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Ryu CW, 2011, NEURORADIOLOGY, V53, P883, DOI 10.1007/s00234-010-0804-4; Sadatomo T, 2005, NEUROSURG REV, V28, P196, DOI 10.1007/s10143-005-0379-4; Sadatomo T, 2008, NEUROSURGERY, V62, P602, DOI 10.1227/01.NEU.0000311347.35583.0C; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; You SH, 2010, J NEUROL NEUROSUR PS, V81, P479, DOI 10.1136/jnnp.2008.169573; Yu J, 2010, J INT MED RES, V38, P1785, DOI 10.1177/147323001003800525	36	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166654	10.1371/journal.pone.0166654	http://dx.doi.org/10.1371/journal.pone.0166654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977691	gold, Green Published, Green Submitted			2022-12-26	WOS:000391217400005
J	Andradi-Brown, DA; Macaya-Solis, C; Exton, DA; Gress, E; Wright, G; Rogers, AD				Andradi-Brown, Dominic A.; Macaya-Solis, Consuelo; Exton, Dan A.; Gress, Erika; Wright, Georgina; Rogers, Alex D.			Assessing Caribbean Shallow and Mesophotic Reef Fish Communities Using Baited-Remote Underwater Video (BRUV) and Diver-Operated Video (DOV) Survey Techniques	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; VISUAL CENSUS; MIGRATION PATTERNS; TEMPERATE; ASSEMBLAGES; DENSITY; PROTECTION; STATIONS; BEHAVIOR; IMPACTS	Fish surveys form the backbone of reef monitoring and management initiatives throughout the tropics, and understanding patterns in biases between techniques is crucial if outputs are to address key objectives optimally. Often biases are not consistent across natural environmental gradients such as depth, leading to uncertainty in interpretation of results. Recently there has been much interest in mesophotic reefs (reefs from 30-150 m depth) as refuge habitats from fishing pressure, leading to many comparisons of reef fish communities over depth gradients. Here we compare fish communities using stereo-video footage recorded via baited remote underwater video (BRUV) and diver-operated video (DOV) systems on shallow and mesophotic reefs in the Mesoamerican Barrier Reef, Caribbean. We show inconsistent responses across families, species and trophic groups between methods across the depth gradient. Fish species and family richness were higher using BRUV at both depth ranges, suggesting that BRUV is more appropriate for recording all components of the fish community. Fish length distributions were not different between methods on shallow reefs, yet BRUV recorded more small fish on mesophotic reefs. However, DOV consistently recorded greater relative fish community biomass of herbivores, suggesting that studies focusing on herbivores should consider using DOV. Our results highlight the importance of considering what component of reef fish community researchers and managers are most interested in surveying when deciding which survey technique to use across natural gradients such as depth.	[Andradi-Brown, Dominic A.; Macaya-Solis, Consuelo; Rogers, Alex D.] Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford, England; [Andradi-Brown, Dominic A.; Exton, Dan A.; Gress, Erika; Wright, Georgina] Operat Wallacea, Wallace House, Spilsby, Lincolnshire, England; [Macaya-Solis, Consuelo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile	University of Oxford; Universidad de Chile	Andradi-Brown, DA (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford, England.; Andradi-Brown, DA (corresponding author), Operat Wallacea, Wallace House, Spilsby, Lincolnshire, England.	dominic.andradi-brown@zoo.ox.ac.uk	Exton, Dan/L-5695-2019	Exton, Dan/0000-0001-8885-5828	Fisheries Society of the British Isles PhD Studentship; Operation Wallacea	Fisheries Society of the British Isles PhD Studentship; Operation Wallacea	DAAB was funded by a Fisheries Society of the British Isles (http://www.fsbi.org.uk) PhD Studentship. Operation Wallacea (www.opwall.com) provided fieldwork support for DAAB, EG, GW, DAE and ADR. Operation Wallacea provided support in the form of salaries for authors DAAB, EG, GW and DAE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andradi-Brown D, 2016, MESOPHOTIC CORAL ECO, P67, DOI DOI 10.1007/S10530-011-0005-Z; Andradi-Brown DA, 2016, REEF ENCOUNTER, V31, P26; Andradi-Brown DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156641; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Bowman A.W., 2014, R PACKAGE SM NONPARA; Box SJ, 2011, P 63 GULF CAR FISH I, P43; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Cole RG, 2007, MAR BIOL, V150, P1379, DOI 10.1007/s00227-006-0420-3; de la Moriniere EC, 2003, ESTUAR COAST SHELF S, V57, P1079, DOI 10.1016/S0272-7714(03)00011-8; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; Doiron S, 2014, TOUR MANAG PERSPECT, V10, P19, DOI 10.1016/j.tmp.2013.12.003; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; English S., 1997, SURVEY MANUAL TROPIC; FEDDERN HENRY A., 1965, BULL MAR SCI, V15, P896; Gobert B, 2005, FISH RES, V73, P159, DOI 10.1016/j.fishres.2004.12.008; Goetze JS, 2015, J EXP MAR BIOL ECOL, V462, P74, DOI 10.1016/j.jembe.2014.10.004; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey ES, 2012, CORAL REEFS, V31, P939, DOI 10.1007/s00338-012-0955-3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Holmes TH, 2013, LIMNOL OCEANOGR-METH, V11, P337, DOI 10.4319/lom.2013.11.337; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; PRIEDE IG, 1994, J MAR BIOL ASSOC UK, V74, P481, DOI 10.1017/S0025315400047615; R Core Team, 2021, R LANGUAGE ENV STAT; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Sanderson SL, 1986, B MARINE SCI, V39; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sieber A, 2010, UNDERWATER TECHNOL, V29, DOI 10.3723/ut.29.073; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tessier A, 2013, AQUAT BIOL, V18, P229, DOI 10.3354/ab00506; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Titus BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119645; Wand M, 1995, KEMSMOOTH FUNCTIONS; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010	54	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168235	10.1371/journal.pone.0168235	http://dx.doi.org/10.1371/journal.pone.0168235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959907	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900050
J	Chang, JTH; Wang, F; Chapin, W; Huang, RS				Chang, Jeremy T-H.; Wang, Fan; Chapin, William; Huang, R. Stephanie			Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas	PLOS ONE			English	Article							DOWN-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; DNA-REPAIR; TARGET PREDICTION; HMSH2 EXPRESSION; METASTASIS; INVASION; GENE; MIGRATION	Breast cancer is the second-most common cancer and second-leading cause of cancer mortality in American women. The dysregulation of microRNAs ( miRNAs) plays a key role in almost all cancers, including breast cancer. We comprehensively analyzed miRNA expression, global gene expression, and patient survival from the Cancer Genomes Atlas (TCGA) to identify clinically relevant miRNAs and their potential gene targets in breast tumors. In our analysis, we found that increased expression of 12 mature miRNAs D hsa-miR-320a, hsami-R-361-5p, hsa-miR-103a-3p, hsa-miR-21-5p, hsa-miR-374b-5p, hsa-miR-140-3p, hsami-R-25-3p, hsa-miR-651-5p, hsa-miR-200c-3p, hsa-miR-30a-5p, hsa-miR-30c-5p, and hsa-let-7i-5p D each predicted improved breast cancer survival. Of the 12 miRNAs, miR320a, miR-361-5p, miR-21-5p, miR-103a-3p were selected for further analysis. By correlating global gene expression with miRNA expression and then employing miRNA target prediction analysis, we suggest that the four miRNAs may exert protective phenotypes by targeting breast oncogenes that contribute to patient survival. We propose that miR-320a targets the survival-associated genes RAD51, RRP1B, and TDG; miR-361-5p targets ARCN1; and miR-21-5p targets MSH2, RMND5A, STAG2, and UBE2D3. The results of our stringent bioinformatics approach for identifying clinically relevant miRNAs and their targets indicate that miR-320a, miR-361-5p, and miR-21-5p may contribute to breast cancer survival.	[Chang, Jeremy T-H.] Univ Chicago, Biol Sci Coll Div, Chicago, IL 60637 USA; [Wang, Fan; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Chapin, William] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Huang, RS (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu	Wang, Fan/Z-3850-2019	Chang, Jeremy/0000-0002-2680-4934; Huang, R. Stephanie/0000-0002-9862-0368; Chapin, William/0000-0001-9616-8462	National Institutes of Health/NIDDK [2T35DK062719-26]; National Institute of Health [K08GM089941, R21 CA139278, UO1GM61393]; University of Chicago Support Grant [P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the National Institute of Health [UL1RR024999]; Circle of Service Foundation Early Career Investigator award; Avon Foundation Research Grant; Conquer Cancer Foundation of ASCO Translational Research Professorship award	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Support Grant; Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the National Institute of Health; Circle of Service Foundation Early Career Investigator award; Avon Foundation Research Grant; Conquer Cancer Foundation of ASCO Translational Research Professorship award	WC received support from National Institutes of Health/NIDDK grant 2T35DK062719-26. RSH received supported from the National Institute of Health [grant K08GM089941, R21 CA139278, UO1GM61393]; University of Chicago Support Grant [#P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; the National Center for Advancing Translational Sciences of the National Institute of Health [UL1RR024999]; Circle of Service Foundation Early Career Investigator award, Avon Foundation Research Grant, and a Conquer Cancer Foundation of ASCO Translational Research Professorship award In Memory of Merrill J. Egorin, MD (awarded to Dr. MJ Ratain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2013, BIOCHEM BIOPH RES CO, V437, P557, DOI 10.1016/j.bbrc.2013.06.114; Bock N, 2000, ANTICANCER RES, V20, P119; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Chang CW, 2016, ONCOTARGET, V7, P16462, DOI 10.18632/oncotarget.7656; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Chintamani, 2007, Int Semin Surg Oncol, V4, P5, DOI 10.1186/1477-7800-4-5; D'Ippolito E, 2016, CANC RES; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Egeland NG, 2015, INT J MOL SCI, V16, P24243, DOI 10.3390/ijms161024243; Evers L, 2014, GENOME MED, V6, DOI 10.1186/gm526; Feng ZM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1655-5; Fu J, 2014, BIOCHEM BIOPH RES CO, V445, P314, DOI 10.1016/j.bbrc.2014.01.174; Haakensen VD, 2016, INT J CANCER, V139, P1117, DOI 10.1002/ijc.30142; He DX, 2014, MOL PHARMACOL, V86, P536, DOI 10.1124/mol.114.092759; Hemmatzadeh M, 2016, BIOMED PHARMACOTHER, V78, P129, DOI 10.1016/j.biopha.2016.01.026; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100993; Huo D, 2016, ONCOTARGET; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim MS, 2012, NEOPLASMA, V59, P524, DOI 10.4149/neo_2012_067; Knezevic J, 2015, ONCOGENE, V34, P5997, DOI 10.1038/onc.2015.48; Kobayashi H, 2015, BIOCHEM BIOPH RES CO, V467, P121, DOI 10.1016/j.bbrc.2015.09.106; Kuang Y, 2016, ASIAN PAC J TROP MED, V9, P456, DOI 10.1016/j.apjtm.2016.03.025; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Lee M, 2014, ONCOGENE, V33, P1818, DOI 10.1038/onc.2013.133; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Li Q, 2014, ONCOGENE, V33, P2589, DOI 10.1038/onc.2013.226; Li WT, 2016, INT J ONCOL, V48, P1155, DOI 10.3892/ijo.2016.3319; Lira D, 2015, EUR REV MED PHARMACO, V19, P3229; Liu DC, 2014, BIOCHEM BIOPH RES CO, V445, P151, DOI 10.1016/j.bbrc.2014.01.140; Liu L, 2014, MOL CANCER RES, V12, P1597, DOI 10.1158/1541-7786.MCR-14-0201; Liu Y, 2015, BREAST CANCER RES TR, V152, P183, DOI 10.1007/s10549-015-3460-x; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Lu YH, 2016, BIOCHEM BIOPH RES CO, V473, P1315, DOI 10.1016/j.bbrc.2016.04.069; Ma F, 2015, ONCOTARGET, V6, P17404, DOI 10.18632/oncotarget.3744; Markou A, 2016, CLIN CHEM, V62, P1002, DOI 10.1373/clinchem.2015.253716; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Nanchari SR, 2015, TUMOR BIOL, V36, P615, DOI 10.1007/s13277-014-2613-6; O'Reilly EA, 2015, BBA CLIN, V3, P257, DOI 10.1016/j.bbacli.2015.03.003; Parplys AC, 2015, CELL CYCLE, V14, P3190, DOI 10.1080/15384101.2015.1055996; Peng B, EPIGENETICS, V1, P138; Petrovic N, 2016, MOL DIAGN THER, V20, P97, DOI 10.1007/s40291-016-0186-3; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Qi XM, 2014, FEBS LETT, V588, P3732, DOI 10.1016/j.febslet.2014.08.021; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Qiao Y, 2016, TUMOR BIOL, V37, P10279, DOI 10.1007/s13277-016-4894-4; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Sato S, 2016, CANC RES; Shen SJ, 2014, CHEM RES TOXICOL, V27, P27, DOI 10.1021/tx400305w; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song CL, 2015, ONCOTARGET, V6, P34968, DOI 10.18632/oncotarget.5198; Song NN, 2016, PAK J PHARM SCI, V29, P679; Spagnoletti I, 2004, ONCOL REP, V11, P845; Sun EH, 2014, EUR REV MED PHARMACO, V18, P2783; Sun JJ, 2016, CELL PHYSIOL BIOCHEM, V38, P777, DOI 10.1159/000443033; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Tommasi S, 2016, ONCOTARGET; Vasovcak P, 2012, DNA REPAIR, V11, P616, DOI 10.1016/j.dnarep.2012.04.004; Wang BY, 2015, AM J CANCER RES, V5, P2719; Wang WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064660; Wang Xiaopai, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P631; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang Y, 2016, ONCOTARGET; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wolfson Benjamin, 2014, World J Stem Cells, V6, P591, DOI 10.4252/wjsc.v6.i5.591; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu YY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020013; Xiong J, 2016, BIOCH BIOPHYS RES CO; Xue JY, 2014, WORLD J CLIN ONCOL, V5, P730, DOI 10.5306/wjco.v5.i4.730; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang HP, 2014, ONCOL LETT, V8, P1043, DOI 10.3892/ol.2014.2298; Yang H, 2016, J CANCER, V7, P1152, DOI 10.7150/jca.14745; Yatsuoka T, 1999, INT J PANCREATOL, V25, P97, DOI 10.1385/IJGC:25:2:97; Yu J, 2016, ONCOTARGET; Zadeh MM, 2016, J BREAST CANCER, V19, P45, DOI 10.4048/jbc.2016.19.1.45; Zhang G, 2016, ONCOTARGET; Zhu JW, 2015, EUR J MED CHEM, V96, P196, DOI 10.1016/j.ejmech.2015.04.021; Zhu XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12460	80	70	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168284	10.1371/journal.pone.0168284	http://dx.doi.org/10.1371/journal.pone.0168284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959953	gold, Green Published			2022-12-26	WOS:000392753900055
J	Howie, RN; Durham, EL; Black, L; Bennfors, G; Parsons, TE; Elsalanty, ME; Yu, JC; Weinberg, SM; Cray, JJ				Howie, R. Nicole; Durham, Emily L.; Black, Laurel; Bennfors, Grace; Parsons, Trish E.; Elsalanty, Mohammed E.; Yu, Jack C.; Weinberg, Seth M.; Cray, James J., Jr.			Effects of In Utero Thyroxine Exposure on Murine Cranial Suture Growth	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; THYROID-HORMONE; SKELETAL DEVELOPMENT; BETA-CATENIN; BONE-GROWTH; STEM-CELLS; C-JUN; CRANIOSYNOSTOSIS; MICE; DIFFERENTIATION	Large scale surveillance studies, case studies, as well as cohort studies have identified the influence of thyroid hormones on calvarial growth and development. Surveillance data suggests maternal thyroid disorders (hyperthyroidism, hypothyroidism with pharmacological replacement, and Maternal Graves Disease) are linked to as much as a 2.5 fold increased risk for craniosynostosis. Craniosynostosis is the premature fusion of one or more calvarial growth sites (sutures) prior to the completion of brain expansion. Thyroid hormones maintain proper bone mineral densities by interacting with growth hormone and aiding in the regulation of insulin like growth factors (IGFs). Disruption of this hormonal control of bone physiology may lead to altered bone dynamics thereby increasing the risk for craniosynostosis. In order to elucidate the effect of exogenous thyroxine exposure on cranial suture growth and morphology, wild type C57BL6 mouse litters were exposed to thyroxine in utero (control = no treatment; low similar to 167 ng per day; high similar to 667 ng per day). Thyroxine exposed mice demonstrated craniofacial dysmorphology (brachycranic). High dose exposed mice showed diminished area of the coronal and widening of the sagittal sutures indicative of premature fusion and compensatory growth. Presence of thyroid receptors was confirmed for the murine cranial suture and markers of proliferation and osteogenesis were increased in sutures from exposed mice. Increased Htra1 and Igf1 gene expression were found in sutures from high dose exposed individuals. Pathways related to the HTRA1/IGF axis, specifically Akt and Wnt, demonstrated evidence of increased activity. Overall our data suggest that maternal exogenous thyroxine exposure can drive calvarial growth alterations and altered suture morphology.	[Howie, R. Nicole; Durham, Emily L.; Black, Laurel; Bennfors, Grace; Cray, James J., Jr.] Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC USA; [Parsons, Trish E.; Weinberg, Seth M.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Oral Biol, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Orthoped Surg, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Oral & Maxillofacial Surg, Augusta, GA USA; [Elsalanty, Mohammed E.; Yu, Jack C.] Augusta Univ, Inst Regenerat & Reparat Med, Augusta, GA USA; [Yu, Jack C.] Augusta Univ, Div Plast Surg, Dept Surg, Augusta, GA USA	Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Cray, JJ (corresponding author), Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC USA.	crayj@musc.edu		Black, Laurel/0000-0003-4530-1133; Durham, Emily/0000-0002-6322-9393; Weinberg, Seth/0000-0001-9467-4556	National Institute of Dental and Craniofacial Research [R03DE023350A]; Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award; National Institutes of Health National Institute of Dental and Craniofacial Research [5T32DE017551]; National Institutes of Health National Institute of General Medicine [P30GM103331]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023350, T32DE017551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award; National Institutes of Health National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study utilized the facilities and resources of the MUSC Center for Oral Health Research (COHR). This work was funded in part by the National Institute of Dental and Craniofacial Research [R03DE023350A to JJC], and the Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award to JJC. Micro-Computed Tomography scans were made possible by the National Institute on Aging (NIA) 1P01AG036675 (ME). ELD and RNH are funded through a training grant from the National Institutes of Health National Institute of Dental and Craniofacial Research [5T32DE017551]. The MUSC Center for Oral Health Research (COHR), is partially supported by the National Institutes of Health National Institute of General Medicine [P30GM103331].	Akita S, 1996, PLAST RECONSTR SURG, V97, P1, DOI 10.1097/00006534-199601000-00001; AKITA S, 1994, THYROID, V4, P99, DOI 10.1089/thy.1994.4.99; Ardalan M, 2012, PEDIATR NEUROSURG, V48, P152, DOI 10.1159/000346261; ARNAUD E, 1995, J NEUROSURG, V83, P476, DOI 10.3171/jns.1995.83.3.0476; Bassett JHD, 2016, ENDOCR REV, V37, P135, DOI 10.1210/er.2015-1106; Bassett JH, 2016, ENDOCR REV; Borgatti P, 2000, FEBS LETT, V477, P27, DOI 10.1016/S0014-5793(00)01758-0; Browne ML, 2011, BIRTH DEFECTS RES A, V91, P93, DOI 10.1002/bdra.20752; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; BURR W, 1986, CLIN OBSTET GYNAECOL, V13, P277; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Capelo LP, 2008, BONE, V43, P921, DOI 10.1016/j.bone.2008.06.020; Capuco AV, 1999, P SOC EXP BIOL MED, V221, P345, DOI 10.1046/j.1525-1373.1999.d01-91.x; Carmichael S, 2015, AM J MED GENETICS A; Carmichael SL, 2010, BIRTH DEFECTS RES A, V88, P1032, DOI 10.1002/bdra.20717; CHADDUCK WM, 1992, NEUROSURGERY, V30, P867, DOI 10.1227/00006123-199206000-00008; Cray JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069067; Darnerud PO, 1996, TOXICOLOGY, V106, P105, DOI 10.1016/0300-483X(95)03169-G; DULHUNTY AF, 1986, J MUSCLE RES CELL M, V7, P225, DOI 10.1007/BF01753555; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gauthier K, 2014, ENDOCRINOLOGY, V155, P3206, DOI 10.1210/en.2014-1597; Glanz S, 2016, STEM CELLS DEV, V25, P687, DOI 10.1089/scd.2015.0368; Glinoer D, 1998, THYROID, V8, P859, DOI 10.1089/thy.1998.8.859; Hashmi SS, 2012, BIRTH DEFECTS RES A, V94, P1004, DOI 10.1002/bdra.23077; Heuze Yann, 2014, Curr Genet Med Rep, V2, P135; Jin SW, 2016, J KOREAN NEUROSURG S, V59, P192, DOI 10.3340/jkns.2016.59.3.192; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; JURILOFF DM, 1985, TERATOLOGY, V31, P319, DOI 10.1002/tera.1420310302; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim HY, 2013, BONE RES, V1, DOI 10.4248/BR201302004; Krause K, 2015, EUR THYROID J, V4, P59, DOI 10.1159/000437304; Krude H, 1997, EXP CLIN ENDOCR DIAB, V105, P6, DOI 10.1055/s-0029-1211924; LAMB JC, 1986, TOXICOL APPL PHARM, V84, P115, DOI 10.1016/0041-008X(86)90420-5; LAMBERG BA, 1986, CLIN ENDOCRINOL, V25, P259, DOI 10.1111/j.1365-2265.1986.tb01690.x; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maruyama T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10526; McNab T, 2005, CLIN INVEST MED, V28, P127; McNabb FMA, 1992, THYROID HORMONES, Vxv; Miller M.T, 2000, CRANIOSYNOSTOSIS DIA, P184; Murphy E, 2004, CLIN ENDOCRINOL, V61, P285, DOI 10.1111/j.1365-2265.2004.02053.x; O'Shea PJ, 2003, MOL ENDOCRINOL, V17, P1410, DOI 10.1210/me.2002-0296; Oppenheimer JH, 1983, MOL BASIS THYROID HO, Vxv; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Parsons TE, 2014, ANAT REC, V297, P826, DOI 10.1002/ar.22899; PENFOLD JL, 1975, J PEDIATR-US, V86, P360, DOI 10.1016/S0022-3476(75)80963-2; PIRINEN S, 1995, ACTA ODONTOL SCAND, V53, P179, DOI 10.3109/00016359509005969; Proff P, 2006, J CRANIO MAXILL SURG, V34, P96, DOI 10.1016/S1010-5182(06)60021-8; Radetti G, 2002, Minerva Pediatr, V54, P383; Rasmussen SA, 2008, AM J MED GENET A, V146A, P149, DOI 10.1002/ajmg.a.32106; Rasmussen SA, 2007, OBSTET GYNECOL, V110, P369, DOI 10.1097/01.AOG.0000270157.88896.76; Reefhuis J, 2011, HUM REPROD, V26, P451, DOI 10.1093/humrep/deq313; Richardson S, 2011, BIRTH DEFECTS RES A, V91, P623, DOI 10.1002/bdra.20823; Robubi A, 2014, BONE JOINT RES, V3, P236, DOI 10.1302/2046-3758.37.2000231; Rybchyn MS, 2011, J BIOL CHEM, V286, P23771, DOI 10.1074/jbc.M111.251116; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; THORDARSON G, 1992, BIOL REPROD, V47, P676, DOI 10.1095/biolreprod47.4.676; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vecchione L, 2010, ANAT REC, V293, P32, DOI 10.1002/ar.21024; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Williams GR, 2013, EUR THYROID J, V2, P3, DOI 10.1159/000345548; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wojcicka A, 2013, BBA-GEN SUBJECTS, V1830, P3979, DOI 10.1016/j.bbagen.2012.05.005; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139; Zimmerman D, 1999, THYROID, V9, P727, DOI 10.1089/thy.1999.9.727	69	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167805	10.1371/journal.pone.0167805	http://dx.doi.org/10.1371/journal.pone.0167805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959899	Green Submitted, Green Published, gold			2022-12-26	WOS:000392753900016
J	Lee, YH; Lai, YH				Lee, Yu-Hsiang; Lai, Yun-Han			Synthesis, Characterization, and Biological Evaluation of Anti-HER2 Indocyanine Green-Encapsulated PEG-Coated PLGA Nanoparticles for Targeted Phototherapy of Breast Cancer Cells	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; DRUG-DELIVERY; ABLATION; AMPLIFICATION; NANOMEDICINE; PEGYLATION; RECEPTOR	Human epidermal growth factor receptor 2 (HER2)-overexpressed breast cancer is known to be more aggressive and resistant to medicinal treatment and therefore to whom an alternative therapeutics is needed. Indocyanine green (ICG) has been widely exploited in breast cancer phototherapy. However, drawbacks of accelerated degradation and short half-life (2-4 min) in blood seriously hamper its use in the clinic. To overcome these challenges, an anti-HER2 ICG-encapsulated polyethylene glycol-coated poly(lactic-co-glycolic acid) nanoparticles (HIPPNPs) were developed in this study. Through the analyses of degradation rate coefficients of ICG with and without polymeric encapsulation, the photostability of HIPPNPentrapped ICG significantly enhanced 4 folds (P < 0.05) while its thermal stabilities at 4 and 37 E C significantly enhanced 5 and 3 (P < 0.05 for each) folds, respectively, under equal lighting and/or heating treatment for 48 h. The target specificity of HIPPNPs to HER2-positive cells was demonstrated based on a 6-fold (P < 0.05) enhancement of uptake efficiency of HIPPNPs in MDA-MB-453/HER2(+) cells within 4 h as compared with that in MCF7/HER2 (-) cells. Moreover, the HIPPNPs with <= 25 mu M ICG equivalent were nontoxic to cells in the absence of light illumination, and enabled to generate similar amount of singlet oxygen and hyperthermia effect as compared with that used by free ICG upon NIR irradiation. After 808 nm-laser irradiation with intensity of 6 W/cm(2) for 5 min, the viability of MDA-MB-453 cells pre-treated by HIPPNPs with <= 5 mu M ICG equivalent for 4 h significantly reduced as compared with that treated by equal concentration of free ICG (P < 0.05) and > 90% of the cells were eradicated while the dose of HIPPNPs was increased to 25 mu M ICG equivalent. In summary, the developed HIPPNPs are anticipated as a feasible tool for use in phototherapy of breast cancer cells with HER2 expression.	[Lee, Yu-Hsiang; Lai, Yun-Han] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Lee, Yu-Hsiang] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan, Taiwan	National Central University; National Central University	Lee, YH (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Lee, YH (corresponding author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan, Taiwan.	yuhsianl@ncu.edu.tw			Ministry of Science and Technology, R.O.C. [MOST 105-2221-E-008-014]	Ministry of Science and Technology, R.O.C.	This work was financially supported by Ministry of Science and Technology, R.O.C. (Grant Number: MOST 105-2221-E-008-014; Y.-H. Lee) Website: https://www.most.gov.tw/en/public. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi RJ, 2008, J NEURO-ONCOL, V86, P165, DOI 10.1007/s11060-007-9467-3; BJORNSSON OG, 1983, J CLIN CHEM CLIN BIO, V21, P453; Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z; Choudhury A, 2004, Breast Dis, V20, P25; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Gajendiran M, 2014, J MATER CHEM B, V2, P418, DOI 10.1039/c3tb21113d; Goldberg SN, 1996, ACAD RADIOL, V3, P212, DOI 10.1016/S1076-6332(96)80443-0; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135; Hauck TS, 2008, ADV MATER, V20, P3832, DOI 10.1002/adma.200800921; Hu CMJ, 2010, MOL PHARMACEUT, V7, P914, DOI 10.1021/mp900316a; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Jain KK, 2008, MED PRIN PRACT, V17, P89, DOI 10.1159/000112961; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Leonard DS, 2002, BRIT J SURG, V89, P262, DOI 10.1046/j.0007-1323.2001.02022.x; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mastropasqua R, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/343515; Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068; Mundra V, 2015, J CONTROL RELEASE, V220, P130, DOI 10.1016/j.jconrel.2015.10.029; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saxena V, 2004, J PHOTOCH PHOTOBIO B, V74, P29, DOI 10.1016/j.jphotobiol.2004.01.002; Saxena V, 2003, J PHARM SCI, V92, P2090, DOI 10.1002/jps.10470; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Shemesh CS, 2015, PHARM RES-DORDR, V32, P1604, DOI 10.1007/s11095-014-1560-7; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; Tinoco G, 2013, J CANCER, V4, P117, DOI 10.7150/jca.4925; Yang J, 2007, J MATER CHEM, V17, P2695, DOI 10.1039/b702538f; Zelken JA, 2015, ANN SURG ONCOL, V22, pS1271, DOI 10.1245/s10434-015-4743-5	43	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168192	10.1371/journal.pone.0168192	http://dx.doi.org/10.1371/journal.pone.0168192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942034	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600058
J	Vieira, AR; Rodrigues, ASB; Sequeira, V; Neves, A; Paiva, RB; Paulo, OS; Gordo, LS				Vieira, Ana Rita; Rodrigues, Ana Sofia B.; Sequeira, Vera; Neves, Ana; Paiva, Rafaela Barros; Paulo, Octavio S.; Gordo, Leonel Serrano			Genetic and Morphological Variation of the Forkbeard, Phycis phycis (Pisces, Phycidae): Evidence of Panmixia and Recent Population Expansion along Its Distribution Area	PLOS ONE			English	Article							COD GADUS-MORHUA; STOCK IDENTIFICATION; ATLANTIC COD; HOLISTIC APPROACH; MARINE FISH; BODY SHAPE; GROWTH; SEA; DIVERGENCE; TRACHURUS	The knowledge of population structure of a species is essential to effectively assess and manage fisheries. In the present study, genetics, by mitochondrial DNA cytochrome b sequence analysis, and body geometric morphometrics were used to evaluate the existence of distinct populations of the forkbeard (Phycis phycis), an important commercial species in several European countries, especially Portugal and Spain. For geometric morphometric analysis, specimens were collected in the Northeast Atlantic Ocean-Azores, Madeira and mainland Portugal, and for genetic analysis, these samples were complemented with samples collected in the Mediterranean Sea-Spain, Italy and Croatia, in order to cover the entire distribution area of the species. Body shape of the forkbeard from the Northeast Atlantic was found to be highly variable. This variation was probably associated with different environmental factors between the study areas. Despite morphological variation, a low genetic differentiation between samples from different areas was found, most likely due to gene flow that occurred in the past or with the demographic history of the species. Moreover, the presence of unique haplotypes in the Northeast Atlantic and in the Mediterranean suggests that recent gene flow between populations from these areas should be limited. Altogether, a high haplotype diversity, a low nucleotide diversity, a "star-like" network and the results of the mismatch distribution, indicate a possible signature of recent population expansions, which probably started during the end of the Last Glacial Maximum and led to the colonization of the Northeast Atlantic and the Mediterranean.	[Vieira, Ana Rita; Sequeira, Vera; Neves, Ana; Paiva, Rafaela Barros; Gordo, Leonel Serrano] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Vieira, Ana Rita; Neves, Ana; Paiva, Rafaela Barros; Paulo, Octavio S.; Gordo, Leonel Serrano] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Rodrigues, Ana Sofia B.; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, cE3c, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Vieira, AR (corresponding author), Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.; Vieira, AR (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal.	arivieira@fc.ul.pt	Paulo, Octávio/D-9921-2011; Sequeira, Vera/B-1673-2012; Vieira, Ana Rita/B-1677-2012; Neves, Ana/B-3611-2012	Paulo, Octávio/0000-0001-5408-5212; Sequeira, Vera/0000-0001-7173-4982; Vieira, Ana Rita/0000-0002-5640-7999; Neves, Ana/0000-0003-3885-2738; Rodrigues, Ana Sofia/0000-0003-4887-3823	Programa Operacional Pesca [PROMAR 31-03-05-FEP-8]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73506/2010, SFRH/BD/73879/2010, SFRH/BPD/70200/2010, SFRH/BD/92769/2013, SFRH/BD/80268/2011]	Programa Operacional Pesca; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially supported by the Programa Operacional Pesca 2007-2013 (http://www.promar.gov.pt/) through the project PROMAR 31-03-05-FEP-8. Fundacao para a Ciencia e a Tecnologia (http//www.fct.pt/) supported the fellowship attributed to ARV (SFRH/BD/73506/2010), ASBR (SFRH/BD/73879/2010), VS (SFRH/BPD/70200/2010), AN (SFRH/BD/92769/2013) and RBP (SFRH/BD/80268/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P104, DOI 10.1016/j.fishres.2007.09.020; Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Almada VC, 2001, GLOBAL ECOL BIOGEOGR, V10, P411, DOI 10.1046/j.1466-822X.2001.00244.x; Almada VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044404; Antonucci F, 2009, J MORPHOL, V270, P843, DOI 10.1002/jmor.10725; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Arnason E, 2004, GENETICS, V166, P1871, DOI 10.1534/genetics.166.4.1871; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow GW, 1961, SYSTEMATIC BIOL; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bookstein F., 1990, P MICHIGAN MORPHOMET; Bookstein F. L., 1997, MORPHOMETRIC TOOL LA; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Bush ABG, 1999, J GEOPHYS RES-ATMOS, V104, P24509, DOI 10.1029/1999JD900447; Cadrin SX, 2000, REV FISH BIOL FISHER, V10, P91, DOI 10.1023/A:1008939104413; CAMPANA SE, 1995, MAR ECOL PROG SER, V122, P115, DOI 10.3354/meps122115; CARR SM, 1995, MOL ECOL, V4, P79, DOI 10.1111/j.1365-294X.1995.tb00194.x; Catarino D, 2013, DEEP-SEA RES PT II, V98, P160, DOI 10.1016/j.dsr2.2013.02.010; Chow S, 1998, MOL ECOL, V7, P1255; Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397; Cimmaruta R, 2008, FISH RES, V89, P114, DOI 10.1016/j.fishres.2007.09.030; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Comesana AS, 2008, FISH RES, V89, P122, DOI 10.1016/j.fishres.2007.09.014; COMYNS BH, 1993, FISH B-NOAA, V91, P210; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; CROWLEY TJ, 1981, MAR MICROPALEONTOL, V6, P97, DOI 10.1016/0377-8398(81)90001-3; D'Anatro A, 2011, J ZOOL, V285, P139, DOI 10.1111/j.1469-7998.2011.00823.x; Domingues VS, 2006, MOL PHYLOGENET EVOL, V40, P139, DOI 10.1016/j.ympev.2006.02.009; Domingues VS, 2007, MAR BIOL, V150, P509, DOI 10.1007/s00227-006-0367-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2012, FAO YB FISH AQ STAT; Franchini P, 2014, MOL ECOL, V23, P1828, DOI 10.1111/mec.12590; Fu YX, 1997, GENETICS, V147, P915; GATZ A J JR, 1979, Tulane Studies in Zoology and Botany, V21, P91; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Hayes DB, 1996, CAN J FISH AQUAT SCI, V53, P383, DOI 10.1139/f95-273; Hurlbut T, 1998, CAN J FISH AQUAT SCI, V55, P2274, DOI 10.1139/cjfas-55-10-2274; Inada T, 1990, FAO SPECIES CATALOGU, V10, P39; INE, 2013, STAT DAT FISH 2001 2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Komakhidze A, 1998, 1 INT S FISH EC TRAB, P143; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marcus LF, 1996, NATO ASI SERIES A; MELVIN GD, 1992, CAN J FISH AQUAT SCI, V49, P266, DOI 10.1139/f92-031; METHVEN D A, 1985, Journal of Northwest Atlantic Fishery Science, V6, P9; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Morato T, 1999, ARQUIPELAGO LIFE MAR, P17; Mousset S, 2004, MOL BIOL EVOL, V21, P724, DOI 10.1093/molbev/msh066; Murta AG, 2008, FISH RES, V89, P152, DOI 10.1016/j.fishres.2007.09.026; Neethling M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-325; Nyboer EA, 2013, BIOL J LINN SOC, V110, P449, DOI 10.1111/bij.12122; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; PAPACONSTANTINOU C, 1989, FISH RES, V7, P329, DOI 10.1016/0165-7836(89)90065-9; Pina-Martins F, 2008, MOL ECOL RESOUR, V8, P1254, DOI 10.1111/j.1755-0998.2008.02164.x; Planes S, 2001, EVOLUTION, V55, P2263; POGSON GH, 1995, GENETICS, V139, P375; Ripley B. D., 1996, PATTERN RECOGNITION; Robalo JI, 2013, MAR BIOL, V160, P2461, DOI 10.1007/s00227-013-2241-5; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf F.J., 1990, SPECIAL PUBLICATION, V2, p[227, 380]; Rohlf F. J., 2010, TPSDIG VERSION 2; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Schneider S, 1999, GENETICS, V152, P1079; Sequeira V, 2011, HYDROBIOLOGIA, V669, P133, DOI 10.1007/s10750-011-0655-y; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Silva SE, 2013, BIOL J LINN SOC, V108, P494, DOI 10.1111/j.1095-8312.2012.02041.x; SLATKIN M, 1991, GENETICS, V129, P555; Stefanni S, 2007, MOL PHYLOGENET EVOL, V42, P38, DOI 10.1016/j.ympev.2006.05.035; Swain DP, 1999, FISH RES, V43, P113, DOI 10.1016/S0165-7836(99)00069-7; TAJIMA F, 1989, GENETICS, V123, P585; TAYLOR EB, 1985, CAN J FISH AQUAT SCI, V42, P2020, DOI 10.1139/f85-249; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Vieira AR, 2016, HELGOLAND MAR RES, V70, DOI 10.1186/s10152-016-0455-x; Vieira AR, 2014, J MAR BIOL ASSOC UK, V94, P623, DOI 10.1017/S0025315413001549; Vieira A, 2014, HYDROBIOLOGIA, V728, P103, DOI 10.1007/s10750-014-1809-5; WEBB PW, 1984, AM ZOOL, V24, P107; Wilks SS, 1932, BIOMETRIKA, V24, P471; WIMBERGER PH, 1992, BIOL J LINN SOC, V45, P197, DOI 10.1111/j.1095-8312.1992.tb00640.x	94	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167045	10.1371/journal.pone.0167045	http://dx.doi.org/10.1371/journal.pone.0167045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941988	Green Submitted, Green Published, gold			2022-12-26	WOS:000392745600007
J	Caniffi, C; Cerniello, FM; Gobetto, MN; Sueiro, ML; Costa, MA; Arranz, C				Caniffi, Carolina; Cerniello, Flavia M.; Gobetto, Maria N.; Sueiro, Maria L.; Costa, Maria A.; Arranz, Cristina			Vascular Tone Regulation Induced by C-Type Natriuretic Peptide: Differences in Endothelium-Dependent and -Independent Mechanisms Involved in Normotensive and Spontaneously Hypertensive Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; POTASSIUM CHANNELS; CYCLIC-GMP; K+-CHANNELS; BRADYKININ; EXPRESSION; AORTA; CONTRACTIONS; RECEPTOR	Given that the role of C-type natriuretic peptide (CNP) in the regulation of vascular tone in hypertensive states is unclear, we hypothesized that impaired response of the nitric oxide system to CNP in spontaneously hypertensive rats (SHR) could affect vascular relaxation induced by the peptide in this model of hypertension, and that other endothelial systems or potassium channels opening could also be involved. We examined the effect of CNP on isolated SHR aortas, and the hindlimb vascular resistance (HVR) in response to CNP administration compared to normotensive rats. Aortas were mounted in an isometric organ bath and contracted with phenylephrine. CNP relaxed arteries in a concentration-dependent manner but was less potent in inducing relaxation in SHR. The action of CNP was diminished by removal of the endothelium, inhibition of nitric oxide synthase by N-omega-nitro-L-arginine methyl ester, and inhibition of soluble guanylyl cyclase by 1H-[1,2,4] oxadiazolo[4,3-alpha]quinoxalin-1-one in both groups. In contrast, blockade of cyclooxygenase or subtype 2 bradykinin receptor increased CNP potency only in SHR. In both Wistar and SHR, CNP relaxation was blunted by tetraethylammonium and partially inhibited by BaCl2 and iberiotoxin, indicating that it was due to opening of the Kir and BKCa channels. However, SHR seem to be more sensitive to Kir channel blockade and less sensitive to BKCa channel blockade than normotensive rats. In addition, CNP decreases HVR in Wistar and SHR, but the effect of CNP increasing blood flow was more marked in SHR. We conclude that CNP induces aorta relaxation by activation of the nitric oxide system and opening of potassium channels, but the response to the peptide is impaired in conductance vessel of hypertensive rats.	[Caniffi, Carolina; Cerniello, Flavia M.; Gobetto, Maria N.; Sueiro, Maria L.; Costa, Maria A.; Arranz, Cristina] Univ Buenos Aires, CONICET, Inst Quim & Metab Farm IQUIMEFA, Fac Farm & Bioquim,Catedra Fisiol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Caniffi, C (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Metab Farm IQUIMEFA, Fac Farm & Bioquim,Catedra Fisiol, Buenos Aires, DF, Argentina.	ccaniffi@ffyb.uba.ar			UBACYT from Universidad de Buenos Aires, Argentina [20020100100060]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP-112-201101-00581]	UBACYT from Universidad de Buenos Aires, Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially supported by grants UBACYT No 20020100100060 (2011-2014) from Universidad de Buenos Aires, Argentina, MAC; and PIP-112-201101-00581 from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina, CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095446; Costa MA, 2007, BIOCHEM BIOPH RES CO, V359, P180, DOI 10.1016/j.bbrc.2007.05.095; ASANO M, 1995, J PHARMACOL EXP THER, V275, P775; Blacher J, 2000, ARCH INTERN MED, V160, P1085, DOI 10.1001/archinte.160.8.1085; Brunner F, 2001, CARDIOVASC RES, V51, P577, DOI 10.1016/S0008-6363(01)00283-8; Bujak-Gizycka B, 2011, ACTA BIOCHIM POL, V58, P199; CAMPBELL DJ, 1995, J HYPERTENS, V13, P739; Caniffi C, 2010, PEPTIDES, V31, P1309, DOI 10.1016/j.peptides.2010.03.030; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; Chen HH, 1998, J CARDIOVASC PHARM, V32, pS22; Cox RH, 2002, VASC PHARMACOL, V38, P13, DOI 10.1016/S1537-1891(02)00122-2; Eichhorn B, 2007, N-S ARCH PHARMACOL, V376, P145, DOI 10.1007/s00210-007-0193-3; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; GE T, 1995, CIRC RES, V76, P1003, DOI 10.1161/01.RES.76.6.1003; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gryglewski RJ, 2002, PEDIATR PATHOL MOL M, V21, P279, DOI 10.1080/02770930290056514; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Ihara E, 2001, J PHYSIOL-LONDON, V534, P701, DOI 10.1111/j.1469-7793.2001.t01-1-00701.x; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; Kim MY, 2005, AM J PHYSIOL-HEART C, V289, pH792, DOI 10.1152/ajpheart.00050.2005; Li Y, 2014, HYPERTENSION, V63, P846, DOI 10.1161/HYPERTENSIONAHA.113.01772; Liang CC, 2010, FORMOS J ENDOCRIN ME, V1, P1; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; Madhani M, 2003, BRIT J PHARMACOL, V139, P1289, DOI 10.1038/sj.bjp.0705365; MONCADA S, 1991, PHARMACOL REV, V43, P109; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Numaguchi Y, 1999, CARDIOVASC RES, V41, P682, DOI 10.1016/S0008-6363(98)00239-9; OZA NB, 1990, J CLIN INVEST, V85, P597, DOI 10.1172/JCI114479; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; Parkington HC, 2002, J PHYSIOL-LONDON, V542, P929, DOI 10.1113/jphysiol.2002.021030; Piech A, 2003, CARDIOVASC RES, V57, P456, DOI 10.1016/S0008-6363(02)00676-4; Pitt B, 1996, CARDIOVASC DRUG THER, V10, P469, DOI 10.1007/BF00051113; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Quayle JM, 1996, J PHYSIOL-LONDON, V494, P715, DOI 10.1113/jphysiol.1996.sp021527; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; Robertson BE, 1996, AM J PHYSIOL-HEART C, V271, pH696, DOI 10.1152/ajpheart.1996.271.2.H696; Rodriguez JA, 2006, AM J PHYSIOL-HEART C, V290, pH30, DOI 10.1152/ajpheart.00349.2005; SCHMAIER AH, 1988, J BIOL CHEM, V263, P16327; Simon A, 2009, AM J PHYSIOL-LUNG C, V296, pL248, DOI 10.1152/ajplung.90303.2008; TADDEI S, 1993, J CARDIOVASC PHARM, V22, pS328, DOI 10.1097/00005344-199322008-00086; Vanhoutte PM, 2010, J PHYSL 22, V586, P5295; Villar IC, 2007, CARDIOVASC RES, V74, P515, DOI 10.1016/j.cardiores.2007.02.032; Woodard GE, 2008, INT REV CEL MOL BIO, V268, P59, DOI 10.1016/S1937-6448(08)00803-4; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	49	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167817	10.1371/journal.pone.0167817	http://dx.doi.org/10.1371/journal.pone.0167817			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936197	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100205
J	Chung, HR; Vakil, M; Munroe, M; Parikh, A; Meador, BM; Wu, PT; Jeong, JH; Woods, JA; Wilund, KR; Boppart, MD				Chung, Hae R.; Vakil, Mayand; Munroe, Michael; Parikh, Alay; Meador, Benjamin M.; Wu, Pei T.; Jeong, Jin H.; Woods, Jeffrey A.; Wilund, Kenneth R.; Boppart, Marni D.			The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy	PLOS ONE			English	Article							PROTEIN GERANYLGERANYLATION; ATORVASTATIN TREATMENT; UBIQUITIN-PROTEASOME; OXIDATIVE STRESS; CREATINE-KINASE; INCREASES; APOPTOSIS; THERAPY; MICE; HYPERCHOLESTEROLEMIA	HMG-CoA reductase inhibitors (statins) are the most effective pharmacological means of reducing cardiovascular disease risk. The most common side effect of statin use is skeletal muscle myopathy, which may be exacerbated by exercise. Hypercholesterolemia and training status are factors that are rarely considered in the progression of myopathy. The purpose of this study was to determine the extent to which acute and chronic exercise can influence statin-induced myopathy in hypercholesterolemic (ApoE(-/-)) mice. Mice either received daily injections of saline or simvastatin (20 mg/kg) while: 1) remaining sedentary (Sed), 2) engaging in daily exercise for two weeks (novel, Nov), or 3) engaging in daily exercise for two weeks after a brief period of training (accustomed, Acct) (2x3 design, n = 60). Cholesterol, activity, strength, and indices of myofiber damage and atrophy were assessed. Running wheel activity declined in both exercise groups receiving statins (statin x time interaction, p<0.05). Cholesterol, grip strength, and maximal isometric force were significantly lower in all groups following statin treatment (statin main effect, p<0.05). Mitochondrial content and myofiber size were increased and 4-HNE was decreased by exercise (statin x exercise interaction, p<0.05), and these beneficial effects were abrogated by statin treatment. Exercise (Acct and Nov) increased atrogin-1 mRNA in combination with statin treatment, yet enhanced fiber damage or atrophy was not observed. The results from this study suggest that exercise (Nov, Acct) does not exacerbate statin-induced myopathy in ApoE(-/-) mice, yet statin treatment reduces activity in a manner that prevents muscle from mounting a beneficial adaptive response to training.	[Chung, Hae R.; Vakil, Mayand; Meador, Benjamin M.; Wu, Pei T.; Jeong, Jin H.; Wilund, Kenneth R.] Univ Illinois, Dept Kinesiol & Community Hlth, Renal & Cardiovasc Dis Res Lab, Urbana, IL USA; [Munroe, Michael; Parikh, Alay; Boppart, Marni D.] Univ Illinois, Dept Kinesiol & Community Hlth, Mol Muscle Physiol Lab, Urbana, IL 61801 USA; [Munroe, Michael; Parikh, Alay; Boppart, Marni D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Woods, Jeffrey A.] Univ Illinois, Dept Kinesiol & Community Hlth, Exercise Immunol Res Lab, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Boppart, MD (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Mol Muscle Physiol Lab, Urbana, IL 61801 USA.; Boppart, MD (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	mboppart@illinois.edu		Jeong, Jin hee/0000-0002-8748-8429; Meador, Benjamin/0000-0001-8687-1023	University of Illinois (Center for Health, Aging, and Disability)	University of Illinois (Center for Health, Aging, and Disability)	This work was funded by an internal grant provided by the University of Illinois (Center for Health, Aging, and Disability).	Ballard KD, 2013, ATHEROSCLEROSIS, V230, P121, DOI 10.1016/j.atherosclerosis.2013.07.001; Bouitbir J, 2012, MUSCLE NERVE, V46, P367, DOI 10.1002/mus.23309; Bouitbir J, 2011, J APPL PHYSIOL, V111, P1477, DOI 10.1152/japplphysiol.00107.2011; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006; Dodd SL, 2010, MUSCLE NERVE, V41, P110, DOI 10.1002/mus.21526; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Hubal MJ, 2011, MUSCLE NERVE, V44, P393, DOI 10.1002/mus.22081; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Kang J, 2008, J VASC SURG, V48, P701, DOI 10.1016/j.jvs.2008.04.006; Kavazis AN, 2014, J APPL PHYSIOL, V117, P223, DOI 10.1152/japplphysiol.00210.2014; Kwak HB, 2012, FREE RADICAL BIO MED, V52, P198, DOI 10.1016/j.freeradbiomed.2011.10.449; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Matzno S, 2005, J PHARM PHARMACOL, V57, P1475, DOI 10.1211/jpp.57.11.0014; Maxwell AJ, 2009, VASC MED, V14, P249, DOI 10.1177/1358863X08100040; Meador BM, 2011, MUSCLE NERVE, V44, P882, DOI 10.1002/mus.22236; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Muraki A, 2012, J APPL PHYSIOL, V113, P479, DOI 10.1152/japplphysiol.01362.2011; Mutoh T, 1999, FEBS LETT, V444, P85, DOI 10.1016/S0014-5793(99)00031-9; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Seachrist JL, 2005, TOXICOL SCI, V88, P551, DOI 10.1093/toxsci/kfi305; Sinzinger H, 2002, J CARDIOVASC PHARM, V40, P163, DOI 10.1097/00005344-200208000-00001; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; Sirvent P, 2012, TOXICOL APPL PHARM, V259, P263, DOI 10.1016/j.taap.2012.01.008; SMIT JWA, 1995, EUR J CLIN INVEST, V25, P79, DOI 10.1111/j.1365-2362.1995.tb01530.x; Thompson PD, 1997, METABOLISM, V46, P1206, DOI 10.1016/S0026-0495(97)90218-3; Tomlinson SS, 2005, PHYS THER, V85, P459, DOI 10.1093/ptj/85.5.459; Ucar M, 2000, DRUG SAFETY, V22, P441, DOI 10.2165/00002018-200022060-00003; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599; Zhang L, 2011, EUR J VASC ENDOVASC, V42, P393, DOI 10.1016/j.ejvs.2011.05.016; Zhong WB, 2003, ENDOCRINOLOGY, V144, P3852, DOI 10.1210/en.2003-0098	41	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168065	10.1371/journal.pone.0168065	http://dx.doi.org/10.1371/journal.pone.0168065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936249	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100266
J	Hartman, MHT; Vreeswijk-Baudoin, I; Groot, HE; van de Kolk, KWA; de Boer, RA; Leach, IM; Vliegenthart, R; Sillje, HHW; van der Harst, P				Hartman, Minke H. T.; Vreeswijk-Baudoin, Inge; Groot, Hilde E.; van de Kolk, Kees W. A.; de Boer, Rudolf A.; Leach, Irene Mateo; Vliegenthart, Rozemarijn; Sillje, Herman H. W.; van der Harst, Pim			Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion	PLOS ONE			English	Article							IL-6 RECEPTOR; ANTIBODY; HEART; MECHANISMS; DISEASE; TOCILIZUMAB; LEVEL	Background Interleukin-6 (IL-6) levels are upregulated in myocardial infarction. Recent data suggest a causal role of the IL-6 receptor (IL-6R) in coronary heart disease. We evaluated if IL-6R blockade by a monoclonal antibody (MR16-1) prevents the heart from adverse left ventricular remodeling in a mouse model of ischemia-reperfusion (I/R). Methods CJ57/BL6 mice underwent I/R injury (left coronary artery ligation for 45 minutes) or sham surgery, and thereafter received MR16-1 (2mg/mouse) 5 minutes before reperfusion and 0.5mg/mouse weekly during four weeks, or control IgG treatment. Cardiac Magnetic Resonance Imaging (CMR) and hemodynamic measurements were performed to determine cardiac function after four weeks. Results I/R caused left ventricular dilatation and a decrease in left ventricular ejection fraction (LVEF). However, LVEF was significantly lower in the MR16-1 treatment group compared to the IgG group (28 +/- 4% vs. 35 +/- 6%, p = 0.02; sham 45 +/- 6% vs. 43 +/- 4%, respectively; p = NS). Cardiac relaxation (assessed by dP/dT) was not significantly different between the MR16-1 and IgG groups. Also, no differences were observed in histological myocardial fibrosis, infarct size and myocyte hypertrophy between the groups. Conclusion Blockade of the IL-6R receptor by the monoclonal MR16-1 antibody for four weeks started directly after I/R injury did not prevent the process of cardiac remodeling in mice, but rather associated with a deterioration in the process of adverse cardiac remodeling.	[Hartman, Minke H. T.; Vreeswijk-Baudoin, Inge; Groot, Hilde E.; de Boer, Rudolf A.; Leach, Irene Mateo; Sillje, Herman H. W.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van de Kolk, Kees W. A.] Univ Groningen, Univ Med Ctr Groningen, Cent Anim Facil, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Leach, IM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	i.v.mateo.leach@umcg.nl	de Boer, Rudolf/ABE-9879-2020	Hartman, Minke H.T./0000-0002-6965-3259	Netherlands organization for health research and development (ZonMw) [90.700.441, 114.024.032]	Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was supported by the Netherlands organization for health research and development (ZonMw grant "Clinical fellow", grant number 90.700.441 and ZonMW grant "Meer kennis met minder dieren", grant number 114.024.032).	Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Askevold Erik Tandberg, 2014, Curr Heart Fail Rep, V11, P146, DOI 10.1007/s11897-014-0185-9; Askevold ET, 2013, CIRC-HEART FAIL, V6, P91, DOI 10.1161/CIRCHEARTFAILURE.112.972653; De Gennaro L, 2012, INFLAMMATION, V35, P363, DOI 10.1007/s10753-011-9326-4; Fahmi A, 2013, CELL SIGNAL, V25, P898, DOI 10.1016/j.cellsig.2012.12.008; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Gjesdal O, 2011, NAT REV CARDIOL, V8, P673, DOI 10.1038/nrcardio.2011.154; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kaminski KA, 2009, ATHEROSCLEROSIS, V206, P581, DOI 10.1016/j.atherosclerosis.2009.03.033; Katsume A, 2002, CYTOKINE, V20, P304, DOI 10.1006/cyto.2002.2012; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Laura PA, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/974694; Malaviya AP, 2014, RHEUMATOLOGY, V53, P1344, DOI 10.1093/rheumatology/keu168; Matsushita K, 2005, LAB INVEST, V85, P1210, DOI 10.1038/labinvest.3700322; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Papavassiliu T, 2005, RADIOLOGY, V236, P57, DOI 10.1148/radiol.2353040601; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Sposito AC, 2011, ARTERIOSCL THROM VAS, V31, P1240, DOI 10.1161/ATVBAHA.110.218685; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Uchiyama Y, 2008, INT IMMUNOPHARMACOL, V8, P1595, DOI 10.1016/j.intimp.2008.07.002; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168	33	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167195	10.1371/journal.pone.0167195	http://dx.doi.org/10.1371/journal.pone.0167195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936014	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100071
J	Huang, YR; Zhong, C; Lin, HX; Huang, J				Huang, Yiran; Zhong, Cheng; Lin, Hai Xiang; Huang, Jing			Aligning Metabolic Pathways Exploiting Binary Relation of Reactions	PLOS ONE			English	Article							PROTEIN-INTERACTION; NETWORK ALIGNMENT; GLOBAL ALIGNMENT; LARGE-SCALE; INFORMATION; TOOL	Metabolic pathway alignment has been widely used to find one-to-one and/or one-to-many reaction mappings to identify the alternative pathways that have similar functions through different sets of reactions, which has important applications in reconstructing phylogeny and understanding metabolic functions. The existing alignment methods exhaustively search reaction sets, which may become infeasible for large pathways. To address this problem, we present an effective alignment method for accurately extracting reaction mappings between two metabolic pathways. We show that connected relation between reactions can be formalized as binary relation of reactions in metabolic pathways, and the multiplications of zero-one matrices for binary relations of reactions can be accomplished in finite steps. By utilizing the multiplications of zero-one matrices for binary relation of reactions, we efficiently obtain reaction sets in a small number of steps without exhaustive search, and accurately uncover biologically relevant reaction mappings. Furthermore, we introduce a measure of topological similarity of nodes (reactions) by comparing the structural similarity of the k-neighborhood subgraphs of the nodes in aligning metabolic pathways. We employ this similarity metric to improve the accuracy of the alignments. The experimental results on the KEGG database show that when compared with other state-of-the-art methods, in most cases, our method obtains better performance in the node correctness and edge correctness, and the number of the edges of the largest common connected subgraph for one-to-one reaction mappings, and the number of correct one-to-many reaction mappings. Our method is scalable in finding more reaction mappings with better biological relevance in large metabolic pathways.	[Huang, Yiran] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Yiran; Zhong, Cheng] Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China; [Lin, Hai Xiang] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands; [Huang, Jing] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China	South China University of Technology; Guangxi University; Delft University of Technology; Guangxi University	Huang, YR (corresponding author), South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Huang, YR; Zhong, C (corresponding author), Guangxi Univ, Sch Comp Elect & Informat, Nanning, Peoples R China.	hyr@gxu.edu.cn; chzhong@gxu.edu.cn		Lin, Hai Xiang/0000-0002-1653-4854	National Natural Science Foundation of China [61462005]; Natural Science Foundation of Guangxi [2014GXNSFAA118396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work is supported in part by the National Natural Science Foundation of China under Grant No. 61462005, and Natural Science Foundation of Guangxi under Grant No. 2014GXNSFAA118396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaka G, 2013, BIOINFORMATICS, V29, P145, DOI 10.1093/bioinformatics/btt235; Alberich R, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-58; Ay F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S2; Ay F, 2011, J COMPUT BIOL, V18, P219, DOI 10.1089/cmb.2010.0280; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheng Q, 2009, BIOINFORMATICS, V25, P1989, DOI 10.1093/bioinformatics/btp287; Fionda V, 2011, J COMPUT BIOL, V18, P595, DOI 10.1089/cmb.2009.0144; Hasan MM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0756-0; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Heymans M, 2003, BIOINFORMATICS, V19, pi138, DOI 10.1093/bioinformatics/btg1018; Hochuli M, 1999, J BACTERIOL, V181, P3226, DOI 10.1128/JB.181.10.3226-3237.1999; Jiang CR, 2010, INT ASIA CONF INFORM, P88, DOI 10.1109/CAR.2010.5456772; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Li YL, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-111; Malod-Dognin N, 2015, BIOINFORMATICS, V31, P2182, DOI 10.1093/bioinformatics/btv130; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Neyshabur B, 2013, BIOINFORMATICS, V29, P1654, DOI 10.1093/bioinformatics/btt202; Pinter RY, 2005, BIOINFORMATICS, V21, P3401, DOI 10.1093/bioinformatics/bti554; Rosen KH., 1999, DISCRETE MATH ITS AP; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Song B, 2011, IEEE ACM T COMPUT BI, V8, P732, DOI 10.1109/TCBB.2010.41; Tian YY, 2007, BIOINFORMATICS, V23, P232, DOI 10.1093/bioinformatics/btl571; Tohsato Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P376; Wernicke S, 2007, BIOINFORMATICS, V23, P1978, DOI 10.1093/bioinformatics/btm279; Yang QW, 2007, J COMPUT BIOL, V14, P56, DOI 10.1089/cmb.2006.0076; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	28	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168044	10.1371/journal.pone.0168044	http://dx.doi.org/10.1371/journal.pone.0168044			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936108	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100260
J	Kumar, PG; Kavitha, MS; Ahn, BC				Kumar, Pugalendhi Ganesh; Kavitha, Muthu Subash; Ahn, Byeong-Cheol			Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-SetBased F-Information and Water Swirl Algorithm of Human Gene Expression Data	PLOS ONE			English	Article							MICROARRAY DATA; DECISION RULES; EXPERT-SYSTEM; CLASSIFICATION; PREDICTION; MACHINE; TUMOR; PROFILES; PATTERNS	This study describes a novel approach to reducing the challenges of highly nonlinear multi-class gene expression values for cancer diagnosis. To build a fruitful system for cancer diagnosis, in this study, we introduced two levels of gene selection such as filtering and embedding for selection of potential genes and the most relevant genes associated with cancer, respectively. The filter procedure was implemented by developing a fuzzy rough set (FR)-based method for redefining the criterion function of f-information (FI) to identify the potential genes without discretizing the continuous gene expression values. The embedded procedure is implemented by means of a water swirl algorithm (WSA), which attempts to optimize the rule set and membership function required to classify samples using a fuzzy-rule-based multiclassification system (FRBMS). Two novel update equations are proposed in WSA, which have better exploration and exploitation abilities while designing a self-learning FRBMS. The efficiency of our new approach was evaluated on 13 multicategory and 9 binary datasets of cancer gene expression. Additionally, the performance of the proposed FRFI-WSA method in designing an FRBMS was compared with existing methods for gene selection and optimization such as genetic algorithm (GA), particle swarm optimization (PSO), and artificial bee colony algorithm (ABC) on all the datasets. In the global cancer map with repeated measurements (GCM_ RM) dataset, the FRFI-WSA showed the smallest number of 16 most relevant genes associated with cancer using a minimal number of 26 compact rules with the highest classification accuracy (96.45%). In addition, the statistical validation used in this study revealed that the biological relevance of the most relevant genes associated with cancer and their linguistics detected by the proposed FRFI-WSA approach are better than those in the other methods. The simple interpretable rules with most relevant genes and effectively classified samples suggest that the proposed FRFI-WSA approach is reliable for classification of an individual's cancer gene expression data with high precision and therefore it could be helpful for clinicians as a clinical decision support system.	[Kumar, Pugalendhi Ganesh] Anna Univ, Dept Informat Technol, Reg Campus, Coimbatore, Tamil Nadu, India; [Kavitha, Muthu Subash] Kyungpook Natl Univ, Sch Elect Engn, Dept Comp Vis & Image Proc, Daegu, South Korea; [Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea	Anna University; Anna University of Technology Coimbatore; Kyungpook National University; Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Kavitha, M.S./AAI-6438-2020; Kumar, Ganesh/D-5585-2019	Kumar, Ganesh/0000-0001-8681-8169; Kavitha, Muthu Subash/0000-0002-1676-561X	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]; grant of the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015M2A2A7A01045177]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; grant of the National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001) and a grant of the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. NRF-2015M2A2A7A01045177).; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C0001) and a grant of the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2015M2A2A7A01045177).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cengel Y. A., 2006, FLUID MECH FUNDAMENT; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chowdary D, 2006, J MOL DIAGN, V8, P31, DOI 10.2353/jmoldx.2006.050056; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Czajkowski M, 2014, ARTIF INTELL MED, V61, P35, DOI 10.1016/j.artmed.2014.01.005; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; GaneshKumar P, 2014, IEEE ACM T COMPUT BI, V11, P347, DOI 10.1109/TCBB.2014.2307325; Gordon GJ, 2002, CANCER RES, V62, P4963; Haque MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146116; Hippo Y, 2002, CANCER RES, V62, P233; Ho SY, 2006, BIOSYSTEMS, V85, P165, DOI 10.1016/j.biosystems.2006.01.002; Hu QH, 2012, IEEE T FUZZY SYST, V20, P636, DOI 10.1109/TFUZZ.2011.2181180; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Komori O, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/798189; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Kumar PG, 2015, INT J DATA MIN BIOIN, V11, P31, DOI 10.1504/IJDMB.2015.066333; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lee CS, 2011, IEEE T SYST MAN CY B, V41, P139, DOI 10.1109/TSMCB.2010.2048899; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Li J., 2002, KENT RIDGE BIOMEDICA; Liu L, 2015, TRANSL CANCER RES, V4, P212, DOI 10.3978/j.issn.2218-676X.2015.05.04; Menser S, 2006, PROCEEDINGS OF THE IEEE SOUTHEASTCON 2006, P250, DOI 10.1109/second.2006.1629359; Moon H, 2007, ARTIF INTELL MED, V41, P197, DOI 10.1016/j.artmed.2007.07.003; Nguyen T. H., 2015, INT J CORR, V2015, P1, DOI DOI 10.1152/AJPHEART.00499.2014; Nutt CL, 2003, CANCER RES, V63, P1602; Pamukcu E, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/370640; Pancho DP, 2013, IEEE T FUZZY SYST, V21, P1133, DOI 10.1109/TFUZZ.2013.2245130; Peterson LE, 2008, INT J APPROX REASON, V47, P17, DOI 10.1016/j.ijar.2007.03.006; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Risinger JI, 2003, CANCER RES, V63, P6; Saito PT, 2015, PLOS ONE, V10, P1; Schaefer G, 2010, IEEE T INF TECHNOL B, V14, P23, DOI 10.1109/TITB.2009.2033590; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sundaresh Suman, 2005, Int J Bioinform Res Appl, V1, P31, DOI 10.1504/IJBRA.2005.006901; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Trawinski K, 2013, IEEE T FUZZY SYST, V21, P950, DOI 10.1109/TFUZZ.2012.2236844; Trawinski K, 2011, INT J UNCERTAIN FUZZ, V19, P589, DOI 10.1142/S0218488511007155; Tsipouras MG, 2007, IEEE T BIO-MED ENG, V54, P2089, DOI 10.1109/TBME.2007.893500; Whitworth J, 2015, EUR J HUM GENET, V23, P581, DOI 10.1038/ejhg.2014.157; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Xu R, 2007, IEEE ACM T COMPUT BI, V4, P65, DOI 10.1109/TCBB.2007.1009; Yeang CH, 2001, BIOINFORMATICS S1, V17; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; Yoon Y, 2010, IEEE T SYST MAN CY C, V40, P216, DOI 10.1109/TSMCC.2009.2036594; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	56	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167504	10.1371/journal.pone.0167504	http://dx.doi.org/10.1371/journal.pone.0167504			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936033	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100112
J	Mahmud, M; Piwoni, A; Filiczak, N; Janicka, M; Gubernator, J				Mahmud, Mohamed; Piwoni, Adriana; Filiczak, Nina; Janicka, Martyna; Gubernator, Jerzy			Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro	PLOS ONE			English	Article							CANCER-CELLS; TUMOR-GROWTH; APOPTOSIS; DELIVERY; PROLIFERATION; PHOSPHOLIPIDS; NANOPARTICLES; INHIBITION; PACLITAXEL; PROTEINS	The incorporation of hydrophobic drugs into liposomes improve their bioavailability and leads to increased stability and anticancer activity, along with decreased drug toxicity. Curcumin (Cur) is a natural polyphenol compound with a potent anticancer activity in pancreatic adenocarcinoma (PA). In the present study, different types of Cur-loaded liposomal formulations were prepared and characterized in terms of size, shape, zeta potential, optimal drug-to-lipid ratio and stability at 4 degrees C, 37 degrees C; and in human plasma in vitro. The best formulation in terms of these parameters was PEGylated, cholesterol-free formulation based upon hydrogenated soya PC (HSPC: DSPE-PEG(2000): Cur, termed H5), which had a 0.05/10 molar ratio of drug-to-lipid, was found to be stable and had a 96% Cur incorporation efficiency. All Cur-loaded liposomal formulations had potent anticancer activity on the PA cancer cell lines AsPC-1 and BxPC-3, and were less toxic to a normal cell line (NHDF). Furthermore, apoptosis-induction induced by Cur in PA cells was associated with morphological changes including cell shrinkage, cytoplasmic blebbing, irregularity in shape and the externalization of cell membrane phosphatidylserine, which was preceded by an increase in intracellular reactive oxygen species (ROS) generation and caspase 3/7 activation. Because the liposomal formulations tested here, especially the H5 variant which exhibited slow release of the Cur in the human plasma test, the formulation may be stable enough to facilitate the accumulation of pharmacologically active amounts of Cur in target cancer tissue by EPR. Therefore, our formulations could serve as a promising therapeutic approach for pancreatic cancer and other cancers.	[Mahmud, Mohamed; Piwoni, Adriana; Filiczak, Nina; Janicka, Martyna; Gubernator, Jerzy] Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, Wroclaw, Poland	University of Wroclaw	Mahmud, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, Wroclaw, Poland.	mohamed.mahmud2@uwr.edu.pl	Filipczak, Nina/AAL-8886-2020	Filipczak, Nina/0000-0001-9285-8298; Mahmud, Mohamed/0000-0003-3237-7999	University of Wroclaw; Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW)	University of Wroclaw; Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW)	The authors would like to gratefully and sincerely thank the University of Wroclaw for supporting this research. This work was supported through the Wroclaw Center of Biotechnology program, The Leading National Research Center (KNOW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2002, BIOSCIENCE REP, V22, P225, DOI 10.1023/A:1020186505848; ALLEN TM, 1988, P NATL ACAD SCI USA, V85, P8067, DOI 10.1073/pnas.85.21.8067; ALLEN TM, 1989, BIOCHIM BIOPHYS ACTA, V981, P27, DOI 10.1016/0005-2736(89)90078-3; Chen J, 2016, DRUG DELIV, V23, P1426, DOI 10.3109/10717544.2015.1088598; Chen Y, 2012, MOLECULES, V17, P5972, DOI 10.3390/molecules17055972; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dhule SS, 2012, NANOMED-NANOTECHNOL, V8, P440, DOI 10.1016/j.nano.2011.07.011; Dos Santos N, 2002, BBA-BIOMEMBRANES, V1561, P188, DOI 10.1016/S0005-2736(02)00345-0; Drummond DC, 1999, PHARMACOL REV, V51, P691; El Kateb N, 2008, J MICROENCAPSUL, V25, P399, DOI [10.1080/02652040802012453, 10.1080/02652040802012453 ]; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; FREDERIK P M, 1991, Micron and Microscopica Acta, V22, P41, DOI 10.1016/0739-6260(91)90081-A; Gubernator J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091487; Gubernator J, 2010, J CONTROL RELEASE, V146, P68, DOI 10.1016/j.jconrel.2010.05.021; Hail N, 2008, FREE RADICAL BIO MED, V44, P1382, DOI 10.1016/j.freeradbiomed.2007.12.034; Hazzah HA, 2015, INT J PHARMACEUT, V492, P248, DOI 10.1016/j.ijpharm.2015.06.022; Husain K., 2014, J DRUG METABOLISM TO, V5, P1; Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857; Kanai M, 2012, POTENTIAL ROLE CURCU; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kesharwani P, 2015, COLLOID SURFACE B, V132, P138, DOI 10.1016/j.colsurfb.2015.05.007; Krasnici S, 2003, INT J CANCER, V105, P561, DOI 10.1002/ijc.11108; KULKARNI SB, 1995, J MICROENCAPSUL, V12, P229, DOI 10.3109/02652049509010292; Lasic DD, 1996, NATURE, V380, P561, DOI 10.1038/380561a0; Lasic DD., 1993, LIPOSOMES PHYS APPL; Li H-J, 2016, P NATL ACAD SCI; Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Lin YG, 2007, CLIN CANCER RES, V13, P3423, DOI 10.1158/1078-0432.CCR-06-3072; Liu AC, 2006, J PHARMACEUT BIOMED, V40, P720, DOI 10.1016/j.jpba.2005.09.032; Lombardi L, 2012, EXPERT OPIN THER TAR, V16, pS71, DOI 10.1517/14728222.2012.662959; Maeda H, 2011, ADV DRUG DELIVER REV, V63, P129, DOI 10.1016/j.addr.2010.05.001; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mimeault M, 2005, PANCREAS, V31, P301, DOI 10.1097/01.mpa.0000175893.04660.1b; Narang AS, 2011, ADV DRUG DELIVER REV, V63, P640, DOI 10.1016/j.addr.2011.04.002; Ranjan AP, 2013, ANTICANCER RES, V33, P3603; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Salmazi R, 2015, INT J NANOMED, V10, P4815, DOI 10.2147/IJN.S82385; Sari TP, 2015, FOOD HYDROCOLLOID, V43, P540, DOI 10.1016/j.foodhyd.2014.07.011; Semple SC, 1998, ADV DRUG DELIVER REV, V32, P3, DOI 10.1016/S0169-409X(97)00128-2; Singh RK, 2015, CLIN MED INSIGHTS-TH, V7, P63, DOI 10.4137/CMT.S33407; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tod J, 2013, PANCREATOLOGY, V13, P1, DOI 10.1016/j.pan.2012.11.311; Ulukaya E, 2008, TOXICOL IN VITRO, V22, P232, DOI 10.1016/j.tiv.2007.08.006; Verrax J, 2011, BIOCHEM PHARMACOL, V82, P1540, DOI 10.1016/j.bcp.2011.07.102; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281, DOI 10.2174/187152012803833026; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; WEINBERG ED, 1992, BIOL TRACE ELEM RES, V34, P123, DOI 10.1007/BF02785242; Wong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123461; WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C; Yamada T, 1997, CELL MOL LIFE SCI, V53, P435, DOI 10.1007/s000180050052; Yang T, 2007, DRUG DELIV, V14, P301, DOI 10.1080/10717540601098799; Yoshizawa Y, 2011, INT J PHARMACEUT, V412, P132, DOI 10.1016/j.ijpharm.2011.04.008	59	47	48	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167787	10.1371/journal.pone.0167787	http://dx.doi.org/10.1371/journal.pone.0167787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936114	Green Published, gold			2022-12-26	WOS:000389587100188
J	Martiny, AC; Ma, LY; Mouginot, C; Chandler, JW; Zinser, ER				Martiny, Adam C.; Ma, Lanying; Mouginot, Cealine; Chandler, Jeremy W.; Zinser, Erik R.			Interactions between Thermal Acclimation, Growth Rate, and Phylogeny Influence Prochlorococcus Elemental Stoichiometry	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; RESOURCE-ALLOCATION; MARINE PROCHLOROCOCCUS; TEMPERATURE; SYNECHOCOCCUS; RATIOS; NITROGEN; PHOSPHORUS; ECOTYPES; PLANKTON	Variability in plankton elemental requirements can be important for global ocean biogeochemistry but we currently have a limited understanding of how ocean temperature influences the plankton C/N/P ratio. Multiple studies have put forward a 'translation-compensation' hypothesis to describe the positive relationship between temperature and plankton N/P or C/P as cells should have lower demand for P-rich ribosomes and associated depressed QP when growing at higher temperature. However, temperature affects many cellular processes beyond translation with unknown outcomes on cellular elemental composition. In addition, the impact of temperature on growth and elemental composition of phytoplankton is likely modulated by the life history and growth rate of the organism. To test the direct and indirect (via growth rate changes) effect of temperature, we here analyzed the elemental composition and ratios in six strains affiliated with the globally abundant marine Cyanobacteria Prochlorococcus. We found that temperature had a significant positive effect on the carbon and nitrogen cell quota, whereas no clear trend was observed for the phosphorus cell quota. The effect on N/P and C/P were marginally significantly positive across Prochlorococcus. The elemental composition and ratios of individual strains were also affected but we found complex interactions between the strain identity, temperature, and growth rate in controlling the individual elemental ratios in Prochlorococcus and no common trends emerged. Thus, the observations presented here does not support the 'translation-compensation' theory and instead suggest unique cellular elemental effects as a result of rising temperature among closely related phytoplankton lineages. Thus, the biodiversity context should be considered when predicting future elemental ratios and how cycles of carbon, nitrogen, and phosphorus may change in a future ocean.	[Martiny, Adam C.; Mouginot, Cealine] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Martiny, Adam C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Ma, Lanying; Chandler, Jeremy W.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Tennessee System; University of Tennessee Knoxville	Martiny, AC (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.; Martiny, AC (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	amartiny@uci.edu	Martiny, Adam/AAC-4459-2019	Martiny, Adam/0000-0003-2829-4314	National Science Foundation [OCE-1046297, OCE-1559002, OCE-1030518, OCE-1233964]; Division Of Ocean Sciences [1559002] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support for this work was provided by the National Science Foundation Dimensions of Biodiversity (OCE-1046297) and Biological Oceanography (OCE-1559002) programs (to ACM) as well as Biological (OCE-1030518) and Chemical (OCE-1233964) Oceanography programs (to ERZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this work was provided by the National Science Foundation Dimensions of Biodiversity (OCE-1046297) and Biological Oceanography (OCE-1559002) programs (to ACM) as well as Biological (OCE-1030518) and Chemical (OCE-1233964) Oceanography programs (to ERZ). We thank the captain and crew of the R/V Thomas G. Thompson for support during the POWOW1 cruise.	Alexander H, 2015, P NATL ACAD SCI USA, V112, pE2182, DOI 10.1073/pnas.1421993112; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bonachela JA, 2013, BIOGEOSCIENCES, V10, P4341, DOI 10.5194/bg-10-4341-2013; Boyd PW, 2015, NAT CLIM CHANGE, V5, P71, DOI [10.1038/NCLIMATE2441, 10.1038/nclimate2441]; Bremer H., 2008, ECOSAL PLUS, V3, P765; Chandler JW, 2016, ENV MICROBIOL REP, V8, P272, DOI 10.1111/1758-2229.12378; DROOP MR, 1973, J PHYCOL, V9, P264; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Flynn KJ, 2010, J PHYCOL, V46, P1, DOI 10.1111/j.1529-8817.2009.00756.x; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Galbraith ED, 2015, P NATL ACAD SCI USA, V112, P8199, DOI 10.1073/pnas.1423917112; Garcia NS, 2016, ISME J; Grob C, 2013, ENV MICROBIOL; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomas MW, 2010, BIOGEOSCIENCES, V7, P695, DOI 10.5194/bg-7-695-2010; Martiny AC, 2013, GLOBAL BIOGEOCHEM CY, V27, P723, DOI 10.1002/gbc.20061; Martiny AC, 2016, LIMNOL OCEANOGR, V61, P531, DOI 10.1002/lno.10233; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Mouginot C, 2015, LIMNOL OCEANOGR, V60, P1634, DOI 10.1002/lno.10123; Nielsen MV, 1996, MAR ECOL PROG SER, V136, P205, DOI 10.3354/meps136205; NIELSEN MV, 1991, J PLANKTON RES, V13, P389, DOI 10.1093/plankt/13.2.389; Oksanen J., 2016, R PACKAG; REDFIELD AC, 1958, AM SCI, V46, P205; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Talarmin A, 2016, GLOBAL BIOGEOCHEM CY; Teng YC, 2014, NAT GEOSCI, V7, P895, DOI 10.1038/NGEO2303; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Yvon-Durocher G, 2015, GLOBAL ECOL BIOGEOGR, V24, P562, DOI 10.1111/geb.12280; Zimmerman AE, 2014, ENVIRON MICROBIOL, V16, P1398, DOI 10.1111/1462-2920.12329; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205	48	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168291	10.1371/journal.pone.0168291	http://dx.doi.org/10.1371/journal.pone.0168291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936127	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100287
J	Muller, A; Clarkson, C				Muller, Antoine; Clarkson, Chris			Identifying Major Transitions in the Evolution of Lithic Cutting Edge Production Rates	PLOS ONE			English	Article							MIDDLE STONE-AGE; PREPARED CORE TECHNOLOGIES; SOUTH-AFRICA; MODERN HUMANS; TOOL USE; PALEOLITHIC TRANSITION; KAPTHURIN FORMATION; BLADE PRODUCTION; WEST TURKANA; COGNITION	The notion that the evolution of core reduction strategies involved increasing efficiency in cutting edge production is prevalent in narratives of hominin technological evolution. Yet a number of studies comparing two different knapping technologies have found no significant differences in edge production. Using digital analysis methods we present an investigation of raw material efficiency in eight core technologies broadly representative of the long-term evolution of lithic technology. These are bipolar, multiplatform, discoidal, biface, Levallois, prismatic blade, punch blade and pressure blade production. Raw material efficiency is assessed by the ratio of cutting edge length to original core mass. We also examine which flake attributes contribute to maximising raw material efficiency, as well as compare the difference between expert and intermediate knappers in terms of cutting edge produced per gram of core. We identify a gradual increase in raw material efficiency over the broad sweep of lithic technological evolution. The results indicate that the most significant transition in efficiency likely took place with the introduction of small foliate biface, Levallois and prismatic blade knapping, all introduced in the Middle Stone Age / Middle Palaeolithic among early Homo sapiens and Neanderthals. This suggests that no difference in raw material efficiency existed between these species. With prismatic blade technology securely dated to the Middle Palaeolithic, by including the more recent punch and pressure blade technology our results dispel the notion that the transition to the Upper Palaeolithic was accompanied by an increase in efficiency. However, further increases in cutting edge efficiency are evident, with pressure blades possessing the highest efficiency in this study, indicating that late/epi-Palaeolithic and Neolithic blade technologies further increased efficiency.	[Muller, Antoine; Clarkson, Chris] Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia	University of Queensland	Muller, A (corresponding author), Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia.	antoine.muller@uqconnect.edu.au		Muller, Antoine/0000-0003-1646-796X				Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Beck C, 2015, LITHIC TECHNOLOGICAL SYSTEMS AND EVOLUTIONARY THEORY, P83; Bleed P, 2008, J ARCHAEOL METHOD TH, V15, P154, DOI 10.1007/s10816-007-9046-0; Boeda E., 1993, B SOC PREHIST FR; Bordaz J., 1970, TOOLS OLD NEW STONE; Bordes F., 1969, TEBIWA, V12, P1; Bourguignon L, 1997, MOUSTERIEN TYPE QUIN; Brantingham PG, 2000, J ARCHAEOL SCI, V27, P255, DOI 10.1006/jasc.1999.0456; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Brumm A, 2010, J ARCHAEOL SCI, V37, P451, DOI 10.1016/j.jas.2009.09.012; Chazan M, 1997, J HUM EVOL, V33, P719, DOI 10.1006/jhev.1997.0167; CHAZAN M, 1995, CURR ANTHROPOL, V36, P749, DOI 10.1086/204430; Clark G., 2002, J HUM EVOL, V42, P185, DOI [10.1006/jhev.2001.0517, DOI 10.1006/JHEV.2001.0517]; Clark J. E., 2012, EMERGENCE PRESSURE B, P43; Cole J, 2015, CAMB ARCHAEOL J, V25, P713, DOI 10.1017/S0959774315000141; Collins M. B., 1999, CLOVIS BLADE TECHNOL; Combier J., 1967, MEMOIRE U BORDEAU; Crabtree D. E., 1967, TEBIWA, V10, P60; CRABTREE DE, 1968, AM ANTIQUITY, V33, P446, DOI 10.2307/278596; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I, 2003, J HUM EVOL, V44, P203, DOI 10.1016/S0047-2484(02)00206-3; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Delagnes A., 2000, ACTA ANTHR SINICA, V19, P181; Delagnes A, 2006, INTERD CONTRIB ARCH, P85, DOI 10.1007/0-387-24661-4_5; Derevianko A.P., 1995, DEFINITION INTERPRET, V23, P455; Desrosiers P. M., 2012, EMERGENCE PRESSURE B, P181; Dibble E., 1995, DEFINITION INTERPRET, P41; Diez-Martin F, 2010, QUATERNARY RES, V74, P376, DOI 10.1016/j.yqres.2010.07.019; Eren MI, 2011, J ARCHAEOL SCI, V38, P2731, DOI 10.1016/j.jas.2011.06.011; Eren MI, 2011, AM ANTIQUITY, V76, P229, DOI 10.7183/0002-7316.76.2.229; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Finlay N, 2008, J ARCHAEOL METHOD TH, V15, P68, DOI 10.1007/s10816-007-9048-y; Fisher LE, 2006, J ANTHROPOL ARCHAEOL, V25, P226, DOI 10.1016/j.jaa.2005.09.005; Flenniken JJ, 2003, MESOAMERICAN LITHIC TECHNOLOGY: EXPERIMENTATION AND INTERPRETATION, P98; Frey SH, 2008, PHILOS T R SOC B, V363, P1951, DOI 10.1098/rstb.2008.0008; Geribas N, 2010, J ARCHAEOL SCI, V37, P2857, DOI 10.1016/j.jas.2010.06.026; Golani, 2013, PALEORIENT, V39, P95; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Gowlett J.A.J., 2011, PALEOANTHROPOLOGY, V2011, P174, DOI DOI 10.4207/PA.2011.ART51; GOWLETT JAJ, 1988, WORLD ARCHAEOL, V20, P13, DOI 10.1080/00438243.1988.9980053; Gowlett JAJ., 1984, CULTURE ED SOC, V38, P199, DOI 10.1111/j.1468-2273.1984.tb01387.x; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hayden B, 1996, INTERD CONT, P9; Heighway Z, 2011, CUTTING EDGE CORE TE; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; Hiscock P, 2011, WORLD ARCHAEOL, V43, P653, DOI 10.1080/00438243.2011.624755; Jaubert J., 1993, B SOCI T PR HISTORIQ, V90, P328; Jaubert J., 1995, DEFINITION INTERPRET, V23, P227; Jennings TA, 2010, J ARCHAEOL SCI, V37, P2155, DOI 10.1016/j.jas.2010.02.020; JESKE RJ, 1992, AM ANTIQUITY, V57, P467, DOI 10.2307/280935; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; Klein RG, 1989, HUMAN CAREER HUMAN B; krdla P, 2014, QUARTAR, V61, P87; Kuchikura Y, 1973, PALEORIENT, V1, P87; Leduc C, DANISJ J ARCHAEOLOGY, V1, P62; Leroi-Gourhan A., 1957, PREHISTORIC MAN; Leroi-Gourhan Andre, 1993, GESTURE SPEECH; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Ludwig B.V., 1998, EARLY HUMAN BEHAV GL, P84; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Mahaney R.A., 2014, PALEOANTHROPOLOGY, V2014, P586, DOI DOI 10.4207/PA.2014.ART90; Marks AE, 2006, INTERD CONTRIB ARCH, P121, DOI 10.1007/0-387-24661-4_7; Martinez K, 2010, P NATL ACAD SCI USA, V107, P5762, DOI 10.1073/pnas.0913856107; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MASAO FT, 1982, ETHNOS, V47, P262; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MELLARS P, 1989, HUMAN REVOLUTION, P338; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Moore MW, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P13; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Nishiaki Y., 1989, PALE ORIENT, V15, P215, DOI DOI 10.3406/paleo.1989.4497; Nonaka T, 2010, J HUM EVOL, V59, P155, DOI 10.1016/j.jhevol.2010.04.006; Pasty J.-F., 2000, BULL SOC PREHIST FR, V97, P165; Pelegrin J., 2003, BLADE MAKING TECHNIQ; Pelegrin J., 2009, COGNITIVE ARCHAEOLOG, P95; Peresani M., PALEO; Piperno M, 2009, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-1-4020-9060-8_10; Prasciunas MM, 2007, AM ANTIQUITY, V72, P334, DOI 10.2307/40035817; Price T. D, 2007, PRINCIPLES ARCHAEOLO; Rasic R., 2001, LITHIC DEBITAGE CONT, P61; Renfrew C., 2012, ARCHAEOLOGY THEORIES; Robbins LH, 2000, J ARCHAEOL SCI, V27, P1085, DOI 10.1006/jasc.2000.0597; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Rots V., 2009, QUARTAR, V56, P37; Schick K. D., 1993, MAKING SILENT STONES; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shea JJ, 2008, J HUM EVOL, V55, P448, DOI 10.1016/j.jhevol.2008.05.014; SHEETS PD, 1977, LAT AM RES REV, V12, P139; SHEETS PD, 1972, SCIENCE, V175, P632, DOI 10.1126/science.175.4022.632; SHELLEY PH, 1990, J FIELD ARCHAEOL, V17, P187, DOI 10.1179/009346990791548349; Sherratt A, 1997, ANTIQUITY, V71, P271, DOI 10.1017/S0003598X00084908; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shipton C., 2013, B MUJ; Shipton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065185; Shott MJ., 1989, N AM ARCHAEOL, V10, P1, DOI DOI 10.2190/AAKD-X5Y1-89H6-NGJW; Sorensen M., 2012, EMERGENCE PRESSURE B, P237, DOI [DOI 10.1007/978-1-4614-2003-3, 10.1007/978-1-4614-2003-3_9, DOI 10.1007/978-1-4614-2003-3_9]; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; Stout D, 2007, NEUROPSYCHOLOGIA, V45, P1091, DOI 10.1016/j.neuropsychologia.2006.09.014; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Stout D, 2011, EUR J NEUROSCI, V33, P1328, DOI 10.1111/j.1460-9568.2011.07619.x; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Stout D, 2009, CAMB ARCHAEOL J, V19, P85, DOI 10.1017/S0959774309000055; Swinnen C., 1994, PALEO, V6, P89; Szeletian J., 2009, SOURCEBOOK PALEOLITH, P407; Titmus GL, 2003, MESOAMERICAN LITHIC TECHNOLOGY: EXPERIMENTATION AND INTERPRETATION, P72; Tixier J., 1972, B SOC PREHISTORIQUE, V69, P134; Tomka S.A., 2001, LITHIC DEBITAGE CONT, P207; Toth N., 2006, OLDOWAN CASE STUDIES, P155; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Tryon CA, 2006, CURR ANTHROPOL, V47, P367, DOI 10.1086/503066; Uomini NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072693; Usik VI, 1993, PALEORIENT, V19, P5, DOI DOI 10.3406/PALE0.1993.4593; Van Peer P, 1998, CURR ANTHROPOL, V39, pS115, DOI 10.1086/204692; Van Peer P., 1992, LEVALLOIS REDUCTION, V13; Vaquero M, 2001, J FIELD ARCHAEOL, V28, P93, DOI 10.1179/jfa.2001.28.1-2.93; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wendorf F., 1974, MIDDLE STONE AGE SEQ; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White M, 2011, DEV QUATER SCI, V14, P53; Whittaker J.C., 1994, FLINT KNAPPING MAKIN; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851	137	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167244	10.1371/journal.pone.0167244	http://dx.doi.org/10.1371/journal.pone.0167244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936135	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100077
J	Navarro, MO; Kwan, GT; Batalov, O; Choi, CY; Pierce, NT; Levin, LA				Navarro, Michael O.; Kwan, Garfield T.; Batalov, Olga; Choi, Chelsea Y.; Pierce, N. Tessa; Levin, Lisa A.			Development of Embryonic Market Squid, Doryteuthis opalescens, under Chronic Exposure to Low Environmental pH and [O-2]	PLOS ONE			English	Article							CALAMARY SEPIOTEUTHIS-AUSTRALIS; OCEAN ACIDIFICATION; CARBONATE CHEMISTRY; SEPIA-OFFICINALIS; CO2 TOLERANCE; EGG MASSES; OXYGEN; VARIABILITY; STATOLITH; TEMPERATURE	The market squid, Doryteuthis opalescens, is an important forage species for the inshore ecosystems of the California Current System. Due to increased upwelling and expansion of the oxygen minimum zone in the California Current Ecosystem, the inshore environment is expected to experience lower pH and [O-2] conditions in the future, potentially impacting the development of seafloor-attached encapsulated embryos. To understand the consequences of this co-occurring environmental pH and [O-2] stress for D. opalescens encapsulated embryos, we performed two laboratory experiments. In Experiment 1, embryo capsules were chronically exposed to a treatment of higher (normal) pH (7.93) and [O-2] (242 mu M) or a treatment of low pH (7.57) and [O-2] (80 mu M), characteristic of upwelling events and/or La Nina conditions. The low pH and low [O-2] treatment extended embryo development duration by 5-7 days; embryos remained at less developed stages more often and had 54.7% smaller statolith area at a given embryo size. Importantly, the embryos that did develop to mature embryonic stages grew to sizes that were similar (non-distinct) to those exposed to the high pH and high [O-2] treatment. In Experiment 2, we exposed encapsulated embryos to a single stressor, low pH (7.56) or low [O-2] (85 mu M), to understand the importance of environmental pH and [O-2] rising and falling together for squid embryogenesis. Embryos in the low pH only treatment had smaller yolk reserves and bigger statoliths compared to those in low [O-2] only treatment. These results suggest that D. opalescens developmental duration and statolith size are impacted by exposure to environmental [O-2] and pH (pCO(2)) and provide insight into embryo resilience to these effects.	[Navarro, Michael O.; Kwan, Garfield T.; Choi, Chelsea Y.; Levin, Lisa A.] UCSD, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Navarro, Michael O.; Pierce, N. Tessa; Levin, Lisa A.] UCSD, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Kwan, Garfield T.; Pierce, N. Tessa] UCSD, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA USA; [Batalov, Olga] UCSD, Div Biol Sci, La Jolla, CA USA; [Choi, Chelsea Y.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of Rochester	Navarro, MO (corresponding author), UCSD, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.; Navarro, MO (corresponding author), UCSD, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	monavarro@alaska.edu		Kwan, Garfield/0000-0001-9183-2731	National Oceanic and Atmospheric Administration (NOAA) [NA100AR4170060]; California Sea Grant College Program through NOAA's National Sea Grant College Program [R/CC-02, R/CC-04]; U.S. Department of Commerce; National Science Foundation-Division of Ocean Sciences [0903551, 0927445, 1041062]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant College Program through NOAA's National Sea Grant College Program; U.S. Department of Commerce; National Science Foundation-Division of Ocean Sciences(National Science Foundation (NSF))	This work was funded by National Oceanic and Atmospheric Administration (NOAA: http://www.noaa.gov/) Grant No. NA100AR4170060, California Sea Grant College Program (https://caseagrant.ucsd.edu/) Project Nos. R/CC-02 and R/CC-04, through NOAA's National Sea Grant College Program (http://seagrant.noaa.gov/), U.S. Department of Commerce (https://www.commerce.gov/), and by the National Science Foundation-Division of Ocean Sciences (http://www.nsf.gov/div/index.jsp?div=oce) Award Nos. 0903551, 0927445 and 1041062. The statements, findings, conclusions and recommendations are those of the authors and do not necessarily reflect the views of California Sea Grant, state agencies, NOAA, NSF or the U.S. Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipkin AI, 2000, J ZOOL, V250, P31, DOI 10.1111/j.1469-7998.2000.tb00575.x; ARNOLD JM, 1965, BIOL BULL, V128, P24, DOI 10.2307/1539386; BENNINGTON CC, 1994, ECOLOGY, V75, P717, DOI 10.2307/1941729; Bockmon EE, 2013, BIOGEOSCIENCES, V10, P5967, DOI 10.5194/bg-10-5967-2013; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Booth JAT, 2014, LIMNOL OCEANOGR, V59, P1127, DOI 10.4319/lo.2014.59.4.1127; Booth JAT, 2012, CONT SHELF RES, V45, P108, DOI 10.1016/j.csr.2012.06.009; BUDELMANN BU, 1979, BRAIN RES, V160, P261, DOI 10.1016/0006-8993(79)90423-2; Chen DS, 1996, BIOL BULL, V190, P69, DOI 10.2307/1542676; Cohen CS, 1996, BIOL BULL, V190, P8, DOI 10.2307/1542671; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; Fields W. G., 1965, Fishery Bulletin California, VNo. 131, P1; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Gobler CJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0976; Gutowska MA, 2009, MAR BIOL, V156, P515, DOI 10.1007/s00227-008-1096-7; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; HANLON RT, 1989, J EXP BIOL, V141, P187; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hu MY, 2016, VIE MILIEU, V66, P57; Hu MRY, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1064196; Hu MY, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-51; Hu MY, 2011, AM J PHYSIOL-REG I, V301, pR1700, DOI 10.1152/ajpregu.00107.2011; Hu MY, 2011, AM J PHYSIOL-REG I, V300, pR1100, DOI 10.1152/ajpregu.00653.2010; Hu MY, 2009, COMP BIOCHEM PHYS A, V153, P278, DOI 10.1016/j.cbpa.2009.02.040; Kaplan MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063714; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Nam S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049549; Navarro M. M., 2014, THESIS; Navarro MO, 2014, WATER-SUI, V6, P2233, DOI 10.3390/w6082233; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Perretti CT, 2016, FISH OCEANOGR, V25, P491, DOI 10.1111/fog.12167; Perretti CT, 2014, THESIS; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H. O., 2010, GUIDE BEST PRACTICES, P167; Reum JCP, 2016, ICES J MAR SCI, V73, P582, DOI 10.1093/icesjms/fsu231; Roberts MJ, 2005, ICES J MAR SCI, V62, P33, DOI 10.1016/j.icesjms.2004.10.002; Robin JP, 2014, ADV MAR BIOL, V67, P361, DOI 10.1016/B978-0-12-800287-2.00004-4; Rosa R, 2014, J EXP BIOL, V217, P518, DOI 10.1242/jeb.096081; Rosa R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1695; Rosa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038282; Send U, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007517; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Steer MA, 2002, MAR ECOL PROG SER, V243, P143, DOI 10.3354/meps243143; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270; Takeshita Y, 2015, BIOGEOSCIENCES, V12, P5853, DOI 10.5194/bg-12-5853-2015; Vidal EAG, 2002, B MAR SCI, V71, P915; Warner RR, 2009, MAR ECOL PROG SER, V379, P109, DOI 10.3354/meps07903; Zeidberg L.D., 2011, MAR ECOL, V33, P326; Zeidberg LD, 2011, MAR ECOL-EVOL PERSP, V32, P468, DOI 10.1111/j.1439-0485.2011.00445.x	53	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167461	10.1371/journal.pone.0167461	http://dx.doi.org/10.1371/journal.pone.0167461			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936085	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100102
J	Scholtens, RM; de Rooij, SEJA; Vellekoop, AE; Vrouenraets, BC; van Munster, BC				Scholtens, Rikie M.; de Rooij, Sophia E. J. A.; Vellekoop, Annelies E.; Vrouenraets, Bart C.; van Munster, Barbara C.			Preoperative CSF Melatonin Concentrations and the Occurrence of Delirium in Older Hip Fracture Patients: A Preliminary Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; ENDOGENOUS MELATONIN; CIRCADIAN-RHYTHM; ELDERLY-PATIENTS; VALIDATION; SECRETION; DEMENTIA; RISK; CARE	Background Delirium is characterized by disturbances in circadian rhythm. Melatonin regulates our circadian rhythm. Our aim was to compare preoperative cerebrospinal fluid (CSF) melatonin levels in patients with and without postoperative delirium. Methods Prospective cohort study with hip fracture patients >= 65 years who were acutely admitted to the hospital for surgical treatment and received spinal anaesthesia. CSF was collected after cannulation, before administering anaesthetics. Melatonin was measured by radioimmunoassay (RIA). Data on delirium was obtained from medical and nursing records. Nurses screened every shift for delirium using the Delirium Observation Screening Scale (DOSS). If the DOSS was >= 3, a psychiatrist was consulted to diagnose possible delirium using the DSM-IV criteria. At admission, demographic data, medical history, and information on functional and cognitive status was obtained. Results Seventy-six patients met the inclusion criteria. Sixty patients were included in the analysis. Main reasons for exclusion were technical difficulties, insufficient CSF or exogenous melatonin use. Thirteen patients (21.7%) experienced delirium during hospitalisation. Baseline characteristics did not differ between patients with and without postoperative delirium. In patients with and without postoperative delirium melatonin levels were 12.88 pg/ml (SD 6.3) and 11.72 pg/ml (SD 4.5) respectively, p-value 0.47. No differences between patients with and without delirium were found in mean melatonin levels in analyses stratified for cognitive impairment or age. Conclusion Preoperative CSF melatonin levels did not differ between patients with and without postoperative delirium. This suggests that, if disturbances in melatonin secretion occur, these might occur after surgery due to postoperative inflammation.	[Scholtens, Rikie M.; de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, Amsterdam, Netherlands; [de Rooij, Sophia E. J. A.; van Munster, Barbara C.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Vellekoop, Annelies E.] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Vrouenraets, Bart C.] Sint Lucas Andreas Hosp, Dept Surg, Amsterdam, Netherlands; [van Munster, Barbara C.] Gelre Hosp, Dept Geriatr, Apeldoorn, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Sint Lucas Andreas Hospital; Gelre Hospitals	Scholtens, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, Amsterdam, Netherlands.	r.m.scholtens@amc.uva.nl						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Bumb JM, 2014, SLEEP BIOL RHYTHMS, V12, P69, DOI 10.1111/sbr.12039; Cronin AJ, 2000, LANCET, V356, P1244, DOI 10.1016/S0140-6736(00)02795-1; de Jonghe A, 2014, CAN MED ASSOC J, V186, pE547, DOI 10.1503/cmaj.140495; Fitzgerald JM, 2013, MED HYPOTHESES, V81, P568, DOI 10.1016/j.mehy.2013.06.032; Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635; Gavinski K, 2016, J HOSP MED, V11, P494, DOI 10.1002/jhm.2580; IBM SPSS Statistics for Windows, 2013, IBM SPSS STAT WINDOW; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, DEMENT GERIATR COGN, V10, P393, DOI 10.1159/000017177; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Leentjens AFG, 2014, J PSYCHOSOM RES, V77, P240, DOI 10.1016/j.jpsychores.2014.07.014; Legros C, 2014, J NEUROENDOCRINOL, V26, P151, DOI 10.1111/jne.12134; Leston J, 2010, NEUROSCI LETT, V469, P294, DOI 10.1016/j.neulet.2009.12.008; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Longatti P, 2004, MINIM INVAS NEUROSUR, V47, P350, DOI 10.1055/s-2004-830130; Longatti P, 2007, J PINEAL RES, V42, P113, DOI 10.1111/j.1600-079X.2006.00391.x; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Mishima K, 1999, BIOL PSYCHIAT, V45, P417, DOI 10.1016/S0006-3223(97)00510-6; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Piotrowicz K, 2015, EXP GERONTOL, V72, P45, DOI 10.1016/j.exger.2015.09.007; Rizzo V, 2002, J CHROMATOGR B, V774, P17, DOI 10.1016/S1570-0232(02)00168-X; Rousseau A, 1999, J NEURAL TRANSM, V106, P883, DOI 10.1007/s007020050208; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Scholtens RM, 2016, J PSYCHOSOM RES, V86, P20, DOI 10.1016/j.jpsychores.2016.05.005; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shigeta H, 2001, AM J SURG, V182, P449, DOI 10.1016/S0002-9610(01)00761-9; Siddiqi N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub3; Tan DX, 2016, MED HYPOTHESES, V86, P3, DOI 10.1016/j.mehy.2015.11.018; Tan DX, 2010, CURR NEUROPHARMACOL, V8, P162, DOI 10.2174/157015910792246263; Tricoire H, 2002, ENDOCRINOLOGY, V143, P84, DOI 10.1210/en.143.1.84; van Velthuijsen EL, 2016, INT J GERIATR PSYCH, V31, P974, DOI 10.1002/gps.4441; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Zhao ZY, 2002, CHRONOBIOL INT, V19, P1171, DOI 10.1081/CBI-120015958; Zhou JN, 2003, J PINEAL RES, V35, P125, DOI 10.1034/j.1600-079X.2003.00065.x	39	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167621	10.1371/journal.pone.0167621	http://dx.doi.org/10.1371/journal.pone.0167621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936113	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100133
J	Sullivan, MJ; Carey, AJ; Leclercq, SY; Tan, CK; Ulett, GC				Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.			Increased Age, but Not Parity Predisposes to Higher Bacteriuria Burdens Due to Streptococcus Urinary Tract Infection and Influences Bladder Cytokine Responses, Which Develop Independent of Tissue Bacterial Loads	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; ESCHERICHIA-COLI 83972; ASYMPTOMATIC BACTERIURIA; DENDRITIC CELLS; INNATE; EPIDEMIOLOGY; ACTIVATION; VIRULENCE; PATHWAYS; INFANTS	Streptococcus agalactiae causes urinary tract infection (UTI) in pregnant adults, non-pregnant adults, immune-compromised individuals and the elderly. The pathogenesis of S. agalactiae UTI in distinct patient populations is poorly understood. In this study, we used murine models of UTI incorporating young mice, aged and dam mice to show that uropathogenic S. agalactiae causes bacteriuria at significantly higher levels in aged mice compared to young mice and this occurs coincident with equivalent levels of bladder tissue colonisation at 24 h post-infection (p.i.). In addition, aged mice exhibited significantly higher bacteriuria burdens at 48 h compared to young mice, confirming a divergent pattern of bacterial colonization in the urinary tract of aged and young mice. Multiparous mice, in contrast, exhibited significantly lower urinary titres of S. agalactiae compared to age-matched nulliparous mice suggesting that parity enhances the ability of the host to control S. agalactiae bacteriuria. Additionally, we show that both age and parity alter the expression levels of several key regulatory and pro-inflammatory cytokines, which are known to be important the immune response to UTI, including Interleukin (IL)-1 beta, IL-12(p40), and Monocyte Chemoattractant Protein-1 (MCP-1). Finally, we demonstrate that other cytokines, including IL-17 are induced significantly in the S. agalactiae-infected bladder regardless of age and parity status. Collectively, these findings show that the host environment plays an important role in influencing the severity of S. agalactiae UTI; infection dynamics, particularly in the context of bacteriuria, depend on age and parity, which also affect the nature of innate immune responses to infection.	[Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Sullivan, Matthew J.; Carey, Alison J.; Leclercq, Sophie Y.; Tan, Chee K.; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Leclercq, Sophie Y.] Ezequiel Dias Fdn Funed, Ctr Res & Dev, Belo Horizonte, MG, Brazil; [Carey, Alison J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia	Griffith University; Griffith University; Menzies Health Institute Queensland; Queensland University of Technology (QUT)	Ulett, GC (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.; Ulett, GC (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia.	g.ulett@griffith.edu.au	Sullivan, Matthew J/C-3857-2009	Sullivan, Matthew J/0000-0003-2276-3132; Ulett, Glen/0000-0002-9638-8091	National Health and Medical Research Council (NHMRC) [APP1005315]; Griffith Health Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil [248427/2013-0]; NHMRC [APP1052464]; Australian Research Council [FT110101048]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Griffith Health Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grants (APP1005315) and funding from the Griffith Health Institute, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-Brazil (248427/2013-0 to SYL). AJC is supported by a NHMRC Early Career Peter Doherty Fellowship (APP1052464). GCU is supported by a Australian Research Council Future Fellowship (FT110101048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Alvarez JR, 2010, AM J PERINAT, V27, P231, DOI 10.1055/s-0029-1239485; Carey AJ, 2016, CRIT REV MICROBIOL, V42, P780, DOI 10.3109/1040841X.2015.1028885; Cohen HJ, 2003, AM J MED, V114, P180, DOI 10.1016/S0002-9343(02)01484-5; Dobrindt U, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010021; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Freitas CH, 2012, CLINICS, V67, P457, DOI 10.6061/clinics/2012(05)09; Friedlander JI, 2014, J ENDOUROL, V28, P871, DOI 10.1089/end.2014.0002; Gerli R, 2000, MECH AGEING DEV, V121, P37; Goldfarb DS, 1998, CLIN GERIATR MED, V14, P367; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; High KP, 2012, SEMIN IMMUNOL, V24, P373, DOI 10.1016/j.smim.2012.04.007; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; Inadera H, 1999, J INTERF CYTOK RES, V19, P1179, DOI 10.1089/107999099313127; Ipe DS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00014; Ipe DS, 2016, INFECT IMMUN, V84, P307, DOI 10.1128/IAI.00938-15; Ipe DS, 2013, FEMS MICROBIOL LETT, V346, P1, DOI 10.1111/1574-6968.12204; Kline KA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0012-2012; Kline KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097798; Kline KA, 2012, INFECT IMMUN, V80, P4186, DOI 10.1128/IAI.00684-12; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Koves B, 2014, J UROLOGY, V191, P519, DOI 10.1016/j.juro.2013.07.060; Krambeck AE, 2013, J UROLOGY, V189, P158, DOI 10.1016/j.juro.2012.09.023; Kulkarni R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059091; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Lung TL, 2000, VACCINE, V18, P1606, DOI 10.1016/S0264-410X(99)00494-6; Matsumoto T, 2001, Curr Urol Rep, V2, P330, DOI 10.1007/s11934-001-0073-1; MCCUE JD, 1993, PHARMACOTHERAPY, V13, pS51; Muller AE, 2006, ACTA OBSTET GYN SCAN, V85, P1027, DOI 10.1080/00016340600780508; Nikolich-Zugich J, 2014, J IMMUNOL, V193, P2622, DOI 10.4049/jimmunol.1401174; Roos V, 2006, INFECT IMMUN, V74, P615, DOI 10.1128/IAI.74.1.615-624.2006; Rowe Theresa A, 2013, Aging health, V9, DOI 10.2217/ahe.13.38; Rudick CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109321; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Tan CK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-273; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; Trivalle C, 1998, J MED MICROBIOL, V47, P649, DOI 10.1099/00222615-47-7-649; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Ulett KB, 2009, J CLIN MICROBIOL, V47, P2055, DOI 10.1128/JCM.00154-09; Valiathan R, 2016, SCAND J IMMUNOL, V83, P255, DOI 10.1111/sji.12413; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Verani JR, 2010, CLIN PERINATOL, V37, P375, DOI 10.1016/j.clp.2010.02.002; [王春生 Wang Chunsheng], 2012, [中国公路学报, China Journal of Highway and Transport], V25, P81; Watts RE, 2012, J INFECT DIS, V206, P1242, DOI 10.1093/infdis/jis493	56	4	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167732	10.1371/journal.pone.0167732	http://dx.doi.org/10.1371/journal.pone.0167732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936166	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000389587100167
J	Sung, YY; Yoon, T; Jang, S; Kim, HK				Sung, Yoon-Young; Yoon, Taesook; Jang, Seol; Kim, Ho Kyoung			Forsythia suspensa Suppresses House Dust Mite Extract-Induced Atopic Dermatitis in NC/Nga Mice	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY RESPONSES; TACROLIMUS OINTMENT; ACTIVATION; CHEMOKINE; BLOCKADE; FRUCTUS; KERATINOCYTES; PATHOGENESIS; SEVERITY	Forsythia suspensa (F. suspensa) is a traditional medicine for treatment of inflammation. In this study, we evaluated the therapeutic effects of an ethanol extract from F. suspensa fruits on atopic dermatitis both in vivo and in vitro. We investigated the inhibitory effects of F. suspensa extract on the development of atopic dermatitis-like skin lesions in an NC/Nga mouse model exposed to Dermatophagoides farinae crude extract. Topical application of F. suspensa extract to the mice attenuated the atopic dermatitis symptoms, including increased dermatitis severity score, ear thickness, infiltration of inflammatory cells in the skin lesions, serum levels of IgE, TNF-alpha, and histamine, and expression of chemokines, cytokines, and adhesion molecules in ear tissue. In addition, F. suspensa extract inhibited the production of chemokines in TNF-alpha/IFN-gamma-activated human keratinocytes. High-performance liquid chromatography analysis of FSE revealed the presence of four chemical constituents (forsythiaside, phillyrin, pinoresinol, and phylligenin). These compounds inhibited the production of chemokines in TNF-alpha/IFN-gamma-activated human keratinocytes. These results suggest that the F. suspensa might be a useful candidate for treating allergic skin inflammatory disorders.	[Sung, Yoon-Young; Jang, Seol; Kim, Ho Kyoung] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea; [Yoon, Taesook] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea	Korea Institute of Oriental Medicine (KIOM); Ewha Womans University	Kim, HK (corresponding author), Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon, South Korea.	hkkim@kiom.re.kr			Korea Research Council of Fundamental Science and Technology [G10102]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP [NRF-2015M3A9E3052336]	Korea Research Council of Fundamental Science and Technology; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government, MSIP(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by project (G10102) "Development of herbal materials for treatment and prevention of allergic disease," which was funded by the Korea Research Council of Fundamental Science and Technology. This research was also supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, MSIP (NRF-2015M3A9E3052336).	Albanesi Cristina, 2005, Current Drug Targets - Inflammation and Allergy, V4, P329, DOI 10.2174/1568010054022033; Bardana EJ, 2004, ALLERGY, V59, P25, DOI 10.1111/j.1398-9995.2004.00565.x; Bulfone-Paus S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00394; Carroll CL, 2006, DRUG TODAY, V42, P431, DOI 10.1358/dot.2006.42.7.1003316; Chen L, 2010, IMMUNOL CELL BIOL, V88, P334, DOI 10.1038/icb.2009.107; Cheng GD, 2014, EXP THER MED, V7, P179, DOI 10.3892/etm.2013.1378; Choi JK, 2014, AM J CHINESE MED, V42, P967, DOI 10.1142/S0192415X1450061X; Dilshara MG, 2015, BMB REP, V48, P559, DOI 10.5483/BMBRep.2015.48.10.003; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Hanifin JM, 2005, J AM ACAD DERMATOL, V53, pS186, DOI 10.1016/j.jaad.2005.04.062; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Je IG, 2015, TOXICOL APPL PHARM, V287, P119, DOI 10.1016/j.taap.2015.05.006; Jeong YI, 2015, ALLERGY ASTHMA IMMUN, V7, P557, DOI 10.4168/aair.2015.7.6.557; Jung HW, 2010, NEUROSCI LETT, V480, P215, DOI 10.1016/j.neulet.2010.06.043; Kanda N, 2006, BIOCHEM PHARMACOL, V72, P463, DOI 10.1016/j.bcp.2006.05.001; Kim MS, 2003, INFLAMMATION, V27, P129, DOI 10.1023/A:1023865727780; KRUTMANN J, 1990, J INVEST DERMATOL, V95, P127, DOI 10.1111/1523-1747.ep12477839; Kwon DJ, 2012, BIOCHEM BIOPH RES CO, V417, P1254, DOI 10.1016/j.bbrc.2011.12.119; Kwon TR, 2014, PHOTOCHEM PHOTOBIOL, V90, P1160, DOI 10.1111/php.12284; Lee H, 2014, BIOMOL THER, V22, P438, DOI 10.4062/biomolther.2014.023; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lim H, 2008, J ETHNOPHARMACOL, V118, P113, DOI 10.1016/j.jep.2008.03.016; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Nedoszytko B, 2014, POSTEP DERM ALERGOL, V31, P84, DOI 10.5114/pdia.2014.40920; NISHIBE S, 1982, CHEM PHARM BULL, V30, P4548; Otsuka A, 2015, ALLERGY, V70, P131, DOI 10.1111/all.12526; Ozaki Y, 1997, BIOL PHARM BULL, V20, P861, DOI 10.1248/bpb.20.861; Park JH, 2015, J ETHNOPHARMACOL, V171, P85, DOI 10.1016/j.jep.2015.05.039; Pastore Saveria, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P497; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Prieto JM, 2003, J PHARM PHARMACOL, V55, P1275, DOI 10.1211/0022357021620; Qu HH, 2012, BIOORG CHEM, V40, P87, DOI 10.1016/j.bioorg.2011.09.005; Sasakawa T, 2004, INT ARCH ALLERGY IMM, V133, P55, DOI 10.1159/000076128; Seo WY, 2015, BMB REP, V48, P495, DOI 10.5483/BMBRep.2015.48.9.259; Simpson D, 2005, DRUGS, V65, P827, DOI 10.2165/00003495-200565060-00011; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI [10.1155/2012/416739, DOI 10.1155/2012/416739]; Vestergaard C, 2000, J INVEST DERMATOL, V115, P640, DOI 10.1046/j.1523-1747.2000.00115.x; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458; Zhong WT, 2013, FITOTERAPIA, V90, P132, DOI 10.1016/j.fitote.2013.06.003	43	20	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167687	10.1371/journal.pone.0167687	http://dx.doi.org/10.1371/journal.pone.0167687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936051	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100151
J	Yang, ZF; Kim, S; Mahajan, S; Zamani, A; Faccio, R				Yang, Zhengfeng; Kim, Seokho; Mahajan, Sahil; Zamani, Ali; Faccio, Roberta			Phospholipase C gamma 1 (PLC gamma 1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/beta-Catenin/CyclinD1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-GAMMA; BONE HOMEOSTASIS; CELL DEVELOPMENT; MURINE MODEL; M-CSF; SURVIVAL; ALPHA(V)BETA(3); PROLIFERATION; ACTIVATION; PRECURSORS	Phospholipases C gamma (PLC gamma) 1 and 2 are a class of highly homologous enzymes modulating a variety of cellular pathways through production of inositol 1,4,5-trisphosphate and diacylglycerol (DAG). Our previous studies demonstrated the importance of PLC gamma 2 in osteoclast (OC) differentiation by modulating inositol 1,4,5-trisphosphate-mediated calcium oscillations and the up-regulation of the transcription factor NFATc1. Surprisingly, despite being expressed throughout osteoclastogenesis, PLC gamma 1 did not compensate for PLC gamma 2 deficiency. Because both isoforms are activated during osteoclastogenesis, it is plausible that PLC gamma 1 modulates OC development independently of PLC gamma 2. Here, we utilized PLC gamma 1-specific shRNAs to delete PLC gamma 1 in OC precursors derived from wild type (WT) mice. Differently from PLC gamma 2, we found that PLC gamma 1 shRNA significantly suppresses OC differentiation by limiting colony-stimulating factor 1 (CSF-1)-dependent proliferation and beta-catenin/cyclinD1 levels. Confirming the specificity toward CSF-1 signaling, PLC gamma 1 is recruited to the CSF-1 receptor following exposure to the cytokine. To understand how PLC gamma 1 controls cell proliferation, we turned to its downstream effector, DAG. By utilizing cells lacking the DAG kinase zeta, which have increased DAG levels, we demonstrate that DAG modulates CSF-1-dependent proliferation and beta-catenin/cyclinD1 levels in OC precursors. Most importantly, the proliferation and osteoclastogenesis defects observed in the absence of PLC gamma 1 are normalized in PLC gamma 1/DAG kinase zeta double null cells. Taken together, our study shows that PLC gamma 1 controls OC numbers via a CSF-1-dependent DAG/beta-catenin/cyclinD1 pathway.	[Yang, Zhengfeng; Kim, Seokho; Mahajan, Sahil; Zamani, Ali; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63110 USA; [Kim, Seokho] Korea Res Inst Biosci & Biotechnol, Aging Res Inst, Daejeon 34141, South Korea; [Zamani, Ali] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed Surg, Box 8233,660 S Euclid, St Louis, MO 63110 USA	Washington University (WUSTL); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Pennsylvania; Washington University (WUSTL)	Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63110 USA.; Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Box 8233,660 S Euclid, St Louis, MO 63110 USA.	faccior@wustl.edu	Yang, Zhengfeng/AAA-7014-2020		Broad Institute RNAi Consortium (TRC); Children's Discovery Institute (CDI); Genome Institute at Washington University (TGI); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066551, R01AR053628] Funding Source: NIH RePORTER	Broad Institute RNAi Consortium (TRC); Children's Discovery Institute (CDI); Genome Institute at Washington University (TGI); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully thank Dr. Gary Koretzky (Weill Cornell Medical College, Ithaca, NY) for the DGK zeta<SUP>-/-</SUP> mice. The shPlcg1 plasmids were provided by Washington University RNAi core, supported by the Broad Institute RNAi Consortium (TRC), the Children's Discovery Institute (CDI), and the Genome Institute at Washington University (TGI).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Decker CE, 2015, P NATL ACAD SCI USA, V112, P15654, DOI 10.1073/pnas.1511285112; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Maeda K, 2013, J MOL MED, V91, P15, DOI 10.1007/s00109-012-0974-0; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Qiang YW, 2010, BRIT J HAEMATOL, V148, P726, DOI 10.1111/j.1365-2141.2009.08009.x; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yang Yong Ryoul, 2012, Adv Biol Regul, V52, P138; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zamani A, 2015, J BONE MINER RES, V30, P1852, DOI 10.1002/jbmr.2533; Zheng YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119739; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777	44	6	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1178	1186		10.1074/jbc.M116.764928	http://dx.doi.org/10.1074/jbc.M116.764928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941021	Green Published, hybrid			2022-12-26	WOS:000393339800003
J	Falk, AR; Kaye, TG; Zhou, ZH; Burnham, DA				Falk, Amanda R.; Kaye, Thomas G.; Zhou, Zhonghe; Burnham, David A.			Laser Fluorescence Illuminates the Soft Tissue and Life Habits of the Early Cretaceous Bird Confuciusornis	PLOS ONE			English	Article							PRIMARY FEATHER RACHISES; POOR FLIGHT ABILITY; WING TIP SLOTS; AVIAN FLIGHT; ARCHAEOPTERYX; EVOLUTION; PROPATAGIUM; REDUCTION; SHAPE; DRAG	In this paper we report the discovery of non-plumage soft tissues in Confuciusornis, a basal beaked bird from the Early Cretaceous Jehol Biota in northeastern China. Various soft tissues are visualized and interpreted through the use of laser-stimulated fluorescence, providing much novel anatomical information about this early bird, specifically reticulate scales covering the feet, and the well-developed and robust pro-and postpatagium. We also include a direct comparison between the forelimb soft tissues of Confuciusornis and modern avian patagia. Furthermore, apparently large, fleshy phalangeal pads are preserved on the feet. The reticulate scales, robust phalangeal pads as well as the highly recurved pedal claws strongly support Confuciusornis as an arboreal bird. Reticulate scales are more rounded than scutate scales and do not overlap, thus allowing for more flexibility in the toe. The extent of the pro-and postpatagium and the robust primary feather rachises are evidence that Confuciusornis was capable of powered flight, contrary to previous reports suggesting otherwise. A unique avian wing shape is also reconstructed based on plumage preserved. These soft tissues combined indicate an arboreal bird with the capacity for shortterm (non-migratory) flight, and suggest that, although primitive, Confuciusornis already possessed many relatively advanced avian anatomical characteristics.	[Falk, Amanda R.] Ctr Coll Danville, Dept Biol, Danville, KY 40422 USA; [Kaye, Thomas G.] Burke Museum Hist & Culture, Seattle, WA USA; [Zhou, Zhonghe] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Burnham, David A.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Burnham, David A.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas; University of Kansas	Falk, AR (corresponding author), Ctr Coll Danville, Dept Biol, Danville, KY 40422 USA.	amanda.falk@centre.edu			U.S. State Department; University of Kansas Natural History Museum and Biodiversity Institute; University of Kansas Department of Geology; National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China	U.S. State Department; University of Kansas Natural History Museum and Biodiversity Institute; University of Kansas Department of Geology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ARF was funded in part by a Fulbright Grant from the U.S. State Department, a Panorama small grant from the University of Kansas Natural History Museum and Biodiversity Institute, and the University of Kansas Department of Geology. Z. Zhou was supported by the National Basic Research Program of China (973 Program; 2012CB821906), the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann T, 2012, J EXP BIOL, V215, P405, DOI 10.1242/jeb.059451; Barrett PM, 2006, INTEGR ZOOL, V1, P15, DOI 10.1111/j.1749-4877.2006.00006.x; Baumel J. J., 1993, HDB AVIAN ANATOMY NO, P45; Baumel JJ, 1993, HDB AVIAN ANATOMY, P189; Birkmann H, 1996, J PALEONTOL, V70, P1084, DOI 10.1017/S0022336000038774; Brown RE, 1996, J EXP ZOOL, V276, P112, DOI 10.1002/(SICI)1097-010X(19961001)276:2<112::AID-JEZ4>3.0.CO;2-R; BROWN RE, 1995, J MORPHOL, V225, P91, DOI 10.1002/jmor.1052250108; BROWN RE, 1994, J MORPHOL, V219, P205, DOI 10.1002/jmor.1052190209; BRUSH AH, 1985, J EXP ZOOL, V236, P303, DOI 10.1002/jez.1402360307; Burnham DA, 2011, J SYST PALAEONTOL, V9, P103, DOI 10.1080/14772019.2010.522201; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; HOMBERGER DG, 1986, ZOOMORPHOLOGY, V106, P103, DOI 10.1007/BF00312112; Kaye TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125923; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Martin LD, 2005, CURR SCI INDIA, V89, P1089; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; Navalon G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14864; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; Paul GS, 2010, SCIENCE, V330, DOI 10.1126/science.1192963; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Perez-Tris J, 2001, J AVIAN BIOL, V32, P207, DOI 10.1111/j.0908-8857.2001.320301.x; Peters DS, 1999, J ORNITHOL, V140, P41, DOI 10.1007/BF02462087; Proctor NS, 1993, MANUAL ORNITHOLOGY; Sachs G, 2006, J THEOR BIOL, V239, P93, DOI 10.1016/j.jtbi.2005.07.016; SAVILE DBO, 1957, EVOLUTION, V11, P212, DOI 10.2307/2406051; Schopf JW, 2011, TOP GEOBIOL, V36, P241, DOI 10.1007/978-94-007-0680-4_10; Schopf JW, 2006, ASTROBIOLOGY, V6, P1, DOI 10.1089/ast.2006.6.1; TUCKER VA, 1993, J EXP BIOL, V180, P285; TUCKER VA, 1995, J EXP BIOL, V198, P775; Wang X, 2011, J EVOLUTION BIOL, V24, P1226, DOI 10.1111/j.1420-9101.2011.02253.x; Zhang F, 1998, VERT PALASICA, V35, P126; Zhang ZH, 2009, J ORNITHOL, V150, P783, DOI 10.1007/s10336-009-0399-x; Zheng XT, 2010, SCIENCE, V330, DOI 10.1126/science.1193223; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zinoviev AV, 2009, PALEONTOL J+, V43, P444, DOI 10.1134/S0031030109040145	39	20	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167284	10.1371/journal.pone.0167284	http://dx.doi.org/10.1371/journal.pone.0167284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973609	gold, Green Published, Green Submitted			2022-12-26	WOS:000392754300022
J	Urabe, CT; Tanaka, G; Aihara, K; Mimura, M				Urabe, Chiyori T.; Tanaka, Gouhei; Aihara, Kazuyuki; Mimura, Masayasu			Parameter Scaling for Epidemic Size in a Spatial Epidemic Model with Mobile Individuals	PLOS ONE			English	Article							MEASLES METAPOPULATION DYNAMICS; PANDEMIC INFLUENZA; LATTICE MODEL; SPREAD; STRATEGIES; PERSISTENCE; NETWORK	In recent years, serious infectious diseases tend to transcend national borders and widely spread in a global scale. The incidence and prevalence of epidemics are highly influenced not only by pathogen-dependent disease characteristics such as the force of infection, the latent period, and the infectious period, but also by human mobility and contact patterns. However, the effect of heterogeneous mobility of individuals on epidemic outcomes is not fully understood. Here, we aim to elucidate how spatial mobility of individuals contributes to the final epidemic size in a spatial susceptible-exposed-infectious-recovered (SEIR) model with mobile individuals in a square lattice. After illustrating the interplay between the mobility parameters and the other parameters on the spatial epidemic spreading, we propose an index as a function of system parameters, which largely governs the final epidemic size. The main contribution of this study is to show that the proposed index is useful for estimating how parameter scaling affects the final epidemic size. To demonstrate the effectiveness of the proposed index, we show that there is a positive correlation between the proposed index computed with the real data of human airline travels and the actual number of positive incident cases of influenza B in the entire world, implying that the growing incidence of influenza B is attributed to increased human mobility.	[Urabe, Chiyori T.; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Mimura, Masayasu] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; Meiji University	Urabe, CT (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	chiyori@iis.u-tokyo.ac.jp	Tanaka, Gouhei/Y-3230-2019	Tanaka, Gouhei/0000-0002-6223-4406; Urabe, Chiyori T./0000-0001-5815-4289	Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan [H26-ShinkoJitsuyoka-General-016]; CREST; JST; JSPS KAKENHI Grant [15H05707]; Aihara Project; FIRST program from JSPS	Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan; CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FIRST program from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan (H26-ShinkoJitsuyoka-General-016), CREST, JST and JSPS KAKENHI Grant Number 15H05707 (KA), and the Aihara Project, the FIRST program from JSPS, initiated by CSTP (CTU, GT, and KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bell D, 2006, EMERG INFECT DIS, V12, P81; BOCCARA N, 1992, J PHYS A-MATH GEN, V25, P2447, DOI 10.1088/0305-4470/25/9/018; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferreira SC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041125; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Fuks H, 2001, DISCRETE DYN NAT SOC, V6, P191, DOI 10.1155/S1026022601000206; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Hall IM, 2007, EPIDEMIOL INFECT, V135, P1133, DOI 10.1017/S0950268806007783; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003561; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Pearson K, 1905, NATURE, V72, P294, DOI 10.1038/072294b0; Rhodes CJ, 1996, J THEOR BIOL, V180, P125, DOI 10.1006/jtbi.1996.0088; Rhodes CJ, 1997, THEOR POPUL BIOL, V52, P101, DOI 10.1006/tpbi.1997.1323; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Ruan ZY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036117; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Shu P., 2015, CHAOS, V25; Shu P, 2016, ARXIV160202050; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Tang M, 2009, EPL, V87; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Tsai MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013292; White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Yashima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098518	47	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168127	10.1371/journal.pone.0168127	http://dx.doi.org/10.1371/journal.pone.0168127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973605	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300057
J	Wilkie, H; Nicol, L; Gossner, A; Hopkins, J				Wilkie, Hazel; Nicol, Louise; Gossner, Anton; Hopkins, John			Mucosal Expression of T Cell Gene Variants Is Associated with Differential Resistance to Teladorsagia circumcincta	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODES; HELMINTH-PARASITES; IMMUNE REGULATION; BLACKFACE SHEEP; INFECTED SHEEP; HOST IMMUNITY; ROR-GAMMA; MECHANISMS; LAMBS; TH2	Resistance of sheep to the gastrointestinal nematode Teladorsagia circumcincta is a heritable characteristic. Control of parasite colonization and egg production is strongly linked to IgA antibody levels regulated by Th2 T cell activation within lymphoid tissue; and persistently- infected susceptible animals develop an inflammatory Th1/Th17 response within the abomasum that fails to control infection. Differential T cell polarization therefore is associated with parasite resistance and/or susceptibility and is controlled by a specific set of transcription factors and cytokine receptors. Transcript variants of these genes have been characterized in sheep, while in humans and mice different variants of the genes are associated with inflammatory diseases. RT-qPCR was used to quantify mucosal expression of the transcript variants of the sheep genes in trickle-infected animals with defined phenotypic traits. Genes that encode full-length GATA3 and IL17RB were shown to be significantly increased in resistant sheep that had controlled parasite infection. Expression levels of both were significantly negatively correlated with abomasal worm count (a parameter of susceptibility) and positively correlated with body weight (a parameter of resistance). These data show that polarized Th2 T cells within the abomasal mucosa play an important role in the maintenance of resistance.	[Hopkins, John] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; Univ Edinburgh, RD SVS, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hopkins, J (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	john.hopkins@ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Wilkie, Hazel/0000-0002-6586-4518	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant [BB/J004227/1]; BBSRC Industrial CASE scholarship; Sheep Improved Genetics Ltd; AHDB Beef and Lamb [BB/J012653/1]; BBSRC Doctoral Training Grant [BB/D526245/1]; Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme [NE/D000645/1]; BBSRC [BBS/E/D/20231762, BBS/E/D/20231760] Funding Source: UKRI; NERC [NE/D000645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231762, BBS/E/D/20231760, 1232400] Funding Source: researchfish; Natural Environment Research Council [NE/D000645/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sheep Improved Genetics Ltd; AHDB Beef and Lamb; BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute (BB/J004227/1), by a BBSRC Industrial CASE scholarship to JH, for HW, sponsored by Sheep Improved Genetics Ltd (no funding was obtained from SIG Ltd) and supported by AHDB Beef and Lamb (Grant BB/J012653/1). LN was a BBSRC postgraduate student funded by the BBSRC Doctoral Training Grant BB/D526245/1. This does not alter our adherence to PLOS ONE policies on sharing data. The initial work was funded by the Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme (grant NE/D000645/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Armour J, 1996, VET PARASITOLOGY; Beraldi D, 2008, INT J PARASITOL, V38, P1567, DOI 10.1016/j.ijpara.2008.04.011; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Craig NM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-87; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Dawson H, 2009, INFECT IMMUN, V77, P2576, DOI 10.1128/IAI.00827-07; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Gossner AG, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-26; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Hayes KS, 2004, IMMUNOL REV, V201, P75, DOI 10.1111/j.0105-2896.2004.00193.x; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Lacroux C, 2006, VET RES, V37, P607, DOI 10.1051/vetres:2006022; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Neill DR, 2010, IMMUNOL CELL BIOL, V88, P502, DOI 10.1038/icb.2010.43; Nicol L, 2016, VET RES, V47, DOI 10.1186/s13567-016-0314-4; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Pei C, 2016, INFECT IMMUN; Pena MT, 2006, VET PARASITOL, V138, P240, DOI 10.1016/j.vetpar.2005.12.026; Pernthaner A, 2005, INFECT IMMUN, V73, P2175, DOI 10.1128/IAI.73.4.2175-2183.2005; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Stear MJ, 1999, VET IMMUNOL IMMUNOP, V72, P213, DOI 10.1016/S0165-2427(99)00134-8; Strain SAJ, 2002, PARASITOLOGY, V124, P545, DOI 10.1017/S0031182002001531; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilkie H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149644; Wilkie H, 2015, VET PARASITOL, V212, P206, DOI 10.1016/j.vetpar.2015.08.023; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168194	10.1371/journal.pone.0168194	http://dx.doi.org/10.1371/journal.pone.0168194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973603	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300064
J	Fuller, M; Li, XR; Fisch, R; Bughara, M; Wicksteed, B; Kovatcheva-Datchary, P; Layden, BT				Fuller, Miles; Li, Xiaoran; Fisch, Robert; Bughara, Moneb; Wicksteed, Barton; Kovatcheva-Datchary, Petia; Layden, Brian T.			FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by Antibiotics	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; HUMAN GUT MICROBIOTA; FATTY-ACID RECEPTOR; ANTIMICROBIAL DEFENSE; INSULIN-RESISTANCE; HOST; RESPONSES; PROMOTES; GPR43; MICE	During the insulin resistant phase of pregnancy, the mRNA expression of free fatty acid 2 receptor (Ffar2) is upregulated and as we recently reported, this receptor contributes to insulin secretion and pancreatic beta cell mass expansion in order to maintain normal glucose homeostasis during pregnancy. As impaired gestational glucose levels can affect metabolic health of offspring, we aimed to explore the role of maternal Ffar2 expression during pregnancy on the metabolic health of offspring and also the effects of antibiotics, which have been shown to disrupt gut microbiota fermentative activity (the source of the FFA2 ligands) on gestational glucose homeostasis. We found that maternal Ffar2 expression and impaired glucose tolerance during pregnancy had no effect on the growth rates, ad lib glucose and glucose tolerance in the offspring between 3 and 6 weeks of age. To disrupt short chain fatty acid production, we chronically treated WT mice and Ffar2(-/-) mice with broad range antibiotics and further compared their glucose tolerance prior to pregnancy and at gestational day 15, and also quantified cecum and plasma SCFAs. We found that during pregnancy antibiotic treatment reduced the levels of SCFAs in the cecum of the mice, but resulted in elevated levels of plasma SCFAs and altered concentrations of individual SCFAs. Along with these changes, gestational glucose tolerance in WT mice, but not Ffar2(-/-) mice improved while on antibiotics. Additional data showed that gestational glucose tolerance worsened in Ffar2(-/-) mice during a second pregnancy. Together, these results indicate that antibiotic treatment alone is inadequate to deplete plasma SCFA concentrations, and that modulation of gut microbiota by antibiotics does not disrupt the contribution of FFA2 to gestational glucose tolerance.	[Fuller, Miles; Li, Xiaoran; Fisch, Robert; Bughara, Moneb; Wicksteed, Barton; Layden, Brian T.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Kovatcheva-Datchary, Petia] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Layden, Brian T.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Layden, Brian T.] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Gothenburg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Layden, BT (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.; Layden, BT (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA.; Layden, BT (corresponding author), Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL USA.	blayde1@uic.edu		Bughrara, Moneb/0000-0002-1100-6518	National Institutes of Health [R01DK104927-01A1]; University of Chicago DRC [P30DK020595]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development [1IK2BX001587-01]; American Heart Association [15PRE25750015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago DRC; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BTL is supported by the National Institutes of Health under award number, R01DK104927-01A1, The University of Chicago DR&C (P30DK020595) and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development (Grant no. 1IK2BX001587-01). MF is supported by the American Heart Association under award number 15PRE25750015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bellamy L, SCI DIR LANCET, V373, P1773; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Chen YF, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0262-8; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Fuller M, 2015, AM J PHYSIOL-ENDOC M, V309, pE840, DOI 10.1152/ajpendo.00171.2015; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Hendrickx APA, 2015, MBIO, V6, DOI 10.1128/mBio.01346-15; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Kahraman S, 2014, AM J PHYSIOL-ENDOC M, V307, pE906, DOI 10.1152/ajpendo.00210.2014; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kelder T, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.18; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Layden BT, 2010, J ENDOCRINOL, V207, P265, DOI 10.1677/JOE-10-0298; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; Ornoy A, 2015, BIRTH DEFECTS RES C, V105, P53, DOI 10.1002/bdrc.21090; Pedersen J., 1968, ARCH DIS CHILD, V43, P391, DOI DOI 10.1136/ADC.43.229.391-A; Priyadarshini M, 2016, TRENDS ENDOCRIN MET, V27, P653, DOI 10.1016/j.tem.2016.03.011; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167837	10.1371/journal.pone.0167837	http://dx.doi.org/10.1371/journal.pone.0167837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959892	gold, Green Published, Green Submitted			2022-12-26	WOS:000392753900017
J	Gerber, EM; Sadeh, B; Ward, A; Knight, RT; Deouell, LY				Gerber, Edden M.; Sadeh, Boaz; Ward, Andrew; Knight, Robert T.; Deouell, Leon Y.			Non-Sinusoidal Activity Can Produce Cross-Frequency Coupling in Cortical Signals in the Absence of Functional Interaction between Neural Sources	PLoS One			English	Article							OSCILLATORY ACTIVITY; THETA-OSCILLATIONS; GAMMA-POWER; CORTEX; PHASE; MEMORY; EXCITABILITY; ALPHA; EEG	The analysis of cross-frequency coupling (CFC) has become popular in studies involving intracranial and scalp EEG recordings in humans. It has been argued that some cases where CFC is mathematically present may not reflect an interaction of two distinct yet functionally coupled neural sources with different frequencies. Here we provide two empirical examples from intracranial recordings where CFC can be shown to be driven by the shape of a periodic waveform rather than by a functional interaction between distinct sources. Using simulations, we also present a generalized and realistic scenario where such coupling may arise. This scenario, which we term waveform-dependent CFC, arises when sharp waveforms (e.g., cortical potentials) occur throughout parts of the data, in particular if they occur rhythmically. Since the waveforms contain both low-and high-frequency components, these components can be inherently phase-aligned as long as the waveforms are spaced with appropriate intervals. We submit that such behavior of the data, which seems to be present in various cortical signals, cannot be interpreted as reflecting functional modulation between distinct neural sources without additional evidence. In addition, we show that even low amplitude periodic potentials that cannot be readily observed or controlled for, are sufficient for significant CFC to occur.	[Gerber, Edden M.; Deouell, Leon Y.] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Sadeh, Boaz; Ward, Andrew; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Deouell, Leon Y.] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel	Hebrew University of Jerusalem; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Gerber, EM (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	edden.gerber@gmail.com	Deouell, Leon Y./W-9624-2019	Gerber, Edden/0000-0001-6704-0013	NINDS [R37 NS021135-27]; US-Israel Binational Research Foundation [2013070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US-Israel Binational Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NINDS Grant R37 NS021135-27 to RTK, and the US-Israel Binational Research Foundation Grant 2013070 to RTK and LYD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brazier D. R. S. M. A. B., 1961, FED NEWS, P646; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Cole S. R., 2016, BIORXIV, P49304; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; Delorme A., J NEUROSCI METHODS, V134, P9; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KOZELKA JW, 1990, J CLIN NEUROPHYSIOL, V7, P191, DOI 10.1097/00004691-199004000-00004; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Little Simon, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS44, DOI 10.1016/S1353-8020(13)70013-0; Lozano-Soldevilla D, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00087; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Sadeh B, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P268, DOI 10.1016/B978-0-12-398451-7.00021-X; Szczepanski SM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001936; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021	31	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167351	10.1371/journal.pone.0167351	http://dx.doi.org/10.1371/journal.pone.0167351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941990	Green Submitted, gold, Green Published			2022-12-26	WOS:000392745600013
J	Boehme, SA; Franz-Bacon, K; Ludka, J; DiTirro, DN; Ly, TW; Bacon, KB				Boehme, Stefen A.; Franz-Bacon, Karin; Ludka, John; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.			MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction	PLOS ONE			English	Article							SMALL INTERFERING RNA; OXIDATIVE STRESS; EPITHELIAL-CELLS; DISEASE; NEUTROPHIL; MECHANISMS; EMPHYSEMA; EXACERBATIONS; EXPRESSION; PREVENTION	Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung inflammation resulting in a progressive decline in lung function whose principle cause is cigarette smoke. MAP3K19 is a novel kinase expressed predominantly by alveolar and interstitial macrophages and bronchial epithelial cells in the lung. We found that MAP3K19 mRNA was overexpressed in a limited sampling of lung tissue from COPD patients, and a closer examination found it to be overexpressed in bronchoalveolar macrophages from COPD patients, as well as the bronchial epithelium and inflammatory cells in the lamina propria. We further found MAP3K19 to be induced in various cell lines upon environmental stress, such as cigarette smoke, oxidative and osmotic stress. Exogenous expression of MAP3K19 in cells caused an upregulation of transcriptionally active NF-kappa B, and secretion of the chemokines CXCL-8, CCL-20 and CCL-7. Inhibition of MAP3K19 activity by siRNA or small molecular weight inhibitors caused a decrease in cigarette smoke-induced inflammation in various murine models, which included a decrease in pulmonary neutrophilia and KC levels. In a chronic cigarette smoke model, inhibition of MAP3K19 significantly attenuated emphysematous changes in airway parenchyma. Finally, in a viral exacerbation model, mice exposed to cigarette smoke and influenza A virus showed a decrease in pulmonary neutrophilia, pro-inflammatory cytokines and viral load upon inhibition of MAP3K19. Collectively, these results suggest that inhibition of MAP3K19 may represent a novel strategy to target COPD that promises to have a potential therapeutic benefit for patients.	[Boehme, Stefen A.; Ludka, John; DiTirro, Danielle N.; Ly, Tai Wei; Bacon, Kevin B.] Axikin Pharmaceut Inc, San Diego, CA 92121 USA; [Franz-Bacon, Karin] DNA Consulting Inc, San Diego, CA USA; [Ludka, John] Calif Inst Biomed Res, La Jolla, CA USA; [DiTirro, Danielle N.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Brandeis University	Boehme, SA (corresponding author), Axikin Pharmaceut Inc, San Diego, CA 92121 USA.	sboehme@axikin.com			DNA Consulting, Inc.; Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research [P30 AI036214]; VA San Diego Healthcare System; Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	DNA Consulting, Inc.; Axikin Pharmaceuticals, Inc.; Genomics and Sequencing Core at the UC San Diego Center for AIDS Research; VA San Diego Healthcare System(US Department of Veterans Affairs); Veterans Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors Stefen A. Boehme, John Ludka, Danielle DiTirro, Tai Wei Ly and Kevin B. Bacon are currently or previously employees of Axikin Pharmaceuticals, Inc. Karin Franz-Bacon is an employee of DNA Consulting, Inc. Axikin Pharmaceuticals, Inc., provided support in the form of salaries for all of the authors (SAB, KFB, JL, DDT, TWL, KBB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We would like to acknowledge the original contributions to the cloning of MAP3K19 by Drs. S. Watanabe, S. Kondo and J. Encinas (WO 2005/001083 A1). We also thank Dr. Gerrard Manning at the Salk Institute (presently at Genentech Inc.), Jon Athanacio for technical expertise, Drs. Gary Anderson and Andrew Lilja at University of Melbourne, Karen Stebbins and Dr. Dan Lorrain for help with the smoking model, and Pinyi Du at the Genomics and Sequencing Core, UCSD for their outstanding contributions. We would also like to thank Drs. Ruth McLaughlin, Emma Moss and Karen Bingham at Biopta for access to COPD lung tissue, Dr. Claire Weston, Casey Laris and Jeff Hodson at Reveal Biosciences for their histology and imaging work and Dr. Clifton Drew for interpreting the clinical pathology. We would also like to thank Dr. Cesare Saltini (University of Rome and University of Florida) for his help in obtaining patient samples and many insightful discussions. This work was performed with the support of the Genomics and Sequencing Core at the UC San Diego Center for AIDS Research (P30 AI036214), the VA San Diego Healthcare System, and the Veterans Medical Research Foundation.	Angelis N, 2014, J THORAC DIS, V6, pS167, DOI 10.3978/j.issn.2072-1439.2014.03.07; Austin V, 2016, CLIN SCI, V130, P1039, DOI 10.1042/CS20160043; Awji EG, 2015, TOXICOL SCI, V147, P75, DOI 10.1093/toxsci/kfv108; Barnes PJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.76; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2010, SCIENCE, V330, P40, DOI 10.1126/science.1196017; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bernardo I, 2015, PHARMACOL THERAPEUT, V155, P60, DOI 10.1016/j.pharmthera.2015.08.005; Boehme SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154874; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; Delzell John E Jr, 2013, FP Essent, V409, P23; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Ellisen LW, 2010, NAT MED, V16, P754, DOI 10.1038/nm0710-754; Eurlings IMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107757; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Gutbier B, 2010, PULM PHARMACOL THER, V23, P334, DOI 10.1016/j.pupt.2010.03.007; Heijink IH, 2015, AM J RESP CELL MOL, V52, P554, DOI 10.1165/rcmb.2013-0505OC; Hurst JR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-40; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Konigshoff M, 2009, SWISS MED WKLY, V139, P554, DOI smw-12528; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackay AJ, 2013, IMMUNOL ALLERGY CLIN, V33, P95, DOI 10.1016/j.iac.2012.10.006; Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Patel RR, 2008, DRUGS, V68, P1511, DOI 10.2165/00003495-200868110-00004; Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215; Polverino F, 2016, AM J PHYSIOL-LUNG C, V311, pL687, DOI 10.1152/ajplung.00304.2016; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sethi S, 2012, AM J MED, V125, P1162, DOI 10.1016/j.amjmed.2012.06.024; Shaykhiev Renat, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS252, DOI 10.1513/AnnalsATS.201402-049AW; Sohal SS, 2013, EXPERT REV RESP MED, V7, P275, DOI [10.1586/ERS.13.26, 10.1586/ers.13.26]; Stebbins KJ, 2010, J PHARMACOL EXP THER, V332, P764, DOI 10.1124/jpet.109.161919; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Tang K, 2004, J APPL PHYSIOL, V97, P15559; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10	48	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167169	10.1371/journal.pone.0167169	http://dx.doi.org/10.1371/journal.pone.0167169			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935962	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100068
J	Kim, CS; Bae, EH; Ma, SK; Kweon, SS; Kim, SW				Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kweon, Sun-Seog; Kim, Soo Wan			Impact of Transient and Persistent Acute Kidney Injury on Chronic Kidney Disease Progression and Mortality after Gastric Surgery for Gastric Cancer	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; LONG-TERM OUTCOMES; RISK; RECOVERY; DEATH; ASSOCIATION; DYSFUNCTION	Acute kidney injury (AKI) is common after gastric surgery for gastric cancer and associated with adverse outcomes. However, the impact of transient or persistent AKI on clinical outcomes after gastric surgery for gastric cancer has not been described. We performed a retrospective study of 4,886 patients with normal renal function who underwent partial or total gastrectomy for gastric cancer between June 2002 and December 2012. AKI patients were classified as transient and persistent AKI based on the return of serum creatinine to the level indicating no AKI within 7 days. Our outcomes included occurrence of new-onset chronic kidney disease (CKD) and mortality 1 year after gastric surgery. AKI occurred in 638 (13.1%) after gastric surgery. Transient AKI was documented in 574 (90%). Use of diuretics and contrast agents was a common risk factor for persistent and transient AKI. Length of intensive care unit (ICU) and hospital stay, and ICU admission rate were higher in patients with transient AKI than in those without AKI. Although patients with persistent AKI had a higher new-onset CKD 1 year after gastric surgery after adjusting for multiple covariates, transient AKI was not associated with new-onset CKD. The 1-year mortality rates were significantly higher in patients with transient and persistent AKI. Not only persistent AKI but transient AKI is associated with increased risk of hospital complications and a significantly higher risk of long-term mortality than patients without AKI after gastric surgery. Moreover, persistent AKI, but not transient AKI, is associated with CKD progression at 1 year.	[Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun Gun, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skimw@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01051769]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2016R1A2B4007870]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning [2014M3C1A3053036]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2084]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT Future Planning; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01051769), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2016R1A2B4007870), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT &Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chalikias G, 2016, CARDIOVASC DRUG THER, V30, P515, DOI 10.1007/s10557-016-6683-0; Choi JS, 2013, AM J CARDIOL, V112, P41, DOI 10.1016/j.amjcard.2013.02.051; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fidalgo P, 2014, J CRIT CARE, V29, P1028, DOI 10.1016/j.jcrc.2014.07.024; Field A, 2009, DISCOVERING STAT USI, P372; Heung M, 2015, AM J KIDNEY DIS; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082289; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wehbe E, 2013, CLIN J AM SOC NEPHRO, V8, P19, DOI 10.2215/CJN.04800512; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011	25	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168119	10.1371/journal.pone.0168119	http://dx.doi.org/10.1371/journal.pone.0168119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936153	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100273
J	Kingsley, J; Karanth, S; Revere, FL; Agrawal, D				Kingsley, James; Karanth, Siddharth; Revere, Frances Lee; Agrawal, Deepak			Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study	PLOS ONE			English	Article							SOCIETY TASK-FORCE; COLORECTAL-CANCER; DECISION-ANALYSIS; PATIENT FACTORS; IMPACT; SURVEILLANCE; QUALITY; RECOMMENDATIONS; POLYPECTOMY; POPULATION	Background Inadequate bowel preparation during screening colonoscopy necessitates repeating colonoscopy. Studies suggest inadequate bowel preparation rates of 20-60%. This increases the cost of colonoscopy for our society. Aim The aim of this study is to determine the impact of inadequate bowel preparation rate on the cost effectiveness of colonoscopy compared to other screening strategies for colorectal cancer (CRC). Methods A microsimulation model of CRC screening strategies for the general population at average risk for CRC. The strategies include fecal immunochemistry test (FIT) every year, colonoscopy every ten years, sigmoidoscopy every five years, or stool DNA test every 3 years. The screening could be performed at private practice offices, outpatient hospitals, and ambulatory surgical centers. Results At the current assumed inadequate bowel preparation rate of 25%, the cost of colonoscopy as a screening strategy is above society's willingness to pay (<$50,000/QALY). Threshold analysis demonstrated that an inadequate bowel preparation rate of 13% or less is necessary before colonoscopy is considered more cost effective than FIT. At inadequate bowel preparation rates of 25%, colonoscopy is still more cost effective compared to sigmoidoscopy and stool DNA test. Sensitivity analysis of all inputs adjusted by +/- 10% showed incremental cost effectiveness ratio values were influenced most by the specificity, adherence, and sensitivity of FIT and colonoscopy. Conclusions Screening colonoscopy is not a cost effective strategy when compared with fecal immunochemical test, as long as the inadequate bowel preparation rate is greater than 13%.	[Kingsley, James] Texas Hlth Presbyterian Hosp, Dept Internal Med, Dallas, TX USA; [Karanth, Siddharth; Revere, Frances Lee] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Agrawal, Deepak] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agrawal, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Deepak.Agrawal@UTSouthwestern.edu	Karanth, Siddharth/K-6758-2019; Revere, Frances/AAE-8132-2022; Agrawal, Deepak/L-6592-2019	Karanth, Siddharth/0000-0002-4923-2692; Agrawal, Deepak/0000-0001-7224-6921				American Cancer Society, 2011, COL CANC FACTS FIG 2; Tran AH, 2014, JAMA INTERN MED, V174, P1675, DOI 10.1001/jamainternmed.2014.3746; [Anonymous], 2014, MED LETT DRUGS THER, V56, P100; Ben-Horin S, 2007, AM J GASTROENTEROL, V102, P2680, DOI 10.1111/j.1572-0241.2007.01486.x; Borg BB, 2009, CLIN GASTROENTEROL H, V7, P670, DOI 10.1016/j.cgh.2009.02.014; Bourikas LA, 2013, WORLD J GASTRO ENDOS, V5, P468, DOI 10.4253/wjge.v5.i10.468; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Chan WK, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-86; Chiu HM, 2006, AM J GASTROENTEROL, V101, P2719, DOI 10.1111/j.1572-0241.2006.00868.x; Chung YW, 2009, J CLIN GASTROENTEROL, V43, P448, DOI 10.1097/MCG.0b013e3181662442; de Leone A, 2013, WORLD J GASTRO ENDOS, V5, P433, DOI 10.4253/wjge.v5.i9.433; Djalalov S, 2014, MED DECIS MAKING, V34, P809, DOI 10.1177/0272989X14536779; Edejer T, 2003, MAKING CHOICES HLTH; Fatima H, 2010, GASTROINTEST ENDOSC, V71, P1244, DOI 10.1016/j.gie.2009.11.053; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Hassan C, 2012, CLIN GASTROENTEROL H, V10, P501, DOI 10.1016/j.cgh.2011.12.037; Hendry PO, 2007, COLORECTAL DIS, V9, P745, DOI 10.1111/j.1463-1318.2007.01220.x; Henry SG, 2007, J GEN INTERN MED, V22, P1415, DOI 10.1007/s11606-007-0281-6; Howard K, 2005, J MED SCREEN, V12, P96, DOI 10.1258/0969141053908276; Johnson DA, 2014, AM J GASTROENTEROL; Khandker RK, 2000, INT J TECHNOL ASSESS, V16, P799, DOI 10.1017/S0266462300102077; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Kruse GR, 2015, J GEN INTERN MED, V30, P277, DOI 10.1007/s11606-014-3015-6; Ladabaum U, 2006, AM J PREV MED, V30, P378, DOI 10.1016/j.amepre.2005.12.010; Ladabaum U, 2014, AM J GASTROENTEROL; Ladabaum U, 2004, ANN M AM GASTR ASS; Larsen Michael, 2011, Am J Gastroenterol, V106, P2058, DOI 10.1038/ajg.2011.238; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liang PS, 2014, AM J GASTROENTEROL, V109, P1725, DOI 10.1038/ajg.2014.328; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Maciosek MV, 2006, AM J PREV MED, V31, P80, DOI 10.1016/j.amepre.2006.03.009; Manno M, 2012, DIGEST LIVER DIS, V44, P576, DOI 10.1016/j.dld.2012.02.012; Matro R, 2010, AM J GASTROENTEROL, V105, P1954, DOI 10.1038/ajg.2010.160; Menees SB, 2014, AM J GASTROENTEROL, V109, P148, DOI 10.1038/ajg.2013.243; Ness RM, 2001, AM J GASTROENTEROL, V96, P1797, DOI 10.1016/S0002-9270(01)02437-6; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; Pignone M, 2005, EC MODELS COLORECTAL; Pyenson B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-92; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rex DK, 2002, AM J GASTROENTEROL, V97, P1696; Rex DK, 2014, CLIN GASTROENTEROL H, V12, P458, DOI 10.1016/j.cgh.2013.11.003; Ries L, 1997, NIH PUBL, V278; Serper M, 2014, CLIN GASTROENTEROL H, V12, P451, DOI 10.1016/j.cgh.2013.07.036; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Sheffield KM, 2013, JAMA INTERN MED, V173, P542, DOI 10.1001/jamainternmed.2013.2912; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Simon S., ORG COMMIT GOAL 80 C; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Wang HS, 2013, GASTROINTEST ENDOSC, V77, P71, DOI 10.1016/j.gie.2012.08.038; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wong MCS, 2014, AM J GASTROENTEROL, V109, P1072, DOI 10.1038/ajg.2014.136; Zauber AG, 2007, COST EFFECTIVENESS D; ZAUBER AG, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	62	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167452	10.1371/journal.pone.0167452	http://dx.doi.org/10.1371/journal.pone.0167452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936028	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100099
J	Tan, GL; Huang, Y; Sheng, HH				Tan, Guolong; Huang, Yao; Sheng, Haohao			Magnetoelectric Response in Multiferroic SrFe12O19 Ceramics	PLOS ONE			English	Article							NEGATIVE CAPACITANCE; OXIDE	We report here realization of ferroelectricity, ferromagnetism and magnetocapacitance effect in singleSrFe(12)O(19)ceramic at room temperature. The ceramics demonstrate a saturated polarization hysteresis loop, two nonlinear I-V peaks and large anomaly of dielectric constant near Curie temperature, which confirm the intrinsic ferroelectricity of SrFe12O19 ceramicswith subsequent heat-treatment in O(2)atmosphere. The remnant polarization of the SrFe12O19 ceramic is estimated to be 103 mu C/cm(2). The ceramic also exhibits strong ferromagnetic characterization, the coercive field and remnant magnetic moment are 6192Oe and 35.8emu/g, respectively. Subsequent annealing SrFe12O19 ceramics in O-2 plays a key role on revealing its intrinsic ferroelectricity and improving the ferromagnetism through transforming Fe2+ into Fe3+. By applying a magnetic field, the capacitance demonstrates remarkable change along with B field, the maximum rate of change in epsilon(Delta epsilon(B)/epsilon(0)) is 1174%, which reflects a giant magnetocapacitance effect in SrFe12O19. XPS and molecular magnetic moment measurements confirmed the transformation of Fe2+ into Fe3+ and removal of oxygen vacancies upon O-2 heat treatment. These combined functional responses in SrFe12O19 ceramics opens substantial possibilities for applications in novel electric devices.	[Tan, Guolong; Huang, Yao; Sheng, Haohao] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Peoples R China	Wuhan University of Technology	Tan, GL (corresponding author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan, Peoples R China.	gltan@whut.edu.cn	Tan, Guolong/A-1098-2013	Tan, Guolong/0000-0003-0961-5506	Hubei Natural Science Foundation [2014CFB166]; Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology) [2016-KF-15]	Hubei Natural Science Foundation(Natural Science Foundation of Hubei Province); Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology)	This work was supported by the Hubei Natural Science Foundation (under the contract no. 2014CFB166) and the Open fund of State Key Laboratory of Advanced Technology for Materials Synthesis and Processing (Wuhan University of Technology) under the contract no. 2016-KF-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratkovsky AM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.132103; CARVER JC, 1972, J CHEM PHYS, V57, P973, DOI 10.1063/1.1678348; Catalan G, 2015, NAT MATER, V14, P137, DOI 10.1038/nmat4195; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Chun S. H., 2010, PHY REV LETT, V304; Eerenstein W, 2007, NAT MATER, V6, P348, DOI 10.1038/nmat1886; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Ershov M, 1998, IEEE T ELECTRON DEV, V45, P2196, DOI 10.1109/16.725254; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; Grechnev G.E., 2015, 151000513V1 ARXIV CO; Hill NA, 2002, ANNU REV MATER RES, V32, P1, DOI 10.1146/annurev.matsci.32.101901.152309; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Ishiwata S, 2008, SCIENCE, V319, P1643, DOI 10.1126/science.1154507; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Khan AI, 2015, NAT MATER, V14, P182, DOI [10.1038/nmat4148, 10.1038/NMAT4148]; Khomskii D, 2009, PHYSICS, V2, P20, DOI 10.1103/Physics.2.20; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137201; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kimura T, 2012, ANNU REV CONDEN MA P, V3, P93, DOI 10.1146/annurev-conmatphys-020911-125101; Lee JH, 2010, NATURE, V466, P954, DOI 10.1038/nature09331; Levin I, 2006, ADV MATER, V18, P2044, DOI 10.1002/adma.200600288; Lobo RPSM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.172105; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Mazumdar D, 2016, J ELECTRON SPECTROSC, V208, P63, DOI 10.1016/j.elspec.2015.10.002; MOMOZAWA N, 1993, J PHYS SOC JPN, V62, P1292, DOI 10.1143/JPSJ.62.1292; Pokharel BP, 2000, J APPL PHYS, V88, P5364, DOI 10.1063/1.1317241; RADO GT, 1964, PHYS REV LETT, V13, P335, DOI 10.1103/PhysRevLett.13.335; Reiner JW, 2009, SCIENCE, V323, P1018, DOI 10.1126/science.1169058; Rowley S. E., SCI REP; Scott JF, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/02/021001; Shen S. P., NATURE COMM; Shen SP, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.180404; Singh A. K., 2009, APPL PHYS, V106; Stucki N., 2008, THESIS U GEN SWITZ, P48; Sugimoto M, 1999, J AM CERAM SOC, V82, P269, DOI 10.1111/j.1551-2916.1999.tb20058.x; Tan GL, 2016, ACTA MATER, V121, P144, DOI 10.1016/j.actamat.2016.08.083; Tan GL, 2015, J AM CERAM SOC, V98, P1812, DOI 10.1111/jace.13530; Tan GL, 2011, J ELECTROCERAM, V26, P170, DOI 10.1007/s10832-011-9641-z; Tan GL, 2013, J ELECTRON MATER, V42, P906, DOI 10.1007/s11664-012-2426-6; Tan GL, 2013, J MAGN MAGN MATER, V327, P87, DOI 10.1016/j.jmmm.2012.09.047; Tokunaga Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257201; Tokura Y, 2006, SCIENCE, V312, P1481, DOI 10.1126/science.1125227; Vaz CAF, 2010, ADV MATER, V22, P2900, DOI 10.1002/adma.200904326; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Wang JH, 2007, PROCEEDINGS OF THE 3RD INTERNATIONAL YELLOW RIVER FORUM ON SUSTAINABLE WATER RESOURCES MANAGEMENT AND DELTA ECOSYSTEM MAINTENANCE, VOL I, P259; Yamasaki Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207204; Yang N, 2007, J ALLOY COMPD, V438, P263, DOI 10.1016/j.jallcom.2006.08.037; Zheng RY, 2008, J APPL PHYS, V104, DOI 10.1063/1.2966696	50	14	14	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167084	10.1371/journal.pone.0167084	http://dx.doi.org/10.1371/journal.pone.0167084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935996	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100059
J	Wang, X; Wei, YZ; Xue, YW; Lu, PO; Yu, LJ; Shen, BZ				Wang, Xin; Wei, Yuzhe; Xue, Yingwei; Lu, Peiou; Yu, Lijuan; Shen, Baozhong			Predictive Role of the Number of F-18-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer	PLOS ONE			English	Article							METABOLIC TUMOR VOLUME; POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; PROGNOSTIC VALUE; F-18-FDG PET/CT; FOLLOW-UP; CARCINOMA; CT; SURVIVAL; GLUCOSE-TRANSPORTER-1	Objectives The aim of this study was to investigate the predictive value of the numbers of metabolically positive lymph nodes (MPLN) detected by F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET)/computed tomography (CT) in patients with locally advanced gastric cancer (LAGC). Methods We retrospectively analyzed the records of 50 patients with LAGC (stage T2-T4) who had undergone pre-operative PET/CT examination and laparotomy (total gastrectomy, n = 11; subtotal gastrectomy, n = 13; distal gastrectomy, n = 22; and bypass with gastrojejunstomy, n = 4). The numbers of MPLN were determined by combining visual observations with semiquantitative measurements of the maximized standardized uptake value (SUVmax). Performance was investigated in terms of predicting post-surgical overall survival (OS). Results The median post-surgical OS was 32.57 months (range 3.0-94 months). The numbers of MPLN were moderately correlated with the numbers of histological positive LN (r = 0.694, p = 0.001). In univariate analyses, the numbers of MPLN (<= 2 vs. >= 3), PET/CT LN (positivity vs. negativity), SUVmax of LN (< 2.8 vs. >= 2.8), TNM stage (I, II vs. III, IV), and surgery type (R0 vs. non-R0) were significantly associated with OS. In multivariate analysis, surgery type (R0 vs. non-R0) and numbers of MPLN (<= 2 vs. >= 3) were both independent factors for poor OS. Conclusions This explored study indicates that the number of MPLN could provide additional information for LAGC prognosis. Patients with MPLNs >= 3 may be at the risk of the more bad outcomes, and the further clinical trials are needed.	[Wang, Xin; Lu, Peiou; Yu, Lijuan] Harbin Med Univ, Canc Hosp, PET CT MRI Ctr, Harbin, Heilongjiang Pr, Peoples R China; [Wei, Yuzhe; Xue, Yingwei] Harbin Med Univ, Canc Hosp, Dept Surg Gastroenterol, Harbin, Heilongjiang Pr, Peoples R China; [Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, X (corresponding author), Harbin Med Univ, Canc Hosp, PET CT MRI Ctr, Harbin, Heilongjiang Pr, Peoples R China.	xinwang826@vip.163.com		Wang, Xin/0000-0002-3499-8871	Heilongjiang Province Natural Science Foundation of China [H201448]	Heilongjiang Province Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Heilongjiang Province Natural Science Foundation of China (No. H201448).	Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Alakus H, 2010, NUCL MED COMMUN, V31, P532, DOI 10.1097/MNM.0b013e32833823ac; Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Chung HW, 2010, J CANCER RES CLIN, V136, P1929, DOI 10.1007/s00432-010-0852-5; Coupe NA, 2014, ANN NUCL MED, V28, P128, DOI 10.1007/s12149-013-0791-8; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Ha TK, 2011, J KOREAN SURG SOC, V81, P104, DOI 10.4174/jkss.2011.81.2.104; Huang W, 2014, J NUCL MED, V55, P1584, DOI 10.2967/jnumed.114.142919; Hur H, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-86; Jensen EH, 2007, SURG ONCOL CLIN N AM, V16, P329, DOI 10.1016/j.soc.2007.03.003; Karpeh MS, 2000, ANN SURG, V232, P362, DOI 10.1097/00000658-200009000-00008; Kawamura T, 2001, CANCER-AM CANCER SOC, V92, P634, DOI 10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X; Kim EY, 2011, EUR J RADIOL, V79, P183, DOI 10.1016/j.ejrad.2010.02.005; Kim J, 2014, NUCL MED MOLEC IMAG, V48, P33, DOI 10.1007/s13139-013-0243-3; Kim SK, 2006, EUR J NUCL MED MOL I, V33, P148, DOI 10.1007/s00259-005-1887-8; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Lowy AM, 1999, ANN SURG, V229, P303, DOI 10.1097/00000658-199903000-00001; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Ozkan E, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-75; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Park JC, 2012, EUR J NUCL MED MOL I, V39, P1107, DOI 10.1007/s00259-012-2116-x; Roder JD, 1998, CANCER-AM CANCER SOC, V82, P621, DOI 10.1002/(SICI)1097-0142(19980215)82:4<621::AID-CNCR2>3.3.CO;2-2; Rosenbaum SJ, 2006, ABDOM IMAGING, V31, P25, DOI 10.1007/s00261-005-0031-3; Sarela AI, 2006, ANN SURG, V243, P189, DOI 10.1097/01.sla.0000197382.43208.a5; Smyth E, 2012, CANCER-AM CANCER SOC, V118, P5481, DOI 10.1002/cncr.27550; Song BI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001037; Stahl A, 2003, EUR J NUCL MED MOL I, V30, P288, DOI 10.1007/s00259-002-1029-5; von Schulthess GK, 2006, RADIOLOGY, V238, P405, DOI 10.1148/radiol.2382041977; Yamada A, 2006, ANN NUCL MED, V20, P597, DOI 10.1007/BF02984657; Yang QM, 2008, HEPATO-GASTROENTEROL, V55, P782; Youn SH, 2012, J GASTRIC CANCER, V12, P179, DOI 10.5230/jgc.2012.12.3.179; Yun MJ, 2005, J NUCL MED, V46, P1582; Zhang XF, 2004, WORLD J GASTROENTERO, V10, P3405	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166836	10.1371/journal.pone.0166836	http://dx.doi.org/10.1371/journal.pone.0166836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936109	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100045
J	Yong, MK; Cameron, PU; Spelman, T; Elliott, JH; Fairley, CK; Boyle, J; Miyamasu, M; Lewin, SR				Yong, Michelle K.; Cameron, Paul U.; Spelman, Tim; Elliott, Julian H.; Fairley, Christopher K.; Boyle, Jeffrey; Miyamasu, Misato; Lewin, Sharon R.			Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay	PLOS ONE			English	Article							T-CELL-ACTIVATION; IFN-GAMMA PRODUCTION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; VIRAL REPLICATION; INTERFERON-GAMMA; DENDRITIC CELLS; SUPPRESSION; SENESCENCE; CYTOKINES	Objectives HIV infection is characterised by persistent immune dysfunction of both the adaptive and innate immune responses. The aim of this study was to evaluate these responses using a novel high throughput assay in healthy controls and HIV-infected individuals prior to and following anti-retroviral treatment (ART). Design Cross-sectional study. Methods Whole blood was assessed using the QuantiFERON Monitor (R) (QFM) assay containing adaptive and innate immunostimulants. Interferon (IFN)-gamma levels (IU/mL) were measured by enzyme-linked immunosorbent assay (ELISA). Results We recruited HIV-infected participants (n = 20 off ART and viremic; n = 59 on suppressive ART) and HIV-uninfected controls (n = 229). Median IFN-gamma production was significantly higher in HIV-infected participants compared to controls (IFN-gamma 512 vs 223 IU/ml, p<0.0001), but within the HIV-infected participants there was no difference between those on or off ART (median IFN-gamma 512 vs 593 IU/ml p = 0.94). Amongst the HIV-infected participants, IFN-gamma production was higher in individuals with CD4 count>350 compared to <350 cells/mu L (IFN-gamma IU/ml 561 vs 259 p = 0.02) and in males compared to females (IFN-gamma 542 vs 77 IU/ml p = 0.04). There were no associations between IFN-gamma production and age, plasma HIV RNA, nadir CD4 count or duration of HIV infection. Using a multivariable analysis, neither CD4 nor sex were independently predictive of IFN-gamma production. Conclusion Using a high throughput assay which assesses both adaptive and innate immune function, we showed elevated IFN-gamma production in HIV-infected patients both on and off ART. Further research is warranted to determine if changes in QuantiFERON Monitor (R) are associated with clinical outcomes.	[Yong, Michelle K.; Cameron, Paul U.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Yong, Michelle K.; Cameron, Paul U.; Elliott, Julian H.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Yong, Michelle K.; Cameron, Paul U.; Elliott, Julian H.; Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Boyle, Jeffrey; Miyamasu, Misato] QIAGEN, Germantown, MD USA	University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Monash University	Yong, MK (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Yong, MK (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia.; Yong, MK (corresponding author), Alfred Hosp, Melbourne, Vic, Australia.	Michelle.Yong@unimelb.edu.au	Lewin, Sharon/Z-3297-2019; Yong, Michelle/AAC-2549-2020	Yong, Michelle/0000-0002-8692-4145; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Christopher, Fairley/0000-0001-9081-1664	QIAGEN; National Health and Medical Research Council (NHMRC) [0607212]; National Institutes for Health [U19 AI096109]	QIAGEN; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This investigator initiated industry funded study was supported in part by QIAGEN. The study design, statistical analysis and preparation of the manuscript were done independent of the sponsor. MKY was awarded a PhD Scholarship by the National Health and Medical Research Council (NHMRC 0607212). SRL is an NHMRC Practitioner Fellow. SRL and PUC are supported by the National Institutes for Health U19 AI096109. JB and MM are employees of the sponsor but did not have any additional role in the study design, analysis, decision to publish or preparation of the original manuscript.	Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Fernandez S, 2006, CLIN IMMUNOL, V120, P163, DOI 10.1016/j.clim.2006.04.570; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gazzola L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-51; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Jiang YJ, 2013, J CLIN IMMUNOL, V33, P1376, DOI 10.1007/s10875-013-9930-1; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Martinson JA, 2007, CELL IMMUNOL, V250, P75, DOI 10.1016/j.cellimm.2008.01.007; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-125; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roff SR, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00498; Snyder-Cappione JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015412; Sood S, 2014, TRANSPLANTATION, V97, pE50, DOI 10.1097/TP.0000000000000078; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Tincati C, 2009, JAIDS-J ACQ IMM DEF, V51, P642, DOI 10.1097/QAI.0b013e3181add695; Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334; Watanabe D, 2010, VIRAL IMMUNOL, V23, P619, DOI 10.1089/vim.2010.0065	23	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166549	10.1371/journal.pone.0166549	http://dx.doi.org/10.1371/journal.pone.0166549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935986	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100034
J	Main, HG; Xie, J; Muralidhar, GG; Elfituri, O; Xu, H; Kajdacsy-Balla, AA; Barbolina, MV				Main, H. Gurler; Xie, J.; Muralidhar, G. G.; Elfituri, O.; Xu, H.; Kajdacsy-Balla, A. A.; Barbolina, M. V.			Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CX3CR1; PRIMARY DEBULKING SURGERY; NEOADJUVANT CHEMOTHERAPY; CANCER; CX(3)CR1; CELLS; EXPRESSION; MIGRATION; ORIGIN; IDENTIFICATION	Epithelial ovarian carcinoma is the most common cause of death from gynecologic cancers largely due to advanced, relapsed and chemotherapy-resistant peritoneal metastasis, which is refractory to the currently used treatment approaches. Mechanisms supporting advanced and relapsed peritoneal metastasis are largely unknown, precluding development of more effective targeted therapies. In this study, we investigated the function of a potentially targetable fractalkine axis in the formation and the development of advanced and relapsed peritoneal metastasis and its impact on patients' outcomes. Our mouse model studies support a role for the fractalkine receptor (CX(3)CR1) in the initiation of peritoneal adhesion important for recolonization of relapsed peritoneal metastasis. We show that downregulation of CX(3)CR1 results in reduction of metastatic burden at several peritoneal sites commonly colonized by advanced and relapsed metastatic ovarian carcinoma. We show that the chemokine fractalkine (CX(3)CL1), an activating ligand of CX(3)CR1, regulates organ-specific peritoneal colonization. High expression of CX(3)CR1 correlates with significantly shorter survival, specifically in post-menopausal patients with advanced and terminal stages of the disease. Taken together, our studies support a key regulatory role for the fractalkine axis in advanced and relapsed peritoneal metastasis in epithelial ovarian carcinoma.	[Main, H. Gurler; Xie, J.; Muralidhar, G. G.; Barbolina, M. V.] Univ Illinois, Dept Biopharmaceut Sci, 833 South Wood St, Chicago, IL 60612 USA; [Elfituri, O.; Xu, H.; Kajdacsy-Balla, A. A.] Univ Illinois, Dept Pathol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Barbolina, MV (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, 833 South Wood St, Chicago, IL 60612 USA.	mvb@uic.edu	Xie, Jia/L-5939-2019		National Cancer Institute [CA160917]; Ovarian Cancer Research Foundation Liz Tilberis Scholar Award; NATIONAL CANCER INSTITUTE [R21CA160917] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Foundation Liz Tilberis Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs William Beck, Joanna Burdette, Jonna Frasor and Peter Penzes for their helpful suggestions on various methods and data analysis as well as critical reading of the manuscript. This study was supported by the National Cancer Institute (grant # CA160917 to MVB) and Ovarian Cancer Research Foundation Liz Tilberis Scholar Award (to MVB).	Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bookman MA, 2012, CLIN OBSTET GYNECOL, V55, P96, DOI 10.1097/GRF.0b013e31824b45da; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Chang SJ, 2015, J GYNECOL ONCOL, V26, P336, DOI 10.3802/jgo.2015.26.4.336; Chi DS, 2012, GYNECOL ONCOL, V124, P10, DOI 10.1016/j.ygyno.2011.08.014; Colombo PE, 2014, CRIT REV ONCOL HEMAT, V89, P207, DOI 10.1016/j.critrevonc.2013.08.017; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Crum CP, 2013, J PATHOL, V231, P402, DOI 10.1002/path.4263; Davis A, 2014, GYNECOL ONCOL, V133, P624, DOI 10.1016/j.ygyno.2014.02.038; Desjardins M, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-70; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Dubeau L, 2013, ANN ONCOL, V24, P28, DOI 10.1093/annonc/mdt308; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Erreni M, 2016, J IMMUNOL, V196, P902, DOI 10.4049/jimmunol.1501335; Gaudin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021546; Gurler H, 2015, BIOMOLECULES, V5, P3438, DOI 10.3390/biom5043438; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hundhausen Christian, 2003, Blood, V102, P1186; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Jamieson-Gladney WL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3016; Karlstrom S, 2013, J MED CHEM, V56, P3177, DOI 10.1021/jm3012273; Kim M, 2012, MOL CANCER RES, V10, P1419, DOI 10.1158/1541-7786.MCR-12-0361; Kim M, 2012, MOL CANCER RES, V10, P11, DOI 10.1158/1541-7786.MCR-11-0256; Kurman RJ, 2013, ANN ONCOL, V24, P16, DOI 10.1093/annonc/mdt463; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Pomel Christophe, 2007, Cancer Imaging, V7, P210, DOI 10.1102/1470-7330.2007.0030; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rooper L, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-57; Seward SM, 2015, CANCER METAST REV, V34, P5, DOI 10.1007/s10555-014-9536-y; Shen F, 2016, MOL CANCER RES, V14, P518, DOI 10.1158/1541-7786.MCR-16-0013; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tautermann CS, 2014, BIOORG MED CHEM LETT, V24, P4073, DOI 10.1016/j.bmcl.2014.07.009; Thibault B, 2014, CANCER METAST REV, V33, P17, DOI 10.1007/s10555-013-9456-2; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Tsubota K, 2009, INVEST OPHTH VIS SCI, V50, P4753, DOI 10.1167/iovs.08-2596; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Walton J, 2016, CANCER RES, V76, P6118, DOI 10.1158/0008-5472.CAN-16-1272; Wiedemeyer WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00034; Wollberg AR, 2014, P NATL ACAD SCI USA, V111, P5409, DOI 10.1073/pnas.1316510111; Zhang Q, 2004, HUM REPROD, V19, P409, DOI 10.1093/humrep/deh085	52	18	18	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					3025	3036		10.1038/onc.2016.456	http://dx.doi.org/10.1038/onc.2016.456			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27941884	Green Accepted			2022-12-26	WOS:000402000400010
J	Wang, WQ; Zhu, YL; Huang, K; Shan, YL; Du, J; Dong, XY; Ma, P; Wu, PF; Zhang, J; Huang, WH; Zhang, T; Liao, BJ; Yao, DY; Pan, GJ; Liu, JJ				Wang, Wenqian; Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Dong, Xiaoya; Ma, Ping; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Liao, Baojian; Yao, Deyang; Pan, Guangjin; Liu, Jiajun			Suppressing P16(Ink4a) and P14(ARF) pathways overcomes apoptosis in individualized human embryonic stem cells	FASEB JOURNAL			English	Article						BMI1; hESCs; mESCs; senescence	CELLULAR SENESCENCE; INK4A-ARF LOCUS; FREE CULTURE; BMI-1; CONTRIBUTES; SURVIVAL; GROWTH; STATES; NAIVE; LINES	Dissociation-induced apoptosis is a striking phenomenon in human embryonic stem cells (hESCs), but not in naive mouse ESCs. Rho-associated kinase-dependent actin-myosin hyperactivation is an underlying mechanism that triggers apoptosis in dissociated hESCs; however, in this study, we show that the Ink4A-ARFmediated senescence pathway is another mechanism to cause apoptosis in individualized hESCs. We show that P16(INK4A) and P14(ARF) are immediately induced in hESCs upon dissociation, but not in mouse ESCs. Overexpression of BMI1, a suppressor for Ink4A-ARF, greatly promotes survival and cloning efficiency of individualized hESCs mechanistically via direct binding the H3K27me3-marked Ink4A-ARF locus. Forced expression of BMI1 in hESCs does not reduce the actin-myosin activation that is triggered by dissociation, which indicates it is an independent pathway for hESC survival. Furthermore, dual inhibition of both Ink4A-ARF and actin-myosin hyperactivation enables successful passaging of hESCs via gelatin, a nonbioactive matrix. In sum, we provide an additional mechanism that underlies cell death in individualized hESCs that might help to fully understand the differential cell characteristics between naive and primed ESCs.-Wang, W., Zhu, Y., Huang, K., Shan, Y., Du, J., Dong, X., Ma, P. , Wu, P., Zhang, J., Huang, W., Zhang, T., Liao, B., Yao, D., Pan, G., Liu, J. Suppressing P16(Ink4a) and P14(ARF) pathways overcomes apoptosis in individualized human embryonic stem cells.	[Wang, Wenqian; Dong, Xiaoya; Ma, Ping; Liu, Jiajun] Sun Yat Sen Univ, Dept Hematol, 600 Tianhe Ave, Guangzhou 510530, Peoples R China; [Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Yao, Deyang; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Liao, Baojian; Yao, Deyang; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JJ (corresponding author), Sun Yat Sen Univ, Dept Hematol, 600 Tianhe Ave, Guangzhou 510530, Peoples R China.; Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Peoples R China.	jiajun.l@163.com	Liao, Baojian/AAI-6286-2021	Zhu, Yanling/0000-0003-4728-5421	National Basic Research Program of China; 973 Program of China [2012CB966503, 2015CB964902, 2015CB964901]; National Natural Science Foundation of China [31371514, 31421004, 31500948]; Natural Science Foundation of Guangdong Province [2014A030312012]; Science and Information Technology of Guangzhou Key [201508020258]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015293, 2014327]; Frontier and Key Technology Innovation; Department of Science and Technology of Guangdong Province [2014B020225005, 2014B020225006, 2016B030229008]; International Science and Technology Cooperation Program of China [2014DFA30180]; Chinese Academy of Science; Science and Technology Planning Project of Guangdong Province [2014B030301058]	National Basic Research Program of China(National Basic Research Program of China); 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Information Technology of Guangzhou Key; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Frontier and Key Technology Innovation; Department of Science and Technology of Guangdong Province; International Science and Technology Cooperation Program of China; Chinese Academy of Science(Chinese Academy of Sciences); Science and Technology Planning Project of Guangdong Province	The authors thank the laboratory members at Guangzhou Institutes of Biomedicine and Health for their kind assistance. This work was supported by the National Basic Research Program of China, 973 Program of China (2012CB966503, 2015CB964902, 2015CB964901); the National Natural Science Foundation of China (31371514, 31421004, 31500948); a cooperation grant of the Natural Science Foundation of Guangdong Province (2014A030312012); the Science and Information Technology of Guangzhou Key Project (201508020258); the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015293, 2014327); the Frontier and Key Technology Innovation special grant from the Department of Science and Technology of Guangdong Province (2014B020225005, 2014B020225006, 2016B030229008); International Science and Technology Cooperation Program of China (2014DFA30180); "Hundred Talents Program" of the Chinese Academy of Science (to G.P.); and the Science and Technology Planning Project of Guangdong Province (2014B030301058). The authors declare no conflicts of interest.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Greenlee AR, 2005, TOXICOL IN VITRO, V19, P389, DOI 10.1016/j.tiv.2004.11.002; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Kong YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03474; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	26	6	7	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1130	1140		10.1096/fj.201600782R	http://dx.doi.org/10.1096/fj.201600782R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27965321				2022-12-26	WOS:000395671200026
J	Qin, Z; Yang, SQ; Zhao, LM; You, X; Yan, QJ; Jiang, ZQ				Qin, Zhen; Yang, Shaoqing; Zhao, Liming; You, Xin; Yan, Qiaojuan; Jiang, Zhengqiang			Catalytic Mechanism of a Novel Glycoside Hydrolase Family 16 "Elongating" -Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme structure; glycoside hydrolase; protein crystallization	CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; LAMINARINASE 16A; IN-VITRO; GLYCOSYNTHASE; OLIGOSACCHARIDES; AMYLOSUCRASE; RECOGNITION; EFFICIENT; COMPLEX	Carbohydrates are complex macromolecules in biological metabolism. Enzymatic synthesis of carbohydrates is recognized as a powerful tool to overcome the problems associated with large scale synthesis of carbohydrates. Novel enzymes with significant transglycosylation ability are still in great demand in glycobiology studies. Here we report a novel glycoside hydrolase family 16 elongating -transglycosylase from Paecilomyces thermophila (PtBgt16A), which efficiently catalyzes the synthesis of higher polymeric oligosaccharides using -1,3/1,4-oligosaccharides as donor/acceptor substrates. Further structural information reveals that PtBgt16A has a binding pocket around the -1 subsite. The catalytic mechanism of PtBgt16A is partly similar to an exo-glycoside hydrolase, which cleaves the substrate from the non-reducing end one by one. However, PtBgt16A releases the reducing end product and uses the remainder glucosyl as a transglycosylation donor. This catalytic mechanism has similarity with the catalytic mode of amylosucrase, which catalyzes the transglycosylation products gradually extend by one glucose unit. PtBgt16A thus has the potential to be a tool enzyme for the enzymatic synthesis of new -oligosaccharides and glycoconjugates.	[Qin, Zhen; Yang, Shaoqing; Jiang, Zhengqiang] Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [You, Xin; Yan, Qiaojuan] China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100083, Peoples R China; [Zhao, Liming] East China Univ Sci & Technol, Sch Biotechnol, Res & Dev Ctr Separat & Extract Technol Fermentat, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	China Agricultural University; East China University of Science & Technology	Jiang, ZQ (corresponding author), China Agr Univ, POB 294,17 Qinghua Donglu, Beijing 100083, Peoples R China.	zhqjiang@cau.edu.cn		qin, zhen/0000-0003-2133-8572	National Science Fund for Distinguished Young Scholars [31325021]; Program for Changjiang Scholars [T2014055]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Science Fund for Distinguished Young Scholars Grant 31325021 and Program for Changjiang Scholars Grant T2014055. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Blanco N, 2015, FEBS J, V282, P715, DOI 10.1111/febs.13176; Campbell P, 1999, PLANT J, V18, P371, DOI 10.1046/j.1365-313X.1999.00459.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YS, 2014, BBA-PROTEINS PROTEOM, V1844, P366, DOI 10.1016/j.bbapap.2013.11.005; Cobucci-Ponzano B, 2012, NAT PROD REP, V29, P697, DOI 10.1039/c2np20032e; Cobucci-Ponzano B, 2011, ADV SYNTH CATAL, V353, P2284, DOI 10.1002/adsc.201100461; Diez-Municio M, 2014, MICROB BIOTECHNOL, V7, P315, DOI 10.1111/1751-7915.12124; Dobruchowska JM, 2016, GLYCOBIOLOGY, V26, P1157, DOI 10.1093/glycob/cww074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 2002, J BIOL CHEM, V277, P30102, DOI 10.1074/jbc.M203971200; Hua CW, 2010, APPL MICROBIOL BIOT, V88, P509, DOI 10.1007/s00253-010-2759-0; Ilari A, 2009, FEBS J, V276, P1048, DOI 10.1111/j.1742-4658.2008.06848.x; Jeng WY, 2011, J BIOL CHEM, V286, P45030, DOI 10.1074/jbc.M111.271213; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Labourel A, 2014, J BIOL CHEM, V289, P2027, DOI 10.1074/jbc.M113.538843; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundemo P, 2017, APPL MICROBIOL BIOT, V101, P1121, DOI 10.1007/s00253-016-7833-9; Magee AS, 2015, BIOPOLYMERS, V103, P665, DOI 10.1002/bip.22685; Matsuzawa T, 2016, FEBS J, V283, P2340, DOI 10.1111/febs.13743; Meng DD, 2016, APPL MICROBIOL BIOT, V100, P4923, DOI 10.1007/s00253-016-7334-x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Mouyna I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00081; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perez X, 2011, BIOMACROMOLECULES, V12, P494, DOI 10.1021/bm1013537; Qin Z, 2016, APPL MICROBIOL BIOT, V100, P1765, DOI 10.1007/s00253-015-7057-4; Qin Z, 2015, ACTA CRYSTALLOGR D, V71, P1714, DOI 10.1107/S1399004715011037; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seibel J, 2006, BIOCATAL BIOTRANSFOR, V24, P157, DOI 10.1080/10242420500538274; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Spadiut O, 2011, J AM CHEM SOC, V133, P10892, DOI 10.1021/ja202788q; Teze D, 2014, PROTEIN ENG DES SEL, V27, P13, DOI 10.1093/protein/gzt057; Vasur J, 2010, J AM CHEM SOC, V132, P1724, DOI 10.1021/ja909129b; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Wei JH, 2013, EUR J ORG CHEM, V2013, P2414, DOI 10.1002/ejoc.201201507; Yang SQ, 2008, J AGR FOOD CHEM, V56, P5345, DOI 10.1021/jf800303b	44	15	15	3	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1666	1678		10.1074/jbc.M116.762419	http://dx.doi.org/10.1074/jbc.M116.762419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956553	hybrid, Green Published			2022-12-26	WOS:000395515600011
J	Frohlich, J; Senturk, D; Saravanapandian, V; Golshani, P; Reiter, LT; Sankar, R; Thibert, RL; DiStefano, C; Huberty, S; Cook, EH; Jeste, SS				Frohlich, Joel; Senturk, Damla; Saravanapandian, Vidya; Golshani, Peyman; Reiter, Lawrence T.; Sankar, Raman; Thibert, Ronald L.; DiStefano, Charlotte; Huberty, Scott; Cook, Edwin H.; Jeste, Shafali S.			A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome	PLOS ONE			English	Article							ANGELMAN-SYNDROME; EEG; DYNAMICS; AUTISM; ABNORMALITIES; OSCILLATIONS; MIDAZOLAM; SYNAPSE	Background Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism spectrum disorder (ASD). A distinct electrophysiological (EEG) pattern characterized by excessive activity in the beta band has been noted in clinical reports. We asked whether EEG power in the beta band, as well as in other frequency bands, distinguished children with Dup15q syndrome from those with non-syndromic ASD and then examined the clinical correlates of this electrophysiological biomarker in Dup15q syndrome. Methods In the first study, we recorded spontaneous EEG from children with Dup15q syndrome (n = 11), age-and-IQ-matched children with ASD (n = 10) and age-matched typically developing (TD) children (n = 9) and computed relative power in 6 frequency bands for 9 regions of interest (ROIs). Group comparisons were made using a repeated measures analysis of variance. In the second study, we recorded spontaneous EEG from a larger cohort of individuals with Dup15q syndrome (n = 27) across two sites and examined age, epilepsy, and duplication type as predictors of beta power using simple linear regressions. Results In the first study, spontaneous beta1 (12-20 Hz) and beta2 (20-30 Hz) power were significantly higher in Dup15q syndrome compared with both comparison groups, while delta (1-4 Hz) was significantly lower than both comparison groups. Effect sizes in all three frequency bands were large (vertical bar d vertical bar > 1). In the second study, we found that beta2 power was significantly related to epilepsy diagnosis in Dup15q syndrome. Conclusions Here, we have identified an electrophysiological biomarker of Dup15q syndrome that may facilitate clinical stratification, treatment monitoring, and measurement of target engagement for future clinical trials. Future work will investigate the genetic and neural underpinnings of this electrophysiological signature as well as the functional consequences of excessive beta oscillations in Dup15q syndrome.	[Frohlich, Joel; Saravanapandian, Vidya; DiStefano, Charlotte; Huberty, Scott; Jeste, Shafali S.] Univ Calif Los Angeles, Semel Inst Neurosci, Ctr Autism Res & Treatment, 760 Westwood Plaza,Suite A7-452, Los Angeles, CA 90095 USA; [Senturk, Damla] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Room 21-254C CHS, Los Angeles, CA 90024 USA; [Golshani, Peyman] David Geffen Sch Med, Dept Neurol & Psychiat, 710 Westwood Plaza, Los Angeles, CA USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, 855 Monroe Ave,Link 415, Memphis, TN 38163 USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, 855 Monroe Ave,Link 415, Memphis, TN 38163 USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Thibert, Ronald L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Cook, Edwin H.] Univ Illinois, Dept Psychiat, MC 747, Chicago, IL 60612 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frohlich, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, Ctr Autism Res & Treatment, 760 Westwood Plaza,Suite A7-452, Los Angeles, CA 90095 USA.	joelfrohlich@gmail.com	Jeste, Shafali S/N-2350-2017; Reiter, Lawrence/H-4161-2019; Frohlich, Joel/AAC-3214-2020	Jeste, Shafali S/0000-0003-2955-6902; Reiter, Lawrence/0000-0002-4100-2630; Frohlich, Joel/0000-0001-8382-4344; Huberty, Scott/0000-0003-2637-031X; SARAVANAPANDIAN, VIDYA/0000-0001-5825-612X	National Institute of Mental Health of the National Institutes of Health [T32MH073526]; Dup15q Alliance [20144605]; National Institute of General Medical Sciences [R01 GM111378-01A1]; National Institute of Mental Health [K23MH094517-01]; National Institute of Child Health and Human Development [U54HD087101]; NIMH [K23M H094517-01]; IDDRC [U54HD087101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH094517, T32MH073526] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dup15q Alliance; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JF was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number T32MH073526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also funded by grant 20144605 from the Dup15q Alliance (SSJ received funding) (http://www.dup15q.org), R01 GM111378-01A1 from the National Institute of General Medical Sciences (DS received funding) (https://www.nigms.nih.gov), National Institute of Mental Health K23MH094517-01 (SSJ received funding) (https://www.nimh.nih.gov), and National Institute of Child Health and Human Development U54HD087101 (SSJ and PG received funding) (https://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank the children and families who participated in this research for making this work possible. We especially thank Andrei Irimia and Iman Mohammad-Rezazadeh for their assistance with EEG signal processing and Amaya Miquelajauregui for giving her thoughts and insights on this manuscript. Joel Frohlich was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number T32MH073526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health This work was also funded by grant 20144605 from the Dup15q Alliance, to whom we extend our sincere gratitude, as well as R01 GM11137801A1 from the National Institute of General Medical Sciences NIGMS (NIH), NIMH K23M H094517-01, and IDDRC U54HD087101.	Al Ageeli E, 2014, EUR J MED GENET, V57, P5, DOI 10.1016/j.ejmg.2013.10.008; Berrios J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10702; BUCHSBAUM MS, 1985, BIOL PSYCHIAT, V20, P832, DOI 10.1016/0006-3223(85)90208-2; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cook EH, 1997, AM J HUM GENET, V60, P928; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; DiStefano C, 2016, J NEURODEVELOPMENTAL, V8, P1; DOMINO EF, 1989, PSYCHOPHARMACOL BULL, V25, P460; Elliot C., 2007, DIFFERENTIAL ABILITI; Errington AC, 2011, J NEUROSCI, V31, P8669, DOI 10.1523/JNEUROSCI.0317-11.2011; Fain G. L., 1999, MOL CELLULAR PHYSL N; Feshchenko VA, 1997, NEUROPSYCHOBIOLOGY, V35, P211, DOI 10.1159/000119347; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; Jeste SS, 2015, CURR OPIN NEUROL; Judson MC, 2016, NEURON, V90, P56, DOI 10.1016/j.neuron.2016.02.040; LANCEL M, 1994, BRAIN RES, V646, P85, DOI 10.1016/0006-8993(94)90060-4; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Macdonald RL, 1991, SEMINARS NEUROSCIENC; McEvoy K, 2015, BRAIN IMAGING BEHAV, V9, P104, DOI 10.1007/s11682-014-9343-7; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mullen E., 1989, INFANT MULLEN SCALES; Muthaffar O, 2015, ANN M AM EP SOC 2015; NICKEL B, 1989, NEUROPHARMACOLOGY, V28, P799, DOI 10.1016/0028-3908(89)90170-6; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pillai J, 2006, EPILEPSIA, V47, P14, DOI 10.1111/j.1528-1167.2006.00654.x; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Poyares D, 2004, J PSYCHIATR RES, V38, P327, DOI 10.1016/j.jpsychires.2003.10.003; Robinson AA, 2015, J CHILD NEUROL, V30, P58, DOI 10.1177/0883073814530498; Roid G.H., 1997, LEITER INT PERFORMAN; Roid GH., 2003, STANFORD BINET INTEL, V5th; Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; van Lier H, 2004, NEUROPHARMACOLOGY, V47, P163, DOI 10.1016/j.neuropharm.2004.03.017; Veauthier J, 2009, SEIZURE-EUR J EPILEP, V18, P392, DOI 10.1016/j.seizure.2009.02.001; Voytek B, 2015, J NEUROSCI, V35, P13257, DOI 10.1523/JNEUROSCI.2332-14.2015; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wisor JP, 2002, BRAIN RES, V955, P221, DOI 10.1016/S0006-8993(02)03467-4; Zimmerman I., 2011, PRESCHOOL LANGUAGE S	50	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167179	10.1371/journal.pone.0167179	http://dx.doi.org/10.1371/journal.pone.0167179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977700	Green Published, gold			2022-12-26	WOS:000391217400015
J	Boyer, KA; Andriacchi, TP				Boyer, Katherine A.; Andriacchi, Thomas P.			The Nature of Age-Related Differences in Knee Function during Walking: Implication for the Development of Knee Osteoarthritis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; TIBIOFEMORAL KINEMATICS; GAIT; MECHANICS; JOINT; SYSTEMS; COORDINATION; DEFICIENT; STRENGTH; GENDER	Background Changes in knee kinematics have been identified in the early stages of osteoarthritis (OA). However, there is a paucity of information on the nature of kinematic change that occur with aging prior to the development of OA, This study applied a robust statistical method (Principal Component Analysis) to test the hypothesis that coupling between primary (flexion) and secondary (anterior-posterior translation, internal-external rotation) joint motions in walking would differ for age groupings of healthy subjects. Methods Seventy-four healthy participants divided into three groups with mean ages of 24 +/- 2.3 years (younger), 48 +/- 4.7years (middle-age) and 64 +/- 2.4 years (older) were examined. Principal Component Analysis was used to characterize and statistically compare the patterns of knee joint movement and their relationships in walking. Results There were significant differences between the younger group and both the middle-age and older groups in the knee frontal plane angle and the coupling between knee flexion (PC1, p <= 0.04) and the relative magnitudes of secondary plane motions in early and late stance (PC3, p<0.01). Two additional principal components (PC2, p = 0.03 and PC5, p<0.01) described differences in early stance knee flexion and relationship with secondary plane motion through-out stance for the older compared with middle-age group. Conclusions It appears there are changes in knee kinematics that occur with aging. The kinematic differences were identified for middle-aged as well as older adults suggesting midlife changes in neuromuscular physiology or behavior may have important consequences. These kinematic measures offer the potential to identify early markers for the risk of developing knee OA with aging.	[Boyer, Katherine A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Boyer, Katherine A.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Andriacchi, Thomas P.] Stanford Univ, Dept Mech Engn, Stanford, CA USA; [Andriacchi, Thomas P.] Stanford Univ, Dept Orthoped Surg, Stanford, CA USA; [Andriacchi, Thomas P.] Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Stanford University; Stanford University	Boyer, KA (corresponding author), Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA.; Boyer, KA (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.	kboyer@kin.umass.edu			National Institutes of Aging [AR049792-06]	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for collection of the data was provided by the National Institutes of Aging AR049792-06 to Andriacchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration on Aging, 2014, PROF OLD AM 2014; Alexander EJ, 2001, J BIOMECH, V34, P355, DOI 10.1016/S0021-9290(00)00192-5; Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; Andriacchi TP, 2015, ANN BIOMED ENG, V43, P376, DOI 10.1007/s10439-014-1117-2; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Beijersbergen CMI, 2013, AGEING RES REV, V12, P618, DOI 10.1016/j.arr.2013.03.001; Bohannon RW, 2007, PHYS THER, V87, P1642, DOI 10.2522/ptj.20060037; Boyer KA, 2012, GAIT POSTURE, V36, P149, DOI 10.1016/j.gaitpost.2012.02.007; Chu CR, 2015, J ORTHOP RES, V33, P939, DOI 10.1002/jor.22817; Cofre Lizama LE, 2011, GAIT POSTURE, V33, P484, DOI 10.1016/j.gaitpost.2010.12.030; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Dyrby CO, 2004, J ORTHOP RES, V22, P794, DOI 10.1016/j.orthres.2003.11.003; Favre J, 2014, OSTEOARTHR CARTILAGE, V22, P464, DOI 10.1016/j.joca.2013.12.014; Georgoulis AD, 2003, AM J SPORT MED, V31, P75, DOI 10.1177/03635465030310012401; Hagemeister N, 2005, J BIOMECH, V38, P1926, DOI 10.1016/j.jbiomech.2005.05.013; Kozanek M, 2009, J BIOMECH, V42, P1877, DOI 10.1016/j.jbiomech.2009.05.003; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Laxafoss E, 2013, SKELETAL RADIOL, V42, P531, DOI 10.1007/s00256-012-1509-z; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; NIGG BM, 1994, GAIT POSTURE, V2, P213, DOI DOI 10.1016/0966-6362(94)90106-6; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Scanlan SF, 2014, KNEE, V21, P74, DOI 10.1016/j.knee.2013.06.003; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; St-Onge N, 2004, KNEE SURG SPORT TR A, V12, P203, DOI 10.1007/s00167-003-0420-5; Zhang LQ, 2003, GAIT POSTURE, V17, P34, DOI 10.1016/S0966-6362(02)00052-8	31	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167352	10.1371/journal.pone.0167352	http://dx.doi.org/10.1371/journal.pone.0167352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973527	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300024
J	Gonzales-Andres, C; Lopes, PFM; Cortes, J; Sanchez-Lizaso, JL; Pennino, MG				Gonzales-Andres, Cristina; Lopes, Priscila F. M.; Cortes, Jorge; Luis Sanchez-Lizaso, Jose; Grazia Pennino, Maria			Abundance and Distribution Patterns of Thunnus albacares in Isla del Coco National Park through Predictive Habitat Suitability Models	PLOS ONE			English	Article							NINO SOUTHERN-OSCILLATION; MARINE PROTECTED AREAS; YELLOWFIN TUNA; EL-NINO; OCEANIC ISLAND; BIGEYE TUNA; COSTA-RICA; CONSERVATION; BIODIVERSITY; COMPLEXITY	Information on the distribution and habitat preferences of ecologically and commercially important species is essential for their management and protection. This is especially important as climate change, pollution, and overfishing change the structure and functioning of pelagic ecosystems. In this study, we used Bayesian hierarchical spatial-temporal models to map the Essential Fish Habitats of the Yellowfin tuna (Thunnus albacares) in the waters around Isla del Coco National Park, Pacific Costa Rica, based on independent underwater observations from 1993 to 2013. We assessed if observed changes in the distribution and abundance of this species are related with habitat characteristics, fishing intensity or more extreme climatic events, including the El Nino Southern Oscillation, and changes on the average sea surface temperature. Yellowfin tuna showed a decreasing abundance trend in the sampled period, whereas higher abundances were found in shallow and warmer waters, with high concentration of chlorophyll- a, and in surrounding seamounts. In addition, El Nino Southern Oscillation events did not seem to affect Yellowfin tuna distribution and abundance. Understanding the habitat preferences of this species, using approaches as the one developed here, may help design integrated programs for more efficient management of vulnerable species.	[Gonzales-Andres, Cristina; Luis Sanchez-Lizaso, Jose] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Gonzales-Andres, Cristina; Grazia Pennino, Maria] Univ Valencia, Dept Estat & Invest Operat, SMEG, Valencia, Spain; [Lopes, Priscila F. M.; Grazia Pennino, Maria] Univ Fed Rio Grande do Norte, Dept Ecol, Fisheries Ecol Management & Econ Unit FEME, Natal, RN, Brazil; [Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Jose, Costa Rica	Universitat d'Alacant; University of Valencia; Universidade Federal do Rio Grande do Norte; Universidad Costa Rica	Gonzales-Andres, C (corresponding author), Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain.; Gonzales-Andres, C (corresponding author), Univ Valencia, Dept Estat & Invest Operat, SMEG, Valencia, Spain.	cristinacap80@hotmail.com	Cortés, Jorge/AAC-9782-2020; Lopes, Priscila/H-2028-2012; Grazia, Maria/E-3454-2015; Lizaso, José Luis L Sánchez/J-4939-2017	Cortés, Jorge/0000-0001-7004-8649; Lopes, Priscila/0000-0002-6774-5117; Grazia, Maria/0000-0002-7577-2617; Lizaso, José Luis L Sánchez/0000-0002-3927-5699	Marine Stewardship Council	Marine Stewardship Council	The study was funded by "Marine Stewardship Council" in its Scholarship Program. The author who receives the funds was the main author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Gonzalez J, 2008, REV BIOL TROP S2, V56, P49; Sibaja-Cordero JA, 2008, REV BIOL TROP, V56, P113; Alfaro EJ, 2016, REV BIOL TROP, V64, pS59; Alverson F. G., 1963, Bulletin Inter-American Tropical Tuna Commission, V7, P293; Arias A, 2016, ORYX, V50, P18, DOI 10.1017/S0030605314000337; Brenes C, 2016, REV BIOL TROP, V64, pS121; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Cortes J., 2008, COSTA RICA REV BIOL, V56, P1; Cortes J, 2012, REV BIOL TROP, V60, P131; Cubero-Pardo P., 2013, ANALISIS PESQUERIA A; Dagorn L, 2006, AQUAT LIVING RESOUR, V19, P85, DOI 10.1051/alr:2006008; De Anda-Montanez JA, 2004, DEEP-SEA RES PT II, V51, P575, DOI 10.1016/j.dsr2.2004.05.013; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Ely B, 2005, EVOL BIOL, V5, P1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fonteneau A., 1991, AQUAT LIVING RESOUR; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Pennino MG, 2013, J SEA RES, V83, P209, DOI 10.1016/j.seares.2013.03.005; Haedrich R. L., 2003, COPEIA, V2, P422, DOI [10.1643/0045-8511(2003)003[0422:BR]2.0.CO;2, DOI 10.1643/0045-8511(2003)003[0422:BR]2.0.CO;2]; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holland Kim N., 2007, Fish and Aquatic Resources Series, V12, P189; HOLLAND KN, 1990, FISH B-NOAA, V88, P493; Holland KN, 1999, FISH B-NOAA, V97, P392; ICCAT: International Commission for the Conservation of Atlantic Tunas, 2002, REP BIENN PER 2000 2; IOTC: Indian Ocean Tuna Commision, 2004, 6 SESS IOTC WORK PAR; Alvarado JJ, 2012, REV BIOL TROP, V60, P129; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Lauria V, 2015, SCI REP-UK, V5, DOI 10.1038/srep13245; Lauria V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117006; Lavelle JW, 2010, OCEANOGRAPHY, V23, P90, DOI 10.5670/oceanog.2010.64; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Lizano OG., 2008, COSTA RICA REV BIOL, V56, P31; Lizano OG, 2012, REV BIOL TROP, V60, P43; Lopez-Garro A, 2016, COSTA RICA REV BI S1, V64, pS249; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McPhaden MJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048275; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moreno JID, 2000, ICES J MAR SCI, V57, P1091, DOI 10.1006/jmsc.2000.0705; Mug-Villanueva, 2002, ANALISIS TENDENCIAS; Munoz F, 2013, STOCH ENV RES RISK A, V27, P1171, DOI 10.1007/s00477-012-0652-3; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Ortega G. S, 1998, ANALISIS FLUCTUACION; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Quiroz Z. C., 2005, BIOMETRICS, V71, P2082; R Dev. Team, 2015, R LANG ENV STAT COMP; Rojas W, 2012, REV BIOL TROP, V60, P15; Roos M, 2011, BAYESIAN ANAL, V6, P259, DOI 10.1214/11-BA609; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Starr RM, 2012, REV BIOL TROP, V60, P347; Torres-Orozco E, 2006, FISH B-NOAA, V104, P197; Trujillo P, 1950, 201531 U BRIT COL; Vianna GMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095565; White ER, 2015, CONSERV BIOL, V29, P1186, DOI 10.1111/cobi.12478; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Yu J.Y., 2012, GEOPHYS RES LETT, V39; Zuur AF, 2009, STAT BIOL HLTH, P579	63	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168212	10.1371/journal.pone.0168212	http://dx.doi.org/10.1371/journal.pone.0168212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973538	gold, Green Published			2022-12-26	WOS:000392754300065
J	Kim, JA; Hwang, B; Park, SN; Huh, S; Im, K; Choi, S; Chung, HY; Huh, J; Seo, EJ; Lee, JH; Bang, D; Lee, DS				Kim, Jung-Ah; Hwang, Byungjin; Park, Si Nae; Huh, Sunghoon; Im, Kyongok; Choi, Sungbin; Chung, Hye Yoon; Huh, JooRyung; Seo, Eul-Ju; Lee, Je-Hwan; Bang, Duhee; Lee, Dong Soon			Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing	PLOS ONE			English	Article							RAPID DISEASE PROGRESSION; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL-ABERRATIONS; TRANSCRIPTION FACTORS; RECURRENT MUTATIONS; HIGH-THROUGHPUT; NOTCH1; SUSCEPTIBILITY; TRANSFORMATION; FEATURES	Chronic lymphocytic leukemia (CLL) is extremely rare in Asian countries and there has been one report on genetic changes for 5 genes (TP53, SF3B1, NOTCH1, MYD88, and BIRC3) by Sanger sequencing in Chinese CLL. Yet studies of CLL in Asian countries using Next generation sequencing have not been reported. We aimed to characterize the genomic profiles of Korean CLL and to find out ethnic differences in somatic mutations with prognostic implications. We performed targeted sequencing for 87 gene panel using next-generation sequencing along with G-banding and fluorescent in situ hybridization (FISH) for chromosome 12, 13q14.3 deletion, 17p13 deletion, and 11q22 deletion. Overall, 36 out of 48 patients (75%) harbored at least one mutation and mean number of mutation per patient was 1.6 (range 0-6). Aberrant karyotypes were observed in 30.4% by G-banding and 66.7% by FISH. Most recurrent mutation (>10% frequency) was ATM (20.8%) followed by TP53 (14.6%), SF3B1 (10.4%), KLHL6 (8.3%), and BCOR (6.25%). Mutations of MYD88 was associated with moderate adverse prognosis by multiple comparisons (P = 0.055). Mutation frequencies of MYD88, SAMHD1, EGR2, DDX3X, ZMYM3, and MED12 showed similar incidence with Caucasians, while mutation frequencies of ATM, TP53, KLHL6, BCOR and CDKN2A tend to be higher in Koreans than in Caucasians. Especially, ATM mutation showed 1.5 fold higher incidence than Caucasians, while mutation frequencies of SF3B1, NOTCH1, CHD2 and POT1 tend to be lower in Koreans than in Caucasians. However, mutation frequencies between Caucasians and Koreans were not significantly different statistically, probably due to low number of patients. Collectively, mutational profile and adverse prognostic genes in Korean CLL were different from those of Caucasians, suggesting an ethnic difference, while profile of cytogenetic aberrations was similar to those of Caucasians.	[Kim, Jung-Ah; Chung, Hye Yoon; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Hwang, Byungjin; Huh, Sunghoon; Bang, Duhee] Yonsei Univ, Dept Chem, Seoul, South Korea; [Park, Si Nae; Im, Kyongok; Lee, Dong Soon] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Choi, Sungbin] Univ British Columbia, Sci, Vancouver, BC, Canada; [Huh, JooRyung] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Seo, Eul-Ju] Univ Ulsan, Dept Lab Med, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Je-Hwan] Univ Ulsan, Dept Internal Med, Coll Med, Asan Med Ctr, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Seoul National University (SNU); University of British Columbia; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Bang, D (corresponding author), Yonsei Univ, Dept Chem, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea.	duheebang@gmail.com; soonlee@snu.ac.kr		Kim, Jung Ah/0000-0001-6934-1987	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A1A10052286]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A02062419]; Cancer Research Institute, Seoul National University	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Cancer Research Institute, Seoul National University	Support was provided by: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A10052286) [http://www.nrf.re.kr/] (to DSL); Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A02062419) [http://www.nrf.re.kr/] (to JAK); and a research grant from Cancer Research Institute, Seoul National University (2013) [http://cri.snu.ac.kr/] (to JAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AHN Y-O, 1991, Journal of Korean Medical Science, V6, P299; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernasconi P, 2008, BRIT J HAEMATOL, V142, P695, DOI 10.1111/j.1365-2141.2008.07245.x; Chang YH, 2006, LEUKEMIA RES, V30, P695, DOI 10.1016/j.leukres.2005.10.013; Chen PM, 1997, ACTA HAEMATOL-BASEL, V97, P196; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Devalliere J, 2012, FASEB J, V26, P2592, DOI 10.1096/fj.11-193383; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dores GAM, 2007, BRIT J HAEMATOL, V139, P809, DOI 10.1111/j.1365-2141.2007.06856.x; ELROUBY S, 1993, BLOOD, V82, P3452; Fabbri G, 2013, J EXP MED, V210, P2273, DOI 10.1084/jem.20131448; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fuchs O, 2008, BLOOD CELL MOL DIS, V40, P401, DOI 10.1016/j.bcmd.2007.11.005; Gale RP, 2000, LEUKEMIA RES, V24, P665, DOI 10.1016/S0145-2126(00)00038-2; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Gonzalez-Gascon YMI, 2015, HEMATOL ONCOL, V17; Grever MR, 2007, J CLIN ONCOL, V25, P799, DOI 10.1200/JCO.2006.08.3089; Grossmann V, 2013, BLOOD, V122, P521; Gunawardana C, 2008, BRIT J HAEMATOL, V142, P606, DOI 10.1111/j.1365-2141.2008.07226.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hyde RK, 2011, NAT GENET, V43, P926, DOI 10.1038/ng.949; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lan Q, 2010, EUR J HAEMATOL, V85, P492, DOI 10.1111/j.1600-0609.2010.01518.x; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lee S, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P1, DOI 10.1109/ROBOT.1999.769891; Lee SJ, 2016, LEUKEMIA LYMPHOMA, V57, P585, DOI 10.3109/10428194.2015.1068307; Matsuda A, 2005, BLOOD, V106, P2633, DOI 10.1182/blood-2005-01-0040; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nelson BP, 2007, AM J CLIN PATHOL, V128, P323, DOI 10.1309/21TN2RUWKR827UW2; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Puiggros A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435983; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; Rossi D, 2012, BRIT J HAEMATOL, V158, P426, DOI 10.1111/j.1365-2141.2012.09155.x; Rossi D, 2011, BLOOD, V117, P3391, DOI 10.1182/blood-2010-09-302174; Sellar RS, 2015, BRIT J HAEMATOL, V170, P282, DOI 10.1111/bjh.13291; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Skowronska A, 2012, HAEMATOL-HEMATOL J, V97, P142, DOI 10.3324/haematol.2011.048827; Sutton LA, 2015, HAEMATOLOGICA, V100, P370, DOI 10.3324/haematol.2014.109777; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tamura K, 2001, EUR J HAEMATOL, V67, P152, DOI 10.1034/j.1600-0609.2001.5790514.x; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wu SJ, 2013, ANN HEMATOL, V92, P799, DOI 10.1007/s00277-013-1700-x; Xia Y, 2015, ONCOTARGET, V6, P5426, DOI 10.18632/oncotarget.3101; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Yoon JH, 2014, HEMATOL ONCOL, V32, P169, DOI 10.1002/hon.2103; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070	58	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167641	10.1371/journal.pone.0167641	http://dx.doi.org/10.1371/journal.pone.0167641			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959900	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900013
J	Masuda, R; Hatakeyama, M; Yokoyama, K; Tanaka, M				Masuda, Reiji; Hatakeyama, Makoto; Yokoyama, Katsuhide; Tanaka, Masaru			Recovery of Coastal Fauna after the 2011 Tsunami in Japan as Determined by Bimonthly Underwater Visual Censuses Conducted over Five Years	PLOS ONE			English	Article							FISH ASSEMBLAGES; BENTHIC COMMUNITIES; SEA; BAY; IMPACTS; CORAL; REEF; DISTURBANCE; ZOOPLANKTON; POPULATIONS	Massive tsunamis induce catastrophic disturbance in marine ecosystems, yet they can provide unique opportunities to observe the process of regeneration. Here, we report the recovery of fauna after the 2011 tsunami in northeast Japan based on underwater visual censuses performed every two months over five years. Both total fish abundance and species richness increased from the first to the second year after the tsunami followed by stabilization in the following years. Short-lived fish, such as the banded goby Pterogobius elapoides, were relatively abundant in the first two years, whereas long-lived species, such as the black rockfish Sebastes cheni, increased in the latter half of the survey period. Tropical fish species were recorded only in the second and third years after the tsunami. The body size of long-lived fish increased during the survey period resulting in a gradual increase of total fish biomass. The recovery of fish assemblages was slow at one site located in the inner bay, where the impact of the tsunami was the strongest. Apart from fish, blooms of the moon jellyfish Aurelia sp. occurred only in the first two years after the tsunami, whereas the abundances of sea cucumber Apostichopus japonicus and abalone Haliotis discus hannai increased after the second year. Although we lack quantitative data prior to the tsunami, we conclude that it takes approximately three years for coastal reef fish assemblages to recover from a heavy disturbance such as a tsunami and that the recovery is dependent on species-specific life span and habitat.	[Masuda, Reiji] Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan; [Yokoyama, Katsuhide] Tokyo Metropolitan Univ, Hachioji, Tokyo, Japan; [Tanaka, Masaru] Int Inst Adv Studies, Kyoto, Japan	Kyoto University; Tokyo Metropolitan University	Masuda, R (corresponding author), Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan.	reiji@kais.kyoto-u.ac.jp	Yokoyama, Katsuhide/AAM-7655-2021	Yokoyama, Katsuhide/0000-0003-1576-6239	Mitsui Co., Ltd. [K11-F1-037]; JSPS KAKENHI [25249068]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency	Mitsui Co., Ltd.(Mitsui & Co., LTD.); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by the Mitsui & Co., Ltd. Environmental Fund (K11-F1-037) for MH (https://www.mitsui.com/jp/ja/csr/contribution/environment/fund/), JSPS KAKENHI Grant Number 25249068 for KY (http://www.jsps.go.jp/english/e-grants/index.html), the Tohoku Ecosystem-Associated Marine Science (TEAMS) project from the Ministry of Education, Culture, Sports, Science and Technology, Japan for RM (http://www.i-teams.jp/e/about/), and CREST Program from the Japan Science and Technology Agency for RM (http://www.jst.go.jp/kisoken/crest/en/project/33/e33_13.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, MAR ENVIRON RES, V112, P86, DOI 10.1016/j.marenvres.2015.09.011; Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Desmond JS, 2002, ESTUARIES, V25, P552, DOI 10.1007/BF02804890; Eby LA, 2004, ESTUARIES, V27, P342, DOI 10.1007/BF02803390; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Froese F., 2009, FISHBASE; Glynn PW, 2014, MAR ECOL PROG SER, V495, P233, DOI 10.3354/meps10594; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hinz H, 2009, ECOL APPL, V19, P761, DOI 10.1890/08-0351.1; Hirase S, 2016, MAR ECOL-EVOL PERSP, V37, P1161, DOI 10.1111/maec.12377; HIROSE T, 1974, Bulletin of Tohoku National Fisheries Research Institute, V33, P87; Kamimura Y, 2014, ICHTHYOL RES, V61, P108, DOI 10.1007/s10228-013-0381-8; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Krishnankutty N, 2006, CURR SCI INDIA, V90, P772; Lefevre CD, 2015, MAR ECOL PROG SER, V537, P205, DOI 10.3354/meps11457; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Masuda R, 2008, ENVIRON BIOL FISH, V82, P387, DOI 10.1007/s10641-007-9300-z; Masuda R, 2010, FISH B-NOAA, V108, P162; Masuda R, 2009, HYDROBIOLOGIA, V616, P269, DOI 10.1007/s10750-008-9598-3; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakayama Kouji, 2013, Aquabiology (Tokyo), V35, P582; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ohata R, 2011, FISHERIES SCI, V77, P207, DOI 10.1007/s12562-010-0320-9; Oksanen J., 2016, PACKAGE VEGAN; Paltzat DL, 2008, AQUACULTURE, V275, P124, DOI 10.1016/j.aquaculture.2007.12.014; Panchenko V.V., 2011, J ICHTHYOL+, V51, P217, DOI [10.1134/S0032945211010103, DOI 10.1134/S0032945211010103]; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pommer CD, 2016, MAR ECOL PROG SER, V548, P47, DOI 10.3354/meps11649; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; R Core Team, 2012, R LANG ENV STAT COMP; Sakurai M, 2010, B KAGOSHIMA JUNSHIN, V40, p67 ; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Sekigawa Takeshi, 2002, Suisan Zoshoku, V50, P395; Shinomiya A, 1985, THESIS; SHIOGAKI M, 1981, JPN J ICHTHYOL, V28, P70; Shoji J, 2005, MAR BIOL, V147, P863, DOI 10.1007/s00227-005-1579-8; Shoji J, 2016, J OCEANOGR, V72, P91, DOI 10.1007/s10872-015-0311-7; Smith TM, 2016, MAR ECOL PROG SER, V542, P97, DOI 10.3354/meps11531; Takami H, 2013, FISH OCEANOGR, V22, P113, DOI 10.1111/fog.12008; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; The 2011 Tohoku Earthquake Tsunami Joint Survey Group (TETJSG), 2011, J JAPAN SOC CIVIL B, V67, P63, DOI DOI 10.2208/KAIGAN.67.63; THISTLE D, 1981, MAR ECOL PROG SER, V6, P223, DOI 10.3354/meps006223; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001; Yamada Yuichiro, 2012, Aquabiology (Tokyo), V34, P556; YAMASHITA Y, 1984, B JPN SOC SCI FISH, V50, P189; Yatsuya K, 2008, J APPL PHYCOL, V20, P797, DOI 10.1007/s10811-007-9293-1; Yokoyama K, 2012, J JAPAN SOC CIVIL EN, V68, p1391 ; Yoshida G, 2001, FISHERIES SCI, V67, P1023, DOI 10.1046/j.1444-2906.2001.00357.x; Zama A., 2001, FISH FAUNA MIYAGI PR	58	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168261	10.1371/journal.pone.0168261	http://dx.doi.org/10.1371/journal.pone.0168261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942028	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600060
J	Wiesmeier, M; Gautam, S; Kirschnek, S; Hacker, G				Wiesmeier, Michael; Gautam, Sanjivan; Kirschnek, Susanne; Haecker, Georg			Characterisation of Neutropenia-Associated Neutrophil Elastase Mutations in a Murine Differentiation Model In Vitro and In Vivo	PLoS One			English	Article							SEVERE CONGENITAL NEUTROPENIA; UNFOLDED PROTEIN RESPONSE; PLURIPOTENT STEM-CELLS; CYCLIC NEUTROPENIA; CATHEPSIN-G; ELANE MUTATIONS; MICE; APOPTOSIS; GLUCOSE-6-PHOSPHATASE-BETA; GRANULOPOIESIS	Severe congenital neutropenia (SCN) is characterised by a differentiation block in the bone marrow and low neutrophil numbers in the peripheral blood, which correlates with increased risk of bacterial infections. Several underlying gene defects have been identified in SCN patients. Mutations in the neutrophil elastase (ELANE) gene are frequently found in SCN and cyclic neutropenia. Both mislocalization and misfolding of mutant neutrophil elastase protein resulting in ER stress and subsequent induction of the unfolded protein response (UPR) have been proposed to be responsible for neutrophil survival and maturation defects. However, the detailed molecular mechanisms still remain unclear, in part due to the lack of appropriate in vitro and in vivo models. Here we used a system of neutrophil differentiation from immortalised progenitor lines by conditional expression of Hoxb8, permitting the generation of mature near-primary neutrophils in vitro and in vivo. NE-deficient Hoxb8 progenitors were reconstituted with murine and human forms of typical NE mutants representative of SCN and cyclic neutropenia, and differentiation of the cells was analysed in vitro and in vivo. ER stress induction by NE mutations could be recapitulated during neutrophil differentiation in all NE mutant-reconstituted Hoxb8 cells. Despite ER stress induction, no change in survival, maturation or function of differentiating cells expressing either murine or human NE mutants was observed. Further analysis of in vivo differentiation of Hoxb8 cells in a murine model of adoptive transfer did not reveal any defects in survival or differentiation in the mouse. Although the Hoxb8 system has been found to be useful for dissection of defects in neutrophil development, our findings indicate that the use of murine systems for analysis of NE-mutation-associated pathogenesis is complicated by differences between humans and mice in the physiology of granulopoiesis, which may go beyond possible differences in expression and activity of neutrophil elastase itself.	[Wiesmeier, Michael; Gautam, Sanjivan; Kirschnek, Susanne; Haecker, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, Med Ctr, Fac Med, Freiburg, Germany; [Gautam, Sanjivan] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Gautam, Sanjivan] Univ Freiburg, Fac Biol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Kirschnek, S (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Med Ctr, Fac Med, Freiburg, Germany.	susanne.kirschnek@uniklinik-freiburg.de			MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg - Else Kroner Fresenius-Stiftung	MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg - Else Kroner Fresenius-Stiftung	MW was supported the MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg funded by Else Kroner Fresenius-Stiftung (https://www.uniklinik-freiburg.de/medizin2/motivate.html; http://www.ekfs.de/de/wissenschaftliche-foerderung/nachwuchsfoerderung/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Gautam S, 2013, CELL DEATH DIFFER, V20, P1068, DOI 10.1038/cdd.2013.39; Germeshausen M, 2013, HUM MUTAT, V34, P905, DOI 10.1002/humu.22308; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Grenda DS, 2002, BLOOD, V100, P3221, DOI 10.1182/blood-2002-05-1372; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Massullo P, 2005, BLOOD, V105, P3397, DOI 10.1182/blood-2004-07-2618; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; Newburger PE, 2010, PEDIATR BLOOD CANCER, V55, P314, DOI 10.1002/pbc.22537; Owen CA, 1997, AM J PHYSIOL-LUNG C, V272, pL385, DOI 10.1152/ajplung.1997.272.3.L385; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, ANN NY ACAD SCI, V1176, P94, DOI 10.1111/j.1749-6632.2009.04963.x; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Xia J, 2008, CURR OPIN HEMATOL, V15, P1, DOI 10.1097/MOH.0b013e3282f13cd2	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168055	10.1371/journal.pone.0168055	http://dx.doi.org/10.1371/journal.pone.0168055			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942017	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600049
J	Bolton, PE; West, AJ; Cardilini, APA; Clark, JA; Maute, KL; Legge, S; Brazill-Boast, J; Griffith, SC; Rollins, LA				Bolton, Peri E.; West, Andrea J.; Cardilini, Adam P. A.; Clark, Jennalee A.; Maute, Kimberley L.; Legge, Sarah; Brazill-Boast, James; Griffith, Simon C.; Rollins, Lee A.			Three Molecular Markers Show No Evidence of Population Genetic Structure in the Gouldian Finch (Erythrura gouldiae)	PLOS ONE			English	Article							PER-GENERATION RULE; SPATIAL AUTOCORRELATION; NORTHERN AUSTRALIA; CONSERVATION; DIVERSITY; SOFTWARE; SIZE; INFERENCE; DIFFERENTIATION; POLYMORPHISM	Assessment of genetic diversity and connectivity between regions can inform conservation managers about risk of inbreeding, potential for adaptation and where population boundaries lie. The Gouldian finch (Erythrura gouldiae) is a threatened species in northern Australia, occupying the savannah woodlands of the biogeographically complex monsoon tropics. We present the most comprehensive population genetic analysis of diversity and structure the Gouldian finch using 16 microsatellite markers, mitochondrial control region and 3,389 SNPs from genotyping-by-sequencing. Mitochondrial diversity is compared across three related, co-distributed finches with different conservation threat-statuses. There was no evidence of genetic differentiation across the western part of the range in any of the molecular markers, and haplotype diversity but not richness was lower than a common co-distributed species. Individuals within the panmictic population in the west may be highly dispersive within this wide area, and we urge caution when interpreting anecdotal observations of changes to the distribution and/or flock sizes of Gouldian finch populations as evidence of overall changes to the population size of this species.	[Bolton, Peri E.; Clark, Jennalee A.; Brazill-Boast, James; Griffith, Simon C.; Rollins, Lee A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [West, Andrea J.; Cardilini, Adam P. A.; Rollins, Lee A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia; [Maute, Kimberley L.] Univ Wollongong, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Legge, Sarah] Australian Wildlife Conservancy, Perth, WA, Australia; [Legge, Sarah] Charles Darwin Univ, Natl Environm Sci Programme Threatened Species Re, Darwin, NT, Australia; [Brazill-Boast, James] NSW Off Environm & Heritage, Reg Operat Div, Ecosyst & Threatened Species Unit, Sydney, NSW, Australia	Macquarie University; Deakin University; University of Wollongong; Charles Darwin University; Office of Environment & Heritage - New South Wales	Bolton, PE (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	peri.bolton@mq.edu.au	Griffith, Simon/AAH-3706-2021; Legge, Sarah/AAB-7229-2019; Maute, Kimberly L/D-4642-2017; Griffith, Simon/A-1996-2010; Rollins, Lee/G-3688-2011; Legge, Sarah/GYE-1554-2022; Brazill-Boast, James/R-6195-2019	Griffith, Simon/0000-0001-7612-4999; Legge, Sarah/0000-0001-6968-2781; Maute, Kimberly L/0000-0003-4791-8743; Griffith, Simon/0000-0001-7612-4999; Rollins, Lee/0000-0002-3279-7005; Cardilini, Adam/0000-0002-1032-3466	Australian Research Council [DP0881019, LP0668122, DP130100418]; Save the Gouldian Fund; Macquarie University; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Save the Gouldian Fund; Macquarie University; Australian Postgraduate Award(Australian Government)	Financial support for fieldwork at Wyndham was from an Australian Research Council Grant to Sarah Pryke and SCG (DP0881019), Save the Gouldian Fund, and a Macquarie University Research Excellence Scholarship to JB-B. Funding for fieldwork at Northern Territory and Australian Wildlife Conservancy's Mornington sanctuary was from Australian Research Council Linkage Grant to Stephen Garnett (LP0668122), supporters of the Australian Wildlife Conservancy, the University of Wollongong, Northern Territory Department of Infrastructure, Planning and Environment, Charles Darwin University, Stuart Leslie Bird Research Fund, and the Professor Allen Keast Award (Birdlife Australia). The Australian Agricultural Company, Australian Department of Defence, Australian Wildlife Conservancy and Jawoyn association allowed KLM access to their land. The genetics work was supported by Australian Research Council grants to SCG and LAR (DP130100418), and an Australian Postgraduate Award to PEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Australian Bureau of Statistics, 2011, AUSTR STAND GEOGR CL; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Berney FL., 1902, EMU; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brazill-Boast J, 2013, EVOL ECOL, V27, P1189, DOI 10.1007/s10682-013-9651-1; Brazill-Boast J, 2011, J ANIM ECOL, V80, P39, DOI 10.1111/j.1365-2656.2010.01756.x; Brazill-Boast J, 2010, EMU, V110, P170, DOI 10.1071/MU09045; Catullo RA, 2014, J BIOGEOGR, V41, P659, DOI 10.1111/jbi.12230; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Epps CW, 2015, MOL ECOL; Esparza-Salas R, 2007, THESIS; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Hague MTJ, 2016, HEREDITY, V116, P92, DOI 10.1038/hdy.2015.76; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Holland SM, 2012, ANAL RAREFACTION; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jackson H, 2013, CONSERV GENET, V14, P1291, DOI 10.1007/s10592-013-0514-7; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearns AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4994; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Kruck NC, 2013, MOL ECOL RESOUR, V13, P715, DOI 10.1111/1755-0998.12112; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Legge S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137997; Lepais O, 2014, MOL ECOL RESOUR, V14, P1314, DOI 10.1111/1755-0998.12273; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lloyd MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063981; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Maute KL, 2013, J COMP PHYSIOL B, V183, P1023, DOI 10.1007/s00360-013-0775-y; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nei M., 1987, MOL EVOLUTIONARY GEN; Newhouse DJ, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0546-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Potter S, 2012, MOL ECOL, V21, P2254, DOI 10.1111/j.1365-294X.2012.05523.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivers MC, 2014, GLOB ECOL CONSERV, V2, P81, DOI 10.1016/j.gecco.2014.08.005; Rollins LA, 2012, ECOL EVOL, V2, P1208, DOI 10.1002/ece3.259; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Smedley J. H., 1904, Emu, Viv, P69; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tidemann SC., 1996, BIRD CONSERV INT; van Rooij EP, 2011, EMU, V111, P297, DOI 10.1071/MU10092; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Willoughby JR, 2015, BIOL CONSERV, V191, P495, DOI 10.1016/j.biocon.2015.07.025; Wilson GA, 2003, GENETICS, V163, P1177; WOINARSKI JCZ, 1992, EMU, V92, P33, DOI 10.1071/MU9920033; Wright S, 1931, GENETICS, V16, P0097; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	89	7	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167723	10.1371/journal.pone.0167723	http://dx.doi.org/10.1371/journal.pone.0167723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936082	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100163
J	Ford, BM; Franks, LN; Radominska-Pandya, A; Prather, PL				Ford, Benjamin M.; Franks, Lirit N.; Radominska-Pandya, Anna; Prather, Paul L.			Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ESTROGEN-RECEPTOR; CB2 RECEPTOR; ALLOSTERIC MODULATORS; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; INVERSE AGONISM; RAT-BRAIN; IN-VITRO; ANTAGONIST	Tamoxifen (Tam) is a selective estrogen receptor (ER) modulator (SERM) that is an essential drug to treat ER-positive breast cancer. Aside from known actions at ERs, recent studies have suggested that some SERMs like Tam also exhibit novel activity at cannabinoid subtype 1 and 2 receptors (CB1R and CB2Rs). Interestingly, cis-(E-Tam) and trans-(Z-Tam) isomers of Tam exhibit over a 100-fold difference in affinity for ERs. Therefore, the current study assessed individual isomers of Tam and subsequent cytochrome P450 metabolic products, 4-hydroxytamoxifen (4OHT) and 4-hydroxy-N-desmethyl tamoxifen (End) for affinity and activity at CBRs. Results showed that Z-4OHT, but not Z-Tam or Z-End, exhibits higher affinity for both CB1 and CB2Rs relative to the E-isomer. Furthermore, Z- and E-isomers of Tam and 4OHT show slightly higher affinity for CB2Rs, while both End isomers are relatively CB1R-selective. When functional activity was assessed by G-protein activation and regulation of the downstream effector adenylyl cyclase, all isomers examined act as full CB1 and CB2R inverse agonists. Interestingly, Z-Tam appears to be more efficacious than the full inverse agonist AM630 at CB2Rs, while both Z-Tam and Z-End exhibit characteristics of insurmountable antagonism at CB1 and CB2Rs, respectively. Collectively, these results suggest that the SERMs Tam, 4OHT and End elicit ER-independent actions via CBRs in an isomer-specific manner. As such, this novel structural scaffold might be used to develop therapeutically useful drugs for treatment of a variety of diseases mediated via CBRs.	[Ford, Benjamin M.; Franks, Lirit N.; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Coll Med, Little Rock, AR 72205 USA; [Radominska-Pandya, Anna] Univ Arkansas Med Sci, Coll Med, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Prather, PL (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Coll Med, Little Rock, AR 72205 USA.	PratherPaulL@uams.edu			UAMS Department of Pharmacology and Toxicology	UAMS Department of Pharmacology and Toxicology	These studies were supported by bridging funds provided by the UAMS Department of Pharmacology and Toxicology Dr. Paul L. Prather.	Azizi-Malekabadi H, 2015, ARQ NEURO-PSIQUIAT, V73, P132, DOI 10.1590/0004-282X20140221; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328; Brents LK, 2012, BIOCHEM PHARMACOL, V83, P952, DOI 10.1016/j.bcp.2012.01.004; Buggy Y, 2011, DRUG SAFETY, V34, P501, DOI 10.2165/11588510-000000000-00000; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Ciaglia E, 2015, ONCOTARGET, V6, P15464, DOI 10.18632/oncotarget.3895; Clarke M, 1998, LANCET, V351, P1451; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; Dalton GD, 2009, CNS NEUROL DISORD-DR, V8, P422, DOI 10.2174/187152709789824615; Detsi A, 2002, J ORG CHEM, V67, P4608, DOI 10.1021/jo0255328; Elkins P, 2014, J PHARMACEUT BIOMED, V88, P174, DOI 10.1016/j.jpba.2013.07.010; Fantegrossi WE, 2014, LIFE SCI, V97, P45, DOI 10.1016/j.lfs.2013.09.017; Fong Tung M, 2014, Adv Pharmacol, V70, P121, DOI 10.1016/B978-0-12-417197-8.00004-3; Franks LN, 2014, EUR J PHARMACOL, V737, P140, DOI 10.1016/j.ejphar.2014.05.007; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gennari L, 2010, CLIN INTERV AGING, V5, P19; GUO Y, 1994, J MED CHEM, V37, P3867, DOI 10.1021/jm00049a002; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; Idris AI, 2010, CURR NEUROPHARMACOL, V8, P243, DOI 10.2174/157015910792246173; Iusuf D, 2011, J PHARMACOL EXP THER, V337, P710, DOI 10.1124/jpet.110.178301; Jager NGL, 2014, BREAST CANCER RES TR, V143, P477, DOI 10.1007/s10549-013-2826-1; Jankowitz RC, 2013, BREAST, V22, pS165, DOI 10.1016/j.breast.2013.07.032; Jordan VC, 2014, ENDOCR-RELAT CANCER, V21, pR235, DOI 10.1530/ERC-14-0092; JORDAN VC, 1988, ENDOCRINOLOGY, V122, P1449, DOI 10.1210/endo-122-4-1449; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; KATZENELLENBOGEN JA, 1985, J STEROID BIOCHEM, V22, P589, DOI 10.1016/0022-4731(85)90210-9; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kumar P, 2014, BIOCHEM BIOPH RES CO, V443, P144, DOI 10.1016/j.bbrc.2013.11.071; Kumar P, 2013, BIOCHEM BIOPH RES CO, V435, P76, DOI 10.1016/j.bbrc.2013.04.040; Lan R, 1999, AAPS PharmSci, V1, pE4; Landsman RS, 1998, LIFE SCI, V62, pPL109, DOI 10.1016/S0024-3205(97)01187-9; Lee HO, 1997, ARCH PHARM RES, V20, P572, DOI 10.1007/BF02975214; LIEN EA, 1991, CANCER RES, V51, P4837; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Lunn CA, 2006, EXPERT OPIN THER TAR, V10, P653, DOI 10.1517/14728222.10.5.653; MACKIE K, 1995, J NEUROSCI, V15, P6552; Madadi NR, 2013, BIOORG MED CHEM LETT, V23, P2019, DOI 10.1016/j.bmcl.2013.02.025; Mancino S, 2015, NEUROPSYCHOPHARMACOL; Maximov PY, 2014, BRIT J PHARMACOL, V171, P5624, DOI 10.1111/bph.12864; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; May LT, 2003, CURR OPIN PHARMACOL, V3, P551, DOI 10.1016/S1471-4892(03)00107-3; Mc Ilroy M, 2006, ENDOCR-RELAT CANCER, V13, P1135, DOI 10.1677/erc.1.01222; Mella-Raipan JA, 2013, MOLECULES, V18, P3972, DOI 10.3390/molecules18043972; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Nazarali SA, 2014, BREAST CANCER-TARGET, V6, P29, DOI 10.2147/BCTT.S43763; OSBORNE CK, 1992, J CLIN ONCOL, V10, P304, DOI 10.1200/JCO.1992.10.2.304; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Pliska V, 2014, BIOCHEM PHARMACOL, V91, P119, DOI 10.1016/j.bcp.2014.06.025; Prather PL, 2013, BIOCHEM BIOPH RES CO, V441, P339, DOI 10.1016/j.bbrc.2013.10.057; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Ramos JA, 2012, INDIAN J UROL, V28, P9, DOI 10.4103/0970-1591.94942; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Saidak Z, 2006, BRIT J PHARMACOL, V147, P671, DOI 10.1038/sj.bjp.0706661; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Seely KA, 2012, NEUROPHARMACOLOGY, V63, P905, DOI 10.1016/j.neuropharm.2012.06.046; Shi DM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-173; Shim JY, 2003, BIOPOLYMERS, V71, P169, DOI 10.1002/bip.10424; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; ter Heine R, 2014, BRIT J CLIN PHARMACO, V78, P572, DOI 10.1111/bcp.12388; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Vasiljevik T, 2013, J MED CHEM, V56, P4537, DOI 10.1021/jm400268b; Velasco G, 2007, MOL NEUROBIOL, V36, P60, DOI 10.1007/s12035-007-0002-5; Velasco G, 2016, PROG NEURO-PSYCHOPH, V64, P259, DOI 10.1016/j.pnpbp.2015.05.010; WEST RE, 1985, J BIOL CHEM, V260, P4428; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Xie S, 2007, J CLIN PHARM THER, V32, P209, DOI 10.1111/j.1365-2710.2007.00817.x; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005	76	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167240	10.1371/journal.pone.0167240	http://dx.doi.org/10.1371/journal.pone.0167240			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936172	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100076
J	Kawabata, N; Matsuda, M				Kawabata, Noriyuki; Matsuda, Michiyuki			Cell Density-Dependent Increase in Tyrosine-Monophosphorylated ERK2 in MDCK Cells Expressing Active Ras or Raf	PLOS ONE			English	Article							PROTEIN PHOSPHATASE-1; CONTACT INHIBITION; KINASE CASCADE; MAP KINASE; PHOSPHORYLATION; ACTIVATION; VISUALIZATION; BIOSENSORS; NRAS	The extracellular signal-regulated kinase (ERK) is one of the principal hub proteins that transmit growth signals from upstream oncogene products including Ras and BRaf to downstream effector proteins. However, there are both reports supporting and refuting the increase in ERK activity in cancer tissues expressing the active Ras and BRaf proteins. We considered that the cell density might account for this discrepancy. To examine this possibility, we prepared Madin-Darby canine kidney (MDCK) cells that expressed an active HRas, NRas, KRas, or BRaf and an ERK biosensor based on the principle of Forster resonance energy transfer (FRET). As we anticipated, expression of the active Ras or BRaf increased ERK activity at low cell densities. However, the ERK activity was markedly suppressed at high cell densities irrespective of the expression of the active Ras or BRaf. Western blotting analysis with Phos-tag gel revealed the decrease of tyrosine and threonine-diphosphorylated active ERK and the increase of tyrosine-monophosphorylated inactive ERK at high cell density. In addition, we found that calyculin A, an inhibitor for PPP-subfamily protein serine/threonine phosphatases, decreased the tyrosine-monophosphorylated ERK. Our study suggests that PPP-subfamily phosphatases may be responsible for cell density-dependent ERK dephosphorylation in cancer cells expressing active Ras or BRaf protein.	[Kawabata, Noriyuki; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan	Kyoto University	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan.	matsuda.michiyuki.2c@kyoto-u.ac.jp	Kawabata, Noriyuki/CAF-6693-2022	Kawabata, Noriyuki/0000-0001-7235-763X; Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology [15H02397]; Japan Agency for Medical Research and Development [15H0594]; Naito Foundation; Grants-in-Aid for Scientific Research [15H05949] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 15H02397: Ministry of Education, Culture, Sports, Science, and Technology; http://www.mext.go.jp/en/ 15H0594: Japan Agency for Medical Research and Development; http://www.amed.go.jp/en/ No grant number: Naito Foundation; https://www.naito-f.or.jp/jp/index.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; BOS JL, 1989, CANCER RES, V49, P4682; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Iwamoto N, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab1967; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Li SJ, 2004, ASIAN J WATER ENV PO, V1, P1, DOI DOI 10.1152/AJPCELL.00020.2004; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; Miyawaki A, 2015, MOL CELL, V58, P632, DOI 10.1016/j.molcel.2015.03.002; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oldach L, 2014, CHEM BIOL, V21, P186, DOI 10.1016/j.chembiol.2013.12.012; PASTAN I, 1978, NATURE, V274, P645, DOI 10.1038/274645a0; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Sakurai A, 2012, J BIOL CHEM, V287, P31703, DOI 10.1074/jbc.M112.377804; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Smalley KM, 2007, BRIT J CANCER, V96, P445, DOI 10.1038/sj.bjc.6603596; Swingle Mark, 2007, V365, P23; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Wayne J, 2006, MOL CELL BIOCHEM, V286, P181, DOI 10.1007/s11010-005-9089-z; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	49	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167940	10.1371/journal.pone.0167940	http://dx.doi.org/10.1371/journal.pone.0167940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936234	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100236
J	Muhammad, YS; Hussain, I; Shoukry, AM				Muhammad, Yousaf Shad; Hussain, Ijaz; Shoukry, Alaa Mohamd			Multivariate Multi-Objective Allocation in Stratified Random Sampling: A Game Theoretic Approach	PLOS ONE			English	Article							PUBLIC-GOODS GAME; COOPERATION; EVOLUTION	We consider the problem of multivariate multi-objective allocation where no or limited information is available within the stratum variance. Results show that a game theoretic approach (based on weighted goal programming) can be applied to sample size allocation problems. We use simulation technique to determine payoff matrix and to solve a minimax game.	[Muhammad, Yousaf Shad; Hussain, Ijaz] Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan; [Shoukry, Alaa Mohamd] King Saud Univ, Arriyadh Community Coll, Riyadh, Saudi Arabia; [Shoukry, Alaa Mohamd] KSA Workers Univ, King Saud Univ, Cairo, Egypt	Quaid I Azam University; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University	Muhammad, YS (corresponding author), Quaid I Azam Univ, Dept Stat, Islamabad, Pakistan.	yousuf@qau.edu.pk	Hussain, Ijaz/AAN-5885-2020; Muhammad, Yousaf Shad/ABH-1579-2021; Muhammad, Yousaf Shad/ABH-1068-2021	Hussain, Ijaz/0000-0002-1586-1503; Muhammad, Yousaf Shad/0000-0002-3541-6220; Muhammad, Yousaf Shad/0000-0002-3541-6220	Deanship of Scientific Research at King Saud University [RG-1437-027]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through research group no RG-1437-027.	AGGARWAL OP, 1959, ANN MATH STAT, V30, P206, DOI 10.1214/aoms/1177706376; Andersen R., 1979, TOTAL SURVEY ERROR; Ansari A. H., 2009, INT J STAT SCI KOLKA, V1, P45; Bethel J. W., 1986, OPTIMUM ALLOCATION A; Blackwell D, 1979, THEORY GAMES STAT DE; CHATTERJEE S, 1968, J AM STAT ASSOC, V63, P530, DOI 10.2307/2284023; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Chromy JR., 1987, P SECTION; Cochran WG., 1963, SAMPLING TECHNIQUES; Dalenius T, 1951, SKAND AKTUARIETIDSKR, V34, P133; Dalenius T., 1957, SAMPLING SWEDEN CONT; ERICSON WA, 1965, J AM STAT ASSOC, V60, P750, DOI 10.2307/2283243; FOLKS JL, 1965, J AM STAT ASSOC, V60, P225, DOI 10.2307/2283148; Ghosh JK, 1963, CALCUTTA STATISTICAL, V12, P4, DOI [10.1177/0008068319630102, DOI 10.1177/0008068319630102]; Ghosh SP., 1958, CALCUTTA STAT ASSOC, V8, P81, DOI [10.1177/0008068319580204, DOI 10.1177/0008068319580204]; Groves R.M., 2004, SURVEY ERRORS SURVEY, V536; Jahan N., 2001, DHAKA U J SCI, V49, P197; Jahan N., 1994, J INDIAN STAT ASSOC, V32, P95; Khan A., 2002, CALCUTTA STAT ASS B, V52, P323, DOI DOI 10.1177/0008068320020518; Khan MGM, 2010, J OFF STAT, V26, P695; Khan Mohammad GM, 2008, J INDIAN SOC AGR STA, V62, P42; KISH L, 1976, J ROY STAT SOC A STA, V139, P80, DOI 10.2307/2344384; Kish L, 1965, SURVEY SAMPLING; KOKAN AR, 1967, J ROY STAT SOC B, V29, P115; Kozak M, 2006, COMMUN STAT-SIMUL C, V35, P901, DOI 10.1080/03610910600880286; Linacre SJ, 1993, J OFF STAT, V9, P611; Romero C, 2001, OMEGA-INT J MANAGE S, V29, P63, DOI 10.1016/S0305-0483(00)00026-8; SWINDEL BF, 1972, J AM STAT ASSOC, V67, P684, DOI 10.2307/2284468; Tamiz M, 1998, EUR J OPER RES, V111, P569, DOI 10.1016/S0377-2217(97)00317-2; Varshney R., 2011, J MATH MODEL ALGORIT, V10, P393, DOI DOI 10.1007/S10852-011-9164-2; Varshney R, 2012, MATH METHOD OPER RES, V75, P185, DOI 10.1007/s00186-012-0380-y; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; Yates F, 1960, SAMPLING METHODS CEN, V54; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	36	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167705	10.1371/journal.pone.0167705	http://dx.doi.org/10.1371/journal.pone.0167705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936039	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100160
J	Paldino, S; Kondor, D; Bojic, I; Sobolevsky, S; Gonzalez, MC; Ratti, C				Paldino, Silvia; Kondor, Daniel; Bojic, Iva; Sobolevsky, Stanislav; Gonzalez, Marta C.; Ratti, Carlo			Uncovering Urban Temporal Patterns from Geo-Tagged Photography	PLOS ONE			English	Article							MOBILE; ATTRACTIVENESS	We live in a world where digital trails of different forms of human activities compose big urban data, allowing us to detect many aspects of how people experience the city in which they live or come to visit. In this study we propose to enhance urban planning by taking into a consideration individual preferences using information from an unconventional big data source: dataset of geo-tagged photographs that people take in cities which we then use as a measure of urban attractiveness. We discover and compare a temporal behavior of residents and visitors in ten most photographed cities in the world. Looking at the periodicity in urban attractiveness, the results show that the strongest periodic patterns for visitors are usually weekly or monthly. Moreover, by dividing cities into two groups based on which continent they belong to (i.e., North America or Europe), it can be concluded that unlike European cities, behavior of visitors in the US cities in general is similar to the behavior of their residents. Finally, we apply two indices, called "dilatation attractiveness index" and "dilatation index", to our dataset which tell us the spatial and temporal attractiveness pulsations in the city. The proposed methodology is not only important for urban planning, but also does support various business and public stakeholder decision processes, concentrated for example around the question how to attract more visitors to the city or estimate the impact of special events organized there.	[Paldino, Silvia] Univ Calabria, Dept Phys, Arcavacata Di Rende, CS, Italy; [Paldino, Silvia; Kondor, Daniel; Bojic, Iva; Sobolevsky, Stanislav; Ratti, Carlo] MIT, SENSEable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bojic, Iva] SMART Ctr, SENSEable City Lab, Singapore, Singapore; [Sobolevsky, Stanislav] NYU, Ctr Urban Sci Progress, Brooklyn, NY USA; [Gonzalez, Marta C.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Calabria; Massachusetts Institute of Technology (MIT); New York University; Massachusetts Institute of Technology (MIT)	Bojic, I (corresponding author), MIT, SENSEable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Bojic, I (corresponding author), SMART Ctr, SENSEable City Lab, Singapore, Singapore.	ivabojic@mit.edu	Gonzalez, Marta C./E-9456-2011; Kondor, Daniel/AAD-9871-2019; Sobolevsky, Stanislav/ABH-7108-2020	Gonzalez, Marta C./0000-0002-8482-0318; Kondor, Daniel/0000-0003-3720-7462; Sobolevsky, Stanislav/0000-0001-6281-0656; Bojic, Iva/0000-0002-4664-3349	BBVA; MIT SMART Program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; Accenture; Air Liquide; Coca Cola Company; Emirates Integrated Telecommunications Company; ENELfoundation; Ericsson; Expo; Ferrovial; Liberty Mutual; Regional Municipality of Wood Buffalo; Volkswagen Electronics Research Lab; UBER; National Research Foundation; Prime Minister's Office, Singapore; Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG; research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations" - Croatian Science Foundation [UIP-11-2013-8813]; Department of Transportation's grant of the New England [UTC Y25]; MIT Portugal Program; Center for Complex Engineering Systems at KACST-MIT; SENSEable city lab consortium; SENSEable city lab	BBVA(BBVA Foundation); MIT SMART Program; Center for Complex Engineering Systems (CCES) at KACST; Center for Complex Engineering Systems (CCES) at MIT; Accenture; Air Liquide; Coca Cola Company; Emirates Integrated Telecommunications Company; ENELfoundation; Ericsson(Ericsson); Expo; Ferrovial; Liberty Mutual; Regional Municipality of Wood Buffalo; Volkswagen Electronics Research Lab; UBER; National Research Foundation; Prime Minister's Office, Singapore; Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG(Singapore-MIT Alliance for Research & Technology Centre (SMART)); research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations" - Croatian Science Foundation; Department of Transportation's grant of the New England; MIT Portugal Program; Center for Complex Engineering Systems at KACST-MIT; SENSEable city lab consortium; SENSEable city lab	The authors want to recognize the support of BBVA, MIT SMART Program, Center for Complex Engineering Systems (CCES) at KACST and MIT, Accenture, Air Liquide, The Coca Cola Company, Emirates Integrated Telecommunications Company, The ENELfoundation, Ericsson, Expo 2015, Ferrovial, Liberty Mutual, The Regional Municipality of Wood Buffalo, Volkswagen Electronics Research Lab, UBER, and all the members of the MIT Senseable City Lab Consortium for supporting the research. The research was also supported by the National Research Foundation, Prime Minister's Office, Singapore, under its CREATE programme, Singapore-MIT Alliance for Research and Technology (SMART) Future Urban Mobility (FM) IRG and by research project "Managing Trust and Coordinating Interactions in Smart Networks of People, Machines and Organizations," funded by the Croatian Science Foundation under the project UIP-11-2013-8813. M.C.G. and S.P. were partially funded by the Department of Transportation's grant of the New England UTC Y25, the MIT Portugal Program, and the Center for Complex Engineering Systems at KACST-MIT. This research has been partially funded through the SENSEable city lab consortium. The consortium provided support in the form of salaries for some of the authors (IB, DK, CR) employed by the SENSEable city lab, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds31; Belyi A, 2016, ARXIV160105532; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bojic I, 2016, APPL GEOGR, V73, P47, DOI 10.1016/j.apgeog.2016.06.006; Bojic I, 2015, 2015 IEEE International WIE Conference on Electrical and Computer Engineering (WIECON-ECE), P305, DOI 10.1109/WIECON-ECE.2015.7443924; Bojic I, 2015, LECT NOTES COMPUT SC, V9471, P194, DOI 10.1007/978-3-319-27433-1_14; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockwell P. J., 2013, TIME SERIES THEORY M; Crandall David J, 2009, P INT C WORLD WID WE, DOI DOI 10.1145/1526709.1526812; Dkondor, 2016, FLICKRTEMPORAL; Fisher D, 2007, IEEE T VIS COMPUT GR, V13, P1184, DOI 10.1109/TVCG.2007.70561; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grauwin S, 2015, GEOTECH ENVIRON, V13, P363, DOI 10.1007/978-3-319-11469-9_15; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Hoteit S, 2014, COMPUT NETW, V64, P296, DOI 10.1016/j.comnet.2014.02.011; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Louail T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05276; Pereira RHM, 2013, GEOGR ANAL, V45, P77, DOI 10.1111/gean.12002; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Pei T, 2014, INT J GEOGR INF SCI, V28, P1988, DOI 10.1080/13658816.2014.913794; Ratti C., 2014, ARXIV14054301, P10; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Reades J, 2007, IEEE PERVAS COMPUT, V6, P30, DOI 10.1109/MPRV.2007.53; Sobolevsky S, 2015, ARXIV150600036; Sobolevsky S, 2015, IEEE INT CONGR BIG, P600, DOI 10.1109/BigDataCongress.2015.92; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Spirn Anne W., 1998, LANGUAGE LANDSCAPE; Toole Jameson L., 2012, P ACM SIGKDD INT WOR, P1, DOI [10.1145/2346496.2346498, DOI 10.1145/2346496.2346498]; Wang H, 2013, PROCEEDINGS OF THE 5TH (2013) INTERNATIONAL CONFERENCE ON FINANCIAL RISK AND CORPORATE FINANCE MANAGEMENT, VOLS I AND II, P1, DOI 10.1109/ijcnn.2013.6706812	30	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165753	10.1371/journal.pone.0165753	http://dx.doi.org/10.1371/journal.pone.0165753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27935979	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100016
J	Shanaki, M; Fadaei, R; Moradi, N; Emamgholipour, S; Poustchi, H				Shanaki, Mehrnoosh; Fadaei, Reza; Moradi, Nariman; Emamgholipour, Solaleh; Poustchi, Hossein			The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients	PLOS ONE			English	Article							DISEASE; FAMILY	Numerous studies have shown that C1q/TNF-related proteins (CTRPs) are involved in the pathophysiology of metabolic disorders, such as Non-alcoholic fatty liver disease (NAFLD) and Type 2 Diabetes (T2DM). There is a little information concerning CTRP13 in the context of NAFLD and T2DM. We evaluated the plasma levels of CTRP13 in healthy control and patients with NAFLD, T2DM and NAFLD+T2DM, and also correlations between CTRP13 plasma levels and clinical and subclinical features. Circulating CTRP13 was examined in 88 male (20 healthy control, 22 T2DM patients, 22 NAFLD patients and 22 NAFLD+T2DM patients). CTRP13 and adiponectin plasma levels were measured by ELISA method. CTRP13 serum levels were higher in the control group than the other groups (all p <0.001). CTRP13 had significant negative correlation with unfavorable anthropometric and metabolic factors including BMI, visceral fat, Insulin, HOMA-IR, TG, AST, ALT and gamma-GT and have a positive correlation with plasma concentration of adiponectin. CTRP13 had a significant inverse correlation with cIMT (r = -0.345) and liver stiffness (LS) (r = -0.372) (both, p <0.001). Also, the multiple stepwise linear regression has shown that visceral fat is a significant predictor of CTRP13 serum levels (p <0.001). Multiple stepwise linear regression with LS as the dependent variable showed that ALT (p < 0.001) and SBP (p = 0.010) were two predictor factors for LS. Strikingly, multiple stepwise linear regression showed that CTRP13 (p = 0.006) and SBP (p = 0.007) were two independent predictors for cIMT. Lower CTRP13 in patients with T2DM, NAFLD and NAFLD + T2DM was associated with increased risk of the diseases. CTRP13 have negative associations with unfavorable metabolic factors and also is a negative predictor of cIMT. Our results suggested that CTRP13 could be an associated factor with NAFLD in patients with and without T2DM.	[Shanaki, Mehrnoosh] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Lab Sci, Tehran, Iran; [Fadaei, Reza; Emamgholipour, Solaleh] Univ Tehran Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Moradi, Nariman] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Poustchi, Hossein] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran.	h.poustchi@gmail.com	Emamgholipour, Solaleh/T-6035-2017; Fadaei, Reza/M-9456-2016	Fadaei, Reza/0000-0002-4989-1137; Emamgholipour, Solaleh/0000-0002-9949-5773; Moradi, Nariman/0000-0001-7760-4804; Shanaki, Mehrnoosh/0000-0002-2684-1014				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Emamgholipour S, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0099-z; Germano G, 2012, EUR HEART J, V33, P137; Jung CH, 2014, J CLIN ENDOCR METAB, V99, pE2477, DOI 10.1210/jc.2014-2524; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Medina-Bravo P, 2011, ARCH MED RES, V42, P115, DOI 10.1016/j.arcmed.2011.03.002; Merat S, 2015, ARCH IRAN MED, V18, P515, DOI 015188/AIM.009; Mirza MS, 2011, OBESITY VISCERAL FAT; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Qu H, 2015, J CLIN LIPIDOL, V9, P289, DOI 10.1016/j.jacl.2015.03.006; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shabani P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118650; WANG HF, 2016, POWER ELECTRON POWER, P1, DOI DOI 10.1186/S12872-016-0266-7; Wang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/971683; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133955; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846	27	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168082	10.1371/journal.pone.0168082	http://dx.doi.org/10.1371/journal.pone.0168082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936230	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100270
J	Tanino, H; Kosaka, Y; Nishimiya, H; Tanaka, Y; Minatani, N; Kikuchi, M; Shida, A; Waraya, M; Katoh, H; Enomoto, T; Sengoku, N; Kajita, S; Hoffman, RM; Watanabe, M				Tanino, Hirokazu; Kosaka, Yoshimasa; Nishimiya, Hiroshi; Tanaka, Youko; Minatani, Naoko; Kikuchi, Mariko; Shida, Akiko; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Sengoku, Norihiko; Kajita, Sabine; Hoffman, Robert M.; Watanabe, Masahiko			BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy	PLOS ONE			English	Article							SUBTYPES	BRCAness is defined as the set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation or deletion, results in DNA repair deficiency. In the present study, we addressed BRCAness, therapeutic efficacy, recurrence, and survival in patients with triple negative breast cancer (TNBC) who were treated with neoadjuvant chemotherapy at Kitasato University Hospital, Japan, between April 2006 and October 2012. BRCAness was determined by preoperative core needle biopsy (CNB) specimens and surgical specimens. Assay was performed using Multiplex Ligation-dependent Probe Amplification (MLPA) with P376-B2 BRCA1ness probemix (MRC-Holland, Amsterdam, The Netherlands). The relative copy number ratio of each sample was compared to Human Genomic DNA (Promega, Madison, WI, USA) as reference samples was calculated with Coffalyser. NET default settings. The BRCAness score was calculated with the relative copy number ratio of various DNA sequences. Values of 0.5 or more were determined as the BRCA1-like Type (BRCAness) and those of less than 0.5 as the Sporadic Type to analyze pathological complete response (pCR) rate, recurrence, and survival. pCR (ypT0/Tis/N0) was observed in 15 patients (pCR rate: 37.5%). These patients had no recurrence. Twelve patients recurred, 8 died from breast cancer. The BRCA1-like Type were 22 and Sporadic Type were 18 in CNB specimens. No major differences were observed between the BRCA1-like Type and Sporadic Type with pCR rate, recurrence rate and survival. Twenty four surgical specimens of non-pCR patients were available and 9 were BRCA1-like Type, who had more recurrences (7/9 vs. 5/15), and their relapse-free survival was also lower (p<0.05) than that of Sporadic Type. Seven BRCA1-like Type patients remained BRCA1-like Type in surgical specimens, were worse in recurrence (p<0.01) and survival (p<0.05) compared with 6 patients whose BRCA status in surgical specimens turned to Sporadic Type. New clinical trials assessing the true recurrence (TR) rate of BRCA-type patients are expected since neither platinum-containing drugs nor poly (ADP-ribose) polymerase (PARP) inhibitors are effective against tumors with nonfunctional BRCA genes.	[Tanino, Hirokazu; Kosaka, Yoshimasa; Nishimiya, Hiroshi; Tanaka, Youko; Minatani, Naoko; Kikuchi, Mariko; Shida, Akiko; Waraya, Mina; Katoh, Hiroshi; Enomoto, Takumo; Sengoku, Norihiko; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan; [Kajita, Sabine] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Kitasato University; Kitasato University; Anti Cancer Inc; University of California System; University of California San Diego	Tanino, H (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan.	htanino@med.kitasato-u.ac.jp	Tanino, Hirokazu/AAN-4455-2021					Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Nishimiya H, 2014, ANTICANCER RES, V34, P259; Oonk AMM, 2012, ANN ONCOL, V23, P2301, DOI 10.1093/annonc/mdr621; Telli Melinda, 2014, Am Soc Clin Oncol Educ Book, pe37, DOI 10.14694/EdBook_AM.2014.34.e37; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Von Minckwitz G, 2014, ASCO MEETING ABSTRAC, V32, P1005, DOI [10.1200/jco.2014.32.15_suppl, DOI 10.1200/jco.2014.32.15_suppl.1005]; Wessels LFA, 2002, CANCER RES, V62, P7110	12	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0165721	10.1371/journal.pone.0165721	http://dx.doi.org/10.1371/journal.pone.0165721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935989	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100014
J	Thi, VHD; Coriton, O; Le Clainche, I; Arnaud, D; Gordon, SP; Linc, G; Catalan, P; Hasterok, R; Vogel, JP; Jahier, J; Chalhoub, B				Vinh Ha Dinh Thi; Coriton, Olivier; Le Clainche, Isabelle; Arnaud, Dominique; Gordon, Sean P.; Linc, Gabriella; Catalan, Pilar; Hasterok, Robert; Vogel, John P.; Jahier, Joseph; Chalhoub, Boulos			Recreating Stable Brachypodium hybridum Allotetraploids by Uniting the Divergent Genomes of B. distachyon and B. stacei	PLOS ONE			English	Article							MODEL GRASS; INTERSPECIFIC HYBRIDIZATION; GENE-EXPRESSION; REPRODUCTIVE ISOLATION; SYNTHETIC POLYPLOIDS; BRASSICA-RAPA; EVOLUTION; WHEAT; MECHANISMS; BARRIERS	Brachypodium hybridum (2n = 30) is a natural allopolyploid with highly divergent subgenomes derived from two extant diploid species, B. distachyon (2n = 10) and B. stacei (2n = 20) that differ in chromosome evolution and number. We created synthetic B. hybridum allotetraploids by hybridizing various lines of B. distachyon and B. stacei. The initial amphihaploid F1 interspecific hybrids were obtained at low frequencies when B. distachyon was used as the maternal parent (0.15% or 0.245% depending on the line used) and were sterile. No hybrids were obtained from reciprocal crosses or when autotetraploids of the parental species were crossed. Colchicine treatment was used to double the genome of the F1 amphihaploid lines leading to allotetraploids. The genome-doubled F1 plants produced a few S1 (first selfed generation) seeds after self-pollination. S1 plants from one parental combination (Bd3-1xBsta5) were fertile and gave rise to further generations whereas those of another parental combination (Bd21xABR114) were sterile, illustrating the importance of the parental lineages crossed. The synthetic allotetraploids were stable and resembled the natural B. hybridum at the phenotypic, cytogenetic and genomic levels. The successful creation of synthetic B. hybridum offers the possibility to study changes in genome structure and regulation at the earliest stages of allopolyploid formation in comparison with the parental species and natural B. hybridum.	[Vinh Ha Dinh Thi; Le Clainche, Isabelle; Arnaud, Dominique; Chalhoub, Boulos] Univ Evry Val dEssonne, Org & Evolut Complex Genomes, Inst Natl Rech Agron, Evry, France; [Coriton, Olivier; Jahier, Joseph] Univ Rennes 1, Unite Mixte Rech INRA, Agrocampus Rennes, Inst Genet Environm & Protect Plantes, Le Rheu, France; [Gordon, Sean P.; Vogel, John P.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Linc, Gabriella] Hungarian Acad Sci, Inst Agr, Agr Res Ctr, Brunszv U 2, Martonvasar, Hungary; [Catalan, Pilar] Univ Zaragoza, Dept Agr & Environm Sci, High Polytech Sch Huesca, Huesca, Spain; [Catalan, Pilar] Tomsk State Univ, Inst Biol, Dept Bot, Tomsk, Russia; [Hasterok, Robert] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland; [Vogel, John P.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chalhoub, Boulos] Univ Paris Saclay, Univ Evry Val dEssonne, Inst Syst & Synthet Biol, Genopole,Ctr Natl Rech Sci, Evry, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; United States Department of Energy (DOE); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Zaragoza; Tomsk State University; University of Silesia in Katowice; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Genopole; UDICE-French Research Universities; Universite Paris Saclay	Chalhoub, B (corresponding author), Univ Evry Val dEssonne, Org & Evolut Complex Genomes, Inst Natl Rech Agron, Evry, France.; Chalhoub, B (corresponding author), Univ Paris Saclay, Univ Evry Val dEssonne, Inst Syst & Synthet Biol, Genopole,Ctr Natl Rech Sci, Evry, France.	chalhoub@evry.inra.fr	Catalan, Pilar/N-7641-2014; Catalan, Pilar/AAL-8833-2020; Hasterok, Robert/A-1629-2008	DINH, Thi Vinh Ha/0000-0002-5420-7352; Vogel, John/0000-0003-1786-2689; Hasterok, Robert/0000-0001-6667-2721	French ANR (Agence Nationale de la Recherche) [ANR-11-BSV5-0015]; Vietnamese International Education Development (VIED); Ministry of Education and Training Vietnam (MOET)	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Vietnamese International Education Development (VIED); Ministry of Education and Training Vietnam (MOET)	This project was funded by the French ANR (Agence Nationale de la Recherche, www.agence-nationale-recherche.fr) 2011 (Ploid-ploid-Wheat, ANR-11-BSV5-0015). Vinh Ha Dinh Thi was support by a PhD fellowship from the Vietnamese International Education Development (VIED) and Ministry of Education and Training Vietnam (MOET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Akama S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1376; BARKER M. S., 2012, PLANT GENOME DIVERSI, V1, P155, DOI [10.1007/978-3-7091-1130-7_11, DOI 10.1007/978-3-7091-1130-7_11]; Barker MS, 2016, NEW PHYTOL, V210, P391, DOI 10.1111/nph.13698; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Besnard G, 2008, ANN BOT-LONDON, V101, P25, DOI 10.1093/aob/mcm275; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bouchenak-Khelladi Y, 2014, AM J BOT, V101, P300, DOI 10.3732/ajb.1300439; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Buggs RJA, 2012, AM J BOT, V99, P372, DOI 10.3732/ajb.1100395; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Catalan P, 2014, TRENDS PLANT SCI, V19, P414, DOI 10.1016/j.tplants.2014.05.002; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; CataluYn P., 2016, GENETICS GENOMICS BR, P9, DOI DOI 10.1007/7397_2015_17; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Choudhary BR, 2000, PLANT BREEDING, V119, P417, DOI 10.1046/j.1439-0523.2000.00503.x; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; Cousin A, 2009, CYTOM PART A, V75A, P1015, DOI 10.1002/cyto.a.20816; Dart S, 2004, CAN J BOT, V82, P185, DOI [10.1139/B03-134, 10.1139/b03-134]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Estep MC, 2014, P NATL ACAD SCI USA, V111, P15149, DOI 10.1073/pnas.1404177111; Fujimoto R, 2011, PLANT MOL BIOL, V77, P419, DOI 10.1007/s11103-011-9820-y; GANGADEVI T, 1985, THEOR APPL GENET, V70, P330, DOI 10.1007/BF00304921; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Ghani MA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0272-9; Giraldo P, 2012, GENOME, V55, P523, DOI [10.1139/g2012-039, 10.1139/G2012-039]; Gordon S. P, 2016, GENETICS GENOMICS BR, P313, DOI DOI 10.1007/7397_2015_19; Hammami R, 2014, PLANT SYST EVOL, V300, P2029, DOI 10.1007/s00606-014-1021-0; Hasterok R, 2002, CHROMOSOME RES, V10, P83, DOI 10.1023/A:1014278429178; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-20; Hong SY, 2011, WEED RES, V51, P612, DOI 10.1111/j.1365-3180.2011.00877.x; Idziak D, 2008, GENOME, V51, P387, DOI 10.1139/G08-017; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Jahier J., 1992, TECHNIQUES PLANT CYT; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee CB, 2008, SEX PLANT REPROD, V21, P183, DOI 10.1007/s00497-008-0077-9; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lopez-Alvarez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051058; Ludwig-Muller J, 2005, J EXP BOT, V56, P2095, DOI 10.1093/jxb/eri208; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Mariam AL, 1996, THEOR APPL GENET, V93, P664, DOI 10.1007/BF00224060; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; MEJIAJIMENEZ A, 1994, THEOR APPL GENET, V88, P324, DOI 10.1007/BF00223640; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; Nasrallah ME, 2000, PLANT PHYSIOL, V124, P1605, DOI 10.1104/pp.124.4.1605; Natalis LC, 2012, AM J BOT, V99, P1847, DOI 10.3732/ajb.1200085; Ng DWK, 2012, HEREDITY, V108, P419, DOI 10.1038/hdy.2011.92; Osabe K, 2012, INT J MOL SCI, V13, P8696, DOI 10.3390/ijms13078696; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; POYSA V, 1990, THEOR APPL GENET, V79, P187, DOI 10.1007/BF00225950; Presgraves DC, 2010, CURR BIOL, V20, pR440, DOI 10.1016/j.cub.2010.03.032; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Scopece G, 2008, AM NAT, V171, P315, DOI 10.1086/527501; SITCH LA, 1987, EUPHYTICA, V36, P497, DOI 10.1007/BF00041493; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; STEBBINS GL, 1985, ANN MO BOT GARD, V72, P824, DOI 10.2307/2399224; Suay L, 2014, NEW PHYTOL, V201, P645, DOI 10.1111/nph.12534; Szadkowski E, 2011, NEW PHYTOL, V191, P884, DOI 10.1111/j.1469-8137.2011.03729.x; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tate JA, 2009, AM J BOT, V96, P979, DOI 10.3732/ajb.0800299; TAYLOR NL, 1980, EUPHYTICA, V29, P441, DOI 10.1007/BF00025144; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Yao XC, 2012, PLANT CELL REP, V31, P781, DOI 10.1007/s00299-011-1200-1	85	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167171	10.1371/journal.pone.0167171	http://dx.doi.org/10.1371/journal.pone.0167171			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936041	gold, Green Published			2022-12-26	WOS:000389587100070
J	Li, HQ; Fang, MS; Xu, MZ; Li, SH; Du, J; Li, WY; Chen, H				Li, Huqun; Fang, Maosheng; Xu, Mingzhen; Li, Shihong; Du, Juan; Li, Weiyong; Chen, Hui			Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; ATYPICAL ANTIPSYCHOTICS; WEIGHT-GAIN; DELTA-5 DESATURASE; RATS RELATIONSHIP; RISK; PALMITATE; INCREASE; INFLAMMATION; ASSOCIATION	Background Atypical antipsychotics such as olanzapine cause metabolic side effects leading to obesity and insulin resistance. The underlying mechanisms remain elusive. In this study we investigated the effects of chronic treatment of olanzapine on the fatty acid composition of plasma in mice. Methods Twenty 8-week female Balb/c mice were randomly assigned to two groups: the OLA group and the control group. After treatment with olanzapine (10 mg/kg/day) or vehicle intraperitoneally for 8 weeks, fasting glucose, insulin levels and oral glucose tolerance test were determined. Effects on plasma fatty acid profile and plasma indices of D5 desaturase, D6 desaturase and SCD1 activity were also investigated. Results Chronic administration of olanzapine significantly elevated fasting glucose and insulin levels, impaired glucose tolerance, but did not increase body weight. Total saturated fatty acids and n-6 polyunsaturated fatty acids were significantly increased and total monounsaturated fatty acids were significantly decreased, while total n-3 polyunsaturated fatty acids showed no prominent changes. Chronic olanzapine treatment significantly up-regulated D6 desaturase activity while down-regulating D5 desaturase activity. Palmitic acid (C16: 0), dihomo-gamma linolenic acid (C20:3n-6) and D6 desaturase were associated with an increase probability of insulin resistance, whereas nervonic acid (C24: 1) and SCD1 were significantly associated with a lower insulin resistance probability. Conclusions All results indicated that such drug-induced effects on fatty acid profile in plasma were relevant for the metabolic adverse effects associated with olanzapine and possibly other antipsychotics. Further studies are needed to investigate geneticand other mechanisms to explain how plasma fatty acids regulate glucose metabolism and affect the risk of insulin resistance.	[Li, Huqun; Xu, Mingzhen; Li, Shihong; Li, Weiyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan, Peoples R China; [Fang, Maosheng] Wuhan Mental Hlth Ctr, Wuhan, Peoples R China; [Du, Juan] Hubei Univ Chinese Med, Coll Pharm, Wuhan, Peoples R China; [Chen, Hui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan, Peoples R China	Huazhong University of Science & Technology; Hubei University of Chinese Medicine; Huazhong University of Science & Technology	Li, WY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan, Peoples R China.; Chen, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan, Peoples R China.	wenzhang_sci@163.com; shining119@163.com			Natural Science Foundation of China [81573509]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant 81573509) awarded to WY Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Baptista T, 2008, CNS DRUGS, V22, P477, DOI 10.2165/00023210-200822060-00003; Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b; Boyda HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053459; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chen XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21454; Chow LS, 2013, METABOLISM, V62, P100, DOI 10.1016/j.metabol.2012.06.004; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Hahn M, 2011, SCHIZOPHR RES, V131, P90, DOI 10.1016/j.schres.2011.06.004; Han E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154683; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Henderson DC, 2007, J CLIN PSYCHIAT, V68, P18; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jacobs S, 2015, AM J CLIN NUTR, V102, P155, DOI 10.3945/ajcn.114.102707; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Mann S, 2013, PHARMACOL BIOCHEM BE, V103, P717, DOI 10.1016/j.pbb.2012.12.002; Mayneris-Perxachs J, 2014, CLIN NUTR, V33, P90, DOI 10.1016/j.clnu.2013.03.001; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; McNamara RK, 2011, SCHIZOPHR RES, V129, P66, DOI 10.1016/j.schres.2011.03.016; McNamara RK, 2011, SCHIZOPHR RES, V129, P57, DOI 10.1016/j.schres.2011.03.006; McNamara RK, 2009, SCHIZOPHR RES, V107, P150, DOI 10.1016/j.schres.2008.09.027; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Newcomer JW, 2005, CNS DRUGS, V19, P1; Ntambi JM, 1999, J LIPID RES, V40, P1549; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Pardo V, 2015, J BIOL CHEM, V290, P11663, DOI 10.1074/jbc.M115.649483; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Roden M, 2012, DIABETES, V61, P2397, DOI 10.2337/db12-0662; Sacher J, 2008, NEUROPSYCHOPHARMACOL, V33, P1633, DOI 10.1038/sj.npp.1301541; Salto LM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010052; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Sethom MM, 2011, PROSTAG LEUKOTR ESS, V85, P137, DOI 10.1016/j.plefa.2011.06.006; Shobo M, 2011, BEHAV BRAIN RES, V216, P561, DOI 10.1016/j.bbr.2010.08.046; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Tan CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23873; Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001	52	5	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167930	10.1371/journal.pone.0167930	http://dx.doi.org/10.1371/journal.pone.0167930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973621	Green Published, gold, Green Submitted			2022-12-26	WOS:000392754300048
J	Morvai, B; Nanuru, S; Mul, D; Kusche, N; Milne, G; Szekely, T; Komdeur, J; Miklosi, A; Pogany, A				Morvai, Boglarka; Nanuru, Sabine; Mul, Douwe; Kusche, Nina; Milne, Gregory; Szekely, Tamas; Komdeur, Jan; Miklosi, Adam; Pogany, Akos			Diurnal and Reproductive Stage-Dependent Variation of Parental Behaviour in Captive Zebra Finches	PLOS ONE			English	Article							DIFFERENTIAL-ALLOCATION; INCUBATION BEHAVIOR; BIPARENTAL CARE; WILD; FEMALE; ATTRACTIVENESS; TEMPERATURE; COOPERATION; SYNCHRONY; CONFLICT	Parental care plays a key role in ontogeny, life-history trade-offs, sexual selection and intrafamilial conflict. Studies focusing on understanding causes and consequences of variation in parental effort need to quantify parental behaviour accurately. The applied methods are, however, diverse even for a given species and type of parental effort, and rarely validated for accuracy. Here we focus on variability of parental behaviour from a methodological perspective to investigate the effect of different samplings on various estimates of parental effort. We used nest box cameras in a captive breeding population of zebra finches, Taeniopygia guttata, a widely used model system of sexual selection, intra-familial dynamics and parental care. We investigated diurnal and reproductive stage-dependent variation in parental effort (including incubation, brooding, nest attendance and number of feedings) based on 12h and 3h continuous video-recordings taken at various reproductive stages. We then investigated whether shorter (1h) sampling periods provided comparable estimates of overall parental effort and division of labour to those of longer (3h) sampling periods. Our study confirmed female-biased division of labour during incubation, and showed that the difference between female and male effort diminishes with advancing reproductive stage. We found individually consistent parental behaviours within given days of incubation and nestling provisioning. Furthermore, parental behaviour was consistent over the different stages of incubation, however, only female brooding was consistent over nestling provisioning. Parental effort during incubation did not predict parental effort during nestling provisioning. Our analyses revealed that 1h sampling may be influenced heavily by stochastic and diurnal variation. We suggest using a single longer sampling period (3h) may provide a consistent and accurate estimate for overall parental effort during incubation in zebra finches. Due to the large within-individual variation, we suggest repeated longer sampling over the reproductive stage may be necessary for accurate estimates of parental effort post-hatching.	[Morvai, Boglarka; Kusche, Nina; Miklosi, Adam; Pogany, Akos] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Nanuru, Sabine; Mul, Douwe; Komdeur, Jan] Univ Groningen, Groningen Inst Evolut Life Sci, Behav & Physiol Ecol, Groningen, Netherlands; [Milne, Gregory; Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	Eotvos Lorand University; University of Groningen; University of Bath	Pogany, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	akos.pogany@ttk.elte.hu	Komdeur, Jan/X-1261-2019; Pogány, Ákos/AAF-2637-2020; Morvai, Boglárka/GPG-4272-2022	Komdeur, Jan/0000-0002-9241-0124; Pogány, Ákos/0000-0001-9498-0158; Morvai, Boglárka/0000-0001-6360-9284; Milne, Gregory/0000-0002-9594-3321	Hungarian Scientific Research Fund [OTKA K109337]; Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group) [MTA 01 031]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group)	This study received funding from the Hungarian Scientific Research Fund (OTKA K109337) and the Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group, MTA 01 031). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Arnold KE, 2016, ANIM BEHAV, V113, P69, DOI 10.1016/j.anbehav.2015.12.013; Bartlett TL, 2005, AUK, V122, P835, DOI 10.1642/0004-8038(2005)122[0835:DOLIAB]2.0.CO;2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Canty A., 2015, BOOT BOOTSTRAP R S P; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Foster VS, 2007, ETHOLOGY, V113, P511, DOI 10.1111/j.1439-0310.2007.01350.x; Gilby AJ, 2013, ANIM BEHAV, V85, P1329, DOI 10.1016/j.anbehav.2013.03.023; Gilby AJ, 2011, ANIM BEHAV, V82, P479, DOI 10.1016/j.anbehav.2011.05.022; Gilby AJ, 2011, ANIM BEHAV, V81, P289, DOI 10.1016/j.anbehav.2010.10.020; Gorman HE, 2003, ANIM BEHAV, V65, P745, DOI 10.1006/anbe.2003.2120; Gorman HE, 2005, J AVIAN BIOL, V36, P413; Griffith SC, 2010, EMU, V110, P1, DOI 10.1071/MU09057; Grunst ML, 2016, J AVIAN BIOL, V47, P57, DOI 10.1111/jav.00758; Harper DGC., 1994, RINGING MIGR, V15, P84, DOI DOI 10.1080/03078698.1994.9674078; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hill DL, 2014, J EXP BIOL, V217, P1326, DOI 10.1242/jeb.095323; Hill DL, 2011, BEHAV ECOL SOCIOBIOL, V65, P2049, DOI 10.1007/s00265-011-1214-2; Klug H, 2014, ECOL EVOL, V4, P2330, DOI 10.1002/ece3.1083; Kosztolanyi A, 2009, BEHAV ECOL, V20, P446, DOI 10.1093/beheco/arn140; Lendvai AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141194; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mainwaring MC, 2011, BEHAV ECOL SOCIOBIOL, V65, P2261, DOI 10.1007/s00265-011-1235-x; Mariette MM, 2015, AM NAT, V185, P270, DOI 10.1086/679441; Mariette MM, 2012, J AVIAN BIOL, V43, P131, DOI 10.1111/j.1600-048X.2012.05555.x; Mariette MM, 2011, AUK, V128, P26, DOI 10.1525/auk.2011.10117; Martin P., 2007, MEASURING BEHAV INTR, V3; Murphy MT, 2015, J FIELD ORNITHOL, V86, P41, DOI 10.1111/jofo.12087; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Peter A, 2015, SOLOMON CODER SIMPLE; Pogany A, 2014, BEHAVIOUR, V151, P1885, DOI 10.1163/1568539X-00003221; Pogany A, 2012, AUK, V129, P773, DOI 10.1525/auk.2012.12080; Pooley EL, 2014, ANIM BEHAV, V97, P153, DOI 10.1016/j.anbehav.2014.09.012; R Core Team, 2021, R LANGUAGE ENV STAT; Rehling A, 2012, ANIM BEHAV, V83, P35, DOI 10.1016/j.anbehav.2011.10.003; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Royle N, 2012, EVOLUTION OF PARENTAL CARE, pXIV; Royle NJ, 2006, ANIM BEHAV, V72, P123, DOI 10.1016/j.anbehav.2005.09.023; Royle NJ, 2002, NATURE, V416, P733, DOI 10.1038/416733a; Suarez ME, 1996, POULTRY SCI, V75, P924, DOI 10.3382/ps.0750924; Tzschentke B, 1999, ORNIS FENNICA, V76, P189; Walter I, 2009, J EXP BIOL, V212, P2328, DOI 10.1242/jeb.029009; ZANN R, 1991, EMU, V91, P107, DOI 10.1071/MU9910107; Zann RA., 1996, ZEBRA FINCH SYNTHESI	49	9	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167368	10.1371/journal.pone.0167368	http://dx.doi.org/10.1371/journal.pone.0167368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973549	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300026
J	Luby, CH; Dawson, JC; Goldman, IL				Luby, Claire H.; Dawson, Julie C.; Goldman, Irwin L.			Assessment and Accessibility of Phenotypic and Genotypic Diversity of Carrot (Daucus carota L. var. sativus) Cultivars Commercially Available in the United States	PLOS ONE			English	Article							GENETIC-STRUCTURE; R-PACKAGE; INTELLECTUAL PROPERTY; POPULATIONS; RIGHTS	Increased use of intellectual property rights over plant germplasm has led to a complicated landscape for exchange among plant breeders. Our goal was to examine phenotypic and genotypic diversity present in commercially available carrot (Daucus carota L. var. sativus) germplasm in relation to the freedom to operate-the ability for plant breeders to access and use crop genetic diversity. A collection of 140 commercially available carrot cultivars were grown in replicated field trials in the Madison, WI area in 2013 and 2014. Phenotypic measurements were recorded for leaf and root characteristics. Illumina sequencing was used to conduct genotyping by sequencing analysis on all cultivars to understand the range of genetic diversity present. Additionally, the intellectual property rights associated with each cultivar was noted to determine the freedom to operate. We found that although one-third of the commercially available US carrot cultivars in our study are restricted through some form of intellectual property rights, the genetic and phenotypic variability of the protected cultivars does not represent a completely separate group from the available material. Phenotypic analyses including ANOVA and principal components analysis, suggest that many of the traits differed significantly based on market class, but not by whether the cultivar had freedom to operate. The principal components and F-st analyses on the genotyping by sequencing data revealed that carrot market classes (F-st = 0.065) and freedom to operate classes (F-st = 0.023) were not genetically distinct, and that principle components 1 and 2 account for only 10.1% of the total genotypic variation, implying that cultivated carrot germplasm in the US forms an unstructured population. Our findings suggest that the genetic diversity present in carrot cultivars that have freedom to operate is potentially large enough to support carrot breeding efforts in most market classes given present levels of intellectual property protection.	[Luby, Claire H.; Dawson, Julie C.; Goldman, Irwin L.] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Luby, CH (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	cluby@wisc.edu			Clif Bar Family Foundation Seed Matters program; North Central SARE graduate student grant [GNC13-175]	Clif Bar Family Foundation Seed Matters program; North Central SARE graduate student grant	CHL received a graduate student fellowship from the Clif Bar Family Foundation Seed Matters program < http://seedmatters.org/about-us/programs/seed-matters-graduate-fellowships/> that supported her work on this project. CHL and ILG received a North Central SARE graduate student grant (GNC13-175) in 2013 < http://www.northcentralsare.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2009, FORDHAM LAW REV, V77, P2275; Arscott SA, 2010, COMPR REV FOOD SCI F, V9, P223, DOI 10.1111/j.1541-4337.2009.00103.x; BANGA O., 1963, Genetica Agraria, V17, P357; BANGA O., 1957, EUPHYTICA, V6, P64; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradeen JM, 2002, J AM SOC HORTIC SCI, V127, P383, DOI 10.21273/JASHS.127.3.383; Brothwell D, 1969, FOOD ANTIQUITY SURVE; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Holland J.B., 2003, PLANT BREEDING REV, V22, DOI DOI 10.1002/9780470650202.CH2; Howard PH, 2015, CROP SCI, V55, P2489, DOI 10.2135/cropsci2014.09.0669; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jondle RJ, 2015, CROP SCI, V55, P2496, DOI 10.2135/cropsci2014.10.0693; Kloppenburg JR., 2005, 1 SEED POLITICAL EC; Kuznetsova A., 2015, R PACKAGE VERSION PA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lence SH, 2016, EUR REV AGRIC ECON, V43, P1, DOI 10.1093/erae/jbv007; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Luby CH, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050479; Morrell CH, 1998, BIOMETRICS, V54, P1560, DOI 10.2307/2533680; Murphy DJ, 2007, PLANT BREEDING AND BIOTECHNOLOGY: SOCIETAL CONTEXT AND THE FUTURE OF AGRICULTURE, P1; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Pardey P, 2013, NAT BIOTECHNOL, V31, P25, DOI 10.1038/nbt.2467; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Pritchard JK, 2000, GENETICS, V155, P945; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Shim SI, 2000, THEOR APPL GENET, V101, P227, DOI 10.1007/s001220051473; Simon P. W., 2000, Plant Breeding Reviews, V19, P157; Stolarczyk J., 2011, Chronica Horticulturae, V51, P13; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167865	10.1371/journal.pone.0167865	http://dx.doi.org/10.1371/journal.pone.0167865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959910	Green Published, Green Submitted, gold			2022-12-26	WOS:000392753900020
J	Braga, LM; Prado, GF; Umeda, IIK; Kawauchi, TS; Taboada, AMF; Azevedo, RS; Pereira, HG; Grupi, CJ; Souza, HCC; Moreira, DAR; Nakagawa, NK				Braga, Lays Magalhaes; Prado, Gustavo Faibischew; Kikuchi Umeda, Iracema Ioco; Kawauchi, Tatiana Satie; Froes Taboada, Adriana Marques; Azevedo, Raymundo Soares; Pereira Filho, Horacio Gomes; Grupi, Cesar Jose; Cavenague Souza, Hayala Cristina; Ribeiro Moreira, Dalmo Antonio; Nakagawa, Naomi Kondo			Reproducibility for Heart Rate Variability Analysis during 6-Min Walk Test in Patients with Heart Failure and Agreement between Devices	PLOS ONE			English	Article							RATE MONITOR; POLAR S810; RELIABILITY; SECONDARY; INTERVALS; THERAPY; DEATH; TRIAL; TIME; ECG	Heart rate variability (HRV) analysis is a useful method to assess abnormal functioning in the autonomic nervous system and to predict cardiac events in patients with heart failure (HF). HRV measurements with heart rate monitors have been validated with an electrocardiograph in healthy subjects but not in patients with HF. We explored the reproducibility of HRV in two consecutive six-minute walk tests (6MW), 60-minute apart, using a heart rate monitor (PolarS810i) and a portable electrocardiograph (called Holter) in 50 HF patients (mean age 59 years, NYHA II, left ventricular ejection fraction similar to 35%). The reproducibility for each device was analysed using a paired t-test or the Wilcoxon signed-rank test. Additionally, we assessed the agreement between the two devices based on the HRV indices at rest, during the 6MW and during recovery using concordance correlation coefficients (CCC), 95% confidence intervals and Bland-Altman plots. The test-retest for the HRV analyses was reproducible using Holter and PolarS810i at rest but not during recovery. In the second 6MW, patients showed significant increases in rMSSD and walking distance. The PolarS810i measurements had remarkably high concordance correlation [0.86<CCC<0.99] based on Holter at rest, during 6MW and recovery. At higher rates, a small effect in increasing differences between Holter and Polar in R-R intervals was observed. In conclusion, our study showed good reproducibility of HRV at rest in two consecutive 6MW using Holter and PolarS810i. Additionally, PolarS810i produced good agreements in short-term HRV indices based on Holter simultaneous recordings at rest, during the 6MW and recovery in HF patients.	[Braga, Lays Magalhaes; Kawauchi, Tatiana Satie; Nakagawa, Naomi Kondo] Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil; [Prado, Gustavo Faibischew] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, Brazil; [Kikuchi Umeda, Iracema Ioco; Froes Taboada, Adriana Marques; Cavenague Souza, Hayala Cristina; Ribeiro Moreira, Dalmo Antonio] Dante Pazzanese Inst Cardiol Sao Paulo State, Sao Paulo, Brazil; [Azevedo, Raymundo Soares] Univ Sao Paulo, Dept Pathol, Sch Med, Sao Paulo, Brazil; [Pereira Filho, Horacio Gomes; Grupi, Cesar Jose] Univ Sao Paulo, Fac Med, Hosp Clin, Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Nakagawa, NK (corresponding author), Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil.	naomi.kondo@usp.br	Souza, Hayala/ABB-4473-2020; Nakagawa, Naomi Kondo/AAM-5681-2020; Azevedo, Raymundo S/B-7593-2008; Nakagawa, Naomi Kondo/B-4602-2009; PEREIRA FILHO, HORACIO/R-1497-2016	Souza, Hayala/0000-0002-7970-5403; Nakagawa, Naomi Kondo/0000-0001-7826-6798; Azevedo, Raymundo S/0000-0003-0660-2371; Nakagawa, Naomi Kondo/0000-0001-7826-6798; Prado, Gustavo/0000-0001-8023-4904	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 2013/13598-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/13598-1). The funder had no role in study design, data collection, data analysis, data interpretation, decision to publish or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; Barbosa MPCR, 2014, CLIN PHYSIOL FUNCT I; Bilchick KC, 2002, AM J CARDIOL, V90, P24, DOI 10.1016/S0002-9149(02)02380-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; COOK JR, 1991, J AM COLL CARDIOL, V17, P480, DOI 10.1016/S0735-1097(10)80119-6; Correa FR, 2013, INT J SPORTS MED, V34, P111, DOI 10.1055/s-0032-1321888; Correa FR, 2012, J RESP CARDIOV PHY T, V1, P37; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c; Porto LGG, 2009, PACE, V32, P43, DOI 10.1111/j.1540-8159.2009.02175.x; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; Heart rate variability: standards of measurement physiological interpretation and clinical use, 1996, AQUACULTURE, V93, P1043, DOI [10.1111/j.1542-474X.1996.tb00275.x, DOI 10.1161/STR.0b013e3182587839]; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Jiang W, 1997, AM J CARDIOL, V80, P808, DOI 10.1016/S0002-9149(97)00526-2; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lucreziotti S, 2000, AM HEART J, V139, P1088, DOI 10.1067/mhj.2000.106168; Malfatto G, 1998, AM J CARDIOL, V81, P834, DOI 10.1016/S0002-9149(98)00021-6; NIEMELA MJ, 1994, J AM COLL CARDIOL, V23, P1370, DOI 10.1016/0735-1097(94)90379-4; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Nunan D, 2008, EUR J APPL PHYSIOL, V103, P529, DOI 10.1007/s00421-008-0742-6; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Ponikowski P, 1996, CLIN SCI, V91, P391, DOI 10.1042/cs0910391; Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7; Caruso FCR, 2011, DISABIL REHABIL, V33, P751, DOI 10.3109/09638288.2010.511420; Sandercock GRH, 2004, PHYSIOL MEAS, V25, P1115, DOI 10.1088/0967-3334/25/5/003; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Shah SA, 2013, AM J CARDIOL, V112, P533, DOI 10.1016/j.amjcard.2013.04.018; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039; VANHOOGENHUYZE D, 1991, AM J CARDIOL, V68, P1668, DOI 10.1016/0002-9149(91)90327-H; Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Wu G, 2003, AM HEART J, V146, P129, DOI 10.1016/S0002-8703(03)00119-4	38	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167407	10.1371/journal.pone.0167407	http://dx.doi.org/10.1371/journal.pone.0167407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936043	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100092
J	Huang, YW; Zhang, YT; Li, K; Zhao, J				Huang, Yuanwei; Zhang, Yanting; Li, Ke; Zhao, Jin			Changes in Prevalence of HIV or Syphilis among Male Sex Workers and Non-Commercial Men Who Have Sex with Men in Shenzhen, China: Results of a Second Survey	PLOS ONE			English	Article							RISK-FACTORS; MONEY BOYS; INFECTION; BEHAVIORS	Background A previous time-location sampling survey (TLS) was performed in 2008 to evaluate the HIV or syphilis infection rate among male sex workers (MSWs) and non-commercial men who have sex with men (ncMSM) in Shenzhen, China. This is a second TLS performed in 2014. This article describes the findings and changes in the prevalence of HIV and syphilis. Methods TLS was used to collect information as a second cross-sectional survey to an earlier TLS assessment. Data on behavior (e.g., sexual history and sexual behavior) were analyzed. Blood specimens were drawn for HIV and syphilis testing. To determine the changes in the prevalence of HIV and syphilis, we analyzed these results and compared them to the results of our first survey. Results A total of 965 participants were recruited, including 489 MSWs and 476 ncMSM. Overall, the prevalence of HIV was 9.7%: 2.9% for MSWs and 16.8% for ncMSM (P<0.001). 10.9% of the 965 participants tested positive for syphilis: 4.5% among MSWs and 17.4% among ncMSM (P<0.001). The HIV prevalence in MSWs decreased from 4.5% in 2008 to 2.9% in 2014 (P = 0.143) but increased in ncMSM (7.0% in 2008 vs 16.8% in 2014, P<0.001). Decreased syphilis rates were observed in both MSWs (12.9% in 2008 vs 4.5% in 2014, P<0.001) and ncMSM (20.2% in 2008 vs 17.4% in 2014, P = 0.221). Conclusions Overall, there was a decline in the prevalence of HIV and syphilis in MSWs but not in ncMSM. The study indicated the need for continued efforts to improve public health, particularly to counter the rising rate of HIV in ncMSM.	[Huang, Yuanwei; Zhang, Yanting; Li, Ke] Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Zhao, Jin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China	Shantou University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Li, K (corresponding author), Shantou Univ, Coll Med, Dept Prevent Med, Shantou, Guangdong, Peoples R China.; Zhao, J (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China.	keli1122@126.com; szhaojin@gmail.com			National Natural Science Foundation of China [81573211, 81270043]; National Natural Science Foundation of Guangdong Province [2014A030313772]; Shenzhen Technology and Research Fund [JCYJ20140410171018515, JCYJ20140416104959068]; Medical Key Laboratory of Shenzhen	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Technology and Research Fund; Medical Key Laboratory of Shenzhen	This work was supported in part by grants from the National Natural Science Foundation of China (81573211 and 81270043), the National Natural Science Foundation of Guangdong Province (2014A030313772), Shenzhen Technology and Research Fund (JCYJ20140410171018515 and JCYJ20140416104959068) and the Medical Key Laboratory of Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18848; Cai WD, 2010, SEX TRANSM INFECT, V86, P15, DOI 10.1136/sti.2009.037440; Chen L, 2016, JAIDS-J ACQ IMM DEF, V71, P316, DOI 10.1097/QAI.0000000000000833; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cui Y, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20609; Ghanem Khalil G, 2010, Curr Infect Dis Rep, V12, P140, DOI 10.1007/s11908-010-0083-6; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Huan XP, 2015, ASIA-PAC J PUBLIC HE, V27, pNP854, DOI 10.1177/1010539513480230; Huang Qin, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1297; Liu SS, 2012, AIDS BEHAV, V16, P835, DOI 10.1007/s10461-011-9978-y; Meng XD, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-17; Shi Tong-Xin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P668; Shimelis T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0919-7; Stevenson J, 2006, DERMATOL CLIN, V24, P497, DOI 10.1016/j.det.2006.06.013; Tang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126604; Tun W, 2008, SEX TRANSM INFECT, V84, P455, DOI 10.1136/sti.2008.031336; Wu Z., 2010, 2010 2 INT C FUT COM, V2; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zhao J, 2015, ARCH SEX BEHAV, V44, P2055, DOI 10.1007/s10508-014-0350-y; Zhao J, 2012, SEX TRANSM DIS, V39, P942, DOI 10.1097/OLQ.0b013e31826f356f; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9	22	3	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167619	10.1371/journal.pone.0167619	http://dx.doi.org/10.1371/journal.pone.0167619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935980	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100132
J	Miller, R; Jelbert, SA; Taylor, AH; Cheke, LG; Gray, RD; Loissel, E; Clayton, NS				Miller, Rachael; Jelbert, Sarah A.; Taylor, Alex H.; Cheke, Lucy G.; Gray, Russell D.; Loissel, Elsa; Clayton, Nicola S.			Performance in Object-Choice Aesop's Fable Tasks Are Influenced by Object Biases in New Caledonian Crows but not in Human Children	PLOS ONE			English	Article							CONVERGENT EVOLUTION; CORVUS-MONEDULOIDES; COGNITION; CORVIDS	The ability to reason about causality underlies key aspects of human cognition, but the extent to which non-humans understand causality is still largely unknown. The Aesop's Fable paradigm, where objects are inserted into water-filled tubes to obtain out-of-reach rewards, has been used to test casual reasoning in birds and children. However, success on these tasks may be influenced by other factors, specifically, object preferences present prior to testing or arising during pre-test stone-dropping training. Here, we assessed this 'objectbias' hypothesis by giving New Caledonian crows and 5-10 year old children two objectchoice Aesop's Fable experiments: sinking vs. floating objects, and solid vs. hollow objects. Before each test, we assessed subjects' object preferences and/or trained them to prefer the alternative object. Both crows and children showed pre-test object preferences, suggesting that birds in previous Aesop's Fable studies may also have had initial preferences for objects that proved to be functional on test. After training to prefer the non-functional object, crows, but not children, performed more poorly on these two object-choice Aesop's Fable tasks than subjects in previous studies. Crows dropped the non-functional objects into the tube on their first trials, indicating that, unlike many children, they do not appear to have an a priori understanding of water displacement. Alternatively, issues with inhibition could explain their performance. The crows did, however, learn to solve the tasks over time. We tested crows further to determine whether their eventual success was based on learning about the functional properties of the objects, or associating dropping the functional object with reward. Crows inserted significantly more rewarded, non-functional objects than non-rewarded, functional objects. These findings suggest that the ability of New Caledonian crows to produce performances rivaling those of young children on object-choice Aesop's Fable tasks is partly due to pre-existing object preferences.	[Miller, Rachael; Jelbert, Sarah A.; Cheke, Lucy G.; Loissel, Elsa; Clayton, Nicola S.] Univ Cambridge, Dept Psychol, Cambridge, England; [Taylor, Alex H.; Gray, Russell D.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Gray, Russell D.] Max Planck Gesell, Max Planck Inst Sci Human Hist, Jena, Germany	University of Cambridge; University of Auckland; Max Planck Society	Jelbert, SA (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	saj48@cam.ac.uk	Taylor, Alex H/D-6428-2012	Loissel, Elsa/0000-0002-1272-7448; Jelbert, Sarah/0000-0002-7503-0648; Cheke, Lucy/0000-0001-5588-7575; Clayton, Nicola/0000-0003-1835-423X; Miller (Harrison), Rachael/0000-0003-2996-9571	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC [3399933]; Rutherford Discovery Fellowship from the Royal Society of New Zealand	European Research Council under the European Union's Seventh Framework Programme (FP7) / ERC(European Research Council (ERC)); Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand)	This research was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC Grant Agreement No. 3399933, awarded to NSC (funding RM, SAJ, EL & NSC). AHT was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, DEV TIME COURSE HUMA; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Call J, 1999, CHILD DEV, V70, P381, DOI 10.1111/1467-8624.00028; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Cheke LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040574; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Clayton NS, 2015, Q J EXP PSYCHOL, V68, P209, DOI 10.1080/17470218.2014.943673; DENNETT DC, 1983, BEHAV BRAIN SCI, V6, P343, DOI 10.1017/S0140525X00016393; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hofmann MM, 2016, ANIM COGN; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jacobs IF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2504; Jelbert Sarah A, 2015, Commun Integr Biol, V8, pe1035846, DOI 10.1080/19420889.2015.1035846; Jelbert SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092895; Kabadayi C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160104; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Logan CJ, 2015, BIORXIV; Logan CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1707; Logan CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103049; Moll FW, 2015, CURR BIOL, V25, P2196, DOI 10.1016/j.cub.2015.07.013; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Silva FJ, 2005, LEARN BEHAV, V33, P47; Smirnova A, 2015, CURR BIOL, V25, P256, DOI 10.1016/j.cub.2014.11.063; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0796; Taylor AH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0837; Taylor AH, 2012, P NATL ACAD SCI USA, V109, P16389, DOI 10.1073/pnas.1208724109; Taylor AH, 2012, BEHAV BRAIN SCI, V35, P241, DOI 10.1017/S0140525X11001956; Taylor AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026887; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Veit L, 2015, P NATL ACAD SCI USA, V112, P15208, DOI 10.1073/pnas.1509760112; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Vonk J, 2015, CURR BIOL, V25, pR69, DOI 10.1016/j.cub.2014.12.001	37	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168056	10.1371/journal.pone.0168056	http://dx.doi.org/10.1371/journal.pone.0168056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936242	Green Published, gold			2022-12-26	WOS:000389587100265
J	Rane, TD; Armani, AM				Rane, Tushar D.; Armani, Andrea M.			Two-Photon Microscopy Analysis of Gold Nanoparticle Uptake in 3D Cell Spheroids	PLOS ONE			English	Article							NANORODS; CANCER; CYTOTOXICITY; THERAPY; TISSUE	Nanomaterials can be synthesized from a wide range of material systems in numerous morphologies, creating an extremely diverse portfolio. As result of this tunability, these materials are emerging as a new class of nanotherapeutics and imaging agents. One particularly interesting nanomaterial is the gold nanoparticle. Due to its inherent biocompatibility and tunable photothermal behavior, it has made a rapid transition from the lab setting to in vivo testing. In most nanotherapeutic applications, the efficacy of the agent is directly related to the target of interest. However, the optimization of the AuNP size and shape for efficacy in vitro, prior to testing in in vivo models of a disease, has been largely limited to two dimensional monolayers of cells. Two dimensional cell cultures are unable to reproduce conditions experienced by AuNP in the body. In this article, we systematically investigate the effect of different properties of AuNP on the penetration depth into 3D cell spheroids using two- photon microscopy. The 3D spheroids are formed from the HCT116 cell line, a colorectal carcinoma cell line. In addition to studying different sizes and shapes of AuNPs, we also study the effect of an oligo surface chemistry. There is a significant difference between AuNP uptake profiles in the 2D monolayers of cells as compared to the 3D cell spheroids. Additionally, the range of sizes and shapes studied here also exhibit marked differences in uptake penetration depth and efficacy. Finally, our results demonstrate that two- photon microscopy enables quantitative AuNP localization and concentration data to be obtained at the single spheroid level without fluorescent labeling of the AuNP, thus, providing a viable technique for large scale screening of AuNP properties in 3D cell spheroids as compared to tedious and time consuming techniques like electron microscopy.	[Rane, Tushar D.; Armani, Andrea M.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA	University of Southern California	Armani, AM (corresponding author), Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA.	armani@usc.edu	Armani, Andrea/X-7611-2019	Armani, Andrea/0000-0001-9890-5104	Office of Naval Research [N000141410374, N000141110910]	Office of Naval Research(Office of Naval Research)	This work was supported by the Office of Naval Research [N000141410374, N000141110910], http://www.onr.nayy.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Bae KH, 2011, MOL CELLS, V31, P295, DOI 10.1007/s10059-011-0051-5; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dykman LA, 2014, CHEM REV, V114, P1258, DOI 10.1021/cr300441a; Gao NY, 2014, J PHYS CHEM C, V118, P13904, DOI 10.1021/jp502038v; Giljohann DA, 2007, NANO LETT, V7, P3818, DOI 10.1021/nl072471q; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jain S, 2014, BR J RADIOL; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kim D, 2010, ACS NANO, V4, P3689, DOI 10.1021/nn901877h; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Scheinberg DA, 2010, NAT REV CLIN ONCOL, V7, P266, DOI 10.1038/nrclinonc.2010.38; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	22	34	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167548	10.1371/journal.pone.0167548	http://dx.doi.org/10.1371/journal.pone.0167548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936027	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100121
J	Shen, W; Kong, CX; Xue, Y; Liu, YQ; Cai, MH; Zhang, YX; Jiang, TY; Zhou, XS; Zhou, M				Shen, Wei; Kong, Chuixing; Xue, Ying; Liu, Yiqi; Cai, Menghao; Zhang, Yuanxing; Jiang, Tianyi; Zhou, Xiangshan; Zhou, Mian			Kinase Screening in Pichia pastoris Identified Promising Targets Involved in Cell Growth and Alcohol Oxidase 1 Promoter (P-AOX1) Regulation	PLOS ONE			English	Article							METHANOL UTILIZATION PATHWAY; YEAST HANSENULA-POLYMORPHA; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; PROTEIN EXPRESSION; CLONING; REPRESSION; GENE; GLUCOKINASE; HEXOKINASE	As one of the most commonly used eukaryotic recombinant protein expression systems, P. pastoris relies heavily on the AOX1 promoter (P-AOX1), which is strongly induced by methanol but strictly repressed by glycerol and glucose. However, the complicated signaling pathways involved in P-AOX1 regulation when supplemented with different carbon sources are poorly understood. Here we constructed a kinase deletion library in P. pastoris and identified 27 mutants which showed peculiar phenotypes in cell growth or PAOX1 regulation. We analyzed both annotations and possible functions of these 27 targets, and then focused on the MAP kinase Hog1. In order to locate its potential downstream components, we performed the phosphoproteome analysis on glycerol cultured WT and Delta hog1 strains and identified 157 differentially phosphorylated proteins. Our results identified important kinases involved in P. pastoris cell growth and P-AOX1 regulation, which could serve as valuable targets for further mechanistic studies.	[Shen, Wei; Kong, Chuixing; Xue, Ying; Liu, Yiqi; Cai, Menghao; Zhang, Yuanxing; Zhou, Xiangshan; Zhou, Mian] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Zhang, Yuanxing] SCICB, Shanghai, Peoples R China; [Jiang, Tianyi] Roche R&D Ctr China Ltd, Shanghai, Peoples R China	East China University of Science & Technology; Roche Holding	Zhou, XS; Zhou, M (corresponding author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.	xszhou@ecust.edu.cn; mianzhou@ecust.edu.cn			Chinese National High Technology Research and Development Program [2014AA093501]; National Natural Science Foundation of China [31600056]; National Special Fund for State Key Laboratory of Bioreactor [2060204]; Shanghai Pujiang Program [15PJ1401600]; Roche RD (China) Ltd	Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Fund for State Key Laboratory of Bioreactor; Shanghai Pujiang Program(Shanghai Pujiang Program); Roche RD (China) Ltd	This work was sponsored by Chinese National High Technology Research and Development Program (2014AA093501), National Natural Science Foundation of China (31600056), National Special Fund for State Key Laboratory of Bioreactor (2060204), and Shanghai Pujiang Program (15PJ1401600). Roche R&D (China) Ltd provided support in the form of salary for author [TJ], but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the "author contributions" section.	Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Corvey C, 2005, J BIOL CHEM, V280, P25323, DOI 10.1074/jbc.M503719200; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Houard S, 2002, BIOCHIMIE, V84, P1089, DOI 10.1016/S0300-9084(02)00011-1; Karp H, 2003, CURR GENET, V44, P268, DOI 10.1007/s00294-003-0448-6; KORCH C, 1991, MOL GEN GENET, V229, P96, DOI 10.1007/BF00264218; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; Laht S, 2002, GENE, V296, P195, DOI 10.1016/S0378-1119(02)00859-4; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Mizuno T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005491; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Okuzaki D, 1997, GENES CELLS, V2, P753, DOI 10.1046/j.1365-2443.1997.1590358.x; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; PAVLIK P, 1993, CURR GENET, V24, P21, DOI 10.1007/BF00324660; Piao HL, 2012, TRAFFIC, V13, P1522, DOI 10.1111/j.1600-0854.2012.01406.x; Polupanov AS, 2012, INT J BIOCHEM CELL B, V44, P1906, DOI 10.1016/j.biocel.2012.07.017; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Weinhandl K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-5; Zhang P, 2010, APPL ENVIRON MICROB, V76, P6108, DOI 10.1128/AEM.00607-10	26	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167766	10.1371/journal.pone.0167766	http://dx.doi.org/10.1371/journal.pone.0167766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936065	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100180
J	Singhi, D; Jain, A; Srivastava, P				Singhi, Divya; Jain, Aayushi; Srivastava, Preeti			Localization of Low Copy Number Plasmid pRC4 in Replicating Rod and Non-Replicating Cocci Cells of Rhodococcus erythropolis PR4	PLOS ONE			English	Article							ESCHERICHIA-COLI CHROMOSOME; MULTICOPY PLASMIDS; BACTERIAL PLASMIDS; BACILLUS-SUBTILIS; VIBRIO-CHOLERAE; SEGREGATION; TERMINUS; GENE; MECHANISMS; DIVISION	Rhodococcus are gram-positive bacteria, which can exist in two different shapes rod and cocci. A number of studies have been done in the past on replication and stability of small plasmids in this bacterium; however, there are no reports on spatial localization and segregation of these plasmids. In the present study, a low copy number plasmid pDS3 containing pRC4 replicon was visualized in growing cells of Rhodococcus erythropolis PR4 (NBRC100887) using P1 parS-ParB-GFP system. Cells were initially cocci and then became rod shaped in exponential phase. Cocci cells were found to be non-replicating as evident by the presence of single fluorescence focus corresponding to the plasmid and diffuse fluorescence of DnaB-GFP. Rod shaped cells contained plasmid either present as one fluorescent focus observed at the cell center or two foci localized at quarter positions. The results suggest that the plasmid is replicated at the cell center and then it goes to quarter position. In order to observe the localization of plasmid with respect to nucleoid, plasmid segregation was also studied in filaments where it was found to be replicated at the cell center in a nucleoid free region. To the best of our knowledge, this is the first report on segregation of small plasmids in R. erythropolis.	[Singhi, Divya; Jain, Aayushi; Srivastava, Preeti] Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Srivastava, P (corresponding author), Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India.	preetisrivastava@hotmail.com		Jain, Aayushi/0000-0002-9103-1923	Science and Enginering Research Board, Department of Science and Technology, India; Department of Science and Technology, Government of India	Science and Enginering Research Board, Department of Science and Technology, India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	Science and Enginering Research Board, Department of Science and Technology, India.; The authors would like to thank Dr. Dhruba Chattoraj, NCI, NIH for the kind gift of several plasmids and strains used in the present study, Dr. Shilpi Sharma, IIT Delhi for advices and Mr. Siddhant Malviya, IIT Delhi for help in the image analysis. Financial support from Department of Science and Technology, Government of India is gratefully acknowledged.	Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; CHANG S, 1987, J BACTERIOL, V169, P3952, DOI 10.1128/jb.169.9.3952-3962.1987; DABBS ER, 1990, PLASMID, V23, P242, DOI 10.1016/0147-619X(90)90056-I; FINNERTY WR, 1992, ANNU REV MICROBIOL, V46, P193, DOI 10.1146/annurev.mi.46.100192.001205; Gordon GS, 1997, CELL, V90, P1113, DOI 10.1016/S0092-8674(00)80377-3; Guynet Catherine, 2011, Mob Genet Elements, V1, P236; HASHIMOTO Y, 1992, J GEN MICROBIOL, V138, P1003, DOI 10.1099/00221287-138-5-1003; Hayashi H, 2014, BIOSCI BIOTECH BIOCH, V78, P510, DOI 10.1080/09168451.2014.890029; Ho TQ, 2002, EMBO J, V21, P1864, DOI 10.1093/emboj/21.7.1864; Knoppova M, 2007, CURR MICROBIOL, V55, P234, DOI 10.1007/s00284-007-0106-1; Larkin MJ, 1998, ANTON LEEUW INT J G, V74, P133, DOI 10.1023/A:1001776500413; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; MEACOCK PA, 1980, CELL, V20, P529, DOI 10.1016/0092-8674(80)90639-X; Million-Weaver S, 2014, PLASMID, V75, P27, DOI 10.1016/j.plasmid.2014.07.002; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Reyes-Lamothe R, 2014, NUCLEIC ACIDS RES, V42, P1042, DOI 10.1093/nar/gkt918; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shavandi M, 2009, BIORESOURCE TECHNOL, V100, P475, DOI 10.1016/j.biortech.2008.06.011; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Srivastava P, 2006, J BACTERIOL, V188, P1060, DOI 10.1128/JB.188.3.1060-1070.2006; Srivastava P, 2007, MOL MICROBIOL, V66, P1016, DOI 10.1111/j.1365-2958.2007.05973.x; Srivastava P, 2006, PLASMID, V56, P24, DOI 10.1016/j.plasmid.2006.01.003; Wang JD, 2004, J BACTERIOL, V186, P7084, DOI 10.1128/JB.186.21.7084-7090.2004; Wegrzyn K, 2013, MICROBIOL-SGM, V159, P1010, DOI 10.1099/mic.0.065490-0; Yao SY, 2007, J BACTERIOL, V189, P1946, DOI 10.1128/JB.01451-06	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166491	10.1371/journal.pone.0166491	http://dx.doi.org/10.1371/journal.pone.0166491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935968	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100030
J	Somalinga, V; Buhrman, G; Arun, A; Rose, RB; Grunden, AM				Somalinga, Vijayakumar; Buhrman, Greg; Arun, Ashikha; Rose, Robert B.; Grunden, Amy M.			A High-Resolution Crystal Structure of a Psychrohalophilic alpha-Carbonic Anhydrase from Photobacterium profundum Reveals a Unique Dimer Interface	PLOS ONE			English	Article								Bacterial alpha-carbonic anhydrases (alpha-CA) are zinc containing metalloenzymes that catalyze the rapid interconversion of CO2 to bicarbonate and a proton. We report the first crystal structure of a pyschrohalophilic alpha-CA from a deep-sea bacterium, Photobacterium profundum. Size exclusion chromatography of the purified P. profundum alpha-CA (PprCA) reveals that the protein is a heterogeneous mix of monomers and dimers. Furthermore, an "in-gel" carbonic anhydrase activity assay, also known as protonography, revealed two distinct bands corresponding to monomeric and dimeric forms of PprCA that are catalytically active. The crystal structure of PprCA was determined in its native form and reveals a highly conserved "knot-topology" that is characteristic of alpha-CA's. Similar to other bacterial alpha-CA's, PprCA also crystallized as a dimer. Furthermore, dimer interface analysis revealed the presence of a chloride ion (Cl-) in the interface which is unique to PprCA and has not been observed in any other alpha-CA's characterized so far. Molecular dynamics simulation and chloride ion occupancy analysis shows 100% occupancy for the Cl- ion in the dimer interface. Zinc coordinating triple histidine residues, substrate binding hydrophobic patch residues, and the hydrophilic proton wire residues are highly conserved in PprCA and are identical to other well-studied alpha-CA's.	[Somalinga, Vijayakumar; Arun, Ashikha; Grunden, Amy M.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Buhrman, Greg; Rose, Robert B.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Grunden, AM (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	amgrunde@ncsu.edu		Grunden, Amy/0000-0002-8025-753X	National Science Foundation [1332341]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (US) nsf.gov, Award number 1332341. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r; De Luca V, 2015, J ENZYM INHIB MED CH, V30, P277, DOI 10.3109/14756366.2014.917085; Di Fiore A, 2015, INT J MOL SCI, V16, P15456, DOI 10.3390/ijms160715456; Di Fiore A, 2013, ACTA CRYSTALLOGR D, V69, P1150, DOI 10.1107/S0907444913007208; Dosmic JF, 2010, BIOCHIM BIOPHYS ACTA, V1804, P326; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; James P, 2014, ACTA CRYSTALLOGR D, V70, P2607, DOI 10.1107/S1399004714016526; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richard SB, 2000, BIOCHEMISTRY-US, V39, P992, DOI 10.1021/bi991001a; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SULTEMEYER D, 1993, PHYSIOL PLANTARUM, V88, P179, DOI 10.1111/j.1399-3054.1993.tb01776.x; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; TSUZUKI M, 1989, AQUAT BOT, V34, P85, DOI 10.1016/0304-3770(89)90051-X; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054	17	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168022	10.1371/journal.pone.0168022	http://dx.doi.org/10.1371/journal.pone.0168022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936100	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100256
J	Tellevik, MG; Blomberg, B; Kommedal, O; Maselle, SY; Langeland, N; Moyo, SJ				Tellevik, Marit G.; Blomberg, Bjorn; Kommedal, Oyvind; Maselle, Samuel Y.; Langeland, Nina; Moyo, Sabrina J.			High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI; RISK-FACTORS; SUSCEPTIBILITY; COLONIZATION; SOUTH; BACTERIA; TRENDS	Background Faecal carriage of ESBL-producing bacteria is a potential risk for transmission and infection. Little is known about faecal carriage of antibiotic resistance in Tanzania. This study aimed to investigate the prevalence of faecal carriage of ESBL-producing Enterobacteriaceae and to identify risk factors for carriage among young children in Tanzania. Methodology/Principal Findings From August 2010 to July 2011, children below 2 years of age were recruited in Dar es Salaam, including healthy community children (n = 250) and children hospitalized due to diarrhoea (n = 250) or other diseases (n = 103). ChromID ESBL agar and ChromID CARBA SMART agar were used for screening. Antimicrobial susceptibility testing was performed by the disk diffusion method. ESBL genotypes were identified by Real-Time PCR and sequencing. The overall prevalence of ESBL carriage was 34.3% (207/603). The prevalence of ESBL carriage was significantly higher among hospitalized children (50.4%), compared to community children (11.6%; P < 0.001; OR = 7.75; 95% CI: 4.99-12.03). We found high prevalence of Multidrug-resistance (94%) among Escherichia coli and Klebsiella pneumoniae isolates. No resistance to carbapenems was detected. For the majority of isolates (94.7%) we detected a bla(CTX-M-15)-like gene. In addition, the plasmid mediated AmpC beta-lactamase CMY-2 was detected for the first time in Tanzania. ESBL prevalence was significantly higher among HIV positive (89.7%) than HIV negative (16.9%) children (P = 0.001; OR = 9.99; 95% CI: 2.52-39.57). Use of antibiotics during the past 14 days and age below 1 year was also associated with ESBL carriage. Conclusions/Significance We report a high rate of faecal carriage of ESBL-producing Enterobacteriaceae among children below 2 years of age in Tanzania, particularly those with HIV-infection. Resistance to a majority of the available antimicrobials commonly used for children in Tanzania leaves few treatment options for infections when caused by these bacteria.	[Tellevik, Marit G.; Blomberg, Bjorn; Langeland, Nina] Haukeland Hosp, Dept Med, Natl Ctr Trop Infect Dis, Bergen, Norway; [Blomberg, Bjorn; Langeland, Nina; Moyo, Sabrina J.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Kommedal, Oyvind] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Maselle, Samuel Y.; Moyo, Sabrina J.] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Muhimbili University of Health & Allied Sciences	Moyo, SJ (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Moyo, SJ (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania.	Sabrina.Moyo@uib.no	; Blomberg, Bjorn/B-9605-2015	Moyo, sabrina/0000-0003-4735-1513; Blomberg, Bjorn/0000-0001-5647-4297	University of Bergen, Norway; National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway	University of Bergen, Norway; National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway	This study was supported by the University of Bergen, Norway, and by the National Centre for Tropical Infectious Diseases, Haukeland University Hospital, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Blanc V, 2014, J ANTIMICROB CHEMOTH, V69, P1231, DOI 10.1093/jac/dkt519; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Boutet-Dubois A, 2013, EUR J CLIN MICROBIOL, V32, P1063, DOI 10.1007/s10096-013-1851-7; CLSI, C28A3 CLSI, V29th; Cornejo-Juarez P, 2016, SUPPORT CARE CANCER, V24, P253, DOI 10.1007/s00520-015-2772-z; Cotton MF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-40; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Desta K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161685; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Eibach D, 2016, INT J MED MICROBIOL, V306, P249, DOI 10.1016/j.ijmm.2016.05.006; Farra A, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.07.001; Hijazi SM, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0121-9; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Jean SS, 2016, INT J ANTIMICROB AG, V47, P328, DOI 10.1016/j.ijantimicag.2016.01.008; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Kommedal O, 2016, APMIS, V124, P603, DOI 10.1111/apm.12549; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Marbou WJ, 2016, J INFECT PU IN PRESS; Moore LSP, 2014, J ANTIMICROB CHEMOTH, V69, P3409, DOI 10.1093/jac/dku307; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Mshana SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1527-x; Nelson Edwin, 2014, BMC Res Notes, V7, P279, DOI 10.1186/1756-0500-7-279; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Stoesser N, 2015, J ANTIMICROB CHEMOTH, V70, P1893, DOI 10.1093/jac/dkv021; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Tischendorf J, 2016, AM J INFECT CONTROL, V44, P539, DOI 10.1016/j.ajic.2015.12.005; WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Health Organization, 2014, ANT RES GLOB REP SUR	33	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168024	10.1371/journal.pone.0168024	http://dx.doi.org/10.1371/journal.pone.0168024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936054	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100257
J	Xing, N; Guan, XX; An, B; Cui, BB; Wang, ZG; Wang, XY; Zhang, XJ; Du, Q; Zhao, XM; Huang, Y; Tong, DW				Xing, Na; Guan, Xiaoxiao; An, Bin; Cui, Beibei; Wang, Zengguo; Wang, Xiaoya; Zhang, Xiujuan; Du, Qian; Zhao, Xiaomin; Huang, Yong; Tong, Dewen			Ultrasensitive Detection of Porcine Epidemic Diarrhea Virus from Fecal Samples Using Functionalized Nanoparticles	PLOS ONE			English	Article							SWINE; PCR; ANTIBODIES; ROTAVIRUS; SERUM; PIGS; DNA	Porcine epidemic diarrhea virus (PEDV) is the main causative agent of porcine diarrhea, which has resulted in devastating damage to swine industry and become a perplexed global problem. PEDV infection causes lesions and clinical symptoms, and infected pigs often succumb to severe dehydration. If there is not a timely and effective method to control its infection, PEDV will spread rapidly across the whole swine farm. Therefore, preclinical identification of PEDV is of great significance for preventing the outbreak and spread of this disease. In this study, a functionalized nanoparticles-based PCR method (UNDP-PCR) specific for PEDV was developed through systematic optimization of functionalized magnetic beads and gold nanoparticles which were further used to specifically enrich viral RNA from the lysate of PEDV stool samples, forming a MMPs-RNA-AuNPs complex. Then, oligonucleotides specific for PEDV coated on AuNPs were eluted from the complex and were further amplified and characterized by PCR. The detection limitation of the established UNDP-PCR method for PEDV was 25 copies in per gram PEDV stool samples, which is 400-fold more sensitive than conventional RT-PCR for stool samples. The UNDP-PCR for PEDV exhibited reliable reproducibility and high specificity, no cross-reaction was observed with other porcine viruses. In 153 preclinical fecal samples, the positive detection rate of UNDP-PCR specific for PEDV (30.72%) was much higher than that of conventional RT-PCR (5.88%) and SYBR Green real-time RT-PCR. In a word, this study provided a RNA extraction and transcription free, rapid and economical method for preclinical PEDV infection, which showed higher sensitivity, specificity and reproducibility, and exhibited application potency for evaluating viral loads of preclinical samples.	[Xing, Na; Guan, Xiaoxiao; An, Bin; Cui, Beibei; Wang, Zengguo; Wang, Xiaoya; Zhang, Xiujuan; Du, Qian; Zhao, Xiaomin; Huang, Yong; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Huang, Y; Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	Yonghuang@nwsuaf.edu.cn; dwtong@nwsuaf.edu.cn	Huang, Yong/G-9365-2011; du, qian/GYJ-7090-2022		scientific and technological project in Shaanxi province [2015NY155]; innovation project of science and technology plan projects in Shaanxi province [2016KTCL02-13]; Key project of Shaanxi province science and technology innovation team [2013KCT-28]	scientific and technological project in Shaanxi province; innovation project of science and technology plan projects in Shaanxi province; Key project of Shaanxi province science and technology innovation team	This study was funded by grants from the scientific and technological project in Shaanxi province (Grant No. 2015NY155), the innovation project of science and technology plan projects in Shaanxi province (2016KTCL02-13), Key project of Shaanxi province science and technology innovation team (2013KCT-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144818; Ben Salem AN, 2010, J VIROL METHODS, V165, P283, DOI 10.1016/j.jviromet.2010.02.010; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Chen YP, 2015, ACS NANO, V9, P3184, DOI 10.1021/acsnano.5b00240; Ding L., 2011, CHIN J VET MED, V47, P9; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Ge FF, 2013, ARCH VIROL, V158, P2227, DOI 10.1007/s00705-013-1722-7; Gerber PF, 2015, METHODSX, V2, P368, DOI 10.1016/j.mex.2015.10.001; Gerber PF, 2014, VET J, V202, P33, DOI 10.1016/j.tvjl.2014.07.018; Gou HC, 2015, MOL CELL PROBE, V29, P48, DOI 10.1016/j.mcp.2014.11.004; Huang Y, 2013, AQ SCI TECH, V1, P1, DOI DOI 10.1016/J.VIRUSRES.2013.03.014; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141545; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097869; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kim YK, 2015, J VIROL METHODS, V225, P4, DOI 10.1016/j.jviromet.2015.08.024; Marthaler D, 2014, J VIROL METHODS, V209, P30, DOI 10.1016/j.jviromet.2014.08.018; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Ren XF, 2011, VIRUS GENES, V42, P229, DOI 10.1007/s11262-011-0570-3; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; Shi L HY, 2012, ACTA AGR BOREALI OCC, V21, P6; Song D, 2015, CLIN EXP VACCINE RES, V4, P166, DOI 10.7774/cevr.2015.4.2.166; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Wang LT, 2013, TROP ANIM HEALTH PRO, V45, P1087, DOI 10.1007/s11250-012-0329-4; Wang W, 2014, TALANTA, V128, P263, DOI 10.1016/j.talanta.2014.05.011; Wang Z. S., 2010, ANXIETY STRESS COPIN, V19, P1; Xu XG, 2012, J VIROL METHODS, V183, P69, DOI 10.1016/j.jviromet.2012.03.034; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Xu XR, 2008, ANTIVIR RES, V78, P188, DOI 10.1016/j.antiviral.2007.12.012; Yuan WZ, 2015, J VIROL METHODS, V220, P18, DOI 10.1016/j.jviromet.2015.04.008; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhao PD, 2014, J VIROL METHODS, V206, P150, DOI 10.1016/j.jviromet.2014.06.006; Zhou WG, 2016, VET MICROBIOL, V182, P75, DOI 10.1016/j.vetmic.2015.10.019	36	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167325	10.1371/journal.pone.0167325	http://dx.doi.org/10.1371/journal.pone.0167325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936019	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100085
J	Kerr, C; Szmacinski, H; Fisher, ML; Nance, B; Lakowicz, JR; Akbar, A; Keillor, JW; Wong, TL; Godoy-Ruiz, R; Toth, EA; Weber, DJ; Eckert, RL				Kerr, C.; Szmacinski, H.; Fisher, M. L.; Nance, B.; Lakowicz, J. R.; Akbar, A.; Keillor, J. W.; Wong, T. Lok; Godoy-Ruiz, R.; Toth, E. A.; Weber, D. J.; Eckert, R. L.			Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival	ONCOGENE			English	Article							TISSUE TRANSGLUTAMINASE; MESENCHYMAL TRANSITION; INHIBITORS; LOCALIZATION; POTENT; FRET; DIFFERENTIATION; EXPRESSION; MECHANISM; DOMAIN	Type 2 transglutaminase (TG2) is an important cancer stem cell survival protein that exists in open and closed conformations. The major intracellular form is the closed conformation that functions as a GTP-binding GTPase and is required for cancer stem cell survival. However, at a finite rate, TG2 transitions to an open conformation that exposes the transamidase catalytic site involved in protein-protein crosslinking. The activities are mutually exclusive, as the closed conformation has GTP binding/GTPase activity, and the open conformation transamidase activity. We recently showed that GTP binding, but not transamidase activity, is required for TG2-dependent cancer stem cell invasion, migration and tumour formation. However, we were surprised that transamidase sites-specific inhibitors reduce cancer stem cell survival. We now show that compounds NC9, VA4 and VA5, which react exclusively at the TG2 transamidase site, inhibit both transamidase and GTP-binding activities. Transamidase activity is inhibited by direct inhibitor binding at the transamidase site, and GTP binding is blocked because inhibitor interaction at the transamidase site locks the protein in the extended/open conformation to disorganize/inactivate the GTP binding/GTPase site. These findings suggest that transamidase site-specific inhibitors can inhibit GTP binding/signalling by driving a conformation change that disorganizes the TG2 GTP binding to reduce TG2-dependent signalling, and that drugs designed to target this site may be potent anti-cancer agents.	[Kerr, C.; Szmacinski, H.; Fisher, M. L.; Nance, B.; Lakowicz, J. R.; Toth, E. A.; Weber, D. J.; Eckert, R. L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108N Greene St, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, R. L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Toth, E. A.; Weber, D. J.; Eckert, R. L.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Wong, T. Lok; Toth, E. A.; Weber, D. J.] Inst Biosci & Biotechnol Res, Rockville, MD USA; [Wong, T. Lok; Toth, E. A.; Weber, D. J.] Ctr Biomol Therapeut, Rockville, MD USA; [Akbar, A.; Keillor, J. W.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Ottawa	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Godoy Ruiz, Raquel/GOH-1617-2022	GODOY-RUIZ, RAQUEL/0000-0003-4569-0781; Nance, Bailey/0000-0002-2617-651X	National Institutes of Health [R01-CA184027, R01-CA131074]; NATIONAL CANCER INSTITUTE [R01CA184027, R01CA131074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R01-CA184027 and R01-CA131074 to Richard Eckert.	Adhikary G, 2015, CARCINOGENESIS, V36, P800, DOI 10.1093/carcin/bgv064; Adhikary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084324; Agnihotri N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3371; Badarau E, 2013, AMINO ACIDS, V44, P119, DOI 10.1007/s00726-011-1188-4; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; BERGAMINI CM, 1988, FEBS LETT, V239, P255, DOI 10.1016/0014-5793(88)80928-1; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cariati M, 2008, HISTOPATHOLOGY, V52, P99, DOI 10.1111/j.1365-2559.2007.02895.x; Caron NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044159; Chen Y, 2003, DIFFERENTIATION, V71, P528, DOI 10.1111/j.1432-0436.2003.07109007.x; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Clouthier CM, 2012, ANGEW CHEM INT EDIT, V51, P12464, DOI 10.1002/anie.201205575; Eckert RL, 2015, MOL CARCINOGEN, V54, P947, DOI 10.1002/mc.22375; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Eckert RL, 2009, AMINO ACIDS, V36, P739, DOI 10.1007/s00726-008-0123-9; Fisher ML, 2015, ONCOTARGET, V6, P20525, DOI 10.18632/oncotarget.3890; Fisher ML, 2015, MOL CANCER RES, V13, P1083, DOI 10.1158/1541-7786.MCR-14-0685-T; Fu J, 2013, NEURO-ONCOLOGY, V15, P1353, DOI 10.1093/neuonc/not079; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Keillor JW, 2014, BIOORG CHEM, V57, P186, DOI 10.1016/j.bioorg.2014.06.003; Keillor Jeffrey W, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P415; Kiraly R, 2009, FEBS J, V276, P7083, DOI 10.1111/j.1742-4658.2009.07420.x; Kumar A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3085; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; LAKOWICZ JR, 1992, ANAL BIOCHEM, V202, P316, DOI 10.1016/0003-2697(92)90112-K; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mehta K, 2009, AMINO ACIDS, V36, P709, DOI 10.1007/s00726-008-0128-4; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x; Pardin C, 2009, BIOCHEMISTRY-US, V48, P3346, DOI 10.1021/bi802021c; Pavlyukov MS, 2012, BIOCHEM BIOPH RES CO, V421, P773, DOI 10.1016/j.bbrc.2012.04.082; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Prime ME, 2012, J MED CHEM, V55, P1021, DOI 10.1021/jm201310y; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048	55	30	30	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 25	2017	36	21					2981	2990		10.1038/onc.2016.452	http://dx.doi.org/10.1038/onc.2016.452			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV7ZP	27941875	Green Accepted			2022-12-26	WOS:000402000400006
J	Choi, YM; Kim, KB; Lee, JH; Chun, YK; An, IS; An, S; Bae, S				Choi, Y. M.; Kim, K. B.; Lee, J. H.; Chun, Y. K.; An, I. S.; An, S.; Bae, S.			DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer	ONCOGENE			English	Article							RNA-BINDING PROTEIN; PROMOTER METHYLATION; MYELOID-LEUKEMIA; RHOBTB2 DBC2; HEPATOCELLULAR-CARCINOMA; LIGASE COMPLEXES; DNA METHYLATION; BLADDER-CANCER; BTB PROTEINS; E3 LIGASE	The gene encoding 'deleted in breast cancer 2' (DBC2), also referred to as RHOBTB2 (Rho-related BTB domain-containing protein 2), is classified as a tumor suppressor gene. DBC2 is a substrate-specific adaptor protein for a novel class of Cullin-3 (CUL3)-based E3 ubiquitin ligases; however, it is unclear if the substrate adaptor function of DBC2 is required for its tumor suppressor activity. Furthermore, the key substrates of DBC2-mediated ubiquitination have yet to be identified. In the present study, we established a genome-wide human cDNA library-based in vitro ubiquitination target screening assay and identified Musashi-2 (MSI2) as a novel ubiquitination target protein of DBC2. MSI2 directly interacted with DBC2, and this interaction promoted MSI2 polyubiquitination and proteasomal degradation in breast cancer cells. Overexpression and knockdown experiments demonstrated that DBC2 suppressed MSI2-associated oncogenic functions and induced apoptosis. Immunohistochemistry analysis of a breast cancer tissue microarray revealed that DBC2 and MSI2 protein levels are inversely correlated in both normal breast tissues and breast cancer tissues. Taken together, these findings provide evidence that DBC2 suppresses tumorigenesis in breast cancer by ubiquitinating MSI2.	[Choi, Y. M.; An, S.; Bae, S.] Konkuk Univ, KU Ctr Integrated Sci & Technol, 120 Neungdong Ro, Seoul 05029, South Korea; [Choi, Y. M.; Kim, K. B.; An, I. S.] Korea Inst Dermatol Sci, 2nd Enterprise Res Bldg, Seoul, Chungcheongbuk, South Korea; [Lee, J. H.] Dankook Univ, Lab Mol Oncol, Coll Med, Cheil Gen Hosp, Seoul, South Korea; [Lee, J. H.; Chun, Y. K.] Dankook Univ, Womens Healthcare Ctr, Coll Med, Seoul, South Korea; [Chun, Y. K.] Dankook Univ, Coll Med, Cheil Gen Hosp, Dept Pathol, Seoul, South Korea	Konkuk University; Dankook University; Dankook University; Dankook University	Bae, S (corresponding author), Konkuk Univ, KU Ctr Integrated Sci & Technol, 120 Neungdong Ro, Seoul 05029, South Korea.	sbae@konkuk.ac.kr			KU Research Professor Program of Konkuk University; National Research Foundation of Korea (NRF) from the Ministry of Science, ICT and Future Planning [20110028646, 2013R1A1A1012205]	KU Research Professor Program of Konkuk University; National Research Foundation of Korea (NRF) from the Ministry of Science, ICT and Future Planning	We thank all the members of our research group for their support and advice during this study. This work was supported by the KU Research Professor Program of Konkuk University (to SB) and National Research Foundation of Korea (NRF) grants from the Ministry of Science, ICT and Future Planning (Grant 20110028646 to SA and Grant 2013R1A1A1012205 to SB).	Bae S, 2008, INT J MOL MED, V21, P381; Bae SH, 2012, CELL RES, V22, P873, DOI 10.1038/cr.2012.38; Barbouti A, 2003, CANCER RES, V63, P1202; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Cho YG, 2008, ACTA ONCOL, V47, P366, DOI 10.1080/02841860701644094; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; Dong W, 2012, ASIAN PAC J CANCER P, V13, P2021, DOI 10.7314/APJCP.2012.13.5.2021; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; Freeman SN, 2010, CANCER BIOL THER, V10, P1123, DOI 10.4161/cbt.10.11.13786; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gao C, 2015, INT J ONCOL, V46, P732, DOI 10.3892/ijo.2014.2749; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Han LL, 2013, BIOTECHNOL LETT, V35, P1175, DOI 10.1007/s10529-013-1190-x; Han YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136484; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jin Z, 2013, CANCER BIOTHER RADIO, V28, P709, DOI 10.1089/cbr.2012.1386; Jung JH, 2011, CELL DEATH DIFFER, V18, P1865, DOI 10.1038/cdd.2011.57; Kagara N, 2012, AM J PATHOL, V181, P257, DOI 10.1016/j.ajpath.2012.03.019; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Manjarrez JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090054; Mao HT, 2011, GENE, V486, P74, DOI 10.1016/j.gene.2011.07.018; Mao HT, 2010, MOL CARCINOGEN, V49, P283, DOI 10.1002/mc.20598; Nikpour P, 2011, J CELL MOL MED, V15, P1210, DOI 10.1111/j.1582-4934.2010.01090.x; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Shi Y, 2008, UROL ONCOL-SEMIN ORI, V26, P465, DOI 10.1016/j.urolonc.2007.08.009; Shilpa V, 2014, INDIAN J MED RES, V140, P616; Taggart J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10739; Tang WW, 2014, INT J MOL MED, V33, P722, DOI 10.3892/ijmm.2013.1593; Thol F, 2013, ANN HEMATOL, V92, P315, DOI 10.1007/s00277-012-1637-5; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Wang MH, 2015, AM J CANCER RES, V5, P1089; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang HJ, 2014, EXP CELL RES, V320, P119, DOI 10.1016/j.yexcr.2013.09.009; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zmetakova I, 2013, NEOPLASMA, V60, P635, DOI 10.4149/neo_2013_082; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	52	17	20	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 18	2017	36	20					2802	2812		10.1038/onc.2016.441	http://dx.doi.org/10.1038/onc.2016.441			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EV3ZM	27941885	hybrid, Green Published			2022-12-26	WOS:000401697800003
J	Mathieu, C; Bui, LC; Petit, E; Haddad, I; Agbulut, O; Vinh, J; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; Bui, Linh-Chi; Petit, Emile; Haddad, Iman; Agbulut, Onnik; Vinh, Joelle; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Molecular Mechanisms of Allosteric Inhibition of Brain Glycogen Phosphorylase by Neurotoxic Dithiocarbamate Chemicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; carbohydrate metabolism; disulfide; glycogen; glycogen storage disease; Parkinson disease; toxicology	ETHYLENE-BIS-DITHIOCARBAMATE; ALDEHYDE DEHYDROGENASE; GLUCOSE-METABOLISM; CHRONIC EXPOSURE; FUNGICIDE MANEB; DISULFIRAM; RAT; DISEASE; DIETHYLDITHIOCARBAMATE; IDENTIFICATION	Dithiocarbamates (DTCs) are important industrial chemicals used extensively as pesticides and in a variety of therapeutic applications. However, they have also been associated with neurotoxic effects and in particular with the development of Parkinson-like neuropathy. Although different pathways and enzymes (such as ubiquitin ligases or the proteasome) have been identified as potential targets of DTCs in the brain, the molecular mechanisms underlying their neurotoxicity remain poorly understood. There is increasing evidence that alteration of glycogen metabolism in the brain contributes to neurodegenerative processes. Interestingly, recent studies with N,N-diethyldithiocarbamate suggest that brain glycogen phosphorylase (bGP) and glycogen metabolism could be altered by DTCs. Here, we provide molecular and mechanistic evidence that bGP is a target of DTCs. To examine this system, we first tested thiram, a DTC pesticide known to display neurotoxic effects, observing that it can react rapidly with bGP and readily inhibits its glycogenolytic activity (k(inact) = 1.4 x 10(5)m(-1) s(-1)). Using cysteine chemical labeling, mass spectrometry, and site-directed mutagenesis approaches, we show that thiram (and certain of its metabolites) alters the activity of bGP through the formation of an intramolecular disulfide bond (Cys(318)-Cys(326)), known to act as a redox switch that precludes the allosteric activation of bGP by AMP. Given the key role of glycogen metabolism in brain functions and neurodegeneration, impairment of the glycogenolytic activity of bGP by DTCs such as thiram may be a new mechanism by which certain DTCs exert their neurotoxic effects.	[Mathieu, Cecile; Bui, Linh-Chi; Petit, Emile; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, CNRS, UMR 8251, Sorbonne Paris Cite,Unite BFA, F-75013 Paris, France; [Haddad, Iman] Univ Paris Sci & Lettres, CNRS, USR,ESPCI ParisTech, Lab Spectrometrie Masse Biol & Prote, F-3149 Paris, France; [Agbulut, Onnik] UPMC Univ Paris 06, Sorbonne Univ,Inst Biol Paris Seine, CNRS, UMR 8256,Biol Adaptat & Ageing, F-75005 Paris, France; [Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, CNRS, UMR 8251, Sorbonne Paris Cite,Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Agbulut, Onnik/0000-0003-1923-8871	University Paris Diderot; University Paris Diderot (Ecole Doctorale BioSPC); CNRS	University Paris Diderot; University Paris Diderot (Ecole Doctorale BioSPC); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by University Paris Diderot, CNRS, and a Ph.D. fellowship from University Paris Diderot (Ecole Doctorale BioSPC; to C.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amici M, 2002, J BIOL INORG CHEM, V7, P750, DOI 10.1007/s00775-002-0352-4; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Domico LM, 2007, NEUROTOXICOLOGY, V28, P1079, DOI 10.1016/j.neuro.2007.04.008; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; FERRAZ HB, 1988, NEUROLOGY, V38, P550, DOI 10.1212/WNL.38.4.550; GERTZ HJ, 1985, MECH AGEING DEV, V31, P25, DOI 10.1016/0047-6374(85)90024-7; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; IQBAL J, 1991, FREE RADICAL BIO MED, V10, P69, DOI 10.1016/0891-5849(91)90023-V; Kona FR, 2011, CURR CANCER DRUG TAR, V11, P338; MADAN A, 1995, DRUG METAB DISPOS, V23, P1153; Madan A, 1998, ALCOHOL CLIN EXP RES, V22, P1212, DOI 10.1111/j.1530-0277.1998.tb03901.x; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; Malka F, 2009, FEBS J, V276, P4900, DOI 10.1111/j.1742-4658.2009.07189.x; Mathieu C, 2016, J BIOL CHEM, V291, P23842, DOI 10.1074/jbc.M116.757062; Mathieu C, 2016, J BIOL CHEM, V291, P18072, DOI 10.1074/jbc.M116.738898; Mathieu C, 2015, EXPERT OPIN DRUG MET, V11, P81, DOI 10.1517/17425255.2015.975691; MECO G, 1994, SCAND J WORK ENV HEA, V20, P301, DOI 10.5271/sjweh.1394; MILLER DB, 1982, NEUROBEH TOXICOL TER, V4, P779; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; de la Cruz VP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/494316; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Pratt-Hyatt M, 2010, DRUG METAB DISPOS, V38, P2286, DOI 10.1124/dmd.110.034710; Rahman MA, 1997, PHARMACOL BIOCHEM BE, V56, P409, DOI 10.1016/S0091-3057(96)00222-5; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sato N, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3339/fnagi.2015,00199, 10.3389/fnagi.2015.00199]; Shen ML, 2000, BIOCHEM PHARMACOL, V60, P947, DOI 10.1016/S0006-2952(00)00435-4; Sickmann HM, 2012, NEUROCHEM INT, V60, P267, DOI 10.1016/j.neuint.2011.12.019; Sook Han M, 2003, NEUROTOXICOLOGY, V24, P425; STROMME JH, 1963, BIOCHEM PHARMACOL, V12, P705, DOI 10.1016/0006-2952(63)90046-7; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Vaccari A, 1999, J PHARMACOL EXP THER, V288, P1; Veverka KA, 1997, BIOCHEM PHARMACOL, V53, P511, DOI 10.1016/S0006-2952(96)00767-8; Viquez OM, 2012, CHEM RES TOXICOL, V25, P2310, DOI 10.1021/tx300198h; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472	46	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1603	1612		10.1074/jbc.M116.766725	http://dx.doi.org/10.1074/jbc.M116.766725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965358	Green Published, hybrid			2022-12-26	WOS:000395515600006
J	Vitrac, H; MacLean, DM; Karlstaedt, A; Taegtmeyer, H; Jayaraman, V; Bogdanov, M; Dowhan, W				Vitrac, Heidi; MacLean, David M.; Karlstaedt, Anja; Taegtmeyer, Heinrich; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William			Dynamic Lipid-dependent Modulation of Protein Topology by Post-translational Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); glycerophospholipid; lipid-protein interaction; membrane protein; phosphorylation; post-translational modification (PTM)	POLYTOPIC MEMBRANE-PROTEIN; ESCHERICHIA-COLI; LACTOSE PERMEASE; DUAL-TOPOLOGY; TRANSMEMBRANE SEGMENTS; TOPOGENIC SIGNALS; ORIENTATION; DETERMINANTS; CHOLESTEROL; INSERTION	Membrane protein topology and folding are governed by structural principles and topogenic signals that are recognized and decoded by the protein insertion and translocation machineries at the time of initial membrane insertion and folding. We previously demonstrated that the lipid environment is also a determinant of initial protein topology, which is dynamically responsive to post-assembly changes in membrane lipid composition. However, the effect on protein topology of post-assembly phosphorylation of amino acids localized within initially cytoplasmically oriented extramembrane domains has never been investigated. Here, we show in a controlled in vitro system that phosphorylation of a membrane protein can trigger a change in topological arrangement. The rate of change occurred on a scale of seconds, comparable with the rates observed upon changes in the protein lipid environment. The rate and extent of topological rearrangement were dependent on the charges of extramembrane domains and the lipid bilayer surface. Using model membranes mimicking the lipid compositions of eukaryotic organelles, we determined that anionic lipids, cholesterol, sphingomyelin, and membrane fluidity play critical roles in these processes. Our results demonstrate how post-translational modifications may influence membrane protein topology in a lipid-dependent manner, both along the organelle trafficking pathway and at their final destination. The results provide further evidence that membrane protein topology is dynamic, integrating for the first time the effect of changes in lipid composition and regulators of cellular processes. The discovery of a new topology regulatory mechanism opens additional avenues for understanding unexplored structure-function relationships and the development of optimized topology prediction tools.	[Vitrac, Heidi; MacLean, David M.; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6 200, Houston, TX 77030 USA; [Vitrac, Heidi; MacLean, David M.; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, McGovern Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA; [Karlstaedt, Anja; Taegtmeyer, Heinrich] Univ Texas Houston, McGovern Med Sch, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Vitrac, H; Dowhan, W (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6 200, Houston, TX 77030 USA.	Heidi.Vitrac@uth.tmc.edu; william.dowhan@uth.tmc.edu	Karlstaedt, Anja/N-6557-2019; Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Karlstaedt, Anja/0000-0001-5689-3571; Vitrac, Heidi/0000-0002-8858-4914; MacLean, David/0000-0001-8294-6075	National Institutes of Health [R37 GM 20478, K99 NS 094761, R01 GM 113212, R01 GM 094246-04, R01 HL 61483]; Roderick MacDonald Research Fund; John Dunn Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM113212, R01GM094246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS094761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roderick MacDonald Research Fund; John Dunn Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R37 GM 20478 (to W.D.), K99 NS 094761 (to D.M.M.), R01 GM 113212 and R01 GM 094246-04 (to V.J.), and R01 HL 61483 (to H.T.), the Roderick MacDonald Research Fund (to A.K.), and the John Dunn Research Foundation (to W.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Binder WH, 2003, ANGEW CHEM INT EDIT, V42, P5802, DOI 10.1002/anie.200300586; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655; Bowie JU, 2005, NATURE, V433, P367, DOI 10.1038/433367a; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Herate C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145617; Hickey KD, 2011, J LIPIDS, V2011, DOI 10.1155/2011/208457; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; KRISHTALIK LI, 1995, FEBS LETT, V369, P140, DOI 10.1016/0014-5793(95)00756-Y; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; LeBarron J, 2016, LANGMUIR, V32, P10752, DOI 10.1021/acs.langmuir.6b02597; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Monne M, 2005, FEBS J, V272, P28, DOI 10.1111/j.1432-1033.2004.04394.x; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; Prange R, 2004, J GEN VIROL, V85, P1221, DOI 10.1099/vir.0.19737-0; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Schlebach JP, 2015, J MEMBRANE BIOL, V248, P371, DOI 10.1007/s00232-014-9726-0; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Serdiuk T, 2015, STRUCTURE, V23, P754, DOI 10.1016/j.str.2015.02.009; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stott BM, 2008, J LIPID RES, V49, P1202, DOI 10.1194/jlr.M700479-JLR200; Su MG, 2014, NUCLEIC ACIDS RES, V42, pD537, DOI 10.1093/nar/gkt1221; Tsaousis GN, 2014, BBA-PROTEINS PROTEOM, V1844, P316, DOI 10.1016/j.bbapap.2013.11.001; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; White SH, 2005, BIOCHEM SOC T, V33, P1012, DOI 10.1042/BST0331012; WHITLEY P, 1994, NAT STRUCT BIOL, V1, P858, DOI 10.1038/nsb1294-858; Yamamoto H, 2012, BIOCHEMISTRY-US, V51, P3596, DOI 10.1021/bi2018915; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700	61	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1613	1624		10.1074/jbc.M116.765719	http://dx.doi.org/10.1074/jbc.M116.765719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974465	Green Published, hybrid			2022-12-26	WOS:000395515600007
J	Kim, HS; Williamson, EA; Nickoloff, JA; Hromas, RA; Lee, SH				Kim, Hyun-Suk; Williamson, Elizabeth A.; Nickoloff, Jac A.; Hromas, Robert A.; Lee, Suk-Hee			Metnase Mediates Loading of Exonuclease 1 onto Single Strand Overhang DNA for End Resection at Stalled Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PATHWAY CHOICE; HOMOLOGOUS RECOMBINATION; HUMAN-CELLS; GENOME INSTABILITY; BREAK REPAIR; BIOCHEMICAL-CHARACTERIZATION; MAMMALIAN-CELLS; NHEJ REPAIR; EXO1; RESTART	Stalling at DNA replication forks generates stretches of single- stranded (ss) DNA on both strands that are exposed to nucleolytic degradation, potentially compromising genome stability. One enzyme crucial for DNA replication fork repair and restart of stalled forks in human is Metnase (also known as SETMAR), a chimeric fusion protein consisting of a su(var) 3-9, enhancer-of-zeste and trithorax (SET) histone methylase and transposase nuclease domain. We previously showed that Metnase possesses a unique fork cleavage activity necessary for its function in replication restart and that its SET domain is essential for recovery from hydroxyurea-induced DNA damage. However, its exact role in replication restart is unclear. In this study, we show that Metnase associates with exonuclease 1 (Exo1), a 5' -exonuclease crucial for 5' -end resection to mediate DNA processing at stalled forks. Metnase DNA cleavage activity was not required for Exo1 5' -exonuclease activity on the lagging strand daughter DNA, but its DNA binding activity mediated loading of Exo1 onto ssDNA overhangs. Metnase-induced enhancement of Exo1-mediated DNA strand resection required the presence of these overhangs but did not require Metnase's DNA cleavage activity. These results suggest that Metnase enhances Exo1-mediated exonuclease activity on the lagging strand DNA by facilitating Exo1 loading onto a single strand gap at the stalled replication fork.	[Kim, Hyun-Suk; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Williamson, Elizabeth A.; Hromas, Robert A.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Williamson, Elizabeth A.; Hromas, Robert A.] Shands Hlth Care Syst, Gainesville, FL 32610 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Colorado State University	Lee, SH (corresponding author), Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iu.edu			National Institutes of Health [R01 CA151367, R01 GM084020, R01 CA139429]; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [R01CA151367, R01CA139429, R01CA205224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109645, R01GM084020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA151367 (to S.-H. L.), R01 GM084020 (to J. A. N. and R. A. H.), and R01 CA139429 (to R. A. H.) and by the Indiana University Simon Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; [Anonymous], 1980, BASIC LIFE SCI, V15, P1; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costes A, 2013, BIOMOLECULES, V3, P39, DOI 10.3390/biom3010039; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215; Kim HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139418; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Lambert S, 2013, CURR OPIN GENET DEV, V23, P132, DOI 10.1016/j.gde.2012.11.009; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Ngo GHP, 2014, NUCLEIC ACIDS RES, V42, P10516, DOI 10.1093/nar/gku746; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rass U, 2013, CHROMOSOMA, V122, P499, DOI 10.1007/s00412-013-0431-z; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721; Wu YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005675; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	67	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1414	1425		10.1074/jbc.M116.745646	http://dx.doi.org/10.1074/jbc.M116.745646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974460	Green Published, hybrid			2022-12-26	WOS:000393339800023
J	Yeasmin, AMST; Waliullah, TM; Kondo, A; Kaneko, A; Koike, N; Ushimaru, T				Yeasmin, Akter M. S. T.; Waliullah, Talukdar Muhammad; Kondo, Akihiro; Kaneko, Atsuki; Koike, Naoki; Ushimaru, Takashi			Orchestrated Action of PP2A Antagonizes Atg13 Phosphorylation and Promotes Autophagy after the Inactivation of TORC1	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; VACUOLE TARGETING PATHWAY; KINASE SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; REGULATES AUTOPHAGY; ALZHEIMERS-DISEASE; AMYLOID-BETA; OKADAIC ACID; CELL-GROWTH; YEAST	Target of rapamycin complex 1 (TORC1) phosphorylates autophagy-related Atg13 and represses autophagy under nutrient-rich conditions. However, when TORC1 becomes inactive upon nutrient depletion or treatment with the TORC1 inhibitor rapamycin, Atg13 dephosphorylation occurs rapidly, and autophagy is induced. At present, the phosphatases involved in Atg13 dephosphorylation remain unknown. Here, we show that two protein phosphatase 2A (PP2A) phosphatases, PP2A-Cdc55 and PP2A-Rts1, which are activated by inactivation of TORC1, are required for sufficient Atg13 dephosphorylation and autophagy induction after TORC1 inactivation in budding yeast. After rapamycin treatment, dephosphorylation of Atg13, activation of Atg1 kinase, pre-autophagosomal structure (PAS) formation and autophagy induction are all impaired in PP2A-deleted cells. Conversely, overexpression of non-phosphorylatable Atg13 suppressed defects in autophagy in PP2A mutant. This study revealed that the orchestrated action of PP2A antagonizes Atg13 phosphorylation and promotes autophagy after the inactivation of TORC1.	[Yeasmin, Akter M. S. T.; Waliullah, Talukdar Muhammad; Ushimaru, Takashi] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Kaneko, Atsuki; Koike, Naoki; Ushimaru, Takashi] Shizuoka Univ, Fac Sci, Suruga Ku, Shizuoka, Japan	Shizuoka University; Shizuoka University	Ushimaru, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan.; Ushimaru, T (corresponding author), Shizuoka Univ, Fac Sci, Suruga Ku, Shizuoka, Japan.	takashi.ushimaru@gmail.com	Talukdar, Muhammad Waliullah/O-5971-2016	Talukdar, Muhammad Waliullah/0000-0001-9951-2871; Akter, Mst Yeasmin/0000-0002-1246-617X	Ministry of Education, Science, Sports, and Culture of Japan [19370082, 23570225]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (No. 19370082 and 23570225).	Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; BLANKSON H, 1995, EXP CELL RES, V218, P522, DOI 10.1006/excr.1995.1187; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Evans DRH, 1997, GENETICS, V145, P227; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Magnaudeix A, 2013, NEUROBIOL AGING, V34, P770, DOI 10.1016/j.neurobiolaging.2012.06.026; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Samari HR, 2005, BIOCHEM J, V386, P237, DOI 10.1042/BJ20040609; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x; Zuzuarregui A, 2012, NAT METHODS, V9, P594, DOI [10.1038/NMETH.2017, 10.1038/nmeth.2017]	55	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166636	10.1371/journal.pone.0166636	http://dx.doi.org/10.1371/journal.pone.0166636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973551	Green Submitted, Green Published, gold			2022-12-26	WOS:000392754300010
J	Li, PZ; Ying, J; Yang, GJ; Li, AF; Wang, J; Lu, JW; Wang, JR; Xu, T; Yi, HG; Li, KW; Jin, SG; Bao, QY; Zhang, KB				Li, Peizhen; Ying, Jun; Yang, Guangjian; Li, Aifang; Wang, Jian; Lu, Junwan; Wang, Junrong; Xu, Teng; Yi, Huiguang; Li, Kewei; Jin, Shouguang; Bao, Qiyu; Zhang, Kaibo			Structure-Function Analysis of the Transmembrane Protein AmpG from Pseudomonas aeruginosa	PLOS ONE			English	Article							BETA-LACTAMASE INDUCTION; ESCHERICHIA-COLI; GENE; EXPRESSION; SEQUENCE; MUTATIONS; RELEASE; LEVEL; PCR	AmpG is a transmembrane protein with permease activity that transports meuropeptide from the periplasm to the cytoplasm, which is essential for the induction of the ampC encoding beta-lactamase. To obtain new insights into the relationship between AmpG structure and function, comparative genomics analysis, secondary and tertiary structure modeling, site-directed mutational analyses and genetic complementation experiments were performed in this study. AmpGs from different genera of bacteria (Escherichia coli, Vibrio cholerae and Acinetobacter baumannii) could complement AmpG function in Pseudomonas aeruginosa. The minimal inhibitory concentration (MIC) to ampicillin is 512 mu g/ml for wild type strain PAO1, while it is 32 mu g/ml for an ampG deletion mutant strain (PAO1 Delta ampG) with a corresponding decrease in the activity of the ampC-encoded beta-lactamase. Site-directed mutagenesis of conserved AmpG residues (G29, A129, Q131 and A197) resulted in a loss of function, resulting in a loss of resistance to ampicillin in PAO1 Delta ampG. The G29A, G29V, A129T, A129V, A129D, A197S and A197D mutants had lower resistance to ampicillin and significantly decreased activity of the AmpC beta-lactamase. The G29A, G29V, A129V, A197S and A197D mutants had decreased ampG mRNA transcript levels. The A129T and A129D mutants had normal ampG mRNA transcript levels, but the function of the protein was drastically reduced. Our experimental results demonstrate that the conserved amino acids played essential roles in maintaining the function of AmpG. Combined with the AmpG structural information, these critical amino acids can be targeted for the development of new anti-bacterial agents.	[Li, Peizhen; Ying, Jun; Yang, Guangjian; Li, Aifang; Wang, Jian; Xu, Teng; Yi, Huiguang; Li, Kewei; Bao, Qiyu; Zhang, Kaibo] Wenzhou Med Univ, Sch Lab Med & Life Sci, Inst Biomed Informat, Wenzhou, Peoples R China; [Lu, Junwan; Zhang, Kaibo] Lishui Coll, Sch Med, Lishui, Peoples R China; [Wang, Junrong] Wenling Womens & Childrens Hosp, Wenling, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Wenzhou Medical University; Lishui University; State University System of Florida; University of Florida	Bao, QY; Zhang, KB (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Inst Biomed Informat, Wenzhou, Peoples R China.; Zhang, KB (corresponding author), Lishui Coll, Sch Med, Lishui, Peoples R China.	baoqy@genomics.cn; 893286261@qq.com	Jin, Shouguang/N-5548-2016; Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763	Natural Science Foundation of Zhejiang Province [LY14C060005]; Science and Technology Foundation of National Health and Family Planning Commission of China [WKJ2012-2-032]; National Natural Science Foundation of China [81401702, 81501808, 81501780]; Science and Technology Foundation of Wenling City [W201195, W201075, 2016C31BE0029]; NIH [R21-AI119043]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Foundation of National Health and Family Planning Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Wenling City; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by grants from the Natural Science Foundation of Zhejiang Province (LY14C060005), the Science and Technology Foundation of National Health and Family Planning Commission of China (WKJ2012-2-032), the National Natural Science Foundation of China (81401702, 81501808, 81501780), the Science and Technology Foundation of Wenling City (W201195, W201075, 2016C31BE0029), and the NIH (R21-AI119043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin DM, 2009, J BACTERIOL, V191, P2012, DOI 10.1128/JB.01547-08; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; Garcia DL, 2008, J BACTERIOL, V190, P3799, DOI 10.1128/JB.01194-07; Hanson ND, 2002, J ANTIMICROB CHEMOTH, V49, P1011, DOI 10.1093/jac/dkf052; Huang YW, 2010, ANTIMICROB AGENTS CH, V54, P2583, DOI 10.1128/AAC.01283-09; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Klepeis JL, 2005, COMPUT CHEM ENG, V29, P423, DOI 10.1016/j.compchemeng.2004.07.017; Komolafe O O, 2003, Malawi Med J, V15, P63; Kong KF, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-328; KORFMANN G, 1989, ANTIMICROB AGENTS CH, V33, P1946, DOI 10.1128/AAC.33.11.1946; Langaee TY, 2000, ANTIMICROB AGENTS CH, V44, P583, DOI 10.1128/AAC.44.3.583-589.2000; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMIDT H, 1995, MICROBIOL-SGM, V141, P1085, DOI 10.1099/13500872-141-5-1085; Schmidtke AJ, 2008, ANTIMICROB AGENTS CH, V52, P3922, DOI 10.1128/AAC.00341-08; Simner PJ, 2011, DIAGN MICR INFEC DIS, V69, P326, DOI 10.1016/j.diagmicrobio.2010.10.029; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Trepanier S, 1997, ANTIMICROB AGENTS CH, V41, P2399, DOI 10.1128/AAC.41.11.2399; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yang TC, 2013, FEMS MICROBIOL LETT, V340, P101, DOI 10.1111/1574-6968.12071; Ying JC, 2015, INT J BIOL SCI, V11, P11, DOI 10.7150/ijbs.10320; Zamorano L, 2011, ANTIMICROB AGENTS CH, V55, P1990, DOI 10.1128/AAC.01688-10; Zhang Y, 2010, ANTIMICROB AGENTS CH, V54, P4772, DOI 10.1128/AAC.00009-10	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168060	10.1371/journal.pone.0168060	http://dx.doi.org/10.1371/journal.pone.0168060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959942	Green Submitted, Green Published, gold			2022-12-26	WOS:000392753900036
J	Shah, SN; Gelderman, MP; Lewis, EMA; Farrel, J; Wood, F; Strader, MB; Alayash, AI; Vostal, JG				Shah, Sandeep N.; Gelderman, Monique P.; Lewis, Emily M. A.; Farrel, John; Wood, Francine; Strader, Michael Brad; Alayash, Abdu I.; Vostal, Jaroslav G.			Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model	PLOS ONE			English	Article							HUMAN ERYTHROID PROGENITORS; EX-VIVO GENERATION; HEMATOPOIETIC STEM; FETAL-HEMOGLOBIN; IN-VITRO; HEREDITARY PERSISTENCE; GENE-EXPRESSION; CORD BLOOD; ENUCLEATION; MICE	Reliance on volunteer blood donors can lead to transfusion product shortages, and current liquid storage of red blood cells (RBCs) is associated with biochemical changes over time, known as 'the storage lesion'. Thus, there is a need for alternative sources of transfusable RBCs to supplement conventional blood donations. Extracorporeal production of stem cellderived RBCs (stemRBCs) is a potential and yet untapped source of fresh, transfusable RBCs. A number of groups have attempted RBC differentiation from CD34(+) cells. However, it is still unclear whether these stemRBCs could eventually be effective substitutes for traditional RBCs due to potential differences in oxygen carrying capacity, viability, deformability, and other critical parameters. We have generated ex vivo stemRBCs from primary human cord blood CD34(+) cells and compared them to donor-derived RBCs based on a number of in vitro parameters. In vivo, we assessed stemRBC circulation kinetics in an animal model of transfusion and oxygen delivery in a mouse model of exercise performance. Our novel, chronically anemic, SCID mouse model can evaluate the potential of stemRBCs to deliver oxygen to tissues (muscle) under resting and exercise-induced hypoxic conditions. Based on our data, stem cell-derived RBCs have a similar biochemical profile compared to donor-derived RBCs. While certain key differences remain between donor-derived RBCs and stemRBCs, the ability of stemRBCs to deliver oxygen in a living organism provides support for further development as a transfusion product.	[Shah, Sandeep N.; Gelderman, Monique P.; Lewis, Emily M. A.; Farrel, John; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Wood, Francine; Strader, Michael Brad; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Jaroslav.Vostal@fda.hhs.gov			FDA Critical Path research funding	FDA Critical Path research funding	Funding for this project came through FDA Critical Path research funding.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; [Anonymous], 2013, 2011 NATL BLOOD COLL; Anstee DJ, 2012, CURR OPIN HEMATOL, V19, P163, DOI 10.1097/MOH.0b013e328352240a; Baek EJ, 2009, TRANSFUSION, V49, P2285, DOI 10.1111/j.1537-2995.2009.02303.x; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Beutler E., 1995, OSMOTIC FRAGILITY; Beutler E, 1983, OSMOTIC FRAGILITY; Buehler PW, 2004, TRANSFUSION, V44, P1516, DOI 10.1111/j.1537-2995.2004.04081.x; Can A, 2012, JOVE-J VIS EXP, V59, P3638, DOI DOI 10.3791/3638; CONLEY CL, 1963, BLOOD, V21, P261, DOI 10.1182/blood.V21.3.261.261; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Darling RC, 1941, J CLIN INVEST, V20, P739, DOI 10.1172/JCI101267; Dhabangi A, 2015, JAMA-J AM MED ASSOC, V314, P2514, DOI 10.1001/jama.2015.13977; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; Gelderman MP, 2010, TRANSFUSION MED, V20, P341, DOI 10.1111/j.1365-3148.2010.01016.x; Gelderman MP, 2015, HAEMATOLOGICA, V100, P611, DOI 10.3324/haematol.2014.117325; Gelderman MP, 2011, TRANSFUSION, V51, P1096, DOI 10.1111/j.1537-2995.2010.02972.x; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Goo YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097390; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; GUEST GM, 1948, BLOOD, V3, P541, DOI 10.1182/blood.V3.5.541.541; Heaven MR, 2016, J MASS SPECTROM, V51, P1, DOI 10.1002/jms.3716; Jin H, 2014, BIOMED RES INT, V2014; Jin HM, 2011, INT J MOL SCI, V12, P4770, DOI 10.3390/ijms12084770; Jung K, 2004, J ETHNOPHARMACOL, V93, P75, DOI 10.1016/j.jep.2004.03.022; Khodabux CM, 2013, TRANSFUSION, V53, P3230, DOI 10.1111/trf.12169; Kirby BS, 2014, AM J PHYSIOL-HEART C, V307, pH1737, DOI 10.1152/ajpheart.00542.2014; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Leberbauer C, 2005, BLOOD, V105, P85, DOI 10.1182/blood-2004-03-1002; Leparc GF, 2015, CANCER CONTROL, V22, P6; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; Migliaccio AR, 2012, CELL STEM CELL, V10, P115, DOI 10.1016/j.stem.2012.01.001; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Mountford J, 2010, BRIT J HAEMATOL, V149, P22, DOI 10.1111/j.1365-2141.2010.08079.x; Ngo DA, 2012, BRIT J HAEMATOL, V156, P259, DOI 10.1111/j.1365-2141.2011.08916.x; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Patel S, 2015, J CLIN DIAGN RES, V9, pOD9, DOI 10.7860/JCDR/2015/12878.6548; Rousseau GF, 2014, BIOTECHNOL J, V9, P28, DOI 10.1002/biot.201200368; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh VK, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00026; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tao ZY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-251; Timmins NE, 2011, TISSUE ENG PART C-ME, V17, P1131, DOI [10.1089/ten.tec.2011.0207, 10.1089/ten.TEC.2011.0207]; Zhang X, 2007, BIOL RES, V40, P41, DOI 10.4067/S0716-97602007000100005; Zimring JC, 2011, TRANSFUSION, V51, P435, DOI 10.1111/j.1537-2995.2010.03024.x	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166657	10.1371/journal.pone.0166657	http://dx.doi.org/10.1371/journal.pone.0166657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959920	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900004
J	Storch, K; Dickreuter, E; Artati, A; Adamski, J; Cordes, N				Storch, Katja; Dickreuter, Ellen; Artati, Anna; Adamski, Jerzy; Cordes, Nils			BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MAGNETIC-FIELDS; NEUROBLASTOMA-CELLS; TUMOR-GROWTH; RESISTANCE; EXPOSURE; PROLIFERATION; MECHANISMS; APOPTOSIS; LEVEL	Each year more than 450,000 Germans are expected to be diagnosed with cancer subsequently receiving standard multimodal therapies including surgery, chemotherapy and radiotherapy. On top, molecular-targeted agents are increasingly administered. Owing to intrinsic and acquired resistance to these therapeutic approaches, both the better molecular understanding of tumor biology and the consideration of alternative and complementary therapeutic support are warranted and open up broader and novel possibilities for therapy personalization. Particularly the latter is underpinned by the increasing utilization of noninvasive complementary and alternative medicine by the population. One investigated approach is the application of low-dose electromagnetic fields (EMF) to modulate cellular processes. A particular system is the BEMER therapy as a Physical Vascular Therapy for which a normalization of the microcirculation has been demonstrated by a low-frequency, pulsed EMF pattern. Open remains whether this EMF pattern impacts on cancer cell survival upon treatment with radiotherapy, chemotherapy and the molecular-targeted agent Cetuximab inhibiting the epidermal growth factor receptor. Using more physiological, three-dimensional, matrix-based cell culture models and cancer cell lines originating from lung, head and neck, colorectal and pancreas, we show significant changes in distinct intermediates of the glycolysis and tricarboxylic acid cycle pathways and enhanced cancer cell radiosensitization associated with increased DNA double strand break numbers and higher levels of reactive oxygen species upon BEMER treatment relative to controls. Intriguingly, exposure of cells to the BEMER EMF pattern failed to result in sensitization to chemotherapy and Cetuximab. Further studies are necessary to better understand the mechanisms underlying the cellular alterations induced by the BEMER EMF pattern and to clarify the application areas for human disease.	[Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany; [Artati, Anna; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res DZD eV, Munich, Germany; [Cordes, Nils] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, Dresden, Germany; [Cordes, Nils] German Canc Consortium DKTK, Dresden, Germany; [Cordes, Nils] German Canc Res Ctr, Heidelberg, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Cordes, N (corresponding author), Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Cordes, N (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, Dresden, Germany.; Cordes, N (corresponding author), German Canc Consortium DKTK, Dresden, Germany.; Cordes, N (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	Nils.Cordes@OncoRay.de		Adamski, Jerzy/0000-0001-9259-0199; Cordes, Nils/0000-0001-5684-629X	BEMER Int. AG (Liechtenstein); Deutsche Krebshilfe [108976]; European Union (RADIATE) [642623]; EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen [100066308]; German Federal Ministry of Education and Research (BMBF)	BEMER Int. AG (Liechtenstein); Deutsche Krebshilfe(Deutsche Krebshilfe); European Union (RADIATE); EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The research and authors were in part supported by the BEMER Int. AG (Liechtenstein) and grants from the Deutsche Krebshilfe (108976 to N.C.), the European Union (RADIATE; GA No. 642623 to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). This work was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research and authors were in part supported by the BEMER Int. AG (Liechtenstein) and grants from the Deutsche Krebshilfe (108976 to N.C.), the European Union (RADIATE; GA No.642623 to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). This work was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). We are grateful to R. Grenman for providing UTSCC15 cell line.	Al-Dimassi S, 2014, CLIN TRANSL ONCOL, V16, P511, DOI 10.1007/s12094-014-1162-1; Baharara J, 2015, CYTOTECHNOLOGY; Bohn Wolfgang, 2013, J Complement Integr Med, V10, pS1, DOI 10.1515/jcim-2013-0036; Bohn Wolfgang, 2013, J Complement Integr Med, V10, pS5, DOI 10.1515/jcim-2013-0037; Buckner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124136; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Cameron IL, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0125-5; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Delle Monache S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061484; Destefanis M, 2015, INT J RADIAT BIOL, V91, P964, DOI 10.3109/09553002.2015.1101648; Duan YQ, 2014, FOOD FUNCT, V5, P2289, DOI [10.1039/c4fo00250d, 10.1039/C4FO00250D]; Eke I., 2015, J BIOL METHODS, V2, P31, DOI [DOI 10.14440/JBM.2015.96, 10.14440/jbm.2015.96]; Eke I, 2016, INT J ONCOL, V48, P313, DOI 10.3892/ijo.2015.3230; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Elson E, 2009, ELECTROMAGN BIOL MED, V28, P275, DOI [10.1080/15368370903114271, 10.3109/15368370903114271]; Falone S, 2007, INT J BIOCHEM CELL B, V39, P2093, DOI 10.1016/j.biocel.2007.06.001; Francisco AC, 2013, INT J MOL SCI, V14, P14974, DOI 10.3390/ijms140714974; GORCZYNSKA E, 1991, ENVIRON RES, V55, P188, DOI 10.1016/S0013-9351(05)80175-6; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang Y, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/4927035; Karagiannis TC, 2004, CELL MOL LIFE SCI, V61, P2137, DOI 10.1007/s00018-004-4174-0; Kim J, 2010, BIOCHEM BIOPH RES CO, V400, P739, DOI 10.1016/j.bbrc.2010.08.140; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Marchesi N, 2014, J CELL PHYSIOL, V229, P1776, DOI 10.1002/jcp.24631; Miao XD, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0247-z; Patruno A, 2012, J CELL PHYSIOL, V227, P2767, DOI 10.1002/jcp.23024; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Piatkowski J, 2009, MULT SCLER, V15, pS255; Piatkowski J, 2011, ALTERN THER HEALTH M, V17, P22; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Rihova B, 2011, J DRUG TARGET, V19, P890, DOI 10.3109/1061186X.2011.622403; Ruiz-Gomez MJ, 2009, ELECTROMAGN BIOL MED, V28, P201, DOI 10.1080/15368370802608696; Ruiz-Gomez MJ, 2002, BIOELECTROMAGNETICS, V23, P578, DOI 10.1002/bem.10054; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Tannock IF, 2001, CANCER METAST REV, V20, P123, DOI 10.1023/A:1013125027697; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tofani S, 2001, BIOELECTROMAGNETICS, V22, P419, DOI 10.1002/bem.69; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Walther M, 2007, ELECTROMAGN BIOL MED, V26, P179, DOI 10.1080/15368370701580814; Wen JA, 2011, BIOELECTROMAGNETICS, V32, P322, DOI 10.1002/bem.20646; Winker R, 2005, MUTAT RES-GEN TOX EN, V585, P43, DOI 10.1016/j.mrgentox.2005.04.013; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yao CG, 2008, IEEE ENG MED BIO, P1044, DOI 10.1109/IEMBS.2008.4649338	45	30	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167931	10.1371/journal.pone.0167931	http://dx.doi.org/10.1371/journal.pone.0167931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959944	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900024
J	Watanabe, K; Bizen, N; Sato, N; Takebayashi, H				Watanabe, Keisuke; Bizen, Norihisa; Sato, Noboru; Takebayashi, Hirohide			Endoplasmic Reticulum-Localized Transmembrane Protein Dpy19L1 Is Required for Neurite Outgrowth	PLOS ONE			English	Article							NEURONAL MIGRATION; C-MANNOSYLTRANSFERASE; MICROTUBULES; NETWORK; GLOBOZOOSPERMIA; ORGANIZATION; DELETION; ELEGANS; AXON; LIS1	The endoplasmic reticulum (ER), including the nuclear envelope, is a continuous and intricate membrane-bound organelle responsible for various cellular functions. In neurons, the ER network is found in cell bodies, axons, and dendrites. Recent studies indicate the involvement of the ER network in neuronal development, such as neuronal migration and axonal outgrowth. However, the regulation of neural development by ER-localized proteins is not fully understood. We previously reported that the multi-transmembrane protein Dpy19L1 is required for neuronal migration in the developing mouse cerebral cortex. A Dpy19L family member, Dpy19L2, which is a causative gene for human Globozoospermia, is suggested to act as an anchor of the acrosome to the nuclear envelope. In this study, we found that the patterns of exogenous Dpy19L1 were partially coincident with the ER, including the nuclear envelope in COS-7 cells at the level of the light microscope. The reticular distribution of Dpy19L1 was disrupted by microtubule depolymerization that induces retraction of the ER. Furthermore, Dpy19L1 showed a similar distribution pattern with a ER marker protein in embryonic mouse cortical neurons. Finally, we showed that Dpy19L1 knockdown mediated by siRNA resulted in decreased neurite outgrowth in cultured neurons. These results indicate that transmembrane protein Dpy19L1 is localized to the ER membrane and regulates neurite extension during development.	[Watanabe, Keisuke; Bizen, Norihisa; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Watanabe, Keisuke; Sato, Noboru] Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan	Niigata University; Niigata University	Watanabe, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan.; Watanabe, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan.	watak@med.niigata-u.ac.jp	Takebayashi, Hirohide/AAO-1693-2020; LARIJANI, Professor Banafshe/H-3909-2015	LARIJANI, Professor Banafshe/0000-0003-4735-1169	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25123703]; MEXT [25117001, 15K06736]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was funded by a Grant-in-Aid for Scientific Research on Innovative Areas, "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; http://www.mext.go.jp/english/) [25123703] (to KW), a Grant-in-Aid for Scientific Research on Innovative Areas, "Glial assembly" from MEXT [25117001] (to HT), a Grant-in-Aid for Scientific Research (C) from MEXT [15K06736] (to KW) and a grant from Takeda Science Foundation (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; BROADWELL RD, 1983, J HISTOCHEM CYTOCHEM, V31, P1077, DOI 10.1177/31.9.6309951; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carson AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-45; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; Du HP, 2001, GENETICS, V158, P197; ElInati E, 2012, HUM MOL GENET, V21, P3695, DOI 10.1093/hmg/dds200; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Middelkoop TC, 2012, DEV BIOL, V361, P338, DOI 10.1016/j.ydbio.2011.10.029; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa Y, 2016, MOL BIOL CELL, V27, P744, DOI 10.1091/mbc.E15-06-0373; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sutherland DJ, 2014, TRENDS NEUROSCI, V37, P424, DOI 10.1016/j.tins.2014.05.008; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167985	10.1371/journal.pone.0167985	http://dx.doi.org/10.1371/journal.pone.0167985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959946	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900030
J	Kliemann, BS; Levin, AS; Moura, ML; Boszczowski, I; Lewis, JJ				Kliemann, Breno S.; Levin, Anna S.; Luisa Moura, M.; Boszczowski, Icaro; Lewis, James J.			Socioeconomic Determinants of Antibiotic Consumption in the State of Sao Paulo, Brazil: The Effect of Restricting Over-The-Counter Sales	PLOS ONE			English	Article							RESISTANCE; IMPACT; ASSOCIATION; COUNTRIES	Background Improper antibiotic use is one of the main drivers of bacterial resistance to antibiotics, increasing infectious diseases morbidity and mortality and raising costs of healthcare. The level of antibiotic consumption has been shown to vary according to socioeconomic determinants (SED) such as income and access to education. In many Latin American countries, antibiotics could be easily purchased without a medical prescription in private pharmacies before enforcement of restrictions on over-the-counter (OTC) sales in recent years. Brazil issued a law abolishing OTC sales in October 2010. This study seeks to find SED of antibiotic consumption in the Brazilian state of Sao Paulo (SSP) and to estimate the impact of the 2010 law. Methods Data on all oral antibiotic sales having occurred in the private sector in SSP from 2008 to 2012 were pooled into the 645 municipalities of SSP. Linear regression was performed to estimate consumption levels that would have occurred in 2011 and 2012 if no law regulating OTC sales had been issued in 2010. These values were compared to actual observed levels, estimating the effect of this law. Linear regression was performed to find association of antibiotic consumption levels and of a greater effect of the law with municipality level data on SED obtained from a nationwide census. Results Oral antibiotic consumption in SSP rose from 8.44 defined daily doses per 1,000 inhabitants per day (DID) in 2008 to 9.95 in 2010, and fell to 8.06 DID in 2012. Determinants of a higher consumption were higher human development index, percentage of urban population, density of private health establishments, life expectancy and percentage of females; lower illiteracy levels and lower percentage of population between 5 and 15 years old. A higher percentage of females was associated with a stronger effect of the law. Conclusions SSP had similar antibiotic consumption levels as the whole country of Brazil, and they were effectively reduced by the policy.	[Kliemann, Breno S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England; [Kliemann, Breno S.] Univ Fed Parana, Hlth Sci Sect, Course Med, Curitiba, Parana, Brazil; [Levin, Anna S.; Luisa Moura, M.; Boszczowski, Icaro] Univ Sao Paulo, Hosp Clin, Infect Control Dept, Sao Paulo, Brazil; [Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Fac Med, Sao Paulo, Brazil; [Levin, Anna S.] Univ Sao Paulo, LIM54, Fac Med, Sao Paulo, Brazil; [Lewis, James J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal do Parana; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Kliemann, BS (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England.; Kliemann, BS (corresponding author), Univ Fed Parana, Hlth Sci Sect, Course Med, Curitiba, Parana, Brazil.	brenokliemann@gmail.com	Levin, Anna S/C-8831-2012; Levin, Anna S./AAJ-1712-2021; Boszczowski, Icaro/ACH-0889-2022; Boszczowski, Icaro/AAF-9675-2022; Moura, Maria Luisa/N-5654-2015	Levin, Anna S/0000-0003-2427-8368; Levin, Anna S./0000-0003-2427-8368; Moura, Maria Luisa/0000-0003-1013-8233; Lewis, James/0000-0002-8603-2761	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/19128-1]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil [240720/2013-0]; UK Medical Research Council [MR/K012126/1]; Medical Research Council [MR/K007467/1, MR/K012126/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partially funded by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant #2011/19128-1) - http://www.fapesp.br/. The author BSK received a scholarship grant by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (grant #240720/2013-0) - http://www.cnpq.br/. The author JJL receives salary support from the UK Medical Research Council (MR/K012126/1) - http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; [Anonymous], 2015, GUID ATC CLASS DDD A; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Covvey JR, 2014, J ANTIMICROB CHEMOTH, V69, P835, DOI 10.1093/jac/dkt439; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Instituto Brasileiro de Geografia e Estatistica, 1990, GEOGR; Kiffer CRV, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-17; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Lopez Jose J, 2009, Rev Salud Publica (Bogota), V11, P432; Luis BF, 2011, REV CHIL INFECTOL, V28, P107, DOI /S0716-10182011000200001; Marra F, 2010, CAN J INFECT DIS MED, V21, pE99, DOI 10.1155/2010/965268; Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y; Matuz M, 2006, BRIT J CLIN PHARMACO, V61, P96, DOI 10.1111/j.1365-2125.2005.02525.x; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Moura ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001605; Nicolini P, 2006, CIENCIA SAUDE COLETI, V13, P689; De Miranda EJP, 2014, REV INST MED TROP SP, V56, P313, DOI 10.1590/S0036-46652014000400009; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Ramay BM, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0011-3; Rivas P, 2011, REV PANAM SALUD PUBL, V30, P592, DOI 10.1590/S1020-49892011001200016; Rocha MC, 2012, REV PAUL PEDIATR, V30, P471; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8; Santa-Ana-Tellez Y, 2015, ANTIMICROB AGENTS CH, V59, P105, DOI 10.1128/AAC.03629-14; Schmid B, 2010, REV SAUDE PUBL, V44, P1039, DOI 10.1590/S0034-89102010000600008; Ternhag A, 2014, SCAND J INFECT DIS, V46, P888, DOI 10.3109/00365548.2014.954264; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; WHO, 2001, WHO GLOB STRAT CONT; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; World Health Organization, 2015, GLOB HLTH OBS DAT	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167885	10.1371/journal.pone.0167885	http://dx.doi.org/10.1371/journal.pone.0167885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941993	gold, Green Accepted, Green Published			2022-12-26	WOS:000392745600036
J	Peck, DT; Smith, ML; Seeley, TD				Peck, David T.; Smith, Michael L.; Seeley, Thomas D.			Varroa destructor Mites Can Nimbly Climb from Flowers onto Foraging Honey Bees	PLOS ONE			English	Article							PARASITIC MITE; JACOBSONI OUD; COLONIES; AGE; HYMENOPTERA; POPULATION; SURVIVAL; BEHAVIOR; LARVAE	Varroa destructor, the introduced parasite of European honey bees associated with massive colony deaths, spreads readily through populations of honey bee colonies, both managed colonies living crowded together in apiaries and wild colonies living widely dispersed in natural settings. Mites are hypothesized to spread between most managed colonies via phoretically riding forager bees when they engage in robbing colonies or they drift between hives. However, widely spaced wild colonies show Varroa infestation despite limited opportunities for robbing and little or no drifting of bees between colonies. Both wild and managed colonies may also exchange mites via another mechanism that has received remarkably little attention or study: floral transmission. The present study tested the ability of mites to infest foragers at feeders or flowers. We show that Varroa destructor mites are highly capable of phoretically infesting foraging honey bees, detail the mechanisms and maneuvers by which they do so, and describe mite behaviors post-infestation.	[Peck, David T.; Smith, Michael L.; Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Peck, DT (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	dtp36@cornell.edu		Peck, David/0000-0002-4650-6811; Smith, Michael/0000-0002-3454-962X	National Science Foundation's Graduate Research Fellowship Program [DGE-1144153]; Hatch Grant from the Cornell University Agricultural Experiment Station [NYC-191400]	National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); Hatch Grant from the Cornell University Agricultural Experiment Station	This research was supported by the National Science Foundation's Graduate Research Fellowship Program (DGE-1144153 to DTP and MLS) (www.nsf.gov). This research was also supported by a Hatch Grant (Project No. NYC-191400) from the Cornell University Agricultural Experiment Station (to TDS) (cuaes.cals.cornell.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; BowenWalker PL, 1997, PARASITOLOGY, V114, P151, DOI 10.1017/S0031182096008323; COLWELL RK, 1985, NAT HIST, V94, P56; Delfinado-Baker M., 1992, International Journal of Acarology, V18, P315; Department of Agriculture and Water Services Australia, 2016, HON BEES CROP POLL V; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Eickwort George C., 1994, P218; EWALD PW, 1995, J PARASITOL, V81, P659, DOI 10.2307/3283951; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hartwig A, 1987, P 31 INT C AP WARS P, P229; Ish-Am G, 1985, THESIS, P57; Isle of Man Government, 2015, BEE KEEP OFF DIS FRE; Kather R, 2015, CHEMOECOLOGY, V25, P215, DOI 10.1007/s00049-015-0191-8; Kather R, 2015, J CHEM ECOL, V41, P178, DOI 10.1007/s10886-015-0548-z; Kevan PG, 2006, AM BEE J, V146, P694; KEVAN PG, 1990, BEE WORLD, V71, P119, DOI 10.1080/0005772X.1990.11099048; KIMSEY LS, 1984, J ZOOL, V204, P541, DOI 10.1111/j.1469-7998.1984.tb02386.x; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; KRAUS B, 1986, APIDOLOGIE, V17, P257, DOI 10.1051/apido:19860307; Kuenen LPS, 1997, J INSECT BEHAV, V10, P213, DOI 10.1007/BF02765554; Land BB, 2004, ETHOLOGY, V110, P1, DOI 10.1046/j.1439-0310.2003.00947.x; LE CONTE Y, 1987, APIDOLOGIE, V18, P305, DOI 10.1051/apido:19870402; LE CONTE Y, 1989, SCIENCE, V245, P638, DOI 10.1126/science.245.4918.638; LEES AD, 1948, J EXP BIOL, V25, P145; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Pernal SF, 2005, EXP APPL ACAROL, V37, P1, DOI 10.1007/s10493-005-1117-x; Pettis JS, 2003, INT J ACAROL, V29, P291, DOI 10.1080/01647950308684342; RICKLI M, 1992, NATURWISSENSCHAFTEN, V79, P320, DOI 10.1007/BF01138711; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Seeley TD, 1995, WISDOM HIVE, P76; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103	37	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167798	10.1371/journal.pone.0167798	http://dx.doi.org/10.1371/journal.pone.0167798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942015	gold, Green Published			2022-12-26	WOS:000392745600031
J	Akiba, R; Yokouchi, H; Mori, M; Oshitari, T; Baba, T; Sawai, S; Kuwabara, S; Yamamoto, S				Akiba, Ryutaro; Yokouchi, Hirotaka; Mori, Masahiro; Oshitari, Toshiyuki; Baba, Takayuki; Sawai, Setsu; Kuwabara, Satoshi; Yamamoto, Shuichi			Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)	PLOS ONE			English	Article							NERVE-FIBER LAYER; AQUAPORIN-4 WATER CHANNEL; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; MULLER CELLS; NEURITIS; DISTINCTION; THICKNESS; MICROPERIMETRY; SEGMENTATION	Background Previous studies of neuromyelitis optica spectrum disorder (NMOSD) using spectral domain optical coherence tomography (SD-OCT) showed that the outer nuclear layer (ONL) in eyes without a history of optic neuritis (ON) was thinner than that of healthy controls. It remains unclear whether the ONL thinning is caused by a direct attack on the retina by an autoantibody or a retrograde degeneration. Objective To determine the mechanisms involved in the retinal damage in eyes with NMOSD without ON. Methods SD-OCT was used to determine the thicknesses of the different retinal layers of 21 eyes of 12 NMOSD patients without prior ON and 19 eyes of 10 healthy controls. Eyes with peripapillary retinal nerve fiber layer (RNFL) thinning were excluded to eliminate the confounding effects of retrograde degeneration. Microperimetry was used to determine the central retinal sensitivity. The data of the two groups were compared using generalized estimated equation models to account for inter-eye dependencies. Results The ganglion cell plus inner plexiform layer and the inner nuclear layer plus outer plexiform layer thicknesses of the NMOSD eyes were not significantly different from that of the control eyes (P = 0.28, P = 0.78). However, the ONL and average macular thickness (AMT) in the NMOSD eyes were significantly thinner than that of the control eyes (P = 0.022, P = 0.036). The retinal sensitivity in the central 10 degrees, 10 degrees to 2 degrees, and 2 degrees sectors were significantly lower in the NMOSD eyes than in the control eyes (P = 0.013, P = 0.022, P = 0.002). Conclusions The ONL thinning, AMT thinning, and reduced retinal sensitivity in eyes with NMOSD without significant peripapillary RNFL thinning are most likely due to direct retinal pathology.	[Akiba, Ryutaro; Yokouchi, Hirotaka; Oshitari, Toshiyuki; Baba, Takayuki; Yamamoto, Shuichi] Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chiba, Chiba, Japan; [Mori, Masahiro; Sawai, Setsu; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba, Chiba, Japan	Chiba University; Chiba University	Yokouchi, H (corresponding author), Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chiba, Chiba, Japan.	yokouchi123@peace.ocn.ne.jp		Oshitari, Toshiyuki/0000-0002-8273-845X; Akiba, Ryutaro/0000-0001-8078-3794; Kuwabara, Satoshi/0000-0002-4716-8578				Alexander P, 2012, EYE, V26, P678, DOI 10.1038/eye.2012.7; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gella L, 2011, CURR EYE RES, V36, P943, DOI 10.3109/02713683.2011.599105; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Hasler PW, 2008, BRIT J OPHTHALMOL, V92, P645, DOI 10.1136/bjo.2007.130971; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiao YJ, 2013, NEUROLOGY, V81, P1197, DOI 10.1212/WNL.0b013e3182a6cb5c; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Lange AP, 2013, J NEURO-OPHTHALMOL, V33, P213, DOI 10.1097/WNO.0b013e31829c510e; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lima VC, 2010, BRIT J OPHTHALMOL, V94, P64, DOI 10.1136/bjo.2009.159772; Lujan BJ, 2015, RETINA-J RET VIT DIS, V35, P1511, DOI 10.1097/IAE.0000000000000527; Markowitz SN, 2013, CAN J OPHTHALMOL, V48, P350, DOI 10.1016/j.jcjo.2012.03.004; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Nielsen S, 1997, J NEUROSCI, V17, P171; Noval S, 2006, ACTA OPHTHALMOL SCAN, V84, P790, DOI 10.1111/j.1600-0420.2006.00724.x; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Ozturk F, 2008, J GLAUCOMA, V17, P118, DOI 10.1097/IJG.0b013e31814b97fd; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; Outteryck O, 2015, MULTIPLE SCLEROSIS; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Ringelstein M, 2014, MULT SCLER J, V20, P617, DOI 10.1177/1352458513503053; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tomizawa Y, 2012, J INT MED RES, V40, P1483, DOI 10.1177/147323001204000427; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Zajda M, 2015, MULTIPLE SCLEROSIS; Zamvil SS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000062	44	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167473	10.1371/journal.pone.0167473	http://dx.doi.org/10.1371/journal.pone.0167473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936154	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100105
J	de Almeida, DV; Macieira, KV; Grinsztejn, BGJ; dos Santos, VGV; Guimaraes, ML				de Almeida, Dalziza Victalina; Macieira, Karine Venegas; Jegerhorn Grinsztejn, Beatriz Gilda; Veloso dos Santos, Valdilea Goncalves; Guimaraes, Monick Lindenmeyer			Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; RIO-DE-JANEIRO; DRUG-USERS; VACCINE; PREVALENCE; EPITOPES; BRAZIL; GP120; REGION; BROAD	Various HIV-1 env genetic and biochemical features impact the elicitation of cross-reactive neutralizing antibodies in natural infections. Thus, we aimed to investigate cross-neutralizing antibodies in individuals infected with HIV-1 env subtypes B, F1, C or the B/Bbr variant as well as env characteristics. Therefore, plasma samples from Brazilian chronically HIV-1 infected individuals were submitted to the TZM-bl neutralization assay. We also analyzed putative N-glycosylation sites (PNGLs) and the size of gp120 variable domains in the context of HIV-1 subtypes prevalent in Brazil. We observed a greater breadth and potency of the anti-Env neutralizing response in individuals infected with the F1 or B HIV-1 subtypes compared with the C subtype and the variant B/Bbr. We observed greater V1 B/Bbr and smaller V4 F1 than those of other subtypes (p<0.005), however neither was there a correlation verified between the variable region length and neutralization potency, nor between PNLG and HIV-1 subtypes. The enrichment of W at top of V3 loop in weak neutralizing response viruses and the P in viruses with higher neutralization susceptibility was statistically significant (p = 0.013). Some other signatures sites were associated to HIV-1 subtype-specific F1 and B/Bbr samples might influence in the distinct neutralizing response. These results indicate that a single amino acid substitution may lead to a distinct conformational exposure or load in the association domain of the trimer of gp120 and interfere with the induction power of the neutralizing response, which affects the sensitivity of the neutralizing antibody and has significant implications for vaccine design.	[de Almeida, Dalziza Victalina; Macieira, Karine Venegas; Guimaraes, Monick Lindenmeyer] Oswaldo Cruz Inst FIOCRUZ, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil; [Jegerhorn Grinsztejn, Beatriz Gilda; Veloso dos Santos, Valdilea Goncalves] Natl Inst Infectol FIOCRUZ, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	de Almeida, DV (corresponding author), Oswaldo Cruz Inst FIOCRUZ, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil.	dalziza@ioc.fiocruz.br			Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation [38619]; Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC) [383-0920]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E26/110.517/2012]; CNPq	Collaboration for AIDS Vaccine Discovery (CAVD) - Bill & Melinda Gates Foundation; Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation (Grant # 38619) Global HIV Vaccine Enterprise (GHVE) Central Service Facilities (CSFs), especially Dr D Montefiori's Vaccine Immune Monitoring Center (VIMC) (Grant # 383-0920). This work was partially supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (grant number E26/110.517/2012). Monick Lindenmeyer Guimaraes is recipient of a CNPq Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida DV, 2013, AIDS RES HUM RETROV, V29, P488, DOI [10.1089/aid.2012.0052, 10.1089/AID.2012.0052]; Asokan M, 2015, J VIROL, V89, P12501, DOI 10.1128/JVI.02097-15; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; BONGERTZ V, 1994, BRAZ J MED BIOL RES, V27, P1225; Bongertz V, 2000, J ACQ IMMUN DEF SYND, V23, P184; BONGERTZ V, 1991, BRAZ J MED BIOL RES, V24, P815; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; Chuang GY, 2013, J VIROL, V87, P10047, DOI 10.1128/JVI.00984-13; Cortes FH, 2013, VACCINE, V31, P1106, DOI 10.1016/j.vaccine.2012.12.023; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Covas DT, 1998, J ACQ IMMUN DEF SYND, V19, P74, DOI 10.1097/00042560-199809010-00012; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074072; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; Doria-Rose NA, 2015, CURR OPIN VIROL, V11, P137, DOI 10.1016/j.coviro.2015.04.002; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guimaraes ML, 2001, J CLIN VIROL, V21, P143, DOI 10.1016/S1386-6532(01)00158-5; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Morgado MG, 1998, J ACQ IMMUN DEF SYND, V18, P488, DOI 10.1097/00042560-199808150-00011; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Niculescu I, 2015, AIDS RES HUM RETROV, V31, P488, DOI 10.1089/aid.2014.0189; Pimentel VF, 2013, AIDS RES HUM RETROV, V29, P1553, DOI [10.1089/aid.2013.0050, 10.1089/AID.2013.0050]; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; Yoon H, 2015, NUCLEIC ACIDS RES, V43, pW213, DOI 10.1093/nar/gkv404; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	61	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167690	10.1371/journal.pone.0167690	http://dx.doi.org/10.1371/journal.pone.0167690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936047	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100153
J	Gracia-Rubio, I; Valverde, O; Martinez-Laorden, E; Moscoso-Castro, M; Milanes, MV; Laorden, ML				Gracia-Rubio, Irene; Valverde, Olga; Martinez-Laorden, Elena; Moscoso-Castro, Maria; Milanes, M. Victoria; Laorden, M. Luisa			Maternal Separation Impairs Cocaine-Induced Behavioural Sensitization in Adolescent Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; DOPAMINE D2 RECEPTORS; TRANSCRIPTION FACTORS; D-2 RECEPTORS; ADULT RATS; MORPHINE-WITHDRAWAL; MILD STRESS; EXPRESSION; ADDICTION; BRAIN	Adverse early-life conditions induce persistent disturbances that give rise to negative emotional states. Therefore, early life stress confers increased vulnerability to substance use disorders, mainly during adolescence as the brain is still developing. In this study, we investigated the consequences of maternal separation, a model of maternal neglect, on the psychotropic effects of cocaine and the neuroplasticity of the dopaminergic system. Our results show that mice exposed to maternal separation displayed attenuated behavioural sensitization, while no changes were found in the rewarding effects of cocaine in the conditioned place preference paradigm and in the reinforcing effects of cocaine in the self-administration paradigm. The evaluation of neuroplasticity in the striatal dopaminergic pathways revealed that mice exposed to maternal separation exhibited decreased protein expression levels of D2 receptors and increased levels of the transcriptional factor Nurr1. Furthermore, animals exposed to maternal separation and treated with cocaine exhibited increased DA turnover and protein expression levels of DAT and D2R, while decreased Nurr1 and Pitx3 protein expression levels were observed when compared with saline-treated mice. Taken together, our data demonstrate that maternal separation caused an impairment of cocaine-induced behavioural sensitization possibly due to a dysfunction of the dopaminergic system, a dysfunction that has been proposed as a factor of vulnerability for developing substance use disorders.	[Gracia-Rubio, Irene; Valverde, Olga; Moscoso-Castro, Maria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Neurobiol Behav Res Grp GReNeC, Barcelona, Spain; [Valverde, Olga] IMIM Hosp Mar Res Inst, Neurosci Res Program, Barcelona, Spain; [Martinez-Laorden, Elena; Milanes, M. Victoria; Laorden, M. Luisa] Univ Murcia, Grp Cellular & Mol Pharmacol, Fac Med, Murcia, Spain; [Martinez-Laorden, Elena; Milanes, M. Victoria; Laorden, M. Luisa] IMIB, Murcia, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Murcia	Valverde, O (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Neurobiol Behav Res Grp GReNeC, Barcelona, Spain.; Valverde, O (corresponding author), IMIM Hosp Mar Res Inst, Neurosci Res Program, Barcelona, Spain.	olga.valverde@upf.edu	Milanés, M Victoria/K-6591-2017; Milanés, M. Victoria/AGB-4075-2022; Gracia-Rubio, Irene/E-5545-2014; Valverde, Olga/D-8654-2012	Milanés, M Victoria/0000-0002-0984-2218; Milanés, M. Victoria/0000-0002-0984-2218; Gracia-Rubio, Irene/0000-0003-1028-8581; Valverde, Olga/0000-0003-2264-7852	UE MedBioinformatics project [634143]; MINECO [SAF2013-41761-R-FEDER, SAF2013-49076-P-FEDER]; Spanish Ministry of Health [Retic-ISCIII-RD/12/0028/0024-FEDER, RETICS-ISCIII-RD 12/0028/003-FEDER, 2014/020]; Generalitat de Catalunya [2014SGR34]; Fundacion Seneca [15405/PI/10]; Region de Murcia; FPI [BES-2011-046655, SAF2010-15793]	UE MedBioinformatics project; MINECO(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Seneca(Fundacion Seneca); Region de Murcia; FPI(Spanish Government)	This study was supported by UE MedBioinformatics project (Grant Agreement Number: 634143), MINECO (SAF2013-41761-R-FEDER and SAF2013-49076-P-FEDER), Spanish Ministry of Health (Retic-ISCIII-RD/12/0028/0024-FEDER and RETICS-ISCIII-RD 12/0028/003-FEDER and Plan Nacional sobre Drogas 2014/020), Generalitat de Catalunya (2014SGR34) and Fundacion Seneca (15405/PI/10), Region de Murcia. IG-R was funded by FPI fellowship BES-2011-046655 associated to SAF2010-15793.	Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Bissonette GB, 2016, GENES BRAIN BEHAV, V15, P62, DOI 10.1111/gbb.12257; Blanco E, 2012, PSYCHOPHARMACOLOGY, V220, P27, DOI 10.1007/s00213-011-2446-6; Burke AR, 2014, PSYCHOPHARMACOLOGY, V231, P1557, DOI 10.1007/s00213-013-3369-1; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Campos-Melo D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00044; Cheetham A, 2010, CLIN PSYCHOL REV, V30, P621, DOI 10.1016/j.cpr.2010.04.005; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Doremus-Fitzwater TL, 2010, PHARMACOL BIOCHEM BE, V96, P198, DOI 10.1016/j.pbb.2010.05.005; Enman NM, 2015, BIOL PSYCHIAT, V78, P871, DOI 10.1016/j.biopsych.2015.04.024; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Garcia-Perez D, 2016, ADDICT BIOL, V21, P374, DOI 10.1111/adb.12209; Garcia-Perez D, 2015, BRAIN STRUCT FUNCT, V220, P1901, DOI 10.1007/s00429-014-0761-5; Garcia-Perez D, 2015, ADDICT BIOL, V20, P104, DOI 10.1111/adb.12083; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; Gerra G, 2009, NEUROSCI BIOBEHAV R, V33, P601, DOI 10.1016/j.neubiorev.2007.08.002; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Han X, 2015, PSYCHOPHARMACOLOGY, V232, P1003, DOI 10.1007/s00213-014-3734-8; Hays SL, 2012, BEHAV BRAIN RES, V227, P7, DOI 10.1016/j.bbr.2011.10.033; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Katunar MR, 2009, J NEUROSCI RES, V87, P1014, DOI 10.1002/jnr.21911; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kikusui T, 2005, PSYCHOPHARMACOLOGY, V178, P202, DOI 10.1007/s00213-004-1989-1; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TA, 2003, DEV BRAIN RES, V141, P109, DOI 10.1016/S0165-3806(03)00003-8; Leo D, 2007, EXP NEUROL, V203, P472, DOI 10.1016/j.expneurol.2006.08.024; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Martin M, 2000, EUR J NEUROSCI, V12, P4038, DOI 10.1046/j.1460-9568.2000.00287.x; Martini M, 2012, PSYCHOPHARMACOLOGY, V219, P149, DOI 10.1007/s00213-011-2385-2; Matsuzawa S, 1999, BRAIN RES, V835, P298, DOI 10.1016/S0006-8993(99)01606-6; Matthews K, 1999, PSYCHOPHARMACOLOGY, V141, P123, DOI 10.1007/s002130050816; MATTINGLY BA, 1994, PSYCHOPHARMACOLOGY, V114, P239, DOI 10.1007/BF02244843; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Nazarian A, 2004, BRAIN RES BULL, V63, P295, DOI 10.1016/j.brainresbull.2004.03.004; O'Connor RM, 2015, NEUROPHARMACOLOGY, V99, P168, DOI 10.1016/j.neuropharm.2015.07.012; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Planeta CS, 2002, BRAZ J MED BIOL RES, V35, P1367, DOI 10.1590/S0100-879X2002001100015; PUGLISIALLEGRA S, 1991, LIFE SCI, V48, P1263, DOI 10.1016/0024-3205(91)90521-C; Reddy SDN, 2011, P NATL ACAD SCI USA, V108, P4200, DOI 10.1073/pnas.1101193108; Rezayof A, 2002, PHARMACOL BIOCHEM BE, V74, P187, DOI 10.1016/S0091-3057(02)00989-9; Rodriguez-Arias M., 2015, ADDICT BIOL; Rojas P, 2010, J NEUROSCI RES, V88, P2284, DOI 10.1002/jnr.22377; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Soria G, 2005, NEUROPSYCHOPHARMACOL, V30, P1670, DOI 10.1038/sj.npp.1300707; SPEAR LP, 1979, BEHAV NEURAL BIOL, V26, P401, DOI 10.1016/S0163-1047(79)91410-9; Tourino C, 2012, BRIT J PHARMACOL, V167, P892, DOI 10.1111/j.1476-5381.2012.02043.x; Tseng KY, 2000, MOL BRAIN RES, V80, P1, DOI 10.1016/S0169-328X(00)00107-8; Valverde O, 1997, PSYCHOPHARMACOLOGY, V131, P79, DOI 10.1007/s002130050268; Vazquez V, 2007, PSYCHOPHARMACOLOGY, V193, P475, DOI 10.1007/s00213-007-0789-9; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; WEISS RD, 1992, AM J DRUG ALCOHOL AB, V18, P121, DOI 10.3109/00952999208992825; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49	56	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167483	10.1371/journal.pone.0167483	http://dx.doi.org/10.1371/journal.pone.0167483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936186	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100108
J	Kaul, SC; Ishida, Y; Tamura, K; Wada, T; Iitsuka, T; Garg, S; Kim, M; Gao, R; Nakai, S; Okamoto, Y; Terao, K; Wadhwa, R				Kaul, Sunil C.; Ishida, Yoshiyuki; Tamura, Kazuya; Wada, Teruo; Iitsuka, Tomoko; Garg, Sukant; Kim, Mijung; Gao, Ran; Nakai, Shoichi; Okamoto, Youji; Terao, Keiji; Wadhwa, Renu			Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts	PLOS ONE			English	Article							STUDYING CHEMOTYPE VARIATIONS; NF-KAPPA-B; WITHANIA-SOMNIFERA; NMR-SPECTROSCOPY; CANCER-CELLS; GAMMA-CYCLODEXTRIN; ALCOHOLIC EXTRACT; LEAF EXTRACT; WITHAFERIN; APOPTOSIS	Ashwagandha (Withania somnifera) is an Ayurvedic herb commonly used in world-renowned traditional Indian home medicine system. Roots of Ashwagandha have been traditionally known to possess a variety of therapeutic and health promoting potentials that have not been sufficiently supported by laboratory studies. Nevertheless, most, if not all, of the preventive and therapeutic potentials have been assigned to its bioactive components, steroidal alkaloids and lactones. In contrast to the traditional use of roots, we have been exploring bioactivities in leaves of Ashwagandha. Here, we report that the leaves possess higher content of active Withanolides, Withaferin-A (Wi-A) and Withanone (Wi-N), as compared to the roots. We also established, for the first time, hydroponic cultivation of Ashwagandha and investigated the effect of various cultivation conditions on the content of Wi-A and Wi-N by chemical analysis and bioassays. We report that the Withanone/Withaferin Arich leaves could be obtained by manipulating light condition during hydroponic cultivation. Furthermore, we recruited cyclodextrins to prepare extracts with desired ratio of Wi-N and Wi-A. Hydroponically grown Ashwagandha and its extracts with high ratio of withanolides are valuable for cancer treatment.	[Kaul, Sunil C.; Iitsuka, Tomoko; Garg, Sukant; Kim, Mijung; Gao, Ran; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki, Japan; [Ishida, Yoshiyuki; Terao, Keiji] CycloChem Co Ltd, Chuo Ku, 7-4-5 Minatojima Minamimachi, Kobe, Hyogo, Japan; [Tamura, Kazuya; Nakai, Shoichi] DAI DAN Co Ltd, 390 Kitanagai, Miyoshi, Saitama, Japan; [Wada, Teruo] Osaka Prefecture Univ, 1-1 Nakakugakuencho, Sakai, Osaka, Japan; [Garg, Sukant; Wadhwa, Renu] Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Okamoto, Youji] Zuiron Private Ltd, 2-3-1 Nakajyosanjimacho, Tokushima, Tokushima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka Metropolitan University; University of Tsukuba	Wadhwa, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki, Japan.; Wadhwa, R (corresponding author), Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	AIST-Industrial Collaboration Funds	AIST-Industrial Collaboration Funds	The study was partly supported by AIST-Industrial Collaboration Funds. Dr. Yoshiyuki Ishida and Dr. Keiji Terao are research employees of CycloChem Co., Ltd. Mr. Kazuya Tamura and Mr. Shoichi Nakai are employees of DAI-DAN Co., Ltd. Dr. Youji Okamoto is an employee of Zuiron Private Ltd. These three commercial companies significantly contributed in the present study starting from conceptualization, investigation, analyses of the data to supervision. The specific roles of these authors are articulated in the 'author contributions' section.	Akihisa T, 2009, REGULATION OF PLANT, V44, P177; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; Bhatia A, 2013, PHYTOCHEMISTRY, V93, P105, DOI 10.1016/j.phytochem.2013.03.013; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Dar PA, 2016, CURR PHARM DESIGN, V22, P535, DOI 10.2174/1381612822666151125001751; Das T, 2014, BIOCHEM PHARMACOL, V91, P31, DOI 10.1016/j.bcp.2014.06.022; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Devi P. Uma, 1996, Indian Journal of Experimental Biology, V34, P927; Devi PU, 1996, INT J RADIAT BIOL, V69, P193, DOI 10.1080/095530096146020; Gao R, 2014, MOL CANCER THER, V13, P2930, DOI 10.1158/1535-7163.MCT-14-0324; Gautam A, 2016, MOL NEUROBIOL, V53, P1760, DOI 10.1007/s12035-015-9117-2; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Kalani A, 2012, BMJ CASE REP, V2012; Kamigauchi M, 2007, CHEM PHARM BULL, V55, P729, DOI 10.1248/cpb.55.729; Kataria H, 2016, MOL NEUROBIOL, V53, P4143, DOI 10.1007/s12035-015-9320-1; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Khanna D, 2007, CURR OPIN PHARMACOL, V7, P344, DOI 10.1016/j.coph.2007.03.002; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kuboyama T, 2014, BIOL PHARM BULL, V37, P892, DOI 10.1248/bpb.b14-00022; Lee J, 2015, MOL CARCINOGEN, V54, P417, DOI 10.1002/mc.22110; Lopez-Miranda S, 2016, FOOD CHEM, V203, P379, DOI 10.1016/j.foodchem.2016.02.100; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mantegna S, 2012, FOOD CHEM, V130, P746, DOI 10.1016/j.foodchem.2011.07.038; Miyoshi N, 2011, J NUTR BIOCHEM, V22, P1121, DOI 10.1016/j.jnutbio.2010.09.011; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Namdeo AG, 2011, PLANTA MED, V77, P1958, DOI 10.1055/s-0031-1279997; Raghavan A, 2015, MOL NEUROBIOL, V52, P1093, DOI 10.1007/s12035-014-8907-2; Sangwan Neelam S, 2014, Recent Pat Biotechnol, V8, P25, DOI 10.2174/1872208307666131218125300; Shah N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120554; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Sidhu OP, 2011, PHYTOCHEM ANALYSIS, V22, P492, DOI 10.1002/pca.1307; Singh D, 2007, PHYTOTHER RES, V21, P905, DOI 10.1002/ptr.2180; Singh N, 2011, AFR J TRADIT COMPLEM, V8, P208, DOI 10.4314/ajtcam.v8i5S.9; Singh P, 2015, MOL BIOL INT, V2015, P1, DOI DOI 10.1080/02648725.2015.1020467; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Terao K, 2006, NUTR RES, V26, P503, DOI 10.1016/j.nutres.2006.08.004; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; Uchida R, 2015, INT J MOL SCI, V16, P10105, DOI 10.3390/ijms160510105; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Vyas AR, 2014, AAPS J, V16, P1, DOI 10.1208/s12248-013-9531-1; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	54	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166945	10.1371/journal.pone.0166945	http://dx.doi.org/10.1371/journal.pone.0166945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936030	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100050
J	Seemanova, E; Varon, R; Vejvalka, J; Jarolim, P; Seeman, P; Chrzanowska, KH; Digweed, M; Resnick, I; Kremensky, I; Saar, K; Hoffmann, K; Dutrannoy, V; Karbasiyan, M; Ghani, M; Baric, I; Tekin, M; Kovacs, P; Krawczak, M; Reis, A; Sperling, K; Nothnagel, M				Seemanova, Eva; Varon, Raymonda; Vejvalka, Jan; Jarolim, Petr; Seeman, Pavel; Chrzanowska, Krystyna H.; Digweed, Martin; Resnick, Igor; Kremensky, Ivo; Saar, Kathrin; Hoffmann, Katrin; Dutrannoy, Veronique; Karbasiyan, Mohsen; Ghani, Mehdi; Baric, Ivo; Tekin, Mustafa; Kovacs, Peter; Krawczak, Michael; Reis, Andre; Sperling, Karl; Nothnagel, Michael			The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?	PLOS ONE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; MAP-O-MAT; 657DEL5 MUTATION; CANCER-RISK; NBS1 GENE; HUMAN GENOME; CLINICAL-MANIFESTATION; DEFECTIVE RESPONSE; FEMALE FERTILITY	The vast majority of patients with Nijmegen Breakage Syndrome (NBS) are of Slavic origin and carry a deleterious deletion (c.657de15; rs587776650) in the NBN gene on chromosome 8q21. This mutation is essentially confined to Slavic populations and may thus be considered a Slavic founder mutation. Notably, not a single parenthood of a homozygous c.657de15 carrier has been reported to date, while heterozygous carriers do reproduce but have an increased cancer risk. These observations seem to conflict with the considerable carrier frequency of c.657de15 of 0.5% to 1% as observed in different Slavic populations because deleterious mutations would be eliminated quite rapidly by purifying selection. Therefore, we propose that heterozygous c.657de15 carriers have increased reproductive success, i.e., that the mutation confers heterozygote advantage. In fact, in our cohort study of the reproductive history of 24 NBS pedigrees from the Czech Republic, we observed that female carriers gave birth to more children on average than female non-carriers, while no such reproductive differences were observed for males. We also estimate that c.657de15 likely occurred less than 300 generations ago, thus supporting the view that the original mutation predated the historic split and subsequent spread of the 'Slavic people'. We surmise that the higher fertility of female c.657de15 carriers reflects a lower miscarriage rate in these women, thereby reflecting the role of the NBN gene product, nibrin, in the repair of DNA double strand breaks and their processing in immune gene rearrangements, telomere maintenance, and meiotic recombination, akin to the previously described role of the DNA repair genes BRCA1 and BRCA2.	[Seemanova, Eva] Charles Univ Prague, Med Sch 2, Dept Clin Genet, Inst Biol & Med Genet, Prague, Czech Republic; [Varon, Raymonda; Digweed, Martin; Dutrannoy, Veronique; Karbasiyan, Mohsen; Sperling, Karl] Charite Univ Med Berlin, Inst Med & Human Genet, Berlin, Germany; [Vejvalka, Jan] Charles Univ Prague, Med Sch 2, Dept Informat, Prague, Czech Republic; [Jarolim, Petr] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Seeman, Pavel] Charles Univ Prague, Med Sch 2, Dept Pediat Neurol, DNA Lab, Prague, Czech Republic; [Seeman, Pavel] Univ Hosp Motol, Prague, Czech Republic; [Chrzanowska, Krystyna H.] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Resnick, Igor] Hadassah Hebrew Univ, Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel; [Kremensky, Ivo] Med Univ, Univ Hosp Obstet & Gynecol, Natl Genet Lab, Sofia, Bulgaria; [Saar, Kathrin] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Hoffmann, Katrin] Martin Luther Univ Halle Wittenberg, Inst Human Genet, Halle, Germany; [Ghani, Mehdi] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Baric, Ivo] Univ Hosp Ctr Zagreb, Dept Paediat, Zagreb, Croatia; [Baric, Ivo] Univ Zagreb, Sch Med, Zagreb, Croatia; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Mol Genet, Ankara, Turkey; [Kovacs, Peter] Univ Leipzig, Med Ctr, IFB AdiposityDiseases, Leipzig, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Reis, Andre] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, Erlangen, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, Cologne, Germany	Charles University Prague; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Charles University Prague; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Charles University Prague; Motol University Hospital; Children's Memorial Health Institute; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University Sofia; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Martin Luther University Halle Wittenberg; University of Toronto; University of Zagreb; University of Zagreb; Ankara University; Leipzig University; University of Kiel; University of Erlangen Nuremberg; University of Cologne	Seemanova, E (corresponding author), Charles Univ Prague, Med Sch 2, Dept Clin Genet, Inst Biol & Med Genet, Prague, Czech Republic.; Nothnagel, M (corresponding author), Univ Cologne, Cologne Ctr Genom, Cologne, Germany.	eva.seemanova@lfmotol.cuni.cz; michael.nothnagel@uni-koeln.de	Krawczak, Michael/A-8964-2010; Reis, André/D-2309-2009; Tekin, Mustafa/ABG-7627-2020; Nothnagel, Michael/L-7187-2019; Nothnagel, Michael/G-6545-2014	Krawczak, Michael/0000-0003-2603-1502; Reis, André/0000-0002-6301-6363; Nothnagel, Michael/0000-0001-8305-7114; Kovacs, Peter/0000-0002-0290-5423; Jarolim, Petr/0000-0002-9612-8652; Chrzanowska, Krystyna/0000-0003-3888-0624; Tekin, Mustafa/0000-0002-3525-7960; Reis, AlessanRSS/0000-0001-8486-7469; Ghani, Mahdi/0000-0001-6455-7199; Saar, Kathrin/0000-0002-4483-1557	Sander Stiftung; DFG; German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN); Ministry of Science, Education and Sport of the Republic of Croatia [108-1081870-1885]; Czech Ministry of Health [AZV 12-31899 A, DRO 00064203]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01501]; Collaborative Research Center - German Research Foundation [CRC 1052, C01, B03]	Sander Stiftung; DFG(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Czech Ministry of Health(Ministry of Health, Czech Republic); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Collaborative Research Center - German Research Foundation	This work was supported by grants from the Sander Stiftung to KS and ES, by grants from the DFG to AR, KS and MD, by the German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) grants to MK and MN, by grant 108-1081870-1885 of the Ministry of Science, Education and Sport of the Republic of Croatia to IB, and by grants AZV 12-31899 A and DRO 00064203 from the Czech Ministry of Health to PS. The Sorb study was supported by Federal Ministry of Education and Research (BMBF), Germany, (FKZ: 01E01501) and by grants from the Collaborative Research Center funded by the German Research Foundation (CRC 1052; C01, B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Bogdanova N, 2008, BREAST CANCER RES TR, V112, P75, DOI 10.1007/s10549-007-9820-4; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Buslov KG, 2005, INT J CANCER, V114, P585, DOI 10.1002/ijc.20765; Carlomagno F, 1999, GENE CHROMOSOME CANC, V25, P393, DOI 10.1002/(SICI)1098-2264(199908)25:4<393::AID-GCC12>3.0.CO;2-8; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cheung VG, 2006, GENOME RES, V16, P973, DOI 10.1101/gr.5320706; Chrzanowska KH, 2006, INT J CANCER, V118, P1269, DOI 10.1002/ijc.21439; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Cilli D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114651; Cybulski C, 2004, CANCER RES, V64, P1215, DOI 10.1158/0008-5472.CAN-03-2502; Delhanty JDA, 2005, CYTOGENET GENOME RES, V111, P237, DOI 10.1159/000086894; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Digweed M, 1999, BIOESSAYS, V21, P649, DOI 10.1002/(SICI)1521-1878(199908)21:8<649::AID-BIES4>3.0.CO;2-O; Drabek J, 2002, CANCER GENET CYTOGEN, V138, P157, DOI 10.1016/S0165-4608(02)00594-0; Gao P, 2013, MUTAGENESIS, V28, P683, DOI 10.1093/mutage/get048; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gillespie J. H., 2004, POPULATION GENETICS; Gorbsky GJ., 2014, FEBS J, V282, P2471; Gorski B, 2003, INT J CANCER, V106, P379, DOI 10.1002/ijc.11231; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; He M, 2012, BREAST CANCER RES TR, V133, P111, DOI 10.1007/s10549-011-1700-2; Huang LO, 2013, HUM GENET, V132, P245, DOI 10.1007/s00439-012-1257-0; Kanka C, 2007, ANTICANCER RES, V27, P3015; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; Kushniarevich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135820; Kwiatkowski F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127363; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lombard DB, 2000, CANCER RES, V60, P2331; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Mateju M, 2012, BREAST CANCER RES TR, V133, P809, DOI 10.1007/s10549-012-2049-x; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Matise TC, 1999, AM J HUM GENET, V65, pA435; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Maurer M, 2010, J APPL GENET, V51, P211, DOI 10.1007/BF03195730; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Pardini B, 2009, MUTAT RES-FUND MOL M, V666, P64, DOI 10.1016/j.mrfmmm.2009.04.004; Petersen MB, 2000, CYTOGENET CELL GENET, V91, P199, DOI 10.1159/000056844; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Resnick IB, 2003, AM J MED GENET A, V120A, P174, DOI 10.1002/ajmg.a.20188; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Rozhanskii I. L. K AA, 2012, ADV ANTHR, V2, P139, DOI DOI 10.4236/aa.2012.23017; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Seeman P, 2004, PEDIATR NEUROL, V30, P195, DOI 10.1016/j.pediatrneurol.2003.07.003; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Seemanova E, 2004, Cas Lek Cesk, V143, P538; Seemanova E, 2004, CAS LEK CESK, V143, P542; Shimada M, 2009, CANCER RES, V69, P1768, DOI 10.1158/0008-5472.CAN-08-3016; Smith KR, 2013, CURR OPIN OBSTET GYN, V25, P207, DOI 10.1097/GCO.0b013e32835f1731; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Steffen J, 2004, INT J CANCER, V111, P67, DOI 10.1002/ijc.20239; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Varon R, 2000, EUR J HUM GENET, V8, P900, DOI 10.1038/sj.ejhg.5200554; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Voskarides K, 2014, GENET TEST MOL BIOMA, V18, P533, DOI 10.1089/gtmb.2014.0053; Yuan JS, 2010, J BIOL CHEM, V285, P1097, DOI 10.1074/jbc.M109.078436; Ziolkowska I, 2006, J APPL GENET, V47, P269, DOI 10.1007/BF03194635	69	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167984	10.1371/journal.pone.0167984	http://dx.doi.org/10.1371/journal.pone.0167984			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936167	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000389587100245
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William			Computerized Analysis of Verbal Fluency: Normative Data and the Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; WORD-ASSOCIATION TEST; COMPONENT ANALYSIS; NEUROPSYCHOLOGICAL OUTCOMES; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; CATEGORY FLUENCY; DESIGN FLUENCY; LOBE LESIONS; FREE-RECALL	In verbal fluency (VF) tests, subjects articulate words in a specified category during a short test period (typically 60 s). Verbal fluency tests are widely used to study language development and to evaluate memory retrieval in neuropsychiatric disorders. Performance is usually measured as the total number of correct words retrieved. Here, we describe the properties of a computerized VF (C-VF) test that tallies correct words and repetitions while providing additional lexical measures of word frequency, syllable count, and typicality. In addition, the C-VF permits (1) the analysis of the rate of responding over time, and (2) the analysis of the semantic relationships between words using a new method, Explicit Semantic Analysis (ESA), as well as the established semantic clustering and switching measures developed by Troyer et al. (1997). In Experiment 1, we gathered normative data from 180 subjects ranging in age from 18 to 82 years in semantic ("animals) and phonemic (letter "F") conditions. The number of words retrieved in 90 s correlated with education and daily hours of computeruse. The rate of word production declined sharply over time during both tests. In semantic conditions, correct-word scores correlated strongly with the number of ESA and Troyer-defined semantic switches as well as with an ESA-defined semantic organization index (SOI). In phonemic conditions, ESA revealed significant semantic influences in the sequence of words retrieved. In Experiment 2, we examined the test-retest reliability of different measures across three weekly tests in 40 young subjects. Different categories were used for each semantic ("animals", "parts of the body", and "foods") and phonemic (letters "F", "A", and "S") condition. After regressing out the influences of education and computeruse, we found that correct-word z-scores in the first session did not differ from those of the subjects in Experiment 1. Word production was uniformly greater in semantic than phonemic conditions. Intraclass correlation coefficients (ICCs) of correct-word z-scores were higher for phonemic (0.91) than semantic (0.77) tests. In semantic conditions, good reliability was also seen for the SOI (ICC = 0.68) and ESA-defined switches in semantic categories (ICC = 0.62). In Experiment 3, we examined the performance of subjects from Experiment 2 when instructed to malinger: 38% showed abnormal (p<0.05) performance in semantic conditions. Simulated malingerers with abnormal scores could be distinguished with 80% sensitivity and 89% specificity from subjects with abnormal scores in Experiment 1 using lexical, temporal, and semantic measures. In Experiment 4, we tested patients with mild and severe traumatic brain injury (mTBI and sTBI). Patients with mTBI performed within the normal range, while patients with sTBI showed significant impairments in correct-word z-scores and category shifts. The lexical, temporal, and semantic measures of the C-VF provide an automated and comprehensive description of verbal fluency performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA 95820 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.; Wyma, John M.] NeuroBehav Syst Inc, Berkeley, CA 94706 USA	University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), UC Davis Dept Neurol, Sacramento, CA 95820 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), UC Davis Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94706 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X	"VA Rehabilitation Research and Development Grants'' [CX000583, CX001000]; "VA Research and Development Grants'' [CX000583, CX001000]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	"VA Rehabilitation Research and Development Grants''; "VA Research and Development Grants''; Veterans Affairs(US Department of Veterans Affairs)	The funding source should be changed from "VA Rehabilitation Research and Development Grants grant CX000583 and CX001000 to DLW" to "VA Research and Development Grants grant CX000583 and CX001000 to DLW".	Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benito-Cuadrado MM, 2002, J CLIN EXP NEUROPSYC, V24, P1117, DOI 10.1076/jcen.24.8.1117.8376; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BUTTERS N, 1978, ARCH NEUROL-CHICAGO, V35, P585, DOI 10.1001/archneur.1978.00500330033006; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P262, DOI 10.1093/arclin/act001; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Connelly V., 2005, EDUC PSYCHOL-UK, V25, P99, DOI [10.1080/0144341042000294912, DOI 10.1080/0144341042000294912]; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Passos VMD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0454-6; Delis DC, 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; Ehlen F, 2015, PSYCHON B REV; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; Fernaeus SE, 2008, CORTEX, V44, P161, DOI 10.1016/j.cortex.2006.04.002; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Gabrilovich E., 2011, ACM T INFORM SYSTEMS, V29, P1, DOI DOI 10.1145/1961209.1961211; Gabrilovich E, 2009, J ARTIF INTELL RES, V34, P443, DOI 10.1613/jair.2669; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Hall JR, 2011, AGING NEUROPSYCHOL C, V18, P353, DOI [10.1080/13825585.2011.557495, 10.3109/17482941.2010.538698]; Hankee LD, 2013, EXP AGING RES, V39, P515, DOI 10.1080/0361073X.2013.839029; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Ide N, 2001, PROCEEDINGS OF CORPU; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; Juhasz BJ, 2012, PSYCHIAT RES, V200, P177, DOI 10.1016/j.psychres.2012.06.035; Kaplan E., 1983, THE ASSESSMENT OF AP; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kertesz A., 1982, WESTERN APHASIA BATT; Khalil MS, 2010, J CLIN EXP NEUROPSYC, V32, P1028, DOI 10.1080/13803391003672305; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Ledoux K, 2014, J CLIN EXP NEUROPSYC, V36, P205, DOI 10.1080/13803395.2013.878689; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nicodemus KK, 2014, CORTEX, V55, P182, DOI 10.1016/j.cortex.2013.12.004; OBER BA, 1986, J CLIN EXP NEUROPSYC, V8, P75, DOI 10.1080/01688638608401298; Ostrosky-Solis F, 2007, ARCH CLIN NEUROPSYCH, V22, P367, DOI 10.1016/j.acn.2007.01.011; Pakhomov SVS, 2016, NEUROPSYCHOLOGIA, V89, P42, DOI 10.1016/j.neuropsychologia.2016.05.031; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1997, EUR PSYCHIAT, V12, P124, DOI 10.1016/S0924-9338(97)80200-3; Roberts PM, 1997, BRAIN LANG, V59, P412, DOI 10.1006/brln.1997.1753; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Rosselli M, 2009, AGING NEUROPSYCHOL C, V16, P721, DOI 10.1080/13825580902912739; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Stolwyk R, 2015, J CLIN EXP NEUROPSYC, P1; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Takacs A, 2014, CHILD NEUROPSYCHOL, V20, P415, DOI 10.1080/09297049.2013.799645; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vita MG, 2014, J ALZHEIMERS DIS, V42, P1171, DOI 10.3233/JAD-140570; Vonberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115846; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Woods DL, 2015, FRONT HUM NEUROSCI; Woods DL, 2016, PLOS ONE; Woods DL, 2016, FRONTIERS IN HUMAN N; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1	113	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166439	10.1371/journal.pone.0166439	http://dx.doi.org/10.1371/journal.pone.0166439			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936001	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100026
J	Keysselt, K; Kreutzmann, T; Rother, K; Kerner, C; Krohn, K; Przybilla, J; Buske, P; Loffler-Wirth, H; Loeffler, M; Galle, J; Aust, G				Keysselt, K.; Kreutzmann, T.; Rother, K.; Kerner, C.; Krohn, K.; Przybilla, J.; Buske, P.; Loeffler-Wirth, H.; Loeffler, M.; Galle, J.; Aust, G.			Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency	ONCOGENE			English	Article							COLORECTAL-CANCER; LYNCH SYNDROME; TUMOR-DEVELOPMENT; TUMORIGENESIS; PROLIFERATION; MOUSE; NICHE; MODEL; NOTCH; HOMEOSTASIS	Mutations in mismatch repair (MMR) genes result in microsatellite instability (MSI) and early onset of colorectal cancer. To get mechanistic insights into the time scale, sequence and frequency of intestinal stem cell (ISC) transformation, we quantified MSI and growth characteristics of organoids of Msh2-deficient and control mice from birth until tumor formation and related them to tissue gene expression. Although in Msh2-deficient organoids MSI continuously increased from birth, growth characteristics remained stable at first. Months before tumor onset, normal Msh2-deficient tissue contained tumor precursor cells forming organoids with higher MSI, cystic growth and growth rates resembling temporarily those of tumor organoids. Consistently, Msh2-deficient tissue exhibited a tumor-like gene signature. Normal Msh2-deficient organoids showed increased inheritable transient cyst-like growth, which became independent of R-spondin. ISC transformation proceeded faster in vitro than in vivo independent of the underlying genotype but more under MMR deficiency. Transient cyst-like growth but not MSI was suppressed by aspirin. In summary, as highlighted by organoids, molecular alterations continuously proceeded long before tumor onset in MMR-deficient intestine, thus increasing its susceptibility for ISC transformation.	[Keysselt, K.; Kreutzmann, T.; Rother, K.; Kerner, C.; Aust, G.] Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany; [Rother, K.; Przybilla, J.; Buske, P.; Loeffler-Wirth, H.; Galle, J.] Univ Leipzig, Interdisciplinary Ctr Bioinformat IZBI, Leipzig, Germany; [Krohn, K.] Univ Leipzig, Core Unit DNA Technol, Interdisciplinary Ctr Clin Res Leipzig IZKF, Leipzig, Germany; [Loeffler, M.] Univ Leipzig, Inst Med Stat Informat & Epidemiol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Aust, G (corresponding author), Univ Leipzig, Fac Med, Res Labs, Dept Surg, Liebigstr 19, D-04103 Leipzig, Germany.	gabriela.aust@medizin.uni-leipzig.de	Rother, Karen/GQI-3824-2022; Rother, Karen/GQI-3786-2022	Kreutzmann, Tobias/0000-0002-6070-243X; Loeffler-Wirth, Henry/0000-0001-8239-440X	BMBF grant HNPCC-Sys [031 6065A]; BMBF grant INDRA [031A312]	BMBF grant HNPCC-Sys; BMBF grant INDRA	The study was supported by the BMBF grants HNPCC-Sys (grant number: 031 6065A) and INDRA (grant number: 031A312).	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bhalla A, 2013, CLIN LAB MED, V33, P835, DOI 10.1016/j.cll.2013.10.001; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Germann M, 2014, STEM CELL RES, V13, P355, DOI 10.1016/j.scr.2014.08.002; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Giardiello FM, 2014, GASTROENTEROLOGY, V147, P502, DOI 10.1053/j.gastro.2014.04.001; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Harris AR, 2014, J CELL SCI, V127, P2507, DOI 10.1242/jcs.142349; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; Kortum B, 2015, GUT, V64, P1905, DOI 10.1136/gutjnl-2014-307663; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Martinez P, 2009, AGING CELL, V8, P2, DOI 10.1111/j.1474-9726.2008.00441.x; Mcilhatton MA, 2011, CANCER PREV RES, V4, P684, DOI 10.1158/1940-6207.CAPR-10-0319; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Przybilla J, 2014, AGING CELL, V13, P320, DOI 10.1111/acel.12177; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Staffa L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121980; Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700; Tian H, 2015, CELL REP, V11, P33, DOI 10.1016/j.celrep.2015.03.007; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Woerner SM, 2015, MOL CARCINOGEN, V54, P1376, DOI 10.1002/mc.22213	40	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 11	2017	36	19					2750	2761		10.1038/onc.2016.429	http://dx.doi.org/10.1038/onc.2016.429			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EU6CF	27941880	Green Published			2022-12-26	WOS:000401120900012
J	Stam, NJ; Wilkens, S				Stam, Nicholas J.; Wilkens, Stephan			Structure of the Lipid Nanodisc-reconstituted Vacuolar ATPase Proton Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EM; isothermal titration calorimetry (ITC); protein structure; proton transport; vacuolar ATPase; V-o proton channel; lipid nanodisc	RENAL TUBULAR-ACIDOSIS; YEAST V-ATPASE; H+-ATPASE; CRYSTAL-STRUCTURE; SUBUNIT; ACIDIFICATION; CELLS; V-1; PUMP; PURIFICATION	Eukaryotic vacuolar H+-ATPase (V-ATPase) is a multisub-unit enzyme complex that acidifies subcellular organelles and the extracellular space. V-ATPase consists of soluble V-1-ATPase and membrane-integral V-o proton channel sectors. To investigate the mechanism of V-ATPase regulation by reversible disassembly, we recently determined a cryo-EM reconstruction of yeast V-o. The structure indicated that, when V-1 is released from V-o, the N-terminal cytoplasmic domain of subunit a (a(NT)) changes conformation to bind rotor subunit d. However, insufficient resolution precluded a precise definition of the a(NT)-d interface. Here we reconstituted V-o into lipid nanodiscs for single-particle EM. 3D reconstructions calculated at similar to 15-angstrom resolution revealed two sites of contact between a(NT) and d that are mediated by highly conserved charged residues. Alanine mutagenesis of some of these residues disrupted the a(NT)-d interaction, as shown by isothermal titration calorimetry and gel filtration of recombinant subunits. A recent cryo-EM study of holo V-ATPase revealed three major conformations corresponding to three rotational states of the central rotor of the enzyme. Comparison of the three V-ATPase conformations with the structure of nanodisc-bound V-o revealed that V-o is halted in rotational state 3. Combined with our prior work that showed autoinhibited V-1-ATPase to be arrested in state 2, we propose a model in which the conformational mismatch between free V-1 and V-o functions to prevent unintended reassembly of holo V-ATPase when activity is not needed.	[Stam, Nicholas J.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Brown D, 1997, J EXP BIOL, V200, P257; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Diab HI, 2013, J BIOL CHEM, V288, P11366, DOI 10.1074/jbc.M112.419259; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2014, EXPERT OPIN DRUG DIS, V9, P505, DOI 10.1517/17460441.2014.902155; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2014, J MOL BIOL, V426, P286, DOI 10.1016/j.jmb.2013.09.018; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vavassori S, 2014, J CELL BIOL, V205, P7, DOI 10.1083/jcb.201403040; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	15	15	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1749	1761		10.1074/jbc.M116.766790	http://dx.doi.org/10.1074/jbc.M116.766790			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965356	Green Published, hybrid			2022-12-26	WOS:000395515600017
J	Dalzon, B; Lebas, C; Jimenez, G; Gutjahr, A; Terrat, C; Exposito, JY; Verrier, B; Lethias, C				Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire			Poly(Lactic Acid) Nanoparticles Targeting alpha 5 beta 1 Integrin as Vaccine Delivery Vehicle, a Prospective Study	PLOS ONE			English	Article							HUMAN FIBRONECTIN; CELL-ADHESION; RGD; SURFACE; SITES; FORMULATION; RESPONSES; THERAPY	Biodegradable polymeric nanoparticles are vehicles of choice for drug delivery and have the ability to encapsulate and present at their surface different molecules of interest. Among these bio-nanocarriers, poly(lactic acid) (PLA) nanoparticles have been used as adjuvant and vehicle for enhanced vaccine efficacy. In order to develop an approach to efficient vaccine delivery, we developed nanoparticles to target alpha 5 beta 1 positive cells. We first overproduced, in bacteria, human fibronectin FNIII9/10 recombinant proteins possessing an integrin alpha 5 beta 1 binding site, the RGDS sequence, or a mutated form of this site. After having confirmed the integrin binding properties of these recombinant proteins in cell culture assays, we were able to formulate PLA nanoparticles with these FNIII9/10 proteins at their surface. We then confirmed, by fluorescence and confocal microscopy, an enhanced cellular uptake by alpha 5 beta 1(+) cells of RGDS-FNIII9/10 coated PLA nanoparticles, in comparison to KGES-FNIII9/10 coated or non-coated controls. As a first vaccination approach, we prepared PLA nanoparticles co-coated with p24 (an HIV antigen), and RGDS-or KGES-FNIII9/10 proteins, followed by subcutaneous vaccine administration, in mice. Although we did not detect improvements in the apparent humoral response to p24 antigen in the serum of RGDS/p24 nanoparticle-treated mice, the presence of the FNIII proteins increased significantly the avidity index of anti-p24 antibodies compared to p24-nanoparticle-injected control mice. Future developments of this innovative targeted vaccine are discussed.	[Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire] Univ Lyon 1, Inst Biol & Chim Prot, Federat Rech,Gerland Lyon Sud, SFR BioSci Unite Mixte Serv 3444 US8, Lyon, France; [Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire] CNRS, Lab Biol Tissulaire & Ingn Therapeut, Unite Mixte Rech, Lyon, France; [Jimenez, Gina] Univ Lyon 1, CNRS, INSERM, UMR 5310,U1217,Inst NeuroMyogene, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Exposito, JY (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, Federat Rech,Gerland Lyon Sud, SFR BioSci Unite Mixte Serv 3444 US8, Lyon, France.	jy.exposito@ibcp.fr	Dalzon, Bastien/GPP-4184-2022; verrier, bernard/J-4094-2017	verrier, bernard/0000-0002-8478-7095	AFM doctoral fellowship; ANRT PhD fellowship; Fondation Pierre Berge - Sidaction; FP7 European grants [241904, 280873]; HIVERA; InvivoGen	AFM doctoral fellowship; ANRT PhD fellowship(French National Research Agency (ANR)); Fondation Pierre Berge - Sidaction; FP7 European grants; HIVERA; InvivoGen	GJ is supported by an AFM doctoral fellowship, AG by an ANRT PhD fellowship in collaboration with InvivoGen, whereas JYE and BV are supported by grants from the Fondation Pierre Berge - Sidaction, two FP7 European grants CUT'HIVAC (No. 241904) and ADITEC (No. 280873) and HIVERA support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CAS, 2006, INT IMMUNOL, V18, P1295, DOI 10.1093/intimm/dxl062; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bobbala S, 2016, PHARM RES-DORDR, V33, P2078, DOI 10.1007/s11095-016-1979-0; Burrows L, 1999, BIOCHEM J, V344, P527, DOI 10.1042/0264-6021:3440527; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Elefteriou F, 1999, EUR J BIOCHEM, V263, P840, DOI 10.1046/j.1432-1327.1999.00563.x; Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; Garg A, 2009, INT J PHARMACEUT, V366, P201, DOI 10.1016/j.ijpharm.2008.09.016; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GOODWIN AE, 1995, J IMMUNOL METHODS, V187, P213, DOI 10.1016/0022-1759(95)00187-6; GRENZ H, 1993, J CELL SCI, V105, P739; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; Jancic C, 1998, IMMUNOLOGY, V95, P283; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kankaanpaa P, 2015, NANOSCALE, V7, P17889, DOI 10.1039/c5nr06218g; Kenny FN, 2015, CELL TISSUE RES, V360, P571, DOI 10.1007/s00441-014-2064-9; Khanbeigi RA, 2012, J CONTROL RELEASE, V162, P259, DOI 10.1016/j.jconrel.2012.07.019; Kim H, 2016, J BIOMED NANOTECHNOL, V12, P536, DOI 10.1166/jbn.2016.2189; Legaz S, 2016, NANOTOXICOLOGY, V16, P1; Legaz S, 2015, PROTEIN EXPRES PURIF, V113, P94, DOI 10.1016/j.pep.2015.05.009; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Mann JFS, 2014, J VIROL, V88, P6959, DOI 10.1128/JVI.00183-14; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Pavot V, 2014, NANOMEDICINE-UK, V9, P2703, DOI [10.2217/NNM.14.156, 10.2217/nnm.14.156]; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Pavot V, 2013, J CONTROL RELEASE, V167, P60, DOI 10.1016/j.jconrel.2013.01.015; Pereira M, 2007, TISSUE ENG, V13, P567, DOI 10.1089/ten.2006.0228; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pike DB, 2010, ADV DRUG DELIVER REV, V62, P167, DOI 10.1016/j.addr.2009.11.027; Primard C, 2010, BIOMATERIALS, V31, P6060, DOI 10.1016/j.biomaterials.2010.04.021; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Saini V, 2010, J DRUG TARGET, V18, P212, DOI 10.3109/10611860903386920; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Stolzoff M, 2015, BIOMACROMOLECULES, V16, P1958, DOI 10.1021/acs.biomac.5b00336; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Torrano AA, 2013, NANOMEDICINE-UK, V8, P1815, DOI 10.2217/nnm.12.178; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Waithman J, 2016, EUR J IMMUNOL, V46, P543, DOI 10.1002/eji.201646293; Wang F, 2013, INT J MOL SCI, V14, P13447, DOI 10.3390/ijms140713447	45	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167663	10.1371/journal.pone.0167663	http://dx.doi.org/10.1371/journal.pone.0167663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973577	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300037
J	Rhead, R; Masimirembwa, C; Cooke, G; Takaruza, A; Nyamukapa, C; Mutsimhi, C; Gregson, S				Rhead, Rebecca; Masimirembwa, Collen; Cooke, Graham; Takaruza, Albert; Nyamukapa, Constance; Mutsimhi, Cosmas; Gregson, Simon			Might ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; NEVIRAPINE PLASMA-CONCENTRATIONS; ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; CYP2B6; PHARMACOGENETICS; RIFAMPICIN; EFAVIRENZ; REGIMENS; AFRICA	Background As we endeavour to examine rates of viral suppression in PLHIV, reliable data on ART adherence are needed to distinguish between the respective contributions of poor adherence and treatment failure on high viral load. Self-reported data are susceptible to response bias and although biomarker data on drug presence and concentration can provide a superior, alternative method of measurement, complications due to drug-drug interactions and genetic variations can cause some inaccuracies. We investigate the feasibility of combining both biomarker and self-report data to produce a potentially more accurate measure of ART adherence. Methods Data were taken from a large general-population survey in the Manicaland province, Zimbabwe, conducted in 2009-2011. HIV-infected adults who had initiated ART (N = 560) provided self-report data on adherence and dried blood spot samples that were analysed for traces of ART medication. A new three-category measure of ART adherence was constructed, based on biomarker data but using self-report data to adjust for cases with abnormally low and high drug concentrations due to possible drug-drug interactions and genetic factors, and was assessed for plausibility using survey data on socio-demographic correlates. Results 94.3% (528/560) and 92.7% (519/560) of the sample reported faithful adherence to their medication and had traces of ART medication, respectively. The combined measure estimated good evidence of ART adherence at 69% and excellent evidence of adherence at 53%. The regression analysis results showed plausible patterns of ART adherence by socio-demographic status with men and younger participants being more likely to adhere poorly to medication, and higher socio-economic status individuals and those living in more urban locations being more likely to adhere well. Conclusion Biomarker and self-reported measures of adherence can be combined in a meaningful way to produce a potentially more accurate measure of ART adherence. Results indicate that ART adherence in Manicaland is at best 69%, which not only allows for considerable room for improvement but also suggests that the area may be falling short of the UNAIDS' 90% target regarding viral suppression. Increased efforts are needed to improve ART adherence particularly amongst the young male population in rural areas of east Zimbabwe.	[Rhead, Rebecca; Gregson, Simon] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Masimirembwa, Collen; Mutsimhi, Cosmas] African Inst Biomed Res & Technol, Harare, Zimbabwe; [Cooke, Graham] Imperial Coll London, Dept Med, London, England; [Takaruza, Albert; Nyamukapa, Constance] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Imperial College London; Biomedical Research Training Institute	Rhead, R (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	r.rhead@imperial.ac.uk		Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069; Rhead, Rebecca/0000-0002-5863-604X; Masimirembwa, Collen/0000-0002-4053-212X	Wellcome Trust [084401/Z/07/B]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Manicaland Project is funded by Wellcome Trust https://wellcome.ac.uk/funding. Grant Number: 084401/Z/07/B. Recipient is SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2014, HIV AIDS JUNPO 90 90; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Branch RA, 2000, CLIN PHARMACOL THER, V68, P401, DOI 10.1067/mcp.2000.110561; Burman WJ, 1999, CLIN INFECT DIS, V28, P419, DOI 10.1086/515174; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; de Truchis P, 2016, J ANTIMICROB CHEMOTH, V71, P3222, DOI 10.1093/jac/dkw286; Dhoro M, 2013, CURR HIV RES, V11, P481, DOI 10.2174/1570162X113119990048; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; Erickson DA, 1999, DRUG METAB DISPOS, V27, P1488; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2011, POPUL DEV REV, V37, P333, DOI 10.1111/j.1728-4457.2011.00413.x; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2004, AIDS, V18, P2391; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Liechty CA, 2003, AIDS, V17, P1383, DOI 10.1097/00002030-200306130-00013; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Manzou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086060; Matimba A, 2008, EUR J HUM GENET, V16, P780, DOI 10.1038/ejhg.2008.49; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Mehlotra RK, 2007, BRIT J CLIN PHARMACO, V64, P391, DOI 10.1111/j.1365-2125.2007.02884.x; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Melbourne K M, 1999, AIDS Read, V9, P329; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Pearson CR, 2007, AIDS BEHAV, V11, P161, DOI 10.1007/s10461-006-9133-3; Penzak SR, 2007, HIV MED, V8, P86, DOI 10.1111/j.1468-1293.2007.00432.x; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007; Rotger M, 2007, CLIN PHARMACOL THER, V81, P557, DOI 10.1038/sj.clpt.6100072; Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001; Schaefer R, 2016, SPATIAL PATTER UNPUB; Schur N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20063; Simoni JM, 2014, AIDS BEHAV, V18, P2285, DOI 10.1007/s10461-014-0905-x; ter Heine R, 2008, J INT AIDS SOC, V11, pP242; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; Wang J, 2006, PHARMACOGENET GENOM, V16, P191; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167852	10.1371/journal.pone.0167852	http://dx.doi.org/10.1371/journal.pone.0167852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973550	Green Published, Green Submitted, gold			2022-12-26	WOS:000392754300046
J	Xu, YF; Wu, JY; Yin, CC; Mao, YD				Xu, Yaofang; Wu, Jiayi; Yin, Chang-Cheng; Mao, Youdong			Unsupervised Cryo-EM Data Clustering through Adaptively Constrained K-Means Algorithm	PLOS ONE			English	Article							ELECTRON-MICROSCOPY IMAGES; SINGLE-PARTICLES; BIOLOGICAL MACROMOLECULES; ANGSTROM RESOLUTION; RECONSTRUCTION; PROJECTIONS; CLASSIFICATION; HETEROGENEITY; COMPLEXES; SOFTWARE	In single-particle cryo-electron microscopy (cryo-EM), K-means clustering algorithm is widely used in unsupervised 2D classification of projection images of biological macromolecules. 3D ab initio reconstruction requires accurate unsupervised classification in order to separate molecular projections of distinct orientations. Due to background noise in single-particle images and uncertainty of molecular orientations, traditional K-means clustering algorithm may classify images into wrong classes and produce classes with a large variation in membership. Overcoming these limitations requires further development on clustering algorithms for cryo-EM data analysis. We propose a novel unsupervised data clustering method building upon the traditional K-means algorithm. By introducing an adaptive constraint term in the objective function, our algorithm not only avoids a large variation in class sizes but also produces more accurate data clustering. Applications of this approach to both simulated and experimental cryo-EM data demonstrate that our algorithm is a significantly improved alterative to the traditional K-means algorithm in single-particle cryo-EM analysis.	[Xu, Yaofang; Yin, Chang-Cheng] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biophys, Beijing, Peoples R China; [Wu, Jiayi; Mao, Youdong] Peking Univ, Ctr Quantitat Biol, Sch Phys, Inst Condensed Matter Phys,State Key Lab Artifici, Beijing, Peoples R China; [Mao, Youdong] Harvard Med Sch, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Intel Parallel Comp Ctr Struct Biol, Boston, MA USA	Peking University; Peking University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yin, CC (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biophys, Beijing, Peoples R China.; Mao, YD (corresponding author), Peking Univ, Ctr Quantitat Biol, Sch Phys, Inst Condensed Matter Phys,State Key Lab Artifici, Beijing, Peoples R China.; Mao, YD (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Intel Parallel Comp Ctr Struct Biol, Boston, MA USA.	ccyin@hsc.pku.edu.cn; youdong_mao@dfci.harvard.edu	吴, 家怡/GSI-7419-2022; Mao, Youdong/AFJ-2673-2022	Mao, Youdong/0000-0001-9302-2257	grant of the Thousand Talents Plan of China; National Natural Science Foundation of China [91530321]; Intel Parallel Computing Center program; National Science Foundation under NSF [1541959]; NIH, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID) [AI100645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER	grant of the Thousand Talents Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Intel Parallel Computing Center program; National Science Foundation under NSF(National Science Foundation (NSF)); NIH, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant of the Thousand Talents Plan of China (YM), by a grant from National Natural Science Foundation of China 91530321 (YM), by the Intel Parallel Computing Center program (YM). The cryo-EM experiments were performed in part at the Center for Nanoscale Systems at Harvard University, a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award no. 1541959. The cryo-EM facility was funded through the NIH grant AI100645, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID). The data processing was performed in part in the Sullivan supercomputer, which is funded in part by a gift from Mr. and Mrs. Daniel J. Sullivan, Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloise D, 2009, MACH LEARN, V75, P245, DOI 10.1007/s10994-009-5103-0; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Banerjee A, 2006, DATA MIN KNOWL DISC, V13, P365, DOI 10.1007/s10618-006-0040-z; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bhamre T, 2016, J STRUCT BIOL, V195, P72, DOI 10.1016/j.jsb.2016.04.013; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1982, J MOL BIOL, V161, P134, DOI 10.1016/0022-2836(82)90282-0; Frank J, 2006, 3 DIMENSIONAL ELECT, Vxiv; Frank J, 2006, 3 DIMENSIONAL ELECT; GONCHAROV AB, 1988, ULTRAMICROSCOPY, V25, P317, DOI 10.1016/0304-3991(88)90006-X; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jaitly N, 2010, BIOINFORMATICS, V26, P2406, DOI 10.1093/bioinformatics/btq456; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Malinen MI, 2014, LECT NOTES COMPUT SC, V8621, P32, DOI 10.1007/978-3-662-44415-3_4; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X; Penczek PA, 2010, IMAGE RESTORATION CR, P35; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; SCHATZ M, 1990, ULTRAMICROSCOPY, V32, P255, DOI 10.1016/0304-3991(90)90003-5; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M., 1980, Pattern Recognition in Practice. Proceedings of an International Workshop, P235; van Heel M, 1997, SCANNING MICROSC, V11, P195; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404; Wu J, ARXIV 2016 1604 0453; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011; Zhao ZZ, 2014, J STRUCT BIOL, V186, P153, DOI 10.1016/j.jsb.2014.03.003; Zhu SZ, 2010, KNOWL-BASED SYST, V23, P883, DOI 10.1016/j.knosys.2010.06.003	45	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167765	10.1371/journal.pone.0167765	http://dx.doi.org/10.1371/journal.pone.0167765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959895	Green Submitted, gold, Green Published			2022-12-26	WOS:000392753900015
J	Belle, L; Fransolet, G; Somja, J; Binsfeld, M; Delvenne, P; Drion, P; Hannon, M; Beguin, Y; Ehx, G; Baron, F				Belle, Ludovic; Fransolet, Gilles; Somja, Joan; Binsfeld, Marilene; Delvenne, Philippe; Drion, Pierre; Hannon, Muriel; Beguin, Yves; Ehx, Gregory; Baron, Frederic			Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease	PLoS One			English	Article							STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; CONSENSUS DEVELOPMENT PROJECT; DOSE-DEPENDENT MANNER; WORKING GROUP-REPORT; CHRONIC GVHD; MARROW TRANSPLANTATION; KINASE INHIBITOR; CLINICAL-TRIALS; IN-VITRO	Background Sclerodermatous chronic Graft-versus-Host Disease (scl-cGVHD) is one of the most severe form of cGVHD. The Platelet-derived Grotwth Factor (PDGF) and the Transforming Growth Factor-beta (TGF-beta) play a significant role in the fibrosing process occurring in scl-cGVHD. This prompted us to assess the impact of the PDGF-r and c-Abl tyrosine kinase inhibitor imatinib on scl-cGVHD. Methods To assess the impact of imatinib on T cell subset proliferation in vivo, Balb/cJ recipient mice were lethally (7 Gy) irradiated and then injected with 10x10(6) bone marrow cells from B10.D2 mice on day 0. Fourteen days later, 70x10(6) carboxyfluorescein succinimidyl ester (CFSE)labeled splenocytes from B10.D2 mice were infused and imatinib or sterile water was administered for 5 days. To induce severe scl-cGVHD, Balb/cJ mice were injected i.v. with 10.10(6) bone marrow cells and 70.10(6) splenocytes from B10.D2 donor mice after 7 Gy irradiation. Mice were then given sterile water or imatinib from day +7 after transplantation to the end of the experiment (day +52). Results Imatinib decreased the proliferation of total T cells (P = 0.02), CD8+ T cells (P = 0.01), and of regulatory T cells (Tregs) (P = 0.02) in the spleen. In the severe scl-cGVHD model, imatinib-treated mice had significantly lower levels of PDGF-r phosphorylation than control mice on day 29 after transplantation (P = 0.008). However, scl-cGVHD scores were similar between vehicle-and imatinib-treated mice during the whole experiment, while there was a suggestion for less weight loss in imatinib-treated mice that reached statistical significance at day +52 following transplantation (P = 0.02). Conclusions Imatinib had a limited impact in murine scl-cGVHD despite significant inhibition of PDGF-r.	[Belle, Ludovic; Fransolet, Gilles; Binsfeld, Marilene; Hannon, Muriel; Beguin, Yves; Ehx, Gregory; Baron, Frederic] Univ Liege, Hematol Res Unit, GIGA I, Liege, Belgium; [Somja, Joan; Delvenne, Philippe] Univ Liege, Dept Pathol, Liege, Belgium; [Drion, Pierre] Univ Liege, GIGA R, Liege, Belgium; [Beguin, Yves; Baron, Frederic] CHU Liege, Dept Med, Div Hematol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Fransolet, G (corresponding author), Univ Liege, Hematol Res Unit, GIGA I, Liege, Belgium.	gilles.fransolet@ulg.ac.be	Binsfeld, Marilene/AAG-9121-2020; Ehx, Gregory/AAH-1706-2021	Ehx, Gregory/0000-0002-7018-1770	National Fund for Scientific Research (FNRS) [PDR T.0069.15-7/7]; Leon Fredericq fund; Anti-Cancer Center at the University of Liege; Belgian Federation Against Cancer	National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq fund; Anti-Cancer Center at the University of Liege; Belgian Federation Against Cancer	This study was supported by funds from: the National Fund for Scientific Research (FNRS, grant PDR T.0069.15-7/7), the Leon Fredericq fund and Anti-Cancer Center at the University of Liege, and the Belgian Federation Against Cancer. LB, GF, GE were/are Televie Research Assistant and FB is Senior Research Associate at the National Fund for Scientific Research (FNRS) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2016, CLIN CANCER RES, V22, P319, DOI 10.1158/1078-0432.CCR-15-1443; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Baron F, 2004, SPRINGER SEMIN IMMUN, V26, P71, DOI 10.1007/s00281-004-0165-3; Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Baron F, 2002, BIOL BLOOD MARROW TR, V8, P351, DOI 10.1053/bbmt.2002.v8.pm12171481; Belle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052564; Binsfeld M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113764; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chen J, 2007, INT J ONCOL, V31, P1133; Chu YW, 2008, BIOL BLOOD MARROW TR, V14, P365, DOI 10.1016/j.bbmt.2007.12.002; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Cwynarski K, 2004, LEUKEMIA, V18, P1332, DOI 10.1038/sj.leu.2403401; de Masson A, 2012, BLOOD, V120, P5089, DOI 10.1182/blood-2012-09-453928; Demetri GD, 2009, CLIN CANCER RES, V15, P5910, DOI 10.1158/1078-0432.CCR-09-0542; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duarte RF, 2014, BONE MARROW TRANSPL, V49, P49, DOI 10.1038/bmt.2013.129; Dubovsky JA, 2014, J CLIN INVEST, V124, P4867, DOI 10.1172/JCI75328; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Flynn R, 2015, BLOOD, V125, P4085, DOI 10.1182/blood-2014-08-595470; Fransolet G, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0281-2; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Hannon M, 2015, CLIN CANCER RES, V21, P3131, DOI 10.1158/1078-0432.CCR-14-3374; Hannon M, 2014, TRANSFUSION, V54, P353, DOI 10.1111/trf.12279; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Inamoto Y, 2013, BLOOD, V121, P5098, DOI 10.1182/blood-2012-10-464198; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; Larmonier N, 2008, J IMMUNOL, V181, P6955, DOI 10.4049/jimmunol.181.10.6955; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Magro L, 2008, BONE MARROW TRANSPL, V42, P757, DOI 10.1038/bmt.2008.252; Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Olivieri A, 2013, BLOOD, V122, P4111, DOI 10.1182/blood-2013-05-494278; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Pirson L, 2006, STEM CELLS, V24, P1814, DOI 10.1634/stemcells.2005-0290; Poulin JF, 2003, BLOOD, V102, P4600, DOI 10.1182/blood-2003-05-1428; Reddy P, 2012, BIOL BLOOD MARROW TR, V18, pS17, DOI 10.1016/j.bbmt.2011.10.034; Rodgers CJ, 2013, BONE MARROW TRANSPL, V48, P323, DOI 10.1038/bmt.2012.96; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; Servais S, 2016, EXPERT OPIN INV DRUG, P1; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Toubert A, 2012, TISSUE ANTIGENS, V79, P83, DOI 10.1111/j.1399-0039.2011.01820.x; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507; Zerr P, 2012, AM J PATHOL, V181, P1672, DOI 10.1016/j.ajpath.2012.07.017; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167997	10.1371/journal.pone.0167997	http://dx.doi.org/10.1371/journal.pone.0167997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942010	gold, Green Published, Green Submitted			2022-12-26	WOS:000392745600044
J	Bruckner, S; Kammer, T				Brueckner, Sabrina; Kammer, Thomas			No Modulation of Visual Cortex Excitability by Transcranial Direct Current Stimulation	PLOS ONE			English	Article							THETA-BURST STIMULATION; HUMAN MOTOR CORTEX; MAGNETIC STIMULATION; CORTICAL EXCITABILITY; PHOSPHENE THRESHOLDS; LOW-FREQUENCY; LIGHT DEPRIVATION; MOVING PHOSPHENE; TDCS; PERCEPTION	Measuring phosphene thresholds (PTs) is often used to investigate changes in the excitability of the human visual cortex through different brain stimulation methods like repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS). In several studies, PT increase or decrease has been shown after rTMS or tDCS application. Recently, using PT measurements we showed that the state of the neurons in the visual cortex after rTMS might have an influence on the modulatory effects of stimulation. In the present study we aimed to investigate whether visual cortex activity following stimulation influences the modulatory effects of tDCS as well. In a between-group design, anodal or cathodal tDCS was applied to the visual cortex twice per subject, with either high or low visual demand following stimulation. We observed no modulation of PT neither directly following both anodal and cathodal tDCS nor following the visual demand periods. We rather found high inter-individual variability in the response to tDCS, and intra-individual reliability in the direction of modulation was observed for cathodal tDCS only. Thus, our results do not confirm the modulatory effects of tDCS on visual cortex excitability published previously. Moreover, they support the confirmation that tDCS effects have little reliability on varied TMS outcome measurements.	[Brueckner, Sabrina; Kammer, Thomas] Univ Ulm, Sect Neurostimulat, Dept Psychiat, Ulm, Germany	Ulm University	Bruckner, S (corresponding author), Univ Ulm, Sect Neurostimulat, Dept Psychiat, Ulm, Germany.	sabrina.brueckner@uni-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645; Lorenz, Sabrina/0000-0001-5798-4838				Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2004, NEUROREPORT, V15, P297, DOI 10.1097/00001756-200402090-00017; Antal A, 2004, NEUROREPORT, V15, P1307, DOI 10.1097/01.wnr.0000127460.08361.84; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00642; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BARKER AT, 1985, J PHYSIOL-LONDON, V369, pP3; Bocci T, 2014, J NEURAL TRANSM, V121, P221, DOI 10.1007/s00702-013-1104-z; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Brighina F, 2002, EXP BRAIN RES, V145, P177, DOI 10.1007/s00221-002-1096-7; Bruckner S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00591; Bruckner S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159743; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Fierro B, 2005, J PHYSIOL-LONDON, V565, P659, DOI 10.1113/jphysiol.2004.080184; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Gratton C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101430; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nozari N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084338; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Pirulli C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00226; Pirulli C, 2013, BRAIN STIMUL, V6, P683, DOI 10.1016/j.brs.2012.12.005; Rauschecker AM, 2004, EXP BRAIN RES, V157, P124, DOI 10.1007/s00221-004-1910-5; Simis M, 2013, NEUROREPORT, V24, P973, DOI 10.1097/WNR.0000000000000021; Siniatchkin M, 2011, CLIN NEUROPHYSIOL, V122, P2475, DOI 10.1016/j.clinph.2011.05.003; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167697	10.1371/journal.pone.0167697	http://dx.doi.org/10.1371/journal.pone.0167697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936117	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100155
J	Kaplan, DA; Olabarrieta, M; Frederick, P; Valle-Levinson, A				Kaplan, David A.; Olabarrieta, Maitane; Frederick, Peter; Valle-Levinson, Arnoldo			Freshwater Detention by Oyster Reefs: Quantifying a Keystone Ecosystem Service	PLOS ONE			English	Article							SEA-LEVEL; RESTORATION; POPULATION; FLORIDA; BAY; USA	Oyster reefs provide myriad ecosystem services, including water quality improvement, fisheries and other faunal support, shoreline protection from erosion and storm surge, and economic productivity. However, their role in directing flow during non-storm conditions has been largely neglected. In regions where oyster reefs form near the mouth of estuarine rivers, they likely alter ocean-estuary exchange by acting as fresh water "dams". We hypothesize that these reefs have the potential to detain fresh water and influence salinity over extensive areas, thus providing a "keystone" ecosystem service by supporting estuarine functions that rely on the maintenance of estuarine (i.e., brackish) conditions in the near-shore environment. In this work, we investigated the effects of shore-parallel reefs on estuarine salinity using field data and hydrodynamic modeling in a degraded reef complex in the northeastern Gulf of Mexico. Results suggested that freshwater detention by long linear chains of oyster reefs plays an important role in modulating salinities, not only in the oysters' local environment, but over extensive estuarine areas (tens of square kilometers). Field data confirmed the presence of salinity differences between landward and seaward sides of the reef, with long-term mean salinity differences of >30% between sides. Modeled results expanded experimental findings by illustrating how oyster reefs affect the lateral and offshore extent of freshwater influence. In general, the effects of simulated reefs were most pronounced when they were highest in elevation, without gaps, and when riverine discharge was low. Taken together, these results describe a poorly documented ecosystem service provided by oyster reefs; provide an estimate of the magnitude and spatial extent of this service; and offer quantitative information to help guide future oyster reef restoration.	[Kaplan, David A.; Olabarrieta, Maitane; Valle-Levinson, Arnoldo] Univ Florida, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA; [Frederick, Peter] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kaplan, DA (corresponding author), Univ Florida, Engn Sch Sustainable Infrastruct & Environm, Gainesville, FL 32611 USA.	dkaplan@ufl.edu		Valle, Arnoldo/0000-0002-3852-0971; Kaplan, David/0000-0002-0103-0928; Frederick, Peter/0000-0002-8098-9490	Florida SeaGrant [GM02389]	Florida SeaGrant	This work was partially supported by Florida SeaGrant under contract number GM02389. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bilkovic DM, 2008, MAR ECOL PROG SER, V358, P27, DOI 10.3354/meps07279; Blair S, 2015, ECOSYSTEM SERVICES V; Bureau UC, GENERATED D KAPLAN U; Camp E. V., 2015, ECOLOGY SOC, V20; Chassignet EP, 2000, DYNAM ATMOS OCEANS, V32, P155, DOI 10.1016/S0377-0265(00)00046-4; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Dekshenieks MM, 2000, ESTUARIES, V23, P593, DOI 10.2307/1352887; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Frederick P, 2016, J SHELLFISH RES, V35, P359, DOI 10.2983/035.035.0210; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Grinnell RS, 1972, STRUCTURE DEV OYSTER; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Livingston RJ, 2000, ESTUAR COAST SHELF S, V50, P655, DOI 10.1006/ecss.1999.0597; Madsen PA, 1988, COASTAL ENG P, V1; McCay DPF, 2003, MAR ECOL PROG SER, V264, P197; MOAC, 2007, MAR OYST ADV COMM 20; Rodriguez AB, 2014, NAT CLIM CHANGE, V4, P493, DOI [10.1038/nclimate2216, 10.1038/NCLIMATE2216]; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Seavey JR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00205.1; Shchepetkin A, 2005, REGIONAL OCEAN MODEL; Styles R, 2015, J COASTAL RES, V31, P978, DOI 10.2112/JCOASTRES-D-14-00115.1; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tolley SG, 2005, J SHELLFISH RES, V24, P1007; van de Koppel J, 2015, ANNU REV MAR SCI, V7, P139, DOI 10.1146/annurev-marine-010814-015805; Wang H, 2008, ECOL MODEL, V211, P77, DOI 10.1016/j.ecolmodel.2007.08.018; Wright EE, 2005, J SEDIMENT RES, V75, P621, DOI 10.2110/jsr.2005.051	31	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167694	10.1371/journal.pone.0167694	http://dx.doi.org/10.1371/journal.pone.0167694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936184	Green Published, gold			2022-12-26	WOS:000389587100154
J	Muller, A; Seinige, D; Jansen, W; Klein, G; Ehricht, R; Monecke, S; Kehrenberg, C				Mueller, Anja; Seinige, Diana; Jansen, Wiebke; Klein, Guenter; Ehricht, Ralf; Monecke, Stefan; Kehrenberg, Corinna			Variety of Antimicrobial Resistances and Virulence Factors in Staphylococcus aureus Isolates from Meat Products Legally and Illegally Introduced to Germany	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CLONAL COMPLEXES; IDENTIFICATION; POULTRY; SUSCEPTIBILITY; OXACILLIN; SPREAD; GENES; GRLA; FOOD	Food products of animal origin can serve as a vehicle for Staphylococcus (S.) aureus, a facultative pathogen involved in a variety of diseases. As a result, international trade and illegal transportation of foodstuffs can facilitate the distribution of S. aureus over long distances. In this study, we investigated S. aureus isolates recovered from meat products confiscated from passengers returning from non-EU countries at two German airports and from samples of legally imported meats from non-EU countries. The aim was to characterize isolates in regard to their genetic relatedness as well as their antimicrobial resistance profiles and major virulence factors in order to assess potential risks associated with these products. The isolates were characterized by spa typing, MLST, macrorestriction analysis, microarray analysis and antimicrobial susceptibility testing. MRSA isolates were further characterized by dru typing. The characteristics of the majority of the isolates indicated a human origin, rather than an association with livestock. The results further revealed a considerable heterogeneity among the MRSA isolates, despite their common origin. Overall, a plenitude of major virulence factors and antimicrobial resistances was detected among the isolates, highlighting the potential risks associated with contaminated meat products and the transportation of such products among different countries.	[Mueller, Anja; Seinige, Diana; Jansen, Wiebke; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Fdn, Hannover, Germany; [Jansen, Wiebke] Univ Namur, Integrated Vet Res Unit, Namur, Belgium; [Ehricht, Ralf; Monecke, Stefan] Alere Technol GmbH, Jena, Germany; [Ehricht, Ralf; Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany	University of Veterinary Medicine Hannover, Foundation; University of Namur; Alere; Technische Universitat Dresden	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Fdn, Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022	Muller, Anja/0000-0002-3179-6684	German Federal Ministry of Education and Research [13N12697]; Alere Technologies GmbH	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Alere Technologies GmbH	This work was in part supported by the German Federal Ministry of Education and Research within the research program for civil safety and security, project ZooGloW [grant number 13N12697]. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Alere Technologies GmbH provided support in the form of salaries for authors (RE SM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8; Beutlich J, 2015, INT J FOOD MICROBIOL, V209, P13, DOI 10.1016/j.ijfoodmicro.2014.10.017; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Clinical and Laboratory Standards Institute (CLSI), 2020, PERFORMANCE STANDARD, V5th; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; CLSI, 2021, PERFORMANCE STANDARD, V5th; Croes S, 2010, CLIN MICROBIOL INFEC, V16, P979, DOI [10.1111/j.1469-0691.2010.02956.x, 10.1111/j.1469-0691.2009.02956.x]; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; EC, 2016, EU MARK SIT POULTR; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Gales AC, 2009, BRAZ J INFECT DIS, V13, P90, DOI 10.1590/S1413-86702009000200004; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Gomez-Sanz E, 2013, ANTIMICROB AGENTS CH, V57, P5763, DOI 10.1128/AAC.00948-13; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Jansen W, 2016, ZOONOSES PUBLIC HLTH, V63, P53, DOI 10.1111/zph.12204; Jansen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150023; Kadariya J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/827965; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P813, DOI 10.1128/AAC.49.2.813-815.2005; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P1267, DOI 10.1128/AAC.35.7.1267; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; MCDOUGAL LK, 1986, J CLIN MICROBIOL, V23, P832, DOI 10.1128/JCM.23.5.832-839.1986; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nadarajah J, 2006, J MED MICROBIOL, V55, P1675, DOI 10.1099/jmm.0.46700-0; Ogata K, 2012, APPL ENVIRON MICROB, V78, P2797, DOI 10.1128/AEM.07470-11; Rodriguez-Lazaro D, 2015, INT J FOOD MICROBIOL, V209, P29, DOI 10.1016/j.ijfoodmicro.2014.08.016; Sallam KI, 2015, J FOOD PROTECT, V78, P1879, DOI 10.4315/0362-028X.JFP-15-150; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Schmitz FJ, 1998, J ANTIMICROB CHEMOTH, V41, P481, DOI 10.1093/jac/41.4.481; Schwarz S, 2010, VET MICROBIOL, V141, P1, DOI 10.1016/j.vetmic.2009.12.013; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Tilahun AY, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/468285; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157	40	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167864	10.1371/journal.pone.0167864	http://dx.doi.org/10.1371/journal.pone.0167864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936152	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100220
J	Brigida, ABS; Rojas, CA; Grativol, C; de Armas, EM; Entenza, JOP; Thiebaut, F; Lima, MD; Farrinelli, L; Hemerly, AS; Lifschitz, S; Ferreira, PCG				Santa Brigida, Ailton B.; Rojas, Cristian A.; Grativol, Clicia; de Armas, Elvismary M.; Entenza, Julio O. P.; Thiebaut, Flavia; Lima, Marcelo de F.; Farrinelli, Laurent; Hemerly, Adriana S.; Lifschitz, Sergio; Ferreira, Paulo C. G.			Sugarcane transcriptome analysis in response to infection caused by Acidovorax avenae subsp avenae	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; RECEPTOR-LIKE KINASES; ALDEHYDE-DEHYDROGENASE GENE; SPECTRUM DISEASE RESISTANCE; GENOME-WIDE ANALYSIS; RNA-SEQ DATA; ARABIDOPSIS-THALIANA; PLANT DEFENSE; ENHANCED RESISTANCE; PRIMARY METABOLISM	Sugarcane is an important tropical crop mainly cultivated to produce ethanol and sugar. Crop productivity is negatively affected by Acidovorax avenae subsp avenae (Aaa), which causes the red stripe disease. Little is known about the molecular mechanisms triggered in response to the infection. We have investigated the molecular mechanism activated in sugarcane using a RNA-seq approach. We have produced a de novo transcriptome assembly (TR7) from sugarcane RNA-seq libraries submitted to drought and infection with Aaa. Together, these libraries present 247 million of raw reads and resulted in 168,767 reference transcripts. Mapping in TR7 of reads obtained from infected libraries, revealed 798 differentially expressed transcripts, of which 723 were annotated, corresponding to 467 genes. GO and KEGG enrichment analysis showed that several metabolic pathways, such as code for proteins response to stress, metabolism of carbohydrates, processes of transcription and translation of proteins, amino acid metabolism and biosynthesis of secondary metabolites were significantly regulated in sugarcane. Differential analysis revealed that genes in the biosynthetic pathways of ET and JA PRRs, oxidative burst genes, NBS-LRR genes, cell wall fortification genes, SAR induced genes and pathogenesis-related genes (PR) were upregulated. In addition, 20 genes were validated by RT-qPCR. Together, these data contribute to a better understanding of the molecular mechanisms triggered by the Aaa in sugarcane and opens the opportunity for the development of molecular markers associated with disease tolerance in breeding programs.	[Santa Brigida, Ailton B.; Thiebaut, Flavia; Hemerly, Adriana S.; Ferreira, Paulo C. G.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian A.] Univ Fed Integracao Latino Amer, Inst Latino Amer Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil; [Grativol, Clicia] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil; [de Armas, Elvismary M.; Entenza, Julio O. P.; Lifschitz, Sergio] Pontificia Univ Catolica Rio de Janeiro, Dept Informat, Rio De Janeiro, RJ, Brazil; [Lima, Marcelo de F.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, Seropedica, RJ, Brazil; [Farrinelli, Laurent] Fasteris SA, 1228 Plan Les Ouates, Geneva, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana; Universidade Estadual do Norte Fluminense; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil.	paulof@bioqmed.ufrj.br	Lifschitz, Sérgio/F-2816-2014; Thiebaut, Flavia/B-3867-2018; Thiebaut, Flavia/AAU-5318-2021	Lifschitz, Sérgio/0000-0003-3073-3734; Thiebaut, Flavia/0000-0002-8833-1722; Grativol, Clicia/0000-0002-8873-701X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio; Fundacao de Amparo a Pesquisa do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FASTERIS SA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio; Fundacao de Amparo a Pesquisa do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FASTERIS SA	The work was supported by the following: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - ABSB and PCGF; Institute Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio - PCGF; Fundacao de Amparo a Pesquisa do Rio de Janeiro - PCGF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - PCGF. FASTERIS SA provided support in the form of salaries for authors [L.F.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of L.F. are articulated in the "author contributions" section.	Acharya BR, 2007, PLANT J, V50, P488, DOI 10.1111/j.1365-313X.2007.03064.x; Agrawal GK, 2001, J PLANT PHYSIOL, V158, P133, DOI 10.1078/0176-1617-00186; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Alvarez ME, 2010, MOL PLANT PATHOL, V11, P563, DOI [10.1111/J.1364-3703.2010.00621.X, 10.1111/j.1364-3703.2010.00621.x]; [Anonymous], J NATURAL RESOURCES; Pascual MB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0640-0; Berger S, 2004, PHYSIOL PLANTARUM, V122, P419, DOI 10.1111/j.1399-3054.2004.00433.x; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Bohman S, 2002, THEOR APPL GENET, V105, P498, DOI 10.1007/s00122-002-0885-5; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Champigny MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00230; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Cheavegatti-Gianotto Adriana, 2011, Trop Plant Biol, V4, P62, DOI 10.1007/s12042-011-9068-3; Chern M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006049; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Czernic P, 1999, PLANT J, V18, P321, DOI 10.1046/j.1365-313X.1999.00447.x; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ding B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00675; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ederli L, 2011, J PLANT PHYSIOL, V168, P1784, DOI 10.1016/j.jplph.2011.05.018; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Fontana PD, 2013, EUR J PLANT PATHOL, V137, P525, DOI 10.1007/s10658-013-0263-y; Fontana PD, 2016, GENOME ANNOUNC, V4, P15; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Franco SD, 2015, BIOCHEM BIOPH RES CO, V466, P629, DOI 10.1016/j.bbrc.2015.09.054; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Giglioti E. A., 2000, FALSE RED STRIPE GUI; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo J, 2016, POSTHARVEST BIOL TEC, V111, P337, DOI 10.1016/j.postharvbio.2015.09.002; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Helliwell EE, 2013, PLANT BIOTECHNOL J, V11, P33, DOI 10.1111/pbi.12004; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Hiruma K, 2013, P NATL ACAD SCI USA, V110, P9589, DOI 10.1073/pnas.1305745110; Hotta C. T., 2010, Tropical Plant Biology, V3, P75, DOI 10.1007/s12042-010-9050-5; Huang WZ, 2008, PLANT MOL BIOL, V68, P451, DOI 10.1007/s11103-008-9382-9; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; Isaacs M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00566; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jorda L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00897; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Karkonen A, 2015, PHYTOCHEMISTRY, V112, P22, DOI 10.1016/j.phytochem.2014.09.016; Kim NH, 2015, J EXP BOT, V66, P3367, DOI 10.1093/jxb/erv147; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Kwon Y, 2011, J PLANT RES, V124, P193, DOI 10.1007/s10265-010-0354-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson E, 2012, ANN BOT-LONDON, V110, P923, DOI 10.1093/aob/mcs151; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Li B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05698; Li B, 2011, J GEN PLANT PATHOL, V77, P64, DOI 10.1007/s10327-010-0280-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2016, SCI CHINA LIFE SCI; Liu B, 2014, INT J AEROSPACE ENG, V2014, DOI 10.1155/2014/540235; Liu H., 2012, OPTIM METHOD SOFTW, V1, P1, DOI DOI 10.1128/GEN0MEA.00936-13; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu PP, 2011, PLANT PHYSIOL, V155, P1762, DOI 10.1104/pp.110.171694; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2016, J EXPT BOT; Maccheroni W., 2006, ATUALIZACAO PRODUCAO, P239; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Morkunas I, 2005, PLANT PHYSIOL BIOCH, V43, P363, DOI 10.1016/j.plaphy.2005.02.011; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muchembled J, 2006, PHYTOCHEMISTRY, V67, P1104, DOI 10.1016/j.phytochem.2006.02.025; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nery FC, 2006, BIOCHEM BIOPH RES CO, V341, P847, DOI 10.1016/j.bbrc.2006.01.036; Nery FC, 2004, J BIOL CHEM, V279, P11444, DOI 10.1074/jbc.M306672200; Ohme-Takagi Masaru S H, 1995, PLANT CELL, V7, P173; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Park CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00177; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Petrussa E, 2013, INT J MOL SCI, V14, P14950, DOI 10.3390/ijms140714950; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Postma J, 2013, J CHEM INF MODEL, V53, P627; Pratelli R, 2014, J EXP BOT, V65, P5535, DOI 10.1093/jxb/eru320; Renard-Merlier D, 2007, PHYTOCHEMISTRY, V68, P1156, DOI 10.1016/j.phytochem.2007.02.011; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Rout E, 2016, EUR J PLANT PATHOL, V144, P345, DOI 10.1007/s10658-015-0772-y; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; Schaarschmidt S, 2006, J EXP BOT, V57, P4015, DOI 10.1093/jxb/erl172; Schafer P, 2004, MOL PLANT MICROBE IN, V17, P366, DOI 10.1094/MPMI.2004.17.4.366; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; Schestibratov KA, 2005, SCI HORTIC-AMSTERDAM, V106, P177, DOI 10.1016/j.scienta.2005.03.016; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tegeder M, 2012, CURR OPIN PLANT BIOL, V15, P315, DOI 10.1016/j.pbi.2012.02.001; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; UK CI, 1995, AC AV SUBSP AV DISTR; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Vargas L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114744; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang G., 2012, J APPL MATH, V2012, P1, DOI DOI 10.1155/2012/265760; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wen JQ, 2004, PLANT J, V37, P668, DOI 10.1111/j.1365-313X.2003.01994.x; Wrzaczek M, 2010, TRANSCRIPTIONAL REGU, V1, P1; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Yeh Y-H, 2016, PLANT CELL; Yoon J, 2015, J INTEGR PLANT BIOL, V57, P902, DOI 10.1111/jipb.12422; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang W., 2013, CLIN TRANSL ONCOL, P1, DOI DOI 10.1007/S00417-013-2267-X; ZHANG W, 2014, PLOS ONE, V9; Zhang XJ, 2013, PLANT PHYSIOL BIOCH, V67, P189, DOI 10.1016/j.plaphy.2013.03.013; Zvereva AS, 2012, VIRUSES-BASEL, V4, P2578, DOI 10.3390/v4112578	151	29	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166473	10.1371/journal.pone.0166473	http://dx.doi.org/10.1371/journal.pone.0166473			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936012	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100028
J	Valenti, G; Bonomi, AG; Westerterp, KR				Valenti, Giulio; Bonomi, Alberto G.; Westerterp, Klaas R.			Diurnal Patterns of Physical Activity in Relation to Activity Induced Energy Expenditure in 52 to 83 Years-Old Adults	PLOS ONE			English	Article							DOUBLY LABELED WATER; SEDENTARY BEHAVIOR; ACTIVITY LEVEL; SLEEP; MEN; AGE	Background Ageing is associated with a declining physical activity level (PAL) and changes in the diurnal activity pattern. Changes in the activity pattern might help explaining the age-associated reduction of physical activity. Objective The aims were to investigate diurnal activity patterns within groups of older adults classified by PAL, to investigate diurnal activity patterns within age-groups and to investigate the association between the drop in activity and aerobic fitness. Methods Thirty-one healthy subjects aged between 52 and 83y were recruited for the study. Subjects were divided in sedentary (PAL< 1.75), moderately active (1.75< PAL< 1.90), and active (1.90< PAL) older adults with energy expenditure measurements obtained with the doubly labelled water technique. Diurnal activity patterns were based on activity counts from an accelerometer during wake time and then divided in four quarters of equal time length. Additionally, aerobic fitness was measured as maximal oxygen uptake. Results Subjects had a PAL between 1.43 and 2.34 and an aerobic fitness between 18 and 49 ml/kg/min. Overall, activity patterns showed a peak in the first quarter of wake time (around 10AM) followed by a gradual decline of, on average, 5% per hour. Active subjects reached their peak in the first quarter and remained active until after the third quarter (11% drop each quarter on average). Moderately active and sedentary subjects reached their peak during the second quarter with a decrease during the third quarter (respectively 29% and 17% drop each quarter on average). The drop in physical activity between the first and the second half of the wake time was negatively associated with aerobic fitness (r = -0.39, p< 0.05). Conclusion Active older adults maintained a larger amount of body movement for longer during their wake time. Diurnal physical activity declined more in adults >= 66 years old with lower aerobic fitness.	[Valenti, Giulio; Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Bonomi, Alberto G.] Philips Res Labs, Personal Hlth Solut, Eindhoven, Netherlands	Maastricht University; Philips; Philips Research	Valenti, G (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	g.valenti@maastrichtuniversity.nl		Valenti, Giulio/0000-0002-8002-6133	Maastricht University; Philips Research Laboratories	Maastricht University; Philips Research Laboratories	Maastricht University provided support in the form of materials and salaries for GV and KRW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips Research Laboratories provided support in the form of salaries for AGB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The clinical trial was not sponsored by Philips Research Laboratories.	Aadland E, 2012, J OBES, V2012, DOI 10.1155/2012/810594; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Barbosa JF, 2015, PHYSIOTHERAPY; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Cai ZY, 2014, J STRENGTH COND RES, V28, P2597, DOI 10.1519/JSC.0000000000000428; Chen T, 2015, J PHYS ACT HLTH; COSTILL DL, 1970, J APPL PHYSIOL, V28, P251, DOI 10.1152/jappl.1970.28.3.251; Egerton T, 2015, J GERONTOL A; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Gabriel KP, 2012, MED SCI SPORT EXER, V44, P104, DOI 10.1249/MSS.0b013e318229056e; Hoos MB, 2003, EUR J APPL PHYSIOL, V89, P624, DOI 10.1007/s00421-003-0891-6; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huang G, 2015, EUR J PREV CARDIOL; Karstoft K, 2015, IMMUNOL CELL BIOL; Kokkinos Peter, 2012, ISRN Cardiol, V2012, P718789, DOI 10.5402/2012/718789; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lucertini F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141970; Luik AL, 2015, PSYCHONEUROENDOCRINO, V53, P207, DOI 10.1016/j.psyneuen.2015.01.011; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Meijer EP, 2002, J AM GERIATR SOC, V50, P349, DOI 10.1046/j.1532-5415.2002.50069.x; Meijer EP, 2001, INT J OBESITY, V25, P935, DOI 10.1038/sj.ijo.0801644; Melton L J 3rd, 2000, Mayo Clin Proc, V75 Suppl, pS10; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rothenberg E M, 2002, J Nutr Health Aging, V6, P177; Sartini C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1976-y; Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Westerterp K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P485, DOI 10.1097/00075197-200011000-00011; WESTERTERP KR, 1988, J APPL PHYSIOL, V65, P53, DOI 10.1152/jappl.1988.65.1.53; Westerterp KR, 1995, RES S1, P49; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wouters-Adriaens MPE, 2006, BRIT J NUTR, V95, P1166, DOI 10.1079/BJN20061784; Xiao L, 2015, BIOSTATISTICS, V16, P352, DOI 10.1093/biostatistics/kxu045	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167824	10.1371/journal.pone.0167824	http://dx.doi.org/10.1371/journal.pone.0167824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	27936145	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100207
J	Patel, D; Salloum, D; Saqcena, M; Chatterjee, A; Mroz, V; Ohh, M; Foster, DA				Patel, Deven; Salloum, Darin; Saqcena, Mahesh; Chatterjee, Amrita; Mroz, Victoria; Ohh, Michael; Foster, David A.			A Late G(1) Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; RESTRICTION POINT; PHOSPHATIDIC-ACID; TRANSFORMED-CELLS; GROWTH-FACTOR; CANCER-CELLS; S-PHASE; CYCLE; RAPAMYCIN; PROLIFERATION	Lipids are important nutrients that proliferating cells require to maintain energy homeostasis as well as to build plasma membranes for newly synthesized cells. Previously, we identified nutrient-sensing checkpoints that exist in the latter part of the G1 phase of the cell cycle that are dependent upon essential amino acids, Gln, and finally, a checkpoint mediated by mammalian target of rapamycin (mTOR), which integrates signals from both nutrients and growth factors. In this study, we have identified and temporally mapped a lipid-mediated G1 checkpoint. This checkpoint is located after the Gln checkpoint and before the mTOR-mediated cell cycle checkpoint. Intriguingly, clear cell renal cell carcinoma cells (ccRCC) have a dysregulated lipid-mediated checkpoint due in part to defective phosphatase and tensin homologue (PTEN). Whendeprived of lipids, instead of arresting in G1, these cells continue to cycle and utilize lipid droplets as a source of lipids. Lipid droplets have been known to maintain endoplasmic reticulum homeostasis and prevent cytotoxic endoplasmic reticulum stress in ccRCC. Dysregulation of the lipid-mediated checkpoint forces these cells to utilize lipid droplets, which could potentially lead to therapeutic opportunities that exploit this property of ccRCC.	[Patel, Deven; Salloum, Darin; Saqcena, Mahesh; Chatterjee, Amrita; Mroz, Victoria; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Patel, Deven; Saqcena, Mahesh; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Salloum, Darin; Chatterjee, Amrita; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON M5S 1A8, Canada	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; University of Toronto	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Patel, Deven/J-4886-2019; Saqcena, Mahesh/U-5973-2017	Saqcena, Mahesh/0000-0002-2210-3444	National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA046677, R01CA179542] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College, is acknowledged.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Brenner W, 2002, INT J CANCER, V99, P53, DOI 10.1002/ijc.10303; Chatterjee A, 2015, CANCER LETT, V360, P134, DOI 10.1016/j.canlet.2015.01.043; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gan W., 2015, CELL CYCLE, P1; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kearney AY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135962; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Saqcena M, 2015, ONCOGENE, V34, P2672, DOI 10.1038/onc.2014.207; Saqcena M, 2015, CELL CYCLE, V14, P2285, DOI 10.1080/15384101.2015.1046653; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Schneider E, 2011, INT J ONCOL, V38, P823, DOI 10.3892/ijo.2010.893; Schonenberger D, 2016, CANCER RES, V76, P2025, DOI 10.1158/0008-5472.CAN-15-1859; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	36	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					936	944		10.1074/jbc.M116.757864	http://dx.doi.org/10.1074/jbc.M116.757864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956548	Green Published, hybrid			2022-12-26	WOS:000392318700015
J	Noorman, F; van Dongen, TTCF; Plat, MCJ; Badloe, JF; Hess, JR; Hoencamp, R				Noorman, Femke; van Dongen, Thijs T. C. F.; Plat, Marie-Christine J.; Badloe, John F.; Hess, John R.; Hoencamp, Rigo			Transfusion:-80 degrees C Frozen Blood Products Are Safe and Effective in Military Casualty Care	PLOS ONE			English	Article							OPERATION ENDURING FREEDOM; TRAUMA PATIENTS; WHOLE-BLOOD; PLATELET MICROPARTICLES; CONTROL RESUSCITATION; TRANSFUSION MEDICINE; APHERESIS PLATELETS; MASSIVE TRANSFUSION; BATTLE CASUALTIES; IRAQI FREEDOM	Introduction The Netherlands Armed Forces use -80 degrees C frozen red blood cells (RBCs), plasma and platelets combined with regular liquid stored RBCs, for the treatment of (military) casualties in Medical Treatment Facilities abroad. Our objective was to assess and compare the use of -80 degrees C frozen blood products in combination with the different transfusion protocols and their effect on the outcome of trauma casualties. Materials and Methods Hemovigilance and combat casualties data from Afghanistan 2006-2010 for 272 (military) trauma casualties with or without massive transfusions (MT: >= 6 RBC/24hr, N = 82 and non-MT: 1-5 RBC/24hr, N = 190) were analyzed retrospectively. In November 2007, a massive transfusion protocol (MTP; 4: 3: 1 RBC:Plasma:Platelets) for ATLS (R) class III/IV hemorrhage was introduced in military theatre. Blood product use, injury severity and mortality were assessed pre-and post-introduction of the MTP. Data were compared to civilian and military trauma studies to assess effectiveness of the frozen blood products and MTP. Results No ABO incompatible blood products were transfused and only 1 mild transfusion reaction was observed with 3,060 transfused products. In hospital mortality decreased post-MTP for MT patients from 44% to 14% (P = 0.005) and for non-MT patients from 12.7% to 5.9% (P = 0.139). Average 24-hour RBC, plasma and platelet ratios were comparable and accompanying 24-hour mortality rates were low compared to studies that used similar numbers of liquid stored (and on site donated) blood products. Conclusion This report describes for the first time that the combination of -80 degrees C frozen platelets, plasma and red cells is safe and at least as effective as standard blood products in the treatment of (military) trauma casualties. Frozen blood can save the lives of casualties of armed conflict without the need for in-theatre blood collection. These results may also contribute to solutions for logistic problems in civilian blood supply in remote areas.	[Noorman, Femke; Badloe, John F.] Minist Def, Mil Blood Bank, Leiden, Netherlands; [van Dongen, Thijs T. C. F.] Minist Def, Utrecht, Netherlands; [van Dongen, Thijs T. C. F.] Univ Med Ctr Utrecht, Div Surg, Dept Trauma, Utrecht, Netherlands; [Plat, Marie-Christine J.] Minist Def, Expert Ctr Force Hlth Protect, Doorn, Netherlands; [Hess, John R.] Harborview Med Ctr, Transfus Serv, Seattle, WA USA; [Hoencamp, Rigo] Minist Def, Leiden, Netherlands; [Hoencamp, Rigo] Leiden Univ, Med Ctr, Alrijne Med Ctr Leiderdorp, Dept Surg, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Harborview Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Dongen, TTCF (corresponding author), Minist Def, Mil Blood Bank, Leiden, Netherlands.	f.noorman@mindef.nl; t.t.c.vandongen-4@umcutrecht.nl	Hoencamp, Rigo/AAL-4984-2021	Kubickova, Karolina/0000-0002-9556-3185; Noorman, Femke/0000-0002-4891-2047				Allen CJ, 2015, AM SURGEON, V81, P663; Beckett Andrew, 2015, Can J Surg, V58, pS153; Bohonek M, 2010, TRANSFUSION, V50, P1007, DOI 10.1111/j.1537-2995.2009.02532.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Chandler MH, 2012, SEMIN CARDIOTHORAC V, V16, P153, DOI 10.1177/1089253212452344; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Dumont LJ, 2013, TRANSFUSION, V53, P128, DOI 10.1111/j.1537-2995.2012.03735.x; Ellis AM, 2010, ADF HLTH, V11, P25; Hakre S, 2011, TRANSFUSION, V51, P473, DOI 10.1111/j.1537-2995.2010.02906.x; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Henkelman S, 2015, VOX SANG, V108, P103, DOI 10.1111/vox.12218; Hess JR, 2008, TRANSFUSION MED, V18, P143, DOI 10.1111/j.1365-3148.2008.00855.x; Hess JR, 2005, CRIT CARE, V9, pS10, DOI 10.1186/cc3780; Hirshberg A, 2003, J TRAUMA, V54, P454, DOI 10.1097/01.TA.0000053245.08642.1F; Hoencamp R, 2014, WORLD J SURG, V38, P2551, DOI 10.1007/s00268-014-2645-5; Hoencamp R, 2014, WORLD J SURG, V38, P1713, DOI 10.1007/s00268-014-2462-x; Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holley A, 2013, ANAESTH INTENS CARE, V41, P10, DOI 10.1177/0310057X1304100104; Idenburg FJ, 2015, WORLD J SURG, V39, P2413, DOI 10.1007/s00268-015-3136-z; Inaba K, 2011, J TRAUMA, V71, P1766, DOI 10.1097/TA.0b013e31823bdbf9; Johansson PI, 2009, VOX SANG, V96, P111, DOI 10.1111/j.1423-0410.2008.01130.x; Johnson L, 2014, TRANSFUSION; Johnson L, 2014, TRANSFUSION, V54, P1917, DOI 10.1111/trf.12578; Kautza BC, 2012, J TRAUMA ACUTE CARE, V72, P106, DOI 10.1097/TA.0b013e3182410a3c; Khuri SF, 1999, J THORAC CARDIOV SUR, V117, P172, DOI 10.1016/S0022-5223(99)70483-6; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Lelkens CCM, 2006, TRANSFUS APHER SCI, V34, P289, DOI 10.1016/j.transci.2005.11.008; Markov NP, 2012, J VASC SURG, V56, P728, DOI 10.1016/j.jvs.2012.02.048; Matijevic N, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29338; Mittag D, 2015, TRANSFUSION, V55, P2197, DOI 10.1111/trf.13138; Morton AP, 2013, J SURG RES, V179, P5, DOI 10.1016/j.jss.2012.05.054; Muller MCA, 2015, TRANSFUSION, V55, P164, DOI 10.1111/trf.12816; Neuhaus SJ, 2010, MED J AUSTRALIA, V192, P203, DOI 10.5694/j.1326-5377.2010.tb03479.x; Noorman F, 2014, TRANSFUSION, V54, p74A; Noorman F, 2012, TRANSFUSION, V52, p33A; Olszewski A, 2014, INT MARIT HEALTH, V65, P23, DOI 10.5603/MH.2014.0006; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; Pommerening MJ, 2015, SURGERY, V158, P618, DOI 10.1016/j.surg.2015.06.014; Raynel S, 2015, TRANSFUSION, V55, P2422, DOI 10.1111/trf.13165; Reade MC, 2013, ANAESTH INTENS CARE, V41, P804; Reade MC., 2012, PILOT MULTICENTRE BL; Schreiber MA, 2015, ANN SURG, V262, P426, DOI 10.1097/SLA.0000000000001404; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Slichter SJ, 2014, TRANSFUS MED REV, V28, P212, DOI 10.1016/j.tmrv.2014.09.001; Slichter SJ, 2014, PHASE 1 SAFETY STUDY; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sparrow RL, 2015, TRANSFUS MED REV, V29, P120, DOI 10.1016/j.tmrv.2014.09.007; Spinella PC, 2012, TRANSFUSION, V52, P1146, DOI 10.1111/j.1537-2995.2012.03594.x; Stanworth SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9394; Strandenes G, 2014, SHOCK, V41, P70, DOI 10.1097/SHK.0000000000000150; Stubbs JR, 2016, TRANSFUSION, V56, pS173, DOI 10.1111/trf.13501; Thiels Cornelius A, 2015, Air Med J, V34, P104, DOI 10.1016/j.amj.2014.10.011; Torrance HDT, 2015, J TRAUMA ACUTE CARE, V78, P535, DOI 10.1097/TA.0000000000000534; Valeri CR, 2006, TRANSFUSION, V46, p1S, DOI 10.1111/j.1537-2995.2006.00922.x; VALERI CR, 1989, TRANSFUSION, V29, P429, DOI 10.1046/j.1537-2995.1989.29589284145.x; Valeri CR, 2000, VOX SANG, V79, P168, DOI 10.1159/000031236; VALERI CR, 1974, NEW ENGL J MED, V290, P353, DOI 10.1056/NEJM197402142900702; Valeri CR, 2005, TRANSFUSION, V45, P1829, DOI 10.1111/j.1537-2995.2005.00614.x; van Dongen TT, 2015, INJURY, V39; Windelov NA, 2014, J TRAUMA ACUTE CARE, V77, P692, DOI 10.1097/TA.0000000000000437	63	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168401	10.1371/journal.pone.0168401	http://dx.doi.org/10.1371/journal.pone.0168401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959967	Green Published, gold, Green Submitted			2022-12-26	WOS:000392753900063
J	Park, HJ; Ahn, JY; Jung, HY; Lee, JH; Jung, KW; Kim, DH; Choi, KD; Song, HJ; Lee, GH; Kim, JH; Han, S				Park, Hee Jung; Ahn, Ji Yong; Jung, Hwoon-Yong; Lee, Jeong Hoon; Jung, Kee Wook; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Kim, Jin-Ho; Han, Seungbong			Clinical Characteristics and Outcomes of Gastric Cancer Patients Aged over 80 Years: A Retrospective Case-Control Study	PLOS ONE			English	Article							OLDER; CARCINOMA; PROGNOSIS; RESECTION; SURGERY; YOUNG	Background and Aims The average human life expectancy is increasing worldwide, thus the proportion of elderly gastric cancer patients is also increasing. In this case-control study, we investigated the clinical and oncologic outcomes of gastric cancer in patients over 80 years old. Methods From January 2004 to December 2010, 291 patients aged over 80 years old (case group) were diagnosed and treated with gastric cancer at Asan Medical Center, Seoul, Korea. From the same period, 291 patients aged 18 to 80 years old were selected as the control group. The clinical findings and clinical outcomes of gastric cancer were retrospectively reviewed and compared between the two groups. Results There were significant differences in the overall 5-year survival rate between the case and control groups (30.9% vs. 73.8%, respectively; P<0.001). In patients who received the curative treatment, overall 3- and 5-year survival rates showed 74.3% and 57.9% in case group and 91.6% and 86.5% in the control group. When analysis was confined to resectable elderly patients with a favorable performance, the curative resection group showed significantly better overall 3-and 5-year survival rates than the conservative treatment group (73.7% and 58.8% vs. 29.8% and 0%, respectively). Conclusions Although elderly gastric cancer patients show an advanced stage at diagnosis and poor prognosis compared with non-elderly patients, elderly patients with good performance could benefit from curative resection. Thus, the clinical decision whether to undergo curative resection or conservative management should be made on an individualized basis.	[Park, Hee Jung; Ahn, Ji Yong; Jung, Hwoon-Yong; Lee, Jeong Hoon; Jung, Kee Wook; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Kim, Jin-Ho] Univ Ulsan, Asan Digest Dis Res Inst, Dept Gastroenterol, Coll Med,Asan Med Ctr, Seoul, South Korea; [Han, Seungbong] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan	Jung, HY (corresponding author), Univ Ulsan, Asan Digest Dis Res Inst, Dept Gastroenterol, Coll Med,Asan Med Ctr, Seoul, South Korea.	hyjung@amc.seoul.kr	Ahn, Ji Yong/AGO-1695-2022					Ahn JY, 2011, GASTROINTEST ENDOSC, V74, P485, DOI 10.1016/j.gie.2011.04.038; Arai Tomio, 2004, Gastric Cancer, V7, P154; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Canedo P, 2007, HELICOBACTER, V12, P45, DOI 10.1111/j.1523-5378.2007.00564.x; Endo S, 2013, INT J CLIN ONCOL, V18, P1014, DOI 10.1007/s10147-012-0482-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; FUJIMOTO S, 1994, SURGERY, V115, P516; Fujiwara S, 2012, HEPATO-GASTROENTEROL, V59, P620, DOI 10.5754/hge10269; HALLISSEY MT, 1990, BRIT MED J, V301, P513, DOI 10.1136/bmj.301.6751.513; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kitamura K, 1996, BRIT J CANCER, V73, P798, DOI 10.1038/bjc.1996.139; Kunisaki C, 2006, AM J SURG, V191, P216, DOI 10.1016/j.amjsurg.2005.09.001; LAUREN P, 1965, ACTA PATHOL MIC SC, P6431; Liang YX, 2013, WORLD J GASTROENTERO, V19, P6568, DOI 10.3748/wjg.v19.i39.6568; Maehara Y, 1996, CANCER-AM CANCER SOC, V77, P1774, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Ministry of health labour and welfare, 2012, ABR LIF TABL JAP 201; Mita K, 2013, J GASTROINTEST SURG, V17, P2067, DOI 10.1007/s11605-013-2364-5; MITSUDOMI T, 1989, WORLD J SURG, V13, P225, DOI 10.1007/BF01658407; National institute on aging U.S. department of health and human services, 2011, WHY POP AG MAT GLOB; Peleteiro B, 2011, BRIT J CANCER, V104, P198, DOI 10.1038/sj.bjc.6605993; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Statistics Korea, 2012, AV LIF SPAN KOR	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167615	10.1371/journal.pone.0167615	http://dx.doi.org/10.1371/journal.pone.0167615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942044	Green Published, gold, Green Submitted			2022-12-26	WOS:000392745600023
J	Cardoso, ARP; Araujo, MAL; Andrade, RFV; Saraceni, V; Miranda, AE; Dourado, MIC				Paulo Cardoso, Ana Rita; Leite Araujo, Maria Alix; Vieira Andrade, Roumayne Fernandes; Saraceni, Valeria; Miranda, Angelica E.; Costa Dourado, Maria Ines			Underreporting of Congenital Syphilis as a Cause of Fetal and Infant Deaths in Northeastern Brazil	PLOS ONE			English	Article							MATERNAL SYPHILIS; PREGNANCY; OUTCOMES; STATE	Introduction Of all syphilis-related pregnancy outcomes, fetal death is certainly the most common one, being directly related to the availability, accessibility and quality of prenatal care. The present study aimed to analyze the underreporting of fetal and infant deaths and other maternal factors associated with congenital syphilis (CS) death. Methods This cross-sectional study integrated data of infants that were diagnosed and/or died of CS from the Sistema de Informacao de Agravos de Notificacao-Sinan (Notifiable Diseases Information System) and the Sistema de Informacao de Mortalidade-SIM (Mortality Information System) in Fortaleza, Northeastern Brasil to identify unreported cases of congenital syphilis. We assessed data during the period from 2007 to 2013. Results The underreporting of CS as a cause of fetal or infant death increased from 41 to 415 cases (90.1%) during 2007-2013. Exactly 3,209 cases of CS were identified in Sinan and 6,578 deaths in SIM. After database linkage, we identified 382 cases that were reported in the SIM and SINAN databases consisting of 309 fetal deaths and 73 infant deaths related to CS. From the children notified at Sinan that born alive, 3.0% (78/2,542) died; Out of these, 39 (50.0%) were early and 25 (32.1%) were late neonatal deaths. The proportion of death by CS increased from 0.62 to 5.8 from 2007 to 2013. At logistic regression, the variable that maintained statistical significance with fetal and infant death outcomes was the presence of CS signs and/or symptoms at birth (OR = 3.20; IC 95% 1.54-6.62; p = 0.002). Conclusions Neonatal and Infant deaths following CS-associated live births are underreported in Northeastern Brazil. Data base linkage identified unreported fetal and neonatal deaths due to CS leading to an increased awareness of fetal/infant mortality due to this infection.	[Paulo Cardoso, Ana Rita; Leite Araujo, Maria Alix; Vieira Andrade, Roumayne Fernandes] Univ Fortaleza, Collect Hlth Post Grad Program, Fortaleza, Ceara, Brazil; [Saraceni, Valeria] Rio de Janeiro Municipal Secretary Hlth, Rio De Janeiro, Brazil; [Miranda, Angelica E.] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Spain; [Costa Dourado, Maria Ines] Univ Fed Bahia, Inst Collect Heath, Salvador, BA, Brazil	Universidade Fortaleza; Universidade Federal da Bahia	Cardoso, ARP (corresponding author), Univ Fortaleza, Collect Hlth Post Grad Program, Fortaleza, Ceara, Brazil.	rita_cardoso84@hotmail.com	Miranda, Angelica/AAE-5571-2021; Dourado, Ines/Q-6535-2016	Dourado, Ines/0000-0003-1675-2146; Miranda, Angelica/0000-0002-5556-8379	Cearense Foundation for Research Support; National Research Council - FUNCAP / CNPq	Cearense Foundation for Research Support; National Research Council - FUNCAP / CNPq	The study was funded by the Cearense Foundation for Research Support and the National Research Council - FUNCAP / CNPq whose grant amounts were R$ 83.421,50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasil Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, B EP SIL; Bronhara Bruna, 2008, Rev. bras. epidemiol., V11, P709, DOI 10.1590/S1415-790X2008000400017; Ceara. Governo do Estado do Ceara. Secretaria da Saude, 2013, COORD PROM PROT SAUD; da Silva ZP, 2009, CAD SAUDE PUBLICA, V25, P1981, DOI 10.1590/S0102-311X2009000900012; Campos ALD, 2010, CAD SAUDE PUBLICA, V26, P1747, DOI 10.1590/S0102-311X2010000900008; de Araujo CL, 2012, REV SAUDE PUBL, V46, P479, DOI 10.1590/S0034-89102012000300010; Soeiro CMD, 2014, CAD SAUDE PUBLICA, V30, P715, DOI 10.1590/0102-311X00156312; do Nascimento MI, 2012, REV BRAS GINECOL OBS, V34, P56, DOI 10.1590/S0100-72032012000200003; Magalhaes DMD, 2013, CAD SAUDE PUBLICA, V29, P1109, DOI 10.1590/S0102-311X2013001000008; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Domingues RMSM, 2013, REV SAUDE PUBL, V47, P147, DOI 10.1590/S0034-89102013000100019; Ministerio da Saude, 2001, MAN PROC SIST INF MO; Ministerio da Saude (BR), 2009, MAN VIG OB INF FET C, V2; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Organizacao Mundial da Saude (OMS), 2001, CLASS EST INT DOENC; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Qin JB, 2014, SEX TRANSM DIS, V41, P13, DOI 10.1097/OLQ.0000000000000062; Saraceni Valéria, 2005, Cad. Saúde Pública, V21, P1244, DOI 10.1590/S0102-311X2005000400027; Saraceni V, 2012, CAD SAUDE PUBLICA, V28, P490, DOI 10.1590/S0102-311X2012000300009; Serruya SJ, 2015, SEX HEALTH, V12, P164, DOI 10.1071/SH14191; WHO, 2012, GLOB INC PREV SEL CU; World Health Organization, 2011, METH SURV MON CONG S	24	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167255	10.1371/journal.pone.0167255	http://dx.doi.org/10.1371/journal.pone.0167255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941983	Green Published, gold			2022-12-26	WOS:000392745600011
J	Swann, JW; Woods, K; Wu, Y; Glanemann, B; Garden, OA				Swann, James W.; Woods, Kelly; Wu, Ying; Glanemann, Barbara; Garden, Oliver A.			Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia	PLOS ONE			English	Article							REGULATORY T-CELLS; BLOOD MONONUCLEAR-CELLS; FUNCTIONAL-CHARACTERIZATION; AUTOIMMUNE-DISEASES; CYTOKINE PRODUCTION; TH17 CELLS; INTERLEUKIN-10; RESPONSES; ENTEROPATHY; MODULATION	Background Immune-mediated haemolytic anaemia (IMHA) is reported to be the most common autoimmune disease of dogs, resulting in significant morbidity and mortality in affected animals. Haemolysis is caused by the action of autoantibodies, but the immunological changes that result in their production have not been elucidated. Aims To investigate the frequency of regulatory T cells (Tregs) and other lymphocyte subsets and to measure serum concentrations of cytokines and peripheral blood mononuclear cell expression of cytokine genes in dogs with IMHA, healthy dogs and dogs with inflammatory diseases. Animals 19 dogs with primary IMHA, 22 dogs with inflammatory diseases and 32 healthy control dogs. Methods Residual EDTA-anti-coagulated blood samples were stained with fluorophore-conjugated monoclonal antibodies and analysed by flow cytometry to identify Tregs and other lymphocyte subsets. Total RNA was also extracted from peripheral blood mononuclear cells to investigate cytokine gene expression, and concentrations of serum cytokines (interleukins 2, 6 10, CXCL-8 and tumour necrosis factor a) were measured using enhanced chemiluminescent assays. Principal component analysis was used to investigate latent variables that might explain variability in the entiredataset. Results There was no difference in the frequency or absolute numbers of Tregs among groups, nor in the proportions of other lymphocyte subsets. The concentrations of pro-inflammatory cytokines were greater in dogs with IMHA compared to healthy controls, but the concentration of IL-10 and the expression of cytokine genes did not differ between groups. Principal component analysis identified four components that explained the majority of the variability in the dataset, which seemed to correspond to different aspects of the immune response. Conclusions The immunophenotype of dogs with IMHA differed from that of dogs with inflammatory diseases and from healthy control dogs; some of these changes could suggest abnormalities in peripheral tolerance that permit development of autoimmune disease. The frequency of Tregs did not differ between groups, suggesting that deficiency in the number of these cells is not responsible for development of IMHA.	[Swann, James W.; Glanemann, Barbara; Garden, Oliver A.] Royal Vet Coll, Dept Clin Sci & Serv, Hawskhead Lane, Hatfield, Herts, England; [Swann, James W.; Woods, Kelly; Wu, Ying; Garden, Oliver A.] Royal Vet Coll, Immune Regulat Lab, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Garden, OA (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hawskhead Lane, Hatfield, Herts, England.; Garden, OA (corresponding author), Royal Vet Coll, Immune Regulat Lab, London, England.	ogarden@rvc.ac.uk		Swann, James/0000-0001-7988-9997	Kennel Club Charitable Trust; Biotechnology and Biological Sciences Research Council [BB/M009513/1]	Kennel Club Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by a grant from the Kennel Club Charitable Trust (https://kccharitabletrust.org.uk) awarded to JWS. There was no grant number for this award. KW was supported by a grant from the Biotechnology and Biological Sciences Research Council (number BB/M009513/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Ahmad E, 2011, J INVEST ALLERG CLIN, V21, P297; BARKER RN, 1991, CLIN EXP IMMUNOL, V85, P33, DOI 10.1111/j.1365-2249.1991.tb05678.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Berentsen S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/363278; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Corato A, 1997, VET IMMUNOL IMMUNOP, V59, P191, DOI 10.1016/S0165-2427(97)00032-9; Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Ellis JS, 2013, IMMUNOLOGY, V139, P179, DOI 10.1111/imm.12065; Elson CJ, 2000, CURR OPIN IMMUNOL, V12, P664, DOI 10.1016/S0952-7915(00)00160-6; Fagiolo E, 1996, AUTOIMMUNITY, V24, P147, DOI 10.3109/08916939608995360; Fagiolo E, 1999, IMMUNOL INVEST, V28, P347, DOI 10.3109/08820139909062268; Fagiolo E, 2002, AUTOIMMUNITY, V35, P39, DOI 10.1080/08916930290005891; FAGIOLO E, 1994, IMMUNOL INVEST, V23, P449, DOI 10.3109/08820139409066839; Garden OA, 2011, INT IMMUNOPHARMACOL, V11, P576, DOI 10.1016/j.intimp.2010.11.003; Giltiay NV, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3918; Hall AM, 2002, BLOOD, V100, P4529, DOI 10.1182/blood-2002-05-1383; Hall AM, 2012, HAEMATOL-HEMATOL J, V97, P1494, DOI 10.3324/haematol.2011.060822; Han L, 2015, FRONT MED-PRC, V9, P10, DOI 10.1007/s11684-015-0388-9; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kjelgaard-Hansen M, 2011, J VET INTERN MED, V25, P76, DOI 10.1111/j.1939-1676.2010.0642.x; Knueppel A, 2011, EXP ANIM TOKYO, V60, P471, DOI 10.1538/expanim.60.471; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; McCullough S, 2003, VET CLIN N AM-SMALL, V33, P1295, DOI 10.1016/j.cvsm.2003.08.003; McManus PM, 2001, J AM VET MED ASSOC, V218, P1308, DOI 10.2460/javma.2001.218.1308; Miller MA, 2007, CURR MED CHEM, V14, P1409, DOI 10.2174/092986707780831131; Mitchell KD, 2009, J VET INTERN MED, V23, P585, DOI 10.1111/j.1939-1676.2009.0282.x; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mqadmi A, 2005, BLOOD, V105, P3746, DOI 10.1182/blood-2004-12-4692; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piek CJ, 2011, VET IMMUNOL IMMUNOP, V144, P346, DOI 10.1016/j.vetimm.2011.08.010; Pietschmann P, 2003, EXP GERONTOL, V38, P1119, DOI 10.1016/S0531-5565(03)00189-X; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; RIVAS AL, 1992, CLIN IMMUNOL IMMUNOP, V64, P36, DOI 10.1016/0090-1229(92)90057-U; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saxena A, 2015, CYTOKINE, V74, P27, DOI 10.1016/j.cyto.2014.10.031; Swann JW, 2016, VET J, V207, P13, DOI 10.1016/j.tvjl.2015.10.022; Titmarsh HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137377; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Ward FJ, 2008, BLOOD, V111, P680, DOI 10.1182/blood-2007-07-101345; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu L, 2012, EXP HEMATOL, V40, P994, DOI 10.1016/j.exphem.2012.08.008; Zanella A, 2014, HAEMATOLOGICA, V99, P1547, DOI 10.3324/haematol.2014.114561	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168296	10.1371/journal.pone.0168296	http://dx.doi.org/10.1371/journal.pone.0168296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942026	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000392745600063
J	Alajez, NM				Alajez, Nehad M.			Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROGNOSTIC-SIGNIFICANCE; GENOMICS; INVASION; TUMORS	Colorectal cancer (CRC) is the fourth-ranked cause of cancer-related deaths worldwide. Despite recent advances in CRC management, distant recurrence (DR) remains the major cause of mortality in patients with preoperative chemotherapy and radiotherapy, underscoring a need to precisely identify novel gene signatures for predicting the risk of systemic relapse. Herein, we integrated two independent CRC gene expression datasets: the GSE71222 dataset, including 26 patients who developed DR and 126 patients who did not develop DR, and the GSE21510 dataset, including 23 patients who developed DR and 76 patients who did not develop DR. Our data revealed 37 common upregulated genes (fold change (FC) >= 1.5, P < 0.05) and three common downregulated genes (FC <= 1.5, P < 0.05) between DR and non-recurrent patients from the two datasets. We subsequently validated the upregulated gene panel in the Cancer Genome Atlas CRC datasets (379 patients), which identified a five-gene signature (S100A2, VIP, HOXC6, DACT1, KIF26B) associated with poor overall survival (OS, log-rank test P-value: 1.19 x 10(-4)) and poor disease-free survival (DFS, log-rank test P-value: 0.002). In a Cox proportional hazards multiple regression model, the five-gene signature and tumor stage retained their significance as independent prognostic factors for CRC DFS and OS. Therefore, our data identified a novel DR gene expression signature associated with worse prognosis in CRC.	[Alajez, Nehad M.] King Saud Univ, Dept Anat, Coll Med, Stem Cell Unit, Riyadh, Saudi Arabia	King Saud University	Alajez, NM (corresponding author), King Saud Univ, Dept Anat, Coll Med, Stem Cell Unit, Riyadh, Saudi Arabia.	nalajez@ksu.edu.sa		Alajez, Nehad/0000-0002-1546-1091	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-toub M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0123-0; Al-toub M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt325; Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Alajez NM, 2016, SAUDI J GASTROENTERO, V22, P288, DOI 10.4103/1319-3767.187602; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hamid ARAH, 2015, PROSTATE, V75, P1868, DOI 10.1002/pros.23065; Knijn N, 2016, AM J SURG PATHOL, V40, P103, DOI 10.1097/PAS.0000000000000518; Kumar M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0369-9; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Masuda T, 2016, INT J ONCOL, V48, P975, DOI 10.3892/ijo.2016.3329; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Takahashi H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1783-y; Tsai HL, 2008, J SURG ONCOL, V97, P383, DOI 10.1002/jso.20942; Tsukamoto S, 2011, CLIN CANCER RES, V17, P2444, DOI 10.1158/1078-0432.CCR-10-2884; Vishnubalaji R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.556; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Yuan GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034004	25	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167455	10.1371/journal.pone.0167455	http://dx.doi.org/10.1371/journal.pone.0167455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27935967	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100100
J	Cautain, B; Castillo, F; Musso, L; Ferreira, BI; de Pedro, N; Quesada, LR; Machado, S; Vicente, F; Dallavalle, S; Link, W				Cautain, Bastien; Castillo, Francisco; Musso, Loana; Ferreira, Bibiana I.; de Pedro, Nuria; Quesada, Lorena Rodriguez; Machado, Susana; Vicente, Francisca; Dallavalle, Sabrina; Link, Wolfgang			Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DUAL-SPECIFICITY PHOSPHATASE; CYCLOADDITION REACTIONS; NITRILE SULFIDES; INHIBITORS; CANCER; TRANSLOCATION; SCREEN; POTENT; CELLS	FOXO factors are tumour suppressor proteins commonly inactivated in human tumours by posttranslational modifications. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. Therefore, the pharmacological activation of FOXO proteins is considered as an attractive therapeutic approach to treat cancer and age-related diseases. In order to identify agents capable of activating FOXOs, we tested a collection of small chemical compounds using image-based high content screening technology. Here, we report the discovery of LOM612 (compound 1a), a newly synthesized isothiazolonaphthoquinone as a potent FOXO relocator. Compound 1a induces nuclear translocation of a FOXO3a reporter protein as well as endogenous FOXO3a and FOXO1 in U2OS cells in a dose-dependent manner. This activity does not affect the subcellular localization of other cellular proteins including NFkB or inhibit CRM1-mediated nuclear export. Furthermore, compound 1a shows a potent antiproliferative effect in human cancer cell lines.	[Cautain, Bastien; Castillo, Francisco; de Pedro, Nuria; Quesada, Lorena Rodriguez; Vicente, Francisca] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain; [Musso, Loana; Dallavalle, Sabrina] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, I-20122 Milan, Italy; [Ferreira, Bibiana I.; Machado, Susana; Link, Wolfgang] Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal; [Ferreira, Bibiana I.; Link, Wolfgang] Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal	University of Milan; Universidade do Algarve	Link, W (corresponding author), Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal.; Link, W (corresponding author), Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal.	walink@ualg.pt	Machado, Susana/K-4033-2012; Link, Wolfgang/F-4435-2012; Dallavalle, Sabrina/AGY-7086-2022; Cautain, Bastien/W-1948-2018	Machado, Susana/0000-0002-3152-1701; Link, Wolfgang/0000-0002-3340-5165; Dallavalle, Sabrina/0000-0002-8813-8922; Cautain, Bastien/0000-0002-1324-3576; ferreira, Bibiana/0000-0003-4772-9395; Castillo Correa, Francisco Jose/0000-0001-5587-9612	Fundacao para a Ciencia e a Tecnologia (FCT) Research Center [UID/BIM/04773/2013 CBMR1334]; FCT [SFRH/BPD/100434/2014R]; ProRegem grant [PD/BD/114258/2016]	Fundacao para a Ciencia e a Tecnologia (FCT) Research Center; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ProRegem grant	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Research Center Grant UID/BIM/04773/2013 CBMR1334. B. I. Ferreira is the recipient of a FCT 2014 research grant SFRH/BPD/100434/2014R. S. Machado is the recipient of a ProRegem grant PD/BD/114258/2016.; This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) Research Center Grant UID/BIM/04773/2013 CBMR1334. B. I. Ferreira is the recipient of a FCT 2014 research grant SFRH/BPD/100434/2014R. S. Machado is the recipient of a ProRegem grant PD/BD/114258/2016. We acknowledge COST Actions CM1106 (Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells) for facilitating the collaboration between chemists and biologists. We thank D. Pasarella for coordinating the COST Action CM1106. We are indebted to N. Martinet for organizing and handling the COST Action CM1106 compound collection.	Blagosklonny MV, 2012, ONCOTARGET, V3, P1711, DOI 10.18632/oncotarget.890; Blunt CE, 2015, ANGEW CHEM INT EDIT, V54, P8740, DOI 10.1002/anie.201503323; Brisson M, 2004, MOL PHARMACOL, V66, P824, DOI 10.1124/mol.104.001784; Brisson M, 2007, MOL PHARMACOL, V71, P184, DOI 10.1124/mol.106.028589; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Pham CD, 2013, ORG LETT, V15, P2230, DOI 10.1021/ol400791n; Cortes R, 2014, METALLOMICS, V6, P622, DOI 10.1039/c3mt00194f; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Feng X, 2011, AM SOC MICROBIOLOGY, V31, P3457, DOI 1042/BJ20040167; Ferreira BI, 2015, CANCER J, V21, P441, DOI 10.1097/PPO.0000000000000161; Granda TG, 2013, INVEST NEW DRUG, V31, P66, DOI 10.1007/s10637-012-9835-5; Hill R, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0482-y; HOFFMANN I, 1994, J CELL SCI, P75; Hogan IT, TETRAHEDRON PERGAMON; HOWE RK, 1978, J ORG CHEM, V43, P3736, DOI 10.1021/jo00413a024; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; John F C Ross, 2013, ARKIVOC, V2013, P372; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Martins R., 2015, AGING CELL; Martins RK, 2015, MOLECULAR INHIBITORS, V43; Mori M, 2014, CHEMMEDCHEM, V9, P973, DOI 10.1002/cmdc.201400044; Nakae K, 1999, J BIOMOL SCREEN, V4, P67; Nakae K, 2013, J NAT PROD, V76, P510, DOI 10.1021/np300643f; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Patel MN, 2013, NAT REV DRUG DISCOV, V12, P35, DOI 10.1038/nrd3913; PATON RM, 1980, J CHEM SOC CHEM COMM, P1194, DOI 10.1039/c39800001194; Peyregne VP, 2005, MOL CANCER THER, V4, P595; Reese CB, 2003, ORG BIOMOL CHEM, V1, P3160, DOI 10.1039/b306341k; SANDERS MJ, 1980, J ORG CHEM, V45, P3753, DOI 10.1021/jo01307a007; Shi F, 2006, ORG LETT, V8, P1411, DOI 10.1021/ol060207i; STRATMANN K, 1994, J ORG CHEM, V59, P6279, DOI 10.1021/jo00100a032; Tarrado-Castellarnau M, 2015, PHARM RES; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Zanella F, 2010, CURR CANCER DRUG TAR, V10, P135, DOI 10.2174/156800910791054158; Zanella F, 2008, CHEMBIOCHEM, V9, P2229, DOI 10.1002/cbic.200800255; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zanella F, 2013, TRAFFIC, V14, P247, DOI 10.1111/tra.12034; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14	48	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167491	10.1371/journal.pone.0167491	http://dx.doi.org/10.1371/journal.pone.0167491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936162	Green Published, gold, Green Submitted			2022-12-26	WOS:000389587100109
J	Dunstan, RH; Sparkes, DL; Dascombe, BJ; Macdonald, MM; Evans, CA; Stevens, CJ; Crompton, MJ; Gottfries, J; Franks, J; Murphy, G; Wood, R; Roberts, TK				Dunstan, R. Hugh; Sparkes, Diane L.; Dascombe, Benjamin J.; Macdonald, Margaret M.; Evans, Craig A.; Stevens, Christopher J.; Crompton, Marcus J.; Gottfries, Johan; Franks, Jesse; Murphy, Grace; Wood, Ryan; Roberts, Timothy K.			Sweat Facilitated Amino Acid Losses in Male Athletes during Exercise at 32-34 degrees C	PLOS ONE			English	Article							HUMAN ECCRINE SWEAT; STRATUM-CORNEUM; PROTEIN; CHILDREN	Sweat contains amino acids and electrolytes derived from plasma and athletes can lose 1-2L of sweat per hour during exercise. Sweat may also contain contributions of amino acids as well as urea, sodium and potassium from the natural moisturizing factors (NMF) produced in the stratum corneum. In preliminary experiments, one participant was tested on three separate occasions to compare sweat composition with surface water washings from the same area of skin to assess contributions from NMF. Two participants performed a 40 minute self-paced cycle session with sweat collected from cleansed skin at regular intervals to assess the contributions to the sweat load from NMF over the period of exercise. The main study investigated sweat amino acid composition collected from nineteen male athletes following standardised endurance exercise regimes at 32-34 degrees C and 20-30% RH. Plasma was also collected from ten of the athletes to compare sweat and plasma composition of amino acids. The amino acid profiles of the skin washings were similar to the sweat, suggesting that the NMF could contribute certain amino acids into sweat. Since the sweat collected from athletes contained some amino acid contributions from the skin, this fluid was subsequently referred to as "faux" sweat. Samples taken over 40 minutes of exercise showed that these contributions diminished over time and were minimal at 35 minutes. In the main study, the faux sweat samples collected from the athletes with minimal NMF contributions, were characterised by relatively high levels of serine, histidine, ornithine, glycine and alanine compared with the corresponding levels measured in the plasma. Aspartic acid was detected in faux sweat but not in the plasma. Glutamine and proline were lower in the faux sweat than plasma in all the athletes. Three phenotypic groups of athletes were defined based on faux sweat volumes and composition profiles of amino acids with varying relative abundances of histidine, serine, glycine and ornithine. It was concluded that for some individuals, faux sweat resulting from exercise at 32-34 degrees C and 20-30% RH posed a potentially significant source of amino acid loss.	[Dunstan, R. Hugh; Sparkes, Diane L.; Macdonald, Margaret M.; Evans, Craig A.; Crompton, Marcus J.; Franks, Jesse; Murphy, Grace; Wood, Ryan; Roberts, Timothy K.] Univ Newcastle, Callaghan, NSW, Australia; [Dascombe, Benjamin J.] La Trobe Univ, Melbourne, Vic, Australia; [Stevens, Christopher J.] Southern Cross Univ, Sch Hlth & Human Sci, Coffs Harbour, NSW, Australia; [Gottfries, Johan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Newcastle; La Trobe University; Southern Cross University; University of Gothenburg	Dunstan, RH (corresponding author), Univ Newcastle, Callaghan, NSW, Australia.	hugh.dunstan@newcastle.edu.au	Roberts, Tim K/A-4286-2009; Stevens, Christopher/R-6258-2017	Stevens, Christopher/0000-0002-4641-0342; Dascombe, Ben/0000-0003-3374-3575	Harold Stannet Williams and Judith Mason Research Foundation; Gideon Lang Research Foundation	Harold Stannet Williams and Judith Mason Research Foundation; Gideon Lang Research Foundation	This work was funded by the Harold Stannet Williams and Judith Mason Research Foundation [http//www.anz.com/resources/2/f/2fce2b804a47773887c8cfac93b0266b/20140109_MasonNatMedGuidelines.pdf?MOD-AJPERES] and the Gideon Lang Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG MD, 1973, METABOLISM, V22, P561, DOI 10.1016/0026-0495(73)90069-3; BOOTH FW, 1985, FED PROC, V44, P2293; BURKE RC, 1966, YALE J BIOL MED, V38, P355; Dunstan R. H., 2014, Food and Nutrition Sciences, V5, P231, DOI 10.4236/fns.2014.52028; Dunstan RH, 2015, COMP EXERC PHYSIOL, V11, P201, DOI 10.3920/CEP150027; Embden G, 1910, BIOCHEM Z, V28, P230; Evans C, 2008, NUTR NEUROSCI, V11, P9, DOI 10.1179/147683008X301360; GITLITZ PH, 1974, CLIN CHEM, V20, P1305; HIER SW, 1946, J BIOL CHEM, V166, P327; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LACEY JM, 1990, NUTR REV, V48, P297, DOI 10.1111/j.1753-4887.1990.tb02967.x; LIAPPIS N, 1979, EUR J APPL PHYSIOL, V42, P227, DOI 10.1007/BF00423292; LIAPPIS N, 1972, AM J CLIN NUTR, V25, P661; MacIntosh BR, 2002, CAN J APPL PHYSIOL, V27, P42, DOI 10.1139/h02-003; Mark H, 2013, INT J COSMETIC SCI, V35, P163, DOI 10.1111/ics.12019; Maughan RJ, 2007, INT J SPORT NUTR EXE, V17, P583, DOI 10.1123/ijsnem.17.6.583; McSWINEY B. A., 1934, PROC ROY SOC MED, V27, P839; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Phillips SM, 2004, NUTRITION, V20, P689, DOI 10.1016/j.nut.2004.04.009; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Rawlings AV, 2004, DERMATOLOGIC THERAPY; ROBINSON S, 1954, PHYSIOL REV, V34, P202, DOI 10.1152/physrev.1954.34.2.202; SATO K, 1983, AM J PHYSIOL, V245, pR203, DOI 10.1152/ajpregu.1983.245.2.R203; SCOTT IR, 1982, BIOCHIM BIOPHYS ACTA, V719, P110, DOI 10.1016/0304-4165(82)90314-2; Stevens CJ, 2013, J SPORT SCI, V31, P1271, DOI 10.1080/02640414.2013.779740; Tipton KD, 2001, INT J SPORT NUTR EXE, V11, P109, DOI 10.1123/ijsnem.11.1.109; Weschler LB, 2008, J APPL PHYSIOL, V105, P1376, DOI 10.1152/japplphysiol.00924.2007; WHO, 2007, WHO TECH REP SER, V935, P1	29	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167844	10.1371/journal.pone.0167844	http://dx.doi.org/10.1371/journal.pone.0167844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936120	gold, Green Published, Green Submitted			2022-12-26	WOS:000389587100213
J	Grasso, R; Abe, T; Cirrone, GAP; Cuttone, G; Gulino, M; Musumeci, F; Romano, F; Ryuto, H; Scordino, A				Grasso, Rosaria; Abe, Tomoko; Cirrone, Giuseppe A. P.; Cuttone, Giacomo; Gulino, Marisa; Musumeci, Francesco; Romano, Francesco; Ryuto, Hiromichi; Scordino, Agata			Effects of Ion Irradiation on Seedlings Growth Monitored by Ultraweak Delayed Luminescence	PLOS ONE			English	Article							HADRON THERAPY; CANCER; QUALITY; MUTANTS; HARVEST; DAMAGE	The optical technique based on the measurement of delayed luminescence emitted from the biological samples has demonstrated its ability to provide valid and predictive information on the functional status of various biological systems. We want to extend this technique to study the effect of ionizing radiation on biological systems. In particular we are interested in the action of ion beams, used for therapeutic purposes or to increase the biological diversity. In general, the assessment of the damage that radiation produces both in the target objects and in the surrounding tissues, requires considerable time because is based on biochemical analysis or on the examination of the evolution of the irradiated systems. The delayed luminescence technique could help to simplify this investigation. We have so started our studies performing irradiations of some relatively simple vegetable models. In this paper we report results obtained from mung bean (Vigna radiata) seeds submitted to a C-12 ion beam at the energy of 62 MeV/nucleon. The dry seeds were irradiated at doses from 50 to 7000 Gy. The photoinduced delayed luminescence of each seed before and after ion irradiation was measured. The growth of seedlings after irradiation was compared with that of untreated seeds. A growth reduction on increasing the dose was registered. The results show strong correlations between the ion irradiation dose, seeds growth and delayed luminescence intensity. In particular, the delayed luminescence intensity is correlated by a logistic function to the seedlings elongation and, after performing a suitable measurement campaign based on blind tests, it could become a tool able to predict the growth of seeds after ion irradiation. Moreover these results demonstrate that measurements of delayed luminescence could be used as a fast and non-invasive technique to check the effects of ion beams on relatively simple biological systems.	[Grasso, Rosaria; Musumeci, Francesco; Scordino, Agata] Catania Univ, Dept Phys & Astron, Catania, Italy; [Grasso, Rosaria; Cirrone, Giuseppe A. P.; Cuttone, Giacomo; Gulino, Marisa; Musumeci, Francesco; Romano, Francesco; Scordino, Agata] Ist Nazl Fis Nucl Catania, Lab Nazl Sud, Catania, Italy; [Abe, Tomoko] RIKEN Nishina Ctr, Wako, Saitama, Japan; [Gulino, Marisa] Univ Enna Kore, Fac Ingn & Architettura, Enna, Italy; [Ryuto, Hiromichi] Kyoto Univ, Photon & Elect Sci & Engn Ctr, Kyoto, Japan	University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); RIKEN; Universita Kore di ENNA; Kyoto University	Grasso, R (corresponding author), Catania Univ, Dept Phys & Astron, Catania, Italy.; Grasso, R (corresponding author), Ist Nazl Fis Nucl Catania, Lab Nazl Sud, Catania, Italy.	grasso@lns.infn.it	Grasso, Rosaria/A-9143-2012; Grasso, Rosaria/AAH-1726-2019; Gulino, Marisa/AAC-4620-2021; Cirrone, Giuseppe/AAF-7101-2021; Romano, Francesco Paolo/F-9896-2014	Grasso, Rosaria/0000-0003-4864-9880; Cirrone, Giuseppe/0000-0001-5733-9281; Romano, Francesco Paolo/0000-0003-4932-4455; Cuttone, Giacomo/0000-0002-9534-4855				Abe T, 2002, J RADIAT RES, V43, pS157; Baran I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127006; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Blakely EA, 2004, RADIOTHER ONCOL, V73, pS134, DOI 10.1016/S0167-8140(04)80035-5; Brizhik L, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021902; Brizhik L, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031902; Choi J, 2012, RADIAT ONCOL J, V30, P1, DOI 10.3857/roj.2012.30.1.1; Costanzo E, 2008, EUR BIOPHYS J BIOPHY, V37, P235, DOI 10.1007/s00249-007-0221-8; Habermehl D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113591; Ho M.-W., 1995, NEURONETWORK WORLD, V5, P733; Honda I, 2006, EUPHYTICA, V152, P61, DOI 10.1007/s10681-006-9177-5; Hsu BD, 2007, PLANT SCI, V172, P604, DOI 10.1016/j.plantsci.2006.11.006; Lanzano L, 2009, LUMINESCENCE, V24, P409, DOI 10.1002/bio.1127; LI KH, 1983, PHYS LETT A, V93, P262; Liu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085323; Lodge M, 2007, RADIOTHER ONCOL, V83, P110, DOI 10.1016/j.radonc.2007.04.007; Morishita T, 2003, NUCL INSTRUM METH B, V206, P565, DOI 10.1016/S0168-583X(03)00826-7; Niggli HJ, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1899185; Niggli HJ, 2014, J ELECT ELECT SYST, V3, P126, DOI DOI 10.4172/2332-0796.1000126; Pelaz L, 2004, J APPL PHYS, V96, P5947, DOI 10.1063/1.1808484; Saeys W, 2008, APPL OPTICS, V47, P908, DOI 10.1364/AO.47.000908; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Scordino A, 2000, J PHOTOCH PHOTOBIO B, V56, P181, DOI 10.1016/S1011-1344(00)00078-6; Scordino A, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.117005; Scordino A, 2014, J PHOTOCH PHOTOBIO B, V139, P76, DOI 10.1016/j.jphotobiol.2014.03.027; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Subedi PP, 2007, POSTHARVEST BIOL TEC, V43, P326, DOI 10.1016/j.postharvbio.2006.09.012; Wang TJC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136307; Yu ZL, 2000, IEEE T PLASMA SCI, V28, P128, DOI 10.1109/27.842882; Zhang BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112624; Zude M, 2007, POSTHARVEST BIOL TEC, V45, P30, DOI 10.1016/j.postharvbio.2007.01.010	31	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167998	10.1371/journal.pone.0167998	http://dx.doi.org/10.1371/journal.pone.0167998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936220	Green Published, Green Submitted, gold			2022-12-26	WOS:000389587100246
J	Hong, S; Rovira, A; Davies, P; Ahlstrom, C; Muellner, P; Rendahl, A; Olsen, K; Bender, JB; Wells, S; Perez, A; Alvarez, J				Hong, Samuel; Rovira, Albert; Davies, Peter; Ahlstrom, Christina; Muellner, Petra; Rendahl, Aaron; Olsen, Karen; Bender, Jeff B.; Wells, Scott; Perez, Andres; Alvarez, Julio			Serotypes and Antimicrobial Resistance in Salmonella enterica Recovered from Clinical Samples from Cattle and Swine in Minnesota, 2006 to 2015	PLOS ONE			English	Article							FOOD ANIMALS; CAMPYLOBACTER-JEJUNI; MONITORING-SYSTEM; UNITED-STATES; NONTYPHOIDAL SALMONELLA; HUMAN HEALTH; TYPHIMURIUM; PATHOGENS; CONSEQUENCES; EPIDEMIOLOGY	Salmonellosis remains one of the leading causes of foodborne disease worldwide despite preventive efforts at various stages of the food production chain. The emergence of multi drug resistant (MDR) non-typhoidal Salmonella enterica represents an additional challenge for public health authorities. Food animals are considered a major reservoir and potential source of foodborne salmonellosis; thus, monitoring of Salmonella strains in livestock may help to detect emergence of new serotypes/MDR phenotypes and to gain a better understanding of Salmonella epidemiology. For this reason, we analyzed trends over a nine-year period in serotypes, and antimicrobial resistance, of Salmonella isolates recovered at the Minnesota Veterinary Diagnostic Laboratory (MVDL) from swine (n = 2,537) and cattle (n = 1,028) samples. Prevalence of predominant serotypes changed over time; in swine, S. Typhimurium and S. Derby decreased and S. Agona and S. 4,5,12:i:-increased throughout the study period. In cattle, S. Dublin, S. Montevideo and S. Cerro increased and S. Muenster became less frequent. Median minimum inhibitory concentration (MIC) values and proportion of antibiotic resistant isolates were higher for those recovered from swine compared with cattle, and were particularly high for certain antibiotic-serotype combinations. The proportion of resistant swine isolates was also higher than observed in the NARMS data, probably due to the different cohort of animals represented in each dataset. Results provide insight into the dynamics of antimicrobial resistant Salmonella in livestock in Minnesota, and can help to monitor emerging trends in antimicrobial resistance.	[Hong, Samuel; Davies, Peter; Bender, Jeff B.; Wells, Scott; Perez, Andres; Alvarez, Julio] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Rovira, Albert; Olsen, Karen] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Ahlstrom, Christina; Muellner, Petra] Epiinteract, Wellington, New Zealand; [Rendahl, Aaron] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Alvarez, J (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Hong, Samuel Leandro/ABC-7942-2020; Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Hong, Samuel Leandro/0000-0001-6354-4943; Alvarez, Julio/0000-0002-8999-9417; Bender, Jeffrey/0000-0003-4645-9936; Rendahl, Aaron/0000-0001-5434-3592	Global Food Venture MNDrive initiative; Alberta Innovates [201401123] Funding Source: researchfish	Global Food Venture MNDrive initiative; Alberta Innovates	This work was supported by Global Food Venture MNDrive initiative (https.//mndrive.umn.edu/food/projects) JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Aerts M, 2011, SCI REPORT SUBMITTED; Altman D.G., 1991, PRACTICAL STATISTIC; Angulo FJ, 2004, REV SCI TECH OIE, V23, P485; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; Batz M, 2014, FOODBORNE PATHOG DIS, V11, P395, DOI 10.1089/fpd.2013.1658; Bjork KE, 2015, PREV VET MED, V122, P265, DOI 10.1016/j.prevetmed.2015.10.010; CDC, 2012, NAT ANT RES MON SYST; CDC, 2013, NAT ANT RES MON SYST; CDC, 2012, SALM ANN REP; CDC, 2019, NAT ANT RES MON SYST; CDC, 2013, ANTIBIOTIC RESISTANC; CDC, OUTBR MULT RES SALM; Chen S, 2004, APPL ENVIRON MICROB, V70, P1, DOI 10.1128/AEM.70.1.1-7.2004; Cito F, 2013, OUTBREAK UNUSUAL SAL; CLSI, 2012, M100S22 CLSI, V32; Cochrane D, 1949, J AM STAT ASS, V44; Davis MA, 1999, EMERG INFECT DIS, V5, P802, DOI 10.3201/eid0506.990610; DOHOO I, 2003, VET EPIDEMIOLOGIC RE, P391; Douris A, 2008, MICROB DRUG RESIST, V14, P55, DOI 10.1089/mdr.2008.0787; FDA, 2015, NARMS NOW INT DAT HA; FDA, 2008, FED REG, V73, P1; FDA, NARMS INT RERP 2012; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Foley S L, 2008, J Anim Sci, V86, pE149; Frye JG, 2007, INT J ANTIMICROB AG, V30, P134, DOI 10.1016/j.ijantimicag.2007.03.013; Frye JG, 2008, MICROB DRUG RESIST, V14, P251, DOI 10.1089/mdr.2008.0844; Garcia L. S., 2010, CLIN MICROBIOLOGY PR; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Gilbert JM, 2007, FUTURE MICROBIOL, V2, P493, DOI 10.2217/17460913.2.5.493; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Gossner CM, 2012, EURO SURVEILL, V17; Gray JT, 2004, ANTIMICROB AGENTS CH, V48, P3179, DOI 10.1128/AAC.48.8.3179-3181.2004; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hopkins K L, 2010, Euro Surveill, V15, P19580; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Muellner P, 2011, PREV VET MED, V102, P242, DOI 10.1016/j.prevetmed.2011.07.011; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Nielsen LR, 2013, VET MICROBIOL, V162, P1, DOI 10.1016/j.vetmic.2012.08.003; Oksanen J., 2007, COMMUNITY ECOL PACKA, V10; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Rigney CP, 2004, JAVMA-J AM VET MED A, V224, P524, DOI 10.2460/javma.2004.224.524; ROSEF O, 1985, APPL ENVIRON MICROB, V49, P1507, DOI 10.1128/AEM.49.6.1507-1510.1985; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Team RC, 2014, R LANG ENV STAT COMP; Travers K, 2002, CLIN INFECT DIS, V34, pS131, DOI 10.1086/340251; USDA, 2011, NAT ANT RES MON SYST; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Velge P, 2005, VET RES, V36, P267, DOI 10.1051/vetres:2005005; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; Zhao S, 2007, VET MICROBIOL, V123, P122, DOI 10.1016/j.vetmic.2007.03.001; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	58	41	44	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0168016	10.1371/journal.pone.0168016	http://dx.doi.org/10.1371/journal.pone.0168016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936204	gold, Green Submitted, Green Published			2022-12-26	WOS:000389587100252
J	Irum, B; Khan, SY; Ali, M; Daud, M; Kabir, F; Rauf, B; Fatima, F; Iqbal, H; Khan, AO; Al Obaisi, S; Naeem, MA; Nasir, IA; Khan, SN; Husnain, T; Riazuddin, S; Akram, J; Eghrari, AO; Riazuddin, SA				Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Daud, Muhammad; Kabir, Firoz; Rauf, Bushra; Fatima, Fareeha; Iqbal, Hira; Khan, Arif O.; Al Obaisi, Saif; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh; Akram, Javed; Eghrari, Allen O.; Riazuddin, S. Amer			Deletion at the GCNT2 Locus Causes Autosomal Recessive Congenital Cataracts	PLOS ONE			English	Article							ADULT-I-PHENOTYPE; CONSANGUINEOUS PAKISTANI FAMILIES; ANTIGEN-EXPRESSION; MOLECULAR-GENETICS; NONSENSE MUTATION; ASSOCIATION; LINKAGE; CELLS; MAPS; LENS	Purpose The aim of this study is to identify the molecular basis of autosomal recessive congenital cataracts (arCC) in a large consanguineous pedigree. Methods All participating individuals underwent a detailed ophthalmic examination. Each patient's medical history, particularly of cataracts and other ocular abnormalities, was compiled from available medical records and interviews with family elders. Blood samples were donated by all participating family members and used to extract genomic DNA. Genetic analysis was performed to rule out linkage to known arCC loci and genes. Whole-exome sequencing libraries were prepared and paired-end sequenced. A large deletion was found that segregated with arCC in the family, and chromosome walking was conducted to estimate the proximal and distal boundaries of the deletion mutation. Results Exclusion and linkage analysis suggested linkage to a region of chromosome 6p24 harboring GCNT2 (glucosaminyl (N-acetyl) transferase 2) with a two-point logarithm of odds score of 5.78. PCR amplifications of the coding exons of GCNT2 failed in individuals with arCC, and whole-exome data analysis revealed a large deletion on chromosome 6p in the region harboring GCNT2. Chromosomal walking using multiple primer pairs delineated the extent of the deletion to approximately 190 kb. Interestingly, a failure to amplify a junctional fragment of the deletion break strongly suggests an insertion in addition to the large deletion. Conclusion Here, we report a novel insertion/deletion mutation at the GCNT2 locus that is responsible for congenital cataracts in a large consanguineous family.	[Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Daud, Muhammad; Kabir, Firoz; Rauf, Bushra; Eghrari, Allen O.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Irum, Bushra; Rauf, Bushra; Fatima, Fareeha; Iqbal, Hira; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan; [Khan, Arif O.; Al Obaisi, Saif] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Riazuddin, Sheikh; Akram, Javed] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore, Pakistan; [Riazuddin, Sheikh; Akram, Javed] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan; [Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan; Johns Hopkins University	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA.; Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.	riazuddin@jhmi.edu	Husnain, Tayyab/AAE-9033-2019; Iqbal, Hira/B-1283-2012; Eghrari, Allen/AAI-9282-2021; Nasir, Idrees Ahmad/T-7695-2019; Eghrari, Allen/ABH-4964-2020	Iqbal, Hira/0000-0002-1286-4880; Eghrari, Allen/0000-0003-2798-038X; Naeem, Muhammad Asif/0000-0001-8547-6419	National Eye Institute [R01EY022714]; Knights Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, grant R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Safieh L, 2009, MOL VIS, V15, P980; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Borck G, 2012, HUM GENET, V131, P209, DOI 10.1007/s00439-011-1062-1; Butt T, 2007, MOL VIS, V13, P1635; Chen GY, 2005, MOL CELL BIOL, V25, P7828, DOI 10.1128/MCB.25.17.7828-7838.2005; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1979, J BIOL CHEM, V254, P3700; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Inaba N, 2003, BLOOD, V101, P2870, DOI 10.1182/blood-2002-09-2838; Jiao XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157005; Jiaox X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137973; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Khan SY, 2016, EXP EYE RES; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lin M, 2006, TRANSFUSION, V46, P1982, DOI 10.1111/j.1537-2995.2006.01006.x; MARSH WL, 1960, NATURE, V188, P753, DOI 10.1038/188753a0; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; WATANABE K, 1979, J BIOL CHEM, V254, P3221; WIENER AS, 1956, ANN INTERN MED, V44, P221, DOI 10.7326/0003-4819-44-2-221; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Wussuki-Lior O, 2011, MOL VIS, V17, P1011; YAMAGUCH.H, 1972, P JPN ACAD, V48, P625, DOI 10.2183/pjab1945.48.625; Yasmeen A, 2010, MOL VIS, V16, P682; Yu LC, 2003, BLOOD, V101, P2081, DOI 10.1182/blood-2002-09-2693; Yu LC, 2001, BLOOD, V98, P3840, DOI 10.1182/blood.V98.13.3840; Yu LC, 2011, CURR OPIN HEMATOL, V18, P421, DOI 10.1097/MOH.0b013e32834baae9; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	50	7	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167562	10.1371/journal.pone.0167562	http://dx.doi.org/10.1371/journal.pone.0167562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936067	Green Submitted, gold, Green Published			2022-12-26	WOS:000389587100125
J	Milicevic, NM; Nohroudi, K; Schmidt, F; Schmidt, H; Ringer, C; Sorensen, GL; Milicevic, Z; Westermann, J				Milicevic, Novica M.; Nohroudi, Klaus; Schmidt, Friederike; Schmidt, Hendrik; Ringer, Cornelia; Sorensen, Grith Lykke; Milicevic, Zivana; Westermann, Juergen			Growth of Murine Splenic Tissue Is Suppressed by Lymphotoxin beta-Receptor Signaling (LT beta R) Originating from Splenic and Non-Splenic Tissues	PLOS ONE			English	Article							MICROFIBRIL-ASSOCIATED GLYCOPROTEIN; TUMOR-NECROSIS-FACTOR; T-CELL HOMEOSTASIS; LYMPH-NODE; SECRETORY LYSOSOMES; MESSENGER-RNA; PROTEIN 4; EXPRESSION; SECONDARY; MFAP4	Development and maintenance of secondary lymphoid organs such as lymph nodes and spleen essentially depend on lymphotoxin beta-receptor (LT beta R) signaling. It is unclear, however, by which molecular mechanism their size is limited. Here, we investigate whether the LT beta R pathway is also growth suppressing. By using splenic tissue transplantation it is possible to analyze a potential contribution of LT beta R signaling inside and outside of the implanted tissue. We show that LT beta R signaling within the endogenous spleen and within non-splenic tissues both significantly suppressed the regeneration of implanted splenic tissue. The suppressive activity positively correlated with the total number of LT beta R expressing cells in the animal (regenerate weights of 115 +/- 8 mg in LT beta R deficient recipients and of 12 +/- 9 mg in wild-type recipients), affected also developed splenic tissue, and was induced but not executed via LT beta R signaling. Two-dimensional differential gel electrophoresis and subsequent mass spectrometry of stromal splenic tissue was applied to screen for potential factors mediating the LT beta R dependent suppressive activity. Thus, LT beta R dependent growth suppression is involved in regulating the size of secondary lymphoid organs, and might be therapeutically used to eradicate tertiary lymphoid tissues during autoimmune diseases.	[Milicevic, Novica M.; Milicevic, Zivana] Univ Belgrade, Inst Histol & Embryol, Fac Med, Beograd, Serbia; [Nohroudi, Klaus] Univ Cologne, Dept Anat 1, Cologne, Germany; [Schmidt, Friederike; Schmidt, Hendrik; Ringer, Cornelia; Westermann, Juergen] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Anat, Lubeck, Germany; [Sorensen, Grith Lykke] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat, Odense, Denmark	University of Belgrade; University of Cologne; University of Lubeck; University of Southern Denmark	Westermann, J (corresponding author), Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Anat, Lubeck, Germany.	westermann@anat.uni-luebeck.de		Sorensen, Grith Lykke/0000-0002-5273-1097	Ministry for Education, Science and Technological Development of Republic of Serbia [175005]; Alexander von Humboldt-Foundation [DEU/1033146]; Deutsche Forschungsgemeinschaft [SFB 654]; Lundbeck Foundation [R67-2010-6409, R108-2012-10802, R164-2013-15355] Funding Source: researchfish; Novo Nordisk Fonden [NNF16OC0021136] Funding Source: researchfish	Ministry for Education, Science and Technological Development of Republic of Serbia; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	NMM: Ministry for Education, Science and Technological Development of Republic of Serbia; grant number: 175005; http://www.mpn.gov.rs and Alexander von Humboldt-Foundation; grant number: DEU/1033146; https://www.humboldt-foundation.de. JW: Deutsche Forschungsgemeinschaft; grant number: SFB 654, C4; http://www.dfg.de/.	Almeida ARM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00125; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Aoki K, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-99; Banczyk D, 2014, EUR J IMMUNOL, V44, P93, DOI 10.1002/eji.201343811; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Boehm T, 2014, ANNU REV ANIM BIOSCI, V2, P259, DOI 10.1146/annurev-animal-022513-114201; Boulianne B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00243; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Browning JL, 2002, J IMMUNOL, V168, P5079, DOI 10.4049/jimmunol.168.10.5079; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cyster JG, 2014, J IMMUNOL, V192, P2007, DOI 10.4049/jimmunol.1400059; De Trez C, 2008, J IMMUNOL, V180, P238, DOI 10.4049/jimmunol.180.1.238; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; FORCE WR, 1995, J IMMUNOL, V155, P5280; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Hrebicek T, 2007, ELECTROPHORESIS, V28, P1161, DOI 10.1002/elps.200600639; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kalies K, 2008, J IMMUNOL, V180, P5457, DOI 10.4049/jimmunol.180.8.5457; KOBAYASHI R, 1994, BIOCHEM BIOPH RES CO, V198, P1262, DOI 10.1006/bbrc.1994.1178; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koroleva EP, 2016, CYTOKINE IN PRESS; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Lausen M, 1999, J BIOL CHEM, V274, P32234, DOI 10.1074/jbc.274.45.32234; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; METCALF D, 1963, AUST J EXP BIOL MED, V41, P437, DOI 10.1038/icb.1963.64; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Milicevic NM, 2005, IMMUNOLOGY, V116, P308, DOI 10.1111/j.1365-2567.2005.02226.x; Milicevic NM, 2016, CELL TISSUE RES, V365, P135, DOI 10.1007/s00441-016-2374-1; Milicevic NM, 2011, J IMMUNOL, V186, P1486, DOI 10.4049/jimmunol.1000740; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Montaudouin C, 2013, J IMMUNOL, V190, P106, DOI 10.4049/jimmunol.1200907; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; PABST R, 1991, INT REV CYTOL, V128, P215; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2016, ARTERIOSCL THROM VAS, V36, P122, DOI 10.1161/ATVBAHA.115.306672; Schmidt H, 2008, PROTEOMICS, V8, P2911, DOI 10.1002/pmic.200800170; Schmidt H, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-41; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Summers-DeLuca LE, 2007, J EXP MED, V204, P1071, DOI 10.1084/jem.20061968; Textor J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003752; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Westermann J, 2005, J IMMUNOL, V174, P2517, DOI 10.4049/jimmunol.174.5.2517; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046; Withers DR, 2011, CURR BIOL, V21, pR381, DOI 10.1016/j.cub.2011.03.022	68	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166901	10.1371/journal.pone.0166901	http://dx.doi.org/10.1371/journal.pone.0166901			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936003	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100047
J	Wang, KW; Wang, MH; Gannon, M; Holterman, A				Wang, Kewei; Wang, Minhua; Gannon, Maureen; Holterman, AiXuan			Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6	PLOS ONE			English	Article							NUCLEAR FACTOR 6; ONECUT TRANSCRIPTION FACTORS; FACTOR-I; CELLULAR INHIBITOR; GENE-EXPRESSION; SIGNAL TRANSDUCER; RAT HEPATOCYTES; LIVER FIBROSIS; MURINE LIVER; CANCER CELLS	Background and Aims Growth hormone (GH) not only supports hepatic metabolism but also protects against hepatocyte cell death. Hnf6 (or Oc1) belonging to the Onecut family of hepatocyte transcription factors known to regulate differentiated hepatic function, is a GH-responsive gene. We evaluate if GH mediates Hnf6 activity to attenuate hepatic apoptotic injury. Methods We used an animal model of hepatic apoptosis by bile duct ligation (BDL) with Hnf6 -/-(KO) mice in which hepatic Hnf6 was conditionally inactivated. GH was administered to adult wild type WT and KO mice for the 7 days of BDL to enhance Hnf6 expression. In vitro, primary hepatocytes derived from KO and WT liver were treated with LPS and hepatocyte apoptosis was assessed with and without GH treatment. Results In WT mice, GH treatment enhanced Hnf6 expression during BDL, inhibited Caspase -3, -8 and -9 responses and diminished hepatic apoptotic and fibrotic injury. GH-mediated upregulation of Hnf6 expression and parallel suppression of apoptosis and fibrosis in WT BDL liver were abrogated in KO mice. LPS activated apoptosis and suppressed Hnf6 expression in primary hepatocytes. GH/LPS co-treatment enhanced Hnf6 expression with corresponding attenuation of apoptosis in WT-derived hepatocytes, but not in KO hepatocytes. ChiP-on-ChiP and electromobility shift assays of KO and WT liver nuclear extracts identified Ciap1 (or Birc2) as an Hnf6-bound target gene. Ciap1 expression patterns closely follow Hnf6 expression in the liver and in hepatocytes. Conclusion GH broad protective actions on hepatocytes during liver injury are effected through Hnf6, with Hnf6 transcriptional activation of Ciap1 as an underlying molecular mediator.	[Wang, Kewei; Wang, Minhua; Holterman, AiXuan] Univ Illinois, Coll Med, Dept Surg Pediat Surg, Peoria, IL 61605 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Mol Physiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Illinois System; University of Illinois Peoria; Vanderbilt University; Vanderbilt University; Vanderbilt University	Holterman, A (corresponding author), Univ Illinois, Coll Med, Dept Surg Pediat Surg, Peoria, IL 61605 USA.	aixuan.l.holterman@osfhealthcare.org		Holterman, Aixuan/0000-0003-2819-7434	NIH [R21 DK070784-02, U01DK089540, R01DK105689]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Grant support was provided by NIH R21 DK070784-02 to AH, and U01DK089540 and R01DK105689 to MG.	Akazawa Y, 2013, AM J PHYSIOL-GASTR L, V305, pG611, DOI 10.1152/ajpgi.00111.2013; Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Blaas L, 2010, HEPATOLOGY, V51, P1319, DOI 10.1002/hep.23469; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Budhidarmo R, 2015, SEMIN CELL DEV BIOL, V39, P80, DOI 10.1016/j.semcdb.2014.12.002; CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Delesque-Touchard N, 2000, J BIOL CHEM, V275, P34173, DOI 10.1074/jbc.M004027200; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Gatto M, 2008, LAB INVEST, V88, P986, DOI 10.1038/labinvest.2008.63; Glaser S, 2010, AM J PHYSIOL-GASTR L, V299, pG769, DOI 10.1152/ajpgi.00237.2010; Guicciardi ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092124; Held MA, 2005, AM J PHYSIOL-GASTR L, V288, pG986, DOI 10.1152/ajpgi.00287.2004; Holterman AXL, 2002, HEPATOLOGY, V35, P1392, DOI 10.1053/jhep.2002.33680; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jung SA, 2015, J BIOL CHEM, V290, P9974, DOI 10.1074/jbc.M114.600874; Koyama Y, 2015, CLIN RES HEPATOL GAS, V39, pS75, DOI 10.1016/j.clinre.2015.06.011; Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Lannoy VJ, 2002, DIABETOLOGIA, V45, P1136, DOI 10.1007/s00125-002-0856-z; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lucifora J, 2015, NAT REV GASTRO HEPAT, V12, P377, DOI 10.1038/nrgastro.2015.103; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Margagliotti S, 2007, DEV BIOL, V311, P579, DOI 10.1016/j.ydbio.2007.09.013; Metalli VD, 2007, DIGEST LIVER DIS, V39, P654, DOI 10.1016/j.dld.2007.03.008; Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6; Onori P, 2007, J HISTOCHEM CYTOCHEM, V55, P327, DOI 10.1369/jhc.6R7125.2006; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Saleem M, 2013, CHEM BIOL DRUG DES, V82, P243, DOI 10.1111/cbdd.12176; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Silke J, 2014, METHOD ENZYMOL, V545, P35, DOI 10.1016/B978-0-12-801430-1.00002-0; Stiedl P, 2015, HEPATOLOGY, V61, P613, DOI 10.1002/hep.27408; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; Tan YJ, 2002, HEPATOLOGY, V35, P790, DOI 10.1053/jhep.2002.32482; Vanderpool C, 2012, HEPATOLOGY, V55, P232, DOI 10.1002/hep.24631; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang KPC, 2011, J SURG RES, V167, P237, DOI 10.1016/j.jss.2009.07.051; Wang KW, 2013, CELL SIGNAL, V25, P867, DOI 10.1016/j.cellsig.2012.12.012; Wang MH, 2004, HEPATOLOGY, V40, P600, DOI 10.1002/hep.20349; Wang MH, 2008, AM J PHYSIOL-GASTR L, V295, pG357, DOI 10.1152/ajpgi.00581.2007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Zhang H, 2009, MECH DEV; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhao DJ, 2015, LIFE SCI, V137, P81, DOI 10.1016/j.lfs.2015.07.011	54	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0167085	10.1371/journal.pone.0167085	http://dx.doi.org/10.1371/journal.pone.0167085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4PU	27936029	Green Submitted, Green Published, gold			2022-12-26	WOS:000389587100060
